Citrus Sinensis ID: 003384
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 824 | 2.2.26 [Sep-21-2011] | |||||||
| Q8GUH1 | 834 | U-box domain-containing p | yes | no | 0.894 | 0.883 | 0.568 | 0.0 | |
| Q94A51 | 805 | U-box domain-containing p | no | no | 0.615 | 0.629 | 0.447 | 1e-121 | |
| Q9SW11 | 835 | U-box domain-containing p | no | no | 0.891 | 0.880 | 0.322 | 1e-102 | |
| Q0DR28 | 518 | U-box domain-containing p | no | no | 0.467 | 0.743 | 0.465 | 1e-101 | |
| Q9FKG6 | 845 | U-box domain-containing p | no | no | 0.558 | 0.544 | 0.406 | 1e-99 | |
| Q9FKG5 | 796 | U-box domain-containing p | no | no | 0.483 | 0.5 | 0.453 | 3e-98 | |
| Q9LU47 | 819 | Putative U-box domain-con | no | no | 0.498 | 0.501 | 0.430 | 1e-96 | |
| Q8S8S7 | 801 | U-box domain-containing p | no | no | 0.441 | 0.454 | 0.424 | 2e-86 | |
| Q9FGD7 | 765 | Putative U-box domain-con | no | no | 0.558 | 0.601 | 0.322 | 8e-63 | |
| O80623 | 815 | Probable receptor-like pr | no | no | 0.319 | 0.322 | 0.385 | 1e-50 |
| >sp|Q8GUH1|PUB33_ARATH U-box domain-containing protein 33 OS=Arabidopsis thaliana GN=PUB33 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 880 bits (2274), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 459/808 (56%), Positives = 571/808 (70%), Gaps = 71/808 (8%)
Query: 25 MGTKFPASSLEEEKVQAYREIERQDMHNHLDMCLLICRQMGVRAEKLDTESESTEKGILE 84
MG KFP +++EE+V+ +RE ER+ +H LD L IC+Q GVRAEK+ E ES E GI++
Sbjct: 89 MGAKFPVGAVKEEEVRVFREKEREKVHMILDDYLRICQQRGVRAEKMFIEMESIENGIVQ 148
Query: 85 LISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAPASCHIWFICNGNLIYTREGS 144
LIS GIRKLVMGAAAD+HY ++M DLKS+KAI VR++AP C IWF C G LI+TRE +
Sbjct: 149 LISELGIRKLVMGAAADRHYSRRMTDLKSRKAIFVRREAPTLCQIWFTCKGYLIHTREAT 208
Query: 145 LDGIDPEISSPS--------FQASHNTENRHPNCLRSQSVVLRHNRPMKLTNPVQDLFHR 196
+D + E +SP Q E+ H + R QS T+ VQ L
Sbjct: 209 MDDTESEYASPRPSISASDLLQTFSTPESEHQHISRVQS-----------TDSVQQL--- 254
Query: 197 VRSMNFDRNVGNVMTSQDSIGGLSSPASRSDAEVSSDECTTGRSTSQGSLSSCSSRGVID 256
V N +++ S SD +++DE S GS
Sbjct: 255 ---------VSNGSSTEQS-------GRVSDGSLNTDE---EERESDGS----------- 284
Query: 257 VAMIPLIRTEGVSTLPPSKEDLQSSPPSVLDGSVDDNLYDQLAQAMAEAENSRREAFEEA 316
G +T+ S SS P DG VDD+ ++ +A +EA +S++EAF E
Sbjct: 285 -------EVTGSATVMSSGHSSPSSFP---DG-VDDSFNVKIRKATSEAHSSKQEAFAET 333
Query: 317 LRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQ 376
LRR KAEK+A+++IRRAK SES Y+EELKRRK+ E A+A K +K + + +MEELQ
Sbjct: 334 LRRQKAEKNALDAIRRAKQSESAYSEELKRRKDTEIAVAKEKERFITIKNEQEVIMEELQ 393
Query: 377 IALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRK 436
A+ QK++LESQIA+SD T ++L QK+ AV+LLQ + E++ELQ ERD+A++EAEELR
Sbjct: 394 SAMAQKAMLESQIAKSDGTMEKLNQKLDIAVKLLQKLRDEREELQTERDRALREAEELRS 453
Query: 437 SRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLH 496
+ +S+ +PQ+F+DFSFSEIE AT++FD +LKIGEGGYGSIY GLLRH QVAIKML+
Sbjct: 454 HAE--TSTLQLPQYFTDFSFSEIEEATNHFDSTLKIGEGGYGSIYVGLLRHTQVAIKMLN 511
Query: 497 PHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPP 556
P+S QGP E+QQE+D+LSK+RHPN++TL+GACPE W+LVYEYLP GSLEDRL+CKDNSPP
Sbjct: 512 PNSSQGPVEYQQEVDVLSKMRHPNIITLIGACPEGWSLVYEYLPGGSLEDRLTCKDNSPP 571
Query: 557 LSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 616
LSWQ R+RIATE+C+ L+FLHS K HS+VHGDLKPANILLD+N VSKLSDFG L N
Sbjct: 572 LSWQNRVRIATEICAALVFLHSNKAHSLVHGDLKPANILLDSNLVSKLSDFGTCSLLHPN 631
Query: 617 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE 676
S RTD GT AY+DPE +SGELTPKSDVYSFGIILLRLLTGRPAL I+ E
Sbjct: 632 GSKS------VRTDVTGTVAYLDPEASSSGELTPKSDVYSFGIILLRLLTGRPALRISNE 685
Query: 677 VQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 736
V+YALD G L +LLDPLAGDWPFVQAEQLA LA+RCCE ++RP+LG +VWRVLEPMRA
Sbjct: 686 VKYALDNGTLNDLLDPLAGDWPFVQAEQLARLALRCCETVSENRPDLGTEVWRVLEPMRA 745
Query: 737 SCGGSTSYRLGSEERCEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSP 796
S GGS+S+ LG E PPYF CPIFQEVMQDPHVAADGFTYEAEA++ WLDS H+TSP
Sbjct: 746 SSGGSSSFHLGRNEHRIAPPYFICPIFQEVMQDPHVAADGFTYEAEAIRAWLDSEHDTSP 805
Query: 797 MTNLPLAHKNLVPNLALRSAIQEWLQQH 824
MTN+ L+H +L+ N ALRSAIQEWLQ H
Sbjct: 806 MTNVKLSHTSLIANHALRSAIQEWLQHH 833
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q94A51|PUB32_ARATH U-box domain-containing protein 32 OS=Arabidopsis thaliana GN=PUB32 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 437 bits (1125), Expect = e-121, Method: Compositional matrix adjust.
Identities = 236/527 (44%), Positives = 357/527 (67%), Gaps = 20/527 (3%)
Query: 300 QAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGKL 359
+AM + S R + EA ++ + + E++ +AKA E L +E +RK EE L KL
Sbjct: 295 KAMHDIGQSDRTVYGEAGKKWEEDASTTEALCKAKALEGLCIKESSQRKRLEELLEKEKL 354
Query: 360 ELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDE 419
E++ + +Q++ M+ELQ+ + LESQ+ + KE +K +A+ELL+++++++DE
Sbjct: 355 EVKMVIEQNNGFMKELQMVQGRNLKLESQMRKLQDLEKEHGEKFDTAMELLKSFRQKRDE 414
Query: 420 LQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGS 479
++++ + AVKE LR+ K + S + D+SF EI AT+ FDPS K+GEG YGS
Sbjct: 415 IRIDHENAVKEVNALRRLVKGETGESSGSEML-DYSFMEINEATNEFDPSWKLGEGKYGS 473
Query: 480 IYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTLVYEYL 539
+YKG L+H+QVA+KML + EF++ ++ILS++RHPNLVTL+GACPE +L+Y+Y+
Sbjct: 474 VYKGNLQHLQVAVKMLPSYGSLNHFEFERRVEILSRVRHPNLVTLMGACPESRSLIYQYI 533
Query: 540 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN 599
PNGSLED S ++N P LSW++RIRIA+E+CS L+FLHS P I+HG+LKP+ ILLD+N
Sbjct: 534 PNGSLEDCFSSENNVPALSWESRIRIASEICSALLFLHSNIP-CIIHGNLKPSKILLDSN 592
Query: 600 FVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGI 659
V+K++D+GIS+ + + + ++DP ++DP + S E+T +SD+Y+FGI
Sbjct: 593 LVTKINDYGISQLIPIDGLD--------KSDP-----HVDPHYFVSREMTLESDIYAFGI 639
Query: 660 ILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKS 719
ILL+LLT RP GI ++V+ AL+ + +LD AGDWP + ++LAN+A+RCC+ + +
Sbjct: 640 ILLQLLTRRPVSGILRDVKCALENDNISAVLDNSAGDWPVARGKKLANVAIRCCKKNPMN 699
Query: 720 RPELGKDVWRVLEPMRA---SCGGSTSYRLGSEERCEPPPYFTCPIFQEVMQDPHVAADG 776
RP+L V R ++ M+A ++SY + R PP ++ CPIFQEVM+DP +AADG
Sbjct: 700 RPDLAV-VLRFIDRMKAPEVPSSETSSYANQNVPR-RPPSHYLCPIFQEVMKDPLIAADG 757
Query: 777 FTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWLQQ 823
FTYEAEA++ WL +GH+TSPMTNL + NL+PN AL AIQ+W Q
Sbjct: 758 FTYEAEAIREWLANGHDTSPMTNLKMEDCNLIPNHALHLAIQDWQNQ 804
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 6 EC: . EC: 3 EC: . EC: 2 EC: . EC: - |
| >sp|Q9SW11|PUB35_ARATH U-box domain-containing protein 35 OS=Arabidopsis thaliana GN=PUB35 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 372 bits (954), Expect = e-102, Method: Compositional matrix adjust.
Identities = 266/826 (32%), Positives = 413/826 (50%), Gaps = 91/826 (11%)
Query: 25 MGTKFPASSLEEEKVQAYR-EIERQDMHNHLDMCLLICRQMGVRAEKLDTESESTEKGIL 83
MG P S + ++ V AYR EI Q L R+ V E L ES++ I
Sbjct: 67 MGNAIPISEVRDDVVTAYRQEILWQSEEMLKPYTKLFVRR-KVAVEVLVIESDNVAAAIA 125
Query: 84 ELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAPASCHIWFICNGNLIYTREG 143
E ++ I ++V+G ++ + +K D+ S + P C ++ + G L R
Sbjct: 126 EEVTRDSIDRIVIGGSSRSFFSRKA-DICS----VISALMPNFCTVYVVSKGKLSCVRPS 180
Query: 144 SLDGIDPEISSPSFQASHNTENRHPNCLRSQSVVLR----HNRPMKLTNPVQDLFHRVRS 199
DG + I + ++++ S V+ +RP+ L PV+ + H
Sbjct: 181 DSDG-NATIREDGSERTNSSSGSSGPTSDSSDVMSSAHDSQSRPLSL--PVRRMQH---- 233
Query: 200 MNFDRNVG--NVMTSQDSIGGLSSPASRSDAEVSSDECTTGRSTSQGSLSSCSSRGVIDV 257
F G +V S+G + DAE + D + RS+
Sbjct: 234 --FPAIAGQASVPMETSSVGSDETRCMSLDAEEARDVSSINRSS---------------- 275
Query: 258 AMIPLIRTEGVSTLPPSKEDLQSSPPSVLDGSVDDNLYDQLAQAMAEAENSRREAFEEAL 317
T+ S P + D Y++ +AM+ + +S RE
Sbjct: 276 -------TDTTSRWTPRRRD-----------------YEERKEAMSSS-SSNREYGNFGT 310
Query: 318 RRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQI 377
R + + RA S ++ L + + + N E+E+++ + V E +
Sbjct: 311 RFSWSGMGVDTTHSRASQQASNMSDALSE-QSYTDNQVNLNFEVEKLRAELRHVQEMYAV 369
Query: 378 ALDQKSLLESQIAESDQ-------TAKELEQKIISAVELL----QNYKKEQDELQMERDK 426
A + ++ E +Q +EL+ K A EL QN++K + + + R++
Sbjct: 370 AQTETFDASRKLGELNQRRLEEAIKLEELKLKEYEARELAEKEKQNFEKARRDAESMRER 429
Query: 427 AVKEAEELRKSRKEASSSSH----------MPQF-FSDFSFSEIEGATHNFDPSLKIGEG 475
A +E + R++ ++++ + PQ + F++ EI AT +F LKIG G
Sbjct: 430 AEREIAQRREAERKSARDTKEKEKLEGTLGSPQLQYQHFAWEEIMAATSSFSEELKIGMG 489
Query: 476 GYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTLV 535
YG++YK L H +K+L Q +FQQE++ILSKIRHP+LV L+GACPE LV
Sbjct: 490 AYGAVYKCNLHHTTAVVKVLQSAENQLSKQFQQELEILSKIRHPHLVLLLGACPEQGALV 549
Query: 536 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANIL 595
YEY+ NGSLEDRL +NSPPL W R RIA E+ + L+FLH KP I+H DLKPANIL
Sbjct: 550 YEYMENGSLEDRLFQVNNSPPLPWFERFRIAWEVAAALVFLHKSKPKPIIHRDLKPANIL 609
Query: 596 LDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVY 655
LD NFVSK+ D G+S + + +S+ T+ +T P GT Y+DPE+ +G ++ KSD+Y
Sbjct: 610 LDHNFVSKVGDVGLSTMVQVDPLST-KFTIYKQTSPVGTLCYIDPEYQRTGRISSKSDIY 668
Query: 656 SFGIILLRLLTGRPALGITKEVQYALDTG-KLKNLLDPLAGDWPFVQAEQLANLAMRCCE 714
SFG+ILL+LLT +PA+ +T V+ A+D+ + +LD AG+WP + +LA LA+ C E
Sbjct: 669 SFGMILLQLLTAKPAIALTHFVESAMDSNDEFLKILDQKAGNWPIEETRELAALALCCTE 728
Query: 715 MSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGSEERCEPPPYFTCPIFQEVMQDPHVAA 774
+ K RP+L + LE ++ + + G +PP +F CP+ ++VM +P VAA
Sbjct: 729 LRGKDRPDLKDQILPALENLKKVAEKARNSFSGVS--TQPPTHFICPLLKDVMNEPCVAA 786
Query: 775 DGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEW 820
DG+TY+ A++ WL H TSPMT+ PL KNL+PN L +AI EW
Sbjct: 787 DGYTYDRHAIEEWLKE-HNTSPMTDSPLHSKNLLPNYTLYTAIMEW 831
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q0DR28|PUB57_ORYSJ U-box domain-containing protein 57 OS=Oryza sativa subsp. japonica GN=PUB57 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 370 bits (950), Expect = e-101, Method: Compositional matrix adjust.
Identities = 190/408 (46%), Positives = 257/408 (62%), Gaps = 23/408 (5%)
Query: 418 DELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGY 477
D+L+ ERD AV++ ELR S+H+ DFS ++E AT +F + ++G+ Y
Sbjct: 120 DQLKHERDNAVQQVNELR------DQSTHI---ILDFSRKDMEQATEHFKNAREVGDTEY 170
Query: 478 GSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTLVYE 537
G YKG++ +M+V IK+ L FQQE+ IL + RHPN++T +G C EV LVYE
Sbjct: 171 GHTYKGMIHNMKVLIKLSSSQKL-----FQQEVSILRQWRHPNIITFIGVCSEVSALVYE 225
Query: 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD 597
+LPNG+LEDR+ C +NS PLSW R +I E+C L+FLHS K ++VHGDL+P NIL+D
Sbjct: 226 WLPNGNLEDRIICTNNSAPLSWYNRTQIIGEICCALLFLHSNKSTALVHGDLRPCNILID 285
Query: 598 ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSF 657
AN+ SK+ +FG+S Q N T YMDPEF +GELT SDVYS
Sbjct: 286 ANYRSKICNFGMSNLFLQLGTFPPNLT--------ARLPYMDPEFNTTGELTTLSDVYSL 337
Query: 658 GIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSR 717
G+I+LRLLTG P L ++++V AL + L L+D AGDWP+++A+QLA + + C M+R
Sbjct: 338 GVIILRLLTGMPPLTLSEKVAEALGSDSLHLLIDKSAGDWPYIEAKQLALIGLSCTGMTR 397
Query: 718 KSRPELGKDVWRVLEPM-RASCGGSTSYRLGSEERCEPPPYFTCPIFQEVMQDPHVAADG 776
K RP+L +VW V+EP+ R + Y + P F CPI E+M+DP VA+DG
Sbjct: 398 KKRPDLLNEVWIVIEPLTRKPPAATWPYLQSASGDSSVPAAFICPISMEIMKDPQVASDG 457
Query: 777 FTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWLQQH 824
FTYEAEA++ W D G SPMTNL L + NLVPN LRS I +LQQ
Sbjct: 458 FTYEAEAIRCWFDRGISRSPMTNLALPNLNLVPNRVLRSFIHGYLQQQ 505
|
Possesses E3 ubiquitin-protein ligase in vitro. May be involved in cell death signaling. Oryza sativa subsp. japonica (taxid: 39947) EC: 6 EC: . EC: 3 EC: . EC: 2 EC: . EC: - |
| >sp|Q9FKG6|PUB52_ARATH U-box domain-containing protein 52 OS=Arabidopsis thaliana GN=PUB52 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 365 bits (936), Expect = 1e-99, Method: Compositional matrix adjust.
Identities = 199/490 (40%), Positives = 290/490 (59%), Gaps = 30/490 (6%)
Query: 355 ANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYK 414
N E+E+++ + V E +A + ++ E +Q E +K++ E + K
Sbjct: 357 VNLNFEIEKLRAELKHVQEMYAMAQTETVGASKKLTELNQRRFEESEKLVELKEKEEVAK 416
Query: 415 KEQDELQMERDKAVKEAEELR-----------------------KSRKEASSSSHMPQFF 451
+ + ++A+KEAE+++ K + +AS S Q+
Sbjct: 417 DTASKEKQRYEEAMKEAEKVKELMMKEALHRREAEFKAERDAREKDKLQASLVSPGVQY- 475
Query: 452 SDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEID 511
+++ EI AT +F +LKIG G YGS+YK L H A+K+LH Q +F QE++
Sbjct: 476 QHYTWEEIAAATSDFAENLKIGIGAYGSVYKCNLHHTTGAVKVLHAGETQLSKQFDQELE 535
Query: 512 ILSKIRHPNLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCS 571
ILSKIRHP+LV L+GACPE LVYEY+ NGSL+DRL +++PP+ W R RIA E+ S
Sbjct: 536 ILSKIRHPHLVLLLGACPERGCLVYEYMDNGSLDDRLMLVNDTPPIPWFERFRIALEVAS 595
Query: 572 VLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDP 631
L+FLH KP I+H DLKP NILLD NFVSKL D G+S ++Q+++SS T+ +T P
Sbjct: 596 ALVFLHKSKPRPIIHRDLKPGNILLDHNFVSKLGDVGLSTMVNQDDVSSR--TIFKQTSP 653
Query: 632 KGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYAL-DTGKLKNLL 690
GT Y+DPE+ +G ++PKSDVYS G+++L+L+T +PA+ IT V+ A+ D + +L
Sbjct: 654 VGTLCYIDPEYQRTGIISPKSDVYSLGVVILQLITAKPAIAITHMVEEAIGDDAEFMAIL 713
Query: 691 DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGSEE 750
D AG WP +LA L + C EM R+ RP+L + LE +R + + L S
Sbjct: 714 DKKAGSWPISDTRELAALGLCCTEMRRRDRPDLKDQIIPALERLRKVADKAQN--LLSRT 771
Query: 751 RCEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPN 810
PP +F CP+ + VM +P VAADG+TY+ EA++ WL +TSP+TNLPL +KNL+ N
Sbjct: 772 PSGPPSHFICPLLKGVMNEPCVAADGYTYDREAIEEWLRQ-KDTSPVTNLPLPNKNLIAN 830
Query: 811 LALRSAIQEW 820
L SAI EW
Sbjct: 831 YTLYSAIMEW 840
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9FKG5|PUB51_ARATH U-box domain-containing protein 51 OS=Arabidopsis thaliana GN=PUB51 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 360 bits (923), Expect = 3e-98, Method: Compositional matrix adjust.
Identities = 188/415 (45%), Positives = 265/415 (63%), Gaps = 17/415 (4%)
Query: 423 ERDKAVKEAEELRKSRKEASSSSH----MPQFFSDFSFSEIEGATHNFDPSLKIGEGGYG 478
ER +A AEE+RK ++ + Q + F + EI AT +F LKIG GGYG
Sbjct: 382 ERLEAEARAEEVRKEKQRLEDALEGGPLQRQQYMKFEWEEIVEATSSFSDELKIGVGGYG 441
Query: 479 SIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTLVYEY 538
S+Y+ L H VA+K+LH +F QE++ILSKIRHP+L+ L+GACPE +LVYEY
Sbjct: 442 SVYRCNLHHTTVAVKVLHSDKSSLTKQFHQELEILSKIRHPHLLLLLGACPERGSLVYEY 501
Query: 539 LPNGSLEDRLSCKD------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPA 592
+ NGSLE+RL + PPL W R RIA E+ S L FLH+ +P IVH DLKPA
Sbjct: 502 MHNGSLEERLMKRRPNVDTPQPPPLRWFERFRIAWEIASALYFLHTNEPRPIVHRDLKPA 561
Query: 593 NILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKS 652
NILLD N VSK+ D G+S+ ++ + S+ +T+ T P GTF Y+DPE+ +G +TP+S
Sbjct: 562 NILLDRNNVSKIGDVGLSKMVNLD--PSHASTVFNETGPVGTFFYIDPEYQRTGVVTPES 619
Query: 653 DVYSFGIILLRLLTGRPALGITKEVQYAL--DTGKLKNLLDPLAGDWPFVQAEQLANLAM 710
D+Y+FGIILL+L+T R A+G+ ++ AL TGK +LD AGDWP +A+++ + +
Sbjct: 620 DIYAFGIILLQLVTARSAMGLAHSIEKALRDQTGKFTEILDKTAGDWPVKEAKEMVMIGL 679
Query: 711 RCCEMSRKSRPELGKDVWRVLEPMR--ASCGGSTSYRLGSEERCEPPPYFTCPIFQEVMQ 768
RC EM ++ RP+LGK++ VLE ++ AS + + P +F CPI ++VM+
Sbjct: 680 RCAEMRKRDRPDLGKEILPVLERLKEVASIARNMFADNLIDHHHNAPTHFYCPITKDVME 739
Query: 769 DPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWLQQ 823
+P VA+DG+TYE A+K WL H+ SPMT+LP +L+PN +L SAI+EW Q
Sbjct: 740 NPCVASDGYTYEKRAIKEWLQKNHK-SPMTDLPFPSDSLLPNHSLLSAIKEWRSQ 793
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LU47|PUB53_ARATH Putative U-box domain-containing protein 53 OS=Arabidopsis thaliana GN=PUB53 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 354 bits (909), Expect = 1e-96, Method: Compositional matrix adjust.
Identities = 180/418 (43%), Positives = 264/418 (63%), Gaps = 7/418 (1%)
Query: 407 VELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQF-FSDFSFSEIEGATHN 465
E + ++E+ E R+ +K E ++ K SS P+ + +F++ EI AT +
Sbjct: 400 TEKFEQKRREEREAAQRREAEMKATHEAKEKEKLEESSLVAPKLQYQEFTWEEIINATSS 459
Query: 466 FDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLV 525
F LKIG G YG +YK L H A+K+LH +F QE++ILSKIRHP+LV L+
Sbjct: 460 FSEDLKIGMGAYGDVYKCNLHHTIAAVKVLHSAESSLSKQFDQELEILSKIRHPHLVLLL 519
Query: 526 GACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 585
GACP+ LVYEY+ NGSLEDRL ++S P+ W R+RIA E+ S L+FLH KP I+
Sbjct: 520 GACPDHGALVYEYMENGSLEDRLFQVNDSQPIPWFVRLRIAWEVASALVFLHKSKPTPII 579
Query: 586 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS 645
H DLKPANILL+ NFVSK+ D G+S + + S T+ +T P GT Y+DPE+ +
Sbjct: 580 HRDLKPANILLNHNFVSKVGDVGLSTMIQAADPLSTKFTMYKQTSPVGTLCYIDPEYQRT 639
Query: 646 GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG---KLKNLLDPLAGDWPFVQA 702
G ++PKSDVY+FG+I+L+LLTG+ A+ +T V+ A++ +L +LD AG+WP +
Sbjct: 640 GRISPKSDVYAFGMIILQLLTGQQAMALTYTVETAMENNNDDELIQILDEKAGNWPIEET 699
Query: 703 EQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGSEERCEPPPYFTCPI 762
QLA LA++C E+ K RP+L + VLE ++ + + S +PP +F CP+
Sbjct: 700 RQLAALALQCTELRSKDRPDLEDQILPVLESLKKVADKARNSL--SAAPSQPPSHFFCPL 757
Query: 763 FQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEW 820
++VM++P +AADG+TY+ A++ W++ H TSP+TN PL + NL+PN L +AI EW
Sbjct: 758 LKDVMKEPCIAADGYTYDRRAIEEWME-NHRTSPVTNSPLQNVNLLPNHTLYAAIVEW 814
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8S8S7|PUB34_ARATH U-box domain-containing protein 34 OS=Arabidopsis thaliana GN=PUB34 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 320 bits (821), Expect = 2e-86, Method: Compositional matrix adjust.
Identities = 157/370 (42%), Positives = 231/370 (62%), Gaps = 6/370 (1%)
Query: 451 FSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEI 510
+ ++ EI AT F P IGEGGYG +Y+ L A+K++ + + EF +E+
Sbjct: 427 YRKYTIEEIVTATEGFSPEKVIGEGGYGKVYQCSLDSTPAAVKVVRLDTPEKKQEFLKEV 486
Query: 511 DILSKIRHPNLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELC 570
++LS++RHP++V L+GACPE LVYEYL NGSLE+ + + N PPL W R R+ E+
Sbjct: 487 EVLSQLRHPHVVLLLGACPENGCLVYEYLENGSLEEYIFHRKNKPPLPWFIRFRVIFEVA 546
Query: 571 SVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTD 630
L FLHS KP IVH DLKP NILL+ N+VSK++D G+++ ++ +++ +N T+ +
Sbjct: 547 CGLAFLHSSKPEPIVHRDLKPGNILLNRNYVSKIADVGLAKLVT--DVAPDNVTMYRNSV 604
Query: 631 PKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLL 690
GT Y+DPE+ +G + PKSD+Y+FGII+L+LLT R GI V+ A+ G L +L
Sbjct: 605 LAGTLHYIDPEYHRTGTIRPKSDLYAFGIIILQLLTARNPSGIVPAVENAVKKGTLTEML 664
Query: 691 DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGSEE 750
D DWP + E+LA + ++C E + RP+L +V VL+ + S + GS
Sbjct: 665 DKSVTDWPLAETEELARIGLKCAEFRCRDRPDLKSEVIPVLKRL-VETANSKVKKEGSNL 723
Query: 751 RCEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPN 810
R P ++ CPI +E+M++P +AADGFTYE +A+ WL+ H SP+T L H L PN
Sbjct: 724 RA--PSHYFCPILREIMEEPEIAADGFTYERKAILAWLEK-HNISPVTRQKLDHFKLTPN 780
Query: 811 LALRSAIQEW 820
LRSAI++W
Sbjct: 781 HTLRSAIRDW 790
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9FGD7|PUB50_ARATH Putative U-box domain-containing protein 50 OS=Arabidopsis thaliana GN=PUB50 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 242 bits (618), Expect = 8e-63, Method: Compositional matrix adjust.
Identities = 177/549 (32%), Positives = 272/549 (49%), Gaps = 89/549 (16%)
Query: 325 DAIESIRRAKASESLYAEELKR----------RKEFEEALANGKL-ELERMKKQHDEVME 373
+ +E +RR L +E R R E+ +L N ++ E E K+ E E
Sbjct: 243 EKLEYVRRKVNEAKLMIDEKSREVKVNAERSNRAEWAISLCNSRIGEFEAWIKEESERRE 302
Query: 374 ELQIALD-QKSLLE--SQIAESDQTA----KELEQKIISAVELLQNYKK----EQDELQM 422
+LQ LD K +E E +T EL++ + S V+ + K E + + +
Sbjct: 303 KLQATLDSDKECIEEAKNYVEKGKTKLHSLAELQEVLSSKVKTMMEAKSQAEVELERVVL 362
Query: 423 ERDKAVKEAEELRKSR----------KE-----ASSSSHMPQFFSDFSFSEIEGATHNFD 467
+R + + E E+LR R KE + S + + ++ +I AT +
Sbjct: 363 QRGEMITEIEKLRSQRDVFNRRIEFCKEREVIGSVSKEEVKCGYREYVAEDIRLATETYS 422
Query: 468 PSLKIGEGG-YGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVG 526
L++ GG + ++Y+G ++H VA+K++ SL + F ++ +L++IRHPNLV + G
Sbjct: 423 DRLRLKSGGNWTNVYRGRIKHTTVAVKVI-GDSLSDEA-FGAKVKLLNEIRHPNLVAIAG 480
Query: 527 ACPEV-WTLVYEYLPNGSLEDRLSCKDN----SPPLSWQTRIRIATELCSVLIFLHSCKP 581
C + L++EY+ NG+L D L S L W RIRIA ++CS L FLHS KP
Sbjct: 481 FCSQRPKCLLFEYMHNGNLRDNLFTSQRKSRRSKILKWHDRIRIAHQVCSGLGFLHSVKP 540
Query: 582 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 641
IVHG L P+ ILLD N V K++ FG+
Sbjct: 541 KPIVHGRLTPSKILLDRNLVPKITGFGL-------------------------------- 568
Query: 642 FLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQ 701
+ S + K DV +FG++LL LLTGR G+ K + +++ + LD AG WP
Sbjct: 569 IMHSDQSDTKPDVMAFGVLLLHLLTGRNWHGLLKAM--SMNQTSILRDLDQTAGKWPLEL 626
Query: 702 AEQLANLAMRCCEMSRKSRPELG-KDVWRVLEPMRASC------GG---STSYRLGSEER 751
A++ LA++C ++R + K++ L +R GG +T+ + +
Sbjct: 627 AKEFGALAVKCSSVNRGGNMDFSTKEIMEELGKIREKADEFKTKGGYEEATNSNMDEGDP 686
Query: 752 CEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNL 811
+ P F CPI QEVM++PHVAADGF+YE EA++ WL GH+TSPMTNL L ++ L PN
Sbjct: 687 NDIPSVFMCPILQEVMKNPHVAADGFSYELEAIQEWLSMGHDTSPMTNLRLDYQMLTPNH 746
Query: 812 ALRSAIQEW 820
LRS IQ+W
Sbjct: 747 TLRSLIQDW 755
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 6 EC: . EC: 3 EC: . EC: 2 EC: . EC: - |
| >sp|O80623|Y2393_ARATH Probable receptor-like protein kinase At2g39360 OS=Arabidopsis thaliana GN=At2g39360 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 202 bits (514), Expect = 1e-50, Method: Compositional matrix adjust.
Identities = 111/288 (38%), Positives = 176/288 (61%), Gaps = 25/288 (8%)
Query: 459 IEGATHNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIR 517
I+ AT +FD SL IG GG+G +YKG+LR +VA+K P S QG +EF+ E+++L++ R
Sbjct: 480 IKEATDDFDESLVIGVGGFGKVYKGVLRDKTEVAVKRGAPQSRQGLAEFKTEVEMLTQFR 539
Query: 518 HPNLVTLVGACPEV--WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIF 575
H +LV+L+G C E +VYEY+ G+L+D L D+ P LSW+ R+ I L +
Sbjct: 540 HRHLVSLIGYCDENSEMIIVYEYMEKGTLKDHLYDLDDKPRLSWRQRLEICVGAARGLHY 599
Query: 576 LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF---LSQNEISSNNTTLCCRTDPK 632
LH+ +I+H D+K ANILLD NF++K++DFG+S+ L Q +S T K
Sbjct: 600 LHTGSTRAIIHRDVKSANILLDDNFMAKVADFGLSKTGPDLDQTHVS---------TAVK 650
Query: 633 GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPAL--GITKE----VQYALDT--- 683
G+F Y+DPE+L +LT KSDVYSFG+++L ++ GRP + + +E +++A+
Sbjct: 651 GSFGYLDPEYLTRQQLTEKSDVYSFGVVMLEVVCGRPVIDPSLPREKVNLIEWAMKLVKK 710
Query: 684 GKLKNLLDP-LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRV 730
GKL++++DP L G + ++ + +C + RP +G +W +
Sbjct: 711 GKLEDIIDPFLVGKVKLEEVKKYCEVTEKCLSQNGIERPAMGDLLWNL 758
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 824 | ||||||
| 359489801 | 881 | PREDICTED: U-box domain-containing prote | 0.950 | 0.888 | 0.672 | 0.0 | |
| 224064033 | 809 | predicted protein [Populus trichocarpa] | 0.907 | 0.924 | 0.688 | 0.0 | |
| 147772798 | 881 | hypothetical protein VITISV_015820 [Viti | 0.951 | 0.889 | 0.668 | 0.0 | |
| 356568394 | 883 | PREDICTED: U-box domain-containing prote | 0.962 | 0.898 | 0.661 | 0.0 | |
| 357507363 | 896 | U-box domain-containing protein [Medicag | 0.962 | 0.885 | 0.658 | 0.0 | |
| 87240964 | 884 | Protein kinase; U box [Medicago truncatu | 0.962 | 0.897 | 0.658 | 0.0 | |
| 224127680 | 810 | predicted protein [Populus trichocarpa] | 0.893 | 0.908 | 0.657 | 0.0 | |
| 356531997 | 883 | PREDICTED: U-box domain-containing prote | 0.962 | 0.898 | 0.652 | 0.0 | |
| 356522608 | 879 | PREDICTED: U-box domain-containing prote | 0.946 | 0.887 | 0.627 | 0.0 | |
| 356506214 | 877 | PREDICTED: U-box domain-containing prote | 0.950 | 0.892 | 0.620 | 0.0 |
| >gi|359489801|ref|XP_002274993.2| PREDICTED: U-box domain-containing protein 33-like [Vitis vinifera] gi|297745303|emb|CBI40383.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1082 bits (2799), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 543/807 (67%), Positives = 646/807 (80%), Gaps = 24/807 (2%)
Query: 25 MGTKFPASSLEEEKVQAYREIERQDMHNHLDMCLLICRQMGVRAEKLDTESESTEKGILE 84
MG KFPAS L+E++V+AYR++ERQDMH L+ LLICR+ GVRAEKL ESE+ EKGILE
Sbjct: 90 MGGKFPASKLKEQEVKAYRDLERQDMHKILNDYLLICRKAGVRAEKLYIESENVEKGILE 149
Query: 85 LISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAPASCHIWFICNGNLIYTREGS 144
LIS +GI+KLV+GAAADKHY ++M++ KSKKA VR +AP CHIWF+C G+LIYTREGS
Sbjct: 150 LISEHGIKKLVVGAAADKHYSRRMLEPKSKKAAYVRDKAPLFCHIWFVCRGHLIYTREGS 209
Query: 145 LDGIDPEISSP-SFQASHNTENRHPNCLRSQSVVLRHNRPMKLTNPVQDLFHRVRSMNFD 203
L+G D E+ +P S QAS N E N RS SV L N P KL NP QDL R+M+
Sbjct: 210 LNGADIELRTPPSQQASPNNETGQSNTFRSMSVSLGQNHPSKLVNPGQDL---PRTMSVP 266
Query: 204 RNVGNVMTSQDSIGGLSSPASRSDAEVSSD--ECTTGRSTSQGS-LSSCSSRGVIDVAMI 260
+ V++S D GG+S+P SR E SSD + + RS SQ S S+CSS M
Sbjct: 267 VRI-TVLSSPDGTGGVSAPWSRMGREGSSDYWDGISKRSPSQASGFSTCSSGD-----MA 320
Query: 261 PLIRTEGVSTL--PPSKEDLQ-SSPPSVLDGSVDDNLYDQLAQAMAEAENSRREAFEEAL 317
+ +G+ + P +K+ L SSPPSVL+ +N+YDQL QAM EAENSRREAF+E+L
Sbjct: 321 GEVNEDGLESRASPVAKQALHHSSPPSVLE----ENIYDQLEQAMVEAENSRREAFQESL 376
Query: 318 RRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQI 377
RR KAEKDAIE+IRRAK +E ++EELK R++ EEAL ELE ++ + E+MEEL+I
Sbjct: 377 RRSKAEKDAIEAIRRAKEAERSFSEELKLRRDIEEALQAQGKELESLRNKQQEIMEELKI 436
Query: 378 ALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKS 437
+L+ KSLLE+QIA+S+Q KELE+KII+AVELLQNYKKE+DELQ+ERD A+K AEEL+K
Sbjct: 437 SLNHKSLLENQIADSEQVVKELEEKIIAAVELLQNYKKERDELQIERDNAIKTAEELKK- 495
Query: 438 RKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHP 497
+ +S+SH PQ+F++FSF+EIE AT NFDPS+KIGEGGYGSIYKG LRH QVAIKMLH
Sbjct: 496 --KGASTSHTPQYFAEFSFAEIEKATQNFDPSVKIGEGGYGSIYKGCLRHTQVAIKMLHS 553
Query: 498 HSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPL 557
S QGP+EFQQE+DILSK+RHPNLVTL+GACPE W L+YEYLPNGSLEDRL+C+DN+PPL
Sbjct: 554 DSFQGPTEFQQEVDILSKLRHPNLVTLIGACPEAWALIYEYLPNGSLEDRLNCRDNTPPL 613
Query: 558 SWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 617
SWQ RIRIA ELCSVLIFLHS P SIVHGDLKP+NILLDANF SKLSDFGI R +S +
Sbjct: 614 SWQARIRIAAELCSVLIFLHSNNPDSIVHGDLKPSNILLDANFGSKLSDFGICRVISHDG 673
Query: 618 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEV 677
SSN+ T+CCRT PKGTFAYMDPEFL+SGELT KSDVYSFGIILLRLLTG+PA+GITKEV
Sbjct: 674 NSSNSATMCCRTGPKGTFAYMDPEFLSSGELTVKSDVYSFGIILLRLLTGKPAIGITKEV 733
Query: 678 QYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 737
Q+ALD G L LLDPLAGDWPFVQA+QLA +A+RCCEM+RKSRP+L +VWRVLEPM+ S
Sbjct: 734 QHALDQGNLNTLLDPLAGDWPFVQAKQLALMALRCCEMNRKSRPDLVSEVWRVLEPMKVS 793
Query: 738 CGG-STSYRLGSEERCEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSP 796
CG S+S+R+GSEER + PPYF CPIFQE+MQDP VAADGFTYEAEAL+GWLD GH TSP
Sbjct: 794 CGASSSSFRVGSEERGQIPPYFICPIFQEIMQDPCVAADGFTYEAEALRGWLDGGHSTSP 853
Query: 797 MTNLPLAHKNLVPNLALRSAIQEWLQQ 823
MTNL L H NLVPN ALRSAIQEWLQQ
Sbjct: 854 MTNLKLGHLNLVPNRALRSAIQEWLQQ 880
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224064033|ref|XP_002301358.1| predicted protein [Populus trichocarpa] gi|222843084|gb|EEE80631.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1075 bits (2781), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 551/800 (68%), Positives = 627/800 (78%), Gaps = 52/800 (6%)
Query: 25 MGTKFPASSLEEEKVQAYREIERQDMHNHLDMCLLICRQMGVRAEKLDTESESTEKGILE 84
MGTKF AS+L+E++V+AYRE+ERQ MH LD L ICR+MGVRAEKL E ES EKGILE
Sbjct: 62 MGTKFRASALKEQEVRAYREVERQAMHKMLDEYLSICRKMGVRAEKLYVEMESIEKGILE 121
Query: 85 LISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAPASCHIWFICNGNLIYTREGS 144
LISH+GI+KLVMGAAADK + K MMD+KSKKAISV QAPASCHIWFIC G+LI+TREG+
Sbjct: 122 LISHHGIKKLVMGAAADKRHSKNMMDIKSKKAISVCLQAPASCHIWFICKGHLIHTREGA 181
Query: 145 LDGIDPEISSPSFQASHNTENRHPNCLRSQSVVLRHNRPMKLTNPVQDLFHRVRSMNFDR 204
LDG ++ S S Q S +TE + +RSQS+ L N +KLTNP QDL RVRSMN +
Sbjct: 182 LDGTGTDVGSSSQQTSPHTEAGQLSHMRSQSIALGQNHFVKLTNPAQDLVRRVRSMNVNG 241
Query: 205 NVGNVMTSQDSIGGLSSPASRSDAEVSSDECTTGRSTSQGSLSSCSSRGVIDVAMIPLIR 264
G LS+PAS
Sbjct: 242 RGGR----------LSTPAS---------------------------------------- 251
Query: 265 TEGVSTLPPSKEDLQSSPPSVLDGSVDDNLYDQLAQAMAEAENSRREAFEEALRRGKAEK 324
+G + P S+ D S DGS +D LYDQL +AM++AENSRREAFEEA+RR KAEK
Sbjct: 252 PDGGPSTPSSRSDADGSSDEYDDGSTEDPLYDQLEKAMSDAENSRREAFEEAVRRAKAEK 311
Query: 325 DAIESIRRAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSL 384
A E+ R+AKASE+LY EE KRRKE EE LA K ELER+ ++ DEVMEEL+IA DQKSL
Sbjct: 312 YAFEATRKAKASENLYTEESKRRKEVEEELAKEKEELERINRECDEVMEELRIAEDQKSL 371
Query: 385 LESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSS 444
LE QI ESDQ KELEQKIISAV LLQNYKKEQDELQ ERD A+KE EELR+S+ EAS +
Sbjct: 372 LEKQIKESDQMVKELEQKIISAVGLLQNYKKEQDELQKERDNALKEVEELRRSQTEASGT 431
Query: 445 SHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPS 504
HM QFFS+FS SEIE AT +FDPSLKIGEGGYGSIYKG+LR QVA+KMLH +SLQGP+
Sbjct: 432 -HMSQFFSEFSLSEIEEATQHFDPSLKIGEGGYGSIYKGVLRQTQVAVKMLHSNSLQGPA 490
Query: 505 EFQQEIDILSKIRHPNLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIR 564
EFQQE+D+LSK+RHPNL+TL+GACPE WTL+YEYLPNGSLEDRLSC+DNSPPLSWQTRIR
Sbjct: 491 EFQQEVDVLSKMRHPNLITLIGACPEAWTLIYEYLPNGSLEDRLSCRDNSPPLSWQTRIR 550
Query: 565 IATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 624
IA ELCSVLIFLHS K HSIVHGDLKPANILLD NFV+KLSDFGI R L E SSNNT
Sbjct: 551 IAAELCSVLIFLHSSKQHSIVHGDLKPANILLDENFVTKLSDFGICRLLHHKEGSSNNTA 610
Query: 625 LCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG 684
+C RTDPKGTF+YMDPEFL++GELTPKSDVYSFGIILLRLLT R LGITKEVQ LD G
Sbjct: 611 IC-RTDPKGTFSYMDPEFLSTGELTPKSDVYSFGIILLRLLTARQPLGITKEVQCELDKG 669
Query: 685 KLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGSTSY 744
LK LLDPLAGDWPFVQAEQLA+LA+RCCEMSRK+RP+L +VWRVLEPM+ASCGGS+ +
Sbjct: 670 NLKTLLDPLAGDWPFVQAEQLAHLALRCCEMSRKNRPDLLSEVWRVLEPMKASCGGSSFF 729
Query: 745 RLGSEERCEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAH 804
+LGSEE +PP YF CPIFQEVM+DPHVAADG+TYEAEALKGWLDSGH+TSPMTNL LAH
Sbjct: 730 QLGSEEHFQPPSYFICPIFQEVMRDPHVAADGYTYEAEALKGWLDSGHDTSPMTNLKLAH 789
Query: 805 KNLVPNLALRSAIQEWLQQH 824
++L+PN ALRSAIQEWLQQ
Sbjct: 790 RDLIPNRALRSAIQEWLQQQ 809
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147772798|emb|CAN67166.1| hypothetical protein VITISV_015820 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1062 bits (2747), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 539/806 (66%), Positives = 640/806 (79%), Gaps = 22/806 (2%)
Query: 25 MGTKFPASSLEEEKVQAYREIERQDMHNHLDMCLLICRQMGVRAEKLDTESESTEKGILE 84
MG KFPAS L+E++V+AYR++ERQDMH L+ +LICR+ GVRAEKL ESE+ EKGILE
Sbjct: 90 MGGKFPASKLKEQEVKAYRDLERQDMHKILNDYILICRKAGVRAEKLYIESENVEKGILE 149
Query: 85 LISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAPASCHIWFICNGNLIYTREGS 144
LIS +GI+KLV+GAAADKHY ++M++ KSKKA VR +AP CHIWF+C G+LIYTREGS
Sbjct: 150 LISEHGIKKLVVGAAADKHYSRRMLEPKSKKAAYVRDKAPLFCHIWFVCRGHLIYTREGS 209
Query: 145 LDGIDPEISSP-SFQASHNTENRHPNCLRSQSVVLRHNRPMKLTNPVQDLFHRVRSMNFD 203
BG D E+ +P S QAS N E N RS SV L N KL NP QDL R+M+
Sbjct: 210 XBGADIELRTPPSQQASPNNETGQSNTFRSMSVSLGQNHXSKLVNPGQDL---PRTMSVP 266
Query: 204 RNVGNVMTSQDSIGGLSSPASRSDAEVSSD--ECTTGRSTSQGSLSSCSSRGVIDVAMIP 261
+ V++S D GG+S+P SR E SSD + + RS SQ S S S G M
Sbjct: 267 VRI-TVLSSPDGTGGVSAPWSRMGREGSSDYWDGISKRSPSQXSGFSXCSSG----DMAG 321
Query: 262 LIRTEGVSTL--PPSKEDLQ-SSPPSVLDGSVDDNLYDQLAQAMAEAENSRREAFEEALR 318
+ +G+ + P +K+ L SSPPSVL+ +N+YDQL QAM EAENSRREAF+E+LR
Sbjct: 322 EVNEDGLESRASPXAKQALHHSSPPSVLE----ENIYDQLEQAMVEAENSRREAFQESLR 377
Query: 319 RGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIA 378
R KAEK AIE+IRRAK +E ++EELK R++ EEAL ELE ++ + E+MEEL+I+
Sbjct: 378 RSKAEKXAIEAIRRAKEAERSFSEELKLRRDIEEALQAQGKELESLRNKQQEIMEELKIS 437
Query: 379 LDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSR 438
L+ KSLLE+QIA+S+Q KELE+KIISAVELLQNYKKE+DELQ+ERD A+K AEEL+K
Sbjct: 438 LNHKSLLENQIADSEQVVKELEEKIISAVELLQNYKKERDELQIERDNAIKTAEELKK-- 495
Query: 439 KEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPH 498
+ +S+SH PQ+F++FSF+EIE AT NFDPS+KIGEGGYGSIYKG LRH QVAIKMLH
Sbjct: 496 -KGASTSHTPQYFAEFSFAEIEKATQNFDPSVKIGEGGYGSIYKGCLRHTQVAIKMLHSD 554
Query: 499 SLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLS 558
S QGPSEFQQE+DILSK+RHPNLVTL+GACPE W L+YEYLPNGSLEDRL+C+DN+PPLS
Sbjct: 555 SFQGPSEFQQEVDILSKLRHPNLVTLIGACPEAWALIYEYLPNGSLEDRLNCRDNTPPLS 614
Query: 559 WQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 618
WQ RIRIA ELCSVLIFLHS P SIVHGDLKP+NILLDANF SKLSDFGI R +S +
Sbjct: 615 WQARIRIAAELCSVLIFLHSNNPDSIVHGDLKPSNILLDANFGSKLSDFGICRVISHDGN 674
Query: 619 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 678
SSN+ T+CCRT PKGTFAYMDPEFL+SGELT KSDVYSFGIILLRLLTG+PA+GITKEVQ
Sbjct: 675 SSNSATMCCRTGPKGTFAYMDPEFLSSGELTVKSDVYSFGIILLRLLTGKPAIGITKEVQ 734
Query: 679 YALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC 738
+ALD G L LLDPLAGDWPFVQA+QLA +A+RC EM+RKSRP+L +VWRVLEPM+ SC
Sbjct: 735 HALDQGNLNTLLDPLAGDWPFVQAKQLALMALRCXEMNRKSRPDLVSEVWRVLEPMKVSC 794
Query: 739 GG-STSYRLGSEERCEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPM 797
G S+S+R+GSEER + PPYF CPIFQE+MQDP VAADGFTYEAEAL+GWLD GH TSPM
Sbjct: 795 GASSSSFRVGSEERGQIPPYFICPIFQEIMQDPCVAADGFTYEAEALRGWLDGGHSTSPM 854
Query: 798 TNLPLAHKNLVPNLALRSAIQEWLQQ 823
TNL L H NLVPN ALRSAIQEWLQQ
Sbjct: 855 TNLKLGHLNLVPNRALRSAIQEWLQQ 880
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356568394|ref|XP_003552396.1| PREDICTED: U-box domain-containing protein 33-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1035 bits (2676), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 535/809 (66%), Positives = 629/809 (77%), Gaps = 16/809 (1%)
Query: 25 MGTKFPASSLEEEKVQAYREIERQDMHNHLDMCLLICRQMGVRAEKLDTESESTEKGILE 84
+G KFPAS+L+EE+VQAY E ERQ MH LD L IC++MGVRAEKL E +S EKGILE
Sbjct: 82 LGGKFPASALKEEQVQAYWEEERQGMHRILDDYLRICQRMGVRAEKLHIEMDSIEKGILE 141
Query: 85 LISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAPASCHIWFICNGNLIYTREGS 144
LIS +GI+KLVMGAA+DK+Y ++MMDLKSKKAISV +QAPASCHI F+C G LI+TR+ S
Sbjct: 142 LISQHGIQKLVMGAASDKYYNRRMMDLKSKKAISVCKQAPASCHIQFVCKGRLIHTRDRS 201
Query: 145 LDGIDPEISSPSFQASHNTENRHPNCLRSQSVVLRHNRPMKLTNPVQDLFHRVRSMNFDR 204
+ + +++SP Q N+ LRSQSV L +R LTNP +LF RVRS N D
Sbjct: 202 SNEGNADVTSPLVQQVPNS----VRSLRSQSVTLGQDRRANLTNPALELFRRVRSAN-DG 256
Query: 205 NVGNVMT--SQDSIGGLSSPASRSDAEVSSDECTTGRSTSQGSLSSCSSRGVIDVAMIPL 262
+ + MT S + G S+P R EVSSDE S LS+CS V ++A P
Sbjct: 257 HGASFMTVSSPEDTEGFSTPHDRMGTEVSSDESDRLSRMSPSGLSTCSDSAV-ELAFTPS 315
Query: 263 I---RTEGVSTLPPSK---EDLQ-SSPPSVLDGSVDDNLYDQLAQAMAEAENSRREAFEE 315
+ +E L S+ EDL SSPPS LDG +DD +Y+QL QA AEAEN+ A++E
Sbjct: 316 LINESSENALELTLSRRIIEDLHYSSPPSTLDGGMDDTIYEQLEQARAEAENATLNAYQE 375
Query: 316 ALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEEL 375
+RR KAEKDA E+IR+ KASESLY EEL RK EE L K ELE MK D+V EEL
Sbjct: 376 TVRRRKAEKDAFEAIRKVKASESLYTEELNLRKMTEEKLRKEKEELESMKSLRDKVKEEL 435
Query: 376 QIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELR 435
+ALDQK LESQIA S+ KELEQKI+SAV+LLQ+YK E+DELQM+RD A++EAEELR
Sbjct: 436 CLALDQKESLESQIASSELMVKELEQKILSAVDLLQSYKNERDELQMQRDNALREAEELR 495
Query: 436 KSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKML 495
K + EAS + ++PQ FS+FSFSEI+ AT NF+PS KIGEGGYGSI+KG+LRH +VAIKML
Sbjct: 496 KKQGEASGT-NVPQLFSEFSFSEIKEATSNFNPSSKIGEGGYGSIFKGVLRHTEVAIKML 554
Query: 496 HPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSP 555
+ S+QGP EFQQE+D+LSK+RHPNL+TL+GACP+ W LVYEYLPNGSLEDRL+CK+N+P
Sbjct: 555 NSDSMQGPLEFQQEVDVLSKLRHPNLITLIGACPDSWALVYEYLPNGSLEDRLACKNNTP 614
Query: 556 PLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 615
PLSWQ RIRIA ELCS LIFLHS KPHS+VHGDLKP+NILLDAN +SKLSDFGI R LS
Sbjct: 615 PLSWQARIRIAAELCSALIFLHSSKPHSVVHGDLKPSNILLDANLISKLSDFGICRILSN 674
Query: 616 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITK 675
E SS+NTT RTDPKGTF YMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITK
Sbjct: 675 CESSSSNTTEFWRTDPKGTFVYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITK 734
Query: 676 EVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 735
EV+YALDTGKLK+LLDPLAGDWPFVQAEQLA LA+RCC+M+RKSRP+L DVWRVL+ MR
Sbjct: 735 EVKYALDTGKLKSLLDPLAGDWPFVQAEQLARLALRCCDMNRKSRPDLYSDVWRVLDAMR 794
Query: 736 ASCGGSTSYRLGSEERCEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETS 795
S GG+ S+ L SE +PP YF CPIFQEVM+DPHVAADGFTYEAEA++GWLD GH+ S
Sbjct: 795 VSSGGANSFGLSSEGLLQPPSYFICPIFQEVMRDPHVAADGFTYEAEAIRGWLDGGHDNS 854
Query: 796 PMTNLPLAHKNLVPNLALRSAIQEWLQQH 824
PMTN LAH NLVPN ALRSAIQ+WLQ H
Sbjct: 855 PMTNSKLAHHNLVPNRALRSAIQDWLQNH 883
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357507363|ref|XP_003623970.1| U-box domain-containing protein [Medicago truncatula] gi|355498985|gb|AES80188.1| U-box domain-containing protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1030 bits (2664), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 533/810 (65%), Positives = 636/810 (78%), Gaps = 17/810 (2%)
Query: 25 MGTKFPASSLEEEKVQAYREIERQDMHNHLDMCLLICRQMGVRAEKLDTESESTEKGILE 84
MG KFPASSL++++V+AYRE+ERQ++H LD L IC++MGVRAEKL E E+ EKGI+E
Sbjct: 94 MGAKFPASSLKDQEVRAYREMERQNVHKTLDEYLRICQRMGVRAEKLHIEMENIEKGIIE 153
Query: 85 LISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAPASCHIWFICNGNLIYTREGS 144
LIS +GIRKL+MGAA+DK+Y ++MMDL+S+KAI V +QAP+SCHI FIC G+LI+TR+ S
Sbjct: 154 LISQHGIRKLIMGAASDKNYSRRMMDLRSRKAIYVCEQAPSSCHIQFICKGHLIHTRDRS 213
Query: 145 LDGIDPEISSPSFQASHNTENRHPNCLRSQSVVLRHNRPMKLTNPVQDLFHRVRSMNFDR 204
LD + E++SP Q N+ P+ RSQS+ L N + Q+LF RVRS N D
Sbjct: 214 LDERNVEVASPLLQQGPNSV--RPS--RSQSITLGQNHRTNSISSSQELFRRVRSAN-DG 268
Query: 205 NVGNVMTSQDSIG--GLSSPASRSDAEVSSDECTTGRSTSQGSLSSCSSRGVIDVAMIPL 262
++ T+ + G S+P +R EVSSDE TS LS+ S ID + P
Sbjct: 269 MTASITTNSSPVDNEGFSTPRNRRGTEVSSDESDRLSRTSPSGLSTFSD-STIDPTLTPY 327
Query: 263 I---RTEGVSTLPPS----KEDLQS-SPPSVLDGSVDDNLYDQLAQAMAEAENSRREAFE 314
E S L S EDL+ SPPSVLDG V+D LYDQL QAM+EA N+ R A++
Sbjct: 328 SVAESCENASDLTLSHLIKDEDLRHLSPPSVLDGGVNDTLYDQLEQAMSEANNATRHAYQ 387
Query: 315 EALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEE 374
E RRGKAEKDAIE+IRRAKASESLY +EL RK EE L K ELE + Q D+V EE
Sbjct: 388 ETFRRGKAEKDAIEAIRRAKASESLYTDELNLRKMAEEELRKEKEELESVTSQRDKVNEE 447
Query: 375 LQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEEL 434
L++A+D KS LESQ+A S+ +ELEQKIISAVELLQ+YK E+DELQ++RD A++EAE+L
Sbjct: 448 LRLAVDLKSSLESQLASSEVMIQELEQKIISAVELLQSYKNERDELQIQRDNALREAEDL 507
Query: 435 RKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKM 494
RK + E SS+ H+PQ FS+FSFSEIE AT NF+PSLKIGEGGYG+IYKGLLRH +VAIK+
Sbjct: 508 RKKQGEGSST-HVPQLFSEFSFSEIEEATSNFNPSLKIGEGGYGNIYKGLLRHTEVAIKI 566
Query: 495 LHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNS 554
LH +S+QGP EFQQE+D+LSK+RHPNL+TL+GACPE W+LVYEYLPNGSLEDRL+CKDN+
Sbjct: 567 LHANSMQGPLEFQQEVDVLSKLRHPNLITLIGACPESWSLVYEYLPNGSLEDRLACKDNT 626
Query: 555 PPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 614
PLSWQTRIRIA ELCS LIFLHS KPHSIVHGDLKP+NI+LD N VSKLSDFGI R LS
Sbjct: 627 HPLSWQTRIRIAAELCSALIFLHSSKPHSIVHGDLKPSNIILDGNLVSKLSDFGICRVLS 686
Query: 615 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGIT 674
E SSNN T +TDPKGTF YMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGIT
Sbjct: 687 NYENSSNNNTQFWKTDPKGTFVYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGIT 746
Query: 675 KEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 734
KEV+YA+DTGKL +LLDPLAGDWPFVQAEQLA LA+RCCEM+RKSRP+L DVWR+L+ M
Sbjct: 747 KEVKYAVDTGKLTSLLDPLAGDWPFVQAEQLARLALRCCEMNRKSRPDLHSDVWRILDAM 806
Query: 735 RASCGGSTSYRLGSEERCEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHET 794
RAS GG+ S+ L SE +PP YF CPIFQEVM+DPHVAADGFTYEAEA++GWLDSGH+
Sbjct: 807 RASSGGTNSFGLSSEGPHQPPSYFICPIFQEVMRDPHVAADGFTYEAEAIRGWLDSGHDA 866
Query: 795 SPMTNLPLAHKNLVPNLALRSAIQEWLQQH 824
SPMTN L+H+NLVPN ALRSAIQ+WLQ H
Sbjct: 867 SPMTNSTLSHQNLVPNRALRSAIQDWLQSH 896
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|87240964|gb|ABD32822.1| Protein kinase; U box [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1030 bits (2663), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 533/810 (65%), Positives = 636/810 (78%), Gaps = 17/810 (2%)
Query: 25 MGTKFPASSLEEEKVQAYREIERQDMHNHLDMCLLICRQMGVRAEKLDTESESTEKGILE 84
MG KFPASSL++++V+AYRE+ERQ++H LD L IC++MGVRAEKL E E+ EKGI+E
Sbjct: 82 MGAKFPASSLKDQEVRAYREMERQNVHKTLDEYLRICQRMGVRAEKLHIEMENIEKGIIE 141
Query: 85 LISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAPASCHIWFICNGNLIYTREGS 144
LIS +GIRKL+MGAA+DK+Y ++MMDL+S+KAI V +QAP+SCHI FIC G+LI+TR+ S
Sbjct: 142 LISQHGIRKLIMGAASDKNYSRRMMDLRSRKAIYVCEQAPSSCHIQFICKGHLIHTRDRS 201
Query: 145 LDGIDPEISSPSFQASHNTENRHPNCLRSQSVVLRHNRPMKLTNPVQDLFHRVRSMNFDR 204
LD + E++SP Q N+ P+ RSQS+ L N + Q+LF RVRS N D
Sbjct: 202 LDERNVEVASPLLQQGPNSV--RPS--RSQSITLGQNHRTNSISSSQELFRRVRSAN-DG 256
Query: 205 NVGNVMTSQDSIG--GLSSPASRSDAEVSSDECTTGRSTSQGSLSSCSSRGVIDVAMIPL 262
++ T+ + G S+P +R EVSSDE TS LS+ S ID + P
Sbjct: 257 MTASITTNSSPVDNEGFSTPRNRRGTEVSSDESDRLSRTSPSGLSTFSD-STIDPTLTPY 315
Query: 263 I---RTEGVSTLPPS----KEDLQS-SPPSVLDGSVDDNLYDQLAQAMAEAENSRREAFE 314
E S L S EDL+ SPPSVLDG V+D LYDQL QAM+EA N+ R A++
Sbjct: 316 SVAESCENASDLTLSHLIKDEDLRHLSPPSVLDGGVNDTLYDQLEQAMSEANNATRHAYQ 375
Query: 315 EALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEE 374
E RRGKAEKDAIE+IRRAKASESLY +EL RK EE L K ELE + Q D+V EE
Sbjct: 376 ETFRRGKAEKDAIEAIRRAKASESLYTDELNLRKMAEEELRKEKEELESVTSQRDKVNEE 435
Query: 375 LQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEEL 434
L++A+D KS LESQ+A S+ +ELEQKIISAVELLQ+YK E+DELQ++RD A++EAE+L
Sbjct: 436 LRLAVDLKSSLESQLASSEVMIQELEQKIISAVELLQSYKNERDELQIQRDNALREAEDL 495
Query: 435 RKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKM 494
RK + E SS+ H+PQ FS+FSFSEIE AT NF+PSLKIGEGGYG+IYKGLLRH +VAIK+
Sbjct: 496 RKKQGEGSST-HVPQLFSEFSFSEIEEATSNFNPSLKIGEGGYGNIYKGLLRHTEVAIKI 554
Query: 495 LHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNS 554
LH +S+QGP EFQQE+D+LSK+RHPNL+TL+GACPE W+LVYEYLPNGSLEDRL+CKDN+
Sbjct: 555 LHANSMQGPLEFQQEVDVLSKLRHPNLITLIGACPESWSLVYEYLPNGSLEDRLACKDNT 614
Query: 555 PPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 614
PLSWQTRIRIA ELCS LIFLHS KPHSIVHGDLKP+NI+LD N VSKLSDFGI R LS
Sbjct: 615 HPLSWQTRIRIAAELCSALIFLHSSKPHSIVHGDLKPSNIILDGNLVSKLSDFGICRVLS 674
Query: 615 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGIT 674
E SSNN T +TDPKGTF YMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGIT
Sbjct: 675 NYENSSNNNTQFWKTDPKGTFVYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGIT 734
Query: 675 KEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 734
KEV+YA+DTGKL +LLDPLAGDWPFVQAEQLA LA+RCCEM+RKSRP+L DVWR+L+ M
Sbjct: 735 KEVKYAVDTGKLTSLLDPLAGDWPFVQAEQLARLALRCCEMNRKSRPDLHSDVWRILDAM 794
Query: 735 RASCGGSTSYRLGSEERCEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHET 794
RAS GG+ S+ L SE +PP YF CPIFQEVM+DPHVAADGFTYEAEA++GWLDSGH+
Sbjct: 795 RASSGGTNSFGLSSEGPHQPPSYFICPIFQEVMRDPHVAADGFTYEAEAIRGWLDSGHDA 854
Query: 795 SPMTNLPLAHKNLVPNLALRSAIQEWLQQH 824
SPMTN L+H+NLVPN ALRSAIQ+WLQ H
Sbjct: 855 SPMTNSTLSHQNLVPNRALRSAIQDWLQSH 884
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224127680|ref|XP_002320134.1| predicted protein [Populus trichocarpa] gi|222860907|gb|EEE98449.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1029 bits (2661), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 527/801 (65%), Positives = 611/801 (76%), Gaps = 65/801 (8%)
Query: 25 MGTKFPASSLEEEKVQAYREIERQDMHNHLDMCLLICRQMGVRAEKLDTESESTEKGILE 84
MGTKFPAS L+E++V+AY EIERQ+M L L +CR+MGVRAEKL E ES EKGILE
Sbjct: 65 MGTKFPASKLKEQEVRAYWEIERQEMLKMLGEYLFLCRKMGVRAEKLYVEMESIEKGILE 124
Query: 85 LISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAPASCHIWFICNGNLIYTREGS 144
LIS +GIRKLVMGAAADK Y K MMD+KSKKA+SV QAPASCHIWFIC G+LI TR+G+
Sbjct: 125 LISQHGIRKLVMGAAADKRYSKNMMDIKSKKAVSVCLQAPASCHIWFICKGHLIQTRKGA 184
Query: 145 LDGIDPEISSPSFQASHNTENRHPNCLRSQSVVLRHNRPMKLTNPVQDLFHRVRSMNFDR 204
LDG D ++ S Q S NTE N +RSQS++ + +KLTNP QDLF ++ + R
Sbjct: 185 LDGTDTDVRPSSQQKSPNTEAGQSNIMRSQSILFGQHHHVKLTNPAQDLFRKMEGLQLHR 244
Query: 205 NVGNVMTSQDSIGGLSSPASRSDAEVSSDECTTGRSTSQGSLSSCSSRGVIDVAMIPLIR 264
G + T +I ++R
Sbjct: 245 --GQMQTG---------------------------------------------VLINMMR 257
Query: 265 TEGVSTLPPSKEDLQSSPPSVLDGSVDDNLYDQLAQAMAEAENSRREAFEEALRRGKAEK 324
+GV LP +Q S DGS++D LYDQL QAMAEAENSR EA EEA+R K E+
Sbjct: 258 YQGV--LP----KIQFSHH---DGSIEDPLYDQLEQAMAEAENSRFEASEEAVRCAKEER 308
Query: 325 DAIESIRRAKASESLYAEELKRR-------KEFEEALANGKLELERMKKQHDEVMEELQI 377
D +E+IR+AKASESLY EE KRR + +E L ELE++ K+ DEVM EL I
Sbjct: 309 DVVEAIRKAKASESLYTEESKRRTVVEEELAKEKEELEKINKELEKINKEQDEVMGELCI 368
Query: 378 ALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKS 437
A D KSLLE QI ESD+ KELEQKIISAV LLQNYKKE+D L RD A+KEAEELR++
Sbjct: 369 AQDHKSLLEKQIEESDEMVKELEQKIISAVGLLQNYKKERDHLHKGRDYALKEAEELRRN 428
Query: 438 RKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHP 497
+ EASS+ HMP+FFSDFSFSEIE ATH+FDPS KIGEGGYG+IYKG+LR QVA+KML
Sbjct: 429 QTEASST-HMPRFFSDFSFSEIEEATHHFDPSRKIGEGGYGNIYKGVLRQTQVAVKMLDS 487
Query: 498 HSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPL 557
+S+QGP+EFQQE+++LSK+RHPNL+TLVGACPE WTL+YEYLPNGSLEDRLSCKDNSPPL
Sbjct: 488 NSMQGPAEFQQEVNVLSKMRHPNLITLVGACPEAWTLIYEYLPNGSLEDRLSCKDNSPPL 547
Query: 558 SWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 617
SWQTRIRIATELCSVLIFLHS KPHSIVHGDLKPANILLD NFV+KLSDFGI R L E
Sbjct: 548 SWQTRIRIATELCSVLIFLHSSKPHSIVHGDLKPANILLDENFVTKLSDFGICRLLDHKE 607
Query: 618 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEV 677
SSNNTT+C RTDPKGTF YMDPEF+++GEL+PKSDVYSFGIILLRLLT R ALGITKEV
Sbjct: 608 GSSNNTTIC-RTDPKGTFVYMDPEFVSTGELSPKSDVYSFGIILLRLLTARQALGITKEV 666
Query: 678 QYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 737
+YALD G LK LLDPLAGDWPFVQAE LA++A+RCCEM+RK+RP+L +VWRVLEPM+AS
Sbjct: 667 RYALDKGTLKTLLDPLAGDWPFVQAEMLAHMALRCCEMNRKNRPDLASEVWRVLEPMKAS 726
Query: 738 CGGSTSYRLGSEERCEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPM 797
CG S+ +LGSEE +PP YFTCPIFQEVM+DPHVAADGFTYEAEALKGWLDSGH+TSPM
Sbjct: 727 CGTSSFSQLGSEEHFQPPSYFTCPIFQEVMRDPHVAADGFTYEAEALKGWLDSGHDTSPM 786
Query: 798 TNLPLAHKNLVPNLALRSAIQ 818
TN LAH +L+PN ALRSAIQ
Sbjct: 787 TNFKLAHCDLIPNRALRSAIQ 807
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356531997|ref|XP_003534561.1| PREDICTED: U-box domain-containing protein 33-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1019 bits (2634), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 528/809 (65%), Positives = 625/809 (77%), Gaps = 16/809 (1%)
Query: 25 MGTKFPASSLEEEKVQAYREIERQDMHNHLDMCLLICRQMGVRAEKLDTESESTEKGILE 84
+G KFPAS+L+EE+V+AY E ERQ MH LD L IC++MGVRAEKL E +S EKGILE
Sbjct: 82 LGGKFPASTLKEEQVEAYWEEERQGMHGILDEYLCICQRMGVRAEKLHIEMDSIEKGILE 141
Query: 85 LISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAPASCHIWFICNGNLIYTREGS 144
LIS +GIRKLVMGAA+DK+Y ++MMDLKSKKA+SV +QAPASCHI F+C G+LI+TR+ S
Sbjct: 142 LISQHGIRKLVMGAASDKYYNRRMMDLKSKKAVSVCKQAPASCHIQFVCKGHLIHTRDRS 201
Query: 145 LDGIDPEISSPSFQASHNTENRHPNCLRSQSVVLRHNRPMKLTNPVQDLFHRVRSMNFDR 204
D + E++SP Q N+ LRS S+ L + +TNP +LF RVRS N D
Sbjct: 202 SDEGNAEVASPLVQQVPNS----LKSLRSLSITLGQDCQANITNPALELFRRVRSAN-DG 256
Query: 205 NVGNVM--TSQDSIGGLSSPASRSDAEVSSDECTTGRSTSQGSLSSCSSRGVIDVAMIP- 261
+ + M +S + GLS+P R EVSSDE S LS+CS V ++A+ P
Sbjct: 257 HGASFMAVSSPEDTEGLSTPRDRMGTEVSSDESDRLSRMSPSGLSTCSDSAV-ELALTPS 315
Query: 262 LIRTEGVSTLPPS-----KEDLQ-SSPPSVLDGSVDDNLYDQLAQAMAEAENSRREAFEE 315
LI + L + EDL SSPPS LDG +DD +YDQL QA AEAEN+ A++E
Sbjct: 316 LINESSENALELTLSHLIIEDLHHSSPPSTLDGGMDDTIYDQLEQARAEAENATLNAYQE 375
Query: 316 ALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEEL 375
+RR KAEKDA E+IR+ KASESLYAEEL +RK EE L K ELE MK D V EEL
Sbjct: 376 TVRRMKAEKDAFEAIRKIKASESLYAEELNQRKMAEEKLRKEKEELENMKSLRDTVKEEL 435
Query: 376 QIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELR 435
++ALDQK+ LESQIA ++ KELEQKI+SAV LLQ+YK E+DELQM+ D A++EAEELR
Sbjct: 436 RLALDQKASLESQIASTELMIKELEQKILSAVGLLQSYKNERDELQMQCDNALREAEELR 495
Query: 436 KSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKML 495
K + EAS + H+PQ S+FSFSEI+ AT NF+PS KIGEGGYGSI+KG+L H +VAIKML
Sbjct: 496 KKQGEASGT-HVPQLCSEFSFSEIKEATSNFNPSSKIGEGGYGSIFKGVLHHTEVAIKML 554
Query: 496 HPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSP 555
+ S+QGP EFQQE+D+LSK+RHPNL+TL+GACP+ W LVYEYLPNGSLEDRL+CKDN+P
Sbjct: 555 NSDSMQGPLEFQQEVDVLSKLRHPNLITLIGACPDSWALVYEYLPNGSLEDRLACKDNTP 614
Query: 556 PLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 615
PLSWQ RIRIA ELCS LIFLHS KPHS+VHGDLKP+NILLDAN +SKLSDFGI R LS
Sbjct: 615 PLSWQARIRIAAELCSALIFLHSSKPHSVVHGDLKPSNILLDANLISKLSDFGICRILSN 674
Query: 616 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITK 675
E S +NTT RTDPKGTF YMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGIT
Sbjct: 675 CESSGSNTTEFWRTDPKGTFVYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITM 734
Query: 676 EVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 735
EV+YALDTGKLK+LLDPLAGDWPFVQAEQLA LA+RCC+M+RKSRP+L DVWR+L+ MR
Sbjct: 735 EVKYALDTGKLKSLLDPLAGDWPFVQAEQLARLALRCCDMNRKSRPDLYSDVWRILDAMR 794
Query: 736 ASCGGSTSYRLGSEERCEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETS 795
S GG+ S+ L SE + P YF CPIFQEVM+DPHVAADGFTYEAEA++GWLD GH+ S
Sbjct: 795 VSSGGANSFGLSSEGLLQSPSYFICPIFQEVMRDPHVAADGFTYEAEAIRGWLDGGHDNS 854
Query: 796 PMTNLPLAHKNLVPNLALRSAIQEWLQQH 824
PMTN LAH NLVPN ALRSAIQ+WLQ H
Sbjct: 855 PMTNSKLAHHNLVPNRALRSAIQDWLQNH 883
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356522608|ref|XP_003529938.1| PREDICTED: U-box domain-containing protein 33-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 991 bits (2561), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 508/810 (62%), Positives = 607/810 (74%), Gaps = 30/810 (3%)
Query: 25 MGTKFPASSLEEEKVQAYREIERQDMHNHLDMCLLICRQMGVRAEKLDTESESTEKGILE 84
MG KFPAS+L EE+VQ Y E ER M+ LD L IC+ MGVRA KL E + EKGI+E
Sbjct: 90 MGAKFPASALREEEVQDYHETERLKMYKTLDAYLSICQGMGVRAGKLQIEMDCIEKGIVE 149
Query: 85 LISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAPASCHIWFICNGNLIYTREGS 144
LIS YGI+KLVMGAA+DK++ ++M +SKKAI V +QAPASCHI FICNG LI+TR+ S
Sbjct: 150 LISQYGIQKLVMGAASDKYHSRRMTAPRSKKAIYVCEQAPASCHIQFICNGYLIHTRDCS 209
Query: 145 LDGIDPEISSPSFQASHNTENRHPNCLRSQSVVLRHNRPMKLTNPVQDLFHRVRSMNFDR 204
LD + E++ P Q N+E LRSQS+V N +KLTNP Q+LF RVRS+N
Sbjct: 210 LDIGNVEVAFPMAQQMANSEVGGSPKLRSQSIVQGQNHGIKLTNPAQELFRRVRSVN--- 266
Query: 205 NVGNVMTSQDSIGGLSSPASRSDAEVSSDECTTGRSTSQGSLSSCSSRGVIDVAMIPLIR 264
G S AS SD +GRS S S CS ++ + P +
Sbjct: 267 -----------DGHRRSLASVSDESYGQ----SGRSPS--VFSMCSHSISVEPGLTPNLI 309
Query: 265 TEGVST---------LPPSKEDLQSSPPSVLDGSVDDNLYDQLAQAMAEAENSRREAFEE 315
++G +K S+ PS +DG +DD LYDQL QAMAEA NS+R+A++E
Sbjct: 310 SDGSENELDLTLNGPFLINKNLHHSASPSEMDGGMDDALYDQLEQAMAEAVNSKRDAYQE 369
Query: 316 ALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEEL 375
+RRG AEK+AI++IRRAK +E+LY EELK RKE EEA+ +L MK Q D+V EEL
Sbjct: 370 TVRRGNAEKNAIDAIRRAKTTENLYKEELKLRKEQEEAVEKANEKLNNMKSQTDKVNEEL 429
Query: 376 QIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELR 435
++AL Q S LE+QIA ++ KELEQKIISA LLQNYK E D+LQ++RD AV EAEE R
Sbjct: 430 RLALFQNSSLENQIASTELMIKELEQKIISAENLLQNYKDELDDLQIQRDIAVGEAEEFR 489
Query: 436 KSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKML 495
+ + EASSS+H Q FS+FSF EI+ AT NF+PS KIGEGGYGSI+KG+LRH +VAIKML
Sbjct: 490 RKQWEASSSAHKLQCFSEFSFQEIKEATSNFNPSQKIGEGGYGSIFKGILRHAEVAIKML 549
Query: 496 HPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSP 555
+ S QGP EFQQE+++LSK+RHPN++TL+GACPE WTLVYEYLPNGSLEDRL+CKDNSP
Sbjct: 550 NRDSTQGPEEFQQEVEVLSKLRHPNIITLIGACPESWTLVYEYLPNGSLEDRLNCKDNSP 609
Query: 556 PLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR-FLS 614
PLSWQTRIRIATELCS LIFLHS KPHSI HGDLKPANILLDAN VSKLSDFGI R LS
Sbjct: 610 PLSWQTRIRIATELCSALIFLHSNKPHSIAHGDLKPANILLDANLVSKLSDFGICRILLS 669
Query: 615 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGIT 674
+ SSN+TT RTDPKGTF Y+DPEFLASGELTPKSDVYSFGIILLRL+TG+PALGI
Sbjct: 670 CQDSSSNSTTQFWRTDPKGTFVYLDPEFLASGELTPKSDVYSFGIILLRLMTGKPALGII 729
Query: 675 KEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 734
KEVQYALD GKLK++LDP AGDWPF+ AE+L LA+RCCEM+RKSRP+L DVWR+LEPM
Sbjct: 730 KEVQYALDAGKLKSILDPFAGDWPFMLAEELVRLALRCCEMNRKSRPDLYPDVWRILEPM 789
Query: 735 RASCGGSTSYRLGSEERCEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHET 794
RAS G + +++LGS+ C+PPPYF CPIF EVMQDPHVAADGFTYEAEA++ WL+SGH+T
Sbjct: 790 RASSGVTNTFQLGSQGLCQPPPYFICPIFLEVMQDPHVAADGFTYEAEAIREWLESGHDT 849
Query: 795 SPMTNLPLAHKNLVPNLALRSAIQEWLQQH 824
SP TN LAH++LVPN LR AIQ WLQ H
Sbjct: 850 SPRTNSKLAHRHLVPNHTLRHAIQNWLQSH 879
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356506214|ref|XP_003521882.1| PREDICTED: U-box domain-containing protein 33-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 969 bits (2504), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 498/803 (62%), Positives = 601/803 (74%), Gaps = 20/803 (2%)
Query: 25 MGTKFPASSLEEEKVQAYREIERQDMHNHLDMCLLICRQMGVRAEKL-DTESESTEKGIL 83
MG KFPAS+L EE VQ Y E ER MH LD L IC++MGVRA KL E + EKGI+
Sbjct: 92 MGAKFPASALREEGVQDYHERERLKMHKTLDAYLFICQRMGVRARKLLHIEMDCIEKGIV 151
Query: 84 ELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAPASCHIWFICNGNLIYTREG 143
ELIS YGI+KLVMGAA+DK++ ++M L+SKKAI V +QAPASCHI FICNG LI+TR+
Sbjct: 152 ELISRYGIQKLVMGAASDKYHSRRMTSLRSKKAIYVCEQAPASCHIQFICNGYLIHTRDC 211
Query: 144 SLDGIDPEISSPSFQASHNTENRHPNCLRSQSVVLRHNRPMKLTNPVQDLFHRVRSMNFD 203
SL+ + E+ P Q N+E H L QS++ N +KLTNP Q+LF RVRS+N D
Sbjct: 212 SLNRGNVEVEFPLLQQMANSEVGHSPNLSFQSILQGQNHGIKLTNPAQELFRRVRSVN-D 270
Query: 204 RNVGNVMTSQDSIGGLSSPASRSDAEVSSDECTTGRSTSQGSLSSCSSRGVIDVAMIPLI 263
++ ++ + S G L+ P+ S S + T + GS +D+ +
Sbjct: 271 GHMRSLESVSSSEGFLTPPSKFSKNISSIEPGLTPNLINDGS------ENALDLIL---- 320
Query: 264 RTEGVSTLPP--SKEDLQSSPPSVLDGSVDDNLYDQLAQAMAEAENSRREAFEEALRRGK 321
P +K+ SS PSVLD +DD LY QL Q MAEA N+RR+A++E +RR K
Sbjct: 321 ------NYPSLINKDLHHSSSPSVLDEGMDDALYYQLEQVMAEASNARRDAYQETVRRSK 374
Query: 322 AEKDAIESIRRAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQ 381
AEKDAI++I RAKA+E+LY EELK RKE EEA+ +L MK Q D+V EEL++ALDQ
Sbjct: 375 AEKDAIDAIHRAKATENLYKEELKLRKEQEEAVEKANEKLNNMKSQTDKVNEELRLALDQ 434
Query: 382 KSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEA 441
S LE+QIA ++ KEL+QKIISA++LLQNYK E D+LQ++RD AV EAEE R + EA
Sbjct: 435 NSSLENQIASTELMVKELKQKIISALDLLQNYKDELDDLQIQRDNAVGEAEEFRSKQGEA 494
Query: 442 SSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQ 501
SSS+ FSDFSF EI+ AT NF+PS KIGEGGYGSI+KG+LRH +VAIKML+P S Q
Sbjct: 495 SSSAQELHCFSDFSFQEIKEATSNFNPSKKIGEGGYGSIFKGVLRHTEVAIKMLNPDSTQ 554
Query: 502 GPSEFQQEIDILSKIRHPNLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQT 561
GP EFQQE+++LSK+RHPNL+TL+GAC E WTLVYEYLPNGSLEDRL+ KDN+PPLSWQT
Sbjct: 555 GPLEFQQEVEVLSKLRHPNLITLIGACAESWTLVYEYLPNGSLEDRLNRKDNTPPLSWQT 614
Query: 562 RIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 621
RI IA ELCS L FLHS KPHSI HGDLKPANILLDAN VSKLSDFGI R LS + SSN
Sbjct: 615 RICIAAELCSALNFLHSNKPHSIAHGDLKPANILLDANLVSKLSDFGICRILSCQDSSSN 674
Query: 622 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYAL 681
+TT RT PKGTF Y+DPEFLASGELTPKSDVYSFGIILLRL+TG+PALGI KEVQYAL
Sbjct: 675 STTQFWRTVPKGTFVYVDPEFLASGELTPKSDVYSFGIILLRLMTGKPALGIIKEVQYAL 734
Query: 682 DTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGS 741
D GKLK++LDPLAG+WPF+ AE+L LA+RCCEM+RK+RPEL DVWR+LEPMRAS +
Sbjct: 735 DAGKLKSILDPLAGEWPFMLAEELIRLALRCCEMNRKNRPELYSDVWRILEPMRASSVVT 794
Query: 742 TSYRLGSEERCEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLP 801
+ +LGS+ C+PPPYF CPIF EVMQDPHVA+DGFTYEAEA++ WL+SG +TSP TN
Sbjct: 795 NTSQLGSQRLCQPPPYFICPIFLEVMQDPHVASDGFTYEAEAIREWLESGRDTSPRTNSK 854
Query: 802 LAHKNLVPNLALRSAIQEWLQQH 824
LAH+NLVPN ALR AIQ WLQ H
Sbjct: 855 LAHRNLVPNHALRHAIQNWLQSH 877
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 824 | ||||||
| TAIR|locus:2050669 | 834 | AT2G45910 [Arabidopsis thalian | 0.650 | 0.642 | 0.667 | 3.6e-192 | |
| TAIR|locus:2101353 | 805 | AT3G49060 [Arabidopsis thalian | 0.615 | 0.629 | 0.447 | 4.6e-135 | |
| TAIR|locus:2117343 | 835 | AT4G25160 [Arabidopsis thalian | 0.674 | 0.665 | 0.369 | 7.1e-103 | |
| TAIR|locus:2151641 | 796 | AT5G61560 [Arabidopsis thalian | 0.563 | 0.582 | 0.414 | 4.4e-101 | |
| TAIR|locus:2176177 | 819 | AT5G51270 [Arabidopsis thalian | 0.626 | 0.630 | 0.384 | 7e-97 | |
| TAIR|locus:504954932 | 789 | AT5G57035 [Arabidopsis thalian | 0.616 | 0.643 | 0.366 | 6.2e-96 | |
| UNIPROTKB|Q0DR28 | 518 | PUB57 "U-box domain-containing | 0.566 | 0.901 | 0.41 | 6.3e-92 | |
| TAIR|locus:2047605 | 801 | AT2G19410 [Arabidopsis thalian | 0.608 | 0.625 | 0.359 | 2.3e-88 | |
| TAIR|locus:2143094 | 701 | AT5G12000 [Arabidopsis thalian | 0.521 | 0.613 | 0.387 | 1.9e-85 | |
| TAIR|locus:2128131 | 764 | AT4G31230 [Arabidopsis thalian | 0.549 | 0.592 | 0.404 | 2.2e-84 |
| TAIR|locus:2050669 AT2G45910 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1862 (660.5 bits), Expect = 3.6e-192, P = 3.6e-192
Identities = 364/545 (66%), Positives = 441/545 (80%)
Query: 280 SSPPSVLDGSVDDNLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESL 339
SSP S DG VDD+ ++ +A +EA +S++EAF E LRR KAEK+A+++IRRAK SES
Sbjct: 298 SSPSSFPDG-VDDSFNVKIRKATSEAHSSKQEAFAETLRRQKAEKNALDAIRRAKQSESA 356
Query: 340 YAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKEL 399
Y+EELKRRK+ E A+A K +K + + +MEELQ A+ QK++LESQIA+SD T ++L
Sbjct: 357 YSEELKRRKDTEIAVAKEKERFITIKNEQEVIMEELQSAMAQKAMLESQIAKSDGTMEKL 416
Query: 400 EQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEI 459
QK+ AV+LLQ + E++ELQ ERD+A++EAEELR S E +S+ +PQ+F+DFSFSEI
Sbjct: 417 NQKLDIAVKLLQKLRDEREELQTERDRALREAEELR-SHAE-TSTLQLPQYFTDFSFSEI 474
Query: 460 EGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHP 519
E AT++FD +LKIGEGGYGSIY GLLRH QVAIKML+P+S QGP E+QQE+D+LSK+RHP
Sbjct: 475 EEATNHFDSTLKIGEGGYGSIYVGLLRHTQVAIKMLNPNSSQGPVEYQQEVDVLSKMRHP 534
Query: 520 NLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 579
N++TL+GACPE W+LVYEYLP GSLEDRL+CKDNSPPLSWQ R+RIATE+C+ L+FLHS
Sbjct: 535 NIITLIGACPEGWSLVYEYLPGGSLEDRLTCKDNSPPLSWQNRVRIATEICAALVFLHSN 594
Query: 580 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 639
K HS+VHGDLKPANILLD+N VSKLSDFG L N S RTD GT AY+D
Sbjct: 595 KAHSLVHGDLKPANILLDSNLVSKLSDFGTCSLLHPNGSKS------VRTDVTGTVAYLD 648
Query: 640 PEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPF 699
PE +SGELTPKSDVYSFGIILLRLLTGRPAL I+ EV+YALD G L +LLDPLAGDWPF
Sbjct: 649 PEASSSGELTPKSDVYSFGIILLRLLTGRPALRISNEVKYALDNGTLNDLLDPLAGDWPF 708
Query: 700 VQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGSEERCEPPPYFT 759
VQAEQLA LA+RCCE ++RP+LG +VWRVLEPMRAS GGS+S+ LG E PPYF
Sbjct: 709 VQAEQLARLALRCCETVSENRPDLGTEVWRVLEPMRASSGGSSSFHLGRNEHRIAPPYFI 768
Query: 760 CPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQE 819
CPIFQEVMQDPHVAADGFTYEAEA++ WLDS H+TSPMTN+ L+H +L+ N ALRSAIQE
Sbjct: 769 CPIFQEVMQDPHVAADGFTYEAEAIRAWLDSEHDTSPMTNVKLSHTSLIANHALRSAIQE 828
Query: 820 WLQQH 824
WLQ H
Sbjct: 829 WLQHH 833
|
|
| TAIR|locus:2101353 AT3G49060 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1160 (413.4 bits), Expect = 4.6e-135, Sum P(2) = 4.6e-135
Identities = 236/527 (44%), Positives = 357/527 (67%)
Query: 300 QAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGKL 359
+AM + S R + EA ++ + + E++ +AKA E L +E +RK EE L KL
Sbjct: 295 KAMHDIGQSDRTVYGEAGKKWEEDASTTEALCKAKALEGLCIKESSQRKRLEELLEKEKL 354
Query: 360 ELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDE 419
E++ + +Q++ M+ELQ+ + LESQ+ + KE +K +A+ELL+++++++DE
Sbjct: 355 EVKMVIEQNNGFMKELQMVQGRNLKLESQMRKLQDLEKEHGEKFDTAMELLKSFRQKRDE 414
Query: 420 LQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGS 479
++++ + AVKE LR+ K + S + D+SF EI AT+ FDPS K+GEG YGS
Sbjct: 415 IRIDHENAVKEVNALRRLVKGETGESSGSEML-DYSFMEINEATNEFDPSWKLGEGKYGS 473
Query: 480 IYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTLVYEYL 539
+YKG L+H+QVA+KML + EF++ ++ILS++RHPNLVTL+GACPE +L+Y+Y+
Sbjct: 474 VYKGNLQHLQVAVKMLPSYGSLNHFEFERRVEILSRVRHPNLVTLMGACPESRSLIYQYI 533
Query: 540 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN 599
PNGSLED S ++N P LSW++RIRIA+E+CS L+FLHS P I+HG+LKP+ ILLD+N
Sbjct: 534 PNGSLEDCFSSENNVPALSWESRIRIASEICSALLFLHSNIP-CIIHGNLKPSKILLDSN 592
Query: 600 FVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGI 659
V+K++D+GIS+ + + + ++DP ++DP + S E+T +SD+Y+FGI
Sbjct: 593 LVTKINDYGISQLIPIDGLD--------KSDP-----HVDPHYFVSREMTLESDIYAFGI 639
Query: 660 ILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKS 719
ILL+LLT RP GI ++V+ AL+ + +LD AGDWP + ++LAN+A+RCC+ + +
Sbjct: 640 ILLQLLTRRPVSGILRDVKCALENDNISAVLDNSAGDWPVARGKKLANVAIRCCKKNPMN 699
Query: 720 RPELGKDVWRVLEPMRAS---CGGSTSYRLGSEERCEPPPYFTCPIFQEVMQDPHVAADG 776
RP+L V R ++ M+A ++SY + R PP ++ CPIFQEVM+DP +AADG
Sbjct: 700 RPDLAV-VLRFIDRMKAPEVPSSETSSYANQNVPR-RPPSHYLCPIFQEVMKDPLIAADG 757
Query: 777 FTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWLQQ 823
FTYEAEA++ WL +GH+TSPMTNL + NL+PN AL AIQ+W Q
Sbjct: 758 FTYEAEAIREWLANGHDTSPMTNLKMEDCNLIPNHALHLAIQDWQNQ 804
|
|
| TAIR|locus:2117343 AT4G25160 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 922 (329.6 bits), Expect = 7.1e-103, Sum P(3) = 7.1e-103
Identities = 212/574 (36%), Positives = 321/574 (55%)
Query: 256 DVAMIPLIRTEGVSTLPPSKEDLQSSPPSVLDGSVDDNLYDQLAQAMAEAENSRREAFEE 315
DV+ I T+ S P + D + + + S + Y + +
Sbjct: 267 DVSSINRSSTDTTSRWTPRRRDYEERKEA-MSSSSSNREYGNFGTRFSWSGMGVDTTHSR 325
Query: 316 ALRRGKAEKDAI--ESIRRAKASESLYAEELKRR-KEFEEALANGKLELERMKKQHDEVM 372
A ++ DA+ +S + + + E+L+ + +E A + E ++ E+
Sbjct: 326 ASQQASNMSDALSEQSYTDNQVNLNFEVEKLRAELRHVQEMYAVAQTETFDASRKLGELN 385
Query: 373 E---ELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVK 429
+ E I L++ L E + E + K+ +K E ++ ++ + E+ R+ K
Sbjct: 386 QRRLEEAIKLEELKLKEYEARELAEKEKQNFEKARRDAESMR--ERAEREIAQRREAERK 443
Query: 430 EAEELRKSRK-EASSSSHMPQF-FSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH 487
A + ++ K E + S PQ + F++ EI AT +F LKIG G YG++YK L H
Sbjct: 444 SARDTKEKEKLEGTLGS--PQLQYQHFAWEEIMAATSSFSEELKIGMGAYGAVYKCNLHH 501
Query: 488 MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTLVYEYLPNGSLEDR 547
+K+L Q +FQQE++ILSKIRHP+LV L+GACPE LVYEY+ NGSLEDR
Sbjct: 502 TTAVVKVLQSAENQLSKQFQQELEILSKIRHPHLVLLLGACPEQGALVYEYMENGSLEDR 561
Query: 548 LSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDF 607
L +NSPPL W R RIA E+ + L+FLH KP I+H DLKPANILLD NFVSK+ D
Sbjct: 562 LFQVNNSPPLPWFERFRIAWEVAAALVFLHKSKPKPIIHRDLKPANILLDHNFVSKVGDV 621
Query: 608 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG 667
G+S + + +S+ T+ +T P GT Y+DPE+ +G ++ KSD+YSFG+ILL+LLT
Sbjct: 622 GLSTMVQVDPLSTK-FTIYKQTSPVGTLCYIDPEYQRTGRISSKSDIYSFGMILLQLLTA 680
Query: 668 RPALGITKEVQYALDTG-KLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD 726
+PA+ +T V+ A+D+ + +LD AG+WP + +LA LA+ C E+ K RP+L
Sbjct: 681 KPAIALTHFVESAMDSNDEFLKILDQKAGNWPIEETRELAALALCCTELRGKDRPDLKDQ 740
Query: 727 VWRVLEPMRASCGGSTSYRLGSEERCEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKG 786
+ LE ++ + + G +PP +F CP+ ++VM +P VAADG+TY+ A++
Sbjct: 741 ILPALENLKKVAEKARNSFSGVST--QPPTHFICPLLKDVMNEPCVAADGYTYDRHAIEE 798
Query: 787 WLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEW 820
WL H TSPMT+ PL KNL+PN L +AI EW
Sbjct: 799 WLKE-HNTSPMTDSPLHSKNLLPNYTLYTAIMEW 831
|
|
| TAIR|locus:2151641 AT5G61560 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 913 (326.5 bits), Expect = 4.4e-101, Sum P(3) = 4.4e-101
Identities = 202/487 (41%), Positives = 296/487 (60%)
Query: 353 ALANGKLELERMKKQHDEVMEELQIALDQKSLL--ESQIAESDQTAKELEQKIISAVELL 410
A+A ++ ++ KK D + A K+L E + E + +E ++ + EL+
Sbjct: 314 AVAQSEV-IDASKKMQDLNQRRSEEATRLKNLTIREEEADEVVEMERERQEDAENEAELV 372
Query: 411 QNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSH----MPQFFSDFSFSEIEGATHNF 466
+ + + E ER +A AEE+RK ++ + Q + F + EI AT +F
Sbjct: 373 RECIERETE---ERLEAEARAEEVRKEKQRLEDALEGGPLQRQQYMKFEWEEIVEATSSF 429
Query: 467 DPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVG 526
LKIG GGYGS+Y+ L H VA+K+LH +F QE++ILSKIRHP+L+ L+G
Sbjct: 430 SDELKIGVGGYGSVYRCNLHHTTVAVKVLHSDKSSLTKQFHQELEILSKIRHPHLLLLLG 489
Query: 527 ACPEVWTLVYEYLPNGSLEDRLSCK------DNSPPLSWQTRIRIATELCSVLIFLHSCK 580
ACPE +LVYEY+ NGSLE+RL + PPL W R RIA E+ S L FLH+ +
Sbjct: 490 ACPERGSLVYEYMHNGSLEERLMKRRPNVDTPQPPPLRWFERFRIAWEIASALYFLHTNE 549
Query: 581 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 640
P IVH DLKPANILLD N VSK+ D G+S+ ++ + S+ +T+ T P GTF Y+DP
Sbjct: 550 PRPIVHRDLKPANILLDRNNVSKIGDVGLSKMVNLDP--SHASTVFNETGPVGTFFYIDP 607
Query: 641 EFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYAL--DTGKLKNLLDPLAGDWP 698
E+ +G +TP+SD+Y+FGIILL+L+T R A+G+ ++ AL TGK +LD AGDWP
Sbjct: 608 EYQRTGVVTPESDIYAFGIILLQLVTARSAMGLAHSIEKALRDQTGKFTEILDKTAGDWP 667
Query: 699 FVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR--ASCGGSTSYRLGSEERCEPPP 756
+A+++ + +RC EM ++ RP+LGK++ VLE ++ AS + + P
Sbjct: 668 VKEAKEMVMIGLRCAEMRKRDRPDLGKEILPVLERLKEVASIARNMFADNLIDHHHNAPT 727
Query: 757 YFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSA 816
+F CPI ++VM++P VA+DG+TYE A+K WL H+ SPMT+LP +L+PN +L SA
Sbjct: 728 HFYCPITKDVMENPCVASDGYTYEKRAIKEWLQKNHK-SPMTDLPFPSDSLLPNHSLLSA 786
Query: 817 IQEWLQQ 823
I+EW Q
Sbjct: 787 IKEWRSQ 793
|
|
| TAIR|locus:2176177 AT5G51270 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 917 (327.9 bits), Expect = 7.0e-97, Sum P(3) = 7.0e-97
Identities = 204/530 (38%), Positives = 308/530 (58%)
Query: 299 AQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALAN-G 357
A + E SR ++ R KDA+ S+ ++ + ++ L
Sbjct: 291 ASKRSSPETSRSVSWNPQFRDFDERKDAMSSMSSNFEYGNVVTPLGHYFTDNQDTLNEIS 350
Query: 358 KLELERMKKQHDEVMEELQI-ALDQKSLLESQIAESDQTAKELEQKIISA--VELLQNYK 414
KL E ++ H E+ Q+ LD L +++ + T E E K I+ E + +
Sbjct: 351 KLRAE-LRHAH-EMYAVAQVETLDASRKL-NELKFEELTLLEHETKGIAKKETEKFEQKR 407
Query: 415 KEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQF-FSDFSFSEIEGATHNFDPSLKIG 473
+E+ E R+ +K E ++ K SS P+ + +F++ EI AT +F LKIG
Sbjct: 408 REEREAAQRREAEMKATHEAKEKEKLEESSLVAPKLQYQEFTWEEIINATSSFSEDLKIG 467
Query: 474 EGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWT 533
G YG +YK L H A+K+LH +F QE++ILSKIRHP+LV L+GACP+
Sbjct: 468 MGAYGDVYKCNLHHTIAAVKVLHSAESSLSKQFDQELEILSKIRHPHLVLLLGACPDHGA 527
Query: 534 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPAN 593
LVYEY+ NGSLEDRL ++S P+ W R+RIA E+ S L+FLH KP I+H DLKPAN
Sbjct: 528 LVYEYMENGSLEDRLFQVNDSQPIPWFVRLRIAWEVASALVFLHKSKPTPIIHRDLKPAN 587
Query: 594 ILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSD 653
ILL+ NFVSK+ D G+S + + S T+ +T P GT Y+DPE+ +G ++PKSD
Sbjct: 588 ILLNHNFVSKVGDVGLSTMIQAADPLSTKFTMYKQTSPVGTLCYIDPEYQRTGRISPKSD 647
Query: 654 VYSFGIILLRLLTGRPALGITKEVQYALDTG---KLKNLLDPLAGDWPFVQAEQLANLAM 710
VY+FG+I+L+LLTG+ A+ +T V+ A++ +L +LD AG+WP + QLA LA+
Sbjct: 648 VYAFGMIILQLLTGQQAMALTYTVETAMENNNDDELIQILDEKAGNWPIEETRQLAALAL 707
Query: 711 RCCEMSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGSEERCEPPPYFTCPIFQEVMQDP 770
+C E+ K RP+L + VLE ++ + + S +PP +F CP+ ++VM++P
Sbjct: 708 QCTELRSKDRPDLEDQILPVLESLKKVADKARNSL--SAAPSQPPSHFFCPLLKDVMKEP 765
Query: 771 HVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEW 820
+AADG+TY+ A++ W+++ H TSP+TN PL + NL+PN L +AI EW
Sbjct: 766 CIAADGYTYDRRAIEEWMEN-HRTSPVTNSPLQNVNLLPNHTLYAAIVEW 814
|
|
| TAIR|locus:504954932 AT5G57035 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 851 (304.6 bits), Expect = 6.2e-96, Sum P(3) = 6.2e-96
Identities = 193/527 (36%), Positives = 296/527 (56%)
Query: 302 MAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGKLEL 361
+ + E+ R + K + D ++ K+ E+L RKE + L+ K
Sbjct: 259 LVDDEHCRSILRHSTVSTSKIQMDPRPHLKTPKSGVRAEVEQL--RKEVQTTLSMYKQAC 316
Query: 362 ERMKKQHDEVMEELQIALDQKSLLESQIAESD---QTAKELEQKIISAVELLQNYK---- 414
E + + +V + + + + + + + + A E ++K + AV+ ++ K
Sbjct: 317 EELVHKQTQVQSLSSECIKETERVITALEKEEMRRKAAAEEKEKHLKAVKEVEEAKSMLA 376
Query: 415 KEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGE 474
KE E Q+ A+K++ E +K ++ + ++ EI AT NF IGE
Sbjct: 377 KEFCERQLAELDALKQSIEKQKVIEQLFLRDGR---YRKYTKEEIAAATDNFSSRKIIGE 433
Query: 475 GGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTL 534
GGYG +YK L H VA+K+L P S++ EF +EI +LS++RHP++V L+GACPE L
Sbjct: 434 GGYGKVYKCSLDHTPVALKVLKPDSVEKKEEFLKEISVLSQLRHPHVVLLLGACPENGCL 493
Query: 535 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANI 594
VYEY+ NGSL+ +S K P LSW R RI E L FLH+ KP IVH DLKP NI
Sbjct: 494 VYEYMENGSLDCHISPKKGKPSLSWFIRFRIIYETACGLAFLHNSKPEPIVHRDLKPGNI 553
Query: 595 LLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDV 654
LLD NFVSK+ D G+++ +S + ++ T+ + GT YMDPE+ +G + PKSD+
Sbjct: 554 LLDRNFVSKIGDVGLAKLMSDE--APDSVTVYRNSIIAGTLYYMDPEYQRTGTIRPKSDL 611
Query: 655 YSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCE 714
Y+FGII+L+LLT R G+ V+ A+ G +++LD DWP +A++LA +A+RC +
Sbjct: 612 YAFGIIILQLLTARHPNGLLFCVEDAVKRGCFEDMLDGSVKDWPIAEAKELARIAIRCSQ 671
Query: 715 MSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGSEE-RCEPPPYFTCPIFQEVMQDPHVA 773
+ + RP+L V L+ + S RL +E+ P ++ CPI +E+M+DP +A
Sbjct: 672 LKCRDRPDLSTQVLPALKRILESANS----RLKTEQANARAPTHYYCPILKEIMEDPQIA 727
Query: 774 ADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEW 820
ADGFTYE +A+K W+ + SP+T L H +L PN LRSAI+EW
Sbjct: 728 ADGFTYERKAIKEWIQKHQDVSPVTKHRLKHSDLTPNHTLRSAIREW 774
|
|
| UNIPROTKB|Q0DR28 PUB57 "U-box domain-containing protein 57" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 916 (327.5 bits), Expect = 6.3e-92, P = 6.3e-92
Identities = 205/500 (41%), Positives = 294/500 (58%)
Query: 334 KASESLYAEELKRRKEFE--EALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAE 391
K S++ E + F E + + +++ K D + + +A + + + + E
Sbjct: 28 KFEPSVWCEAIDIHNTFSAGEIITGDIICFQKILKPPD-IPKYPSVASFLQHVCDRKTYE 86
Query: 392 SDQTAKELEQKIISAVELLQNY--KKEQ-----DELQMERDKAVKEAEELRKSRKEASSS 444
+ LE++I++ Y +KE+ D+L+ ERD AV++ ELR S
Sbjct: 87 EVRKVHILEEEIVTLKHQADTYLVQKEKAVTAYDQLKHERDNAVQQVNELR------DQS 140
Query: 445 SHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPS 504
+H+ DFS ++E AT +F + ++G+ YG YKG++ +M+V IK+ L
Sbjct: 141 THI---ILDFSRKDMEQATEHFKNAREVGDTEYGHTYKGMIHNMKVLIKLSSSQKL---- 193
Query: 505 EFQQEIDILSKIRHPNLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIR 564
FQQE+ IL + RHPN++T +G C EV LVYE+LPNG+LEDR+ C +NS PLSW R +
Sbjct: 194 -FQQEVSILRQWRHPNIITFIGVCSEVSALVYEWLPNGNLEDRIICTNNSAPLSWYNRTQ 252
Query: 565 IATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 624
I E+C L+FLHS K ++VHGDL+P NIL+DAN+ SK+ +FG+S Q N T
Sbjct: 253 IIGEICCALLFLHSNKSTALVHGDLRPCNILIDANYRSKICNFGMSNLFLQLGTFPPNLT 312
Query: 625 LCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG 684
YMDPEF +GELT SDVYS G+I+LRLLTG P L ++++V AL +
Sbjct: 313 --------ARLPYMDPEFNTTGELTTLSDVYSLGVIILRLLTGMPPLTLSEKVAEALGSD 364
Query: 685 KLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGST-S 743
L L+D AGDWP+++A+QLA + + C M+RK RP+L +VW V+EP+ +T
Sbjct: 365 SLHLLIDKSAGDWPYIEAKQLALIGLSCTGMTRKKRPDLLNEVWIVIEPLTRKPPAATWP 424
Query: 744 YRLGSEERCEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLA 803
Y + P F CPI E+M+DP VA+DGFTYEAEA++ W D G SPMTNL L
Sbjct: 425 YLQSASGDSSVPAAFICPISMEIMKDPQVASDGFTYEAEAIRCWFDRGISRSPMTNLALP 484
Query: 804 HKNLVPNLALRSAIQEWLQQ 823
+ NLVPN LRS I +LQQ
Sbjct: 485 NLNLVPNRVLRSFIHGYLQQ 504
|
|
| TAIR|locus:2047605 AT2G19410 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 823 (294.8 bits), Expect = 2.3e-88, Sum P(3) = 2.3e-88
Identities = 187/520 (35%), Positives = 299/520 (57%)
Query: 302 MAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGKLEL 361
++E +S R E + + K E + E + R K L + K ++ EE L + + ++
Sbjct: 289 VSEHRDSDRSPPETSRKSKKVEIE--EEVERLK--NELQSTVFKYKQACEE-LFSTQNKV 343
Query: 362 ERMKKQHDEVMEELQIALDQKSLLESQIA-ESDQTAKELEQKIISAVELLQNYKKEQDEL 420
+ + ++ + + A++++ L + A E ++ K +++ + +A LL +E +
Sbjct: 344 KMLSTEYLNESKRVNNAVEKEELQRNTAALEKERYMKAVKE-VETAKALLA---REFCQR 399
Query: 421 QMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSI 480
Q+ A++ E +K + + H + ++ EI AT F P IGEGGYG +
Sbjct: 400 QIAEVNALRTYLEKKKVIDQLLGTDHR---YRKYTIEEIVTATEGFSPEKVIGEGGYGKV 456
Query: 481 YKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTLVYEYLP 540
Y+ L A+K++ + + EF +E+++LS++RHP++V L+GACPE LVYEYL
Sbjct: 457 YQCSLDSTPAAVKVVRLDTPEKKQEFLKEVEVLSQLRHPHVVLLLGACPENGCLVYEYLE 516
Query: 541 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF 600
NGSLE+ + + N PPL W R R+ E+ L FLHS KP IVH DLKP NILL+ N+
Sbjct: 517 NGSLEEYIFHRKNKPPLPWFIRFRVIFEVACGLAFLHSSKPEPIVHRDLKPGNILLNRNY 576
Query: 601 VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGII 660
VSK++D G+++ ++ +++ +N T+ + GT Y+DPE+ +G + PKSD+Y+FGII
Sbjct: 577 VSKIADVGLAKLVT--DVAPDNVTMYRNSVLAGTLHYIDPEYHRTGTIRPKSDLYAFGII 634
Query: 661 LLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSR 720
+L+LLT R GI V+ A+ G L +LD DWP + E+LA + ++C E + R
Sbjct: 635 ILQLLTARNPSGIVPAVENAVKKGTLTEMLDKSVTDWPLAETEELARIGLKCAEFRCRDR 694
Query: 721 PELGKDVWRVLEPMRASCGGSTSYRLGSEERCEPPPYFTCPIFQEVMQDPHVAADGFTYE 780
P+L +V VL+ + S + GS R P YF CPI +E+M++P +AADGFTYE
Sbjct: 695 PDLKSEVIPVLKRL-VETANSKVKKEGSNLRA-PSHYF-CPILREIMEEPEIAADGFTYE 751
Query: 781 AEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEW 820
+A+ WL+ H SP+T L H L PN LRSAI++W
Sbjct: 752 RKAILAWLEK-HNISPVTRQKLDHFKLTPNHTLRSAIRDW 790
|
|
| TAIR|locus:2143094 AT5G12000 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 788 (282.4 bits), Expect = 1.9e-85, Sum P(2) = 1.9e-85
Identities = 172/444 (38%), Positives = 265/444 (59%)
Query: 289 SVDDNLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRK 348
S D D + M + + E F+ G +++ A +S R +A ELK+
Sbjct: 247 SFSDESSDVGSMMMMGSIDLSAENFDMVGGSGSSDESASQSTRDIEAEMKRLKIELKQTM 306
Query: 349 EFEEALANGKLELERMKKQHDE-VMEELQIALDQKSLLESQIAESDQTAKELEQ-KIISA 406
+ + L ++ + ++ MEE + + ++ E+ +A + E+E+ K +A
Sbjct: 307 DMYSSACKEALNAKKKANELNQWKMEEARRFEEARNAEEAALAVA-----EMEKAKCRAA 361
Query: 407 VELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQF---FSDFSFSEIEGAT 463
+E + ++ EL+ +R K E + R+S+++ + S + Q + +S EIE AT
Sbjct: 362 LEAAEKAQR-MAELEGQRRKQA-EMKARRESQEKDRALSALVQNDVRYRKYSIDEIEVAT 419
Query: 464 HNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVT 523
F + KIGEGGYG +Y G L H VAIK+L P + QG +FQQE+++LS IRHP++V
Sbjct: 420 ERFANNRKIGEGGYGPVYHGTLDHTPVAIKVLRPDAAQGKKQFQQEVEVLSSIRHPHMVL 479
Query: 524 LVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 583
L+GACPE LVYE++ NGSLEDRL + NSPPLSW+ R +IA E+ + L FLH KP
Sbjct: 480 LLGACPEYGCLVYEFMDNGSLEDRLFRRGNSPPLSWRKRFQIAAEIATALSFLHQAKPEP 539
Query: 584 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 643
+VH DLKPANILLD N+VSK+SD G++R + + +N T T GTF Y+DPE+
Sbjct: 540 LVHRDLKPANILLDKNYVSKISDVGLARLVPASV--ANTVTQYHMTSAAGTFCYIDPEYQ 597
Query: 644 ASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAE 703
+G+LT KSD++S GI+LL+++T + +G+ V A+D G K++LDP+ DWP +A
Sbjct: 598 QTGKLTTKSDIFSLGIMLLQIITAKSPMGLAHHVSRAIDKGTFKDMLDPVVPDWPVEEAL 657
Query: 704 QLANLAMRCCEMSRKSRPELGKDV 727
A L +RC E+ ++ RP+LGK++
Sbjct: 658 NFAKLCLRCAELRKRDRPDLGKEI 681
|
|
| TAIR|locus:2128131 AT4G31230 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 803 (287.7 bits), Expect = 2.2e-84, Sum P(2) = 2.2e-84
Identities = 192/475 (40%), Positives = 272/475 (57%)
Query: 277 DLQSSPPSVLDGS-VDDNLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKA 335
D +PP + + S VD ++ + + S AF + A + +A
Sbjct: 280 DPNRTPPRLSNFSDVDYCSFESMTFGRRSMDLSSPTAFSTGSFENERFSSASQGGDDVEA 339
Query: 336 SESLYAEELKRRKEF-----EEAL-ANGKL-ELERMKKQHDEVMEELQIALDQKSLLESQ 388
ELK+ E +EAL A K EL+R K + EE ++A ++ +L
Sbjct: 340 EMRRLKLELKQTMEMYSTACKEALTAKHKATELQRWKLAEERKFEEAKLA-EEAALA--- 395
Query: 389 IAESDQTAKELEQKIISAVELLQNYKKEQDELQMERD-KAVKEAEELRKSRKEASSSSHM 447
IAE ++ AK + + A E Q + +++ + KA+KE+E +R +A ++
Sbjct: 396 IAEKEK-AKS--KAAMEAAEAAQRIADIESRKRVDAETKALKESE----ARTKAVNALAK 448
Query: 448 PQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQ 507
+ +S EIE AT FD KIGEG YG +YK L H VA+K L P + QG S+FQ
Sbjct: 449 DVRYRKYSIEEIEDATEFFDDKYKIGEGSYGPVYKCYLDHTPVAVKALRPDAAQGRSQFQ 508
Query: 508 QEIDILSKIRHPNLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIAT 567
+E+++L IRHPN+V L+GACPE LVYE++ NGSLEDRL + +SP LSWQTR RIA
Sbjct: 509 KEVEVLCSIRHPNMVLLLGACPECGCLVYEFMANGSLEDRLFRQGDSPALSWQTRFRIAA 568
Query: 568 ELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCC 627
E+ +VL+FLH KP +VH DLKPANILLD NFVSKL+D G++R + + +N T
Sbjct: 569 EIGTVLLFLHQTKPEPLVHRDLKPANILLDRNFVSKLADVGLARLVPPSV--ANTVTQYH 626
Query: 628 RTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLK 687
T GTF Y+DPE+ +G L KSD+YS GI+ L+L+TG+P +G+T V+ AL+ G LK
Sbjct: 627 MTSTAGTFCYIDPEYQQTGMLGVKSDIYSLGIMFLQLITGKPPMGLTHYVERALEKGNLK 686
Query: 688 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGST 742
+LLDP DWP + A LA++C E+ RK RP+L K + L +R ST
Sbjct: 687 DLLDPAVSDWPVEDTTEFAKLALKCAEIRRKDRPDLSKVILPELNRLRVLAEEST 741
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q8GUH1 | PUB33_ARATH | 2, ., 7, ., 1, 1, ., - | 0.5680 | 0.8944 | 0.8836 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 6.3.2 | 0.691 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 824 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-50 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-47 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-46 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-46 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-43 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-41 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-40 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-38 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-38 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-33 | |
| cd01989 | 146 | cd01989, STK_N, The N-terminal domain of Eukaryoti | 2e-30 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-30 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-28 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-28 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-27 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-27 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-26 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-26 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 9e-26 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-25 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 9e-25 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-24 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-24 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-24 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-24 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-24 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-24 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-23 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-23 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-23 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-23 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 8e-23 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-22 | |
| smart00504 | 63 | smart00504, Ubox, Modified RING finger domain | 2e-22 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-22 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-22 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-22 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-22 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-22 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 8e-22 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 8e-22 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-21 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-21 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-21 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-21 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-21 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 8e-21 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 8e-21 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 9e-21 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-20 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-20 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-20 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-20 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-20 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 6e-20 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 7e-20 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 8e-20 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-19 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-19 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-19 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-19 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-19 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-19 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 6e-19 | |
| pfam04564 | 73 | pfam04564, U-box, U-box domain | 7e-19 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 7e-19 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-18 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-18 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-18 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-18 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-18 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-18 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-18 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-18 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-18 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-18 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-17 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-17 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-17 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-17 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-17 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-17 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-17 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-17 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-17 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-17 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 6e-17 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 7e-17 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 7e-17 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-16 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-16 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-16 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-16 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-16 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-16 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-16 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-16 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-16 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-16 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-16 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-16 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-16 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-16 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-16 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-16 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 6e-16 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-16 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 7e-16 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 7e-16 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 9e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-15 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-15 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-15 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-15 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-15 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-15 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-15 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-15 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-15 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 5e-15 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-15 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 6e-15 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 7e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 7e-15 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 7e-15 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 7e-15 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 8e-15 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-14 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-14 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-14 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-14 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-14 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-14 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-14 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-14 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-14 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 6e-14 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 7e-14 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 8e-14 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 8e-14 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 9e-14 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 9e-14 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 9e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-13 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-13 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-13 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-13 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-13 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-12 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-12 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-12 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-12 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-12 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 5e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 6e-12 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-12 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 6e-12 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 7e-12 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 7e-12 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 8e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-11 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-11 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-11 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-11 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-11 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-11 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 5e-11 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 6e-11 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 6e-11 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 8e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 8e-11 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 9e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 9e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-10 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-10 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-10 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-10 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-10 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-10 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 7e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 8e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-09 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-09 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-09 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-09 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-09 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-09 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-09 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 6e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 6e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 7e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 7e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 8e-09 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 9e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-08 | |
| TIGR02169 | 1164 | TIGR02169, SMC_prok_A, chromosome segregation prot | 1e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-08 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-08 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-08 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 3e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-08 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-08 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-08 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-08 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 7e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 7e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 8e-08 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 9e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-07 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-07 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-07 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-07 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-07 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 6e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 6e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 6e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 8e-07 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 9e-07 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 1e-06 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 1e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-06 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-06 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-06 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-06 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-06 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 2e-06 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 2e-06 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-06 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-06 | |
| COG0419 | 908 | COG0419, SbcC, ATPase involved in DNA repair [DNA | 3e-06 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 4e-06 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-06 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 4e-06 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 5e-06 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-06 | |
| TIGR02169 | 1164 | TIGR02169, SMC_prok_A, chromosome segregation prot | 6e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 6e-06 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 8e-06 | |
| COG1579 | 239 | COG1579, COG1579, Zn-ribbon protein, possibly nucl | 9e-06 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 9e-06 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 2e-05 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 2e-05 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 2e-05 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 2e-05 | |
| COG0419 | 908 | COG0419, SbcC, ATPase involved in DNA repair [DNA | 2e-05 | |
| COG0419 | 908 | COG0419, SbcC, ATPase involved in DNA repair [DNA | 2e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-05 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-05 | |
| TIGR02168 | 1179 | TIGR02168, SMC_prok_B, chromosome segregation prot | 2e-05 | |
| TIGR02168 | 1179 | TIGR02168, SMC_prok_B, chromosome segregation prot | 2e-05 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 2e-05 | |
| PRK03918 | 880 | PRK03918, PRK03918, chromosome segregation protein | 2e-05 | |
| COG1340 | 294 | COG1340, COG1340, Uncharacterized archaeal coiled- | 2e-05 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 3e-05 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-05 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-05 | |
| TIGR02169 | 1164 | TIGR02169, SMC_prok_A, chromosome segregation prot | 4e-05 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 4e-05 | |
| TIGR02168 | 1179 | TIGR02168, SMC_prok_B, chromosome segregation prot | 5e-05 | |
| TIGR02168 | 1179 | TIGR02168, SMC_prok_B, chromosome segregation prot | 5e-05 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 6e-05 | |
| COG0419 | 908 | COG0419, SbcC, ATPase involved in DNA repair [DNA | 6e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 6e-05 | |
| COG1842 | 225 | COG1842, PspA, Phage shock protein A (IM30), suppr | 6e-05 | |
| pfam04012 | 220 | pfam04012, PspA_IM30, PspA/IM30 family | 7e-05 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 7e-05 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 8e-05 | |
| PRK12704 | 520 | PRK12704, PRK12704, phosphodiesterase; Provisional | 9e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 9e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 9e-05 | |
| TIGR02168 | 1179 | TIGR02168, SMC_prok_B, chromosome segregation prot | 1e-04 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 1e-04 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 1e-04 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 1e-04 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-04 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-04 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 2e-04 | |
| TIGR02168 | 1179 | TIGR02168, SMC_prok_B, chromosome segregation prot | 2e-04 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 2e-04 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 2e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-04 | |
| pfam13868 | 349 | pfam13868, Trichoplein, Tumour suppressor, Mitosta | 2e-04 | |
| pfam09731 | 493 | pfam09731, Mitofilin, Mitochondrial inner membrane | 2e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-04 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-04 | |
| pfam12128 | 1198 | pfam12128, DUF3584, Protein of unknown function (D | 2e-04 | |
| pfam02463 | 1162 | pfam02463, SMC_N, RecF/RecN/SMC N terminal domain | 2e-04 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 3e-04 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-04 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-04 | |
| TIGR02168 | 1179 | TIGR02168, SMC_prok_B, chromosome segregation prot | 4e-04 | |
| TIGR02168 | 1179 | TIGR02168, SMC_prok_B, chromosome segregation prot | 4e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-04 | |
| COG0419 | 908 | COG0419, SbcC, ATPase involved in DNA repair [DNA | 5e-04 | |
| TIGR02168 | 1179 | TIGR02168, SMC_prok_B, chromosome segregation prot | 5e-04 | |
| PRK03918 | 880 | PRK03918, PRK03918, chromosome segregation protein | 5e-04 | |
| TIGR03319 | 514 | TIGR03319, RNase_Y, ribonuclease Y | 5e-04 | |
| COG4487 | 438 | COG4487, COG4487, Uncharacterized protein conserve | 5e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-04 | |
| TIGR02168 | 1179 | TIGR02168, SMC_prok_B, chromosome segregation prot | 6e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 6e-04 | |
| pfam00430 | 132 | pfam00430, ATP-synt_B, ATP synthase B/B' CF(0) | 6e-04 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 7e-04 | |
| TIGR02168 | 1179 | TIGR02168, SMC_prok_B, chromosome segregation prot | 8e-04 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 8e-04 | |
| PRK03918 | 880 | PRK03918, PRK03918, chromosome segregation protein | 8e-04 | |
| pfam13863 | 126 | pfam13863, DUF4200, Domain of unknown function (DU | 8e-04 | |
| pfam13949 | 292 | pfam13949, ALIX_LYPXL_bnd, ALIX V-shaped domain bi | 8e-04 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 9e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 9e-04 | |
| TIGR02169 | 1164 | TIGR02169, SMC_prok_A, chromosome segregation prot | 0.001 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 0.001 | |
| TIGR02168 | 1179 | TIGR02168, SMC_prok_B, chromosome segregation prot | 0.001 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 0.001 | |
| pfam13514 | 1118 | pfam13514, AAA_27, AAA domain | 0.001 | |
| pfam01576 | 859 | pfam01576, Myosin_tail_1, Myosin tail | 0.001 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 0.002 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 0.002 | |
| COG4477 | 570 | COG4477, EzrA, Negative regulator of septation rin | 0.002 | |
| PRK14139 | 185 | PRK14139, PRK14139, heat shock protein GrpE; Provi | 0.002 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 0.002 | |
| PRK12705 | 508 | PRK12705, PRK12705, hypothetical protein; Provisio | 0.002 | |
| PRK00409 | 782 | PRK00409, PRK00409, recombination and DNA strand e | 0.002 | |
| COG4372 | 499 | COG4372, COG4372, Uncharacterized protein conserve | 0.002 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.002 | |
| TIGR02169 | 1164 | TIGR02169, SMC_prok_A, chromosome segregation prot | 0.003 | |
| TIGR02169 | 1164 | TIGR02169, SMC_prok_A, chromosome segregation prot | 0.003 | |
| TIGR02168 | 1179 | TIGR02168, SMC_prok_B, chromosome segregation prot | 0.003 | |
| pfam02463 | 1162 | pfam02463, SMC_N, RecF/RecN/SMC N terminal domain | 0.003 | |
| COG0711 | 161 | COG0711, AtpF, F0F1-type ATP synthase, subunit b [ | 0.003 | |
| pfam00769 | 244 | pfam00769, ERM, Ezrin/radixin/moesin family | 0.003 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 0.003 | |
| PRK02224 | 880 | PRK02224, PRK02224, chromosome segregation protein | 0.003 | |
| COG0419 | 908 | COG0419, SbcC, ATPase involved in DNA repair [DNA | 0.004 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 0.004 | |
| pfam01576 | 859 | pfam01576, Myosin_tail_1, Myosin tail | 0.004 | |
| COG4026 | 290 | COG4026, COG4026, Uncharacterized protein containi | 0.004 | |
| pfam12037 | 276 | pfam12037, DUF3523, Domain of unknown function (DU | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 176 bits (448), Expect = 1e-50
Identities = 79/200 (39%), Positives = 110/200 (55%), Gaps = 20/200 (10%)
Query: 472 IGEGGYGSIYKGLLRHM--QVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLVGAC 528
+GEGG+G++Y + +VAIK++ E +EI+IL K+ HPN+V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 529 --PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 586
LV EY GSL+D L K+N LS +RI ++ L +LHS + I+H
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLL--KENEGKLSEDEILRILLQILEGLEYLHS---NGIIH 115
Query: 587 GDLKPANILLDA-NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE-FLA 644
DLKP NILLD+ N KL+DFG+S+ L+ + S T+ GT AYM PE L
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSD--KSLLKTIV------GTPAYMAPEVLLG 167
Query: 645 SGELTPKSDVYSFGIILLRL 664
G + KSD++S G+IL L
Sbjct: 168 KGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 168 bits (429), Expect = 2e-47
Identities = 83/268 (30%), Positives = 117/268 (43%), Gaps = 30/268 (11%)
Query: 471 KIGEGGYGSIYKGLLR--HMQVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTLVGA 527
K+GEG +G +Y + VAIK++ + +EI IL K++HPN+V L
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65
Query: 528 C---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 584
+++ LV EY G L D L LS ++ S L +LHS I
Sbjct: 66 FEDEDKLY-LVMEYCEGGDLFDLL---KKRGRLSEDEARFYLRQILSALEYLHS---KGI 118
Query: 585 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 644
VH DLKP NILLD + KL+DFG++R L E TT GT YM PE L
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL---TTFV------GTPEYMAPEVLL 169
Query: 645 SGELTPKSDVYSFGIILLRLLTGR-PALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAE 703
D++S G+IL LLTG+ P G + ++ GK K P D
Sbjct: 170 GKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDIS----P 225
Query: 704 QLANLAMRCCEMSRKSRP---ELGKDVW 728
+ +L + + R E + +
Sbjct: 226 EAKDLIRKLLVKDPEKRLTAEEALQHPF 253
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 5e-46
Identities = 98/273 (35%), Positives = 137/273 (50%), Gaps = 34/273 (12%)
Query: 471 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTLV 525
K+G G +G++YK + VA+K+L S + + Q EI IL ++ HPN+V L+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRS-EKSKKDQTARREIRILRRLSHPNIVRLI 64
Query: 526 GAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 582
A ++ LV EY G L D LS PLS +IA ++ L +LHS +
Sbjct: 65 DAFEDKDHLY-LVMEYCEGGDLFDYLS---RGGPLSEDEAKKIALQILRGLEYLHS---N 117
Query: 583 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 642
I+H DLKP NILLD N V K++DFG+++ L ++ SS+ TT GT YM PE
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKS--SSSLTTFV------GTPWYMAPEV 169
Query: 643 LASGEL-TPKSDVYSFGIILLRLLTGRPAL-GITKEVQYALDTGKLKNLLDPLAGDWPFV 700
L G PK DV+S G+IL LLTG+P G Q L + L PL D P
Sbjct: 170 LLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLI---RRILGPPLEFDEPKW 226
Query: 701 --QAEQLANLAMRCCEMSRKSRP---ELGKDVW 728
+E+ +L +C RP E+ + W
Sbjct: 227 SSGSEEAKDLIKKCLNKDPSKRPTAEEILQHPW 259
|
Length = 260 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 164 bits (418), Expect = 7e-46
Identities = 85/263 (32%), Positives = 127/263 (48%), Gaps = 32/263 (12%)
Query: 471 KIGEGGYGSIYKGLLR------HMQVAIKML-HPHSLQGPSEFQQEIDILSKIRHPNLVT 523
K+GEG +G +YKG L+ ++VA+K L S Q EF +E I+ K+ HPN+V
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 524 LVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 581
L+G C E +V EY+ G L L + N P LS + A ++ + +L S
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLESKN- 122
Query: 582 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 641
+H DL N L+ N V K+SDFG+SR L ++ + K +M PE
Sbjct: 123 --FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY-------YRKRGGKLPIRWMAPE 173
Query: 642 FLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTGKLKNLLDPLAGDWP 698
L G+ T KSDV+SFG++L + T +P G++ +EV L G L P
Sbjct: 174 SLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNG---YRLPQ-----P 225
Query: 699 FVQAEQLANLAMRCCEMSRKSRP 721
+L +L ++C + RP
Sbjct: 226 PNCPPELYDLMLQCWAEDPEDRP 248
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 156 bits (398), Expect = 4e-43
Identities = 87/264 (32%), Positives = 125/264 (47%), Gaps = 33/264 (12%)
Query: 471 KIGEGGYGSIYKGLLR------HMQVAIKML-HPHSLQGPSEFQQEIDILSKIRHPNLVT 523
K+GEG +G +YKG L+ ++VA+K L S Q EF +E I+ K+ HPN+V
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 524 LVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPP-LSWQTRIRIATELCSVLIFLHSCK 580
L+G C E +V EY+P G L D L + N P LS + A ++ + +L S
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYL--RKNRPKELSLSDLLSFALQIARGMEYLESKN 123
Query: 581 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 640
+H DL N L+ N V K+SDFG+SR L ++ K +M P
Sbjct: 124 ---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYK-------VKGGKLPIRWMAP 173
Query: 641 EFLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTGKLKNLLDPLAGDW 697
E L G+ T KSDV+SFG++L + T P G++ EV L G L
Sbjct: 174 ESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKG---YRLPK----- 225
Query: 698 PFVQAEQLANLAMRCCEMSRKSRP 721
P +L L ++C + RP
Sbjct: 226 PPNCPPELYKLMLQCWAEDPEDRP 249
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 4e-41
Identities = 83/265 (31%), Positives = 131/265 (49%), Gaps = 35/265 (13%)
Query: 471 KIGEGGYGSIYKGLLR------HMQVAIKMLHPH-SLQGPSEFQQEIDILSKIRHPNLVT 523
K+GEG +G +YKG L+ +VA+K L S + EF +E I+ K+ HPN+V
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 524 LVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 581
L+G C E +V EY+P G L D L + + L+ + +++A ++ + +L S
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYLES--- 120
Query: 582 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF--AYMD 639
+ VH DL N L+ N V K+SDFG+SR + +++ R G +M
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYY--------RKRGGGKLPIKWMA 172
Query: 640 PEFLASGELTPKSDVYSFGIILLRLLTG--RPALGIT-KEVQYALDTGKLKNLLDPLAGD 696
PE L G+ T KSDV+SFG++L + T +P G++ +EV L+ G L
Sbjct: 173 PESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDG---YRLPRPENC 229
Query: 697 WPFVQAEQLANLAMRCCEMSRKSRP 721
+L L ++C + RP
Sbjct: 230 PD-----ELYELMLQCWAYDPEDRP 249
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (377), Expect = 3e-40
Identities = 68/205 (33%), Positives = 100/205 (48%), Gaps = 23/205 (11%)
Query: 471 KIGEGGYGSIYKGLLR-----HMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTL 524
K+GEG +G +YKG L+ +VA+K L S + +F +E ++ K+ HPN+V L
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 525 VGACPEV--WTLVYEYLPNGSLEDRL------SCKDNSPPLSWQTRIRIATELCSVLIFL 576
+G C E LV EY+ G L D L LS + + A ++ + +L
Sbjct: 62 LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121
Query: 577 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 636
S K VH DL N L+ + V K+SDFG+SR + ++ P
Sbjct: 122 ASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD---YYRKKTGGKLP---IR 172
Query: 637 YMDPEFLASGELTPKSDVYSFGIIL 661
+M PE L G T KSDV+SFG++L
Sbjct: 173 WMAPESLKDGIFTSKSDVWSFGVLL 197
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 2e-38
Identities = 73/209 (34%), Positives = 109/209 (52%), Gaps = 20/209 (9%)
Query: 466 FDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVT 523
F+ KIG+GG+G +YK + VAIK++ S + + EI IL K +HPN+V
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 524 LVGA--CP-EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 580
G+ E+W +V E+ GSL+D L K + L+ + EL L +LHS
Sbjct: 62 YYGSYLKKDELW-IVMEFCSGGSLKDLL--KSTNQTLTESQIAYVCKELLKGLEYLHS-- 116
Query: 581 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 640
+ I+H D+K ANILL ++ KL DFG+S LS + + NT + GT +M P
Sbjct: 117 -NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK--ARNTMV-------GTPYWMAP 166
Query: 641 EFLASGELTPKSDVYSFGIILLRLLTGRP 669
E + K+D++S GI + L G+P
Sbjct: 167 EVINGKPYDYKADIWSLGITAIELAEGKP 195
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 4e-38
Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 20/207 (9%)
Query: 471 KIGEGGYGSIYKGLLRHM--QVAIK--MLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVG 526
+G G +GS+Y L + +A+K L S + ++EI ILS ++HPN+V G
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 527 AC----PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 582
+ + EY+ GSL L L + ++ L +LHS +
Sbjct: 67 SERDEEKNTLNIFLEYVSGGSLSSLL---KKFGKLPEPVIRKYTRQILEGLAYLHS---N 120
Query: 583 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 642
IVH D+K ANIL+D++ V KL+DFG ++ L E ++ +GT +M PE
Sbjct: 121 GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSV------RGTPYWMAPEV 174
Query: 643 LASGELTPKSDVYSFGIILLRLLTGRP 669
+ E +D++S G ++ + TG+P
Sbjct: 175 IRGEEYGRAADIWSLGCTVIEMATGKP 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 2e-33
Identities = 88/269 (32%), Positives = 123/269 (45%), Gaps = 22/269 (8%)
Query: 471 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSE---FQQEIDILSKIRHP-NLVTL-- 524
K+GEG +G +Y VA+K+L E F +EI IL+ + HP N+V L
Sbjct: 7 KLGEGSFGEVYLAR-DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65
Query: 525 VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 584
LV EY+ GSLED L PLS + I ++ S L +LHS I
Sbjct: 66 FFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGI 122
Query: 585 VHGDLKPANILLDAN-FVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 643
+H D+KP NILLD + V KL DFG+++ L +S+ L + GT YM PE L
Sbjct: 123 IHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALP--STSVGTPGYMAPEVL 180
Query: 644 ASGEL---TPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK------LKNLLDPLA 694
L + SD++S GI L LLTG P K T K +L PL+
Sbjct: 181 LGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLS 240
Query: 695 GDWPFVQAEQLANLAMRCCEMSRKSRPEL 723
P + ++ ++L + K+R
Sbjct: 241 PSNPELISKAASDLLKKLLAKDPKNRLSS 269
|
Length = 384 |
| >gnl|CDD|238947 cd01989, STK_N, The N-terminal domain of Eukaryotic Serine Threonine kinases | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 2e-30
Identities = 37/118 (31%), Positives = 60/118 (50%), Gaps = 5/118 (4%)
Query: 18 HARTNDSMGTKFPASSLEEEKVQAYREIERQDMHNHLDMCLLICRQMGVRAEKLDTESES 77
H + P+SS + E AY++ E ++ L C + GV+ E + E +
Sbjct: 34 HVHPPITSI---PSSSGKLEVASAYKQEEDKEAKELLLPYRCFCSRKGVQCEDVVLEDDD 90
Query: 78 TEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAPASCHIWFICNG 135
K I+E ++ +GI KLVMGA++D H+ K KS A SV ++AP C ++ + G
Sbjct: 91 VAKAIVEYVADHGITKLVMGASSDNHFSMK--FKKSDVASSVLKEAPDFCTVYVVSKG 146
|
The Serine Threonine kinases are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. The N-terminal domain is homologous to the USP family which has a ATP binding fold. The N-terminal domain is predicted to be involved in ATP binding. Length = 146 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 4e-30
Identities = 64/213 (30%), Positives = 97/213 (45%), Gaps = 30/213 (14%)
Query: 471 KIGEGGYGSIYKGLLRH----MQVAIK--MLHPHSLQGPSEFQQEIDILSKIRHPNLVTL 524
+IG+G +G +Y L+R +K L S + + E+ IL K+ HPN++
Sbjct: 7 QIGKGSFGKVY--LVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKY 64
Query: 525 VGACPEVWT------LVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLH 577
E + +V EY G L ++ K P + + +LC L +LH
Sbjct: 65 Y----ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120
Query: 578 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 637
S K I+H D+KP NI L +N + KL DFGIS+ LS + T+ GT Y
Sbjct: 121 SRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAK--TVV------GTPYY 169
Query: 638 MDPEFLASGELTPKSDVYSFGIILLRLLTGRPA 670
+ PE + KSD++S G +L L T +
Sbjct: 170 LSPELCQNKPYNYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 3e-28
Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 20/205 (9%)
Query: 471 KIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPS--EFQQEIDILSKIRHPNLVTLVG 526
IG G +G +YKGL VAIK + ++ + QEID+L ++HPN+V +G
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 527 ACPEVWTL--VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 584
+ +L + EY NGSL + P ++ L +LH +
Sbjct: 67 SIETSDSLYIILEYAENGSLRQIIK---KFGPFPESLVAVYVYQVLQGLAYLHE---QGV 120
Query: 585 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 644
+H D+K ANIL + V KL+DFG++ L+ GT +M PE +
Sbjct: 121 IHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--------DASVVGTPYWMAPEVIE 172
Query: 645 SGELTPKSDVYSFGIILLRLLTGRP 669
+ SD++S G ++ LLTG P
Sbjct: 173 MSGASTASDIWSLGCTVIELLTGNP 197
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 60/205 (29%), Positives = 95/205 (46%), Gaps = 22/205 (10%)
Query: 471 KIGEGGYGSIYKGLLR--HMQVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTLVGA 527
+G+G G +YK + A+K +H + + +E+ L P +V GA
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 528 C--PEVWTLVYEYLPNGSLEDRL--SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 583
++V EY+ GSL D L K P L+ IA ++ L +LH
Sbjct: 68 FYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLA-----YIARQILKGLDYLH--TKRH 120
Query: 584 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 643
I+H D+KP+N+L+++ K++DFGIS+ L NT C T GT YM PE +
Sbjct: 121 IIHRDIKPSNLLINSKGEVKIADFGISKVLE-------NTLDQCNTF-VGTVTYMSPERI 172
Query: 644 ASGELTPKSDVYSFGIILLRLLTGR 668
+ +D++S G+ LL G+
Sbjct: 173 QGESYSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 73/220 (33%), Positives = 108/220 (49%), Gaps = 18/220 (8%)
Query: 471 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC- 528
K+G G +G ++ G +VA+K L P ++ P F QE I+ K+RH LV L C
Sbjct: 13 KLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS-PEAFLQEAQIMKKLRHDKLVQLYAVCS 71
Query: 529 -PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 587
E +V EY+ GSL D L L + +A ++ + +L S + +H
Sbjct: 72 EEEPIYIVTEYMSKGSLLDFLK-SGEGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHR 127
Query: 588 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 647
DL NIL+ N V K++DFG++R + +E R K + PE G
Sbjct: 128 DLAARNILVGENLVCKIADFGLARLIEDDE-------YTAREGAKFPIKWTAPEAANYGR 180
Query: 648 LTPKSDVYSFGIILLRLLT-GR-PALGITK-EVQYALDTG 684
T KSDV+SFGI+L ++T GR P G+T EV ++ G
Sbjct: 181 FTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERG 220
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 63/236 (26%), Positives = 100/236 (42%), Gaps = 46/236 (19%)
Query: 464 HNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKML---HPHSLQGPSEFQQEIDILSKI-R 517
+F IGEG + ++ + + AIK+L + + E ++L+++
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 518 HPNLVTLVGACPEVWT--------LVYEYLPNGSLED---RLSCKDNSPPLSWQTRIR-I 565
HP ++ L +T V EY PNG L + D + R
Sbjct: 61 HPGIIKLY------YTFQDEENLYFVLEYAPNGELLQYIRKYGSLD-------EKCTRFY 107
Query: 566 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 625
A E+ L +LHS I+H DLKP NILLD + K++DFG ++ L N +N
Sbjct: 108 AAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGD 164
Query: 626 CCRTDPK------------GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 669
D + GT Y+ PE L SD+++ G I+ ++LTG+P
Sbjct: 165 ATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKP 220
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 73/208 (35%), Positives = 101/208 (48%), Gaps = 27/208 (12%)
Query: 472 IGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTL 524
+G+G +G + L+R A+K+L + E + E +ILS+I HP +V L
Sbjct: 1 LGKGSFGKVL--LVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL 58
Query: 525 VGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIR-IATELCSVLIFLHSCKP 581
A E LV EY P G L LS S + R R A E+ L +LHS
Sbjct: 59 HYAFQTEEKLYLVLEYAPGGELFSHLS---KEGRFS-EERARFYAAEIVLALEYLHS--- 111
Query: 582 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 641
I++ DLKP NILLDA+ KL+DFG+++ LS S T C GT Y+ PE
Sbjct: 112 LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFC------GTPEYLAPE 163
Query: 642 FLASGELTPKSDVYSFGIILLRLLTGRP 669
L D +S G++L +LTG+P
Sbjct: 164 VLLGKGYGKAVDWWSLGVLLYEMLTGKP 191
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 68/220 (30%), Positives = 111/220 (50%), Gaps = 18/220 (8%)
Query: 471 KIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 529
K+G G +G +++GL + VA+K L P ++ P +F E I+ K+RHP L+ L C
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 530 --EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 587
E +V E + GSL + L L I +A ++ S + +L + + +H
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQ-GGAGRALKLPQLIDMAAQVASGMAYLEA---QNYIHR 127
Query: 588 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 647
DL N+L+ N + K++DFG++R + ++ + R K + PE
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKEDIYEA-------REGAKFPIKWTAPEAALYNR 180
Query: 648 LTPKSDVYSFGIILLRLLT-GR-PALGIT-KEVQYALDTG 684
+ KSDV+SFGI+L ++T GR P G+T EV +D G
Sbjct: 181 FSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG 220
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 9e-26
Identities = 61/192 (31%), Positives = 98/192 (51%), Gaps = 18/192 (9%)
Query: 472 IGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEV 531
IG+G +G + G R +VA+K L S + F E +++ +RHPNLV L+G +
Sbjct: 14 IGKGEFGDVMLGDYRGQKVAVKCLKDDSTAAQA-FLAEASVMTTLRHPNLVQLLGVVLQG 72
Query: 532 WTL--VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDL 589
L V EY+ GSL D L + + ++ ++ A ++C + +L VH DL
Sbjct: 73 NPLYIVTEYMAKGSLVDYLRSRGRAV-ITLAQQLGFALDVCEGMEYLEEKN---FVHRDL 128
Query: 590 KPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELT 649
N+L+ + V+K+SDFG+++ SQ + S K + PE L + +
Sbjct: 129 AARNVLVSEDLVAKVSDFGLAKEASQGQDSG-----------KLPVKWTAPEALREKKFS 177
Query: 650 PKSDVYSFGIIL 661
KSDV+SFGI+L
Sbjct: 178 TKSDVWSFGILL 189
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 68/222 (30%), Positives = 106/222 (47%), Gaps = 50/222 (22%)
Query: 472 IGEGGYGSIYKGLL------RHMQ-VAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVT 523
+GEG +G +YKG L VAIK L + EF+QE +++S ++HPN+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 524 LVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSP---------------PLSWQTRIRIA 566
L+G C + +++EYL +G L + L NSP L + IA
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLV--RNSPHSDVGAESGDETVKSSLDCSDFLHIA 130
Query: 567 TELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS------ 620
++ + + +L S H VH DL N L+ K+SDFG+SR +I S
Sbjct: 131 IQIAAGMEYLSS---HHFVHRDLAARNCLVGEGLTVKISDFGLSR-----DIYSADYYRV 182
Query: 621 -NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIIL 661
+ + L R +M PE + G+ T +SD++SFG++L
Sbjct: 183 QSKSLLPVR--------WMPPEAILYGKFTTESDIWSFGVVL 216
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 9e-25
Identities = 70/213 (32%), Positives = 98/213 (46%), Gaps = 29/213 (13%)
Query: 471 KIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPS--EFQQEIDILSKIRHPNLVTLVG 526
KIG G +G +Y L +A+K + + E E+ +L ++HPNLV G
Sbjct: 7 KIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG 66
Query: 527 ACPEV----WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIAT-ELCSVLIFLHSCKP 581
EV + EY G+LE+ L + IR+ T +L L +LHS
Sbjct: 67 V--EVHREKVYIFMEYCSGGTLEELLEHGRILD----EHVIRVYTLQLLEGLAYLHSHG- 119
Query: 582 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRT--DPKGTFAYMD 639
IVH D+KPANI LD N V KL DFG + NNTT GT AYM
Sbjct: 120 --IVHRDIKPANIFLDHNGVIKLGDFGCAV------KLKNNTTTMGEEVQSLAGTPAYMA 171
Query: 640 PEFLASGELTPK---SDVYSFGIILLRLLTGRP 669
PE + G+ +D++S G ++L + TG+
Sbjct: 172 PEVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 62/207 (29%), Positives = 97/207 (46%), Gaps = 27/207 (13%)
Query: 471 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTLVGA 527
++G G G + K L R + + + +Q E+DIL K P +V GA
Sbjct: 8 ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67
Query: 528 C---PEVWTLVYEYLPNGSLEDRL-SCKDNSP--PLSWQTRIRIATELCSVLIFLHSCKP 581
++ + EY+ GSL+ L + P L +IA + L +LH
Sbjct: 68 FYNNGDIS-ICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLTYLHE--K 119
Query: 582 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 641
H I+H D+KP+NIL+++ KL DFG+S L N ++ GT +YM PE
Sbjct: 120 HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLV-NSLAKTFV---------GTSSYMAPE 169
Query: 642 FLASGELTPKSDVYSFGIILLRLLTGR 668
+ + + KSD++S G+ L+ L TGR
Sbjct: 170 RIQGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 67/212 (31%), Positives = 98/212 (46%), Gaps = 27/212 (12%)
Query: 472 IGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTL 524
I +G YG ++ L + AIK++ + ++ Q E DILS+ + P +V L
Sbjct: 1 ISKGAYGRVF--LAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58
Query: 525 VGACPEVWTL--VYEYLPNG---SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 579
+ L V EYLP G SL + + D RI IA E+ L +LHS
Sbjct: 59 YYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDED-----VARIYIA-EIVLALEYLHS- 111
Query: 580 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI--SSNNTTLCCRTDPKGTFAY 637
+ I+H DLKP NIL+D+N KL+DFG+S+ +++ R GT Y
Sbjct: 112 --NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRI--VGTPDY 167
Query: 638 MDPEFLASGELTPKSDVYSFGIILLRLLTGRP 669
+ PE + + D +S G IL L G P
Sbjct: 168 IAPEVILGQGHSKTVDWWSLGCILYEFLVGIP 199
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 64/209 (30%), Positives = 96/209 (45%), Gaps = 28/209 (13%)
Query: 471 KIGEGGYGSIYKG-----LLRHMQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTL 524
K+G+G +G + +G + + VA+K L L +F +E I+ + H NL+ L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 525 VGACPEVWT----LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 580
G V T +V E P GSL DRL KD T A ++ + + +L S
Sbjct: 62 YGV---VLTHPLMMVTELAPLGSLLDRLR-KDALGHFLISTLCDYAVQIANGMRYLES-- 115
Query: 581 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE---ISSNNTTLCCRTDPKGTFAY 637
+H DL NILL ++ K+ DFG+ R L QNE + + K FA+
Sbjct: 116 -KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHL--------KVPFAW 166
Query: 638 MDPEFLASGELTPKSDVYSFGIILLRLLT 666
PE L + + SDV+ FG+ L + T
Sbjct: 167 CAPESLRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 60/225 (26%), Positives = 104/225 (46%), Gaps = 48/225 (21%)
Query: 472 IGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQGPSE-FQQEIDILSKIRHPNLVT 523
+GEG +G ++ G H VA+K L + + F++E ++L+ +H N+V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 524 LVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSP-------------PLSWQTRIRIATE 568
G C E +V+EY+ +G L L + + P L+ ++IA +
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFL--RSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 569 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN------ 622
+ S +++L S VH DL N L+ + V K+ DFG+SR ++ + +
Sbjct: 131 IASGMVYLAS---QHFVHRDLATRNCLVGYDLVVKIGDFGMSR-----DVYTTDYYRVGG 182
Query: 623 -TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 666
T L R +M PE + + T +SDV+SFG++L + T
Sbjct: 183 HTMLPIR--------WMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 64/215 (29%), Positives = 110/215 (51%), Gaps = 30/215 (13%)
Query: 471 KIGEGGYGSIYKGLLRH--------MQVAIKMLHPHS-LQGPSEFQQEIDILSKIRHPNL 521
++GEG +G + R+ QVA+K L+ Q S+F++EI+IL + H N+
Sbjct: 11 QLGEGHFGKVELC--RYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68
Query: 522 VTLVGACPEVWT----LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 577
V G C + L+ EYLP+GSL D L + + ++ + + ++++C + +L
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLG 126
Query: 578 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE--ISSNNTTLCCRTDPKGTF 635
S + +H DL NIL+++ + K+SDFG+++ L +++ P F
Sbjct: 127 SQR---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEP----GESP--IF 177
Query: 636 AYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRP 669
Y PE L + + + SDV+SFG+ L L T G P
Sbjct: 178 WYA-PECLRTSKFSSASDVWSFGVTLYELFTYGDP 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 70/208 (33%), Positives = 100/208 (48%), Gaps = 25/208 (12%)
Query: 471 KIGEGGYGSIYKGLLRHMQ----VAIKMLH-PHSLQG-PSEFQQEIDILSKIRHPNLVTL 524
K+GEG YG +YK R + VA+K + + +G PS +EI +L +++HPN+V L
Sbjct: 6 KLGEGTYGVVYKA--RDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKL 63
Query: 525 --VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 582
V LV+EY L+ L PLS I +L L + HS H
Sbjct: 64 LDVIHTERKLYLVFEYCDM-DLKKYL--DKRPGPLSPNLIKSIMYQLLRGLAYCHS---H 117
Query: 583 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE- 641
I+H DLKP NIL++ + V KL+DFG++R T T T Y PE
Sbjct: 118 RILHRDLKPQNILINRDGVLKLADFGLARA-----FGIPLRTY---THEVVTLWYRAPEI 169
Query: 642 FLASGELTPKSDVYSFGIILLRLLTGRP 669
L S + D++S G I ++TG+P
Sbjct: 170 LLGSKHYSTAVDIWSVGCIFAEMITGKP 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 80/256 (31%), Positives = 125/256 (48%), Gaps = 25/256 (9%)
Query: 471 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 529
K+G G +G ++ G H +VAIK L S+ P F E +++ +++HP LV L
Sbjct: 13 KLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS-PEAFLAEANLMKQLQHPRLVRLYAVVT 71
Query: 530 -EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGD 588
E ++ EY+ NGSL D L + L+ I +A ++ + F+ + +H D
Sbjct: 72 QEPIYIITEYMENGSLVDFLKTPEGIK-LTINKLIDMAAQIAEGMAFIER---KNYIHRD 127
Query: 589 LKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL 648
L+ ANIL+ K++DFG++R + NE ++ R K + PE + G
Sbjct: 128 LRAANILVSETLCCKIADFGLARLIEDNEYTA-------REGAKFPIKWTAPEAINYGTF 180
Query: 649 TPKSDVYSFGIILLRLLT-GR-PALGITK-EVQYALDTGKLKNLLDPLAGDWPFVQAEQL 705
T KSDV+SFGI+L ++T GR P G+T EV L+ G P + P E+L
Sbjct: 181 TIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRM----PRPDNCP----EEL 232
Query: 706 ANLAMRCCEMSRKSRP 721
L C + + RP
Sbjct: 233 YELMRLCWKEKPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 2e-23
Identities = 56/199 (28%), Positives = 104/199 (52%), Gaps = 16/199 (8%)
Query: 472 IGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPE 530
+G G +G ++ G R + VAIKM+ ++ +F +E ++ K+ HPNLV L G C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMS-EDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 531 VWTL--VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGD 588
+ V EY+ NG L + L ++ L + + + +++C + +L S + +H D
Sbjct: 71 QRPIFIVTEYMANGCLLNYL--RERKGKLGTEWLLDMCSDVCEAMEYLES---NGFIHRD 125
Query: 589 LKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL 648
L N L+ + V K+SDFG++R++ ++ +S+ T K + PE
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGT-------KFPVKWAPPEVFDYSRF 178
Query: 649 TPKSDVYSFGIILLRLLTG 667
+ KSDV+SFG+++ + +
Sbjct: 179 SSKSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 99.4 bits (247), Expect = 4e-23
Identities = 82/257 (31%), Positives = 125/257 (48%), Gaps = 25/257 (9%)
Query: 470 LKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 528
+K+G+G +G ++ G +VAIK L P ++ P F QE ++ K+RH LV L
Sbjct: 12 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVV 70
Query: 529 PE-VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 587
E +V EY+ GSL D L + L + +A ++ S + ++ + VH
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLK-GEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHR 126
Query: 588 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 647
DL+ ANIL+ N V K++DFG++R + NE ++ R K + PE G
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEYTA-------RQGAKFPIKWTAPEAALYGR 179
Query: 648 LTPKSDVYSFGIILLRLLT-GR-PALG-ITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQ 704
T KSDV+SFGI+L L T GR P G + +EV ++ G P + P E
Sbjct: 180 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM----PCPPECP----ES 231
Query: 705 LANLAMRCCEMSRKSRP 721
L +L +C + RP
Sbjct: 232 LHDLMCQCWRKEPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 6e-23
Identities = 64/224 (28%), Positives = 105/224 (46%), Gaps = 21/224 (9%)
Query: 472 IGEGGYGSIYKGLLR-----HMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTLV 525
+G G +GS+ KG+ ++VA+K L H G EF +E +++++ HP +V L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 526 GAC-PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 584
G C E LV E P G L L K + +A ++ + +L S
Sbjct: 63 GVCKGEPLMLVMELAPLGPLLKYL--KKR-REIPVSDLKELAHQVAMGMAYLESKH---F 116
Query: 585 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 644
VH DL N+LL +K+SDFG+SR L + + T + + PE +
Sbjct: 117 VHRDLAARNVLLVNRHQAKISDFGMSRAL-----GAGSDYYRATTAGRWPLKWYAPECIN 171
Query: 645 SGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTGK 685
G+ + KSDV+S+G+ L + +P + EV L++G+
Sbjct: 172 YGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGE 215
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 8e-23
Identities = 72/265 (27%), Positives = 115/265 (43%), Gaps = 31/265 (11%)
Query: 471 KIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVT 523
IG+G +G++ K +R + K + ++ E QQ E++IL +++HPN+V
Sbjct: 7 TIGKGSFGTVRK--VRRKSDGKILVWKEIDYGNMT-EKEKQQLVSEVNILRELKHPNIVR 63
Query: 524 ----LVGACPEVWTLVYEYLPNGSLEDRLS-CKDNSPPLSWQTRIRIATELCSVLIFLH- 577
++ + +V EY G L + CK + + RI T+L L H
Sbjct: 64 YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123
Query: 578 -SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 636
S ++++H DLKPANI LDAN KL DFG+++ L S+ GT
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL---GHDSSFAKTYV-----GTPY 175
Query: 637 YMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 696
YM PE L KSD++S G ++ L P ++Q A K+K
Sbjct: 176 YMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLA---SKIKEGKFR---R 229
Query: 697 WPFVQAEQLANLAMRCCEMSRKSRP 721
P+ + +L + + RP
Sbjct: 230 IPYRYSSELNEVIKSMLNVDPDKRP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 2e-22
Identities = 58/204 (28%), Positives = 105/204 (51%), Gaps = 25/204 (12%)
Query: 471 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 529
K+G G +G +++GL + ++VAIK+L L +FQ+E+ L ++RH +L++L C
Sbjct: 13 KLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS 72
Query: 530 E---VWTLVYEYLPNGSLEDRLSCKD----NSPPLSWQTRIRIATELCSVLIFLHSCKPH 582
V+ ++ E + GSL L + L I +A ++ + +L
Sbjct: 73 VGEPVY-IITELMEKGSLLAFLRSPEGQVLPVASL-----IDMACQVAEGMAYLEE---Q 123
Query: 583 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 642
+ +H DL NIL+ + V K++DFG++R + ++ S++ K + + PE
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDK--------KIPYKWTAPEA 175
Query: 643 LASGELTPKSDVYSFGIILLRLLT 666
+ G + KSDV+SFGI+L + T
Sbjct: 176 ASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|128780 smart00504, Ubox, Modified RING finger domain | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 2e-22
Identities = 36/64 (56%), Positives = 45/64 (70%), Gaps = 1/64 (1%)
Query: 757 YFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSA 816
F CPI EVM+DP + G TYE A++ WL S H T P+T PL H++L+PNLAL+SA
Sbjct: 1 EFLCPISLEVMKDPVILPSGQTYERSAIEKWLLS-HGTDPVTGQPLTHEDLIPNLALKSA 59
Query: 817 IQEW 820
IQEW
Sbjct: 60 IQEW 63
|
Modified RING finger domain, without the full complement of Zn2+-binding ligands. Probable involvement in E2-dependent ubiquitination. Length = 63 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 96.9 bits (242), Expect = 4e-22
Identities = 66/207 (31%), Positives = 107/207 (51%), Gaps = 26/207 (12%)
Query: 471 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSE--FQQEIDILSKIRHPNLVTLVG 526
KIGEG G +YK R +VAIK + L+ ++ EI I+ +HPN+V
Sbjct: 26 KIGEGASGEVYKATDRATGKEVAIKKMR---LRKQNKELIINEILIMKDCKHPNIVDYYD 82
Query: 527 AC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRI-RIATELCSVLIFLHSCKPH 582
+ E+W +V EY+ GSL D ++ N ++ + +I + E+ L +LHS
Sbjct: 83 SYLVGDELW-VVMEYMDGGSLTDIITQ--NFVRMN-EPQIAYVCREVLQGLEYLHS---Q 135
Query: 583 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 642
+++H D+K NILL + KL+DFG + L++ E S N+ + GT +M PE
Sbjct: 136 NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK-EKSKRNSVV-------GTPYWMAPEV 187
Query: 643 LASGELTPKSDVYSFGIILLRLLTGRP 669
+ + PK D++S GI+ + + G P
Sbjct: 188 IKRKDYGPKVDIWSLGIMCIEMAEGEP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 4e-22
Identities = 62/208 (29%), Positives = 101/208 (48%), Gaps = 24/208 (11%)
Query: 471 KIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTL 524
+IGEG +G ++K + + VA+K + L+G P++ +EI L +HP +V L
Sbjct: 7 RIGEGAHGIVFKA--KDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKL 64
Query: 525 VGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 582
+ + LV EY+P L + L +D PL L + ++H+ +
Sbjct: 65 LDVFPHGSGFVLVMEYMP-SDLSEVL--RDEERPLPEAQVKSYMRMLLKGVAYMHA---N 118
Query: 583 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 642
I+H DLKPAN+L+ A+ V K++DFG++R S+ E + T Y PE
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL-------YSHQVATRWYRAPEL 171
Query: 643 L-ASGELTPKSDVYSFGIILLRLLTGRP 669
L + + P D+++ G I LL G P
Sbjct: 172 LYGARKYDPGVDLWAVGCIFAELLNGSP 199
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 5e-22
Identities = 92/314 (29%), Positives = 137/314 (43%), Gaps = 43/314 (13%)
Query: 449 QFF-SDFSFS-EIEGATHNFDPSLKIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPS 504
QFF S S S I + I G G+ YKG + MQ +K ++ + S
Sbjct: 673 QFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSS 732
Query: 505 EFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTR 562
E + K++HPN+V L+G C + L++EY+ +L + L LSW+ R
Sbjct: 733 EIAD----MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR------NLSWERR 782
Query: 563 IRIATELCSVLIFLH-SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 621
+IA + L FLH C P ++V G+L P I++D L S
Sbjct: 783 RKIAIGIAKALRFLHCRCSP-AVVVGNLSPEKIIIDGKDEPHL-------------RLSL 828
Query: 622 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR----PALG----I 673
LC T + AY+ PE + ++T KSD+Y FG+IL+ LLTG+ G I
Sbjct: 829 PGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSI 888
Query: 674 TKEVQYALDTGKLKNLLDP-LAGDWPFVQAE--QLANLAMRCCEMSRKSRPELGKDVWRV 730
+ +Y L +DP + GD Q E ++ NLA+ C +RP DV +
Sbjct: 889 VEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARP-CANDVLKT 947
Query: 731 LEPMRASCGGSTSY 744
LE S +
Sbjct: 948 LESASRSSSSCVTG 961
|
Length = 968 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 5e-22
Identities = 74/271 (27%), Positives = 124/271 (45%), Gaps = 50/271 (18%)
Query: 472 IGEGGYGSIYKGLLR-----HMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTLV 525
IG G +G + +G L+ + VAIK L S + +F E I+ + HPN++ L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 526 GACPEVWTL--VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 583
G + + + EY+ NGSL+ L ++N + + + + S + +L +
Sbjct: 72 GVVTKSRPVMIITEYMENGSLDKFL--RENDGKFTVGQLVGMLRGIASGMKYLSE---MN 126
Query: 584 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD---- 639
VH DL NIL+++N V K+SDFG+SR L D + T+
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLE---------------DSEATYTTKGGKIP 171
Query: 640 -----PEFLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG-KLKNLL 690
PE +A + T SDV+SFGI++ +++ RP ++ ++V A++ G +L
Sbjct: 172 IRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRL---- 227
Query: 691 DPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 721
P D P + L + C + R RP
Sbjct: 228 -PPPMDCPSALYQ----LMLDCWQKDRNERP 253
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 5e-22
Identities = 73/220 (33%), Positives = 113/220 (51%), Gaps = 17/220 (7%)
Query: 470 LKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 528
+K+G+G +G ++ G +VAIK L P ++ P F QE I+ K+RH LV L
Sbjct: 12 VKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM-PEAFLQEAQIMKKLRHDKLVPLYAVV 70
Query: 529 PE-VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 587
E +V E++ GSL D L D L + +A ++ + ++ + +H
Sbjct: 71 SEEPIYIVTEFMGKGSLLDFLKEGDGKY-LKLPQLVDMAAQIADGMAYIERM---NYIHR 126
Query: 588 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 647
DL+ ANIL+ N V K++DFG++R + NE ++ R K + PE G
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNEYTA-------RQGAKFPIKWTAPEAALYGR 179
Query: 648 LTPKSDVYSFGIILLRLLT-GR-PALG-ITKEVQYALDTG 684
T KSDV+SFGI+L L+T GR P G + +EV ++ G
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERG 219
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 8e-22
Identities = 68/216 (31%), Positives = 107/216 (49%), Gaps = 35/216 (16%)
Query: 466 FDPSLKIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNL 521
FD K+GEG YGS+YK + H + VAIK++ E +EI IL + P +
Sbjct: 5 FDILEKLGEGSYGSVYKAI--HKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYI 60
Query: 522 VTLVGAC---PEVWTLVYEYLPNGSLED--RLSCKDNSPPLSWQTRIRIATELCSV---L 573
V G+ ++W +V EY GS+ D +++ K L+ + IA L L
Sbjct: 61 VKYYGSYFKNTDLW-IVMEYCGAGSVSDIMKITNK----TLTEE---EIAAILYQTLKGL 112
Query: 574 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 633
+LHS + +H D+K NILL+ +KL+DFG+S L + ++ NT + G
Sbjct: 113 EYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQL-TDTMAKRNTVI-------G 161
Query: 634 TFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 669
T +M PE + K+D++S GI + + G+P
Sbjct: 162 TPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 8e-22
Identities = 67/229 (29%), Positives = 111/229 (48%), Gaps = 27/229 (11%)
Query: 472 IGEGGYGSIYKG-------LLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL 524
+G G +GS+Y+G +V++ + + +QEI +LSK++HPN+V
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 525 VGACPEVWTL-VY-EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATE-LCSVLIFLHSCKP 581
+G E L ++ E +P GSL L + P + IR+ T + L +LH
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFP----EPVIRLYTRQILLGLEYLHD--- 120
Query: 582 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 641
+ VH D+K ANIL+D N V KL+DFG+++ ++ + KG+ +M PE
Sbjct: 121 RNTVHRDIKGANILVDTNGVVKLADFGMAK-----QVVEFSFAKSF----KGSPYWMAPE 171
Query: 642 FLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNL 689
+A G +D++S G +L + TG+P + V G+ K L
Sbjct: 172 VIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKEL 220
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 64/211 (30%), Positives = 90/211 (42%), Gaps = 30/211 (14%)
Query: 471 KIGEGGYGSIYKGLLR--HMQVAIK-MLHPHSLQGPSEF-QQEIDILSKIRHPNLVTLVG 526
+GEG YG + K + VAIK + + +E+ +L ++RH N+V L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 527 AC--PEVWTLVYEYLPNGSLEDRLSCKDNSPP-----LSWQTRIRIATELCSVLIFLHSC 579
A LV+EY+ LE + PP WQ L + + HS
Sbjct: 68 AFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQ--------LLQAIAYCHS- 118
Query: 580 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 639
H+I+H D+KP NIL+ + V KL DFG +R L + L TD T Y
Sbjct: 119 --HNIIHRDIKPENILVSESGVLKLCDFGFARALRAR----PASPL---TDYVATRWYRA 169
Query: 640 PEFL-ASGELTPKSDVYSFGIILLRLLTGRP 669
PE L DV++ G I+ LL G P
Sbjct: 170 PELLVGDTNYGKPVDVWAIGCIMAELLDGEP 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 4e-21
Identities = 59/196 (30%), Positives = 104/196 (53%), Gaps = 16/196 (8%)
Query: 469 SLKIGEGGYGSIYKGL-LRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGA 527
+IG G +G ++ G L +VAIK + ++ +F +E ++ K+ HP LV L G
Sbjct: 9 VQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS-EEDFIEEAQVMMKLSHPKLVQLYGV 67
Query: 528 CPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 585
C E LV+E++ +G L D L + S +T + + ++C + +L S +++
Sbjct: 68 CTERSPICLVFEFMEHGCLSDYLRAQRGK--FSQETLLGMCLDVCEGMAYLES---SNVI 122
Query: 586 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS 645
H DL N L+ N V K+SDFG++RF+ ++ +S+ T K + PE +
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGT-------KFPVKWSSPEVFSF 175
Query: 646 GELTPKSDVYSFGIIL 661
+ + KSDV+SFG+++
Sbjct: 176 SKYSSKSDVWSFGVLM 191
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 4e-21
Identities = 68/214 (31%), Positives = 99/214 (46%), Gaps = 31/214 (14%)
Query: 471 KIGEGGYGSIYKG--LLRHMQVAIKMLH----PHSLQGPSEFQQEIDILSKIRHPNLVT- 523
IG G +Y L + +VAIK + S+ E ++E+ +S+ HPN+V
Sbjct: 8 VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVD---ELRKEVQAMSQCNHPNVVKY 64
Query: 524 ----LVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVL---IFL 576
+VG E+W LV YL GSL D + +S P IAT L VL +L
Sbjct: 65 YTSFVVGD--ELW-LVMPYLSGGSLLDIMK---SSYPRGGLDEAIIATVLKEVLKGLEYL 118
Query: 577 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 636
HS + +H D+K NILL + K++DFG+S L+ + R GT
Sbjct: 119 HS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKV----RKTFVGTPC 171
Query: 637 YMDPEFLASGE-LTPKSDVYSFGIILLRLLTGRP 669
+M PE + K+D++SFGI + L TG
Sbjct: 172 WMAPEVMEQVHGYDFKADIWSFGITAIELATGAA 205
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 5e-21
Identities = 73/224 (32%), Positives = 99/224 (44%), Gaps = 41/224 (18%)
Query: 472 IGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGAC 528
IGEG YG +YK + VAIK++ E ++E +IL K HPN+ T GA
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDI-IEDEEEEIKEEYNILRKYSNHPNIATFYGAF 72
Query: 529 ---------PEVWTLVYEYLPNGSLED---RLSCKDNSPPLSWQTRIRIA---TELCSVL 573
++W LV E GS+ D L K W IA E L
Sbjct: 73 IKKNPPGNDDQLW-LVMELCGGGSVTDLVKGLRKKGKRLKEEW-----IAYILRETLRGL 126
Query: 574 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 633
+LH + ++H D+K NILL N KL DFG+S L + + NT + G
Sbjct: 127 AYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL-DSTLGRRNTFI-------G 175
Query: 634 TFAYMDPEFLASGE-----LTPKSDVYSFGIILLRLLTGRPALG 672
T +M PE +A E +SDV+S GI + L G+P L
Sbjct: 176 TPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLC 219
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 5e-21
Identities = 78/256 (30%), Positives = 124/256 (48%), Gaps = 25/256 (9%)
Query: 471 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 529
K+G G +G ++ G + +VA+K L P ++ P F +E I+ K+RH LV L
Sbjct: 13 KLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS-PESFLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 530 E-VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGD 588
E +V EY+ GSL D L + L + +A ++ + + ++ + +H D
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKDGEGRA-LKLPNLVDMAAQVAAGMAYIERM---NYIHRD 127
Query: 589 LKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL 648
L+ ANIL+ V K++DFG++R + NE ++ R K + PE G
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLIEDNEYTA-------RQGAKFPIKWTAPEAALYGRF 180
Query: 649 TPKSDVYSFGIILLRLLT-GR-PALGI-TKEVQYALDTGKLKNLLDPLAGDWPFVQAEQL 705
T KSDV+SFGI+L L+T GR P G+ +EV ++ G P D P L
Sbjct: 181 TIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM----PCPQDCPI----SL 232
Query: 706 ANLAMRCCEMSRKSRP 721
L ++C + + RP
Sbjct: 233 HELMLQCWKKDPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 8e-21
Identities = 59/203 (29%), Positives = 107/203 (52%), Gaps = 22/203 (10%)
Query: 471 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 528
K+G G YG +Y+G+ + + VA+K L +++ EF +E ++ +I+HPNLV L+G C
Sbjct: 13 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 71
Query: 529 ---PEVWTLVYEYLPNGSLEDRLSCKDNS--PPLSWQTRIRIATELCSVLIFLHSCKPHS 583
P + ++ E++ G+L D L + + + +AT++ S + +L +
Sbjct: 72 TREPPFY-IITEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQISSAMEYLEK---KN 124
Query: 584 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 643
+H DL N L+ N + K++DFG+SR ++ + T K + PE L
Sbjct: 125 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-------TYTAHAGAKFPIKWTAPESL 177
Query: 644 ASGELTPKSDVYSFGIILLRLLT 666
A + + KSDV++FG++L + T
Sbjct: 178 AYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 8e-21
Identities = 68/211 (32%), Positives = 100/211 (47%), Gaps = 31/211 (14%)
Query: 471 KIGEGGYGSIYKG--LLRHMQVAIK-MLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLVG 526
KIGEG YG +YK L VAIK + +G P +EI +L ++ HPN++ L+
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLL- 64
Query: 527 ACPEVWT------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIR-IATELCSVLIFLHSC 579
+V+ LV+E++ + L + KD L ++ I+ +L L F HS
Sbjct: 65 ---DVFRHKGDLYLVFEFM-DTDLYKLI--KDRQRGLP-ESLIKSYLYQLLQGLAFCHS- 116
Query: 580 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 639
H I+H DLKP N+L++ V KL+DFG++R S T T Y
Sbjct: 117 --HGILHRDLKPENLLINTEGVLKLADFGLAR-----SFGSPVRPY---THYVVTRWYRA 166
Query: 640 PE-FLASGELTPKSDVYSFGIILLRLLTGRP 669
PE L + D++S G I LL+ RP
Sbjct: 167 PELLLGDKGYSTPVDIWSVGCIFAELLSRRP 197
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.0 bits (232), Expect = 9e-21
Identities = 65/216 (30%), Positives = 104/216 (48%), Gaps = 34/216 (15%)
Query: 471 KIGEGGYGSIYKGL-LRHMQ-VAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVG 526
+IGEG YG +YK + + VA+K + + + P +EI +L K+RHPN+V L
Sbjct: 6 QIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK- 64
Query: 527 ACPEVWT--------LVYEYLPNGSLEDRLSCKDN--SPPLSWQTRIRIATELCSVLIFL 576
E+ T +V+EY+ + L L + + Q + +L L +L
Sbjct: 65 ---EIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTES---QIK-CYMKQLLEGLQYL 116
Query: 577 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 636
HS I+H D+K +NIL++ + V KL+DFG++R + S++ T T
Sbjct: 117 HSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYT-KRNSADYTNRVI------TLW 166
Query: 637 YMDPEFL-ASGELTPKSDVYSFGIILLRLLTGRPAL 671
Y PE L + P+ D++S G IL L G+P
Sbjct: 167 YRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 1e-20
Identities = 64/206 (31%), Positives = 93/206 (45%), Gaps = 20/206 (9%)
Query: 471 KIGEGGYGSIYKGLLRHMQ--VAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTLVGA 527
IG+G +G +YK + + VAIK++ + + QQEI LS+ R P + G+
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67
Query: 528 CPEVWTL--VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 585
+ L + EY GS D L L I E+ L +LH +
Sbjct: 68 FLKGSKLWIIMEYCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEGK---I 120
Query: 586 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS 645
H D+K ANILL KL+DFG+S L+ +S NT + GT +M PE +
Sbjct: 121 HRDIKAANILLSEEGDVKLADFGVSGQLTST-MSKRNTFV-------GTPFWMAPEVIKQ 172
Query: 646 GELTPKSDVYSFGIILLRLLTGRPAL 671
K+D++S GI + L G P L
Sbjct: 173 SGYDEKADIWSLGITAIELAKGEPPL 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 1e-20
Identities = 67/208 (32%), Positives = 103/208 (49%), Gaps = 24/208 (11%)
Query: 472 IGEGGYGSIYKGLLRHMQV--AIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC- 528
+G+G +G +YK + + A K++ S + +F EIDILS+ +HPN+V L A
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 529 --PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 586
++W L+ E+ G+L D + + Q R + ++ L FLHS H ++H
Sbjct: 73 YENKLWILI-EFCDGGAL-DSIMLELERGLTEPQIRY-VCRQMLEALNFLHS---HKVIH 126
Query: 587 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA-- 644
DLK NILL + KL+DFG+S + N +TL R GT +M PE +A
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVS--------AKNKSTLQKRDTFIGTPYWMAPEVVACE 178
Query: 645 ---SGELTPKSDVYSFGIILLRLLTGRP 669
K+D++S GI L+ L P
Sbjct: 179 TFKDNPYDYKADIWSLGITLIELAQMEP 206
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 2e-20
Identities = 64/203 (31%), Positives = 104/203 (51%), Gaps = 19/203 (9%)
Query: 471 KIGEGGYGSIYKGLLR-HMQVAIK---MLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVG 526
KIG+G +G +YKG+L+ + +VA+K P L+ +F QE +IL + HPN+V L+G
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLK--RKFLQEAEILKQYDHPNIVKLIG 59
Query: 527 ACPEVWTL--VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 584
C + + V E +P GSL L K N + ++ + + + + +L S +
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSL--DAAAGMEYLES---KNC 114
Query: 585 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 644
+H DL N L+ N V K+SDFG+SR + ++ + P + PE L
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL---KQIP---IKWTAPEALN 168
Query: 645 SGELTPKSDVYSFGIILLRLLTG 667
G T +SDV+S+GI+L +
Sbjct: 169 YGRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 91.8 bits (229), Expect = 3e-20
Identities = 67/211 (31%), Positives = 98/211 (46%), Gaps = 36/211 (17%)
Query: 472 IGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQ------EIDILSKIRHPNL 521
+G G +G + L+RH A+K+L + + +Q E IL IRHP L
Sbjct: 9 LGTGSFGRVM--LVRHKGSGKYYALKILSKAKI---VKLKQVEHVLNEKRILQSIRHPFL 63
Query: 522 VTLVGACPEVWTL--VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 579
V L G+ + L V EY+P G L L K P R A ++ L +LHS
Sbjct: 64 VNLYGSFQDDSNLYLVMEYVPGGELFSHLR-KSGRFPEP-VARFYAA-QVVLALEYLHSL 120
Query: 580 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT-TLCCRTDPKGTFAYM 638
IV+ DLKP N+LLD++ K++DFG ++ + T TLC GT Y+
Sbjct: 121 D---IVYRDLKPENLLLDSDGYIKITDFGFAKRV------KGRTYTLC------GTPEYL 165
Query: 639 DPEFLASGELTPKSDVYSFGIILLRLLTGRP 669
PE + S D ++ GI++ +L G P
Sbjct: 166 APEIILSKGYGKAVDWWALGILIYEMLAGYP 196
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 3e-20
Identities = 73/275 (26%), Positives = 128/275 (46%), Gaps = 47/275 (17%)
Query: 472 IGEGGYGSIYKGLLRH-------MQVAIKMLHPH-SLQGPSEFQQEIDILSKIRHPNLVT 523
+G+G +G +Y+GL + +VAIK ++ + S++ EF E ++ + ++V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 524 LVGAC----PEVWTLVYEYLPNGSLEDRL-SCK------DNSPPLSWQTRIRIATELCSV 572
L+G P + +V E + G L+ L S + P + Q I++A E+
Sbjct: 74 LLGVVSTGQPTL--VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131
Query: 573 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 632
+ +L + K VH DL N ++ + K+ DFG++R + + + R K
Sbjct: 132 MAYLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYY--------RKGGK 180
Query: 633 GTFA--YMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGITKE--VQYALDTGKL 686
G +M PE L G T KSDV+SFG++L + T +P G++ E +++ +D G L
Sbjct: 181 GLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHL 240
Query: 687 KNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 721
D P ++L L C + + K RP
Sbjct: 241 ---------DLPENCPDKLLELMRMCWQYNPKMRP 266
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 6e-20
Identities = 74/269 (27%), Positives = 132/269 (49%), Gaps = 31/269 (11%)
Query: 472 IGEGGYGSIYKGLLRH-----MQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTLV 525
IG G +G + +G L+ + VAIK L ++ + +F E I+ + HPN++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 526 G----ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 581
G + P + ++ E++ NG+L+ L D T I++ L + +
Sbjct: 72 GVVTKSRPVM--IITEFMENGALDSFLRQNDGQ-----FTVIQLVGMLRGIAAGMKYLSE 124
Query: 582 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 641
+ VH DL NIL+++N V K+SDFG+SRFL + +++ T K + PE
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD---TSDPTYTSSLGGKIPIRWTAPE 181
Query: 642 FLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTGKLKNLLDPLAGDWP 698
+A + T SDV+S+GI++ +++ RP ++ ++V A++ ++ P D P
Sbjct: 182 AIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE----QDYRLPPPMDCP 237
Query: 699 FVQAEQLANLAMRCCEMSRKSRPELGKDV 727
L L + C + R +RP+ G+ V
Sbjct: 238 TA----LHQLMLDCWQKDRNARPKFGQIV 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 7e-20
Identities = 66/266 (24%), Positives = 110/266 (41%), Gaps = 29/266 (10%)
Query: 472 IGEGGYGSIYKGLL----RHMQVAIKMLHPHSLQGPSEFQQ--------EIDILSKIRHP 519
IG+G YG +Y L M V L Q+ EI+ L + H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 520 NLVTLVG--ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 577
N+V +G E ++ EY+P GS+ SC Q ++ L +LH
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIG---SCLRTYGRFEEQLVRFFTEQVLEGLAYLH 125
Query: 578 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 637
S I+H DLK N+L+DA+ + K+SDFGIS+ + N ++ +G+ +
Sbjct: 126 S---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSM------QGSVFW 176
Query: 638 MDPEFLASGE--LTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG 695
M PE + S + K D++S G ++L + GR + + G ++ P+
Sbjct: 177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRS-APPIPP 235
Query: 696 DWPFVQAEQLANLAMRCCEMSRKSRP 721
D + + C ++ +RP
Sbjct: 236 DVSMNLSPVALDFLNACFTINPDNRP 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 8e-20
Identities = 80/299 (26%), Positives = 132/299 (44%), Gaps = 56/299 (18%)
Query: 472 IGEGGYGSIYKGLLRHMQ-------VAIKMLHPHSLQGPSEFQ---QEIDILSKIRHPNL 521
+GEG +G + K ++ VA+KML ++ SE + E ++L ++ HP++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVNHPHV 65
Query: 522 VTLVGACP--EVWTLVYEYLPNGSLE------------------DRLSCKDNSP---PLS 558
+ L GAC L+ EY GSL +R S ++P L+
Sbjct: 66 IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125
Query: 559 WQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 618
I A ++ + +L K +VH DL N+L+ K+SDFG+SR + + +
Sbjct: 126 MGDLISFAWQISRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEED- 181
Query: 619 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGITKE 676
+ R+ + +M E L T +SDV+SFG++L ++T G P GI E
Sbjct: 182 -----SYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE 236
Query: 677 VQYALDTGKLKNLLDP-LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 734
+L NLL + P +E++ NL + C + RP D+ + LE M
Sbjct: 237 --------RLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTF-ADISKELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 60/194 (30%), Positives = 97/194 (50%), Gaps = 30/194 (15%)
Query: 489 QVAIKMLHP----HSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNG 542
VA+K+L P ++ + +F +E+ ILS++ PN+ L+G C ++ EY+ NG
Sbjct: 48 LVAVKVLRPDASDNARE---DFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENG 104
Query: 543 SLEDRLS--------CKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANI 594
L L NS LS+ T + +AT++ S + +L S + VH DL N
Sbjct: 105 DLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNC 161
Query: 595 LLDANFVSKLSDFGISRFLSQNEIS--SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKS 652
L+ N+ K++DFG+SR L ++ L R +M E + G+ T KS
Sbjct: 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIR--------WMAWESVLLGKFTTKS 213
Query: 653 DVYSFGIILLRLLT 666
DV++FG+ L +LT
Sbjct: 214 DVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 2e-19
Identities = 81/297 (27%), Positives = 137/297 (46%), Gaps = 58/297 (19%)
Query: 472 IGEGGYGSIYK----GLLRH---MQVAIKMLHPH-SLQGPSEFQQEIDILSKIRHPNLVT 523
IG+G +G +++ GLL + VA+KML S ++FQ+E ++++ HPN+V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 524 LVGACP--EVWTLVYEYLPNGSLEDRL-------------------SCKDNSPPLSWQTR 562
L+G C + L++EY+ G L + L C N PLS +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 563 IRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR--FLSQNEISS 620
+ IA ++ + + +L K VH DL N L+ N V K++DFG+SR + + +S
Sbjct: 133 LCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 621 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG--RPALGIT-KEV 677
N + R +M PE + T +SDV+++G++L + + +P G+ +EV
Sbjct: 190 ENDAIPIR--------WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEV 241
Query: 678 QYALDTGKLKNLLD--PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 732
Y + G + + D PL +L NL C RP + R+L+
Sbjct: 242 IYYVRDGNVLSCPDNCPL----------ELYNLMRLCWSKLPSDRPSFA-SINRILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 2e-19
Identities = 61/192 (31%), Positives = 95/192 (49%), Gaps = 16/192 (8%)
Query: 489 QVAIKML---HPHSLQGPSEFQQEIDILSKIRHPNLVTLV--GACPEVWTL-VYEYLPNG 542
+VAIK+L P + F++E + +++ HPN+V L+ G P V+EY+P
Sbjct: 5 EVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGR 64
Query: 543 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV- 601
+L + L+ L R+ ++ L H+ IVH DLKP NI++ V
Sbjct: 65 TLREVLA---ADGALPAGETGRLMLQVLDALACAHN---QGIVHRDLKPQNIMVSQTGVR 118
Query: 602 --SKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGI 659
+K+ DFGI L ++ TL T+ GT Y PE L +TP SD+Y++G+
Sbjct: 119 PHAKVLDFGIGTLLPGVR-DADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGL 177
Query: 660 ILLRLLTGRPAL 671
I L LTG+ +
Sbjct: 178 IFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 2e-19
Identities = 71/268 (26%), Positives = 117/268 (43%), Gaps = 32/268 (11%)
Query: 465 NFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQE--ID---ILSKIRHP 519
+F+ KIG+G +G ++K ++R + + L + ++E ID +L+K+
Sbjct: 1 DFEILNKIGKGSFGVVFK-VVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSS 59
Query: 520 NLVTLVGACPEVWTL--VYEYLPNGSLEDRLSCKDNSP---PLSWQTRIRIATELCSVLI 574
++ + + L V EY NG L L + P W+ I+I L
Sbjct: 60 YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLA---- 115
Query: 575 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 634
LHS K I+H D+K N+ LDA K+ D G+++ LS N +N GT
Sbjct: 116 HLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV--------GT 164
Query: 635 FAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 694
Y+ PE KSDV++ G++L TG+ Q AL ++ + P++
Sbjct: 165 PYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDA--NNQGALILKIIRGVFPPVS 222
Query: 695 GDWPFVQAEQLANLAMRCCEMSRKSRPE 722
+ Q QLA L +C + RP+
Sbjct: 223 Q--MYSQ--QLAQLIDQCLTKDYRQRPD 246
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 5e-19
Identities = 75/284 (26%), Positives = 131/284 (46%), Gaps = 50/284 (17%)
Query: 472 IGEGGYGSIYKGLLR-----HMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTLV 525
IG G +G +++G+L+ + VAIK L P ++ + +F E I+ + H N++ L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 526 GACPEV--WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 583
G + ++ EY+ NG+L+ L D + ++ L + + +
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGE-----FSSYQLVGMLRGIAAGMKYLSDMN 127
Query: 584 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA------- 636
VH DL NIL+++N K+SDFG+SR L DP+GT+
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVLED--------------DPEGTYTTSGGKIP 173
Query: 637 --YMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG-KLKNLL 690
+ PE +A + T SDV+SFGI++ +++ RP ++ EV A++ G +L
Sbjct: 174 IRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRL---- 229
Query: 691 DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 734
P D P + L ++C + R RP D+ +L+ +
Sbjct: 230 -PAPMDCP----SAVYQLMLQCWQQDRARRPRFV-DIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 5e-19
Identities = 76/257 (29%), Positives = 128/257 (49%), Gaps = 27/257 (10%)
Query: 471 KIGEGGYGSIYKGLL-RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 529
K+G G +G ++ +H +VA+K + P S+ F E +++ ++H LV L
Sbjct: 13 KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVVT 71
Query: 530 -EVWTLVYEYLPNGSLEDRLSCKD-NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 587
E ++ E++ GSL D L + + PL I + ++ + F+ + +H
Sbjct: 72 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIEQ---RNYIHR 126
Query: 588 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 647
DL+ ANIL+ A+ V K++DFG++R + NE ++ R K + PE + G
Sbjct: 127 DLRAANILVSASLVCKIADFGLARVIEDNEYTA-------REGAKFPIKWTAPEAINFGS 179
Query: 648 LTPKSDVYSFGIILLRLLT-GR-PALGITK-EVQYALDTGKLKNLLDPLAGDWPFVQAEQ 704
T KSDV+SFGI+L+ ++T GR P G++ EV AL+ G + E+
Sbjct: 180 FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENC--------PEE 231
Query: 705 LANLAMRCCEMSRKSRP 721
L N+ MRC + + RP
Sbjct: 232 LYNIMMRCWKNRPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 6e-19
Identities = 65/213 (30%), Positives = 108/213 (50%), Gaps = 36/213 (16%)
Query: 472 IGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGP----SEFQQEIDILSKIRH---PN 520
IG G YG++Y+G H+ VA+K++ +L P S+ Q+E+ +LS++R PN
Sbjct: 9 IGRGAYGAVYRGK--HVPTGRVVALKII---NLDTPDDDVSDIQREVALLSQLRQSQPPN 63
Query: 521 LVTLVGAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 577
+ G+ P +W ++ EY GS+ + + P++ + I E+ L ++H
Sbjct: 64 ITKYYGSYLKGPRLW-IIMEYAEGGSVRTLM----KAGPIAEKYISVIIREVLVALKYIH 118
Query: 578 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 637
++H D+K ANIL+ KL DFG++ L+QN SS +T GT +
Sbjct: 119 K---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN--SSKRSTFV------GTPYW 167
Query: 638 MDPEFLASG-ELTPKSDVYSFGIILLRLLTGRP 669
M PE + G K+D++S GI + + TG P
Sbjct: 168 MAPEVITEGKYYDTKADIWSLGITIYEMATGNP 200
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|203049 pfam04564, U-box, U-box domain | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 7e-19
Identities = 27/70 (38%), Positives = 38/70 (54%)
Query: 755 PPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALR 814
P F PI E+M+DP + G TY+ ++ L S T P T PL H L+PNL L+
Sbjct: 2 PDEFLDPITLELMKDPVILPSGITYDRSTIERHLLSVDPTDPFTREPLTHDQLIPNLELK 61
Query: 815 SAIQEWLQQH 824
I WL+++
Sbjct: 62 EKIDAWLEEN 71
|
This domain is related to the Ring finger pfam00097 but lacks the zinc binding residues. Length = 73 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 7e-19
Identities = 80/278 (28%), Positives = 122/278 (43%), Gaps = 26/278 (9%)
Query: 463 THNFDPSLKIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPSEFQ---QEIDILSKIR 517
NF KIG+G + +YK LL VA+K + + Q +EID+L ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 518 HPNLVTLVGACPEVWTL--VYEYLPNGSLEDRLS-CKDNSPPLSWQTRIRIATELCSVLI 574
HPN++ + + E L V E G L + K + +T + +LCS L
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 575 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 634
+HS I+H D+KPAN+ + A V KL D G+ RF S ++++ GT
Sbjct: 121 HMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV--------GT 169
Query: 635 FAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 694
YM PE + KSD++S G +L + + K Y+L K PL
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLP 229
Query: 695 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 732
D +E+L +L RC + RP D+ VL+
Sbjct: 230 AD---HYSEELRDLVSRCINPDPEKRP----DISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 1e-18
Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 28/211 (13%)
Query: 472 IGEGGYGSIYKGL-------LRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL 524
+G+G +G +Y L QV P + + + + EI +L ++H +V
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 525 VGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 582
G E ++ EY+P GS++D+L L+ + ++ + +LHS +
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHS---N 123
Query: 583 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK----GTFAYM 638
IVH D+K ANIL D+ KL DFG S+ L T+C GT +M
Sbjct: 124 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ---------TICSSGTGMKSVTGTPYWM 174
Query: 639 DPEFLASGELTPKSDVYSFGIILLRLLTGRP 669
PE ++ K+DV+S G ++ +LT +P
Sbjct: 175 SPEVISGEGYGRKADVWSVGCTVVEMLTEKP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 2e-18
Identities = 65/231 (28%), Positives = 93/231 (40%), Gaps = 54/231 (23%)
Query: 472 IGEGGYGSIYKGLLRHMQV-----AIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVG 526
+G GG+G + ++ +K H E +IL + HP +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 527 -------------ACP--EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCS 571
C E+WT++ + G ++ + R IA C
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRD---RGLFDE------------YTARFYIA---CV 102
Query: 572 VLIF--LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT-TLCCR 628
VL F LH+ I++ DLKP N+LLD+N KL DFG ++ L S T T C
Sbjct: 103 VLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLK----SGQKTWTFC-- 153
Query: 629 TDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQY 679
GT Y+ PE + + D +S GI+L LLTGRP G E
Sbjct: 154 ----GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM 200
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 68/210 (32%), Positives = 100/210 (47%), Gaps = 28/210 (13%)
Query: 471 KIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSEF---QQEIDILSKIRHPNLVTLV 525
+IG G YG +YK VAIK++ L+ +F QQEI +L + RHPN+V
Sbjct: 10 RIGSGTYGDVYKARDIATGELVAIKVI---KLEPGDDFEIIQQEISMLKECRHPNIVAYF 66
Query: 526 GA---CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 582
G+ ++W +V EY GSL+D + PLS + E L +LH
Sbjct: 67 GSYLRRDKLW-IVMEYCGGGSLQDIY--QVTRGPLSELQIAYVCRETLKGLAYLHETG-- 121
Query: 583 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 642
+H D+K ANILL + KL+DFG+S L+ I+ + + GT +M PE
Sbjct: 122 -KIHRDIKGANILLTEDGDVKLADFGVSAQLT-ATIAKRKSFI-------GTPYWMAPEV 172
Query: 643 LA---SGELTPKSDVYSFGIILLRLLTGRP 669
A G K D+++ GI + L +P
Sbjct: 173 AAVERKGGYDGKCDIWALGITAIELAELQP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 78/299 (26%), Positives = 132/299 (44%), Gaps = 66/299 (22%)
Query: 471 KIGEGGYGSIY----KGLLRHMQ------------VAIKMLHPHSLQGP-SEFQQEIDIL 513
K+GEG +G ++ +GL + VA+KML + ++F +EI I+
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 514 SKIRHPNLVTLVGAC--PEVWTLVYEYLPNGSL---------EDRLSCKDNSPPLSWQTR 562
S++++PN++ L+G C + ++ EY+ NG L E + +N P +S
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 563 IRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS--S 620
+ +A ++ S + +L S + VH DL N L+ ++ K++DFG+SR L +
Sbjct: 132 LYMAVQIASGMKYLASL---NFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188
Query: 621 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA 680
L R +M E + G+ T SDV++FG+ L + T + KE Y+
Sbjct: 189 GRAVLPIR--------WMAWESILLGKFTTASDVWAFGVTLWEMFT------LCKEQPYS 234
Query: 681 L--DTGKLKNLLDPLAGDWPFVQAEQ------------LANLAMRCCEMSRKSRPELGK 725
L D ++N G++ Q Q + L MRC K RP K
Sbjct: 235 LLSDEQVIEN-----TGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNK 288
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-18
Identities = 58/200 (29%), Positives = 98/200 (49%), Gaps = 18/200 (9%)
Query: 471 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 529
++G G +G + G R VAIKM+ S+ EF +E ++ K+ H LV L G C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 530 EVWTL--VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 587
+ + V EY+ NG L + L +++ + + ++C + +L S +H
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYL--REHGKRFQPSQLLEMCKDVCEGMAYLES---KQFIHR 124
Query: 588 DLKPANILLDANFVSKLSDFGISRFLSQNE-ISSNNTTLCCRTDPKGTFAYMDPEFLASG 646
DL N L+D K+SDFG+SR++ +E SS + R P PE L
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSP--------PEVLLYS 176
Query: 647 ELTPKSDVYSFGIILLRLLT 666
+ + KSDV++FG+++ + +
Sbjct: 177 KFSSKSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 2e-18
Identities = 60/210 (28%), Positives = 106/210 (50%), Gaps = 21/210 (10%)
Query: 472 IGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQGPSE---------FQQEIDILSKIRHPN 520
IG G +GS+Y G+ +A+K + S+ S+ +EI +L +++H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 521 LVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 578
+V +G+ + + EY+P GS+ L+ + +R ++ L +LH+
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVR---QILKGLNYLHN 124
Query: 579 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 638
I+H D+K ANIL+D K+SDFGIS+ L N +S+ R +G+ +M
Sbjct: 125 ---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNG--ARPSLQGSVFWM 179
Query: 639 DPEFLASGELTPKSDVYSFGIILLRLLTGR 668
PE + T K+D++S G +++ +LTG+
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 4e-18
Identities = 78/268 (29%), Positives = 125/268 (46%), Gaps = 31/268 (11%)
Query: 472 IGEGGYGSIYKGLL-----RHMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTLV 525
IG G +G + G L R + VAIK L ++ + +F E I+ + HPN++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 526 GA---CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 582
G V +V EY+ NGSL+ L D T I++ L + +
Sbjct: 72 GVVTKSKPV-MIVTEYMENGSLDAFLRKHDGQ-----FTVIQLVGMLRGIASGMKYLSDM 125
Query: 583 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 642
VH DL NIL+++N V K+SDFG+SR L + ++ T K + PE
Sbjct: 126 GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTT-----RGGKIPIRWTAPEA 180
Query: 643 LASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTGKLKNLLDPLAGDWPF 699
+A + T SDV+S+GI++ +++ RP ++ ++V A++ G L P+ D P
Sbjct: 181 IAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG--YRLPAPM--DCPA 236
Query: 700 VQAEQLANLAMRCCEMSRKSRPELGKDV 727
L L + C + R RP+ + V
Sbjct: 237 A----LHQLMLDCWQKDRNERPKFEQIV 260
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 5e-18
Identities = 59/202 (29%), Positives = 89/202 (44%), Gaps = 20/202 (9%)
Query: 472 IGEGGYGSIY--KGLLRHMQVAIKMLHPHSLQGPSEF--QQEIDILSKIRHPNLVTLVGA 527
+G G +G ++ + V IK + + Q E +L + HPN++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 528 CPEVWTL--VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 585
E L V EY P G+L + + + NS L T + + +L+ LH I+
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYIQKRCNSL-LDEDTILHFFVQ---ILLALHHVHTKLIL 123
Query: 586 HGDLKPANILLDAN-FVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 644
H DLK NILLD + V K+ DFGIS+ LS S T + GT Y+ PE
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKILSSK--SKAYTVV-------GTPCYISPELCE 174
Query: 645 SGELTPKSDVYSFGIILLRLLT 666
KSD+++ G +L L +
Sbjct: 175 GKPYNQKSDIWALGCVLYELAS 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 5e-18
Identities = 67/259 (25%), Positives = 119/259 (45%), Gaps = 21/259 (8%)
Query: 472 IGEGGYGSIYKGLLRHMQ-VAIKM--LHPHS-LQGPSEF---QQEIDILSKIRHPNLVTL 524
+G+G YG++Y GL Q +A+K L + L E+ Q+E+D+L ++H N+V
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 525 VGACPEVWTL--VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 582
+G C + T+ E++P GS+ L + PL + ++ + +LH+ +
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSIL---NRFGPLPEPVFCKYTKQILDGVAYLHN---N 121
Query: 583 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 642
+VH D+K N++L N + KL DFG +R L+ + ++ + GT +M PE
Sbjct: 122 CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNML--KSMHGTPYWMAPEV 179
Query: 643 LASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQA 702
+ KSD++S G + + TG+P L + G + L+ L P +
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRL----PDSFS 235
Query: 703 EQLANLAMRCCEMSRKSRP 721
+ C + RP
Sbjct: 236 AAAIDFVTSCLTRDQHERP 254
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 5e-18
Identities = 82/260 (31%), Positives = 121/260 (46%), Gaps = 30/260 (11%)
Query: 471 KIGEGGYGSIYK-GLLRHMQV-AIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVG 526
K+G+G YGS+YK L Q A+K + S+ + + EI IL+ + HPN+++
Sbjct: 7 KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKE 66
Query: 527 ACPEVWTL--VYEYLPNGSLEDRLS-CKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 583
A + L V EY P G L +S K + Q RI +L L LH K
Sbjct: 67 AFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--- 123
Query: 584 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 643
I+H DLK ANILL AN + K+ D GIS+ L +N T + GT YM PE
Sbjct: 124 ILHRDLKSANILLVANDLVKIGDLGISKVLKKN---MAKTQI-------GTPHYMAPEVW 173
Query: 644 ASGELTPKSDVYSFGIILLRLLTGRPALG--ITKEVQYALDTGKLKNLLDPLAGDWPFVQ 701
+ KSD++S G +L + T P ++++Y + GK P+ P +
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGK----YPPI----PPIY 225
Query: 702 AEQLANLAMRCCEMSRKSRP 721
++ L N ++ K RP
Sbjct: 226 SQDLQNFIRSMLQVKPKLRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 1e-17
Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 25/206 (12%)
Query: 471 KIGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGA- 527
KIG+G G++Y + +VAIK ++ EI ++ + +HPN+V + +
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 528 --CPEVWTLVYEYLPNGSLEDRLS--CKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 583
E+W +V EYL GSL D ++ C D + + E L FLHS +
Sbjct: 86 LVGDELW-VVMEYLAGGSLTDVVTETCMDEGQIAA------VCRECLQALEFLHS---NQ 135
Query: 584 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 643
++H D+K NILL + KL+DFG ++ + S +T+ GT +M PE +
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMV------GTPYWMAPEVV 187
Query: 644 ASGELTPKSDVYSFGIILLRLLTGRP 669
PK D++S GI+ + ++ G P
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 1e-17
Identities = 59/197 (29%), Positives = 90/197 (45%), Gaps = 21/197 (10%)
Query: 471 KIGEGGYGSIYKGLLR-----HMQVAIKMLHPHSLQGPSE-FQQEIDILSKIRHPNLVTL 524
IGEG +G +Y+G+ + VA+K + E F QE I+ + HP++V L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 525 VGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 582
+G E VW +V E P G L L S L+ + I + +L + L +L S +
Sbjct: 73 IGVITENPVW-IVMELAPLGELRSYLQVNKYSLDLA--SLILYSYQLSTALAYLESKR-- 127
Query: 583 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 642
VH D+ N+L+ + KL DFG+SR+L + K +M PE
Sbjct: 128 -FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKG-------KLPIKWMAPES 179
Query: 643 LASGELTPKSDVYSFGI 659
+ T SDV+ FG+
Sbjct: 180 INFRRFTSASDVWMFGV 196
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 62/220 (28%), Positives = 106/220 (48%), Gaps = 35/220 (15%)
Query: 471 KIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVT 523
++GEG +G ++ + M VA+K L +L +FQ+E ++L+ ++H ++V
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 524 LVGAC--PEVWTLVYEYLPNGSLE--------DRLSCKDNSP-----PLSWQTRIRIATE 568
G C + +V+EY+ +G L D + D P L + IA++
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 569 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI--SSNNTTLC 626
+ S +++L S VH DL N L+ AN + K+ DFG+SR + + +T L
Sbjct: 132 IASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 188
Query: 627 CRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 666
R +M PE + + T +SDV+SFG+IL + T
Sbjct: 189 IR--------WMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-17
Identities = 64/213 (30%), Positives = 103/213 (48%), Gaps = 22/213 (10%)
Query: 465 NFDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNL 521
NF K+GEG Y ++YKG R VA+K +H + +G PS +EI ++ +++H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 522 VTL--VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 579
V L V LV+EY+ + L+ + L T +L + F C
Sbjct: 61 VRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAF---C 116
Query: 580 KPHSIVHGDLKPANILLDANFVSKLSDFGISRF--LSQNEISSNNTTLCCRTDPKGTFAY 637
+ ++H DLKP N+L++ KL+DFG++R + N S+ TL Y
Sbjct: 117 HENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLW----------Y 166
Query: 638 MDPE-FLASGELTPKSDVYSFGIILLRLLTGRP 669
P+ L S + D++S G I+ ++TGRP
Sbjct: 167 RAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRP 199
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 56/224 (25%), Positives = 105/224 (46%), Gaps = 22/224 (9%)
Query: 472 IGEGGYGSIYKGLLR------HMQVAIKMLHPHSLQGPS-EFQQEIDILSKIRHPNLVTL 524
+G G +G++YKG+ + VAIK+L + + E E +++ + HP++V L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 525 VGACP-EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 583
+G C L+ + +P G L D + +++ + Q + ++ + +L
Sbjct: 75 LGICLSSQVQLITQLMPLGCLLDYV--RNHKDNIGSQYLLNWCVQIAKGMSYLEE---KR 129
Query: 584 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 643
+VH DL N+L+ K++DFG+++ L +E + K +M E +
Sbjct: 130 LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYH------AEGGKVPIKWMALESI 183
Query: 644 ASGELTPKSDVYSFGIILLRLLT--GRPALGI-TKEVQYALDTG 684
T KSDV+S+G+ + L+T +P GI E+ L+ G
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKG 227
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 83/284 (29%), Positives = 132/284 (46%), Gaps = 46/284 (16%)
Query: 471 KIGEGGYGSIYKGLL-----RHMQ-VAIKMLHPHS-LQGPSEFQQEIDILSKIRHPNLVT 523
++GE +G IYKG L H Q VAIK L + Q EFQQE +++++ HPN+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 524 LVGACPEVW--TLVYEYLPNGSLEDRL---------SCKDNS-----PPLSWQTRIRIAT 567
L+G + +++EYL G L + L C + L + IA
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 568 ELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCC 627
++ + + +L S H VH DL NIL+ K+SD G+SR EI S +
Sbjct: 132 QIAAGMEYLSS---HFFVHKDLAARNILIGEQLHVKISDLGLSR-----EIYSADYY--- 180
Query: 628 RTDPKGTFA--YMDPEFLASGELTPKSDVYSFGIILLRLLTG--RPALGITKEVQYALDT 683
R PK +M PE + G+ + SD++SFG++L + + +P G + Q ++
Sbjct: 181 RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--QEVIEM 238
Query: 684 GKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 727
+ + LL P + D P ++ +L C + RP KD+
Sbjct: 239 VRKRQLL-PCSEDCP----PRMYSLMTECWQEGPSRRPRF-KDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 64/217 (29%), Positives = 101/217 (46%), Gaps = 36/217 (16%)
Query: 471 KIGEGGYGSIYKGLLRHM--QVAIKMLHPHSLQGPSE---FQ--QEIDILSKIRHPNLVT 523
K+GEG Y +YK + VAIK + + + F +EI +L +++HPN++
Sbjct: 7 KLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIG 66
Query: 524 LVGACPEVWT------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIR-IATELCSVLIFL 576
L+ +V+ LV+E++ LE + KD S L+ I+ L +L
Sbjct: 67 LL----DVFGHKSNINLVFEFME-TDLEKVI--KDKSIVLT-PADIKSYMLMTLRGLEYL 118
Query: 577 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR-FLSQNEISSNNTTLCCRTDPKGTF 635
HS + I+H DLKP N+L+ ++ V KL+DFG++R F S N ++ T
Sbjct: 119 HS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV---------TR 166
Query: 636 AYMDPE-FLASGELTPKSDVYSFGIILLRLLTGRPAL 671
Y PE + D++S G I LL P L
Sbjct: 167 WYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFL 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 4e-17
Identities = 65/226 (28%), Positives = 106/226 (46%), Gaps = 35/226 (15%)
Query: 472 IGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQGP-SEFQQEIDILSKI-RHPNLVTLV 525
IGEG +G + + +++ M AIKML + + +F E+++L K+ HPN++ L+
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 526 GACPEVWTL--VYEYLPNGSLEDRLSCK-------------DNSPPLSWQTRIRIATELC 570
GAC L EY P G+L D L + L+ Q ++ A+++
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129
Query: 571 SVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTD 630
+ + +L +H DL N+L+ N SK++DFG+SR +T
Sbjct: 130 TGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLSR---------GEEVYVKKTM 177
Query: 631 PKGTFAYMDPEFLASGELTPKSDVYSFGIILLRL--LTGRPALGIT 674
+ +M E L T KSDV+SFG++L + L G P G+T
Sbjct: 178 GRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT 223
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 5e-17
Identities = 64/205 (31%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 471 KIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSE-FQQEIDILSKIRHPNLVTLVGA 527
+IG+G +G +YKG+ + VAIK++ + E QQEI +LS+ P + G+
Sbjct: 11 RIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGS 70
Query: 528 ---CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 584
++W ++ EYL GS D L PL I E+ L +LHS +
Sbjct: 71 YLKGTKLW-IIMEYLGGGSALDLL----KPGPLEETYIATILREILKGLDYLHSERK--- 122
Query: 585 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 644
+H D+K AN+LL KL+DFG++ L+ +I N GT +M PE +
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV--------GTPFWMAPEVIK 174
Query: 645 SGELTPKSDVYSFGIILLRLLTGRP 669
K+D++S GI + L G P
Sbjct: 175 QSAYDFKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 6e-17
Identities = 61/194 (31%), Positives = 101/194 (52%), Gaps = 22/194 (11%)
Query: 472 IGEGGYGSIYKGLLRHMQVAIKML-HPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPE 530
IG+G +G + G R +VA+K + + + Q F E +++++RH NLV L+G E
Sbjct: 14 IGKGEFGDVMLGDYRGNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 531 ---VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 587
+V EY+ GSL D L + S L ++ + ++C + +L + ++ VH
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEA---NNFVHR 126
Query: 588 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 647
DL N+L+ + V+K+SDFG+++ E SS T K + PE L +
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDT------GKLPVKWTAPEALREKK 175
Query: 648 LTPKSDVYSFGIIL 661
+ KSDV+SFGI+L
Sbjct: 176 FSTKSDVWSFGILL 189
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 6e-17
Identities = 63/220 (28%), Positives = 113/220 (51%), Gaps = 18/220 (8%)
Query: 471 KIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL--VGA 527
K+G G +G ++ G + +VA+K L P ++ + F +E +++ ++H LV L V
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA-FLEEANLMKTLQHDKLVRLYAVVT 71
Query: 528 CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 587
E ++ EY+ GSL D L D + I + ++ + ++ + +H
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLK-SDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHR 127
Query: 588 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 647
DL+ AN+L+ + + K++DFG++R + NE ++ R K + PE + G
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIEDNEYTA-------REGAKFPIKWTAPEAINFGS 180
Query: 648 LTPKSDVYSFGIILLRLLT-GR-PALGITK-EVQYALDTG 684
T KSDV+SFGI+L ++T G+ P G++ +V AL G
Sbjct: 181 FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG 220
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 7e-17
Identities = 66/205 (32%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 471 KIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSE-FQQEIDILSKIRHPNLVTLVGA 527
KIG+G +G ++KG+ Q VAIK++ + E QQEI +LS+ P + G+
Sbjct: 11 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 528 C---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 584
++W ++ EYL GS D L PL I E+ L +LHS K
Sbjct: 71 YLKDTKLW-IIMEYLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEKK--- 122
Query: 585 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 644
+H D+K AN+LL + KL+DFG++ L+ +I N GT +M PE +
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV--------GTPFWMAPEVIK 174
Query: 645 SGELTPKSDVYSFGIILLRLLTGRP 669
K+D++S GI + L G P
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 7e-17
Identities = 72/267 (26%), Positives = 115/267 (43%), Gaps = 22/267 (8%)
Query: 465 NFDPSLKIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPSEFQ---QEIDILSKIRHP 519
NF KIG G + +Y+ LL + VA+K + L +EID+L ++ HP
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 520 NLVTLVGACPE--VWTLVYEYLPNGSLEDRLS-CKDNSPPLSWQTRIRIATELCSVLIFL 576
N++ + E +V E G L + K + +T + +LCS L +
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 577 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 636
HS ++H D+KPAN+ + A V KL D G+ RF S ++++ GT
Sbjct: 123 HS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV--------GTPY 171
Query: 637 YMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 696
YM PE + KSD++S G +L + + K Y+L + PL D
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSD 231
Query: 697 WPFVQAEQLANLAMRCCEMSRKSRPEL 723
+E+L L C + RP++
Sbjct: 232 H---YSEELRQLVNMCINPDPEKRPDI 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 1e-16
Identities = 66/227 (29%), Positives = 110/227 (48%), Gaps = 42/227 (18%)
Query: 471 KIGEGGYGSIY----KGLLRHMQ--------------VAIKMLHPHSLQGP-SEFQQEID 511
K+GEG +G ++ +G+ + M VA+KML + + ++F +EI
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 512 ILSKIRHPNLVTLVGACPEVWTL--VYEYLPNGSLEDRLS--------CKDNSPPLSWQT 561
I+S+++ PN++ L+ C L + EY+ NG L LS K + +S+ T
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 562 RIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS-- 619
I +AT++ S + +L S + VH DL N L+ N+ K++DFG+SR L +
Sbjct: 132 LIFMATQIASGMKYLSSL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188
Query: 620 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 666
L R +M E + G+ T SDV++FG+ L +LT
Sbjct: 189 QGRAVLPIR--------WMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 65/237 (27%), Positives = 109/237 (45%), Gaps = 30/237 (12%)
Query: 458 EIEGATHNFDPSLKIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPSEFQQEIDILSK 515
E E + +G+G YG +Y L +++AIK + + +EI + S
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY 61
Query: 516 IRHPNLVTLVGACPE--VWTLVYEYLPNGSLEDRLSCK-----DNSPPLSWQTRIRIATE 568
++H N+V +G+ E + + E +P GSL L K DN + + T+ +
Sbjct: 62 LKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK-----Q 116
Query: 569 LCSVLIFLHSCKPHSIVHGDLKPANILLDA-NFVSKLSDFGISRFLSQ-NEISSNNTTLC 626
+ L +LH + IVH D+K N+L++ + V K+SDFG S+ L+ N + T
Sbjct: 117 ILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT--- 170
Query: 627 CRTDPKGTFAYMDPEFLASGE--LTPKSDVYSFGIILLRLLTGRPALGITKEVQYAL 681
GT YM PE + G +D++S G ++ + TG+P E Q A+
Sbjct: 171 ------GTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM 221
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 1e-16
Identities = 84/248 (33%), Positives = 116/248 (46%), Gaps = 44/248 (17%)
Query: 472 IGEGGYGSIYKGLLRHMQ----VAIKMLH-PHSLQG-PSEFQQEIDILSKIR---HPNLV 522
IGEG YG++YK R + VA+K + P S +G P +EI +L ++ HPN+V
Sbjct: 7 IGEGAYGTVYKA--RDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64
Query: 523 TLVGAC--PEVW-----TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIF 575
L+ C P TLV+E++ + L LS K P L +T + +L + F
Sbjct: 65 RLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLS-KCPKPGLPPETIKDLMRQLLRGVDF 122
Query: 576 LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 635
LHS H IVH DLKP NIL+ ++ K++DFG++R I S L T T
Sbjct: 123 LHS---HRIVHRDLKPQNILVTSDGQVKIADFGLAR------IYSFEMAL---TSVVVTL 170
Query: 636 AYMDPE-FLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD--- 691
Y PE L S TP D++S G I L RP T E +L + D
Sbjct: 171 WYRAPEVLLQSSYATP-VDMWSVGCIFAELFRRRPLFRGTSEAD------QLDKIFDVIG 223
Query: 692 -PLAGDWP 698
P +WP
Sbjct: 224 LPSEEEWP 231
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-16
Identities = 74/270 (27%), Positives = 121/270 (44%), Gaps = 46/270 (17%)
Query: 471 KIGEGGYGSIYKGLLRHM----QVAIKMLHPHSLQGP--SEFQQEIDILSKIRHPNLVTL 524
KIGEG +G L++ Q IK ++ + E ++E+ +LS ++HPN+V
Sbjct: 7 KIGEGSFGKAI--LVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64
Query: 525 VGACPEVWTL--VYEYLPNGSLEDRLSCKDNSP-----PLSWQTRIRIATELCSVLIFLH 577
+ E L V +Y G L +++ + L W ++C L +H
Sbjct: 65 QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDW------FVQICLALKHVH 118
Query: 578 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 637
K I+H D+K NI L + KL DFGI+R L N+T RT GT Y
Sbjct: 119 DRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVL-------NSTVELART-CIGTPYY 167
Query: 638 MDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNL-LDPLAGD 696
+ PE + KSD+++ G +L + T +++A + G +KNL L + G
Sbjct: 168 LSPEICENRPYNNKSDIWALGCVLYEMCT----------LKHAFEAGNMKNLVLKIIRGS 217
Query: 697 WPFVQAE---QLANLAMRCCEMSRKSRPEL 723
+P V + L NL + + + + RP +
Sbjct: 218 YPPVSSHYSYDLRNLVSQLFKRNPRDRPSV 247
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 63/213 (29%), Positives = 100/213 (46%), Gaps = 35/213 (16%)
Query: 471 KIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQ------QEIDILSKIRHPN 520
+GEG YG + K +H + VAIK L+ + +EI +L ++RH N
Sbjct: 8 LVGEGSYGMVMK--CKHKETGQIVAIKKF----LESEDDKMVKKIAMREIRMLKQLRHEN 61
Query: 521 LVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 578
LV L+ + LV+E++ + L+D L N L + ++ + F HS
Sbjct: 62 LVNLIEVFRRKKRLYLVFEFVDHTVLDD-LEKYPNG--LDESRVRKYLFQILRGIEFCHS 118
Query: 579 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL-SQNEISSNNTTLCCRTDPKGTFAY 637
H+I+H D+KP NIL+ + V KL DFG +R L + E+ TD T Y
Sbjct: 119 ---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY---------TDYVATRWY 166
Query: 638 MDPEFLASGELTPKS-DVYSFGIILLRLLTGRP 669
PE L ++ D+++ G ++ +LTG P
Sbjct: 167 RAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 62/207 (29%), Positives = 105/207 (50%), Gaps = 24/207 (11%)
Query: 472 IGEGGYGSIYKGLL-----RHMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTLV 525
IG+G +G +Y G L + + A+K L+ L+ +F +E I+ HPN+++L+
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 526 GAC------PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 579
G C P V V Y+ +G L + + + ++P + + I ++ + +L S
Sbjct: 63 GICLPSEGSPLV---VLPYMKHGDLRNFIRSETHNPTV--KDLIGFGLQVAKGMEYLASK 117
Query: 580 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 639
K VH DL N +LD +F K++DFG++R + E S + T K +M
Sbjct: 118 K---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN----HTGAKLPVKWMA 170
Query: 640 PEFLASGELTPKSDVYSFGIILLRLLT 666
E L + + T KSDV+SFG++L L+T
Sbjct: 171 LESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 69/279 (24%), Positives = 121/279 (43%), Gaps = 42/279 (15%)
Query: 465 NFDPSLKIGEGGYGSIYKGLLRHMQ-------VAIKMLHPHSLQGP-SEFQQEIDILSKI 516
N +G G +G ++ + ++ V +K L + SEF++E+D+ K+
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 517 RHPNLVTLVGACPEV--WTLVYEYLPNGSLEDRL------SCKDNSPPLSWQTRIRIATE 568
H N+V L+G C E ++ EY G L+ L K PPLS + ++ + T+
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 569 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR-FLSQNEISSNNTTLCC 627
+ + L + VH DL N L+ + K+S +S+ + N +
Sbjct: 126 IALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPL 182
Query: 628 RTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG--RPALGIT-KEVQYALDTG 684
R ++ PE + + + KSDV+SFG+++ + T P G++ +EV L G
Sbjct: 183 R--------WLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAG 234
Query: 685 KLKNLLDPLAGDWPFVQA--EQLANLAMRCCEMSRKSRP 721
KL+ P + +L L RC ++ K RP
Sbjct: 235 KLE---------LPVPEGCPSRLYKLMTRCWAVNPKDRP 264
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 2e-16
Identities = 70/260 (26%), Positives = 124/260 (47%), Gaps = 31/260 (11%)
Query: 471 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC-P 529
IGEG +G++ +G +VA+K + F +E +++K+ H NLV L+G
Sbjct: 13 IIGEGEFGAVLQGEYTGQKVAVKNIKCDVTA--QAFLEETAVMTKLHHKNLVRLLGVILH 70
Query: 530 EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDL 589
+V E + G+L + L + + +S ++ + ++ + +L S K +VH DL
Sbjct: 71 NGLYIVMELMSKGNLVNFLRTRGRAL-VSVIQLLQFSLDVAEGMEYLESKK---LVHRDL 126
Query: 590 KPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELT 649
NIL+ + V+K+SDFG++R + +N+ L + + PE L + +
Sbjct: 127 AARNILVSEDGVAKVSDFGLARV---GSMGVDNSKLPVK--------WTAPEALKHKKFS 175
Query: 650 PKSDVYSFGIILLRLLT-GR---PALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQL 705
KSDV+S+G++L + + GR P + + KEV+ ++ G ++P G V
Sbjct: 176 SKSDVWSYGVLLWEVFSYGRAPYPKMSL-KEVKECVEKGY---RMEPPEGCPADVYV--- 228
Query: 706 ANLAMRCCEMSRKSRPELGK 725
L C E K RP K
Sbjct: 229 --LMTSCWETEPKKRPSFHK 246
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 66/218 (30%), Positives = 105/218 (48%), Gaps = 37/218 (16%)
Query: 465 NFDPSLKIGEGGYGSIYKGLLRHM--QVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLV 522
D +KIGEG G + + QVA+K + Q E+ I+ +HPN+V
Sbjct: 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIV 79
Query: 523 T-----LVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRI---RIATELCSVL- 573
LVG E+W +V E+L G+L D ++ TR+ +IAT +VL
Sbjct: 80 EMYSSYLVG--DELW-VVMEFLEGGALTDIVT----------HTRMNEEQIATVCLAVLK 126
Query: 574 --IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDP 631
FLH+ ++H D+K +ILL ++ KLSDFG F +Q +S + R
Sbjct: 127 ALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFG---FCAQ--VSKE---VPRRKSL 175
Query: 632 KGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 669
GT +M PE ++ + D++S GI+++ ++ G P
Sbjct: 176 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-16
Identities = 64/226 (28%), Positives = 104/226 (46%), Gaps = 35/226 (15%)
Query: 472 IGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQGP-SEFQQEIDILSKI-RHPNLVTLV 525
IGEG +G + K ++ M AIK + ++ + +F E+++L K+ HPN++ L+
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 526 GACPEVWTL--VYEYLPNGSLEDRLSCK-------------DNSPPLSWQTRIRIATELC 570
GAC L EY P+G+L D L + LS Q + A ++
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 571 SVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTD 630
+ +L +H DL NIL+ N+V+K++DFG+SR +T
Sbjct: 123 RGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---------GQEVYVKKTM 170
Query: 631 PKGTFAYMDPEFLASGELTPKSDVYSFGIILLRL--LTGRPALGIT 674
+ +M E L T SDV+S+G++L + L G P G+T
Sbjct: 171 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 216
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 3e-16
Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 18/208 (8%)
Query: 465 NFDPSLKIGEGGYGS--IYKGLLRHMQVAIKMLHPHSLQGPSEF--QQEIDILSKIRHPN 520
++ P +G+G +G +Y+ V K ++ L EI ILS ++HPN
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPN 60
Query: 521 LVTLVGACPEVWTLV--YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 578
++ + TL+ EY G+L D++ + + + ++ S + ++H
Sbjct: 61 IIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQL-FEEEMVLWYLFQIVSAVSYIHK 119
Query: 579 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 638
I+H D+K NI L + KL DFGIS+ L +E S T + GT YM
Sbjct: 120 ---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILG-SEYSMAETVV-------GTPYYM 168
Query: 639 DPEFLASGELTPKSDVYSFGIILLRLLT 666
PE + KSD+++ G +L LLT
Sbjct: 169 SPELCQGVKYNFKSDIWALGCVLYELLT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 3e-16
Identities = 70/274 (25%), Positives = 123/274 (44%), Gaps = 42/274 (15%)
Query: 472 IGEGGYGSIYKGLLRHM--------QVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLV 522
+G G +G +Y+G + +VA+K L + Q EF +E ++S HPN+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 523 TLVGAC--PEVWTLVYEYLPNGSL----EDRLSCKDNSPPLSWQTRIRIATELCSVLIFL 576
L+G C E ++ E + G L D + P L+ + + I ++ ++L
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 577 HSCKPHSIVHGDLKPANILL-----DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDP 631
+ H +H DL N L+ DA+ V K+ DFG++R + +++ +
Sbjct: 123 E--QMH-FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRK------EGEG 173
Query: 632 KGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GR---PALGITKEVQYALDTGKLK 687
+M PE L G+ T +SDV+SFG+++ +LT G+ PAL + +Q+ G+L+
Sbjct: 174 LLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQ 233
Query: 688 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 721
P +++ L C RP
Sbjct: 234 K---------PENCPDKIYQLMTNCWAQDPSERP 258
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 4e-16
Identities = 61/208 (29%), Positives = 102/208 (49%), Gaps = 25/208 (12%)
Query: 472 IGEGGYGSIYKGLLRH--------MQVAIKMLHPHSLQGPS-EFQQEIDILSKIRHPNLV 522
+GEG +G + L R+ QVA+K L P S + ++EI+IL + H N+V
Sbjct: 12 LGEGHFGKVE--LCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69
Query: 523 TLVGACPEVW----TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 578
G C E L+ E+LP+GSL++ L N ++ + +++ A ++C + +L S
Sbjct: 70 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLP--RNKNKINLKQQLKYAVQICKGMDYLGS 127
Query: 579 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 638
VH DL N+L+++ K+ DFG+++ I ++ + D +
Sbjct: 128 ---RQYVHRDLAARNVLVESEHQVKIGDFGLTK-----AIETDKEYYTVKDDLDSPVFWY 179
Query: 639 DPEFLASGELTPKSDVYSFGIILLRLLT 666
PE L + SDV+SFG+ L LLT
Sbjct: 180 APECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 4e-16
Identities = 60/219 (27%), Positives = 104/219 (47%), Gaps = 34/219 (15%)
Query: 471 KIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVT 523
++GEG +G ++ + M VA+K L S +FQ+E ++L+ ++H ++V
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 524 LVGACPE--VWTLVYEYLPNGSLEDRLSC-----------KDNSP-PLSWQTRIRIATEL 569
G C E +V+EY+ +G L L +D +P L+ + IA+++
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 570 CSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI--SSNNTTLCC 627
S +++L S VH DL N L+ V K+ DFG+SR + + T L
Sbjct: 132 ASGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 628 RTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 666
R +M PE + + T +SD++SFG++L + T
Sbjct: 189 R--------WMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 4e-16
Identities = 61/205 (29%), Positives = 101/205 (49%), Gaps = 20/205 (9%)
Query: 472 IGEGGYGSIYKGLLRHMQ------VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLV 525
+G+G +GS+ +Q VA+K L + + +F++EI+IL ++H N+V
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 526 GACPEV----WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 581
G C LV EYLP GSL D L + L + + A+++C + +L S +
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQ--KHRERLDHRKLLLYASQICKGMEYLGSKR- 128
Query: 582 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 641
VH DL NIL+++ K+ DFG+++ L Q++ R + + PE
Sbjct: 129 --YVHRDLATRNILVESENRVKIGDFGLTKVLPQDK-----EYYKVREPGESPIFWYAPE 181
Query: 642 FLASGELTPKSDVYSFGIILLRLLT 666
L + + SDV+SFG++L L T
Sbjct: 182 SLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 4e-16
Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 26/203 (12%)
Query: 473 GEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQ----EIDILSKIRHPNLVTLVGAC 528
G GG S K + +A K++H + S ++ E+ I+ + R P +V+ GA
Sbjct: 16 GNGGSVSKVKHIPTGTVMAKKVVH---IGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 529 ---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 585
+ + E++ GSL DR+ K P+ + +IA + L +L++ H I+
Sbjct: 73 LNENNI-CMCMEFMDCGSL-DRIYKKGG--PIPVEILGKIAVAVVEGLTYLYNV--HRIM 126
Query: 586 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS 645
H D+KP+NIL+++ KL DFG+S L I+S T GT YM PE +
Sbjct: 127 HRDIKPSNILVNSRGQIKLCDFGVSGEL----INSIADTFV------GTSTYMSPERIQG 176
Query: 646 GELTPKSDVYSFGIILLRLLTGR 668
G+ T KSDV+S GI ++ L G+
Sbjct: 177 GKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 5e-16
Identities = 49/164 (29%), Positives = 72/164 (43%), Gaps = 19/164 (11%)
Query: 508 QEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI 565
E IL ++ HP LV L + E LV + L G L LS K S + +++
Sbjct: 49 NERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKV---KFS-EEQVKF 104
Query: 566 -ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 624
E+ L +LHS I+H D+KP NILLD ++DF I+ ++ + T+
Sbjct: 105 WICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTS 158
Query: 625 LCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR 668
GT YM PE L + D +S G+ L G+
Sbjct: 159 TS------GTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGK 196
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 5e-16
Identities = 66/214 (30%), Positives = 98/214 (45%), Gaps = 29/214 (13%)
Query: 465 NFDPSLKIGEGGYGSIY--KGLLRHMQVAIKM--LHPHSLQGPSEFQQEIDILSKIRHPN 520
++ KIGEG +G IY K IK L ++ ++E+ +L+K++HPN
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 521 LVTLVGACPEVWTL--VYEYLPNGSLEDRLSCK-----DNSPPLSWQTRIRIATELCSVL 573
+VT + E L V EY G L R++ + LSW +I + L
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLG------L 114
Query: 574 IFLHSCKPHSIVHGDLKPANILLDAN-FVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 632
+H K I+H D+K NI L N V+KL DFGI+R L N++ T
Sbjct: 115 KHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-------NDSMELAYT-CV 163
Query: 633 GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 666
GT Y+ PE + K+D++S G +L L T
Sbjct: 164 GTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 6e-16
Identities = 65/236 (27%), Positives = 110/236 (46%), Gaps = 54/236 (22%)
Query: 471 KIGEGGYGSIY--------------------KGLLRHMQVAIKMLHPHSLQGP-SEFQQE 509
K+GEG +G ++ KG R + VA+K+L P + + ++F +E
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKG--RPLLVAVKILRPDANKNARNDFLKE 69
Query: 510 IDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCK----------DNSPP- 556
+ ILS+++ PN++ L+G C + ++ EY+ NG L LS D PP
Sbjct: 70 VKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPA 129
Query: 557 -----LSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR 611
+S+ + + +A ++ S + +L S + VH DL N L+ N K++DFG+SR
Sbjct: 130 HCLPAISYSSLLHVALQIASGMKYLSSL---NFVHRDLATRNCLVGENLTIKIADFGMSR 186
Query: 612 FLSQNEIS--SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLL 665
L + L R +M E + G+ T SDV++FG+ L +L
Sbjct: 187 NLYAGDYYRIQGRAVLPIR--------WMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 6e-16
Identities = 56/199 (28%), Positives = 104/199 (52%), Gaps = 16/199 (8%)
Query: 471 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 529
++G G +G ++ G R ++VAIK ++ ++ +F +E ++ K+ HP LV L G C
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS-EEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 530 EVWTL--VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 587
+ L V E++ NG L + L + LS + + ++C + +L +S +H
Sbjct: 70 QQKPLYIVTEFMENGCLLNYL--RQRQGKLSKDMLLSMCQDVCEGMEYLER---NSFIHR 124
Query: 588 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 647
DL N L+ + V K+SDFG++R++ +E +S+ + K + PE +
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS-------SGAKFPVKWSPPEVFNFSK 177
Query: 648 LTPKSDVYSFGIILLRLLT 666
+ KSDV+SFG+++ + T
Sbjct: 178 YSSKSDVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 7e-16
Identities = 62/212 (29%), Positives = 92/212 (43%), Gaps = 26/212 (12%)
Query: 466 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPN 520
F ++G+GGYG ++ + VA+K + L +E + E DIL+ +
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 521 LVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSW-QTRIRIATELCSVLIFLH 577
LV L+ A E L EY+P G L+ N LS R +A +V
Sbjct: 63 LVKLLYAFQDDEYLYLAMEYVPGGDFRTLLN---NLGVLSEDHARFYMAEMFEAV----D 115
Query: 578 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 637
+ +H DLKP N L+DA+ KL+DFG LS+ ++ N+ + G+ Y
Sbjct: 116 ALHELGYIHRDLKPENFLIDASGHIKLTDFG----LSKGIVTYANSVV-------GSPDY 164
Query: 638 MDPEFLASGELTPKSDVYSFGIILLRLLTGRP 669
M PE L D +S G +L L G P
Sbjct: 165 MAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFP 196
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 7e-16
Identities = 52/224 (23%), Positives = 99/224 (44%), Gaps = 23/224 (10%)
Query: 505 EFQQEIDILSKIRHPNLVTLVGACPEV--WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTR 562
++EI +++++ HP+++ ++GA E + L E++ GS+ LS
Sbjct: 49 ALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLS---KYGAFKEAVI 105
Query: 563 IRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN-FVSKLSDFGISRFLSQNEISSN 621
I +L L +LH + I+H D+K AN+L+D+ +++DFG + L
Sbjct: 106 INYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARL-------- 154
Query: 622 NTTLCCRTDPKG----TFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEV 677
+ +G T A+M PE L + DV+S G +++ + T +P K
Sbjct: 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS 214
Query: 678 QYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 721
+ K+ + P + L ++ +RC E+ + RP
Sbjct: 215 NHLALIFKIASATTA--PSIPEHLSPGLRDVTLRCLELQPEDRP 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 9e-16
Identities = 69/229 (30%), Positives = 118/229 (51%), Gaps = 30/229 (13%)
Query: 472 IGEGGYGSIYKGL------LRHMQVAIKMLHPHSLQGPS---EFQQEIDILSKIRHPNLV 522
+G G +G++YKG+ + VAIK+L+ + GP EF E I++ + HP+LV
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPHLV 72
Query: 523 TLVGAC--PEVWTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSC 579
L+G C P + LV + +P+G L D + KDN + Q + ++ +++L
Sbjct: 73 RLLGVCLSPTI-QLVTQLMPHGCLLDYVHEHKDN---IGSQLLLNWCVQIAKGMMYLEE- 127
Query: 580 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 639
+VH DL N+L+ + K++DFG++R L +E N K +M
Sbjct: 128 --RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYN------ADGGKMPIKWMA 179
Query: 640 PEFLASGELTPKSDVYSFGIILLRLLT--GRPALGI-TKEVQYALDTGK 685
E + + T +SDV+S+G+ + L+T G+P GI T+E+ L+ G+
Sbjct: 180 LECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGE 228
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 1e-15
Identities = 66/208 (31%), Positives = 101/208 (48%), Gaps = 28/208 (13%)
Query: 471 KIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSE-FQQEIDILSKIRHPNLVTLVGA 527
+IG+G +G ++KG+ Q VAIK++ + E QQEI +LS+ P + G+
Sbjct: 11 RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 528 C---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIAT---ELCSVLIFLHSCKP 581
++W ++ EYL GS D L + P +IAT E+ L +LHS K
Sbjct: 71 YLKGTKLW-IIMEYLGGGSALDLL----RAGPFD---EFQIATMLKEILKGLDYLHSEKK 122
Query: 582 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 641
+H D+K AN+LL KL+DFG++ L+ +I N GT +M PE
Sbjct: 123 ---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV--------GTPFWMAPE 171
Query: 642 FLASGELTPKSDVYSFGIILLRLLTGRP 669
+ K+D++S GI + L G P
Sbjct: 172 VIQQSAYDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 1e-15
Identities = 58/224 (25%), Positives = 105/224 (46%), Gaps = 32/224 (14%)
Query: 464 HNFDPSLKIGEGGYGSIYKGLLRHM-------QVAIKMLHPHSLQGPSEFQQEIDILSKI 516
HN ++GEG +G ++ ++ VA+K L S +F +E ++L+ +
Sbjct: 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL 64
Query: 517 RHPNLVTLVGACPE--VWTLVYEYLPNGSLE--------DRLSCKDNSPP--LSWQTRIR 564
+H ++V G C E +V+EY+ +G L D + + + P L+ +
Sbjct: 65 QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124
Query: 565 IATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI--SSNN 622
IA ++ + +++L S VH DL N L+ N + K+ DFG+SR + + +
Sbjct: 125 IAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGH 181
Query: 623 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 666
T L R +M PE + + T +SDV+S G++L + T
Sbjct: 182 TMLPIR--------WMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 1e-15
Identities = 71/260 (27%), Positives = 123/260 (47%), Gaps = 47/260 (18%)
Query: 437 SRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQV----AI 492
S +SSS+ + S SE+E +IG G G++YK + H A+
Sbjct: 54 SSSSSSSSASGSAPSAAKSLSELERVN-------RIGSGAGGTVYK--VIHRPTGRLYAL 104
Query: 493 KMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVW------TLVYEYLPNGSLE 545
K+++ H + +EI+IL + HPN+V C +++ ++ E++ GSLE
Sbjct: 105 KVIYGNHEDTVRRQICREIEILRDVNHPNVVK----CHDMFDHNGEIQVLLEFMDGGSLE 160
Query: 546 DRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLS 605
+ L+ +A ++ S + +LH IVH D+KP+N+L+++ K++
Sbjct: 161 GTHIADE--QFLA-----DVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIA 210
Query: 606 DFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF----LASGELTPKS-DVYSFGII 660
DFG+SR L+Q N++ GT AYM PE L G + D++S G+
Sbjct: 211 DFGVSRILAQTMDPCNSSV--------GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVS 262
Query: 661 LLRLLTGRPALGITKEVQYA 680
+L GR G+ ++ +A
Sbjct: 263 ILEFYLGRFPFGVGRQGDWA 282
|
Length = 353 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 62/220 (28%), Positives = 98/220 (44%), Gaps = 40/220 (18%)
Query: 465 NFDPSLKIGEGGYGSIYKGLLRHMQV----AIKMLHPH---SLQGPSEFQQEIDILSKIR 517
+ + +G G +G ++ L+R A+K++ L+ E +L ++
Sbjct: 2 DLERIKTVGTGTFGRVH--LVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS 59
Query: 518 HPNLVTLVGACPEVWT--------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATEL 569
HP ++ L WT ++ EY+P G L L NS S T + A+E+
Sbjct: 60 HPFIIRLF------WTEHDQRFLYMLMEYVPGGELFSYLR---NSGRFSNSTGLFYASEI 110
Query: 570 CSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRT 629
L +LHS IV+ DLKP NILLD KL+DFG ++ ++ TLC
Sbjct: 111 VCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLC--- 159
Query: 630 DPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 669
GT Y+ PE + S D ++ GI++ +L G P
Sbjct: 160 ---GTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYP 196
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 63/208 (30%), Positives = 95/208 (45%), Gaps = 25/208 (12%)
Query: 471 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTLV 525
++GEG GS+ K L++ M A+K + P +Q E++I + P +V
Sbjct: 8 RLGEGAGGSVTKCRLKNTGMIFALKTITTDP--NPDLQKQILRELEINKSCKSPYIVKYY 65
Query: 526 GACPEVWT----LVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 580
GA + + + EY GSL+ K + + +IA + L +LHS K
Sbjct: 66 GAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK 125
Query: 581 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 640
I+H D+KP+NILL KL DFG+S L ++S T GT YM P
Sbjct: 126 ---IIHRDIKPSNILLTRKGQVKLCDFGVSGEL----VNSLAGTFT------GTSFYMAP 172
Query: 641 EFLASGELTPKSDVYSFGIILLRLLTGR 668
E + + SDV+S G+ LL + R
Sbjct: 173 ERIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 65/242 (26%), Positives = 110/242 (45%), Gaps = 47/242 (19%)
Query: 472 IGEGGYGSIYKGLLR-------HMQVAIKML----HPHSLQGPSEFQQEIDILSKI-RHP 519
+GEG +G + K VA+KML L S+ E++++ I +H
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDL---SDLVSEMEMMKMIGKHK 76
Query: 520 NLVTLVGACPE---VWTLVYEYLPNGSLEDRLSCKDNSPP---------------LSWQT 561
N++ L+G C + ++ +V EY +G+L D L + PP L+ +
Sbjct: 77 NIINLLGVCTQEGPLYVVV-EYAAHGNLRDFL--RARRPPGEYASPDDPRPPEETLTQKD 133
Query: 562 RIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 621
+ A ++ + FL S K +H DL N+L+ + V K++DFG++R + +
Sbjct: 134 LVSFAYQVARGMEFLASKK---CIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRK 190
Query: 622 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGITKEVQY 679
T+ + +M PE L T +SDV+SFG++L + T G P GI E +
Sbjct: 191 ------TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 244
Query: 680 AL 681
L
Sbjct: 245 KL 246
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 63/206 (30%), Positives = 99/206 (48%), Gaps = 19/206 (9%)
Query: 471 KIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTL-- 524
KIGEG YG +YKG + VA+K + S + PS +EI +L +++HPN+V L
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 525 VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 584
V L++E+L + L+ L D+ P + + + L +L + C +
Sbjct: 67 VLMQESRLYLIFEFL-SMDLKKYL---DSLPKGQYMDAELVKSYLYQILQGILFCHSRRV 122
Query: 585 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE-FL 643
+H DLKP N+L+D V KL+DFG++R + + T T Y PE L
Sbjct: 123 LHRDLKPQNLLIDNKGVIKLADFGLAR--------AFGIPVRVYTHEVVTLWYRAPEVLL 174
Query: 644 ASGELTPKSDVYSFGIILLRLLTGRP 669
S + D++S G I + T +P
Sbjct: 175 GSPRYSTPVDIWSIGTIFAEMATKKP 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 71/274 (25%), Positives = 128/274 (46%), Gaps = 43/274 (15%)
Query: 471 KIGEGGYGSIYKGLLRHM-------QVAIKMLHPH-SLQGPSEFQQEIDILSKIRHPNLV 522
++G+G +G +Y+G R + +VA+K ++ SL+ EF E ++ ++V
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 523 TLVGACP--EVWTLVYEYLPNGSLEDRLSC-------KDNSPPLSWQTRIRIATELCSVL 573
L+G + +V E + +G L+ L PP + Q I++A E+ +
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 574 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 633
+L++ K VH DL N ++ +F K+ DFG++R + + + R KG
Sbjct: 133 AYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYY--------RKGGKG 181
Query: 634 TF--AYMDPEFLASGELTPKSDVYSFGIILLRL--LTGRPALGITKE--VQYALDTGKLK 687
+M PE L G T SD++SFG++L + L +P G++ E +++ +D G L
Sbjct: 182 LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYL- 240
Query: 688 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 721
D P E++ +L C + + K RP
Sbjct: 241 --------DQPDNCPERVTDLMRMCWQFNPKMRP 266
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 19/208 (9%)
Query: 465 NFDPSLKIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPSEFQ---QEIDILSKIRHP 519
NF KIG G + +Y+ LL VA+K + + Q +EID+L ++ HP
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 520 NLVTLVGACPE--VWTLVYEYLPNGSLEDRLS-CKDNSPPLSWQTRIRIATELCSVLIFL 576
N++ + + E +V E G L + K + +T + +LCS + +
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 577 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 636
HS ++H D+KPAN+ + A V KL D G+ RF S ++++ GT
Sbjct: 123 HS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV--------GTPY 171
Query: 637 YMDPEFLASGELTPKSDVYSFGIILLRL 664
YM PE + KSD++S G +L +
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 5e-15
Identities = 63/216 (29%), Positives = 97/216 (44%), Gaps = 44/216 (20%)
Query: 472 IGEGGYGSIYKGLLRH-------MQVAIKML-HPHSLQGPSEFQQEIDILSKIRHPNLVT 523
+G G +G +Y+GL R +QVA+K L S Q S+F E I+SK H N+V
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 524 LVGACPEV--WTLVYEYLPNGSLEDRLSCKDNSP------PLSWQTRIRIATELCSVLIF 575
L+G E ++ E + G L+ L ++N P L+ + + A V
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFL--RENRPRPERPSSLTMKDLLFCA---RDVAKG 128
Query: 576 LHSCKPHSIVHGDLKPANILLD---ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTD-- 630
+ + +H D+ N LL V+K++DFG++R +I R
Sbjct: 129 CKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR-----DIY--------RASYY 175
Query: 631 PKGTFA-----YMDPEFLASGELTPKSDVYSFGIIL 661
KG A +M PE G T K+DV+SFG++L
Sbjct: 176 RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLL 211
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 5e-15
Identities = 64/226 (28%), Positives = 104/226 (46%), Gaps = 35/226 (15%)
Query: 472 IGEGGYGSIYKGLLR----HMQVAIKMLHPHSLQGP-SEFQQEIDILSKI-RHPNLVTLV 525
IGEG +G + K ++ M AIK + ++ + +F E+++L K+ HPN++ L+
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 526 GACPE--VWTLVYEYLPNGSLEDRLS-------------CKDNSPPLSWQTRIRIATELC 570
GAC L EY P+G+L D L + LS Q + A ++
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134
Query: 571 SVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTD 630
+ +L +H DL NIL+ N+V+K++DFG+SR +T
Sbjct: 135 RGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---------GQEVYVKKTM 182
Query: 631 PKGTFAYMDPEFLASGELTPKSDVYSFGIILLRL--LTGRPALGIT 674
+ +M E L T SDV+S+G++L + L G P G+T
Sbjct: 183 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 228
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 5e-15
Identities = 57/182 (31%), Positives = 87/182 (47%), Gaps = 17/182 (9%)
Query: 490 VAIKMLHPH-SLQGPSEFQQEIDILSKIRHPNLVTLVGACPE----VWTLVYEYLPNGSL 544
VA+K L Q S +++EI+IL + H N+V G C E L+ EY+P GSL
Sbjct: 36 VAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSL 95
Query: 545 EDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKL 604
D L K L+ + A ++C + +LHS +H DL N+LLD + + K+
Sbjct: 96 RDYLP-KHK---LNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKI 148
Query: 605 SDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRL 664
DFG+++ + + R D + E L + + SDV+SFG+ L L
Sbjct: 149 GDFGLAKAVPEGHEYYR-----VREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYEL 203
Query: 665 LT 666
LT
Sbjct: 204 LT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 6e-15
Identities = 69/231 (29%), Positives = 98/231 (42%), Gaps = 71/231 (30%)
Query: 471 KIGEGGYGSIYKGLLRHMQ----VAIK---------MLHPHSLQGPSEFQQEIDILSKIR 517
KIGEG YG ++K R+ + VAIK ++ +L+ EI +L +++
Sbjct: 8 KIGEGSYGVVFK--CRNRETGQIVAIKKFVESEDDPVIKKIALR-------EIRMLKQLK 58
Query: 518 HPNLVTLVGACPEVWT------LVYEYL-----------PNGSLEDRLSCKDNSPPLSWQ 560
HPNLV L+ EV+ LV+EY P G K + WQ
Sbjct: 59 HPNLVNLI----EVFRRKRKLHLVFEYCDHTVLNELEKNPRGV--PEHLIKK----IIWQ 108
Query: 561 TRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 620
T L ++ C H+ +H D+KP NIL+ KL DFG +R L+
Sbjct: 109 T-----------LQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD- 156
Query: 621 NNTTLCCRTDPKGTFAYMDPEFLASGELT--PKSDVYSFGIILLRLLTGRP 669
TD T Y PE L G+ P DV++ G + LLTG+P
Sbjct: 157 -------YTDYVATRWYRAPELLV-GDTQYGPPVDVWAIGCVFAELLTGQP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 7e-15
Identities = 59/196 (30%), Positives = 95/196 (48%), Gaps = 20/196 (10%)
Query: 472 IGEGGYGSIYKGLLR-HMQVAIKMLH---PHSLQGPSEFQQEIDILSKIRHPNLVTLVGA 527
+G+G +G ++KG L+ VA+K P L+ +F E IL + HPN+V L+G
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELK--IKFLSEARILKQYDHPNIVKLIGV 60
Query: 528 CPEVWT--LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 585
C + +V E +P G L K + L + ++ A + + + +L S + +
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKKDE--LKTKQLVKFALDAAAGMAYLES---KNCI 115
Query: 586 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS 645
H DL N L+ N V K+SDFG+SR SS+ + + PE L
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK-------QIPIKWTAPEALNY 168
Query: 646 GELTPKSDVYSFGIIL 661
G + +SDV+S+GI+L
Sbjct: 169 GRYSSESDVWSYGILL 184
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 7e-15
Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 29/208 (13%)
Query: 471 KIGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVT----- 523
KIG+G G++Y + +VAIK ++ EI ++ + ++PN+V
Sbjct: 26 KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85
Query: 524 LVGACPEVWTLVYEYLPNGSLEDRLS--CKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 581
LVG E+W +V EYL GSL D ++ C D + + E L FLHS
Sbjct: 86 LVG--DELW-VVMEYLAGGSLTDVVTETCMDEGQIAA------VCRECLQALDFLHS--- 133
Query: 582 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 641
+ ++H D+K NILL + KL+DFG ++ + S +T+ GT +M PE
Sbjct: 134 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMV------GTPYWMAPE 185
Query: 642 FLASGELTPKSDVYSFGIILLRLLTGRP 669
+ PK D++S GI+ + ++ G P
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 7e-15
Identities = 64/225 (28%), Positives = 102/225 (45%), Gaps = 47/225 (20%)
Query: 471 KIGEGGYGSIYKGLLRHMQ----VAIKM-LHPHSLQG-PSEFQQEIDILSKIRHPNLVTL 524
KIG+G +G ++K RH + VA+K L + +G P +EI IL ++H N+V L
Sbjct: 19 KIGQGTFGEVFKA--RHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNL 76
Query: 525 VGACPEVWT----------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRI--------RIA 566
+ C T LV+E+ C+ + L + ++
Sbjct: 77 IEICRTKATPYNRYKGSFYLVFEF-----------CEHDLAGLLSNKNVKFTLSEIKKVM 125
Query: 567 TELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLC 626
L + L ++H K I+H D+K ANIL+ + + KL+DFG++R S ++ S N
Sbjct: 126 KMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPN---- 178
Query: 627 CRTDPKGTFAYMDPEFLASGE--LTPKSDVYSFGIILLRLLTGRP 669
T+ T Y PE L GE P D++ G I+ + T P
Sbjct: 179 RYTNRVVTLWYRPPELLL-GERDYGPPIDMWGAGCIMAEMWTRSP 222
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 7e-15
Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 20/205 (9%)
Query: 471 KIGEGGYGSIYKGL--LRHMQVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTL--V 525
K+GEG Y +++KG L VA+K + H P +E+ +L ++H N+VTL +
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71
Query: 526 GACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 585
TLV+EYL + L+ L DN L ++I + +L L C I+
Sbjct: 72 IHTERCLTLVFEYLDS-DLKQYL---DNCGNLMSMHNVKIF--MFQLLRGLSYCHKRKIL 125
Query: 586 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE-FLA 644
H DLKP N+L++ KL+DFG++R S + +N + T Y P+ L
Sbjct: 126 HRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--------TLWYRPPDVLLG 177
Query: 645 SGELTPKSDVYSFGIILLRLLTGRP 669
S E + D++ G IL + TGRP
Sbjct: 178 STEYSTPIDMWGVGCILYEMATGRP 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 8e-15
Identities = 65/207 (31%), Positives = 98/207 (47%), Gaps = 21/207 (10%)
Query: 471 KIGEGGYGSIYKGLLRHMQ--VAIKM--LHPHSLQGPSEFQQEIDILSKIRHPNLVTL-- 524
KIGEG YG +YK R +A+K L PS +EI +L +++H N+V L
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 525 VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 584
V + LV+EYL + L+ + D+SP + R+ I T L +L + C H +
Sbjct: 69 VVHSEKRLYLVFEYL-DLDLKKHM---DSSPDFAKNPRL-IKTYLYQILRGIAYCHSHRV 123
Query: 585 VHGDLKPANILLD-ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE-F 642
+H DLKP N+L+D KL+DFG++R + T T Y PE
Sbjct: 124 LHRDLKPQNLLIDRRTNALKLADFGLARAFG--------IPVRTFTHEVVTLWYRAPEIL 175
Query: 643 LASGELTPKSDVYSFGIILLRLLTGRP 669
L S + D++S G I ++ +P
Sbjct: 176 LGSRHYSTPVDIWSVGCIFAEMVNQKP 202
|
Length = 294 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 68/265 (25%), Positives = 120/265 (45%), Gaps = 33/265 (12%)
Query: 472 IGEGGYGSIYK----GLLRH---MQVAIKMLHPHSLQGPSE-FQQEIDILSKI-RHPNLV 522
+G G +G + + GL + M+VA+KML P + E E+ I+S + H N+V
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 523 TLVGAC----PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 578
L+GAC P + ++ EY G L + L K S L+ + + + ++ + FL S
Sbjct: 103 NLLGACTIGGPIL--VITEYCCYGDLLNFLRRKRESF-LTLEDLLSFSYQVAKGMAFLAS 159
Query: 579 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL--SQNEISSNNTTLCCRTDPKGTFA 636
+ +H DL N+LL + K+ DFG++R + N + N L +
Sbjct: 160 ---KNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVK-------- 208
Query: 637 YMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 696
+M PE + + T +SDV+S+GI+L + + LG +D+ K + +
Sbjct: 209 WMAPESIFNCVYTFESDVWSYGILLWEIFS----LGSNPYPGMPVDSKFYKLIKEGYRMA 264
Query: 697 WPFVQAEQLANLAMRCCEMSRKSRP 721
P ++ ++ C + RP
Sbjct: 265 QPEHAPAEIYDIMKTCWDADPLKRP 289
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-14
Identities = 71/221 (32%), Positives = 106/221 (47%), Gaps = 39/221 (17%)
Query: 472 IGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVG 526
+G G YG +YKG RH++ AIK++ + E + EI++L K H N+ T G
Sbjct: 24 VGNGTYGQVYKG--RHVKTGQLAAIKVMDV-TEDEEEEIKLEINMLKKYSHHRNIATYYG 80
Query: 527 A----CP-----EVWTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFL 576
A P ++W LV E+ GS+ D + + K N+ W I E+ L L
Sbjct: 81 AFIKKSPPGHDDQLW-LVMEFCGAGSVTDLVKNTKGNALKEDWIAYI--CREILRGLAHL 137
Query: 577 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 636
H+ H ++H D+K N+LL N KL DFG+S L + + NT + GT
Sbjct: 138 HA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT-VGRRNTFI-------GTPY 186
Query: 637 YMDPEFLASGELTP------KSDVYSFGIILLRLLTGRPAL 671
+M PE +A E P +SD++S GI + + G P L
Sbjct: 187 WMAPEVIACDE-NPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 65/211 (30%), Positives = 97/211 (45%), Gaps = 30/211 (14%)
Query: 471 KIGEGGYGSIYKGLLRHMQ----VAIKMLH-PHSLQG-PSEFQQEIDILSKIRHPNLVTL 524
KIGEG YG +YK R VA+K + +G PS +EI +L ++ HPN+V L
Sbjct: 6 KIGEGTYGVVYKA--RDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRL 63
Query: 525 --VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRI--RIATELCSVLIFLHSCK 580
V LV+E+L + L+ + D+SP + +L + + HS
Sbjct: 64 LDVVHSENKLYLVFEFL-DLDLKKYM---DSSPLTGLDPPLIKSYLYQLLQGIAYCHS-- 117
Query: 581 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 640
H ++H DLKP N+L+D KL+DFG++R + + T T Y P
Sbjct: 118 -HRVLHRDLKPQNLLIDREGALKLADFGLAR--------AFGVPVRTYTHEVVTLWYRAP 168
Query: 641 EFLASGEL--TPKSDVYSFGIILLRLLTGRP 669
E L TP D++S G I ++ RP
Sbjct: 169 EILLGSRQYSTP-VDIWSIGCIFAEMVNRRP 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 74.8 bits (183), Expect = 2e-14
Identities = 64/208 (30%), Positives = 102/208 (49%), Gaps = 29/208 (13%)
Query: 471 KIGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVT----- 523
KIG+G G++Y + +VAI+ ++ EI ++ + ++PN+V
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 524 LVGACPEVWTLVYEYLPNGSLEDRLS--CKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 581
LVG E+W +V EYL GSL D ++ C D + + E L FLHS
Sbjct: 87 LVG--DELW-VVMEYLAGGSLTDVVTETCMDEGQIAA------VCRECLQALEFLHS--- 134
Query: 582 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 641
+ ++H D+K NILL + KL+DFG F +Q I+ + R+ GT +M PE
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFG---FCAQ--ITPEQSK---RSTMVGTPYWMAPE 186
Query: 642 FLASGELTPKSDVYSFGIILLRLLTGRP 669
+ PK D++S GI+ + ++ G P
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 3e-14
Identities = 68/216 (31%), Positives = 97/216 (44%), Gaps = 25/216 (11%)
Query: 465 NFDPSLKIGEGGYGSIYKGLLRHMQ----VAIKM--LHPHSLQGPSEFQQEIDILSKIRH 518
NF KIGEG YG +YK R+ VA+K L + PS +EI +L ++ H
Sbjct: 1 NFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 58
Query: 519 PNLVTL--VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFL 576
PN+V L V LV+E+L +D D SP + I + L +L L
Sbjct: 59 PNIVKLLDVIHTENKLYLVFEFLH----QDLKKFMDASPLSGIPLPL-IKSYLFQLLQGL 113
Query: 577 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 636
C H ++H DLKP N+L++ KL+DFG++R + T T
Sbjct: 114 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG--------VPVRTYTHEVVTLW 165
Query: 637 YMDPE-FLASGELTPKSDVYSFGIILLRLLTGRPAL 671
Y PE L + D++S G I ++T R AL
Sbjct: 166 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 3e-14
Identities = 37/91 (40%), Positives = 51/91 (56%), Gaps = 13/91 (14%)
Query: 582 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 641
H ++H D+KP+NILLDA+ KL DFGIS L ++ +T G AYM PE
Sbjct: 134 HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK---------AKTRSAGCAAYMAPE 184
Query: 642 FLASGELTPK----SDVYSFGIILLRLLTGR 668
+ + PK +DV+S GI L+ L TG+
Sbjct: 185 RIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 3e-14
Identities = 68/228 (29%), Positives = 101/228 (44%), Gaps = 33/228 (14%)
Query: 465 NFDPSLKIGEGGYGSIYKGLLRHM----QVAIKMLHPHSLQG--PSEFQQEIDILSKIRH 518
F+ +IGEG YG +Y+ R VA+K + + + P +EI +L +RH
Sbjct: 8 EFEKLNRIGEGTYGIVYRA--RDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRH 65
Query: 519 PNLVTL----VGACPEVWTLVYEYLPNGSLEDRLSCKDNSP-PLSWQTRIRIATELCSVL 573
PN+V L VG + LV EY +D S DN P P S + +L L
Sbjct: 66 PNIVELKEVVVGKHLDSIFLVMEYCE----QDLASLLDNMPTPFSESQVKCLMLQLLRGL 121
Query: 574 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS--QNEISSNNTTLCCRTDP 631
+LH + I+H DLK +N+LL K++DFG++R ++ TL
Sbjct: 122 QYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLW----- 173
Query: 632 KGTFAYMDPEFL-ASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 678
Y PE L T D+++ G IL LL +P L E++
Sbjct: 174 -----YRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE 216
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 74.5 bits (184), Expect = 3e-14
Identities = 68/218 (31%), Positives = 106/218 (48%), Gaps = 39/218 (17%)
Query: 471 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQ---EIDILSKIR-HPNLVTL 524
K+G+G YG ++K + R VA+K + + + ++ Q+ EI L ++ HPN+V L
Sbjct: 14 KLGKGAYGIVWKAIDRRTKEVVALKKIF-DAFRNATDAQRTFREIMFLQELGDHPNIVKL 72
Query: 525 VGACPEV----WTLVYEYLPN--------GSLEDRLSCKDNSPPLSWQTRIRIATELCSV 572
+ LV+EY+ LED + I +L
Sbjct: 73 LNVIKAENDKDIYLVFEYMETDLHAVIRANILED-------------VHKRYIMYQLLKA 119
Query: 573 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 632
L ++HS +++H DLKP+NILL+++ KL+DFG++R LS+ E + N L TD
Sbjct: 120 LKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVL---TDYV 173
Query: 633 GTFAYMDPEFL-ASGELTPKSDVYSFGIILLRLLTGRP 669
T Y PE L S T D++S G IL +L G+P
Sbjct: 174 ATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKP 211
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 3e-14
Identities = 72/221 (32%), Positives = 105/221 (47%), Gaps = 39/221 (17%)
Query: 472 IGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVG 526
+G G YG +YKG RH++ AIK++ + E +QEI++L K H N+ T G
Sbjct: 14 VGNGTYGQVYKG--RHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIATYYG 70
Query: 527 AC---------PEVWTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFL 576
A ++W LV E+ GS+ D + + K N+ W I E+ L L
Sbjct: 71 AFIKKNPPGMDDQLW-LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYI--CREILRGLSHL 127
Query: 577 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 636
H H ++H D+K N+LL N KL DFG+S L + + NT + GT
Sbjct: 128 HQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT-VGRRNTFI-------GTPY 176
Query: 637 YMDPEFLASGELTP------KSDVYSFGIILLRLLTGRPAL 671
+M PE +A E P KSD++S GI + + G P L
Sbjct: 177 WMAPEVIACDE-NPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-14
Identities = 70/235 (29%), Positives = 109/235 (46%), Gaps = 24/235 (10%)
Query: 471 KIGEGGYGSIYKGL--LRHMQVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTL--V 525
K+GEG Y ++YKG L VA+K + H P +E+ +L ++H N+VTL +
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 526 GACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 585
+ TLV+EYL + L+ L NS + + L +L L+ C ++
Sbjct: 73 IHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMH-----NVKLFLFQLLRGLNYCHRRKVL 126
Query: 586 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE-FLA 644
H DLKP N+L++ KL+DFG++R S + +N + T Y P+ L
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--------TLWYRPPDILLG 178
Query: 645 SGELTPKSDVYSFGIILLRLLTGRPAL-GITKEVQYALDTGKLKNLLDPLAGDWP 698
S + + + D++ G I + TGRP G T E Q + L P WP
Sbjct: 179 STDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHF---IFRILGTPTEETWP 230
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 4e-14
Identities = 73/264 (27%), Positives = 117/264 (44%), Gaps = 31/264 (11%)
Query: 471 KIGEGGYGSIYKGLLR--HMQVAIKMLH---PHSLQGPSEFQQEIDILSKIRHPNLVTLV 525
+IG G +G ++ G LR + VA+K P L+ ++F QE IL + HPN+V L+
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLK--AKFLQEARILKQYSHPNIVRLI 59
Query: 526 GACPEVWT--LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 583
G C + +V E + G L + P L + I++ + + +L S
Sbjct: 60 GVCTQKQPIYIVMELVQGGDFLTFL--RTEGPRLKVKELIQMVENAAAGMEYLES---KH 114
Query: 584 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 643
+H DL N L+ V K+SDFG+SR + E +T + P + PE L
Sbjct: 115 CIHRDLAARNCLVTEKNVLKISDFGMSR---EEEDGVYASTGGMKQIP---VKWTAPEAL 168
Query: 644 ASGELTPKSDVYSFGIILLRL--LTGRPALGIT-KEVQYALDTGKLKNLLDPLAGDWPFV 700
G + +SDV+SFGI+L L P ++ ++ + A++ G L P +
Sbjct: 169 NYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQG---VRLPC-----PEL 220
Query: 701 QAEQLANLAMRCCEMSRKSRPELG 724
+ + L RC E RP
Sbjct: 221 CPDAVYRLMERCWEYDPGQRPSFS 244
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 4e-14
Identities = 66/278 (23%), Positives = 112/278 (40%), Gaps = 52/278 (18%)
Query: 472 IGEGGYGSIYKGLLRH-----MQVAIKMLHP--HSLQGPSEFQQEIDILSKIRHPNLVTL 524
+GEG +GS+ +G L ++VA+K + H+ EF E + HPN++ L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 525 VGACPEVWTL--------VYEYLPNGSLEDRL---SCKDNSPPLSWQTRIRIATELCSVL 573
+G C E +L + ++ +G L L L QT ++ ++ +
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 574 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR------FLSQNEISSNNTTLCC 627
+L + + +H DL N +L + ++DFG+S+ + Q I+
Sbjct: 127 EYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIA-------- 175
Query: 628 RTDPKGTFAYMDPEFLASGELTPKSDVYSFGI----ILLRLLTGRPALGITKEVQYALDT 683
K ++ E LA T KSDV++FG+ I R T P + + Y
Sbjct: 176 ----KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHG 231
Query: 684 GKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 721
+LK D L ++L +L C K RP
Sbjct: 232 NRLKQPEDCL---------DELYDLMYSCWRADPKDRP 260
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 6e-14
Identities = 69/260 (26%), Positives = 114/260 (43%), Gaps = 38/260 (14%)
Query: 472 IGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQ-GPSEFQQ-------------EIDILSK 515
+GEG YG + K L VAIK + + ++ +Q E+ I+++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 516 IRHPNLVTLVGA-CPEVW-TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVL 573
I+H N++ LV + LV + + L+ + D L+ I ++ + L
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVV---DRKIRLTESQVKCILLQILNGL 132
Query: 574 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS---SNNTTLCCR-- 628
LH +H DL PANI +++ + K++DFG++R S S + T+ R
Sbjct: 133 NVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREE 189
Query: 629 -TDPKGTFAYMDPEFL-ASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL 686
T T Y PE L + + D++S G I LLTG+P E+ G++
Sbjct: 190 MTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID---QLGRI 246
Query: 687 KNLL-DPLAGDWPFVQAEQL 705
LL P +WP QA++L
Sbjct: 247 FELLGTPNEDNWP--QAKKL 264
|
Length = 335 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 7e-14
Identities = 68/210 (32%), Positives = 100/210 (47%), Gaps = 25/210 (11%)
Query: 471 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTLVGA 527
++G+G YGS+YK L R V + M S+F Q E+DIL K P +V GA
Sbjct: 8 ELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGA 67
Query: 528 CPEVWTLVY---EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 584
+ VY EY+ GSL+ + + + RI + L FL + H+I
Sbjct: 68 F-FIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK--EEHNI 124
Query: 585 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 644
+H D+KP N+L++ N KL DFG+S S T + C++ YM PE +
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVS---GNLVASLAKTNIGCQS-------YMAPERIK 174
Query: 645 SGEL------TPKSDVYSFGIILLRLLTGR 668
SG T +SDV+S G+ +L + GR
Sbjct: 175 SGGPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 8e-14
Identities = 63/210 (30%), Positives = 99/210 (47%), Gaps = 27/210 (12%)
Query: 471 KIGEGGYGSIYKGLLRHMQ----VAIKML--HPHSLQGPSEFQQEIDILSKIRHPNLVTL 524
+I EG YG +Y+ R + VA+K L P +EI+IL K++HPN+VT+
Sbjct: 12 RIEEGTYGVVYRA--RDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTV 69
Query: 525 ----VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 580
VG+ + +V EY+ + L+ + + P + +L S + LH
Sbjct: 70 KEVVVGSNLDKIYMVMEYVEH-DLKSLM--ETMKQPFLQSEVKCLMLQLLSGVAHLHD-- 124
Query: 581 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 640
+ I+H DLK +N+LL+ + K+ DFG++R E S T T Y P
Sbjct: 125 -NWILHRDLKTSNLLLNNRGILKICDFGLAR-----EYGSPLKPY---TQLVVTLWYRAP 175
Query: 641 E-FLASGELTPKSDVYSFGIILLRLLTGRP 669
E L + E + D++S G I LLT +P
Sbjct: 176 ELLLGAKEYSTAIDMWSVGCIFAELLTKKP 205
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 8e-14
Identities = 75/248 (30%), Positives = 111/248 (44%), Gaps = 32/248 (12%)
Query: 466 FDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLH-PHSLQG-PSEFQQEIDILSKIR---H 518
++P +IG G YG++YK H VA+K + + G P +E+ +L ++ H
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61
Query: 519 PNLVTLVGACPEVWT-------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCS 571
PN+V L+ C T LV+E++ + L L K P L +T + +
Sbjct: 62 PNIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLD-KVPPPGLPAETIKDLMRQFLR 119
Query: 572 VLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDP 631
L FLH+ + IVH DLKP NIL+ + KL+DFG++R I S L T
Sbjct: 120 GLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLAR------IYSCQMAL---TPV 167
Query: 632 KGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD 691
T Y PE L D++S G I + +P E A GK+ +L+
Sbjct: 168 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE---ADQLGKIFDLIG 224
Query: 692 -PLAGDWP 698
P DWP
Sbjct: 225 LPPEDDWP 232
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 9e-14
Identities = 68/239 (28%), Positives = 111/239 (46%), Gaps = 24/239 (10%)
Query: 471 KIGEGGYGSIYKGL--LRHMQVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTL--V 525
K+GEG Y +++KG L VA+K + H P +E+ +L ++H N+VTL +
Sbjct: 13 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 526 GACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 585
+ TLV+EYL +D D+ + ++I L +L L C ++
Sbjct: 73 VHTDKSLTLVFEYLD----KDLKQYMDDCGNIMSMHNVKIF--LYQILRGLAYCHRRKVL 126
Query: 586 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE-FLA 644
H DLKP N+L++ KL+DFG++R S + +N + T Y P+ L
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--------TLWYRPPDVLLG 178
Query: 645 SGELTPKSDVYSFGIILLRLLTGRPAL-GITKEVQYALDTGKLKNLLDPLAGDWPFVQA 702
S E + + D++ G I + +GRP G T E + L + L P WP + +
Sbjct: 179 SSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHL---IFRLLGTPTEETWPGISS 234
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 9e-14
Identities = 52/198 (26%), Positives = 98/198 (49%), Gaps = 16/198 (8%)
Query: 470 LKIGEGGYGSIYKGLLR----HMQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTL 524
+++G G +G + KG+ + + VAIK+L + + E +E +I+ ++ +P +V +
Sbjct: 1 VELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRM 60
Query: 525 VGAC-PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 583
+G C E LV E G L LS K + +S + + V + + + +
Sbjct: 61 IGVCEAEALMLVMEMASGGPLNKFLSGKKDEITVS-----NVVELMHQVSMGMKYLEGKN 115
Query: 584 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 643
VH DL N+LL +K+SDFG+S+ L ++++ R+ K + PE +
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKAL-----GADDSYYKARSAGKWPLKWYAPECI 170
Query: 644 ASGELTPKSDVYSFGIIL 661
+ + +SDV+S+GI +
Sbjct: 171 NFRKFSSRSDVWSYGITM 188
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 9e-14
Identities = 65/214 (30%), Positives = 102/214 (47%), Gaps = 31/214 (14%)
Query: 466 FDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVT 523
+ +KIGEG G + +H QVA+KM+ Q E+ I+ +H N+V
Sbjct: 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVE 82
Query: 524 -----LVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRI---RIATELCSVLIF 575
LVG E+W L+ E+L G+L D +S QTR+ +IAT SVL
Sbjct: 83 MYKSYLVGE--ELWVLM-EFLQGGALTDIVS----------QTRLNEEQIATVCESVLQA 129
Query: 576 LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 635
L ++H D+K +ILL + KLSDFG +S++ + R GT
Sbjct: 130 LCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD--------VPKRKSLVGTP 181
Query: 636 AYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 669
+M PE ++ + D++S GI+++ ++ G P
Sbjct: 182 YWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-13
Identities = 62/210 (29%), Positives = 106/210 (50%), Gaps = 26/210 (12%)
Query: 471 KIGEGGYGSIYKGLLRHMQV--AIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 528
++G+G +G +YK + A K++ S + ++ EI+IL+ HP +V L+GA
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 529 ---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIR-IATELCSVLIFLHSCKPHSI 584
++W ++ E+ P G+++ + D + +I+ I ++ L +LHS K I
Sbjct: 79 YWDGKLWIMI-EFCPGGAVDAIMLELDRGLT---EPQIQVICRQMLEALQYLHSMK---I 131
Query: 585 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 644
+H DLK N+LL + KL+DFG+S + N TL R GT +M PE +
Sbjct: 132 IHRDLKAGNVLLTLDGDIKLADFGVS--------AKNVKTLQRRDSFIGTPYWMAPEVVM 183
Query: 645 SGEL--TP---KSDVYSFGIILLRLLTGRP 669
+ TP K+D++S GI L+ + P
Sbjct: 184 CETMKDTPYDYKADIWSLGITLIEMAQIEP 213
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 76/285 (26%), Positives = 122/285 (42%), Gaps = 40/285 (14%)
Query: 464 HNFDPSLKIGEGGYGSIYKGLLRHMQ-----VAIKMLHPHSLQG--PSEFQQEIDILSKI 516
++ +IGEG YG ++K R ++ VA+K + + + P +E+ +L +
Sbjct: 1 QQYECVAEIGEGAYGKVFKA--RDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 58
Query: 517 R---HPNLVTLVGACP-------EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIA 566
HPN+V L C TLV+E++ + L L K P + +T +
Sbjct: 59 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLD-KVPEPGVPTETIKDMM 116
Query: 567 TELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLC 626
+L L FLHS H +VH DLKP NIL+ ++ KL+DFG++R S ++
Sbjct: 117 FQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV-- 171
Query: 627 CRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL 686
T Y PE L D++S G I + +P + +V GK+
Sbjct: 172 -------TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKI 221
Query: 687 KNLLD-PLAGDWPFVQAEQLANLAMRCCEMSRKSRP---ELGKDV 727
+++ P DWP A + + K ELGKD+
Sbjct: 222 LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDL 266
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 61/232 (26%), Positives = 96/232 (41%), Gaps = 38/232 (16%)
Query: 465 NFDPSLKIGEGGYGSIYKGLLRHM--QVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPN 520
+++ K+GEG +G +YK VA+K + H+ + P +EI IL K++HPN
Sbjct: 9 DYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPN 68
Query: 521 LVTLVGACPEVWTLVYEYLPNGSLEDRLS--------CKDNSPPLSWQTRIR-------- 564
+V L+ + E P+ S R S D S L ++
Sbjct: 69 VVPLI-------DMAVER-PDKSKRKRGSVYMVTPYMDHDLSGLLE-NPSVKLTESQIKC 119
Query: 565 IATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 624
+L + +LH I+H D+K ANIL+D + K++DFG++R +
Sbjct: 120 YMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGG 176
Query: 625 LCCRTDPKG---TFAYMDPEFLASGE--LTPKSDVYSFGIILLRLLTGRPAL 671
T Y PE L GE T D++ G + + T RP L
Sbjct: 177 GGGTRKYTNLVVTRWYRPPELLL-GERRYTTAVDIWGIGCVFAEMFTRRPIL 227
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 63/209 (30%), Positives = 102/209 (48%), Gaps = 24/209 (11%)
Query: 471 KIGEGGYGSIYKGLLRHMQV--AIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 528
++G+G +G +YK + V A K++ S + ++ EIDIL+ HPN+V L+ A
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 529 ---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 585
+W L+ E+ G++ D + + P Q R+ + + L +LH K I+
Sbjct: 72 YYENNLWILI-EFCAGGAV-DAVMLELERPLTEPQIRV-VCKQTLEALNYLHENK---II 125
Query: 586 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL-- 643
H DLK NIL + KL+DFG+S + N T+ R GT +M PE +
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVS--------AKNTRTIQRRDSFIGTPYWMAPEVVMC 177
Query: 644 ASGELTP---KSDVYSFGIILLRLLTGRP 669
+ + P K+DV+S GI L+ + P
Sbjct: 178 ETSKDRPYDYKADVWSLGITLIEMAQIEP 206
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.4 bits (176), Expect = 2e-13
Identities = 65/212 (30%), Positives = 95/212 (44%), Gaps = 33/212 (15%)
Query: 471 KIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSEFQQ--EIDILSKI-RHPNLVTLV 525
++G+G +GS+Y + VAIK + E E+ L K+ HPN+V L
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMK-KKFYSWEECMNLREVKSLRKLNEHPNIVKLK 64
Query: 526 GACPEVWT------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIR-IATELCSVLIFLHS 578
EV+ V+EY+ G+L L P S ++ IR I ++ L +H
Sbjct: 65 ----EVFRENDELYFVFEYM-EGNLYQ-LMKDRKGKPFS-ESVIRSIIYQILQGLAHIHK 117
Query: 579 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 638
H H DLKP N+L+ V K++DFG++R EI S TD T Y
Sbjct: 118 ---HGFFHRDLKPENLLVSGPEVVKIADFGLAR-----EIRSRPPY----TDYVSTRWYR 165
Query: 639 DPE-FLASGELTPKSDVYSFGIILLRLLTGRP 669
PE L S + D+++ G I+ L T RP
Sbjct: 166 APEILLRSTSYSSPVDIWALGCIMAELYTLRP 197
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 3e-13
Identities = 75/262 (28%), Positives = 117/262 (44%), Gaps = 37/262 (14%)
Query: 472 IGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPSEFQQ----EIDILSKIRHPNLVTLV 525
+G G G++YK LL +A+K++ L E Q+ E++IL K P ++
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVI---PLDITVELQKQIMSELEILYKCDSPYIIGFY 65
Query: 526 GA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 583
GA ++ E++ GSL D + RIA + L +L S K
Sbjct: 66 GAFFVENRISICTEFMDGGSL-------DVYRKIPEHVLGRIAVAVVKGLTYLWSLK--- 115
Query: 584 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 643
I+H D+KP+N+L++ KL DFG+S L ++S T GT AYM PE +
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFGVSTQL----VNSIAKTYV------GTNAYMAPERI 165
Query: 644 ASGELTPKSDVYSFGIILLRLLTGR-PALGITKEVQYALDTGKLKNLLD---PLAGDWPF 699
+ + SDV+S GI + L GR P I K + L+ ++D P+ F
Sbjct: 166 SGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQF 225
Query: 700 VQAEQLANLAMRCCEMSRKSRP 721
+E+ + +C K RP
Sbjct: 226 --SEKFVHFITQCMRKQPKERP 245
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 4e-13
Identities = 60/209 (28%), Positives = 98/209 (46%), Gaps = 22/209 (10%)
Query: 472 IGEGGYGSIYKGL-------LRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL 524
+G+G +G +Y L QV P + + S + EI +L ++H +V
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 525 VGACPE----VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 580
G + T+ EY+P GS++D+L L+ + ++ + +LHS
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLHS-- 124
Query: 581 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 640
+ IVH D+K ANIL D+ KL DFG S+ L I + T + T GT +M P
Sbjct: 125 -NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT--ICMSGTGIRSVT---GTPYWMSP 178
Query: 641 EFLASGELTPKSDVYSFGIILLRLLTGRP 669
E ++ K+DV+S G ++ +LT +P
Sbjct: 179 EVISGEGYGRKADVWSLGCTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 4e-13
Identities = 73/276 (26%), Positives = 130/276 (47%), Gaps = 43/276 (15%)
Query: 471 KIGEGGYGSIYKGLLR-------HMQVAIKMLHPH-SLQGPSEFQQEIDILSKIRHPNLV 522
++G+G +G +Y+G+ + +VAIK ++ S++ EF E ++ + ++V
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 523 TLVGACPEVW-TLV-YEYLPNGSLEDRL----SCKDNSP---PLSWQTRIRIATELCSVL 573
L+G + TLV E + G L+ L +N+P P S + I++A E+ +
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132
Query: 574 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 633
+L++ K VH DL N ++ +F K+ DFG++R + + + R KG
Sbjct: 133 AYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY--------RKGGKG 181
Query: 634 TFA--YMDPEFLASGELTPKSDVYSFGIILLRL--LTGRPALGITKE--VQYALDTGKLK 687
+M PE L G T SDV+SFG++L + L +P G++ E +++ ++ G L
Sbjct: 182 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLL- 240
Query: 688 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 723
D P + L L C + + K RP
Sbjct: 241 --------DKPDNCPDMLFELMRMCWQYNPKMRPSF 268
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 5e-13
Identities = 63/217 (29%), Positives = 101/217 (46%), Gaps = 27/217 (12%)
Query: 465 NFDPSLKIGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSEFQQEIDILSKIRHPN 520
+F+ +IG G YG +YK R++ AIK++ + + QQEI ++ +H N
Sbjct: 10 DFELIQRIGSGTYGDVYKA--RNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSN 67
Query: 521 LVTLVGAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 577
+V G+ ++W + E+ GSL+D + PLS ++ E L +LH
Sbjct: 68 IVAYFGSYLRRDKLW-ICMEFCGGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLH 123
Query: 578 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 637
S +H D+K ANILL N KL+DFG+S ++ T+ R GT +
Sbjct: 124 S---KGKMHRDIKGANILLTDNGHVKLADFGVSAQIT--------ATIAKRKSFIGTPYW 172
Query: 638 MDPEFLA---SGELTPKSDVYSFGIILLRLLTGRPAL 671
M PE A G D+++ GI + L +P +
Sbjct: 173 MAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 69.4 bits (169), Expect = 1e-12
Identities = 55/205 (26%), Positives = 100/205 (48%), Gaps = 23/205 (11%)
Query: 471 KIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGA- 527
KIG+G G+++ + +VAIK ++ EI ++ ++++PN+V + +
Sbjct: 26 KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSF 85
Query: 528 -CPEVWTLVYEYLPNGSLEDRLS--CKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 584
+ +V EYL GSL D ++ C D + + + E L FLH+ + +
Sbjct: 86 LVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAA------VCRECLQALEFLHA---NQV 136
Query: 585 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 644
+H D+K N+LL + KL+DFG ++ + S +T+ GT +M PE +
Sbjct: 137 IHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ--SKRSTMV------GTPYWMAPEVVT 188
Query: 645 SGELTPKSDVYSFGIILLRLLTGRP 669
PK D++S GI+ + ++ G P
Sbjct: 189 RKAYGPKVDIWSLGIMAIEMVEGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 62/217 (28%), Positives = 100/217 (46%), Gaps = 25/217 (11%)
Query: 464 HNFDPSLKIGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSEFQQEIDILSKIRHP 519
H+++ ++G G YG +YK R++ A+K++ S QQEI ++ + +H
Sbjct: 9 HDYELIQRVGSGTYGDVYKA--RNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHC 66
Query: 520 NLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 577
N+V G+ E + EY GSL+D + PLS + E L +LH
Sbjct: 67 NIVAYFGSYLSREKLWICMEYCGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLH 123
Query: 578 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 637
S +H D+K ANILL N KL+DFG++ ++ T+ R GT +
Sbjct: 124 S---KGKMHRDIKGANILLTDNGDVKLADFGVAAKIT--------ATIAKRKSFIGTPYW 172
Query: 638 MDPEFLA---SGELTPKSDVYSFGIILLRLLTGRPAL 671
M PE A +G D+++ GI + L +P +
Sbjct: 173 MAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 66/289 (22%), Positives = 120/289 (41%), Gaps = 51/289 (17%)
Query: 471 KIGEGGYGSIYKG----LLRHMQVAIKMLHPHSLQGPSE---FQQEIDILSKIRHPNLVT 523
+IG G +G + G + +V +K L + P E F QE+ ++ HPN++
Sbjct: 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQ 59
Query: 524 LVGACPEV--WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRI--RIATELCSVLIFLHSC 579
+G C E + LV E+ P G L++ L Q + R+A E+ S L++LH
Sbjct: 60 CLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ- 118
Query: 580 KPHSIVHGDLKPANILLDANFVSKLSDFGI--SRFLSQNEISSNNTTLCCRTDPKGTFAY 637
+H DL N L A+ K+ D+G+ ++ I+ + + R +
Sbjct: 119 --ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR--------W 168
Query: 638 MDPEFLAS-------GELTPKSDVYSFGIILLRLLTGR----PALGITKEVQYALDTGKL 686
+ PE + + T KS+++S G+ + L T P L + ++ + +
Sbjct: 169 LAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDI 228
Query: 687 K----NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVL 731
K L + W V M+ C + ++RP ++V +L
Sbjct: 229 KLPKPQLDLKYSDRWYEV---------MQFCWLDPETRPTA-EEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 59/227 (25%), Positives = 109/227 (48%), Gaps = 25/227 (11%)
Query: 471 KIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPS---EFQQEIDILSKIRHPNLVT 523
++G G +G++ KG+ + + VA+K+L + P+ E +E +++ ++ +P +V
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVR 60
Query: 524 LVGACP-EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELC-SVLIFLHSCKP 581
++G C E W LV E G L L + + TEL V + + +
Sbjct: 61 MIGICEAESWMLVMELAELGPLNKFLQKNKH-------VTEKNITELVHQVSMGMKYLEE 113
Query: 582 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 641
+ VH DL N+LL +K+SDFG+S+ L +E +T K + PE
Sbjct: 114 TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADE-----NYYKAKTHGKWPVKWYAPE 168
Query: 642 FLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTGK 685
+ + + KSDV+SFG+++ + +P G+ EV +++G+
Sbjct: 169 CMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGE 215
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 3e-12
Identities = 51/206 (24%), Positives = 81/206 (39%), Gaps = 26/206 (12%)
Query: 472 IGEGGYGSIY--KGLLRHMQVAIKMLHPHSLQGPSEFQ----QEIDILSKIRHPNLVTLV 525
I +G +GS+Y K AIK+L + ++ + ++ + P + L
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 526 GA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 583
+ + LV EYL G S L + E+ + LH
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCA---SLIKTLGGLPEDWAKQYIAEVVLGVEDLHQ---RG 117
Query: 584 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 643
I+H D+KP N+L+D KL+DFG+SR +N+ GT Y+ PE +
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK------------KFVGTPDYLAPETI 165
Query: 644 ASGELTPKSDVYSFGIILLRLLTGRP 669
SD +S G ++ L G P
Sbjct: 166 LGVGDDKMSDWWSLGCVIFEFLFGYP 191
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 61/208 (29%), Positives = 94/208 (45%), Gaps = 27/208 (12%)
Query: 472 IGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQ----EIDILSKIRHPNLVT 523
+GEG YG + K RH + VAIK + E ++ E+ +L ++ N+V
Sbjct: 9 VGEGAYGVVLK--CRHKETKEIVAIKKFKDS--EENEEVKETTLRELKMLRTLKQENIVE 64
Query: 524 LVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 581
L A LV+EY+ LE + PP ++ + + ++ +H C
Sbjct: 65 LKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPP------EKVRSYIYQLIKAIHWCHK 118
Query: 582 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 641
+ IVH D+KP N+L+ N V KL DFG +R LS+ ++ T+ T Y PE
Sbjct: 119 NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN-------YTEYVATRWYRSPE 171
Query: 642 FLASGELTPKSDVYSFGIILLRLLTGRP 669
L D++S G IL L G+P
Sbjct: 172 LLLGAPYGKAVDMWSVGCILGELSDGQP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 4e-12
Identities = 67/245 (27%), Positives = 103/245 (42%), Gaps = 39/245 (15%)
Query: 471 KIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTL--V 525
K+GEG Y ++YKG + VA+K + +G P +E +L ++H N+VTL +
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDI 71
Query: 526 GACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS------- 578
+ TLV+EYL D + + +V +FL
Sbjct: 72 IHTKKTLTLVFEYLD----------TDLKQYMDDCGGG---LSMHNVRLFLFQLLRGLAY 118
Query: 579 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS--QNEISSNNTTLCCRTDPKGTFA 636
C ++H DLKP N+L+ KL+DFG++R S S+ TL
Sbjct: 119 CHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLW---------- 168
Query: 637 YMDPE-FLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG 695
Y P+ L S E + D++ G I + TGRP + +V+ L + L P
Sbjct: 169 YRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHK-IFRVLGTPTEE 227
Query: 696 DWPFV 700
WP V
Sbjct: 228 TWPGV 232
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 5e-12
Identities = 58/209 (27%), Positives = 98/209 (46%), Gaps = 22/209 (10%)
Query: 472 IGEGGYGSIY----KGLLRHMQVAIKMLHPHSLQGPSE---FQQEIDILSKIRHPNLVTL 524
+G+G +G +Y R + V P S + E + EI +L + H +V
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 525 VGAC---PE-VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 580
G E ++ E++P GS++D+L + L+ + ++ + +LHS
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLK---SYGALTENVTRKYTRQILEGVSYLHS-- 124
Query: 581 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 640
+ IVH D+K ANIL D+ KL DFG S+ L I + T + T GT +M P
Sbjct: 125 -NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQT--ICLSGTGMKSVT---GTPYWMSP 178
Query: 641 EFLASGELTPKSDVYSFGIILLRLLTGRP 669
E ++ K+D++S G ++ +LT +P
Sbjct: 179 EVISGEGYGRKADIWSVGCTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 6e-12
Identities = 58/221 (26%), Positives = 89/221 (40%), Gaps = 49/221 (22%)
Query: 472 IGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQ---EIDILSKIRH-PNLVTLVGA 527
IG G +G++ K L + + + S E ++ ++D++ + P +V GA
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 528 ---------CPEV--------WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELC 570
C E+ + VYE L K P I +
Sbjct: 72 LFREGDCWICMELMDISLDKFYKYVYEVL-----------KSVIP-----EEILGKIAVA 115
Query: 571 SVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTD 630
+V + + I+H D+KP+NILLD N KL DFGIS L + I+ +T
Sbjct: 116 TVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQL-VDSIA--------KTR 166
Query: 631 PKGTFAYMDPEFLASGELTP---KSDVYSFGIILLRLLTGR 668
G YM PE + +SDV+S GI L + TG+
Sbjct: 167 DAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 6e-12
Identities = 59/225 (26%), Positives = 106/225 (47%), Gaps = 44/225 (19%)
Query: 471 KIGEGGYGSIYKGLL-------RHMQVAIKMLHPHSLQGP--SEFQQEIDILSKIRHPNL 521
++GE +G +YKG L + VAIK L + +GP EF+ E + S+++HPN+
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNI 70
Query: 522 VTLVGACP--EVWTLVYEYLPN----------------GSLEDRLSCKDNSPPLSWQTRI 563
V L+G + ++++ Y + GS +D + K P + +
Sbjct: 71 VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADF---V 127
Query: 564 RIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS--N 621
I T++ + + FL S H +VH DL N+L+ K+SD G+ R + +
Sbjct: 128 HIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMG 184
Query: 622 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 666
N+ L R +M PE + G+ + SD++S+G++L + +
Sbjct: 185 NSLLPIR--------WMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 6e-12
Identities = 53/214 (24%), Positives = 90/214 (42%), Gaps = 29/214 (13%)
Query: 467 DPSLKIGEGGYGSIYKGLLRHMQVAIKML-HPH--SLQGPSEFQQEIDILSKIRHPNLVT 523
S+ I E SIYKG+ + +V I+ H + EI L +I N++
Sbjct: 23 YTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILK 82
Query: 524 LVG-------ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFL 576
+ G P + +L+ EY G L + L D LS++T++ +A + C L L
Sbjct: 83 IYGFIIDIVDDLPRL-SLILEYCTRGYLREVL---DKEKDLSFKTKLDMAIDCCKGLYNL 138
Query: 577 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 636
+ K + + +L + L+ N+ K+ G+ + LS + N
Sbjct: 139 Y--KYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNF-----------MV 185
Query: 637 YMDPEFLAS--GELTPKSDVYSFGIILLRLLTGR 668
Y + L E T K D+YS G++L + TG+
Sbjct: 186 YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 7e-12
Identities = 52/205 (25%), Positives = 98/205 (47%), Gaps = 23/205 (11%)
Query: 472 IGEGGYGSIYKGLL------RHMQVAIKMLHPHSLQGPSEFQQEID---ILSKIRHPNLV 522
+G G +G+++KG+ + VAIK + S G FQ+ D + + H +V
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAYIV 72
Query: 523 TLVGACP-EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 581
L+G CP LV + P GSL D + + + L Q + ++ + +L
Sbjct: 73 RLLGICPGASLQLVTQLSPLGSLLDHV--RQHRDSLDPQRLLNWCVQIAKGMYYLEE--- 127
Query: 582 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 641
H +VH +L NILL ++ + +++DFG++ L ++ ++ K +M E
Sbjct: 128 HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKY------FYSEHKTPIKWMALE 181
Query: 642 FLASGELTPKSDVYSFGIILLRLLT 666
+ G T +SDV+S+G+ + +++
Sbjct: 182 SILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 7e-12
Identities = 58/201 (28%), Positives = 90/201 (44%), Gaps = 22/201 (10%)
Query: 471 KIGEGGYGSIY----KGLLRHMQVAIKMLHPHSLQGPSEF---QQEIDILSKIRHPNLVT 523
++G+G +G++Y K + ++ + P P+E QE +LSK+ HP +V
Sbjct: 7 RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66
Query: 524 LVGACPE--VWTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 580
+ E + ++ EY L+ +L K LS ++ +L+ +H
Sbjct: 67 FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLS---ENQVCEWFIQLLLGVHYMH 123
Query: 581 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 640
I+H DLK NI L N + K+ DFG+SR L + TT GT YM P
Sbjct: 124 QRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGS--CDLATTF------TGTPYYMSP 174
Query: 641 EFLASGELTPKSDVYSFGIIL 661
E L KSD++S G IL
Sbjct: 175 EALKHQGYDSKSDIWSLGCIL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 8e-12
Identities = 66/213 (30%), Positives = 103/213 (48%), Gaps = 22/213 (10%)
Query: 465 NFDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSL-QG-PSEFQQEIDILSKIRHPN 520
++ KIGEG YG+++K R VA+K + +G PS +EI +L +++H N
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60
Query: 521 LVTL--VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 578
+V L V + TLV+EY + SC + P ++ +L L F HS
Sbjct: 61 IVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKS---FMFQLLKGLAFCHS 117
Query: 579 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 638
H+++H DLKP N+L++ N KL+DFG++R + + C + T Y
Sbjct: 118 ---HNVLHRDLKPQNLLINKNGELKLADFGLAR--------AFGIPVRCYSAEVVTLWYR 166
Query: 639 DPEFLASGELTPKS-DVYSFGIILLRLLT-GRP 669
P+ L +L S D++S G I L GRP
Sbjct: 167 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 31/214 (14%)
Query: 466 FDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVT 523
D +KIGEG G + ++ VA+K + Q E+ I+ +H N+V
Sbjct: 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 81
Query: 524 -----LVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRI---RIATELCSVLIF 575
LVG E+W +V E+L G+L D ++ TR+ +IA +VL
Sbjct: 82 MYNSYLVG--DELW-VVMEFLEGGALTDIVT----------HTRMNEEQIAAVCLAVLKA 128
Query: 576 LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 635
L ++H D+K +ILL + KLSDFG +S+ E+ + + GT
Sbjct: 129 LSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVPRRKSLV-------GTP 180
Query: 636 AYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 669
+M PE ++ P+ D++S GI+++ ++ G P
Sbjct: 181 YWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 63/209 (30%), Positives = 96/209 (45%), Gaps = 28/209 (13%)
Query: 472 IGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQ---EIDILSK-IRHPNLVT 523
IG+G +G + L +H A+K+L ++ E + E ++L K ++HP LV
Sbjct: 3 IGKGSFGKVL--LAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 524 LVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-ATELCSVLIFLHSCK 580
L + + V +Y+ G L L + + P + R R A E+ S L +LHS
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFP----EPRARFYAAEIASALGYLHSLN 116
Query: 581 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 640
I++ DLKP NILLD+ L+DFG+ + E S +T C GT Y+ P
Sbjct: 117 ---IIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFC------GTPEYLAP 165
Query: 641 EFLASGELTPKSDVYSFGIILLRLLTGRP 669
E L D + G +L +L G P
Sbjct: 166 EVLRKQPYDRTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 63/214 (29%), Positives = 101/214 (47%), Gaps = 31/214 (14%)
Query: 466 FDPSLKIGEGGYGSIYKGLLRHM--QVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVT 523
D +KIGEG G + +H QVA+K + Q E+ I+ H N+V
Sbjct: 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVD 83
Query: 524 -----LVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRI---RIATELCSVLIF 575
LVG E+W +V E+L G+L D ++ TR+ +IAT SVL
Sbjct: 84 MYNSYLVG--DELW-VVMEFLEGGALTDIVT----------HTRMNEEQIATVCLSVLRA 130
Query: 576 LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 635
L ++H D+K +ILL ++ KLSDFG +S+ E+ + + GT
Sbjct: 131 LSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK-EVPKRKSLV-------GTP 182
Query: 636 AYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 669
+M PE ++ + D++S GI+++ ++ G P
Sbjct: 183 YWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 59/218 (27%), Positives = 95/218 (43%), Gaps = 45/218 (20%)
Query: 471 KIGEGGYGSIYKGLLRHMQ----VAIKML--HPHSLQGPSEFQQEIDILSKIR-HPNLVT 523
KIGEG + + K + + AIK + H SL+ + + EI L ++ HPN++
Sbjct: 6 KIGEGTFSEVLKA--QSRKTGKYYAIKCMKKHFKSLEQVNNLR-EIQALRRLSPHPNILR 62
Query: 524 LVGACPEV--------WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIF 575
L+ EV LV+E L + +L + + K PL + +L L
Sbjct: 63 LI----EVLFDRKTGRLALVFE-LMDMNLYELI--KGRKRPLPEKRVKSYMYQLLKSLDH 115
Query: 576 LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCR---TDPK 632
+H + I H D+KP NIL+ + + KL+DFG R + + T+
Sbjct: 116 MHR---NGIFHRDIKPENILIKDDIL-KLADFGSCR------------GIYSKPPYTEYI 159
Query: 633 GTFAYMDPE-FLASGELTPKSDVYSFGIILLRLLTGRP 669
T Y PE L G PK D+++ G + +L+ P
Sbjct: 160 STRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFP 197
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 2e-11
Identities = 61/231 (26%), Positives = 98/231 (42%), Gaps = 52/231 (22%)
Query: 464 HNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHP--HSLQGPSEFQQ----EIDILSK 515
+ IGEG YG + + ++VAIK + P H F Q EI IL +
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQT-----FCQRTLREIKILRR 59
Query: 516 IRHPNLVTL--------VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLS--------W 559
+H N++ + + +V+ +V E + L + + LS +
Sbjct: 60 FKHENIIGILDIIRPPSFESFNDVY-IVQELMET-DLYKLIK----TQHLSNDHIQYFLY 113
Query: 560 QTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 619
Q +R L ++HS +++H DLKP+N+LL+ N K+ DFG++R
Sbjct: 114 QI-LR-------GLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDH 162
Query: 620 SNNTTLCCRTDPKGTFAYMDPE-FLASGELTPKSDVYSFGIILLRLLTGRP 669
+ T+ T Y PE L S T D++S G IL +L+ RP
Sbjct: 163 TGFL-----TEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRP 208
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 70/238 (29%), Positives = 105/238 (44%), Gaps = 48/238 (20%)
Query: 466 FDPSLKIGEGGYGSIYKGLLRHM--QVAIKMLH-PHSLQG-PSEFQQEIDILSKIRHPNL 521
FD +IGEG YG +YK + VA+K + + +G P +EI IL ++ H N+
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68
Query: 522 VTLVGACPEVWT----------------LVYEYLPN---GSLEDRLS--CKDNSPPLSWQ 560
V L E+ T LV+EY+ + G LE L +D+
Sbjct: 69 VNLK----EIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDH------- 117
Query: 561 TRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 620
I + + +L L+ C + +H D+K +NILL+ KL+DFG++R + E
Sbjct: 118 ----IKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP 173
Query: 621 NNTTLCCRTDPKGTFAYMDPEFLASGEL-TPKSDVYSFGIILLRLLTGRPALGITKEV 677
T+ T Y PE L E P DV+S G IL L T +P +E+
Sbjct: 174 -------YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL 224
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 57/211 (27%), Positives = 101/211 (47%), Gaps = 28/211 (13%)
Query: 490 VAIKMLHPHSLQGP-SEFQQEIDILSKI-RHPNLVTLVGACPEVWTL--VYEYLPNGSLE 545
VA+KML + + S+ E++++ I +H N++ L+GAC + L + EY G+L
Sbjct: 50 VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 109
Query: 546 DRLSCKD-------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPA 592
+ L + ++++ + ++ + +L S K +H DL
Sbjct: 110 EYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAAR 166
Query: 593 NILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKS 652
N+L+ N V K++DFG++R + N I T T+ + +M PE L T +S
Sbjct: 167 NVLVTENNVMKIADFGLARDV--NNIDYYKKT----TNGRLPVKWMAPEALFDRVYTHQS 220
Query: 653 DVYSFGIILLRLLT--GRPALGITKEVQYAL 681
DV+SFG+++ + T G P GI E + L
Sbjct: 221 DVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 251
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 61/209 (29%), Positives = 97/209 (46%), Gaps = 22/209 (10%)
Query: 472 IGEGGYGSIY----KGLLRHMQVAIKMLHPHSLQGPSE---FQQEIDILSKIRHPNLVTL 524
+G G +G +Y R + V P S + E + EI +L +RH +V
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 525 VGAC--PE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 580
G PE ++ EY+P GS++D+L L+ R ++ + +LHS
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLHS-- 124
Query: 581 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 640
+ IVH D+K ANIL D+ KL DFG S+ + I + T + T GT +M P
Sbjct: 125 -NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQT--ICMSGTGIKSVT---GTPYWMSP 178
Query: 641 EFLASGELTPKSDVYSFGIILLRLLTGRP 669
E ++ K+DV+S ++ +LT +P
Sbjct: 179 EVISGEGYGRKADVWSVACTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 68/249 (27%), Positives = 113/249 (45%), Gaps = 23/249 (9%)
Query: 461 GATHNFDPSLKIGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQG-PSEFQQEIDILSKIR 517
G +++ K+GEG Y ++YKG + VA+K++ +G P +E +L ++
Sbjct: 2 GKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLK 61
Query: 518 HPNLVTL--VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIAT-ELCSVLI 574
H N+V L + E TLV+EY+ D D P +++ +L L
Sbjct: 62 HANIVLLHDIIHTKETLTLVFEYVHT----DLCQYMDKHPGGLHPENVKLFLFQLLRGLS 117
Query: 575 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 634
++H I+H DLKP N+L+ KL+DFG++R S + +N + T
Sbjct: 118 YIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV--------T 166
Query: 635 FAYMDPE-FLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPL 693
Y P+ L S E + D++ G I + ++ G A K++Q L+ L L P
Sbjct: 167 LWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLV-LGTPN 225
Query: 694 AGDWPFVQA 702
WP V +
Sbjct: 226 EDTWPGVHS 234
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 73/276 (26%), Positives = 118/276 (42%), Gaps = 59/276 (21%)
Query: 472 IGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQGPSE-----FQQEIDILSKIRHPNLV 522
+G+G YG + L+RH Q IK L +L+ S +QE +LS+++HPN+V
Sbjct: 8 VGKGSYGEV--SLVRHRTDGKQYVIKKL---NLRNASRRERKAAEQEAQLLSQLKHPNIV 62
Query: 523 TLVGACPEVWT-------LVYEYLPNGSLEDRLSCKD-----NSPPLSWQTRIRIATELC 570
E W +V + G L +L + + + W +I +A
Sbjct: 63 AY----RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMA---- 114
Query: 571 SVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL-SQNEISSNNTTLCCRT 629
L +LH I+H DLK N+ L + K+ D GI+R L +Q +++S TL
Sbjct: 115 --LQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAS---TLI--- 163
Query: 630 DPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGI--TKEVQYALDTGKLK 687
GT YM PE ++ KSDV++ G + + T + A + Y + GKL
Sbjct: 164 ---GTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLP 220
Query: 688 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 723
P+ D+ + +L L + RP +
Sbjct: 221 ----PMPKDY----SPELGELIATMLSKRPEKRPSV 248
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 63/217 (29%), Positives = 89/217 (41%), Gaps = 41/217 (18%)
Query: 472 IGEGGYGSIY---------KGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLV 522
+G+GGYG ++ G + M+V K + + + + E +IL ++HP +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 523 TLVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATE------LCSVLI 574
L+ A L+ EYL G L L R I E L + +
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHLE------------REGIFMEDTACFYLSEISL 111
Query: 575 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT--TLCCRTDPK 632
L I++ DLKP NILLDA KL+DFG L + I T C
Sbjct: 112 ALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFG----LCKESIHEGTVTHTFC------ 161
Query: 633 GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 669
GT YM PE L D +S G ++ +LTG P
Sbjct: 162 GTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAP 198
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 73/272 (26%), Positives = 121/272 (44%), Gaps = 36/272 (13%)
Query: 471 KIGEGGYGSIYKGLLR---HMQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTL-- 524
K+GEG Y ++YKG+ R + VA+K++ + +G P +E +L ++H N+V L
Sbjct: 12 KLGEGSYATVYKGISRINGQL-VALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHD 70
Query: 525 VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIAT-ELCSVLIFLHSCKPHS 583
+ E T V+EY+ D P +R+ +L L ++H
Sbjct: 71 IIHTKETLTFVFEYMHT----DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHG---QH 123
Query: 584 IVHGDLKPANILLDANFVSKLSDFGISRFLS--QNEISSNNTTLCCRTDPKGTFAYMDPE 641
I+H DLKP N+L+ KL+DFG++R S SS TL Y P+
Sbjct: 124 ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLW----------YRPPD 173
Query: 642 -FLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD-PLAGDWPF 699
L + + + D++ G I + +L G+PA +V L+ K+ +L P WP
Sbjct: 174 VLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLE--KIWTVLGVPTEDTWP- 230
Query: 700 VQAEQLANLAMRCCEMSRKSRPELGKDVWRVL 731
++ L E +P+ + VW+ L
Sbjct: 231 ----GVSKLPNYKPEWFLPCKPQQLRVVWKRL 258
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 55/212 (25%), Positives = 97/212 (45%), Gaps = 32/212 (15%)
Query: 474 EGGYGSIYKGLLRHM------QVAIKMLHPHSLQGPSEFQ-----QEIDILSKIRHPNLV 522
EG +G I+ G+L +V +K + H+ SE Q QE +L + H N++
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA----SEIQVTLLLQESCLLYGLSHQNIL 71
Query: 523 TLVGACPEVWT---LVYEYLPNGSLED-----RLSCKDNSPPLSWQTRIRIATELCSVLI 574
++ C E ++Y Y+ G+L+ RL +N LS Q + +A ++ +
Sbjct: 72 PILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMS 131
Query: 575 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 634
+LH ++H D+ N ++D K++D +SR L + C +
Sbjct: 132 YLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYH------CLGDNENRP 182
Query: 635 FAYMDPEFLASGELTPKSDVYSFGIILLRLLT 666
+M E L + E + SDV+SFG++L L+T
Sbjct: 183 VKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 4e-11
Identities = 64/206 (31%), Positives = 103/206 (50%), Gaps = 28/206 (13%)
Query: 472 IGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQ---EIDILSKIRHPNLVTLV 525
+G G G + K L R + +A K++H L+ P+ Q E+ +L + P +V
Sbjct: 9 LGAGNGGVVTKVLHRPSGLIMARKLIH---LEIKPAIRNQIIRELKVLHECNSPYIVGFY 65
Query: 526 GAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 582
GA E+ ++ E++ GSL D++ K P + +I IA + L +L + H
Sbjct: 66 GAFYSDGEI-SICMEHMDGGSL-DQVLKKAGRIPENILGKISIA--VLRGLTYLR--EKH 119
Query: 583 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 642
I+H D+KP+NIL+++ KL DFG+S L I S + GT +YM PE
Sbjct: 120 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFV------GTRSYMSPER 169
Query: 643 LASGELTPKSDVYSFGIILLRLLTGR 668
L T +SD++S G+ L+ + GR
Sbjct: 170 LQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 4e-11
Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 29/208 (13%)
Query: 472 IGEGGYGSIYKGLLRHMQ-------VAIKMLHPHSLQGPSEFQ--QEIDILSKIRHPNLV 522
+G+G +G ++ L+R + A+K+L +L+ + E DIL+++ HP +V
Sbjct: 4 LGQGSFGKVF--LVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61
Query: 523 TLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-ATELCSVLIFLHSC 579
L A L+ ++L G L RLS + + ++ EL L LHS
Sbjct: 62 KLHYAFQTEGKLYLILDFLRGGDLFTRLS----KEVMFTEEDVKFYLAELALALDHLHSL 117
Query: 580 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 639
I++ DLKP NILLD KL+DFG+S+ +E + C GT YM
Sbjct: 118 ---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKAYSFC------GTVEYMA 166
Query: 640 PEFLASGELTPKSDVYSFGIILLRLLTG 667
PE + T +D +SFG+++ +LTG
Sbjct: 167 PEVVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 4e-11
Identities = 63/270 (23%), Positives = 113/270 (41%), Gaps = 35/270 (12%)
Query: 472 IGEGGYGSIYK-------GLLRHMQVAIKMLHPHSLQGPSEFQQEID--------ILSKI 516
+G G +G +YK L ++ I + +P + E + I I ++
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALK-EINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 517 RHPNLVTLVGACPEVWTL--VYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVL 573
RHPN+V E L V + + L + S K+ + + I ++ L
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126
Query: 574 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 633
+LH K IVH DL P NI+L + ++DFG+++ T G
Sbjct: 127 RYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK---------LTSVVG 175
Query: 634 TFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPL 693
T Y PE + + K+DV++FG IL ++ T +P T + A T ++ + +PL
Sbjct: 176 TILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLA--TKIVEAVYEPL 233
Query: 694 AGDWPFVQAEQLANLAMRCCEMSRKSRPEL 723
+ +E + ++ C ++RP++
Sbjct: 234 PEG---MYSEDVTDVITSCLTPDAEARPDI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 5e-11
Identities = 66/225 (29%), Positives = 107/225 (47%), Gaps = 28/225 (12%)
Query: 472 IGEGGYGSIYKGLLRHM--QVAIKMLHP--HSLQGPSEFQQEIDILSKIRHPNLV----T 523
IG+G YG + + H +VAIK ++ + + +EI +L +RHP++V
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 67
Query: 524 LVGACPEVWT---LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 580
++ + +V+E L L + D+ P Q + +L L ++H+
Sbjct: 68 MLPPSRREFKDIYVVFE-LMESDLHQVIKANDDLTPEHHQFFL---YQLLRALKYIHTA- 122
Query: 581 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT-TLCCRTDPKGTFAYMD 639
++ H DLKP NIL +A+ K+ DFG++R ++ N+T T TD T Y
Sbjct: 123 --NVFHRDLKPKNILANADCKLKICDFGLAR------VAFNDTPTAIFWTDYVATRWYRA 174
Query: 640 PEFLAS--GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALD 682
PE S + TP D++S G I +LTG+P L K V + LD
Sbjct: 175 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP-LFPGKNVVHQLD 218
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 5e-11
Identities = 64/238 (26%), Positives = 94/238 (39%), Gaps = 58/238 (24%)
Query: 472 IGEGGYGSIYKGLLRHMQ----VAIKML-------HPHSLQGPSEFQQEIDILSKIRHPN 520
IG G +G ++ L+R A+K+L + + E DIL+ P
Sbjct: 9 IGRGAFGEVW--LVRDKDTGQVYAMKVLRKSDMIKRNQI----AHVRAERDILADADSPW 62
Query: 521 LVTLVGACPEVWT--------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV 572
+V L ++ LV EY+P G L + L KD P R IA EL
Sbjct: 63 IVKLY------YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPE-ET-ARFYIA-ELVLA 113
Query: 573 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS----------RFLSQNEISSNN 622
L +H +H D+KP NIL+DA+ KL+DFG+ +L+ +
Sbjct: 114 LDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170
Query: 623 TTLCCRTDPK-----------GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 669
+ R GT Y+ PE L + D +S G+IL +L G P
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFP 228
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 6e-11
Identities = 67/219 (30%), Positives = 100/219 (45%), Gaps = 29/219 (13%)
Query: 464 HNFDPSLKIGEGGYGSIYKGLLRH---MQV-AIKMLHPHSLQGPSE---FQQEIDILSKI 516
+FD IG G +G + L+RH QV A+K+L + S+ F +E DI++
Sbjct: 43 EDFDVIKVIGRGAFGEVQ--LVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA 100
Query: 517 RHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLI 574
+V L A + +V EY+P G L + +S D P W R A E+ L
Sbjct: 101 NSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYD--IPEKW-ARFYTA-EVVLALD 156
Query: 575 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 634
+HS +H D+KP N+LLD + KL+DFG + N + +T + GT
Sbjct: 157 AIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-------GT 206
Query: 635 FAYMDPEFLAS----GELTPKSDVYSFGIILLRLLTGRP 669
Y+ PE L S G + D +S G+ L +L G
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 245
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 6e-11
Identities = 69/277 (24%), Positives = 116/277 (41%), Gaps = 51/277 (18%)
Query: 472 IGEGGYGSIYKGLLRH----MQVAIKMLHPH--SLQGPSEFQQEIDILSKIRHPNLVTLV 525
+GEG +GS+ +G L ++VA+K + + +F E + + HPN++ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 526 GACPEVW--------TLVYEYLPNGSLEDRL---SCKDNSPPLSWQTRIRIATELCSVLI 574
G C + ++ ++ +G L L D L Q ++ T++ S +
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 575 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR------FLSQNEISSNNTTLCCR 628
+L S S +H DL N +L+ N ++DFG+S+ + Q I+
Sbjct: 127 YLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIA--------- 174
Query: 629 TDPKGTFAYMDPEFLASGELTPKSDVYSFGI----ILLRLLTGRPALGITKEVQYALDTG 684
K ++ E LA T KSDV+SFG+ I R T P + ++ Y
Sbjct: 175 ---KMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGN 231
Query: 685 KLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 721
+LK D L G L +L C ++ K RP
Sbjct: 232 RLKQPPDCLDG---------LYSLMSSCWLLNPKDRP 259
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 8e-11
Identities = 65/211 (30%), Positives = 93/211 (44%), Gaps = 28/211 (13%)
Query: 471 KIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSEFQ---QEIDILSKIRHPNLVTLV 525
+IG G +G++Y VAIK + Q ++Q +E+ L ++RHPN +
Sbjct: 22 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81
Query: 526 GACPEVWT--LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 583
G T LV EY GS D L + PL I L +LHS H
Sbjct: 82 GCYLREHTAWLVMEYCL-GSASDILEV--HKKPLQEVEIAAICHGALQGLAYLHS---HE 135
Query: 584 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 643
+H D+K NILL KL+DFG S + +S N+ + GT +M PE +
Sbjct: 136 RIHRDIKAGNILLTEPGTVKLADFG-----SASLVSPANSFV-------GTPYWMAPEVI 183
Query: 644 AS---GELTPKSDVYSFGIILLRLLTGRPAL 671
+ G+ K DV+S GI + L +P L
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 8e-11
Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 28/211 (13%)
Query: 471 KIGEGGYGSIY--KGLLRHMQVAIKMLHPHSLQGPSEFQ---QEIDILSKIRHPNLVTLV 525
+IG G +G++Y + + VAIK + Q ++Q +E+ L K+RHPN +
Sbjct: 22 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 526 GACPEVWT--LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 583
G T LV EY GS D L + PL + L +LHS H+
Sbjct: 82 GCYLREHTAWLVMEYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHS---HN 135
Query: 584 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 643
++H D+K NILL + KL DFG S + ++ N + GT +M PE +
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFG-----SASIMAPANXFV-------GTPYWMAPEVI 183
Query: 644 AS---GELTPKSDVYSFGIILLRLLTGRPAL 671
+ G+ K DV+S GI + L +P L
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 9e-11
Identities = 60/228 (26%), Positives = 98/228 (42%), Gaps = 49/228 (21%)
Query: 471 KIGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSEFQ---QEIDILSKIRHPNLVT 523
IG G YG +YK ++ + AIK Q Q +EI +L +++H N+V+
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66
Query: 524 LVGACPE-----VWTLVYEYLPNGSLE----DRLSCKDNSPP-----LSWQTRIRIATEL 569
LV E V+ L+++Y + + R + + + PP L WQ +
Sbjct: 67 LVEVFLEHADKSVY-LLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ--------I 117
Query: 570 CSVLIFLHSCKPHSIVHGDLKPANILLDANF----VSKLSDFGISRFL---SQNEISSNN 622
+ + +LHS + ++H DLKPANIL+ V K+ D G++R + +
Sbjct: 118 LNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDP 174
Query: 623 TTLCCRTDPKGTFAYMDPEF-LASGELTPKSDVYSFGIILLRLLTGRP 669
+ T Y PE L + T D+++ G I LLT P
Sbjct: 175 VVV--------TIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEP 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 9e-11
Identities = 65/228 (28%), Positives = 97/228 (42%), Gaps = 34/228 (14%)
Query: 463 THNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHP 519
T ++ IG+G YG +YK + A+K+L P S E + E +IL + HP
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHP 79
Query: 520 NLVTLVG--------ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIR---IATE 568
N+V G ++W LV E GS+ + + L R+ I+
Sbjct: 80 NVVKFYGMFYKADKLVGGQLW-LVLELCNGGSVTELVKGL-----LICGQRLDEAMISYI 133
Query: 569 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCR 628
L L+ L + I+H D+K NILL KL DFG+S L+ + N +
Sbjct: 134 LYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV---- 189
Query: 629 TDPKGTFAYMDPEFLASGE-----LTPKSDVYSFGIILLRLLTGRPAL 671
GT +M PE +A + + DV+S GI + L G P L
Sbjct: 190 ----GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 65/214 (30%), Positives = 105/214 (49%), Gaps = 35/214 (16%)
Query: 472 IGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQ--QEIDILSKIRH-PNLVTL 524
+G G YG + K +RH+ +A+K + ++ + + ++DI + P VT
Sbjct: 9 LGRGAYGVVDK--MRHVPTGTIMAVKRI-RATVNSQEQKRLLMDLDISMRSVDCPYTVTF 65
Query: 525 VGAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRI--RIATELCSVLIFLHSC 579
GA +VW + + + SL D+ K L+ I +IA + L +LHS
Sbjct: 66 YGALFREGDVW--ICMEVMDTSL-DKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS- 121
Query: 580 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 639
S++H D+KP+N+L++ N KL DFGIS +L + ++ +T G YM
Sbjct: 122 -KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV-DSVA--------KTIDAGCKPYMA 171
Query: 640 PEFLASGELTP-----KSDVYSFGIILLRLLTGR 668
PE + + EL KSDV+S GI ++ L TGR
Sbjct: 172 PERI-NPELNQKGYDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 64/211 (30%), Positives = 97/211 (45%), Gaps = 28/211 (13%)
Query: 471 KIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSEFQ---QEIDILSKIRHPNLVTLV 525
+IG G +G++Y H VA+K + Q ++Q +E+ L +++HPN +
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 526 GACPEVWT--LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 583
G + T LV EY GS D L + PL I L +LHS H+
Sbjct: 88 GCYLKEHTAWLVMEYCL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHS---HN 141
Query: 584 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 643
++H D+K NILL KL+DFG S ++ S N+ + GT +M PE +
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFG-----SASKSSPANSFV-------GTPYWMAPEVI 189
Query: 644 AS---GELTPKSDVYSFGIILLRLLTGRPAL 671
+ G+ K DV+S GI + L +P L
Sbjct: 190 LAMDEGQYDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (155), Expect = 1e-10
Identities = 59/221 (26%), Positives = 95/221 (42%), Gaps = 46/221 (20%)
Query: 472 IGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQGPSEFQ---------QEIDILSKIRHPN 520
IG G YG + + +VAIK + F +EI +L +RH N
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISN-------VFDDLIDAKRILREIKLLRHLRHEN 60
Query: 521 LVTLVGACP--------EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIR-IATELCS 571
++ L+ +V+ +V E + L + PL+ I+ ++
Sbjct: 61 IIGLLDILRPPSPEDFNDVY-IVTELMET-DLHKVIKSPQ---PLTDD-HIQYFLYQILR 114
Query: 572 VLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT--LCCRT 629
L +LHS ++H DLKP+NIL+++N K+ DFG++R + +E T + R
Sbjct: 115 GLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRW 171
Query: 630 DPKGTFAYMDPE-FLASGELTPKSDVYSFGIILLRLLTGRP 669
Y PE L+S T D++S G I LLT +P
Sbjct: 172 -------YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKP 205
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 32/104 (30%), Positives = 52/104 (50%), Gaps = 11/104 (10%)
Query: 566 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 625
A E+ L FLH I++ DLK N+LLD+ K++DFG+ + + + T+
Sbjct: 102 AAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCK---EGILGGVTTST 155
Query: 626 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 669
C GT Y+ PE L+ P D ++ G++L +L G+
Sbjct: 156 FC-----GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQS 194
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 71/273 (26%), Positives = 118/273 (43%), Gaps = 49/273 (17%)
Query: 472 IGEGGYGSIYKGLLRH------------MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHP 519
+G+G + +IYKG+LR + V +K+L + F + ++S++ H
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGS-DHRDSLAFFETASLMSQLSHK 61
Query: 520 NLVTLVGAC-PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 578
+LV L G C + +V EY+ G L+ L + N+ L W ++ +A +L S L +L
Sbjct: 62 HLVKLYGVCVRDENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLED 119
Query: 579 CKPHSIVHGDLKPANILL---DAN-----FVSKLSDFGISRFLSQNEISSNNTTLCCRTD 630
K +VHG++ NIL+ N F+ KLSD GI T+ R +
Sbjct: 120 KK---LVHGNVCGKNILVARYGLNEGYVPFI-KLSDPGIPI------------TVLSREE 163
Query: 631 PKGTFAYMDPEFLASGE--LTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKN 688
++ PE + +G+ LT +D +SFG LL + + T + ++
Sbjct: 164 RVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQH 223
Query: 689 LLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 721
L D +LANL +C RP
Sbjct: 224 RLPMP--DCA-----ELANLINQCWTYDPTKRP 249
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 65/240 (27%), Positives = 113/240 (47%), Gaps = 41/240 (17%)
Query: 472 IGEGGYGSIYKGLL---------RHMQVAIKMLHPHSLQGP-SEFQQEIDILSKI-RHPN 520
+GEG +G + R +VA+KML + + S+ E++++ I +H N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 521 LVTLVGACPEVWTL--VYEYLPNGSLEDRLSCKDNSPP---------------LSWQTRI 563
++ L+GAC + L + EY G+L + L + PP LS++ +
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRAR--RPPGMEYCYNPTQVPEEQLSFKDLV 143
Query: 564 RIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT 623
A ++ + +L S K +H DL N+L+ + V K++DFG++R + + I
Sbjct: 144 SCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDI--HHIDYYKK 198
Query: 624 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGITKEVQYAL 681
T T+ + +M PE L T +SDV+SFG++L + T G P G+ E + L
Sbjct: 199 T----TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 254
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 59/214 (27%), Positives = 105/214 (49%), Gaps = 30/214 (14%)
Query: 488 MQVAIKMLHPHSL-QGPSEFQQEIDILSKI-RHPNLVTLVGACPE---VWTLVYEYLPNG 542
+ VA+KML + + S+ E++++ I +H N++ L+GAC + ++ LV EY G
Sbjct: 45 VTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLV-EYASKG 103
Query: 543 SLEDRL-------------SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDL 589
+L + L +CK L+++ + A ++ + +L S K +H DL
Sbjct: 104 NLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDL 160
Query: 590 KPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELT 649
N+L+ + V K++DFG++R + + T + + +M PE L T
Sbjct: 161 AARNVLVTEDNVMKIADFGLARDVHNIDYYKKTT------NGRLPVKWMAPEALFDRVYT 214
Query: 650 PKSDVYSFGIILLRLLT--GRPALGITKEVQYAL 681
+SDV+SFG++L + T G P GI E + L
Sbjct: 215 HQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 248
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 63/238 (26%), Positives = 113/238 (47%), Gaps = 37/238 (15%)
Query: 472 IGEGGYGSIYK----GLLRHMQ-----VAIKMLHPHSL-QGPSEFQQEIDILSKI-RHPN 520
+GEG +G + + G+ + VA+KML ++ + ++ E++++ I +H N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 521 LVTLVGACPEVWTL--VYEYLPNGSLEDRLSCK-----DNSP--------PLSWQTRIRI 565
++ L+G C + L + EY G+L + L + D + LS++ +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 566 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 625
A ++ + +L S + +H DL N+L+ + V K++DFG++R + I T
Sbjct: 140 AYQVARGMEYLESRR---CIHRDLAARNVLVTEDNVMKIADFGLARGVHD--IDYYKKTS 194
Query: 626 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGITKEVQYAL 681
R K +M PE L T +SDV+SFGI++ + T G P GI E + L
Sbjct: 195 NGRLPVK----WMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKL 248
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 4e-10
Identities = 61/216 (28%), Positives = 99/216 (45%), Gaps = 29/216 (13%)
Query: 465 NFDPSLKIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSE---FQQEIDILSKIR 517
++D IG G +G + L+RH A+K+L + S+ F +E DI++
Sbjct: 44 DYDVVKVIGRGAFGEVQ--LVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 101
Query: 518 HPNLVTLVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIF 575
P +V L A + +V EY+P G L + +S D P W + T V++
Sbjct: 102 SPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD--VPEKWA---KFYT--AEVVLA 154
Query: 576 LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 635
L + ++H D+KP N+LLD + KL+DFG + + + +T + GT
Sbjct: 155 LDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-------GTP 207
Query: 636 AYMDPEFLAS----GELTPKSDVYSFGIILLRLLTG 667
Y+ PE L S G + D +S G+ L +L G
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 7e-10
Identities = 65/211 (30%), Positives = 97/211 (45%), Gaps = 28/211 (13%)
Query: 471 KIGEGGYGSIY--KGLLRHMQVAIKMLHPHSLQGPSEFQ---QEIDILSKIRHPNLVTLV 525
+IG G +G++Y + + + VAIK + Q ++Q +E+ L +I+HPN +
Sbjct: 32 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYK 91
Query: 526 GACPEVWT--LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 583
G T LV EY GS D L + PL I L +LHS H+
Sbjct: 92 GCYLREHTAWLVMEYCL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHS---HN 145
Query: 584 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 643
++H D+K NILL KL+DFG S + S N+ + GT +M PE +
Sbjct: 146 MIHRDIKAGNILLTEPGQVKLADFG-----SASIASPANSFV-------GTPYWMAPEVI 193
Query: 644 AS---GELTPKSDVYSFGIILLRLLTGRPAL 671
+ G+ K DV+S GI + L +P L
Sbjct: 194 LAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 8e-10
Identities = 36/104 (34%), Positives = 56/104 (53%), Gaps = 11/104 (10%)
Query: 566 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 625
A E+ L+FLH H +++ DLK NILLDA KL+DFG+ + + ++ TT
Sbjct: 102 AAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCK---EGILNGVTTTT 155
Query: 626 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 669
C GT Y+ PE L E P D ++ G+++ ++ G+P
Sbjct: 156 FC-----GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQP 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 57/225 (25%), Positives = 107/225 (47%), Gaps = 22/225 (9%)
Query: 472 IGEGGYGSIYKGLLR------HMQVAIKMLHPH-SLQGPSEFQQEIDILSKIRHPNLVTL 524
+G G +G++YKG+ + VAIK+L + S + E E +++ + P + L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 525 VGAC-PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 583
+G C LV + +P G L D + ++N + Q + ++ + +L +
Sbjct: 75 LGICLTSTVQLVTQLMPYGCLLDYV--RENKDRIGSQDLLNWCVQIAKGMSYLEEVR--- 129
Query: 584 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 643
+VH DL N+L+ + K++DFG++R L +E + K +M E +
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYH------ADGGKVPIKWMALESI 183
Query: 644 ASGELTPKSDVYSFGIILLRLLT--GRPALGI-TKEVQYALDTGK 685
T +SDV+S+G+ + L+T +P GI +E+ L+ G+
Sbjct: 184 LHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGE 228
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 61/209 (29%), Positives = 96/209 (45%), Gaps = 29/209 (13%)
Query: 472 IGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSE---FQQEIDILSKIRHPNLVTL 524
IG G +G + L+RH A+K+L + S+ F +E DI++ P +V L
Sbjct: 51 IGRGAFGEVQ--LVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108
Query: 525 VGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 582
A + +V EY+P G L + +S D P W R T V++ L +
Sbjct: 109 FYAFQDDRYLYMVMEYMPGGDLVNLMSNYD--VPEKWA---RFYT--AEVVLALDAIHSM 161
Query: 583 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 642
+H D+KP N+LLD + KL+DFG +++ + +T + GT Y+ PE
Sbjct: 162 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-------GTPDYISPEV 214
Query: 643 LAS----GELTPKSDVYSFGIILLRLLTG 667
L S G + D +S G+ L +L G
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 52/205 (25%), Positives = 80/205 (39%), Gaps = 22/205 (10%)
Query: 472 IGEGGYGSIYKGLLRHM--QVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVG 526
+G+GG+G + ++ A K L L +G E IL K+ +V+L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 527 A--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 584
A + LV + G L+ + P I A ++ L LH I
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIY-NVGEPGFPEARAIFYAAQIICGLEHLHQ---RRI 116
Query: 585 VHGDLKPANILLDANFVSKLSDFGIS-RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 643
V+ DLKP N+LLD + ++SD G++ +I GT YM PE L
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGR----------AGTPGYMAPEVL 166
Query: 644 ASGELTPKSDVYSFGIILLRLLTGR 668
D ++ G L ++ GR
Sbjct: 167 QGEVYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 55/201 (27%), Positives = 91/201 (45%), Gaps = 19/201 (9%)
Query: 472 IGEGGYGS--IYKGLLRHMQVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 528
+GEG +G + + + + A+K + P S + ++E +L+K++HPN+V +
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF 67
Query: 529 PEVWTL--VYEYLPNGSLEDRLSCKDNSPPL-SWQTRIRIATELCSVLIFLHSCKPHSIV 585
L V EY G L ++ K L T ++ ++C + +H + ++
Sbjct: 68 EADGHLYIVMEYCDGGDLMQKI--KLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VL 122
Query: 586 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS 645
H D+K NI L N KL DFG +R L ++ C GT Y+ PE +
Sbjct: 123 HRDIKSKNIFLTQNGKVKLGDFGSARLL------TSPGAYACTY--VGTPYYVPPEIWEN 174
Query: 646 GELTPKSDVYSFGIILLRLLT 666
KSD++S G IL L T
Sbjct: 175 MPYNNKSDIWSLGCILYELCT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 64/223 (28%), Positives = 96/223 (43%), Gaps = 40/223 (17%)
Query: 472 IGEGGYGSIYKGLLRH--MQVAIKMLHP-HSLQGPSEFQQEIDILSKIR-HPNLVTLVG- 526
IG+G YG ++K L + + A+K+L P H + E + E +IL + HPN+V G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID--EEIEAEYNILKALSDHPNVVKFYGM 83
Query: 527 -------ACPEVWTLVYEYLPNGSLEDRLSC-----KDNSPPLSWQTRIRIATELCSVLI 574
++W LV E GS+ D + + P+ IA L L+
Sbjct: 84 YYKKDVKNGDQLW-LVLELCNGGSVTDLVKGFLKRGERMEEPI-------IAYILHEALM 135
Query: 575 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 634
L + +H D+K NILL KL DFG+S L+ + N + GT
Sbjct: 136 GLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV--------GT 187
Query: 635 FAYMDPEFLASGE-----LTPKSDVYSFGIILLRLLTGRPALG 672
+M PE +A + + DV+S GI + L G P L
Sbjct: 188 PFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLA 230
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 66/275 (24%), Positives = 114/275 (41%), Gaps = 40/275 (14%)
Query: 472 IGEGGYGSIYKGLLRH-----MQVAIKMLHPH--SLQGPSEFQQEIDILSKIRHPNLVTL 524
+G+G +GS+ + L+ +VA+KML S EF +E + + HPN++ L
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 525 VGACPE--------VWTLVYEYLPNGSLEDRL---SCKDNSPPLSWQTRIRIATELCSVL 573
+G + ++ ++ +G L L + L QT +R ++ S +
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 574 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 633
+L S + +H DL N +L+ N ++DFG+S+ + + C P
Sbjct: 127 EYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQG---CASKLPVK 180
Query: 634 TFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGI-TKEV-QYALDTGKLKNL 689
A E LA T SDV++FG+ + ++T P G+ E+ Y + +LK
Sbjct: 181 WLAL---ESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQP 237
Query: 690 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELG 724
D L E + L +C K RP
Sbjct: 238 PDCL---------EDVYELMCQCWSPEPKCRPSFQ 263
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 26/212 (12%)
Query: 465 NFDPSLKIGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHP 519
+F+ ++G G G + K ++H + +A K++H ++ +E+ +L + P
Sbjct: 6 DFERISELGAGNGGVVTK--VQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSP 63
Query: 520 NLVTLVGAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFL 576
+V GA E+ ++ E++ GSL+ L P + +++ + L +L
Sbjct: 64 YIVGFYGAFYSDGEI-SICMEHMDGGSLDQVLKEAKRIPE---EILGKVSIAVLRGLAYL 119
Query: 577 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 636
+ H I+H D+KP+NIL+++ KL DFG+S L I S + GT +
Sbjct: 120 R--EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFV------GTRS 167
Query: 637 YMDPEFLASGELTPKSDVYSFGIILLRLLTGR 668
YM PE L + +SD++S G+ L+ L GR
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 70/239 (29%), Positives = 106/239 (44%), Gaps = 45/239 (18%)
Query: 465 NFDPSLKIGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQGPSEFQQ---EIDILSKIR 517
+F+ I G YG++Y L+RH + A+K ++ +L ++ QQ E DIL+
Sbjct: 2 DFETIKLISNGAYGAVY--LVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAE 59
Query: 518 HPNLVTLVGA-------CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELC 570
+P +V++ + C +V EY+ G D + N L E
Sbjct: 60 NPFVVSMFCSFETKRHLC-----MVMEYVEGG---DCATLLKNIGALPVDMARMYFAETV 111
Query: 571 SVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTD 630
L +LH+ + IVH DLKP N+L+ + KL+DFG LS+ + S T L
Sbjct: 112 LALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFG----LSKIGLMSLTTNLYEGHI 164
Query: 631 PKGTFAYMD------PEFLA------SGELTPKSDVYSFGIILLRLLTG-RPALGITKE 676
K T ++D PE++A G P D ++ GIIL L G P G T E
Sbjct: 165 EKDTREFLDKQVCGTPEYIAPEVILRQGYGKP-VDWWAMGIILYEFLVGCVPFFGDTPE 222
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 55/225 (24%), Positives = 104/225 (46%), Gaps = 22/225 (9%)
Query: 472 IGEGGYGSIYKGLLR------HMQVAIKML-HPHSLQGPSEFQQEIDILSKIRHPNLVTL 524
+G G +G++YKGL + VAIK L S + E E +++ + +P++ L
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 525 VGAC-PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 583
+G C L+ + +P G L D + +++ + Q + ++ + +L
Sbjct: 75 LGICLTSTVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYLEE---RR 129
Query: 584 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 643
+VH DL N+L+ K++DFG+++ L +E + K +M E +
Sbjct: 130 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYH------AEGGKVPIKWMALESI 183
Query: 644 ASGELTPKSDVYSFGIILLRLLT--GRPALGI-TKEVQYALDTGK 685
T +SDV+S+G+ + L+T +P GI E+ L+ G+
Sbjct: 184 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 228
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 5e-09
Identities = 60/224 (26%), Positives = 101/224 (45%), Gaps = 34/224 (15%)
Query: 471 KIGEGGYGSIYKGLLRH-----MQVAIKMLHPHSLQGP---SEFQQEIDILSKIRHPNLV 522
IG+GG G +Y L + +VA+K + + P F +E I + + HP +V
Sbjct: 9 LIGKGGMGEVY---LAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIV 65
Query: 523 TLVGACPEVWTLVYE--YLPNGSLEDRL----SCKDNSPPLSWQTRI----RIATELCSV 572
+ C + + Y Y+ +L+ L + S L+ +T + I ++C+
Sbjct: 66 PVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICAT 125
Query: 573 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE-----ISSNNTTLCC 627
+ ++HS ++H DLKP NILL + D+G + F E I + +C
Sbjct: 126 IEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182
Query: 628 R--TDPK---GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 666
T P GT YM PE L + +D+Y+ G+IL ++LT
Sbjct: 183 SSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 5e-09
Identities = 56/220 (25%), Positives = 96/220 (43%), Gaps = 38/220 (17%)
Query: 464 HNFDPSLKIGEGGYGSI----YKGLLRHMQVAIKMLHPHSLQGPSEFQ---QEIDILSKI 516
+F+ +G G +G + +KG + AIK L + + Q QE IL ++
Sbjct: 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYY--AIKCLKKREILKMKQVQHVAQEKSILMEL 75
Query: 517 RHPNLVTLVGACPE---VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVL 573
HP +V ++ + + V+ + E++ G L L P +A + L
Sbjct: 76 SHPFIVNMMCSFQDENRVY-FLLEFVVGGELFTHLRKAGRFPN-------DVAKFYHAEL 127
Query: 574 I----FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRT 629
+ +LHS I++ DLKP N+LLD K++DFG ++ ++ TLC
Sbjct: 128 VLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLC--- 176
Query: 630 DPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 669
GT Y+ PE + S D ++ G++L + G P
Sbjct: 177 ---GTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYP 213
|
Length = 329 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-09
Identities = 64/208 (30%), Positives = 93/208 (44%), Gaps = 26/208 (12%)
Query: 472 IGEGGYGSIY--KGLLRHMQVAIKMLHPHSLQGPSEFQQEID-----ILSKIRHPNLVTL 524
IG+G +G + K L A+K+L + E Q+ I +L ++HP LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKE-QKHIMAERNVLLKNVKHPFLVGL 61
Query: 525 VGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-ATELCSVLIFLHSCKP 581
+ E V +++ G L L ++ S P + R R A E+ S L +LHS
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQ-RERSFP---EPRARFYAAEIASALGYLHSIN- 116
Query: 582 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 641
IV+ DLKP NILLD+ L+DFG+ + S TT C GT Y+ PE
Sbjct: 117 --IVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFC------GTPEYLAPE 166
Query: 642 FLASGELTPKSDVYSFGIILLRLLTGRP 669
+ D + G +L +L G P
Sbjct: 167 VIRKQPYDNTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 6e-09
Identities = 66/250 (26%), Positives = 101/250 (40%), Gaps = 57/250 (22%)
Query: 464 HNFDPSLKIGEGGYGSIYKGLLRH--------MQVAIK--MLHPHSLQGPSEFQQEIDIL 513
+F+ IG G +G + L++ M+ K ML + + + E DIL
Sbjct: 1 DDFESIKVIGRGAFGEVR--LVQKKDTGHIYAMKKLRKSEMLEKEQV---AHVRAERDIL 55
Query: 514 SKIRHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSW-QTRIRIATELC 570
++ +P +V L + L+ EYLP G + L KD + +TR IA
Sbjct: 56 AEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDT---FTEEETRFYIA---- 108
Query: 571 SVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS------------RFLSQNEI 618
++ + S +H D+KP N+LLDA KLSDFG+ R LS
Sbjct: 109 ETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALP 168
Query: 619 SSNNTTLCCRTDPK------------------GTFAYMDPE-FLASGELTPKSDVYSFGI 659
S+ + K GT Y+ PE FL +G + D +S G+
Sbjct: 169 SNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG-YNKECDWWSLGV 227
Query: 660 ILLRLLTGRP 669
I+ +L G P
Sbjct: 228 IMYEMLVGYP 237
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 6e-09
Identities = 48/150 (32%), Positives = 74/150 (49%), Gaps = 14/150 (9%)
Query: 471 KIGEGGYGSIYKGL----LRHMQVAIKMLHPH-SLQGPSEFQQEIDILSKIRHPNLVTLV 525
+IG G +G + G QV +K L S+Q +F +E ++H NL+ +
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 526 GACPEV--WTLVYEYLPNGSLEDRL-SCK--DNSPPLSWQTRIRIATELCSVLIFLHSCK 580
G C EV + LV E+ P G L+ L SC+ + P T R+A E+ L+ LH
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTP-DPTTLQRMACEIALGLLHLHK-- 118
Query: 581 PHSIVHGDLKPANILLDANFVSKLSDFGIS 610
++ +H DL N LL A+ K+ D+G+S
Sbjct: 119 -NNFIHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 7e-09
Identities = 66/234 (28%), Positives = 103/234 (44%), Gaps = 36/234 (15%)
Query: 472 IGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTLVG 526
IG+G +G + + R Q A+K + + SE E +L+++ P +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 527 A--CPEVWTLVYEYLPNGSLEDRLS---CKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 581
+ PE LV ++ G L L D S + R A LC+ L LH
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLS-----RARFYTAELLCA-LENLHK--- 111
Query: 582 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 641
++++ DLKP NILLD L DFG+ + +++ +N T C GT Y+ PE
Sbjct: 112 FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTN--TFC------GTPEYLAPE 163
Query: 642 FLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL--KNLLDPL 693
L T D ++ G++L +LTG P Y + ++ K L +PL
Sbjct: 164 LLLGHGYTKAVDWWTLGVLLYEMLTGLPPF-------YDENVNEMYRKILQEPL 210
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 7e-09
Identities = 64/209 (30%), Positives = 93/209 (44%), Gaps = 28/209 (13%)
Query: 472 IGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSE---FQQEIDILSK-IRHPNLVT 523
IG+G +G + L RH A+K+L ++ E E ++L K ++HP LV
Sbjct: 3 IGKGSFGKVL--LARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 524 LVGACPEVWTL--VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-ATELCSVLIFLHSCK 580
L + L V +Y+ G L L + R R A E+ S L +LHS
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHL----QRERCFLEPRARFYAAEIASALGYLHSL- 115
Query: 581 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 640
+IV+ DLKP NILLD+ L+DFG+ + E + +T C GT Y+ P
Sbjct: 116 --NIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFC------GTPEYLAP 165
Query: 641 EFLASGELTPKSDVYSFGIILLRLLTGRP 669
E L D + G +L +L G P
Sbjct: 166 EVLHKQPYDRTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 8e-09
Identities = 59/219 (26%), Positives = 94/219 (42%), Gaps = 29/219 (13%)
Query: 465 NFDPSLKIGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGP---SEFQQEIDILSKIR 517
+FD +G G +G + ++R A+K++ L S F++E DILS
Sbjct: 2 DFDVKSLVGRGHFGEVQ--VVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN 59
Query: 518 HPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIF 575
P + L A + LV EY P G L L+ ++ + + L +++
Sbjct: 60 SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYED--QFD-EDMAQFY--LAELVLA 114
Query: 576 LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 635
+HS VH D+KP N+L+D KL+DFG S +++N P GT
Sbjct: 115 IHSVHQMGYVHRDIKPENVLIDRTGHIKLADFG-----SAARLTANKMVNS--KLPVGTP 167
Query: 636 AYMDPEFLASGELTPKS------DVYSFGIILLRLLTGR 668
Y+ PE L + K D +S G+I ++ GR
Sbjct: 168 DYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 9e-09
Identities = 63/218 (28%), Positives = 96/218 (44%), Gaps = 29/218 (13%)
Query: 465 NFDPSLKIGEGGYGSIY---------KGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSK 515
NF+ +G G YG ++ G L M+V K + + E +L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 516 IRH-PNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV 572
+R P LVTL A L+ +Y+ G L L +++ + R+ IA E+
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFT--ESEVRVYIA-EIVLA 117
Query: 573 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR-FLSQNEISSNNTTLCCRTDP 631
L LH I++ D+K NILLD+ L+DFG+S+ FL++ E + + C
Sbjct: 118 LDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY--SFC----- 167
Query: 632 KGTFAYMDPEFLASGELTPKS--DVYSFGIILLRLLTG 667
GT YM PE + G D +S G++ LLTG
Sbjct: 168 -GTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 1e-08
Identities = 35/99 (35%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 572 VLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDP 631
VL+ +H ++H D+K ANILL +N + KL DFG S+ + T C
Sbjct: 152 VLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFC----- 206
Query: 632 KGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRP 669
GT Y+ PE + K+D++S G++L LLT RP
Sbjct: 207 -GTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRP 244
|
Length = 496 |
| >gnl|CDD|233758 TIGR02169, SMC_prok_A, chromosome segregation protein SMC, primarily archaeal type | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 1e-08
Identities = 32/165 (19%), Positives = 68/165 (41%), Gaps = 19/165 (11%)
Query: 296 DQLAQAMAEAENSRREAFEEALRRGKAEKDAIES--------IRRAKASESLYAEELK-- 345
+L + + E E E ++ G+ E+ ++ I + S + EL+
Sbjct: 261 SELEKRLEEIEQLLEELNKKIKDLGEEEQLRVKEKIGELEAEIASLERSIAEKERELEDA 320
Query: 346 --RRKEFEEALANGKLE-------LERMKKQHDEVMEELQIALDQKSLLESQIAESDQTA 396
R + E + E +E +K+ D++ EE ++ L +++ E D+
Sbjct: 321 EERLAKLEAEIDKLLAEIEELEREIEEERKRRDKLTEEYAELKEELEDLRAELEEVDKEF 380
Query: 397 KELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEA 441
E ++ E L+ K+E +EL+ E D+ +E + L + +
Sbjct: 381 AETRDELKDYREKLEKLKREINELKRELDRLQEELQRLSEELADL 425
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. It is found in a single copy and is homodimeric in prokaryotes, but six paralogs (excluded from this family) are found in eukarotes, where SMC proteins are heterodimeric. This family represents the SMC protein of archaea and a few bacteria (Aquifex, Synechocystis, etc); the SMC of other bacteria is described by TIGR02168. The N- and C-terminal domains of this protein are well conserved, but the central hinge region is skewed in composition and highly divergent [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1164 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 73/274 (26%), Positives = 118/274 (43%), Gaps = 52/274 (18%)
Query: 472 IGEGGYGSIYKGL---------LRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLV 522
+G+G + I+KG+ L +V +K+L F + ++S++ H +LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 523 TLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 580
G C + +V EY+ GSL+ L N +SW ++ +A +L L FL
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLED-- 118
Query: 581 PHSIVHGDLKPANILL----DANFVS----KLSDFGISRFLSQNEISSNNTTLCCRTDPK 632
+ HG++ N+LL D + KLSD GIS + EI L R
Sbjct: 119 -KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEI------LLER---- 167
Query: 633 GTFAYMDPEFLA-SGELTPKSDVYSFGIILLRLLTG--RP--ALGITKEVQYALDTGKLK 687
++ PE + L+ +D +SFG L + +G +P AL K++Q+ D +L
Sbjct: 168 --IPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQLP 225
Query: 688 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 721
A W +LANL +C + RP
Sbjct: 226 ------APKW-----TELANLINQCMDYEPDFRP 248
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 56/210 (26%), Positives = 102/210 (48%), Gaps = 22/210 (10%)
Query: 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNL 521
+F+ ++G G G ++K + + +A K++H ++ +E+ +L + P +
Sbjct: 6 DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65
Query: 522 VTLVGAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 578
V GA E+ ++ E++ GSL+ L P Q +++ + L +L
Sbjct: 66 VGFYGAFYSDGEI-SICMEHMDGGSLDQVLKKAGRIPE---QILGKVSIAVIKGLTYLR- 120
Query: 579 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 638
+ H I+H D+KP+NIL+++ KL DFG+S L I S + GT +YM
Sbjct: 121 -EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFV------GTRSYM 169
Query: 639 DPEFLASGELTPKSDVYSFGIILLRLLTGR 668
PE L + +SD++S G+ L+ + GR
Sbjct: 170 SPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 60/216 (27%), Positives = 90/216 (41%), Gaps = 42/216 (19%)
Query: 472 IGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQEID-----ILSKIRHPNLV 522
IG+G +G + L + A+K+L ++ E Q I +L ++HP LV
Sbjct: 3 IGKGSFGKVL--LAKRKSDGSFYAVKVLQKKTILKKKE-QNHIMAERNVLLKNLKHPFLV 59
Query: 523 TLVGA--CPEVWTLVYEYLPNGSL------EDRLSCKDNSPPLSWQTRIRI-ATELCSVL 573
L + E V +Y+ G L E + R R A E+ S +
Sbjct: 60 GLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFL----------EPRARFYAAEVASAI 109
Query: 574 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 633
+LHS +I++ DLKP NILLD+ L+DFG+ + E +T C G
Sbjct: 110 GYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFC------G 158
Query: 634 TFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 669
T Y+ PE L D + G +L +L G P
Sbjct: 159 TPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 65/246 (26%), Positives = 96/246 (39%), Gaps = 30/246 (12%)
Query: 471 KIGEGGYGSIYKGLLRHMQ--VAIK--MLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVG 526
KIGEG YG +YK ++ VA+K L P +EI +L + + +
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67
Query: 527 ACPEVWT--------LVYEYLPNG--SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFL 576
V LV+EYL + D + + PL +T +L +
Sbjct: 68 DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDS-NGRGPGRPLPAKTIKSFMYQLLKGVAHC 126
Query: 577 HSCKPHSIVHGDLKPANILLD-ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 635
H H ++H DLKP N+L+D + K++D G+ R S + T T
Sbjct: 127 HK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFS--------IPVKSYTHEIVTL 175
Query: 636 AYMDPE-FLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 694
Y PE L S + D++S G I + +P E+Q L KL L P
Sbjct: 176 WYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKL--LGTPTE 233
Query: 695 GDWPFV 700
WP V
Sbjct: 234 QVWPGV 239
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 3e-08
Identities = 35/141 (24%), Positives = 65/141 (46%), Gaps = 6/141 (4%)
Query: 296 DQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALA 355
+L +A E E EE +A ++ + + A EELKR E E
Sbjct: 354 AELEEAKEELEEKLSALLEELEELFEALREELAELEAELAEIRNELEELKREIESLEE-- 411
Query: 356 NGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKK 415
LER+ ++ +++ EEL+ + L++++ E ++ +ELE+++ + L+ ++
Sbjct: 412 ----RLERLSERLEDLKEELKELEAELEELQTELEELNEELEELEEQLEELRDRLKELER 467
Query: 416 EQDELQMERDKAVKEAEELRK 436
E ELQ E + KE L
Sbjct: 468 ELAELQEELQRLEKELSSLEA 488
|
Length = 1163 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 61/217 (28%), Positives = 93/217 (42%), Gaps = 27/217 (12%)
Query: 465 NFDPSLKIGEGGYGSIY---------KGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSK 515
NF+ +G G YG ++ G L M+V K + + E +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 516 IRH-PNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV 572
IR P LVTL A L+ +Y+ G L LS ++ Q E+
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYS---GEIVLA 117
Query: 573 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 632
L LH I++ D+K NILLD+N L+DFG+S+ ++E+ + C
Sbjct: 118 LEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV-ERAYSFC------ 167
Query: 633 GTFAYMDPEFLASGEL--TPKSDVYSFGIILLRLLTG 667
GT YM P+ + G+ D +S G+++ LLTG
Sbjct: 168 GTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 4e-08
Identities = 64/218 (29%), Positives = 97/218 (44%), Gaps = 30/218 (13%)
Query: 465 NFDPSLKIGEGGYGSIY---------KGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSK 515
NF+ +G G YG ++ G L M+V K + + E ++L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 516 IRH-PNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-ATELCS 571
+R P LVTL A L+ +Y+ G + L +DN + +R + E+
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFS----EDEVRFYSGEIIL 116
Query: 572 VLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR-FLSQNEISSNNTTLCCRTD 630
L LH IV+ D+K NILLD+ L+DFG+S+ FLS+ + + C
Sbjct: 117 ALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK--ERTYSFC---- 167
Query: 631 PKGTFAYMDPEFLASGELTPKS-DVYSFGIILLRLLTG 667
GT YM PE + K+ D +S GI++ LLTG
Sbjct: 168 --GTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 4e-08
Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 28/207 (13%)
Query: 472 IGEGGYGSIYKGLL-----RHMQVAIKMLHPHSLQGPSEFQQ-----EIDILSKIRHPNL 521
+G G +G + +G L R + VAI L G S+ Q+ E L + H N+
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLR----AGCSDKQRRGFLAEALTLGQFDHSNI 68
Query: 522 VTLVGACPEVWTL--VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 579
V L G T+ V EY+ NG+L+ L + + L + + L S + +L
Sbjct: 69 VRLEGVITRGNTMMIVTEYMSNGALDSFL--RKHEGQLVAGQLMGMLPGLASGMKYLSEM 126
Query: 580 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 639
VH L +L++++ V K+S F R L +++ + TT+ K +
Sbjct: 127 ---GYVHKGLAAHKVLVNSDLVCKISGF---RRLQEDKSEAIYTTM----SGKSPVLWAA 176
Query: 640 PEFLASGELTPKSDVYSFGIILLRLLT 666
PE + + SDV+SFGI++ +++
Sbjct: 177 PEAIQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 62/246 (25%), Positives = 104/246 (42%), Gaps = 32/246 (13%)
Query: 432 EELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQ-- 489
+ L+ +K+ S S+ P+ + + + NF +L G G +G + ++
Sbjct: 5 KNLQLHKKKDSDSTKEPKRKNKMKYEDF-----NFIRTL--GTGSFGRVILATYKNEDFP 57
Query: 490 -VAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTLVGACPE--VWTLVYEYLPNGS 543
VAIK + + E IL+ I HP V L G+ + LV E++ G
Sbjct: 58 PVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGE 117
Query: 544 LEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSK 603
L P A ++ + +L S +IV+ DLKP N+LLD + K
Sbjct: 118 FFTFLRRNKRFPN---DVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIK 171
Query: 604 LSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLR 663
++DFG ++ + + TLC GT Y+ PE L + +D ++ GI +
Sbjct: 172 MTDFGFAKV-----VDTRTYTLC------GTPEYIAPEILLNVGHGKAADWWTLGIFIYE 220
Query: 664 LLTGRP 669
+L G P
Sbjct: 221 ILVGCP 226
|
Length = 340 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 4e-08
Identities = 45/165 (27%), Positives = 65/165 (39%), Gaps = 31/165 (18%)
Query: 514 SKIRHPNLVTLVGACPEVWTLVY---EYLPNGSL-----EDRLSCKDNSPPLSWQTRIRI 565
+ RHP LV L AC + V EY G L D S + R
Sbjct: 57 NSERHPFLVNLF-ACFQTEDHVCFVMEYAAGGDLMMHIHTDVFS----------EPRAVF 105
Query: 566 -ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 624
A + L +LH + IV+ DLK N+LLD K++DFG+ + +T
Sbjct: 106 YAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCK--EGMGFGDRTST 160
Query: 625 LCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 669
C GT ++ PE L T D + G+++ +L G
Sbjct: 161 FC------GTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGES 199
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 49/145 (33%), Positives = 68/145 (46%), Gaps = 17/145 (11%)
Query: 534 LVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPA 592
V EYL G L + SC P + A E+ L FLHS IV+ DLK
Sbjct: 73 FVMEYLNGGDLMFHIQSCHKFDLPRA----TFYAAEIICGLQFLHS---KGIVYRDLKLD 125
Query: 593 NILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKS 652
NILLD + K++DFG+ + +N + T C GT Y+ PE L +
Sbjct: 126 NILLDTDGHIKIADFGMCK---ENMLGDAKTCTFC-----GTPDYIAPEILLGQKYNTSV 177
Query: 653 DVYSFGIILLRLLTGR-PALGITKE 676
D +SFG++L +L G+ P G +E
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGHDEE 202
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 7e-08
Identities = 47/164 (28%), Positives = 78/164 (47%), Gaps = 14/164 (8%)
Query: 292 DNLYDQLAQAMAEAE--NSRREAFEEALRRGKAEKD-----------AIESIRRAKAS-E 337
+ L +LA E E SR E EE L + E + +ES+ A A +
Sbjct: 719 EELKRELAALEEELEQLQSRLEELEEELEELEEELEELQERLEELEEELESLEEALAKLK 778
Query: 338 SLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAK 397
E ++R+ +E L + ELE +++ D + EL+ ++ LE +I E ++ +
Sbjct: 779 EEIEELEEKRQALQEELEELEEELEEAERRLDALERELESLEQRRERLEQEIEELEEEIE 838
Query: 398 ELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEA 441
ELE+K+ E L+ +KE +EL+ E ++ E EEL KE
Sbjct: 839 ELEEKLDELEEELEELEKELEELKEELEELEAEKEELEDELKEL 882
|
Length = 1163 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 7e-08
Identities = 52/165 (31%), Positives = 74/165 (44%), Gaps = 22/165 (13%)
Query: 509 EIDILSKIRHPNLVTLVGACPEVWTL--VYEYLPNGSLEDRLS-CKDNSPPLSWQTRIRI 565
E +L RHP L L + L V EY G L LS + S + R
Sbjct: 45 ESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED---RARFYG 101
Query: 566 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT-- 623
A E+ S L +LHSC +V+ DLK N++LD + K++DFG L + IS T
Sbjct: 102 A-EIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFG----LCKEGISDGATMK 153
Query: 624 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR 668
T C GT Y+ PE L + D + G+++ ++ GR
Sbjct: 154 TFC------GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 8e-08
Identities = 40/111 (36%), Positives = 54/111 (48%), Gaps = 17/111 (15%)
Query: 560 QTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 619
+ + IA EL L LH + IV+ DLKP NILLDA L DFG LS+ ++
Sbjct: 97 RAKFYIA-ELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFG----LSKANLT 148
Query: 620 SNNT--TLCCRTDPKGTFAYMDPEFLASGE-LTPKSDVYSFGIILLRLLTG 667
N T T C GT Y+ PE L + T D +S G+++ + G
Sbjct: 149 DNKTTNTFC------GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 9e-08
Identities = 60/211 (28%), Positives = 95/211 (45%), Gaps = 37/211 (17%)
Query: 472 IGEGGYGSI--YKGLLRHMQVAIK-MLHPHSLQGPSEFQ-QEIDILSKIRHPNLVTL--V 525
+G G +G + + L VAIK ++ P S ++ +E+ +L +RH N+++L +
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDI 77
Query: 526 GACP-EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 584
P E V E L G+ RL S PL Q ++ L ++HS +
Sbjct: 78 FISPLEDIYFVTELL--GTDLHRLL---TSRPLEKQFIQYFLYQILRGLKYVHSA---GV 129
Query: 585 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK-----GTFAYMD 639
VH DLKP+NIL++ N K+ DFG++R DP+ T Y
Sbjct: 130 VHRDLKPSNILINENCDLKICDFGLARI----------------QDPQMTGYVSTRYYRA 173
Query: 640 PE-FLASGELTPKSDVYSFGIILLRLLTGRP 669
PE L + + D++S G I +L G+P
Sbjct: 174 PEIMLTWQKYDVEVDIWSAGCIFAEMLEGKP 204
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 34/98 (34%), Positives = 50/98 (51%), Gaps = 12/98 (12%)
Query: 573 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 632
L ++HS +++H DLKP+N+LL+AN K+ DFG++R + + T+
Sbjct: 121 LKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLAR--------TTSEKGDFMTEYV 169
Query: 633 GTFAYMDPE-FLASGELTPKSDVYSFGIILLRLLTGRP 669
T Y PE L E T DV+S G I LL +P
Sbjct: 170 VTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKP 207
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 33/103 (32%), Positives = 51/103 (49%), Gaps = 11/103 (10%)
Query: 566 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 625
A E+ L FLH I++ DLK N+LLD + K++DFG+ + +N +
Sbjct: 102 AAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCK---ENMNGEGKAST 155
Query: 626 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR 668
C GT Y+ PE L + D +SFG++L +L G+
Sbjct: 156 FC-----GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 58/212 (27%), Positives = 93/212 (43%), Gaps = 30/212 (14%)
Query: 472 IGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL----V 525
IG G +G +Y+ + +VAIK + LQ P +E+ I+ + H N++ L
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKV----LQDPQYKNRELLIMKNLNHINIIFLKDYYY 129
Query: 526 GACPE------VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 579
C + +V E++P + N+ L + +LC L ++HS
Sbjct: 130 TECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS- 188
Query: 580 KPHSIVHGDLKPANILLDAN-FVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 638
I H DLKP N+L+D N KL DFG ++ L + S + +C R Y
Sbjct: 189 --KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSV--SYICSRF-------YR 237
Query: 639 DPEF-LASGELTPKSDVYSFGIILLRLLTGRP 669
PE L + T D++S G I+ ++ G P
Sbjct: 238 APELMLGATNYTTHIDLWSLGCIIAEMILGYP 269
|
Length = 440 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 59/226 (26%), Positives = 101/226 (44%), Gaps = 32/226 (14%)
Query: 471 KIGEGGYGSIYKGLLR----HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL-- 524
K+G G YG +YK + + A+K + + + +EI +L +++HPN++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSA--CREIALLRELKHPNVIALQK 65
Query: 525 ---VGACPEVWTLVYEYLPNG---SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 578
+ +VW L+++Y + ++ + K N P+ R + + L +L +H
Sbjct: 66 VFLSHSDRKVW-LLFDYAEHDLWHIIKFHRASKANKKPMQL-PRSMVKSLLYQILDGIHY 123
Query: 579 CKPHSIVHGDLKPANILLDANFVS----KLSDFGISRFLSQNEISSNNTTL--CCRTDP- 631
+ ++H DLKPANIL+ K++D G +R N+ L DP
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF--------NSPLKPLADLDPV 175
Query: 632 KGTFAYMDPEFLASGELTPKS-DVYSFGIILLRLLTGRPALGITKE 676
TF Y PE L K+ D+++ G I LLT P +E
Sbjct: 176 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 221
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 32/226 (14%)
Query: 471 KIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL-- 524
K+G G YG +YK + + A+K + + + +EI +L +++HPN+++L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSA--CREIALLRELKHPNVISLQK 65
Query: 525 ---VGACPEVWTLVYEYLPNG---SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 578
A +VW L+++Y + ++ + K N P+ R + + L +L +H
Sbjct: 66 VFLSHADRKVW-LLFDYAEHDLWHIIKFHRASKANKKPVQL-PRGMVKSLLYQILDGIHY 123
Query: 579 CKPHSIVHGDLKPANILLDANFVS----KLSDFGISRFLSQNEISSNNTTL--CCRTDP- 631
+ ++H DLKPANIL+ K++D G +R N+ L DP
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF--------NSPLKPLADLDPV 175
Query: 632 KGTFAYMDPEFLASGELTPKS-DVYSFGIILLRLLTGRPALGITKE 676
TF Y PE L K+ D+++ G I LLT P +E
Sbjct: 176 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 221
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 35/102 (34%), Positives = 52/102 (50%), Gaps = 11/102 (10%)
Query: 566 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 625
A E+ S L+FLH I++ DLK N+LLD KL+DFG+ + N ++ +T
Sbjct: 102 AAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTT--STF 156
Query: 626 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG 667
C GT Y+ PE L P D ++ G++L +L G
Sbjct: 157 C------GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 3e-07
Identities = 35/103 (33%), Positives = 54/103 (52%), Gaps = 11/103 (10%)
Query: 566 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 625
A E+ L FLHS I++ DLK N++LD + K++DFG+ + +N N +
Sbjct: 102 AAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCK---ENVFGDNRAST 155
Query: 626 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR 668
C GT Y+ PE L + T D +SFG++L +L G+
Sbjct: 156 FC-----GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 3e-07
Identities = 63/232 (27%), Positives = 98/232 (42%), Gaps = 38/232 (16%)
Query: 472 IGEGGYGSIY------KGLLRHMQV----AIKMLHPHSLQGPSEFQQEIDILSKIRH--- 518
IG GG+G +Y G + M+ IKM QG + E +LS +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-----QGETLALNERIMLSLVSTGDC 56
Query: 519 PNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFL 576
P +V + A P+ + + + + G L LS S A E+ L +
Sbjct: 57 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEAEMRFYAAEIILGLEHM 113
Query: 577 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 636
H+ +V+ DLKPANILLD + ++SD G++ S+ + ++ GT
Sbjct: 114 HN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----------VGTHG 160
Query: 637 YMDPEFLASGELTPKS-DVYSFGIILLRLLTGR-PALGITKEVQYALDTGKL 686
YM PE L G S D +S G +L +LL G P + ++ +D L
Sbjct: 161 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 212
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 22/209 (10%)
Query: 471 KIGEGGYG-----SIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLV 525
+IG G +G IY V ++ S + +EF Q+ D ++HPN++ +
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 526 GACPEV--WTLVYEYLPNGSLEDRLSCKD----NSPPLSWQTRIRIATELCSVLIFLHSC 579
G C E + LV+EY G L+ LS + NS L Q R+A E+ + + +H
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ---RMACEIAAGVTHMHK- 117
Query: 580 KPHSIVHGDLKPANILLDANFVSKLSDFGI--SRFLSQNEISSNNTTLCCR-TDPKGTFA 636
H+ +H DL N L ++ K+ D+GI SR+ + ++ + R P+
Sbjct: 118 --HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGE 175
Query: 637 YMDPEFLASGELTPKSDVYSFGIILLRLL 665
+ L + E T S+V++ G+ L L
Sbjct: 176 FHGG--LITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 4e-07
Identities = 63/225 (28%), Positives = 102/225 (45%), Gaps = 49/225 (21%)
Query: 471 KIGEGGYGSI----YKGLLRHMQVAIK---------MLHPHSLQGPSEFQQEIDILSKIR 517
++G+G YG + VAIK +L +L+ E+ +L R
Sbjct: 7 ELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALR-------ELKLLRHFR 59
Query: 518 -HPNLVTLV-------GACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLS---WQTRI-RI 565
H N+ L G E++ +YE L L + + PL+ +Q+ I +I
Sbjct: 60 GHKNITCLYDMDIVFPGNFNELY--LYEELMEADLHQIIR---SGQPLTDAHFQSFIYQI 114
Query: 566 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 625
LC L ++HS +++H DLKP N+L++A+ K+ DFG++R S+N +
Sbjct: 115 ---LCG-LKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM- 166
Query: 626 CCRTDPKGTFAYMDPEFLASGELTPKS-DVYSFGIILLRLLTGRP 669
T+ T Y PE + S + K+ DV+S G IL LL +P
Sbjct: 167 ---TEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKP 208
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 5e-07
Identities = 57/239 (23%), Positives = 95/239 (39%), Gaps = 75/239 (31%)
Query: 472 IGEGGYGSIYKGLLRH--MQVAIK---MLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVG 526
+G G G ++ + +VA+K + P S++ +EI I+ ++ H N+V
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVK---HALREIKIIRRLDHDNIVK--- 66
Query: 527 ACPEVWTLVYEYL-PNGSLEDRLSCKDNSPPLSWQTRIRIA--------TELCSV----- 572
VYE L P+GS D + + T + T+L +V
Sbjct: 67 --------VYEVLGPSGS--------DLTEDVGSLTELNSVYIVQEYMETDLANVLEQGP 110
Query: 573 ----------------LIFLHSCKPHSIVHGDLKPANILLDA-NFVSKLSDFGISRFL-- 613
L ++HS +++H DLKPAN+ ++ + V K+ DFG++R +
Sbjct: 111 LSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDP 167
Query: 614 --SQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRP 669
S S T Y P L S T D+++ G I +LTG+P
Sbjct: 168 HYSHKGYLSEGLV---------TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKP 217
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 5e-07
Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 11/104 (10%)
Query: 566 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 625
A E+ L FLHS I++ DLK N++LDA K++DFG+ + +N T
Sbjct: 107 AAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCK---ENIFGGKTTRT 160
Query: 626 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 669
C GT Y+ PE +A D ++FG++L +L G+P
Sbjct: 161 FC-----GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQP 199
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 6e-07
Identities = 33/148 (22%), Positives = 69/148 (46%), Gaps = 5/148 (3%)
Query: 299 AQAMAEAENSRREAFEEALRRGKAEKDAIE-SIRRAK----ASESLYAEELKRRKEFEEA 353
+ E EE + + E + +E + A+ A E +RR+ E+
Sbjct: 770 LEEALAKLKEEIEELEEKRQALQEELEELEEELEEAERRLDALERELESLEQRRERLEQE 829
Query: 354 LANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNY 413
+ + E+E ++++ DE+ EEL+ + L+ ++ E + +ELE ++ E +
Sbjct: 830 IEELEEEIEELEEKLDELEEELEELEKELEELKEELEELEAEKEELEDELKELEEEKEEL 889
Query: 414 KKEQDELQMERDKAVKEAEELRKSRKEA 441
++E EL+ E + +E E+LR+ +E
Sbjct: 890 EEELRELESELAELKEEIEKLRERLEEL 917
|
Length = 1163 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 6e-07
Identities = 58/209 (27%), Positives = 89/209 (42%), Gaps = 31/209 (14%)
Query: 472 IGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTL 524
+G+G +G + L+R A+K+L + E E +L RHP L L
Sbjct: 3 LGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 525 VGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-ATELCSVLIFLHSCKP 581
A + V EY G L LS + + R R E+ S L +LHS
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLS----RERVFTEERARFYGAEIVSALEYLHS--- 113
Query: 582 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT--TLCCRTDPKGTFAYMD 639
+V+ D+K N++LD + K++DFG L + IS T T C GT Y+
Sbjct: 114 RDVVYRDIKLENLMLDKDGHIKITDFG----LCKEGISDGATMKTFC------GTPEYLA 163
Query: 640 PEFLASGELTPKSDVYSFGIILLRLLTGR 668
PE L + D + G+++ ++ GR
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 6e-07
Identities = 50/174 (28%), Positives = 70/174 (40%), Gaps = 33/174 (18%)
Query: 509 EIDILSKIRHPNLVTLVGACPEVW-TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIAT 567
EIDIL I H ++ L+ A W + V +P D + D S PL + I I
Sbjct: 136 EIDILKTISHRAIINLIHAYR--WKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQR 192
Query: 568 ELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCC 627
L L +LH I+H D+K NI LD + L DFG + C
Sbjct: 193 RLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAA----------------C 233
Query: 628 RTD-----PK-----GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPAL 671
+ D P+ GT PE LA K+D++S G++L + L
Sbjct: 234 KLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 8e-07
Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 24/208 (11%)
Query: 472 IGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSE---FQQEIDILSKIRHPNLVTLVG 526
IG G +G + ++H + A+K+L+ + +E F++E ++L + TL
Sbjct: 9 IGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHY 68
Query: 527 ACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 584
A + LV +Y G L LS ++ P R IA +++ +HS
Sbjct: 69 AFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPED-MARFYIA----EMVLAIHSIHQLHY 123
Query: 585 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 644
VH D+KP N+LLD N +L+DFG ++Q+ ++ + GT Y+ PE L
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAV-------GTPDYISPEILQ 176
Query: 645 S-----GELTPKSDVYSFGIILLRLLTG 667
+ G+ P+ D +S G+ + +L G
Sbjct: 177 AMEDGMGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 9e-07
Identities = 59/209 (28%), Positives = 92/209 (44%), Gaps = 31/209 (14%)
Query: 472 IGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTL 524
+G+G +G + L+R A+K+L + E E +L RHP L +L
Sbjct: 3 LGKGTFGKVI--LVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 525 VGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-ATELCSVLIFLHSCKP 581
+ + V EY+ G L LS + + R R E+ S L +LHS K
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLS----RERVFSEDRTRFYGAEIVSALDYLHSGK- 115
Query: 582 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT--TLCCRTDPKGTFAYMD 639
IV+ DLK N++LD + K++DFG L + I+ T T C GT Y+
Sbjct: 116 --IVYRDLKLENLMLDKDGHIKITDFG----LCKEGITDAATMKTFC------GTPEYLA 163
Query: 640 PEFLASGELTPKSDVYSFGIILLRLLTGR 668
PE L + D + G+++ ++ GR
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 1e-06
Identities = 35/155 (22%), Positives = 72/155 (46%), Gaps = 10/155 (6%)
Query: 296 DQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALA 355
++L + + E E E + K E + +E R+A E EE E E L
Sbjct: 754 EELQERLEELEEELESLEEALAKL-KEEIEELEEKRQALQEELEELEEELE--EAERRLD 810
Query: 356 NGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKK 415
+ ELE ++++ + + +E++ ++ LE ++ E ++ +ELE+++ E L+ +
Sbjct: 811 ALERELESLEQRRERLEQEIEELEEEIEELEEKLDELEEELEELEKELEELKEELEELEA 870
Query: 416 EQDEL-------QMERDKAVKEAEELRKSRKEASS 443
E++EL + E+++ +E EL E
Sbjct: 871 EKEELEDELKELEEEKEELEEELRELESELAELKE 905
|
Length = 1163 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 1e-06
Identities = 33/148 (22%), Positives = 68/148 (45%)
Query: 294 LYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEA 353
L ++L E + E + + E+ E R A E + R +E EE
Sbjct: 686 LEEELKSLKNELRSLEDLLEELRRQLEELERQLEELKRELAALEEELEQLQSRLEELEEE 745
Query: 354 LANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNY 413
L + ELE ++++ +E+ EEL+ + + L+ +I E ++ + L++++ E L+
Sbjct: 746 LEELEEELEELQERLEELEEELESLEEALAKLKEEIEELEEKRQALQEELEELEEELEEA 805
Query: 414 KKEQDELQMERDKAVKEAEELRKSRKEA 441
++ D L+ E + + E L + +E
Sbjct: 806 ERRLDALERELESLEQRRERLEQEIEEL 833
|
Length = 1163 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-06
Identities = 45/140 (32%), Positives = 65/140 (46%), Gaps = 19/140 (13%)
Query: 572 VLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDP 631
+++ L ++H DLK ANI L + KL DFG S+ S + ++ C
Sbjct: 178 IVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFC----- 232
Query: 632 KGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALG-----ITKEVQYA-LD-- 682
GT Y+ PE + K+D++S G+IL LLT RP G I ++V Y D
Sbjct: 233 -GTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPF 291
Query: 683 ----TGKLKNLLDPLAGDWP 698
+ +K LLDPL P
Sbjct: 292 PCPVSSGMKALLDPLLSKNP 311
|
Length = 478 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 1e-06
Identities = 58/236 (24%), Positives = 94/236 (39%), Gaps = 38/236 (16%)
Query: 464 HNFDPSLKIGEGGYGSIYKGLLRHMQV-----AIKMLHPHSLQGPSEFQQ---EIDILSK 515
+F +G+G G ++ L ++ A+K+L + ++ ++ E +IL+
Sbjct: 1 KHFKKIKLLGKGDVGRVF---LVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILAT 57
Query: 516 IRHPNLVTLVG--ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVL 573
+ HP L TL LV +Y P G L L + LS + A E+ L
Sbjct: 58 LDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQ-RQPGKCLSEEVARFYAAEVLLAL 116
Query: 574 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS----------------QNE 617
+LH IV+ DLKP NILL + LSDF +S+ +
Sbjct: 117 EYLH-LL--GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSV 173
Query: 618 ISSNNTTLCCRTDPK-----GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR 668
S + T + GT Y+ PE ++ D ++ GI+L +L G
Sbjct: 174 NSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 42/144 (29%), Positives = 67/144 (46%), Gaps = 16/144 (11%)
Query: 534 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-ATELCSVLIFLHSCKPHSIVHGDLKPA 592
LV EY+ G L + + P + R A E+C L FLH I++ DLK
Sbjct: 73 LVIEYVNGGDLMFHMQRQRKLP----EEHARFYAAEICIALNFLHE---RGIIYRDLKLD 125
Query: 593 NILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKS 652
N+LLDA+ KL+D+G+ + + + T+ C GT Y+ PE L E
Sbjct: 126 NVLLDADGHIKLTDYGMCK---EGLGPGDTTSTFC-----GTPNYIAPEILRGEEYGFSV 177
Query: 653 DVYSFGIILLRLLTGRPALGITKE 676
D ++ G+++ ++ GR I +
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIITD 201
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 34/97 (35%), Positives = 47/97 (48%), Gaps = 11/97 (11%)
Query: 573 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 632
L +LHS I+H D+KP N+L+++N V K+ DFG++R +E T
Sbjct: 116 LKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE-------SKHMTQEV 165
Query: 633 GTFAYMDPEFL-ASGELTPKSDVYSFGIILLRLLTGR 668
T Y PE L S T D++S G I LL R
Sbjct: 166 VTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 55/212 (25%), Positives = 86/212 (40%), Gaps = 20/212 (9%)
Query: 472 IGEGGYGSIYKGLLRHM--QVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVG 526
+G+GG+G + +R A K L ++ G S E IL K+ +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67
Query: 527 A--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 584
A + LV + G L+ + N P + + A E+ L LH +
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGN-PGFEEERALFYAAEILCGLEDLHR---ENT 123
Query: 585 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 644
V+ DLKP NILLD ++SD G++ + + E GT YM PE L
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV---------GTVGYMAPEVLN 174
Query: 645 SGELTPKSDVYSFGIILLRLLTGRPALGITKE 676
+ T D + G ++ ++ G+ KE
Sbjct: 175 NQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 2e-06
Identities = 35/139 (25%), Positives = 69/139 (49%), Gaps = 7/139 (5%)
Query: 307 NSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELK-RRKEFEEALANGKLELERMK 365
E EE L R + E + ++ +A + + EELK +E E L + EL +K
Sbjct: 238 RKELEELEEELSRLEEELEELQE-ELEEAEKEI--EELKSELEELREELEELQEELLELK 294
Query: 366 KQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERD 425
++ +E+ E+ + ++ LE+++ E ++ +EL++KI + E L+ + +EL+
Sbjct: 295 EEIEELEGEISLLRERLEELENELEELEERLEELKEKIEALKEELEERETLLEELEQLLA 354
Query: 426 ---KAVKEAEELRKSRKEA 441
+A +E EE + E
Sbjct: 355 ELEEAKEELEEKLSALLEE 373
|
Length = 1163 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 2e-06
Identities = 47/167 (28%), Positives = 81/167 (48%), Gaps = 8/167 (4%)
Query: 275 KEDLQSSPPSVLDGSVDDNLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAK 334
+E+L+S ++ + ++ QA+ E E EEA RR A + +ES+ + +
Sbjct: 764 EEELESLEEALAKLKEEIEELEEKRQALQEELEELEEELEEAERRLDALERELESLEQRR 823
Query: 335 ASESLYAEELK-RRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESD 393
EEL+ +E EE L + ELE ++K+ +E+ EEL+ +K LE ++
Sbjct: 824 ERLEQEIEELEEEIEELEEKLDELEEELEELEKELEELKEELEELEAEKEELEDEL---- 879
Query: 394 QTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKE 440
KELE++ E L+ + E EL+ E +K + EEL +
Sbjct: 880 ---KELEEEKEELEEELRELESELAELKEEIEKLRERLEELEAKLER 923
|
Length = 1163 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 33/104 (31%), Positives = 52/104 (50%), Gaps = 11/104 (10%)
Query: 566 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 625
A E+ L FLHS I++ DLK N++LD+ K++DFG+ + +N T
Sbjct: 107 AAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENMWDGVTTKT 160
Query: 626 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 669
C GT Y+ PE +A D ++FG++L +L G+
Sbjct: 161 FC-----GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 199
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 3e-06
Identities = 57/225 (25%), Positives = 87/225 (38%), Gaps = 60/225 (26%)
Query: 472 IGEGGYGSIYKGLLRH--MQVAIK-MLHPHSLQGPSEFQQEID---------ILSKIRHP 519
+G G YG + +VAIK + P FQ I +L + H
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRP--------FQSAIHAKRTYRELRLLKHMDHE 74
Query: 520 NLVTLVGACPEVWTLVYEYLPNGSLED-------------RLSCKDNSPPLSWQTRIR-I 565
N++ L+ +V+T P SLED L+ LS I+ +
Sbjct: 75 NVIGLL----DVFT------PASSLEDFQDVYLVTHLMGADLNNIVKCQKLS-DDHIQFL 123
Query: 566 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 625
++ L ++HS I+H DLKP+NI ++ + K+ DFG++R
Sbjct: 124 VYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE--------- 171
Query: 626 CCRTDPKGTFAYMDPE-FLASGELTPKSDVYSFGIILLRLLTGRP 669
T T Y PE L D++S G I+ LLTG+
Sbjct: 172 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKT 214
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|223496 COG0419, SbcC, ATPase involved in DNA repair [DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 3e-06
Identities = 30/142 (21%), Positives = 53/142 (37%), Gaps = 4/142 (2%)
Query: 299 AQAMAEAENSRRE--AFEEAL--RRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEAL 354
Q E+ A EE L + E + + E L +E +E L
Sbjct: 192 GQLSELLEDIEDLLEALEEELKELKKLEEIQEEQEEEELEQEIEALEERLAELEEEKERL 251
Query: 355 ANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYK 414
K L ++ E ++ + L + L ++ E + +ELE++I E L+ +
Sbjct: 252 EELKARLLEIESLELEALKIREEELRELERLLEELEEKIERLEELEREIEELEEELEGLR 311
Query: 415 KEQDELQMERDKAVKEAEELRK 436
+EL+ +K E L K
Sbjct: 312 ALLEELEELLEKLKSLEERLEK 333
|
Length = 908 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 4e-06
Identities = 38/146 (26%), Positives = 72/146 (49%), Gaps = 9/146 (6%)
Query: 297 QLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEF-EEALA 355
+L + E + E+ K+ K+ + S+ EEL+R+ E + LA
Sbjct: 668 ELKELEEELAELEAQ-LEKLEEELKSLKNELRSLEDLLEELRRQLEELERQLEELKRELA 726
Query: 356 NGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKK 415
+ ELE+++ + +E+ EEL+ ++ L+ ++ ELE+++ S E L K+
Sbjct: 727 ALEEELEQLQSRLEELEEELEELEEELEELQERLE-------ELEEELESLEEALAKLKE 779
Query: 416 EQDELQMERDKAVKEAEELRKSRKEA 441
E +EL+ +R +E EEL + +EA
Sbjct: 780 EIEELEEKRQALQEELEELEEELEEA 805
|
Length = 1163 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 4e-06
Identities = 58/220 (26%), Positives = 98/220 (44%), Gaps = 27/220 (12%)
Query: 465 NFDPSLKIGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQGPSEFQQ---EIDILSKIRHP 519
+ P IG G YG + + +VAIK + PH+ P+ ++ E+ IL +H
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKI-PHAFDVPTLAKRTLRELKILRHFKHD 64
Query: 520 NLVTL-------VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV 572
N++ + +V+ +V + L L + PL+ + +L
Sbjct: 65 NIIAIRDILRPPGADFKDVY-VVMD-LMESDLHHIIHSDQ---PLTEEHIRYFLYQLLRG 119
Query: 573 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 632
L ++HS ++H DLKP+N+L++ + ++ DFG++R LS + T+
Sbjct: 120 LKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFM----TEYV 172
Query: 633 GTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPAL 671
T Y PE L S E T D++S G I +L GR L
Sbjct: 173 ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 4e-06
Identities = 57/212 (26%), Positives = 88/212 (41%), Gaps = 20/212 (9%)
Query: 472 IGEGGYGSIYKGLLRHM--QVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVG 526
+G+GG+G + +R A K L ++ G + E IL K+ +V+L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67
Query: 527 A--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 584
A + LV + G L+ + N P Q I A ELC L L I
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGN-PGFDEQRAIFYAAELCCGLEDLQR---ERI 123
Query: 585 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 644
V+ DLKP NILLD ++SD G++ + + E GT YM PE +
Sbjct: 124 VYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV---------GTVGYMAPEVIN 174
Query: 645 SGELTPKSDVYSFGIILLRLLTGRPALGITKE 676
+ + T D + G ++ ++ G+ KE
Sbjct: 175 NEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 4e-06
Identities = 24/112 (21%), Positives = 49/112 (43%), Gaps = 16/112 (14%)
Query: 506 FQQEIDILSKIRH-----PNLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQ 560
++E+ IL + P ++ + + L+ E++ +L+ +S +
Sbjct: 38 REREVAILQLLARKGLPVPKVLASGESDGWSY-LLMEWIEGETLD----------EVSEE 86
Query: 561 TRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 612
+ IA +L +L LH + HGDL P NIL+D + + D+ + +
Sbjct: 87 EKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 5e-06
Identities = 39/173 (22%), Positives = 70/173 (40%), Gaps = 25/173 (14%)
Query: 297 QLAQAMAEAENSRR------EAFEEALRRGKAEKDAIESIRR--AKASESLYAEELK--- 345
+L + E E EEA + + K +E +R + E L + +
Sbjct: 240 ELEELEEELSRLEEELEELQEELEEAEKEIEELKSELEELREELEELQEELLELKEEIEE 299
Query: 346 ----------RRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQT 395
R +E E L + LE +K++ + + EEL+ LE +AE ++
Sbjct: 300 LEGEISLLRERLEELENELEELEERLEELKEKIEALKEELEERETLLEELEQLLAELEEA 359
Query: 396 AKELEQK----IISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSS 444
+ELE+K + EL + ++E EL+ E + E EEL++ +
Sbjct: 360 KEELEEKLSALLEELEELFEALREELAELEAELAEIRNELEELKREIESLEER 412
|
Length = 1163 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 5e-06
Identities = 61/208 (29%), Positives = 92/208 (44%), Gaps = 29/208 (13%)
Query: 472 IGEGGYGSIY---KGLLRHMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRH---PNLV 522
IG GG+G +Y K M A+K L + QG + E +LS + P +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKM-YAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 523 TLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 580
+ A P+ + + + G L LS S + ATE+ L +H+
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLS---QHGVFSEKEMRFYATEIILGLEHMHN-- 115
Query: 581 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 640
+V+ DLKPANILLD + ++SD G++ S+ + ++ GT YM P
Sbjct: 116 -RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----------VGTHGYMAP 164
Query: 641 EFLASGELTPKS-DVYSFGIILLRLLTG 667
E L G S D +S G +L +LL G
Sbjct: 165 EVLQKGTAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|233758 TIGR02169, SMC_prok_A, chromosome segregation protein SMC, primarily archaeal type | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 6e-06
Identities = 28/155 (18%), Positives = 61/155 (39%), Gaps = 11/155 (7%)
Query: 297 QLAQAMAEAEN--SRREAFEEALRRGKAEKDAIESIRRAKASE-----SLYAEELKRRKE 349
+LA+ AE + + E E + + +D + E + E K E
Sbjct: 323 RLAKLEAEIDKLLAEIEELEREIEEERKRRDKLTEEYAELKEELEDLRAELEEVDKEFAE 382
Query: 350 FEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKI---ISA 406
+ L + + +LE++K++ +E+ EL ++ L ++A+ + +E KI
Sbjct: 383 TRDELKDYREKLEKLKREINELKRELDRLQEELQRLSEELADLNAAIAGIEAKINELEEE 442
Query: 407 VELLQNYKKEQDELQMERDKAVKEAEELRKSRKEA 441
E + ++ E ++E+ A E +
Sbjct: 443 KEDKA-LEIKKQEWKLEQLAADLSKYEQELYDLKE 476
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. It is found in a single copy and is homodimeric in prokaryotes, but six paralogs (excluded from this family) are found in eukarotes, where SMC proteins are heterodimeric. This family represents the SMC protein of archaea and a few bacteria (Aquifex, Synechocystis, etc); the SMC of other bacteria is described by TIGR02168. The N- and C-terminal domains of this protein are well conserved, but the central hinge region is skewed in composition and highly divergent [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1164 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 6e-06
Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 24/208 (11%)
Query: 472 IGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSE---FQQEIDILSKIRHPNLVTLVG 526
IG G +G + L++ A+K+L+ + +E F++E D+L + + TL
Sbjct: 9 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHY 68
Query: 527 ACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 584
A + LV +Y G L LS ++ P R +A ++I + S
Sbjct: 69 AFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPED-MARFYLA----EMVIAIDSVHQLHY 123
Query: 585 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 644
VH D+KP NIL+D N +L+DFG L ++ ++ + GT Y+ PE L
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-------GTPDYISPEILQ 176
Query: 645 S-----GELTPKSDVYSFGIILLRLLTG 667
+ G+ P+ D +S G+ + +L G
Sbjct: 177 AMEDGKGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 8e-06
Identities = 43/160 (26%), Positives = 70/160 (43%), Gaps = 20/160 (12%)
Query: 518 HPNLVTLVGAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-ATELCSVL 573
HP LV L +C V E++ G L + + P + R + E+ L
Sbjct: 55 HPFLVGL-HSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLP----EEHARFYSAEISLAL 109
Query: 574 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 633
FLH I++ DLK N+LLDA KL+D+G+ + + + T+ C G
Sbjct: 110 NFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCK---EGIRPGDTTSTFC-----G 158
Query: 634 TFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGI 673
T Y+ PE L + D ++ G+++ ++ GR I
Sbjct: 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|224495 COG1579, COG1579, Zn-ribbon protein, possibly nucleic acid-binding [General function prediction only] | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 9e-06
Identities = 39/155 (25%), Positives = 67/155 (43%), Gaps = 19/155 (12%)
Query: 309 RREAFEEALRRGKAEKDAI----ESIRRAKAS--------ESLYAEELKRRKEFEEALAN 356
R + +AL++ KAE +A+ E++ ES E +R K EE L+
Sbjct: 25 RIKEIRKALKKAKAELEALNKALEALEIELEDLENQVSQLESEIQEIRERIKRAEEKLSA 84
Query: 357 GKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKE 416
K E E E+QIA ++ + LE ++AE + ++LE++I E L+ +K
Sbjct: 85 VKDERELRALNI-----EIQIAKERINSLEDELAELMEEIEKLEKEIEDLKERLERLEKN 139
Query: 417 QDELQMERDKAVKEAEELRK--SRKEASSSSHMPQ 449
E + ++ V E E + S K +
Sbjct: 140 LAEAEARLEEEVAEIREEGQELSSKREELKEKLDP 174
|
Length = 239 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 9e-06
Identities = 54/212 (25%), Positives = 87/212 (41%), Gaps = 20/212 (9%)
Query: 472 IGEGGYGSIYKGLLRHM--QVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVG 526
+G+GG+G + +R A K L ++ G + E IL K+ +V+L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 67
Query: 527 A--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 584
A + LV + G L+ + N P + + A E+ L LH I
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYNMGN-PGFDEERAVFYAAEITCGLEDLHR---ERI 123
Query: 585 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 644
V+ DLKP NILLD ++SD G++ + + E GT YM PE +
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRV---------GTVGYMAPEVVK 174
Query: 645 SGELTPKSDVYSFGIILLRLLTGRPALGITKE 676
+ T D + G ++ ++ G+ KE
Sbjct: 175 NERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 2e-05
Identities = 32/149 (21%), Positives = 59/149 (39%), Gaps = 8/149 (5%)
Query: 297 QLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALAN 356
+L + + E E E ++ E + K EEL+ R+ E
Sbjct: 292 ELKEEIEELEGEISLLRERLEELENELEELEERLEELKEKIEALKEELEERETLLE---- 347
Query: 357 GKLELERMKKQHDEVMEELQIALD-QKSLLESQIAESDQTAKELEQKIISAVELLQNYKK 415
ELE++ + +E EEL+ L LE + ELE ++ L+ K+
Sbjct: 348 ---ELEQLLAELEEAKEELEEKLSALLEELEELFEALREELAELEAELAEIRNELEELKR 404
Query: 416 EQDELQMERDKAVKEAEELRKSRKEASSS 444
E + L+ ++ + E+L++ KE +
Sbjct: 405 EIESLEERLERLSERLEDLKEELKELEAE 433
|
Length = 1163 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 2e-05
Identities = 36/151 (23%), Positives = 73/151 (48%), Gaps = 8/151 (5%)
Query: 293 NLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRR----AKASESLYAEELKRRK 348
L ++LA+ A+ E E + ++ +D +E +RR + EL +
Sbjct: 671 ELEEELAELEAQLE-KLEEELKSLKNELRSLEDLLEELRRQLEELERQLEELKRELAALE 729
Query: 349 EFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVE 408
E E L + ELE ++ +E +EELQ L++ LE ++ ++ +L+++I E
Sbjct: 730 EELEQLQSRLEELEEELEELEEELEELQERLEE---LEEELESLEEALAKLKEEIEELEE 786
Query: 409 LLQNYKKEQDELQMERDKAVKEAEELRKSRK 439
Q ++E +EL+ E ++A + + L + +
Sbjct: 787 KRQALQEELEELEEELEEAERRLDALERELE 817
|
Length = 1163 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 2e-05
Identities = 37/153 (24%), Positives = 65/153 (42%), Gaps = 16/153 (10%)
Query: 304 EAENSRREAFEEALRRGKAEKDAI---ESIRRAKASESLYAEELKRRKEF---EEALANG 357
+ E RE E L + AE + + + E L R+E E LA
Sbjct: 336 KEELEERETLLEELEQLLAELEEAKEELEEKLSALLEELEELFEALREELAELEAELAEI 395
Query: 358 KLELERMKKQHDEV-------MEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELL 410
+ ELE +K++ + + E L+ ++ LE+++ E +EL +++ E L
Sbjct: 396 RNELEELKREIESLEERLERLSERLEDLKEELKELEAELEELQTELEELNEELEELEEQL 455
Query: 411 QNYKKEQDELQMERDKAVKEAEELRKSRKEASS 443
+ + EL+ E + EEL++ KE SS
Sbjct: 456 EELRDRLKELERELAEL---QEELQRLEKELSS 485
|
Length = 1163 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 2e-05
Identities = 36/179 (20%), Positives = 75/179 (41%), Gaps = 34/179 (18%)
Query: 296 DQLAQAMAEAENSRREAFEE------ALRRGKAEKDA----IESIRRAKAS-ESLYAEEL 344
++L Q + E E E E+ L + E + +E + K E E
Sbjct: 824 ERLEQEIEELEEEIEELEEKLDELEEELEELEKELEELKEELEELEAEKEELEDELKELE 883
Query: 345 KRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTA-------- 396
+ ++E EE L + EL +K++ +++ E L+ + LE ++ E ++
Sbjct: 884 EEKEELEEELRELESELAELKEEIEKLRERLEELEAKLERLEVELPELEEELEEEYEDTL 943
Query: 397 -KELEQKI--------------ISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKE 440
ELE++I + A+E + ++ +EL+ +R+ + E+L + +E
Sbjct: 944 ETELEREIERLEEEIEALGPVNLRAIEEYEEVEERYEELKSQREDLEEAKEKLLEVIEE 1002
|
Length = 1163 |
| >gnl|CDD|223496 COG0419, SbcC, ATPase involved in DNA repair [DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 2e-05
Identities = 34/156 (21%), Positives = 72/156 (46%), Gaps = 8/156 (5%)
Query: 293 NLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEE 352
+L + + E EE + + ++ I + L+ +E E
Sbjct: 263 SLELEALKIREEELRELERLLEELEEKIERLEELEREIEELEEELEGLRALLEELEELLE 322
Query: 353 ALANGKLELERMKKQHDEVMEELQIALDQK----SLLESQIAESDQTAKELEQKIISAVE 408
L + + LE+++++ +++ EL+ ++K LLE ++ E ++ +ELE+++ A+E
Sbjct: 323 KLKSLEERLEKLEEKLEKLESELEELAEEKNELAKLLEERLKELEERLEELEKELEKALE 382
Query: 409 LLQNYKKEQDEL---QMERDKAVKEA-EELRKSRKE 440
L+ ++ EL E A++E EEL + KE
Sbjct: 383 RLKQLEEAIQELKEELAELSAALEEIQEELEELEKE 418
|
Length = 908 |
| >gnl|CDD|223496 COG0419, SbcC, ATPase involved in DNA repair [DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 2e-05
Identities = 43/205 (20%), Positives = 84/205 (40%), Gaps = 27/205 (13%)
Query: 276 EDLQSSPPSVLDGSVDDNLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESI----- 330
ED +L+ + + + E ++ +E R ++ ++S+
Sbjct: 565 EDRLQELKELLEELRLLRTRKEELEELRERLKELKKKLKELEERLSQLEELLQSLELSEA 624
Query: 331 -RRAKASESLYAEELKRRKE---FEEALANGKLELERMKKQ-HDEVMEELQIALDQKSLL 385
+ +E EL++ EE L ELE ++ E+ ELQ +++ L
Sbjct: 625 ENELEEAEEELESELEKLNLQAELEELLQAALEELEEKVEELEAEIRRELQRIENEEQLE 684
Query: 386 ESQIAESDQTAKELEQ-------------KIISAVELLQNYKKEQDELQMERD---KAVK 429
E ++ E +Q +ELEQ +I +E L++ K E +EL+ E + KA++
Sbjct: 685 E-KLEELEQLEEELEQLREELEELLKKLGEIEQLIEELESRKAELEELKKELEKLEKALE 743
Query: 430 EAEELRKSRKEASSSSHMPQFFSDF 454
EELR+ +A + + +
Sbjct: 744 LLEELREKLGKAGLRADILRNLLAQ 768
|
Length = 908 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 37/123 (30%), Positives = 61/123 (49%), Gaps = 13/123 (10%)
Query: 546 DRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLS 605
R + + SP LS+ + + ++ + + FL S + VH DL N+L+ + K+
Sbjct: 225 RRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNVLICEGKLVKIC 281
Query: 606 DFGISRFL--SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLR 663
DFG++R + N IS +T L +M PE + + T SDV+SFGI+L
Sbjct: 282 DFGLARDIMRDSNYISKGSTFL--------PLKWMAPESIFNNLYTTLSDVWSFGILLWE 333
Query: 664 LLT 666
+ T
Sbjct: 334 IFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 31/104 (29%), Positives = 53/104 (50%), Gaps = 11/104 (10%)
Query: 566 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 625
A E+ L FLH I++ DLK N++LD+ K++DFG+ + ++ + T
Sbjct: 107 AAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVTTRT 160
Query: 626 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 669
C GT Y+ PE +A D +++G++L +L G+P
Sbjct: 161 FC-----GTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQP 199
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 2e-05
Identities = 33/157 (21%), Positives = 63/157 (40%), Gaps = 7/157 (4%)
Query: 292 DNLYDQLAQAMAEAEN-SRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKR---- 346
L LA+ AE E R A + R +A E L E +
Sbjct: 729 SALRKDLARLEAEVEQLEERIAQLSKELTELEAEIEELEERLEEAEEELAEAEAEIEELE 788
Query: 347 --RKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKII 404
++ +E L + L+ ++ + + EE ++ LE +IA +++ ++LE++I
Sbjct: 789 AQIEQLKEELKALREALDELRAELTLLNEEAANLRERLESLERRIAATERRLEDLEEQIE 848
Query: 405 SAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEA 441
E +++ E +EL+ ++ E E L R
Sbjct: 849 ELSEDIESLAAEIEELEELIEELESELEALLNERASL 885
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179 |
| >gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 2e-05
Identities = 22/136 (16%), Positives = 49/136 (36%), Gaps = 7/136 (5%)
Query: 297 QLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALAN 356
L + AE EA R E+ + RR + E E + + +
Sbjct: 804 ALDELRAELTLLNEEAANLRERLESLERRIAATERRLEDLEEQIEELSEDIESLAAEIEE 863
Query: 357 GKLELERMKKQHDEVMEE-------LQIALDQKSLLESQIAESDQTAKELEQKIISAVEL 409
+ +E ++ + + ++ E L + + L ++ E + EL +++ E
Sbjct: 864 LEELIEELESELEALLNERASLEEALALLRSELEELSEELRELESKRSELRRELEELREK 923
Query: 410 LQNYKKEQDELQMERD 425
L + + L++ D
Sbjct: 924 LAQLELRLEGLEVRID 939
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 48.2 bits (114), Expect = 2e-05
Identities = 32/132 (24%), Positives = 69/132 (52%), Gaps = 6/132 (4%)
Query: 299 AQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGK 358
A+ +AE ++A EAL++ E E +++ +A E AEELK+ +E + A
Sbjct: 1677 AEEAKKAEEDEKKA-AEALKKEAEEAKKAEELKKKEAEEKKKAEELKKAEEENKIKAE-- 1733
Query: 359 LELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQD 418
E ++ ++ + EE + ++K + E ++ A+E+ ++ + +E + +E +
Sbjct: 1734 -EAKKEAEEDKKKAEEAKKDEEEKKKIAHLKKEEEKKAEEIRKEKEAVIE--EELDEEDE 1790
Query: 419 ELQMERDKAVKE 430
+ +ME DK +K+
Sbjct: 1791 KRRMEVDKKIKD 1802
|
Length = 2084 |
| >gnl|CDD|235175 PRK03918, PRK03918, chromosome segregation protein; Provisional | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 2e-05
Identities = 41/148 (27%), Positives = 67/148 (45%), Gaps = 11/148 (7%)
Query: 304 EAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRR-KEFEEA------LAN 356
E + E+ L + E + ES+ EEL+ R KE E L +
Sbjct: 552 EELKKKLAELEKKLDELEEELAELLKELEELGFESV--EELEERLKELEPFYNEYLELKD 609
Query: 357 GKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKE 416
+ ELER +K+ ++ EEL A ++ + E ++ E + +ELE+K + E + ++E
Sbjct: 610 AEKELEREEKELKKLEEELDKAFEELAETEKRLEELRKELEELEKKY--SEEEYEELREE 667
Query: 417 QDELQMERDKAVKEAEELRKSRKEASSS 444
EL E E EEL K R+E +
Sbjct: 668 YLELSRELAGLRAELEELEKRREEIKKT 695
|
Length = 880 |
| >gnl|CDD|224259 COG1340, COG1340, Uncharacterized archaeal coiled-coil protein [Function unknown] | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 29/158 (18%), Positives = 65/158 (41%), Gaps = 5/158 (3%)
Query: 292 DNLYDQLAQAMAEAENSRREAFEEALRRG--KAEKDAIESIRRAKASESLYAEELKRRKE 349
D + +L + E + + E L K+ + IE + + + + L EE + +
Sbjct: 79 DEINAKLQELRKEYRELKEKRNEFNLGGRSIKSLEREIERLEKKQQTSVLTPEEERELVQ 138
Query: 350 FEEALANGKLELERMKKQHDEVMEELQIALDQKSLLES---QIAESDQTAKELEQKIISA 406
+ L + ++ ++++++ E + K +I E A+E +++I
Sbjct: 139 KIKELRKELEDAKKALEENEKLKELKAEIDELKKKAREIHEKIQELANEAQEYHEEMIKL 198
Query: 407 VELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSS 444
E +KE DEL E + K+ +EL + + +
Sbjct: 199 FEEADELRKEADELHEEFVELSKKIDELHEEFRNLQNE 236
|
Length = 294 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 3e-05
Identities = 38/181 (20%), Positives = 72/181 (39%), Gaps = 28/181 (15%)
Query: 292 DNLYDQLAQAMAEAENSRRE------AFEEALRRGKAEKDAIESIRRAKASESLYAEEL- 344
+L D L + + E R+ + + +E + EEL
Sbjct: 698 RSLEDLLEELRRQLEELERQLEELKRELAALEEELEQLQSRLEELEEELEELEEELEELQ 757
Query: 345 KRRKEFEEAL-------ANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAE------ 391
+R +E EE L A K E+E ++++ + EEL+ ++ E ++
Sbjct: 758 ERLEELEEELESLEEALAKLKEEIEELEEKRQALQEELEELEEELEEAERRLDALERELE 817
Query: 392 --------SDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASS 443
+Q +ELE++I E L ++E +EL+ E ++ +E EEL ++E
Sbjct: 818 SLEQRRERLEQEIEELEEEIEELEEKLDELEEELEELEKELEELKEELEELEAEKEELED 877
Query: 444 S 444
Sbjct: 878 E 878
|
Length = 1163 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 33/114 (28%), Positives = 51/114 (44%), Gaps = 12/114 (10%)
Query: 563 IRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 622
I + ++ ++ LHS IV+ D+KP N+LLD +LSD G++ E+
Sbjct: 98 IHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAV-----ELKDGK 149
Query: 623 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE 676
T T GT YM PE L + D ++ G + ++ GR KE
Sbjct: 150 TI----TQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKE 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 3e-05
Identities = 36/132 (27%), Positives = 62/132 (46%), Gaps = 17/132 (12%)
Query: 535 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANI 594
+Y ++ + + + KD PL QTR I +L + ++H K ++H D+K NI
Sbjct: 249 LYSFMYDEAFD----WKDR--PLLKQTR-AIMKQLLCAVEYIHDKK---LIHRDIKLENI 298
Query: 595 LLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDV 654
L+ + L DFG + + + + + GT A PE LA +D+
Sbjct: 299 FLNCDGKIVLGDFGTAMPFEKEREAFDYGWV-------GTVATNSPEILAGDGYCEITDI 351
Query: 655 YSFGIILLRLLT 666
+S G+ILL +L+
Sbjct: 352 WSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 33/103 (32%), Positives = 52/103 (50%), Gaps = 12/103 (11%)
Query: 566 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 625
A E+C L LH IV+ DLKP NILLD + ++SD G++ + + + T+
Sbjct: 108 AAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ------TI 158
Query: 626 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR 668
R GT YM PE + + T D ++ G +L ++ G+
Sbjct: 159 KGRV---GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|233758 TIGR02169, SMC_prok_A, chromosome segregation protein SMC, primarily archaeal type | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 4e-05
Identities = 33/166 (19%), Positives = 73/166 (43%), Gaps = 17/166 (10%)
Query: 292 DNLYDQLAQAMAEAENS------RREAFEEALRRGKAE----KDAIESIRRAKASESLYA 341
+N D+L+Q +++A E E+ + K ++ + S+ + +
Sbjct: 701 ENRLDELSQELSDASRKIGEIEKEIEQLEQEEEKLKERLEELEEDLSSLEQEIENVKSEL 760
Query: 342 EEL-KRRKEFEEALANGKLEL---ERMKKQH--DEVMEELQIALDQKSLLESQIAESDQT 395
+EL R +E EE L + L E E+ EL ++ S +E+++ E +Q
Sbjct: 761 KELEARIEELEEDLHKLEEALNDLEARLSHSRIPEIQAELSKLEEEVSRIEARLREIEQK 820
Query: 396 AKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEA 441
L + + +Q ++++ +L+ E+ K++++ E +KE
Sbjct: 821 LNRLTLEKEYLEKEIQELQEQRIDLK-EQIKSIEKEIENLNGKKEE 865
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. It is found in a single copy and is homodimeric in prokaryotes, but six paralogs (excluded from this family) are found in eukarotes, where SMC proteins are heterodimeric. This family represents the SMC protein of archaea and a few bacteria (Aquifex, Synechocystis, etc); the SMC of other bacteria is described by TIGR02168. The N- and C-terminal domains of this protein are well conserved, but the central hinge region is skewed in composition and highly divergent [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1164 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 4e-05
Identities = 33/136 (24%), Positives = 55/136 (40%), Gaps = 19/136 (13%)
Query: 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD 597
+ R+ CK N + I ++ + L ++H H I HGD+KP NI++D
Sbjct: 110 VENTKEIFKRIKCK-NKKLIK-----NIMKDMLTTLEYIHE---HGISHGDIKPENIMVD 160
Query: 598 ANFVSKLSDFGISRFLSQN----EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSD 653
N + D+GI+ + E S L +GT Y + +T + D
Sbjct: 161 GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDL-----HRGTLYYAGLDAHNGACVTRRGD 215
Query: 654 VYSFGIILLRLLTGRP 669
+ S G +L+ G
Sbjct: 216 LESLGYCMLK-WAGIK 230
|
Length = 294 |
| >gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 5e-05
Identities = 34/154 (22%), Positives = 70/154 (45%), Gaps = 12/154 (7%)
Query: 296 DQLAQAMAE-----AENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEF 350
++L + E AE EA E L E + + L + E
Sbjct: 344 EKLEELKEELESLEAELEELEAELEELESRLEELEE-QLETLRSKVAQLELQIASLNNEI 402
Query: 351 EEALANGKLE-LERMKKQHDEVMEELQIALD--QKSLLESQIAESDQTAKELEQKIISAV 407
E A +LE LE +++ + +EEL L+ + L++++ E ++ +EL++++
Sbjct: 403 ERLEA--RLERLEDRRERLQQEIEELLKKLEEAELKELQAELEELEEELEELQEELERLE 460
Query: 408 ELLQNYKKEQDELQMERDKAVKEAEELRKSRKEA 441
E L+ ++E +E + D A +E +L+ +R ++
Sbjct: 461 EALEELREELEEAEQALDAAERELAQLQ-ARLDS 493
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179 |
| >gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 5e-05
Identities = 30/134 (22%), Positives = 57/134 (42%), Gaps = 9/134 (6%)
Query: 309 RREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGKLELERMKKQH 368
R E E L + E E +E +E EE L +LE+ ++++
Sbjct: 233 RLEELREELEELQEELKEAEEELEELTAEL---------QELEEKLEELRLEVSELEEEI 283
Query: 369 DEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAV 428
+E+ +EL ++ S LE Q + LE+++ L+ + + DEL E +
Sbjct: 284 EELQKELYALANEISRLEQQKQILRERLANLERQLEELEAQLEELESKLDELAEELAELE 343
Query: 429 KEAEELRKSRKEAS 442
++ EEL++ +
Sbjct: 344 EKLEELKEELESLE 357
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 6e-05
Identities = 43/186 (23%), Positives = 73/186 (39%), Gaps = 49/186 (26%)
Query: 296 DQLAQAMAEAENSRREAFEEAL-------RRGKAEK--------------------DAIE 328
+++ A E RR+ EEA R+ +AE+ +E
Sbjct: 147 EEIINAKPEE---RRKLIEEAAGVSKYKERKEEAERKLERTEENLERLEDLLEELEKQLE 203
Query: 329 SIRRAKASESLYAEELKRRKEFEEALANGKL------------ELERMKKQHDEVMEELQ 376
+ R Y E +E E AL KL EL R++++ +E+ EEL+
Sbjct: 204 KLERQAEKAERYQELKAELRELELALLLAKLKELRKELEELEEELSRLEEELEELQEELE 263
Query: 377 IALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRK 436
A + L+S++ +EL +++ E L K+E +EL+ E + EEL
Sbjct: 264 EAEKEIEELKSEL-------EELREELEELQEELLELKEEIEELEGEISLLRERLEELEN 316
Query: 437 SRKEAS 442
+E
Sbjct: 317 ELEELE 322
|
Length = 1163 |
| >gnl|CDD|223496 COG0419, SbcC, ATPase involved in DNA repair [DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 6e-05
Identities = 31/145 (21%), Positives = 64/145 (44%), Gaps = 11/145 (7%)
Query: 296 DQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALA 355
+ L + +AE E + E R + E +E+++ + L+ +E
Sbjct: 235 EALEERLAELEEEKERLEELKARLLEIESLELEALKIREEELRELERLLEELEE------ 288
Query: 356 NGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKK 415
++ER+++ E+ E + ++LLE ++ K LE+++ E L+ +
Sbjct: 289 ----KIERLEELEREIEELEEELEGLRALLEELEELLEKL-KSLEERLEKLEEKLEKLES 343
Query: 416 EQDELQMERDKAVKEAEELRKSRKE 440
E +EL E+++ K EE K +E
Sbjct: 344 ELEELAEEKNELAKLLEERLKELEE 368
|
Length = 908 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 6e-05
Identities = 58/209 (27%), Positives = 92/209 (44%), Gaps = 26/209 (12%)
Query: 472 IGEGGYGSIYKGLLRHM-QV-AIKMLHPHSLQGPSE---FQQEIDILSKIRHPNLVTLVG 526
IG G +G + +++ QV A+K+L+ + +E F++E D+L + L
Sbjct: 9 IGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHY 68
Query: 527 ACP--EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 584
A LV +Y G L LS ++ P R +A +++ + S
Sbjct: 69 AFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPED-MARFYLA----EMVLAIDSVHQLGY 123
Query: 585 VHGDLKPANILLDANFVSKLSDFGIS-RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 643
VH D+KP N+LLD N +L+DFG R L+ + SN GT Y+ PE L
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAV--------GTPDYISPEIL 175
Query: 644 -----ASGELTPKSDVYSFGIILLRLLTG 667
G P+ D +S G+ + +L G
Sbjct: 176 QAMEDGKGRYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|224755 COG1842, PspA, Phage shock protein A (IM30), suppresses sigma54-dependent transcription [Transcription / Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 6e-05
Identities = 38/155 (24%), Positives = 74/155 (47%), Gaps = 24/155 (15%)
Query: 296 DQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALA 355
+LA+A R+A +A+ R K + +E + AE+L+ + E AL
Sbjct: 38 SELAKA--------RQALAQAIARQKQLERKLEEAQA-------RAEKLEEKA--ELALQ 80
Query: 356 NGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKK 415
G +L R E +EE Q D LE+++ ++++ ++L++++ + + + +
Sbjct: 81 AGNEDLAR------EALEEKQSLEDLAKALEAELQQAEEQVEKLKKQLAALEQKIAELRA 134
Query: 416 EQDELQMERDKAVKEAEELRKSRKEASSSSHMPQF 450
+++ L R A K E++ +S SSSS M F
Sbjct: 135 KKEAL-KARKAAAKAQEKVNRSLGGGSSSSAMAAF 168
|
Length = 225 |
| >gnl|CDD|217843 pfam04012, PspA_IM30, PspA/IM30 family | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 7e-05
Identities = 37/155 (23%), Positives = 58/155 (37%), Gaps = 31/155 (20%)
Query: 296 DQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALA 355
LAQ +A + R+ E+ + K E A ++ K +E L E L E+
Sbjct: 44 QALAQVIARQKQLERKLEEQKEQAKKLENKARAALT--KGNEELAREALAEIATLEKQAE 101
Query: 356 NGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKK 415
+ + + + A++Q L Q+A LE KI Q K
Sbjct: 102 -----------ALETQLTQQRSAVEQ---LRKQLA-------ALETKI-------QQLKA 133
Query: 416 EQDELQMERDKAVKEAEELRKSRKEASSSSHMPQF 450
++ L+ R KA K E + S AS+ S F
Sbjct: 134 KKTALKA-RLKAAKAQEAVNTSLGSASTESATDSF 167
|
This family includes PspA a protein that suppresses sigma54-dependent transcription. The PspA protein, a negative regulator of the Escherichia coli phage shock psp operon, is produced when virulence factors are exported through secretins in many Gram-negative pathogenic bacteria and its homologue in plants, VIPP1, plays a critical role in thylakoid biogenesis, essential for photosynthesis. Activation of transcription by the enhancer-dependent bacterial sigma(54) containing RNA polymerase occurs through ATP hydrolysis-driven protein conformational changes enabled by activator proteins that belong to the large AAA(+) mechanochemical protein family. It has been shown that PspA directly and specifically acts upon and binds to the AAA(+) domain of the PspF transcription activator. Length = 220 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 7e-05
Identities = 50/206 (24%), Positives = 87/206 (42%), Gaps = 21/206 (10%)
Query: 472 IGEGGYGSIYKGLLRHM--QVAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTLVG 526
+G+GG+G + +R A K L+ L+ ++ E IL+K+ +V+L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 527 ACPEVWT---LVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 582
A + T LV + G L + + + +P ++ S L LH
Sbjct: 61 AF-QTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---R 116
Query: 583 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 642
I++ DLKP N+LLD + ++SD G++ L + + GT +M PE
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA--------GTPGFMAPEL 168
Query: 643 LASGELTPKSDVYSFGIILLRLLTGR 668
L E D ++ G+ L ++ R
Sbjct: 169 LQGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 8e-05
Identities = 31/149 (20%), Positives = 67/149 (44%), Gaps = 4/149 (2%)
Query: 297 QLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALAN 356
+++ E E E R + ++ + E+L E + E EEA
Sbjct: 303 EISLLRERLEELENELEELEERLEELKEKIEALKEELEERETLLEELEQLLAELEEAKEE 362
Query: 357 GKLELERMKKQHDEVMEELQIALD----QKSLLESQIAESDQTAKELEQKIISAVELLQN 412
+ +L + ++ +E+ E L+ L + + + +++ E + + LE+++ E L++
Sbjct: 363 LEEKLSALLEELEELFEALREELAELEAELAEIRNELEELKREIESLEERLERLSERLED 422
Query: 413 YKKEQDELQMERDKAVKEAEELRKSRKEA 441
K+E EL+ E ++ E EEL + +E
Sbjct: 423 LKEELKELEAELEELQTELEELNEELEEL 451
|
Length = 1163 |
| >gnl|CDD|237177 PRK12704, PRK12704, phosphodiesterase; Provisional | Back alignment and domain information |
|---|
Score = 45.5 bits (109), Expect = 9e-05
Identities = 27/117 (23%), Positives = 60/117 (51%), Gaps = 7/117 (5%)
Query: 321 KAEKDAIESIRRAKASESLYAEELKRRKEFE--EALANGKLELERMKKQHDEVMEELQIA 378
+AE++A + AK AE +K+ E E + + E E+ ++ +++L+
Sbjct: 35 EAEEEAKRILEEAKKE----AEAIKKEALLEAKEEIHKLRNEFEKELRERRNELQKLEKR 90
Query: 379 LDQK-SLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEEL 434
L QK L+ ++ ++ +ELE+K + Q +K+++EL+ ++ ++E E +
Sbjct: 91 LLQKEENLDRKLELLEKREEELEKKEKELEQKQQELEKKEEELEELIEEQLQELERI 147
|
Length = 520 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 9e-05
Identities = 30/92 (32%), Positives = 46/92 (50%), Gaps = 9/92 (9%)
Query: 575 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 634
FL S K +H DL NILL N V K+ DFG++R + ++ D +
Sbjct: 188 FLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK------GDARLP 238
Query: 635 FAYMDPEFLASGELTPKSDVYSFGIILLRLLT 666
+M PE + T +SDV+SFG++L + +
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 9e-05
Identities = 46/173 (26%), Positives = 72/173 (41%), Gaps = 32/173 (18%)
Query: 509 EIDILSKIRHPNLVTLVGA-------C---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLS 558
E IL I HP+++ L G C P T +Y YL + + ++ D
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYL---AAKRNIAICD------ 183
Query: 559 WQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 618
+ I + + +LH + I+H D+K NI ++ L DFG + F +I
Sbjct: 184 ---ILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACF--PVDI 235
Query: 619 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPAL 671
++N GT A PE LA P D++S GI+L + T +L
Sbjct: 236 NANKYY-----GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 1e-04
Identities = 33/143 (23%), Positives = 60/143 (41%), Gaps = 2/143 (1%)
Query: 304 EAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGKLELER 363
E E +E L+ + E + + + E E E EE + + EL
Sbjct: 235 EELREELEELQEELKEAEEELEELT--AELQELEEKLEELRLEVSELEEEIEELQKELYA 292
Query: 364 MKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQME 423
+ + + ++ QI ++ + LE Q+ E + +ELE K+ E L +++ +EL+ E
Sbjct: 293 LANEISRLEQQKQILRERLANLERQLEELEAQLEELESKLDELAEELAELEEKLEELKEE 352
Query: 424 RDKAVKEAEELRKSRKEASSSSH 446
+ E EEL +E S
Sbjct: 353 LESLEAELEELEAELEELESRLE 375
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 45.9 bits (108), Expect = 1e-04
Identities = 46/172 (26%), Positives = 79/172 (45%), Gaps = 17/172 (9%)
Query: 286 LDGSVDDNLYDQLAQAMA-EAENSRREAFEEALR----RGKAEKDAIESIRRA----KAS 336
L S D +D A EA EEA + + + + A E+ ++A KA
Sbjct: 1072 LKPSYKDFDFDAKEDNRADEATEEAFGKAEEAKKTETGKAEEARKAEEAKKKAEDARKAE 1131
Query: 337 ESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTA 396
E+ AE+ ++ +E +A ++E+ R K + EE + A D K ++ AE + A
Sbjct: 1132 EARKAEDARKAEEARKAEDAKRVEIAR-KAEDARKAEEARKAEDAKKAEAARKAEEVRKA 1190
Query: 397 KEL----EQKIISAVELLQNYKKEQDELQMERDK---AVKEAEELRKSRKEA 441
+EL + + A + +K ++ + E K AVK+AEE +K +EA
Sbjct: 1191 EELRKAEDARKAEAARKAEEERKAEEARKAEDAKKAEAVKKAEEAKKDAEEA 1242
|
Length = 2084 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 45.5 bits (107), Expect = 1e-04
Identities = 36/148 (24%), Positives = 72/148 (48%), Gaps = 7/148 (4%)
Query: 300 QAMAEAENSRR-EAFEEALRRGKAEK-DAIESIRRA-----KASESLYAEELKRRKEFEE 352
QA +AE +R+ + ++A + KA++ E ++A KA E+ A+E K++ E +
Sbjct: 1269 QAAIKAEEARKADELKKAEEKKKADEAKKAEEKKKADEAKKKAEEAKKADEAKKKAEEAK 1328
Query: 353 ALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQN 412
A+ + K+ E + A ++ + AE+ + KE +K A +
Sbjct: 1329 KKADAAKKKAEEAKKAAEAAKAEAEAAADEAEAAEEKAEAAEKKKEEAKKKADAAKKKAE 1388
Query: 413 YKKEQDELQMERDKAVKEAEELRKSRKE 440
KK+ DE + + ++ K+A+EL+K+
Sbjct: 1389 EKKKADEAKKKAEEDKKKADELKKAAAA 1416
|
Length = 2084 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 1e-04
Identities = 43/154 (27%), Positives = 78/154 (50%), Gaps = 5/154 (3%)
Query: 291 DDNLYDQLAQAMAEAENSRRE---AFEEALRRGKAEKDAIESIRRAKASESLYAEELKRR 347
D N+ + A+ +AE +R E E ++ KAE+ + KA E AEE K++
Sbjct: 1575 DKNMALRKAEEAKKAEEARIEEVMKLYEEEKKMKAEEAKKAEEAKIKAEELKKAEEEKKK 1634
Query: 348 KE-FEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISA 406
E ++ A K + E +KK +E + +K+ + + AE + A+E E+K A
Sbjct: 1635 VEQLKKKEAEEKKKAEELKKAEEENKIKAA-EEAKKAEEDKKKAEEAKKAEEDEKKAAEA 1693
Query: 407 VELLQNYKKEQDELQMERDKAVKEAEELRKSRKE 440
++ K+ +EL+ + + K+AEEL+K+ +E
Sbjct: 1694 LKKEAEEAKKAEELKKKEAEEKKKAEELKKAEEE 1727
|
Length = 2084 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 49/165 (29%), Positives = 75/165 (45%), Gaps = 21/165 (12%)
Query: 509 EIDILSKIRHPNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI- 565
E +L RHP L L + + V EY G L LS ++ + + R R
Sbjct: 45 ENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLS-RER---VFSEDRARFY 100
Query: 566 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT-- 623
E+ S L +LHS K ++V+ DLK N++LD + K++DFG L + I T
Sbjct: 101 GAEIVSALDYLHSEK--NVVYRDLKLENLMLDKDGHIKITDFG----LCKEGIKDGATMK 154
Query: 624 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR 668
T C GT Y+ PE L + D + G+++ ++ GR
Sbjct: 155 TFC------GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 41/164 (25%), Positives = 68/164 (41%), Gaps = 33/164 (20%)
Query: 512 ILSKIRHPNLV----TLVG---AC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQT 561
+L + HP+++ TLV C P + +Y YL S PL
Sbjct: 110 LLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTK-----------RSRPLPIDQ 158
Query: 562 RIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 621
+ I ++ L +LH+ I+H D+K NI ++ + D G ++F ++
Sbjct: 159 ALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQF---PVVAPA 212
Query: 622 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLL 665
L GT PE LA + K+D++S GI+L +L
Sbjct: 213 FLGLA------GTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 40/142 (28%), Positives = 67/142 (47%), Gaps = 16/142 (11%)
Query: 536 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANIL 595
Y+ + +++ LS D S L+ + ++ + FL S + VH DL N+L
Sbjct: 214 YKGSNDSEVKNLLS-DDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVL 269
Query: 596 LDANFVSKLSDFGISRFL--SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSD 653
L + K+ DFG++R + N +S +T L + +M PE + T SD
Sbjct: 270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVK--------WMAPESIFDNLYTTLSD 321
Query: 654 VYSFGIILLRL--LTGRPALGI 673
V+S+GI+L + L G P G+
Sbjct: 322 VWSYGILLWEIFSLGGTPYPGM 343
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 2e-04
Identities = 30/138 (21%), Positives = 61/138 (44%), Gaps = 10/138 (7%)
Query: 309 RREAFEEALRRGKAE--KDAIESIRRAKAS-ESLYAEELKRRKEFEEALANGKLELERMK 365
E AL K + + +E + + E E + +E E+ + K ELE ++
Sbjct: 221 ELRELELALLLAKLKELRKELEELEEELSRLEEELEELQEELEEAEKEIEELKSELEELR 280
Query: 366 KQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERD 425
++ +E+ EEL ++ LE +I+ + +ELE + L+ ++ +EL+ + +
Sbjct: 281 EELEELQEELLELKEEIEELEGEISLLRERLEELENE-------LEELEERLEELKEKIE 333
Query: 426 KAVKEAEELRKSRKEASS 443
+E EE +E
Sbjct: 334 ALKEELEERETLLEELEQ 351
|
Length = 1163 |
| >gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 2e-04
Identities = 33/165 (20%), Positives = 69/165 (41%), Gaps = 14/165 (8%)
Query: 293 NLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEE 352
L +++AQ E E E R +AE++ E+ + E+ + + K E
Sbjct: 744 QLEERIAQLSKELTELEAEIEELEERLEEAEEELAEAEAEIEELEAQIEQLKEELKALRE 803
Query: 353 ALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQN 412
AL + EL + ++ + E L+ + + E ++ + ++ +EL + I S ++
Sbjct: 804 ALDELRAELTLLNEEAANLRERLESLERRIAATERRLEDLEEQIEELSEDIESLAAEIEE 863
Query: 413 YKKEQDELQMERDKAVKE--------------AEELRKSRKEASS 443
++ +EL+ E + + E EEL + +E S
Sbjct: 864 LEELIEELESELEALLNERASLEEALALLRSELEELSEELRELES 908
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 2e-04
Identities = 43/152 (28%), Positives = 77/152 (50%), Gaps = 21/152 (13%)
Query: 299 AQAMAEAENSRREAFEEALRRGKAEKDAIESIRRA-----KASESLYAEELKRRKE---F 350
A+A +AE R+ EEA + A+K E++++A A E+ AEE + +E F
Sbjct: 1202 AEAARKAEEERK--AEEARKAEDAKK--AEAVKKAEEAKKDAEEAKKAEEERNNEEIRKF 1257
Query: 351 EEA-LANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVEL 409
EEA +A+ +K + +EL+ A ++K E++ AE + A E ++K
Sbjct: 1258 EEARMAHFARRQAAIKAEEARKADELKKAEEKKKADEAKKAEEKKKADEAKKK------- 1310
Query: 410 LQNYKKEQDELQMERDKAVKEAEELRKSRKEA 441
K+ DE + + ++A K+A+ +K +EA
Sbjct: 1311 -AEEAKKADEAKKKAEEAKKKADAAKKKAEEA 1341
|
Length = 2084 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 2e-04
Identities = 37/155 (23%), Positives = 74/155 (47%), Gaps = 16/155 (10%)
Query: 299 AQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGK 358
A+ + +AE +++ E+ ++ EK E +++A+ + A E ++ E ++ A
Sbjct: 1622 AEELKKAEEEKKKV-EQLKKKEAEEKKKAEELKKAEEENKIKAAEEAKKAEEDKKKAEEA 1680
Query: 359 LELERMKKQHDEVM----EELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYK 414
+ E +K+ E + EE + A + K + ++++ K E+ I A E K
Sbjct: 1681 KKAEEDEKKAAEALKKEAEEAKKAEELKKKEAEEKKKAEELKKAEEENKIKAEEA----K 1736
Query: 415 KEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQ 449
KE +E DK K+AEE +K +E +H+ +
Sbjct: 1737 KEAEE-----DK--KKAEEAKKDEEEKKKIAHLKK 1764
|
Length = 2084 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 2e-04
Identities = 44/163 (26%), Positives = 63/163 (38%), Gaps = 33/163 (20%)
Query: 534 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPAN 593
L+ E+LP G + L KD +T+ IA + ++ S +H D+KP N
Sbjct: 78 LIMEFLPGGDMMTLLMKKDTLT--EEETQFYIAETVLAI----DSIHQLGFIHRDIKPDN 131
Query: 594 ILLDANFVSKLSDFGI---------------------SRFLSQNEISSNNTTLCCRTDPK 632
+LLD+ KLSDFG+ S F QN S R +
Sbjct: 132 LLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQ 191
Query: 633 ------GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 669
GT Y+ PE D +S G+I+ +L G P
Sbjct: 192 LAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|206039 pfam13868, Trichoplein, Tumour suppressor, Mitostatin | Back alignment and domain information |
|---|
Score = 44.1 bits (105), Expect = 2e-04
Identities = 38/161 (23%), Positives = 78/161 (48%), Gaps = 20/161 (12%)
Query: 294 LYDQLAQAMAEAENSRREAFEEALRRGKAEKDAI-ESIRRAKASESLYAEELKRRK---- 348
L + + E E R+E +EE L+ E++ + E I R + + A+E + ++
Sbjct: 72 GRAVLQEQIEEREKRRQEEYEERLQ----EREQMDEIIERIQEEDEAEAQEKREKQKKLR 127
Query: 349 -EFEEALANGKLELERMKKQHDEVMEELQIA------LDQKSLLESQIAESDQTAKELEQ 401
E +E ++E + +K+ + EEL+I +++ E++ E + KE E
Sbjct: 128 EEIDEFNEE-RIERKEEEKERER-EEELKILEYQREKAEREEEREAERRERKE-EKEREV 184
Query: 402 KIISA-VELLQNYKKEQDELQMERDKAVKEAEELRKSRKEA 441
+ A E ++ ++E DEL+ + + E +E +K ++EA
Sbjct: 185 ARLRAQQEEAEDEREELDELRADLYQEEYERKERQKEKEEA 225
|
Trichoplein or mitostatin, was first defined as a meiosis-specific nuclear structural protein. It has since been linked with mitochondrial movement. It is associated with the mitochondrial outer membrane, and over-expression leads to reduction in mitochondrial motility whereas lack of it enhances mitochondrial movement. The activity appears to be mediated through binding the mitochondria to the actin intermediate filaments (IFs). Length = 349 |
| >gnl|CDD|220369 pfam09731, Mitofilin, Mitochondrial inner membrane protein | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 2e-04
Identities = 45/192 (23%), Positives = 82/192 (42%), Gaps = 28/192 (14%)
Query: 273 PSKEDLQSSPPSVLDGSVDDNLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRR 332
P ++L S ++D +DNL D L +A A+ + ++ E++ +E +
Sbjct: 136 PVVQELVSIFNDLIDSIKEDNLKDDLESLIASAKEELDQLSKKLAELKAEEEEELERALK 195
Query: 333 AKASESL--YAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIA 390
K E L EEL R E +EA ++++ + + EEL+ ++K L ++
Sbjct: 196 EKREELLSKLEEELLARLESKEAA-----LEKQLRLEFEREKEELRKKYEEK--LRQELE 248
Query: 391 E-----SDQTAKELEQKIISAVELLQNYKKEQDE-LQMERD----------KAVKEAEEL 434
+ EL + A+EL + + KE E ++ ER+ +K E+
Sbjct: 249 RQAEAHEQKLKNELALQ---AIELQREFNKEIKEKVEEERNGRLAKLAELNSRLKGLEKA 305
Query: 435 RKSRKEASSSSH 446
SR EA +H
Sbjct: 306 LDSRSEAEDENH 317
|
Mitofilin controls mitochondrial cristae morphology. Mitofilin is enriched in the narrow space between the inner boundary and the outer membranes, where it forms a homotypic interaction and assembles into a large multimeric protein complex. The first 78 amino acids contain a typical amino-terminal-cleavable mitochondrial presequence rich in positive-charged and hydroxylated residues and a membrane anchor domain. In addition, it has three centrally located coiled coil domains. Length = 493 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 31/118 (26%), Positives = 58/118 (49%), Gaps = 11/118 (9%)
Query: 546 DRLSCKDNSP--PLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSK 603
D +D PL +R ++++ + FL S + +H D+ N+LL V+K
Sbjct: 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAK 252
Query: 604 LSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIIL 661
+ DFG++R + N++ + + + +M PE + T +SDV+S+GI+L
Sbjct: 253 ICDFGLARDI------MNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILL 304
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (104), Expect = 2e-04
Identities = 52/211 (24%), Positives = 87/211 (41%), Gaps = 39/211 (18%)
Query: 468 PSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HP 519
LK+ +G +G + +L+H +Q IK + +++ E + ++ +P
Sbjct: 20 KKLKLIDGKFGKVS--VLKHKPTQKLFVQKIIKAKNFNAI--------EPMVHQLMKDNP 69
Query: 520 NLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 577
N + L + + L+ +Y+ +G L D L LS +I +L L LH
Sbjct: 70 NFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLK---KEGKLSEAEVKKIIRQLVEALNDLH 126
Query: 578 SCKPHSIVHGDLKPANILLD-ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 636
H+I+H D+K N+L D A L D+G L + T C GT
Sbjct: 127 K---HNIIHNDIKLENVLYDRAKDRIYLCDYG----LCKII----GTPSCYD----GTLD 171
Query: 637 YMDPEFLASGELTPKSDVYSFGIILLRLLTG 667
Y PE + D ++ G++ LLTG
Sbjct: 172 YFSPEKIKGHNYDVSFDWWAVGVLTYELLTG 202
|
Length = 267 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 33/117 (28%), Positives = 56/117 (47%), Gaps = 12/117 (10%)
Query: 550 CKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI 609
K L+ + I + ++ + FL S K +H DL NILL N V K+ DFG+
Sbjct: 172 YKK---VLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGL 225
Query: 610 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 666
+R + + + + D + +M PE + T +SDV+SFG++L + +
Sbjct: 226 ARDIYK------DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 33/113 (29%), Positives = 55/113 (48%), Gaps = 13/113 (11%)
Query: 556 PLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR--FL 613
PL+ + I + ++ + FL S K +H DL NILL N V K+ DFG++R +
Sbjct: 170 PLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYK 226
Query: 614 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 666
+ + + L +M PE + T +SDV+SFG++L + +
Sbjct: 227 DPDYVRKGSARL--------PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 55/221 (24%), Positives = 102/221 (46%), Gaps = 48/221 (21%)
Query: 470 LKIGEGGYGSIYKGLLRHM--QVAIKMLHP--HSLQGPSEFQQEIDILSKIRHPNLVTLV 525
++G G YG++ L R +VAIK L+ S +E+ +L ++H N++ L+
Sbjct: 21 KQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLL 80
Query: 526 GACPEVWT------------LVYEYLPN--GSL--EDRLSCKDNSPPLSWQTRIR-IATE 568
+V+T LV ++ G L ++LS + RI+ + +
Sbjct: 81 ----DVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLS----------EDRIQFLVYQ 126
Query: 569 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCR 628
+ L ++H+ I+H DLKP N+ ++ + K+ DFG++R + +E++ T R
Sbjct: 127 MLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR-QTDSEMTGYVVTRWYR 182
Query: 629 TDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 669
P+ +M T D++S G I+ +LTG+P
Sbjct: 183 A-PEVILNWM--------HYTQTVDIWSVGCIMAEMLTGKP 214
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|221432 pfam12128, DUF3584, Protein of unknown function (DUF3584) | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 2e-04
Identities = 39/184 (21%), Positives = 76/184 (41%), Gaps = 43/184 (23%)
Query: 277 DLQSSPPSVLDGSVDDNLYD-QLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKA 335
DL P +++GS D LY L + + A E LR R +A
Sbjct: 569 DLD---PQLVEGSDSDTLYGVSLDLQRLDVPDY--AANETELRE-----------RLQQA 612
Query: 336 SESLYAEELKRRKEFEEALA---------------------NGKLELERMKKQHDEVMEE 374
E+L + ++K+ EE L +L+L+R++ + + ++
Sbjct: 613 EEALQSAV-AKQKQAEEQLVQANAELEEQKRAEAEARTALKQARLDLQRLQNEQQSLKDK 671
Query: 375 LQIAL-DQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEE 433
L++A+ ++K E+Q+ + D K+L ++ + L+ K + EL+ ER + E
Sbjct: 672 LELAIAERKQQAETQLRQLDAQLKQLLEQQQAF---LEALKDDFRELRTERLAKWQVVEG 728
Query: 434 LRKS 437
+
Sbjct: 729 ELDN 732
|
This protein is found in bacteria and eukaryotes. Proteins in this family are typically between 943 to 1234 amino acids in length. This family contains a P-loop motif suggesting it is a nucleotide binding protein. It may be involved in replication. Length = 1198 |
| >gnl|CDD|217051 pfam02463, SMC_N, RecF/RecN/SMC N terminal domain | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 37/140 (26%), Positives = 69/140 (49%), Gaps = 1/140 (0%)
Query: 304 EAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGKLELER 363
N R + L R + E+ K E L A+ LK KE E+ + EL+
Sbjct: 233 LKLNEERIDLLQELLRDEQEEIESSKQELEKEEEIL-AQVLKENKEEEKEKKLQEEELKL 291
Query: 364 MKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQME 423
+ K+ +E+ EL +K E ++ ES++ K+LE+++ E ++ +KE EL+++
Sbjct: 292 LAKEEEELKSELLKLERRKVDDEEKLKESEKELKKLEKELKKEKEEIEELEKELKELEIK 351
Query: 424 RDKAVKEAEELRKSRKEASS 443
R+ +E E+L K +++
Sbjct: 352 REAEEEEEEQLEKLQEKLEQ 371
|
This domain is found at the N terminus of SMC proteins. The SMC (structural maintenance of chromosomes) superfamily proteins have ATP-binding domains at the N- and C-termini, and two extended coiled-coil domains separated by a hinge in the middle. The eukaryotic SMC proteins form two kind of heterodimers: the SMC1/SMC3 and the SMC2/SMC4 types. These heterodimers constitute an essential part of higher order complexes, which are involved in chromatin and DNA dynamics. This family also includes the RecF and RecN proteins that are involved in DNA metabolism and recombination. Length = 1162 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 3e-04
Identities = 24/130 (18%), Positives = 58/130 (44%), Gaps = 8/130 (6%)
Query: 318 RRGKAEKDAIESIRRAKASESLYAEELKRR-KEFEEALANGKLELERMKKQHDEVMEELQ 376
R K ++ + + + LK + E+ L + +LE +++Q +E+ EL
Sbjct: 667 RELKELEEELAELEAQLEKLEEELKSLKNELRSLEDLLEELRRQLEELERQLEELKRELA 726
Query: 377 IALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRK 436
++ L+S++ +ELE+++ E L+ ++ +EL+ E + + +L++
Sbjct: 727 ALEEELEQLQSRL-------EELEEELEELEEELEELQERLEELEEELESLEEALAKLKE 779
Query: 437 SRKEASSSSH 446
+E
Sbjct: 780 EIEELEEKRQ 789
|
Length = 1163 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 3e-04
Identities = 56/227 (24%), Positives = 95/227 (41%), Gaps = 41/227 (18%)
Query: 458 EIEGATHNFDPSLKIGEGGYGSIYKGL--LRHMQVAIKMLHP--HSLQGPSEFQQEIDIL 513
E+ N P +G G YGS+ ++VA+K L S+ +E+ +L
Sbjct: 14 EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 70
Query: 514 SKIRHPNLVTLVGACPEVWTL-----VY--EYLPNGSLEDRLSCK----DNSPPLSWQTR 562
++H N++ L+ +L VY +L L + + C+ D+ L +Q
Sbjct: 71 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ-- 128
Query: 563 IRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 622
+ L ++HS I+H DLKP+N+ ++ + K+ DFG++R
Sbjct: 129 ------ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE------ 173
Query: 623 TTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGR 668
T T Y PE + + D++S G I+ LLTGR
Sbjct: 174 -----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 3e-04
Identities = 42/167 (25%), Positives = 69/167 (41%), Gaps = 23/167 (13%)
Query: 504 SEFQQEIDILSKIRHPNLVTLVGAC---PEVWTLVYEYLPNGSLEDRLS--CKDNSPPLS 558
QQEI +++HPN++ V + E++ +V + GS ED L + P
Sbjct: 44 KLLQQEIITSRQLQHPNILPYVTSFIVDSELY-VVSPLMAYGSCEDLLKTHFPEGLP--- 99
Query: 559 WQTRIR-IATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 617
+ I I ++ + L ++HS +H +K ++ILL + LS S +
Sbjct: 100 -ELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSM---- 151
Query: 618 ISSNNTTLCCRTDPKGT---FAYMDPEFLASGEL--TPKSDVYSFGI 659
I PK + ++ PE L KSD+YS GI
Sbjct: 152 IKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGI 198
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 4e-04
Identities = 37/166 (22%), Positives = 69/166 (41%), Gaps = 32/166 (19%)
Query: 309 RREAFEEA-------LRRGKAEK-------------DAIESIRRAKASESLYAEELKRRK 348
RR FEEA RR + E+ D + + R S AE+ +R K
Sbjct: 157 RRAIFEEAAGISKYKERRKETERKLERTRENLDRLEDILNELERQLKSLERQAEKAERYK 216
Query: 349 EFEEALANGKL-----ELERMKKQHDEVMEELQIALDQKSLLESQIAESD---QTAK--- 397
E + L +L LE ++++ +E+ EEL+ A ++ L +++ E + + +
Sbjct: 217 ELKAELRELELALLVLRLEELREELEELQEELKEAEEELEELTAELQELEEKLEELRLEV 276
Query: 398 -ELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEAS 442
ELE++I + L E L+ ++ + L + +E
Sbjct: 277 SELEEEIEELQKELYALANEISRLEQQKQILRERLANLERQLEELE 322
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179 |
| >gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 4e-04
Identities = 25/97 (25%), Positives = 47/97 (48%)
Query: 345 KRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKII 404
++ +E EE +A + L ++K+ +E+ EEL+ + L QI+ + LE ++
Sbjct: 684 EKIEELEEKIAELEKALAELRKELEELEEELEQLRKELEELSRQISALRKDLARLEAEVE 743
Query: 405 SAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEA 441
E + KE EL+ E ++ + EE + EA
Sbjct: 744 QLEERIAQLSKELTELEAEIEELEERLEEAEEELAEA 780
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 4e-04
Identities = 24/82 (29%), Positives = 45/82 (54%), Gaps = 6/82 (7%)
Query: 585 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 644
+H DL NILL ++K+ DFG++R + N++ + + + +M PE +
Sbjct: 236 IHRDLAARNILLTHGRITKICDFGLARDI------RNDSNYVVKGNARLPVKWMAPESIF 289
Query: 645 SGELTPKSDVYSFGIILLRLLT 666
+ T +SDV+S+GI+L + +
Sbjct: 290 NCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|223496 COG0419, SbcC, ATPase involved in DNA repair [DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 5e-04
Identities = 33/153 (21%), Positives = 68/153 (44%), Gaps = 7/153 (4%)
Query: 295 YDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEAL 354
+++ + + E E E E L + E +E S+ L EL E + +
Sbjct: 405 LEEIQEELEELEKELEEL-ERELEELEEEIKKLEEQINQLESKELMIAELAGAGE-KCPV 462
Query: 355 ANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISA----VELL 410
+L E K+ + EL+ L+++ E + AE + +ELE+++ +ELL
Sbjct: 463 CGQELPEEHEKELLELYELELE-ELEEELSREKEEAELREEIEELEKELRELEEELIELL 521
Query: 411 QNYKKEQDELQMERDKAVKEAEELRKSRKEASS 443
+ + ++EL+ + +K EEL + +++
Sbjct: 522 ELEEALKEELEEKLEKLENLLEELEELKEKLQL 554
|
Length = 908 |
| >gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 5e-04
Identities = 28/145 (19%), Positives = 57/145 (39%)
Query: 297 QLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALAN 356
Q N R+ E + + E E E E + + E L
Sbjct: 303 QKQILRERLANLERQLEELEAQLEELESKLDELAEELAELEEKLEELKEELESLEAELEE 362
Query: 357 GKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKE 416
+ ELE ++ + +E+ E+L+ + + LE QIA + + LE ++ + + ++E
Sbjct: 363 LEAELEELESRLEELEEQLETLRSKVAQLELQIASLNNEIERLEARLERLEDRRERLQQE 422
Query: 417 QDELQMERDKAVKEAEELRKSRKEA 441
+EL + ++A + + E
Sbjct: 423 IEELLKKLEEAELKELQAELEELEE 447
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179 |
| >gnl|CDD|235175 PRK03918, PRK03918, chromosome segregation protein; Provisional | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 5e-04
Identities = 31/123 (25%), Positives = 60/123 (48%), Gaps = 3/123 (2%)
Query: 321 KAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALD 380
A K+ E I+ K + +KR + EE + + ELE + ++ +E+ EL +
Sbjct: 162 NAYKNLGEVIKEIKRRIERLEKFIKRTENIEELIKEKEKELEEVLREINEISSELPELRE 221
Query: 381 QKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQD---ELQMERDKAVKEAEELRKS 437
+ LE ++ E ++ +E+E+ L + +K ++ EL+ ++ KE EEL +
Sbjct: 222 ELEKLEKEVKELEELKEEIEELEKELESLEGSKRKLEEKIRELEERIEELKKEIEELEEK 281
Query: 438 RKE 440
KE
Sbjct: 282 VKE 284
|
Length = 880 |
| >gnl|CDD|188306 TIGR03319, RNase_Y, ribonuclease Y | Back alignment and domain information |
|---|
Score = 43.0 bits (102), Expect = 5e-04
Identities = 32/142 (22%), Positives = 66/142 (46%), Gaps = 11/142 (7%)
Query: 298 LAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANG 357
+ +A EAE ++EA EA + +E + + +E L E +R + EE L
Sbjct: 38 IEEAKKEAETLKKEALLEAKEEVHKLRAELERELKERRNE-LQRLE-RRLLQREETLDR- 94
Query: 358 KLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKE- 416
++E + K+ + + ++ + +++ L+ + E ++ E +++ L Q KE
Sbjct: 95 --KMESLDKKEENLEKKEKELSNKEKNLDEKEEELEELIAEQREELERISGLTQEEAKEI 152
Query: 417 -----QDELQMERDKAVKEAEE 433
++E + E K +KE EE
Sbjct: 153 LLEEVEEEARHEAAKLIKEIEE 174
|
Members of this family are RNase Y, an endoribonuclease. The member from Bacillus subtilis, YmdA, has been shown to be involved in turnover of yitJ riboswitch [Transcription, Degradation of RNA]. Length = 514 |
| >gnl|CDD|226889 COG4487, COG4487, Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 5e-04
Identities = 32/158 (20%), Positives = 68/158 (43%), Gaps = 16/158 (10%)
Query: 292 DNLYDQLAQAMAEAENSR---REAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRK 348
+ + L + EA R R A ++ L + + + + ++ +E + EL +
Sbjct: 38 SRILNTLEEFEKEANEKRAQYRSAKKKELSQLEEQLINQKKEQKNLFNEQIKQFELALQD 97
Query: 349 EFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQ-TAKELEQKIISAV 407
E LE + + D+ +E L+ LD+ S ++ + Q TA+ +E+K +
Sbjct: 98 E-----IAKLEALELLNLEKDKELELLEKELDELSK---ELQKQLQNTAEIIEKKRENNK 149
Query: 408 EL----LQNYKKEQDELQMERDKAVKEAEELRKSRKEA 441
+N KK ++ L++ER+K ++ E +
Sbjct: 150 NEERLKFENEKKLEESLELEREKFEEQLHEANLDLEFK 187
|
Length = 438 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 5e-04
Identities = 44/163 (26%), Positives = 64/163 (39%), Gaps = 33/163 (20%)
Query: 534 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPAN 593
L+ E+LP G + L KD + Q I ++ + + +H D+KP N
Sbjct: 78 LIMEFLPGGDMMTLLMKKDTLSEEATQFYI------AETVLAIDAIHQLGFIHRDIKPDN 131
Query: 594 ILLDANFVSKLSDFGIS------------RFLSQNEIS-----SNNTTLCCRTDPK---- 632
+LLDA KLSDFG+ R L+ N S + N+ T K
Sbjct: 132 LLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQ 191
Query: 633 ------GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 669
GT Y+ PE D +S G+I+ +L G P
Sbjct: 192 LAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 6e-04
Identities = 30/152 (19%), Positives = 63/152 (41%), Gaps = 9/152 (5%)
Query: 297 QLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALAN 356
+ Q A + E+ + + +E + + L E + E E LA
Sbjct: 284 EELQKELYALANEISRLEQQKQILRERLANLER-QLEELEAQL-EELESKLDELAEELAE 341
Query: 357 GKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVE-------L 409
+ +LE +K++ + + EL+ + LES++ E ++ + L K+
Sbjct: 342 LEEKLEELKEELESLEAELEELEAELEELESRLEELEEQLETLRSKVAQLELQIASLNNE 401
Query: 410 LQNYKKEQDELQMERDKAVKEAEELRKSRKEA 441
++ + + L+ R++ +E EEL K +EA
Sbjct: 402 IERLEARLERLEDRRERLQQEIEELLKKLEEA 433
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 6e-04
Identities = 55/215 (25%), Positives = 90/215 (41%), Gaps = 43/215 (20%)
Query: 472 IGEGGYGSIYKGLL--------------RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIR 517
+G G IY G+L + ++V +K+L P F + ++ ++
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 518 HPNLVTLVGACPEVW--TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIF 575
H ++V L G C +V E++ G L+ L S L+ + ++A +L S L +
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLD--LFMHRKSDVLTTPWKFKVAKQLASALSY 120
Query: 576 LHSCKPHSIVHGDLKPANILL-------DANFVSKLSDFGIS-RFLSQNEISSNNTTLCC 627
L +VHG++ NILL + KLSD GI LS+ E C
Sbjct: 121 LEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQE--------CV 169
Query: 628 RTDPKGTFAYMDPEFLA-SGELTPKSDVYSFGIIL 661
P ++ PE + S L+ +D +SFG L
Sbjct: 170 ERIP-----WIAPECVEDSKNLSIAADKWSFGTTL 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|109486 pfam00430, ATP-synt_B, ATP synthase B/B' CF(0) | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 6e-04
Identities = 32/112 (28%), Positives = 55/112 (49%), Gaps = 22/112 (19%)
Query: 296 DQLAQAMAEAENSRREA------FEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKE 349
+++A + EAE ++A E+ L +A +A E I AK A++LK
Sbjct: 33 EKIANNIKEAEERLKQAAALLAEAEQQLA--QARAEASEIINNAKKE----AQKLK---- 82
Query: 350 FEEALANGKLELERMKKQ-HDEVMEELQIALDQKSLLESQIAE-SDQTAKEL 399
EE LA + + ER+ + E+ +E + AL + L Q+A + Q A++L
Sbjct: 83 -EEILAEAQKDAERLLESARAEIEQEKEQALAE---LRQQVAALAVQIAEKL 130
|
Part of the CF(0) (base unit) of the ATP synthase. The base unit is thought to translocate protons through membrane (inner membrane in mitochondria, thylakoid membrane in plants, cytoplasmic membrane in bacteria). The B subunits are thought to interact with the stalk of the CF(1) subunits. This domain should not be confused with the ab CF(1) proteins (in the head of the ATP synthase) which are found in pfam00006. Length = 132 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 7e-04
Identities = 42/160 (26%), Positives = 72/160 (45%), Gaps = 20/160 (12%)
Query: 518 HPNLVTLVGACPEVWT---LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-ATELCSVL 573
HP LV L +C + + V EY+ G L + + P + R + E+ L
Sbjct: 55 HPFLVGL-HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP----EEHARFYSAEISLAL 109
Query: 574 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 633
+LH I++ DLK N+LLD+ KL+D+G+ + + + T+ C G
Sbjct: 110 NYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTSTFC-----G 158
Query: 634 TFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGI 673
T Y+ PE L + D ++ G+++ ++ GR I
Sbjct: 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 8e-04
Identities = 32/149 (21%), Positives = 65/149 (43%), Gaps = 5/149 (3%)
Query: 296 DQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRR-KEFEEAL 354
++L + + E E E E+AL + E + +E E EEL R+ + L
Sbjct: 680 EELEEKIEELEEKIAEL-EKALAELRKELEELEEELEQLRKE---LEELSRQISALRKDL 735
Query: 355 ANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYK 414
A + E+E+++++ ++ +EL + LE ++ E+++ E E +I ++ K
Sbjct: 736 ARLEAEVEQLEERIAQLSKELTELEAEIEELEERLEEAEEELAEAEAEIEELEAQIEQLK 795
Query: 415 KEQDELQMERDKAVKEAEELRKSRKEASS 443
+E L+ D+ E L +
Sbjct: 796 EELKALREALDELRAELTLLNEEAANLRE 824
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 8e-04
Identities = 35/146 (23%), Positives = 66/146 (45%), Gaps = 7/146 (4%)
Query: 299 AQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGK 358
A+ +AE +++ ++ + KAE+ R + LY EE K + E + K
Sbjct: 1560 AEEKKKAEEAKKAEEDKNMALRKAEEAKKAEEARIEEVMKLYEEEKKMKAEEAKKAEEAK 1619
Query: 359 LELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELL---QNYKK 415
++ E +KK +E + Q+ K + ++++ K E+ I A E + KK
Sbjct: 1620 IKAEELKKAEEEKKKVEQL----KKKEAEEKKKAEELKKAEEENKIKAAEEAKKAEEDKK 1675
Query: 416 EQDELQMERDKAVKEAEELRKSRKEA 441
+ +E + + K AE L+K +EA
Sbjct: 1676 KAEEAKKAEEDEKKAAEALKKEAEEA 1701
|
Length = 2084 |
| >gnl|CDD|235175 PRK03918, PRK03918, chromosome segregation protein; Provisional | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 8e-04
Identities = 29/141 (20%), Positives = 63/141 (44%), Gaps = 11/141 (7%)
Query: 309 RREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGKLELERMKKQH 368
E EE + + ++ ++ ++ K Y + + +E+ + L + L R++++
Sbjct: 264 LEERIEELKKEIEELEEKVKELKELKEKAEEYIKLSEFYEEYLDELREIEKRLSRLEEEI 323
Query: 369 DEVMEELQIALDQKSLLESQIAESDQTAKELE---------QKIISAVELLQNYKKEQDE 419
+ + E ++ +++ LE + + K LE ++ + E L+ KK
Sbjct: 324 NGIEERIKELEEKEERLEELKKKLKELEKRLEELEERHELYEEAKAKKEELERLKKRLTG 383
Query: 420 LQMERDKAVKEAEELRKSRKE 440
L E K KE EEL K+++E
Sbjct: 384 LTPE--KLEKELEELEKAKEE 402
|
Length = 880 |
| >gnl|CDD|206034 pfam13863, DUF4200, Domain of unknown function (DUF4200) | Back alignment and domain information |
|---|
Score = 39.9 bits (94), Expect = 8e-04
Identities = 25/100 (25%), Positives = 47/100 (47%), Gaps = 9/100 (9%)
Query: 345 KRRKEFEEALANGKLELERMKKQHDEVMEELQ---IALDQK-SLLESQIAESDQTAKELE 400
KRR+ E +L L+ +++ + E L+ L++K L+ + + D+ KE E
Sbjct: 5 KRREMEEV-----QLALDAKREEFERREELLKQREEELEKKEEELQESLIKFDKFLKENE 59
Query: 401 QKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKE 440
K A + + KK + E + E + E EEL+ ++
Sbjct: 60 AKRRRAEKKAEEEKKLRKEKEEEIKELKAELEELKAEIEK 99
|
This family is found in eukaryotes. It is a coiled-coil domain of unknwon function. Length = 126 |
| >gnl|CDD|222469 pfam13949, ALIX_LYPXL_bnd, ALIX V-shaped domain binding to HIV | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 8e-04
Identities = 37/185 (20%), Positives = 72/185 (38%), Gaps = 24/185 (12%)
Query: 265 TEGVSTLPPS-----KEDLQSSPPSVLDGSVDDNLYDQLAQAMAEAENSRREAFEEALRR 319
EG LPPS +E L+ S+DD +L+Q E +E
Sbjct: 1 LEGPLGLPPSLLEKAEEIRSEGGIERLERSLDD--LPELSQRN-------EEILDEIKEL 51
Query: 320 GKAEKDAIESIRRA-------KASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVM 372
E+ E +R S L AE + +++ L +++ + +E
Sbjct: 52 LDEEESEDEQLRAKYGERWTRPPSSELTAELREELRKYRGYLEQASESDAQLRSKLEEHE 111
Query: 373 EELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAE 432
E L++ + LE+ + S + ++ + L+ + +EL+ ER+K ++E +
Sbjct: 112 ENLELLSGPEEELEALLPSSSPS---KTPEVSEQISRLRELLNKLNELKAEREKLLEELK 168
Query: 433 ELRKS 437
E +
Sbjct: 169 EKAQD 173
|
The binding of the LYPxL motif of late HIV p6Gag and EIAV p9Gag to this domain is necessary for viral budding.This domain is generally central between an N-terminal Bro1 domain, pfam03097 and a C-terminal proline-rich domain. The retroviruses thus used this domain to hijack the ESCRT system of the cell. Length = 292 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 9e-04
Identities = 41/166 (24%), Positives = 83/166 (50%), Gaps = 26/166 (15%)
Query: 299 AQAMAEAENSRREAFEEALRRGKAEKDAIESIR----RAKASESLYAEELKRRKEFEEAL 354
A+ +A+ ++++A EEA + +A+K A E+ + + KA E+ A+E K++ E +
Sbjct: 1427 AEEKKKADEAKKKA-EEAKKADEAKKKAEEAKKAEEAKKKAEEAKKADEAKKKAEEAKKA 1485
Query: 355 ANGKLELERMKKQHDEV---------MEELQIALDQKSLLESQIAESDQTAKEL----EQ 401
K + E KK+ DE +E + A + K E++ AE + A E E+
Sbjct: 1486 DEAKKKAEEAKKKADEAKKAAEAKKKADEAKKAEEAKKADEAKKAEEAKKADEAKKAEEK 1545
Query: 402 KIISAVELLQNYKKEQDELQME--------RDKAVKEAEELRKSRK 439
K ++ + KK +++ + E ++ A+++AEE +K+ +
Sbjct: 1546 KKADELKKAEELKKAEEKKKAEEAKKAEEDKNMALRKAEEAKKAEE 1591
|
Length = 2084 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 9e-04
Identities = 32/120 (26%), Positives = 47/120 (39%), Gaps = 35/120 (29%)
Query: 585 VHGDLKPANILLDANFVSKLSDFGI---------SRFLSQN------------EISSNNT 623
+H D+KP NIL+D + KL+DFG+ S++ + E S +
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182
Query: 624 --------------TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 669
C GT Y+ PE L T D +S G+IL +L G+P
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQP 242
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|233758 TIGR02169, SMC_prok_A, chromosome segregation protein SMC, primarily archaeal type | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 0.001
Identities = 32/162 (19%), Positives = 67/162 (41%), Gaps = 12/162 (7%)
Query: 292 DNLYDQLAQAMAEAENSRREAFE--EALRRGKAEKDAIES-IRRAKASESLYAEELKRRK 348
+ L +L+ +E E + L + IE I + + E E L+ +
Sbjct: 684 EGLKRELSSLQSELRRIENRLDELSQELSDASRKIGEIEKEIEQLEQEEEKLKERLEELE 743
Query: 349 EFEEALANGKLELERMKKQHDEVMEELQIALDQ---------KSLLESQIAESDQTAKEL 399
E +L ++ K+ + +EEL+ L + L S+I E +L
Sbjct: 744 EDLSSLEQEIENVKSELKELEARIEELEEDLHKLEEALNDLEARLSHSRIPEIQAELSKL 803
Query: 400 EQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEA 441
E+++ L+ +++ + L +E++ KE +EL++ R +
Sbjct: 804 EEEVSRIEARLREIEQKLNRLTLEKEYLEKEIQELQEQRIDL 845
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. It is found in a single copy and is homodimeric in prokaryotes, but six paralogs (excluded from this family) are found in eukarotes, where SMC proteins are heterodimeric. This family represents the SMC protein of archaea and a few bacteria (Aquifex, Synechocystis, etc); the SMC of other bacteria is described by TIGR02168. The N- and C-terminal domains of this protein are well conserved, but the central hinge region is skewed in composition and highly divergent [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1164 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 0.001
Identities = 27/126 (21%), Positives = 61/126 (48%), Gaps = 1/126 (0%)
Query: 316 ALRRGKAEKDAIESIRRAKASESLYAEELKRRKEF-EEALANGKLELERMKKQHDEVMEE 374
++ G K + + +R EL+ + E EE L + K EL ++ +E+ +
Sbjct: 651 SITGGSRNKRSSLAQKRELKELEEELAELEAQLEKLEEELKSLKNELRSLEDLLEELRRQ 710
Query: 375 LQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEEL 434
L+ Q L+ ++A ++ ++L+ ++ E L+ ++E +ELQ ++ +E E L
Sbjct: 711 LEELERQLEELKRELAALEEELEQLQSRLEELEEELEELEEELEELQERLEELEEELESL 770
Query: 435 RKSRKE 440
++ +
Sbjct: 771 EEALAK 776
|
Length = 1163 |
| >gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 0.001
Identities = 35/151 (23%), Positives = 66/151 (43%), Gaps = 6/151 (3%)
Query: 296 DQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASE-----SLYAEELKRRKEF 350
++ + +AEAE + E E + + K E A+ +E A +R +
Sbjct: 771 EEAEEELAEAE-AEIEELEAQIEQLKEELKALREALDELRAELTLLNEEAANLRERLESL 829
Query: 351 EEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELL 410
E +A + LE +++Q +E+ E+++ + LE I E + + L + S E L
Sbjct: 830 ERRIAATERRLEDLEEQIEELSEDIESLAAEIEELEELIEELESELEALLNERASLEEAL 889
Query: 411 QNYKKEQDELQMERDKAVKEAEELRKSRKEA 441
+ E +EL E + + ELR+ +E
Sbjct: 890 ALLRSELEELSEELRELESKRSELRRELEEL 920
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 42.1 bits (98), Expect = 0.001
Identities = 37/145 (25%), Positives = 73/145 (50%), Gaps = 9/145 (6%)
Query: 299 AQAMAEAENSRR-EAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANG 357
A + +AE ++ E ++A KAE+D ++R+A+ E+ AEE + + +
Sbjct: 1548 ADELKKAEELKKAEEKKKAEEAKKAEEDKNMALRKAE--EAKKAEEARIEEVMKLYEEEK 1605
Query: 358 KLELERMKKQHDEVM--EELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKK 415
K++ E KK + + EEL+ A ++K +E + + K+ E+ + E K
Sbjct: 1606 KMKAEEAKKAEEAKIKAEELKKAEEEKKKVEQLKKKEAEEKKKAEE--LKKAEEENKIKA 1663
Query: 416 EQDELQMERDKAVKEAEELRKSRKE 440
++ + E DK K+AEE +K+ ++
Sbjct: 1664 AEEAKKAEEDK--KKAEEAKKAEED 1686
|
Length = 2084 |
| >gnl|CDD|205692 pfam13514, AAA_27, AAA domain | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 0.001
Identities = 37/156 (23%), Positives = 61/156 (39%), Gaps = 13/156 (8%)
Query: 288 GSVDDNLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRR 347
GSV D L + + R+ AL K K+ IR + + + +K
Sbjct: 129 GSVRDELEKEADELWKP--RGRKPEINVAL---KELKELEAEIREVQLKTRTWKDLVKAL 183
Query: 348 KEFEEALANGKLELERMKKQHDEVMEELQIALDQ---KSLLESQIAESDQTAKELEQKII 404
E EE LAN + EL +++K+ +E L+ L + LE Q+A E+
Sbjct: 184 DEAEEELANLRKELRQLEKEKQR-LERLRRLLPLLAERKALEQQLAA----LGEVIDLPP 238
Query: 405 SAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKE 440
AVE + + E + + + E L+ E
Sbjct: 239 DAVERYEEARAELRAARRNLELLTERLEALQAELDE 274
|
This domain is found in a number of double-strand DNA break proteins. This domain contains a P-loop motif. Length = 1118 |
| >gnl|CDD|144972 pfam01576, Myosin_tail_1, Myosin tail | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 0.001
Identities = 47/174 (27%), Positives = 70/174 (40%), Gaps = 33/174 (18%)
Query: 292 DNLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKR----- 346
+L DQL + E+A RR +AEKD +++ +A +L EE K
Sbjct: 443 HDLTDQLGEG-----GRNVHELEKARRRLEAEKDELQAALE-EAEAALELEESKVLRAQV 496
Query: 347 -----RKEFEEALANGKLELERMKKQHDEVMEELQIALDQ-----------KSLLESQIA 390
R E E LA + E E +K H +E LQ L+ K LE I
Sbjct: 497 ELSQIRSEIERRLAEKEEEFENTRKNHQRAIESLQATLEAEAKGKAEASRLKKKLEGDIN 556
Query: 391 ESDQTAKELEQKIISAVELLQNYKKEQD---ELQMERDKAVKEAEELRKSRKEA 441
E + L+ + E +N KK Q ELQ + ++ + E+ R+ A
Sbjct: 557 ELEIA---LDHANKANAEAQKNVKKYQQQVKELQTQVEEEQRAREDAREQLAVA 607
|
The myosin molecule is a multi-subunit complex made up of two heavy chains and four light chains it is a fundamental contractile protein found in all eukaryote cell types. This family consists of the coiled-coil myosin heavy chain tail region. The coiled-coil is composed of the tail from two molecules of myosin. These can then assemble into the macromolecular thick filament. The coiled-coil region provides the structural backbone the thick filament. Length = 859 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 41.7 bits (97), Expect = 0.002
Identities = 40/157 (25%), Positives = 75/157 (47%), Gaps = 18/157 (11%)
Query: 300 QAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGKL 359
A EAE + +A ++ +A+K A + + KA E A+E K++ E ++ A+
Sbjct: 1354 AAADEAEAAEEKAEAAEKKKEEAKKKADAA--KKKAEEKKKADEAKKKAEEDKKKADELK 1411
Query: 360 ELERMKKQHDEV---MEELQIALDQKSLLES--------QIAESDQTAKELEQKIISAVE 408
+ KK+ DE EE + A + K E + AE + A+E ++K A +
Sbjct: 1412 KAAAAKKKADEAKKKAEEKKKADEAKKKAEEAKKADEAKKKAEEAKKAEEAKKKAEEAKK 1471
Query: 409 LLQNYKKEQ-----DELQMERDKAVKEAEELRKSRKE 440
+ KK + DE + + ++A K+A+E +K+ +
Sbjct: 1472 ADEAKKKAEEAKKADEAKKKAEEAKKKADEAKKAAEA 1508
|
Length = 2084 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 41.3 bits (96), Expect = 0.002
Identities = 49/156 (31%), Positives = 84/156 (53%), Gaps = 17/156 (10%)
Query: 299 AQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEF---EEALA 355
A+ +A+ ++++A EEA ++ K A E+ + KA E+ AEE K+ E EEA
Sbjct: 1479 AEEAKKADEAKKKA-EEAKKKADEAKKAAEA--KKKADEAKKAEEAKKADEAKKAEEAKK 1535
Query: 356 NGKLELERMKKQHDEV--MEELQIALDQKSLLESQIAESDQT--------AKELEQKIIS 405
+ + KK+ DE+ EEL+ A ++K E++ AE D+ AK+ E+ I
Sbjct: 1536 ADEAKKAEEKKKADELKKAEELKKAEEKKKAEEAKKAEEDKNMALRKAEEAKKAEEARIE 1595
Query: 406 AV-ELLQNYKKEQDELQMERDKAVKEAEELRKSRKE 440
V +L + KK + E + ++A +AEEL+K+ +E
Sbjct: 1596 EVMKLYEEEKKMKAEEAKKAEEAKIKAEELKKAEEE 1631
|
Length = 2084 |
| >gnl|CDD|226883 COG4477, EzrA, Negative regulator of septation ring formation [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 0.002
Identities = 38/164 (23%), Positives = 75/164 (45%), Gaps = 13/164 (7%)
Query: 292 DNLYDQLAQAMAEAEN---SRREAFEEALRRGKAEKDAI-ESIRRAKASESLYAEELKRR 347
++LYD L + EA+N + L + K + + E I R K S L EL
Sbjct: 291 ESLYDLLERE-VEAKNVVEENLPILPDYLEKAKENNEHLKEEIERVKESYRLAETELGSV 349
Query: 348 KEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAV 407
++FE+ EL+ ++ DE++E ++ S L+ + E ++ ++E +
Sbjct: 350 RKFEK-------ELKELESVLDEILENIEAQEVAYSELQDNLEEIEKALTDIEDEQEKVQ 402
Query: 408 ELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFF 451
E L + +K++ E + ++ + E+ K E S+ +P+ F
Sbjct: 403 EHLTSLRKDELEARENLERLKSKLHEI-KRYMEKSNLPGLPETF 445
|
Length = 570 |
| >gnl|CDD|237621 PRK14139, PRK14139, heat shock protein GrpE; Provisional | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.002
Identities = 31/94 (32%), Positives = 49/94 (52%), Gaps = 14/94 (14%)
Query: 294 LYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKE-FEE 352
L D +A AE EN RR A E+ KA K AIES +AE L K+ E
Sbjct: 51 LQDSFLRAKAETENVRRRAQEDV---AKAHKFAIES----------FAESLLPVKDSLEA 97
Query: 353 ALANGKLELERMKKQHDEVMEELQIALDQKSLLE 386
ALA+ +LE++++ + +++L A ++ ++E
Sbjct: 98 ALADESGDLEKLREGVELTLKQLTSAFEKGRVVE 131
|
Length = 185 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 41/135 (30%), Positives = 54/135 (40%), Gaps = 17/135 (12%)
Query: 534 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPAN 593
LV ++ G L +S N P + R A E+ L LH IV DL P N
Sbjct: 62 LVLQHAEGGKLWSHISKFLNIPEECVK---RWAAEMVVALDALHR---EGIVCRDLNPNN 115
Query: 594 ILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSD 653
ILLD +L+ F +E+ + C + Y PE E T D
Sbjct: 116 ILLDDRGHIQLTYFS-----RWSEVEDS----CDGEAVENM--YCAPEVGGISEETEACD 164
Query: 654 VYSFGIILLRLLTGR 668
+S G IL LLTG+
Sbjct: 165 WWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|237178 PRK12705, PRK12705, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 0.002
Identities = 32/134 (23%), Positives = 55/134 (41%), Gaps = 5/134 (3%)
Query: 298 LAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEE-LKRRKEFEEALAN 356
L +A EAE A EA E++ R + E EE L +++E +A A
Sbjct: 39 LQEAQKEAEEKLEAALLEAKELLLRERNQQRQEARREREELQREEERLVQKEEQLDARAE 98
Query: 357 GKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKE 416
+L+ ++ Q +E + L + LE Q+ L + LL+ E
Sbjct: 99 ---KLDNLENQLEEREKALSARELELEELEKQLDNELYRVAGLTPEQARK-LLLKLLDAE 154
Query: 417 QDELQMERDKAVKE 430
+E + +R K ++E
Sbjct: 155 LEEEKAQRVKKIEE 168
|
Length = 508 |
| >gnl|CDD|234750 PRK00409, PRK00409, recombination and DNA strand exchange inhibitor protein; Reviewed | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 0.002
Identities = 38/131 (29%), Positives = 58/131 (44%), Gaps = 39/131 (29%)
Query: 312 AFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEV 371
AFE A R G E I AK L E+ K +L +
Sbjct: 490 AFEIAKRLGLPE----NIIEEAKK---LIGED--------------KEKLNEL------- 521
Query: 372 MEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEA 431
IA SL E + E +Q A+E E + A +L + ++++++LQ E DK ++EA
Sbjct: 522 -----IA----SLEELER-ELEQKAEEAEALLKEAEKLKEELEEKKEKLQEEEDKLLEEA 571
Query: 432 E-ELRKSRKEA 441
E E +++ KEA
Sbjct: 572 EKEAQQAIKEA 582
|
Length = 782 |
| >gnl|CDD|226809 COG4372, COG4372, Uncharacterized protein conserved in bacteria with the myosin-like domain [Function unknown] | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 29/133 (21%), Positives = 57/133 (42%), Gaps = 2/133 (1%)
Query: 313 FEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVM 372
LR G + D I RA +E A+ KR E E A +L+ R +++ V
Sbjct: 65 LNRNLRSGVFQLDDIRPQLRALRTELGTAQGEKRAAETEREAARSELQKARQERE--AVR 122
Query: 373 EELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAE 432
+EL A + + ++A + A++L+ ++ + E + + + LQ + + A
Sbjct: 123 QELAAARQNLAKAQQELARLTKQAQDLQTRLKTLAEQRRQLEAQAQSLQASQKQLQASAT 182
Query: 433 ELRKSRKEASSSS 445
+L+ + S
Sbjct: 183 QLKSQVLDLKLRS 195
|
Length = 499 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 27/85 (31%), Positives = 42/85 (49%), Gaps = 6/85 (7%)
Query: 534 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPAN 593
LV EYL G ++ L + ++ +E+ L +LH H I+H DLKP N
Sbjct: 81 LVMEYLIGGDVKSLLHIYGY---FDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDN 134
Query: 594 ILLDANFVSKLSDFGISRFLSQNEI 618
+L+ KL+DFG+S+ E+
Sbjct: 135 MLISNEGHIKLTDFGLSKVTLNREL 159
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|233758 TIGR02169, SMC_prok_A, chromosome segregation protein SMC, primarily archaeal type | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.003
Identities = 32/163 (19%), Positives = 64/163 (39%), Gaps = 26/163 (15%)
Query: 293 NLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELK------- 345
+L +L+ + + EE + R +A IE E Y E+
Sbjct: 783 DLEARLSHSRIPEIQAELSKLEEEVSRIEARLREIEQKLNRLTLEKEYLEKEIQELQEQR 842
Query: 346 -----RRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELE 400
+ K E+ + N + E + +E +EEL+ AL LES++ +L+
Sbjct: 843 IDLKEQIKSIEKEIENLNGKKEEL----EEELEELEAALRD---LESRL-------GDLK 888
Query: 401 QKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASS 443
++ L+ +++ +EL+ + +K K EL+ +
Sbjct: 889 KERDELEAQLRELERKIEELEAQIEKKRKRLSELKAKLEALEE 931
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. It is found in a single copy and is homodimeric in prokaryotes, but six paralogs (excluded from this family) are found in eukarotes, where SMC proteins are heterodimeric. This family represents the SMC protein of archaea and a few bacteria (Aquifex, Synechocystis, etc); the SMC of other bacteria is described by TIGR02168. The N- and C-terminal domains of this protein are well conserved, but the central hinge region is skewed in composition and highly divergent [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1164 |
| >gnl|CDD|233758 TIGR02169, SMC_prok_A, chromosome segregation protein SMC, primarily archaeal type | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.003
Identities = 27/143 (18%), Positives = 54/143 (37%), Gaps = 3/143 (2%)
Query: 295 YDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEAL 354
+ L + E + E +E + + I K EEL+R E L
Sbjct: 366 LEDLRAELEEVDKEFAETRDELKDYREKLEKLKREINELKRELDRLQEELQRL---SEEL 422
Query: 355 ANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYK 414
A+ + ++ + +E+ EE + + E ++ + + EQ++ E +
Sbjct: 423 ADLNAAIAGIEAKINELEEEKEDKALEIKKQEWKLEQLAADLSKYEQELYDLKEEYDRVE 482
Query: 415 KEQDELQMERDKAVKEAEELRKS 437
KE +LQ E +A +A +
Sbjct: 483 KELSKLQRELAEAEAQARASEER 505
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. It is found in a single copy and is homodimeric in prokaryotes, but six paralogs (excluded from this family) are found in eukarotes, where SMC proteins are heterodimeric. This family represents the SMC protein of archaea and a few bacteria (Aquifex, Synechocystis, etc); the SMC of other bacteria is described by TIGR02168. The N- and C-terminal domains of this protein are well conserved, but the central hinge region is skewed in composition and highly divergent [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1164 |
| >gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.003
Identities = 32/167 (19%), Positives = 73/167 (43%), Gaps = 18/167 (10%)
Query: 295 YDQLAQAMAEAENSRREAFEE--ALRRGKAEKDA-IESIRRAKAS------------ESL 339
++L + + E + +EA EE L E + +E +R + +L
Sbjct: 234 LEELREELEELQEELKEAEEELEELTAELQELEEKLEELRLEVSELEEEIEELQKELYAL 293
Query: 340 YAE--ELKRRKEF-EEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTA 396
E L+++K+ E LAN + +LE ++ Q +E+ +L ++ + LE ++ E +
Sbjct: 294 ANEISRLEQQKQILRERLANLERQLEELEAQLEELESKLDELAEELAELEEKLEELKEEL 353
Query: 397 KELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASS 443
+ LE ++ L+ + +EL+ + + + +L ++
Sbjct: 354 ESLEAELEELEAELEELESRLEELEEQLETLRSKVAQLELQIASLNN 400
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179 |
| >gnl|CDD|217051 pfam02463, SMC_N, RecF/RecN/SMC N terminal domain | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.003
Identities = 30/139 (21%), Positives = 57/139 (41%), Gaps = 3/139 (2%)
Query: 303 AEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGKLELE 362
E E L+ + + D E ++ ++ +ELK+ KE E L ELE
Sbjct: 290 KLLAKEEEELKSELLKLERRKVDDEEKLKESEKELKKLEKELKKEKEEIEELEKELKELE 349
Query: 363 RMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQM 422
++ +E E+L + LE E K +++ SA +L + + ++E +
Sbjct: 350 IKREAEEEEEEQL---EKLQEKLEQLEEELLAKKKLESERLSSAAKLKEEELELKNEEEK 406
Query: 423 ERDKAVKEAEELRKSRKEA 441
E ++ +E+ KE
Sbjct: 407 EAKLLLELSEQEEDLLKEE 425
|
This domain is found at the N terminus of SMC proteins. The SMC (structural maintenance of chromosomes) superfamily proteins have ATP-binding domains at the N- and C-termini, and two extended coiled-coil domains separated by a hinge in the middle. The eukaryotic SMC proteins form two kind of heterodimers: the SMC1/SMC3 and the SMC2/SMC4 types. These heterodimers constitute an essential part of higher order complexes, which are involved in chromatin and DNA dynamics. This family also includes the RecF and RecN proteins that are involved in DNA metabolism and recombination. Length = 1162 |
| >gnl|CDD|223783 COG0711, AtpF, F0F1-type ATP synthase, subunit b [Energy production and conversion] | Back alignment and domain information |
|---|
Score = 38.8 bits (91), Expect = 0.003
Identities = 33/130 (25%), Positives = 62/130 (47%), Gaps = 13/130 (10%)
Query: 321 KAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALD 380
K A++ R+AK ++ L E + ++E + LA + ELE ++Q E++E+
Sbjct: 29 KPILKALDE-RQAKIADDLAEAE-RLKEEAQALLAEYEQELEEAREQASEIIEQA----- 81
Query: 381 QKSLLESQIAE-SDQTAKELEQKIISAVELLQNYKKE-QDELQME-RDKAVKEAEELRKS 437
K E E + +ELE+ +A ++ K+ +EL+ E + AV AE+L
Sbjct: 82 -KKEAEQIAEEIKAEAEEELERIKEAAEAEIEAEKERALEELRAEVAELAVAIAEKL--L 138
Query: 438 RKEASSSSHM 447
K+ ++
Sbjct: 139 GKKVDEAAQK 148
|
Length = 161 |
| >gnl|CDD|216108 pfam00769, ERM, Ezrin/radixin/moesin family | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.003
Identities = 37/154 (24%), Positives = 69/154 (44%), Gaps = 26/154 (16%)
Query: 304 EAENSRREA------FEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANG 357
EAE ++E EE +RR A+K+ E A E+LK+ +E + L
Sbjct: 2 EAEREQQELEERMEQMEEDMRR--AQKELEEYEETAL----ELEEKLKQEEEEAQLLEKK 55
Query: 358 KLELERMKKQHDEVMEELQIALD-QKSLLESQIAESDQTAKELEQKIISAVELLQNYKKE 416
ELE ++ +EE A + ++ LE+++ E+ +LE+ E + ++
Sbjct: 56 ADELEEENRR----LEEEAAASEEERERLEAEVDEATAEVAKLEE----EREKKEAETRQ 107
Query: 417 -QDELQMERDKAVKEAEELRKSRKEASSSSHMPQ 449
Q EL+ ++ + +EL EA+++ P
Sbjct: 108 LQQELREAQEAHERARQEL----LEAAAAPTAPP 137
|
This family of proteins contain a band 4.1 domain (pfam00373), at their amino terminus. This family represents the rest of these proteins. Length = 244 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.003
Identities = 27/92 (29%), Positives = 43/92 (46%), Gaps = 12/92 (13%)
Query: 576 LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 635
LHS I+H DLKP+NI++ ++ K+ DFG++R N + + T
Sbjct: 139 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVV---------TR 186
Query: 636 AYMDPEFLASGELTPKSDVYSFGIILLRLLTG 667
Y PE + D++S G I+ L+ G
Sbjct: 187 YYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|179385 PRK02224, PRK02224, chromosome segregation protein; Provisional | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.003
Identities = 39/154 (25%), Positives = 73/154 (47%), Gaps = 14/154 (9%)
Query: 296 DQLAQAMAEAENSRREAFEEALRRGKAEKDA---IESIR-RAKASESLYAEELKRRKEFE 351
++L + + E E EE L R + +A IE + R + E L AE + +E
Sbjct: 478 EELEAELEDLE-EEVEEVEERLERAEDLVEAEDRIERLEERREDLEELIAERRETIEEKR 536
Query: 352 EALAN-----GKLELERMKKQHD--EVMEELQIALDQKSLLESQIAESDQTAKELEQKII 404
E +LE E +K+ E EE + A ++ + L S++AE + + LE +I
Sbjct: 537 ERAEELRERAAELEAEAEEKREAAAEAEEEAEEAREEVAELNSKLAELKERIESLE-RIR 595
Query: 405 SAVELLQNYKKEQDELQMERDKAVKEAEELRKSR 438
+ + + + + E + L+ E+ +A+ E + R+ R
Sbjct: 596 TLLAAIADAEDEIERLR-EKREALAELNDERRER 628
|
Length = 880 |
| >gnl|CDD|223496 COG0419, SbcC, ATPase involved in DNA repair [DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.004
Identities = 30/157 (19%), Positives = 66/157 (42%), Gaps = 9/157 (5%)
Query: 293 NLYDQLAQAMAEAEN---SRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKE 349
L + + E S E E+ + + + +E + K L +R KE
Sbjct: 308 EGLRALLEELEELLEKLKSLEERLEKLEEKLEKLESELEELAEEK--NELAKLLEERLKE 365
Query: 350 FEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVEL 409
EE L + ELE+ ++ ++ E +Q ++ + L + + E + +ELE++ +E
Sbjct: 366 LEERLEELEKELEKALERLKQLEEAIQELKEELAELSAALEEIQEELEELEKE----LEE 421
Query: 410 LQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSH 446
L+ +E +E + ++ + + E E + +
Sbjct: 422 LERELEELEEEIKKLEEQINQLESKELMIAELAGAGE 458
|
Length = 908 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 40.9 bits (95), Expect = 0.004
Identities = 33/142 (23%), Positives = 67/142 (47%), Gaps = 4/142 (2%)
Query: 299 AQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGK 358
A +AE ++ +EA ++ + K A E+ ++A+ ++ A+ K++ E + A
Sbjct: 1292 ADEAKKAEEKKK--ADEAKKKAEEAKKADEAKKKAEEAKK-KADAAKKKAEEAKKAAEAA 1348
Query: 359 LELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQD 418
E EE A ++K + A++ + E ++K A + + KK+ D
Sbjct: 1349 KAEAEAAADEAEAAEEKAEAAEKKKEEAKKKADAAKKKAEEKKKADEAKKKAEEDKKKAD 1408
Query: 419 ELQMERDKAVKEAEELRKSRKE 440
EL+ + A K+A+E +K +E
Sbjct: 1409 ELK-KAAAAKKKADEAKKKAEE 1429
|
Length = 2084 |
| >gnl|CDD|144972 pfam01576, Myosin_tail_1, Myosin tail | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.004
Identities = 48/152 (31%), Positives = 72/152 (47%), Gaps = 26/152 (17%)
Query: 295 YDQLAQAMAEAENSRREAFEEALRRGKAEKDAI----ESIRRAKASESLYAEELKRRK-- 348
D L + + E ++ E E L + AE ES +A E EELK++
Sbjct: 273 LDSLREQLEEESEAKAEL-ERQLSKANAEIQQWRSKFESEGALRAEE---LEELKKKLNQ 328
Query: 349 ---EFEEAL--ANGKL-ELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQK 402
E EEA AN K LE+ K + +E+LQI L++ ++ A ELE+K
Sbjct: 329 KISELEEAAEAANAKCDSLEKTKSRLQSELEDLQIELER----------ANAAASELEKK 378
Query: 403 IISAVELLQNYKKEQDELQMERDKAVKEAEEL 434
+ ++L +K++ DELQ E D A +EA L
Sbjct: 379 QKNFDKILAEWKRKVDELQAELDTAQREARNL 410
|
The myosin molecule is a multi-subunit complex made up of two heavy chains and four light chains it is a fundamental contractile protein found in all eukaryote cell types. This family consists of the coiled-coil myosin heavy chain tail region. The coiled-coil is composed of the tail from two molecules of myosin. These can then assemble into the macromolecular thick filament. The coiled-coil region provides the structural backbone the thick filament. Length = 859 |
| >gnl|CDD|226513 COG4026, COG4026, Uncharacterized protein containing TOPRIM domain, potential nuclease [General function prediction only] | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.004
Identities = 31/132 (23%), Positives = 55/132 (41%), Gaps = 9/132 (6%)
Query: 347 RKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQ---KI 403
RKE + AL L+ + ++ ++ E+ + K LE E ++ KELE+ +
Sbjct: 109 RKELKNALVRAGLKTLQRVPEYMDLKEDY---EELKEKLEELQKEKEELLKELEELEAEY 165
Query: 404 ISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGAT 463
E L+ + E L+ K E +L+K E +P+ + S++ T
Sbjct: 166 EEVQERLKRLEVENSRLEEMLKKLPGEVYDLKKRWDELEPGVELPE---EELISDLVKET 222
Query: 464 HNFDPSLKIGEG 475
N P G+G
Sbjct: 223 LNLAPKDIEGQG 234
|
Length = 290 |
| >gnl|CDD|221389 pfam12037, DUF3523, Domain of unknown function (DUF3523) | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.004
Identities = 34/131 (25%), Positives = 65/131 (49%), Gaps = 13/131 (9%)
Query: 315 EALRRG-KAEKDAIESIRRA-KASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVM 372
AL RG KA ++ +ES A KA E +E R+ E E + + + + K + V
Sbjct: 32 TALERGAKALRE-LESSPHAKKAFELSKMQEKTRQAELEAKIKEYEAQQAQAKLERARVE 90
Query: 373 EELQIALDQKSLLESQIAESDQTAK---ELEQKIISAVELLQNYKKEQDELQMERDKAVK 429
E +++ L+ Q + Q A+ EL +K EL Q ++ ++ L+M+ + ++
Sbjct: 91 AE-----ERRKTLQEQTQQEQQRAQYQDELARKRYQK-ELEQQRRQNEELLKMQEESVLR 144
Query: 430 EAEELRKSRKE 440
+ E +R++ +E
Sbjct: 145 Q-EAMRRATEE 154
|
This presumed domain is functionally uncharacterized. This domain is found in eukaryotes. This domain is typically between 257 to 277 amino acids in length. This domain is found associated with pfam00004. This domain has a conserved LER sequence motif. Length = 276 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 824 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.98 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.98 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.98 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.98 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.98 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.98 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.88 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.88 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.82 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.82 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.81 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.8 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.8 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.79 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.78 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.74 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.72 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.72 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.71 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.71 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.7 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.7 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.69 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.69 | |
| PF04564 | 73 | U-box: U-box domain; InterPro: IPR003613 Quality c | 99.69 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.67 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.66 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.66 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.61 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.53 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.53 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.45 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.35 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.32 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.29 | |
| cd01989 | 146 | STK_N The N-terminal domain of Eukaryotic Serine T | 99.22 | |
| smart00504 | 63 | Ubox Modified RING finger domain. Modified RING fi | 99.16 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.14 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.11 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.1 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.1 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.09 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.07 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.98 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.96 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.96 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.92 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.76 | |
| KOG4642 | 284 | consensus Chaperone-dependent E3 ubiquitin protein | 98.72 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.7 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.67 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.44 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.44 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.4 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.35 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.21 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.19 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.14 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.04 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.04 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.0 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.98 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.89 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.88 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.88 | |
| KOG2042 | 943 | consensus Ubiquitin fusion degradation protein-2 [ | 97.79 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.78 | |
| cd01987 | 124 | USP_OKCHK USP domain is located between the N-term | 97.77 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.7 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.7 | |
| COG5113 | 929 | UFD2 Ubiquitin fusion degradation protein 2 [Postt | 97.64 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.6 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.6 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.6 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.49 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.49 | |
| cd01988 | 132 | Na_H_Antiporter_C The C-terminal domain of a subfa | 97.37 | |
| PRK15118 | 144 | universal stress global response regulator UspA; P | 97.34 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.33 | |
| PF00582 | 140 | Usp: Universal stress protein family; InterPro: IP | 97.31 | |
| cd00293 | 130 | USP_Like Usp: Universal stress protein family. The | 97.29 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.27 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.18 | |
| PRK15456 | 142 | universal stress protein UspG; Provisional | 97.16 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.15 | |
| PRK15005 | 144 | universal stress protein F; Provisional | 97.13 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 96.93 | |
| PRK11175 | 305 | universal stress protein UspE; Provisional | 96.82 | |
| PLN02236 | 344 | choline kinase | 96.82 | |
| PRK10116 | 142 | universal stress protein UspC; Provisional | 96.78 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.74 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 96.65 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.54 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.52 | |
| PF11789 | 57 | zf-Nse: Zinc-finger of the MIZ type in Nse subunit | 96.46 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.26 | |
| PRK11175 | 305 | universal stress protein UspE; Provisional | 96.14 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-49 Score=436.55 Aligned_cols=275 Identities=45% Similarity=0.795 Sum_probs=235.6
Q ss_pred ccCCCChhhHhhhcCCCCccceeeecCceEEEEEEECC-eEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc
Q 003384 450 FFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 528 (824)
Q Consensus 450 ~~~~~~~~ei~~~~~~f~~~~~LG~G~fG~Vykg~~~~-~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~ 528 (824)
....|++.++..+|++|+....||+||||.||+|...+ ..||||++.....+...+|.+|+.+|.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56779999999999999999999999999999999987 89999988775543144699999999999999999999999
Q ss_pred C--C-ceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceee
Q 003384 529 P--E-VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLS 605 (824)
Q Consensus 529 ~--~-~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~ 605 (824)
. + ..+|||||+++|+|.++|+..... +|+|.+|++||.++|+||+|||...+.+||||||||+|||||+++.+||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 4 3 379999999999999999866544 89999999999999999999999776789999999999999999999999
Q ss_pred cccccccccc-ccccCCCccccccCCC-CCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCc---------
Q 003384 606 DFGISRFLSQ-NEISSNNTTLCCRTDP-KGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGIT--------- 674 (824)
Q Consensus 606 DFGla~~~~~-~~~~~~~~~~~~~~~~-~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~--------- 674 (824)
|||+|+.... .... ... .||.+|+|||++..+..+.++|||||||+|+||+||+++.+..
T Consensus 220 DFGLa~~~~~~~~~~---------~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~ 290 (361)
T KOG1187|consen 220 DFGLAKLGPEGDTSV---------STTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLV 290 (361)
T ss_pred CccCcccCCccccce---------eeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHH
Confidence 9999976543 2110 111 6999999999999999999999999999999999999988732
Q ss_pred hHHHHHHhhhccccccCCCC--CCCCh-hhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHH
Q 003384 675 KEVQYALDTGKLKNLLDPLA--GDWPF-VQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 735 (824)
Q Consensus 675 ~~~~~~~~~~~~~~~ld~~~--~~~p~-~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~ 735 (824)
.|....+..+.+.+++|+.. ..++. .....+..++.+|++.+|.+||+| .+|+++|+.+.
T Consensus 291 ~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m-~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 291 EWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTM-SQVVKELEGIL 353 (361)
T ss_pred HHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCH-HHHHHHHHhhc
Confidence 34445666778999999975 45554 577789999999999999999999 55677775543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-45 Score=403.66 Aligned_cols=255 Identities=35% Similarity=0.550 Sum_probs=211.5
Q ss_pred CCccceeeecCceEEEEEEECCeE-EEEEEecCCCCCC--chhHHHHHHHHHhcCCCceeeEecccCC---ceEEEEEec
Q 003384 466 FDPSLKIGEGGYGSIYKGLLRHMQ-VAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACPE---VWTLVYEYL 539 (824)
Q Consensus 466 f~~~~~LG~G~fG~Vykg~~~~~~-VAvK~l~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~L~g~~~~---~~~LV~Ey~ 539 (824)
+.....||.|+||+||+|.+++.. ||||++....... .+.|.+|+.+|.+++|||||+++|+|.+ ..+|||||+
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 344556999999999999999988 9999998754333 3489999999999999999999999955 378999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCc-eEeccccCCcEEecCCC-cceeecccccccccccc
Q 003384 540 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS-IVHGDLKPANILLDANF-VSKLSDFGISRFLSQNE 617 (824)
Q Consensus 540 ~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~g-iiHrDLKp~NILld~~~-~vKL~DFGla~~~~~~~ 617 (824)
++|+|.++|+.. ....+++..++.|+.+||+|+.|||+ ++ ||||||||+||||+.++ ++||+|||+++......
T Consensus 123 ~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 123 PGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred CCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 999999999754 45679999999999999999999999 55 99999999999999998 99999999998765432
Q ss_pred ccCCCccccccCCCCCCcccCChhhhc--cCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCC
Q 003384 618 ISSNNTTLCCRTDPKGTFAYMDPEFLA--SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG 695 (824)
Q Consensus 618 ~~~~~~~~~~~~~~~GT~~Y~APE~l~--~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~ 695 (824)
. ..+...||+.|||||++. ...|+.|+|||||||+||||+||+.||........+.... .. ....
T Consensus 199 ~--------~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~--~~---~~Rp 265 (362)
T KOG0192|consen 199 T--------SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVV--VG---GLRP 265 (362)
T ss_pred c--------cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHH--hc---CCCC
Confidence 1 113467999999999999 5689999999999999999999999998766533222211 11 1222
Q ss_pred CCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhhC
Q 003384 696 DWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC 738 (824)
Q Consensus 696 ~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~~~ 738 (824)
..|...+..+..|+.+||+.+|..||++ .+++..|+.+....
T Consensus 266 ~~p~~~~~~l~~l~~~CW~~dp~~RP~f-~ei~~~l~~~~~~~ 307 (362)
T KOG0192|consen 266 PIPKECPPHLSSLMERCWLVDPSRRPSF-LEIVSRLESIMSHI 307 (362)
T ss_pred CCCccCCHHHHHHHHHhCCCCCCcCCCH-HHHHHHHHHHHHhh
Confidence 3344477899999999999999999999 77888998887643
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=378.62 Aligned_cols=249 Identities=24% Similarity=0.312 Sum_probs=200.4
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCC---chhHHHHHHHHHhcCCCceeeEecccC--CceEEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 536 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~---~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~ 536 (824)
++|+.++.||+|+||.||.+.-+ |..+|+|++++..... ...+..|.+||...++|+||+||.+|. +.+||||
T Consensus 141 ~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiM 220 (550)
T KOG0605|consen 141 DDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIM 220 (550)
T ss_pred ccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEE
Confidence 47899999999999999999754 6889999998865433 456889999999999999999999995 4799999
Q ss_pred EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccc
Q 003384 537 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 616 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 616 (824)
||++||++..+|. +...|+......++.+++.|+..||+ .|+|||||||+|+|||..|++||+|||||..+...
T Consensus 221 EylPGGD~mTLL~---~~~~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 221 EYLPGGDMMTLLM---RKDTLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred EecCCccHHHHHH---hcCcCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccchhhhh
Confidence 9999999999995 45679999999999999999999999 89999999999999999999999999999754321
Q ss_pred cccC---------------CCccc------------------------cccCCCCCCcccCChhhhccCCCCcchhHHhH
Q 003384 617 EISS---------------NNTTL------------------------CCRTDPKGTFAYMDPEFLASGELTPKSDVYSF 657 (824)
Q Consensus 617 ~~~~---------------~~~~~------------------------~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSl 657 (824)
.... ..... ......+|||.|||||++.+.+|+..+|+|||
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL 374 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL 374 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence 1100 00000 01124589999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCC
Q 003384 658 GIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPE 722 (824)
Q Consensus 658 GvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt 722 (824)
|||+||||.|.|||.........-..-.+...+.... ....+.+..+||.+|+. +|.+|-.
T Consensus 375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~---~~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE---EVDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC---cCcccHHHHHHHHHHhc-CHHHhcC
Confidence 9999999999999987765444333322322221111 12234789999999999 9999987
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=375.80 Aligned_cols=244 Identities=32% Similarity=0.499 Sum_probs=197.4
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHHhcCCCceeeEeccc--CCceEEEE
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVY 536 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~ 536 (824)
..+|.....||.|+||+||+|+++ +..||||.+..... ...+-+..|+.||+.++|||||.|++++ .+..+|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 346888889999999999999886 57899999877632 2345578999999999999999999998 56789999
Q ss_pred EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCC------Ccceeeccccc
Q 003384 537 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN------FVSKLSDFGIS 610 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~------~~vKL~DFGla 610 (824)
|||.||+|.++|..+ +.+++.+...++.|||.||++||. ++||||||||+||||+.+ -.+||+|||+|
T Consensus 89 EyC~gGDLs~yi~~~---~~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRR---GRLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 999999999999543 468999999999999999999999 899999999999999764 46899999999
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhcccccc
Q 003384 611 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLL 690 (824)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~l 690 (824)
+.+...... .+..|++.|||||++..++|+.|+|+||+|+|||+|++|++||+.....+.......-...+
T Consensus 163 R~L~~~~~a---------~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~ 233 (429)
T KOG0595|consen 163 RFLQPGSMA---------ETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIV 233 (429)
T ss_pred hhCCchhHH---------HHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcccccc
Confidence 988754321 34569999999999999999999999999999999999999998655444333222222221
Q ss_pred CCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 691 DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 691 d~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
...+......+.+|+...+..++.+|-++..
T Consensus 234 ----~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~ 264 (429)
T KOG0595|consen 234 ----PVLPAELSNPLRELLISLLQRNPKDRISFED 264 (429)
T ss_pred ----CchhhhccCchhhhhhHHHhcCccccCchHH
Confidence 1122333445667888888888888887743
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=370.13 Aligned_cols=238 Identities=26% Similarity=0.377 Sum_probs=198.0
Q ss_pred CCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccC--C-ceEEEEEec
Q 003384 466 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--E-VWTLVYEYL 539 (824)
Q Consensus 466 f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~-~~~LV~Ey~ 539 (824)
.+....||+|..|+|||+.++ +.-+|+|++..... ...+++.+|++|++.++|||||.+||+|. . ..+|+||||
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM 160 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM 160 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence 345567999999999999987 57899999954432 23467899999999999999999999983 3 388999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccccc
Q 003384 540 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 619 (824)
Q Consensus 540 ~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 619 (824)
++|||++++. ..+.+++....+|+.++++||.|||.. ++||||||||+|||++..|.+||||||.++.+....
T Consensus 161 DgGSLd~~~k---~~g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS~-- 233 (364)
T KOG0581|consen 161 DGGSLDDILK---RVGRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNSI-- 233 (364)
T ss_pred CCCCHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhhhh--
Confidence 9999999994 336699999999999999999999963 579999999999999999999999999998765441
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCc-----hHHHHHHhhhccccccCCCC
Q 003384 620 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGIT-----KEVQYALDTGKLKNLLDPLA 694 (824)
Q Consensus 620 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~-----~~~~~~~~~~~~~~~ld~~~ 694 (824)
..+.+||..|||||.+.+..|+.++||||||+.++||.+|+-||... .++.. +..+++...
T Consensus 234 --------a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~L------l~~Iv~~pp 299 (364)
T KOG0581|consen 234 --------ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFEL------LCAIVDEPP 299 (364)
T ss_pred --------cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHH------HHHHhcCCC
Confidence 15568999999999999999999999999999999999999998653 22211 122333233
Q ss_pred CCCChh-hHHHHHHHHHHHhhhccCCCCChH
Q 003384 695 GDWPFV-QAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 695 ~~~p~~-~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
+..|.. .+++++.|+..||+++|.+||+..
T Consensus 300 P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~ 330 (364)
T KOG0581|consen 300 PRLPEGEFSPEFRSFVSCCLRKDPSERPSAK 330 (364)
T ss_pred CCCCcccCCHHHHHHHHHHhcCCcccCCCHH
Confidence 344554 788999999999999999999983
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=385.66 Aligned_cols=243 Identities=26% Similarity=0.400 Sum_probs=206.4
Q ss_pred CCCCccceeeecCceEEEEEEE--CCeEEEEEEecCCCCC---CchhHHHHHHHHHhcCCCceeeEecccCC--ceEEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVY 536 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~--~~~~VAvK~l~~~~~~---~~~~f~~Ei~iL~~l~HpnIv~L~g~~~~--~~~LV~ 536 (824)
..|...+.||+|||+.||.++. .|..||+|++...... ..+.+.+||+|.+.|+|||||+++++|++ +.|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5699999999999999999987 4689999999774333 35678999999999999999999999965 689999
Q ss_pred EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccc
Q 003384 537 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 616 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 616 (824)
|+|..++|..++. ...++++..+..+..||+.||.|||+ ++|||||||..|+||+++.++||+|||||..+...
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999994 56789999999999999999999999 89999999999999999999999999999988755
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCC
Q 003384 617 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 696 (824)
Q Consensus 617 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~ 696 (824)
+. .. .+..|||.|+|||++...+++..+||||+|||||.||+|+|||.... +...+..-+..+ ..
T Consensus 172 ~E--rk------~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~-vkety~~Ik~~~------Y~ 236 (592)
T KOG0575|consen 172 GE--RK------KTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT-VKETYNKIKLNE------YS 236 (592)
T ss_pred cc--cc------ceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch-HHHHHHHHHhcC------cc
Confidence 32 12 34459999999999999999999999999999999999999997543 222222222222 22
Q ss_pred CChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 003384 697 WPFVQAEQLANLAMRCCEMSRKSRPELGKDV 727 (824)
Q Consensus 697 ~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 727 (824)
.|...+....+||.++|+.+|.+||++.+++
T Consensus 237 ~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL 267 (592)
T KOG0575|consen 237 MPSHLSAEAKDLIRKLLRPNPSERPSLDEVL 267 (592)
T ss_pred cccccCHHHHHHHHHHhcCCcccCCCHHHHh
Confidence 4556778999999999999999999995444
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=382.34 Aligned_cols=251 Identities=30% Similarity=0.520 Sum_probs=212.6
Q ss_pred CCCccceeeecCceEEEEEEECCe-EEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccCC--ceEEEEEecCC
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLRHM-QVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVYEYLPN 541 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~~~-~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~~--~~~LV~Ey~~g 541 (824)
.+...+.||+|-||+||.|.+++. .||+|.++... ...+.|.+|++||++|+|+|||+|+|+|.. ..|||||||+.
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~ 285 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK 285 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEeccc
Confidence 345677899999999999999985 89999998764 345789999999999999999999999954 48999999999
Q ss_pred CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCC
Q 003384 542 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 621 (824)
Q Consensus 542 gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 621 (824)
|+|.++|.. ..+..+...+.+.++.|||+|++||++ +++|||||...||||+++..+||+|||||+...++.....
T Consensus 286 GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~ 361 (468)
T KOG0197|consen 286 GSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTAS 361 (468)
T ss_pred CcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccCCCceeec
Confidence 999999965 345678999999999999999999999 8999999999999999999999999999996655543322
Q ss_pred CccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHH--HHHhhhccccccCCCCCCCC
Q 003384 622 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--YALDTGKLKNLLDPLAGDWP 698 (824)
Q Consensus 622 ~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~~p 698 (824)
....-..-|.|||.+..+.++.+||||||||+||||+| |+.|++.....+ ..+..| ..-+.|
T Consensus 362 -------~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~G--------yRlp~P 426 (468)
T KOG0197|consen 362 -------EGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERG--------YRLPRP 426 (468)
T ss_pred -------CCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhcc--------CcCCCC
Confidence 22335678999999999999999999999999999999 999987654432 333333 223457
Q ss_pred hhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHh
Q 003384 699 FVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 736 (824)
Q Consensus 699 ~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~ 736 (824)
..++..+.+++..||..+|++|||+ +.+...|+.+..
T Consensus 427 ~~CP~~vY~lM~~CW~~~P~~RPtF-~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 427 EGCPDEVYELMKSCWHEDPEDRPTF-ETLREVLEDFFT 463 (468)
T ss_pred CCCCHHHHHHHHHHhhCCcccCCCH-HHHHHHHHHhhh
Confidence 7889999999999999999999999 677777777644
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=359.29 Aligned_cols=252 Identities=28% Similarity=0.423 Sum_probs=206.1
Q ss_pred CCCccceeeecCceEEEEEEE--CCeEEEEEEecCCCCCC--chhHHHHHHHHHhcCCCceeeEec-ccC---CceEEEE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVG-ACP---EVWTLVY 536 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~--~~~~VAvK~l~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~L~g-~~~---~~~~LV~ 536 (824)
+|.+.++||+|.||+|||+.. .+..||.|.++-..... ...+..|+.+|++|+|||||++++ .+. +..+|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 578889999999999999975 47889999987443322 345889999999999999999999 452 2478999
Q ss_pred EecCCCChhhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-ceEeccccCCcEEecCCCcceeeccccccccc
Q 003384 537 EYLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPH-SIVHGDLKPANILLDANFVSKLSDFGISRFLS 614 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~-~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~-giiHrDLKp~NILld~~~~vKL~DFGla~~~~ 614 (824)
|||.+|+|..++... .....+++.++++++.|++.||+.+|+.-++ -|+||||||.||+|+.+|.+||+||||++++.
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 999999999998653 4456799999999999999999999994433 38999999999999999999999999999887
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHH--HhhhccccccCC
Q 003384 615 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA--LDTGKLKNLLDP 692 (824)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~--~~~~~~~~~ld~ 692 (824)
...... .+.+|||.||+||.+...+|+.+|||||+||++|||+.-++||.+.+..... +..|..
T Consensus 180 s~~tfA--------~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~------ 245 (375)
T KOG0591|consen 180 SKTTFA--------HSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDY------ 245 (375)
T ss_pred chhHHH--------HhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCC------
Confidence 553321 4567999999999999999999999999999999999999999887543322 222211
Q ss_pred CCCCCC-hhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHH
Q 003384 693 LAGDWP-FVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 732 (824)
Q Consensus 693 ~~~~~p-~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le 732 (824)
.+.| ...+.++..|+..|+..||..||+....|.++..
T Consensus 246 --~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 246 --PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred --CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 1223 6778999999999999999999986444444433
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=365.93 Aligned_cols=237 Identities=29% Similarity=0.379 Sum_probs=199.2
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC---CchhHHHHHHHHHhcCCCceeeEecccC--CceEEE
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLV 535 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~---~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV 535 (824)
..+|++.++||+|+||+||.++.+ ++-+|+|++++.... ..+....|..||..++||.||+|+..|+ +..|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 457999999999999999998765 578999999875332 3456889999999999999999999995 479999
Q ss_pred EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccc
Q 003384 536 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 615 (824)
Q Consensus 536 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~ 615 (824)
+||+.||.|..+|. +...+++....-++.+|+.||.|||+ +|||||||||+|||||..|+++|+|||||+....
T Consensus 104 ld~~~GGeLf~hL~---~eg~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQ---REGRFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHHH---hcCCcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 99999999999994 45668999999999999999999999 8999999999999999999999999999985443
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHH--HHHhhhccccccCCC
Q 003384 616 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ--YALDTGKLKNLLDPL 693 (824)
Q Consensus 616 ~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~--~~~~~~~~~~~ld~~ 693 (824)
.+.. . .+.+||+.|||||++.+.+|+..+|||||||++|||++|.|||...+... ..+..++
T Consensus 178 ~~~~--t------~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k-------- 241 (357)
T KOG0598|consen 178 DGDA--T------RTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK-------- 241 (357)
T ss_pred CCCc--c------ccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc--------
Confidence 3211 1 23579999999999999999999999999999999999999997665332 2222222
Q ss_pred CCCCChhhHHHHHHHHHHHhhhccCCCC
Q 003384 694 AGDWPFVQAEQLANLAMRCCEMSRKSRP 721 (824)
Q Consensus 694 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RP 721 (824)
....|...+....+++...+..+|++|-
T Consensus 242 ~~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 242 LPLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 1223444677899999999999999995
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=370.34 Aligned_cols=241 Identities=27% Similarity=0.427 Sum_probs=193.2
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCC-------chhHHHHHHHHHhcCCCceeeEeccc--CCceE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG-------PSEFQQEIDILSKIRHPNLVTLVGAC--PEVWT 533 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~-------~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~ 533 (824)
.|-..+.||+|+||.|-+|..+ ++.||||+++...... ...+.+|++||++|+|||||+++++| ++..|
T Consensus 173 ~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~Y 252 (475)
T KOG0615|consen 173 YYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSY 252 (475)
T ss_pred eeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceE
Confidence 4777889999999999999775 5899999998753222 12357999999999999999999999 45679
Q ss_pred EEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCC---Ccceeeccccc
Q 003384 534 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN---FVSKLSDFGIS 610 (824)
Q Consensus 534 LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~---~~vKL~DFGla 610 (824)
+||||+.||+|.+.+... +.+.+..-..++.|++.||.|||+ +||+||||||+|||+..+ ..+||+|||+|
T Consensus 253 mVlE~v~GGeLfd~vv~n---k~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 253 MVLEYVEGGELFDKVVAN---KYLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred EEEEEecCccHHHHHHhc---cccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEecccchh
Confidence 999999999999999533 446667778899999999999999 999999999999999765 78999999999
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccCC---CCcchhHHhHHHHHHHHHhCCCCCCCchH---HHHHHhhh
Q 003384 611 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE---LTPKSDVYSFGIILLRLLTGRPALGITKE---VQYALDTG 684 (824)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~---~t~ksDVwSlGvvL~ELltG~~Pf~~~~~---~~~~~~~~ 684 (824)
+....... . .+..||+.|.|||++.+.+ +..++|+||+|||||-+++|.|||..... ....+..|
T Consensus 327 K~~g~~sf---m------~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G 397 (475)
T KOG0615|consen 327 KVSGEGSF---M------KTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKG 397 (475)
T ss_pred hcccccee---h------hhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcC
Confidence 98764321 2 3456999999999998764 33488999999999999999999964322 22333333
Q ss_pred ccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 685 KLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 685 ~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
++.. .+......+++..+||.++|..||++||+..+
T Consensus 398 ~y~f-----~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~e 433 (475)
T KOG0615|consen 398 RYAF-----GPLQWDRISEEALDLINWMLVVDPENRPSADE 433 (475)
T ss_pred cccc-----cChhhhhhhHHHHHHHHHhhEeCcccCcCHHH
Confidence 3321 11122346778999999999999999999843
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=362.79 Aligned_cols=250 Identities=28% Similarity=0.410 Sum_probs=206.5
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCC---CCCchhHHHHHHHHHhc-CCCceeeEecccCC--ceEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDILSKI-RHPNLVTLVGACPE--VWTLV 535 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~---~~~~~~f~~Ei~iL~~l-~HpnIv~L~g~~~~--~~~LV 535 (824)
.+|..++.||.|+|++||+|+.. ++.||||++.+.- ....+-+..|-++|.+| .||.|++||..|.+ .+|+|
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv 152 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV 152 (604)
T ss_pred hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence 35777788999999999999875 5889999987542 22234577899999999 89999999999955 68999
Q ss_pred EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccc
Q 003384 536 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 615 (824)
Q Consensus 536 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~ 615 (824)
+||+++|+|.++|.+ .+.|++.....++.+|+.||.|||+ +|||||||||+|||||.+|++||+|||.|+.+..
T Consensus 153 Le~A~nGdll~~i~K---~Gsfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 153 LEYAPNGDLLDLIKK---YGSFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAKILSP 226 (604)
T ss_pred EEecCCCcHHHHHHH---hCcchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence 999999999999953 3568888899999999999999999 8999999999999999999999999999998876
Q ss_pred cccc-----CCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhcccccc
Q 003384 616 NEIS-----SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLL 690 (824)
Q Consensus 616 ~~~~-----~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~l 690 (824)
.... ........+...+||..|.+||+|..+..++.+|+|+||||||+|+.|+|||...++....-....
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~----- 301 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQA----- 301 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHH-----
Confidence 5443 111111223568999999999999999999999999999999999999999987776443222221
Q ss_pred CCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 003384 691 DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 727 (824)
Q Consensus 691 d~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 727 (824)
+...||..-++.+.+|+.+.|..+|.+|++. +.+
T Consensus 302 --l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~-~qI 335 (604)
T KOG0592|consen 302 --LDYEFPEGFPEDARDLIKKLLVRDPSDRLTS-QQI 335 (604)
T ss_pred --hcccCCCCCCHHHHHHHHHHHccCccccccH-HHH
Confidence 2234556666899999999999999999998 444
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=352.28 Aligned_cols=247 Identities=30% Similarity=0.492 Sum_probs=199.3
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--CC--ceEEEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PE--VWTLVYE 537 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~--~~~LV~E 537 (824)
.++...+.||+|+||.||++... +...|||.+........+.+.+|+.+|++|+|||||+++|.. .+ .++++||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 35677888999999999999886 488999988765322245689999999999999999999963 34 4889999
Q ss_pred ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecC-CCcceeeccccccccccc
Q 003384 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA-NFVSKLSDFGISRFLSQN 616 (824)
Q Consensus 538 y~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~-~~~vKL~DFGla~~~~~~ 616 (824)
|+++|+|.+++..... .|++..+.+++.||++||.|||+ +|||||||||+||||+. +|.+||+|||+++.....
T Consensus 97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 9999999999964432 69999999999999999999998 89999999999999999 799999999999866531
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCC-CCcchhHHhHHHHHHHHHhCCCCCCC-chHHHHHHhhhccccccCCCC
Q 003384 617 EISSNNTTLCCRTDPKGTFAYMDPEFLASGE-LTPKSDVYSFGIILLRLLTGRPALGI-TKEVQYALDTGKLKNLLDPLA 694 (824)
Q Consensus 617 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~t~ksDVwSlGvvL~ELltG~~Pf~~-~~~~~~~~~~~~~~~~ld~~~ 694 (824)
... ........||+.|||||++..+. ..+++|||||||++.||+||.+||.. ..........+.-. ..
T Consensus 172 ~~~-----~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~-----~~ 241 (313)
T KOG0198|consen 172 GTK-----SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED-----SL 241 (313)
T ss_pred ccc-----ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC-----CC
Confidence 111 01123467999999999998643 34599999999999999999999976 23333333333222 22
Q ss_pred CCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 695 GDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 695 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
+.+|...+....+++.+|+..+|..|||+.+
T Consensus 242 P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~e 272 (313)
T KOG0198|consen 242 PEIPDSLSDEAKDFLRKCFKRDPEKRPTAEE 272 (313)
T ss_pred CCCCcccCHHHHHHHHHHhhcCcccCcCHHH
Confidence 3567778889999999999999999999943
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=357.00 Aligned_cols=255 Identities=25% Similarity=0.405 Sum_probs=201.3
Q ss_pred cCCCCccceeeecCceEEEEEEEC-------CeEEEEEEecCCCCC-CchhHHHHHHHHHhc-CCCceeeEecccCC---
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKI-RHPNLVTLVGACPE--- 530 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~-------~~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l-~HpnIv~L~g~~~~--- 530 (824)
.++|.+.++||+|+||.||+|.+. +..||||++...... ....+.+|+.+|..+ +||||++++|+|..
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 357888999999999999999752 256999998754322 234688999999999 89999999998843
Q ss_pred ceEEEEEecCCCChhhhhhccCC---------------------------------------------------------
Q 003384 531 VWTLVYEYLPNGSLEDRLSCKDN--------------------------------------------------------- 553 (824)
Q Consensus 531 ~~~LV~Ey~~ggsL~~~L~~~~~--------------------------------------------------------- 553 (824)
..++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 47899999999999998864211
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCCCccccccCCC
Q 003384 554 --SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDP 631 (824)
Q Consensus 554 --~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~ 631 (824)
..++++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++......... .....
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~------~~~~~ 236 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV------RKGSA 236 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchh------cccCC
Confidence 2358888999999999999999999 899999999999999999999999999998654322111 11234
Q ss_pred CCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchH---HHHHHhhhccccccCCCCCCCChhhHHHHHH
Q 003384 632 KGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKE---VQYALDTGKLKNLLDPLAGDWPFVQAEQLAN 707 (824)
Q Consensus 632 ~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~---~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~ 707 (824)
.+++.|+|||++.+..++.++|||||||+||||++ |.+||..... ....+..+. ....+...+..+.+
T Consensus 237 ~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~l~~ 308 (338)
T cd05102 237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGT--------RMRAPENATPEIYR 308 (338)
T ss_pred CCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCC--------CCCCCCCCCHHHHH
Confidence 56789999999999999999999999999999997 9999975432 111111111 11123445678999
Q ss_pred HHHHHhhhccCCCCChHHHHHHHHHHHH
Q 003384 708 LAMRCCEMSRKSRPELGKDVWRVLEPMR 735 (824)
Q Consensus 708 Li~~Cl~~~P~~RPt~~~~v~~~Le~l~ 735 (824)
|+.+||+.+|.+||++ .++++.|+.+.
T Consensus 309 li~~cl~~dp~~RPs~-~el~~~l~~~~ 335 (338)
T cd05102 309 IMLACWQGDPKERPTF-SALVEILGDLL 335 (338)
T ss_pred HHHHHccCChhhCcCH-HHHHHHHHHHH
Confidence 9999999999999999 77888888754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=345.23 Aligned_cols=243 Identities=22% Similarity=0.346 Sum_probs=198.7
Q ss_pred cceeeecCceEEEEEEECCeEEEEEEecCCCCCC---chhHHHHHHHHHhcCCCceeeEecccCC------ceEEEEEec
Q 003384 469 SLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGACPE------VWTLVYEYL 539 (824)
Q Consensus 469 ~~~LG~G~fG~Vykg~~~~~~VAvK~l~~~~~~~---~~~f~~Ei~iL~~l~HpnIv~L~g~~~~------~~~LV~Ey~ 539 (824)
...||+|++|.||+|.+.+..||||++....... .+.|.+|+.+|++++||||++++|++.+ ..++||||+
T Consensus 25 ~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 25 SVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred CeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 3679999999999999999999999997654333 3567899999999999999999998743 468999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccccc
Q 003384 540 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 619 (824)
Q Consensus 540 ~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 619 (824)
++|+|.+++.. ...+++.....++.+++.||.|||.. .+++||||||+|||++.++.+||+|||+++.+....
T Consensus 105 ~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-- 177 (283)
T PHA02988 105 TRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-- 177 (283)
T ss_pred CCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence 99999999953 34688999999999999999999973 268899999999999999999999999988654321
Q ss_pred CCCccccccCCCCCCcccCChhhhcc--CCCCcchhHHhHHHHHHHHHhCCCCCCCchHHH--HHHhhhccccccCCCCC
Q 003384 620 SNNTTLCCRTDPKGTFAYMDPEFLAS--GELTPKSDVYSFGIILLRLLTGRPALGITKEVQ--YALDTGKLKNLLDPLAG 695 (824)
Q Consensus 620 ~~~~~~~~~~~~~GT~~Y~APE~l~~--~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~ 695 (824)
....||..|+|||++.+ ..++.++|||||||++|||+||+.||....... ..+..+. ...
T Consensus 178 ---------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~-------~~~ 241 (283)
T PHA02988 178 ---------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKN-------NSL 241 (283)
T ss_pred ---------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcC-------CCC
Confidence 12358999999999976 689999999999999999999999997654322 1111111 111
Q ss_pred CCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHH
Q 003384 696 DWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 735 (824)
Q Consensus 696 ~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~ 735 (824)
..|...+..+.+|+.+||+.+|.+||++ ++++..|+.+.
T Consensus 242 ~~~~~~~~~l~~li~~cl~~dp~~Rps~-~ell~~l~~~~ 280 (283)
T PHA02988 242 KLPLDCPLEIKCIVEACTSHDSIKRPNI-KEILYNLSLYK 280 (283)
T ss_pred CCCCcCcHHHHHHHHHHhcCCcccCcCH-HHHHHHHHHHH
Confidence 2333457789999999999999999999 77888887654
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=354.31 Aligned_cols=248 Identities=29% Similarity=0.398 Sum_probs=200.3
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHHhcCCCceeeEecccC----CceEEEE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP----EVWTLVY 536 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~----~~~~LV~ 536 (824)
.|+.+.+||+|.||.||+|+.. +..||+|++..... ..+....+||.||++|+||||++|.+... ..+|||+
T Consensus 118 ~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVF 197 (560)
T KOG0600|consen 118 SFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVF 197 (560)
T ss_pred HHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEE
Confidence 5777788999999999999875 57799999887653 33556789999999999999999999762 3689999
Q ss_pred EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccc
Q 003384 537 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 616 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 616 (824)
|||++ +|.-++. .....|+..++..++.|++.||.|+|. +||+|||||.+|||||++|.+||+|||||+++...
T Consensus 198 eYMdh-DL~GLl~--~p~vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 198 EYMDH-DLSGLLS--SPGVKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred ecccc-hhhhhhc--CCCcccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 99987 7888774 334579999999999999999999999 99999999999999999999999999999987655
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccC-CCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCC
Q 003384 617 EISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG 695 (824)
Q Consensus 617 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~ 695 (824)
.... .+..+-|.+|.|||.+.+. .|+.++|+||.||||.||++|+|.|.+..++.+....-++ +..|...
T Consensus 272 ~~~~-------~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfkl--cGSP~e~ 342 (560)
T KOG0600|consen 272 GSAP-------YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKL--CGSPTED 342 (560)
T ss_pred CCcc-------cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHH--hCCCChh
Confidence 4222 2455679999999999885 7999999999999999999999999988877654332111 1111111
Q ss_pred CCC------------------------hhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 003384 696 DWP------------------------FVQAEQLANLAMRCCEMSRKSRPELGKDV 727 (824)
Q Consensus 696 ~~p------------------------~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 727 (824)
.|+ ...+....+|+..+|..+|.+|.|+.+.+
T Consensus 343 ~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL 398 (560)
T KOG0600|consen 343 YWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSAL 398 (560)
T ss_pred ccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHh
Confidence 111 11234678999999999999999985444
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=336.43 Aligned_cols=231 Identities=26% Similarity=0.391 Sum_probs=198.2
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC---CchhHHHHHHHHHhcCCCceeeEecccCC--ceEEEEE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVYE 537 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~---~~~~f~~Ei~iL~~l~HpnIv~L~g~~~~--~~~LV~E 537 (824)
+|+..+.||.|+||.|..++.+ +..+|+|++...... ..++..+|..+|+.+.||++++|++.|.+ ..|+|||
T Consensus 45 dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvme 124 (355)
T KOG0616|consen 45 DFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVME 124 (355)
T ss_pred hhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEe
Confidence 5888899999999999999876 578999999875433 24567899999999999999999999854 6899999
Q ss_pred ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccc
Q 003384 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 617 (824)
Q Consensus 538 y~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 617 (824)
|++||.|..+|+ ...+|+......++.+|+.||.|||+ ++||+|||||+|||||.+|++||+|||+|+.+....
T Consensus 125 yv~GGElFS~Lr---k~~rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~rT 198 (355)
T KOG0616|consen 125 YVPGGELFSYLR---KSGRFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGRT 198 (355)
T ss_pred ccCCccHHHHHH---hcCCCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEecCcE
Confidence 999999999994 44579999999999999999999999 889999999999999999999999999999765431
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHH--HHhhhccccccCCCCC
Q 003384 618 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQY--ALDTGKLKNLLDPLAG 695 (824)
Q Consensus 618 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~--~~~~~~~~~~ld~~~~ 695 (824)
.+..|||.|+|||++...+|+.++|+|||||++|||+.|.+||...+.+.. .+..+ ..
T Consensus 199 -----------~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~---------~v 258 (355)
T KOG0616|consen 199 -----------WTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEG---------KV 258 (355)
T ss_pred -----------EEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhC---------cc
Confidence 234599999999999999999999999999999999999999987765332 11122 22
Q ss_pred CCChhhHHHHHHHHHHHhhhccCCCC
Q 003384 696 DWPFVQAEQLANLAMRCCEMSRKSRP 721 (824)
Q Consensus 696 ~~p~~~~~~l~~Li~~Cl~~~P~~RP 721 (824)
.+|...+.++.+|+...++.|-..|.
T Consensus 259 ~fP~~fs~~~kdLl~~LL~vD~t~R~ 284 (355)
T KOG0616|consen 259 KFPSYFSSDAKDLLKKLLQVDLTKRF 284 (355)
T ss_pred cCCcccCHHHHHHHHHHHhhhhHhhh
Confidence 45777788999999999999998883
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=334.96 Aligned_cols=246 Identities=27% Similarity=0.387 Sum_probs=195.1
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCC--chhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEe
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY 538 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey 538 (824)
.|+...++|+|+||+|||.+.+ |+-||||++....... .+-..+|+.+|++|+|||+|.|+.+|. ..++||+||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 4777788999999999999876 5789999997643321 234679999999999999999999994 468999999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccc
Q 003384 539 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 618 (824)
Q Consensus 539 ~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 618 (824)
|+..-|.++= . ....++...+..++.|++.|+.|+|+ +++|||||||+||||+.+|.+||||||+|+.+.....
T Consensus 83 ~dhTvL~eLe-~--~p~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd 156 (396)
T KOG0593|consen 83 CDHTVLHELE-R--YPNGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD 156 (396)
T ss_pred cchHHHHHHH-h--ccCCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcCCcc
Confidence 9886555543 2 23447888999999999999999999 8899999999999999999999999999998874321
Q ss_pred cCCCccccccCCCCCCcccCChhhhcc-CCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhc------------
Q 003384 619 SSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK------------ 685 (824)
Q Consensus 619 ~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~------------ 685 (824)
. .+..+.|.+|.|||.+.+ .+|++.+|||++||++.||++|.|.|.+...+...+....
T Consensus 157 ~--------YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~i 228 (396)
T KOG0593|consen 157 N--------YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSI 228 (396)
T ss_pred h--------hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHH
Confidence 1 144568999999999988 6899999999999999999999999998877665443211
Q ss_pred ------cccccCC-------CCCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 686 ------LKNLLDP-------LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 686 ------~~~~ld~-------~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
+..+.-| +...+| ..+.-+.+|+..||..||.+|++-.+
T Consensus 229 F~~N~~F~Gv~lP~~~~~epLe~k~p-~~s~~~ld~~k~cL~~dP~~R~sc~q 280 (396)
T KOG0593|consen 229 FSSNPFFHGVRLPEPEHPEPLERKYP-KISNVLLDLLKKCLKMDPDDRLSCEQ 280 (396)
T ss_pred hccCCceeeeecCCCCCccchhhhcc-cchHHHHHHHHHHhcCCccccccHHH
Confidence 1111111 111122 22447899999999999999998743
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=359.52 Aligned_cols=256 Identities=27% Similarity=0.474 Sum_probs=203.5
Q ss_pred CCCCccceeeecCceEEEEEEECCeEEEEEEecCCCCCC--chhHHHHHHHHHhcCCCceeeEecccC-CceEEEEEecC
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVYEYLP 540 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~~~~VAvK~l~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~L~g~~~-~~~~LV~Ey~~ 540 (824)
..+.+...||+|.||+||+|.|.| .||||+++...... .+.|++|+.+|++-+|-||+-+.|+|. +...||.-+|.
T Consensus 392 ~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~AIiTqwCe 470 (678)
T KOG0193|consen 392 EEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPLAIITQWCE 470 (678)
T ss_pred HHhhccceeccccccceeeccccc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCceeeeehhcc
Confidence 345567789999999999999976 59999998765443 457999999999999999999999994 45689999999
Q ss_pred CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccC
Q 003384 541 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 620 (824)
Q Consensus 541 ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 620 (824)
|-+|+.+|+-.. ..|...+.+.|+.||++|+.|||. ++|||||||+.||||.++++|||+||||+..-.......
T Consensus 471 GsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~ 545 (678)
T KOG0193|consen 471 GSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQ 545 (678)
T ss_pred Cchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccceeeeeeecccc
Confidence 999999997443 568899999999999999999999 999999999999999999999999999997543321111
Q ss_pred CCccccccCCCCCCcccCChhhhccC---CCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCC
Q 003384 621 NNTTLCCRTDPKGTFAYMDPEFLASG---ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 697 (824)
Q Consensus 621 ~~~~~~~~~~~~GT~~Y~APE~l~~~---~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~ 697 (824)
. .....|...|||||++..+ +|+..+||||||||+|||+||..||.....-+.....|+-....|... .
T Consensus 546 q------~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~--~ 617 (678)
T KOG0193|consen 546 Q------LEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSK--I 617 (678)
T ss_pred c------cCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchh--h
Confidence 1 1334689999999999754 689999999999999999999999985443332223333322222221 2
Q ss_pred ChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHH
Q 003384 698 PFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 734 (824)
Q Consensus 698 p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l 734 (824)
....+.++.+|+..||..++++||.+. .|+..|+.+
T Consensus 618 ~s~~pk~mk~Ll~~C~~~~~~eRP~F~-~il~~l~~l 653 (678)
T KOG0193|consen 618 RSNCPKAMKRLLSDCWKFDREERPLFP-QLLSKLEEL 653 (678)
T ss_pred hccCHHHHHHHHHHHHhcCcccCccHH-HHHHHHHHh
Confidence 234567999999999999999999995 455545444
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=323.62 Aligned_cols=246 Identities=26% Similarity=0.416 Sum_probs=201.5
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCC--chhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEe
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY 538 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey 538 (824)
.|...++||+|.||.||+|.+. ++.||||+++.....+ .....+|+..|+.++||||+.|+++|+ +...||+||
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 5677788999999999999875 6889999998754332 235789999999999999999999995 468899999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccc
Q 003384 539 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 618 (824)
Q Consensus 539 ~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 618 (824)
++ .+|+..+. +....|+...+..++.++++||+|||. +.|+||||||.|+|++.+|.+||+|||+|+.+.....
T Consensus 83 m~-tdLe~vIk--d~~i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 83 MP-TDLEVVIK--DKNIILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred cc-ccHHHHhc--ccccccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 96 58999984 556789999999999999999999999 8999999999999999999999999999998875543
Q ss_pred cCCCccccccCCCCCCcccCChhhhccC-CCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCC
Q 003384 619 SSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 697 (824)
Q Consensus 619 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~ 697 (824)
.. +..+-|.+|.|||.+.+. .|+..+|+||.|||+.||+-|.|.|.+..++++.... +..+..|....|
T Consensus 157 ~~--------~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~I--f~~LGTP~~~~W 226 (318)
T KOG0659|consen 157 IQ--------THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKI--FRALGTPTPDQW 226 (318)
T ss_pred cc--------ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHH--HHHcCCCCcccC
Confidence 22 223579999999998875 7999999999999999999999999888776654322 111222222222
Q ss_pred C-----------------------hhhHHHHHHHHHHHhhhccCCCCChHHH
Q 003384 698 P-----------------------FVQAEQLANLAMRCCEMSRKSRPELGKD 726 (824)
Q Consensus 698 p-----------------------~~~~~~l~~Li~~Cl~~~P~~RPt~~~~ 726 (824)
| ...+.++.+|+..++..||.+|++..+.
T Consensus 227 P~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qa 278 (318)
T KOG0659|consen 227 PEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQA 278 (318)
T ss_pred ccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHH
Confidence 2 2335577999999999999999999543
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=354.15 Aligned_cols=240 Identities=30% Similarity=0.411 Sum_probs=201.5
Q ss_pred CCCccceeeecCceEEEEEEECC--eEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEe
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY 538 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~~--~~VAvK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey 538 (824)
+|.....||+|+||.||||+.+. ..||+|.+.+.... ..+.+.+|++|++.|+|||||.+++.|+ ..+++|.||
T Consensus 3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~ 82 (808)
T KOG0597|consen 3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEY 82 (808)
T ss_pred chhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehh
Confidence 56667789999999999997664 78999998765332 2345889999999999999999999995 468899999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccc
Q 003384 539 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 618 (824)
Q Consensus 539 ~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 618 (824)
+.| +|..+|. ....+++..+..|+.++..||.|||+ ++|+|||+||.||||+.+|++|++|||+|+.+.....
T Consensus 83 a~g-~L~~il~---~d~~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~ 155 (808)
T KOG0597|consen 83 AVG-DLFTILE---QDGKLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTS 155 (808)
T ss_pred hhh-hHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhcccCce
Confidence 977 9999994 44569999999999999999999999 8999999999999999999999999999997765321
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCC
Q 003384 619 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWP 698 (824)
Q Consensus 619 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p 698 (824)
..+...|||.|||||...++.|+..+|+||+|||+|||++|+|||....-. .+...+-.-...||
T Consensus 156 --------vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~-------~Lv~~I~~d~v~~p 220 (808)
T KOG0597|consen 156 --------VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSIT-------QLVKSILKDPVKPP 220 (808)
T ss_pred --------eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHH-------HHHHHHhcCCCCCc
Confidence 125567999999999999999999999999999999999999999533221 12222222334577
Q ss_pred hhhHHHHHHHHHHHhhhccCCCCChHHH
Q 003384 699 FVQAEQLANLAMRCCEMSRKSRPELGKD 726 (824)
Q Consensus 699 ~~~~~~l~~Li~~Cl~~~P~~RPt~~~~ 726 (824)
...+..+..|+.-.|+.||..|.++.+.
T Consensus 221 ~~~S~~f~nfl~gLL~kdP~~RltW~~L 248 (808)
T KOG0597|consen 221 STASSSFVNFLQGLLIKDPAQRLTWTDL 248 (808)
T ss_pred ccccHHHHHHHHHHhhcChhhcccHHHH
Confidence 8888999999999999999999998543
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=354.53 Aligned_cols=241 Identities=26% Similarity=0.386 Sum_probs=203.4
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--CCceEEEEEecC
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLP 540 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~Ey~~ 540 (824)
.|..-.+||+|+.|.||.+... +..||||.+........+-+.+|+.+|+.++|+|||.++..| .+..+.|||||+
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ 353 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYME 353 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecC
Confidence 4566678999999999999765 578999999887766667789999999999999999999987 567889999999
Q ss_pred CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccC
Q 003384 541 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 620 (824)
Q Consensus 541 ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 620 (824)
||+|.|.+. ...+++.++..|+.+++.||.|||. +||||||||.+|||++.+|.+||+|||+|..+.....
T Consensus 354 ggsLTDvVt----~~~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-- 424 (550)
T KOG0578|consen 354 GGSLTDVVT----KTRMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-- 424 (550)
T ss_pred CCchhhhhh----cccccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccccccC--
Confidence 999999984 3348999999999999999999999 8999999999999999999999999999987765432
Q ss_pred CCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCChh
Q 003384 621 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV 700 (824)
Q Consensus 621 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~ 700 (824)
.+...+|||+|||||+.....|++++||||||++++||+-|+|||-..+.....+.... -. ......+..
T Consensus 425 ------KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~---ng-~P~lk~~~k 494 (550)
T KOG0578|consen 425 ------KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT---NG-TPKLKNPEK 494 (550)
T ss_pred ------ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh---cC-CCCcCCccc
Confidence 23667899999999999999999999999999999999999999965544332221110 00 112234566
Q ss_pred hHHHHHHHHHHHhhhccCCCCChH
Q 003384 701 QAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 701 ~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
.+..|.+|+.+||+.|+.+||++.
T Consensus 495 lS~~~kdFL~~cL~~dv~~RasA~ 518 (550)
T KOG0578|consen 495 LSPELKDFLDRCLVVDVEQRASAK 518 (550)
T ss_pred cCHHHHHHHHHHhhcchhcCCCHH
Confidence 788999999999999999999994
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=351.01 Aligned_cols=244 Identities=28% Similarity=0.401 Sum_probs=200.3
Q ss_pred hcCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCC----CC-CCchhHHHHHHHHHhcC-CCceeeEeccc--CCc
Q 003384 462 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH----SL-QGPSEFQQEIDILSKIR-HPNLVTLVGAC--PEV 531 (824)
Q Consensus 462 ~~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~----~~-~~~~~f~~Ei~iL~~l~-HpnIv~L~g~~--~~~ 531 (824)
..+.|...+.||+|+||+||.|... +..||||++... .. ...+.+.+|+.+++.++ ||||++++.++ ...
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 4568999999999999999999774 689999987654 11 22346778999999999 99999999987 457
Q ss_pred eEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCC-Ccceeeccccc
Q 003384 532 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN-FVSKLSDFGIS 610 (824)
Q Consensus 532 ~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~-~~vKL~DFGla 610 (824)
.++||||+.||+|.+++.. ..++.+.....++.|++.|+.|+|+ +||+||||||+|||||.+ +++||+|||++
T Consensus 95 ~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred EEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 9999999999999999953 5678889999999999999999999 899999999999999999 99999999999
Q ss_pred cccc-cccccCCCccccccCCCCCCcccCChhhhccCC-CC-cchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccc
Q 003384 611 RFLS-QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE-LT-PKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLK 687 (824)
Q Consensus 611 ~~~~-~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~t-~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~ 687 (824)
.... .... .....||+.|+|||++.+.. |+ .++||||+||+||-|++|+.||+..+.......
T Consensus 169 ~~~~~~~~~---------l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~k----- 234 (370)
T KOG0583|consen 169 AISPGEDGL---------LKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRK----- 234 (370)
T ss_pred cccCCCCCc---------ccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHH-----
Confidence 9773 2221 13456999999999999977 86 789999999999999999999987543322212
Q ss_pred cccCCCCCCCChhh-HHHHHHHHHHHhhhccCCCCChHHHHH
Q 003384 688 NLLDPLAGDWPFVQ-AEQLANLAMRCCEMSRKSRPELGKDVW 728 (824)
Q Consensus 688 ~~ld~~~~~~p~~~-~~~l~~Li~~Cl~~~P~~RPt~~~~v~ 728 (824)
+....-.+|... +..+..|+.+||..+|..|+++ .++.
T Consensus 235 --i~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~-~~i~ 273 (370)
T KOG0583|consen 235 --IRKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITL-LEIL 273 (370)
T ss_pred --HhcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCH-HHHh
Confidence 111112234444 7899999999999999999999 4443
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=369.96 Aligned_cols=255 Identities=29% Similarity=0.530 Sum_probs=213.3
Q ss_pred CCCCccceeeecCceEEEEEEECC-------eEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccC--CceE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWT 533 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~~-------~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~ 533 (824)
.+....+.||+|+||+||+|...+ ..||||.++..... ...+|++|+++|..|+|||||+|+|.|. +..+
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 345566789999999999997653 46999999876554 4678999999999999999999999994 5689
Q ss_pred EEEEecCCCChhhhhhccC-------C----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcc
Q 003384 534 LVYEYLPNGSLEDRLSCKD-------N----SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS 602 (824)
Q Consensus 534 LV~Ey~~ggsL~~~L~~~~-------~----~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~v 602 (824)
+|+|||..|+|.++|.... . .++|+..+.+.||.|||.|+.||-+ +.+|||||-..|+||.++..|
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CcccccchhhhhceeccceEE
Confidence 9999999999999995421 1 3459999999999999999999999 779999999999999999999
Q ss_pred eeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCc--hHHHH
Q 003384 603 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGIT--KEVQY 679 (824)
Q Consensus 603 KL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~--~~~~~ 679 (824)
||+||||++.....++.... ....-.++||+||.+..++|+.+||||||||||||++| |+.|+.+. .++..
T Consensus 643 KIsDfGLsRdiYssDYYk~~------~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe 716 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVR------GNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIE 716 (774)
T ss_pred Eecccccchhhhhhhhhccc------CCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHH
Confidence 99999999976655543322 12234679999999999999999999999999999998 88888654 33444
Q ss_pred HHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHh
Q 003384 680 ALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 736 (824)
Q Consensus 680 ~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~ 736 (824)
.+..|.+ ...|..++..+..|+..||+.+|.+||++ ++|..+|+....
T Consensus 717 ~i~~g~l--------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF-~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 717 CIRAGQL--------LSCPENCPTEVYSLMLECWNENPKRRPSF-KEIHSRLQAWAQ 764 (774)
T ss_pred HHHcCCc--------ccCCCCCCHHHHHHHHHHhhcCcccCCCH-HHHHHHHHHHHh
Confidence 4555544 23577888999999999999999999999 788888887654
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=337.93 Aligned_cols=257 Identities=25% Similarity=0.322 Sum_probs=206.0
Q ss_pred hcCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEeccc--CCceEEEE
Q 003384 462 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVY 536 (824)
Q Consensus 462 ~~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~ 536 (824)
..+.|.....||.|..++||+|++. +..||||+++..... +.+.+.+|+..|+.++||||++++.+| ....++||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 3457888899999999999999875 688999999876433 357899999999999999999999988 56789999
Q ss_pred EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccc
Q 003384 537 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 616 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 616 (824)
.||.+||+.+++...-.. .+++..+..|..++++||.|||+ +|.||||||+.||||+.+|.|||+|||.+-.+...
T Consensus 104 pfMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 999999999999655333 38899999999999999999999 99999999999999999999999999998876654
Q ss_pred cccCCCccccccCCCCCCcccCChhhhcc--CCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhh--hccccccC-
Q 003384 617 EISSNNTTLCCRTDPKGTFAYMDPEFLAS--GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT--GKLKNLLD- 691 (824)
Q Consensus 617 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~--~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~--~~~~~~ld- 691 (824)
+. ... ......+||++|||||++.. .+|+.|+||||||++..||.+|..||.........+.. +.....+.
T Consensus 180 G~---R~~-~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~ 255 (516)
T KOG0582|consen 180 GD---RQV-TRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTS 255 (516)
T ss_pred Cc---eee-EeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccc
Confidence 41 111 11167789999999999754 48999999999999999999999999877665543322 21111110
Q ss_pred CCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHH
Q 003384 692 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD 726 (824)
Q Consensus 692 ~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~ 726 (824)
....+........+.+++..||+.||.+||+..+.
T Consensus 256 ~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskL 290 (516)
T KOG0582|consen 256 GLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKL 290 (516)
T ss_pred cCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHH
Confidence 00111112234589999999999999999998443
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=352.42 Aligned_cols=236 Identities=28% Similarity=0.493 Sum_probs=195.2
Q ss_pred cceeeecCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEecCCCChhh
Q 003384 469 SLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNGSLED 546 (824)
Q Consensus 469 ~~~LG~G~fG~Vykg~~~~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey~~ggsL~~ 546 (824)
+..||.|+.|-||.|.+.+..||||+++... ..+|.-|++|+||||+.+.|+|. ..++||||||+.|-|..
T Consensus 129 LeWlGSGaQGAVF~Grl~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~ 201 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLHNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYE 201 (904)
T ss_pred hhhhccCcccceeeeeccCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHH
Confidence 3469999999999999999999999875422 34778899999999999999995 46889999999999999
Q ss_pred hhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCCCcccc
Q 003384 547 RLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLC 626 (824)
Q Consensus 547 ~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~ 626 (824)
+|. ...+++......|..+||.|+.|||. +.|||||||+-||||..+..|||+|||.++-.....+
T Consensus 202 VLk---a~~~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ST-------- 267 (904)
T KOG4721|consen 202 VLK---AGRPITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKST-------- 267 (904)
T ss_pred HHh---ccCccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccchHhhhhhhh--------
Confidence 994 44567778889999999999999999 7799999999999999999999999999886654321
Q ss_pred ccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCChhhHHHHH
Q 003384 627 CRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLA 706 (824)
Q Consensus 627 ~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~ 706 (824)
+..+.||..|||||++.+.+.+.|+|||||||||||||||..||...+.....+-.| .+. +....|..+++-|.
T Consensus 268 -kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVG--sNs---L~LpvPstcP~Gfk 341 (904)
T KOG4721|consen 268 -KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVG--SNS---LHLPVPSTCPDGFK 341 (904)
T ss_pred -hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEecc--CCc---ccccCcccCchHHH
Confidence 245679999999999999999999999999999999999999996554322211111 111 22345677788999
Q ss_pred HHHHHHhhhccCCCCChHHHHHHHHH
Q 003384 707 NLAMRCCEMSRKSRPELGKDVWRVLE 732 (824)
Q Consensus 707 ~Li~~Cl~~~P~~RPt~~~~v~~~Le 732 (824)
-|+.+||+..|.+||++++ ++..|+
T Consensus 342 lL~Kqcw~sKpRNRPSFrq-il~Hld 366 (904)
T KOG4721|consen 342 LLLKQCWNSKPRNRPSFRQ-ILLHLD 366 (904)
T ss_pred HHHHHHHhcCCCCCccHHH-HHHHHh
Confidence 9999999999999999955 444444
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=355.41 Aligned_cols=240 Identities=23% Similarity=0.307 Sum_probs=200.8
Q ss_pred hcCCCCccceeeecCceEEEEEEECC--eEEEEEEecCCCC---CCchhHHHHHHHHHhcC-CCceeeEeccc--CCceE
Q 003384 462 ATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSL---QGPSEFQQEIDILSKIR-HPNLVTLVGAC--PEVWT 533 (824)
Q Consensus 462 ~~~~f~~~~~LG~G~fG~Vykg~~~~--~~VAvK~l~~~~~---~~~~~f~~Ei~iL~~l~-HpnIv~L~g~~--~~~~~ 533 (824)
...+|...++||+|.||+|+++.+++ ..+|||++++... .+.+....|..|+.... ||.++.|+.+| .++.|
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 44679999999999999999998874 6799999988643 33456778999998885 99999999999 46899
Q ss_pred EEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccc
Q 003384 534 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 613 (824)
Q Consensus 534 LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~ 613 (824)
.||||+.||++..+. ....|++.....++.+++.||.|||. +|||+||||.+|||||..|++||+|||||+-.
T Consensus 446 fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred EEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEeccccccccc
Confidence 999999999954443 44569999999999999999999999 99999999999999999999999999999854
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCC
Q 003384 614 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPL 693 (824)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~ 693 (824)
.-.+ .. .++..|||.|||||++.+..|+.++|||||||+|||||+|++||.++++.+..- .+-..
T Consensus 519 m~~g--~~------TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~Fd-------sI~~d 583 (694)
T KOG0694|consen 519 MGQG--DR------TSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFD-------SIVND 583 (694)
T ss_pred CCCC--Cc------cccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH-------HHhcC
Confidence 3221 11 145679999999999999999999999999999999999999998776543211 11112
Q ss_pred CCCCChhhHHHHHHHHHHHhhhccCCCCCh
Q 003384 694 AGDWPFVQAEQLANLAMRCCEMSRKSRPEL 723 (824)
Q Consensus 694 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 723 (824)
...+|...+.+...++.++|..+|++|-.+
T Consensus 584 ~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 584 EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 234678889999999999999999999876
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=339.09 Aligned_cols=259 Identities=27% Similarity=0.462 Sum_probs=197.1
Q ss_pred CCCCccceeeecCceEEEEEEEC------------------CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR------------------HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTL 524 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~------------------~~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~L 524 (824)
++|...++||+|+||.||++.+. +..||+|++...... ....|.+|+.+|.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 46788889999999999999753 236999998764322 23468899999999999999999
Q ss_pred ecccC--CceEEEEEecCCCChhhhhhccC----------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEe
Q 003384 525 VGACP--EVWTLVYEYLPNGSLEDRLSCKD----------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 586 (824)
Q Consensus 525 ~g~~~--~~~~LV~Ey~~ggsL~~~L~~~~----------------~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiH 586 (824)
+|+|. +..++||||+++|+|.+++.... ....+++..++.++.|++.||.|||+ ++|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCccc
Confidence 99884 46899999999999999885321 12357888999999999999999999 88999
Q ss_pred ccccCCcEEecCCCcceeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh
Q 003384 587 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 666 (824)
Q Consensus 587 rDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt 666 (824)
|||||+|||++.++.+||+|||+++.+....... ......++..|+|||++.++.++.++|||||||++|||++
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~ 235 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYR------IQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeE------ecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHH
Confidence 9999999999999999999999998654332111 1123456889999999998899999999999999999987
Q ss_pred --CCCCCCCchHHHHHHhhhc-cccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHH
Q 003384 667 --GRPALGITKEVQYALDTGK-LKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 732 (824)
Q Consensus 667 --G~~Pf~~~~~~~~~~~~~~-~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le 732 (824)
|..||.............. +...........+...+..+.+|+.+||+.+|.+||++ +++.+.|+
T Consensus 236 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~-~~i~~~l~ 303 (304)
T cd05096 236 LCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSF-SDIHAFLT 303 (304)
T ss_pred ccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCH-HHHHHHHh
Confidence 5577764432221111110 00000111112233456789999999999999999999 66666664
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=336.35 Aligned_cols=241 Identities=25% Similarity=0.343 Sum_probs=193.2
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC---CchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE 537 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~---~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~E 537 (824)
.|...+.||+|+||.||+|... +..||||.+...... ....+.+|+.+++.++||||+++++++. +..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 3677789999999999999874 688999998654322 2235788999999999999999999873 46889999
Q ss_pred ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccc
Q 003384 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 617 (824)
Q Consensus 538 y~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 617 (824)
|+++|+|.+++.... ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 81 IMNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred ecCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 999999998875332 3468999999999999999999999 899999999999999999999999999998653321
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHH--HHHhhhccccccCCCCC
Q 003384 618 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ--YALDTGKLKNLLDPLAG 695 (824)
Q Consensus 618 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~ 695 (824)
. .....||+.|+|||++.+..++.++|||||||+||+|++|++||....... ..+.. .+.....
T Consensus 157 ~---------~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~-----~~~~~~~ 222 (285)
T cd05631 157 T---------VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDR-----RVKEDQE 222 (285)
T ss_pred e---------ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHH-----Hhhcccc
Confidence 1 123468999999999999999999999999999999999999997543211 11111 0111112
Q ss_pred CCChhhHHHHHHHHHHHhhhccCCCCCh
Q 003384 696 DWPFVQAEQLANLAMRCCEMSRKSRPEL 723 (824)
Q Consensus 696 ~~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 723 (824)
.++...+..+.+|+.+||+.+|.+||+.
T Consensus 223 ~~~~~~s~~~~~li~~~l~~~P~~R~~~ 250 (285)
T cd05631 223 EYSEKFSEDAKSICRMLLTKNPKERLGC 250 (285)
T ss_pred cCCccCCHHHHHHHHHHhhcCHHHhcCC
Confidence 2344456789999999999999999984
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=338.68 Aligned_cols=232 Identities=26% Similarity=0.367 Sum_probs=193.3
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE 537 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~---~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~E 537 (824)
+|...+.||+|+||.||+|... +..||||++..... .....+.+|+.+++.++||||+++++++. ...++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 81 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME 81 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence 6788899999999999999886 68899999865322 22456889999999999999999999874 46789999
Q ss_pred ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccc
Q 003384 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 617 (824)
Q Consensus 538 y~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 617 (824)
|+++|+|.+++.. ...+++.....++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~ 155 (291)
T cd05612 82 YVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT 155 (291)
T ss_pred CCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc
Confidence 9999999999853 3468899999999999999999999 899999999999999999999999999987653211
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHH--HHhhhccccccCCCCC
Q 003384 618 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQY--ALDTGKLKNLLDPLAG 695 (824)
Q Consensus 618 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~--~~~~~~~~~~ld~~~~ 695 (824)
....||+.|+|||++.+..++.++|||||||++|+|+||++||........ .+..+ ..
T Consensus 156 -----------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~---------~~ 215 (291)
T cd05612 156 -----------WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG---------KL 215 (291)
T ss_pred -----------ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---------Cc
Confidence 224589999999999998999999999999999999999999976543221 11111 11
Q ss_pred CCChhhHHHHHHHHHHHhhhccCCCCC
Q 003384 696 DWPFVQAEQLANLAMRCCEMSRKSRPE 722 (824)
Q Consensus 696 ~~p~~~~~~l~~Li~~Cl~~~P~~RPt 722 (824)
.+|...+..+.+|+.+||+.+|.+||+
T Consensus 216 ~~~~~~~~~~~~li~~~l~~dp~~R~~ 242 (291)
T cd05612 216 EFPRHLDLYAKDLIKKLLVVDRTRRLG 242 (291)
T ss_pred CCCccCCHHHHHHHHHHcCCCHHHccC
Confidence 234445678999999999999999996
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=335.18 Aligned_cols=249 Identities=28% Similarity=0.374 Sum_probs=194.1
Q ss_pred hcCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC--------------CchhHHHHHHHHHhcCCCceeeEe
Q 003384 462 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--------------GPSEFQQEIDILSKIRHPNLVTLV 525 (824)
Q Consensus 462 ~~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~--------------~~~~f~~Ei~iL~~l~HpnIv~L~ 525 (824)
.-++|.+...||+|.||.|-+|+.. ++.||||++.+.... ..+.+.+||.||++|+|||||+|+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 3457999999999999999999875 588999999653211 124688999999999999999999
Q ss_pred cccC----CceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCc
Q 003384 526 GACP----EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV 601 (824)
Q Consensus 526 g~~~----~~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~ 601 (824)
.+.. +.+|||+|||..|.+...= .....|+..+.+.|+.++..||.|||+ +|||||||||+|+||+.+|+
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCCCc
Confidence 9873 4789999999998875532 233339999999999999999999999 89999999999999999999
Q ss_pred ceeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCC----CCcchhHHhHHHHHHHHHhCCCCCCCchHH
Q 003384 602 SKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE----LTPKSDVYSFGIILLRLLTGRPALGITKEV 677 (824)
Q Consensus 602 vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~----~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~ 677 (824)
+||+|||.+..+.......... .....+|||.|+|||...++. .+.+.||||+||+||.|+.|+.||-.....
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~---~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~ 325 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDD---QLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL 325 (576)
T ss_pred EEeeccceeeecccCCccccHH---HHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH
Confidence 9999999998764442111111 113367999999999987742 245789999999999999999999765544
Q ss_pred HHHHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChH
Q 003384 678 QYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 678 ~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
...-. .... ++.-+-.....+.+.+||.++|.+||+.|.++.
T Consensus 326 ~l~~K--Ivn~---pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~ 367 (576)
T KOG0585|consen 326 ELFDK--IVND---PLEFPENPEINEDLKDLIKRLLEKDPEQRITLP 367 (576)
T ss_pred HHHHH--HhcC---cccCCCcccccHHHHHHHHHHhhcChhheeehh
Confidence 32211 1111 221111124567899999999999999999983
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=341.93 Aligned_cols=245 Identities=27% Similarity=0.357 Sum_probs=196.4
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 536 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~---~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~ 536 (824)
++|...+.||+|+||.||+|.+. +..||||++..... .....+.+|+.++..++||||+++++++. +..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888999999999999999885 57899999875421 22356889999999999999999999884 4688999
Q ss_pred EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccc
Q 003384 537 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 616 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 616 (824)
||++||+|.+++. ....+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~g~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~ 154 (333)
T cd05600 81 EYVPGGDFRTLLN---NLGVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTY 154 (333)
T ss_pred eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCcccccc
Confidence 9999999999994 33468899999999999999999999 89999999999999999999999999999755331
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccC-CCCC
Q 003384 617 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD-PLAG 695 (824)
Q Consensus 617 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld-~~~~ 695 (824)
.....||+.|+|||++.+..++.++|||||||++|||++|++||..................+. +...
T Consensus 155 -----------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 223 (333)
T cd05600 155 -----------ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYD 223 (333)
T ss_pred -----------cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCC
Confidence 1334699999999999999999999999999999999999999976543322111111111111 1111
Q ss_pred CCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 696 DWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 696 ~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
......+..+.+|+.+||..+|.+||++.+
T Consensus 224 ~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ 253 (333)
T cd05600 224 DPRFNLSDEAWDLITKLINDPSRRFGSLED 253 (333)
T ss_pred ccccccCHHHHHHHHHHhhChhhhcCCHHH
Confidence 111234678999999999999999999843
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=344.26 Aligned_cols=234 Identities=22% Similarity=0.335 Sum_probs=194.3
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCC---CCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 536 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~---~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~ 536 (824)
.+|...+.||+|+||.||+|.+. +..||||++.... ......+.+|+.+++.++||||+++++++. +..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 46888899999999999999886 5789999987532 123456889999999999999999999883 5689999
Q ss_pred EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccc
Q 003384 537 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 616 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 616 (824)
||++||+|.+++.. ...+++.....++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 99999999999853 3468888999999999999999999 89999999999999999999999999999865332
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHH--HHhhhccccccCCCC
Q 003384 617 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQY--ALDTGKLKNLLDPLA 694 (824)
Q Consensus 617 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~--~~~~~~~~~~ld~~~ 694 (824)
. ....||+.|+|||++.+..++.++|||||||++|+|+||++||........ .+..+ .
T Consensus 172 ~-----------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~---------~ 231 (329)
T PTZ00263 172 T-----------FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG---------R 231 (329)
T ss_pred c-----------ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcC---------C
Confidence 1 123589999999999999999999999999999999999999976543321 11111 1
Q ss_pred CCCChhhHHHHHHHHHHHhhhccCCCCCh
Q 003384 695 GDWPFVQAEQLANLAMRCCEMSRKSRPEL 723 (824)
Q Consensus 695 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 723 (824)
..+|...+..+.+|+.+||+.+|.+||+.
T Consensus 232 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~ 260 (329)
T PTZ00263 232 LKFPNWFDGRARDLVKGLLQTDHTKRLGT 260 (329)
T ss_pred cCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 12344456789999999999999999973
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=341.69 Aligned_cols=244 Identities=26% Similarity=0.397 Sum_probs=198.0
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchh--HHHHHHHHHhcC-CCceeeEecccCC---ceEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSE--FQQEIDILSKIR-HPNLVTLVGACPE---VWTLV 535 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~--f~~Ei~iL~~l~-HpnIv~L~g~~~~---~~~LV 535 (824)
.+|...++||.|.||.||+|+.. +..||||.++..-.. .++ -.+|+.-|++|+ |||||+|...+.+ ..++|
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 46888899999999999999764 678999998765433 333 458999999999 9999999998843 57999
Q ss_pred EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccc
Q 003384 536 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 615 (824)
Q Consensus 536 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~ 615 (824)
||||+ .+|++++..+ ..+|++..+..|+.||++||+|+|. +|+.||||||+|||+..+..+||+|||||+.+..
T Consensus 89 fE~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 89 FEFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred HHhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEeccccccccccc
Confidence 99995 5999999644 6789999999999999999999999 9999999999999999999999999999997653
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhcc-CCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCC
Q 003384 616 NEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 694 (824)
Q Consensus 616 ~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~ 694 (824)
... .+..+.|.+|.|||++.. +-|+.+.|+|++|||++|+.+-+|.|.+.++++.....-.+ +..|..
T Consensus 163 kpP---------YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~V--LGtP~~ 231 (538)
T KOG0661|consen 163 KPP---------YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEV--LGTPDK 231 (538)
T ss_pred CCC---------cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHH--hCCCcc
Confidence 321 145568999999998754 67999999999999999999999999988877655432110 001111
Q ss_pred CCCC-------------------------hhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 695 GDWP-------------------------FVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 695 ~~~p-------------------------~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
..|+ ...+.++.+|+.+||..||.+|||+.+
T Consensus 232 ~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~ 287 (538)
T KOG0661|consen 232 DSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQ 287 (538)
T ss_pred ccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHH
Confidence 1111 124678899999999999999999943
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=345.66 Aligned_cols=253 Identities=24% Similarity=0.399 Sum_probs=198.5
Q ss_pred cCCCCccceeeecCceEEEEEEEC-------CeEEEEEEecCCCC-CCchhHHHHHHHHHhc-CCCceeeEecccC--Cc
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSL-QGPSEFQQEIDILSKI-RHPNLVTLVGACP--EV 531 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~-------~~~VAvK~l~~~~~-~~~~~f~~Ei~iL~~l-~HpnIv~L~g~~~--~~ 531 (824)
..+|...+.||+|+||.||+|.+. +..||||+++.... .....+.+|+.+|..+ +||||++++|+|. +.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 346888999999999999999742 35799999875432 2235688999999999 8999999999984 46
Q ss_pred eEEEEEecCCCChhhhhhccCC----------------------------------------------------------
Q 003384 532 WTLVYEYLPNGSLEDRLSCKDN---------------------------------------------------------- 553 (824)
Q Consensus 532 ~~LV~Ey~~ggsL~~~L~~~~~---------------------------------------------------------- 553 (824)
.++||||++||+|.+++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 8899999999999998854211
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccccc
Q 003384 554 --------------SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 619 (824)
Q Consensus 554 --------------~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 619 (824)
...+++..++.++.+|+.||.|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 1257889999999999999999999 89999999999999999999999999999865432211
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHH---HHHHhhhccccccCCCCC
Q 003384 620 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEV---QYALDTGKLKNLLDPLAG 695 (824)
Q Consensus 620 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~---~~~~~~~~~~~~ld~~~~ 695 (824)
. ..+...++..|+|||++.+..++.++|||||||++|||++ |.+||...... ...+..+. ..
T Consensus 271 ~------~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~--------~~ 336 (375)
T cd05104 271 V------VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGY--------RM 336 (375)
T ss_pred c------ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCc--------cC
Confidence 0 0122345778999999999999999999999999999998 89999654321 11111111 11
Q ss_pred CCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHH
Q 003384 696 DWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP 733 (824)
Q Consensus 696 ~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~ 733 (824)
..|...+.++.+|+.+||+.+|.+||++ .++++.|+.
T Consensus 337 ~~~~~~~~~l~~li~~cl~~dP~~RPs~-~eil~~l~~ 373 (375)
T cd05104 337 LSPECAPSEMYDIMKSCWDADPLKRPTF-KQIVQLIEQ 373 (375)
T ss_pred CCCCCCCHHHHHHHHHHccCChhHCcCH-HHHHHHHHh
Confidence 1223345689999999999999999999 677777764
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=327.08 Aligned_cols=249 Identities=23% Similarity=0.376 Sum_probs=197.9
Q ss_pred CCCCccceeeecCceEEEEEEEC-----CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccC--CceEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR-----HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLV 535 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~-----~~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV 535 (824)
.+|...+.||+|+||.||+|.+. +..||+|+++..... ....|.+|+.++.+++||||++++|++. +..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46788889999999999999764 367999998764322 2346889999999999999999999873 468999
Q ss_pred EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccc
Q 003384 536 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 615 (824)
Q Consensus 536 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~ 615 (824)
|||+++|+|.+++... ...+++..++.++.+++.||.|||+ ++++||||||+|||++.++.+|++|||++.....
T Consensus 85 ~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 85 TEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 9999999999998533 3468999999999999999999999 8999999999999999999999999998765322
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHH--HHhhhccccccCC
Q 003384 616 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQY--ALDTGKLKNLLDP 692 (824)
Q Consensus 616 ~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~--~~~~~~~~~~ld~ 692 (824)
.... ......++..|+|||.+.+..++.++|||||||++|||++ |.+||........ .+..+
T Consensus 160 ~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~-------- 224 (266)
T cd05064 160 EAIY-------TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDG-------- 224 (266)
T ss_pred cchh-------cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC--------
Confidence 1110 0112345788999999999999999999999999999775 9999975543221 11111
Q ss_pred CCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHH
Q 003384 693 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP 733 (824)
Q Consensus 693 ~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~ 733 (824)
.....+...+..+.+++.+||+.+|.+||++ +++.+.|..
T Consensus 225 ~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~-~~i~~~l~~ 264 (266)
T cd05064 225 FRLPAPRNCPNLLHQLMLDCWQKERGERPRF-SQIHSILSK 264 (266)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCchhCCCH-HHHHHHHHh
Confidence 1112234456789999999999999999999 677777654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=334.39 Aligned_cols=255 Identities=22% Similarity=0.376 Sum_probs=200.3
Q ss_pred CCCCccceeeecCceEEEEEEEC--C----eEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccC-CceEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--H----MQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLV 535 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~----~~VAvK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~-~~~~LV 535 (824)
.+|+..+.||+|+||.||+|.+. + ..||||++..... .....+.+|+.+++.++||||++++|+|. +..++|
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~~~~v 86 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 86 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCCceee
Confidence 36888999999999999999863 2 2489999875432 23457889999999999999999999984 457899
Q ss_pred EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccc
Q 003384 536 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 615 (824)
Q Consensus 536 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~ 615 (824)
+||+++|+|.+++... ...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.+..
T Consensus 87 ~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 87 TQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccccccC
Confidence 9999999999998533 3458889999999999999999999 8999999999999999999999999999987654
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHHHHhhhccccccCCCC
Q 003384 616 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLA 694 (824)
Q Consensus 616 ~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~~~~~~~~~ld~~~ 694 (824)
...... .....++..|+|||++.+..++.++|||||||++|||+| |++||............. . ...
T Consensus 162 ~~~~~~------~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~---~---~~~ 229 (316)
T cd05108 162 DEKEYH------AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE---K---GER 229 (316)
T ss_pred CCccee------ccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh---C---CCC
Confidence 321110 122335778999999999999999999999999999998 999997654322111000 0 011
Q ss_pred CCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHh
Q 003384 695 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 736 (824)
Q Consensus 695 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~ 736 (824)
...+...+..+.+++.+||..+|.+||++ .+++..|..+..
T Consensus 230 ~~~~~~~~~~~~~li~~cl~~~p~~Rps~-~~l~~~l~~~~~ 270 (316)
T cd05108 230 LPQPPICTIDVYMIMVKCWMIDADSRPKF-RELIIEFSKMAR 270 (316)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCcCH-HHHHHHHHHHHc
Confidence 11233455689999999999999999999 566666666544
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=341.25 Aligned_cols=232 Identities=23% Similarity=0.276 Sum_probs=187.7
Q ss_pred ceeeecCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEecCCC
Q 003384 470 LKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNG 542 (824)
Q Consensus 470 ~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~---~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey~~gg 542 (824)
+.||+|+||.||++... +..||||++..... .....+.+|+.+++.++||||+++++++. +..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999875 57899999875422 22345778999999999999999999874 4688999999999
Q ss_pred ChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCCC
Q 003384 543 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 622 (824)
Q Consensus 543 sL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~ 622 (824)
+|.+++.. ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++........
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~--- 151 (323)
T cd05571 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT--- 151 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCc---
Confidence 99998853 3568999999999999999999999 89999999999999999999999999998753221110
Q ss_pred ccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCChhhH
Q 003384 623 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQA 702 (824)
Q Consensus 623 ~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~ 702 (824)
.....||+.|+|||++.+..++.++|||||||++|||+||++||...+........ . .....+|...+
T Consensus 152 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~--~-----~~~~~~p~~~~ 219 (323)
T cd05571 152 -----MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI--L-----MEEIRFPRTLS 219 (323)
T ss_pred -----ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHH--H-----cCCCCCCCCCC
Confidence 12346999999999999999999999999999999999999999755432211110 0 01112344567
Q ss_pred HHHHHHHHHHhhhccCCCCC
Q 003384 703 EQLANLAMRCCEMSRKSRPE 722 (824)
Q Consensus 703 ~~l~~Li~~Cl~~~P~~RPt 722 (824)
..+.+|+.+||+.+|.+||+
T Consensus 220 ~~~~~li~~~L~~dP~~R~~ 239 (323)
T cd05571 220 PEAKSLLAGLLKKDPKQRLG 239 (323)
T ss_pred HHHHHHHHHHccCCHHHcCC
Confidence 78999999999999999994
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=346.28 Aligned_cols=257 Identities=24% Similarity=0.408 Sum_probs=199.9
Q ss_pred cCCCCccceeeecCceEEEEEEECC-------eEEEEEEecCCCCC-CchhHHHHHHHHHhc-CCCceeeEecccC--Cc
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQ-GPSEFQQEIDILSKI-RHPNLVTLVGACP--EV 531 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~~-------~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l-~HpnIv~L~g~~~--~~ 531 (824)
.++|...+.||+|+||.||+|...+ ..||||++...... ....+.+|+.+++.+ +||||++++|+|. ..
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 3468899999999999999987531 47999999754322 234688999999999 8999999999984 46
Q ss_pred eEEEEEecCCCChhhhhhccC-----------------------------------------------------------
Q 003384 532 WTLVYEYLPNGSLEDRLSCKD----------------------------------------------------------- 552 (824)
Q Consensus 532 ~~LV~Ey~~ggsL~~~L~~~~----------------------------------------------------------- 552 (824)
.++||||+++|+|.+++....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 889999999999999885321
Q ss_pred --------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCCCcc
Q 003384 553 --------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 624 (824)
Q Consensus 553 --------~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~ 624 (824)
...++++..+++|+.|++.||.|||+ +||+||||||+|||++.++.+||+|||+++.+.......
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~---- 269 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV---- 269 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCccee----
Confidence 11357889999999999999999999 899999999999999999999999999997654321110
Q ss_pred ccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHHHHhhhccccccCCCCCCCChhhHH
Q 003384 625 LCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAE 703 (824)
Q Consensus 625 ~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~ 703 (824)
......+++.|+|||++.+..++.++|||||||++|+|++ |++||............ ... ......+...+.
T Consensus 270 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~--~~~---~~~~~~~~~~~~ 342 (374)
T cd05106 270 --VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKM--VKR---GYQMSRPDFAPP 342 (374)
T ss_pred --eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHH--HHc---ccCccCCCCCCH
Confidence 0122346778999999998899999999999999999997 99999654321111000 000 011122333467
Q ss_pred HHHHHHHHHhhhccCCCCChHHHHHHHHHHH
Q 003384 704 QLANLAMRCCEMSRKSRPELGKDVWRVLEPM 734 (824)
Q Consensus 704 ~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l 734 (824)
.+.+++.+||+.+|.+||++ .++++.|+.+
T Consensus 343 ~l~~li~~cl~~dp~~RPs~-~~l~~~l~~~ 372 (374)
T cd05106 343 EIYSIMKMCWNLEPTERPTF-SQISQLIQRQ 372 (374)
T ss_pred HHHHHHHHHcCCChhhCcCH-HHHHHHHHHH
Confidence 89999999999999999999 7788888765
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=337.88 Aligned_cols=231 Identities=23% Similarity=0.299 Sum_probs=187.9
Q ss_pred eeecCceEEEEEEEC--CeEEEEEEecCCC---CCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEecCCCCh
Q 003384 472 IGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNGSL 544 (824)
Q Consensus 472 LG~G~fG~Vykg~~~--~~~VAvK~l~~~~---~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey~~ggsL 544 (824)
||+|+||.||+|... +..||+|++.... ......+.+|+.++.+++||||++++++|. +..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999886 5789999986532 223456788999999999999999999884 468999999999999
Q ss_pred hhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCCCcc
Q 003384 545 EDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 624 (824)
Q Consensus 545 ~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~ 624 (824)
.+++.. ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~----- 149 (312)
T cd05585 81 FHHLQR---EGRFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK----- 149 (312)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCc-----
Confidence 999853 3468999999999999999999999 89999999999999999999999999998754322110
Q ss_pred ccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCChhhHHH
Q 003384 625 LCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQ 704 (824)
Q Consensus 625 ~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~ 704 (824)
.....||+.|+|||++.+..++.++|||||||++|+|+||++||........... ... ....+|...+..
T Consensus 150 ---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~--~~~-----~~~~~~~~~~~~ 219 (312)
T cd05585 150 ---TNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRK--ILQ-----EPLRFPDGFDRD 219 (312)
T ss_pred ---cccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHH--HHc-----CCCCCCCcCCHH
Confidence 1234699999999999999999999999999999999999999975543221111 011 111234455678
Q ss_pred HHHHHHHHhhhccCCCCCh
Q 003384 705 LANLAMRCCEMSRKSRPEL 723 (824)
Q Consensus 705 l~~Li~~Cl~~~P~~RPt~ 723 (824)
+.+++.+||+.+|.+||++
T Consensus 220 ~~~li~~~L~~dp~~R~~~ 238 (312)
T cd05585 220 AKDLLIGLLSRDPTRRLGY 238 (312)
T ss_pred HHHHHHHHcCCCHHHcCCC
Confidence 9999999999999999975
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=322.14 Aligned_cols=245 Identities=27% Similarity=0.349 Sum_probs=196.2
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCC--chhHHHHHHHHHhcCCCceeeEe----cccCCceEEEE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLV----GACPEVWTLVY 536 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~L~----g~~~~~~~LV~ 536 (824)
.|+....|++|.||.||+|+++ +.-||+|+++...... +-.-.+||.+|.+++|||||.+- |.-.+..||||
T Consensus 77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VM 156 (419)
T KOG0663|consen 77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVM 156 (419)
T ss_pred HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeH
Confidence 5788889999999999999886 4779999998764322 23467999999999999999984 44467799999
Q ss_pred EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccc
Q 003384 537 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 616 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 616 (824)
|||+. +|..++... ..+|...+...+..|++.||+|||. +.|+||||||+|+|+...|.+||+|||||+.+...
T Consensus 157 e~~Eh-DLksl~d~m--~q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 157 EYVEH-DLKSLMETM--KQPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred HHHHh-hHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 99986 788888533 3578899999999999999999999 89999999999999999999999999999987655
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccC-CCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCC-
Q 003384 617 EISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA- 694 (824)
Q Consensus 617 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~- 694 (824)
.. ..+..+-|.+|.|||.+.+. .|+.+.|+||+|||+.||++++|.|.+..++.+.... +..+..|..
T Consensus 231 ~k--------~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~I--f~llGtPte~ 300 (419)
T KOG0663|consen 231 LK--------PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKI--FKLLGTPSEA 300 (419)
T ss_pred cc--------cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHH--HHHhCCCccc
Confidence 21 12445679999999999875 6999999999999999999999999887765543221 111111111
Q ss_pred -------------------------CCCChh-hHHHHHHHHHHHhhhccCCCCChHH
Q 003384 695 -------------------------GDWPFV-QAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 695 -------------------------~~~p~~-~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
..++.. .++.-.+|+...|..||.+|.|+.+
T Consensus 301 iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~ 357 (419)
T KOG0663|consen 301 IWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAED 357 (419)
T ss_pred cCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHH
Confidence 111111 3467789999999999999999843
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=369.35 Aligned_cols=257 Identities=29% Similarity=0.482 Sum_probs=210.6
Q ss_pred CCCccceeeecCceEEEEEEECC-------eEEEEEEecCC-CCCCchhHHHHHHHHHhcCCCceeeEecccCC--ceEE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPH-SLQGPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTL 534 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~~-------~~VAvK~l~~~-~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~~--~~~L 534 (824)
+......||+|+||.||.|.+.+ ..||||.+... +.+...+|.+|..+|++++|||||+|+|+|.+ ..+|
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i 772 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI 772 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence 44566789999999999998763 24999998765 34456789999999999999999999999943 5789
Q ss_pred EEEecCCCChhhhhhccC----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccc
Q 003384 535 VYEYLPNGSLEDRLSCKD----NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS 610 (824)
Q Consensus 535 V~Ey~~ggsL~~~L~~~~----~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla 610 (824)
++|||.||+|..+|.... ....|+....+.++.+||+|+.||+. +++|||||...|+||+....+||+|||||
T Consensus 773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaDFGlA 849 (1025)
T KOG1095|consen 773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIADFGLA 849 (1025)
T ss_pred EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcccchh
Confidence 999999999999996542 14568999999999999999999999 88999999999999999999999999999
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHHHH---hhhcc
Q 003384 611 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYAL---DTGKL 686 (824)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~---~~~~~ 686 (824)
+.+...+..... ....-...|||||.+..+.++.|+|||||||+|||++| |..||+..+..+... ..|
T Consensus 850 rDiy~~~yyr~~------~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-- 921 (1025)
T KOG1095|consen 850 RDIYDKDYYRKH------GEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-- 921 (1025)
T ss_pred Hhhhhchheecc------CccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC--
Confidence 955544432211 11233568999999999999999999999999999999 999998776544322 222
Q ss_pred ccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhhCCC
Q 003384 687 KNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGG 740 (824)
Q Consensus 687 ~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~~~~~ 740 (824)
..+.|..++..+.+++.+||+.+|++||++ ..+++.+..+......
T Consensus 922 -------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F-~~i~~q~~~i~~~~~~ 967 (1025)
T KOG1095|consen 922 -------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSF-RTIVEQDPAISNAALG 967 (1025)
T ss_pred -------ccCCCCCCChHHHHHHHHHccCChhhCccH-HHHHhhhhhhhhhhcc
Confidence 234577888999999999999999999999 5666777776655433
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=328.87 Aligned_cols=244 Identities=40% Similarity=0.655 Sum_probs=189.1
Q ss_pred cceeeecCceEEEEEEEC------CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEec
Q 003384 469 SLKIGEGGYGSIYKGLLR------HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL 539 (824)
Q Consensus 469 ~~~LG~G~fG~Vykg~~~------~~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey~ 539 (824)
.+.||.|.||.||+|.+. +..|+||+++..... ..+.|.+|++++++++||||++++|+|. +..++||||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 467999999999999988 478999999653222 2467999999999999999999999984 4588999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccccc
Q 003384 540 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 619 (824)
Q Consensus 540 ~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 619 (824)
++|+|.++|... ....+++..+..|+.|++.||.|||+ ++++|+||+++|||++.++.+||+|||++.........
T Consensus 84 ~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 84 PGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccc-cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccc
Confidence 999999999654 24568999999999999999999999 78999999999999999999999999999876322111
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHH--HHHhhhccccccCCCCCC
Q 003384 620 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--YALDTGKLKNLLDPLAGD 696 (824)
Q Consensus 620 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~ 696 (824)
.......+...|+|||.+.+..++.++||||||+++|||+| |+.||....... ..+..+. ...
T Consensus 160 ------~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~--------~~~ 225 (259)
T PF07714_consen 160 ------KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQ--------RLP 225 (259)
T ss_dssp ------EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTE--------ETT
T ss_pred ------ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--------cce
Confidence 11123346789999999999999999999999999999999 789986553322 1112211 122
Q ss_pred CChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHH
Q 003384 697 WPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVL 731 (824)
Q Consensus 697 ~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L 731 (824)
.+...+..+.+++.+||..+|.+||++ +++++.|
T Consensus 226 ~~~~~~~~~~~li~~C~~~~p~~RPs~-~~i~~~L 259 (259)
T PF07714_consen 226 IPDNCPKDIYSLIQQCWSHDPEKRPSF-QEILQEL 259 (259)
T ss_dssp SBTTSBHHHHHHHHHHT-SSGGGS--H-HHHHHHH
T ss_pred eccchhHHHHHHHHHHcCCChhhCcCH-HHHHhcC
Confidence 334456789999999999999999999 5665544
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=327.82 Aligned_cols=247 Identities=26% Similarity=0.324 Sum_probs=192.3
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEe
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY 538 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey 538 (824)
+|...+.||+|+||.||+|... +..||||++..... .....+.+|+.+++.++||||++++++|. +..++||||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY 81 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence 6888899999999999999986 47899999875422 22456889999999999999999999884 468899999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccc
Q 003384 539 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 618 (824)
Q Consensus 539 ~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 618 (824)
+++++|..+.. ....+++..+..++.|++.||.|||. .+|+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 82 VEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred CCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 99887765542 23468899999999999999999999 8999999999999999999999999999987543221
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhcc------------
Q 003384 619 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL------------ 686 (824)
Q Consensus 619 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~------------ 686 (824)
.. .....||+.|+|||++.+..++.++|||||||++|+|++|++||...............
T Consensus 156 ~~-------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (287)
T cd07848 156 AN-------YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLF 228 (287)
T ss_pred cc-------ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhh
Confidence 10 12345899999999999889999999999999999999999999765432221111000
Q ss_pred ------ccccCCCC-------CCCChhhHHHHHHHHHHHhhhccCCCCChH
Q 003384 687 ------KNLLDPLA-------GDWPFVQAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 687 ------~~~ld~~~-------~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
.....+.. ..+....+..+.+|+.+||+.+|.+||++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~ 279 (287)
T cd07848 229 YSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTE 279 (287)
T ss_pred hccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHH
Confidence 00000000 001112456799999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=345.56 Aligned_cols=238 Identities=26% Similarity=0.417 Sum_probs=200.7
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHHhcCCCceeeEecccCC--ceEEEEE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVYE 537 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~---~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~~--~~~LV~E 537 (824)
-|..++.||.|+-|.|..|++. |+.+|||++..... .....+.+|+-||+.+.||||++||+.+.+ .+|||.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 4777888999999999999874 78999999976532 224568899999999999999999999954 6899999
Q ss_pred ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccc
Q 003384 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 617 (824)
Q Consensus 538 y~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 617 (824)
|++||.|.++|. ..++|+....++++.||..|+.|+|. .+|+||||||+|+|||..+.+||+|||+|.+-..+.
T Consensus 93 yv~gGELFdylv---~kG~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk 166 (786)
T KOG0588|consen 93 YVPGGELFDYLV---RKGPLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK 166 (786)
T ss_pred ecCCchhHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecccCCc
Confidence 999999999995 44679999999999999999999999 789999999999999999999999999998765543
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCC-cchhHHhHHHHHHHHHhCCCCCCCchHHH--HHHhhhccccccCCCC
Q 003384 618 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELT-PKSDVYSFGIILLRLLTGRPALGITKEVQ--YALDTGKLKNLLDPLA 694 (824)
Q Consensus 618 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t-~ksDVwSlGvvL~ELltG~~Pf~~~~~~~--~~~~~~~~~~~ld~~~ 694 (824)
.- .+.+|+|.|.|||++.+.+|+ .++||||+|||||.||||+.||+.++--. .-+..|.+
T Consensus 167 lL---------eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f-------- 229 (786)
T KOG0588|consen 167 LL---------ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVF-------- 229 (786)
T ss_pred cc---------cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcc--------
Confidence 21 334599999999999999885 68999999999999999999998554221 11222322
Q ss_pred CCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 003384 695 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 727 (824)
Q Consensus 695 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 727 (824)
+.|...+.+.++|+.+|+..||..|.|+ ++|
T Consensus 230 -~MPs~Is~eaQdLLr~ml~VDp~~RiT~-~eI 260 (786)
T KOG0588|consen 230 -EMPSNISSEAQDLLRRMLDVDPSTRITT-EEI 260 (786)
T ss_pred -cCCCcCCHHHHHHHHHHhccCccccccH-HHH
Confidence 3467778899999999999999999999 444
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=340.92 Aligned_cols=234 Identities=23% Similarity=0.324 Sum_probs=191.8
Q ss_pred CCCCccceeeecCceEEEEEEECC---eEEEEEEecCCC---CCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLRH---MQVAIKMLHPHS---LQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLV 535 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~~---~~VAvK~l~~~~---~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV 535 (824)
.+|...+.||+|+||.||+|.+.+ ..||+|++.... ......+.+|+.+++.++||||+++++++. ...++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 368888999999999999998653 579999986432 223456889999999999999999999984 458899
Q ss_pred EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccc
Q 003384 536 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 615 (824)
Q Consensus 536 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~ 615 (824)
|||+++|+|.+++.. ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 110 ~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 110 LEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 999999999999853 3468899999999999999999999 8999999999999999999999999999986532
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCC
Q 003384 616 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG 695 (824)
Q Consensus 616 ~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~ 695 (824)
.. ....||+.|+|||++.+..++.++|||||||++|||+||.+||............. .. ..
T Consensus 184 ~~-----------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~--~~-----~~ 245 (340)
T PTZ00426 184 RT-----------YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKIL--EG-----II 245 (340)
T ss_pred Cc-----------ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHh--cC-----CC
Confidence 11 23458999999999999889999999999999999999999997655432111110 00 11
Q ss_pred CCChhhHHHHHHHHHHHhhhccCCCC
Q 003384 696 DWPFVQAEQLANLAMRCCEMSRKSRP 721 (824)
Q Consensus 696 ~~p~~~~~~l~~Li~~Cl~~~P~~RP 721 (824)
.+|...+..+.+++.+|++.+|.+|+
T Consensus 246 ~~p~~~~~~~~~li~~~l~~dp~~R~ 271 (340)
T PTZ00426 246 YFPKFLDNNCKHLMKKLLSHDLTKRY 271 (340)
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHcC
Confidence 23444566889999999999999996
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=353.88 Aligned_cols=248 Identities=20% Similarity=0.242 Sum_probs=198.5
Q ss_pred CCCccceeeecCceEEEEEEEC---CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--CCceEEEEEec
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR---HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 539 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~---~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~Ey~ 539 (824)
.|...+.||+|+||.||+|... +..||+|.+..........+.+|+.+|+.++|||||+++++| .+..+|||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4888899999999999999764 457888877554433344678899999999999999999988 45789999999
Q ss_pred CCCChhhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccc
Q 003384 540 PNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 618 (824)
Q Consensus 540 ~ggsL~~~L~~~-~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 618 (824)
+||+|.++|... ....++++..+..++.|++.||.|||+ ++|+||||||+||||+.++.+||+|||+++.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999988532 334578999999999999999999999 8999999999999999999999999999987643221
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCC
Q 003384 619 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWP 698 (824)
Q Consensus 619 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p 698 (824)
.. ......||+.|+|||++.+..++.++|||||||++|+|+||++||........... .+.......|
T Consensus 225 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~------~~~~~~~~~~ 292 (478)
T PTZ00267 225 LD------VASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQ------VLYGKYDPFP 292 (478)
T ss_pred cc------cccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH------HHhCCCCCCC
Confidence 10 11345699999999999999999999999999999999999999976543221111 1111111233
Q ss_pred hhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 003384 699 FVQAEQLANLAMRCCEMSRKSRPELGKDV 727 (824)
Q Consensus 699 ~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 727 (824)
...+..+.+++.+||+.+|.+||++.+.+
T Consensus 293 ~~~s~~~~~li~~~L~~dP~~Rps~~~~l 321 (478)
T PTZ00267 293 CPVSSGMKALLDPLLSKNPALRPTTQQLL 321 (478)
T ss_pred ccCCHHHHHHHHHHhccChhhCcCHHHHH
Confidence 44567899999999999999999985544
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=326.90 Aligned_cols=250 Identities=28% Similarity=0.479 Sum_probs=199.2
Q ss_pred CCCccceeeecCceEEEEEEECC-------eEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccC--CceEE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTL 534 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~~-------~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~L 534 (824)
+|...+.||+|+||.||+|...+ ..||+|.+...... ....|.+|+.++..++||||+++++++. ...++
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 85 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM 85 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence 57778899999999999998643 46999998754322 2346889999999999999999999884 45789
Q ss_pred EEEecCCCChhhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCc
Q 003384 535 VYEYLPNGSLEDRLSCKDN-------------SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV 601 (824)
Q Consensus 535 V~Ey~~ggsL~~~L~~~~~-------------~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~ 601 (824)
+|||+++|+|.+++..... ...+++..++.++.+++.||.|||. ++++||||||+|||++.++.
T Consensus 86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGLT 162 (283)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCCc
Confidence 9999999999999854311 1458889999999999999999999 89999999999999999999
Q ss_pred ceeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHH--
Q 003384 602 SKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ-- 678 (824)
Q Consensus 602 vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~-- 678 (824)
+||+|||+++......... ......+++.|+|||.+.+..++.++|||||||++|||+| |..||.......
T Consensus 163 ~~L~dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~ 236 (283)
T cd05048 163 VKISDFGLSRDIYSADYYR------VQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVI 236 (283)
T ss_pred EEECCCcceeecccccccc------ccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 9999999998654322111 1123457889999999998899999999999999999998 999986543321
Q ss_pred HHHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHH
Q 003384 679 YALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 732 (824)
Q Consensus 679 ~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le 732 (824)
..+..+ .....+...+..+.+|+.+||+.+|.+||++ +++.+.|+
T Consensus 237 ~~i~~~--------~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~-~~i~~~l~ 281 (283)
T cd05048 237 EMIRSR--------QLLPCPEDCPARVYALMIECWNEIPARRPRF-KDIHTRLR 281 (283)
T ss_pred HHHHcC--------CcCCCcccCCHHHHHHHHHHccCChhhCcCH-HHHHHHHh
Confidence 111111 1122345567899999999999999999999 67777665
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=320.87 Aligned_cols=242 Identities=25% Similarity=0.443 Sum_probs=193.6
Q ss_pred eeeecCceEEEEEEEC----CeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEecccC-CceEEEEEecCCCC
Q 003384 471 KIGEGGYGSIYKGLLR----HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVYEYLPNGS 543 (824)
Q Consensus 471 ~LG~G~fG~Vykg~~~----~~~VAvK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~L~g~~~-~~~~LV~Ey~~ggs 543 (824)
.||+|+||.||+|.+. +..||+|++...... ..+.+.+|+.+++.++||||++++|++. +.+++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~ 81 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAESWMLVMELAELGP 81 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCcEEEEecCCCCc
Confidence 5899999999999763 477999998654322 2356889999999999999999999884 46789999999999
Q ss_pred hhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCCCc
Q 003384 544 LEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT 623 (824)
Q Consensus 544 L~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~ 623 (824)
|.+++.. ...+++..+..++.|++.||.|||. ++|+||||||.|||++.++.+||+|||++............
T Consensus 82 L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~- 154 (257)
T cd05116 82 LNKFLQK---NKHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA- 154 (257)
T ss_pred HHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee-
Confidence 9999843 3468899999999999999999999 89999999999999999999999999999866433211110
Q ss_pred cccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHH--HHHhhhccccccCCCCCCCChh
Q 003384 624 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--YALDTGKLKNLLDPLAGDWPFV 700 (824)
Q Consensus 624 ~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~~p~~ 700 (824)
.....++..|+|||.+....++.++|||||||++|||+| |++||....... ..+..+ .....|..
T Consensus 155 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~--------~~~~~~~~ 222 (257)
T cd05116 155 ----KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESG--------ERMECPQR 222 (257)
T ss_pred ----cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCC--------CCCCCCCC
Confidence 122345689999999988889999999999999999998 999997543321 111111 11223445
Q ss_pred hHHHHHHHHHHHhhhccCCCCChHHHHHHHHH
Q 003384 701 QAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 732 (824)
Q Consensus 701 ~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le 732 (824)
.+..+.+++.+||+.+|.+||++ ..|...|+
T Consensus 223 ~~~~l~~li~~~~~~~p~~Rp~~-~~i~~~l~ 253 (257)
T cd05116 223 CPPEMYDLMKLCWTYGVDERPGF-AVVELRLR 253 (257)
T ss_pred CCHHHHHHHHHHhccCchhCcCH-HHHHHHHh
Confidence 67789999999999999999999 66766665
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=334.27 Aligned_cols=249 Identities=25% Similarity=0.353 Sum_probs=189.0
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCC--CCCchhHHHHHHHHHhcCCCceeeEecccC-------CceE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS--LQGPSEFQQEIDILSKIRHPNLVTLVGACP-------EVWT 533 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~--~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~-------~~~~ 533 (824)
+|...++||+|+||.||+|... +..||||++.... ......+.+|+.+++.++||||+++++++. ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4778889999999999999875 5789999987432 223346889999999999999999999862 1368
Q ss_pred EEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccc
Q 003384 534 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 613 (824)
Q Consensus 534 LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~ 613 (824)
+||||+. ++|.+++. ....+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIK---ANDDLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHH---hcccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999995 68988884 33468999999999999999999999 89999999999999999999999999999864
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhcc--CCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHH----------
Q 003384 614 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS--GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYAL---------- 681 (824)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~--~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~---------- 681 (824)
....... .......||+.|+|||++.+ ..++.++|||||||++|+|+||++||..........
T Consensus 154 ~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 228 (338)
T cd07859 154 FNDTPTA-----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPS 228 (338)
T ss_pred ccccCcc-----ccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 3322111 01134569999999999876 678999999999999999999999996543221100
Q ss_pred -------hhhccccccC----CCCC---CCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 682 -------DTGKLKNLLD----PLAG---DWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 682 -------~~~~~~~~ld----~~~~---~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
........+. .... ......+..+.+++.+||+.+|.+||++.+
T Consensus 229 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e 286 (338)
T cd07859 229 PETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEE 286 (338)
T ss_pred HHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHH
Confidence 0000000000 0000 000123457889999999999999999843
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=337.34 Aligned_cols=231 Identities=23% Similarity=0.284 Sum_probs=186.6
Q ss_pred ceeeecCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEecCCC
Q 003384 470 LKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNG 542 (824)
Q Consensus 470 ~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~---~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey~~gg 542 (824)
+.||+|+||.||++... +..||+|++..... .....+.+|+.+++.++||||++++++|. +..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 36999999999999875 57899999875422 22345778999999999999999999874 5689999999999
Q ss_pred ChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCCC
Q 003384 543 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 622 (824)
Q Consensus 543 sL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~ 622 (824)
+|.+++.. ...+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++.........
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~--- 151 (323)
T cd05595 81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--- 151 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCc---
Confidence 99988843 3468999999999999999999999 89999999999999999999999999998753222110
Q ss_pred ccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCChhhH
Q 003384 623 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQA 702 (824)
Q Consensus 623 ~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~ 702 (824)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||............ . .....+|...+
T Consensus 152 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~--~-----~~~~~~p~~~~ 219 (323)
T cd05595 152 -----MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI--L-----MEEIRFPRTLS 219 (323)
T ss_pred -----cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH--h-----cCCCCCCCCCC
Confidence 12346899999999999999999999999999999999999999654432211110 0 01112344566
Q ss_pred HHHHHHHHHHhhhccCCCC
Q 003384 703 EQLANLAMRCCEMSRKSRP 721 (824)
Q Consensus 703 ~~l~~Li~~Cl~~~P~~RP 721 (824)
..+.+++.+||+.+|.+||
T Consensus 220 ~~~~~li~~~L~~dP~~R~ 238 (323)
T cd05595 220 PEAKSLLAGLLKKDPKQRL 238 (323)
T ss_pred HHHHHHHHHHccCCHHHhC
Confidence 7899999999999999998
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=320.19 Aligned_cols=247 Identities=25% Similarity=0.456 Sum_probs=196.6
Q ss_pred CCCccceeeecCceEEEEEEECC-eEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEecCC
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPN 541 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~~-~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey~~g 541 (824)
.|+..+.||+|+||.||+|.+.. ..+|+|.+.... .....|.+|+.+|++++||||++++++|. +..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (256)
T cd05114 5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN 83 (256)
T ss_pred HcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence 47778899999999999998865 579999876432 33567899999999999999999999884 468899999999
Q ss_pred CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCC
Q 003384 542 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 621 (824)
Q Consensus 542 gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 621 (824)
|+|.+++... ...+++..+..++.+++.||.|||+ ++|+||||||+||+++.++.+||+|||+++.........
T Consensus 84 ~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~- 157 (256)
T cd05114 84 GCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS- 157 (256)
T ss_pred CcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCceec-
Confidence 9999988533 2358899999999999999999999 899999999999999999999999999988654322111
Q ss_pred CccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHHHHhhhccccccCCCCCCCChh
Q 003384 622 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV 700 (824)
Q Consensus 622 ~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~ 700 (824)
.....++..|+|||++.+..++.++||||||+++|+|++ |++||................ ....|..
T Consensus 158 ------~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~------~~~~~~~ 225 (256)
T cd05114 158 ------SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGF------RLYRPKL 225 (256)
T ss_pred ------cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC------CCCCCCC
Confidence 122346678999999988889999999999999999999 999997654332211111110 1112333
Q ss_pred hHHHHHHHHHHHhhhccCCCCChHHHHHHHH
Q 003384 701 QAEQLANLAMRCCEMSRKSRPELGKDVWRVL 731 (824)
Q Consensus 701 ~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L 731 (824)
.+..+.+++.+||+.+|.+||++ +++++.|
T Consensus 226 ~~~~~~~li~~c~~~~p~~Rps~-~~l~~~l 255 (256)
T cd05114 226 ASMTVYEVMYSCWHEKPEGRPTF-AELLRAI 255 (256)
T ss_pred CCHHHHHHHHHHccCCcccCcCH-HHHHHhh
Confidence 45689999999999999999999 5555543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=325.10 Aligned_cols=247 Identities=27% Similarity=0.378 Sum_probs=189.2
Q ss_pred CCCccceeeecCceEEEEEEEC---CeEEEEEEecCCCCC--CchhHHHHHHHHHhc---CCCceeeEecccC-------
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR---HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKI---RHPNLVTLVGACP------- 529 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~---~~~VAvK~l~~~~~~--~~~~f~~Ei~iL~~l---~HpnIv~L~g~~~------- 529 (824)
+|...+.||+|+||.||+|... +..||||++...... ....+.+|+.+++.+ +||||++++++|.
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 6888899999999999999873 467999998754322 234567788888776 6999999999872
Q ss_pred CceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccc
Q 003384 530 EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI 609 (824)
Q Consensus 530 ~~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGl 609 (824)
...++||||+. ++|.+++.... ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 34789999996 58988885432 3458999999999999999999999 8999999999999999999999999999
Q ss_pred ccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhcccc-
Q 003384 610 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKN- 688 (824)
Q Consensus 610 a~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~- 688 (824)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|++||............-....
T Consensus 157 ~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~ 227 (290)
T cd07862 157 ARIYSFQM---------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 227 (290)
T ss_pred eEeccCCc---------ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCC
Confidence 97654321 01334589999999999988999999999999999999999999976544322111100000
Q ss_pred ---------------ccCCCCC----CCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 689 ---------------LLDPLAG----DWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 689 ---------------~ld~~~~----~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
.+.+... ......+..+.+|+.+||+.+|++||++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~ 283 (290)
T cd07862 228 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYS 283 (290)
T ss_pred CChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHH
Confidence 0000000 001123567889999999999999999843
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=321.45 Aligned_cols=249 Identities=26% Similarity=0.468 Sum_probs=200.3
Q ss_pred CCCCccceeeecCceEEEEEEECC-eEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEecC
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLP 540 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~~-~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey~~ 540 (824)
++|...++||+|+||.||+|...+ ..||+|.+.... ...+.+.+|+.+++.++||||+++++++. +..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 368888999999999999998764 679999886533 23567899999999999999999998874 46789999999
Q ss_pred CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccC
Q 003384 541 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 620 (824)
Q Consensus 541 ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 620 (824)
+|+|.+++... ....+++..+..++.+++.||.|||+ ++++||||||+|||++.++.+||+|||++..........
T Consensus 85 ~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05072 85 KGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA 160 (261)
T ss_pred CCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCceec
Confidence 99999998543 23568889999999999999999999 889999999999999999999999999998754322111
Q ss_pred CCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHH--HHHhhhccccccCCCCCCC
Q 003384 621 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--YALDTGKLKNLLDPLAGDW 697 (824)
Q Consensus 621 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~~ 697 (824)
.....++..|+|||++.+..++.++|||||||++|+|+| |+.||....... ..+..+ .. ...
T Consensus 161 -------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~----~~----~~~ 225 (261)
T cd05072 161 -------REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG----YR----MPR 225 (261)
T ss_pred -------cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcC----CC----CCC
Confidence 122346788999999988889999999999999999998 999996543322 111111 11 111
Q ss_pred ChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHH
Q 003384 698 PFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP 733 (824)
Q Consensus 698 p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~ 733 (824)
+...+..+.+++.+|++.+|++||++ +++.+.|+.
T Consensus 226 ~~~~~~~~~~li~~~l~~~p~~Rp~~-~~i~~~l~~ 260 (261)
T cd05072 226 MENCPDELYDIMKTCWKEKAEERPTF-DYLQSVLDD 260 (261)
T ss_pred CCCCCHHHHHHHHHHccCCcccCcCH-HHHHHHHhc
Confidence 22345689999999999999999999 778787764
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=337.24 Aligned_cols=240 Identities=27% Similarity=0.376 Sum_probs=198.3
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEeccc--CCceEEEEEec
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 539 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~Ey~ 539 (824)
.|.....||+|.||.||+|.+. ++.||||++...... ..+.+++|+.+|.+++++||.++||++ .....++||||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 4666678999999999999986 478999999876443 357899999999999999999999987 45677999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccccc
Q 003384 540 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 619 (824)
Q Consensus 540 ~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 619 (824)
.||++.+.|. ....+.+..+.-|..++..||.|||. ++.+|||||+.||||..+|.+||+|||++..+.....
T Consensus 94 ~gGsv~~lL~---~~~~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~- 166 (467)
T KOG0201|consen 94 GGGSVLDLLK---SGNILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK- 166 (467)
T ss_pred cCcchhhhhc---cCCCCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechhh-
Confidence 9999999993 44455778888899999999999999 8899999999999999999999999999986654321
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccC-CCCCCCC
Q 003384 620 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD-PLAGDWP 698 (824)
Q Consensus 620 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld-~~~~~~p 698 (824)
.+.+.+||+.|||||++....|+.++||||||++.+||++|.||+.....+ +...++. ...+...
T Consensus 167 -------rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm-------rvlflIpk~~PP~L~ 232 (467)
T KOG0201|consen 167 -------RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM-------RVLFLIPKSAPPRLD 232 (467)
T ss_pred -------ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc-------eEEEeccCCCCCccc
Confidence 225678999999999999889999999999999999999999999654432 1111121 1222223
Q ss_pred hhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 699 FVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 699 ~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
...+..+.+|+..||+.+|+.||++.+
T Consensus 233 ~~~S~~~kEFV~~CL~k~P~~RpsA~~ 259 (467)
T KOG0201|consen 233 GDFSPPFKEFVEACLDKNPEFRPSAKE 259 (467)
T ss_pred cccCHHHHHHHHHHhhcCcccCcCHHH
Confidence 355778999999999999999999843
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=327.37 Aligned_cols=254 Identities=26% Similarity=0.497 Sum_probs=203.0
Q ss_pred CCCccceeeecCceEEEEEEEC-------CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLV 535 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~-------~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV 535 (824)
+|.....||+|+||.||+|... +..+++|.+..........+.+|+.+++.++||||+++++++. +..++|
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (291)
T cd05094 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMV 85 (291)
T ss_pred HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEE
Confidence 4677788999999999999753 2458999987655444567999999999999999999999884 468899
Q ss_pred EEecCCCChhhhhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcc
Q 003384 536 YEYLPNGSLEDRLSCKD-------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS 602 (824)
Q Consensus 536 ~Ey~~ggsL~~~L~~~~-------------~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~v 602 (824)
|||+++++|.+++.... ....+++..++.++.+++.||.|||. ++|+||||||+|||++.++.+
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~~~ 162 (291)
T cd05094 86 FEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLLV 162 (291)
T ss_pred EecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcE
Confidence 99999999999985432 12348999999999999999999999 899999999999999999999
Q ss_pred eeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHH--H
Q 003384 603 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--Y 679 (824)
Q Consensus 603 KL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~--~ 679 (824)
||+|||++.......... ......|+..|+|||++.+..++.++|||||||++|+|+| |++||....... .
T Consensus 163 ~l~dfg~a~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 236 (291)
T cd05094 163 KIGDFGMSRDVYSTDYYR------VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE 236 (291)
T ss_pred EECCCCcccccCCCceee------cCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 999999997654322111 1123457889999999999999999999999999999999 999986543321 1
Q ss_pred HHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHh
Q 003384 680 ALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 736 (824)
Q Consensus 680 ~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~ 736 (824)
....+ .....+...+..+.+++.+||+.+|.+||++ .+|.+.|+.+..
T Consensus 237 ~~~~~--------~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~-~~v~~~l~~~~~ 284 (291)
T cd05094 237 CITQG--------RVLERPRVCPKEVYDIMLGCWQREPQQRLNI-KEIYKILHALGK 284 (291)
T ss_pred HHhCC--------CCCCCCccCCHHHHHHHHHHcccChhhCcCH-HHHHHHHHHHHh
Confidence 11111 1112233456789999999999999999999 788888887744
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=333.88 Aligned_cols=246 Identities=23% Similarity=0.346 Sum_probs=193.3
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEeccc--CCceEEEEEe
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 538 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~Ey 538 (824)
++|+..+.||+|+||.||++... +..||+|++..... .....+.+|+++|++++||||+++++++ .+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence 57889999999999999999886 57899999875422 1234689999999999999999999987 3468999999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccc
Q 003384 539 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 618 (824)
Q Consensus 539 ~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 618 (824)
+++|+|.+++.. ...+++..+..++.+++.||.|||+. .+|+||||||+|||++.++.+||+|||++..+....
T Consensus 85 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 158 (331)
T cd06649 85 MDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158 (331)
T ss_pred CCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcccccccccc-
Confidence 999999999853 34588999999999999999999982 259999999999999999999999999987653321
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhcc------------
Q 003384 619 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL------------ 686 (824)
Q Consensus 619 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~------------ 686 (824)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||............+..
T Consensus 159 ---------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (331)
T cd06649 159 ---------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSI 229 (331)
T ss_pred ---------cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCcccc
Confidence 12345899999999999989999999999999999999999999654322211100000
Q ss_pred ----------------------------ccccCCCCCCC-ChhhHHHHHHHHHHHhhhccCCCCChH
Q 003384 687 ----------------------------KNLLDPLAGDW-PFVQAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 687 ----------------------------~~~ld~~~~~~-p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
..+........ ....+.++.+|+.+||+.+|++||++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ 296 (331)
T cd06649 230 SPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLK 296 (331)
T ss_pred CcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHH
Confidence 00000000001 112456899999999999999999994
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=325.47 Aligned_cols=253 Identities=25% Similarity=0.416 Sum_probs=197.7
Q ss_pred hcCCCCccceeeecCceEEEEEEECC-------eEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccC--Cc
Q 003384 462 ATHNFDPSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EV 531 (824)
Q Consensus 462 ~~~~f~~~~~LG~G~fG~Vykg~~~~-------~~VAvK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~ 531 (824)
.+++|+..+.||+|+||.||+|.+.+ ..||||++..... .....|.+|+.+++.++||||+++++++. ..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 45678999999999999999997642 5699998864322 22346889999999999999999999985 45
Q ss_pred eEEEEEecCCCChhhhhhccCC-------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCccee
Q 003384 532 WTLVYEYLPNGSLEDRLSCKDN-------SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKL 604 (824)
Q Consensus 532 ~~LV~Ey~~ggsL~~~L~~~~~-------~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL 604 (824)
.++||||+++|+|.+++..... ...+++..++.++.+++.||.|||+ .+++||||||+|||++.++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEE
Confidence 8899999999999999854221 2346788999999999999999999 89999999999999999999999
Q ss_pred eccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHHH--H
Q 003384 605 SDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYA--L 681 (824)
Q Consensus 605 ~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~--~ 681 (824)
+|||+++.......... .....+++.|+|||++.++.++.++|||||||++|||++ |.+||......... .
T Consensus 161 ~dfg~~~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~ 234 (277)
T cd05062 161 GDFGMTRDIYETDYYRK------GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV 234 (277)
T ss_pred CCCCCccccCCcceeec------CCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 99999876543321111 122346789999999998899999999999999999999 78898654332111 1
Q ss_pred hhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHH
Q 003384 682 DTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 732 (824)
Q Consensus 682 ~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le 732 (824)
..+. ....+...+..+.+++.+||+.+|.+||++ .+++..|+
T Consensus 235 ~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-~e~l~~l~ 276 (277)
T cd05062 235 MEGG--------LLDKPDNCPDMLFELMRMCWQYNPKMRPSF-LEIISSIK 276 (277)
T ss_pred HcCC--------cCCCCCCCCHHHHHHHHHHcCCChhhCcCH-HHHHHHhh
Confidence 1111 112234456789999999999999999999 56655553
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=336.10 Aligned_cols=231 Identities=23% Similarity=0.265 Sum_probs=187.4
Q ss_pred ceeeecCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEecCCC
Q 003384 470 LKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNG 542 (824)
Q Consensus 470 ~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~---~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey~~gg 542 (824)
+.||+|+||.||++... +..||||++..... .....+.+|+.+++.++||||+++++++. +..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999875 57899999875422 22346788999999999999999999873 4689999999999
Q ss_pred ChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCCC
Q 003384 543 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 622 (824)
Q Consensus 543 sL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~ 622 (824)
+|.+++.. ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~--- 151 (328)
T cd05593 81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAAT--- 151 (328)
T ss_pred CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccc---
Confidence 99988843 3468999999999999999999999 89999999999999999999999999998753221110
Q ss_pred ccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCChhhH
Q 003384 623 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQA 702 (824)
Q Consensus 623 ~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~ 702 (824)
.....||+.|+|||++.+..++.++|||||||++|+|+||++||............ ......+|...+
T Consensus 152 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~-------~~~~~~~p~~~~ 219 (328)
T cd05593 152 -----MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI-------LMEDIKFPRTLS 219 (328)
T ss_pred -----cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHh-------ccCCccCCCCCC
Confidence 12346999999999999989999999999999999999999999765432211110 011122344566
Q ss_pred HHHHHHHHHHhhhccCCCC
Q 003384 703 EQLANLAMRCCEMSRKSRP 721 (824)
Q Consensus 703 ~~l~~Li~~Cl~~~P~~RP 721 (824)
..+.+|+.+||+.+|.+||
T Consensus 220 ~~~~~li~~~L~~dP~~R~ 238 (328)
T cd05593 220 ADAKSLLSGLLIKDPNKRL 238 (328)
T ss_pred HHHHHHHHHHcCCCHHHcC
Confidence 7899999999999999998
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=322.33 Aligned_cols=252 Identities=23% Similarity=0.399 Sum_probs=197.5
Q ss_pred CCCccceeeecCceEEEEEEEC--Ce----EEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccC-CceEEEE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HM----QVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVY 536 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~----~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~L~g~~~-~~~~LV~ 536 (824)
+|...+.||+|+||.||+|.+. +. .|++|.+...... ....+..|+.+++.++||||++++|++. ...++|+
T Consensus 8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~~~~~i~ 87 (279)
T cd05111 8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGASLQLVT 87 (279)
T ss_pred hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECCCccEEEE
Confidence 5677789999999999999873 33 4788887543221 2346778888999999999999999885 4567999
Q ss_pred EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccc
Q 003384 537 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 616 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 616 (824)
||+++|+|.+++... ...+++..+..|+.|++.||.|||+ ++++||||||+|||++.++.+||+|||+++.+...
T Consensus 88 e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 88 QLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred EeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 999999999999532 3468999999999999999999999 88999999999999999999999999999866433
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHH--HHHhhhccccccCCC
Q 003384 617 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--YALDTGKLKNLLDPL 693 (824)
Q Consensus 617 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~--~~~~~~~~~~~ld~~ 693 (824)
..... .....|+..|+|||++.++.++.++|||||||++|||+| |+.||....... ..+..+..
T Consensus 163 ~~~~~------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~------- 229 (279)
T cd05111 163 DKKYF------YSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGER------- 229 (279)
T ss_pred Ccccc------cCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCc-------
Confidence 21111 123457889999999998899999999999999999998 999997543322 11221111
Q ss_pred CCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHh
Q 003384 694 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 736 (824)
Q Consensus 694 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~ 736 (824)
...+...+..+..++.+||..+|..||++ .++...|..+..
T Consensus 230 -~~~~~~~~~~~~~li~~c~~~~p~~Rps~-~el~~~l~~~~~ 270 (279)
T cd05111 230 -LAQPQICTIDVYMVMVKCWMIDENVRPTF-KELANEFTRMAR 270 (279)
T ss_pred -CCCCCCCCHHHHHHHHHHcCCCcccCcCH-HHHHHHHHHHHh
Confidence 11122345678999999999999999999 667777766543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=326.35 Aligned_cols=256 Identities=24% Similarity=0.468 Sum_probs=204.0
Q ss_pred CCCCccceeeecCceEEEEEEEC-------CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC--CceEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTL 534 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~-------~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~L 534 (824)
.+|...+.||+|+||.||++... +..+|+|.+..........+.+|+.++++++||||++++++|. +..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 46788889999999999999752 2458999887554334557899999999999999999999884 46889
Q ss_pred EEEecCCCChhhhhhccC----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCccee
Q 003384 535 VYEYLPNGSLEDRLSCKD----------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKL 604 (824)
Q Consensus 535 V~Ey~~ggsL~~~L~~~~----------~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL 604 (824)
||||+++++|.+++.... ....+++..++.++.|++.||.|||+ +|++||||||+|||++.++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEEe
Confidence 999999999999885322 12358999999999999999999999 89999999999999999999999
Q ss_pred eccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHH--HHH
Q 003384 605 SDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--YAL 681 (824)
Q Consensus 605 ~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~--~~~ 681 (824)
+|||+++......... ......+++.|+|||++.+..++.++|||||||++|+|+| |.+||....... ..+
T Consensus 162 ~dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i 235 (288)
T cd05093 162 GDFGMSRDVYSTDYYR------VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI 235 (288)
T ss_pred ccCCccccccCCceee------cCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 9999998654322111 1123346789999999998899999999999999999998 999996543221 222
Q ss_pred hhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhh
Q 003384 682 DTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 737 (824)
Q Consensus 682 ~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~~ 737 (824)
..+.. ...+...+..+.+|+.+||+.+|.+||++ +++...|+.+...
T Consensus 236 ~~~~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~-~~v~~~l~~~~~~ 282 (288)
T cd05093 236 TQGRV--------LQRPRTCPKEVYDLMLGCWQREPHMRLNI-KEIHSLLQNLAKA 282 (288)
T ss_pred HcCCc--------CCCCCCCCHHHHHHHHHHccCChhhCCCH-HHHHHHHHHHHHh
Confidence 22211 11223345689999999999999999999 7788888887653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=340.76 Aligned_cols=249 Identities=23% Similarity=0.304 Sum_probs=192.7
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 536 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~---~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~ 536 (824)
++|...+.||+|+||.||+|... +..||||++..... .....+.+|+.+|..++||||+++++++. +..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 36888999999999999999875 57899999875321 22345788999999999999999999884 4688999
Q ss_pred EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccc
Q 003384 537 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 616 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 616 (824)
||++||+|.+++.. ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 99999999999853 3468999999999999999999999 89999999999999999999999999999765322
Q ss_pred cccCCCc------------------------------cccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh
Q 003384 617 EISSNNT------------------------------TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 666 (824)
Q Consensus 617 ~~~~~~~------------------------------~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt 666 (824)
....... .........||+.|+|||++.+..++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 1100000 0000113469999999999999999999999999999999999
Q ss_pred CCCCCCCchHHHHHHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCC
Q 003384 667 GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPE 722 (824)
Q Consensus 667 G~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt 722 (824)
|++||.................. .........+..+.+|+.+|+. +|.+|++
T Consensus 235 G~~Pf~~~~~~~~~~~i~~~~~~---~~~~~~~~~s~~~~~li~~ll~-~p~~R~~ 286 (364)
T cd05599 235 GYPPFCSDNPQETYRKIINWKET---LQFPDEVPLSPEAKDLIKRLCC-EAERRLG 286 (364)
T ss_pred CCCCCCCCCHHHHHHHHHcCCCc---cCCCCCCCCCHHHHHHHHHHcc-CHhhcCC
Confidence 99999766543321111111111 1111112345688999999996 8999998
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=344.96 Aligned_cols=254 Identities=28% Similarity=0.448 Sum_probs=203.2
Q ss_pred CCCccceeeecCceEEEEEEECC-----eE-EEEEEecCCC---CCCchhHHHHHHHHHhcCCCceeeEeccc--CCceE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLRH-----MQ-VAIKMLHPHS---LQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWT 533 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~~-----~~-VAvK~l~~~~---~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~ 533 (824)
+-...++||+|+||+||+|.+.- .. ||||..+... .....+|.+|.++|++++|||||++||++ ....+
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ 237 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM 237 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence 33455899999999999998752 23 8999987533 22345799999999999999999999987 45789
Q ss_pred EEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccc
Q 003384 534 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 613 (824)
Q Consensus 534 LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~ 613 (824)
||||+|+||+|.++|.... ..++..+++.++.++|+||.|||+ +++|||||-..|+|++.++.+||+||||++.-
T Consensus 238 ivmEl~~gGsL~~~L~k~~--~~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 238 LVMELCNGGSLDDYLKKNK--KSLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFGLSRAG 312 (474)
T ss_pred EEEEecCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCccccccCC
Confidence 9999999999999996433 369999999999999999999999 89999999999999999999999999998754
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHHHHhhhccccccCC
Q 003384 614 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDP 692 (824)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~~~~~~~~~ld~ 692 (824)
..-.... ....-...|+|||.+..+-|+.++|||||||++||+++ |..||.+.......... . ...
T Consensus 313 ~~~~~~~--------~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI--~---~~~ 379 (474)
T KOG0194|consen 313 SQYVMKK--------FLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKI--V---KNG 379 (474)
T ss_pred cceeecc--------ccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHH--H---hcC
Confidence 3111110 01124679999999999999999999999999999998 88899776543321111 0 111
Q ss_pred CCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhh
Q 003384 693 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 737 (824)
Q Consensus 693 ~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~~ 737 (824)
.....|...+..+..+..+||..+|++||+| ..+.+.|+.+...
T Consensus 380 ~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm-~~i~~~l~~~~~~ 423 (474)
T KOG0194|consen 380 YRMPIPSKTPKELAKVMKQCWKKDPEDRPTM-STIKKKLEALEKK 423 (474)
T ss_pred ccCCCCCCCHHHHHHHHHHhccCChhhccCH-HHHHHHHHHHHhc
Confidence 1223345677899999999999999999999 7788888877654
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=337.72 Aligned_cols=252 Identities=25% Similarity=0.316 Sum_probs=197.6
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE 537 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~---~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~E 537 (824)
+|...+.||+|+||.||+|... +..||||++..... .....+..|+.++..++||||+++++++. +..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME 81 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence 6888899999999999999987 68899999875321 23456889999999999999999999884 46889999
Q ss_pred ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccc
Q 003384 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 617 (824)
Q Consensus 538 y~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 617 (824)
|+++|+|.+++... ..++...+..++.|++.||.|||. +||+||||||+||||+.++.+||+|||++..+....
T Consensus 82 ~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 82 YMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred CCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 99999999999533 568999999999999999999999 899999999999999999999999999998665432
Q ss_pred ccC---------------------CCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchH
Q 003384 618 ISS---------------------NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE 676 (824)
Q Consensus 618 ~~~---------------------~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~ 676 (824)
... ............||+.|+|||++.+..++.++|||||||+||+|++|++||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 000 00000112345699999999999999999999999999999999999999976653
Q ss_pred HHHHHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCC-hHHHH
Q 003384 677 VQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPE-LGKDV 727 (824)
Q Consensus 677 ~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt-~~~~v 727 (824)
............ ..........+..+.+|+.+|+. +|.+||+ + +++
T Consensus 236 ~~~~~~i~~~~~---~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~-~~l 282 (350)
T cd05573 236 QETYNKIINWKE---SLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSF-EEI 282 (350)
T ss_pred HHHHHHHhccCC---cccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCH-HHH
Confidence 322211111101 11111111246789999999997 9999999 6 444
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=320.17 Aligned_cols=251 Identities=27% Similarity=0.485 Sum_probs=200.7
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEecC
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLP 540 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey~~ 540 (824)
.|...+.||.|+||.||+|.+. +..||+|.+.... .....+.+|+.+++.++||||++++++|. +..++||||++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 4677788999999999999875 5789999986532 33467899999999999999999999883 46789999999
Q ss_pred CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccC
Q 003384 541 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 620 (824)
Q Consensus 541 ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 620 (824)
+++|.+++.... ...+++..++.++.|++.||.|||. ++++||||||+|||++.++.+||+|||++..........
T Consensus 86 ~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~ 161 (263)
T cd05052 86 YGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 161 (263)
T ss_pred CCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence 999999985432 3468999999999999999999999 899999999999999999999999999998664332111
Q ss_pred CCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHHHHhhhccccccCCCCCCCCh
Q 003384 621 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPF 699 (824)
Q Consensus 621 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~ 699 (824)
. ....++..|+|||++.+..++.++|||||||++|||+| |.+||........... +.. ......+.
T Consensus 162 ~-------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~---~~~---~~~~~~~~ 228 (263)
T cd05052 162 H-------AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL---LEK---GYRMERPE 228 (263)
T ss_pred c-------CCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH---HHC---CCCCCCCC
Confidence 0 12234678999999998999999999999999999998 9999975432211101 001 11123344
Q ss_pred hhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHH
Q 003384 700 VQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 734 (824)
Q Consensus 700 ~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l 734 (824)
..+..+.+++.+||+.+|.+||++ .++.+.|+.+
T Consensus 229 ~~~~~~~~li~~cl~~~p~~Rp~~-~~l~~~l~~~ 262 (263)
T cd05052 229 GCPPKVYELMRACWQWNPSDRPSF-AEIHQAFETM 262 (263)
T ss_pred CCCHHHHHHHHHHccCCcccCCCH-HHHHHHHHhh
Confidence 556789999999999999999999 6777777653
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=319.01 Aligned_cols=252 Identities=27% Similarity=0.462 Sum_probs=201.0
Q ss_pred cCCCCccceeeecCceEEEEEEECC-eEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEec
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL 539 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~~-~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey~ 539 (824)
..+|...+.||+|+||.||+|.+.+ ..||||.+.... .....+.+|+.++++++||||+++++++. ...++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 3468888999999999999998754 679999987543 23567999999999999999999999884 4588999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccccc
Q 003384 540 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 619 (824)
Q Consensus 540 ~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 619 (824)
++++|.+++.... ...+++..+..++.+++.||.|||. ++|+||||||+|||++.++.+||+|||++.........
T Consensus 84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 9999999985432 3468999999999999999999999 89999999999999999999999999999876532111
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHHHHhhhccccccCCCCCCCC
Q 003384 620 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWP 698 (824)
Q Consensus 620 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p 698 (824)
.. ....++..|+|||++.+..++.++|||||||++|+|+| |++||............... . ....+
T Consensus 160 ~~-------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~---~---~~~~~ 226 (261)
T cd05068 160 AR-------EGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG---Y---RMPCP 226 (261)
T ss_pred cc-------CCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC---C---CCCCC
Confidence 00 11223568999999998899999999999999999999 99999764432211111100 0 01123
Q ss_pred hhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHH
Q 003384 699 FVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP 733 (824)
Q Consensus 699 ~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~ 733 (824)
...+..+.+++.+|++.+|.+||++ +.+...|+.
T Consensus 227 ~~~~~~~~~li~~~l~~~P~~Rp~~-~~l~~~l~~ 260 (261)
T cd05068 227 PGCPKELYDIMLDCWKEDPDDRPTF-ETLQWKLED 260 (261)
T ss_pred CcCCHHHHHHHHHHhhcCcccCCCH-HHHHHHHhc
Confidence 3456789999999999999999999 677777764
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=332.58 Aligned_cols=236 Identities=25% Similarity=0.299 Sum_probs=188.2
Q ss_pred eeeecCceEEEEEEEC--CeEEEEEEecCCC---CCCchhHHHHHHHHHhc-CCCceeeEecccC--CceEEEEEecCCC
Q 003384 471 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTLVYEYLPNG 542 (824)
Q Consensus 471 ~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~---~~~~~~f~~Ei~iL~~l-~HpnIv~L~g~~~--~~~~LV~Ey~~gg 542 (824)
.||+|+||.||+|... +..||||++.... ......+..|..++..+ +||||+++++++. +..++||||++||
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg 81 (316)
T cd05592 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 6999999999999886 4679999987532 12234456677777654 8999999999873 4688999999999
Q ss_pred ChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCCC
Q 003384 543 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 622 (824)
Q Consensus 543 sL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~ 622 (824)
+|.+++.. ...++...+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~---- 151 (316)
T cd05592 82 DLMFHIQS---SGRFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG---- 151 (316)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC----
Confidence 99998843 3468899999999999999999999 8999999999999999999999999999975432211
Q ss_pred ccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCChhhH
Q 003384 623 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQA 702 (824)
Q Consensus 623 ~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~ 702 (824)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+......... ......|...+
T Consensus 152 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~-------~~~~~~~~~~~ 220 (316)
T cd05592 152 ----KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSIL-------NDRPHFPRWIS 220 (316)
T ss_pred ----ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------cCCCCCCCCCC
Confidence 0123468999999999999899999999999999999999999997654322211110 11122344566
Q ss_pred HHHHHHHHHHhhhccCCCCChHHHH
Q 003384 703 EQLANLAMRCCEMSRKSRPELGKDV 727 (824)
Q Consensus 703 ~~l~~Li~~Cl~~~P~~RPt~~~~v 727 (824)
..+.+++.+||+.+|.+||++.+.+
T Consensus 221 ~~~~~ll~~~l~~~P~~R~~~~~~l 245 (316)
T cd05592 221 KEAKDCLSKLFERDPTKRLGVDGDI 245 (316)
T ss_pred HHHHHHHHHHccCCHHHcCCChHHH
Confidence 7899999999999999999985444
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=323.08 Aligned_cols=251 Identities=25% Similarity=0.455 Sum_probs=199.3
Q ss_pred CCCCccceeeecCceEEEEEEEC-------CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccC--CceE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWT 533 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~-------~~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~ 533 (824)
.+|...+.||+|+||.||+|... +..||||.+...... ....|.+|+++|+.++||||+++++++. ...+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 35777889999999999999763 257999998765433 2457999999999999999999999884 4689
Q ss_pred EEEEecCCCChhhhhhccC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcc
Q 003384 534 LVYEYLPNGSLEDRLSCKD-----------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS 602 (824)
Q Consensus 534 LV~Ey~~ggsL~~~L~~~~-----------~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~v 602 (824)
+||||+++|+|.+++.... ....+++..+..++.+++.||.|||. ++++||||||+|||++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCeE
Confidence 9999999999999996432 13458889999999999999999999 899999999999999999999
Q ss_pred eeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHH--H
Q 003384 603 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--Y 679 (824)
Q Consensus 603 KL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~--~ 679 (824)
||+|||++........... .....+++.|+|||++.+..++.++|||||||++|+|++ |..||....... .
T Consensus 162 kl~d~g~~~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~ 235 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRV------GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIE 235 (280)
T ss_pred EECCcccceecccCcceec------CCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 9999999875533221110 123346789999999999999999999999999999998 999986543222 1
Q ss_pred HHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHH
Q 003384 680 ALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 732 (824)
Q Consensus 680 ~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le 732 (824)
....+. ....+...+..+.+++.+||+.+|.+||++ +++++.|+
T Consensus 236 ~~~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~-~eil~~l~ 279 (280)
T cd05049 236 CITQGR--------LLQRPRTCPSEVYDIMLGCWKRDPQQRINI-KDIHERLQ 279 (280)
T ss_pred HHHcCC--------cCCCCCCCCHHHHHHHHHHcCCCcccCCCH-HHHHHHhh
Confidence 111111 111233456789999999999999999999 66766654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=324.63 Aligned_cols=237 Identities=24% Similarity=0.414 Sum_probs=200.3
Q ss_pred hcCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCC---chhHHHHHHHHHhcCCCceeeEecccC--CceEE
Q 003384 462 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTL 534 (824)
Q Consensus 462 ~~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~---~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~L 534 (824)
...+|++.+.||+|.||.|-++..+ ++.||||.+++....+ .-.+.+|++||+.|+||||+.+|.+|. +...|
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 3457888899999999999999764 6899999998765443 446889999999999999999999995 46889
Q ss_pred EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccc
Q 003384 535 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 614 (824)
Q Consensus 535 V~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~ 614 (824)
||||..+|.|+|++. ....|++.....++.||..|+.|+|. ++++|||||.+|||||.|+++||+||||+.++.
T Consensus 131 vMEYaS~GeLYDYiS---er~~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 131 VMEYASGGELYDYIS---ERGSLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEEecCCccHHHHHH---HhccccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhhc
Confidence 999999999999995 44569999999999999999999999 899999999999999999999999999999887
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCC-CcchhHHhHHHHHHHHHhCCCCCCCchHHHH--HHhhhccccccC
Q 003384 615 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL-TPKSDVYSFGIILLRLLTGRPALGITKEVQY--ALDTGKLKNLLD 691 (824)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~--~~~~~~~~~~ld 691 (824)
...+. .++.|++.|.+||++.+.+| ++.+|-|||||+||.|+.|.-||++.+.-.. .+..|...+
T Consensus 205 ~~kfL---------qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrE--- 272 (668)
T KOG0611|consen 205 DKKFL---------QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYRE--- 272 (668)
T ss_pred cccHH---------HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccC---
Confidence 65432 34569999999999999887 5789999999999999999999998765332 222222211
Q ss_pred CCCCCCChhhHHHHHHHHHHHhhhccCCCCCh
Q 003384 692 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 723 (824)
Q Consensus 692 ~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 723 (824)
...+....-||.+||-.||++|-|+
T Consensus 273 -------P~~PSdA~gLIRwmLmVNP~RRATi 297 (668)
T KOG0611|consen 273 -------PETPSDASGLIRWMLMVNPERRATI 297 (668)
T ss_pred -------CCCCchHHHHHHHHHhcCcccchhH
Confidence 1223467889999999999999998
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=341.66 Aligned_cols=255 Identities=24% Similarity=0.394 Sum_probs=201.1
Q ss_pred hcCCCCccceeeecCceEEEEEEECC-------eEEEEEEecCCCCC-CchhHHHHHHHHHhcC-CCceeeEecccC--C
Q 003384 462 ATHNFDPSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQ-GPSEFQQEIDILSKIR-HPNLVTLVGACP--E 530 (824)
Q Consensus 462 ~~~~f~~~~~LG~G~fG~Vykg~~~~-------~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l~-HpnIv~L~g~~~--~ 530 (824)
....|.+.++||+|+||.||+|.+.+ ..||||++...... ....|.+|+.+|+++. ||||++++|+|. .
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 35578889999999999999998642 36999999754322 2356889999999996 999999999995 4
Q ss_pred ceEEEEEecCCCChhhhhhccC----------------------------------------------------------
Q 003384 531 VWTLVYEYLPNGSLEDRLSCKD---------------------------------------------------------- 552 (824)
Q Consensus 531 ~~~LV~Ey~~ggsL~~~L~~~~---------------------------------------------------------- 552 (824)
..+||||||++|+|.++|....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 6899999999999998885421
Q ss_pred -----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEec
Q 003384 553 -----------------------------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD 597 (824)
Q Consensus 553 -----------------------------------~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld 597 (824)
....+++..+..++.|++.||.|||. ++|+||||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEe
Confidence 01347888999999999999999999 8999999999999999
Q ss_pred CCCcceeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchH
Q 003384 598 ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKE 676 (824)
Q Consensus 598 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~ 676 (824)
.++.+||+|||+++.+....... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~ 345 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYV------SKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIV 345 (400)
T ss_pred CCCEEEEEeCCcceecccccccc------ccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccch
Confidence 99999999999998654322110 1123457889999999998899999999999999999997 9999864321
Q ss_pred ---HHHHHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHH
Q 003384 677 ---VQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 734 (824)
Q Consensus 677 ---~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l 734 (824)
....+..+ .....+...+..+.+++.+||+.+|.+||++ ..|.++|+.+
T Consensus 346 ~~~~~~~~~~~--------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-~~l~~~l~~l 397 (400)
T cd05105 346 DSTFYNKIKSG--------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSF-LHLSDIVESL 397 (400)
T ss_pred hHHHHHHHhcC--------CCCCCCccCCHHHHHHHHHHCccCHhHCcCH-HHHHHHHHHH
Confidence 11111111 1112234456789999999999999999999 6788888764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=325.79 Aligned_cols=248 Identities=25% Similarity=0.363 Sum_probs=189.3
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEeccc--CCceEEEEE
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYE 537 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~E 537 (824)
..+|...+.||.|+||.||+|... +..||||++...... ....+.+|+.+++.++||||+++++++ .+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 457999999999999999999885 578999998754322 234678999999999999999999988 446889999
Q ss_pred ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccc
Q 003384 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 617 (824)
Q Consensus 538 y~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 617 (824)
|+. ++|.+++.. ....++...+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 995 577777743 23458888999999999999999999 899999999999999999999999999987543221
Q ss_pred ccCCCccccccCCCCCCcccCChhhhcc-CCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhh-----ccc----
Q 003384 618 ISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG-----KLK---- 687 (824)
Q Consensus 618 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~-----~~~---- 687 (824)
.. .....||+.|+|||++.+ ..++.++|||||||++|+|+||++||.........+..- ...
T Consensus 158 ~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (303)
T cd07869 158 HT--------YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTW 229 (303)
T ss_pred cc--------CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhc
Confidence 10 123458999999999875 468889999999999999999999997654332211110 000
Q ss_pred ----c--ccCCC--CCCCC---------hhhHHHHHHHHHHHhhhccCCCCChH
Q 003384 688 ----N--LLDPL--AGDWP---------FVQAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 688 ----~--~ld~~--~~~~p---------~~~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
. ...+. ....+ ...+..+.+|+.+||+.+|.+||++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~ 283 (303)
T cd07869 230 PGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQ 283 (303)
T ss_pred cchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHH
Confidence 0 00000 00000 01235688999999999999999984
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=333.23 Aligned_cols=232 Identities=27% Similarity=0.359 Sum_probs=186.5
Q ss_pred ceeeecCceEEEEEEE-----CCeEEEEEEecCCC----CCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEe
Q 003384 470 LKIGEGGYGSIYKGLL-----RHMQVAIKMLHPHS----LQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY 538 (824)
Q Consensus 470 ~~LG~G~fG~Vykg~~-----~~~~VAvK~l~~~~----~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey 538 (824)
+.||+|+||.||++.. .+..||||++.... ......+..|+.+|+.++||||++++++|. +..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999875 35789999987532 122345788999999999999999999884 468899999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccc
Q 003384 539 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 618 (824)
Q Consensus 539 ~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 618 (824)
+++|+|.+++.. ...++......++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 82 LSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 999999999843 3467888889999999999999999 8999999999999999999999999999875322211
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCC
Q 003384 619 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWP 698 (824)
Q Consensus 619 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p 698 (824)
. .....||+.|+|||++.+..++.++|||||||+||||++|++||............ .. .....|
T Consensus 156 ~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~------~~-~~~~~~ 220 (323)
T cd05584 156 V--------THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKI------LK-GKLNLP 220 (323)
T ss_pred c--------ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHH------Hc-CCCCCC
Confidence 0 12346899999999999888999999999999999999999999765443221111 00 011234
Q ss_pred hhhHHHHHHHHHHHhhhccCCCCC
Q 003384 699 FVQAEQLANLAMRCCEMSRKSRPE 722 (824)
Q Consensus 699 ~~~~~~l~~Li~~Cl~~~P~~RPt 722 (824)
...+..+.+++.+||+.+|.+||+
T Consensus 221 ~~~~~~~~~li~~~l~~~p~~R~~ 244 (323)
T cd05584 221 PYLTPEARDLLKKLLKRNPSSRLG 244 (323)
T ss_pred CCCCHHHHHHHHHHcccCHhHcCC
Confidence 455678999999999999999994
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=324.15 Aligned_cols=248 Identities=26% Similarity=0.351 Sum_probs=189.9
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEe
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY 538 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey 538 (824)
.+|...++||.|+||.||+|... +..||+|++..... .....+.+|+.+++.++||||+++++++. ...++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46888899999999999999875 57899999875432 22446789999999999999999999874 457899999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccc
Q 003384 539 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 618 (824)
Q Consensus 539 ~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 618 (824)
+++ +|.+++... ...+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 85 LDS-DLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred CCc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 975 898888532 3457889999999999999999999 8999999999999999999999999999875432211
Q ss_pred cCCCccccccCCCCCCcccCChhhhcc-CCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhh----h---------
Q 003384 619 SSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT----G--------- 684 (824)
Q Consensus 619 ~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~----~--------- 684 (824)
. .....||+.|+|||++.+ ..++.++|||||||++|+|+||++||............ +
T Consensus 159 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07871 159 T--------YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPG 230 (288)
T ss_pred c--------ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhc
Confidence 1 123458999999999876 56899999999999999999999999754332111000 0
Q ss_pred -----ccccccCCCCC-----CCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 685 -----KLKNLLDPLAG-----DWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 685 -----~~~~~ld~~~~-----~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
.+...+.+... ......+.++.+|+.+||+.+|.+|||+.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~ 281 (288)
T cd07871 231 ITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEA 281 (288)
T ss_pred cccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHH
Confidence 00000000000 001123467899999999999999999843
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=321.32 Aligned_cols=252 Identities=26% Similarity=0.493 Sum_probs=204.4
Q ss_pred cCCCCccceeeecCceEEEEEEECC-eEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEec
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL 539 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~~-~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey~ 539 (824)
..+|...++||.|+||.||+|.+.+ ..+|+|++..........+..|+.+++.++||||+++++++. +..++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 3468888999999999999998864 789999987765545667999999999999999999999884 4688999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccccc
Q 003384 540 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 619 (824)
Q Consensus 540 ~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 619 (824)
++|+|.+++... ....+++..+..++.+++.||.|||+ ++|+||||||+|||++.++.+||+|||++.........
T Consensus 85 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 85 EKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred ccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 999999999643 23568999999999999999999999 89999999999999999999999999999865432211
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHHHHhhhccccccCCCCCCCC
Q 003384 620 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWP 698 (824)
Q Consensus 620 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p 698 (824)
.....++..|+|||.+.+..++.++|||||||++|+|++ |+.||............ ........+
T Consensus 161 --------~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~------~~~~~~~~~ 226 (261)
T cd05148 161 --------SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI------TAGYRMPCP 226 (261)
T ss_pred --------ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH------HhCCcCCCC
Confidence 123346788999999988899999999999999999998 89999654422111111 011112234
Q ss_pred hhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHH
Q 003384 699 FVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP 733 (824)
Q Consensus 699 ~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~ 733 (824)
...+..+.+++.+||+.+|.+||++ .++.+.|+.
T Consensus 227 ~~~~~~~~~~i~~~l~~~p~~Rpt~-~~l~~~L~~ 260 (261)
T cd05148 227 AKCPQEIYKIMLECWAAEPEDRPSF-KALREELDN 260 (261)
T ss_pred CCCCHHHHHHHHHHcCCCchhCcCH-HHHHHHHhc
Confidence 4556789999999999999999999 677777764
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=317.69 Aligned_cols=244 Identities=25% Similarity=0.459 Sum_probs=194.0
Q ss_pred eeeecCceEEEEEEEC----CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccC-CceEEEEEecCCCCh
Q 003384 471 KIGEGGYGSIYKGLLR----HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVYEYLPNGSL 544 (824)
Q Consensus 471 ~LG~G~fG~Vykg~~~----~~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~L~g~~~-~~~~LV~Ey~~ggsL 544 (824)
.||+|+||.||+|.+. +..||+|++...... ....|.+|+.++++++||||++++|+|. +..++||||+++|+|
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~lv~e~~~~~~L 81 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMASGGPL 81 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCCCeEEEEEeCCCCCH
Confidence 3899999999999874 346999998765322 2356889999999999999999999984 467899999999999
Q ss_pred hhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCCCcc
Q 003384 545 EDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 624 (824)
Q Consensus 545 ~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~ 624 (824)
.+++... ...+++..+..++.+++.||.|||. ++++||||||+|||++.++.+||+|||++..+........
T Consensus 82 ~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~--- 153 (257)
T cd05115 82 NKFLSGK--KDEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK--- 153 (257)
T ss_pred HHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCcccee---
Confidence 9998532 3468999999999999999999999 8999999999999999999999999999986543321111
Q ss_pred ccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHH--HHHhhhccccccCCCCCCCChhh
Q 003384 625 LCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--YALDTGKLKNLLDPLAGDWPFVQ 701 (824)
Q Consensus 625 ~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~~p~~~ 701 (824)
......+++.|+|||++.+..++.++|||||||++|+|++ |.+||....... ..+..+ .....+...
T Consensus 154 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~ 223 (257)
T cd05115 154 --ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQG--------KRLDCPAEC 223 (257)
T ss_pred --ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC--------CCCCCCCCC
Confidence 0122335678999999988889999999999999999996 999996543322 111111 112234456
Q ss_pred HHHHHHHHHHHhhhccCCCCChHHHHHHHHHH
Q 003384 702 AEQLANLAMRCCEMSRKSRPELGKDVWRVLEP 733 (824)
Q Consensus 702 ~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~ 733 (824)
+..+.+++.+||..+|++||++ ..|.+.|+.
T Consensus 224 ~~~l~~li~~c~~~~~~~Rp~~-~~i~~~l~~ 254 (257)
T cd05115 224 PPEMYALMKDCWIYKWEDRPNF-AKVEERMRT 254 (257)
T ss_pred CHHHHHHHHHHcCCChhhCcCH-HHHHHHHhh
Confidence 7799999999999999999999 667666653
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=334.34 Aligned_cols=239 Identities=23% Similarity=0.291 Sum_probs=191.3
Q ss_pred CCCccceeeecCceEEEEEEECC--eEEEEEEecCCC---CCCchhHHHHHHHHHhcCCC-ceeeEeccc--CCceEEEE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHS---LQGPSEFQQEIDILSKIRHP-NLVTLVGAC--PEVWTLVY 536 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~~--~~VAvK~l~~~~---~~~~~~f~~Ei~iL~~l~Hp-nIv~L~g~~--~~~~~LV~ 536 (824)
+|...+.||+|+||.||+|...+ ..||||++.... ......+..|+.++..+.|+ +|+++++++ .+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 47788899999999999998864 689999987532 22345678899999999765 577888877 45689999
Q ss_pred EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccc
Q 003384 537 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 616 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 616 (824)
||++||+|.+++.. ...+++..+..++.|++.||.|||. ++|+||||||+|||++.++.+||+|||++......
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 99999999998843 3468899999999999999999999 89999999999999999999999999998743211
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCC
Q 003384 617 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 696 (824)
Q Consensus 617 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~ 696 (824)
... .....||+.|+|||++.+..++.++|||||||++|+|+||++||............. .....
T Consensus 155 ~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~-------~~~~~ 219 (324)
T cd05587 155 GKT--------TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM-------EHNVS 219 (324)
T ss_pred CCc--------eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH-------cCCCC
Confidence 100 123458999999999999999999999999999999999999997654332211110 11123
Q ss_pred CChhhHHHHHHHHHHHhhhccCCCCChH
Q 003384 697 WPFVQAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 697 ~p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
+|...+..+.+++.+||..+|.+||+..
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~R~~~~ 247 (324)
T cd05587 220 YPKSLSKEAVSICKGLLTKHPAKRLGCG 247 (324)
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHcCCCC
Confidence 3445667899999999999999999863
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=339.56 Aligned_cols=252 Identities=23% Similarity=0.308 Sum_probs=190.6
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC---CchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE 537 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~---~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~E 537 (824)
.|...+.||+|+||+||+|... +..||||++...... ....+.+|+.+++.++||||+++++++. +..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5788899999999999999875 478999999754322 2346889999999999999999999984 46889999
Q ss_pred ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccc
Q 003384 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 617 (824)
Q Consensus 538 y~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 617 (824)
|++||+|.+++.. ...+++.....++.|++.||.|||. .||+||||||+||||+.++++||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 9999999999853 3458888999999999999999999 899999999999999999999999999986442111
Q ss_pred ccCC---------------------------------------CccccccCCCCCCcccCChhhhccCCCCcchhHHhHH
Q 003384 618 ISSN---------------------------------------NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFG 658 (824)
Q Consensus 618 ~~~~---------------------------------------~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlG 658 (824)
.... ....+......||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0000 0000001235799999999999988999999999999
Q ss_pred HHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCChhhHHHHHHHHHH--HhhhccCCCCChHH
Q 003384 659 IILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMR--CCEMSRKSRPELGK 725 (824)
Q Consensus 659 vvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~--Cl~~~P~~RPt~~~ 725 (824)
|++|||+||++||..................+ ........+.++.+|+.+ |+..+|..||++.+
T Consensus 236 ~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~---~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~ 301 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTETQLKVINWENTL---HIPPQVKLSPEAVDLITKLCCSAEERLGRNGADD 301 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHHHHHHHHcccccc---CCCCCCCCCHHHHHHHHHHccCcccccCCCCHHH
Confidence 99999999999997654332221111111100 111112345678889988 44556666999843
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=333.48 Aligned_cols=236 Identities=22% Similarity=0.268 Sum_probs=188.1
Q ss_pred CCccceeeecCceEEEEEEEC--CeEEEEEEecCCC---CCCchhHHHHHHHH---HhcCCCceeeEecccC--CceEEE
Q 003384 466 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDIL---SKIRHPNLVTLVGACP--EVWTLV 535 (824)
Q Consensus 466 f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~---~~~~~~f~~Ei~iL---~~l~HpnIv~L~g~~~--~~~~LV 535 (824)
|.+.+.||+|+||.||+|.+. +..||||++.... ......+.+|+.++ +.++||||+++++++. +..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 566788999999999999875 5789999987532 12234566777665 4668999999999884 568999
Q ss_pred EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccc
Q 003384 536 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 615 (824)
Q Consensus 536 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~ 615 (824)
|||++||+|..++. ...+++..+..++.+++.||.|||+ +||+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 99999999998873 2468999999999999999999999 8999999999999999999999999999874322
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCC
Q 003384 616 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG 695 (824)
Q Consensus 616 ~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~ 695 (824)
... ......||+.|+|||++.+..++.++|||||||++|+|++|++||.............. ...
T Consensus 154 ~~~--------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~-------~~~ 218 (324)
T cd05589 154 FGD--------RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN-------DEV 218 (324)
T ss_pred CCC--------cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-------CCC
Confidence 110 01335699999999999999999999999999999999999999976543221111100 011
Q ss_pred CCChhhHHHHHHHHHHHhhhccCCCCCh
Q 003384 696 DWPFVQAEQLANLAMRCCEMSRKSRPEL 723 (824)
Q Consensus 696 ~~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 723 (824)
..|...+..+.+++.+||+.+|.+||+.
T Consensus 219 ~~p~~~~~~~~~li~~~L~~dP~~R~~~ 246 (324)
T cd05589 219 RYPRFLSREAISIMRRLLRRNPERRLGS 246 (324)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHhHcCCC
Confidence 2344456789999999999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=318.84 Aligned_cols=253 Identities=28% Similarity=0.444 Sum_probs=200.1
Q ss_pred CCCCccceeeecCceEEEEEEEC-----CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccC--CceEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR-----HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLV 535 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~-----~~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV 535 (824)
.+|...+.||+|+||.||+|.+. ...||||.+...... ....|.+|+.+++.++||||+++++++. +..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 46888899999999999999874 247999998754322 2346889999999999999999999873 467899
Q ss_pred EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccc
Q 003384 536 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 615 (824)
Q Consensus 536 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~ 615 (824)
|||+++|+|.+++... ...+++..++.++.+++.||.|||+ ++|+||||||+|||++.++.+||+|||++..+..
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 84 TEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 9999999999998533 3468999999999999999999999 8999999999999999999999999999987752
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHHHHhhhccccccCCCC
Q 003384 616 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLA 694 (824)
Q Consensus 616 ~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~~~~~~~~~ld~~~ 694 (824)
..... . .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||............. ....
T Consensus 159 ~~~~~--~----~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~------~~~~ 226 (266)
T cd05033 159 SEATY--T----TKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVE------DGYR 226 (266)
T ss_pred cccce--e----ccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH------cCCC
Confidence 11110 0 012345788999999998899999999999999999998 999996443222111110 1111
Q ss_pred CCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHH
Q 003384 695 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 734 (824)
Q Consensus 695 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l 734 (824)
...+...+..+.+++.+|++.+|.+||++ +++.+.|+.+
T Consensus 227 ~~~~~~~~~~l~~li~~cl~~~p~~Rp~~-~ei~~~l~~~ 265 (266)
T cd05033 227 LPPPMDCPSALYQLMLDCWQKDRNERPTF-SQIVSTLDKM 265 (266)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCcCH-HHHHHHHHhh
Confidence 12234456789999999999999999999 7777777653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=319.53 Aligned_cols=249 Identities=26% Similarity=0.399 Sum_probs=194.3
Q ss_pred CccceeeecCceEEEEEEECC----eEEEEEEecCCCC--CCchhHHHHHHHHHhcCCCceeeEecccC--------Cce
Q 003384 467 DPSLKIGEGGYGSIYKGLLRH----MQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP--------EVW 532 (824)
Q Consensus 467 ~~~~~LG~G~fG~Vykg~~~~----~~VAvK~l~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--------~~~ 532 (824)
.+.+.||+|+||.||+|.+.. ..||+|.+..... .....+.+|+.+++.++||||++++++|. ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 456789999999999998763 2699998875422 22456889999999999999999999762 135
Q ss_pred EEEEEecCCCChhhhhhcc---CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccc
Q 003384 533 TLVYEYLPNGSLEDRLSCK---DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI 609 (824)
Q Consensus 533 ~LV~Ey~~ggsL~~~L~~~---~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGl 609 (824)
++||||+++|+|.+++... .....+++.....++.|++.||.|||. ++|+||||||+|||++.++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCCc
Confidence 7999999999999887422 223458999999999999999999999 8999999999999999999999999999
Q ss_pred ccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHH--HHHhhhcc
Q 003384 610 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--YALDTGKL 686 (824)
Q Consensus 610 a~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~--~~~~~~~~ 686 (824)
++.+........ .....+++.|+|||++.+..++.++|||||||++|||++ |++||....... ..+..+..
T Consensus 159 ~~~~~~~~~~~~------~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~ 232 (272)
T cd05075 159 SKKIYNGDYYRQ------GRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNR 232 (272)
T ss_pred ccccCcccceec------CCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC
Confidence 987643321110 012346778999999999999999999999999999999 899996543321 11111111
Q ss_pred ccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHH
Q 003384 687 KNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP 733 (824)
Q Consensus 687 ~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~ 733 (824)
...+...+..+.+++.+||+.+|.+||++ .++.+.|+.
T Consensus 233 --------~~~~~~~~~~~~~li~~~l~~~p~~Rps~-~~l~~~l~~ 270 (272)
T cd05075 233 --------LKQPPDCLDGLYSLMSSCWLLNPKDRPSF-ETLRCELEK 270 (272)
T ss_pred --------CCCCCCCCHHHHHHHHHHcCCCcccCcCH-HHHHHHHHh
Confidence 11223445679999999999999999999 677777664
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=332.36 Aligned_cols=238 Identities=21% Similarity=0.295 Sum_probs=191.3
Q ss_pred CCCccceeeecCceEEEEEEECC--eEEEEEEecCCCC---CCchhHHHHHHHHHhc-CCCceeeEecccC--CceEEEE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSL---QGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTLVY 536 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~~--~~VAvK~l~~~~~---~~~~~f~~Ei~iL~~l-~HpnIv~L~g~~~--~~~~LV~ 536 (824)
+|...+.||+|+||.||+|...+ ..||||++..... .....+..|..++..+ +||+|+++++++. +..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 47788899999999999998864 6899999875422 2233567788888877 5899999998874 4688999
Q ss_pred EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccc
Q 003384 537 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 616 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 616 (824)
||+++|+|.+.+.. ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 99999999998843 3458899999999999999999999 89999999999999999999999999998753321
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCC
Q 003384 617 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 696 (824)
Q Consensus 617 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~ 696 (824)
... .....||+.|+|||++.+..++.++|||||||++|||+||++||............. .....
T Consensus 155 ~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~-------~~~~~ 219 (323)
T cd05616 155 GVT--------TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM-------EHNVA 219 (323)
T ss_pred CCc--------cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHH-------hCCCC
Confidence 111 123468999999999999999999999999999999999999997654332211110 01122
Q ss_pred CChhhHHHHHHHHHHHhhhccCCCCCh
Q 003384 697 WPFVQAEQLANLAMRCCEMSRKSRPEL 723 (824)
Q Consensus 697 ~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 723 (824)
+|...+..+.+++.+|++.+|.+|++.
T Consensus 220 ~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 220 YPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 345567789999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=322.65 Aligned_cols=250 Identities=27% Similarity=0.427 Sum_probs=195.9
Q ss_pred CCCccceeeecCceEEEEEEE------CCeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccC--CceEEE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLL------RHMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLV 535 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~------~~~~VAvK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV 535 (824)
.|+..+.||+|+||.||+|.+ .+..||+|.+..... .....|.+|+.+++.++||||+++++++. +..++|
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 85 (283)
T cd05090 6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCML 85 (283)
T ss_pred hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEE
Confidence 467778999999999999975 236799999875332 12346889999999999999999999873 468899
Q ss_pred EEecCCCChhhhhhccC--------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCc
Q 003384 536 YEYLPNGSLEDRLSCKD--------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV 601 (824)
Q Consensus 536 ~Ey~~ggsL~~~L~~~~--------------~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~ 601 (824)
|||+++|+|.+++.... ....+++...+.++.+++.||.|||+ ++++||||||+|||++.++.
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~~ 162 (283)
T cd05090 86 FEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQLH 162 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCCc
Confidence 99999999999985321 12357888999999999999999999 89999999999999999999
Q ss_pred ceeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHH--H
Q 003384 602 SKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEV--Q 678 (824)
Q Consensus 602 vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~--~ 678 (824)
+||+|||+++.......... .....++..|+|||++.+..++.++|||||||++|||++ |.+||...... .
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~ 236 (283)
T cd05090 163 VKISDLGLSREIYSADYYRV------QPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVI 236 (283)
T ss_pred EEeccccccccccCCcceec------ccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 99999999986543321111 122346788999999988889999999999999999998 99999654321 1
Q ss_pred HHHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHH
Q 003384 679 YALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 732 (824)
Q Consensus 679 ~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le 732 (824)
.....+. ....+...+..+.+++.+||+.+|.+||++ ..+.+.|.
T Consensus 237 ~~~~~~~--------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~-~~i~~~l~ 281 (283)
T cd05090 237 EMVRKRQ--------LLPCSEDCPPRMYSLMTECWQEGPSRRPRF-KDIHTRLR 281 (283)
T ss_pred HHHHcCC--------cCCCCCCCCHHHHHHHHHHcccCcccCcCH-HHHHHHhh
Confidence 1111111 112233456789999999999999999999 55655553
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=321.86 Aligned_cols=260 Identities=27% Similarity=0.412 Sum_probs=198.4
Q ss_pred CCCCccceeeecCceEEEEEEEC------CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC----CceE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR------HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP----EVWT 533 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~------~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~----~~~~ 533 (824)
.+|...+.||+|+||.||+|.+. +..||||.+..........|.+|+++++.++||||+++++++. ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 46788889999999999999752 4689999987654444567899999999999999999999762 3578
Q ss_pred EEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccc
Q 003384 534 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 613 (824)
Q Consensus 534 LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~ 613 (824)
+||||+++|+|.+++... ...+++..+..++.+++.||.|||. +||+||||||+|||++.++.+||+|||++...
T Consensus 84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 999999999999998532 3458999999999999999999999 89999999999999999999999999999876
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHH-HHHhhhc-------
Q 003384 614 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ-YALDTGK------- 685 (824)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~-~~~~~~~------- 685 (824)
........ ......++..|+|||++.+..++.++|||||||++|||++|..|+....... ..+....
T Consensus 159 ~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd05081 159 PQDKEYYK-----VREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVY 233 (284)
T ss_pred cCCCccee-----ecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchH
Confidence 43321100 0112234567999999998899999999999999999999987764332111 0000000
Q ss_pred -cccccC-CCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHH
Q 003384 686 -LKNLLD-PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 734 (824)
Q Consensus 686 -~~~~ld-~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l 734 (824)
+...+. ......+...+..+.+|+.+||..+|.+||++ +++...|+.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~-~ei~~~l~~~ 283 (284)
T cd05081 234 HLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSF-SELALQVEAI 283 (284)
T ss_pred HHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCH-HHHHHHHHhc
Confidence 000010 11111233456789999999999999999999 7777777654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=349.75 Aligned_cols=255 Identities=20% Similarity=0.268 Sum_probs=202.3
Q ss_pred hhHhhhcCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEecccCC--
Q 003384 457 SEIEGATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACPE-- 530 (824)
Q Consensus 457 ~ei~~~~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~L~g~~~~-- 530 (824)
.++.....+|.+.+.||+|+||.||+|... +..||||++...... ....+.+|+.++..++|+||+++++.+..
T Consensus 25 ~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~ 104 (496)
T PTZ00283 25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD 104 (496)
T ss_pred ccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence 344455679999999999999999999864 689999998764332 23457889999999999999999876521
Q ss_pred --------ceEEEEEecCCCChhhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCc
Q 003384 531 --------VWTLVYEYLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV 601 (824)
Q Consensus 531 --------~~~LV~Ey~~ggsL~~~L~~~-~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~ 601 (824)
..++||||+++|+|.++|... ....++++..+..++.|++.||.|||+ ++|+||||||+||||+.++.
T Consensus 105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~ 181 (496)
T PTZ00283 105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGL 181 (496)
T ss_pred ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCC
Confidence 257999999999999998543 234578999999999999999999999 89999999999999999999
Q ss_pred ceeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHH
Q 003384 602 SKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYAL 681 (824)
Q Consensus 602 vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~ 681 (824)
+||+|||+++.+........ .....||+.|+|||++.+..++.++|||||||+||||++|++||.........
T Consensus 182 vkL~DFGls~~~~~~~~~~~------~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~- 254 (496)
T PTZ00283 182 VKLGDFGFSKMYAATVSDDV------GRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVM- 254 (496)
T ss_pred EEEEecccCeeccccccccc------cccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH-
Confidence 99999999986643221111 13356999999999999999999999999999999999999999765432211
Q ss_pred hhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHH
Q 003384 682 DTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD 726 (824)
Q Consensus 682 ~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~ 726 (824)
. ....... ...|...+..+.+++.+||+.+|.+||++.+.
T Consensus 255 ~-~~~~~~~----~~~~~~~~~~l~~li~~~L~~dP~~RPs~~el 294 (496)
T PTZ00283 255 H-KTLAGRY----DPLPPSISPEMQEIVTALLSSDPKRRPSSSKL 294 (496)
T ss_pred H-HHhcCCC----CCCCCCCCHHHHHHHHHHcccChhhCcCHHHH
Confidence 1 1111111 12344556789999999999999999999544
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=309.75 Aligned_cols=242 Identities=25% Similarity=0.424 Sum_probs=200.5
Q ss_pred cCCCCccceeeecCceEEEEEEECC--eEEEEEEecCCCC---CCchhHHHHHHHHHhcCCCceeeEecccCC--ceEEE
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLV 535 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~~--~~VAvK~l~~~~~---~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~~--~~~LV 535 (824)
-++|+.++.||+|-||.||.|+.+. .-||+|++.+... ....++.+|++|-+.|+||||+++||+|-+ ..||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 3468999999999999999998874 5699999876532 234579999999999999999999999944 68999
Q ss_pred EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccc
Q 003384 536 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 615 (824)
Q Consensus 536 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~ 615 (824)
+||.++|+|...|... ....++......++.|+|.||.|+|. ++||||||||+|+|++..+.+||+|||-+.....
T Consensus 101 lEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~ 176 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 176 (281)
T ss_pred EEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeecCC
Confidence 9999999999999533 34568888899999999999999999 8899999999999999999999999998765431
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCC
Q 003384 616 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG 695 (824)
Q Consensus 616 ~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~ 695 (824)
.. +....||..|.+||...+..++..+|+|++|++.||++.|.|||.....-.. +. -+.....
T Consensus 177 ----~k------R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~et-Yk------rI~k~~~ 239 (281)
T KOG0580|consen 177 ----NK------RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSET-YK------RIRKVDL 239 (281)
T ss_pred ----CC------ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHH-HH------HHHHccc
Confidence 11 2345699999999999999999999999999999999999999975442221 11 1111222
Q ss_pred CCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 696 DWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 696 ~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
.+|...+....++|.+|+..+|.+|....+
T Consensus 240 ~~p~~is~~a~dlI~~ll~~~p~~r~~l~~ 269 (281)
T KOG0580|consen 240 KFPSTISGGAADLISRLLVKNPIERLALTE 269 (281)
T ss_pred cCCcccChhHHHHHHHHhccCccccccHHH
Confidence 345667789999999999999999999843
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=329.75 Aligned_cols=237 Identities=25% Similarity=0.328 Sum_probs=188.0
Q ss_pred ceeeecCceEEEEEEEC--CeEEEEEEecCCC---CCCchhHHHHHHHHHhc-CCCceeeEecccC--CceEEEEEecCC
Q 003384 470 LKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTLVYEYLPN 541 (824)
Q Consensus 470 ~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~---~~~~~~f~~Ei~iL~~l-~HpnIv~L~g~~~--~~~~LV~Ey~~g 541 (824)
+.||+|+||+||+|... +..||||++.... ......+..|..++..+ +||||+++++++. +..++||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999886 4689999987542 12234567788888764 8999999999884 468899999999
Q ss_pred CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCC
Q 003384 542 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 621 (824)
Q Consensus 542 gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 621 (824)
|+|.+++.. ...+++.....++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-- 152 (316)
T cd05619 81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK-- 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCc--
Confidence 999999843 3468899999999999999999999 89999999999999999999999999998743221110
Q ss_pred CccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCChhh
Q 003384 622 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQ 701 (824)
Q Consensus 622 ~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~ 701 (824)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||............. . ....+|...
T Consensus 153 ------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~-~------~~~~~~~~~ 219 (316)
T cd05619 153 ------TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIR-M------DNPCYPRWL 219 (316)
T ss_pred ------eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH-h------CCCCCCccC
Confidence 123458999999999999899999999999999999999999997654322111110 0 011223345
Q ss_pred HHHHHHHHHHHhhhccCCCCChHHHH
Q 003384 702 AEQLANLAMRCCEMSRKSRPELGKDV 727 (824)
Q Consensus 702 ~~~l~~Li~~Cl~~~P~~RPt~~~~v 727 (824)
+..+.+++.+||+.+|.+||++..++
T Consensus 220 ~~~~~~li~~~l~~~P~~R~~~~~~l 245 (316)
T cd05619 220 TREAKDILVKLFVREPERRLGVKGDI 245 (316)
T ss_pred CHHHHHHHHHHhccCHhhcCCChHHH
Confidence 67899999999999999999985344
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=318.21 Aligned_cols=253 Identities=23% Similarity=0.373 Sum_probs=198.0
Q ss_pred CCccceeeecCceEEEEEEECC-----eEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEecccCC--------
Q 003384 466 FDPSLKIGEGGYGSIYKGLLRH-----MQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACPE-------- 530 (824)
Q Consensus 466 f~~~~~LG~G~fG~Vykg~~~~-----~~VAvK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~L~g~~~~-------- 530 (824)
|.+.+.||+|+||.||+|.... ..||||.+...... ....+.+|+.+++.++||||+++++++..
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567789999999999998642 56999998754322 23468899999999999999999997621
Q ss_pred ceEEEEEecCCCChhhhhhccC---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecc
Q 003384 531 VWTLVYEYLPNGSLEDRLSCKD---NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDF 607 (824)
Q Consensus 531 ~~~LV~Ey~~ggsL~~~L~~~~---~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DF 607 (824)
..++||||+++|+|..++.... ....+++.....++.|++.||.|||. ++++||||||+|||++.++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCc
Confidence 2689999999999999885432 23468999999999999999999999 89999999999999999999999999
Q ss_pred ccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHHHHhhhcc
Q 003384 608 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKL 686 (824)
Q Consensus 608 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~~~~~~ 686 (824)
|+++.+........ .....++..|+|||++.+..++.++|||||||++|||++ |.+||............
T Consensus 158 g~~~~~~~~~~~~~------~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~--- 228 (273)
T cd05035 158 GLSKKIYSGDYYRQ------GRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYL--- 228 (273)
T ss_pred cceeeccccccccc------cccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---
Confidence 99986643322110 112235778999999988889999999999999999999 99999765432211111
Q ss_pred ccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHH
Q 003384 687 KNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 734 (824)
Q Consensus 687 ~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l 734 (824)
........+...+..+.+++.+||+.+|.+||++ .++.+.|+.+
T Consensus 229 ---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~-~e~~~~l~~~ 272 (273)
T cd05035 229 ---RHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTF-TKLREVLENI 272 (273)
T ss_pred ---HcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCH-HHHHHHHHhh
Confidence 1111112344556789999999999999999999 6777777653
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=317.28 Aligned_cols=247 Identities=26% Similarity=0.459 Sum_probs=196.3
Q ss_pred CCCccceeeecCceEEEEEEECC-eEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEecCC
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPN 541 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~~-~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey~~g 541 (824)
+|...+.||+|+||.||+|.+.+ ..||||.+.... .....|.+|+.++++++||||++++++|. +..++||||+.+
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 46778899999999999998875 469999887543 33567999999999999999999999884 357899999999
Q ss_pred CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCC
Q 003384 542 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 621 (824)
Q Consensus 542 gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 621 (824)
|+|.+++... ...+++..++.++.+++.||.|||+ ++++|+||||.|||++.++.+||+|||+++.........
T Consensus 84 ~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~- 157 (256)
T cd05113 84 GCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS- 157 (256)
T ss_pred CcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCceee-
Confidence 9999998533 2368999999999999999999999 899999999999999999999999999988654322110
Q ss_pred CccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHHHHhhhccccccCCCCCCCChh
Q 003384 622 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV 700 (824)
Q Consensus 622 ~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~ 700 (824)
.....++..|+|||++.+..++.++|||||||++|+|+| |..||............. .......+..
T Consensus 158 ------~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~------~~~~~~~~~~ 225 (256)
T cd05113 158 ------SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVS------QGLRLYRPHL 225 (256)
T ss_pred ------cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHh------cCCCCCCCCC
Confidence 122346788999999988889999999999999999999 999997544322111110 0011112333
Q ss_pred hHHHHHHHHHHHhhhccCCCCChHHHHHHHH
Q 003384 701 QAEQLANLAMRCCEMSRKSRPELGKDVWRVL 731 (824)
Q Consensus 701 ~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L 731 (824)
.+..+.+++.+||+.+|.+||++ .+++..|
T Consensus 226 ~~~~~~~li~~cl~~~p~~Rp~~-~~ll~~~ 255 (256)
T cd05113 226 ASEKVYAIMYSCWHEKAEERPTF-QQLLSSI 255 (256)
T ss_pred CCHHHHHHHHHHcCCCcccCCCH-HHHHHhh
Confidence 46789999999999999999999 5554443
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=325.09 Aligned_cols=236 Identities=23% Similarity=0.321 Sum_probs=188.0
Q ss_pred eeecCceEEEEEEEC--CeEEEEEEecCCCCC---CchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEecCCCCh
Q 003384 472 IGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNGSL 544 (824)
Q Consensus 472 LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~---~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey~~ggsL 544 (824)
||+|+||+||++... +..||+|.+...... ....+..|+.+++.++||||+++++++. ...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999875 578999998653222 2245778999999999999999998874 458899999999999
Q ss_pred hhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCCCc
Q 003384 545 EDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT 623 (824)
Q Consensus 545 ~~~L~~~-~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~ 623 (824)
.+++... .....+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++..+......
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~---- 153 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK---- 153 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc----
Confidence 9887432 234568999999999999999999999 89999999999999999999999999998765432211
Q ss_pred cccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHH--HHHhhhccccccCCCCCCCChhh
Q 003384 624 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ--YALDTGKLKNLLDPLAGDWPFVQ 701 (824)
Q Consensus 624 ~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~~p~~~ 701 (824)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ...... .+. ....++...
T Consensus 154 ----~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~----~~~-~~~~~~~~~ 224 (280)
T cd05608 154 ----TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQR----ILN-DSVTYPDKF 224 (280)
T ss_pred ----ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHh----hcc-cCCCCcccC
Confidence 123468999999999999999999999999999999999999996542211 111111 111 111234456
Q ss_pred HHHHHHHHHHHhhhccCCCCCh
Q 003384 702 AEQLANLAMRCCEMSRKSRPEL 723 (824)
Q Consensus 702 ~~~l~~Li~~Cl~~~P~~RPt~ 723 (824)
+..+.+++.+||+.+|.+||++
T Consensus 225 ~~~~~~li~~~l~~~P~~R~~~ 246 (280)
T cd05608 225 SPASKSFCEALLAKDPEKRLGF 246 (280)
T ss_pred CHHHHHHHHHHhcCCHHHhcCC
Confidence 7789999999999999999965
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=338.92 Aligned_cols=250 Identities=23% Similarity=0.276 Sum_probs=189.3
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE 537 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~---~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~E 537 (824)
+|...+.||.|+||.||++... +..||||++..... .....+.+|+++++.++||||++++++|. ...++|||
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E 81 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME 81 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence 6888899999999999999875 57899999864321 22346788999999999999999999984 46899999
Q ss_pred ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccc
Q 003384 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 617 (824)
Q Consensus 538 y~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 617 (824)
|++||+|.+++.. ...++...+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 82 FLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 9999999999853 3568889999999999999999999 899999999999999999999999999997432211
Q ss_pred ccC-----------CCc----------------------------cccccCCCCCCcccCChhhhccCCCCcchhHHhHH
Q 003384 618 ISS-----------NNT----------------------------TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFG 658 (824)
Q Consensus 618 ~~~-----------~~~----------------------------~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlG 658 (824)
... ... .........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 000 000 00000124699999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCC---CChH
Q 003384 659 IILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSR---PELG 724 (824)
Q Consensus 659 vvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~R---Pt~~ 724 (824)
|+||||+||++||................. ..........+..+.+|+.+|+. +|.+| |++.
T Consensus 236 vil~elltG~~Pf~~~~~~~~~~~i~~~~~---~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~ 300 (377)
T cd05629 236 AIMFECLIGWPPFCSENSHETYRKIINWRE---TLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAH 300 (377)
T ss_pred hhhhhhhcCCCCCCCCCHHHHHHHHHccCC---ccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence 999999999999976543222111111111 11101112345689999999997 66665 4763
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=315.67 Aligned_cols=247 Identities=25% Similarity=0.466 Sum_probs=196.3
Q ss_pred CCCccceeeecCceEEEEEEECC-eEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEecCC
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPN 541 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~~-~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey~~g 541 (824)
+|+..+.||+|+||.||+|.+.+ ..+|+|++.... .....+.+|+.+++.++||||+++++++. ...++||||++|
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 47778889999999999998764 579999986433 23457889999999999999999999884 467899999999
Q ss_pred CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCC
Q 003384 542 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 621 (824)
Q Consensus 542 gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 621 (824)
++|.+++... ...+++..+..++.+++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.........
T Consensus 84 ~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~- 157 (256)
T cd05059 84 GCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS- 157 (256)
T ss_pred CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceecccccccc-
Confidence 9999998533 2368999999999999999999999 899999999999999999999999999988654322111
Q ss_pred CccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHHHHhhhccccccCCCCCCCChh
Q 003384 622 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV 700 (824)
Q Consensus 622 ~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~ 700 (824)
.....++..|+|||++.+..++.++|||||||++|+|+| |++||............ ... .....+..
T Consensus 158 ------~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~---~~~---~~~~~~~~ 225 (256)
T cd05059 158 ------SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESV---SAG---YRLYRPKL 225 (256)
T ss_pred ------cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH---HcC---CcCCCCCC
Confidence 112234568999999998999999999999999999999 89999755433221111 111 11123445
Q ss_pred hHHHHHHHHHHHhhhccCCCCChHHHHHHHH
Q 003384 701 QAEQLANLAMRCCEMSRKSRPELGKDVWRVL 731 (824)
Q Consensus 701 ~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L 731 (824)
.+..+.+++.+||..+|.+||++ .++++.|
T Consensus 226 ~~~~~~~li~~cl~~~p~~Rpt~-~~~l~~l 255 (256)
T cd05059 226 APTEVYTIMYSCWHEKPEDRPAF-KKLLSQL 255 (256)
T ss_pred CCHHHHHHHHHHhcCChhhCcCH-HHHHHHh
Confidence 67789999999999999999999 5555443
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=333.06 Aligned_cols=254 Identities=26% Similarity=0.421 Sum_probs=199.6
Q ss_pred CCCCccceeeecCceEEEEEEEC-------CeEEEEEEecCCCCC-CchhHHHHHHHHHhc-CCCceeeEecccC---Cc
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKI-RHPNLVTLVGACP---EV 531 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~-------~~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l-~HpnIv~L~g~~~---~~ 531 (824)
.+|.+.+.||.|+||.||+|... ++.||+|++...... ....+..|+.++.++ +||||++++++|. ..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 46888999999999999999643 257999998754322 124577899999999 8999999999873 35
Q ss_pred eEEEEEecCCCChhhhhhccCC----------------------------------------------------------
Q 003384 532 WTLVYEYLPNGSLEDRLSCKDN---------------------------------------------------------- 553 (824)
Q Consensus 532 ~~LV~Ey~~ggsL~~~L~~~~~---------------------------------------------------------- 553 (824)
.++||||+++|+|.+++.....
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 7899999999999998853211
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCCCccccccCCCCC
Q 003384 554 SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 633 (824)
Q Consensus 554 ~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~G 633 (824)
..++++..+..++.+|+.||.|||+ +||+||||||.|||++.++.+||+|||++..+....... ......+
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~------~~~~~~~ 237 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV------RKGDARL 237 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchh------hccCCCC
Confidence 1368999999999999999999999 899999999999999999999999999998764332111 1123456
Q ss_pred CcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchH---HHHHHhhhccccccCCCCCCCChhhHHHHHHHH
Q 003384 634 TFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKE---VQYALDTGKLKNLLDPLAGDWPFVQAEQLANLA 709 (824)
Q Consensus 634 T~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~---~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li 709 (824)
+..|+|||++.+..++.++|||||||+||||++ |.+||..... ....+..+. ....+...+..+.+++
T Consensus 238 ~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~l~ 309 (337)
T cd05054 238 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGT--------RMRAPEYATPEIYSIM 309 (337)
T ss_pred CccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccC--------CCCCCccCCHHHHHHH
Confidence 788999999999999999999999999999998 9999965321 111111111 1112334456899999
Q ss_pred HHHhhhccCCCCChHHHHHHHHHHHH
Q 003384 710 MRCCEMSRKSRPELGKDVWRVLEPMR 735 (824)
Q Consensus 710 ~~Cl~~~P~~RPt~~~~v~~~Le~l~ 735 (824)
.+||+.+|.+||++ +++++.|+.+.
T Consensus 310 ~~cl~~~p~~RPs~-~ell~~l~~~~ 334 (337)
T cd05054 310 LDCWHNNPEDRPTF-SELVEILGDLL 334 (337)
T ss_pred HHHccCChhhCcCH-HHHHHHHHHHH
Confidence 99999999999999 77888887654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=321.61 Aligned_cols=255 Identities=27% Similarity=0.397 Sum_probs=199.6
Q ss_pred CCCccceeeecCceEEEEEEECC-------eEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccC--CceEE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTL 534 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~~-------~~VAvK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~L 534 (824)
+|.....||+|+||.||+|.... ..+++|.+..... .....+.+|+.+++.++||||+++++.|. +..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 46777889999999999998642 4689998865432 12346889999999999999999999884 46889
Q ss_pred EEEecCCCChhhhhhccC---------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCc
Q 003384 535 VYEYLPNGSLEDRLSCKD---------------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPAN 593 (824)
Q Consensus 535 V~Ey~~ggsL~~~L~~~~---------------------~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~N 593 (824)
||||+.+|+|.+++.... ...++++..++.++.+++.||.|||+ ++|+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhhe
Confidence 999999999999875321 12358899999999999999999998 899999999999
Q ss_pred EEecCCCcceeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCC
Q 003384 594 ILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALG 672 (824)
Q Consensus 594 ILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~ 672 (824)
||++.++.+||+|||+++.......... .....++..|+|||++.+..++.++|||||||++|+|+| |.+||.
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~------~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~ 231 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVK------RSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 231 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhc------ccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCC
Confidence 9999999999999999986543321111 122346778999999988889999999999999999998 999997
Q ss_pred CchHHHHHHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHH
Q 003384 673 ITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 735 (824)
Q Consensus 673 ~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~ 735 (824)
............ .......+...+..+.+++.+||+.+|.+||++ .++...|+.+.
T Consensus 232 ~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~-~~i~~~l~~~~ 287 (290)
T cd05045 232 GIAPERLFNLLK------TGYRMERPENCSEEMYNLMLTCWKQEPDKRPTF-ADISKELEKMM 287 (290)
T ss_pred CCCHHHHHHHHh------CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCH-HHHHHHHHHHH
Confidence 554322111110 011112234456789999999999999999999 77888887764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=315.07 Aligned_cols=249 Identities=29% Similarity=0.486 Sum_probs=199.7
Q ss_pred CCCccceeeecCceEEEEEEECC-eEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC-CceEEEEEecCCC
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVYEYLPNG 542 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~~-~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~-~~~~LV~Ey~~gg 542 (824)
+|++.++||+|+||.||+|...+ ..||+|.+..... ....+.+|+.++++++||||+++++++. ...++||||++++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~~~ 85 (260)
T cd05070 7 SLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSEEPIYIVTEYMSKG 85 (260)
T ss_pred HhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECCCCcEEEEEecCCC
Confidence 57888899999999999998764 6799999876433 4567999999999999999999999874 4578999999999
Q ss_pred ChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCCC
Q 003384 543 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 622 (824)
Q Consensus 543 sL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~ 622 (824)
+|.+++... ....+++..+..++.+++.||.|||+ ++|+||||||+||+++.++.+||+|||++..+.......
T Consensus 86 ~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~-- 159 (260)
T cd05070 86 SLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA-- 159 (260)
T ss_pred cHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCccccc--
Confidence 999998543 23458999999999999999999999 889999999999999999999999999998664332111
Q ss_pred ccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHHHHhhhccccccCCCCCCCChhh
Q 003384 623 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQ 701 (824)
Q Consensus 623 ~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~ 701 (824)
.....++..|+|||++.+..++.++||||||+++|+|++ |.+||............ ........+...
T Consensus 160 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~------~~~~~~~~~~~~ 228 (260)
T cd05070 160 -----RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQV------ERGYRMPCPQDC 228 (260)
T ss_pred -----ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH------HcCCCCCCCCcC
Confidence 112345678999999988889999999999999999999 99999654432211111 011112234455
Q ss_pred HHHHHHHHHHHhhhccCCCCChHHHHHHHHH
Q 003384 702 AEQLANLAMRCCEMSRKSRPELGKDVWRVLE 732 (824)
Q Consensus 702 ~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le 732 (824)
+..+.+|+.+|+..+|.+||++ ..+.+.|+
T Consensus 229 ~~~~~~li~~~l~~~p~~Rpt~-~~l~~~l~ 258 (260)
T cd05070 229 PISLHELMLQCWKKDPEERPTF-EYLQSFLE 258 (260)
T ss_pred CHHHHHHHHHHcccCcccCcCH-HHHHHHHh
Confidence 6789999999999999999999 56666665
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=330.75 Aligned_cols=237 Identities=23% Similarity=0.282 Sum_probs=188.4
Q ss_pred ceeeecCceEEEEEEEC--CeEEEEEEecCCC---CCCchhHHHHHHHHHhc-CCCceeeEecccC--CceEEEEEecCC
Q 003384 470 LKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTLVYEYLPN 541 (824)
Q Consensus 470 ~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~---~~~~~~f~~Ei~iL~~l-~HpnIv~L~g~~~--~~~~LV~Ey~~g 541 (824)
+.||+|+||.||+|... +..||+|++.... ......+..|..++..+ +||||+++++++. +..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 36999999999999885 5789999987532 12334567788888765 8999999999884 468899999999
Q ss_pred CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCC
Q 003384 542 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 621 (824)
Q Consensus 542 gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 621 (824)
|+|.+++.. ...+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--- 151 (316)
T cd05620 81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN--- 151 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC---
Confidence 999998843 3468899999999999999999999 8999999999999999999999999999874321110
Q ss_pred CccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCChhh
Q 003384 622 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQ 701 (824)
Q Consensus 622 ~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~ 701 (824)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||......... .... ......|...
T Consensus 152 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~-~~~~------~~~~~~~~~~ 219 (316)
T cd05620 152 -----RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELF-ESIR------VDTPHYPRWI 219 (316)
T ss_pred -----ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH-HHHH------hCCCCCCCCC
Confidence 013346899999999999999999999999999999999999999765432211 1100 0112233445
Q ss_pred HHHHHHHHHHHhhhccCCCCChHHHH
Q 003384 702 AEQLANLAMRCCEMSRKSRPELGKDV 727 (824)
Q Consensus 702 ~~~l~~Li~~Cl~~~P~~RPt~~~~v 727 (824)
+..+.+++.+||+.+|.+||++.+++
T Consensus 220 ~~~~~~li~~~l~~dP~~R~~~~~~~ 245 (316)
T cd05620 220 TKESKDILEKLFERDPTRRLGVVGNI 245 (316)
T ss_pred CHHHHHHHHHHccCCHHHcCCChHHH
Confidence 67899999999999999999985444
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=331.76 Aligned_cols=232 Identities=25% Similarity=0.301 Sum_probs=187.2
Q ss_pred eeeecCceEEEEEEEC--CeEEEEEEecCCC---CCCchhHHHHHHHHHhc-CCCceeeEecccC--CceEEEEEecCCC
Q 003384 471 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTLVYEYLPNG 542 (824)
Q Consensus 471 ~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~---~~~~~~f~~Ei~iL~~l-~HpnIv~L~g~~~--~~~~LV~Ey~~gg 542 (824)
.||+|+||.||+|... +..||||++.... ......+..|..++..+ +||||+++++++. +..++||||+++|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g 81 (320)
T cd05590 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGG 81 (320)
T ss_pred eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCc
Confidence 6999999999999876 5789999987532 22334577899998876 6999999999884 4689999999999
Q ss_pred ChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCCC
Q 003384 543 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 622 (824)
Q Consensus 543 sL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~ 622 (824)
+|.+++.. ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 82 ~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~--- 152 (320)
T cd05590 82 DLMFHIQK---SRRFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--- 152 (320)
T ss_pred hHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCc---
Confidence 99998843 3468899999999999999999999 89999999999999999999999999998753221110
Q ss_pred ccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCChhhH
Q 003384 623 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQA 702 (824)
Q Consensus 623 ~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~ 702 (824)
.....||+.|+|||++.+..++.++|||||||++|+|++|++||............ .. .....|...+
T Consensus 153 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i--~~-----~~~~~~~~~~ 220 (320)
T cd05590 153 -----TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI--LN-----DEVVYPTWLS 220 (320)
T ss_pred -----ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHH--hc-----CCCCCCCCCC
Confidence 12346999999999999889999999999999999999999999765433211110 00 1112334456
Q ss_pred HHHHHHHHHHhhhccCCCCCh
Q 003384 703 EQLANLAMRCCEMSRKSRPEL 723 (824)
Q Consensus 703 ~~l~~Li~~Cl~~~P~~RPt~ 723 (824)
..+.+++.+||+.+|.+||+.
T Consensus 221 ~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 221 QDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred HHHHHHHHHHcccCHHHCCCC
Confidence 789999999999999999997
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=322.51 Aligned_cols=252 Identities=24% Similarity=0.392 Sum_probs=196.9
Q ss_pred CCCccceeeecCceEEEEEEEC-------CeEEEEEEecCCCCCC-chhHHHHHHHHHhcCCCceeeEecccC--CceEE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTL 534 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~-------~~~VAvK~l~~~~~~~-~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~L 534 (824)
+|...+.||+|+||.||+|.+. +..||||++....... ...|.+|+.+++.++||||+++++++. +..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 3666778999999999999864 2679999987543221 346889999999999999999999884 46789
Q ss_pred EEEecCCCChhhhhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCc
Q 003384 535 VYEYLPNGSLEDRLSCKD-------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV 601 (824)
Q Consensus 535 V~Ey~~ggsL~~~L~~~~-------------~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~ 601 (824)
++||+++++|.+++.... ....+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCCc
Confidence 999999999999984221 12358888999999999999999999 89999999999999999999
Q ss_pred ceeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHHH
Q 003384 602 SKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYA 680 (824)
Q Consensus 602 vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~ 680 (824)
+||+|||+++......... ......+++.|+|||.+.++.++.++|||||||++|||+| |.+||.........
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~ 236 (283)
T cd05091 163 VKISDLGLFREVYAADYYK------LMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVI 236 (283)
T ss_pred eEecccccccccccchhee------eccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 9999999988654332111 0123456889999999988889999999999999999998 88898654332111
Q ss_pred HhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHH
Q 003384 681 LDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 732 (824)
Q Consensus 681 ~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le 732 (824)
..+........+...+..+.+|+.+||+.+|.+||++ .+++..|+
T Consensus 237 ------~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~-~~i~~~l~ 281 (283)
T cd05091 237 ------EMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRF-KDIHSRLR 281 (283)
T ss_pred ------HHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCH-HHHHHHhh
Confidence 1111111222344566789999999999999999999 66666654
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=333.28 Aligned_cols=240 Identities=22% Similarity=0.271 Sum_probs=186.4
Q ss_pred ceeeecCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHHhc-CCCceeeEecccC--CceEEEEEecCC
Q 003384 470 LKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTLVYEYLPN 541 (824)
Q Consensus 470 ~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~---~~~~~f~~Ei~iL~~l-~HpnIv~L~g~~~--~~~~LV~Ey~~g 541 (824)
+.||+|+||.||+|... +..||||++..... .....+..|..++..+ +||||++++++|. ...++||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36999999999999875 57899999975422 2234578999999998 7999999999884 468999999999
Q ss_pred CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCC
Q 003384 542 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 621 (824)
Q Consensus 542 gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 621 (824)
|+|.+++.. ...+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+++........
T Consensus 81 g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~-- 152 (329)
T cd05588 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT-- 152 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccCCCc--
Confidence 999988842 3569999999999999999999999 89999999999999999999999999998743211110
Q ss_pred CccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHH--HHHhhhccccccCCCCCCCCh
Q 003384 622 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ--YALDTGKLKNLLDPLAGDWPF 699 (824)
Q Consensus 622 ~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~~p~ 699 (824)
.....||+.|+|||++.+..++.++|||||||++|+|+||+.||....... ...........+.......|.
T Consensus 153 ------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~ 226 (329)
T cd05588 153 ------TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPR 226 (329)
T ss_pred ------cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCC
Confidence 123468999999999999999999999999999999999999996321100 000000000000011112344
Q ss_pred hhHHHHHHHHHHHhhhccCCCCCh
Q 003384 700 VQAEQLANLAMRCCEMSRKSRPEL 723 (824)
Q Consensus 700 ~~~~~l~~Li~~Cl~~~P~~RPt~ 723 (824)
..+..+.+++.+||+.+|.+||+.
T Consensus 227 ~~~~~~~~li~~~L~~dP~~R~~~ 250 (329)
T cd05588 227 SLSVKASSVLKGFLNKDPKERLGC 250 (329)
T ss_pred CCCHHHHHHHHHHhccCHHHcCCC
Confidence 556789999999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=316.72 Aligned_cols=251 Identities=31% Similarity=0.479 Sum_probs=200.3
Q ss_pred CCCCccceeeecCceEEEEEEECC-eEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC-CceEEEEEecCC
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVYEYLPN 541 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~~-~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~-~~~~LV~Ey~~g 541 (824)
.+|.+.++||+|+||.||+|.+.+ ..||+|++.... .....|.+|+.+++.++||||+++++.+. +..++||||+++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~~ 84 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSK 84 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECCCCcEEEEEcCCC
Confidence 468889999999999999998764 579999987533 23467899999999999999999999774 467899999999
Q ss_pred CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCC
Q 003384 542 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 621 (824)
Q Consensus 542 gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 621 (824)
|+|.+++... ....+++..+..++.+++.||.|||+ ++++||||||.|||++.++.+||+|||++..+.......
T Consensus 85 ~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~- 159 (262)
T cd05071 85 GSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA- 159 (262)
T ss_pred CcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeecccccccc-
Confidence 9999999532 23457899999999999999999999 899999999999999999999999999998664332111
Q ss_pred CccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHHHHhhhccccccCCCCCCCChh
Q 003384 622 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV 700 (824)
Q Consensus 622 ~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~ 700 (824)
.....++..|+|||++.+..++.++|||||||++|+|+| |.+||............ ........+..
T Consensus 160 ------~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~------~~~~~~~~~~~ 227 (262)
T cd05071 160 ------RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV------ERGYRMPCPPE 227 (262)
T ss_pred ------ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHH------hcCCCCCCccc
Confidence 122346788999999988899999999999999999999 88999754322111110 00001112334
Q ss_pred hHHHHHHHHHHHhhhccCCCCChHHHHHHHHHH
Q 003384 701 QAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP 733 (824)
Q Consensus 701 ~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~ 733 (824)
.+..+.+++.+|++.+|.+||++ ..+.+.|+.
T Consensus 228 ~~~~l~~li~~~l~~~p~~Rp~~-~~~~~~l~~ 259 (262)
T cd05071 228 CPESLHDLMCQCWRKEPEERPTF-EYLQAFLED 259 (262)
T ss_pred cCHHHHHHHHHHccCCcccCCCH-HHHHHHHHH
Confidence 56789999999999999999999 677777764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=315.62 Aligned_cols=256 Identities=26% Similarity=0.404 Sum_probs=200.6
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCC---chhHHHHHHHHHhcCCCceeeEeccc--CCceEEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVY 536 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~---~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~ 536 (824)
.+|...+.||+|+||.||+|... +..||||.+....... ...+.+|+.+++.++||||+++++++ .+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 46888899999999999999874 6889999876533222 23578999999999999999999987 35688999
Q ss_pred EecCCCChhhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccc
Q 003384 537 EYLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 615 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~-~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~ 615 (824)
||+++|+|.+++... .....++...+..++.+++.||.|||+ ++++|+||||+|||++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 999999999888532 223458889999999999999999999 8999999999999999999999999999886643
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCC
Q 003384 616 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG 695 (824)
Q Consensus 616 ~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~ 695 (824)
.... .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||............ .+.....+ .
T Consensus 159 ~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~-~~~~~~~~--~ 227 (267)
T cd08228 159 KTTA--------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQ-KIEQCDYP--P 227 (267)
T ss_pred hhHH--------HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHH-HHhcCCCC--C
Confidence 3211 12345889999999999888999999999999999999999998543211110100 01111111 1
Q ss_pred CCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHH
Q 003384 696 DWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 734 (824)
Q Consensus 696 ~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l 734 (824)
..+...+..+.+++.+||..+|.+||++ .++.+.|+.+
T Consensus 228 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~-~~vl~~~~~~ 265 (267)
T cd08228 228 LPTEHYSEKLRELVSMCIYPDPDQRPDI-GYVHQIAKQM 265 (267)
T ss_pred CChhhcCHHHHHHHHHHCCCCcccCcCH-HHHHHHHHHh
Confidence 1122345789999999999999999999 7787887765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=317.59 Aligned_cols=246 Identities=27% Similarity=0.342 Sum_probs=193.5
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--CCceEEEEEec
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 539 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~Ey~ 539 (824)
.+|...+.||+|+||.||+|... +..||+|++..........+.+|+.++++++||||+++++++ .+..++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 46889999999999999999874 578999999765444456788999999999999999999987 45688999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccccc
Q 003384 540 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 619 (824)
Q Consensus 540 ~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 619 (824)
++|+|.+++.. ..++++..+..++.|++.||.|||+ ++|+||||||.||+++.++.+||+|||++..+.....
T Consensus 89 ~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~- 161 (267)
T cd06646 89 GGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA- 161 (267)
T ss_pred CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeeccccc-
Confidence 99999998842 3468999999999999999999999 8999999999999999999999999999986532211
Q ss_pred CCCccccccCCCCCCcccCChhhhc---cCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCC
Q 003384 620 SNNTTLCCRTDPKGTFAYMDPEFLA---SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 696 (824)
Q Consensus 620 ~~~~~~~~~~~~~GT~~Y~APE~l~---~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~ 696 (824)
......|++.|+|||.+. ...++.++|||||||++|+|++|++||............. ...+.+....
T Consensus 162 -------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~ 232 (267)
T cd06646 162 -------KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMS--KSNFQPPKLK 232 (267)
T ss_pred -------ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeee--cCCCCCCCCc
Confidence 012345889999999884 3457889999999999999999999985433221111100 0011111111
Q ss_pred CChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 697 WPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 697 ~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
.+...+..+.+++.+||..+|.+||++.+
T Consensus 233 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~ 261 (267)
T cd06646 233 DKTKWSSTFHNFVKISLTKNPKKRPTAER 261 (267)
T ss_pred cccccCHHHHHHHHHHhhCChhhCcCHHH
Confidence 12234568999999999999999999943
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=314.28 Aligned_cols=245 Identities=27% Similarity=0.486 Sum_probs=195.6
Q ss_pred ceeeecCceEEEEEEECC-----eEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccC-CceEEEEEecCCC
Q 003384 470 LKIGEGGYGSIYKGLLRH-----MQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVYEYLPNG 542 (824)
Q Consensus 470 ~~LG~G~fG~Vykg~~~~-----~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~L~g~~~-~~~~LV~Ey~~gg 542 (824)
++||+|+||.||+|.+.. ..||+|.+...... ....+.+|+.+++.++||||+++++++. +..++||||+++|
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~ 80 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEPLMLVMELAPLG 80 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcCCceEEEEEeCCCC
Confidence 369999999999997642 57999998765442 3456889999999999999999999884 4678999999999
Q ss_pred ChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCCC
Q 003384 543 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 622 (824)
Q Consensus 543 sL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~ 622 (824)
+|.+++... ..+++..+..++.+++.||.|||. .+++||||||+|||++.++.+||+|||+++..........
T Consensus 81 ~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~- 153 (257)
T cd05060 81 PLLKYLKKR---REIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR- 153 (257)
T ss_pred cHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCcccc-
Confidence 999999532 368999999999999999999999 7899999999999999999999999999986643321110
Q ss_pred ccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHH--HHhhhccccccCCCCCCCCh
Q 003384 623 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQY--ALDTGKLKNLLDPLAGDWPF 699 (824)
Q Consensus 623 ~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~--~~~~~~~~~~ld~~~~~~p~ 699 (824)
......++..|+|||.+.+..++.++|||||||++|+|++ |.+||........ .+..+. ....+.
T Consensus 154 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~ 221 (257)
T cd05060 154 ----ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGE--------RLPRPE 221 (257)
T ss_pred ----cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC--------cCCCCC
Confidence 0122335678999999998899999999999999999998 9999975443221 111111 112334
Q ss_pred hhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHH
Q 003384 700 VQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 734 (824)
Q Consensus 700 ~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l 734 (824)
..+..+.+++.+||..+|.+||++ .++.+.|+.+
T Consensus 222 ~~~~~l~~li~~cl~~~p~~Rp~~-~~l~~~l~~~ 255 (257)
T cd05060 222 ECPQEIYSIMLSCWKYRPEDRPTF-SELESTFRRD 255 (257)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCH-HHHHHHHHhc
Confidence 456789999999999999999999 6777777653
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=314.83 Aligned_cols=243 Identities=27% Similarity=0.462 Sum_probs=197.5
Q ss_pred CCCccceeeecCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc---CCceEEEEEecCC
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC---PEVWTLVYEYLPN 541 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~---~~~~~LV~Ey~~g 541 (824)
+|...+.||+|+||.||+|...+..||+|.+.... ....+.+|+.++++++|||+++++|++ ....++||||+++
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~ 84 (256)
T cd05082 7 ELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 84 (256)
T ss_pred hCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCC
Confidence 57788899999999999999999999999986432 345789999999999999999999975 2357899999999
Q ss_pred CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCC
Q 003384 542 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 621 (824)
Q Consensus 542 gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 621 (824)
|+|.+++.... ...+++..+..++.+++.||.|||+ +|++||||||+|||++.++.+||+|||++.......
T Consensus 85 ~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---- 156 (256)
T cd05082 85 GSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---- 156 (256)
T ss_pred CcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccccC----
Confidence 99999985432 3458899999999999999999999 899999999999999999999999999987543221
Q ss_pred CccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHH--HHHhhhccccccCCCCCCCC
Q 003384 622 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--YALDTGKLKNLLDPLAGDWP 698 (824)
Q Consensus 622 ~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~~p 698 (824)
....++..|+|||++.+..++.++|||||||++|+|++ |++||....... ..+..+ .....+
T Consensus 157 -------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~--------~~~~~~ 221 (256)
T cd05082 157 -------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG--------YKMDAP 221 (256)
T ss_pred -------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC--------CCCCCC
Confidence 12235678999999998899999999999999999998 999996543221 111111 111223
Q ss_pred hhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHH
Q 003384 699 FVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP 733 (824)
Q Consensus 699 ~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~ 733 (824)
...+..+.+++.+||+.+|.+||++ .++.+.|+.
T Consensus 222 ~~~~~~~~~li~~~l~~~p~~Rpt~-~~l~~~l~~ 255 (256)
T cd05082 222 DGCPPVVYDVMKQCWHLDAATRPSF-LQLREQLEH 255 (256)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCH-HHHHHHHhc
Confidence 4456789999999999999999999 667666653
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=338.85 Aligned_cols=248 Identities=22% Similarity=0.303 Sum_probs=189.6
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE 537 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~---~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~E 537 (824)
.|...++||+|+||.||+|... +..||||++..... .....+.+|+.++++++||||++++++|. +..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5788899999999999999875 57899999875322 12346889999999999999999999984 46899999
Q ss_pred ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccc
Q 003384 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 617 (824)
Q Consensus 538 y~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 617 (824)
|+++|+|.+++.. ...++......++.||+.||.|||+ ++|+||||||+|||++.+|.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 9999999999853 2458888999999999999999999 899999999999999999999999999986432110
Q ss_pred ccCC---------------------------------------CccccccCCCCCCcccCChhhhccCCCCcchhHHhHH
Q 003384 618 ISSN---------------------------------------NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFG 658 (824)
Q Consensus 618 ~~~~---------------------------------------~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlG 658 (824)
.... ...........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 0000 0000001234699999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCC
Q 003384 659 IILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPE 722 (824)
Q Consensus 659 vvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt 722 (824)
|+||||+||++||................. ..........+..+.+++.+++ .+|.+|++
T Consensus 236 vil~elltG~~Pf~~~~~~~~~~~i~~~~~---~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~ 295 (382)
T cd05625 236 VILYEMLVGQPPFLAQTPLETQMKVINWQT---SLHIPPQAKLSPEASDLIIKLC-RGPEDRLG 295 (382)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHccCC---CcCCCCcccCCHHHHHHHHHHc-cCHhHcCC
Confidence 999999999999986654332222111111 1111111234567888888876 49999997
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=313.06 Aligned_cols=256 Identities=28% Similarity=0.425 Sum_probs=202.5
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 536 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~---~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~ 536 (824)
++|...+.||+|+||.||+|... +..||+|.++.... .....+.+|+.++++++|+||+++++++. +..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 47888899999999999999886 68899998864322 22457889999999999999999999884 4688999
Q ss_pred EecCCCChhhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccc
Q 003384 537 EYLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 615 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~-~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~ 615 (824)
||+++|+|.+++... .....+++..+..++.+++.||.|||+ .||+||||+|+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999988543 234568999999999999999999999 8999999999999999999999999999876543
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCC
Q 003384 616 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG 695 (824)
Q Consensus 616 ~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~ 695 (824)
.... .....|++.|+|||.+.+..++.++|||||||++|+|++|+.||.................. ..
T Consensus 159 ~~~~--------~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~ 226 (267)
T cd08224 159 KTTA--------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCD----YP 226 (267)
T ss_pred CCcc--------cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCC----CC
Confidence 2211 12235889999999999888999999999999999999999999543211110100000011 11
Q ss_pred CCCh-hhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHH
Q 003384 696 DWPF-VQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 735 (824)
Q Consensus 696 ~~p~-~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~ 735 (824)
..|. ..+..+.+++.+||..+|.+||++ ..+.+.|..+.
T Consensus 227 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~-~~il~~~~~~~ 266 (267)
T cd08224 227 PLPADHYSEELRDLVSRCINPDPEKRPDI-SYVLQVAKEMH 266 (267)
T ss_pred CCChhhcCHHHHHHHHHHcCCCcccCCCH-HHHHHHHHHhc
Confidence 1122 445689999999999999999999 67778877653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=322.49 Aligned_cols=243 Identities=23% Similarity=0.310 Sum_probs=193.4
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC---CchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE 537 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~---~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~E 537 (824)
+|+..++||+|+||.||++... +..||||++...... ....+.+|+.+++.++||||+++++.+. +..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4777889999999999999875 578999998653322 2235778999999999999999999884 46899999
Q ss_pred ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccc
Q 003384 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 617 (824)
Q Consensus 538 y~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 617 (824)
|+++|+|.+++... ....+++..+..++.|++.||.|||+ ++|+||||||+|||+++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 99999999888533 23468999999999999999999999 899999999999999999999999999987653221
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCC
Q 003384 618 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 697 (824)
Q Consensus 618 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~ 697 (824)
. .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.......... .+...+.......
T Consensus 157 ~---------~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~---~~~~~~~~~~~~~ 224 (285)
T cd05605 157 T---------IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKRE---EVERRVKEDQEEY 224 (285)
T ss_pred c---------cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHH---HHHHHhhhccccc
Confidence 1 023458999999999998899999999999999999999999997543211100 0011111112223
Q ss_pred ChhhHHHHHHHHHHHhhhccCCCCCh
Q 003384 698 PFVQAEQLANLAMRCCEMSRKSRPEL 723 (824)
Q Consensus 698 p~~~~~~l~~Li~~Cl~~~P~~RPt~ 723 (824)
+...+..+.+|+.+||+.+|.+||+.
T Consensus 225 ~~~~~~~~~~li~~~l~~~P~~R~~~ 250 (285)
T cd05605 225 SEKFSEAARSICRQLLTKDPGFRLGC 250 (285)
T ss_pred CcccCHHHHHHHHHHccCCHHHhcCC
Confidence 44466789999999999999999953
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=333.03 Aligned_cols=241 Identities=25% Similarity=0.330 Sum_probs=189.0
Q ss_pred CCCccceeeecCceEEEEEEE-----CCeEEEEEEecCCC----CCCchhHHHHHHHHHhc-CCCceeeEecccC--Cce
Q 003384 465 NFDPSLKIGEGGYGSIYKGLL-----RHMQVAIKMLHPHS----LQGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVW 532 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~-----~~~~VAvK~l~~~~----~~~~~~f~~Ei~iL~~l-~HpnIv~L~g~~~--~~~ 532 (824)
+|...+.||+|+||.||++.. .+..||+|++.... ......+..|+.++..+ +||||+++++++. ...
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 477889999999999999875 35789999986432 12234678899999999 5999999998874 457
Q ss_pred EEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccc
Q 003384 533 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 612 (824)
Q Consensus 533 ~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~ 612 (824)
++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 899999999999999853 3468899999999999999999999 8999999999999999999999999999986
Q ss_pred cccccccCCCccccccCCCCCCcccCChhhhccC-CCCcchhHHhHHHHHHHHHhCCCCCCCchH--HHHHHhhhccccc
Q 003384 613 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKE--VQYALDTGKLKNL 689 (824)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~--~~~~~~~~~~~~~ 689 (824)
+....... .....||+.|+|||++.+. .++.++|||||||+||||+||+.||..... ....+... +.
T Consensus 155 ~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~-~~-- 224 (332)
T cd05614 155 FLSEEKER-------TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRR-IL-- 224 (332)
T ss_pred ccccCCCc-------cccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHH-Hh--
Confidence 53322111 1234699999999999865 478899999999999999999999964321 01111111 00
Q ss_pred cCCCCCCCChhhHHHHHHHHHHHhhhccCCCCCh
Q 003384 690 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 723 (824)
Q Consensus 690 ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 723 (824)
......+...+..+.+++.+||+.+|.+||+.
T Consensus 225 --~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~ 256 (332)
T cd05614 225 --KCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGA 256 (332)
T ss_pred --cCCCCCCCCCCHHHHHHHHHHcCCCHHHcCCC
Confidence 11122344456789999999999999999953
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=317.18 Aligned_cols=247 Identities=29% Similarity=0.405 Sum_probs=196.1
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCc-eeeEecccC--C------c
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPN-LVTLVGACP--E------V 531 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~--~~~~f~~Ei~iL~~l~Hpn-Iv~L~g~~~--~------~ 531 (824)
.|....+||+|+||+||+|+.. |..||+|.+...... -+....+|+.+|+.|+|+| ||+|++++. + .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 4666678999999999999875 678999999876442 4567889999999999999 999999882 2 5
Q ss_pred eEEEEEecCCCChhhhhhccCCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccc
Q 003384 532 WTLVYEYLPNGSLEDRLSCKDNS-PPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS 610 (824)
Q Consensus 532 ~~LV~Ey~~ggsL~~~L~~~~~~-~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla 610 (824)
+++|+||+. -+|..++...... ..++...+..++.||+.||+|||+ ++|+||||||+||||+++|.+||+|||+|
T Consensus 92 l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 92 LYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred EEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccchH
Confidence 789999995 5899888544321 356778899999999999999999 89999999999999999999999999999
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccC-CCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccc
Q 003384 611 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNL 689 (824)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ 689 (824)
+.+.-... ..+..++|.+|.|||++.+. .|++..||||+|||++||+++++.|.+..+.........+.
T Consensus 168 ra~~ip~~--------~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~l-- 237 (323)
T KOG0594|consen 168 RAFSIPMR--------TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLL-- 237 (323)
T ss_pred HHhcCCcc--------cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHc--
Confidence 95542221 12556789999999999887 79999999999999999999999999887765544332111
Q ss_pred cCCCCCCCChhh-------------------------HHHHHHHHHHHhhhccCCCCChHH
Q 003384 690 LDPLAGDWPFVQ-------------------------AEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 690 ld~~~~~~p~~~-------------------------~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
-.|....||... ..+..+++.+|++.+|.+|.+...
T Consensus 238 GtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~ 298 (323)
T KOG0594|consen 238 GTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKG 298 (323)
T ss_pred CCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHH
Confidence 111112222111 137889999999999999999843
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=333.13 Aligned_cols=232 Identities=22% Similarity=0.263 Sum_probs=185.9
Q ss_pred ceeeecCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEecCCC
Q 003384 470 LKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNG 542 (824)
Q Consensus 470 ~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~---~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey~~gg 542 (824)
+.||+|+||.||++... +..||+|++..... .....+..|+.++..++||||+++++++. +..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999874 57899999875422 22345778999999999999999998873 4689999999999
Q ss_pred ChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCCC
Q 003384 543 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 622 (824)
Q Consensus 543 sL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~ 622 (824)
+|.+++.. ...+++..+..++.||+.||.|||+. +||+||||||+|||++.++.+||+|||+++........
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~--- 152 (325)
T cd05594 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--- 152 (325)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc---
Confidence 99988843 34689999999999999999999962 58999999999999999999999999998753322111
Q ss_pred ccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCChhhH
Q 003384 623 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQA 702 (824)
Q Consensus 623 ~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~ 702 (824)
.....||+.|+|||++.+..++.++|||||||+||+|+||+.||............ ......+|...+
T Consensus 153 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i-------~~~~~~~p~~~~ 220 (325)
T cd05594 153 -----MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI-------LMEEIRFPRTLS 220 (325)
T ss_pred -----cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHH-------hcCCCCCCCCCC
Confidence 12345999999999999999999999999999999999999999755432211110 011112344556
Q ss_pred HHHHHHHHHHhhhccCCCC
Q 003384 703 EQLANLAMRCCEMSRKSRP 721 (824)
Q Consensus 703 ~~l~~Li~~Cl~~~P~~RP 721 (824)
..+.+|+.+||+.+|.+|+
T Consensus 221 ~~~~~li~~~L~~dP~~R~ 239 (325)
T cd05594 221 PEAKSLLSGLLKKDPKQRL 239 (325)
T ss_pred HHHHHHHHHHhhcCHHHhC
Confidence 7899999999999999997
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=322.70 Aligned_cols=257 Identities=25% Similarity=0.408 Sum_probs=202.0
Q ss_pred hcCCCCccceeeecCceEEEEEEECC-------eEEEEEEecCCCC-CCchhHHHHHHHHHhc-CCCceeeEecccC--C
Q 003384 462 ATHNFDPSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSL-QGPSEFQQEIDILSKI-RHPNLVTLVGACP--E 530 (824)
Q Consensus 462 ~~~~f~~~~~LG~G~fG~Vykg~~~~-------~~VAvK~l~~~~~-~~~~~f~~Ei~iL~~l-~HpnIv~L~g~~~--~ 530 (824)
..++|+..+.||+|+||.||+|...+ ..||+|.+..... .....+.+|++++.++ +||||++++++|. .
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 34568888999999999999998642 5799999875422 2234588999999999 8999999999884 3
Q ss_pred ceEEEEEecCCCChhhhhhcc-------------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEec
Q 003384 531 VWTLVYEYLPNGSLEDRLSCK-------------DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD 597 (824)
Q Consensus 531 ~~~LV~Ey~~ggsL~~~L~~~-------------~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld 597 (824)
..++||||+++|+|.+++... .....+++..++.++.|++.||.|||+ ++|+||||||+|||++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEEc
Confidence 588999999999999998532 224568999999999999999999998 8999999999999999
Q ss_pred CCCcceeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchH
Q 003384 598 ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKE 676 (824)
Q Consensus 598 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~ 676 (824)
.++.+||+|||+++.+........ .....++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 240 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRK------TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 240 (293)
T ss_pred CCCeEEeCccccccccccccceec------cCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH
Confidence 999999999999987654321111 122345778999999988899999999999999999998 9999975443
Q ss_pred HHHHHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHH
Q 003384 677 VQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 734 (824)
Q Consensus 677 ~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l 734 (824)
....... ........+...+..+.+|+.+||..+|++||++ +++++.|+.+
T Consensus 241 ~~~~~~~------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-~eil~~l~~~ 291 (293)
T cd05053 241 EELFKLL------KEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTF-KQLVEDLDRM 291 (293)
T ss_pred HHHHHHH------HcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCH-HHHHHHHHHh
Confidence 2211100 0111122344556789999999999999999999 6777777654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=329.79 Aligned_cols=231 Identities=26% Similarity=0.354 Sum_probs=185.8
Q ss_pred eeeecCceEEEEEEEC--CeEEEEEEecCCC---CCCchhHHHHHHHHHhc-CCCceeeEecccC--CceEEEEEecCCC
Q 003384 471 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTLVYEYLPNG 542 (824)
Q Consensus 471 ~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~---~~~~~~f~~Ei~iL~~l-~HpnIv~L~g~~~--~~~~LV~Ey~~gg 542 (824)
.||+|+||.||+|... +..||||++.... ......+..|..++..+ +||||+++++++. +..++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 81 (321)
T cd05591 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG 81 (321)
T ss_pred ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCC
Confidence 5999999999999886 4689999987532 22234577899999876 7999999999884 4689999999999
Q ss_pred ChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCCC
Q 003384 543 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 622 (824)
Q Consensus 543 sL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~ 622 (824)
+|.+.+.. ...+++..+..++.+++.||.|||+ ++|+||||||+|||++.++.+||+|||++.........
T Consensus 82 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~--- 152 (321)
T cd05591 82 DLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--- 152 (321)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCCcc---
Confidence 99988843 3468899999999999999999999 89999999999999999999999999998753222110
Q ss_pred ccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCChhhH
Q 003384 623 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQA 702 (824)
Q Consensus 623 ~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~ 702 (824)
.....||+.|+|||++.+..++.++|||||||++|+|+||++||............ .. .....|...+
T Consensus 153 -----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i--~~-----~~~~~p~~~~ 220 (321)
T cd05591 153 -----TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESI--LH-----DDVLYPVWLS 220 (321)
T ss_pred -----ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHH--Hc-----CCCCCCCCCC
Confidence 12345899999999999989999999999999999999999999766543221111 00 0112233456
Q ss_pred HHHHHHHHHHhhhccCCCCC
Q 003384 703 EQLANLAMRCCEMSRKSRPE 722 (824)
Q Consensus 703 ~~l~~Li~~Cl~~~P~~RPt 722 (824)
..+.+++.+||+.+|.+||+
T Consensus 221 ~~~~~ll~~~L~~dp~~R~~ 240 (321)
T cd05591 221 KEAVSILKAFMTKNPNKRLG 240 (321)
T ss_pred HHHHHHHHHHhccCHHHcCC
Confidence 78999999999999999994
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=322.59 Aligned_cols=250 Identities=26% Similarity=0.377 Sum_probs=193.9
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc----CC---ceE
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC----PE---VWT 533 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~----~~---~~~ 533 (824)
+-.|...+++|.|+||.||+|... +..||||..-.+. +--.+|++||+.++|||||+|..+| +. ...
T Consensus 23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~----r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK----RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC----CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 345778899999999999999886 4789999875432 2335899999999999999998877 12 245
Q ss_pred EEEEecCCCChhhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCC-Ccceeecccccc
Q 003384 534 LVYEYLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN-FVSKLSDFGISR 611 (824)
Q Consensus 534 LV~Ey~~ggsL~~~L~~~-~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~-~~vKL~DFGla~ 611 (824)
|||||||. +|...+... ..+..++...+.-+..||++||+|||. .||+||||||.|+|+|.+ |.+||||||.|+
T Consensus 99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK 174 (364)
T KOG0658|consen 99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAK 174 (364)
T ss_pred HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcce
Confidence 89999975 888888532 234567777888899999999999999 899999999999999976 999999999999
Q ss_pred ccccccccCCCccccccCCCCCCcccCChhhhccC-CCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhcc----
Q 003384 612 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL---- 686 (824)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~---- 686 (824)
.+..++.+. .. ..|..|.|||.+.+. .|+.+.||||.|||+.||+-|+|.|.+.....+....-++
T Consensus 175 ~L~~~epni--SY-------icSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~P 245 (364)
T KOG0658|consen 175 VLVKGEPNI--SY-------ICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTP 245 (364)
T ss_pred eeccCCCce--eE-------EEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCC
Confidence 887665331 11 248899999998875 7999999999999999999999999876655443321110
Q ss_pred ----------c--cccCC--CCCC----CChhhHHHHHHHHHHHhhhccCCCCChHHHHHH
Q 003384 687 ----------K--NLLDP--LAGD----WPFVQAEQLANLAMRCCEMSRKSRPELGKDVWR 729 (824)
Q Consensus 687 ----------~--~~ld~--~~~~----~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~ 729 (824)
. +...+ .... +....+.++.+|+.+++..+|..|.+..+.+..
T Consensus 246 t~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 246 TREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred CHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 0 11111 1111 334456799999999999999999998655543
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=321.23 Aligned_cols=252 Identities=24% Similarity=0.419 Sum_probs=197.6
Q ss_pred CCCccceeeecCceEEEEEEEC-------CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLV 535 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~-------~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV 535 (824)
+|....+||+|+||.||++... +..+|+|.+..........|.+|+++++.++||||+++++++. +..++|
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (280)
T cd05092 6 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMV 85 (280)
T ss_pred hceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEE
Confidence 5677789999999999999642 3579999887654444567999999999999999999999884 467899
Q ss_pred EEecCCCChhhhhhccCC------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcce
Q 003384 536 YEYLPNGSLEDRLSCKDN------------SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSK 603 (824)
Q Consensus 536 ~Ey~~ggsL~~~L~~~~~------------~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vK 603 (824)
|||+++|+|.+++..... ...+++..++.++.|++.||.|||+ ++++||||||+|||++.++.+|
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~~k 162 (280)
T cd05092 86 FEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVVK 162 (280)
T ss_pred EecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCCEE
Confidence 999999999999864321 1358899999999999999999999 8999999999999999999999
Q ss_pred eeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHHHHh
Q 003384 604 LSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALD 682 (824)
Q Consensus 604 L~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~~ 682 (824)
|+|||++........... .....+++.|+|||++.+..++.++|||||||++|+|++ |.+||...........
T Consensus 163 L~dfg~~~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 236 (280)
T cd05092 163 IGDFGMSRDIYSTDYYRV------GGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIEC 236 (280)
T ss_pred ECCCCceeEcCCCceeec------CCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHH
Confidence 999999976543221110 122346789999999999999999999999999999998 9999964433221111
Q ss_pred hhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHH
Q 003384 683 TGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 732 (824)
Q Consensus 683 ~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le 732 (824)
. ........+...+..+.+++.+||..+|.+||++ ++|...|+
T Consensus 237 ~------~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~-~~l~~~l~ 279 (280)
T cd05092 237 I------TQGRELERPRTCPPEVYAIMQGCWQREPQQRMVI-KDIHSRLQ 279 (280)
T ss_pred H------HcCccCCCCCCCCHHHHHHHHHHccCChhhCCCH-HHHHHHHh
Confidence 1 0111112233456789999999999999999999 66666654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=333.06 Aligned_cols=251 Identities=23% Similarity=0.307 Sum_probs=188.3
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHHhcCCCceeeEecccCC--ceEEEEE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVYE 537 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~---~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~~--~~~LV~E 537 (824)
+|+..+.||+|+||+||++... +..||||++..... .....+..|+.++..++||||+++++.+.+ ..++|||
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E 81 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIME 81 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEc
Confidence 6888899999999999999875 57899999875322 223467889999999999999999998843 6889999
Q ss_pred ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccc
Q 003384 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 617 (824)
Q Consensus 538 y~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 617 (824)
|++||+|.+++.. ...+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 82 FLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 9999999999853 3568999999999999999999999 899999999999999999999999999998653221
Q ss_pred ccCCC---------------------------ccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCC
Q 003384 618 ISSNN---------------------------TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPA 670 (824)
Q Consensus 618 ~~~~~---------------------------~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~P 670 (824)
..... ..........||+.|+|||++.+..++.++|||||||+||||++|++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 10000 000001235799999999999999999999999999999999999999
Q ss_pred CCCchHHHHHHhhhccccccCCCCCCCChhhHHHHHHHHHHHhh--hccCCCCChH
Q 003384 671 LGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCE--MSRKSRPELG 724 (824)
Q Consensus 671 f~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~--~~P~~RPt~~ 724 (824)
|..................+. ... ....+..+.+++.+++. .++..||++.
T Consensus 236 f~~~~~~~~~~~i~~~~~~~~--~p~-~~~~s~~~~~li~~l~~~~~~r~~r~~~~ 288 (363)
T cd05628 236 FCSETPQETYKKVMNWKETLI--FPP-EVPISEKAKDLILRFCCEWEHRIGAPGVE 288 (363)
T ss_pred CCCCCHHHHHHHHHcCcCccc--CCC-cCCCCHHHHHHHHHHcCChhhcCCCCCHH
Confidence 976543322111111111000 000 11234577888877543 2334568873
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=320.17 Aligned_cols=257 Identities=28% Similarity=0.437 Sum_probs=197.6
Q ss_pred CCccceeeecCceEEEEEEE------CCeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccC----CceEE
Q 003384 466 FDPSLKIGEGGYGSIYKGLL------RHMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP----EVWTL 534 (824)
Q Consensus 466 f~~~~~LG~G~fG~Vykg~~------~~~~VAvK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~----~~~~L 534 (824)
|...+.||+|+||+||.+.+ .+..||+|.+..... .....|.+|+++|+.++||||++++++|. ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37788999999999988754 246799999875432 23456889999999999999999999873 24789
Q ss_pred EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccc
Q 003384 535 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 614 (824)
Q Consensus 535 V~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~ 614 (824)
||||+++|+|.+++.. ..+++..++.++.+++.||.|||+ ++|+||||||+|||++.++.+||+|||++..+.
T Consensus 86 v~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 86 IMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccccC
Confidence 9999999999999842 358999999999999999999999 899999999999999999999999999998665
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHH-HHHHhh-------hcc
Q 003384 615 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEV-QYALDT-------GKL 686 (824)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~-~~~~~~-------~~~ 686 (824)
........ .....++..|+|||++.+..++.++|||||||++|+|+||..||...... ...... ..+
T Consensus 159 ~~~~~~~~-----~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd05080 159 EGHEYYRV-----REDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRL 233 (283)
T ss_pred Ccchhhcc-----CCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhh
Confidence 33211100 12234677899999998888999999999999999999999998643211 111100 001
Q ss_pred ccccCC-CCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHH
Q 003384 687 KNLLDP-LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 735 (824)
Q Consensus 687 ~~~ld~-~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~ 735 (824)
...++. .....+...+..+.+++.+||+.+|.+||++ +.+++.|+.+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~-~~i~~~l~~~~ 282 (283)
T cd05080 234 IELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTF-RSLIPILKEMH 282 (283)
T ss_pred hhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCH-HHHHHHHHHhh
Confidence 111111 1112234456799999999999999999999 77878887653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=331.10 Aligned_cols=237 Identities=24% Similarity=0.310 Sum_probs=185.9
Q ss_pred ceeeecCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHH-HHHhcCCCceeeEeccc--CCceEEEEEecCC
Q 003384 470 LKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEID-ILSKIRHPNLVTLVGAC--PEVWTLVYEYLPN 541 (824)
Q Consensus 470 ~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~---~~~~~f~~Ei~-iL~~l~HpnIv~L~g~~--~~~~~LV~Ey~~g 541 (824)
+.||+|+||+||+|... +..||||++..... .....+..|.. +++.++||||+++++.+ .+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36999999999999885 58899999865321 12234555555 46789999999999987 3468999999999
Q ss_pred CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCC
Q 003384 542 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 621 (824)
Q Consensus 542 gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 621 (824)
|+|.+++.. ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~--- 151 (323)
T cd05575 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--- 151 (323)
T ss_pred CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC---
Confidence 999998843 3468899999999999999999999 8999999999999999999999999999875322111
Q ss_pred CccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCChhh
Q 003384 622 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQ 701 (824)
Q Consensus 622 ~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~ 701 (824)
......||+.|+|||++.+..++.++|||||||++|+|++|++||............ ... ....+...
T Consensus 152 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i--~~~-----~~~~~~~~ 219 (323)
T cd05575 152 -----TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNI--LNK-----PLRLKPNI 219 (323)
T ss_pred -----ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHH--HcC-----CCCCCCCC
Confidence 012346899999999999999999999999999999999999999765432211110 011 01122334
Q ss_pred HHHHHHHHHHHhhhccCCCCChHHHH
Q 003384 702 AEQLANLAMRCCEMSRKSRPELGKDV 727 (824)
Q Consensus 702 ~~~l~~Li~~Cl~~~P~~RPt~~~~v 727 (824)
+..+.+++.+||+.+|.+||+....+
T Consensus 220 ~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (323)
T cd05575 220 SVSARHLLEGLLQKDRTKRLGAKDDF 245 (323)
T ss_pred CHHHHHHHHHHhhcCHHhCCCCCCCH
Confidence 67899999999999999999985333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=333.94 Aligned_cols=239 Identities=26% Similarity=0.395 Sum_probs=183.7
Q ss_pred CCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEecC
Q 003384 466 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLP 540 (824)
Q Consensus 466 f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey~~ 540 (824)
|...++||+|+||.||+|.+. +..||||++...... ....+.+|+.+++.++||||+++++++. ...++||||++
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 155 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMD 155 (353)
T ss_pred HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCC
Confidence 455678999999999999875 588999998654322 2356889999999999999999999884 46889999999
Q ss_pred CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccC
Q 003384 541 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 620 (824)
Q Consensus 541 ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 620 (824)
+|+|.+.. .++...+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.+......
T Consensus 156 ~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~- 224 (353)
T PLN00034 156 GGSLEGTH-------IADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP- 224 (353)
T ss_pred CCcccccc-------cCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceeccccccc-
Confidence 99986543 24567788999999999999999 89999999999999999999999999999865432111
Q ss_pred CCccccccCCCCCCcccCChhhhcc-----CCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCC
Q 003384 621 NNTTLCCRTDPKGTFAYMDPEFLAS-----GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG 695 (824)
Q Consensus 621 ~~~~~~~~~~~~GT~~Y~APE~l~~-----~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~ 695 (824)
.....||..|+|||++.. ...+.++|||||||++|||++|+.||............... ......
T Consensus 225 -------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~---~~~~~~ 294 (353)
T PLN00034 225 -------CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAI---CMSQPP 294 (353)
T ss_pred -------ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHH---hccCCC
Confidence 123469999999998743 23456899999999999999999999733211100000000 000111
Q ss_pred CCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 696 DWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 696 ~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
..+...+..+.+|+.+||+.+|.+||++.+
T Consensus 295 ~~~~~~~~~l~~li~~~l~~~P~~Rpt~~e 324 (353)
T PLN00034 295 EAPATASREFRHFISCCLQREPAKRWSAMQ 324 (353)
T ss_pred CCCCccCHHHHHHHHHHccCChhhCcCHHH
Confidence 223445678999999999999999999943
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=333.54 Aligned_cols=240 Identities=22% Similarity=0.276 Sum_probs=185.9
Q ss_pred ceeeecCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHHhc-CCCceeeEeccc--CCceEEEEEecCC
Q 003384 470 LKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKI-RHPNLVTLVGAC--PEVWTLVYEYLPN 541 (824)
Q Consensus 470 ~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~---~~~~~f~~Ei~iL~~l-~HpnIv~L~g~~--~~~~~LV~Ey~~g 541 (824)
+.||+|+||.||+|... +..||+|++..... .....+..|+.++.++ +||||+++++++ .+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 36999999999999876 47899999876422 2234577899998877 799999999987 4568999999999
Q ss_pred CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCC
Q 003384 542 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 621 (824)
Q Consensus 542 gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 621 (824)
|+|..++.. ...+++..+..++.+++.||.|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~-- 152 (329)
T cd05618 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT-- 152 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCc--
Confidence 999988843 3468999999999999999999999 89999999999999999999999999998753221110
Q ss_pred CccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHH--HHhhhccccccCCCCCCCCh
Q 003384 622 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQY--ALDTGKLKNLLDPLAGDWPF 699 (824)
Q Consensus 622 ~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~--~~~~~~~~~~ld~~~~~~p~ 699 (824)
.....||+.|+|||++.+..++.++|||||||++|+|+||++||........ ......+...+.......|.
T Consensus 153 ------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~ 226 (329)
T cd05618 153 ------TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR 226 (329)
T ss_pred ------cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCC
Confidence 1234689999999999999999999999999999999999999952110000 00000000001111122345
Q ss_pred hhHHHHHHHHHHHhhhccCCCCCh
Q 003384 700 VQAEQLANLAMRCCEMSRKSRPEL 723 (824)
Q Consensus 700 ~~~~~l~~Li~~Cl~~~P~~RPt~ 723 (824)
..+..+.+++.+||+.+|.+||+.
T Consensus 227 ~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 227 SLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCHHHHHHHHHHhcCCHHHcCCC
Confidence 566789999999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=333.34 Aligned_cols=235 Identities=28% Similarity=0.335 Sum_probs=189.5
Q ss_pred ceeeecCceEEEEEEE-----CCeEEEEEEecCCCC--CCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEecC
Q 003384 470 LKIGEGGYGSIYKGLL-----RHMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLP 540 (824)
Q Consensus 470 ~~LG~G~fG~Vykg~~-----~~~~VAvK~l~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey~~ 540 (824)
+.||+|+||.||++.. .+..||+|++..... .....+..|+.+|++++||||+++++++. ...++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 4699999999998864 357899999875322 22345778999999999999999999884 46889999999
Q ss_pred CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccC
Q 003384 541 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 620 (824)
Q Consensus 541 ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 620 (824)
+|+|.+++.. ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.........
T Consensus 82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~- 154 (318)
T cd05582 82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK- 154 (318)
T ss_pred CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCc-
Confidence 9999999843 3468999999999999999999999 89999999999999999999999999998754332110
Q ss_pred CCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCChh
Q 003384 621 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV 700 (824)
Q Consensus 621 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~ 700 (824)
.....||+.|+|||++.+..++.++|||||||++|+|+||+.||............. . .....|..
T Consensus 155 -------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~--~-----~~~~~p~~ 220 (318)
T cd05582 155 -------AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMIL--K-----AKLGMPQF 220 (318)
T ss_pred -------eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHH--c-----CCCCCCCC
Confidence 123468999999999998889999999999999999999999997654332211110 0 01123444
Q ss_pred hHHHHHHHHHHHhhhccCCCCChHH
Q 003384 701 QAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 701 ~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
.+..+.+|+.+||+.+|.+||++.+
T Consensus 221 ~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 221 LSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 5678999999999999999999633
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=313.18 Aligned_cols=244 Identities=28% Similarity=0.433 Sum_probs=190.5
Q ss_pred eeeecCceEEEEEEEC--CeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEecCCCChh
Q 003384 471 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNGSLE 545 (824)
Q Consensus 471 ~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey~~ggsL~ 545 (824)
.||+|+||.||+|.+. ++.||+|.+..... .....+.+|+++++.++||||++++++|. ...++||||+++++|.
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 81 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL 81 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHH
Confidence 5999999999999874 68899998764322 12356899999999999999999999884 4678999999999999
Q ss_pred hhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCCCccc
Q 003384 546 DRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 625 (824)
Q Consensus 546 ~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~ 625 (824)
+++... ...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++...........
T Consensus 82 ~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~---- 152 (252)
T cd05084 82 TFLRTE--GPRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAST---- 152 (252)
T ss_pred HHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCccccccccccc----
Confidence 998532 3468899999999999999999999 8999999999999999999999999999875432211100
Q ss_pred cccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHHHHhhhccccccCCCCCCCChhhHHH
Q 003384 626 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQ 704 (824)
Q Consensus 626 ~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~ 704 (824)
.....++..|+|||.+.++.++.++|||||||++|+|++ |.+||............. . ......+...+..
T Consensus 153 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~---~---~~~~~~~~~~~~~ 224 (252)
T cd05084 153 --GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE---Q---GVRLPCPELCPDA 224 (252)
T ss_pred --CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHH---c---CCCCCCcccCCHH
Confidence 011224567999999998899999999999999999998 999996443221111100 0 1111234445678
Q ss_pred HHHHHHHHhhhccCCCCChHHHHHHHHH
Q 003384 705 LANLAMRCCEMSRKSRPELGKDVWRVLE 732 (824)
Q Consensus 705 l~~Li~~Cl~~~P~~RPt~~~~v~~~Le 732 (824)
+.+++.+|++.+|.+||++ .++.+.|.
T Consensus 225 ~~~li~~~l~~~p~~Rps~-~~~~~~l~ 251 (252)
T cd05084 225 VYRLMERCWEYDPGQRPSF-STVHQELQ 251 (252)
T ss_pred HHHHHHHHcCCChhhCcCH-HHHHHHHh
Confidence 9999999999999999999 66666553
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=333.11 Aligned_cols=247 Identities=26% Similarity=0.402 Sum_probs=207.7
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCc--hhHHHHHHHHHhcCCCceeeEecccCC--c-eEEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGP--SEFQQEIDILSKIRHPNLVTLVGACPE--V-WTLVY 536 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~--~~f~~Ei~iL~~l~HpnIv~L~g~~~~--~-~~LV~ 536 (824)
.+|...++||+|+||.++..+.+ ++.+++|.+.......+ ....+|+.+++++.|||||.+.++|.+ . .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 47888999999999999877655 57899999987654443 357899999999999999999999943 4 78999
Q ss_pred EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccc
Q 003384 537 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 616 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 616 (824)
+||+||+|.+.+.+.+ +..++...+..|+.|++.||.|||. +.|+|||||+.|||++.++.|||+|||+|+.+...
T Consensus 84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999996554 5679999999999999999999998 78999999999999999999999999999988765
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCC
Q 003384 617 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 696 (824)
Q Consensus 617 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~ 696 (824)
... ....+||+.||+||++.+.+|+.|+|||||||++|||++=+++|...+......... ...+.|
T Consensus 160 ~~~--------a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~--~~~~~P---- 225 (426)
T KOG0589|consen 160 DSL--------ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKIN--RGLYSP---- 225 (426)
T ss_pred hhh--------hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHh--hccCCC----
Confidence 411 134579999999999999999999999999999999999999998776544433322 222333
Q ss_pred CChhhHHHHHHHHHHHhhhccCCCCChHHHHH
Q 003384 697 WPFVQAEQLANLAMRCCEMSRKSRPELGKDVW 728 (824)
Q Consensus 697 ~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~ 728 (824)
.|...+.++..++..|+..+|..||+..+.+.
T Consensus 226 lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~ 257 (426)
T KOG0589|consen 226 LPSMYSSELRSLVKSMLRKNPEHRPSALELLR 257 (426)
T ss_pred CCccccHHHHHHHHHHhhcCCccCCCHHHHhh
Confidence 45566789999999999999999999955443
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=319.11 Aligned_cols=253 Identities=25% Similarity=0.407 Sum_probs=198.8
Q ss_pred CCCCccceeeecCceEEEEEEECC-------eEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccC--CceE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWT 533 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~~-------~~VAvK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~ 533 (824)
++|.....||+|+||.||+|...+ ..||+|.+..... .....+.+|+.+++.++||||++++|++. ...+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL 85 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence 468888999999999999998753 5699999865432 22346889999999999999999999874 4688
Q ss_pred EEEEecCCCChhhhhhccCC-------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeec
Q 003384 534 LVYEYLPNGSLEDRLSCKDN-------SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSD 606 (824)
Q Consensus 534 LV~Ey~~ggsL~~~L~~~~~-------~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~D 606 (824)
+||||+++|+|.+++..... ...+++..++.++.+++.||.|||+ ++|+||||||+|||++.++.+||+|
T Consensus 86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl~d 162 (277)
T cd05032 86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGD 162 (277)
T ss_pred EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEECC
Confidence 99999999999999864321 2347889999999999999999999 8999999999999999999999999
Q ss_pred cccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHHHHhhhc
Q 003384 607 FGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGK 685 (824)
Q Consensus 607 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~~~~~ 685 (824)
||+++.+........ .....++..|+|||.+.++.++.++|||||||++|||+| |.+||............
T Consensus 163 fg~~~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~-- 234 (277)
T cd05032 163 FGMTRDIYETDYYRK------GGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFV-- 234 (277)
T ss_pred cccchhhccCccccc------CCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHH--
Confidence 999986544322111 123346889999999988889999999999999999998 99999654332211111
Q ss_pred cccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHH
Q 003384 686 LKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 732 (824)
Q Consensus 686 ~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le 732 (824)
........|...+..+.+++.+||+.+|.+||++ .++...|+
T Consensus 235 ----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~-~~l~~~l~ 276 (277)
T cd05032 235 ----IDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTF-LEIVSSLK 276 (277)
T ss_pred ----hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCH-HHHHHHhc
Confidence 0111112234456789999999999999999999 66655553
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=336.74 Aligned_cols=247 Identities=23% Similarity=0.308 Sum_probs=189.3
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCC---CCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE 537 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~---~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~E 537 (824)
+|...+.||+|+||.||++... +..||||++.... ......+.+|+.+|+.++||||+++++.+. +..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 6888999999999999999875 5789999986432 122456889999999999999999999884 46889999
Q ss_pred ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccc
Q 003384 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 617 (824)
Q Consensus 538 y~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 617 (824)
|+++|+|.+++.. ...++......++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|..+....
T Consensus 82 ~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 82 YIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 9999999999853 3458888889999999999999999 899999999999999999999999999986432100
Q ss_pred ccC----------------------C-------------CccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHH
Q 003384 618 ISS----------------------N-------------NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILL 662 (824)
Q Consensus 618 ~~~----------------------~-------------~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ 662 (824)
... . ....+......||+.|+|||++.+..++.++|||||||+||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 000 0 00000112347999999999999999999999999999999
Q ss_pred HHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCC
Q 003384 663 RLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 721 (824)
Q Consensus 663 ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RP 721 (824)
||+||++||..................+ ........+..+.+++.+|+ .+|.+|+
T Consensus 236 ell~G~~Pf~~~~~~~~~~~i~~~~~~~---~~~~~~~~s~~~~~li~~l~-~~p~~R~ 290 (376)
T cd05598 236 EMLVGQPPFLADTPAETQLKVINWETTL---HIPSQAKLSREASDLILRLC-CGAEDRL 290 (376)
T ss_pred ehhhCCCCCCCCCHHHHHHHHhccCccc---cCCCCCCCCHHHHHHHHHHh-cCHhhcC
Confidence 9999999997665433222111111111 11111234567888888876 5999999
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=319.36 Aligned_cols=259 Identities=27% Similarity=0.448 Sum_probs=199.2
Q ss_pred CCCCccceeeecCceEEEEEEECC------------------eEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLRH------------------MQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTL 524 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~~------------------~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~L 524 (824)
.+|.+.+.||+|+||.||+|.... ..||+|.+...... ....+.+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 468888999999999999987642 45899998754322 24578899999999999999999
Q ss_pred ecccC--CceEEEEEecCCCChhhhhhccC--------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcE
Q 003384 525 VGACP--EVWTLVYEYLPNGSLEDRLSCKD--------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANI 594 (824)
Q Consensus 525 ~g~~~--~~~~LV~Ey~~ggsL~~~L~~~~--------~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NI 594 (824)
+++|. +..++||||+++++|.+++.... ....+++..++.++.+++.||.|||+ ++|+||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~Ni 161 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhce
Confidence 99884 46889999999999999985432 12368999999999999999999999 8999999999999
Q ss_pred EecCCCcceeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh--CCCCCC
Q 003384 595 LLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALG 672 (824)
Q Consensus 595 Lld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt--G~~Pf~ 672 (824)
|++.++.++|+|||+++.......... .....+++.|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~ 235 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRV------QGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYE 235 (296)
T ss_pred eecCCCceEEccccceeecccCcceee------cCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCC
Confidence 999999999999999876543321111 123457889999999998889999999999999999998 778886
Q ss_pred CchHHHHHHhhhccc-cccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHH
Q 003384 673 ITKEVQYALDTGKLK-NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 732 (824)
Q Consensus 673 ~~~~~~~~~~~~~~~-~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le 732 (824)
............... ..........+...+..+.+++.+||+.+|.+||++ .++.+.|+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~-~el~~~L~ 295 (296)
T cd05051 236 HLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTF-REIHLFLQ 295 (296)
T ss_pred CcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCH-HHHHHHhc
Confidence 543222111111110 000111112233455789999999999999999999 66666654
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=327.76 Aligned_cols=239 Identities=25% Similarity=0.334 Sum_probs=186.6
Q ss_pred eeeecCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHH-HHHhcCCCceeeEecccC--CceEEEEEecCCC
Q 003384 471 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEID-ILSKIRHPNLVTLVGACP--EVWTLVYEYLPNG 542 (824)
Q Consensus 471 ~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~---~~~~~f~~Ei~-iL~~l~HpnIv~L~g~~~--~~~~LV~Ey~~gg 542 (824)
.||+|+||.||+|... +..||+|++..... .....+..|.. +++.++||||+++++++. +..++||||++||
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (321)
T cd05603 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGG 81 (321)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 6999999999999885 57899999865321 12234555554 678899999999999873 4689999999999
Q ss_pred ChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCCC
Q 003384 543 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 622 (824)
Q Consensus 543 sL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~ 622 (824)
+|...+.. ...++...+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++........
T Consensus 82 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~--- 152 (321)
T cd05603 82 ELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--- 152 (321)
T ss_pred CHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCc---
Confidence 99988842 3468888899999999999999999 89999999999999999999999999998753221110
Q ss_pred ccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCChhhH
Q 003384 623 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQA 702 (824)
Q Consensus 623 ~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~ 702 (824)
.....||+.|+|||++.+..++.++|||||||++|||++|++||...+.... ... .... ....|....
T Consensus 153 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~-i~~~-----~~~~~~~~~ 220 (321)
T cd05603 153 -----TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQM-YDN-ILHK-----PLQLPGGKT 220 (321)
T ss_pred -----cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHH-HHH-HhcC-----CCCCCCCCC
Confidence 1234689999999999988999999999999999999999999976543221 111 0111 112344456
Q ss_pred HHHHHHHHHHhhhccCCCCChHHHHHHH
Q 003384 703 EQLANLAMRCCEMSRKSRPELGKDVWRV 730 (824)
Q Consensus 703 ~~l~~Li~~Cl~~~P~~RPt~~~~v~~~ 730 (824)
..+.+++.+||+.+|.+||+....+.++
T Consensus 221 ~~~~~li~~~l~~~p~~R~~~~~~~~~~ 248 (321)
T cd05603 221 VAACDLLVGLLHKDQRRRLGAKADFLEI 248 (321)
T ss_pred HHHHHHHHHHccCCHhhcCCCCCCHHHH
Confidence 7899999999999999999874444333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=313.81 Aligned_cols=251 Identities=30% Similarity=0.494 Sum_probs=201.3
Q ss_pred CCCCccceeeecCceEEEEEEEC-CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC-CceEEEEEecCC
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVYEYLPN 541 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~-~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~-~~~~LV~Ey~~g 541 (824)
..|...++||+|+||.||+|... +..||+|.+.... .....+.+|+.+++.++||||+++++++. +..++||||+++
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~ 84 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVTQEPIYIITEYMEN 84 (260)
T ss_pred HHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEccCCcEEEEEcCCC
Confidence 46888899999999999999875 4789999987543 34567999999999999999999999874 467899999999
Q ss_pred CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCC
Q 003384 542 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 621 (824)
Q Consensus 542 gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 621 (824)
|+|.+++.... ...+++..+..++.+++.||.|||+ .+++||||||+||+++.++.++|+|||++..........
T Consensus 85 ~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~- 159 (260)
T cd05067 85 GSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTA- 159 (260)
T ss_pred CCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCCCccc-
Confidence 99999885432 3568999999999999999999999 889999999999999999999999999997665322111
Q ss_pred CccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHHHHhhhccccccCCCCCCCChh
Q 003384 622 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV 700 (824)
Q Consensus 622 ~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~ 700 (824)
.....++..|+|||++.+..++.++|||||||++|+|++ |++||............. .. .....+..
T Consensus 160 ------~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~---~~---~~~~~~~~ 227 (260)
T cd05067 160 ------REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLE---RG---YRMPRPDN 227 (260)
T ss_pred ------ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHH---cC---CCCCCCCC
Confidence 122346789999999998899999999999999999999 999997544322111110 00 11112334
Q ss_pred hHHHHHHHHHHHhhhccCCCCChHHHHHHHHHH
Q 003384 701 QAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP 733 (824)
Q Consensus 701 ~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~ 733 (824)
.+..+.+++.+|++.+|.+||++ +.+...|+.
T Consensus 228 ~~~~~~~li~~~l~~~p~~Rp~~-~~l~~~l~~ 259 (260)
T cd05067 228 CPEELYELMRLCWKEKPEERPTF-EYLRSVLED 259 (260)
T ss_pred CCHHHHHHHHHHccCChhhCCCH-HHHHHHhhc
Confidence 45689999999999999999999 677777653
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=312.57 Aligned_cols=246 Identities=28% Similarity=0.406 Sum_probs=195.4
Q ss_pred eeeecCceEEEEEEECC-----eEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccC-CceEEEEEecCCCC
Q 003384 471 KIGEGGYGSIYKGLLRH-----MQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVYEYLPNGS 543 (824)
Q Consensus 471 ~LG~G~fG~Vykg~~~~-----~~VAvK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~-~~~~LV~Ey~~ggs 543 (824)
.||+|+||.||+|.+.. ..||||.+..... ...+.+.+|+.++++++||||+++++.+. ...++||||+++|+
T Consensus 2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~~ 81 (257)
T cd05040 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLMMVTELAPLGS 81 (257)
T ss_pred cCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcCCeEEEEEEecCCCc
Confidence 58999999999998742 3699999887655 34567899999999999999999999874 46789999999999
Q ss_pred hhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCCCc
Q 003384 544 LEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT 623 (824)
Q Consensus 544 L~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~ 623 (824)
|.+.+..... ..+++.....++.|++.||.|||. ++++||||||+|||++.++.+||+|||++..+........
T Consensus 82 L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~-- 155 (257)
T cd05040 82 LLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV-- 155 (257)
T ss_pred HHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEecccccccccccccccee--
Confidence 9999864432 568999999999999999999999 8999999999999999999999999999987654321110
Q ss_pred cccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHHHHhhhccccccCCCCCCCChhhH
Q 003384 624 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQA 702 (824)
Q Consensus 624 ~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~ 702 (824)
......++..|+|||++.+..++.++|||||||++|+|+| |++||............... ......+...+
T Consensus 156 ---~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~ 227 (257)
T cd05040 156 ---MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKE-----GERLERPEACP 227 (257)
T ss_pred ---cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc-----CCcCCCCccCC
Confidence 0123457889999999998899999999999999999999 99999654333211111110 11111233446
Q ss_pred HHHHHHHHHHhhhccCCCCChHHHHHHHH
Q 003384 703 EQLANLAMRCCEMSRKSRPELGKDVWRVL 731 (824)
Q Consensus 703 ~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L 731 (824)
..+.+++.+||+.+|.+||++ .++++.|
T Consensus 228 ~~~~~li~~~l~~~p~~Rps~-~~~~~~l 255 (257)
T cd05040 228 QDIYNVMLQCWAHNPADRPTF-AALREFL 255 (257)
T ss_pred HHHHHHHHHHCCCCcccCCCH-HHHHHHh
Confidence 789999999999999999999 5665554
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=318.19 Aligned_cols=253 Identities=23% Similarity=0.399 Sum_probs=199.1
Q ss_pred CCCCccceeeecCceEEEEEEEC--Ce----EEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccC-CceEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HM----QVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLV 535 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~----~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~L~g~~~-~~~~LV 535 (824)
.+|...++||+|+||.||+|.+. +. .||+|++...... ....+.+|+.++..++||||++++|+|. ...+++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~l~ 86 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTSTVQLV 86 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCCcEEE
Confidence 36788889999999999999863 32 5899998754322 2346889999999999999999999884 457899
Q ss_pred EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccc
Q 003384 536 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 615 (824)
Q Consensus 536 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~ 615 (824)
|||+++|+|.+++... ...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.+..
T Consensus 87 ~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 87 TQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred EEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 9999999999998532 3468999999999999999999999 8999999999999999999999999999987643
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHH--HHHhhhccccccCC
Q 003384 616 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--YALDTGKLKNLLDP 692 (824)
Q Consensus 616 ~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~--~~~~~~~~~~~ld~ 692 (824)
..... ......+++.|+|||.+.+..++.++|||||||++|||+| |.+||....... ..+..+.
T Consensus 162 ~~~~~------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~------- 228 (279)
T cd05109 162 DETEY------HADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGE------- 228 (279)
T ss_pred cccee------ecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-------
Confidence 22110 0122345788999999998899999999999999999998 999997543221 1111110
Q ss_pred CCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHh
Q 003384 693 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 736 (824)
Q Consensus 693 ~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~ 736 (824)
....+...+..+.+++.+||+.+|..||++ .++++.|+.+..
T Consensus 229 -~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~-~~l~~~l~~~~~ 270 (279)
T cd05109 229 -RLPQPPICTIDVYMIMVKCWMIDSECRPRF-RELVDEFSRMAR 270 (279)
T ss_pred -cCCCCccCCHHHHHHHHHHcCCChhhCcCH-HHHHHHHHHhhc
Confidence 111123456789999999999999999999 566677766543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=342.41 Aligned_cols=249 Identities=22% Similarity=0.367 Sum_probs=188.4
Q ss_pred hcCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC--------C-
Q 003384 462 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--------E- 530 (824)
Q Consensus 462 ~~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--------~- 530 (824)
...+|...+.||+|+||.||+|... +..||||++... .....+|+.+|+.++|||||++++++. .
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~----~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD----PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC----cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 3457999999999999999999875 578999988543 234568999999999999999987651 1
Q ss_pred -ceEEEEEecCCCChhhhhhc-cCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCC-cceeecc
Q 003384 531 -VWTLVYEYLPNGSLEDRLSC-KDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF-VSKLSDF 607 (824)
Q Consensus 531 -~~~LV~Ey~~ggsL~~~L~~-~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~-~vKL~DF 607 (824)
..++||||+++ +|.+++.. ......+++..+..++.||+.||.|||+ ++||||||||+||||+.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeecc
Confidence 35689999975 67666532 2344578999999999999999999999 8999999999999999664 7999999
Q ss_pred ccccccccccccCCCccccccCCCCCCcccCChhhhccC-CCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhc-
Q 003384 608 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK- 685 (824)
Q Consensus 608 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~- 685 (824)
|+|+.+..... .....||+.|+|||++.+. .|+.++|||||||+||||+||.+||..............
T Consensus 216 Gla~~~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~ 286 (440)
T PTZ00036 216 GSAKNLLAGQR---------SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQV 286 (440)
T ss_pred ccchhccCCCC---------cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 99986543221 1234589999999998764 699999999999999999999999976543322111100
Q ss_pred ---------------cccc-cCC-----CCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 003384 686 ---------------LKNL-LDP-----LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 727 (824)
Q Consensus 686 ---------------~~~~-ld~-----~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 727 (824)
+..+ +.. +...+|...+.++.+|+.+||..+|.+||++.+.+
T Consensus 287 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l 349 (440)
T PTZ00036 287 LGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEAL 349 (440)
T ss_pred hCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 0000 000 00112333456899999999999999999995433
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=314.66 Aligned_cols=255 Identities=27% Similarity=0.416 Sum_probs=200.7
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCC---chhHHHHHHHHHhcCCCceeeEecccC--CceEEEEE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE 537 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~---~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~E 537 (824)
+|...+.||.|+||.||+|... +..||||.+....... ...+.+|+.+++.++||||+++++++. +..++|||
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 82 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence 5777888999999999999864 6889999876533222 346889999999999999999999873 46889999
Q ss_pred ecCCCChhhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccc
Q 003384 538 YLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 616 (824)
Q Consensus 538 y~~ggsL~~~L~~~-~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 616 (824)
|+++++|.+++... .....+++..++.++.+++.||.|||. ++++|+||||+||+++.++.++|+|||++..+...
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 99999999988542 234568999999999999999999999 89999999999999999999999999998765432
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCC
Q 003384 617 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 696 (824)
Q Consensus 617 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~ 696 (824)
... .....|+..|+|||++.+..++.++||||||+++|+|++|..||............ .+.....+ ..
T Consensus 160 ~~~--------~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~--~~ 228 (267)
T cd08229 160 TTA--------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK-KIEQCDYP--PL 228 (267)
T ss_pred Ccc--------cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhh-hhhcCCCC--CC
Confidence 211 12245899999999998888999999999999999999999999643221111111 11111111 01
Q ss_pred CChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHH
Q 003384 697 WPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 734 (824)
Q Consensus 697 ~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l 734 (824)
.+...+..+.+++.+||..+|.+||++ ..|.+.+..+
T Consensus 229 ~~~~~~~~~~~li~~~l~~~p~~Rpt~-~~i~~~~~~~ 265 (267)
T cd08229 229 PSDHYSEELRQLVNMCINPDPEKRPDI-TYVYDVAKRM 265 (267)
T ss_pred CcccccHHHHHHHHHhcCCCcccCCCH-HHHHHHHhhh
Confidence 122356789999999999999999999 7787877765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=327.42 Aligned_cols=196 Identities=27% Similarity=0.412 Sum_probs=167.8
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEeccc--CCceEEEEEe
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 538 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~Ey 538 (824)
++|+..++||.|+||.||++... +..+|+|++..... .....+.+|+++++.++||||++++++| .+..++||||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence 57899999999999999999886 57799998875422 1234688999999999999999999988 3468899999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccc
Q 003384 539 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 618 (824)
Q Consensus 539 ~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 618 (824)
+++|+|.+++.. ...+++.....++.+++.||.|||+. .+|+||||||+|||++.++.+||+|||++..+....
T Consensus 85 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~- 158 (333)
T cd06650 85 MDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158 (333)
T ss_pred CCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc-
Confidence 999999999853 34588899999999999999999972 369999999999999999999999999987553221
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCc
Q 003384 619 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGIT 674 (824)
Q Consensus 619 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~ 674 (824)
.....||..|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 159 ---------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 159 ---------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred ---------cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 12345899999999999888999999999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=317.01 Aligned_cols=257 Identities=23% Similarity=0.342 Sum_probs=203.3
Q ss_pred cCCCCccceeeecCceEEEEEEECC------eEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccC---Cce
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLRH------MQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP---EVW 532 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~~------~~VAvK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~---~~~ 532 (824)
..+|.....||+|+||.||+|.+.. ..|++|++..... .....+.+|+.+++.++||||+++++++. ...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4578888999999999999998754 6799998864322 22356889999999999999999999873 457
Q ss_pred EEEEEecCCCChhhhhhccCCC-----CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecc
Q 003384 533 TLVYEYLPNGSLEDRLSCKDNS-----PPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDF 607 (824)
Q Consensus 533 ~LV~Ey~~ggsL~~~L~~~~~~-----~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DF 607 (824)
+++++|+++|+|.+++...... ..+++..++.++.+++.||.|||+ ++++||||||+|||++.++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECCC
Confidence 8999999999999998643222 568999999999999999999999 89999999999999999999999999
Q ss_pred ccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHHHHhhhcc
Q 003384 608 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKL 686 (824)
Q Consensus 608 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~~~~~~ 686 (824)
|+++.+........ .....++..|+|||++.+..++.++|||||||++||+++ |++||..............
T Consensus 162 g~~~~~~~~~~~~~------~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~- 234 (280)
T cd05043 162 ALSRDLFPMDYHCL------GDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKD- 234 (280)
T ss_pred CCcccccCCceEEe------CCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHc-
Confidence 99986543321110 122346788999999988889999999999999999999 9999976543322111110
Q ss_pred ccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHH
Q 003384 687 KNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 735 (824)
Q Consensus 687 ~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~ 735 (824)
......+...+..+.+++.+||..+|.+||++ .++...|..+.
T Consensus 235 -----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-~~~~~~l~~~~ 277 (280)
T cd05043 235 -----GYRLAQPINCPDELFAVMACCWALDPEERPSF-SQLVQCLTDFH 277 (280)
T ss_pred -----CCCCCCCCcCCHHHHHHHHHHcCCChhhCCCH-HHHHHHHHHHH
Confidence 01111233446789999999999999999999 77888887764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=323.33 Aligned_cols=257 Identities=25% Similarity=0.414 Sum_probs=202.9
Q ss_pred CCCCccceeeecCceEEEEEEECC---------eEEEEEEecCCC-CCCchhHHHHHHHHHhc-CCCceeeEecccC--C
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLRH---------MQVAIKMLHPHS-LQGPSEFQQEIDILSKI-RHPNLVTLVGACP--E 530 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~~---------~~VAvK~l~~~~-~~~~~~f~~Ei~iL~~l-~HpnIv~L~g~~~--~ 530 (824)
.+|.+.+.||+|+||.||++...+ ..+|+|.+.... ......+..|+.+++.+ +||||++++++|. +
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 468889999999999999997532 469999987542 22234688899999999 7999999999884 4
Q ss_pred ceEEEEEecCCCChhhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEec
Q 003384 531 VWTLVYEYLPNGSLEDRLSCKDN-------------SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD 597 (824)
Q Consensus 531 ~~~LV~Ey~~ggsL~~~L~~~~~-------------~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld 597 (824)
..++||||+++|+|.+++..... ...+++..++.++.+++.||.|||+ +|++||||||+|||++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHheEEc
Confidence 68899999999999999964321 2358899999999999999999999 8999999999999999
Q ss_pred CCCcceeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchH
Q 003384 598 ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKE 676 (824)
Q Consensus 598 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~ 676 (824)
.++.+||+|||++........... .....+++.|+|||++.+..++.++|||||||++|+|++ |.+||.....
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~ 248 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKK------TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 248 (307)
T ss_pred CCCcEEECCCcccccccccchhhc------cccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence 999999999999876543221110 012235678999999998899999999999999999998 8899975543
Q ss_pred HHH--HHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhhC
Q 003384 677 VQY--ALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC 738 (824)
Q Consensus 677 ~~~--~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~~~ 738 (824)
... .+..+ .....+...+..+.+|+.+||..+|.+||++ .++++.|+.+....
T Consensus 249 ~~~~~~~~~~--------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-~evl~~l~~~~~~~ 303 (307)
T cd05098 249 EELFKLLKEG--------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTF-KQLVEDLDRILALT 303 (307)
T ss_pred HHHHHHHHcC--------CCCCCCCcCCHHHHHHHHHHcccChhhCcCH-HHHHHHHHHHHHHh
Confidence 221 11111 1112334456789999999999999999999 77888888876643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=328.29 Aligned_cols=239 Identities=21% Similarity=0.316 Sum_probs=190.5
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCC---CCCchhHHHHHHHHHhcC-CCceeeEecccC--CceEEEE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDILSKIR-HPNLVTLVGACP--EVWTLVY 536 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~---~~~~~~f~~Ei~iL~~l~-HpnIv~L~g~~~--~~~~LV~ 536 (824)
+|+..+.||+|+||.||+|... +..||||++.... ......+..|..++..+. ||+|+++++++. +..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3677889999999999999875 5789999987532 122345778999998886 567778888773 4689999
Q ss_pred EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccc
Q 003384 537 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 616 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 616 (824)
||++||+|.+++.. ...+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 99999999998843 3468999999999999999999999 89999999999999999999999999998753322
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCC
Q 003384 617 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 696 (824)
Q Consensus 617 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~ 696 (824)
... .....||+.|+|||++.+..++.++|||||||++|+|+||++||............ .. ....
T Consensus 155 ~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i--~~-----~~~~ 219 (323)
T cd05615 155 GVT--------TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSI--ME-----HNVS 219 (323)
T ss_pred Ccc--------ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH--Hh-----CCCC
Confidence 110 12345899999999999989999999999999999999999999765432211110 00 1112
Q ss_pred CChhhHHHHHHHHHHHhhhccCCCCChH
Q 003384 697 WPFVQAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 697 ~p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
+|...+..+.+++.+||+.+|.+|++..
T Consensus 220 ~p~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 220 YPKSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred CCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 3445567899999999999999999863
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=312.03 Aligned_cols=243 Identities=26% Similarity=0.399 Sum_probs=196.7
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEe
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY 538 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey 538 (824)
+|...+.||+|+||.||+|... +..|++|.+..... .....+.+|+.+++.++||||+++++++. ...++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4677788999999999999875 58899999865422 23456889999999999999999999884 468999999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccc
Q 003384 539 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 618 (824)
Q Consensus 539 ~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 618 (824)
++|++|.+++... ....+++..++.++.+++.||.|||. +|++||||||+||+++.++.+||+|||+++.+.....
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 9999999998643 24568999999999999999999999 8999999999999999999999999999886653321
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCC
Q 003384 619 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWP 698 (824)
Q Consensus 619 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p 698 (824)
. .....|++.|+|||++.+..++.++|||||||++|+|+||+.||........... ..... ....+
T Consensus 157 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~--~~~~~----~~~~~ 222 (256)
T cd08529 157 F--------ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILK--IIRGV----FPPVS 222 (256)
T ss_pred h--------hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHcCC----CCCCc
Confidence 1 1234588999999999999999999999999999999999999976653221111 11111 11222
Q ss_pred hhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 699 FVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 699 ~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
...+..+.+++.+||+.+|.+||++.+
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~ 249 (256)
T cd08529 223 QMYSQQLAQLIDQCLTKDYRQRPDTFQ 249 (256)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHH
Confidence 345678999999999999999999944
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=315.22 Aligned_cols=254 Identities=26% Similarity=0.456 Sum_probs=198.8
Q ss_pred CCCCccceeeecCceEEEEEEEC--C---eEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccC--CceEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--H---MQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLV 535 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~---~~VAvK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV 535 (824)
++|+..+.||+|+||.||+|... + ..+|+|.+..... .....+..|+.+++.++||||+++++++. +..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 46788899999999999999874 2 3699998865422 22456889999999999999999999884 467899
Q ss_pred EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccc
Q 003384 536 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 615 (824)
Q Consensus 536 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~ 615 (824)
|||+++++|.+++.. ....+++..+..++.+++.||.|||. .+++||||||+|||++.++.+||+|||++.....
T Consensus 85 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 85 TEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 999999999999853 23568999999999999999999999 8999999999999999999999999999886543
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHHHHhhhccccccCCCC
Q 003384 616 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLA 694 (824)
Q Consensus 616 ~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~~~~~~~~~ld~~~ 694 (824)
....... .....+++.|+|||++.+..++.++|||||||++|||+| |+.||............. ....
T Consensus 160 ~~~~~~~-----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~------~~~~ 228 (268)
T cd05063 160 DPEGTYT-----TSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIN------DGFR 228 (268)
T ss_pred cccccee-----ccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHh------cCCC
Confidence 2211100 112234568999999988889999999999999999998 999996443221111110 0111
Q ss_pred CCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHH
Q 003384 695 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 734 (824)
Q Consensus 695 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l 734 (824)
...+...+..+.+++.+||+.+|.+||++ .++...|+.+
T Consensus 229 ~~~~~~~~~~~~~li~~c~~~~p~~Rp~~-~~i~~~l~~~ 267 (268)
T cd05063 229 LPAPMDCPSAVYQLMLQCWQQDRARRPRF-VDIVNLLDKL 267 (268)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCcCH-HHHHHHHHhh
Confidence 12233456789999999999999999999 7777777654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=318.20 Aligned_cols=238 Identities=24% Similarity=0.330 Sum_probs=186.7
Q ss_pred eeecCceEEEEEEEC--CeEEEEEEecCCCCC---CchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEecCCCCh
Q 003384 472 IGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNGSL 544 (824)
Q Consensus 472 LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~---~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey~~ggsL 544 (824)
||+|+||.||++... +..||+|.+...... ....+..|++++++++||||+++++++. ...++||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999875 688999998643221 2234567999999999999999999884 468899999999999
Q ss_pred hhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCCCcc
Q 003384 545 EDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 624 (824)
Q Consensus 545 ~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~ 624 (824)
.+++... ....+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~------ 150 (277)
T cd05607 81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT------ 150 (277)
T ss_pred HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce------
Confidence 9888533 23458899999999999999999999 8999999999999999999999999999876543211
Q ss_pred ccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHH--HHHHhhhccccccCCCCCCCChhhH
Q 003384 625 LCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEV--QYALDTGKLKNLLDPLAGDWPFVQA 702 (824)
Q Consensus 625 ~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~--~~~~~~~~~~~~ld~~~~~~p~~~~ 702 (824)
.....||..|+|||++.+..++.++|||||||++|+|++|++||...... ...+........+.. .....+
T Consensus 151 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~ 223 (277)
T cd05607 151 ---ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKF----EHQNFT 223 (277)
T ss_pred ---eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccccc----ccccCC
Confidence 12345899999999999888999999999999999999999999653221 111111111111110 112346
Q ss_pred HHHHHHHHHHhhhccCCCCChHHH
Q 003384 703 EQLANLAMRCCEMSRKSRPELGKD 726 (824)
Q Consensus 703 ~~l~~Li~~Cl~~~P~~RPt~~~~ 726 (824)
..+.+|+.+||+.+|.+||++.+.
T Consensus 224 ~~~~~li~~~L~~~P~~R~~~~~~ 247 (277)
T cd05607 224 EESKDICRLFLAKKPEDRLGSREK 247 (277)
T ss_pred HHHHHHHHHHhccCHhhCCCCccc
Confidence 689999999999999999998443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=328.69 Aligned_cols=247 Identities=23% Similarity=0.306 Sum_probs=189.2
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHHhcCCCceeeEecccCC-------ceE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACPE-------VWT 533 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~~-------~~~ 533 (824)
+|++.+.||+|+||.||+|... +..||||.+..... .....+.+|+.+++.++||||+++++++.. ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4778899999999999999864 68899999864321 223568899999999999999999998732 578
Q ss_pred EEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccc
Q 003384 534 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 613 (824)
Q Consensus 534 LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~ 613 (824)
+||||+. ++|.+.+. ....+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999996 57877773 34568999999999999999999999 89999999999999999999999999999865
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhccC-CCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhh--------
Q 003384 614 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG-------- 684 (824)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~-------- 684 (824)
...... ......||+.|+|||++.+. .++.++|||||||++|||++|++||...+.........
T Consensus 154 ~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~ 226 (372)
T cd07853 154 EPDESK-------HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSL 226 (372)
T ss_pred ccCccc-------cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCH
Confidence 432211 11234689999999998774 57899999999999999999999997654322111000
Q ss_pred ---------cccccc-CCCC-------CCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 685 ---------KLKNLL-DPLA-------GDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 685 ---------~~~~~l-d~~~-------~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
....+. .+.. .......+..+.+|+.+||+.+|.+||++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e 284 (372)
T cd07853 227 EAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAAD 284 (372)
T ss_pred HHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHH
Confidence 000000 0000 0111223567899999999999999999944
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=326.59 Aligned_cols=233 Identities=22% Similarity=0.287 Sum_probs=187.9
Q ss_pred ceeeecCceEEEEEEEC--CeEEEEEEecCCC---CCCchhHHHHHHHHHhc-CCCceeeEeccc--CCceEEEEEecCC
Q 003384 470 LKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDILSKI-RHPNLVTLVGAC--PEVWTLVYEYLPN 541 (824)
Q Consensus 470 ~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~---~~~~~~f~~Ei~iL~~l-~HpnIv~L~g~~--~~~~~LV~Ey~~g 541 (824)
+.||+|+||.||+|.+. +..||||++.... ......+..|..++..+ +||||+++++++ .+..++||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999886 4689999987532 22344577899999888 699999999987 4568999999999
Q ss_pred CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCC
Q 003384 542 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 621 (824)
Q Consensus 542 gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 621 (824)
|+|.+++.. ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-- 152 (318)
T cd05570 81 GDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT-- 152 (318)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCc--
Confidence 999988843 3468999999999999999999999 89999999999999999999999999998743221110
Q ss_pred CccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCChhh
Q 003384 622 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQ 701 (824)
Q Consensus 622 ~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~ 701 (824)
.....||+.|+|||++.+..++.++|||||||++|+|+||+.||............. ......|...
T Consensus 153 ------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~-------~~~~~~~~~~ 219 (318)
T cd05570 153 ------TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSIL-------EDEVRYPRWL 219 (318)
T ss_pred ------ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHH-------cCCCCCCCcC
Confidence 123458999999999999999999999999999999999999997654322211110 0011234445
Q ss_pred HHHHHHHHHHHhhhccCCCCCh
Q 003384 702 AEQLANLAMRCCEMSRKSRPEL 723 (824)
Q Consensus 702 ~~~l~~Li~~Cl~~~P~~RPt~ 723 (824)
+..+.+|+.+||+.+|.+||++
T Consensus 220 ~~~~~~li~~~l~~dP~~R~s~ 241 (318)
T cd05570 220 SKEAKSILKSFLTKNPEKRLGC 241 (318)
T ss_pred CHHHHHHHHHHccCCHHHcCCC
Confidence 6789999999999999999998
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=321.38 Aligned_cols=284 Identities=24% Similarity=0.428 Sum_probs=215.3
Q ss_pred CCCCccceeeecCceEEEEEEEC--C----eEEEEEEecCCCCCC-chhHHHHHHHHHhcCCCceeeEecccC-CceEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--H----MQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLV 535 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~----~~VAvK~l~~~~~~~-~~~f~~Ei~iL~~l~HpnIv~L~g~~~-~~~~LV 535 (824)
.+|...+.||+|+||.||+|.+. + ..||+|.+....... ...+.+|+.+++.++||||++++|+|. ...++|
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~v 86 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLV 86 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCCceee
Confidence 35777889999999999999863 3 257999886543221 236889999999999999999999884 456799
Q ss_pred EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccc
Q 003384 536 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 615 (824)
Q Consensus 536 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~ 615 (824)
+||+++|+|.+++... ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.+..
T Consensus 87 ~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 87 TQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred ehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccccccccccC
Confidence 9999999999998532 3458899999999999999999999 8999999999999999999999999999986643
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchH--HHHHHhhhccccccCC
Q 003384 616 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKE--VQYALDTGKLKNLLDP 692 (824)
Q Consensus 616 ~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~--~~~~~~~~~~~~~ld~ 692 (824)
...... .....++..|+|||++.+..++.++|||||||++|||++ |..||..... ....+..+. .
T Consensus 162 ~~~~~~------~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~---~--- 229 (303)
T cd05110 162 DEKEYN------ADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGE---R--- 229 (303)
T ss_pred cccccc------cCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC---C---
Confidence 221100 122346789999999998899999999999999999997 8999965432 111111111 0
Q ss_pred CCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhhCCCCCCccCCCCCCCCCCCCCcccchhhhccC
Q 003384 693 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGSEERCEPPPYFTCPIFQEVMQD 769 (824)
Q Consensus 693 ~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~~~~~~~~~~~~~e~~~~~P~~f~cPi~~evm~d 769 (824)
...+...+..+.+++.+||..+|.+||++ .++...|..+..... +............|.....|++++.|.+
T Consensus 230 --~~~~~~~~~~~~~li~~c~~~~p~~Rp~~-~~l~~~l~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (303)
T cd05110 230 --LPQPPICTIDVYMVMVKCWMIDADSRPKF-KELAAEFSRMARDPQ--RYLVIQGDDRMKLPSPNDSKFFQNLLDE 301 (303)
T ss_pred --CCCCCCCCHHHHHHHHHHcCCChhhCcCH-HHHHHHHHHHHhchh--hheeeccCCcCCCCCCchhhHHhccccc
Confidence 11122345689999999999999999999 667777777644321 1222233444566788888888887754
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=310.47 Aligned_cols=246 Identities=28% Similarity=0.479 Sum_probs=200.7
Q ss_pred CCCCccceeeecCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEecCC
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPN 541 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey~~g 541 (824)
.+|.....||.|+||.||+|...+..||||.+..... ....+.+|+.+++.++||||+++++++. +..++||||+++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 84 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAK 84 (256)
T ss_pred hhccceeeeecCCCceEEEEEecCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCC
Confidence 4678889999999999999999999999999976543 4567899999999999999999999874 568899999999
Q ss_pred CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCC
Q 003384 542 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 621 (824)
Q Consensus 542 gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 621 (824)
++|.+++.... ...+++..+..++.+++.||.|||. ++++||||||+|||++.++.+||+|||+++......
T Consensus 85 ~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~---- 156 (256)
T cd05039 85 GSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ---- 156 (256)
T ss_pred CcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEccccccccccccc----
Confidence 99999985432 2368999999999999999999999 899999999999999999999999999998663221
Q ss_pred CccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHHHHhhhccccccCCCCCCCChh
Q 003384 622 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV 700 (824)
Q Consensus 622 ~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~ 700 (824)
....++..|+|||++.++.++.++||||||+++|+|++ |+.||.............. . .....+..
T Consensus 157 -------~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~--~----~~~~~~~~ 223 (256)
T cd05039 157 -------DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK--G----YRMEAPEG 223 (256)
T ss_pred -------ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc--C----CCCCCccC
Confidence 11235678999999988889999999999999999997 9999975543221111110 0 01112334
Q ss_pred hHHHHHHHHHHHhhhccCCCCChHHHHHHHHH
Q 003384 701 QAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 732 (824)
Q Consensus 701 ~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le 732 (824)
.+..+.+++.+||..+|.+||++ .++...|+
T Consensus 224 ~~~~~~~li~~~l~~~p~~Rp~~-~~l~~~l~ 254 (256)
T cd05039 224 CPPEVYKVMKDCWELDPAKRPTF-KQLREQLA 254 (256)
T ss_pred CCHHHHHHHHHHhccChhhCcCH-HHHHHHHh
Confidence 46789999999999999999999 66766664
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=331.45 Aligned_cols=234 Identities=24% Similarity=0.335 Sum_probs=186.2
Q ss_pred ceeeecCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHHhc-CCCceeeEecccC--CceEEEEEecCC
Q 003384 470 LKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTLVYEYLPN 541 (824)
Q Consensus 470 ~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~---~~~~~f~~Ei~iL~~l-~HpnIv~L~g~~~--~~~~LV~Ey~~g 541 (824)
+.||+|+||.||+|... +..||+|++..... .....+..|+.++.++ +||||+++++++. ...++||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999875 47899999975422 2234578999999888 6999999999874 468899999999
Q ss_pred CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCC
Q 003384 542 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 621 (824)
Q Consensus 542 gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 621 (824)
|+|..++.. ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~-- 152 (327)
T cd05617 81 GDLMFHMQR---QRKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT-- 152 (327)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCc--
Confidence 999988842 3468999999999999999999999 89999999999999999999999999998743221110
Q ss_pred CccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchH------HHHHHhhhccccccCCCCC
Q 003384 622 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE------VQYALDTGKLKNLLDPLAG 695 (824)
Q Consensus 622 ~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~------~~~~~~~~~~~~~ld~~~~ 695 (824)
.....||+.|+|||++.+..++.++|||||||+||+|+||++||..... ....... .. ....
T Consensus 153 ------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~-----~~-~~~~ 220 (327)
T cd05617 153 ------TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQV-----IL-EKPI 220 (327)
T ss_pred ------eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHH-----HH-hCCC
Confidence 1234689999999999999999999999999999999999999953210 0010000 00 1112
Q ss_pred CCChhhHHHHHHHHHHHhhhccCCCCCh
Q 003384 696 DWPFVQAEQLANLAMRCCEMSRKSRPEL 723 (824)
Q Consensus 696 ~~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 723 (824)
..|...+..+.+++.+||+.+|.+||+.
T Consensus 221 ~~p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 221 RIPRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 2344556789999999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=317.42 Aligned_cols=253 Identities=23% Similarity=0.364 Sum_probs=196.3
Q ss_pred cCCCCccceeeecCceEEEEEEECC-------eEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccC--Cce
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVW 532 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~~-------~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~ 532 (824)
+++|...+.||+|+||.||+|.+.+ ..||+|.+...... ....|.+|+.+++.++||||+++++++. +..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4578888999999999999998753 57899987644322 2346889999999999999999999874 457
Q ss_pred EEEEEecCCCChhhhhhccCC----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCC---cceee
Q 003384 533 TLVYEYLPNGSLEDRLSCKDN----SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF---VSKLS 605 (824)
Q Consensus 533 ~LV~Ey~~ggsL~~~L~~~~~----~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~---~vKL~ 605 (824)
++||||++||+|.+++..... ...+++..++.++.+|+.||.|||. ++++||||||+|||++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEec
Confidence 899999999999999864421 2358999999999999999999999 7899999999999998654 68999
Q ss_pred ccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHHHHhhh
Q 003384 606 DFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTG 684 (824)
Q Consensus 606 DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~~~~ 684 (824)
|||+++.+........ .....++..|+|||++.+..++.++|||||||++|+|++ |+.||............
T Consensus 162 dfg~~~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~- 234 (277)
T cd05036 162 DFGMARDIYRASYYRK------GGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV- 234 (277)
T ss_pred cCccccccCCccceec------CCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-
Confidence 9999987633221110 112234678999999998999999999999999999997 99999754322111000
Q ss_pred ccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHH
Q 003384 685 KLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVL 731 (824)
Q Consensus 685 ~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L 731 (824)
.......+|...+..+.+++.+|++.+|.+||++ .+|++.|
T Consensus 235 -----~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~-~~vl~~l 275 (277)
T cd05036 235 -----TGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNF-ATILERI 275 (277)
T ss_pred -----HcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCH-HHHHHHh
Confidence 0011122344556789999999999999999999 5565554
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=330.50 Aligned_cols=240 Identities=24% Similarity=0.290 Sum_probs=186.8
Q ss_pred ceeeecCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHH-HHHhcCCCceeeEeccc--CCceEEEEEecCC
Q 003384 470 LKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEID-ILSKIRHPNLVTLVGAC--PEVWTLVYEYLPN 541 (824)
Q Consensus 470 ~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~---~~~~~f~~Ei~-iL~~l~HpnIv~L~g~~--~~~~~LV~Ey~~g 541 (824)
+.||+|+||.||+|... +..||||++..... .....+..|.. +++.++||||+++++++ .+..++||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 35999999999999875 57899999865321 12234556655 46779999999999987 4568999999999
Q ss_pred CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCC
Q 003384 542 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 621 (824)
Q Consensus 542 gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 621 (824)
|+|..++. ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--- 151 (325)
T cd05604 81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--- 151 (325)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC---
Confidence 99998884 34568999999999999999999999 8999999999999999999999999999874322111
Q ss_pred CccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCChhh
Q 003384 622 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQ 701 (824)
Q Consensus 622 ~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~ 701 (824)
......||+.|+|||++.+..++.++|||||||++|+|++|++||............ .... ...+...
T Consensus 152 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~--~~~~-----~~~~~~~ 219 (325)
T cd05604 152 -----TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNI--LHKP-----LVLRPGA 219 (325)
T ss_pred -----CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHH--HcCC-----ccCCCCC
Confidence 012346999999999999999999999999999999999999999765432211111 0000 1112234
Q ss_pred HHHHHHHHHHHhhhccCCCCChHHHHHHH
Q 003384 702 AEQLANLAMRCCEMSRKSRPELGKDVWRV 730 (824)
Q Consensus 702 ~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~ 730 (824)
+..+.+++.+|++.+|.+||++...+.++
T Consensus 220 ~~~~~~ll~~ll~~~p~~R~~~~~~~~~i 248 (325)
T cd05604 220 SLTAWSILEELLEKDRQRRLGAKEDFLEI 248 (325)
T ss_pred CHHHHHHHHHHhccCHHhcCCCCCCHHHH
Confidence 56889999999999999999985444333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=354.02 Aligned_cols=266 Identities=23% Similarity=0.323 Sum_probs=204.6
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCC---chhHHHHHHHHHhcCCCceeeEecccC--CceEEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 536 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~---~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~ 536 (824)
++|...++||+|+||.||+|.+. +..||||++....... ...|.+|+.+++.++||||+++++++. +..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 46888999999999999999875 5789999987543222 346889999999999999999999884 4688999
Q ss_pred EecCCCChhhhhhccC--------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccc
Q 003384 537 EYLPNGSLEDRLSCKD--------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFG 608 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~~--------~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFG 608 (824)
||++||+|.+++.... ....+++..++.++.+++.||.|||+ +||+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999885321 12346677889999999999999999 899999999999999999999999999
Q ss_pred cccccccccccCC----------CccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHH
Q 003384 609 ISRFLSQNEISSN----------NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 678 (824)
Q Consensus 609 la~~~~~~~~~~~----------~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~ 678 (824)
+++.......... ...........||+.|+|||++.+..++.++|||||||++|||+||++||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9987622110000 000001123569999999999999999999999999999999999999996543221
Q ss_pred HHHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHh
Q 003384 679 YALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 736 (824)
Q Consensus 679 ~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~ 736 (824)
.... . ....+.........+..+.+++.+|++.+|.+||+..+++.+.|+....
T Consensus 239 i~~~-~---~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 239 ISYR-D---VILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hhhh-h---hccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 1111 1 1111111111123456789999999999999999888888888877654
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=319.72 Aligned_cols=250 Identities=26% Similarity=0.299 Sum_probs=199.7
Q ss_pred CCCccceeeecCceEEEEEEECC--eEEEEEEecCCCCCCc---hhHHHHHHHHHhcCCCceeeEecccC--CceEEEEE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGP---SEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE 537 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~~--~~VAvK~l~~~~~~~~---~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~E 537 (824)
.|...+.||.|.-|+||.+..++ ..+|+|++.+...... .+.+.|.+||+.++||.++.||+.|+ +..|||||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 46777889999999999999986 6799999987654433 35677999999999999999999994 56889999
Q ss_pred ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccc
Q 003384 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 617 (824)
Q Consensus 538 y~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 617 (824)
||+||+|..+++ ++....|+...+..++.+++.||.|||. .|||+|||||+||||-++|++.|+||.|+.......
T Consensus 158 yCpGGdL~~Lrq-kQp~~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 158 YCPGGDLHSLRQ-KQPGKRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred cCCCccHHHHHh-hCCCCccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 999999998875 4456779999999999999999999999 899999999999999999999999999986432100
Q ss_pred cc-----------------------------C-C------------------CccccccCCCCCCcccCChhhhccCCCC
Q 003384 618 IS-----------------------------S-N------------------NTTLCCRTDPKGTFAYMDPEFLASGELT 649 (824)
Q Consensus 618 ~~-----------------------------~-~------------------~~~~~~~~~~~GT~~Y~APE~l~~~~~t 649 (824)
+. . . ..+.......+||-.|+|||++.+.+++
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 00 0 0 0001122356899999999999999999
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCCh
Q 003384 650 PKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 723 (824)
Q Consensus 650 ~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 723 (824)
.++|||+|||+||||+.|..||.+.+.-....+. +.+- ......| ..+..+.+||.+.|.+||.+|...
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NI--v~~~--l~Fp~~~-~vs~~akDLIr~LLvKdP~kRlg~ 382 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNI--VGQP--LKFPEEP-EVSSAAKDLIRKLLVKDPSKRLGS 382 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHH--hcCC--CcCCCCC-cchhHHHHHHHHHhccChhhhhcc
Confidence 9999999999999999999999877643332221 1110 1111222 456789999999999999999985
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=334.33 Aligned_cols=245 Identities=25% Similarity=0.287 Sum_probs=191.4
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCC---CCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEE
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLV 535 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~---~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV 535 (824)
..+|...+.||+|+||.||++... +..||+|++.... ......+.+|+.+++.++||||+++++++. ...++|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 347888999999999999999875 5789999986432 122345788999999999999999999884 458899
Q ss_pred EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccc
Q 003384 536 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 615 (824)
Q Consensus 536 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~ 615 (824)
|||++||+|.+++.. ..++......++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 122 ~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 122 MEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 999999999998842 347888889999999999999999 8999999999999999999999999999986543
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccC----CCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccC
Q 003384 616 NEISSNNTTLCCRTDPKGTFAYMDPEFLASG----ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD 691 (824)
Q Consensus 616 ~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~----~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld 691 (824)
.... ......||+.|+|||++.+. .++.++|||||||+||||++|++||.................
T Consensus 195 ~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~--- 264 (370)
T cd05596 195 NGMV-------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKN--- 264 (370)
T ss_pred CCcc-------cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCC---
Confidence 2211 01234699999999998653 478899999999999999999999976554321111100000
Q ss_pred CCCCCCChhhHHHHHHHHHHHhhhccCC--CCChH
Q 003384 692 PLAGDWPFVQAEQLANLAMRCCEMSRKS--RPELG 724 (824)
Q Consensus 692 ~~~~~~p~~~~~~l~~Li~~Cl~~~P~~--RPt~~ 724 (824)
..........+..+.+|+.+||+.+|.+ ||++.
T Consensus 265 ~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ 299 (370)
T cd05596 265 SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVD 299 (370)
T ss_pred cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHH
Confidence 0110111234678999999999998987 99983
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=311.29 Aligned_cols=250 Identities=30% Similarity=0.475 Sum_probs=198.9
Q ss_pred CCCccceeeecCceEEEEEEECC-eEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC-CceEEEEEecCCC
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVYEYLPNG 542 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~~-~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~-~~~~LV~Ey~~gg 542 (824)
+|.....||+|+||.||+|.+.+ ..||+|.+.... .....+.+|+.+++.++|||++++++++. +..++||||+++|
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~~ 85 (260)
T cd05069 7 SLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSEEPIYIVTEFMGKG 85 (260)
T ss_pred HeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCcEEEEEcCCCC
Confidence 57788899999999999998765 579999876543 23457889999999999999999999874 4578999999999
Q ss_pred ChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCCC
Q 003384 543 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 622 (824)
Q Consensus 543 sL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~ 622 (824)
+|.+++... ....+++..+..++.+++.||.|||+ .|++|+||||+|||++.++.+||+|||++..........
T Consensus 86 ~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~-- 159 (260)
T cd05069 86 SLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA-- 159 (260)
T ss_pred CHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCcccc--
Confidence 999998543 23458899999999999999999999 889999999999999999999999999998664332111
Q ss_pred ccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHHHHhhhccccccCCCCCCCChhh
Q 003384 623 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQ 701 (824)
Q Consensus 623 ~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~ 701 (824)
.....++..|+|||.+.+..++.++|||||||++|+|+| |++||............ ... .....+...
T Consensus 160 -----~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~---~~~---~~~~~~~~~ 228 (260)
T cd05069 160 -----RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQV---ERG---YRMPCPQGC 228 (260)
T ss_pred -----cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---HcC---CCCCCCccc
Confidence 122346788999999988899999999999999999999 99999754332211111 010 111223345
Q ss_pred HHHHHHHHHHHhhhccCCCCChHHHHHHHHHH
Q 003384 702 AEQLANLAMRCCEMSRKSRPELGKDVWRVLEP 733 (824)
Q Consensus 702 ~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~ 733 (824)
+..+.+++.+||..+|.+||++ +.+.+.|+.
T Consensus 229 ~~~~~~li~~~l~~~p~~Rp~~-~~i~~~l~~ 259 (260)
T cd05069 229 PESLHELMKLCWKKDPDERPTF-EYIQSFLED 259 (260)
T ss_pred CHHHHHHHHHHccCCcccCcCH-HHHHHHHhc
Confidence 6789999999999999999999 677776653
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=314.79 Aligned_cols=251 Identities=27% Similarity=0.464 Sum_probs=198.3
Q ss_pred CCCCccceeeecCceEEEEEEEC-----CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccC--CceEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR-----HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLV 535 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~-----~~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV 535 (824)
.+|...+.||+|+||.||+|.+. +..+|+|.+...... ....|.+|+.+++.++||||+++++++. +..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46778889999999999999863 246999998654321 2346889999999999999999999883 468899
Q ss_pred EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccc
Q 003384 536 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 615 (824)
Q Consensus 536 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~ 615 (824)
|||+++|+|.+++... ...+++.++..++.+++.||.|||+ ++++||||||+|||++.++.+||+|||++..+..
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 9999999999999533 3468999999999999999999999 8999999999999999999999999999987654
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHH--HHHhhhccccccCC
Q 003384 616 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--YALDTGKLKNLLDP 692 (824)
Q Consensus 616 ~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~--~~~~~~~~~~~ld~ 692 (824)
....... .....++..|+|||++.+..++.++|||||||++|++++ |..||....... ..+..+
T Consensus 159 ~~~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~-------- 225 (267)
T cd05066 159 DPEAAYT-----TRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG-------- 225 (267)
T ss_pred ccceeee-----cCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCC--------
Confidence 3211100 122334678999999998899999999999999999886 999996543221 111111
Q ss_pred CCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHH
Q 003384 693 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP 733 (824)
Q Consensus 693 ~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~ 733 (824)
.....+...+..+.+++.+|++.+|.+||++ .++.+.|+.
T Consensus 226 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~-~~i~~~l~~ 265 (267)
T cd05066 226 YRLPAPMDCPAALHQLMLDCWQKDRNERPKF-EQIVSILDK 265 (267)
T ss_pred CcCCCCCCCCHHHHHHHHHHcccCchhCCCH-HHHHHHHHh
Confidence 1112233456789999999999999999999 677777765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=319.96 Aligned_cols=259 Identities=27% Similarity=0.461 Sum_probs=196.1
Q ss_pred CCCCccceeeecCceEEEEEEECC----------------eEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEec
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLRH----------------MQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVG 526 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~~----------------~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~L~g 526 (824)
++|.+.+.||+|+||.||++...+ ..||+|.+...... ....|.+|++++++++||||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 468888999999999999987532 24899998754222 2346889999999999999999999
Q ss_pred cc--CCceEEEEEecCCCChhhhhhccC---------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEE
Q 003384 527 AC--PEVWTLVYEYLPNGSLEDRLSCKD---------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANIL 595 (824)
Q Consensus 527 ~~--~~~~~LV~Ey~~ggsL~~~L~~~~---------~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NIL 595 (824)
++ ....++||||+++++|.+++.... ....+++..++.++.+++.||.|||+ ++++||||||+|||
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhhEE
Confidence 88 346889999999999999885332 12347889999999999999999999 89999999999999
Q ss_pred ecCCCcceeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh--CCCCCCC
Q 003384 596 LDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGI 673 (824)
Q Consensus 596 ld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt--G~~Pf~~ 673 (824)
++.++.+||+|||++..+...... ...+...++..|+|||++.++.++.++|||||||++|+|++ |..||..
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~ 235 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYY------RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235 (295)
T ss_pred EcCCCcEEecccccccccccCcce------eccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence 999999999999999765432211 01123446789999999998899999999999999999998 6678865
Q ss_pred chHHHHHHhhhcc-ccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHH
Q 003384 674 TKEVQYALDTGKL-KNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 732 (824)
Q Consensus 674 ~~~~~~~~~~~~~-~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le 732 (824)
............. ...........+...+..+.+|+.+||+.+|.+||++ .+|.+.|+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~-~~i~~~l~ 294 (295)
T cd05097 236 LSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTF-NKIHHFLR 294 (295)
T ss_pred cChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCH-HHHHHHHh
Confidence 4322111111110 0000111111223345789999999999999999999 66766664
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=313.35 Aligned_cols=247 Identities=28% Similarity=0.386 Sum_probs=194.6
Q ss_pred hhcCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhc-CCCceeeEecccC--------
Q 003384 461 GATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGACP-------- 529 (824)
Q Consensus 461 ~~~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l-~HpnIv~L~g~~~-------- 529 (824)
.+++.|+..+.||+|+||.||+|... +..||+|.+.... .....+.+|+.++.++ +||||++++++|.
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 45667888999999999999999875 5789999986543 3345788999999998 7999999999873
Q ss_pred CceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccc
Q 003384 530 EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI 609 (824)
Q Consensus 530 ~~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGl 609 (824)
...++||||+++|+|.+++... ....+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCC
Confidence 2478999999999999998643 23468899999999999999999999 8999999999999999999999999999
Q ss_pred ccccccccccCCCccccccCCCCCCcccCChhhhc-----cCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhh
Q 003384 610 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA-----SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG 684 (824)
Q Consensus 610 a~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~-----~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~ 684 (824)
+........ ......|++.|+|||++. +..++.++|||||||++|||++|++||.............
T Consensus 158 ~~~~~~~~~--------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~ 229 (272)
T cd06637 158 SAQLDRTVG--------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP 229 (272)
T ss_pred ceecccccc--------cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHh
Confidence 876533211 013346899999999986 3458889999999999999999999996543322211111
Q ss_pred ccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 685 KLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 685 ~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
. .+.....+...+..+.+|+.+||..+|.+||++.+
T Consensus 230 ~-----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ 265 (272)
T cd06637 230 R-----NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQ 265 (272)
T ss_pred c-----CCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHH
Confidence 0 01111112234568999999999999999999843
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=334.06 Aligned_cols=259 Identities=25% Similarity=0.409 Sum_probs=201.6
Q ss_pred hhcCCCCccceeeecCceEEEEEEECC-------eEEEEEEecCCCCCC-chhHHHHHHHHHhcC-CCceeeEecccC--
Q 003384 461 GATHNFDPSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQG-PSEFQQEIDILSKIR-HPNLVTLVGACP-- 529 (824)
Q Consensus 461 ~~~~~f~~~~~LG~G~fG~Vykg~~~~-------~~VAvK~l~~~~~~~-~~~f~~Ei~iL~~l~-HpnIv~L~g~~~-- 529 (824)
....+|.+.++||+|+||.||+|.+.+ ..||||++....... ...+.+|+.+|.++. ||||++++|+|.
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~ 113 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence 344567888999999999999998643 579999997543222 346889999999997 999999999984
Q ss_pred CceEEEEEecCCCChhhhhhccC---------------------------------------------------------
Q 003384 530 EVWTLVYEYLPNGSLEDRLSCKD--------------------------------------------------------- 552 (824)
Q Consensus 530 ~~~~LV~Ey~~ggsL~~~L~~~~--------------------------------------------------------- 552 (824)
...++||||+++|+|.+++....
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 45789999999999999986431
Q ss_pred --------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcE
Q 003384 553 --------------------------------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANI 594 (824)
Q Consensus 553 --------------------------------------~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NI 594 (824)
....+++...+.|+.+++.||.|||+ ++|+||||||+||
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~Ni 270 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNV 270 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcceE
Confidence 11347788889999999999999998 8999999999999
Q ss_pred EecCCCcceeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCC
Q 003384 595 LLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGI 673 (824)
Q Consensus 595 Lld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~ 673 (824)
|++.++.+||+|||+++.+........ .....|++.|+|||++.+..++.++|||||||++|||++ |..||..
T Consensus 271 Ll~~~~~~kL~DfGla~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~ 344 (401)
T cd05107 271 LICEGKLVKICDFGLARDIMRDSNYIS------KGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPE 344 (401)
T ss_pred EEeCCCEEEEEecCcceeccccccccc------CCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCC
Confidence 999999999999999986543221100 123357889999999998889999999999999999998 8999965
Q ss_pred chHHHHHHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHH
Q 003384 674 TKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 734 (824)
Q Consensus 674 ~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l 734 (824)
.......... +.. ......|...+..+.+|+.+||..+|.+||++ ++++..|+.+
T Consensus 345 ~~~~~~~~~~--~~~---~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~-~ell~~L~~~ 399 (401)
T cd05107 345 LPMNEQFYNA--IKR---GYRMAKPAHASDEIYEIMQKCWEEKFEIRPDF-SQLVHLVGDL 399 (401)
T ss_pred CCchHHHHHH--HHc---CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCH-HHHHHHHHHH
Confidence 4322211110 000 00112234456789999999999999999999 6777888765
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=321.11 Aligned_cols=259 Identities=23% Similarity=0.385 Sum_probs=202.5
Q ss_pred cCCCCccceeeecCceEEEEEEEC---------CeEEEEEEecCCC-CCCchhHHHHHHHHHhc-CCCceeeEecccC--
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR---------HMQVAIKMLHPHS-LQGPSEFQQEIDILSKI-RHPNLVTLVGACP-- 529 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~---------~~~VAvK~l~~~~-~~~~~~f~~Ei~iL~~l-~HpnIv~L~g~~~-- 529 (824)
..+|.....||+|+||.||+|.+. +..||+|.+.... ......+.+|+.+++.+ +||||+++++++.
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 346788899999999999999752 2469999886532 22345688999999999 8999999999884
Q ss_pred CceEEEEEecCCCChhhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEe
Q 003384 530 EVWTLVYEYLPNGSLEDRLSCKDN-------------SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL 596 (824)
Q Consensus 530 ~~~~LV~Ey~~ggsL~~~L~~~~~-------------~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILl 596 (824)
...++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+ +||+||||||+|||+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceEEE
Confidence 457899999999999999864321 2358889999999999999999999 899999999999999
Q ss_pred cCCCcceeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCch
Q 003384 597 DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITK 675 (824)
Q Consensus 597 d~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~ 675 (824)
+.++.+||+|||+++.......... .....+++.|+|||++.+..++.++|||||||++|+|+| |.+||....
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 244 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKK------TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 244 (304)
T ss_pred cCCCcEEECCCccceeccccccccc------ccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999986643321111 122346788999999988889999999999999999998 888886543
Q ss_pred HHHHHHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhh
Q 003384 676 EVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 737 (824)
Q Consensus 676 ~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~~ 737 (824)
......... .......+...+..+.+|+.+||..+|.+||++ .++++.|+.+...
T Consensus 245 ~~~~~~~~~------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~-~e~l~~l~~~~~~ 299 (304)
T cd05101 245 VEELFKLLK------EGHRMDKPANCTNELYMMMRDCWHAIPSHRPTF-KQLVEDLDRILTL 299 (304)
T ss_pred HHHHHHHHH------cCCcCCCCCCCCHHHHHHHHHHcccChhhCCCH-HHHHHHHHHHHHh
Confidence 322111100 011111233456789999999999999999999 7788888887654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=330.39 Aligned_cols=246 Identities=25% Similarity=0.308 Sum_probs=193.7
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 536 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~---~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~ 536 (824)
++|.....||+|+||.||++... +..||||++..... .....+..|+.+++.++||||+++++++. +..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 36888899999999999999875 57899999875422 22346889999999999999999999884 4688999
Q ss_pred EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccc
Q 003384 537 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 616 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 616 (824)
||+++|+|.+++... ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999999998533 2468999999999999999999999 89999999999999999999999999999866433
Q ss_pred cccCCCccccccCCCCCCcccCChhhhc------cCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhcccccc
Q 003384 617 EISSNNTTLCCRTDPKGTFAYMDPEFLA------SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLL 690 (824)
Q Consensus 617 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~------~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~l 690 (824)
... ......||+.|+|||++. ...++.++|||||||+||+|++|+.||............-.....+
T Consensus 156 ~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~ 228 (330)
T cd05601 156 KMV-------NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFL 228 (330)
T ss_pred Cce-------eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCcc
Confidence 211 012346899999999986 4567899999999999999999999997654332211111111111
Q ss_pred CCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 691 DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 691 d~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
........+..+.+|+..|+. +|.+||++.+
T Consensus 229 ---~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~ 259 (330)
T cd05601 229 ---KFPEDPKVSSDFLDLIQSLLC-GQKERLGYEG 259 (330)
T ss_pred ---CCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHH
Confidence 111112346789999999998 9999999843
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=319.87 Aligned_cols=254 Identities=27% Similarity=0.441 Sum_probs=196.3
Q ss_pred CCCCccceeeecCceEEEEEEECC----eEEEEEEecCCC-CCCchhHHHHHHHHHhc-CCCceeeEecccC--CceEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLRH----MQVAIKMLHPHS-LQGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTLV 535 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~~----~~VAvK~l~~~~-~~~~~~f~~Ei~iL~~l-~HpnIv~L~g~~~--~~~~LV 535 (824)
++|.+...||+|+||.||+|.... ..+++|.++... ......+.+|+.++.++ +||||+++++++. ...++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 367888899999999999998753 347888876422 22235688999999999 7999999999884 357899
Q ss_pred EEecCCCChhhhhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcc
Q 003384 536 YEYLPNGSLEDRLSCKD-------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS 602 (824)
Q Consensus 536 ~Ey~~ggsL~~~L~~~~-------------~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~v 602 (824)
|||+++|+|.+++.... ....+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeE
Confidence 99999999999985422 12358899999999999999999999 899999999999999999999
Q ss_pred eeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHHHH
Q 003384 603 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYAL 681 (824)
Q Consensus 603 KL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~ 681 (824)
||+|||++........ ......+..|+|||++.+..++.++|||||||++|||+| |.+||.........
T Consensus 159 kl~dfg~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~- 228 (297)
T cd05089 159 KIADFGLSRGEEVYVK---------KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELY- 228 (297)
T ss_pred EECCcCCCccccceec---------cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH-
Confidence 9999999864321100 011223567999999988889999999999999999997 99999654332211
Q ss_pred hhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHh
Q 003384 682 DTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 736 (824)
Q Consensus 682 ~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~ 736 (824)
.. .........+...+..+.+|+.+||+.+|.+||++ ..+.+.|+.+..
T Consensus 229 ~~-----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~-~~i~~~l~~~~~ 277 (297)
T cd05089 229 EK-----LPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPF-AQISVQLSRMLE 277 (297)
T ss_pred HH-----HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCH-HHHHHHHHHHHH
Confidence 11 11111112234456789999999999999999999 666677776654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=318.65 Aligned_cols=256 Identities=24% Similarity=0.412 Sum_probs=197.8
Q ss_pred hcCCCCccceeeecCceEEEEEEEC-------CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccC--Cc
Q 003384 462 ATHNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EV 531 (824)
Q Consensus 462 ~~~~f~~~~~LG~G~fG~Vykg~~~-------~~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~ 531 (824)
...+|...+.||+|+||.||+|..+ +..||+|.+...... ....+.+|+.+++.++||||+++++++. ..
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3457888999999999999999754 247999987643221 1235788999999999999999999874 46
Q ss_pred eEEEEEecCCCChhhhhhccC-------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCccee
Q 003384 532 WTLVYEYLPNGSLEDRLSCKD-------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKL 604 (824)
Q Consensus 532 ~~LV~Ey~~ggsL~~~L~~~~-------~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL 604 (824)
.++||||+++|+|.+++.... ....+++..+..++.+++.||.|||+ ++|+||||||+|||++.++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEEE
Confidence 799999999999999996432 13456778889999999999999999 89999999999999999999999
Q ss_pred eccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHHHHhh
Q 003384 605 SDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDT 683 (824)
Q Consensus 605 ~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~~~ 683 (824)
+|||+++.......... .....++..|+|||.+.++.++.++|||||||++|||++ |.+||......... .
T Consensus 161 ~Dfg~~~~~~~~~~~~~------~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~-~- 232 (288)
T cd05061 161 GDFGMTRDIYETDYYRK------GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVL-K- 232 (288)
T ss_pred CcCCccccccccccccc------cCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-H-
Confidence 99999986543321111 122345788999999998899999999999999999998 78899654332211 0
Q ss_pred hccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHH
Q 003384 684 GKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP 733 (824)
Q Consensus 684 ~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~ 733 (824)
...+......+...+..+.+++.+|++.+|.+||++ .++.+.|..
T Consensus 233 ----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-~~ll~~l~~ 277 (288)
T cd05061 233 ----FVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTF-LEIVNLLKD 277 (288)
T ss_pred ----HHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCH-HHHHHHHHh
Confidence 011111112233445789999999999999999999 566666654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=307.95 Aligned_cols=246 Identities=31% Similarity=0.508 Sum_probs=198.5
Q ss_pred ceeeecCceEEEEEEEC-----CeEEEEEEecCCCCCC-chhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEecCC
Q 003384 470 LKIGEGGYGSIYKGLLR-----HMQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPN 541 (824)
Q Consensus 470 ~~LG~G~fG~Vykg~~~-----~~~VAvK~l~~~~~~~-~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey~~g 541 (824)
+.||+|+||.||+|... +..|++|.+....... ...+.+|+.++..++||||+++++++. ...++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 36999999999999876 6789999998654433 567899999999999999999999884 468899999999
Q ss_pred CChhhhhhccCC------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccc
Q 003384 542 GSLEDRLSCKDN------SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 615 (824)
Q Consensus 542 gsL~~~L~~~~~------~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~ 615 (824)
++|.+++..... ...+++..+..++.+++.||.|||+ ++++||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999964421 3679999999999999999999999 8999999999999999999999999999987654
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHHHHhhhccccccCCCC
Q 003384 616 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLA 694 (824)
Q Consensus 616 ~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~~~~~~~~~ld~~~ 694 (824)
..... ......+++.|+|||.+....++.++|||||||++|+|++ |.+||............. ....
T Consensus 158 ~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~------~~~~ 225 (262)
T cd00192 158 DDYYR------KKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLR------KGYR 225 (262)
T ss_pred ccccc------cccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH------cCCC
Confidence 33110 1133457899999999988899999999999999999999 699997654322111111 1112
Q ss_pred CCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHH
Q 003384 695 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVL 731 (824)
Q Consensus 695 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L 731 (824)
...+...+..+.+++.+||..+|.+||++ .+++..|
T Consensus 226 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~-~~l~~~l 261 (262)
T cd00192 226 LPKPEYCPDELYELMLSCWQLDPEDRPTF-SELVERL 261 (262)
T ss_pred CCCCccCChHHHHHHHHHccCCcccCcCH-HHHHHhh
Confidence 22344557799999999999999999999 5665544
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=311.40 Aligned_cols=248 Identities=27% Similarity=0.445 Sum_probs=190.1
Q ss_pred eeeecCceEEEEEEEC-----CeEEEEEEecCCC-CCCchhHHHHHHHHHhcCCCceeeEecccC---CceEEEEEecCC
Q 003384 471 KIGEGGYGSIYKGLLR-----HMQVAIKMLHPHS-LQGPSEFQQEIDILSKIRHPNLVTLVGACP---EVWTLVYEYLPN 541 (824)
Q Consensus 471 ~LG~G~fG~Vykg~~~-----~~~VAvK~l~~~~-~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~---~~~~LV~Ey~~g 541 (824)
.||+|+||.||+|.+. ...||||.+.... ......+.+|+.+++.++||||++++++|. ...++||||+.+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~ 81 (262)
T cd05058 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKH 81 (262)
T ss_pred cccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCC
Confidence 5899999999999863 2569999875432 222457889999999999999999999762 347899999999
Q ss_pred CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCC
Q 003384 542 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 621 (824)
Q Consensus 542 gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 621 (824)
|+|.+++... ...+++..+..++.+++.||.|||. .+++||||||+|||++.++.+||+|||+++.+........
T Consensus 82 ~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 82 GDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 9999998533 2346778889999999999999999 8999999999999999999999999999986543221110
Q ss_pred CccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHHHHhhhccccccCCCCCCCChh
Q 003384 622 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV 700 (824)
Q Consensus 622 ~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~ 700 (824)
. ......++..|+|||++.+..++.++|||||||++|||++ |.+||............ ........+..
T Consensus 157 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~ 226 (262)
T cd05058 157 H----NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYL------LQGRRLLQPEY 226 (262)
T ss_pred c----ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH------hcCCCCCCCCc
Confidence 0 0123456789999999988899999999999999999999 56777654332211111 11111112233
Q ss_pred hHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHH
Q 003384 701 QAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 734 (824)
Q Consensus 701 ~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l 734 (824)
.+..+.+++.+||..+|.+||++ .+++..|+.+
T Consensus 227 ~~~~~~~li~~cl~~~p~~Rp~~-~~il~~l~~~ 259 (262)
T cd05058 227 CPDPLYEVMLSCWHPKPEMRPTF-SELVSRIEQI 259 (262)
T ss_pred CCHHHHHHHHHHcCCChhhCCCH-HHHHHHHHHH
Confidence 45689999999999999999999 6777777664
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=309.59 Aligned_cols=246 Identities=26% Similarity=0.381 Sum_probs=196.1
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC-----CchhHHHHHHHHHhcCCCceeeEecccC--CceEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-----GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTL 534 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~-----~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~L 534 (824)
.+|...+.||.|+||.||+|... +..||+|.+...... ....+.+|+.++++++||||+++++++. +..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46888999999999999999864 588999998654221 1246888999999999999999999884 46889
Q ss_pred EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccc
Q 003384 535 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 614 (824)
Q Consensus 535 V~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~ 614 (824)
||||+++++|.+++.. ...++......++.+++.||.|||. .+|+||||+|+||+++.++.++|+|||+++...
T Consensus 82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 9999999999998853 3468889999999999999999999 899999999999999999999999999987654
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCC
Q 003384 615 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 694 (824)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~ 694 (824)
....... ......|+..|+|||++.+..++.++|||||||++|+|++|++||.............. ....
T Consensus 156 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~-----~~~~ 225 (263)
T cd06625 156 TICSSGT-----GMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT-----QPTN 225 (263)
T ss_pred ccccccc-----cccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhc-----cCCC
Confidence 3211100 00234578999999999998899999999999999999999999965433322211111 1111
Q ss_pred CCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 695 GDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 695 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
...+...+..+.+++.+||..+|.+||++.+
T Consensus 226 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ 256 (263)
T cd06625 226 PQLPSHVSPDARNFLRRTFVENAKKRPSAEE 256 (263)
T ss_pred CCCCccCCHHHHHHHHHHhhcCcccCCCHHH
Confidence 2234456678999999999999999999843
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=321.46 Aligned_cols=253 Identities=26% Similarity=0.444 Sum_probs=194.8
Q ss_pred CCCCccceeeecCceEEEEEEEC--Ce--EEEEEEecCCCC-CCchhHHHHHHHHHhc-CCCceeeEecccC--CceEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HM--QVAIKMLHPHSL-QGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTLV 535 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~--~VAvK~l~~~~~-~~~~~f~~Ei~iL~~l-~HpnIv~L~g~~~--~~~~LV 535 (824)
++|+..+.||+|+||.||+|.+. +. .+|+|.+..... .....+.+|+.++.++ +||||+++++++. ...++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 36788889999999999999875 33 468887654321 2234688999999999 8999999999884 468899
Q ss_pred EEecCCCChhhhhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcc
Q 003384 536 YEYLPNGSLEDRLSCKD-------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS 602 (824)
Q Consensus 536 ~Ey~~ggsL~~~L~~~~-------------~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~v 602 (824)
|||+++|+|.+++.... ....+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCcE
Confidence 99999999999986432 12368899999999999999999999 899999999999999999999
Q ss_pred eeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHHHH
Q 003384 603 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYAL 681 (824)
Q Consensus 603 KL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~ 681 (824)
||+|||++....... . .....++..|+|||++.+..++.++|||||||++|+|+| |.+||.........
T Consensus 164 kl~dfg~~~~~~~~~-----~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~- 233 (303)
T cd05088 164 KIADFGLSRGQEVYV-----K----KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY- 233 (303)
T ss_pred EeCccccCcccchhh-----h----cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHH-
Confidence 999999986322110 0 012235678999999988889999999999999999998 99999654332211
Q ss_pred hhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHH
Q 003384 682 DTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 735 (824)
Q Consensus 682 ~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~ 735 (824)
.. .........+...+..+.+|+.+||+.+|.+||++ +.++..|..+.
T Consensus 234 ~~-----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~-~~il~~l~~~~ 281 (303)
T cd05088 234 EK-----LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSF-AQILVSLNRML 281 (303)
T ss_pred HH-----HhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCH-HHHHHHHHHHH
Confidence 11 01111112233445689999999999999999999 55666666543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=309.54 Aligned_cols=245 Identities=26% Similarity=0.455 Sum_probs=195.4
Q ss_pred CCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCc---------hhHHHHHHHHHhcCCCceeeEecccC--Cce
Q 003384 466 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGP---------SEFQQEIDILSKIRHPNLVTLVGACP--EVW 532 (824)
Q Consensus 466 f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~---------~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~ 532 (824)
|.....||.|+||.||+|... +..||+|.+........ +.+.+|+.++++++||||+++++++. +..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 566778999999999999874 57899998875433222 35789999999999999999999873 467
Q ss_pred EEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccc
Q 003384 533 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 612 (824)
Q Consensus 533 ~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~ 612 (824)
++||||+++++|.+++.. ...+++..+..++.+++.||.|||. ++++||||+|+|||++.++.+||+|||+++.
T Consensus 82 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 82 NIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred EEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 899999999999999943 3568889999999999999999999 8899999999999999999999999999987
Q ss_pred cccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCC
Q 003384 613 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDP 692 (824)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~ 692 (824)
........... .......|+..|+|||++.+..++.++|||||||++|+|++|+.||.............. .
T Consensus 156 ~~~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------~ 227 (267)
T cd06628 156 LEANSLSTKTN--GARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE------N 227 (267)
T ss_pred cccccccCCcc--ccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc------c
Confidence 65322111111 011234588999999999988899999999999999999999999976544332222111 1
Q ss_pred CCCCCChhhHHHHHHHHHHHhhhccCCCCChH
Q 003384 693 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 693 ~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
.....+...+..+.+++.+||+.+|.+||++.
T Consensus 228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ 259 (267)
T cd06628 228 ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAA 259 (267)
T ss_pred CCCcCCcccCHHHHHHHHHHccCCchhCcCHH
Confidence 11223444567899999999999999999984
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=311.82 Aligned_cols=250 Identities=27% Similarity=0.406 Sum_probs=196.2
Q ss_pred HhhhcCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC--CceEE
Q 003384 459 IEGATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTL 534 (824)
Q Consensus 459 i~~~~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~L 534 (824)
++.++.++.....||+|+||.||+|.+. +..||+|.+..........+.+|+.+++.++||||++++|++. +..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 4556777878889999999999999875 4679999887655445567899999999999999999999884 46889
Q ss_pred EEEecCCCChhhhhhccCCCCCC--CHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecC-CCcceeecccccc
Q 003384 535 VYEYLPNGSLEDRLSCKDNSPPL--SWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA-NFVSKLSDFGISR 611 (824)
Q Consensus 535 V~Ey~~ggsL~~~L~~~~~~~~l--~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~-~~~vKL~DFGla~ 611 (824)
||||+++++|.+++.... .++ +...+..++.|++.||.|||+ ++|+||||||+||+++. ++.+||+|||++.
T Consensus 83 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~ 157 (268)
T cd06624 83 FMEQVPGGSLSALLRSKW--GPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSK 157 (268)
T ss_pred EEecCCCCCHHHHHHHhc--ccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence 999999999999986432 234 778889999999999999999 89999999999999986 6799999999987
Q ss_pred ccccccccCCCccccccCCCCCCcccCChhhhccC--CCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccc
Q 003384 612 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG--ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNL 689 (824)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~--~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ 689 (824)
........ .....|++.|+|||++.+. .++.++|||||||++|+|++|++||...............
T Consensus 158 ~~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~--- 226 (268)
T cd06624 158 RLAGINPC--------TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGM--- 226 (268)
T ss_pred ecccCCCc--------cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhh---
Confidence 65432111 1223589999999998664 3788999999999999999999999643221111111000
Q ss_pred cCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 690 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 690 ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
.......|......+.+++.+||+.+|.+||++.+
T Consensus 227 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ 261 (268)
T cd06624 227 -FKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHD 261 (268)
T ss_pred -hccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHH
Confidence 01112234455678999999999999999999943
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=327.15 Aligned_cols=238 Identities=24% Similarity=0.311 Sum_probs=185.4
Q ss_pred eeeecCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHH-HHHhcCCCceeeEeccc--CCceEEEEEecCCC
Q 003384 471 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEID-ILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNG 542 (824)
Q Consensus 471 ~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~---~~~~~f~~Ei~-iL~~l~HpnIv~L~g~~--~~~~~LV~Ey~~gg 542 (824)
.||+|+||.||+|... +..||+|++..... .....+..|.. +++.++||||+++++++ .+..++||||+++|
T Consensus 2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05602 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG 81 (325)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCC
Confidence 6999999999999886 46799999865321 11223444444 56788999999999987 45689999999999
Q ss_pred ChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCCC
Q 003384 543 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 622 (824)
Q Consensus 543 sL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~ 622 (824)
+|.+++.. ...++......++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~---- 151 (325)
T cd05602 82 ELFYHLQR---ERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG---- 151 (325)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC----
Confidence 99998853 3457788888999999999999999 8999999999999999999999999999875322111
Q ss_pred ccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCChhhH
Q 003384 623 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQA 702 (824)
Q Consensus 623 ~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~ 702 (824)
......||+.|+|||++.+..++.++|||||||++|+|++|++||............ ... ....+...+
T Consensus 152 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i--~~~-----~~~~~~~~~ 220 (325)
T cd05602 152 ----TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI--LNK-----PLQLKPNIT 220 (325)
T ss_pred ----CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHH--HhC-----CcCCCCCCC
Confidence 012346999999999999999999999999999999999999999765433211110 000 111233456
Q ss_pred HHHHHHHHHHhhhccCCCCChHHHHHH
Q 003384 703 EQLANLAMRCCEMSRKSRPELGKDVWR 729 (824)
Q Consensus 703 ~~l~~Li~~Cl~~~P~~RPt~~~~v~~ 729 (824)
..+.+++.+|++.+|.+||+..+.+.+
T Consensus 221 ~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (325)
T cd05602 221 NSARHLLEGLLQKDRTKRLGAKDDFME 247 (325)
T ss_pred HHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence 789999999999999999998544433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=312.70 Aligned_cols=254 Identities=25% Similarity=0.390 Sum_probs=201.0
Q ss_pred CCCCccceeeecCceEEEEEEECC-----eEEEEEEecCCC-CCCchhHHHHHHHHHhcCCCceeeEecccC-CceEEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLRH-----MQVAIKMLHPHS-LQGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVY 536 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~~-----~~VAvK~l~~~~-~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~-~~~~LV~ 536 (824)
.+|...+.||+|+||.||+|.+.. ..||||...... ....+.+.+|+.+++.++||||++++++|. +..++||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~lv~ 85 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITENPVWIVM 85 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCCCcEEEE
Confidence 357788899999999999998643 368999886543 223457899999999999999999999884 4578999
Q ss_pred EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccc
Q 003384 537 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 616 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 616 (824)
||+++|+|.+++... ...+++..+..++.+++.||.|||+ .+++||||||+|||++.++.+||+|||+++.....
T Consensus 86 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 86 ELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred EcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 999999999999533 3358999999999999999999999 88999999999999999999999999999866443
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHHHHhhhccccccCCCCC
Q 003384 617 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAG 695 (824)
Q Consensus 617 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~~~~~~~~~ld~~~~ 695 (824)
.... .....++..|+|||.+....++.++|||||||++|+|++ |.+||................ ..
T Consensus 161 ~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~------~~ 227 (270)
T cd05056 161 SYYK-------ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE------RL 227 (270)
T ss_pred ccee-------cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC------cC
Confidence 2111 112235678999999988889999999999999999996 999997654332221111110 01
Q ss_pred CCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHh
Q 003384 696 DWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 736 (824)
Q Consensus 696 ~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~ 736 (824)
..+...+..+.+++.+|+..+|.+||++ .++...|+.+..
T Consensus 228 ~~~~~~~~~~~~li~~~l~~~P~~Rpt~-~~~~~~l~~~~~ 267 (270)
T cd05056 228 PMPPNCPPTLYSLMTKCWAYDPSKRPRF-TELKAQLSDILQ 267 (270)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCH-HHHHHHHHHHHh
Confidence 1233456789999999999999999999 667777776643
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=331.74 Aligned_cols=242 Identities=24% Similarity=0.330 Sum_probs=188.6
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCC---CCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEE
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLV 535 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~---~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV 535 (824)
..+|...+.||+|+||.||++... +..||+|++.... ......+.+|+.+++.++||||+++++++. ...++|
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV 121 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 357888999999999999999886 4789999986421 122345789999999999999999999884 468999
Q ss_pred EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccc
Q 003384 536 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 615 (824)
Q Consensus 536 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~ 615 (824)
|||++||+|.+++.. ..++......++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|..+..
T Consensus 122 ~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 122 MEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred EcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 999999999999842 247888999999999999999999 8999999999999999999999999999986543
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccC----CCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccC
Q 003384 616 NEISSNNTTLCCRTDPKGTFAYMDPEFLASG----ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD 691 (824)
Q Consensus 616 ~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~----~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld 691 (824)
.... ......||+.|+|||++.+. .++.++|||||||+||+|+||++||........... +.+
T Consensus 195 ~~~~-------~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~------i~~ 261 (370)
T cd05621 195 TGMV-------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSK------IMD 261 (370)
T ss_pred CCce-------ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHH------HHh
Confidence 2211 01345699999999998764 378899999999999999999999976543221111 111
Q ss_pred C-CCCCCC--hhhHHHHHHHHHHHhhhccCC--CCChH
Q 003384 692 P-LAGDWP--FVQAEQLANLAMRCCEMSRKS--RPELG 724 (824)
Q Consensus 692 ~-~~~~~p--~~~~~~l~~Li~~Cl~~~P~~--RPt~~ 724 (824)
. ....+| ...+..+.+++..|+..++.+ ||++.
T Consensus 262 ~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~ 299 (370)
T cd05621 262 HKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVE 299 (370)
T ss_pred CCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHH
Confidence 0 001122 234668899999999755433 78873
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=346.52 Aligned_cols=261 Identities=23% Similarity=0.329 Sum_probs=203.1
Q ss_pred hhcCCCCccceeeecCceEEEEEEECC--eEEEEEEecCCCCCCchhHHHHHHHHHhcC-CCceeeEeccc-----CC--
Q 003384 461 GATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVGAC-----PE-- 530 (824)
Q Consensus 461 ~~~~~f~~~~~LG~G~fG~Vykg~~~~--~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~-HpnIv~L~g~~-----~~-- 530 (824)
....++.+.+.|.+|||+.||.+.+.+ ..||+|++-..+....+.+.+||++|++|. |||||.+++.+ .+
T Consensus 34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 345567888899999999999998863 789999988777677778999999999997 99999999943 11
Q ss_pred --ceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccc
Q 003384 531 --VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFG 608 (824)
Q Consensus 531 --~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFG 608 (824)
.++|.||||.||+|-|++..+.... |++.++++|+.++++|+.+||++.+ +|||||||-+||||+.+|+.||||||
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~p-PiIHRDLKiENvLls~~g~~KLCDFG 191 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLKP-PIIHRDLKIENVLLSADGNYKLCDFG 191 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCCC-ccchhhhhhhheEEcCCCCEEeCccc
Confidence 3568999999999999996554433 9999999999999999999999874 89999999999999999999999999
Q ss_pred cccccccccccCCCc-cccccCCCCCCcccCChhhh---ccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhh
Q 003384 609 ISRFLSQNEISSNNT-TLCCRTDPKGTFAYMDPEFL---ASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG 684 (824)
Q Consensus 609 la~~~~~~~~~~~~~-~~~~~~~~~GT~~Y~APE~l---~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~ 684 (824)
.+............. .....-...-|+.|.|||++ .+.+++.|+|||+|||+||-|+....||+..... ++..+
T Consensus 192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l--aIlng 269 (738)
T KOG1989|consen 192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL--AILNG 269 (738)
T ss_pred ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce--eEEec
Confidence 987443322111100 00000111248999999987 4568999999999999999999999999765321 12222
Q ss_pred ccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHH
Q 003384 685 KLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 732 (824)
Q Consensus 685 ~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le 732 (824)
++.- +. ...++..+.+||..||+.+|.+||++.+++.++.+
T Consensus 270 ~Y~~------P~-~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~ 310 (738)
T KOG1989|consen 270 NYSF------PP-FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE 310 (738)
T ss_pred cccC------CC-CccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence 2111 11 23678899999999999999999999665544433
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=332.37 Aligned_cols=249 Identities=23% Similarity=0.294 Sum_probs=190.7
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCC---CCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE 537 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~---~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~E 537 (824)
+|+..+.||+|+||.||++... +..||||++.... ......+..|+.++..++||||+++++.+. +..++|||
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E 81 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME 81 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 6888899999999999999875 5789999987532 222456888999999999999999999884 46899999
Q ss_pred ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccc
Q 003384 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 617 (824)
Q Consensus 538 y~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 617 (824)
|++||+|.+++.. ...++...+..++.|++.||.|||+ +||+||||||+|||++.+|.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 82 FLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred CCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 9999999999843 3568899999999999999999999 899999999999999999999999999987553221
Q ss_pred ccCCC---------------------------ccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCC
Q 003384 618 ISSNN---------------------------TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPA 670 (824)
Q Consensus 618 ~~~~~---------------------------~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~P 670 (824)
..... ..........||+.|+|||++.+..++.++|||||||++|||+||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 00000 000001234799999999999999999999999999999999999999
Q ss_pred CCCchHHHHHHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCCh
Q 003384 671 LGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 723 (824)
Q Consensus 671 f~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 723 (824)
|..................+. .......+..+.+|+.+++. +|.+|++.
T Consensus 236 f~~~~~~~~~~~i~~~~~~~~---~p~~~~~s~~~~~li~~l~~-~p~~R~~~ 284 (360)
T cd05627 236 FCSETPQETYRKVMNWKETLV---FPPEVPISEKAKDLILRFCT-DSENRIGS 284 (360)
T ss_pred CCCCCHHHHHHHHHcCCCcee---cCCCCCCCHHHHHHHHHhcc-ChhhcCCC
Confidence 976543322111111111110 00011245678889988774 99999964
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=331.88 Aligned_cols=247 Identities=26% Similarity=0.382 Sum_probs=206.2
Q ss_pred CCccceeeecCceEEEEEEECC-----eEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccC-CceEEEEEe
Q 003384 466 FDPSLKIGEGGYGSIYKGLLRH-----MQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVYEY 538 (824)
Q Consensus 466 f~~~~~LG~G~fG~Vykg~~~~-----~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~L~g~~~-~~~~LV~Ey 538 (824)
....++||+|.||.|++|.|+. -.||||.+...... ....|.+|+.+|.+|+|||+|+|||... ....+|||+
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp~mMV~EL 191 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQPAMMVFEL 191 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccchhhHHhhh
Confidence 3456689999999999999973 46999999876554 4678999999999999999999999986 457799999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccc
Q 003384 539 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 618 (824)
Q Consensus 539 ~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 618 (824)
++.|||.+.|+. .....|.......++.|||.|+.||.. +++|||||...|+||-..-.+||+||||.+-+...+.
T Consensus 192 aplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 192 APLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred cccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 999999999976 566778899999999999999999999 8999999999999999999999999999998776543
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHHHHhhhccccccCCCCCCC
Q 003384 619 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDW 697 (824)
Q Consensus 619 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~ 697 (824)
.-.. .....-.+.|+|||.+....++.++|||+|||++|||+| |..||.+....+..... -+......
T Consensus 268 ~Yvm-----~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~i------D~~erLpR 336 (1039)
T KOG0199|consen 268 MYVM-----APQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNI------DAGERLPR 336 (1039)
T ss_pred ceEe-----cCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhc------cccccCCC
Confidence 2111 122345789999999999999999999999999999998 88999776654422111 12223456
Q ss_pred ChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 003384 698 PFVQAEQLANLAMRCCEMSRKSRPELGKDV 727 (824)
Q Consensus 698 p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 727 (824)
|..+++++.+++..||..+|.+||++....
T Consensus 337 Pk~csedIY~imk~cWah~paDRptFsair 366 (1039)
T KOG0199|consen 337 PKYCSEDIYQIMKNCWAHNPADRPTFSAIR 366 (1039)
T ss_pred CCCChHHHHHHHHHhccCCccccccHHHHH
Confidence 788899999999999999999999995443
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=314.57 Aligned_cols=242 Identities=25% Similarity=0.375 Sum_probs=192.0
Q ss_pred CCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--CCceEEEEEecCC
Q 003384 466 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPN 541 (824)
Q Consensus 466 f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~Ey~~g 541 (824)
|+..+.||.|+||.||+|... +..+++|.+..........+.+|+++++.++||||++++++| ....++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 566778999999999999886 467899988655444456788999999999999999999987 4468899999999
Q ss_pred CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCC
Q 003384 542 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 621 (824)
Q Consensus 542 gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 621 (824)
|+|..++.. ...++++..+..++.+++.||.|||+ .+++||||||+|||++.++.+||+|||++........
T Consensus 87 ~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--- 158 (282)
T cd06643 87 GAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--- 158 (282)
T ss_pred CcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEcccccccccccccc---
Confidence 999988753 23568999999999999999999999 8999999999999999999999999999875432211
Q ss_pred CccccccCCCCCCcccCChhhhc-----cCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCC
Q 003384 622 NTTLCCRTDPKGTFAYMDPEFLA-----SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 696 (824)
Q Consensus 622 ~~~~~~~~~~~GT~~Y~APE~l~-----~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~ 696 (824)
......||+.|+|||++. +..++.++|||||||++|+|++|++||................ .+ ...
T Consensus 159 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~---~~-~~~ 229 (282)
T cd06643 159 -----RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE---PP-TLA 229 (282)
T ss_pred -----ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcC---CC-CCC
Confidence 112345899999999984 3457889999999999999999999997654433222211110 00 111
Q ss_pred CChhhHHHHHHHHHHHhhhccCCCCChH
Q 003384 697 WPFVQAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 697 ~p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
.+...+..+.+++.+||+.+|.+||++.
T Consensus 230 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~ 257 (282)
T cd06643 230 QPSRWSSEFKDFLKKCLEKNVDARWTTT 257 (282)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHH
Confidence 2333457899999999999999999984
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=317.60 Aligned_cols=253 Identities=25% Similarity=0.336 Sum_probs=197.3
Q ss_pred hcCCCCccceeeecCceEEEEEEEC--CeEEEEEEecC--CCCCCchhHHHHHHHHHhcCCCceeeEecccC-------C
Q 003384 462 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHP--HSLQGPSEFQQEIDILSKIRHPNLVTLVGACP-------E 530 (824)
Q Consensus 462 ~~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~--~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~-------~ 530 (824)
....|...+.||.|+||.|+.+.++ +..||||++.. ......++..+|+.+|+.++|+||+.+++++. .
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 4456777789999999999999876 58899999873 33344567889999999999999999999873 2
Q ss_pred ceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccc
Q 003384 531 VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS 610 (824)
Q Consensus 531 ~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla 610 (824)
..|+|+|+| +.+|...+. .+..|+......+..|+++||.|+|+ .+|+||||||+|+|++.+..+||+|||||
T Consensus 100 DvYiV~elM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred eeEEehhHH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEeccccce
Confidence 479999999 678999984 34458999999999999999999999 78999999999999999999999999999
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhcc-CCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhh------
Q 003384 611 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT------ 683 (824)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~------ 683 (824)
+...... .....+..+.|.+|.|||++.. ..|+...||||.||||.||++|+|.|.+.+.+.+.-..
T Consensus 173 R~~~~~~------~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGt 246 (359)
T KOG0660|consen 173 RYLDKFF------EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGT 246 (359)
T ss_pred eeccccC------cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCC
Confidence 9876431 1112355678999999998765 58999999999999999999999999876554322110
Q ss_pred -----------hccccccC--CCCCCCC-----hhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 003384 684 -----------GKLKNLLD--PLAGDWP-----FVQAEQLANLAMRCCEMSRKSRPELGKDV 727 (824)
Q Consensus 684 -----------~~~~~~ld--~~~~~~p-----~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 727 (824)
......+. |.....| ....+...+|+.+||..||.+|+|..+.+
T Consensus 247 P~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL 308 (359)
T KOG0660|consen 247 PSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEAL 308 (359)
T ss_pred CCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHh
Confidence 00111111 0011111 13456889999999999999999985433
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=308.37 Aligned_cols=256 Identities=25% Similarity=0.411 Sum_probs=202.4
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCC-CCC------chhHHHHHHHHHhcCCCceeeEeccc---CC
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS-LQG------PSEFQQEIDILSKIRHPNLVTLVGAC---PE 530 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~-~~~------~~~f~~Ei~iL~~l~HpnIv~L~g~~---~~ 530 (824)
..+|-...+||+|||++||++.+- .+.||||+-.... ..+ .+...+|.+|.+.|+||.||++|++| .+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 346778889999999999999764 5789999865431 111 13467899999999999999999998 46
Q ss_pred ceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEec---CCCcceeecc
Q 003384 531 VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD---ANFVSKLSDF 607 (824)
Q Consensus 531 ~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld---~~~~vKL~DF 607 (824)
.+|-|+|||+|.+|..+|. ....+++.....|+.||..||.||....+ +|||-||||.||||- ..|.+||.||
T Consensus 542 sFCTVLEYceGNDLDFYLK---QhklmSEKEARSIiMQiVnAL~YLNEikp-PIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLK---QHKLMSEKEARSIIMQIVNALKYLNEIKP-PIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred cceeeeeecCCCchhHHHH---hhhhhhHHHHHHHHHHHHHHHHHHhccCC-CeeeeccCCccEEEecCcccceeEeeec
Confidence 7999999999999999994 34568899999999999999999999774 899999999999995 4578999999
Q ss_pred ccccccccccccCCCccccccCCCCCCcccCChhhhccC----CCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhh
Q 003384 608 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG----ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT 683 (824)
Q Consensus 608 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~----~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~ 683 (824)
||++.+........... .......||.+|++||+|.-+ .++.++||||.|||||.++.|+.||+....-+..+..
T Consensus 618 GLSKIMdddSy~~vdGm-eLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqe 696 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGM-ELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQE 696 (775)
T ss_pred chhhhccCCccCcccce-eeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhh
Confidence 99998876654322211 122457899999999998654 4778999999999999999999999877655555555
Q ss_pred hccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChH
Q 003384 684 GKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 684 ~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
+.+...-....+..| ..+.+...+|.+||++.-++|.+..
T Consensus 697 NTIlkAtEVqFP~KP-vVsseAkaFIRRCLaYRKeDR~DV~ 736 (775)
T KOG1151|consen 697 NTILKATEVQFPPKP-VVSSEAKAFIRRCLAYRKEDRIDVQ 736 (775)
T ss_pred hchhcceeccCCCCC-ccCHHHHHHHHHHHHhhhhhhhhHH
Confidence 544333322222222 4556889999999999999998863
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=325.21 Aligned_cols=254 Identities=25% Similarity=0.386 Sum_probs=197.5
Q ss_pred CCCCccceeeecCceEEEEEEEC-------CeEEEEEEecCCCCC-CchhHHHHHHHHHhc-CCCceeeEecccC---Cc
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKI-RHPNLVTLVGACP---EV 531 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~-------~~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l-~HpnIv~L~g~~~---~~ 531 (824)
.+|.+.+.||+|+||.||+|.+. ++.||||++...... ....+.+|+.+|.++ +||||++++++|. ..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 46888999999999999999742 467999999754322 234588999999999 6899999999873 35
Q ss_pred eEEEEEecCCCChhhhhhccCC----------------------------------------------------------
Q 003384 532 WTLVYEYLPNGSLEDRLSCKDN---------------------------------------------------------- 553 (824)
Q Consensus 532 ~~LV~Ey~~ggsL~~~L~~~~~---------------------------------------------------------- 553 (824)
.++||||+++|+|.+++.....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 7899999999999998854210
Q ss_pred ------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCCCccccc
Q 003384 554 ------SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCC 627 (824)
Q Consensus 554 ------~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~ 627 (824)
...+++..+..++.+++.||.|||+ ++|+||||||+|||++.++.+||+|||++..+....... .
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~------~ 237 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV------R 237 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchh------h
Confidence 1247888899999999999999999 899999999999999999999999999998653322110 1
Q ss_pred cCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchH---HHHHHhhhccccccCCCCCCCChhhHH
Q 003384 628 RTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKE---VQYALDTGKLKNLLDPLAGDWPFVQAE 703 (824)
Q Consensus 628 ~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~---~~~~~~~~~~~~~ld~~~~~~p~~~~~ 703 (824)
.....+++.|+|||++.+..++.++|||||||++|+|++ |..||..... ....+..+. ....|...+.
T Consensus 238 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~ 309 (343)
T cd05103 238 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT--------RMRAPDYTTP 309 (343)
T ss_pred cCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccC--------CCCCCCCCCH
Confidence 122346778999999988899999999999999999997 9999965322 111111111 1111223456
Q ss_pred HHHHHHHHHhhhccCCCCChHHHHHHHHHHHH
Q 003384 704 QLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 735 (824)
Q Consensus 704 ~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~ 735 (824)
.+.+++.+||+.+|.+||++ .++++.|+.+.
T Consensus 310 ~~~~~~~~cl~~~p~~Rps~-~eil~~l~~~~ 340 (343)
T cd05103 310 EMYQTMLDCWHGEPSQRPTF-SELVEHLGNLL 340 (343)
T ss_pred HHHHHHHHHccCChhhCcCH-HHHHHHHHHHH
Confidence 79999999999999999999 67777777654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=316.56 Aligned_cols=244 Identities=25% Similarity=0.385 Sum_probs=196.9
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--CCceEEEEEec
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 539 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~Ey~ 539 (824)
.+|...+.||+|+||.||+|... +..||+|.+..........+.+|+.+++.++||||+++++.| ....++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 47888899999999999999864 578999998766555556789999999999999999999987 45689999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccccc
Q 003384 540 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 619 (824)
Q Consensus 540 ~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 619 (824)
++++|.+++. ...+++..+..++.+++.||.|||+ .||+||||||+|||++.++.+||+|||++.........
T Consensus 100 ~~~~L~~~~~----~~~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 172 (296)
T cd06654 100 AGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (296)
T ss_pred CCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhccccccc
Confidence 9999999884 2357889999999999999999999 89999999999999999999999999998764332111
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCCh
Q 003384 620 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPF 699 (824)
Q Consensus 620 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~ 699 (824)
.....|++.|+|||++.+..++.++|||||||++|+|++|++||............... ..+ ....+.
T Consensus 173 --------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~---~~~-~~~~~~ 240 (296)
T cd06654 173 --------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN---GTP-ELQNPE 240 (296)
T ss_pred --------cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcC---CCC-CCCCcc
Confidence 12345899999999999888999999999999999999999999765432221111100 000 111233
Q ss_pred hhHHHHHHHHHHHhhhccCCCCChHHH
Q 003384 700 VQAEQLANLAMRCCEMSRKSRPELGKD 726 (824)
Q Consensus 700 ~~~~~l~~Li~~Cl~~~P~~RPt~~~~ 726 (824)
..+..+.+++.+||..+|.+||++.+.
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rpt~~ei 267 (296)
T cd06654 241 KLSAIFRDFLNRCLDMDVEKRGSAKEL 267 (296)
T ss_pred ccCHHHHHHHHHHCcCCcccCcCHHHH
Confidence 455679999999999999999998443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=326.28 Aligned_cols=245 Identities=22% Similarity=0.298 Sum_probs=187.9
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCC--CCCchhHHHHHHHHHhcCCCceeeEecccC--------C
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS--LQGPSEFQQEIDILSKIRHPNLVTLVGACP--------E 530 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~--~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--------~ 530 (824)
.++|...+.||+|+||.||++... +..||||++.... ......+.+|+.+++.++||||+++++++. .
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 467999999999999999999875 5789999986532 222456889999999999999999999873 1
Q ss_pred ceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccc
Q 003384 531 VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS 610 (824)
Q Consensus 531 ~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla 610 (824)
..++||||+.+ +|.+.+. ..++...+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++
T Consensus 100 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred eeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCCCc
Confidence 36899999975 5666552 247888899999999999999999 89999999999999999999999999998
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhh----h--
Q 003384 611 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT----G-- 684 (824)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~----~-- 684 (824)
+....... .....||+.|+|||++.+..++.++|||||||++|+|+||+.||...+........ +
T Consensus 171 ~~~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 241 (359)
T cd07876 171 RTACTNFM---------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTP 241 (359)
T ss_pred cccccCcc---------CCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 75432211 12346899999999999999999999999999999999999999754322110000 0
Q ss_pred ----------cccccc-------------------CCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 685 ----------KLKNLL-------------------DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 685 ----------~~~~~l-------------------d~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
...... .+.....+...+..+.+|+.+||..+|.+||++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e 311 (359)
T cd07876 242 SAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDE 311 (359)
T ss_pred cHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHH
Confidence 000000 00000111123457899999999999999999944
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=310.16 Aligned_cols=247 Identities=23% Similarity=0.364 Sum_probs=185.6
Q ss_pred eeeecCceEEEEEEECC----eEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEecCCCC
Q 003384 471 KIGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNGS 543 (824)
Q Consensus 471 ~LG~G~fG~Vykg~~~~----~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey~~ggs 543 (824)
.||+|+||.||+|.+.+ ..+|+|.+...... ....+.+|+.++++++||||++++|+|. ...++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 59999999999997643 56999988754322 2346889999999999999999999884 45789999999999
Q ss_pred hhhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCC
Q 003384 544 LEDRLSCKD--NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 621 (824)
Q Consensus 544 L~~~L~~~~--~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 621 (824)
|.+++.... ....+++..+..++.|++.||.|||+ ++++||||||+||+++.++++||+|||++..........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~- 157 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV- 157 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCcceee-
Confidence 999986432 23356777888999999999999999 899999999999999999999999999987543222111
Q ss_pred CccccccCCCCCCcccCChhhhccC-------CCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHHHHh--hhccccccC
Q 003384 622 NTTLCCRTDPKGTFAYMDPEFLASG-------ELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALD--TGKLKNLLD 691 (824)
Q Consensus 622 ~~~~~~~~~~~GT~~Y~APE~l~~~-------~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~~--~~~~~~~ld 691 (824)
......|+..|+|||++.+. .++.++|||||||++|||++ |++||........... .+.....
T Consensus 158 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~-- 230 (269)
T cd05087 158 -----TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKL-- 230 (269)
T ss_pred -----cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCC--
Confidence 11234578899999998642 35789999999999999996 9999975433221111 1111111
Q ss_pred CCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHH
Q 003384 692 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVL 731 (824)
Q Consensus 692 ~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L 731 (824)
.........+..+.+++.+|+ .+|.+||++ ++|+..|
T Consensus 231 -~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~-~~l~~~l 267 (269)
T cd05087 231 -PKPRLKLPLSDRWYEVMQFCW-LQPEQRPSA-EEVHLLL 267 (269)
T ss_pred -CCCccCCCCChHHHHHHHHHh-cCcccCCCH-HHHHHHh
Confidence 111122234567889999998 689999999 6666555
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=321.65 Aligned_cols=245 Identities=24% Similarity=0.267 Sum_probs=186.6
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCC---CCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE 537 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~---~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~E 537 (824)
+|...++||+|+||.||++... +..||+|++.... ......+..|+.++..++||||+++++++. +..++|||
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD 81 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence 6888899999999999999886 4679999986421 112335788999999999999999999884 46899999
Q ss_pred ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccc
Q 003384 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 617 (824)
Q Consensus 538 y~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 617 (824)
|+++|+|.+++... ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++..+....
T Consensus 82 y~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 82 YYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred ccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 99999999999532 3468899999999999999999999 899999999999999999999999999987543322
Q ss_pred ccCCCccccccCCCCCCcccCChhhhc-----cCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCC
Q 003384 618 ISSNNTTLCCRTDPKGTFAYMDPEFLA-----SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDP 692 (824)
Q Consensus 618 ~~~~~~~~~~~~~~~GT~~Y~APE~l~-----~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~ 692 (824)
.. ......||+.|+|||++. ...++.++|||||||+||||++|++||................. ..
T Consensus 157 ~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~--~~ 227 (332)
T cd05623 157 TV-------QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE--RF 227 (332)
T ss_pred cc-------eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCc--cc
Confidence 11 012346999999999986 34688999999999999999999999976543322111100000 00
Q ss_pred CCCCCChhhHHHHHHHHHHHhhhccCC--CCCh
Q 003384 693 LAGDWPFVQAEQLANLAMRCCEMSRKS--RPEL 723 (824)
Q Consensus 693 ~~~~~p~~~~~~l~~Li~~Cl~~~P~~--RPt~ 723 (824)
.....+...+..+.+|+.+|+..++.. ||++
T Consensus 228 ~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~ 260 (332)
T cd05623 228 QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGI 260 (332)
T ss_pred cCCCccccCCHHHHHHHHHHccChhhhcCCCCH
Confidence 011112234678899999988654433 5676
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=308.82 Aligned_cols=242 Identities=26% Similarity=0.428 Sum_probs=196.4
Q ss_pred CCCccceeeecCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc-CCceEEEEEecCCCC
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC-PEVWTLVYEYLPNGS 543 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~-~~~~~LV~Ey~~ggs 543 (824)
+|...+.||+|+||.||+|...+..||+|.+.... ....+.+|+.+++.++||||+++++++ .+..++||||+++|+
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~v~e~~~~~~ 84 (254)
T cd05083 7 KLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHNGLYIVMELMSKGN 84 (254)
T ss_pred HceeeeeeccCCCCceEecccCCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCcEEEEECCCCCC
Confidence 47788899999999999999889999999986532 345789999999999999999999987 446789999999999
Q ss_pred hhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCCCc
Q 003384 544 LEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT 623 (824)
Q Consensus 544 L~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~ 623 (824)
|.+++.... ...+++..++.++.+++.||.|||. +|++||||||+|||++.++.+||+|||++.......
T Consensus 85 L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~------ 154 (254)
T cd05083 85 LVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV------ 154 (254)
T ss_pred HHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceeccccC------
Confidence 999986432 3458899999999999999999999 899999999999999999999999999987543211
Q ss_pred cccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHH--HHHhhhccccccCCCCCCCChh
Q 003384 624 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--YALDTGKLKNLLDPLAGDWPFV 700 (824)
Q Consensus 624 ~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~~p~~ 700 (824)
.....+..|+|||++.++.++.++|||||||++|+|++ |++||....... .....+ .....+..
T Consensus 155 -----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~ 221 (254)
T cd05083 155 -----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKG--------YRMEPPEG 221 (254)
T ss_pred -----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCC--------CCCCCCCc
Confidence 11234678999999988899999999999999999998 999996554322 111111 01112334
Q ss_pred hHHHHHHHHHHHhhhccCCCCChHHHHHHHHH
Q 003384 701 QAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 732 (824)
Q Consensus 701 ~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le 732 (824)
.+..+.+++.+||+.+|..||++ +++...|+
T Consensus 222 ~~~~~~~li~~~l~~~p~~Rp~~-~~l~~~l~ 252 (254)
T cd05083 222 CPADVYVLMTSCWETEPKKRPSF-HKLREKLE 252 (254)
T ss_pred CCHHHHHHHHHHcCCChhhCcCH-HHHHHHHc
Confidence 56789999999999999999999 56655553
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=334.69 Aligned_cols=189 Identities=24% Similarity=0.313 Sum_probs=161.1
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--CCceEEEEEec
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 539 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~Ey~ 539 (824)
..|...+.||+|+||.||++... +..||||... ...+.+|+.+|+.++||||++++++| ....++||||+
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 46899999999999999999875 5789999753 23578999999999999999999987 45678999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccccc
Q 003384 540 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 619 (824)
Q Consensus 540 ~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 619 (824)
. ++|..++.. ...+++..++.|+.|++.||.|||+ ++||||||||+|||++.++.+||+|||+++........
T Consensus 166 ~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~ 238 (391)
T PHA03212 166 K-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238 (391)
T ss_pred C-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence 5 688888743 3468899999999999999999999 89999999999999999999999999999754322111
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCC
Q 003384 620 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALG 672 (824)
Q Consensus 620 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~ 672 (824)
......||+.|+|||++.+..++.++|||||||+||||+||++||.
T Consensus 239 -------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~ 284 (391)
T PHA03212 239 -------KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLF 284 (391)
T ss_pred -------ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence 0123469999999999999999999999999999999999997763
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=317.54 Aligned_cols=252 Identities=24% Similarity=0.410 Sum_probs=198.7
Q ss_pred cCCCCccceeeecCceEEEEEEEC-------CeEEEEEEecCCCCC-CchhHHHHHHHHHhc-CCCceeeEecccC--Cc
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKI-RHPNLVTLVGACP--EV 531 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~-------~~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l-~HpnIv~L~g~~~--~~ 531 (824)
.++|...+.||+|+||.||+|... +..||||++...... ....+.+|+.+++++ +||||++++++|. +.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 346888999999999999999752 247999998754322 234688999999999 7999999999884 46
Q ss_pred eEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccc
Q 003384 532 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR 611 (824)
Q Consensus 532 ~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~ 611 (824)
.++||||+++|+|.+++.... ...+++.++..++.+++.||.|||+ ++|+|+||||+|||++.++.+||+|||+++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCcccc
Confidence 889999999999999985432 2348999999999999999999999 899999999999999999999999999998
Q ss_pred ccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHH---HHHhhhccc
Q 003384 612 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ---YALDTGKLK 687 (824)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~---~~~~~~~~~ 687 (824)
.+...... .......++..|+|||.+.+..++.++|||||||++|+|+| |.+||....... .....+
T Consensus 190 ~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~--- 260 (302)
T cd05055 190 DIMNDSNY------VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEG--- 260 (302)
T ss_pred cccCCCce------eecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcC---
Confidence 65433211 01123346789999999999899999999999999999998 999986543211 111111
Q ss_pred cccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHH
Q 003384 688 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP 733 (824)
Q Consensus 688 ~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~ 733 (824)
.....+...+..+.+++.+||+.+|++||++ .+++..|+.
T Consensus 261 -----~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~-~ell~~l~~ 300 (302)
T cd05055 261 -----YRMAQPEHAPAEIYDIMKTCWDADPLKRPTF-KQIVQLIGK 300 (302)
T ss_pred -----CcCCCCCCCCHHHHHHHHHHcCCCchhCcCH-HHHHHHHHh
Confidence 0111223345789999999999999999999 677777664
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=311.79 Aligned_cols=248 Identities=26% Similarity=0.352 Sum_probs=191.1
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEe
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY 538 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey 538 (824)
+|...+.||.|+||.||+|... +..||||.+...... ....+.+|+.+++.++||||+++++++. ...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4677889999999999999875 578999998654322 2356889999999999999999999984 568899999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccc
Q 003384 539 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 618 (824)
Q Consensus 539 ~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 618 (824)
+. ++|.+++........+++..+..++.|++.||.|||. ++|+||||||+|||++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 97 6888887554444678999999999999999999999 8999999999999999999999999999875432211
Q ss_pred cCCCccccccCCCCCCcccCChhhhccC-CCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhc------------
Q 003384 619 SSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK------------ 685 (824)
Q Consensus 619 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~------------ 685 (824)
......|++.|+|||++.+. .++.++|||||||++|+|+||++||..............
T Consensus 157 --------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (285)
T cd07861 157 --------VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPG 228 (285)
T ss_pred --------cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhc
Confidence 01234578999999998754 578899999999999999999999976543322111000
Q ss_pred ------ccccc----CCCCCCCChhhHHHHHHHHHHHhhhccCCCCChH
Q 003384 686 ------LKNLL----DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 686 ------~~~~l----d~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
..... ...........+.++.+++.+||+.+|.+||++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ 277 (285)
T cd07861 229 VTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAK 277 (285)
T ss_pred chhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHH
Confidence 00000 0000001122456788999999999999999994
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=311.06 Aligned_cols=233 Identities=26% Similarity=0.412 Sum_probs=181.9
Q ss_pred eeeecCceEEEEEEEC--------------CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC--CceEE
Q 003384 471 KIGEGGYGSIYKGLLR--------------HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTL 534 (824)
Q Consensus 471 ~LG~G~fG~Vykg~~~--------------~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~L 534 (824)
.||+|+||.||+|... ...|++|.+..........|..|+.+++.++||||++++|+|. ...++
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l 81 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM 81 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence 5899999999999753 1358999887654444457889999999999999999999884 45789
Q ss_pred EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCc-------ceeecc
Q 003384 535 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV-------SKLSDF 607 (824)
Q Consensus 535 V~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~-------vKL~DF 607 (824)
||||+++|+|..++... ..++++..++.++.||+.||.|||+ ++|+||||||.|||++.++. +|++||
T Consensus 82 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 82 VEEFVEFGPLDLFMHRK--SDVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EEecccCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 99999999998887532 3468999999999999999999999 89999999999999987664 899999
Q ss_pred ccccccccccccCCCccccccCCCCCCcccCChhhhc-cCCCCcchhHHhHHHHHHHHH-hCCCCCCCchHHHHH-Hhhh
Q 003384 608 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA-SGELTPKSDVYSFGIILLRLL-TGRPALGITKEVQYA-LDTG 684 (824)
Q Consensus 608 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~-~~~~t~ksDVwSlGvvL~ELl-tG~~Pf~~~~~~~~~-~~~~ 684 (824)
|++...... ....|+..|+|||++. +..++.++|||||||+||+|+ +|..||......... ...+
T Consensus 157 g~~~~~~~~------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~ 224 (262)
T cd05077 157 GIPITVLSR------------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEG 224 (262)
T ss_pred CCCccccCc------------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHhc
Confidence 998654321 1234788999999987 467899999999999999998 588888654322111 0111
Q ss_pred ccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHH
Q 003384 685 KLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRV 730 (824)
Q Consensus 685 ~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~ 730 (824)
.. . ........+.+|+.+||+.+|.+||++ .++++.
T Consensus 225 ~~-----~----~~~~~~~~~~~li~~cl~~dp~~Rp~~-~~il~~ 260 (262)
T cd05077 225 QC-----M----LVTPSCKELADLMTHCMNYDPNQRPFF-RAIMRD 260 (262)
T ss_pred Cc-----c----CCCCChHHHHHHHHHHcCCChhhCcCH-HHHHHh
Confidence 00 0 111234678999999999999999999 555443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=311.58 Aligned_cols=245 Identities=28% Similarity=0.470 Sum_probs=189.2
Q ss_pred eeeecCceEEEEEEECC----eEEEEEEecCCC-CCCchhHHHHHHHHHhc-CCCceeeEecccC--CceEEEEEecCCC
Q 003384 471 KIGEGGYGSIYKGLLRH----MQVAIKMLHPHS-LQGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTLVYEYLPNG 542 (824)
Q Consensus 471 ~LG~G~fG~Vykg~~~~----~~VAvK~l~~~~-~~~~~~f~~Ei~iL~~l-~HpnIv~L~g~~~--~~~~LV~Ey~~gg 542 (824)
.||+|+||.||+|.+.+ ..+++|.+.... ......+.+|+.++.++ +||||++++++|. ...++||||+++|
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 81 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence 58999999999998753 357888886432 22335688999999999 7999999999984 3578999999999
Q ss_pred ChhhhhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccc
Q 003384 543 SLEDRLSCKD-------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI 609 (824)
Q Consensus 543 sL~~~L~~~~-------------~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGl 609 (824)
+|.+++.... ....+++..+..++.+++.||.|||+ ++++||||||+|||++.++.+||+|||+
T Consensus 82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCCC
Confidence 9999985432 12358899999999999999999999 8999999999999999999999999999
Q ss_pred ccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHHHHhhhcccc
Q 003384 610 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKN 688 (824)
Q Consensus 610 a~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~~~~~~~~ 688 (824)
+....... . ......+..|+|||++....++.++|||||||++|||+| |.+||......... ..
T Consensus 159 ~~~~~~~~--~-------~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~-~~----- 223 (270)
T cd05047 159 SRGQEVYV--K-------KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY-EK----- 223 (270)
T ss_pred ccccchhh--h-------ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHH-HH-----
Confidence 86322110 0 011234678999999988889999999999999999997 99999654322111 10
Q ss_pred ccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHH
Q 003384 689 LLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 734 (824)
Q Consensus 689 ~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l 734 (824)
.........+...+..+.+++.+|+..+|.+||++ .+++..|..+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-~~il~~l~~~ 268 (270)
T cd05047 224 LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSF-AQILVSLNRM 268 (270)
T ss_pred HhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCH-HHHHHHHHHh
Confidence 00111111233445689999999999999999999 6676776654
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=312.65 Aligned_cols=247 Identities=27% Similarity=0.378 Sum_probs=187.9
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCC--chhHHHHHHHHHhc---CCCceeeEecccC-------C
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKI---RHPNLVTLVGACP-------E 530 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~--~~~f~~Ei~iL~~l---~HpnIv~L~g~~~-------~ 530 (824)
+|...+.||+|+||.||+|... +..||+|.+....... ...+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4778889999999999999875 5789999987543222 23567788888766 6999999999873 2
Q ss_pred ceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccc
Q 003384 531 VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS 610 (824)
Q Consensus 531 ~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla 610 (824)
..++||||+++ +|.+++... ....+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEccccc-CHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCcc
Confidence 36899999974 888887533 23458999999999999999999999 89999999999999999999999999999
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhc-----
Q 003384 611 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK----- 685 (824)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~----- 685 (824)
........ .....||+.|+|||++.+..++.++|||||||++|+|++|++||..............
T Consensus 156 ~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~ 226 (288)
T cd07863 156 RIYSCQMA---------LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP 226 (288)
T ss_pred ccccCccc---------CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCC
Confidence 86543211 1234589999999999988999999999999999999999999975543221111000
Q ss_pred ----ccc-------ccCCCC----CCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 686 ----LKN-------LLDPLA----GDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 686 ----~~~-------~ld~~~----~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
+.. .+.+.. .......+..+.+++.+||+.+|.+||++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ 281 (288)
T cd07863 227 PEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFR 281 (288)
T ss_pred ChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHH
Confidence 000 000000 0011123567899999999999999999843
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=326.81 Aligned_cols=249 Identities=27% Similarity=0.472 Sum_probs=205.4
Q ss_pred ccceeeecCceEEEEEEECC------eEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccCC-ceEEEEEec
Q 003384 468 PSLKIGEGGYGSIYKGLLRH------MQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACPE-VWTLVYEYL 539 (824)
Q Consensus 468 ~~~~LG~G~fG~Vykg~~~~------~~VAvK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~~-~~~LV~Ey~ 539 (824)
+.++||.|-||.||+|++.. -.||||..+.+.. .+.+.|..|.-+|++++|||||+|+|+|.+ ..+||||++
T Consensus 393 l~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P~WivmEL~ 472 (974)
T KOG4257|consen 393 LKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQPMWIVMELA 472 (974)
T ss_pred HHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccceeEEEecc
Confidence 45679999999999999863 2599999887543 345679999999999999999999999965 578999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccccc
Q 003384 540 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 619 (824)
Q Consensus 540 ~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 619 (824)
+-|.|..+|... ...|+..+...++.||+.||.|||+ ..+|||||...|||+.....+||+||||++.+......
T Consensus 473 ~~GELr~yLq~n--k~sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yY 547 (974)
T KOG4257|consen 473 PLGELREYLQQN--KDSLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYY 547 (974)
T ss_pred cchhHHHHHHhc--cccchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchhhhccccchh
Confidence 999999999644 4568888999999999999999999 88999999999999999999999999999988766543
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHHHHhhhccccccCCCCCCCC
Q 003384 620 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWP 698 (824)
Q Consensus 620 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p 698 (824)
.. +...-.+-|||||-+.-..++.++|||-|||++||++. |..||.+..... -+..+-.....+.|
T Consensus 548 ka-------S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD------VI~~iEnGeRlP~P 614 (974)
T KOG4257|consen 548 KA-------SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD------VIGHIENGERLPCP 614 (974)
T ss_pred hc-------cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc------eEEEecCCCCCCCC
Confidence 22 22334678999999999999999999999999999986 999996543211 11112223445678
Q ss_pred hhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHH
Q 003384 699 FVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 735 (824)
Q Consensus 699 ~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~ 735 (824)
..+++.|..|..+||.++|.+||.+ .++...|..+.
T Consensus 615 ~nCPp~LYslmskcWayeP~kRPrf-tei~~~lsdv~ 650 (974)
T KOG4257|consen 615 PNCPPALYSLMSKCWAYEPSKRPRF-TEIKAILSDVL 650 (974)
T ss_pred CCCChHHHHHHHHHhccCcccCCcH-HHHHHHHHHHH
Confidence 8899999999999999999999999 55666665543
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=312.73 Aligned_cols=254 Identities=25% Similarity=0.419 Sum_probs=196.3
Q ss_pred CCCccceeeecCceEEEEEEECC-----eEEEEEEecCCC-CCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLRH-----MQVAIKMLHPHS-LQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 536 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~~-----~~VAvK~l~~~~-~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~ 536 (824)
.|...+.||+|+||.||+|.+.. ..||||.+.... ......|..|+.+++.++||||+++++++. ...++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 46778899999999999998752 369999987542 222457899999999999999999999884 3578999
Q ss_pred EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccc
Q 003384 537 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 616 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 616 (824)
||+++|+|.+++... ...+++..++.++.+++.||.|||+ +|++||||||+|||++.++.+||+|||++......
T Consensus 85 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 85 EFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred ecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 999999999998543 3468999999999999999999999 89999999999999999999999999998865433
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHHHHhhhccccccCCCCC
Q 003384 617 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAG 695 (824)
Q Consensus 617 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~~~~~~~~~ld~~~~ 695 (824)
....... ......++..|+|||++.+..++.++|||||||++|||++ |.+||............. .. ...
T Consensus 160 ~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~---~~---~~~ 230 (269)
T cd05065 160 TSDPTYT---SSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE---QD---YRL 230 (269)
T ss_pred ccccccc---cccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHH---cC---CcC
Confidence 2111100 0011123568999999998999999999999999999886 999996543322111110 00 111
Q ss_pred CCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHH
Q 003384 696 DWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP 733 (824)
Q Consensus 696 ~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~ 733 (824)
..+...+..+.+++.+||+.+|.+||++ ..+...|+.
T Consensus 231 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~-~~i~~~l~~ 267 (269)
T cd05065 231 PPPMDCPTALHQLMLDCWQKDRNARPKF-GQIVSTLDK 267 (269)
T ss_pred CCcccCCHHHHHHHHHHcCCChhhCcCH-HHHHHHHHh
Confidence 2233456789999999999999999999 667666654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=316.08 Aligned_cols=241 Identities=24% Similarity=0.315 Sum_probs=191.7
Q ss_pred CCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC---CchhHHHHHHHHHhcCCCceeeEeccc--CCceEEEEEe
Q 003384 466 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 538 (824)
Q Consensus 466 f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~---~~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~Ey 538 (824)
|...+.||.|+||+||+|.+. ++.||+|.+...... ....+.+|+.+|+.++|+||+.+++++ .+..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 566788999999999999885 578999998654322 223578899999999999999999877 4468899999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccc
Q 003384 539 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 618 (824)
Q Consensus 539 ~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 618 (824)
+++|+|.+++.... ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 82 MNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES 157 (285)
T ss_pred ccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence 99999998885332 3469999999999999999999999 8999999999999999999999999999875432211
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHh-hhccccccCCCCCCC
Q 003384 619 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALD-TGKLKNLLDPLAGDW 697 (824)
Q Consensus 619 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~-~~~~~~~ld~~~~~~ 697 (824)
.....|+..|+|||++.+..++.++|||||||++|+|+||.+||........... ...... ....+
T Consensus 158 ---------~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~----~~~~~ 224 (285)
T cd05632 158 ---------IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLE----TEEVY 224 (285)
T ss_pred ---------ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhc----ccccc
Confidence 0234589999999999988999999999999999999999999975543211111 111111 11122
Q ss_pred ChhhHHHHHHHHHHHhhhccCCCCCh
Q 003384 698 PFVQAEQLANLAMRCCEMSRKSRPEL 723 (824)
Q Consensus 698 p~~~~~~l~~Li~~Cl~~~P~~RPt~ 723 (824)
+...+..+.+|+..|++.+|.+||+.
T Consensus 225 ~~~~~~~~~~li~~~l~~~P~~R~~~ 250 (285)
T cd05632 225 SAKFSEEAKSICKMLLTKDPKQRLGC 250 (285)
T ss_pred CccCCHHHHHHHHHHccCCHhHcCCC
Confidence 33445678999999999999999995
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=315.98 Aligned_cols=259 Identities=27% Similarity=0.447 Sum_probs=195.8
Q ss_pred CCCCccceeeecCceEEEEEEEC------------------CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR------------------HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTL 524 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~------------------~~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~L 524 (824)
++|+..+.||+|+||.||++.+. ...||+|++...... ....|.+|+.+++.++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 46888899999999999998532 235899998754322 23578999999999999999999
Q ss_pred eccc--CCceEEEEEecCCCChhhhhhccCC--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcE
Q 003384 525 VGAC--PEVWTLVYEYLPNGSLEDRLSCKDN--------SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANI 594 (824)
Q Consensus 525 ~g~~--~~~~~LV~Ey~~ggsL~~~L~~~~~--------~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NI 594 (824)
++++ .+..++||||+++|+|.+++..... ...+++..+..++.+++.||.|||+ ++++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChheE
Confidence 9987 3568899999999999999864321 1347788999999999999999999 8999999999999
Q ss_pred EecCCCcceeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh--CCCCCC
Q 003384 595 LLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALG 672 (824)
Q Consensus 595 Lld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt--G~~Pf~ 672 (824)
|++.++.+||+|||+++.+....... ......+++.|+|||...++.++.++|||||||++|||+| |..||.
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~------~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~ 235 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYR------IQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYS 235 (296)
T ss_pred EEcCCCCEEeccCcccccccCCccee------ccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcc
Confidence 99999999999999998654322110 0122345788999999888899999999999999999998 778886
Q ss_pred CchHHHHHHhhhccc-cccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHH
Q 003384 673 ITKEVQYALDTGKLK-NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 732 (824)
Q Consensus 673 ~~~~~~~~~~~~~~~-~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le 732 (824)
...........+... ..........+...+..+.+|+.+||+.+|.+||++ .+|.+.|.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~-~~i~~~l~ 295 (296)
T cd05095 236 QLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSF-QEIHATLL 295 (296)
T ss_pred ccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCH-HHHHHHHh
Confidence 443222111111110 000001111223345789999999999999999999 66666654
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=315.25 Aligned_cols=252 Identities=27% Similarity=0.497 Sum_probs=197.1
Q ss_pred cCCCCccceeeecCceEEEEEEEC-------CeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccC--Cce
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVW 532 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~-------~~~VAvK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~ 532 (824)
.++|.....||+|+||.||+|... +..||+|++..... .....|.+|+.+++.++||||++++++|. +..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 356888899999999999999763 46799999875422 12356889999999999999999999884 467
Q ss_pred EEEEEecCCCChhhhhhccC-------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCc
Q 003384 533 TLVYEYLPNGSLEDRLSCKD-------------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPAN 593 (824)
Q Consensus 533 ~LV~Ey~~ggsL~~~L~~~~-------------------~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~N 593 (824)
++||||+++|+|.+++.... ....+++..++.++.+++.||.|||. ++++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhh
Confidence 99999999999999985321 12357889999999999999999999 899999999999
Q ss_pred EEecCCCcceeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCC
Q 003384 594 ILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALG 672 (824)
Q Consensus 594 ILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~ 672 (824)
||++.++.+||+|||++..+........ .....++..|+|||.+.+..++.++|||||||++|+|++ |..||.
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~ 234 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKA------SENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYY 234 (288)
T ss_pred eEecCCCceEECccccceecccCccccc------cCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999875533221110 012235678999999988899999999999999999998 888885
Q ss_pred CchHHH--HHHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHH
Q 003384 673 ITKEVQ--YALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 732 (824)
Q Consensus 673 ~~~~~~--~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le 732 (824)
...... ..+..+.. ...+...+..+.+|+.+||+.+|.+||++ .++...|+
T Consensus 235 ~~~~~~~~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~-~el~~~l~ 287 (288)
T cd05050 235 GMAHEEVIYYVRDGNV--------LSCPDNCPLELYNLMRLCWSKLPSDRPSF-ASINRILQ 287 (288)
T ss_pred CCCHHHHHHHHhcCCC--------CCCCCCCCHHHHHHHHHHcccCcccCCCH-HHHHHHhh
Confidence 432221 11112111 11233456789999999999999999999 66766664
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=320.22 Aligned_cols=245 Identities=24% Similarity=0.276 Sum_probs=186.3
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCC---CCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE 537 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~---~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~E 537 (824)
+|...+.||+|+||.||++... +..||||++.... ......+.+|+.++..++||||++++++|. +..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD 81 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence 6888899999999999999875 5789999986421 122345889999999999999999999884 46899999
Q ss_pred ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccc
Q 003384 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 617 (824)
Q Consensus 538 y~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 617 (824)
|++||+|.+++... ...++...+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 82 YYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred cCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 99999999998532 3458889999999999999999999 899999999999999999999999999987654322
Q ss_pred ccCCCccccccCCCCCCcccCChhhhcc-----CCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCC
Q 003384 618 ISSNNTTLCCRTDPKGTFAYMDPEFLAS-----GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDP 692 (824)
Q Consensus 618 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~-----~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~ 692 (824)
... .....||+.|+|||++.. +.++.++|||||||++|+|++|+.||..................+.
T Consensus 157 ~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~- 228 (331)
T cd05597 157 TVQ-------SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQ- 228 (331)
T ss_pred Ccc-------ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCccc-
Confidence 110 122358999999999863 4578899999999999999999999976543222111100011111
Q ss_pred CCCCCChhhHHHHHHHHHHHhhhcc--CCCCCh
Q 003384 693 LAGDWPFVQAEQLANLAMRCCEMSR--KSRPEL 723 (824)
Q Consensus 693 ~~~~~p~~~~~~l~~Li~~Cl~~~P--~~RPt~ 723 (824)
.. ......+..+.+++.+|+...+ ..||++
T Consensus 229 ~~-~~~~~~~~~~~~li~~ll~~~~~r~~r~~~ 260 (331)
T cd05597 229 FP-PDVTDVSEEAKDLIRRLICSPETRLGRNGL 260 (331)
T ss_pred CC-CccCCCCHHHHHHHHHHccCcccccCCCCH
Confidence 01 1112246688999999876433 336777
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=314.37 Aligned_cols=260 Identities=25% Similarity=0.416 Sum_probs=196.9
Q ss_pred CCCCccceeeecCceEEEEEEEC------CeEEEEEEecCCC-CCCchhHHHHHHHHHhcCCCceeeEecccC----Cce
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR------HMQVAIKMLHPHS-LQGPSEFQQEIDILSKIRHPNLVTLVGACP----EVW 532 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~------~~~VAvK~l~~~~-~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~----~~~ 532 (824)
..|...+.||+|+||.||.+.+. +..||+|.+.... ......+.+|+.+++.++||||+++++++. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 35678889999999999998752 4679999987543 222457899999999999999999999884 347
Q ss_pred EEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccc
Q 003384 533 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 612 (824)
Q Consensus 533 ~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~ 612 (824)
++||||++|++|.+++... ...+++..+..++.+++.||.|||+ +|++||||||+|||++.++.+||+|||++..
T Consensus 84 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCccccc
Confidence 8999999999999998532 2358999999999999999999999 8999999999999999999999999999986
Q ss_pred cccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHH-HHHh--------h
Q 003384 613 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ-YALD--------T 683 (824)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~-~~~~--------~ 683 (824)
+........ ......|+..|+|||++.+..++.++|||||||++|+|+||+.|+....... .... .
T Consensus 159 ~~~~~~~~~-----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd05079 159 IETDKEYYT-----VKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVT 233 (284)
T ss_pred cccCcccee-----ecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHH
Confidence 643321100 1123457788999999988889999999999999999999887653211100 0000 0
Q ss_pred hccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHH
Q 003384 684 GKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 734 (824)
Q Consensus 684 ~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l 734 (824)
..............+...+..+.+|+.+||+.+|.+||++ ++++..|+.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~-~~il~~l~~~ 283 (284)
T cd05079 234 RLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTF-QNLIEGFEAI 283 (284)
T ss_pred HHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCH-HHHHHHHHhh
Confidence 0000000011111233456789999999999999999999 6777766643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=311.79 Aligned_cols=245 Identities=27% Similarity=0.353 Sum_probs=192.1
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--CCceEEEEEec
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 539 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~Ey~ 539 (824)
.+|...+.||+|+||.||+|... +..||+|.+..........+.+|+.+++.++||||+++++++ .+..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 36777888999999999999874 578999998765444445688999999999999999999987 45688999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccccc
Q 003384 540 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 619 (824)
Q Consensus 540 ~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 619 (824)
++++|.+++.. ...+++.....++.+++.||.|||. +|++|+||||+||+++.++.+||+|||++........
T Consensus 89 ~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~- 161 (267)
T cd06645 89 GGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA- 161 (267)
T ss_pred CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCccc-
Confidence 99999998843 3468999999999999999999999 8999999999999999999999999999876532211
Q ss_pred CCCccccccCCCCCCcccCChhhhc---cCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCC
Q 003384 620 SNNTTLCCRTDPKGTFAYMDPEFLA---SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 696 (824)
Q Consensus 620 ~~~~~~~~~~~~~GT~~Y~APE~l~---~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~ 696 (824)
......|++.|+|||++. ...++.++|||||||++|+|++|.+||.............. .. ..+....
T Consensus 162 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~-~~-~~~~~~~ 232 (267)
T cd06645 162 -------KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTK-SN-FQPPKLK 232 (267)
T ss_pred -------ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhc-cC-CCCCccc
Confidence 112346899999999974 45688999999999999999999999854332211111100 00 1111001
Q ss_pred CChhhHHHHHHHHHHHhhhccCCCCChH
Q 003384 697 WPFVQAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 697 ~p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
.....+..+.+++.+||..+|++||++.
T Consensus 233 ~~~~~~~~~~~li~~~l~~~P~~R~~~~ 260 (267)
T cd06645 233 DKMKWSNSFHHFVKMALTKNPKKRPTAE 260 (267)
T ss_pred ccCCCCHHHHHHHHHHccCCchhCcCHH
Confidence 1112345789999999999999999983
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=307.96 Aligned_cols=252 Identities=30% Similarity=0.508 Sum_probs=200.8
Q ss_pred cCCCCccceeeecCceEEEEEEECC-eEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEec
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL 539 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~~-~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey~ 539 (824)
..+|.+.+.||.|+||.||+|.+.+ ..||||.+.... .....+.+|+.++++++||||+++++++. ...++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 3578888999999999999998764 679999987543 34567999999999999999999999884 4688999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccccc
Q 003384 540 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 619 (824)
Q Consensus 540 ~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 619 (824)
++++|.+++.... ...+++..+..++.+++.||.|||. ++++|+||||+||+++.++.+||+|||++..+......
T Consensus 84 ~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (261)
T cd05034 84 SKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT 159 (261)
T ss_pred CCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence 9999999985432 3468999999999999999999999 88999999999999999999999999998866432211
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHHHHhhhccccccCCCCCCCC
Q 003384 620 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWP 698 (824)
Q Consensus 620 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p 698 (824)
. .....++..|+|||.+.+..++.++|||||||++|+|+| |+.||............ ........+
T Consensus 160 ~-------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~------~~~~~~~~~ 226 (261)
T cd05034 160 A-------REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQV------ERGYRMPRP 226 (261)
T ss_pred h-------hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH------HcCCCCCCC
Confidence 1 112235678999999998899999999999999999999 99999654322111111 000111123
Q ss_pred hhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHH
Q 003384 699 FVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP 733 (824)
Q Consensus 699 ~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~ 733 (824)
...+..+.+++.+|++.+|.+||++ +++.+.|+.
T Consensus 227 ~~~~~~~~~~i~~~l~~~p~~Rp~~-~~l~~~l~~ 260 (261)
T cd05034 227 PNCPEELYDLMLQCWDKDPEERPTF-EYLQSFLED 260 (261)
T ss_pred CCCCHHHHHHHHHHcccCcccCCCH-HHHHHHHhc
Confidence 3346789999999999999999999 677776653
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=305.07 Aligned_cols=242 Identities=27% Similarity=0.438 Sum_probs=190.4
Q ss_pred eeeecCceEEEEEEEC-CeEEEEEEecCCCCCC-chhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEecCCCChhh
Q 003384 471 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNGSLED 546 (824)
Q Consensus 471 ~LG~G~fG~Vykg~~~-~~~VAvK~l~~~~~~~-~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey~~ggsL~~ 546 (824)
+||+|+||.||+|... +..||+|.+....... ...+.+|+++++.++||||++++++|. ...++||||+++++|.+
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 81 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS 81 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHH
Confidence 5999999999999865 4789999987543221 235889999999999999999999884 46889999999999999
Q ss_pred hhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCCCcccc
Q 003384 547 RLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLC 626 (824)
Q Consensus 547 ~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~ 626 (824)
++... ...+++..+..++.+++.||.|||. ++++||||||+||+++.++.+||+|||++..........
T Consensus 82 ~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~------ 150 (250)
T cd05085 82 FLRKK--KDELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS------ 150 (250)
T ss_pred HHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceecccccccc------
Confidence 88532 3458899999999999999999999 899999999999999999999999999987543321110
Q ss_pred ccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHHHHhhhccccccCCCCCCCChhhHHHH
Q 003384 627 CRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQL 705 (824)
Q Consensus 627 ~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l 705 (824)
.....+++.|+|||++.++.++.++|||||||++|+|++ |..||............. . ......+...+..+
T Consensus 151 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~---~---~~~~~~~~~~~~~~ 223 (250)
T cd05085 151 -SGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE---K---GYRMSCPQKCPDDV 223 (250)
T ss_pred -CCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH---c---CCCCCCCCCCCHHH
Confidence 012235678999999998899999999999999999998 999996543322111111 1 01112233456789
Q ss_pred HHHHHHHhhhccCCCCChHHHHHHHH
Q 003384 706 ANLAMRCCEMSRKSRPELGKDVWRVL 731 (824)
Q Consensus 706 ~~Li~~Cl~~~P~~RPt~~~~v~~~L 731 (824)
.+++.+|++.+|.+||++ .++.+.|
T Consensus 224 ~~li~~~l~~~p~~Rp~~-~~l~~~l 248 (250)
T cd05085 224 YKVMQRCWDYKPENRPKF-SELQKEL 248 (250)
T ss_pred HHHHHHHcccCcccCCCH-HHHHHHh
Confidence 999999999999999999 5665554
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=315.69 Aligned_cols=242 Identities=24% Similarity=0.327 Sum_probs=191.1
Q ss_pred CCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCC---chhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEe
Q 003384 466 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY 538 (824)
Q Consensus 466 f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~---~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey 538 (824)
|+..+.||+|+||.||++... +..||||.+....... ...+.+|+.+++.++|+||+.+++.+. +..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 666788999999999999886 5789999986543222 235778999999999999999999874 568899999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccc
Q 003384 539 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 618 (824)
Q Consensus 539 ~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 618 (824)
++||+|.+++.... ...+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 82 MNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred cCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 99999999885432 3458899999999999999999999 8999999999999999999999999999876532211
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCC
Q 003384 619 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWP 698 (824)
Q Consensus 619 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p 698 (824)
.....||+.|+|||++.+..++.++|||||||++|+|++|++||........ ...............+
T Consensus 158 ---------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~---~~~~~~~~~~~~~~~~ 225 (285)
T cd05630 158 ---------IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK---REEVERLVKEVQEEYS 225 (285)
T ss_pred ---------ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch---HHHHHhhhhhhhhhcC
Confidence 0234689999999999999999999999999999999999999975321100 0000111111111223
Q ss_pred hhhHHHHHHHHHHHhhhccCCCCCh
Q 003384 699 FVQAEQLANLAMRCCEMSRKSRPEL 723 (824)
Q Consensus 699 ~~~~~~l~~Li~~Cl~~~P~~RPt~ 723 (824)
...+..+.+|+.+||+.+|.+||++
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~R~s~ 250 (285)
T cd05630 226 EKFSPDARSLCKMLLCKDPKERLGC 250 (285)
T ss_pred ccCCHHHHHHHHHHhhcCHHHccCC
Confidence 3455689999999999999999994
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=325.77 Aligned_cols=246 Identities=21% Similarity=0.268 Sum_probs=189.5
Q ss_pred hcCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCC--CCCchhHHHHHHHHHhcCCCceeeEecccCC-------
Q 003384 462 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS--LQGPSEFQQEIDILSKIRHPNLVTLVGACPE------- 530 (824)
Q Consensus 462 ~~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~--~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~~------- 530 (824)
..++|...+.||+|+||.||++... +..||||++.... ......+.+|+.+++.++||||+++++++..
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3468999999999999999999875 5789999987532 2223567899999999999999999987632
Q ss_pred -ceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccc
Q 003384 531 -VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI 609 (824)
Q Consensus 531 -~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGl 609 (824)
..++||||+++ +|.+.+. ..+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCCC
Confidence 36899999965 6777663 247888999999999999999999 8999999999999999999999999999
Q ss_pred ccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhc----
Q 003384 610 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK---- 685 (824)
Q Consensus 610 a~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~---- 685 (824)
++....... .....||+.|+|||++.+..++.++|||||||+||+|++|+.||...+........-.
T Consensus 173 a~~~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 243 (364)
T cd07875 173 ARTAGTSFM---------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGT 243 (364)
T ss_pred ccccCCCCc---------ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 976532211 1234689999999999999999999999999999999999999976543221100000
Q ss_pred --------c-----------------------ccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 686 --------L-----------------------KNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 686 --------~-----------------------~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
+ ...+.+............+.+|+.+||+.+|.+|||+.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e 314 (364)
T cd07875 244 PCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDE 314 (364)
T ss_pred CCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHH
Confidence 0 000000001111123457899999999999999999943
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=332.93 Aligned_cols=238 Identities=29% Similarity=0.463 Sum_probs=197.1
Q ss_pred eeeecCceEEEEEEECC--eEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccCC--ceEEEEEecCCCChhh
Q 003384 471 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVYEYLPNGSLED 546 (824)
Q Consensus 471 ~LG~G~fG~Vykg~~~~--~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~~--~~~LV~Ey~~ggsL~~ 546 (824)
+||+|.||+||-|++.. ..+|||-+.........-+..|+.+.+.|+|.|||+++|+|.+ .+-|.||-+|||||.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 69999999999999876 4579998877666666678999999999999999999999965 3558999999999999
Q ss_pred hhhccCCCCCC--CHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEec-CCCcceeeccccccccccccccCCCc
Q 003384 547 RLSCKDNSPPL--SWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD-ANFVSKLSDFGISRFLSQNEISSNNT 623 (824)
Q Consensus 547 ~L~~~~~~~~l--~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld-~~~~vKL~DFGla~~~~~~~~~~~~~ 623 (824)
+|..+- +|+ ++.+...+..||++||.|||. +.|||||||-+|||++ -.|.+||+|||.++.+..-.
T Consensus 662 LLrskW--GPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin------ 730 (1226)
T KOG4279|consen 662 LLRSKW--GPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN------ 730 (1226)
T ss_pred HHHhcc--CCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhccCC------
Confidence 997553 445 788899999999999999999 7799999999999995 68999999999998765321
Q ss_pred cccccCCCCCCcccCChhhhccC--CCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCChhh
Q 003384 624 TLCCRTDPKGTFAYMDPEFLASG--ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQ 701 (824)
Q Consensus 624 ~~~~~~~~~GT~~Y~APE~l~~~--~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~ 701 (824)
.+..+..||..|||||++..+ +|++++|||||||++.||.||+|||.-....+.++-.--+. ...++.|...
T Consensus 731 --P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmy----KvHP~iPeel 804 (1226)
T KOG4279|consen 731 --PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMY----KVHPPIPEEL 804 (1226)
T ss_pred --ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcce----ecCCCCcHHH
Confidence 122456799999999999876 69999999999999999999999996444443333221111 1234567788
Q ss_pred HHHHHHHHHHHhhhccCCCCChHH
Q 003384 702 AEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 702 ~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
+.+...+|++|+..+|.+||+...
T Consensus 805 saeak~FilrcFepd~~~R~sA~~ 828 (1226)
T KOG4279|consen 805 SAEAKNFILRCFEPDPCDRPSAKD 828 (1226)
T ss_pred HHHHHHHHHHHcCCCcccCccHHH
Confidence 899999999999999999999843
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=319.06 Aligned_cols=256 Identities=25% Similarity=0.422 Sum_probs=200.8
Q ss_pred CCCCccceeeecCceEEEEEEEC---------CeEEEEEEecCCCC-CCchhHHHHHHHHHhc-CCCceeeEecccC--C
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR---------HMQVAIKMLHPHSL-QGPSEFQQEIDILSKI-RHPNLVTLVGACP--E 530 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~---------~~~VAvK~l~~~~~-~~~~~f~~Ei~iL~~l-~HpnIv~L~g~~~--~ 530 (824)
.+|...+.||+|+||.||+|... ...||+|.+..... .....+..|+.+++.+ +||||++++++|. .
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 46788899999999999999752 24699999875422 2234688999999999 6999999999884 4
Q ss_pred ceEEEEEecCCCChhhhhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEec
Q 003384 531 VWTLVYEYLPNGSLEDRLSCKD-------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD 597 (824)
Q Consensus 531 ~~~LV~Ey~~ggsL~~~L~~~~-------------~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld 597 (824)
..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+ +|++||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEEEc
Confidence 5789999999999999985432 12458999999999999999999999 8999999999999999
Q ss_pred CCCcceeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchH
Q 003384 598 ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKE 676 (824)
Q Consensus 598 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~ 676 (824)
.++.+||+|||+++.......... .....++..|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~ 242 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKK------TSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV 242 (314)
T ss_pred CCCcEEEccccccccccccccccc------cccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999986543221110 012235578999999998899999999999999999999 8999975432
Q ss_pred HH--HHHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhh
Q 003384 677 VQ--YALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 737 (824)
Q Consensus 677 ~~--~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~~ 737 (824)
.. .....+ .....+...+..+.+++.+||..+|.+||++ .++++.|..+...
T Consensus 243 ~~~~~~~~~~--------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~-~~ll~~l~~~~~~ 296 (314)
T cd05099 243 EELFKLLREG--------HRMDKPSNCTHELYMLMRECWHAVPTQRPTF-KQLVEALDKVLAA 296 (314)
T ss_pred HHHHHHHHcC--------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCH-HHHHHHHHHHHHH
Confidence 21 111111 1112234456689999999999999999999 7788888877553
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=312.34 Aligned_cols=256 Identities=26% Similarity=0.390 Sum_probs=200.0
Q ss_pred CChhhHhhhcCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhc-CCCceeeEecccC-
Q 003384 454 FSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGACP- 529 (824)
Q Consensus 454 ~~~~ei~~~~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l-~HpnIv~L~g~~~- 529 (824)
+.++.+.....+|.....||+|+||.||+|... +..+|+|++..... ....+.+|+.+++.+ +||||++++++|.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 345666778889999999999999999999875 57899998765322 235688999999999 6999999999862
Q ss_pred ------CceEEEEEecCCCChhhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcc
Q 003384 530 ------EVWTLVYEYLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS 602 (824)
Q Consensus 530 ------~~~~LV~Ey~~ggsL~~~L~~~-~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~v 602 (824)
+.+++||||+++|+|.+++... .....+++..+..++.+++.||.|||+ ++|+||||||+||+++.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCE
Confidence 3479999999999999987532 234568889999999999999999999 899999999999999999999
Q ss_pred eeeccccccccccccccCCCccccccCCCCCCcccCChhhhcc-----CCCCcchhHHhHHHHHHHHHhCCCCCCCchHH
Q 003384 603 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-----GELTPKSDVYSFGIILLRLLTGRPALGITKEV 677 (824)
Q Consensus 603 KL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-----~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~ 677 (824)
||+|||++..+...... .....|++.|+|||++.. ..++.++|||||||++|+|++|++||......
T Consensus 164 kl~dfg~~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~ 235 (286)
T cd06638 164 KLVDFGVSAQLTSTRLR--------RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM 235 (286)
T ss_pred EEccCCceeecccCCCc--------cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh
Confidence 99999998865432111 123458999999999853 45788999999999999999999999755433
Q ss_pred HHHHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 678 QYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 678 ~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
......... . +.....+...+..+.+++.+||+.+|.+||++.+
T Consensus 236 ~~~~~~~~~---~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e 279 (286)
T cd06638 236 RALFKIPRN---P-PPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSD 279 (286)
T ss_pred HHHhhcccc---C-CCcccCCCCcCHHHHHHHHHHccCCcccCCCHHH
Confidence 322111110 0 0011122334567999999999999999999943
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=315.00 Aligned_cols=246 Identities=24% Similarity=0.379 Sum_probs=199.0
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--CCceEEEEEe
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 538 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~Ey 538 (824)
..+|+..+.||.|+||.||+|... +..|++|.+..........+.+|+.+++.++||||+++++++ .+..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 346888999999999999999864 688999998765555556788999999999999999999988 3568999999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccc
Q 003384 539 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 618 (824)
Q Consensus 539 ~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 618 (824)
+++++|.+++. ...+++..+..++.+++.||.|||+ +|++||||||+||+++.++.+||+|||++........
T Consensus 98 ~~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 98 LAGGSLTDVVT----ETCMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred cCCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 99999999884 2358999999999999999999999 8999999999999999999999999999876543221
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCC
Q 003384 619 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWP 698 (824)
Q Consensus 619 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p 698 (824)
. .....|++.|+|||.+.+..++.++|||||||++|+|++|++||............... . ......+
T Consensus 171 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~--~--~~~~~~~ 238 (296)
T cd06655 171 K--------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN--G--TPELQNP 238 (296)
T ss_pred c--------CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--C--CcccCCc
Confidence 1 12345899999999999888999999999999999999999999765543322111100 0 0011123
Q ss_pred hhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 003384 699 FVQAEQLANLAMRCCEMSRKSRPELGKDV 727 (824)
Q Consensus 699 ~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 727 (824)
...+..+.+++.+||..+|.+||++.+.+
T Consensus 239 ~~~~~~~~~li~~~l~~dp~~Rpt~~~il 267 (296)
T cd06655 239 EKLSPIFRDFLNRCLEMDVEKRGSAKELL 267 (296)
T ss_pred ccCCHHHHHHHHHHhhcChhhCCCHHHHh
Confidence 34556899999999999999999995443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=309.03 Aligned_cols=249 Identities=22% Similarity=0.367 Sum_probs=183.6
Q ss_pred eeeecCceEEEEEEEC----CeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEecCCCC
Q 003384 471 KIGEGGYGSIYKGLLR----HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNGS 543 (824)
Q Consensus 471 ~LG~G~fG~Vykg~~~----~~~VAvK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey~~ggs 543 (824)
.||+|+||.||+|... ...+++|.+..... .....|.+|+.+++.++||||++++|.|. ...++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 5999999999999753 24688888764332 12346889999999999999999999884 46899999999999
Q ss_pred hhhhhhccCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCC
Q 003384 544 LEDRLSCKDN--SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 621 (824)
Q Consensus 544 L~~~L~~~~~--~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 621 (824)
|.+++..... ...+++.....++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++...........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 9999864322 2335677888999999999999999 8999999999999999999999999999875432211100
Q ss_pred CccccccCCCCCCcccCChhhhcc-------CCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHHHHhhhccccccCCC
Q 003384 622 NTTLCCRTDPKGTFAYMDPEFLAS-------GELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPL 693 (824)
Q Consensus 622 ~~~~~~~~~~~GT~~Y~APE~l~~-------~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~~~~~~~~~ld~~ 693 (824)
.....+++.|+|||++.. ..++.++|||||||++|||++ |.+||......... .........+..
T Consensus 159 ------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~~~~~~~ 231 (269)
T cd05042 159 ------KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVL-KQVVREQDIKLP 231 (269)
T ss_pred ------cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHH-HHHhhccCccCC
Confidence 122346788999999743 356789999999999999999 88898654332211 110011111111
Q ss_pred CCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHH
Q 003384 694 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVL 731 (824)
Q Consensus 694 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L 731 (824)
....+...+..+.+++..|+ .+|.+||++ ++|.+.|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~-~~v~~~l 267 (269)
T cd05042 232 KPQLDLKYSDRWYEVMQFCW-LDPETRPTA-EEVHELL 267 (269)
T ss_pred CCcccccCCHHHHHHHHHHh-cCcccccCH-HHHHHHh
Confidence 12233345667888898998 599999998 6666654
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=329.44 Aligned_cols=246 Identities=24% Similarity=0.291 Sum_probs=189.2
Q ss_pred hhhcCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCC---CCCchhHHHHHHHHHhcCCCceeeEecccC--Cce
Q 003384 460 EGATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVW 532 (824)
Q Consensus 460 ~~~~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~---~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~ 532 (824)
.....+|...+.||+|+||.||++... +..||+|++.... ......+.+|+.+++.++||||+++++++. ...
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 118 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 334468999999999999999999886 4789999986422 122345788999999999999999999884 468
Q ss_pred EEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccc
Q 003384 533 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 612 (824)
Q Consensus 533 ~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~ 612 (824)
++||||++||+|.+++.. ..++...+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++..
T Consensus 119 ~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~ 191 (371)
T cd05622 119 YMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (371)
T ss_pred EEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeCCceeE
Confidence 899999999999998842 347888889999999999999999 8999999999999999999999999999986
Q ss_pred cccccccCCCccccccCCCCCCcccCChhhhccC----CCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhcccc
Q 003384 613 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG----ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKN 688 (824)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~----~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~ 688 (824)
+....... .....||+.|+|||++.+. .++.++|||||||+||||++|++||............-....
T Consensus 192 ~~~~~~~~-------~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~ 264 (371)
T cd05622 192 MNKEGMVR-------CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN 264 (371)
T ss_pred cCcCCccc-------ccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC
Confidence 54322110 1235699999999998754 378899999999999999999999986654322111100000
Q ss_pred ccCCCCCCCChhhHHHHHHHHHHHhhhccCC---CCCh
Q 003384 689 LLDPLAGDWPFVQAEQLANLAMRCCEMSRKS---RPEL 723 (824)
Q Consensus 689 ~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~---RPt~ 723 (824)
......+...+..+.+++..|+. +|.. ||++
T Consensus 265 ---~~~~~~~~~~s~~~~~li~~~L~-~~~~r~~r~~~ 298 (371)
T cd05622 265 ---SLTFPDDNDISKEAKNLICAFLT-DREVRLGRNGV 298 (371)
T ss_pred ---cccCCCcCCCCHHHHHHHHHHcC-ChhhhcCCCCH
Confidence 01111122456789999999998 4444 6676
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=306.15 Aligned_cols=249 Identities=24% Similarity=0.447 Sum_probs=195.2
Q ss_pred CCCccceeeecCceEEEEEEEC-CeEEEEEEecCCCCCC------chhHHHHHHHHHhcCCCceeeEecccC--CceEEE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQG------PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLV 535 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~-~~~VAvK~l~~~~~~~------~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV 535 (824)
+|.....||.|+||.||+|... +..+|||.+....... ...+.+|+++++.++||||++++++|. ...++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 3667788999999999999874 5789999886542211 245889999999999999999999984 468899
Q ss_pred EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccc
Q 003384 536 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 615 (824)
Q Consensus 536 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~ 615 (824)
|||+++++|.+++.. ..++++..+..++.+++.||.|||. .+|+|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 999999999999843 2458889999999999999999999 8899999999999999999999999999886532
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCC
Q 003384 616 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG 695 (824)
Q Consensus 616 ~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~ 695 (824)
........ .......|+..|+|||++.+..++.++|||||||++|+|++|++||................... .
T Consensus 155 ~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~ 228 (265)
T cd06631 155 VGLHGTHS--NMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLM----P 228 (265)
T ss_pred cccccccc--ccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCC----C
Confidence 21111100 01123458999999999998889999999999999999999999997654433222211111111 1
Q ss_pred CCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 696 DWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 696 ~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
..+...+..+.+++.+||+.+|.+||++.+
T Consensus 229 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ 258 (265)
T cd06631 229 RLPDSFSAAAIDFVTSCLTRDQHERPSALQ 258 (265)
T ss_pred CCCCCCCHHHHHHHHHHhcCCcccCCCHHH
Confidence 223445678999999999999999999943
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=305.38 Aligned_cols=242 Identities=28% Similarity=0.393 Sum_probs=196.6
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEec
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL 539 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey~ 539 (824)
++|+..+.||.|+||.||+|... +..|++|.+..... ...+.+|+++++.++||||++++|++. ...+++|||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 46888899999999999999886 47899999875432 568999999999999999999999884 4688999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccccc
Q 003384 540 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 619 (824)
Q Consensus 540 ~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 619 (824)
++++|.+++.. ....+++..+..++.+++.||.|||+ .+++||||+|.||+++.++.+||+|||++.........
T Consensus 81 ~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (256)
T cd06612 81 GAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK 155 (256)
T ss_pred CCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCccc
Confidence 99999999853 23568999999999999999999999 78999999999999999999999999998866433211
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCCh
Q 003384 620 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPF 699 (824)
Q Consensus 620 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~ 699 (824)
.....|+..|+|||++.+..++.++|||||||++|+|+||++||............... .......+.
T Consensus 156 --------~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~ 223 (256)
T cd06612 156 --------RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK----PPPTLSDPE 223 (256)
T ss_pred --------cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccC----CCCCCCchh
Confidence 12345889999999999889999999999999999999999999755433221111110 001111223
Q ss_pred hhHHHHHHHHHHHhhhccCCCCChH
Q 003384 700 VQAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 700 ~~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
..+..+.+++.+||+.+|.+||++.
T Consensus 224 ~~~~~~~~~i~~~l~~~P~~Rps~~ 248 (256)
T cd06612 224 KWSPEFNDFVKKCLVKDPEERPSAI 248 (256)
T ss_pred hcCHHHHHHHHHHHhcChhhCcCHH
Confidence 3456899999999999999999994
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=337.37 Aligned_cols=249 Identities=22% Similarity=0.296 Sum_probs=186.0
Q ss_pred HhhhcCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCC------CceeeEecccC-
Q 003384 459 IEGATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRH------PNLVTLVGACP- 529 (824)
Q Consensus 459 i~~~~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~H------pnIv~L~g~~~- 529 (824)
+...+++|.+.++||+|+||+||+|.+. +..||||+++... .....+..|+.++..++| +++++++++|.
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 4445678999999999999999999875 5789999986432 123456778888888765 45888888873
Q ss_pred --CceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCC-------
Q 003384 530 --EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF------- 600 (824)
Q Consensus 530 --~~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~------- 600 (824)
...++|||++ |++|.+++.. ...+++..+..|+.||+.||.|||+. .|||||||||+||||+.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~ 276 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVT 276 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCccccccc
Confidence 3578999988 7788888843 34689999999999999999999971 3899999999999998765
Q ss_pred ---------cceeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCC
Q 003384 601 ---------VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPAL 671 (824)
Q Consensus 601 ---------~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf 671 (824)
.+||+|||++...... .....||+.|+|||++.+..|+.++|||||||+||||+||++||
T Consensus 277 ~~~~~~~~~~vkl~DfG~~~~~~~~-----------~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf 345 (467)
T PTZ00284 277 NRALPPDPCRVRICDLGGCCDERHS-----------RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLY 345 (467)
T ss_pred ccccCCCCceEEECCCCccccCccc-----------cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 4999999987532211 13356999999999999999999999999999999999999999
Q ss_pred CCchHHHHHHhh----hcc-------------ccccC------CCC------------CCCChhhHHHHHHHHHHHhhhc
Q 003384 672 GITKEVQYALDT----GKL-------------KNLLD------PLA------------GDWPFVQAEQLANLAMRCCEMS 716 (824)
Q Consensus 672 ~~~~~~~~~~~~----~~~-------------~~~ld------~~~------------~~~p~~~~~~l~~Li~~Cl~~~ 716 (824)
............ |.+ ..++. +.. ..........+.+|+.+||..|
T Consensus 346 ~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~d 425 (467)
T PTZ00284 346 DTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYD 425 (467)
T ss_pred CCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcC
Confidence 765433211110 000 00000 000 0000112356789999999999
Q ss_pred cCCCCChHH
Q 003384 717 RKSRPELGK 725 (824)
Q Consensus 717 P~~RPt~~~ 725 (824)
|.+||++.+
T Consensus 426 P~~R~ta~e 434 (467)
T PTZ00284 426 RQKRLNARQ 434 (467)
T ss_pred hhhCCCHHH
Confidence 999999943
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=324.92 Aligned_cols=246 Identities=20% Similarity=0.270 Sum_probs=189.3
Q ss_pred hcCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHHhcCCCceeeEecccC--------
Q 003384 462 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP-------- 529 (824)
Q Consensus 462 ~~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~-------- 529 (824)
..++|...+.||+|+||.||++... +..||||++..... .....+.+|+.+++.++||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 3468999999999999999999865 57899999875422 22346778999999999999999999873
Q ss_pred CceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccc
Q 003384 530 EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI 609 (824)
Q Consensus 530 ~~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGl 609 (824)
...++||||+++ +|.+.+. ..+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCcc
Confidence 236899999965 6666663 247888999999999999999999 8999999999999999999999999999
Q ss_pred ccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhh----h-
Q 003384 610 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT----G- 684 (824)
Q Consensus 610 a~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~----~- 684 (824)
++....... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||............ +
T Consensus 166 ~~~~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (355)
T cd07874 166 ARTAGTSFM---------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 236 (355)
T ss_pred cccCCCccc---------cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 975432211 12346899999999999989999999999999999999999999765432211000 0
Q ss_pred -----------cccccc-------------------CCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 685 -----------KLKNLL-------------------DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 685 -----------~~~~~l-------------------d~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
.....+ -+.....+...+..+.+|+.+||..+|.+||++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~e 307 (355)
T cd07874 237 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDE 307 (355)
T ss_pred CCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHH
Confidence 000000 00001112223467899999999999999999944
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=306.76 Aligned_cols=243 Identities=23% Similarity=0.333 Sum_probs=195.0
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCC-CCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEec
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS-LQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL 539 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~-~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey~ 539 (824)
+|+..+.||.|+||.||++... +..||+|.+.... ....+.+..|+.+++.++||||+++++++. ...++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4677889999999999999875 5789999986432 223457889999999999999999999884 4689999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccccc
Q 003384 540 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 619 (824)
Q Consensus 540 ~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 619 (824)
++|+|.+++... ....++......++.+++.||.|||+ ++|+|+||||+|||++.++.++|+|||++.........
T Consensus 81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 156 (255)
T cd08219 81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY 156 (255)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeecccccc
Confidence 999999988532 23458899999999999999999999 89999999999999999999999999998765432211
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCCh
Q 003384 620 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPF 699 (824)
Q Consensus 620 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~ 699 (824)
.....|++.|+|||++.+..++.++||||||+++|+|++|.+||............ ...... ..+.
T Consensus 157 --------~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~--~~~~~~----~~~~ 222 (255)
T cd08219 157 --------ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKV--CQGSYK----PLPS 222 (255)
T ss_pred --------cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHH--hcCCCC----CCCc
Confidence 12345899999999998888999999999999999999999999765443221111 011111 1233
Q ss_pred hhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 700 VQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 700 ~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
..+..+.+++.+||+.+|.+||++.+
T Consensus 223 ~~~~~~~~li~~~l~~~P~~Rp~~~~ 248 (255)
T cd08219 223 HYSYELRSLIKQMFKRNPRSRPSATT 248 (255)
T ss_pred ccCHHHHHHHHHHHhCCcccCCCHHH
Confidence 34567999999999999999999943
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=351.38 Aligned_cols=252 Identities=21% Similarity=0.343 Sum_probs=195.3
Q ss_pred hhcCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEecccC----Cce
Q 003384 461 GATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP----EVW 532 (824)
Q Consensus 461 ~~~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~L~g~~~----~~~ 532 (824)
....+|.+...||.|+||+||++... +..||+|++...... ....|..|+.+|+.|+|||||+++++|. ..+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 34458999999999999999999886 467999998754322 2356889999999999999999999872 358
Q ss_pred EEEEEecCCCChhhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCC----CceEeccccCCcEEecC---------
Q 003384 533 TLVYEYLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKP----HSIVHGDLKPANILLDA--------- 598 (824)
Q Consensus 533 ~LV~Ey~~ggsL~~~L~~~-~~~~~l~~~~~~~ia~qia~aL~~LH~~~~----~giiHrDLKp~NILld~--------- 598 (824)
+|||||+++|+|.++|... .....+++..++.|+.||+.||.|||...+ ++||||||||+||||+.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 8999999999999998642 223569999999999999999999998432 46999999999999964
Q ss_pred --------CCcceeeccccccccccccccCCCccccccCCCCCCcccCChhhhcc--CCCCcchhHHhHHHHHHHHHhCC
Q 003384 599 --------NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS--GELTPKSDVYSFGIILLRLLTGR 668 (824)
Q Consensus 599 --------~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~--~~~t~ksDVwSlGvvL~ELltG~ 668 (824)
.+.+||+|||++..+..... .....||+.|+|||++.+ ..++.++||||||||||+|+||+
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s~---------~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk 240 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIESM---------AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240 (1021)
T ss_pred ccccccCCCCceEEccCCcccccccccc---------ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCC
Confidence 24589999999986543211 123468999999999864 45889999999999999999999
Q ss_pred CCCCCchHHHHHHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 003384 669 PALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 727 (824)
Q Consensus 669 ~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 727 (824)
+||.........+... ...... .....+..+.+|+..||+.+|.+||++.+.+
T Consensus 241 ~PF~~~~~~~qli~~l--k~~p~l----pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL 293 (1021)
T PTZ00266 241 TPFHKANNFSQLISEL--KRGPDL----PIKGKSKELNILIKNLLNLSAKERPSALQCL 293 (1021)
T ss_pred CCCCcCCcHHHHHHHH--hcCCCC----CcCCCCHHHHHHHHHHhcCChhHCcCHHHHh
Confidence 9997554333222211 010000 0122356899999999999999999995544
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=326.17 Aligned_cols=257 Identities=28% Similarity=0.493 Sum_probs=213.1
Q ss_pred hhHhhhcCCCCccceeeecCceEEEEEEECC--eEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC--Cce
Q 003384 457 SEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVW 532 (824)
Q Consensus 457 ~ei~~~~~~f~~~~~LG~G~fG~Vykg~~~~--~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~ 532 (824)
++++-...+....++||.|.||.||.|.|+. ..||||.++.+.+ ..++|..|..+|+.++|||+|+|+|+|. ..+
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 3444444456667899999999999999985 6799999986543 4678999999999999999999999994 579
Q ss_pred EEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccc
Q 003384 533 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 612 (824)
Q Consensus 533 ~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~ 612 (824)
|||.|||..|+|.++|...+ ...++--..+.++.||+.|+.||.. +++|||||...|+|+.++..+||+||||+++
T Consensus 339 YIiTEfM~yGNLLdYLRecn-r~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECN-RSEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred EEEEecccCccHHHHHHHhc-hhhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhh
Confidence 99999999999999997553 3457777888999999999999999 8899999999999999999999999999999
Q ss_pred cccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchH--HHHHHhhhccccc
Q 003384 613 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKE--VQYALDTGKLKNL 689 (824)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~--~~~~~~~~~~~~~ 689 (824)
+..+.+... .+..-.+-|.|||-+....++.|+|||+|||+|||+.| |-.||.+.+. +...++.|
T Consensus 415 MtgDTYTAH-------AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkg----- 482 (1157)
T KOG4278|consen 415 MTGDTYTAH-------AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKG----- 482 (1157)
T ss_pred hcCCceecc-------cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcc-----
Confidence 876654332 22334678999999999999999999999999999998 8889876543 22222222
Q ss_pred cCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHH
Q 003384 690 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 734 (824)
Q Consensus 690 ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l 734 (824)
..-+.|..+++.+.+|++.||+.+|.+||++ .++.+.++-+
T Consensus 483 ---yRM~~PeGCPpkVYeLMraCW~WsPsDRPsF-aeiHqafEtm 523 (1157)
T KOG4278|consen 483 ---YRMDGPEGCPPKVYELMRACWNWSPSDRPSF-AEIHQAFETM 523 (1157)
T ss_pred ---ccccCCCCCCHHHHHHHHHHhcCCcccCccH-HHHHHHHHHH
Confidence 1223577888999999999999999999999 6777777655
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=305.17 Aligned_cols=246 Identities=28% Similarity=0.366 Sum_probs=197.8
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--CCceEEEEEec
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 539 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~Ey~ 539 (824)
.+|...+.||.|+||.||+|... +..+++|++..........+.+|+.+++.++||||++++|++ ....+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 46888899999999999999875 478999999766544567799999999999999999999987 45688999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccccc
Q 003384 540 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 619 (824)
Q Consensus 540 ~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 619 (824)
++++|.+++... ...++...+..++.|++.||.|||. ++|+||||+|+||+++.++.+||+|||++..+.....
T Consensus 83 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 156 (262)
T cd06613 83 GGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA- 156 (262)
T ss_pred CCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhhh-
Confidence 999999988532 2568899999999999999999999 8899999999999999999999999999876543211
Q ss_pred CCCccccccCCCCCCcccCChhhhccC---CCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCC
Q 003384 620 SNNTTLCCRTDPKGTFAYMDPEFLASG---ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 696 (824)
Q Consensus 620 ~~~~~~~~~~~~~GT~~Y~APE~l~~~---~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~ 696 (824)
......|+..|+|||.+.+. .++.++|||||||++|+|+||++||.............. ..+.+....
T Consensus 157 -------~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~--~~~~~~~~~ 227 (262)
T cd06613 157 -------KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISK--SNFPPPKLK 227 (262)
T ss_pred -------ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--ccCCCcccc
Confidence 01234588999999999776 788999999999999999999999976543322221111 101111111
Q ss_pred CChhhHHHHHHHHHHHhhhccCCCCChH
Q 003384 697 WPFVQAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 697 ~p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
.+...+..+.+++.+||..+|.+||++.
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~ 255 (262)
T cd06613 228 DKEKWSPVFHDFIKKCLTKDPKKRPTAT 255 (262)
T ss_pred chhhhhHHHHHHHHHHcCCChhhCCCHH
Confidence 2334567899999999999999999993
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=305.38 Aligned_cols=247 Identities=26% Similarity=0.492 Sum_probs=195.4
Q ss_pred CCCccceeeecCceEEEEEEEC-CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEecCC
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPN 541 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~-~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey~~g 541 (824)
+|+..+.||.|+||.||+|.+. +..+|+|.+.... .....|.+|++++++++||||+++++++. ...++||||+++
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH 83 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence 5777889999999999999876 6789999886543 23457999999999999999999999884 467899999999
Q ss_pred CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCC
Q 003384 542 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 621 (824)
Q Consensus 542 gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 621 (824)
++|.+++... ..++++..+..++.+++.||.|||+ .+++||||||+||+++.++.+||+|||++..........
T Consensus 84 ~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~- 157 (256)
T cd05112 84 GCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS- 157 (256)
T ss_pred CcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCcccc-
Confidence 9999998532 3468899999999999999999999 789999999999999999999999999987654321110
Q ss_pred CccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHHHHhhhccccccCCCCCCCChh
Q 003384 622 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV 700 (824)
Q Consensus 622 ~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~ 700 (824)
.....++..|+|||++.++.++.++|||||||++|||++ |++||.................. ..+..
T Consensus 158 ------~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~------~~~~~ 225 (256)
T cd05112 158 ------STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRL------YKPRL 225 (256)
T ss_pred ------cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCC------CCCCC
Confidence 122335678999999998899999999999999999998 99999754432211111000011 11233
Q ss_pred hHHHHHHHHHHHhhhccCCCCChHHHHHHHH
Q 003384 701 QAEQLANLAMRCCEMSRKSRPELGKDVWRVL 731 (824)
Q Consensus 701 ~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L 731 (824)
.+..+.+|+.+||+.+|.+||++ .++++.|
T Consensus 226 ~~~~~~~l~~~~l~~~p~~Rp~~-~~~l~~l 255 (256)
T cd05112 226 ASQSVYELMQHCWKERPEDRPSF-SLLLHQL 255 (256)
T ss_pred CCHHHHHHHHHHcccChhhCCCH-HHHHHhh
Confidence 45789999999999999999999 5565544
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=316.76 Aligned_cols=194 Identities=25% Similarity=0.396 Sum_probs=157.2
Q ss_pred cceeeecCceEEEEEEEC----CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC----CceEEEEEecC
Q 003384 469 SLKIGEGGYGSIYKGLLR----HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP----EVWTLVYEYLP 540 (824)
Q Consensus 469 ~~~LG~G~fG~Vykg~~~----~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~----~~~~LV~Ey~~ 540 (824)
..+||+|+||.||+|... +..||+|.+.... ....+.+|+.+|+.++||||+++++++. ...++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 357999999999999864 3679999986542 2346789999999999999999999872 34789999985
Q ss_pred CCChhhhhhcc------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEe----cCCCcceeeccccc
Q 003384 541 NGSLEDRLSCK------DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL----DANFVSKLSDFGIS 610 (824)
Q Consensus 541 ggsL~~~L~~~------~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILl----d~~~~vKL~DFGla 610 (824)
++|.+++... .....++...+..++.|++.||.|||+ ++|+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5787776422 122358899999999999999999999 899999999999999 45689999999999
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccC-CCCcchhHHhHHHHHHHHHhCCCCCCC
Q 003384 611 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGI 673 (824)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDVwSlGvvL~ELltG~~Pf~~ 673 (824)
+.+....... .......||+.|+|||++.+. .++.++|||||||++|+|+||++||..
T Consensus 160 ~~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 160 RLFNSPLKPL-----ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCCccc-----cccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 8764332111 111345689999999998774 589999999999999999999999963
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=315.73 Aligned_cols=248 Identities=23% Similarity=0.341 Sum_probs=188.9
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEeccc--CCceEEEEEe
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 538 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~Ey 538 (824)
.+|...+.||+|+||.||+|... +..||+|.+...... ....+.+|+.+++.++||||+++++++ .+..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 46888899999999999999875 578999998754322 234678999999999999999999988 4568999999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccc
Q 003384 539 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 618 (824)
Q Consensus 539 ~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 618 (824)
+++ +|.+++... ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 86 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 86 LDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 975 788877432 3457888999999999999999999 8999999999999999999999999999875432211
Q ss_pred cCCCccccccCCCCCCcccCChhhhcc-CCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhc---------ccc
Q 003384 619 SSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK---------LKN 688 (824)
Q Consensus 619 ~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~---------~~~ 688 (824)
. .....||+.|+|||++.+ ..++.++|||||||++|+|+||++||............-. +..
T Consensus 160 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (309)
T cd07872 160 T--------YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPG 231 (309)
T ss_pred c--------cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Confidence 1 123457999999999865 4688999999999999999999999975433211100000 000
Q ss_pred c--------cC-CCC-----CCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 689 L--------LD-PLA-----GDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 689 ~--------ld-~~~-----~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
+ .. +.. .......+..+.+|+.+|++.+|.+||++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e 282 (309)
T cd07872 232 ISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEE 282 (309)
T ss_pred hcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHH
Confidence 0 00 000 0001123557889999999999999999843
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=319.19 Aligned_cols=246 Identities=23% Similarity=0.287 Sum_probs=187.4
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCC---CCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 536 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~---~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~ 536 (824)
++|...+.||+|+||.||++... +..||+|++.... ......+..|+.++..++||||+++++++. +..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888899999999999999876 4789999986421 112345788999999999999999999884 4688999
Q ss_pred EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccc
Q 003384 537 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 616 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 616 (824)
||++||+|.+++... ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++..+...
T Consensus 81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999999532 3468889999999999999999999 89999999999999999999999999999765433
Q ss_pred cccCCCccccccCCCCCCcccCChhhhcc-----CCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccC
Q 003384 617 EISSNNTTLCCRTDPKGTFAYMDPEFLAS-----GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD 691 (824)
Q Consensus 617 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-----~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld 691 (824)
.... .....||+.|+|||++.+ +.++.++|||||||+||+|++|+.||..................+
T Consensus 156 ~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~- 227 (331)
T cd05624 156 GTVQ-------SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERF- 227 (331)
T ss_pred Ccee-------eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcc-
Confidence 2110 122459999999999875 567889999999999999999999997654332211110000000
Q ss_pred CCCCCCChhhHHHHHHHHHHHhhhccCC--CCCh
Q 003384 692 PLAGDWPFVQAEQLANLAMRCCEMSRKS--RPEL 723 (824)
Q Consensus 692 ~~~~~~p~~~~~~l~~Li~~Cl~~~P~~--RPt~ 723 (824)
+. .......+..+.+++.+|+...+.+ |+++
T Consensus 228 ~~-p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~ 260 (331)
T cd05624 228 QF-PSHITDVSEEAKDLIQRLICSRERRLGQNGI 260 (331)
T ss_pred cC-CCccccCCHHHHHHHHHHccCchhhcCCCCH
Confidence 00 1111234578999999999865533 3455
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=323.66 Aligned_cols=242 Identities=29% Similarity=0.459 Sum_probs=204.0
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCC---chhHHHHHHHHHhcC-CCceeeEecccC--CceEE
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---PSEFQQEIDILSKIR-HPNLVTLVGACP--EVWTL 534 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~---~~~f~~Ei~iL~~l~-HpnIv~L~g~~~--~~~~L 534 (824)
...|.+.+.||.|.||.||+++.. +..+|+|++.+..... ...+.+|+.||+++. |||||.++++|. ...++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 446888899999999999999876 5789999998765543 358999999999998 999999999995 46799
Q ss_pred EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecC----CCcceeeccccc
Q 003384 535 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA----NFVSKLSDFGIS 610 (824)
Q Consensus 535 V~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~----~~~vKL~DFGla 610 (824)
|||+|.||.|.+.+... .+++.....++.+++.++.|||+ .||+||||||+|+|+.. ++.+|++|||++
T Consensus 114 vmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred EEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 99999999999999655 39999999999999999999999 89999999999999953 358999999999
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHH--hhhcccc
Q 003384 611 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYAL--DTGKLKN 688 (824)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~--~~~~~~~ 688 (824)
........ ....+||+.|+|||++....|+..+||||+||++|.|++|.+||.......... ..+.+
T Consensus 187 ~~~~~~~~---------~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~-- 255 (382)
T KOG0032|consen 187 KFIKPGER---------LHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDF-- 255 (382)
T ss_pred eEccCCce---------EeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCC--
Confidence 98765211 145679999999999999999999999999999999999999998776544332 23322
Q ss_pred ccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 689 LLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 689 ~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
+.....|+. .+..+.+++..|+..+|..|+++.+
T Consensus 256 --~f~~~~w~~-is~~akd~i~~ll~~dp~~R~ta~~ 289 (382)
T KOG0032|consen 256 --DFTSEPWDD-ISESAKDFIRKLLEFDPRKRLTAAQ 289 (382)
T ss_pred --CCCCCCccc-cCHHHHHHHHHhcccCcccCCCHHH
Confidence 334445553 4789999999999999999999943
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=315.11 Aligned_cols=243 Identities=25% Similarity=0.381 Sum_probs=196.5
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEec
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL 539 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey~ 539 (824)
.+|...+.||.|+||.||+|... +..||+|.+..........+.+|+.+++.++||||++++++|. +..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 47888999999999999999864 6889999997655555567889999999999999999999884 4689999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccccc
Q 003384 540 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 619 (824)
Q Consensus 540 ~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 619 (824)
++++|.+++. ...+++..+..++.+++.||.|||+ .+++||||||+|||++.++.+||+|||++.........
T Consensus 99 ~~~~L~~~~~----~~~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 171 (297)
T cd06656 99 AGGSLTDVVT----ETCMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (297)
T ss_pred CCCCHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCccC
Confidence 9999999884 2357889999999999999999999 89999999999999999999999999998765432211
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCCh
Q 003384 620 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPF 699 (824)
Q Consensus 620 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~ 699 (824)
.....|++.|+|||.+.+..++.++|||||||++|+|++|.+||.............. ........+.
T Consensus 172 --------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~----~~~~~~~~~~ 239 (297)
T cd06656 172 --------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT----NGTPELQNPE 239 (297)
T ss_pred --------cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc----CCCCCCCCcc
Confidence 1234588999999999988899999999999999999999999965443221111000 0001111233
Q ss_pred hhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 700 VQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 700 ~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
..+..+.+++.+||..+|.+||++.+
T Consensus 240 ~~~~~~~~li~~~l~~~p~~Rps~~~ 265 (297)
T cd06656 240 RLSAVFRDFLNRCLEMDVDRRGSAKE 265 (297)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHH
Confidence 45567899999999999999999943
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=306.67 Aligned_cols=249 Identities=29% Similarity=0.515 Sum_probs=199.0
Q ss_pred CCCCccceeeecCceEEEEEEEC-CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC-CceEEEEEecCC
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVYEYLPN 541 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~-~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~-~~~~LV~Ey~~g 541 (824)
..|...++||+|+||.||+|.+. +..+|+|.+.... .....+.+|+.+++.++|+||+++++.+. ...++||||+++
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~v~e~~~~ 84 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAK 84 (260)
T ss_pred cceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcCCCeEEEEEeCCC
Confidence 46888899999999999999865 4679999887542 23457889999999999999999999874 457899999999
Q ss_pred CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCC
Q 003384 542 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 621 (824)
Q Consensus 542 gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 621 (824)
|+|.+++.... ...+++..+..++.+++.||.|||. .|++||||||+||+++.++.+||+|||++..+.......
T Consensus 85 ~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~- 159 (260)
T cd05073 85 GSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA- 159 (260)
T ss_pred CcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCCccc-
Confidence 99999986432 3468889999999999999999999 789999999999999999999999999997654322111
Q ss_pred CccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHH--HHHhhhccccccCCCCCCCC
Q 003384 622 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--YALDTGKLKNLLDPLAGDWP 698 (824)
Q Consensus 622 ~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~~p 698 (824)
.....++..|+|||++....++.++|||||||++|+|+| |++||....... ..+..+. ....+
T Consensus 160 ------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~--------~~~~~ 225 (260)
T cd05073 160 ------REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY--------RMPRP 225 (260)
T ss_pred ------ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC--------CCCCc
Confidence 122346788999999998889999999999999999999 999997543321 1111111 11122
Q ss_pred hhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHH
Q 003384 699 FVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP 733 (824)
Q Consensus 699 ~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~ 733 (824)
...+..+.+++.+|++.+|.+||++ ..+...|+.
T Consensus 226 ~~~~~~~~~~i~~~l~~~p~~Rp~~-~~l~~~L~~ 259 (260)
T cd05073 226 ENCPEELYNIMMRCWKNRPEERPTF-EYIQSVLDD 259 (260)
T ss_pred ccCCHHHHHHHHHHcccCcccCcCH-HHHHHHHhc
Confidence 3445689999999999999999999 667676653
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=313.34 Aligned_cols=234 Identities=26% Similarity=0.402 Sum_probs=179.8
Q ss_pred eeeecCceEEEEEEEC--------------------------CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeE
Q 003384 471 KIGEGGYGSIYKGLLR--------------------------HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL 524 (824)
Q Consensus 471 ~LG~G~fG~Vykg~~~--------------------------~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L 524 (824)
.||+|+||.||+|.+. ...|++|++..........|.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 5999999999999742 13589999865433333568889999999999999999
Q ss_pred ecccC--CceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCC--
Q 003384 525 VGACP--EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF-- 600 (824)
Q Consensus 525 ~g~~~--~~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~-- 600 (824)
+|+|. ...++||||+++|+|..++.. ....+++..+..++.|++.||.|||+ ++|+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEeccCcc
Confidence 99984 467899999999999998853 23468899999999999999999999 8999999999999997644
Q ss_pred -----cceeeccccccccccccccCCCccccccCCCCCCcccCChhhhcc-CCCCcchhHHhHHHHHHHHH-hCCCCCCC
Q 003384 601 -----VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLL-TGRPALGI 673 (824)
Q Consensus 601 -----~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDVwSlGvvL~ELl-tG~~Pf~~ 673 (824)
.+||+|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|++||..
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~------------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~ 224 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR------------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKE 224 (274)
T ss_pred cCccceeeecCCccccccccc------------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccc
Confidence 4799999987643211 12347888999998875 56899999999999999995 79999965
Q ss_pred chHHHHHHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHH
Q 003384 674 TKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRV 730 (824)
Q Consensus 674 ~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~ 730 (824)
........... . . ...+......+.+++.+||+.+|.+||++ .++++.
T Consensus 225 ~~~~~~~~~~~---~-~----~~~~~~~~~~~~~li~~cl~~~p~~Rps~-~~il~~ 272 (274)
T cd05076 225 RTPSEKERFYE---K-K----HRLPEPSCKELATLISQCLTYEPTQRPSF-RTILRD 272 (274)
T ss_pred cChHHHHHHHH---h-c----cCCCCCCChHHHHHHHHHcccChhhCcCH-HHHHHh
Confidence 43221110000 0 0 01112223578999999999999999999 555443
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=312.13 Aligned_cols=240 Identities=26% Similarity=0.354 Sum_probs=186.9
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEeccc--CCceEEEEEec
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 539 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~Ey~ 539 (824)
+|...++||+|+||.||+|... +..||+|++..... .....+.+|+.++++++||||++++++| .+..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 5677889999999999999874 57899999865422 2234688999999999999999999987 45688999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccccc
Q 003384 540 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 619 (824)
Q Consensus 540 ~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 619 (824)
++|+|..+. .+++..+..++.+++.||.|||+ .||+|+||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~-- 149 (279)
T cd06619 82 DGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-- 149 (279)
T ss_pred CCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc--
Confidence 999986542 46788899999999999999999 899999999999999999999999999987653221
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHH-HHhhhccccccCCCCCCC-
Q 003384 620 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQY-ALDTGKLKNLLDPLAGDW- 697 (824)
Q Consensus 620 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~-~~~~~~~~~~ld~~~~~~- 697 (824)
.....||..|+|||++.+..++.++|||||||++|+|++|+.||........ ...........+......
T Consensus 150 --------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (279)
T cd06619 150 --------AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLP 221 (279)
T ss_pred --------ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCC
Confidence 1234689999999999988999999999999999999999999954211000 000000111111111111
Q ss_pred ChhhHHHHHHHHHHHhhhccCCCCChH
Q 003384 698 PFVQAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 698 p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
....+..+.+++.+|++.+|.+||++.
T Consensus 222 ~~~~~~~~~~li~~~l~~~P~~Rp~~~ 248 (279)
T cd06619 222 VGQFSEKFVHFITQCMRKQPKERPAPE 248 (279)
T ss_pred CCcCCHHHHHHHHHHhhCChhhCCCHH
Confidence 122456799999999999999999984
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=308.62 Aligned_cols=246 Identities=25% Similarity=0.451 Sum_probs=192.9
Q ss_pred eeeecCceEEEEEEECC--------eEEEEEEecCCC-CCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEec
Q 003384 471 KIGEGGYGSIYKGLLRH--------MQVAIKMLHPHS-LQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL 539 (824)
Q Consensus 471 ~LG~G~fG~Vykg~~~~--------~~VAvK~l~~~~-~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey~ 539 (824)
.||+|+||.||+|.... ..||||.+.... ......+.+|+.+++.++||||++++++|. +..++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 59999999999998653 569999876532 123457889999999999999999999884 4689999999
Q ss_pred CCCChhhhhhccC----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCC-----cceeeccccc
Q 003384 540 PNGSLEDRLSCKD----NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF-----VSKLSDFGIS 610 (824)
Q Consensus 540 ~ggsL~~~L~~~~----~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~-----~vKL~DFGla 610 (824)
++|+|.+++.... ....+++..++.++.+++.||.|||+ .+++|+||||+|||++.++ .+||+|||++
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 9999999986432 23458899999999999999999998 7899999999999999877 8999999999
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHHHHhhhccccc
Q 003384 611 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNL 689 (824)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~~~~~~~~~ 689 (824)
........... .....++..|+|||++.++.++.++|||||||++|+|+| |+.||.............
T Consensus 159 ~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~----- 227 (269)
T cd05044 159 RDIYKSDYYRK------EGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT----- 227 (269)
T ss_pred ccccccccccc------CcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHh-----
Confidence 86543321111 123346789999999999999999999999999999998 999997544322211110
Q ss_pred cCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHH
Q 003384 690 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 732 (824)
Q Consensus 690 ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le 732 (824)
.......+...+..+.+++.+||..+|.+||++ +.+.+.|+
T Consensus 228 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~-~~i~~~l~ 268 (269)
T cd05044 228 -AGGRLQKPENCPDKIYQLMTNCWAQDPSERPTF-DRIQEILQ 268 (269)
T ss_pred -cCCccCCcccchHHHHHHHHHHcCCCcccCCCH-HHHHHHHh
Confidence 001112234456789999999999999999999 66666654
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=318.06 Aligned_cols=259 Identities=24% Similarity=0.384 Sum_probs=201.7
Q ss_pred CCCCccceeeecCceEEEEEEECC---------eEEEEEEecCCCC-CCchhHHHHHHHHHhc-CCCceeeEecccC--C
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLRH---------MQVAIKMLHPHSL-QGPSEFQQEIDILSKI-RHPNLVTLVGACP--E 530 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~~---------~~VAvK~l~~~~~-~~~~~f~~Ei~iL~~l-~HpnIv~L~g~~~--~ 530 (824)
.+|.+.+.||+|+||.||++...+ ..||+|.+..... .....+.+|+.+++++ +||||++++++|. .
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 368888999999999999997521 3689998875322 2245788999999999 7999999999884 3
Q ss_pred ceEEEEEecCCCChhhhhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEec
Q 003384 531 VWTLVYEYLPNGSLEDRLSCKD-------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD 597 (824)
Q Consensus 531 ~~~LV~Ey~~ggsL~~~L~~~~-------------~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld 597 (824)
..++||||+++|+|.+++.... ....+++..++.++.|++.||.|||. +||+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEc
Confidence 5789999999999999986432 12358889999999999999999999 8999999999999999
Q ss_pred CCCcceeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchH
Q 003384 598 ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKE 676 (824)
Q Consensus 598 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~ 676 (824)
.++.+||+|||+++.......... .....++..|+|||++.+..++.++|||||||++|||++ |.+||.....
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 242 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKK------TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 242 (334)
T ss_pred CCCcEEECCcccceeccccccccc------ccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 999999999999986543221100 122345678999999999999999999999999999998 8899975443
Q ss_pred HHHHHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhhC
Q 003384 677 VQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC 738 (824)
Q Consensus 677 ~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~~~ 738 (824)
....... ........+...+..+.+++.+||+.+|.+||++ .+++..|+.+....
T Consensus 243 ~~~~~~~------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~-~ell~~l~~~~~~~ 297 (334)
T cd05100 243 EELFKLL------KEGHRMDKPANCTHELYMIMRECWHAVPSQRPTF-KQLVEDLDRVLTVT 297 (334)
T ss_pred HHHHHHH------HcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCH-HHHHHHHHHHhhhc
Confidence 2211110 0111112233456689999999999999999999 77778888776543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=311.21 Aligned_cols=259 Identities=26% Similarity=0.441 Sum_probs=199.3
Q ss_pred CCCccceeeecCceEEEEEEEC------CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccCC----ceE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR------HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACPE----VWT 533 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~------~~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~L~g~~~~----~~~ 533 (824)
.|...+.||+|+||.||+|.+. +..||||++...... ....|.+|+.+++.+.||||+++++++.. ..+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 4667788999999999999864 468999998765432 34579999999999999999999998743 578
Q ss_pred EEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccc
Q 003384 534 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 613 (824)
Q Consensus 534 LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~ 613 (824)
+||||+++++|.+++... ...+++..+..++.+++.||.|||. ++++||||||+|||++.++.+||+|||++...
T Consensus 85 lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred EEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 999999999999999533 2358999999999999999999999 89999999999999999999999999999876
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHH--------Hhhhc
Q 003384 614 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA--------LDTGK 685 (824)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~--------~~~~~ 685 (824)
........ ......++..|+|||.+.+..++.++|||||||++|||+||..||......... .....
T Consensus 160 ~~~~~~~~-----~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd05038 160 PEDKDYYY-----VKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTR 234 (284)
T ss_pred ccCCccee-----ccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHH
Confidence 53221110 011234567899999998889999999999999999999999988543211100 00000
Q ss_pred cccccC-CCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHH
Q 003384 686 LKNLLD-PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 734 (824)
Q Consensus 686 ~~~~ld-~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l 734 (824)
+...+. ......+...+..+.+++.+||+.+|.+||++ .+|+++|+.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~-~ei~~~l~~i 283 (284)
T cd05038 235 LLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSF-ADLILIVDRL 283 (284)
T ss_pred HHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCH-HHHHHHHhhc
Confidence 001110 01111223345789999999999999999999 7777777654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=305.82 Aligned_cols=234 Identities=29% Similarity=0.468 Sum_probs=184.1
Q ss_pred eeeecCceEEEEEEECCe------------EEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC-CceEEEEE
Q 003384 471 KIGEGGYGSIYKGLLRHM------------QVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVYE 537 (824)
Q Consensus 471 ~LG~G~fG~Vykg~~~~~------------~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~-~~~~LV~E 537 (824)
.||+|+||.||+|.+... .|++|.+...... ...|.+|+.+++.++||||++++|+|. ...++|||
T Consensus 2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e 80 (259)
T cd05037 2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVRDENIMVEE 80 (259)
T ss_pred cccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEecCCcEEEEE
Confidence 599999999999988643 3788887654332 567999999999999999999999874 56789999
Q ss_pred ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCC-------cceeeccccc
Q 003384 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF-------VSKLSDFGIS 610 (824)
Q Consensus 538 y~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~-------~vKL~DFGla 610 (824)
|+++|+|.+++.... ..+++..++.++.|++.||.|||. ++|+||||||+|||++.++ .+||+|||++
T Consensus 81 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 81 YVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred cCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 999999999985432 268899999999999999999999 8999999999999999887 7999999998
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccC--CCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHHHHhhhccc
Q 003384 611 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG--ELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLK 687 (824)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~--~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~~~~~~~ 687 (824)
...... ....++..|+|||++.+. .++.++|||||||++|+|++ |..||.............
T Consensus 156 ~~~~~~------------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~--- 220 (259)
T cd05037 156 ITVLSR------------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ--- 220 (259)
T ss_pred cccccc------------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh---
Confidence 765331 123467889999999876 78999999999999999999 577885442211110000
Q ss_pred cccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHH
Q 003384 688 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVL 731 (824)
Q Consensus 688 ~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L 731 (824)
.. ...+......+.+++.+||..+|.+||++ .++++.|
T Consensus 221 ---~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~-~~il~~l 258 (259)
T cd05037 221 ---DQ--HRLPMPDCAELANLINQCWTYDPTKRPSF-RAILRDL 258 (259)
T ss_pred ---cC--CCCCCCCchHHHHHHHHHhccChhhCCCH-HHHHHhc
Confidence 00 11112223689999999999999999999 4554443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=311.50 Aligned_cols=244 Identities=24% Similarity=0.360 Sum_probs=192.6
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--CCceEEEEEec
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 539 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~Ey~ 539 (824)
+.|++.++||.|+||.||+|... +..|++|.+..........+.+|+.+++.++||||+++++++ ....++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 46888899999999999999875 478999998765444456788999999999999999999987 45689999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccccc
Q 003384 540 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 619 (824)
Q Consensus 540 ~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 619 (824)
++++|..++... ...+++..+..++.|++.||.|||. ++++||||||+|||++.++.+||+|||++.........
T Consensus 92 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~ 166 (292)
T cd06644 92 PGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR 166 (292)
T ss_pred CCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceeccccccc
Confidence 999998877432 3468999999999999999999999 89999999999999999999999999998754322110
Q ss_pred CCCccccccCCCCCCcccCChhhhc-----cCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCC
Q 003384 620 SNNTTLCCRTDPKGTFAYMDPEFLA-----SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 694 (824)
Q Consensus 620 ~~~~~~~~~~~~~GT~~Y~APE~l~-----~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~ 694 (824)
.....|++.|+|||++. ...++.++|||||||++|+|++|.+||............. ....+ .
T Consensus 167 --------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~---~~~~~-~ 234 (292)
T cd06644 167 --------RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA---KSEPP-T 234 (292)
T ss_pred --------cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHh---cCCCc-c
Confidence 12345889999999985 3457889999999999999999999997654322211111 11111 1
Q ss_pred CCCChhhHHHHHHHHHHHhhhccCCCCChH
Q 003384 695 GDWPFVQAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 695 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
...+...+..+.+++.+||..+|.+||++.
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ 264 (292)
T cd06644 235 LSQPSKWSMEFRDFLKTALDKHPETRPSAA 264 (292)
T ss_pred CCCCcccCHHHHHHHHHHhcCCcccCcCHH
Confidence 111233456889999999999999999984
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=307.81 Aligned_cols=240 Identities=28% Similarity=0.371 Sum_probs=194.4
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCC-CCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEec
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS-LQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL 539 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~-~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey~ 539 (824)
+|...+.||.|+||.||+|... +..||+|++.... ......+.+|+.+++.++||||+++++++. ...++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 5777889999999999999875 5789999987543 223456889999999999999999999874 4688999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccccc
Q 003384 540 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 619 (824)
Q Consensus 540 ~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 619 (824)
++++|.+++.. .++++..+..++.|++.||.|||. ++++||||+|+||+++.++.++|+|||+++.+......
T Consensus 82 ~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 154 (274)
T cd06609 82 GGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK 154 (274)
T ss_pred CCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeecccccc
Confidence 99999999842 278999999999999999999999 88999999999999999999999999999876543211
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCCh
Q 003384 620 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPF 699 (824)
Q Consensus 620 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~ 699 (824)
.....|++.|+|||++.+..++.++|||||||++|+|+||++||............ .....+ ..+.
T Consensus 155 --------~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~---~~~~~~---~~~~ 220 (274)
T cd06609 155 --------RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLI---PKNNPP---SLEG 220 (274)
T ss_pred --------cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHh---hhcCCC---CCcc
Confidence 12345889999999999888999999999999999999999999755432211111 011111 1111
Q ss_pred h-hHHHHHHHHHHHhhhccCCCCChHH
Q 003384 700 V-QAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 700 ~-~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
. .+..+.+++.+||..+|.+||++.+
T Consensus 221 ~~~~~~~~~~l~~~l~~~p~~Rpt~~~ 247 (274)
T cd06609 221 NKFSKPFKDFVSLCLNKDPKERPSAKE 247 (274)
T ss_pred cccCHHHHHHHHHHhhCChhhCcCHHH
Confidence 2 4568999999999999999999843
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=303.79 Aligned_cols=241 Identities=24% Similarity=0.357 Sum_probs=194.7
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHHhcCCCceeeEecccC--C-ceEEEEE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP--E-VWTLVYE 537 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~-~~~LV~E 537 (824)
+|...+.||.|+||.||++... +..||+|.+..... .....+.+|+.++++++|||++++++.+. + ..++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4778899999999999999875 47899999865432 22346889999999999999999998763 2 4689999
Q ss_pred ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccc
Q 003384 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 617 (824)
Q Consensus 538 y~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 617 (824)
|+++++|.+++... ...++++.++..++.+++.||.+||+ ++++||||||+||+++.++.++|+|||++..+....
T Consensus 81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 99999999998542 23468999999999999999999999 899999999999999999999999999998664322
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHH--HHhhhccccccCCCCC
Q 003384 618 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQY--ALDTGKLKNLLDPLAG 695 (824)
Q Consensus 618 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~--~~~~~~~~~~ld~~~~ 695 (824)
.. .....|++.|+|||++.+..++.++|||||||++|+|++|+.||...+.... ....+. + .
T Consensus 157 ~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~----~----~ 220 (257)
T cd08223 157 DM--------ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGK----L----P 220 (257)
T ss_pred Cc--------cccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC----C----C
Confidence 11 1234589999999999999999999999999999999999999975543221 111111 1 1
Q ss_pred CCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 696 DWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 696 ~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
..+...+..+.+++.+|++.+|.+||++.+
T Consensus 221 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 250 (257)
T cd08223 221 PMPKDYSPELGELIATMLSKRPEKRPSVKS 250 (257)
T ss_pred CCccccCHHHHHHHHHHhccCcccCCCHHH
Confidence 223345678999999999999999999843
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=304.37 Aligned_cols=245 Identities=26% Similarity=0.405 Sum_probs=192.4
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC-----CchhHHHHHHHHHhcCCCceeeEecccC----Cce
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-----GPSEFQQEIDILSKIRHPNLVTLVGACP----EVW 532 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~-----~~~~f~~Ei~iL~~l~HpnIv~L~g~~~----~~~ 532 (824)
.+|...+.||+|+||.||+|... +..||+|.+...... ....+.+|+.+++.++||||+++++++. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 47888999999999999999864 578999988654321 1235888999999999999999999873 357
Q ss_pred EEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccc
Q 003384 533 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 612 (824)
Q Consensus 533 ~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~ 612 (824)
+++|||+++++|.+++.. ...+++.....++.+++.||.|||. .+|+||||||+||+++.++.+||+|||++..
T Consensus 82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 899999999999999853 3458899999999999999999998 7899999999999999999999999999886
Q ss_pred cccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCC
Q 003384 613 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDP 692 (824)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~ 692 (824)
+......... .....|+..|+|||++.+..++.++|||||||++|+|++|++||............. ..+
T Consensus 156 ~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~-----~~~ 225 (266)
T cd06651 156 LQTICMSGTG-----IRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIA-----TQP 225 (266)
T ss_pred cccccccCCc-----cccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHh-----cCC
Confidence 5432111100 123458999999999998889999999999999999999999997554332221111 111
Q ss_pred CCCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 693 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 693 ~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
.....|......+..++ +||..+|.+||++.+
T Consensus 226 ~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~e 257 (266)
T cd06651 226 TNPQLPSHISEHARDFL-GCIFVEARHRPSAEE 257 (266)
T ss_pred CCCCCchhcCHHHHHHH-HHhcCChhhCcCHHH
Confidence 12233444556777887 788899999999943
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=337.95 Aligned_cols=269 Identities=27% Similarity=0.458 Sum_probs=215.7
Q ss_pred ccCCCChhhHhhhcCC---------CCccceeeecCceEEEEEEEC--C---eEEEEEEecCCCC-CCchhHHHHHHHHH
Q 003384 450 FFSDFSFSEIEGATHN---------FDPSLKIGEGGYGSIYKGLLR--H---MQVAIKMLHPHSL-QGPSEFQQEIDILS 514 (824)
Q Consensus 450 ~~~~~~~~ei~~~~~~---------f~~~~~LG~G~fG~Vykg~~~--~---~~VAvK~l~~~~~-~~~~~f~~Ei~iL~ 514 (824)
....+++++-..+... ..+.++||.|.||+||+|.++ + ..||||.++.... ....+|..|+.||.
T Consensus 606 YiDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMG 685 (996)
T KOG0196|consen 606 YIDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMG 685 (996)
T ss_pred ecCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcc
Confidence 3344555554444333 345678999999999999876 2 5699999987533 33567999999999
Q ss_pred hcCCCceeeEecccC--CceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCC
Q 003384 515 KIRHPNLVTLVGACP--EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPA 592 (824)
Q Consensus 515 ~l~HpnIv~L~g~~~--~~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~ 592 (824)
+++||||++|.|+.. ....||.|||++|+|+.+|..++ +.|++.+..-++.+||.|+.||-. +++|||||...
T Consensus 686 QFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAAR 760 (996)
T KOG0196|consen 686 QFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAAR 760 (996)
T ss_pred cCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhh
Confidence 999999999999884 45789999999999999997554 559999999999999999999999 89999999999
Q ss_pred cEEecCCCcceeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCC
Q 003384 593 NILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPAL 671 (824)
Q Consensus 593 NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf 671 (824)
|||++.|..+|++||||++.+.++... ...+ .+..-..+|.|||.+....++.++|||||||||||.++ |..|+
T Consensus 761 NILVNsnLvCKVsDFGLSRvledd~~~-~ytt----~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPY 835 (996)
T KOG0196|consen 761 NILVNSNLVCKVSDFGLSRVLEDDPEA-AYTT----LGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 835 (996)
T ss_pred heeeccceEEEeccccceeecccCCCc-cccc----cCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcc
Confidence 999999999999999999988665411 1111 22334679999999999999999999999999999886 88887
Q ss_pred CCc-h-HHHHHHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhh
Q 003384 672 GIT-K-EVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 737 (824)
Q Consensus 672 ~~~-~-~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~~ 737 (824)
... + ++-.++++| ...+-|.+++..|.+|++.||+++..+||.+ ..++..|+.+.+.
T Consensus 836 WdmSNQdVIkaIe~g--------yRLPpPmDCP~aL~qLMldCWqkdR~~RP~F-~qiV~~lDklIrn 894 (996)
T KOG0196|consen 836 WDMSNQDVIKAIEQG--------YRLPPPMDCPAALYQLMLDCWQKDRNRRPKF-AQIVSTLDKLIRN 894 (996)
T ss_pred cccchHHHHHHHHhc--------cCCCCCCCCcHHHHHHHHHHHHHHhhcCCCH-HHHHHHHHHHhcC
Confidence 533 2 233333332 3344578889999999999999999999999 6777888877553
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=308.61 Aligned_cols=253 Identities=24% Similarity=0.415 Sum_probs=200.4
Q ss_pred CCCCccceeeecCceEEEEEEEC--C----eEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccC-CceEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--H----MQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLV 535 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~----~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~L~g~~~-~~~~LV 535 (824)
.+|...+.||+|+||.||+|.+. + ..||+|.+...... ....+.+|+.+++.++||||++++++|. ...++|
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v 86 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLSSQVQLI 86 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCceEEE
Confidence 35778889999999999999864 2 35899988655332 2356889999999999999999999884 568899
Q ss_pred EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccc
Q 003384 536 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 615 (824)
Q Consensus 536 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~ 615 (824)
|||+++|+|.+++... ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 87 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 87 TQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 9999999999998532 3458999999999999999999999 8999999999999999999999999999987653
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHH--HHHhhhccccccCC
Q 003384 616 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--YALDTGKLKNLLDP 692 (824)
Q Consensus 616 ~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~--~~~~~~~~~~~ld~ 692 (824)
..... ......++..|+|||.+....++.++|||||||++|||+| |++||....... ..+..+
T Consensus 162 ~~~~~------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-------- 227 (279)
T cd05057 162 DEKEY------HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKG-------- 227 (279)
T ss_pred cccce------ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC--------
Confidence 22110 0112234678999999988899999999999999999999 999997654322 111111
Q ss_pred CCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHh
Q 003384 693 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 736 (824)
Q Consensus 693 ~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~ 736 (824)
.....|...+..+.+++.+||..+|..||++ ..+.+.|..+..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~-~~l~~~l~~~~~ 270 (279)
T cd05057 228 ERLPQPPICTIDVYMVLVKCWMIDAESRPTF-KELINEFSKMAR 270 (279)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhhCCCH-HHHHHHHHHHHh
Confidence 1112233455689999999999999999999 667777777643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=311.32 Aligned_cols=245 Identities=28% Similarity=0.409 Sum_probs=192.7
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEeccc--CCceEEEEEec
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 539 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~Ey~ 539 (824)
+|+..+.||+|+||.||++.+. +..||+|.+..... .....+.+|+.++++++||||+++++++ ....++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 5778889999999999999886 68899998865321 1235688999999999999999999987 45688999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccccc
Q 003384 540 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 619 (824)
Q Consensus 540 ~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 619 (824)
++++|..++........+++..+..++.+++.||.|||.. .+|+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 157 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL-- 157 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc--
Confidence 9999998885433344789999999999999999999962 479999999999999999999999999987553221
Q ss_pred CCCccccccCCCCCCcccCChhhhccC------CCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCC
Q 003384 620 SNNTTLCCRTDPKGTFAYMDPEFLASG------ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPL 693 (824)
Q Consensus 620 ~~~~~~~~~~~~~GT~~Y~APE~l~~~------~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~ 693 (824)
.....|++.|+|||.+.+. .++.++|||||||++|+|++|+.||......... ..+.......
T Consensus 158 --------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~ 226 (286)
T cd06622 158 --------AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIF---AQLSAIVDGD 226 (286)
T ss_pred --------cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHH---HHHHHHhhcC
Confidence 1234588899999998554 3578999999999999999999999643321110 0111111112
Q ss_pred CCCCChhhHHHHHHHHHHHhhhccCCCCChH
Q 003384 694 AGDWPFVQAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 694 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
....+...+..+.+++.+||+.+|.+||++.
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ 257 (286)
T cd06622 227 PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYA 257 (286)
T ss_pred CCCCCcccCHHHHHHHHHHcccCcccCCCHH
Confidence 2223445677899999999999999999994
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=313.47 Aligned_cols=193 Identities=25% Similarity=0.404 Sum_probs=156.6
Q ss_pred ceeeecCceEEEEEEECC----eEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc----CCceEEEEEecCC
Q 003384 470 LKIGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC----PEVWTLVYEYLPN 541 (824)
Q Consensus 470 ~~LG~G~fG~Vykg~~~~----~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~----~~~~~LV~Ey~~g 541 (824)
.+||+|+||.||+|...+ ..||+|.+.... ....+.+|+.+|+.++||||+++++++ ....++||||+.+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 579999999999998642 679999886543 234688999999999999999999987 2357899999864
Q ss_pred CChhhhhhcc------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEe----cCCCcceeecccccc
Q 003384 542 GSLEDRLSCK------DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL----DANFVSKLSDFGISR 611 (824)
Q Consensus 542 gsL~~~L~~~------~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILl----d~~~~vKL~DFGla~ 611 (824)
+|.+++... .....+++..+..++.|++.||.|||+ ++|+||||||+|||+ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 777766321 123358899999999999999999999 899999999999999 567899999999998
Q ss_pred ccccccccCCCccccccCCCCCCcccCChhhhccC-CCCcchhHHhHHHHHHHHHhCCCCCCC
Q 003384 612 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGI 673 (824)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDVwSlGvvL~ELltG~~Pf~~ 673 (824)
.+........ ......||+.|+|||++.+. .++.++|||||||++|||+||++||..
T Consensus 161 ~~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 161 LFNSPLKPLA-----DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred ccCCCccccc-----ccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 7643321111 11334689999999998764 589999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=328.27 Aligned_cols=245 Identities=22% Similarity=0.297 Sum_probs=188.1
Q ss_pred CCCCccceeeecCceEEEEEEEC----CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR----HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE 537 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~----~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~E 537 (824)
.+|.....||.|+||.||++... +..||+|.+... ..+.+|+.+|+.++||||+++++++. ...++|||
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP 166 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence 46899999999999999998764 367999987542 24678999999999999999999884 46889999
Q ss_pred ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccc
Q 003384 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 617 (824)
Q Consensus 538 y~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 617 (824)
|+. ++|.+++. ....+++..++.|+.||+.||.|||. +|||||||||+|||++.++.+||+|||+++.+....
T Consensus 167 ~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 167 KYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred hcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 995 68888883 34579999999999999999999999 899999999999999999999999999997654332
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchH------HHHHHhh-h--c---
Q 003384 618 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE------VQYALDT-G--K--- 685 (824)
Q Consensus 618 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~------~~~~~~~-~--~--- 685 (824)
.... .....||+.|+|||++.+..|+.++|||||||+||||++|+.||..... ....... + .
T Consensus 240 ~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~ 313 (392)
T PHA03207 240 DTPQ------CYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEF 313 (392)
T ss_pred cccc------ccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCcccc
Confidence 1111 1235699999999999999999999999999999999999999854321 1000000 0 0
Q ss_pred -----------cccccCCCCCCCC-------hhhHHHHHHHHHHHhhhccCCCCChHHH
Q 003384 686 -----------LKNLLDPLAGDWP-------FVQAEQLANLAMRCCEMSRKSRPELGKD 726 (824)
Q Consensus 686 -----------~~~~ld~~~~~~p-------~~~~~~l~~Li~~Cl~~~P~~RPt~~~~ 726 (824)
+..........++ ...+.++.+++.+||..+|++||++.+.
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~ 372 (392)
T PHA03207 314 PQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDI 372 (392)
T ss_pred CCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHH
Confidence 0000000000010 1234578899999999999999999443
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=302.51 Aligned_cols=245 Identities=25% Similarity=0.417 Sum_probs=196.4
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHHhcCCCceeeEecccCC--ceEEEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVYE 537 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~~--~~~LV~E 537 (824)
.+|++...||+|.|+.||+.... |+.+|+|+++.... .+.+++.+|+.|.+.|+||||++|.....+ ..|||+|
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe 90 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 90 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence 35777788999999999987654 67889988865432 345679999999999999999999998743 5789999
Q ss_pred ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEec---CCCcceeeccccccccc
Q 003384 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD---ANFVSKLSDFGISRFLS 614 (824)
Q Consensus 538 y~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld---~~~~vKL~DFGla~~~~ 614 (824)
+|.|++|..-+..+ ..+++.....++.||+.+|.|+|. ++|||||+||.|+||. .+-.+||+|||+|..+.
T Consensus 91 ~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 91 LVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred cccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 99999997666433 457778888999999999999999 8999999999999995 34578999999999776
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCC
Q 003384 615 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 694 (824)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~ 694 (824)
... . ..+.+|||+|||||++...+|+..+|||+.|||||-|+.|++||.+..... +.++....-+|...
T Consensus 165 ~g~--~-------~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r--lye~I~~g~yd~~~ 233 (355)
T KOG0033|consen 165 DGE--A-------WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR--LYEQIKAGAYDYPS 233 (355)
T ss_pred Ccc--c-------cccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH--HHHHHhccccCCCC
Confidence 221 1 145679999999999999999999999999999999999999997633211 22222333334444
Q ss_pred CCCChhhHHHHHHHHHHHhhhccCCCCChHHH
Q 003384 695 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKD 726 (824)
Q Consensus 695 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~ 726 (824)
..|+ ..+++..+|+.+||..||.+|.|..+.
T Consensus 234 ~~w~-~is~~Ak~LvrrML~~dP~kRIta~EA 264 (355)
T KOG0033|consen 234 PEWD-TVTPEAKSLIRRMLTVNPKKRITADEA 264 (355)
T ss_pred cccC-cCCHHHHHHHHHHhccChhhhccHHHH
Confidence 4554 456789999999999999999997443
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=310.23 Aligned_cols=235 Identities=26% Similarity=0.397 Sum_probs=183.0
Q ss_pred eeeecCceEEEEEEECC---------eEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEec
Q 003384 471 KIGEGGYGSIYKGLLRH---------MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL 539 (824)
Q Consensus 471 ~LG~G~fG~Vykg~~~~---------~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey~ 539 (824)
.||.|+||.||+|.... ..||+|.+........+.+..|+.+++.++||||+++++++. +..++||||+
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYV 81 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecC
Confidence 59999999999997642 348888876544333457889999999999999999999883 5688999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCc--------ceeecccccc
Q 003384 540 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV--------SKLSDFGISR 611 (824)
Q Consensus 540 ~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~--------vKL~DFGla~ 611 (824)
++|+|.+++... ...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++. +|++|||++.
T Consensus 82 ~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 82 KFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred CCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 999999998543 3368899999999999999999999 89999999999999987765 5899999876
Q ss_pred ccccccccCCCccccccCCCCCCcccCChhhhcc-CCCCcchhHHhHHHHHHHHHhC-CCCCCCchHHHHHHhhhccccc
Q 003384 612 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTG-RPALGITKEVQYALDTGKLKNL 689 (824)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDVwSlGvvL~ELltG-~~Pf~~~~~~~~~~~~~~~~~~ 689 (824)
..... ....|++.|+|||++.+ ..++.++|||||||++|+|++| .+||..............
T Consensus 157 ~~~~~------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~---- 220 (258)
T cd05078 157 TVLPK------------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYED---- 220 (258)
T ss_pred ccCCc------------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHc----
Confidence 44321 12347889999999976 4588999999999999999998 467654433221111100
Q ss_pred cCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHH
Q 003384 690 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVL 731 (824)
Q Consensus 690 ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L 731 (824)
....|......+.+|+.+||+.+|.+||++ +++++.|
T Consensus 221 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-~~il~~l 257 (258)
T cd05078 221 ----RHQLPAPKWTELANLINQCMDYEPDFRPSF-RAIIRDL 257 (258)
T ss_pred ----cccCCCCCcHHHHHHHHHHhccChhhCCCH-HHHHHhc
Confidence 112233344689999999999999999999 5555544
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=304.08 Aligned_cols=244 Identities=24% Similarity=0.368 Sum_probs=192.7
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC-----CchhHHHHHHHHHhcCCCceeeEecccCC----ce
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-----GPSEFQQEIDILSKIRHPNLVTLVGACPE----VW 532 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~-----~~~~f~~Ei~iL~~l~HpnIv~L~g~~~~----~~ 532 (824)
.+|...+.||+|+||.||+|... +..||||.+...... ....+.+|+.++++++||||+++++++.+ .+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46888899999999999999875 578999988643211 12467889999999999999999998743 46
Q ss_pred EEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccc
Q 003384 533 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 612 (824)
Q Consensus 533 ~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~ 612 (824)
++||||+++++|.+++.. ...+++.....++.+++.||.|||+ .+++|+||||+|||++.++.+||+|||++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS---YGALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCccccc
Confidence 799999999999999853 2457888999999999999999999 8899999999999999999999999999886
Q ss_pred cccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCC
Q 003384 613 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDP 692 (824)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~ 692 (824)
.......... .....|+..|+|||.+.+..++.++|||||||++|+|++|++||............ ...+
T Consensus 156 ~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~-----~~~~ 225 (265)
T cd06652 156 LQTICLSGTG-----MKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKI-----ATQP 225 (265)
T ss_pred cccccccccc-----cccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHH-----hcCC
Confidence 5432111110 12345899999999998888999999999999999999999999755333222111 1112
Q ss_pred CCCCCChhhHHHHHHHHHHHhhhccCCCCChH
Q 003384 693 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 693 ~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
.....|......+.+++.+|+. +|.+||++.
T Consensus 226 ~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~ 256 (265)
T cd06652 226 TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSAD 256 (265)
T ss_pred CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHH
Confidence 2233455566788999999995 999999983
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=310.06 Aligned_cols=245 Identities=27% Similarity=0.381 Sum_probs=194.7
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEec
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL 539 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey~ 539 (824)
.+|.+.+.||.|+||.||+|.+. +..||+|.+..........|..|+.++++++||||+++++.+. ...++||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 46888889999999999999875 5789999987654444557889999999999999999999884 4688999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccccc
Q 003384 540 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 619 (824)
Q Consensus 540 ~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 619 (824)
++++|.+++... ..++++..+..++.+++.||.|||+ ++|+||||||+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~- 158 (280)
T cd06611 85 DGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ- 158 (280)
T ss_pred CCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhccccc-
Confidence 999999988532 3468999999999999999999999 8999999999999999999999999999875432211
Q ss_pred CCCccccccCCCCCCcccCChhhhc-----cCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCC
Q 003384 620 SNNTTLCCRTDPKGTFAYMDPEFLA-----SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 694 (824)
Q Consensus 620 ~~~~~~~~~~~~~GT~~Y~APE~l~-----~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~ 694 (824)
......||+.|+|||++. +..++.++|||||||++|+|++|++||............. ....+ .
T Consensus 159 -------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~~-~ 227 (280)
T cd06611 159 -------KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKIL---KSEPP-T 227 (280)
T ss_pred -------ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHh---cCCCC-C
Confidence 112345899999999975 3457789999999999999999999997654332221111 10001 1
Q ss_pred CCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 695 GDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 695 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
...+...+..+.+++.+||+.+|.+||++.+
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 258 (280)
T cd06611 228 LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAE 258 (280)
T ss_pred cCCcccCCHHHHHHHHHHhccChhhCcCHHH
Confidence 1123344568999999999999999999943
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=313.31 Aligned_cols=246 Identities=25% Similarity=0.362 Sum_probs=190.5
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEeccc--CCceEEEEEec
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 539 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~Ey~ 539 (824)
+|...+.||+|+||.||++.+. +..+|+|.+...... ....+.+|++++++++||||++++++| .+..++||||+
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~ 81 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHM 81 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeecc
Confidence 6888899999999999999875 467899988654221 134588999999999999999999988 45789999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccccc
Q 003384 540 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 619 (824)
Q Consensus 540 ~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 619 (824)
++++|.+++.. ...+++..+..++.+++.||.|||+. .+++||||||.|||++.++.+||+|||++.......
T Consensus 82 ~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 154 (308)
T cd06615 82 DGGSLDQVLKK---AGRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 154 (308)
T ss_pred CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCcccccccc--
Confidence 99999999853 35688999999999999999999972 379999999999999999999999999987543221
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhcccc-cc--------
Q 003384 620 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKN-LL-------- 690 (824)
Q Consensus 620 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~-~l-------- 690 (824)
.....|+..|+|||++.+..++.++|||||||++|+|+||+.||............+.... ..
T Consensus 155 --------~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (308)
T cd06615 155 --------ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPV 226 (308)
T ss_pred --------cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccc
Confidence 1234589999999999888899999999999999999999999964332111100000000 00
Q ss_pred ---------------------CCCCCCCC-hhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 691 ---------------------DPLAGDWP-FVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 691 ---------------------d~~~~~~p-~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
.......| ...+..+.+|+.+||..+|.+||++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ 283 (308)
T cd06615 227 SGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKE 283 (308)
T ss_pred cCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHH
Confidence 00000001 123567999999999999999999843
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=308.21 Aligned_cols=256 Identities=27% Similarity=0.369 Sum_probs=200.6
Q ss_pred CChhhHhhhcCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhc-CCCceeeEecccC-
Q 003384 454 FSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGACP- 529 (824)
Q Consensus 454 ~~~~ei~~~~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l-~HpnIv~L~g~~~- 529 (824)
+.+.++..++++|.....||+|+||.||+|... +..+|+|++.... .....+.+|+.++.++ +||||++++++|.
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 455677788899999999999999999999874 5789999986532 2245678899999999 8999999999873
Q ss_pred ------CceEEEEEecCCCChhhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcc
Q 003384 530 ------EVWTLVYEYLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS 602 (824)
Q Consensus 530 ------~~~~LV~Ey~~ggsL~~~L~~~-~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~v 602 (824)
...++||||+++|+|.+++... .....+++..+..++.+++.||.|||. .+++||||||+||+++.++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCE
Confidence 2478999999999999988532 234568999999999999999999999 899999999999999999999
Q ss_pred eeeccccccccccccccCCCccccccCCCCCCcccCChhhhccC-----CCCcchhHHhHHHHHHHHHhCCCCCCCchHH
Q 003384 603 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-----ELTPKSDVYSFGIILLRLLTGRPALGITKEV 677 (824)
Q Consensus 603 KL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-----~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~ 677 (824)
||+|||++......... .....|+..|+|||++... .++.++|||||||++|+|++|++||......
T Consensus 168 kl~dfg~~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~ 239 (291)
T cd06639 168 KLVDFGVSAQLTSTRLR--------RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV 239 (291)
T ss_pred EEeecccchhccccccc--------ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH
Confidence 99999998865432211 1234589999999998653 3688999999999999999999999765433
Q ss_pred HHHHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 678 QYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 678 ~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
........ . ..+ ....+......+.+++.+||+.+|.+||++.+
T Consensus 240 ~~~~~~~~--~-~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 283 (291)
T cd06639 240 KTLFKIPR--N-PPP-TLLHPEKWCRSFNHFISQCLIKDFEARPSVTH 283 (291)
T ss_pred HHHHHHhc--C-CCC-CCCcccccCHHHHHHHHHHhhcChhhCcCHHH
Confidence 22211100 0 000 00112234457999999999999999999943
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=306.94 Aligned_cols=244 Identities=35% Similarity=0.528 Sum_probs=191.0
Q ss_pred CCccceeeecCceEEEEEEECC--eEEEEEEecCCCCCCch--hHHHHHHHHHhcCCCceeeEeccc--CCceEEEEEec
Q 003384 466 FDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPS--EFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 539 (824)
Q Consensus 466 f~~~~~LG~G~fG~Vykg~~~~--~~VAvK~l~~~~~~~~~--~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~Ey~ 539 (824)
|+..+.||+|+||+||++...+ ..||+|++......... ...+|+.+++.++||||+++++++ ....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 5567899999999999999874 57999999876432221 234599999999999999999988 45688999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccccc
Q 003384 540 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 619 (824)
Q Consensus 540 ~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 619 (824)
++++|.+++. ....+++..+..++.+++.||.+||+ ++|+|+||||+|||++.++.++|+|||++........
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~- 153 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNE- 153 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTS-
T ss_pred cccccccccc---cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc-
Confidence 9999999995 34568999999999999999999999 8999999999999999999999999999875411110
Q ss_pred CCCccccccCCCCCCcccCChhhhc-cCCCCcchhHHhHHHHHHHHHhCCCCCCCch--HHHHHHhhhccccccCCCCCC
Q 003384 620 SNNTTLCCRTDPKGTFAYMDPEFLA-SGELTPKSDVYSFGIILLRLLTGRPALGITK--EVQYALDTGKLKNLLDPLAGD 696 (824)
Q Consensus 620 ~~~~~~~~~~~~~GT~~Y~APE~l~-~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~--~~~~~~~~~~~~~~ld~~~~~ 696 (824)
......||..|+|||++. +..++.++||||||+++|+|++|..||.... ...................
T Consensus 154 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-- 224 (260)
T PF00069_consen 154 -------NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQ-- 224 (260)
T ss_dssp -------EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTT--
T ss_pred -------ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccccc--
Confidence 113456899999999998 7889999999999999999999999998652 1111111111111100000
Q ss_pred CChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 697 WPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 697 ~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
........+.+++.+||+.+|.+||++.+
T Consensus 225 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~ 253 (260)
T PF00069_consen 225 QSREKSEELRDLIKKMLSKDPEQRPSAEE 253 (260)
T ss_dssp SHTTSHHHHHHHHHHHSSSSGGGSTTHHH
T ss_pred ccchhHHHHHHHHHHHccCChhHCcCHHH
Confidence 01112378999999999999999999843
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=319.89 Aligned_cols=243 Identities=21% Similarity=0.319 Sum_probs=187.3
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHHhcCCCceeeEecccC--------C
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP--------E 530 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--------~ 530 (824)
..+|...+.||.|+||.||+|... +..||||++..... .....+.+|+.+|+.++||||+++++++. .
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 357888899999999999999875 47899999865321 22345778999999999999999998773 2
Q ss_pred ceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccc
Q 003384 531 VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS 610 (824)
Q Consensus 531 ~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla 610 (824)
..+++++++ +++|.+++. ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 94 ~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~ 165 (343)
T cd07878 94 EVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLA 165 (343)
T ss_pred cEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCccc
Confidence 368999988 789988773 2458999999999999999999999 89999999999999999999999999999
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhcc-CCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhh----hc
Q 003384 611 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT----GK 685 (824)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~----~~ 685 (824)
+...... ....||+.|+|||++.+ ..++.++|||||||++|+|++|++||............ +.
T Consensus 166 ~~~~~~~-----------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 234 (343)
T cd07878 166 RQADDEM-----------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGT 234 (343)
T ss_pred eecCCCc-----------CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCC
Confidence 8653221 23458999999999877 57899999999999999999999999754432211100 00
Q ss_pred -------------cccccCCCCCCCC--------hhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 686 -------------LKNLLDPLAGDWP--------FVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 686 -------------~~~~ld~~~~~~p--------~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
....+... ...+ ......+.+|+.+||+.+|.+||++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~e 294 (343)
T cd07878 235 PSPEVLKKISSEHARKYIQSL-PHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASE 294 (343)
T ss_pred CCHHHHHhcchhhHHHHhhcc-ccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHH
Confidence 00000000 0000 112345789999999999999999843
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=301.50 Aligned_cols=243 Identities=29% Similarity=0.467 Sum_probs=191.9
Q ss_pred eeeecCceEEEEEEEC-CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEecCCCChhh
Q 003384 471 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNGSLED 546 (824)
Q Consensus 471 ~LG~G~fG~Vykg~~~-~~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey~~ggsL~~ 546 (824)
+||.|+||.||++.+. ++.||+|.+...... ....+.+|++++++++||||+++++++. ...++||||+++++|.+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~ 81 (251)
T cd05041 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLT 81 (251)
T ss_pred ccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHH
Confidence 6999999999999876 688999988764332 3457899999999999999999999884 45889999999999999
Q ss_pred hhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCCCcccc
Q 003384 547 RLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLC 626 (824)
Q Consensus 547 ~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~ 626 (824)
++... ...+++..+..++.+++.||.|||. ++++||||||+|||++.++.+||+|||++...........
T Consensus 82 ~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~----- 151 (251)
T cd05041 82 FLRKK--KNRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVS----- 151 (251)
T ss_pred HHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceec-----
Confidence 98543 3368889999999999999999999 8999999999999999999999999999876542211110
Q ss_pred ccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHHHHhhhccccccCCCCCCCChhhHHHH
Q 003384 627 CRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQL 705 (824)
Q Consensus 627 ~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l 705 (824)
.....++..|+|||.+.++.++.++|||||||++|+|+| |.+||............ .. ......+...+..+
T Consensus 152 -~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~---~~---~~~~~~~~~~~~~~ 224 (251)
T cd05041 152 -DGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERI---ES---GYRMPAPQLCPEEI 224 (251)
T ss_pred -cccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHH---hc---CCCCCCCccCCHHH
Confidence 011234677999999988899999999999999999999 88998654432211111 00 00112234456789
Q ss_pred HHHHHHHhhhccCCCCChHHHHHHHH
Q 003384 706 ANLAMRCCEMSRKSRPELGKDVWRVL 731 (824)
Q Consensus 706 ~~Li~~Cl~~~P~~RPt~~~~v~~~L 731 (824)
.+++.+|+..+|.+||++ .++++.|
T Consensus 225 ~~li~~~l~~~p~~Rp~~-~ell~~l 249 (251)
T cd05041 225 YRLMLQCWAYDPENRPSF-SEIYNEL 249 (251)
T ss_pred HHHHHHHhccChhhCcCH-HHHHHHh
Confidence 999999999999999999 6665555
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=322.06 Aligned_cols=258 Identities=28% Similarity=0.480 Sum_probs=205.2
Q ss_pred CCCccceeeecCceEEEEEEECC-eEEEEEEecCCCCCCc-hhHHHHHHHHHhcCCCceeeEeccc--CCceEEEEEecC
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGP-SEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLP 540 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~~-~~VAvK~l~~~~~~~~-~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~Ey~~ 540 (824)
...+.++||+|-||+|......+ ..||||+++.....+. ..|.+|+.+|.+|+|||||+|+|+| ++..++|+||++
T Consensus 539 ~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmE 618 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYME 618 (807)
T ss_pred heehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHh
Confidence 34556789999999999998887 8999999998765554 7899999999999999999999999 567889999999
Q ss_pred CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccC
Q 003384 541 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 620 (824)
Q Consensus 541 ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 620 (824)
+|+|..+|..... +.+......+|+.||+.|++||.+ .++|||||.+.|+|+|.++++||+|||+++.+.......
T Consensus 619 nGDLnqFl~ahea-pt~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~ 694 (807)
T KOG1094|consen 619 NGDLNQFLSAHEL-PTAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYR 694 (807)
T ss_pred cCcHHHHHHhccC-cccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCcccccccccCCcee
Confidence 9999999965422 224555677899999999999999 679999999999999999999999999999665554322
Q ss_pred CCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh--CCCCCCCchHHHHHHhhhccccccC-CCCCCC
Q 003384 621 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGITKEVQYALDTGKLKNLLD-PLAGDW 697 (824)
Q Consensus 621 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt--G~~Pf~~~~~~~~~~~~~~~~~~ld-~~~~~~ 697 (824)
. .+..+-.+.|||||.+..++++.++|||+||++|||+++ ...||.....-+..-+.+.+..--. ......
T Consensus 695 v------qgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~ 768 (807)
T KOG1094|consen 695 V------QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSR 768 (807)
T ss_pred e------ecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccC
Confidence 1 133455789999999999999999999999999999875 7788864433222222222211111 122345
Q ss_pred ChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHH
Q 003384 698 PFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP 733 (824)
Q Consensus 698 p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~ 733 (824)
|..++..+.+++++||..+-.+||++ +.+...|..
T Consensus 769 P~~cp~~lyelml~Cw~~es~~RPsF-e~lh~~lq~ 803 (807)
T KOG1094|consen 769 PPACPQGLYELMLRCWRRESEQRPSF-EQLHLFLQE 803 (807)
T ss_pred CCcCcHHHHHHHHHHhchhhhcCCCH-HHHHHHHHH
Confidence 67778899999999999999999999 566555543
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=309.90 Aligned_cols=241 Identities=27% Similarity=0.399 Sum_probs=192.5
Q ss_pred CCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEecC
Q 003384 466 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLP 540 (824)
Q Consensus 466 f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey~~ 540 (824)
|...+.||.|+||.||+|.+. +..||+|.+..... .....+.+|+.+++.++||||++++++|. ...++||||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 556677999999999999875 57899999875432 22346889999999999999999999884 46899999999
Q ss_pred CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccC
Q 003384 541 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 620 (824)
Q Consensus 541 ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 620 (824)
+++|.+++. ..++++..+..++.+++.||.|||+ ++++|+||+|+||+++.++.+||+|||++..+.....
T Consensus 86 ~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-- 156 (277)
T cd06642 86 GGSALDLLK----PGPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-- 156 (277)
T ss_pred CCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcch--
Confidence 999999884 2468899999999999999999999 8999999999999999999999999999876543211
Q ss_pred CCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCChh
Q 003384 621 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV 700 (824)
Q Consensus 621 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~ 700 (824)
......|+..|+|||++.+..++.++|||||||++|||+||++||........... .........+..
T Consensus 157 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~------~~~~~~~~~~~~ 224 (277)
T cd06642 157 ------KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFL------IPKNSPPTLEGQ 224 (277)
T ss_pred ------hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhh------hhcCCCCCCCcc
Confidence 11234588999999999988899999999999999999999999964332211110 001111122334
Q ss_pred hHHHHHHHHHHHhhhccCCCCChHHHH
Q 003384 701 QAEQLANLAMRCCEMSRKSRPELGKDV 727 (824)
Q Consensus 701 ~~~~l~~Li~~Cl~~~P~~RPt~~~~v 727 (824)
.+..+.+++.+||+.+|.+||++.+.+
T Consensus 225 ~~~~~~~li~~~l~~~p~~Rp~~~~il 251 (277)
T cd06642 225 YSKPFKEFVEACLNKDPRFRPTAKELL 251 (277)
T ss_pred cCHHHHHHHHHHccCCcccCcCHHHHH
Confidence 567899999999999999999995444
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=311.58 Aligned_cols=258 Identities=23% Similarity=0.255 Sum_probs=199.0
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC---CchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE 537 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~---~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~E 537 (824)
+|...+.||+|+||.||+|... +..||||.+...... ....+..|+++++.++||||+++++.+. ...++|||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 5788889999999999999885 588999998765433 2346889999999999999999999874 46789999
Q ss_pred ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccc
Q 003384 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 617 (824)
Q Consensus 538 y~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 617 (824)
|+.|++|.+++... ....+++..+..++.|++.||.|||. .+++||||||+|||++.++.++|+|||++.......
T Consensus 82 ~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 82 YCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred ecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 99999999988532 34568999999999999999999999 899999999999999999999999999987553321
Q ss_pred ccCCCc---------------------cccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchH
Q 003384 618 ISSNNT---------------------TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE 676 (824)
Q Consensus 618 ~~~~~~---------------------~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~ 676 (824)
...... .........||..|+|||++.+..++.++|||||||++|+|++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 110000 00011234689999999999988899999999999999999999999976543
Q ss_pred HHHHHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHH
Q 003384 677 VQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVL 731 (824)
Q Consensus 677 ~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L 731 (824)
........ .. ..........+..+.+++.+||..+|.+||+....+.++|
T Consensus 238 ~~~~~~~~--~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll 287 (316)
T cd05574 238 DETFSNIL--KK---EVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIK 287 (316)
T ss_pred HHHHHHHh--cC---CccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHH
Confidence 32211110 00 0000111125678999999999999999999644443333
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=324.07 Aligned_cols=232 Identities=25% Similarity=0.307 Sum_probs=180.4
Q ss_pred eeecCceEEEEEEEC--CeEEEEEEecCCCCC---CchhHHHHHHHHHhc---CCCceeeEecccC--CceEEEEEecCC
Q 003384 472 IGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKI---RHPNLVTLVGACP--EVWTLVYEYLPN 541 (824)
Q Consensus 472 LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~---~~~~f~~Ei~iL~~l---~HpnIv~L~g~~~--~~~~LV~Ey~~g 541 (824)
||+|+||+||+|... +..||||++...... ....+..|..++..+ +||||+++++.+. +..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999875 588999998643211 123455677777765 6999999999874 468999999999
Q ss_pred CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCC
Q 003384 542 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 621 (824)
Q Consensus 542 gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 621 (824)
|+|.+++.. ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.........
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~-- 152 (330)
T cd05586 81 GELFWHLQK---EGRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT-- 152 (330)
T ss_pred ChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCC--
Confidence 999998843 3568899999999999999999999 89999999999999999999999999998753322111
Q ss_pred CccccccCCCCCCcccCChhhhccC-CCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCC-h
Q 003384 622 NTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWP-F 699 (824)
Q Consensus 622 ~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p-~ 699 (824)
.....||+.|+|||++.+. .++.++|||||||+||+|+||+.||......... ........ .++ .
T Consensus 153 ------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~-~~i~~~~~------~~~~~ 219 (330)
T cd05586 153 ------TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMY-RNIAFGKV------RFPKN 219 (330)
T ss_pred ------ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHH-HHHHcCCC------CCCCc
Confidence 1234699999999998765 5899999999999999999999999765432211 11000000 111 1
Q ss_pred hhHHHHHHHHHHHhhhccCCCCChH
Q 003384 700 VQAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 700 ~~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
..+..+.+++.+||+.+|.+||+..
T Consensus 220 ~~~~~~~~li~~~L~~~P~~R~~~~ 244 (330)
T cd05586 220 VLSDEGRQFVKGLLNRNPQHRLGAH 244 (330)
T ss_pred cCCHHHHHHHHHHcCCCHHHCCCCC
Confidence 2456889999999999999999653
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=310.04 Aligned_cols=248 Identities=26% Similarity=0.381 Sum_probs=193.7
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEe
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY 538 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey 538 (824)
++|...+.||+|+||+||+|... +..||+|++..... .....+.+|+++++.++||||+++++++. ..+++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 35777889999999999999876 67899998865432 23457899999999999999999999884 468899999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccc
Q 003384 539 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 618 (824)
Q Consensus 539 ~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 618 (824)
+++|+|.+++.. ..++++.....++.+++.||.|||+. .+++||||||+||+++.++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~- 158 (284)
T cd06620 85 MDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI- 158 (284)
T ss_pred CCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence 999999998843 34689999999999999999999973 379999999999999999999999999986543221
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHH------HHHhhhccccccCC
Q 003384 619 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ------YALDTGKLKNLLDP 692 (824)
Q Consensus 619 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~------~~~~~~~~~~~ld~ 692 (824)
.....|+..|+|||++.+..++.++|||||||++|+|+||+.||....... ..+. ..+......
T Consensus 159 ---------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 228 (284)
T cd06620 159 ---------ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGIL-DLLQQIVQE 228 (284)
T ss_pred ---------cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHH-HHHHHHhhc
Confidence 023458999999999988899999999999999999999999997533210 0000 001111111
Q ss_pred CCCCCCh-hhHHHHHHHHHHHhhhccCCCCChHHHHH
Q 003384 693 LAGDWPF-VQAEQLANLAMRCCEMSRKSRPELGKDVW 728 (824)
Q Consensus 693 ~~~~~p~-~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~ 728 (824)
.....+. ..+..+.+|+.+|++.+|.+||++ +++.
T Consensus 229 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~-~e~~ 264 (284)
T cd06620 229 PPPRLPSSDFPEDLRDFVDACLLKDPTERPTP-QQLC 264 (284)
T ss_pred cCCCCCchhcCHHHHHHHHHHhcCCcccCcCH-HHHh
Confidence 1111111 245679999999999999999999 5554
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=305.29 Aligned_cols=247 Identities=28% Similarity=0.364 Sum_probs=191.3
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEe
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY 538 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey 538 (824)
+|+....||+|+||.||+|... +..||+|++..... ...+.+.+|+.+++.++||||+++++++. ...++||||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~ 81 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEY 81 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEec
Confidence 6788889999999999999886 57899998864322 22346789999999999999999999884 467899999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccc
Q 003384 539 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 618 (824)
Q Consensus 539 ~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 618 (824)
+++++|..++. ....+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 82 ~~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 82 CDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred cCccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 99998887763 23458999999999999999999999 8999999999999999999999999999987644321
Q ss_pred cCCCccccccCCCCCCcccCChhhhcc-CCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhc-ccc--------
Q 003384 619 SSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK-LKN-------- 688 (824)
Q Consensus 619 ~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~-~~~-------- 688 (824)
. .....++..|+|||++.+ ..++.++|||||||++|+|+||++||.............. ...
T Consensus 156 ~--------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd07847 156 D--------YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQI 227 (286)
T ss_pred c--------ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence 1 122357889999999876 4578999999999999999999999976543322111100 000
Q ss_pred ---------ccCCCCC-C-----CChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 689 ---------LLDPLAG-D-----WPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 689 ---------~ld~~~~-~-----~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
...+... . +....+..+.+|+.+||+.+|.+||++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e 279 (286)
T cd07847 228 FSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEE 279 (286)
T ss_pred cccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHH
Confidence 0000000 0 00123567899999999999999999943
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=299.72 Aligned_cols=245 Identities=31% Similarity=0.499 Sum_probs=194.5
Q ss_pred CccceeeecCceEEEEEEECC------eEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEE
Q 003384 467 DPSLKIGEGGYGSIYKGLLRH------MQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE 537 (824)
Q Consensus 467 ~~~~~LG~G~fG~Vykg~~~~------~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~E 537 (824)
.+...||.|+||.||++.... ..||+|++...... ....+..|+.++..++||||+++++++. ...++|||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 456789999999999998864 77999999765433 4567999999999999999999999884 46889999
Q ss_pred ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccc
Q 003384 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 617 (824)
Q Consensus 538 y~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 617 (824)
|+++++|.+++..... ..+++..+..++.+++.||.|||+ .+++||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 82 YMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred ccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 9999999999853321 128999999999999999999999 899999999999999999999999999998765442
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHHHHhhhccccccCCCCCC
Q 003384 618 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGD 696 (824)
Q Consensus 618 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~ 696 (824)
.... ....+++.|+|||.+.+..++.++|||||||++|+|++ |++||................ ...
T Consensus 158 ~~~~-------~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~------~~~ 224 (258)
T smart00219 158 YYKK-------KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGY------RLP 224 (258)
T ss_pred cccc-------ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC------CCC
Confidence 2111 12237889999999988889999999999999999998 899997543322111111100 111
Q ss_pred CChhhHHHHHHHHHHHhhhccCCCCChHHHHHH
Q 003384 697 WPFVQAEQLANLAMRCCEMSRKSRPELGKDVWR 729 (824)
Q Consensus 697 ~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~ 729 (824)
.+...+..+.+++.+|+..+|.+||++ .++.+
T Consensus 225 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~-~~ll~ 256 (258)
T smart00219 225 KPENCPPEIYKLMLQCWAEDPEDRPTF-SELVE 256 (258)
T ss_pred CCCcCCHHHHHHHHHHCcCChhhCcCH-HHHHh
Confidence 233356789999999999999999999 44543
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=304.92 Aligned_cols=253 Identities=24% Similarity=0.395 Sum_probs=195.0
Q ss_pred CCccceeeecCceEEEEEEEC-----CeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEecccCC--------
Q 003384 466 FDPSLKIGEGGYGSIYKGLLR-----HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACPE-------- 530 (824)
Q Consensus 466 f~~~~~LG~G~fG~Vykg~~~-----~~~VAvK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~L~g~~~~-------- 530 (824)
|...+.||+|+||.||+|.+. +..||||++...... ..+.+.+|+.+++.++||||+++++++..
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 455678999999999999863 467999998754322 24568899999999999999999997621
Q ss_pred ceEEEEEecCCCChhhhhhcc---CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecc
Q 003384 531 VWTLVYEYLPNGSLEDRLSCK---DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDF 607 (824)
Q Consensus 531 ~~~LV~Ey~~ggsL~~~L~~~---~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DF 607 (824)
..+++++|+.+|+|.+++... .....+++.....++.+++.||.|||+ ++|+||||||+|||++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECcc
Confidence 247899999999999887432 122357889999999999999999999 89999999999999999999999999
Q ss_pred ccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHHHHhhhcc
Q 003384 608 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKL 686 (824)
Q Consensus 608 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~~~~~~ 686 (824)
|+++.......... .....+++.|++||.+.+..++.++|||||||++|+|++ |++||...............
T Consensus 158 g~~~~~~~~~~~~~------~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 231 (273)
T cd05074 158 GLSKKIYSGDYYRQ------GCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG 231 (273)
T ss_pred cccccccCCcceec------CCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcC
Confidence 99986543221111 112345678999999998899999999999999999999 89999755432211111000
Q ss_pred ccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHH
Q 003384 687 KNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 734 (824)
Q Consensus 687 ~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l 734 (824)
. ....+...+..+.+++.+||+.+|.+||++ .+++..|+.+
T Consensus 232 ~------~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~-~~~~~~l~~~ 272 (273)
T cd05074 232 N------RLKQPPDCLEDVYELMCQCWSPEPKCRPSF-QHLRDQLELI 272 (273)
T ss_pred C------cCCCCCCCCHHHHHHHHHHcCCChhhCcCH-HHHHHHHHhh
Confidence 0 111223445689999999999999999999 7777777653
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=300.89 Aligned_cols=242 Identities=24% Similarity=0.344 Sum_probs=195.2
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCC--CCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEe
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS--LQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY 538 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~--~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey 538 (824)
+|+..+.||.|+||.||.+... +..+++|.+.... ......+.+|+.++++++||||+++++++. +..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 4788899999999988877654 5789999886543 223456889999999999999999999884 467899999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccc
Q 003384 539 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 618 (824)
Q Consensus 539 ~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 618 (824)
+++|+|.+++.... ...+++..+..++.+++.||.|||+ .+++||||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999986432 3568999999999999999999999 7899999999999999999999999999986643321
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHH--hhhccccccCCCCCC
Q 003384 619 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYAL--DTGKLKNLLDPLAGD 696 (824)
Q Consensus 619 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~--~~~~~~~~ld~~~~~ 696 (824)
. .....|++.|+|||++.+..++.++|||||||++|+|++|..||.......... ..+.. ..
T Consensus 157 ~--------~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~--------~~ 220 (256)
T cd08221 157 M--------AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNY--------TP 220 (256)
T ss_pred c--------ccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC--------CC
Confidence 1 123458999999999988888999999999999999999999997654322211 11111 11
Q ss_pred CChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 003384 697 WPFVQAEQLANLAMRCCEMSRKSRPELGKDV 727 (824)
Q Consensus 697 ~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 727 (824)
.+...+..+.+++.+||..+|.+||++ +++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~R~s~-~~l 250 (256)
T cd08221 221 VVSVYSSELISLVHSLLQQDPEKRPTA-DEV 250 (256)
T ss_pred CccccCHHHHHHHHHHcccCcccCCCH-HHH
Confidence 123445689999999999999999998 444
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=300.23 Aligned_cols=240 Identities=27% Similarity=0.429 Sum_probs=194.3
Q ss_pred CCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC-----CchhHHHHHHHHHhcCCCceeeEecccC--CceEEEE
Q 003384 466 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-----GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 536 (824)
Q Consensus 466 f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~-----~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~ 536 (824)
|...+.||+|+||.||+|... +..|++|.+...... ....+.+|+.+++.++||||+++++++. ...++||
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL 81 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence 566778999999999999885 688999998654321 2356889999999999999999999884 4688999
Q ss_pred EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccc
Q 003384 537 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 616 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 616 (824)
||+++++|.+++.. ..++++..+..++.+++.||.|||+ .+++|+||+|+||+++.++.+||+|||++......
T Consensus 82 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 82 ELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 99999999999843 3468899999999999999999999 89999999999999999999999999998865432
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCC-CCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCC
Q 003384 617 EISSNNTTLCCRTDPKGTFAYMDPEFLASGE-LTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG 695 (824)
Q Consensus 617 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~ 695 (824)
.. .....|++.|+|||.+.... ++.++|+|||||++|+|++|++||............+.... ..
T Consensus 156 ~~---------~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-----~~ 221 (258)
T cd06632 156 SF---------AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKE-----LP 221 (258)
T ss_pred cc---------ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhccc-----CC
Confidence 20 12345899999999987766 89999999999999999999999976554333322221111 11
Q ss_pred CCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 696 DWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 696 ~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
..+......+.+++.+||+.+|.+||++.+
T Consensus 222 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 251 (258)
T cd06632 222 PIPDHLSDEAKDFILKCLQRDPSLRPTAAE 251 (258)
T ss_pred CcCCCcCHHHHHHHHHHhhcCcccCcCHHH
Confidence 223345678999999999999999999843
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=305.60 Aligned_cols=241 Identities=26% Similarity=0.383 Sum_probs=194.3
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEec
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL 539 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey~ 539 (824)
.|+..+.||.|+||.||+|.+. +..||||++..... .....+.+|+.+++.++||||+++++++. ...++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4677788999999999999875 57899999875432 22456889999999999999999999884 4689999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccccc
Q 003384 540 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 619 (824)
Q Consensus 540 ~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 619 (824)
+||+|.+++. ..++++.....++.+++.||.|||+ ++++|+||+|+||+++.++.++|+|||++.........
T Consensus 85 ~~~~L~~~i~----~~~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06640 85 GGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred CCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCccc
Confidence 9999999884 2458889999999999999999999 89999999999999999999999999999765432211
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCCh
Q 003384 620 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPF 699 (824)
Q Consensus 620 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~ 699 (824)
.....|+..|+|||++.+..++.++|||||||++|+|+||.+||............ ........+.
T Consensus 158 --------~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~------~~~~~~~~~~ 223 (277)
T cd06640 158 --------RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI------PKNNPPTLTG 223 (277)
T ss_pred --------cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh------hcCCCCCCch
Confidence 12345889999999998888999999999999999999999999754332211110 0001122344
Q ss_pred hhHHHHHHHHHHHhhhccCCCCChHHH
Q 003384 700 VQAEQLANLAMRCCEMSRKSRPELGKD 726 (824)
Q Consensus 700 ~~~~~l~~Li~~Cl~~~P~~RPt~~~~ 726 (824)
..+..+.+++.+||+.+|.+||++.+.
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~i 250 (277)
T cd06640 224 EFSKPFKEFIDACLNKDPSFRPTAKEL 250 (277)
T ss_pred hhhHHHHHHHHHHcccCcccCcCHHHH
Confidence 567789999999999999999999433
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=310.25 Aligned_cols=241 Identities=25% Similarity=0.354 Sum_probs=192.0
Q ss_pred CCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--CCceEEEEEecCC
Q 003384 466 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPN 541 (824)
Q Consensus 466 f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~Ey~~g 541 (824)
|+....||.|+||.||+|... +..||||.+..........+.+|+.++..++||||++++++| .+..++||||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 334457999999999999874 688999998765444556788999999999999999999987 4568999999999
Q ss_pred CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCC
Q 003384 542 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 621 (824)
Q Consensus 542 gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 621 (824)
++|..++. ...+++..+..++.|++.||.|||+ ++++||||||+|||++.++.+||+|||++..+......
T Consensus 103 ~~L~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~-- 173 (297)
T cd06659 103 GALTDIVS----QTRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-- 173 (297)
T ss_pred CCHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhccccccc--
Confidence 99998873 2458899999999999999999999 88999999999999999999999999998755432111
Q ss_pred CccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCChhh
Q 003384 622 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQ 701 (824)
Q Consensus 622 ~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~ 701 (824)
.....|+..|+|||++.+..++.++|||||||++|||++|++||............. ....+. ...+...
T Consensus 174 ------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~---~~~~~~-~~~~~~~ 243 (297)
T cd06659 174 ------RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR---DSPPPK-LKNAHKI 243 (297)
T ss_pred ------ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh---ccCCCC-ccccCCC
Confidence 123458999999999998889999999999999999999999997554332211110 000111 1112234
Q ss_pred HHHHHHHHHHHhhhccCCCCChHH
Q 003384 702 AEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 702 ~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
+..+.+++.+||+.+|.+||++.+
T Consensus 244 ~~~l~~~i~~~l~~~P~~Rps~~~ 267 (297)
T cd06659 244 SPVLRDFLERMLTREPQERATAQE 267 (297)
T ss_pred CHHHHHHHHHHhcCCcccCcCHHH
Confidence 567899999999999999999843
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=300.56 Aligned_cols=252 Identities=25% Similarity=0.347 Sum_probs=198.2
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEeccc--CCceEEEEEe
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 538 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~Ey 538 (824)
++|+..+.||.|+||+||+|... +..+++|++..... .....+.+|+.+++.++||||+++++.+ .+..++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 36888899999999999999874 57899999865432 2456789999999999999999999987 4568899999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccc
Q 003384 539 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 618 (824)
Q Consensus 539 ~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 618 (824)
+++++|.+++........+++.....++.+++.||.|||+ .|++||||+|+||+++.++.+||+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 9999999999654333568999999999999999999999 8999999999999999999999999999987654332
Q ss_pred cCCCccccccCCCCCCcccCChhhhccC-CCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCC
Q 003384 619 SSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 697 (824)
Q Consensus 619 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~ 697 (824)
... .......|+..|+|||++... .++.++|||||||++|+|++|+.||............ ... ..+.....
T Consensus 158 ~~~----~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~--~~~-~~~~~~~~ 230 (267)
T cd06610 158 RTR----KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLT--LQN-DPPSLETG 230 (267)
T ss_pred ccc----cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHH--hcC-CCCCcCCc
Confidence 210 011334689999999998877 7889999999999999999999999755433211111 000 01111110
Q ss_pred --ChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 698 --PFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 698 --p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
....+..+.+++.+||..+|.+||++.+
T Consensus 231 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 260 (267)
T cd06610 231 ADYKKYSKSFRKMISLCLQKDPSKRPTAEE 260 (267)
T ss_pred cccccccHHHHHHHHHHcCCChhhCcCHHH
Confidence 1234578899999999999999999843
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=303.87 Aligned_cols=250 Identities=26% Similarity=0.441 Sum_probs=196.0
Q ss_pred CCCCccceeeecCceEEEEEEEC-------CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccCC--ceE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACPE--VWT 533 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~-------~~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~L~g~~~~--~~~ 533 (824)
.+|.....||.|+||.||+|... ...|++|.+...... ....+.+|+.++++++||||++++++|.+ ..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 46788889999999999999864 256999988654332 23578999999999999999999999854 688
Q ss_pred EEEEecCCCChhhhhhccCCC------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecc
Q 003384 534 LVYEYLPNGSLEDRLSCKDNS------PPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDF 607 (824)
Q Consensus 534 LV~Ey~~ggsL~~~L~~~~~~------~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DF 607 (824)
+||||+++|+|.+++...... ..+++..+..++.+++.||.|||+ .+|+||||||+|||++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998644321 268999999999999999999999 78999999999999999999999999
Q ss_pred ccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHH--HHhhh
Q 003384 608 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQY--ALDTG 684 (824)
Q Consensus 608 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~--~~~~~ 684 (824)
|++.......... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||........ ....+
T Consensus 162 ~~~~~~~~~~~~~-------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~ 234 (275)
T cd05046 162 SLSKDVYNSEYYK-------LRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAG 234 (275)
T ss_pred ccccccCcccccc-------cCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcC
Confidence 9987543221111 123346788999999988888999999999999999999 8889864332211 11111
Q ss_pred ccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHH
Q 003384 685 KLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVL 731 (824)
Q Consensus 685 ~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L 731 (824)
... ...+...+..+.+++.+||+.+|.+||++ .+++..|
T Consensus 235 ~~~-------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~-~~~l~~l 273 (275)
T cd05046 235 KLE-------LPVPEGCPSRLYKLMTRCWAVNPKDRPSF-SELVSAL 273 (275)
T ss_pred CcC-------CCCCCCCCHHHHHHHHHHcCCCcccCCCH-HHHHHHh
Confidence 111 01123345789999999999999999999 5565544
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=309.55 Aligned_cols=248 Identities=24% Similarity=0.330 Sum_probs=189.5
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEe
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY 538 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey 538 (824)
..|...+.||.|+||.||+|... +..||+|.+..... .....+.+|+.+++.++||||+++++++. ...++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 36888899999999999999875 57899999875432 22346789999999999999999999884 468899999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccc
Q 003384 539 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 618 (824)
Q Consensus 539 ~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 618 (824)
++ ++|.+++... ...+++..+..++.+++.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 86 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 86 LD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 97 5888887532 3468899999999999999999999 8999999999999999999999999999875432211
Q ss_pred cCCCccccccCCCCCCcccCChhhhccC-CCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhh---------cccc
Q 003384 619 SSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG---------KLKN 688 (824)
Q Consensus 619 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~---------~~~~ 688 (824)
. .....+++.|+|||++.+. .++.++|||||||++|+|+||++||............. .+..
T Consensus 160 ~--------~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (301)
T cd07873 160 T--------YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPG 231 (301)
T ss_pred c--------ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchh
Confidence 0 1233578999999998754 57889999999999999999999997554321110000 0000
Q ss_pred ccCC------CCC--------CCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 689 LLDP------LAG--------DWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 689 ~ld~------~~~--------~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
++.. ... ......+..+.+|+.+|++.+|.+||++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~e 282 (301)
T cd07873 232 ILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEE 282 (301)
T ss_pred hhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHH
Confidence 0000 000 011223557899999999999999999843
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=294.17 Aligned_cols=265 Identities=24% Similarity=0.291 Sum_probs=205.2
Q ss_pred hhcCCCCccceeeecCceEEEEEEE--CCeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc-------CCc
Q 003384 461 GATHNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC-------PEV 531 (824)
Q Consensus 461 ~~~~~f~~~~~LG~G~fG~Vykg~~--~~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~-------~~~ 531 (824)
...++|.+.+.||+|||+.||.+.. .+..+|+|++......+.+...+|++..++++||||+++++++ ...
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 3456899999999999999998763 4678999999887777788899999999999999999999987 234
Q ss_pred eEEEEEecCCCChhhhhhccCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccc
Q 003384 532 WTLVYEYLPNGSLEDRLSCKDN-SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS 610 (824)
Q Consensus 532 ~~LV~Ey~~ggsL~~~L~~~~~-~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla 610 (824)
.||++.|...|+|.+.+..... +..+++.+++.|+.++++||.+||...+ ++.||||||.|||+...+.++|.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~-~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEP-PYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCC-cccccCCCcceeEecCCCceEEEeccCc
Confidence 7999999999999999976543 3479999999999999999999999664 6999999999999999999999999998
Q ss_pred cccccccccCC-CccccccCCCCCCcccCChhhhcc---CCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhh-c
Q 003384 611 RFLSQNEISSN-NTTLCCRTDPKGTFAYMDPEFLAS---GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG-K 685 (824)
Q Consensus 611 ~~~~~~~~~~~-~~~~~~~~~~~GT~~Y~APE~l~~---~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~-~ 685 (824)
....-.-.... .......+....|..|.|||.+.- ...+.++|||||||+||.|+.|..||+.. +..| .
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~------~~~GgS 250 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERI------YQQGGS 250 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHH------hhcCCe
Confidence 75542221111 011111234457999999999854 45788999999999999999999999521 1222 2
Q ss_pred cccccCCCCCCCC--hhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHH
Q 003384 686 LKNLLDPLAGDWP--FVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP 733 (824)
Q Consensus 686 ~~~~ld~~~~~~p--~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~ 733 (824)
+.-.+-...-.|| ...++.+.+++..|++.+|.+||++ .+++..++.
T Consensus 251 laLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i-~~ll~~~d~ 299 (302)
T KOG2345|consen 251 LALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTI-PELLSKLDD 299 (302)
T ss_pred EEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCH-HHHHHHHHh
Confidence 2111111111111 2267899999999999999999999 455555544
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=305.44 Aligned_cols=252 Identities=27% Similarity=0.361 Sum_probs=196.8
Q ss_pred ChhhHhhhcCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhc-CCCceeeEecccC--
Q 003384 455 SFSEIEGATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGACP-- 529 (824)
Q Consensus 455 ~~~ei~~~~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l-~HpnIv~L~g~~~-- 529 (824)
++.++....+.|+....||.|+||.||+|... +..||+|++.... .....+..|+.++.++ +||||+++++++.
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 44556667788999999999999999999885 5789999986543 2335688999999998 7999999999872
Q ss_pred ------CceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcce
Q 003384 530 ------EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSK 603 (824)
Q Consensus 530 ------~~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vK 603 (824)
+..++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+ ++|+||||+|+||+++.++.++
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEE
Confidence 35789999999999999885432 3457888899999999999999999 8999999999999999999999
Q ss_pred eeccccccccccccccCCCccccccCCCCCCcccCChhhhc-----cCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHH
Q 003384 604 LSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA-----SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 678 (824)
Q Consensus 604 L~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~-----~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~ 678 (824)
|+|||++........ ......|++.|+|||.+. ...++.++|||||||++|+|+||.+||.......
T Consensus 162 l~dfg~~~~~~~~~~--------~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~ 233 (282)
T cd06636 162 LVDFGVSAQLDRTVG--------RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR 233 (282)
T ss_pred EeeCcchhhhhcccc--------CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh
Confidence 999999875532211 012345899999999986 3467889999999999999999999996543322
Q ss_pred HHHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChH
Q 003384 679 YALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 679 ~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
....... ... ....+...+..+.+|+.+||+.+|.+||++.
T Consensus 234 ~~~~~~~---~~~--~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ 274 (282)
T cd06636 234 ALFLIPR---NPP--PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTE 274 (282)
T ss_pred hhhhHhh---CCC--CCCcccccCHHHHHHHHHHhCCChhhCcCHH
Confidence 2111110 000 0111123456899999999999999999984
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=300.74 Aligned_cols=247 Identities=25% Similarity=0.381 Sum_probs=196.0
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEecccC----CceEEEE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP----EVWTLVY 536 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~L~g~~~----~~~~LV~ 536 (824)
+|+....||.|+||.||++... +..||+|.+...... ....+..|+.+++.++||||+++++++. ...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4677889999999999999875 578999998754322 2346888999999999999999998762 2468999
Q ss_pred EecCCCChhhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CCceEeccccCCcEEecCCCcceeecccccccc
Q 003384 537 EYLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCK--PHSIVHGDLKPANILLDANFVSKLSDFGISRFL 613 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~-~~~~~l~~~~~~~ia~qia~aL~~LH~~~--~~giiHrDLKp~NILld~~~~vKL~DFGla~~~ 613 (824)
||+++++|.+++... ....++++..++.++.+++.||.|||..+ ..+++|+||+|+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999998543 22457899999999999999999999321 278999999999999999999999999999876
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCC
Q 003384 614 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPL 693 (824)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~ 693 (824)
...... .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||........... .....
T Consensus 161 ~~~~~~--------~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~------~~~~~ 226 (265)
T cd08217 161 GHDSSF--------AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASK------IKEGK 226 (265)
T ss_pred cCCccc--------ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHH------HhcCC
Confidence 533210 1234589999999999988899999999999999999999999976542211111 01111
Q ss_pred CCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 694 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 694 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
....+...+..+.+++.+|++.+|.+||++.+
T Consensus 227 ~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~ 258 (265)
T cd08217 227 FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEE 258 (265)
T ss_pred CCCCccccCHHHHHHHHHHccCCcccCCCHHH
Confidence 22334455678999999999999999999944
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=302.31 Aligned_cols=248 Identities=25% Similarity=0.398 Sum_probs=191.5
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC--C--------chhHHHHHHHHHhcCCCceeeEecccC--C
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--G--------PSEFQQEIDILSKIRHPNLVTLVGACP--E 530 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~--~--------~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~ 530 (824)
+|...+.||.|+||.||+|... +..||||.+...... . .+.+..|+.+++.++||||+++++++. +
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4666788999999999999764 678999987642111 0 135788999999999999999999884 4
Q ss_pred ceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccc
Q 003384 531 VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS 610 (824)
Q Consensus 531 ~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla 610 (824)
..++||||+++|+|.+++... ..+++..+..++.+++.||.|||+ ++++||||+|+||+++.++.+||+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeecccc
Confidence 688999999999999998533 568999999999999999999999 89999999999999999999999999998
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccCC--CCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhcccc
Q 003384 611 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE--LTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKN 688 (824)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~--~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~ 688 (824)
.......... ......|+..|+|||.+.... ++.++||||||+++|+|++|..||................
T Consensus 156 ~~~~~~~~~~------~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~- 228 (272)
T cd06629 156 KKSDDIYDND------QNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKR- 228 (272)
T ss_pred cccccccccc------ccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccc-
Confidence 7653221110 112345899999999987654 8899999999999999999999997554433222211110
Q ss_pred ccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 689 LLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 689 ~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
.............+..+.+++.+||..+|.+||++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 265 (272)
T cd06629 229 SAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARE 265 (272)
T ss_pred cCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHH
Confidence 0001111112234678999999999999999999843
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=312.07 Aligned_cols=252 Identities=18% Similarity=0.241 Sum_probs=186.1
Q ss_pred cceeeec--CceEEEEEEEC--CeEEEEEEecCCCCCC--chhHHHHHHHHHhcCCCceeeEeccc--CCceEEEEEecC
Q 003384 469 SLKIGEG--GYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLP 540 (824)
Q Consensus 469 ~~~LG~G--~fG~Vykg~~~--~~~VAvK~l~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~Ey~~ 540 (824)
..+||+| +||+||++..+ +..||||++....... ...+.+|+.+++.++||||++++++| .+..++||||++
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 4579999 78999999875 5789999987543221 24577899999999999999999988 456889999999
Q ss_pred CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccC
Q 003384 541 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 620 (824)
Q Consensus 541 ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 620 (824)
+|+|.+++.... ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.++++|||.+..........
T Consensus 83 ~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 83 YGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 999999985332 2358999999999999999999999 899999999999999999999999998765432211111
Q ss_pred CCccccccCCCCCCcccCChhhhcc--CCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHh--hhccccccCC----
Q 003384 621 NNTTLCCRTDPKGTFAYMDPEFLAS--GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALD--TGKLKNLLDP---- 692 (824)
Q Consensus 621 ~~~~~~~~~~~~GT~~Y~APE~l~~--~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~--~~~~~~~ld~---- 692 (824)
... ........++..|+|||++.+ ..++.++|||||||++|||++|++||........... .+.....++.
T Consensus 159 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (327)
T cd08227 159 RVV-HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIP 237 (327)
T ss_pred ccc-ccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchh
Confidence 000 000122357888999999976 4689999999999999999999999975432211111 1111111100
Q ss_pred ---------------------------------CCCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 693 ---------------------------------LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 693 ---------------------------------~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
.........+..+.+|+.+||+.+|.+||++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e 303 (327)
T cd08227 238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSAST 303 (327)
T ss_pred hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHH
Confidence 000111123468999999999999999999943
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=302.57 Aligned_cols=247 Identities=23% Similarity=0.405 Sum_probs=183.1
Q ss_pred eeeecCceEEEEEEECC----eEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEecCCCC
Q 003384 471 KIGEGGYGSIYKGLLRH----MQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNGS 543 (824)
Q Consensus 471 ~LG~G~fG~Vykg~~~~----~~VAvK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey~~ggs 543 (824)
.||+|+||.||+|...+ ..+++|.+..... .....|.+|+.+++.++||||+++++.|. ...++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 59999999999997532 3467777664332 23457999999999999999999999985 45789999999999
Q ss_pred hhhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCCC
Q 003384 544 LEDRLSCKD-NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 622 (824)
Q Consensus 544 L~~~L~~~~-~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~ 622 (824)
|.+++.... ....++...+..++.+++.||.|||+ .+++||||||+|||++.++.+||+|||++..........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~-- 156 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE-- 156 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhh--
Confidence 999986432 23456777788999999999999999 889999999999999999999999999986432211100
Q ss_pred ccccccCCCCCCcccCChhhhcc-------CCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHHH--HhhhccccccCC
Q 003384 623 TTLCCRTDPKGTFAYMDPEFLAS-------GELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYA--LDTGKLKNLLDP 692 (824)
Q Consensus 623 ~~~~~~~~~~GT~~Y~APE~l~~-------~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~--~~~~~~~~~ld~ 692 (824)
......|+..|+|||++.. ..++.++|||||||++|||++ |.+||......... ...+....+.++
T Consensus 157 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 232 (268)
T cd05086 157 ----TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKP 232 (268)
T ss_pred ----cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCC
Confidence 0123457899999998743 245778999999999999997 57788654332211 111112222222
Q ss_pred CCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHH
Q 003384 693 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVL 731 (824)
Q Consensus 693 ~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L 731 (824)
..+......+.+++..|| .+|.+||++ +++++.|
T Consensus 233 ---~~~~~~~~~~~~l~~~c~-~~P~~Rp~~-~~i~~~l 266 (268)
T cd05086 233 ---QLELPYSERWYEVLQFCW-LSPEKRATA-EEVHRLL 266 (268)
T ss_pred ---ccCCCCcHHHHHHHHHHh-hCcccCCCH-HHHHHHh
Confidence 223335678889999999 679999999 5666554
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=303.16 Aligned_cols=249 Identities=23% Similarity=0.387 Sum_probs=194.1
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC------CchhHHHHHHHHHhcCCCceeeEecccC--CceEE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ------GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTL 534 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~------~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~L 534 (824)
+|+....||+|+||.||+|... +..||+|++...... ....+.+|+.+++.++||||+++++++. +..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4777889999999999999864 578999998653321 1346889999999999999999999984 46789
Q ss_pred EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCC-cceeecccccccc
Q 003384 535 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF-VSKLSDFGISRFL 613 (824)
Q Consensus 535 V~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~-~vKL~DFGla~~~ 613 (824)
||||+++++|.+++.. ..++++..+..++.|++.||.|||+ ++++|+||+|.||+++.++ .+||+|||++..+
T Consensus 81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 9999999999999853 3468899999999999999999999 8999999999999998776 6999999999876
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCC
Q 003384 614 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPL 693 (824)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~ 693 (824)
......... ......||..|+|||.+.+..++.++|||||||++|+|++|.+||................ ....
T Consensus 155 ~~~~~~~~~----~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~ 228 (268)
T cd06630 155 AAKGTGAGE----FQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIA--SATT 228 (268)
T ss_pred ccccccCCc----cccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHh--ccCC
Confidence 543211111 1123468999999999988889999999999999999999999996432211000000000 0011
Q ss_pred CCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 694 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 694 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
....+...+..+.+++.+|+..+|.+||++.+
T Consensus 229 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ 260 (268)
T cd06630 229 APSIPEHLSPGLRDVTLRCLELQPEDRPPSRE 260 (268)
T ss_pred CCCCchhhCHHHHHHHHHHcCCCcccCcCHHH
Confidence 22344456678999999999999999999943
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=318.21 Aligned_cols=221 Identities=24% Similarity=0.302 Sum_probs=175.0
Q ss_pred CCCccceeeecCceEEEEEEE--CCeEEEEEEecCCCCCC---chhHHHHHHHHHhcCCCceeeEecccC--CceEEEEE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE 537 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~--~~~~VAvK~l~~~~~~~---~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~E 537 (824)
-|..++.||-|+||+|.++.- ++..+|+|.+.+.+... ...++.|.+||...+.++||+||..|. +.+|+||+
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 466678899999999998854 35679999987754322 346789999999999999999999995 47999999
Q ss_pred ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccc
Q 003384 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 617 (824)
Q Consensus 538 y~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 617 (824)
|++||++..+|.. .+-|.+.....++.++.+|+.++|. .|+|||||||+|||||.+|++||.|||||..+.-..
T Consensus 710 YIPGGDmMSLLIr---mgIFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIR---MGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred ccCCccHHHHHHH---hccCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeeccccccceecc
Confidence 9999999999953 3457888888899999999999999 999999999999999999999999999997553111
Q ss_pred ccCCCc----------------------------------cccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHH
Q 003384 618 ISSNNT----------------------------------TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLR 663 (824)
Q Consensus 618 ~~~~~~----------------------------------~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~E 663 (824)
.+.... ..+..-..+||+.|+|||++...+|+..||+||.||||||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE 863 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence 110000 0011123479999999999999999999999999999999
Q ss_pred HHhCCCCCCCchHHHHHHhhhccccccC
Q 003384 664 LLTGRPALGITKEVQYALDTGKLKNLLD 691 (824)
Q Consensus 664 LltG~~Pf~~~~~~~~~~~~~~~~~~ld 691 (824)
|+.|++||-.............+...++
T Consensus 864 m~~g~~pf~~~tp~~tq~kv~nw~~~l~ 891 (1034)
T KOG0608|consen 864 MLVGQPPFLADTPGETQYKVINWRNFLH 891 (1034)
T ss_pred HhhCCCCccCCCCCcceeeeeehhhccc
Confidence 9999999965544333333333444444
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=307.26 Aligned_cols=247 Identities=27% Similarity=0.369 Sum_probs=191.1
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEe
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY 538 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey 538 (824)
+|+..++||+|+||.||+|.+. +..||+|++...... ..+.+.+|+++++.++||||++++++|. ...++||||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF 81 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence 5778899999999999999985 588999987654322 2456889999999999999999999984 468999999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccc
Q 003384 539 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 618 (824)
Q Consensus 539 ~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 618 (824)
+++++|.++... ...+++..+..++.+++.||.|||+ .+++||||+|+||+++.++.+||+|||++..+.....
T Consensus 82 ~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07846 82 VDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 155 (286)
T ss_pred CCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc
Confidence 999999887632 2348999999999999999999999 8999999999999999999999999999886543321
Q ss_pred cCCCccccccCCCCCCcccCChhhhcc-CCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhc----c----c--
Q 003384 619 SSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK----L----K-- 687 (824)
Q Consensus 619 ~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~----~----~-- 687 (824)
. .....|+..|+|||++.+ ..++.++|||||||++|+|++|++||.............. + .
T Consensus 156 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd07846 156 V--------YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEI 227 (286)
T ss_pred c--------cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHH
Confidence 1 123457899999999875 4578899999999999999999999975543221111100 0 0
Q ss_pred --------cccCCCCC------CCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 688 --------NLLDPLAG------DWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 688 --------~~ld~~~~------~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
....+... ......+..+.+|+.+||+.+|.+||++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~ 279 (286)
T cd07846 228 FQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQ 279 (286)
T ss_pred hccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHH
Confidence 00000000 001133567999999999999999999943
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=301.35 Aligned_cols=249 Identities=30% Similarity=0.388 Sum_probs=195.0
Q ss_pred hhcCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhc-CCCceeeEecccCC-------
Q 003384 461 GATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGACPE------- 530 (824)
Q Consensus 461 ~~~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l-~HpnIv~L~g~~~~------- 530 (824)
..+++|...+.||.|+||.||+|... +..+++|++..... ....+.+|+.+++++ +||||++++++|..
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 45678999999999999999999985 47899999875432 345789999999999 79999999998832
Q ss_pred -ceEEEEEecCCCChhhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccc
Q 003384 531 -VWTLVYEYLPNGSLEDRLSCKD-NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFG 608 (824)
Q Consensus 531 -~~~LV~Ey~~ggsL~~~L~~~~-~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFG 608 (824)
..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCc
Confidence 3689999999999999885422 24568999999999999999999999 899999999999999999999999999
Q ss_pred cccccccccccCCCccccccCCCCCCcccCChhhhcc-----CCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhh
Q 003384 609 ISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-----GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT 683 (824)
Q Consensus 609 la~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-----~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~ 683 (824)
++......... .....|+..|+|||++.. ..++.++|||||||+||+|+||++||............
T Consensus 159 ~~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~ 230 (275)
T cd06608 159 VSAQLDSTLGR--------RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKI 230 (275)
T ss_pred cceecccchhh--------hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHh
Confidence 98765432111 123458999999998854 34678899999999999999999999654322211111
Q ss_pred hccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 684 GKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 684 ~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
.... +.....+...+..+.+|+.+||..+|.+||++.+
T Consensus 231 ---~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ 268 (275)
T cd06608 231 ---PRNP-PPTLKSPENWSKKFNDFISECLIKNYEQRPFMEE 268 (275)
T ss_pred ---hccC-CCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHH
Confidence 0000 0011112234568999999999999999999943
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=310.37 Aligned_cols=242 Identities=23% Similarity=0.334 Sum_probs=192.2
Q ss_pred CCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--CCceEEEEEecCC
Q 003384 466 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPN 541 (824)
Q Consensus 466 f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~Ey~~g 541 (824)
|.....||+|+||.||++... +..||||.+........+.+.+|+.+++.++||||+++++.+ .+..++||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 444567999999999999874 578999998655444455788999999999999999999987 4578999999999
Q ss_pred CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCC
Q 003384 542 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 621 (824)
Q Consensus 542 gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 621 (824)
++|.+++. ...+++..+..++.+++.||.|||+ ++|+||||||+||+++.++.+||+|||++.........
T Consensus 104 ~~L~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~-- 174 (292)
T cd06658 104 GALTDIVT----HTRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK-- 174 (292)
T ss_pred CcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc--
Confidence 99999873 2358899999999999999999999 89999999999999999999999999998754322111
Q ss_pred CccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCChhh
Q 003384 622 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQ 701 (824)
Q Consensus 622 ~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~ 701 (824)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||........... +...+.+.. ......
T Consensus 175 ------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~---~~~~~~~~~-~~~~~~ 244 (292)
T cd06658 175 ------RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR---IRDNLPPRV-KDSHKV 244 (292)
T ss_pred ------CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHhcCCCcc-cccccc
Confidence 1224589999999999888899999999999999999999999975543322111 111111111 112234
Q ss_pred HHHHHHHHHHHhhhccCCCCChHHH
Q 003384 702 AEQLANLAMRCCEMSRKSRPELGKD 726 (824)
Q Consensus 702 ~~~l~~Li~~Cl~~~P~~RPt~~~~ 726 (824)
+..+.+++.+||..+|.+||++.+.
T Consensus 245 ~~~~~~li~~~l~~~P~~Rpt~~~i 269 (292)
T cd06658 245 SSVLRGFLDLMLVREPSQRATAQEL 269 (292)
T ss_pred CHHHHHHHHHHccCChhHCcCHHHH
Confidence 5678999999999999999999443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=297.87 Aligned_cols=247 Identities=31% Similarity=0.456 Sum_probs=194.4
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEeccc--CCceEEEEEe
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 538 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~Ey 538 (824)
+|...+.||+|+||.||+|... +..|++|.+...... ....+..|+.+++.++||||+++++.+ .+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4677889999999999999874 578999998765443 356789999999999999999999987 4568899999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccc
Q 003384 539 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 618 (824)
Q Consensus 539 ~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 618 (824)
+++++|.+++.. ...+++..+..++.+++.||.|||+ .+|+|+||+|.||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 999999999853 3457889999999999999999999 8999999999999999999999999999987654332
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCC---CCcchhHHhHHHHHHHHHhCCCCCCCch-HHHHHHhhhccccccCCCC
Q 003384 619 SSNNTTLCCRTDPKGTFAYMDPEFLASGE---LTPKSDVYSFGIILLRLLTGRPALGITK-EVQYALDTGKLKNLLDPLA 694 (824)
Q Consensus 619 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~---~t~ksDVwSlGvvL~ELltG~~Pf~~~~-~~~~~~~~~~~~~~ld~~~ 694 (824)
..... .....|+..|+|||++.+.. ++.++||||||+++|+|++|++||.... .......... ...+..
T Consensus 155 ~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~---~~~~~~ 227 (264)
T cd06626 155 TMGEE----VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA---GHKPPI 227 (264)
T ss_pred ccccc----ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc---CCCCCC
Confidence 11110 12345889999999998766 8899999999999999999999996442 2111111111 001111
Q ss_pred CCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 695 GDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 695 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
.. ....+..+.+++.+||+.+|.+||++.+
T Consensus 228 ~~-~~~~~~~~~~li~~~l~~~p~~R~~~~~ 257 (264)
T cd06626 228 PD-SLQLSPEGKDFLDRCLESDPKKRPTASE 257 (264)
T ss_pred Cc-ccccCHHHHHHHHHHccCCcccCCCHHH
Confidence 11 1123678899999999999999999943
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=299.13 Aligned_cols=244 Identities=23% Similarity=0.348 Sum_probs=194.8
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEe
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY 538 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey 538 (824)
+|+..+.||+|+||.||++... +..||+|.+..... .....+.+|+.++++++||||+++++++. +..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4778889999999999999874 57899999865322 22357899999999999999999999884 468899999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccc
Q 003384 539 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 618 (824)
Q Consensus 539 ~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 618 (824)
+++++|.+++... ....+++..++.++.+++.||.|||+ ++++|+||+|+|||++.++.++|+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 9999999988532 22357899999999999999999999 8999999999999999999999999999986543221
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCC
Q 003384 619 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWP 698 (824)
Q Consensus 619 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p 698 (824)
. .....|++.|+|||++.+..++.++|||||||++|+|+||+.||............ +.......+
T Consensus 157 ~--------~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~------~~~~~~~~~ 222 (256)
T cd08218 157 L--------ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKI------IRGSYPPVS 222 (256)
T ss_pred h--------hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHH------hcCCCCCCc
Confidence 1 12235889999999999888999999999999999999999999654332211111 111111223
Q ss_pred hhhHHHHHHHHHHHhhhccCCCCChHHH
Q 003384 699 FVQAEQLANLAMRCCEMSRKSRPELGKD 726 (824)
Q Consensus 699 ~~~~~~l~~Li~~Cl~~~P~~RPt~~~~ 726 (824)
...+..+.+++.+||+.+|.+||++.+.
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~v 250 (256)
T cd08218 223 SHYSYDLRNLVSQLFKRNPRDRPSVNSI 250 (256)
T ss_pred ccCCHHHHHHHHHHhhCChhhCcCHHHH
Confidence 3456789999999999999999999443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=294.88 Aligned_cols=244 Identities=27% Similarity=0.445 Sum_probs=197.0
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC----Cc----hhHHHHHHHHHhc-CCCceeeEecccCC--
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ----GP----SEFQQEIDILSKI-RHPNLVTLVGACPE-- 530 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~----~~----~~f~~Ei~iL~~l-~HpnIv~L~g~~~~-- 530 (824)
.+|.+.+.||.|+.++|.+...+ +..+|+|++...... .. +.-.+|+.||+++ .||||++|.+++..
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 35777788999999999887665 578999988653221 12 2345799999998 59999999999854
Q ss_pred ceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccc
Q 003384 531 VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS 610 (824)
Q Consensus 531 ~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla 610 (824)
.+++|+|.|+.|.|.|+|. ....+++....+|+.++..|+.|||. ++||||||||+|||+|+|..+||+|||+|
T Consensus 97 F~FlVFdl~prGELFDyLt---s~VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDFGFa 170 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLT---SKVTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDFGFA 170 (411)
T ss_pred hhhhhhhhcccchHHHHhh---hheeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEecccee
Confidence 5779999999999999994 44678999999999999999999999 89999999999999999999999999999
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhcc------CCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHH--Hh
Q 003384 611 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS------GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA--LD 682 (824)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~------~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~--~~ 682 (824)
+.+..++.. ....|||+|+|||.+.. .+|+..+|+|++|||||.|+.|-|||.....+... +.
T Consensus 171 ~~l~~GekL---------relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~Im 241 (411)
T KOG0599|consen 171 CQLEPGEKL---------RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIM 241 (411)
T ss_pred eccCCchhH---------HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHH
Confidence 988765421 34569999999998843 46889999999999999999999999766554322 22
Q ss_pred hhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 003384 683 TGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 727 (824)
Q Consensus 683 ~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 727 (824)
+|+. ....+.| .+.+....+|+.+||+.+|.+|.|..+.+
T Consensus 242 eGky----qF~speW-adis~~~KdLIsrlLqVdp~~Ritake~L 281 (411)
T KOG0599|consen 242 EGKY----QFRSPEW-ADISATVKDLISRLLQVDPTKRITAKEAL 281 (411)
T ss_pred hccc----ccCCcch-hhccccHHHHHHHHHeeCchhcccHHHHh
Confidence 3322 2233344 34567899999999999999999985544
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=301.49 Aligned_cols=250 Identities=23% Similarity=0.411 Sum_probs=193.6
Q ss_pred CCCccceeeecCceEEEEEEECC---eEEEEEEecCCCCC----------CchhHHHHHHHHHh-cCCCceeeEecccC-
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLRH---MQVAIKMLHPHSLQ----------GPSEFQQEIDILSK-IRHPNLVTLVGACP- 529 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~~---~~VAvK~l~~~~~~----------~~~~f~~Ei~iL~~-l~HpnIv~L~g~~~- 529 (824)
+|+..+.||+|+||.||+|...+ ..+|+|.+...... ....+..|+.++.+ ++||||++++++|.
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 36777889999999999998854 77999987643211 12346778888875 79999999999883
Q ss_pred -CceEEEEEecCCCChhhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecc
Q 003384 530 -EVWTLVYEYLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDF 607 (824)
Q Consensus 530 -~~~~LV~Ey~~ggsL~~~L~~~-~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DF 607 (824)
+..++||||++|++|.+++... .....+++..++.++.+++.||.|||.. .+++|+||+|.|||++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEecc
Confidence 4688999999999999987532 2345689999999999999999999952 57999999999999999999999999
Q ss_pred ccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccc
Q 003384 608 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLK 687 (824)
Q Consensus 608 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~ 687 (824)
|++........ .....|+..|+|||++.+..++.++||||||+++|+|++|++||............. .
T Consensus 159 g~~~~~~~~~~---------~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~--~ 227 (269)
T cd08528 159 GLAKQKQPESK---------LTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIV--E 227 (269)
T ss_pred cceeecccccc---------cccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHh--h
Confidence 99986543320 123458999999999998889999999999999999999999997554322111110 0
Q ss_pred cccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHH
Q 003384 688 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVL 731 (824)
Q Consensus 688 ~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L 731 (824)
....+.. ....+..+.+++.+||+.+|.+||++ .++..++
T Consensus 228 ~~~~~~~---~~~~~~~l~~li~~cl~~~p~~Rp~~-~e~~~~~ 267 (269)
T cd08528 228 AVYEPLP---EGMYSEDVTDVITSCLTPDAEARPDI-IQVSAMI 267 (269)
T ss_pred ccCCcCC---cccCCHHHHHHHHHHCCCCCccCCCH-HHHHHHh
Confidence 1111111 11345689999999999999999999 5565554
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=302.44 Aligned_cols=245 Identities=27% Similarity=0.337 Sum_probs=192.0
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccC----CceEEEEE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP----EVWTLVYE 537 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~----~~~~LV~E 537 (824)
+|...+.||.|+||.||+|... +..||+|.+..... .....+.+|+++++.++||||++++++|. ...++|||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 81 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME 81 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence 5778889999999999999985 58899999875433 22456899999999999999999999873 25789999
Q ss_pred ecCCCChhhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccc
Q 003384 538 YLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 616 (824)
Q Consensus 538 y~~ggsL~~~L~~~-~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 616 (824)
|+++++|.+++... .....++...+..++.+++.||.|||. .+++|+||+|.||+++.++.++|+|||++......
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred ecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 99999999887532 234568889999999999999999999 89999999999999999999999999998754322
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchH-----HH--HHHhhhccccc
Q 003384 617 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE-----VQ--YALDTGKLKNL 689 (824)
Q Consensus 617 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~-----~~--~~~~~~~~~~~ 689 (824)
.. ....++..|+|||.+.+..++.++|||||||++|+|++|..||..... .. ..........+
T Consensus 159 ~~----------~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (287)
T cd06621 159 LA----------GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPEL 228 (287)
T ss_pred cc----------ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhh
Confidence 11 123478899999999988999999999999999999999999975421 11 10011000010
Q ss_pred cCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChH
Q 003384 690 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 690 ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
.+... .....+..+.+++.+||..+|.+||++.
T Consensus 229 ~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~ 261 (287)
T cd06621 229 KDEPG--NGIKWSEEFKDFIKQCLEKDPTRRPTPW 261 (287)
T ss_pred ccCCC--CCCchHHHHHHHHHHHcCCCcccCCCHH
Confidence 00000 0012356899999999999999999994
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=303.62 Aligned_cols=247 Identities=28% Similarity=0.366 Sum_probs=193.6
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCC--CCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEe
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS--LQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY 538 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~--~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey 538 (824)
+|+..+.||+|+||.||+|... +..||||.++... ......+.+|+++++.++||||+++++++. +..++||||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 6888899999999999999886 5789999987532 222457899999999999999999999984 468999999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccc
Q 003384 539 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 618 (824)
Q Consensus 539 ~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 618 (824)
++++.|..++. ....+++..+..++.+++.||.|||. ++++||||+|+||+++.++.+||+|||++........
T Consensus 82 ~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 82 VERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred CCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 99877766553 23458899999999999999999999 8999999999999999999999999999887654321
Q ss_pred cCCCccccccCCCCCCcccCChhhhccC-CCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccc----------
Q 003384 619 SSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLK---------- 687 (824)
Q Consensus 619 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~---------- 687 (824)
.. .....|+..|+|||++.+. .++.++||||||+++|+|++|++||................
T Consensus 156 ~~-------~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (288)
T cd07833 156 SP-------LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQEL 228 (288)
T ss_pred cc-------ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhh
Confidence 00 1234578999999999888 88999999999999999999999997654432221111000
Q ss_pred ----------cccCCC-----CCCCChhhHHHHHHHHHHHhhhccCCCCChH
Q 003384 688 ----------NLLDPL-----AGDWPFVQAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 688 ----------~~ld~~-----~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
...... ...++...+..+.+|+.+||..+|.+||++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 280 (288)
T cd07833 229 FSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCD 280 (288)
T ss_pred cccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHH
Confidence 000000 0012233467899999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=306.63 Aligned_cols=245 Identities=25% Similarity=0.381 Sum_probs=196.2
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--CCceEEEEEec
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 539 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~Ey~ 539 (824)
++|...+.||+|+||.||+|... +..||+|.+..........+.+|+.+++.++||||++++++| .+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 57888899999999999999864 578999998755444456789999999999999999999988 45689999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccccc
Q 003384 540 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 619 (824)
Q Consensus 540 ~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 619 (824)
++++|.+++.. ..+++..+..++.+++.||.|||+ +|++||||||+||+++.++.+||+|||++.........
T Consensus 99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~ 171 (293)
T cd06647 99 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (293)
T ss_pred CCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceecccccccc
Confidence 99999999842 347888999999999999999999 89999999999999999999999999998765432211
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCCh
Q 003384 620 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPF 699 (824)
Q Consensus 620 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~ 699 (824)
.....|++.|+|||++....++.++|||||||++|+|++|++||............+.. .......+.
T Consensus 172 --------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~----~~~~~~~~~ 239 (293)
T cd06647 172 --------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN----GTPELQNPE 239 (293)
T ss_pred --------cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcC----CCCCCCCcc
Confidence 12345889999999998888999999999999999999999999765432211111000 000011122
Q ss_pred hhHHHHHHHHHHHhhhccCCCCChHHHH
Q 003384 700 VQAEQLANLAMRCCEMSRKSRPELGKDV 727 (824)
Q Consensus 700 ~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 727 (824)
..+..+.+++.+||..+|.+||++.+.+
T Consensus 240 ~~~~~l~~li~~~l~~~p~~Rp~~~~il 267 (293)
T cd06647 240 KLSAIFRDFLNRCLEMDVEKRGSAKELL 267 (293)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 3456799999999999999999995443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=302.66 Aligned_cols=247 Identities=26% Similarity=0.394 Sum_probs=199.3
Q ss_pred hhcCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--CCceEEEE
Q 003384 461 GATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVY 536 (824)
Q Consensus 461 ~~~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~ 536 (824)
..+.+|.....||+|+||.||+|.+. +..|++|++..... ....+.+|+++++.++||||+++++++ ....++|+
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 35567888899999999999999987 68899999876543 456788999999999999999999987 45788999
Q ss_pred EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccc
Q 003384 537 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 616 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 616 (824)
||+++++|.+++.... ..+++..+..++.+++.||.|||. .|++|+||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 95 EYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred eccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 9999999999996432 379999999999999999999999 89999999999999999999999999998755432
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCC
Q 003384 617 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 696 (824)
Q Consensus 617 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~ 696 (824)
... .....|+..|+|||++.+..++.++|||||||++|+|++|+.||.............. ..... ..
T Consensus 170 ~~~--------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~--~~ 237 (286)
T cd06614 170 KSK--------RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT--KGIPP--LK 237 (286)
T ss_pred hhh--------hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--cCCCC--Cc
Confidence 211 1233578999999999888899999999999999999999999976554322211110 00111 11
Q ss_pred CChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 697 WPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 697 ~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
.+...+..+.+++.+|++.+|..||++.+
T Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ 266 (286)
T cd06614 238 NPEKWSPEFKDFLNKCLVKDPEKRPSAEE 266 (286)
T ss_pred chhhCCHHHHHHHHHHhccChhhCcCHHH
Confidence 12224568999999999999999999943
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=301.94 Aligned_cols=248 Identities=26% Similarity=0.371 Sum_probs=187.6
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEe
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY 538 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey 538 (824)
.+|.....||.|+||.||+|... +..||||.+...... ....+.+|+++++.++||||+++++++. +..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 46888899999999999999875 588999998754322 2345778999999999999999999884 468899999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccc
Q 003384 539 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 618 (824)
Q Consensus 539 ~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 618 (824)
+.+ +|.+++... ...+++.....++.+++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 85 LDT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred CCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 975 899888533 2368899999999999999999999 8999999999999999999999999999875432111
Q ss_pred cCCCccccccCCCCCCcccCChhhhcc-CCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhh-h---------ccc
Q 003384 619 SSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT-G---------KLK 687 (824)
Q Consensus 619 ~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~-~---------~~~ 687 (824)
. .....++..|+|||++.+ ..++.++|||||||++|+|++|++||.........+.. . .+.
T Consensus 159 ~--------~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (291)
T cd07844 159 T--------YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWP 230 (291)
T ss_pred c--------ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhh
Confidence 0 122347889999999876 45889999999999999999999999654321111100 0 000
Q ss_pred c---------ccCCCC------CCC-ChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 688 N---------LLDPLA------GDW-PFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 688 ~---------~ld~~~------~~~-p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
. ...... ... .......+.+++.+||+.+|.+||++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e 284 (291)
T cd07844 231 GVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAE 284 (291)
T ss_pred hhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHH
Confidence 0 000000 000 0111257789999999999999999843
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=341.57 Aligned_cols=243 Identities=27% Similarity=0.297 Sum_probs=195.8
Q ss_pred cCCCCccceeeecCceEEEEEEECC--eEEEEEEecCCCC---CCchhHHHHHHHHHhcCCCceeeEecccCC--ceEEE
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLV 535 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~~--~~VAvK~l~~~~~---~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~~--~~~LV 535 (824)
..+|.+.++||+|+||.|..++.++ +.||+|++++-.+ ....-|..|.+||..-+.++|+.|+.+|.+ ++|+|
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlV 153 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLV 153 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEE
Confidence 3478899999999999999998864 6799999986322 233468999999999999999999999954 68999
Q ss_pred EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccc
Q 003384 536 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 615 (824)
Q Consensus 536 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~ 615 (824)
|||++||+|-.+|...+ +++......++.+|.-||.-||+ .|+|||||||+|||||..|++||+|||.|-.+..
T Consensus 154 MdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~ 227 (1317)
T KOG0612|consen 154 MDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA 227 (1317)
T ss_pred EecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeeccchhHHhcCC
Confidence 99999999999995433 68888899999999999999999 8999999999999999999999999999987765
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhcc-----CCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhcccccc
Q 003384 616 NEISSNNTTLCCRTDPKGTFAYMDPEFLAS-----GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLL 690 (824)
Q Consensus 616 ~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-----~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~l 690 (824)
++... ....+|||.|++||++.. +.|++.+||||+||++|||+.|..||....-+...-......+.+
T Consensus 228 dG~V~-------s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l 300 (1317)
T KOG0612|consen 228 DGTVR-------SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESL 300 (1317)
T ss_pred CCcEE-------eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhc
Confidence 54322 145679999999999953 569999999999999999999999998766555433333333333
Q ss_pred CCCCCCCChhhHHHHHHHHHHHhhhccCCCCC
Q 003384 691 DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPE 722 (824)
Q Consensus 691 d~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt 722 (824)
... -....+....+||.+.+. +|..|-.
T Consensus 301 ~FP---~~~~VSeeakdLI~~ll~-~~e~RLg 328 (1317)
T KOG0612|consen 301 SFP---DETDVSEEAKDLIEALLC-DREVRLG 328 (1317)
T ss_pred CCC---cccccCHHHHHHHHHHhc-Chhhhcc
Confidence 211 013467889999988775 5555654
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=312.08 Aligned_cols=245 Identities=25% Similarity=0.325 Sum_probs=199.5
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHHhcCCCceeeEeccc--CCceEEE
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLV 535 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~---~~~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV 535 (824)
.+.|..-++||+||||.||-...+ |+.+|.|.+.+... .......+|-.||.+++.|.||.|-.+| .+..++|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 345788889999999999977654 67899988765322 2234577899999999999999998877 5689999
Q ss_pred EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccc
Q 003384 536 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 615 (824)
Q Consensus 536 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~ 615 (824)
|..|+||+|.-+|...++ +.|++...+.++.+|++||.+||. .+||.|||||+|||||+.|+++|+|+|||.-+..
T Consensus 264 LtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 999999999999976554 679999999999999999999999 8999999999999999999999999999998776
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCC
Q 003384 616 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG 695 (824)
Q Consensus 616 ~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~ 695 (824)
.... ...+||.+|||||++.++.|+...|+|||||+||||+.|+.||.....-.. ...+...+.....
T Consensus 340 g~~~---------~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk---~eEvdrr~~~~~~ 407 (591)
T KOG0986|consen 340 GKPI---------RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK---REEVDRRTLEDPE 407 (591)
T ss_pred CCcc---------ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh---HHHHHHHHhcchh
Confidence 5421 345799999999999999999999999999999999999999965432111 1111111112223
Q ss_pred CCChhhHHHHHHHHHHHhhhccCCCCCh
Q 003384 696 DWPFVQAEQLANLAMRCCEMSRKSRPEL 723 (824)
Q Consensus 696 ~~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 723 (824)
.++..-++++..|....|..+|.+|-.-
T Consensus 408 ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 408 EYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred hcccccCHHHHHHHHHHHccCHHHhccC
Confidence 4556667889999999999999998654
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=302.54 Aligned_cols=248 Identities=26% Similarity=0.374 Sum_probs=192.2
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEe
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY 538 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey 538 (824)
+|...+.||.|+||.||+|.+. +..||+|++..... .....+.+|+.+++.++||||+++++++. ...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4677889999999999999875 58899999876542 22457899999999999999999999874 467899999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccc
Q 003384 539 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 618 (824)
Q Consensus 539 ~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 618 (824)
+ +++|.+++... ..++++..+..++.+++.||.|||+ ++++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDE--ERPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 99999988533 2569999999999999999999999 8999999999999999999999999999986644321
Q ss_pred cCCCccccccCCCCCCcccCChhhhccC-CCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhh-cc----------
Q 003384 619 SSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG-KL---------- 686 (824)
Q Consensus 619 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~-~~---------- 686 (824)
. ......|+..|+|||++.+. .++.++|||||||++|+|+||++||............. .+
T Consensus 155 ~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd07832 155 R-------LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPG 227 (286)
T ss_pred C-------ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhh
Confidence 0 01234689999999998654 46889999999999999999999986554322111000 00
Q ss_pred -------ccccCCCCC-----CCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 687 -------KNLLDPLAG-----DWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 687 -------~~~ld~~~~-----~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
.....+... ......+..+.+++.+|++.+|.+||++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~ 278 (286)
T cd07832 228 LTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAE 278 (286)
T ss_pred ccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHH
Confidence 000000000 011123578999999999999999999943
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=305.60 Aligned_cols=249 Identities=23% Similarity=0.277 Sum_probs=191.5
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE 537 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~---~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~E 537 (824)
+|...+.||+|+||.||++... +..|++|.+..... .....+.+|+++++.++||||+++++.+. +..++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 6888899999999999999876 47899999875432 12346789999999999999999999884 45789999
Q ss_pred ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccc
Q 003384 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 617 (824)
Q Consensus 538 y~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 617 (824)
|++|++|.+++.. ...+++..+..++.+++.||.|||+ ++++||||||.|||++.++.+||+|||+++......
T Consensus 82 ~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 82 YVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 9999999999943 3468999999999999999999999 899999999999999999999999999987421111
Q ss_pred ccC-------CCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhcccccc
Q 003384 618 ISS-------NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLL 690 (824)
Q Consensus 618 ~~~-------~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~l 690 (824)
... ............|+..|+|||++.+..++.++|||||||++|+|++|..||........ ..........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~-~~~~~~~~~~ 234 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL-FGQVISDDIE 234 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhcccC
Confidence 000 00000111234578899999999888899999999999999999999999975433211 1111001111
Q ss_pred CCCCCCCChhhHHHHHHHHHHHhhhccCCCCCh
Q 003384 691 DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 723 (824)
Q Consensus 691 d~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 723 (824)
.+. .+...+..+.+++.+||+.+|.+||+.
T Consensus 235 ~~~---~~~~~~~~~~~li~~~l~~~P~~R~~~ 264 (305)
T cd05609 235 WPE---GDEALPADAQDLISRLLRQNPLERLGT 264 (305)
T ss_pred CCC---ccccCCHHHHHHHHHHhccChhhccCc
Confidence 111 111345679999999999999999996
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=304.22 Aligned_cols=242 Identities=26% Similarity=0.374 Sum_probs=201.6
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--CCceEEEEEecC
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLP 540 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~Ey~~ 540 (824)
-|++..+||+|+||.||+++++ |+.||||.+... .+..++..|+.||++++.|++|++||.+ ...+++|||||-
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 4788889999999999999876 688999987654 4567899999999999999999999976 346889999999
Q ss_pred CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccC
Q 003384 541 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 620 (824)
Q Consensus 541 ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 620 (824)
.|+..|++. .++.+|++..+..++...+.||.|||. ..-||||||..||||+-+|++||+|||.|..+....
T Consensus 112 AGSiSDI~R--~R~K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM--- 183 (502)
T KOG0574|consen 112 AGSISDIMR--ARRKPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM--- 183 (502)
T ss_pred CCcHHHHHH--HhcCCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhhH---
Confidence 999999995 445789999999999999999999999 668999999999999999999999999998665432
Q ss_pred CCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCChh
Q 003384 621 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV 700 (824)
Q Consensus 621 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~ 700 (824)
..++...||+.|||||++..-+|+.++||||||++..||..|+|||......... -+...-.|..-..|..
T Consensus 184 -----AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI----FMIPT~PPPTF~KPE~ 254 (502)
T KOG0574|consen 184 -----AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI----FMIPTKPPPTFKKPEE 254 (502)
T ss_pred -----HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee----EeccCCCCCCCCChHh
Confidence 2235677999999999999999999999999999999999999999654432211 0111111222234566
Q ss_pred hHHHHHHHHHHHhhhccCCCCChHH
Q 003384 701 QAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 701 ~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
.+.++.+++..||-.+|++|-+..+
T Consensus 255 WS~~F~DFi~~CLiK~PE~R~TA~~ 279 (502)
T KOG0574|consen 255 WSSEFNDFIRSCLIKKPEERKTALR 279 (502)
T ss_pred hhhHHHHHHHHHhcCCHHHHHHHHH
Confidence 6789999999999999999988744
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=297.08 Aligned_cols=243 Identities=24% Similarity=0.383 Sum_probs=194.1
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEeccc--CCceEEEEEe
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 538 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~Ey 538 (824)
+|+..+.||+|+||.||++... +..+|||.+...... ....+.+|+.+++.++||||+++++.+ .+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4778889999999999998774 578999998754322 245688999999999999999999987 4568899999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCC-Ccceeecccccccccccc
Q 003384 539 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN-FVSKLSDFGISRFLSQNE 617 (824)
Q Consensus 539 ~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~-~~vKL~DFGla~~~~~~~ 617 (824)
+++++|.+++.... ...+++..+..++.+++.||.|||+ ++++||||+|.||+++.+ +.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 99999999995432 3458899999999999999999999 899999999999999854 568999999998664332
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCC
Q 003384 618 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 697 (824)
Q Consensus 618 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~ 697 (824)
.. ....|+..|+|||.+.+..++.++||||||+++|+|++|+.||...+........ .. ......
T Consensus 157 ~~---------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~--~~----~~~~~~ 221 (256)
T cd08220 157 KA---------YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKI--MS----GTFAPI 221 (256)
T ss_pred cc---------cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHH--Hh----cCCCCC
Confidence 11 2245889999999999888999999999999999999999999765432221111 11 111122
Q ss_pred ChhhHHHHHHHHHHHhhhccCCCCChHHH
Q 003384 698 PFVQAEQLANLAMRCCEMSRKSRPELGKD 726 (824)
Q Consensus 698 p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~ 726 (824)
+...+..+.+++.+||..+|.+||++.+.
T Consensus 222 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~l 250 (256)
T cd08220 222 SDRYSPDLRQLILSMLNLDPSKRPQLSQI 250 (256)
T ss_pred CCCcCHHHHHHHHHHccCChhhCCCHHHH
Confidence 33456689999999999999999999543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=303.73 Aligned_cols=247 Identities=26% Similarity=0.307 Sum_probs=190.1
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC-----CchhHHHHHHHHHhcCCCceeeEecccC--CceEEE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-----GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLV 535 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~-----~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV 535 (824)
+|...+.||.|+||.||+|... +..||||.+...... ....+..|+.+++.++||||+++++++. +..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 3677788999999999999875 578999999765432 1235678999999999999999999884 468899
Q ss_pred EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccc
Q 003384 536 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 615 (824)
Q Consensus 536 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~ 615 (824)
|||+ +|+|.+++.... ..+++..+..++.|++.||.|||. ++|+||||+|+|||++.++.+||+|||++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 899999985322 369999999999999999999999 8999999999999999999999999999986643
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhcc-CCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhcc--------
Q 003384 616 NEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL-------- 686 (824)
Q Consensus 616 ~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~-------- 686 (824)
.... .....+++.|+|||++.+ ..++.++|||||||++|+|++|.+||...............
T Consensus 155 ~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (298)
T cd07841 155 PNRK--------MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEEN 226 (298)
T ss_pred CCcc--------ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhh
Confidence 3211 123357889999999865 46788999999999999999999988654432211110000
Q ss_pred ----ccccCC---------CCCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 687 ----KNLLDP---------LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 687 ----~~~ld~---------~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
...... .........+..+.+++.+||+.+|.+||++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e 278 (298)
T cd07841 227 WPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQ 278 (298)
T ss_pred hhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHH
Confidence 000000 000011223568899999999999999999944
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=305.75 Aligned_cols=235 Identities=26% Similarity=0.355 Sum_probs=192.2
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE 537 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~---~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~E 537 (824)
+|...+.||+|+||.||++.+. +..||+|++..... .....+.+|++++++++||||+++++++. ...++|||
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME 81 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence 6788899999999999999885 58899999865322 22456889999999999999999999874 46889999
Q ss_pred ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccc
Q 003384 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 617 (824)
Q Consensus 538 y~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 617 (824)
|+++++|.+++... ..++...+..++.+++.||.|||+ +||+||||+|.|||++.++.+||+|||++.......
T Consensus 82 ~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 155 (290)
T cd05580 82 YVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT 155 (290)
T ss_pred cCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCCC
Confidence 99999999998533 568899999999999999999999 899999999999999999999999999988654321
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCC
Q 003384 618 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 697 (824)
Q Consensus 618 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~ 697 (824)
....|++.|+|||.+.+..++.++||||||+++|+|++|+.||............. . .....
T Consensus 156 -----------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~------~-~~~~~ 217 (290)
T cd05580 156 -----------YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL------E-GKVRF 217 (290)
T ss_pred -----------CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh------c-CCccC
Confidence 23358999999999988888999999999999999999999997654321111110 0 01122
Q ss_pred ChhhHHHHHHHHHHHhhhccCCCCCh
Q 003384 698 PFVQAEQLANLAMRCCEMSRKSRPEL 723 (824)
Q Consensus 698 p~~~~~~l~~Li~~Cl~~~P~~RPt~ 723 (824)
|...+..+.+++.+||..+|.+||+.
T Consensus 218 ~~~~~~~l~~li~~~l~~~p~~R~~~ 243 (290)
T cd05580 218 PSFFSPDAKDLIRNLLQVDLTKRLGN 243 (290)
T ss_pred CccCCHHHHHHHHHHccCCHHHccCc
Confidence 33446789999999999999999943
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=300.02 Aligned_cols=241 Identities=26% Similarity=0.406 Sum_probs=192.1
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCC-CCCchhHHHHHHHHHhcC---CCceeeEecccC--CceEEEE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS-LQGPSEFQQEIDILSKIR---HPNLVTLVGACP--EVWTLVY 536 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~-~~~~~~f~~Ei~iL~~l~---HpnIv~L~g~~~--~~~~LV~ 536 (824)
.|+..+.||.|+||.||+|.+. +..||+|.+.... ......+.+|+.+++.++ |||+++++++|. ...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 4677788999999999999874 5789999987542 223456889999999997 999999999884 4578999
Q ss_pred EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccc
Q 003384 537 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 616 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 616 (824)
||+++++|.+++.. .++++.....++.+++.||.|||+ .+|+||||+|+||+++.++.++|+|||++..+...
T Consensus 82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999998842 368999999999999999999999 89999999999999999999999999999876543
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccC-CCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCC
Q 003384 617 EISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG 695 (824)
Q Consensus 617 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~ 695 (824)
... .....|+..|+|||++.++ .++.++|||||||++|+|++|.+||............ .... ..
T Consensus 155 ~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~---~~~~---~~ 220 (277)
T cd06917 155 SSK--------RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI---PKSK---PP 220 (277)
T ss_pred ccc--------cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcc---ccCC---CC
Confidence 211 1234589999999998754 5788999999999999999999999765433221111 0111 11
Q ss_pred CCCh-hhHHHHHHHHHHHhhhccCCCCChHHH
Q 003384 696 DWPF-VQAEQLANLAMRCCEMSRKSRPELGKD 726 (824)
Q Consensus 696 ~~p~-~~~~~l~~Li~~Cl~~~P~~RPt~~~~ 726 (824)
..+. ..+..+.+++.+||+.+|.+||++.+.
T Consensus 221 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~i 252 (277)
T cd06917 221 RLEDNGYSKLLREFVAACLDEEPKERLSAEEL 252 (277)
T ss_pred CCCcccCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence 1111 245689999999999999999998443
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=321.54 Aligned_cols=244 Identities=25% Similarity=0.369 Sum_probs=199.2
Q ss_pred CCccceeeecCceEEEEEEECCe--EEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--CCceEEEEEecCC
Q 003384 466 FDPSLKIGEGGYGSIYKGLLRHM--QVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPN 541 (824)
Q Consensus 466 f~~~~~LG~G~fG~Vykg~~~~~--~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~Ey~~g 541 (824)
|.++..||.|+||.||++..+.. ..|.|++........+.|.-||+||..++||+||+|++.| ...++|..|||.|
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 45566799999999999988753 3577888777766677899999999999999999999854 6788999999999
Q ss_pred CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCC
Q 003384 542 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 621 (824)
Q Consensus 542 gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 621 (824)
|-...++.. -..+|+..++.-++.+++.||.|||+ ++|||||||..|||++-+|.++|+|||.+....
T Consensus 114 GAVDaimlE--L~r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~------- 181 (1187)
T KOG0579|consen 114 GAVDAIMLE--LGRVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK------- 181 (1187)
T ss_pred chHhHHHHH--hccccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccch-------
Confidence 998887743 34679999999999999999999999 889999999999999999999999999875322
Q ss_pred CccccccCCCCCCcccCChhhhc-----cCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCC
Q 003384 622 NTTLCCRTDPKGTFAYMDPEFLA-----SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 696 (824)
Q Consensus 622 ~~~~~~~~~~~GT~~Y~APE~l~-----~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~ 696 (824)
.+...+..+.|||+|||||+.. ..+|+.++||||||++|.||.-+.||....+.+...+...+- +|...-
T Consensus 182 -~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKS----ePPTLl 256 (1187)
T KOG0579|consen 182 -STRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS----EPPTLL 256 (1187)
T ss_pred -hHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhc----CCCccc
Confidence 1222345678999999999864 468999999999999999999999998766655444333211 222222
Q ss_pred CChhhHHHHHHHHHHHhhhccCCCCChHHH
Q 003384 697 WPFVQAEQLANLAMRCCEMSRKSRPELGKD 726 (824)
Q Consensus 697 ~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~ 726 (824)
.|...+..+.+++.+||..+|..||+..+.
T Consensus 257 qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaql 286 (1187)
T KOG0579|consen 257 QPSHWSRSFSDFLKRCLVKNPRNRPPAAQL 286 (1187)
T ss_pred CcchhhhHHHHHHHHHHhcCCccCCCHHHH
Confidence 355667899999999999999999997543
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=319.50 Aligned_cols=234 Identities=29% Similarity=0.423 Sum_probs=191.4
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCc---hhHHHHHHHHHhcCCCceeeEeccc--CCceEEEEE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGP---SEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYE 537 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~---~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~E 537 (824)
-|...+.||.|+||-||-+.+. ...||||.+.-...+.. ..+..|+..|.+++|||+|.+-|+| ....+||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 4777888999999999999875 47799999876655543 4688999999999999999999998 345679999
Q ss_pred ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccc
Q 003384 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 617 (824)
Q Consensus 538 y~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 617 (824)
||- ||-.|+|.- ...+|-...+..|+.+.+.||+|||+ ++.||||||..||||++.|.|||+|||.|....+.
T Consensus 107 YCl-GSAsDlleV--hkKplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA- 179 (948)
T KOG0577|consen 107 YCL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA- 179 (948)
T ss_pred HHh-ccHHHHHHH--HhccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCch-
Confidence 995 577777742 34678889999999999999999999 78999999999999999999999999988765433
Q ss_pred ccCCCccccccCCCCCCcccCChhhhc---cCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHH--HHHhhhccccccCC
Q 003384 618 ISSNNTTLCCRTDPKGTFAYMDPEFLA---SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ--YALDTGKLKNLLDP 692 (824)
Q Consensus 618 ~~~~~~~~~~~~~~~GT~~Y~APE~l~---~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~--~~~~~~~~~~~ld~ 692 (824)
.+++|||.|||||++. .|.|+-++|||||||+..||.-.+||+-..+.+. +.+..+. .|
T Consensus 180 -----------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNe-----sP 243 (948)
T KOG0577|consen 180 -----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE-----SP 243 (948)
T ss_pred -----------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcC-----CC
Confidence 4567999999999884 4789999999999999999999999976554432 2222211 11
Q ss_pred CCCCCChhhHHHHHHHHHHHhhhccCCCCCh
Q 003384 693 LAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 723 (824)
Q Consensus 693 ~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 723 (824)
... ....+..++.|+..||+.-|.+|||.
T Consensus 244 tLq--s~eWS~~F~~Fvd~CLqKipqeRpts 272 (948)
T KOG0577|consen 244 TLQ--SNEWSDYFRNFVDSCLQKIPQERPTS 272 (948)
T ss_pred CCC--CchhHHHHHHHHHHHHhhCcccCCcH
Confidence 111 23446789999999999999999997
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=302.15 Aligned_cols=241 Identities=24% Similarity=0.361 Sum_probs=192.5
Q ss_pred CCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--CCceEEEEEecCC
Q 003384 466 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPN 541 (824)
Q Consensus 466 f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~Ey~~g 541 (824)
|.....||.|+||.||+|... +..|++|.+........+.+.+|+.+++.++||||+++++++ .+..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 444568999999999999865 578999998655444455688999999999999999999987 4578999999999
Q ss_pred CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCC
Q 003384 542 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 621 (824)
Q Consensus 542 gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 621 (824)
++|.+++.. .++++..+..++.+++.||.|||+ ++|+||||+|+||+++.++.++|+|||++.........
T Consensus 101 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~-- 171 (285)
T cd06648 101 GALTDIVTH----TRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR-- 171 (285)
T ss_pred CCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc--
Confidence 999999853 458899999999999999999999 89999999999999999999999999988754332110
Q ss_pred CccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCChhh
Q 003384 622 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQ 701 (824)
Q Consensus 622 ~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~ 701 (824)
.....|++.|+|||.+.+..++.++|||||||++|+|++|++||........... +.....+ ....+...
T Consensus 172 ------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~---~~~~~~~-~~~~~~~~ 241 (285)
T cd06648 172 ------RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKR---IRDNLPP-KLKNLHKV 241 (285)
T ss_pred ------cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHH---HHhcCCC-CCcccccC
Confidence 1234589999999999888899999999999999999999999965443222111 1111111 11112234
Q ss_pred HHHHHHHHHHHhhhccCCCCChHH
Q 003384 702 AEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 702 ~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
+..+.+++.+||+.+|.+||++.+
T Consensus 242 ~~~l~~li~~~l~~~p~~Rpt~~~ 265 (285)
T cd06648 242 SPRLRSFLDRMLVRDPAQRATAAE 265 (285)
T ss_pred CHHHHHHHHHHcccChhhCcCHHH
Confidence 568999999999999999999943
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=290.92 Aligned_cols=243 Identities=30% Similarity=0.476 Sum_probs=197.3
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--CCceEEEEEecC
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLP 540 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~Ey~~ 540 (824)
.|...+.||+|+||.||+|... +..+++|++..........+.+|+.+++.++||||+++++++ ....++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3677788999999999999986 678999999776544556899999999999999999999987 456889999999
Q ss_pred CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccC
Q 003384 541 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 620 (824)
Q Consensus 541 ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 620 (824)
+++|.+++.... ..+++..+..++.+++.||.+||. ++++||||+|.||+++.++.++|+|||++........
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 999999985432 568999999999999999999999 8999999999999999999999999999886654321
Q ss_pred CCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCChh
Q 003384 621 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV 700 (824)
Q Consensus 621 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~ 700 (824)
.....|+..|+|||++.+..++.++||||||+++|+|++|++||.............. ........+..
T Consensus 154 -------~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~ 222 (253)
T cd05122 154 -------RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT----NGPPGLRNPEK 222 (253)
T ss_pred -------ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh----cCCCCcCcccc
Confidence 1234588999999999888899999999999999999999999976533222222111 11111111222
Q ss_pred hHHHHHHHHHHHhhhccCCCCChHH
Q 003384 701 QAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 701 ~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
.+..+.+++.+||+.+|.+||++.+
T Consensus 223 ~~~~~~~~i~~~l~~~p~~R~t~~~ 247 (253)
T cd05122 223 WSDEFKDFLKKCLQKNPEKRPTAEQ 247 (253)
T ss_pred cCHHHHHHHHHHccCChhhCCCHHH
Confidence 3568999999999999999999943
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=316.26 Aligned_cols=188 Identities=21% Similarity=0.319 Sum_probs=158.3
Q ss_pred CCCCccceeeecCceEEEEEEECC--eEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEec
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL 539 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~~--~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey~ 539 (824)
.+|...+.||+|+||.||+|...+ ..||+|+.... ....|+.++++++||||+++++++. ...++||||+
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 139 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY 139 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc
Confidence 468899999999999999999864 68999974322 3467999999999999999999883 4678999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccccc
Q 003384 540 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 619 (824)
Q Consensus 540 ~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 619 (824)
. |+|.+++.. ...++++..+..|+.||+.||.|||. ++||||||||+|||++.++.+||+|||+++.......
T Consensus 140 ~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~- 212 (357)
T PHA03209 140 S-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA- 212 (357)
T ss_pred C-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccccCcc-
Confidence 5 688888743 34568999999999999999999999 8999999999999999999999999999875322110
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCC-CCCC
Q 003384 620 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR-PALG 672 (824)
Q Consensus 620 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~-~Pf~ 672 (824)
.....||+.|+|||++.+..++.++|||||||++|||+++. ++|.
T Consensus 213 --------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~ 258 (357)
T PHA03209 213 --------FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFE 258 (357)
T ss_pred --------cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcccc
Confidence 12345899999999999999999999999999999999854 4444
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=324.86 Aligned_cols=191 Identities=23% Similarity=0.339 Sum_probs=161.2
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--CCceEEEEEe
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 538 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~Ey 538 (824)
...|.+...||+|+||.||+|.+. +..||||... ...+.+|+++|++|+|||||++++++ ....++||||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 446888999999999999999986 4779999632 23467899999999999999999987 4568899999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccc
Q 003384 539 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 618 (824)
Q Consensus 539 ~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 618 (824)
+. ++|.+++... ...+++..++.|+.|++.||.|||. +|||||||||+||||+.++.+||+|||+++.+.....
T Consensus 242 ~~-~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 242 YR-SDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred cC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 95 6888887432 3469999999999999999999999 8999999999999999999999999999986543211
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCC
Q 003384 619 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPAL 671 (824)
Q Consensus 619 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf 671 (824)
.. ......||+.|+|||++.+..++.++|||||||+||||++|..|+
T Consensus 316 ~~------~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 316 TP------FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred cc------cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 10 012356999999999999999999999999999999999987654
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=299.26 Aligned_cols=239 Identities=28% Similarity=0.410 Sum_probs=192.2
Q ss_pred CCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEecC
Q 003384 466 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLP 540 (824)
Q Consensus 466 f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey~~ 540 (824)
|...+.||.|+||.||+|... +..||||.+..... .....+.+|+.+++.++||||+++++++. +..++||||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 667788999999999999874 57899998764332 22356889999999999999999999884 46889999999
Q ss_pred CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccC
Q 003384 541 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 620 (824)
Q Consensus 541 ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 620 (824)
+|+|.+++. ...+++..+..++.+++.||.|||+ ++++|+||+|.||+++.++.++|+|||++..+.....
T Consensus 86 ~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-- 156 (277)
T cd06641 86 GGSALDLLE----PGPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-- 156 (277)
T ss_pred CCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccchh--
Confidence 999999884 2468899999999999999999999 8999999999999999999999999999876543211
Q ss_pred CCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCChh
Q 003384 621 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV 700 (824)
Q Consensus 621 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~ 700 (824)
......|+..|+|||++.+..++.++|||||||++|+|++|.+||............. .......+..
T Consensus 157 ------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~------~~~~~~~~~~ 224 (277)
T cd06641 157 ------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP------KNNPPTLEGN 224 (277)
T ss_pred ------hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHh------cCCCCCCCcc
Confidence 1123458899999999988889999999999999999999999997544322111110 0011122334
Q ss_pred hHHHHHHHHHHHhhhccCCCCChHH
Q 003384 701 QAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 701 ~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
.+..+.+++.+||+.+|.+||++.+
T Consensus 225 ~~~~~~~~i~~~l~~~p~~Rp~~~~ 249 (277)
T cd06641 225 YSKPLKEFVEACLNKEPSFRPTAKE 249 (277)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHH
Confidence 5678999999999999999999943
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=300.93 Aligned_cols=250 Identities=27% Similarity=0.401 Sum_probs=188.7
Q ss_pred hcCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCC-chhHHHHHHHHHhcCCCceeeEecccC--CceEEEE
Q 003384 462 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 536 (824)
Q Consensus 462 ~~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~-~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~ 536 (824)
++.+|...+.||+|+||.||+|... +..||+|++....... ...+.+|+.+++.++|+||+++++++. +..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4568999999999999999999875 6889999986543322 336789999999999999999999874 4578999
Q ss_pred EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccc
Q 003384 537 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 616 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 616 (824)
||+. ++|.+.+.. ....+++..+..++.|++.||.|||. .+|+|+||||+|||++.++.+||+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 83 EYMH-TDLAQYMIQ--HPGGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred eccc-CCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 9996 677666632 23457788889999999999999999 78999999999999999999999999998754322
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccC-CCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhh-----------
Q 003384 617 EISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG----------- 684 (824)
Q Consensus 617 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~----------- 684 (824)
... .....+++.|+|||++.+. .++.++|||||||++|+|+||.+||.........+...
T Consensus 157 ~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 228 (291)
T cd07870 157 SQT--------YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDT 228 (291)
T ss_pred CCC--------CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhh
Confidence 111 1223578999999998764 57889999999999999999999997554322111110
Q ss_pred -----ccccccCCC-----CCC----C-ChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 685 -----KLKNLLDPL-----AGD----W-PFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 685 -----~~~~~ld~~-----~~~----~-p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
.+....... ... + .......+.+++.+|+..+|.+||++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~ 284 (291)
T cd07870 229 WPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQD 284 (291)
T ss_pred hhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHH
Confidence 000000000 000 0 0112457889999999999999999943
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=308.65 Aligned_cols=240 Identities=24% Similarity=0.368 Sum_probs=200.2
Q ss_pred CCCCccceeeecCceEEEEEE--ECCeEEEEEEecCCCCCC--chhHHHHHHHHHhcCCCceeeEecccC--CceEEEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE 537 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~--~~~~~VAvK~l~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~E 537 (824)
+-|+..+.||+|.|..|-.++ +.|..||||++.+..... ..++.+|+..|+.++|||||+||.+.. ...|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 458888999999999998774 578999999998765544 356889999999999999999999874 57999999
Q ss_pred ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEec-CCCcceeeccccccccccc
Q 003384 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD-ANFVSKLSDFGISRFLSQN 616 (824)
Q Consensus 538 y~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld-~~~~vKL~DFGla~~~~~~ 616 (824)
+-.+|+|+|++.+.. ..+++....+++.||..|+.|+|+. .+|||||||+||.+- .-|-+||.|||++..+...
T Consensus 98 LGD~GDl~DyImKHe--~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHE--EGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred ecCCchHHHHHHhhh--ccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 999999999997544 4588889999999999999999994 599999999998875 5689999999999876654
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCC-cchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCC
Q 003384 617 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELT-PKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG 695 (824)
Q Consensus 617 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t-~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~ 695 (824)
.. .+...|+..|-|||++.+..|+ +++||||||||||-|++|++||.-.+..+ .+..++|-. .
T Consensus 173 ~k---------L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE------TLTmImDCK-Y 236 (864)
T KOG4717|consen 173 KK---------LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE------TLTMIMDCK-Y 236 (864)
T ss_pred ch---------hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh------hhhhhhccc-c
Confidence 31 1345699999999999999997 57899999999999999999996444322 233333322 2
Q ss_pred CCChhhHHHHHHHHHHHhhhccCCCCChH
Q 003384 696 DWPFVQAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 696 ~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
..|...+.+..+||..||..+|++|.+..
T Consensus 237 tvPshvS~eCrdLI~sMLvRdPkkRAslE 265 (864)
T KOG4717|consen 237 TVPSHVSKECRDLIQSMLVRDPKKRASLE 265 (864)
T ss_pred cCchhhhHHHHHHHHHHHhcCchhhccHH
Confidence 34778899999999999999999999983
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=300.55 Aligned_cols=238 Identities=25% Similarity=0.313 Sum_probs=195.0
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE 537 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~---~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~E 537 (824)
+|...+.||.|+||.||+|... +..||+|++..... ...+.+.+|+.++++++||||+++++++. +..++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4778889999999999999886 68899999875432 23457889999999999999999999884 46889999
Q ss_pred ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccc
Q 003384 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 617 (824)
Q Consensus 538 y~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 617 (824)
|+.|++|.+++.. ..+++...+..++.+++.||.|||. ++++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQ---KVKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 9999999999843 2578999999999999999999999 889999999999999999999999999987654332
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchH--HHHHHhhhccccccCCCCC
Q 003384 618 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE--VQYALDTGKLKNLLDPLAG 695 (824)
Q Consensus 618 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~--~~~~~~~~~~~~~ld~~~~ 695 (824)
. .....|+..|+|||++.+..++.++||||||+++|+|++|+.||..... ....... ......
T Consensus 155 ~---------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~------~~~~~~ 219 (258)
T cd05578 155 L---------TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAK------QETADV 219 (258)
T ss_pred c---------ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHH------hccccc
Confidence 1 1234588999999999888899999999999999999999999975542 1111111 110112
Q ss_pred CCChhhHHHHHHHHHHHhhhccCCCCCh
Q 003384 696 DWPFVQAEQLANLAMRCCEMSRKSRPEL 723 (824)
Q Consensus 696 ~~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 723 (824)
..|...+..+.+++.+||+.+|.+||+.
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~ 247 (258)
T cd05578 220 LYPATWSTEAIDAINKLLERDPQKRLGD 247 (258)
T ss_pred cCcccCcHHHHHHHHHHccCChhHcCCc
Confidence 2334456789999999999999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=301.19 Aligned_cols=248 Identities=26% Similarity=0.344 Sum_probs=189.1
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEe
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY 538 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey 538 (824)
+|+..+.||.|+||.||+|... +..||||.+...... ....+.+|++++++++||||+++++++. +..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4778889999999999999875 578999988654322 2346889999999999999999999884 468899999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccc
Q 003384 539 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 618 (824)
Q Consensus 539 ~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 618 (824)
+. ++|..++.... ...+++..+..++.+++.||.|||. ++++||||+|+||+++.++.+||+|||++..+.....
T Consensus 81 ~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 96 68888875432 3568999999999999999999999 8999999999999999999999999999875532211
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCC-CCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhcc-----------
Q 003384 619 SSNNTTLCCRTDPKGTFAYMDPEFLASGE-LTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL----------- 686 (824)
Q Consensus 619 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~----------- 686 (824)
. .....+++.|+|||++.+.. ++.++|||||||++|+|+||+.||...............
T Consensus 156 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (284)
T cd07860 156 T--------YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 227 (284)
T ss_pred c--------cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhh
Confidence 1 12335788999999887644 688999999999999999999999765433221110000
Q ss_pred -----------ccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 687 -----------KNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 687 -----------~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
...............+..+.+++.+||+.+|.+||++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ 277 (284)
T cd07860 228 VTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKA 277 (284)
T ss_pred hhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHH
Confidence 000000000001123457889999999999999999943
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=301.60 Aligned_cols=247 Identities=26% Similarity=0.324 Sum_probs=185.9
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEe
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY 538 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey 538 (824)
+|...+.||.|+||.||+|.+. +..||+|.+...... ....+.+|+.+++.++||||+++++++. ...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4777889999999999999885 678999998654222 2346788999999999999999999884 468899999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccc
Q 003384 539 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 618 (824)
Q Consensus 539 ~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 618 (824)
+. ++|.+++... ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++..+.....
T Consensus 81 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 81 CD-QDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 97 5787776432 3568999999999999999999999 8999999999999999999999999999876533211
Q ss_pred cCCCccccccCCCCCCcccCChhhhccC-CCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhh-----h--------
Q 003384 619 SSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT-----G-------- 684 (824)
Q Consensus 619 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~-----~-------- 684 (824)
. .....+++.|+|||++.+. .++.++|||||||++|+|+||..||............ +
T Consensus 155 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (284)
T cd07839 155 C--------YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWP 226 (284)
T ss_pred C--------cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhH
Confidence 0 1234578999999998775 4789999999999999999988775322211111100 0
Q ss_pred ccccccCC-CCC---------CCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 685 KLKNLLDP-LAG---------DWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 685 ~~~~~ld~-~~~---------~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
.+....+. ... ......+..+.+++.+||+.+|.+|||+.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ 277 (284)
T cd07839 227 GVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEE 277 (284)
T ss_pred HhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHH
Confidence 00000000 000 001123568899999999999999999943
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=299.52 Aligned_cols=249 Identities=26% Similarity=0.363 Sum_probs=191.5
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEec
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL 539 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey~ 539 (824)
+|+..+.||.|+||.||+|... +..||||.+...... ....+.+|+.++++++||||++++++|. +..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4778899999999999999985 678999998765332 2456788999999999999999999984 4689999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccccc
Q 003384 540 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 619 (824)
Q Consensus 540 ~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 619 (824)
++ +|.+++........+++..+..++.+++.||.|||+ ++++||||||+||+++.++.+||+|||++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 888887654444579999999999999999999999 8999999999999999999999999999975533211
Q ss_pred CCCccccccCCCCCCcccCChhhhccC-CCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhc---------ccc-
Q 003384 620 SNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK---------LKN- 688 (824)
Q Consensus 620 ~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~---------~~~- 688 (824)
......+++.|++||++.+. .++.++|||||||++|+|++|++||.............. +..
T Consensus 156 -------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd07836 156 -------TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGI 228 (284)
T ss_pred -------ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHH
Confidence 01234578999999998664 578899999999999999999999975543221110000 000
Q ss_pred -ccCCCCCC-----------CChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 689 -LLDPLAGD-----------WPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 689 -~ld~~~~~-----------~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
........ .....+..+.+++.+|++.+|.+||++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ 277 (284)
T cd07836 229 SQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHD 277 (284)
T ss_pred hcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHH
Confidence 00000000 11123467889999999999999999843
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=295.74 Aligned_cols=243 Identities=26% Similarity=0.397 Sum_probs=193.1
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEe
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY 538 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey 538 (824)
+|...+.||.|+||.||+|... +..||+|.+..... ...+.+.+|+.+++.++||||+++++.+. ...++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4777889999999999999885 57899999865422 23456889999999999999999999884 457899999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCC-cceeecccccccccccc
Q 003384 539 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF-VSKLSDFGISRFLSQNE 617 (824)
Q Consensus 539 ~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~-~vKL~DFGla~~~~~~~ 617 (824)
+++++|.+++... ....+++..+..++.+++.||.|||+ .+++|+||||+||+++.++ .+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 9999999988543 23458999999999999999999999 7899999999999999886 56999999987654322
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCC
Q 003384 618 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 697 (824)
Q Consensus 618 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~ 697 (824)
.. .....|++.|+|||++.+..++.++|||||||++|+|++|..||............ ....+.+ .
T Consensus 157 ~~--------~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~--~~~~~~~----~ 222 (257)
T cd08225 157 EL--------AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKI--CQGYFAP----I 222 (257)
T ss_pred cc--------ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH--hcccCCC----C
Confidence 11 02235899999999998888999999999999999999999999755432222111 1111111 1
Q ss_pred ChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 698 PFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 698 p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
+...+..+.+++.+||..+|.+||++.+
T Consensus 223 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ 250 (257)
T cd08225 223 SPNFSRDLRSLISQLFKVSPRDRPSITS 250 (257)
T ss_pred CCCCCHHHHHHHHHHhccChhhCcCHHH
Confidence 2234568999999999999999999943
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=298.84 Aligned_cols=247 Identities=25% Similarity=0.339 Sum_probs=188.9
Q ss_pred CCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEec
Q 003384 466 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL 539 (824)
Q Consensus 466 f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey~ 539 (824)
|+..+.||.|++|.||+|.+. +..||+|++...... ....+.+|+++++.++||||+++++++. +..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 566788999999999999874 688999998754322 2356889999999999999999999884 4688999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccccc
Q 003384 540 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 619 (824)
Q Consensus 540 ~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 619 (824)
+ ++|.+++.... ...+++..+..++.+++.||.|||. ++++||||+|+|||++.++.++|+|||++..+......
T Consensus 81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT 155 (283)
T ss_pred C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence 5 68998885332 2368999999999999999999999 89999999999999999999999999998755322110
Q ss_pred CCCccccccCCCCCCcccCChhhhccC-CCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhc-------------
Q 003384 620 SNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK------------- 685 (824)
Q Consensus 620 ~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~------------- 685 (824)
.....+++.|+|||++.+. .++.++|||||||++|+|+||++||..............
T Consensus 156 --------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (283)
T cd07835 156 --------YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGV 227 (283)
T ss_pred --------cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhh
Confidence 1233578999999988664 578899999999999999999999975543322111000
Q ss_pred ---------cccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 686 ---------LKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 686 ---------~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
+...............+..+.+++.+|++.+|.+||++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ 276 (283)
T cd07835 228 TSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKA 276 (283)
T ss_pred hhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHH
Confidence 0000000001112233467899999999999999999943
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=295.13 Aligned_cols=244 Identities=25% Similarity=0.368 Sum_probs=193.8
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC-----CCchhHHHHHHHHHhcCCCceeeEecccCC----ce
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-----QGPSEFQQEIDILSKIRHPNLVTLVGACPE----VW 532 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~-----~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~~----~~ 532 (824)
.+|...+.||+|+||.||+|... +..||+|.+..... .....+.+|+.++++++||||+++++++.+ .+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46888999999999999999874 57899998754311 123468899999999999999999998732 47
Q ss_pred EEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccc
Q 003384 533 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 612 (824)
Q Consensus 533 ~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~ 612 (824)
++||||+++++|.+++.. ...+++.....++.+++.||.|||+ .+++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECccccccc
Confidence 899999999999999853 3458889999999999999999999 8999999999999999999999999999986
Q ss_pred cccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCC
Q 003384 613 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDP 692 (824)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~ 692 (824)
......... ......|+..|+|||++.+..++.++|||||||++|+|++|++||............. ..+
T Consensus 156 ~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-----~~~ 225 (264)
T cd06653 156 IQTICMSGT-----GIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIA-----TQP 225 (264)
T ss_pred cccccccCc-----cccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHH-----cCC
Confidence 532211100 0123458999999999998889999999999999999999999997654433222111 111
Q ss_pred CCCCCChhhHHHHHHHHHHHhhhccCCCCChH
Q 003384 693 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 693 ~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
.....|......+.+++.+||. +|..||+..
T Consensus 226 ~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~ 256 (264)
T cd06653 226 TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAE 256 (264)
T ss_pred CCCCCCcccCHHHHHHHHHHhc-CcccCccHH
Confidence 2233455667889999999999 579999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=299.74 Aligned_cols=247 Identities=26% Similarity=0.322 Sum_probs=188.7
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHHhcC-CCceeeEecccC--Cc-----e
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIR-HPNLVTLVGACP--EV-----W 532 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~--~~~~f~~Ei~iL~~l~-HpnIv~L~g~~~--~~-----~ 532 (824)
+|+..+.||+|+||.||+|.+. +..||||.+...... ....+.+|+.+++.+. ||||+++++++. +. .
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~ 81 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL 81 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence 6888899999999999999875 578999987654321 2356889999999995 699999999873 22 6
Q ss_pred EEEEEecCCCChhhhhhccCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecC-CCcceeecccc
Q 003384 533 TLVYEYLPNGSLEDRLSCKDN--SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA-NFVSKLSDFGI 609 (824)
Q Consensus 533 ~LV~Ey~~ggsL~~~L~~~~~--~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~-~~~vKL~DFGl 609 (824)
++||||+++ +|.+++..... ...+++..+..++.||+.||.|||. ++|+||||||+||+++. ++.+||+|||+
T Consensus 82 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg~ 157 (295)
T cd07837 82 YLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGL 157 (295)
T ss_pred EEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeeccc
Confidence 899999985 78888754322 3568999999999999999999999 89999999999999998 89999999999
Q ss_pred ccccccccccCCCccccccCCCCCCcccCChhhhcc-CCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhcccc
Q 003384 610 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKN 688 (824)
Q Consensus 610 a~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~ 688 (824)
+..+...... .....+++.|+|||++.+ ..++.++|||||||++|+|++|.+||...............
T Consensus 158 ~~~~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~-- 227 (295)
T cd07837 158 GRAFSIPVKS--------YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKL-- 227 (295)
T ss_pred ceecCCCccc--------cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH--
Confidence 8755322111 122347889999998865 45789999999999999999999999765543322111000
Q ss_pred ccCCCCC-----------------------CCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 689 LLDPLAG-----------------------DWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 689 ~ld~~~~-----------------------~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
+..+... ......+..+.+++.+||..+|.+||++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~e 287 (295)
T cd07837 228 LGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKA 287 (295)
T ss_pred hCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHH
Confidence 0000000 000124567899999999999999999843
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=303.44 Aligned_cols=257 Identities=17% Similarity=0.193 Sum_probs=180.4
Q ss_pred CCCCccceeeecCceEEEEEEECCe-----EEEEEEecCCCCCCch-----------hHHHHHHHHHhcCCCceeeEecc
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLRHM-----QVAIKMLHPHSLQGPS-----------EFQQEIDILSKIRHPNLVTLVGA 527 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~~~-----~VAvK~l~~~~~~~~~-----------~f~~Ei~iL~~l~HpnIv~L~g~ 527 (824)
+.|.+.++||+|+||.||+|.+.+. .+|+|+.......... ....+...+..+.|+||++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 5789999999999999999987643 5677764332211100 11223344556789999999987
Q ss_pred cCC------ceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCc
Q 003384 528 CPE------VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV 601 (824)
Q Consensus 528 ~~~------~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~ 601 (824)
+.. ..+++++++. .++.+.+.. ...+++..+..|+.|++.||.|||+ ++|+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLV-ENTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGNNR 164 (294)
T ss_pred eeEecCCceEEEEEEehhc-cCHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCc
Confidence 532 2367788774 466666632 2335778889999999999999999 89999999999999999999
Q ss_pred ceeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHH---
Q 003384 602 SKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ--- 678 (824)
Q Consensus 602 vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~--- 678 (824)
+||+|||+|+.+.......... ........||+.|+|||++.+..++.++|||||||+||||++|++||.......
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~-~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYS-KEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred EEEEEcCCceeeccCCcccccc-cccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 9999999998764322111100 011123469999999999999999999999999999999999999997552111
Q ss_pred HHHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHH
Q 003384 679 YALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVL 731 (824)
Q Consensus 679 ~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L 731 (824)
.....+....+..... .+...+..+.+++..|+..+|.+||++ +.+.+.|
T Consensus 244 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~rp~~-~~l~~~~ 293 (294)
T PHA02882 244 HAAKCDFIKRLHEGKI--KIKNANKFIYDFIECVTKLSYEEKPDY-DALIKIF 293 (294)
T ss_pred HHhHHHHHHHhhhhhh--ccCCCCHHHHHHHHHHHhCCCCCCCCH-HHHHHhh
Confidence 1111111111111100 112335789999999999999999999 5565543
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=298.61 Aligned_cols=242 Identities=26% Similarity=0.384 Sum_probs=185.3
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC-CchhHHHHHHH-HHhcCCCceeeEeccc--CCceEEEEEe
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDI-LSKIRHPNLVTLVGAC--PEVWTLVYEY 538 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~-~~~~f~~Ei~i-L~~l~HpnIv~L~g~~--~~~~~LV~Ey 538 (824)
+|+....||+|+||.||+|... +..||||.+...... ....+..|+.+ ++.++||||+++++++ ....++||||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~ 81 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEV 81 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhh
Confidence 6888899999999999999885 688999998754322 23356667765 5667899999999988 4468999999
Q ss_pred cCCCChhhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-ceEeccccCCcEEecCCCcceeeccccccccccc
Q 003384 539 LPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPH-SIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 616 (824)
Q Consensus 539 ~~ggsL~~~L~~~-~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~-giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 616 (824)
++ |+|.+++... .....+++..+..++.|++.||.|||+ + +++||||||+|||++.++.+||+|||++..+...
T Consensus 82 ~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 82 MD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 96 6888777542 234579999999999999999999998 5 8999999999999999999999999998865322
Q ss_pred cccCCCccccccCCCCCCcccCChhhhcc----CCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCC
Q 003384 617 EISSNNTTLCCRTDPKGTFAYMDPEFLAS----GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDP 692 (824)
Q Consensus 617 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~----~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~ 692 (824)
.. .....|+..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.........+.. ....
T Consensus 158 ~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~-----~~~~ 223 (283)
T cd06617 158 VA---------KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQ-----VVEE 223 (283)
T ss_pred cc---------cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHH-----HHhc
Confidence 11 122458899999998865 45788999999999999999999999642211111111 0111
Q ss_pred CCCCCC-hhhHHHHHHHHHHHhhhccCCCCChH
Q 003384 693 LAGDWP-FVQAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 693 ~~~~~p-~~~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
.....+ ...+..+.+++.+||..+|.+||++.
T Consensus 224 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~ 256 (283)
T cd06617 224 PSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYP 256 (283)
T ss_pred CCCCCCccccCHHHHHHHHHHccCChhhCcCHH
Confidence 111111 12456899999999999999999994
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=302.99 Aligned_cols=201 Identities=25% Similarity=0.359 Sum_probs=163.7
Q ss_pred CCCccceeeecCceEEEEEEEC----CeEEEEEEecCCC---CCCchhHHHHHHHHHhcCCCceeeEecccC----CceE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR----HMQVAIKMLHPHS---LQGPSEFQQEIDILSKIRHPNLVTLVGACP----EVWT 533 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~----~~~VAvK~l~~~~---~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~----~~~~ 533 (824)
.|.....||+|+||.||+|... +..||+|.+.... ......+.+|+.+++.++||||++++++|. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 3677889999999999999874 5789999988643 222356788999999999999999999884 4588
Q ss_pred EEEEecCCCChhhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecC----CCcceeecc
Q 003384 534 LVYEYLPNGSLEDRLSCK--DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA----NFVSKLSDF 607 (824)
Q Consensus 534 LV~Ey~~ggsL~~~L~~~--~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~----~~~vKL~DF 607 (824)
+||||+++ +|.+++... .....++...+..++.|++.||.|||+ ++|+||||||+|||++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 666665322 122478999999999999999999999 89999999999999999 999999999
Q ss_pred ccccccccccccCCCccccccCCCCCCcccCChhhhccC-CCCcchhHHhHHHHHHHHHhCCCCCCCc
Q 003384 608 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGIT 674 (824)
Q Consensus 608 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDVwSlGvvL~ELltG~~Pf~~~ 674 (824)
|++..+....... .......+|+.|+|||++.+. .++.++|||||||++|+|++|++||...
T Consensus 157 g~~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 219 (316)
T cd07842 157 GLARLFNAPLKPL-----ADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGR 219 (316)
T ss_pred ccccccCCCcccc-----cccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCC
Confidence 9998664432110 111234689999999988764 5889999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=307.41 Aligned_cols=250 Identities=23% Similarity=0.338 Sum_probs=188.4
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccCC-------ce
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACPE-------VW 532 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~~-------~~ 532 (824)
+++|...+.||+|+||.||+|... +..||||.+..... .....+.+|+.++++++||||+++++++.. ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 457999999999999999999875 57899999864322 223467889999999999999999987632 36
Q ss_pred EEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccc
Q 003384 533 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 612 (824)
Q Consensus 533 ~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~ 612 (824)
++||||+. ++|.+++. ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++..
T Consensus 84 ~lv~e~~~-~~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELME-TDLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhcc-cCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccceee
Confidence 89999996 47877773 3468999999999999999999999 8999999999999999999999999999986
Q ss_pred cccccccCCCccccccCCCCCCcccCChhhhcc-CCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhh--------
Q 003384 613 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT-------- 683 (824)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~-------- 683 (824)
......... ......||+.|+|||.+.+ ..++.++|||||||++|+|++|++||...+........
T Consensus 156 ~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~ 230 (336)
T cd07849 156 ADPEHDHTG-----FLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPS 230 (336)
T ss_pred ccccccccC-----CcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 543221111 1123468999999998755 46889999999999999999999999654322110000
Q ss_pred -hccccccC----------CCCCC--C---ChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 684 -GKLKNLLD----------PLAGD--W---PFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 684 -~~~~~~ld----------~~~~~--~---p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
..+..+.+ +.... + ....+..+.+++.+||+.+|.+||++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e 288 (336)
T cd07849 231 QEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEE 288 (336)
T ss_pred HHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHH
Confidence 00000000 00000 0 0123457899999999999999999943
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=300.46 Aligned_cols=248 Identities=26% Similarity=0.360 Sum_probs=190.7
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCC--chhHHHHHHHHHhcCCCceeeEeccc--C--CceEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGAC--P--EVWTLV 535 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~L~g~~--~--~~~~LV 535 (824)
.+|...+.||.|+||.||+|.+. +..||+|.+....... ...+.+|+.++.+++||||+++++++ . ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 36788889999999999999986 5789999987543221 23567899999999999999999987 3 568999
Q ss_pred EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccc
Q 003384 536 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 615 (824)
Q Consensus 536 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~ 615 (824)
|||+. ++|.+++.... ..+++..+..++.|++.||.|||+ ++++||||||+|||++.++.+||+|||++..+..
T Consensus 85 ~e~~~-~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVE-HDLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcC-cCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 99997 48998885432 368999999999999999999999 8999999999999999999999999999986654
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccC-CCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhh----------
Q 003384 616 NEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG---------- 684 (824)
Q Consensus 616 ~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~---------- 684 (824)
.... .....+++.|+|||++.+. .++.++|||||||++|+|++|.+||.............
T Consensus 159 ~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 230 (293)
T cd07843 159 PLKP--------YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKI 230 (293)
T ss_pred Cccc--------cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHH
Confidence 3211 1233578999999998764 46889999999999999999999997543322110000
Q ss_pred -------------ccccc-cCCCCCCCChh-hHHHHHHHHHHHhhhccCCCCChHH
Q 003384 685 -------------KLKNL-LDPLAGDWPFV-QAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 685 -------------~~~~~-ld~~~~~~p~~-~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
..... .......++.. .+..+.+++.+||+.+|.+||++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~e 286 (293)
T cd07843 231 WPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAED 286 (293)
T ss_pred HHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHH
Confidence 00000 00011122222 4677899999999999999999843
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=295.12 Aligned_cols=245 Identities=27% Similarity=0.355 Sum_probs=190.9
Q ss_pred eeecCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEecCCCCh
Q 003384 472 IGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNGSL 544 (824)
Q Consensus 472 LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~---~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey~~ggsL 544 (824)
||.|+||.||++.+. +..|++|++..... .....+.+|++++++++||||+++++.+. ...++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999986 68899999876543 23456889999999999999999998874 468899999999999
Q ss_pred hhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCCCcc
Q 003384 545 EDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 624 (824)
Q Consensus 545 ~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~ 624 (824)
.+++... ..+++..+..++.|++.||.|||. .+++||||+|+||+++.++.+||+|||++..............
T Consensus 81 ~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENV---GSLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 9998533 368999999999999999999999 8999999999999999999999999999875443211100000
Q ss_pred ccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCChhh--H
Q 003384 625 LCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQ--A 702 (824)
Q Consensus 625 ~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~--~ 702 (824)
........++..|+|||.+....++.++||||||+++|+|++|.+||.............. . ...++... +
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~-----~~~~~~~~~~~ 227 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN--G-----KIEWPEDVEVS 227 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--C-----CcCCCccccCC
Confidence 0011234578899999999888899999999999999999999999975543222111100 0 11122222 6
Q ss_pred HHHHHHHHHHhhhccCCCCChHHHHHHH
Q 003384 703 EQLANLAMRCCEMSRKSRPELGKDVWRV 730 (824)
Q Consensus 703 ~~l~~Li~~Cl~~~P~~RPt~~~~v~~~ 730 (824)
..+.+++.+||+.+|.+||++ ..+.+.
T Consensus 228 ~~~~~~i~~~l~~~p~~Rpt~-~~~~~~ 254 (265)
T cd05579 228 DEAIDLISKLLVPDPEKRLGA-KSIEEI 254 (265)
T ss_pred HHHHHHHHHHhcCCHhhcCCC-ccHHHH
Confidence 789999999999999999998 344333
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=294.23 Aligned_cols=243 Identities=24% Similarity=0.365 Sum_probs=197.2
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEec
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL 539 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey~ 539 (824)
+|...+.||.|+||.||+|... +..|+||++..... .....+.+|+.++..++||||+++++++. ...++||||+
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM 81 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence 6788899999999999999886 58899999876543 23467999999999999999999999884 4688999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccccc
Q 003384 540 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 619 (824)
Q Consensus 540 ~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 619 (824)
++++|.+++... .+++...+..++.+++.||.|||.. .+++||||+|+||+++.++.++|+|||++.........
T Consensus 82 ~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~--~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 82 DGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred CCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhcc--CCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 999999999532 6689999999999999999999973 47999999999999999999999999998866433211
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCch--HHHHHHhhhccccccCCCCCCC
Q 003384 620 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITK--EVQYALDTGKLKNLLDPLAGDW 697 (824)
Q Consensus 620 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~--~~~~~~~~~~~~~~ld~~~~~~ 697 (824)
. ....|+..|+|||.+.+..++.++||||||+++|+|+||++||.... ........ +........
T Consensus 157 ~--------~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~-----~~~~~~~~~ 223 (264)
T cd06623 157 C--------NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQA-----ICDGPPPSL 223 (264)
T ss_pred c--------cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHH-----HhcCCCCCC
Confidence 1 23357899999999998899999999999999999999999996653 11111111 111111222
Q ss_pred Chh-hHHHHHHHHHHHhhhccCCCCChHH
Q 003384 698 PFV-QAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 698 p~~-~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
+.. .+..+.+++.+||..+|.+||++.+
T Consensus 224 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~ 252 (264)
T cd06623 224 PAEEFSPEFRDFISACLQKDPKKRPSAAE 252 (264)
T ss_pred CcccCCHHHHHHHHHHccCChhhCCCHHH
Confidence 333 5678999999999999999999943
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=290.04 Aligned_cols=246 Identities=27% Similarity=0.412 Sum_probs=198.2
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHHhcCCCceeeEecccC----CceEEEE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP----EVWTLVY 536 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~----~~~~LV~ 536 (824)
+|...+.||+|+||.||+|... +..|++|++..... .....+.+|+.++++++||||+++++.+. ...++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 3667788999999999999987 68899999876543 23467899999999999999999999874 4578999
Q ss_pred EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccc
Q 003384 537 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 616 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 616 (824)
||+++++|.+++... ..+++..+..++.+++.||.|||+ .+++|+||+|+||+++.++.+||+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKF---GKLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 999999999998533 379999999999999999999999 89999999999999999999999999999876554
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCC
Q 003384 617 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 696 (824)
Q Consensus 617 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~ 696 (824)
... .......++..|+|||.+.+..++.++||||||+++|+|++|..||............ ... ......
T Consensus 155 ~~~------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~--~~~--~~~~~~ 224 (260)
T cd06606 155 ETG------EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYK--IGS--SGEPPE 224 (260)
T ss_pred ccc------ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHh--ccc--cCCCcC
Confidence 321 0012345899999999998888999999999999999999999999765421111111 000 011122
Q ss_pred CChhhHHHHHHHHHHHhhhccCCCCChHHH
Q 003384 697 WPFVQAEQLANLAMRCCEMSRKSRPELGKD 726 (824)
Q Consensus 697 ~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~ 726 (824)
.+...+..+.+++.+|++.+|.+||++.+.
T Consensus 225 ~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~l 254 (260)
T cd06606 225 IPEHLSEEAKDFLRKCLRRDPKKRPTADEL 254 (260)
T ss_pred CCcccCHHHHHHHHHhCcCChhhCCCHHHH
Confidence 344457799999999999999999999443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=299.96 Aligned_cols=236 Identities=25% Similarity=0.339 Sum_probs=187.4
Q ss_pred eeecCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEecCCCCh
Q 003384 472 IGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNGSL 544 (824)
Q Consensus 472 LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~---~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey~~ggsL 544 (824)
||+|+||+||++... +..||+|.+..... .....+..|+.+|+.++||||+++++++. +..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999765 57899999865322 12345678999999999999999999873 468999999999999
Q ss_pred hhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCCCcc
Q 003384 545 EDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 624 (824)
Q Consensus 545 ~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~ 624 (824)
.+++..... ..+++..+..++.+++.||.|||. .+++||||+|+|||++.++.+||+|||++........
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~------ 150 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK------ 150 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc------
Confidence 999864332 468999999999999999999999 8999999999999999999999999999876543211
Q ss_pred ccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHH--HHHHhhhccccccCCCCCCCChhhH
Q 003384 625 LCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEV--QYALDTGKLKNLLDPLAGDWPFVQA 702 (824)
Q Consensus 625 ~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~--~~~~~~~~~~~~ld~~~~~~p~~~~ 702 (824)
.....|+..|+|||++.+..++.++|||||||++|+|++|+.||...... ...+..... ......+...+
T Consensus 151 ---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~ 222 (277)
T cd05577 151 ---IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTL-----EMAVEYPDKFS 222 (277)
T ss_pred ---cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccc-----cccccCCccCC
Confidence 12335788999999998888999999999999999999999999654321 111111111 11122333456
Q ss_pred HHHHHHHHHHhhhccCCCCChHH
Q 003384 703 EQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 703 ~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
..+.+++.+||+.+|.+||++.+
T Consensus 223 ~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 223 PEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred HHHHHHHHHHccCChhHccCCCc
Confidence 78999999999999999996643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=297.36 Aligned_cols=232 Identities=25% Similarity=0.338 Sum_probs=189.2
Q ss_pred eeecCceEEEEEEEC--CeEEEEEEecCCCCC---CchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEecCCCCh
Q 003384 472 IGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNGSL 544 (824)
Q Consensus 472 LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~---~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey~~ggsL 544 (824)
||.|+||.||+|... +..||+|++...... ....+.+|+.+++.++||||+++++.+. ...++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999987 688999998754322 2356899999999999999999999874 468899999999999
Q ss_pred hhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCCCcc
Q 003384 545 EDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 624 (824)
Q Consensus 545 ~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~ 624 (824)
.+++.. ...++...+..++.+++.||.|||+ ++++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~------ 148 (262)
T cd05572 81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK------ 148 (262)
T ss_pred HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccc------
Confidence 999953 3458899999999999999999999 8999999999999999999999999999986643310
Q ss_pred ccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCch--HHHHHHhhhccccccC-CCCCCCChhh
Q 003384 625 LCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITK--EVQYALDTGKLKNLLD-PLAGDWPFVQ 701 (824)
Q Consensus 625 ~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~--~~~~~~~~~~~~~~ld-~~~~~~p~~~ 701 (824)
.....|++.|++||.+.+..++.++|+||||+++|+|++|.+||.... ....... ... ......|...
T Consensus 149 ---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~------~~~~~~~~~~~~~~ 219 (262)
T cd05572 149 ---TWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYND------ILKGNGKLEFPNYI 219 (262)
T ss_pred ---cccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHH------HhccCCCCCCCccc
Confidence 022357899999999988889999999999999999999999997654 2111111 110 1122334444
Q ss_pred HHHHHHHHHHHhhhccCCCCChH
Q 003384 702 AEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 702 ~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
+..+.+++.+||+.+|.+||++.
T Consensus 220 ~~~~~~~i~~~l~~~p~~R~~~~ 242 (262)
T cd05572 220 DKAAKDLIKQLLRRNPEERLGNL 242 (262)
T ss_pred CHHHHHHHHHHccCChhhCcCCc
Confidence 67899999999999999999953
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=296.77 Aligned_cols=242 Identities=27% Similarity=0.383 Sum_probs=193.0
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEeccc--CCceEEEEEec
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 539 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~Ey~ 539 (824)
+|+..+.||.|+||.||++... +..||+|.+..... .....+.+|+++++.++||||+++++.+ ....++|+||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5677788999999999999886 57899999876532 2335688999999999999999999987 34688999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccccc
Q 003384 540 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 619 (824)
Q Consensus 540 ~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 619 (824)
++++|.+++.... .+++...+..++.+++.||.|||.. .+++|+||||+||+++.++.+||+|||++........
T Consensus 82 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~--~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 156 (265)
T cd06605 82 DGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEK--HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA- 156 (265)
T ss_pred CCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCC--CCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-
Confidence 9999999985332 5788999999999999999999982 5799999999999999999999999999876543211
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCch----HHHHHHhhhccccccCCCCC
Q 003384 620 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITK----EVQYALDTGKLKNLLDPLAG 695 (824)
Q Consensus 620 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~----~~~~~~~~~~~~~~ld~~~~ 695 (824)
....|+..|+|||++.+..++.++|||||||++|+|++|+.||.... ....... ........
T Consensus 157 ---------~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~ 222 (265)
T cd06605 157 ---------KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQ-----YIVNEPPP 222 (265)
T ss_pred ---------hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHH-----HHhcCCCC
Confidence 11458899999999998899999999999999999999999996542 1111111 11111111
Q ss_pred CCChh-hHHHHHHHHHHHhhhccCCCCChHH
Q 003384 696 DWPFV-QAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 696 ~~p~~-~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
..+.. .+..+.+++.+||..+|.+||++.+
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ 253 (265)
T cd06605 223 RLPSGKFSPDFQDFVNLCLIKDPRERPSYKE 253 (265)
T ss_pred CCChhhcCHHHHHHHHHHcCCCchhCcCHHH
Confidence 11222 5668999999999999999999843
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=298.87 Aligned_cols=238 Identities=25% Similarity=0.310 Sum_probs=198.1
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCch---hHHHHHHHHHhcCCCceeeEeccc--CCceEEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPS---EFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVY 536 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~---~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~ 536 (824)
++|+..++||+|.||+|-.++-+ ++.+|||++++......+ .-..|-.+|+..+||.+..|-.+| .+..|.||
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 47889999999999999988654 578999999876443333 456789999999999999998887 46799999
Q ss_pred EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccc
Q 003384 537 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 616 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 616 (824)
||..||.|..+|. ....++......+..+|..||.|||+ ++||.||||.+|+|||.+|++||+|||||+--...
T Consensus 248 eyanGGeLf~HLs---rer~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~ 321 (516)
T KOG0690|consen 248 EYANGGELFFHLS---RERVFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY 321 (516)
T ss_pred EEccCceEeeehh---hhhcccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhcccc
Confidence 9999999999984 34568888888899999999999999 89999999999999999999999999999843222
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCC
Q 003384 617 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 696 (824)
Q Consensus 617 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~ 696 (824)
+ .. .....|||.|+|||++....|+..+|+|.+|||+|||++|+.||...++ +++.+++-.....
T Consensus 322 g--~t------~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh-------~kLFeLIl~ed~k 386 (516)
T KOG0690|consen 322 G--DT------TKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH-------EKLFELILMEDLK 386 (516)
T ss_pred c--ce------eccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch-------hHHHHHHHhhhcc
Confidence 1 11 1446699999999999999999999999999999999999999965433 3333333333445
Q ss_pred CChhhHHHHHHHHHHHhhhccCCCCC
Q 003384 697 WPFVQAEQLANLAMRCCEMSRKSRPE 722 (824)
Q Consensus 697 ~p~~~~~~l~~Li~~Cl~~~P~~RPt 722 (824)
+|...+++...|+.-.|..+|.+|-.
T Consensus 387 FPr~ls~eAktLLsGLL~kdP~kRLG 412 (516)
T KOG0690|consen 387 FPRTLSPEAKTLLSGLLKKDPKKRLG 412 (516)
T ss_pred CCccCCHHHHHHHHHHhhcChHhhcC
Confidence 67788889999999999999999953
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=300.53 Aligned_cols=240 Identities=28% Similarity=0.377 Sum_probs=188.6
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCC---chhHHHHHHHHHhcCCCceeeEecccC--CceEEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 536 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~---~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~ 536 (824)
..|...+.||+|+||.||+|... +..||+|.+....... ...+.+|+.+++.++||||++++++|. +..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45888899999999999999874 6889999986543322 245889999999999999999999884 4688999
Q ss_pred EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccc
Q 003384 537 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 616 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 616 (824)
||++ |+|.+.+... ..++++..+..++.|++.||.|||. .+|+||||+|+||+++.++.+||+|||++......
T Consensus 95 e~~~-g~l~~~~~~~--~~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 95 EYCL-GSASDILEVH--KKPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred HhhC-CCHHHHHHHc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 9997 5777766422 3468999999999999999999999 88999999999999999999999999998754322
Q ss_pred cccCCCccccccCCCCCCcccCChhhhc---cCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCC
Q 003384 617 EISSNNTTLCCRTDPKGTFAYMDPEFLA---SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPL 693 (824)
Q Consensus 617 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~---~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~ 693 (824)
....|++.|+|||++. ...++.++|||||||++|+|+||++||.............. .. .+.
T Consensus 169 ------------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~-~~--~~~ 233 (307)
T cd06607 169 ------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-ND--SPT 233 (307)
T ss_pred ------------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhc-CC--CCC
Confidence 1235788999999874 35688899999999999999999999976543332211110 00 010
Q ss_pred CCCCChhhHHHHHHHHHHHhhhccCCCCChHHH
Q 003384 694 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD 726 (824)
Q Consensus 694 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~ 726 (824)
..+...+..+.+++.+||+.+|.+||++.+.
T Consensus 234 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 264 (307)
T cd06607 234 --LSSNDWSDYFRNFVDSCLQKIPQDRPSSEEL 264 (307)
T ss_pred --CCchhhCHHHHHHHHHHhcCChhhCcCHHHH
Confidence 0122345689999999999999999999443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=299.46 Aligned_cols=248 Identities=25% Similarity=0.306 Sum_probs=186.4
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC-CchhHHHHHHHHHhcC-CCceeeEeccc--CCceEEEEEe
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIR-HPNLVTLVGAC--PEVWTLVYEY 538 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l~-HpnIv~L~g~~--~~~~~LV~Ey 538 (824)
+|.....||+|+||.||++... +..||+|.+...... ....+.+|+.++.++. ||||++++|++ ....+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 3555678999999999999885 578999998754322 2346889999999996 99999999987 3467899999
Q ss_pred cCCCChhhhhhc--cCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccc
Q 003384 539 LPNGSLEDRLSC--KDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 616 (824)
Q Consensus 539 ~~ggsL~~~L~~--~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 616 (824)
+. ++|.++... ......+++.....++.+++.||.|||+. .+|+||||||+|||++.++.+||+|||++..+...
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 86 455554321 12235689999999999999999999972 37999999999999999999999999999765432
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccC---CCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCC
Q 003384 617 EISSNNTTLCCRTDPKGTFAYMDPEFLASG---ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPL 693 (824)
Q Consensus 617 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~---~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~ 693 (824)
... ....|++.|+|||++.+. .++.++|||||||++|+|++|++||.........+... ........
T Consensus 162 ~~~---------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~-~~~~~~~~ 231 (288)
T cd06616 162 IAK---------TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQV-VKGDPPIL 231 (288)
T ss_pred Ccc---------ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhh-cCCCCCcC
Confidence 111 223589999999998776 68999999999999999999999996543221111111 00000011
Q ss_pred CCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 694 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 694 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
....+...+..+.+|+.+||+.+|.+||++.+
T Consensus 232 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ 263 (288)
T cd06616 232 SNSEEREFSPSFVNFINLCLIKDESKRPKYKE 263 (288)
T ss_pred CCcCCCccCHHHHHHHHHHccCChhhCcCHHH
Confidence 11112335678999999999999999999943
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=288.59 Aligned_cols=241 Identities=28% Similarity=0.435 Sum_probs=196.6
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEe
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY 538 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey 538 (824)
+|...+.||+|+||.||+|... +..|++|.+..... .....+.+|++++++++|||++++++++. ...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4677889999999999999875 47899999976644 23457899999999999999999999874 467899999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccc
Q 003384 539 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 618 (824)
Q Consensus 539 ~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 618 (824)
+++++|.+++.. ..++++..+..++.+++.||.|||. +||+||||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKK---FGPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 999999999843 3578999999999999999999999 8999999999999999999999999999987654321
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCC
Q 003384 619 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWP 698 (824)
Q Consensus 619 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p 698 (824)
. .....|+..|+|||.+.+..++.++||||||+++|+|++|++||............. .......+
T Consensus 155 ~--------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~------~~~~~~~~ 220 (254)
T cd06627 155 D--------DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV------QDDHPPLP 220 (254)
T ss_pred c--------ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh------ccCCCCCC
Confidence 1 123458999999999988888999999999999999999999997554322221111 01112233
Q ss_pred hhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 699 FVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 699 ~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
...+..+.+++.+||..+|++||++.+
T Consensus 221 ~~~~~~~~~~i~~~l~~~p~~R~~~~~ 247 (254)
T cd06627 221 EGISPELKDFLMQCFQKDPNLRPTAKQ 247 (254)
T ss_pred CCCCHHHHHHHHHHHhCChhhCcCHHH
Confidence 445678999999999999999999843
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=300.86 Aligned_cols=252 Identities=22% Similarity=0.262 Sum_probs=189.5
Q ss_pred ccceeeecCceEEEEEEECCeEEEEEEecCC--CCCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEecCCCC
Q 003384 468 PSLKIGEGGYGSIYKGLLRHMQVAIKMLHPH--SLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNGS 543 (824)
Q Consensus 468 ~~~~LG~G~fG~Vykg~~~~~~VAvK~l~~~--~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey~~ggs 543 (824)
+.+.+|.|+++.||++...+..||||++... .......+.+|+.+++.++||||+++++++. +..+++|||+++|+
T Consensus 6 i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 3445667777888888888899999998764 2233457999999999999999999999884 46889999999999
Q ss_pred hhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCCCc
Q 003384 544 LEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT 623 (824)
Q Consensus 544 L~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~ 623 (824)
|.+++.... ...++...+..++.+++.||.|||. ++|+||||||+|||++.++.+||+|||.+..+........ .
T Consensus 86 l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~-~ 160 (314)
T cd08216 86 CEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR-V 160 (314)
T ss_pred HHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeecccccccc-c
Confidence 999986432 2358889999999999999999999 8999999999999999999999999999876543221110 1
Q ss_pred cccccCCCCCCcccCChhhhcc--CCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhh--hccccccC--------
Q 003384 624 TLCCRTDPKGTFAYMDPEFLAS--GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT--GKLKNLLD-------- 691 (824)
Q Consensus 624 ~~~~~~~~~GT~~Y~APE~l~~--~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~--~~~~~~ld-------- 691 (824)
.........++..|+|||++.. ..++.++|||||||++|+|++|++||............ +.....++
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYE 240 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhc
Confidence 1111233457889999999876 36889999999999999999999999755433222211 11111110
Q ss_pred ------------C-----CCCCCChhhHHHHHHHHHHHhhhccCCCCChH
Q 003384 692 ------------P-----LAGDWPFVQAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 692 ------------~-----~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
+ .....+......+.+|+.+||+.+|.+||++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~ 290 (314)
T cd08216 241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSAS 290 (314)
T ss_pred CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHH
Confidence 0 01111223356789999999999999999984
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=297.89 Aligned_cols=252 Identities=26% Similarity=0.398 Sum_probs=188.2
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEecccCC---------
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACPE--------- 530 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~L~g~~~~--------- 530 (824)
++|....+||+|+||.||+|... +..||||.+...... ....+.+|+.++++++||||++++++|..
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 46889999999999999999875 578999988653222 12346789999999999999999998732
Q ss_pred -ceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccc
Q 003384 531 -VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI 609 (824)
Q Consensus 531 -~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGl 609 (824)
..++||||+. ++|.+.+... ...+++..+..++.|++.||.|||+ ++++|+||||+|||++.++.+||+|||+
T Consensus 92 ~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 92 GSFYLVFEFCE-HDLAGLLSNK--NVKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred ceEEEEEcCCC-cCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcCCC
Confidence 3589999996 4788877432 2468999999999999999999999 8999999999999999999999999999
Q ss_pred ccccccccccCCCccccccCCCCCCcccCChhhhccC-CCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhh----h
Q 003384 610 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT----G 684 (824)
Q Consensus 610 a~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~----~ 684 (824)
+..+......... ......++..|+|||++.+. .++.++||||||+++|+|+||++||............ +
T Consensus 166 ~~~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~ 241 (310)
T cd07865 166 ARAFSLSKNSKPN----RYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCG 241 (310)
T ss_pred cccccCCcccCCC----CccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 9866543221111 11334678999999998764 4788999999999999999999999755432111100 0
Q ss_pred cccccc----------C----CCC-------CCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 685 KLKNLL----------D----PLA-------GDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 685 ~~~~~l----------d----~~~-------~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
.....+ + +.. .-++......+.+|+.+||..+|.+||++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e 303 (310)
T cd07865 242 SITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADT 303 (310)
T ss_pred CCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHH
Confidence 000000 0 000 0001122456789999999999999999843
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=310.81 Aligned_cols=247 Identities=27% Similarity=0.384 Sum_probs=193.3
Q ss_pred hhcCCCCccceeeecCceEEEEEEECC-eEEEEEEecCC--CCCCchhHHHHHHHHHhcC-CCceeeEeccc--CCceEE
Q 003384 461 GATHNFDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPH--SLQGPSEFQQEIDILSKIR-HPNLVTLVGAC--PEVWTL 534 (824)
Q Consensus 461 ~~~~~f~~~~~LG~G~fG~Vykg~~~~-~~VAvK~l~~~--~~~~~~~f~~Ei~iL~~l~-HpnIv~L~g~~--~~~~~L 534 (824)
.....|+..++||+||.+.||++...+ +.+|+|++... +.+...-|.+|+..|.+|+ |.+||+||+|- +...|+
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 345579999999999999999998875 66788876543 3333567999999999995 99999999975 567899
Q ss_pred EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccc
Q 003384 535 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 614 (824)
Q Consensus 535 V~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~ 614 (824)
||||-+ .+|..+|..+... ...| .+..+..||+.|+.++|. +||||.||||.|+|+-. |.+||+|||+|..+.
T Consensus 438 vmE~Gd-~DL~kiL~k~~~~-~~~~-~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 438 VMECGD-IDLNKILKKKKSI-DPDW-FLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQ 510 (677)
T ss_pred Eeeccc-ccHHHHHHhccCC-CchH-HHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEEe-eeEEeeeechhcccC
Confidence 999874 5899999655432 2234 677889999999999999 89999999999999964 589999999999877
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccC-----------CCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhh
Q 003384 615 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-----------ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT 683 (824)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-----------~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~ 683 (824)
.+.++. .+...+||+.||+||.+... ..++++||||||||||+|+.|++||+......
T Consensus 511 ~DTTsI------~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~----- 579 (677)
T KOG0596|consen 511 PDTTSI------VKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQI----- 579 (677)
T ss_pred ccccce------eeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHH-----
Confidence 665433 23456799999999998542 25678999999999999999999997544322
Q ss_pred hccccccCC-CCCCCChhhHH-HHHHHHHHHhhhccCCCCChHH
Q 003384 684 GKLKNLLDP-LAGDWPFVQAE-QLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 684 ~~~~~~ld~-~~~~~p~~~~~-~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
.++..+.+| ...++|..... ++.+++..||..||++||++.+
T Consensus 580 aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~e 623 (677)
T KOG0596|consen 580 AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPE 623 (677)
T ss_pred HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHH
Confidence 345555565 22344433332 3999999999999999999943
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=305.83 Aligned_cols=251 Identities=22% Similarity=0.313 Sum_probs=191.4
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHHhcCCCceeeEecccC------CceE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP------EVWT 533 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~------~~~~ 533 (824)
.+|...+.||.|+||.||+|... +..||+|++..... .....+.+|+.+|+.++||||+++++++. ...+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 57888899999999999999875 68899999875422 23456788999999999999999998763 2478
Q ss_pred EEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccc
Q 003384 534 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 613 (824)
Q Consensus 534 LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~ 613 (824)
+||||+. |+|.+++. ....+++..+..++.|++.||.|||. ++|+||||||+|||++.++.+||+|||++...
T Consensus 85 lv~e~~~-~~l~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 85 VVMDLME-SDLHHIIH---SDQPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEehhh-hhHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccceee
Confidence 9999995 68988884 23458999999999999999999999 89999999999999999999999999999765
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhcc-CCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHH---h-------
Q 003384 614 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYAL---D------- 682 (824)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~---~------- 682 (824)
........ .......|+..|+|||++.+ ..++.++|||||||++|+|++|++||.......... .
T Consensus 158 ~~~~~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~ 233 (334)
T cd07855 158 SSSPTEHK----YFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSE 233 (334)
T ss_pred cccCcCCC----cccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChh
Confidence 43321110 01123468999999999866 468899999999999999999999996543321100 0
Q ss_pred -------hhccccccCC--CCCCC-----ChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 683 -------TGKLKNLLDP--LAGDW-----PFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 683 -------~~~~~~~ld~--~~~~~-----p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
.......... ..... ....+..+.+++.+||+.+|.+||++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ 290 (334)
T cd07855 234 EVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQ 290 (334)
T ss_pred HhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 0000000000 00001 1224678999999999999999999854
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=289.00 Aligned_cols=244 Identities=27% Similarity=0.436 Sum_probs=198.3
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHHhcCCCceeeEeccc--CCceEEEEEe
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 538 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~Ey 538 (824)
+|...+.||.|+||.||++.+. +..|++|++..... .....+.+|+++++.++|||++++++.+ .+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4777889999999999999987 68899999876543 3445688999999999999999999887 3568899999
Q ss_pred cCCCChhhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccc
Q 003384 539 LPNGSLEDRLSCKD-NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 617 (824)
Q Consensus 539 ~~ggsL~~~L~~~~-~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 617 (824)
+++++|.+++.... ....+++..+..++.+++.||.|||. .|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999986432 23679999999999999999999999 799999999999999999999999999998654432
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCC
Q 003384 618 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 697 (824)
Q Consensus 618 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~ 697 (824)
.. .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||............ .... ....
T Consensus 158 ~~--------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~--~~~~----~~~~ 223 (258)
T cd08215 158 DL--------AKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKI--LKGQ----YPPI 223 (258)
T ss_pred ce--------ecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHH--hcCC----CCCC
Confidence 11 12235899999999998888999999999999999999999999765432211111 1111 1222
Q ss_pred ChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 698 PFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 698 p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
+...+..+.+++.+||..+|.+||++.+
T Consensus 224 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ 251 (258)
T cd08215 224 PSQYSSELRNLVSSLLQKDPEERPSIAQ 251 (258)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 3345678999999999999999999944
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=297.49 Aligned_cols=240 Identities=23% Similarity=0.339 Sum_probs=190.1
Q ss_pred CccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--CCceEEEEEecCCC
Q 003384 467 DPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNG 542 (824)
Q Consensus 467 ~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~Ey~~gg 542 (824)
+...+||+|+||.||+|... +..||||.+..........+.+|+.+++.++||||+++++.+ .+..++||||++++
T Consensus 23 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (292)
T cd06657 23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG 102 (292)
T ss_pred hhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence 34467999999999999874 588999988654433445688999999999999999999987 45789999999999
Q ss_pred ChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCCC
Q 003384 543 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 622 (824)
Q Consensus 543 sL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~ 622 (824)
+|.+++. ...+++.....++.+++.||.|||+ +|++||||+|+||+++.++.++|+|||++.........
T Consensus 103 ~L~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~--- 172 (292)
T cd06657 103 ALTDIVT----HTRMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--- 172 (292)
T ss_pred cHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceeccccccc---
Confidence 9999873 2358899999999999999999999 89999999999999999999999999998755432110
Q ss_pred ccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCChhhH
Q 003384 623 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQA 702 (824)
Q Consensus 623 ~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~ 702 (824)
.....|++.|+|||++.+..++.++|||||||++|+|++|.+||............ ...+.+... .....+
T Consensus 173 -----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~---~~~~~~~~~-~~~~~~ 243 (292)
T cd06657 173 -----RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---RDNLPPKLK-NLHKVS 243 (292)
T ss_pred -----ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HhhCCcccC-CcccCC
Confidence 12345899999999998888999999999999999999999999755433211110 011111110 112345
Q ss_pred HHHHHHHHHHhhhccCCCCChHH
Q 003384 703 EQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 703 ~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
..+.+++.+||+.+|.+||++.+
T Consensus 244 ~~l~~li~~~l~~~P~~R~~~~~ 266 (292)
T cd06657 244 PSLKGFLDRLLVRDPAQRATAAE 266 (292)
T ss_pred HHHHHHHHHHHhCCcccCcCHHH
Confidence 67899999999999999999944
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=305.17 Aligned_cols=246 Identities=21% Similarity=0.278 Sum_probs=189.2
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCC--CCCchhHHHHHHHHHhcCCCceeeEecccC--------C
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS--LQGPSEFQQEIDILSKIRHPNLVTLVGACP--------E 530 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~--~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--------~ 530 (824)
.+.|...+.||+|+||.||+|... +..||||.+.... ......+.+|+.+++.++||||++++++|. .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 457999999999999999999874 6889999986432 222346778999999999999999999873 2
Q ss_pred ceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccc
Q 003384 531 VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS 610 (824)
Q Consensus 531 ~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla 610 (824)
..++||||+. ++|.+.+.. .++...+..++.|++.||.|||. +||+||||||+|||++.++.+||+|||++
T Consensus 95 ~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 95 DVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred cEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCccc
Confidence 3689999996 588887732 27888999999999999999999 89999999999999999999999999999
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhh----h--
Q 003384 611 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT----G-- 684 (824)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~----~-- 684 (824)
+....... .....||..|+|||++.+..++.++|||||||++|+|++|+.||...+........ +
T Consensus 166 ~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 236 (353)
T cd07850 166 RTAGTSFM---------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTP 236 (353)
T ss_pred eeCCCCCC---------CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 86543211 12345889999999999999999999999999999999999999754322110000 0
Q ss_pred -------------------c------cccccCC-----CCCCCChhhHHHHHHHHHHHhhhccCCCCChHHH
Q 003384 685 -------------------K------LKNLLDP-----LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD 726 (824)
Q Consensus 685 -------------------~------~~~~ld~-----~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~ 726 (824)
. +...... .....+...+..+.+++.+||+.+|.+||++.+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ei 308 (353)
T cd07850 237 SDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDA 308 (353)
T ss_pred CHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHH
Confidence 0 0000000 0000012345678999999999999999999543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=298.20 Aligned_cols=248 Identities=27% Similarity=0.330 Sum_probs=189.5
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCC--chhHHHHHHHHHhcCCCceeeEecccC----CceEE
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACP----EVWTL 534 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~L~g~~~----~~~~L 534 (824)
..+|+..+.||.|+||.||+|.+. +..||+|.+....... ...+.+|+.++++++||||+++++++. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 347889999999999999999885 5789999987543221 234678999999999999999999873 34789
Q ss_pred EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccc
Q 003384 535 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 614 (824)
Q Consensus 535 V~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~ 614 (824)
||||+.+ +|.+++... ...+++..+..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++..+.
T Consensus 86 v~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 9999964 788887532 3568999999999999999999999 889999999999999999999999999998664
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhcc-CCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccc-----c
Q 003384 615 QNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLK-----N 688 (824)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~-----~ 688 (824)
..... .....+++.|+|||.+.+ ..++.++|||||||++|+|++|++||................ .
T Consensus 160 ~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 231 (309)
T cd07845 160 LPAKP--------MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNES 231 (309)
T ss_pred CccCC--------CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence 33211 122346889999999876 468899999999999999999999997654433211110000 0
Q ss_pred c---cC------C-CCCCCC--------hhhHHHHHHHHHHHhhhccCCCCChH
Q 003384 689 L---LD------P-LAGDWP--------FVQAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 689 ~---ld------~-~~~~~p--------~~~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
. +. . .....+ ...+..+.+++.+|++.+|.+||++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~ 285 (309)
T cd07845 232 IWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAE 285 (309)
T ss_pred hchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHH
Confidence 0 00 0 000000 11356788999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=293.21 Aligned_cols=247 Identities=28% Similarity=0.401 Sum_probs=189.1
Q ss_pred CCccceeeecCceEEEEEEEC--CeEEEEEEecCCC--CCCchhHHHHHHHHHhcCCCceeeEecccC----CceEEEEE
Q 003384 466 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS--LQGPSEFQQEIDILSKIRHPNLVTLVGACP----EVWTLVYE 537 (824)
Q Consensus 466 f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~--~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~----~~~~LV~E 537 (824)
|...+.||.|+||.||+|... +..||+|++.... ......+.+|+.+++.++|||++++++++. ...++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 566788999999999999886 4889999998653 222346889999999999999999999884 45899999
Q ss_pred ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccc
Q 003384 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 617 (824)
Q Consensus 538 y~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 617 (824)
|+++ +|.+++... ...+++..+..++.+++.||.|||. ++++|+||+|+|||++.++.+||+|||++.......
T Consensus 81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9975 888887432 2478999999999999999999999 899999999999999999999999999998665432
Q ss_pred ccCCCccccccCCCCCCcccCChhhhcc-CCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccc---------
Q 003384 618 ISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLK--------- 687 (824)
Q Consensus 618 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~--------- 687 (824)
... .....++..|+|||.+.+ ..++.++||||||+++|+|+||++||................
T Consensus 155 ~~~-------~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (287)
T cd07840 155 SAD-------YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWP 227 (287)
T ss_pred ccc-------ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcc
Confidence 100 123457889999998765 467899999999999999999999997654322111100000
Q ss_pred cc--------cCCC-------CCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 688 NL--------LDPL-------AGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 688 ~~--------ld~~-------~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
.. ..+. ........+..+.+++.+||+.+|.+||++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ 280 (287)
T cd07840 228 GVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQ 280 (287)
T ss_pred ccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 00 0000 00001112568899999999999999999943
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=295.46 Aligned_cols=250 Identities=24% Similarity=0.360 Sum_probs=187.3
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE 537 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~E 537 (824)
++|.....||.|+||.||+|... +..||+|.+..... .....+.+|+.+++.++||||+++++++. ...++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 36888889999999999999875 57899999865432 22356889999999999999999999984 46889999
Q ss_pred ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecC-CCcceeeccccccccccc
Q 003384 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA-NFVSKLSDFGISRFLSQN 616 (824)
Q Consensus 538 y~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~-~~~vKL~DFGla~~~~~~ 616 (824)
|++ ++|.+++... ....+++.....++.+|+.||.|||. ++++||||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 996 5787777432 22346788888999999999999999 89999999999999985 567999999999754322
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccC-CCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhcc-----cccc
Q 003384 617 EISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL-----KNLL 690 (824)
Q Consensus 617 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~-----~~~l 690 (824)
... .....|++.|+|||++.+. .++.++|||||||++|+|+||++||............... ....
T Consensus 157 ~~~--------~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 228 (294)
T PLN00009 157 VRT--------FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETW 228 (294)
T ss_pred ccc--------cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence 110 1234578999999998764 5789999999999999999999999765433221111000 0000
Q ss_pred -------C--CCCCCC--------ChhhHHHHHHHHHHHhhhccCCCCChHHH
Q 003384 691 -------D--PLAGDW--------PFVQAEQLANLAMRCCEMSRKSRPELGKD 726 (824)
Q Consensus 691 -------d--~~~~~~--------p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~ 726 (824)
+ .....+ ....+..+.+++.+|++.+|.+||++.+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~ 281 (294)
T PLN00009 229 PGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAA 281 (294)
T ss_pred cccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHH
Confidence 0 000000 11235678999999999999999999443
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=344.56 Aligned_cols=249 Identities=30% Similarity=0.479 Sum_probs=195.3
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEec
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL 539 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey~ 539 (824)
..|.....||+|+||.||+|... +..||||.+..... ....|+.++++++|||||+++|+|. +..++||||+
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~ 765 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI 765 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence 34667788999999999999864 68899999864332 2245789999999999999999984 4678999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccccc
Q 003384 540 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 619 (824)
Q Consensus 540 ~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 619 (824)
++|+|.+++. .++|..+..|+.+++.||.|||..+..+|+||||||+|||++.++..++. ||........
T Consensus 766 ~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~--- 835 (968)
T PLN00113 766 EGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD--- 835 (968)
T ss_pred CCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC---
Confidence 9999999993 38899999999999999999996555799999999999999999888875 6655432211
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCc--------hHHHHHHhhhccccccC
Q 003384 620 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGIT--------KEVQYALDTGKLKNLLD 691 (824)
Q Consensus 620 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~--------~~~~~~~~~~~~~~~ld 691 (824)
....||+.|+|||++.+..++.++|||||||++|||+||++||+.. .+............+++
T Consensus 836 ---------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 906 (968)
T PLN00113 836 ---------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWID 906 (968)
T ss_pred ---------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeC
Confidence 1235899999999999999999999999999999999999998532 11112122222333444
Q ss_pred CCCC---CCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHh
Q 003384 692 PLAG---DWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 736 (824)
Q Consensus 692 ~~~~---~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~ 736 (824)
+... ..+.....++.+++.+||+.+|.+||+| .++++.|+.+..
T Consensus 907 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~-~evl~~L~~~~~ 953 (968)
T PLN00113 907 PSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCA-NDVLKTLESASR 953 (968)
T ss_pred ccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCH-HHHHHHHHHhhc
Confidence 4321 2233455678899999999999999999 678888887655
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=295.95 Aligned_cols=231 Identities=26% Similarity=0.326 Sum_probs=177.5
Q ss_pred eeeecCceEEEEEEEC--CeEEEEEEecCCCCCC---chhHHHHHHHHHh---cCCCceeeEecccC--CceEEEEEecC
Q 003384 471 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---PSEFQQEIDILSK---IRHPNLVTLVGACP--EVWTLVYEYLP 540 (824)
Q Consensus 471 ~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~---~~~f~~Ei~iL~~---l~HpnIv~L~g~~~--~~~~LV~Ey~~ 540 (824)
.||+|+||.||++... +..||+|.+....... ...+.+|..++.. .+||||+.+++++. +..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999875 5789999886543221 1234455544443 47999999998873 46889999999
Q ss_pred CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccC
Q 003384 541 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 620 (824)
Q Consensus 541 ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 620 (824)
+|+|.+++.. ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~-- 152 (279)
T cd05633 81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-- 152 (279)
T ss_pred CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc--
Confidence 9999998853 3469999999999999999999999 8899999999999999999999999999875432210
Q ss_pred CCccccccCCCCCCcccCChhhhcc-CCCCcchhHHhHHHHHHHHHhCCCCCCCchHH-HHHHhhhccccccCCCCCCCC
Q 003384 621 NNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEV-QYALDTGKLKNLLDPLAGDWP 698 (824)
Q Consensus 621 ~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~-~~~~~~~~~~~~ld~~~~~~p 698 (824)
....||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||...... ......... ......+
T Consensus 153 --------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-----~~~~~~~ 219 (279)
T cd05633 153 --------HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL-----TVNVELP 219 (279)
T ss_pred --------cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh-----cCCcCCc
Confidence 22358999999999864 56889999999999999999999999643211 111111111 1111233
Q ss_pred hhhHHHHHHHHHHHhhhccCCCCC
Q 003384 699 FVQAEQLANLAMRCCEMSRKSRPE 722 (824)
Q Consensus 699 ~~~~~~l~~Li~~Cl~~~P~~RPt 722 (824)
...+..+.+++.+||..+|.+||+
T Consensus 220 ~~~~~~~~~li~~~l~~~p~~R~~ 243 (279)
T cd05633 220 DSFSPELKSLLEGLLQRDVSKRLG 243 (279)
T ss_pred cccCHHHHHHHHHHhcCCHHHhcC
Confidence 445678999999999999999995
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=292.50 Aligned_cols=239 Identities=19% Similarity=0.272 Sum_probs=182.0
Q ss_pred cCCCCcccee--eecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhc-CCCceeeEeccc--CCceEEE
Q 003384 463 THNFDPSLKI--GEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGAC--PEVWTLV 535 (824)
Q Consensus 463 ~~~f~~~~~L--G~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l-~HpnIv~L~g~~--~~~~~LV 535 (824)
.++|.+.+.+ |.|+||.||++... +..+|+|.+....... .|+.+...+ +||||++++++| .+..++|
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv 87 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLI 87 (267)
T ss_pred HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCeeEEE
Confidence 3455555555 99999999999865 5789999986543221 133333323 799999999987 4578999
Q ss_pred EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCC-cceeeccccccccc
Q 003384 536 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF-VSKLSDFGISRFLS 614 (824)
Q Consensus 536 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~-~vKL~DFGla~~~~ 614 (824)
|||+++|+|.+++... .++++..+..++.|++.||.|||+ .+++||||||+||+++.++ .++|+|||++....
T Consensus 88 ~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 161 (267)
T PHA03390 88 MDYIKDGDLFDLLKKE---GKLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG 161 (267)
T ss_pred EEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence 9999999999998532 379999999999999999999999 8899999999999999988 99999999987553
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCC
Q 003384 615 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 694 (824)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~ 694 (824)
.. ....|+..|+|||++.+..++.++|||||||++|+|++|+.||......... ...+.... ...
T Consensus 162 ~~------------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~--~~~~~~~~-~~~ 226 (267)
T PHA03390 162 TP------------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELD--LESLLKRQ-QKK 226 (267)
T ss_pred CC------------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhh--HHHHHHhh-ccc
Confidence 22 1234899999999999889999999999999999999999999743221110 00011111 111
Q ss_pred CCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 003384 695 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 727 (824)
Q Consensus 695 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 727 (824)
...+...+..+.+++.+||+.+|.+||+..+++
T Consensus 227 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 259 (267)
T PHA03390 227 LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEI 259 (267)
T ss_pred CCcccccCHHHHHHHHHHhccChhhCCchHHHH
Confidence 122335667899999999999999999642433
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=297.62 Aligned_cols=240 Identities=28% Similarity=0.377 Sum_probs=187.4
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCC---chhHHHHHHHHHhcCCCceeeEecccC--CceEEEEE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE 537 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~---~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~E 537 (824)
.|...+.||+|+||.||+|... +..||+|.+....... ...+.+|+.+++.++|||+++++++|. +..++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 3777889999999999999874 5789999987543322 246888999999999999999999884 46789999
Q ss_pred ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccc
Q 003384 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 617 (824)
Q Consensus 538 y~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 617 (824)
|++| +|.+.+.. ...++++..+..++.+++.||.|||. ++|+||||+|+||+++.++.+||+|||++......
T Consensus 106 ~~~g-~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 106 YCLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred CCCC-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 9974 77777642 23568999999999999999999999 89999999999999999999999999998654321
Q ss_pred ccCCCccccccCCCCCCcccCChhhhc---cCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCC
Q 003384 618 ISSNNTTLCCRTDPKGTFAYMDPEFLA---SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 694 (824)
Q Consensus 618 ~~~~~~~~~~~~~~~GT~~Y~APE~l~---~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~ 694 (824)
....|++.|+|||++. .+.++.++|||||||++|+|++|++||.............. ... +
T Consensus 179 -----------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~--~~~-~-- 242 (317)
T cd06635 179 -----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--NES-P-- 242 (317)
T ss_pred -----------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh--ccC-C--
Confidence 2235889999999974 45688999999999999999999999865432221111100 000 0
Q ss_pred CCCChhhHHHHHHHHHHHhhhccCCCCChHHHHH
Q 003384 695 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVW 728 (824)
Q Consensus 695 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~ 728 (824)
...+...+..+.+++.+||+.+|.+||++ .+++
T Consensus 243 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~-~~il 275 (317)
T cd06635 243 TLQSNEWSDYFRNFVDSCLQKIPQDRPTS-EELL 275 (317)
T ss_pred CCCCccccHHHHHHHHHHccCCcccCcCH-HHHH
Confidence 01122345679999999999999999999 4443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=291.37 Aligned_cols=243 Identities=24% Similarity=0.315 Sum_probs=183.5
Q ss_pred CCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC-CchhHHHHHHHHHhcC-CCceeeEecccC----CceEEEEE
Q 003384 466 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIR-HPNLVTLVGACP----EVWTLVYE 537 (824)
Q Consensus 466 f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l~-HpnIv~L~g~~~----~~~~LV~E 537 (824)
|...+.||+|+||.||+|... +..||+|.+...... ......+|+.++.++. ||||+++++++. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 556778999999999999874 578999998754221 2224457999999985 999999999873 45889999
Q ss_pred ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccc
Q 003384 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 617 (824)
Q Consensus 538 y~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 617 (824)
|++ |+|.+.+... ...+++..+..++.+++.||.|||. .+++||||+|+||+++. +.+||+|||++..+....
T Consensus 81 ~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMD-MNLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCC-ccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 997 5777777432 3468999999999999999999999 89999999999999999 999999999998654322
Q ss_pred ccCCCccccccCCCCCCcccCChhhhcc-CCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhcc----c----c
Q 003384 618 ISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL----K----N 688 (824)
Q Consensus 618 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~----~----~ 688 (824)
.. ....++..|+|||++.. +.++.++|||||||++|||++|.+||...+........... . .
T Consensus 154 ~~---------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (282)
T cd07831 154 PY---------TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLK 224 (282)
T ss_pred Cc---------CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 11 12347899999997654 55788999999999999999999999765432211110000 0 0
Q ss_pred ccCC---CCCCC-----------ChhhHHHHHHHHHHHhhhccCCCCChH
Q 003384 689 LLDP---LAGDW-----------PFVQAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 689 ~ld~---~~~~~-----------p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
.+.. ....+ ....+..+.+++.+||+.+|.+||++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~ 274 (282)
T cd07831 225 KFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAK 274 (282)
T ss_pred hhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHH
Confidence 0000 00001 113467899999999999999999994
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=298.73 Aligned_cols=241 Identities=26% Similarity=0.355 Sum_probs=188.2
Q ss_pred CCCccceeeecCceEEEEEEE-----CCeEEEEEEecCCCC----CCchhHHHHHHHHHhc-CCCceeeEecccC--Cce
Q 003384 465 NFDPSLKIGEGGYGSIYKGLL-----RHMQVAIKMLHPHSL----QGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVW 532 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~-----~~~~VAvK~l~~~~~----~~~~~f~~Ei~iL~~l-~HpnIv~L~g~~~--~~~ 532 (824)
+|+..+.||.|+||.||++.. .+..||+|++..... ...+.+.+|+.++..+ +||||+++++++. ...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 467788999999999999876 467899999875322 1235688899999999 5999999998874 357
Q ss_pred EEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccc
Q 003384 533 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 612 (824)
Q Consensus 533 ~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~ 612 (824)
++||||+++++|.+++.. ..++++.....++.+++.||.|||+ .+++||||+|+|||++.++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 899999999999999853 3468889999999999999999999 8999999999999999999999999999986
Q ss_pred cccccccCCCccccccCCCCCCcccCChhhhccC--CCCcchhHHhHHHHHHHHHhCCCCCCCchHHH--HHHhhhcccc
Q 003384 613 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG--ELTPKSDVYSFGIILLRLLTGRPALGITKEVQ--YALDTGKLKN 688 (824)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~--~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~--~~~~~~~~~~ 688 (824)
........ .....|+..|+|||++... .++.++||||||+++|+|+||..||....... ..+..
T Consensus 155 ~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~----- 222 (290)
T cd05613 155 FHEDEVER-------AYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISR----- 222 (290)
T ss_pred cccccccc-------cccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHH-----
Confidence 54322111 1234589999999998753 47789999999999999999999996432110 11111
Q ss_pred ccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCCh
Q 003384 689 LLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 723 (824)
Q Consensus 689 ~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 723 (824)
.+......++...+..+.+++.+||+.+|.+||+.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~ 257 (290)
T cd05613 223 RILKSEPPYPQEMSALAKDIIQRLLMKDPKKRLGC 257 (290)
T ss_pred HhhccCCCCCccCCHHHHHHHHHHhcCCHHHhcCC
Confidence 11111122344566789999999999999999853
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=292.23 Aligned_cols=246 Identities=27% Similarity=0.403 Sum_probs=197.1
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHHhcC-CCceeeEecccC--CceEEEE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIR-HPNLVTLVGACP--EVWTLVY 536 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~---~~~~~f~~Ei~iL~~l~-HpnIv~L~g~~~--~~~~LV~ 536 (824)
+|.....||.|+||.||+|... +..||+|++..... .....+..|+.+++++. ||||+++++++. +..++||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL 81 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence 6788889999999999999885 68899999875322 22346889999999998 999999999884 4688999
Q ss_pred EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccc
Q 003384 537 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 616 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 616 (824)
||+++++|.+++.. ...+++..+..|+.+++.||.|||. .+++|+||+|+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 82 EYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 99999999999953 3469999999999999999999999 89999999999999999999999999999866543
Q ss_pred cccCCC------------ccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhh
Q 003384 617 EISSNN------------TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG 684 (824)
Q Consensus 617 ~~~~~~------------~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~ 684 (824)
...... ..........|+..|+|||.+....++.++||||||+++++|++|++||.............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 235 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL 235 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH
Confidence 211000 00111234568899999999988889999999999999999999999997665332211111
Q ss_pred ccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCCh
Q 003384 685 KLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 723 (824)
Q Consensus 685 ~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 723 (824)
.....++...+..+.+++.+||+.+|.+||++
T Consensus 236 -------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~ 267 (280)
T cd05581 236 -------KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGV 267 (280)
T ss_pred -------hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCc
Confidence 11122344446789999999999999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=303.30 Aligned_cols=256 Identities=21% Similarity=0.297 Sum_probs=193.9
Q ss_pred cCCCChhhHhhhcCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHHhcCCCceeeEec
Q 003384 451 FSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVG 526 (824)
Q Consensus 451 ~~~~~~~ei~~~~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~L~g 526 (824)
++.....++...+++|...+.||+|+||.||+|... +..||+|++..... .....+.+|+.++++++||||+++++
T Consensus 4 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~ 83 (345)
T cd07877 4 YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 83 (345)
T ss_pred chhhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceee
Confidence 334445566677889999999999999999999864 57899999875321 12346788999999999999999998
Q ss_pred ccC--------CceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecC
Q 003384 527 ACP--------EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA 598 (824)
Q Consensus 527 ~~~--------~~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~ 598 (824)
++. ...+++++++ +++|.+++.. ..+++..+..++.|++.||.|||+ ++|+||||||+||+++.
T Consensus 84 ~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~ 155 (345)
T cd07877 84 VFTPARSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNE 155 (345)
T ss_pred eeeecccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcC
Confidence 773 2357788876 7899888742 358999999999999999999999 89999999999999999
Q ss_pred CCcceeeccccccccccccccCCCccccccCCCCCCcccCChhhhcc-CCCCcchhHHhHHHHHHHHHhCCCCCCCchHH
Q 003384 599 NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEV 677 (824)
Q Consensus 599 ~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~ 677 (824)
++.+||+|||++....... ....||..|+|||.+.+ ..++.++|||||||++|+|++|++||......
T Consensus 156 ~~~~kl~dfg~~~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~ 224 (345)
T cd07877 156 DCELKILDFGLARHTDDEM-----------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 224 (345)
T ss_pred CCCEEEecccccccccccc-----------cccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999999999987543211 22357899999999876 56889999999999999999999999654332
Q ss_pred HHHHhh----h----------------ccccccCC----CCCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 678 QYALDT----G----------------KLKNLLDP----LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 678 ~~~~~~----~----------------~~~~~ld~----~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
...... + .....+.. ...+.....+..+.+++.+|++.+|.+||+..+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e 296 (345)
T cd07877 225 DQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 296 (345)
T ss_pred HHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHH
Confidence 111000 0 00000000 000111123567899999999999999999843
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=291.26 Aligned_cols=246 Identities=26% Similarity=0.335 Sum_probs=191.0
Q ss_pred CCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEec
Q 003384 466 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL 539 (824)
Q Consensus 466 f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey~ 539 (824)
|.....||.|++|.||+|... +..+++|.+...... ....+.+|+.+++.++||||+++++++. ...++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 456678999999999999875 578999998754332 3456889999999999999999999874 4688999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccccc
Q 003384 540 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 619 (824)
Q Consensus 540 ~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 619 (824)
++ +|.+++... ...+++..+..++.+++.||.|||. ++|+|+||||+||+++.++.+||+|||++.........
T Consensus 81 ~~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~ 154 (283)
T cd05118 81 DT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP 154 (283)
T ss_pred CC-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccc
Confidence 75 888887543 2578999999999999999999999 88999999999999999999999999999876543210
Q ss_pred CCCccccccCCCCCCcccCChhhhccC-CCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhc---------cccc
Q 003384 620 SNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK---------LKNL 689 (824)
Q Consensus 620 ~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~---------~~~~ 689 (824)
.....++..|+|||.+.+. .++.++||||||+++|+|+||++||...+.......... +...
T Consensus 155 --------~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (283)
T cd05118 155 --------YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKF 226 (283)
T ss_pred --------ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccc
Confidence 1224578899999998876 789999999999999999999999976554332111100 0000
Q ss_pred cC--------------CCCCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 690 LD--------------PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 690 ld--------------~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
.. ..........+..+.+++.+||+.+|.+||++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ 276 (283)
T cd05118 227 TSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQ 276 (283)
T ss_pred hhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHH
Confidence 00 0000011224568999999999999999999954
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=289.73 Aligned_cols=231 Identities=24% Similarity=0.298 Sum_probs=181.0
Q ss_pred ceeeecCceEEEEEEEC--CeEEEEEEecCCCCCC---chhHHHHHHHH-HhcCCCceeeEecccC--CceEEEEEecCC
Q 003384 470 LKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---PSEFQQEIDIL-SKIRHPNLVTLVGACP--EVWTLVYEYLPN 541 (824)
Q Consensus 470 ~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~---~~~f~~Ei~iL-~~l~HpnIv~L~g~~~--~~~~LV~Ey~~g 541 (824)
+.||.|+||.||+|... +..||||++....... ...+..|..++ ..++||||+++++++. +..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46999999999999874 5789999986543221 12344555544 4558999999999984 468999999999
Q ss_pred CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCC
Q 003384 542 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 621 (824)
Q Consensus 542 gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 621 (824)
++|.+++.. ..++++..+..++.|++.||.|||. .+++||||+|+|||++.++.+||+|||++......
T Consensus 82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----- 150 (260)
T cd05611 82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN----- 150 (260)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceecccc-----
Confidence 999999843 3468899999999999999999999 88999999999999999999999999998754321
Q ss_pred CccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHH--HhhhccccccCCCCCCCCh
Q 003384 622 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA--LDTGKLKNLLDPLAGDWPF 699 (824)
Q Consensus 622 ~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~--~~~~~~~~~ld~~~~~~p~ 699 (824)
....|++.|+|||.+.+..++.++||||||+++|+|+||.+||......... ...+.. . .....+.
T Consensus 151 -------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----~-~~~~~~~ 218 (260)
T cd05611 151 -------KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRI----N-WPEEVKE 218 (260)
T ss_pred -------ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccc----C-CCCcccc
Confidence 2235889999999998888999999999999999999999999755432211 111111 0 0111122
Q ss_pred hhHHHHHHHHHHHhhhccCCCCCh
Q 003384 700 VQAEQLANLAMRCCEMSRKSRPEL 723 (824)
Q Consensus 700 ~~~~~l~~Li~~Cl~~~P~~RPt~ 723 (824)
..+..+.+++.+||+.+|.+||+.
T Consensus 219 ~~~~~~~~~i~~~l~~~p~~R~~~ 242 (260)
T cd05611 219 FCSPEAVDLINRLLCMDPAKRLGA 242 (260)
T ss_pred cCCHHHHHHHHHHccCCHHHccCC
Confidence 346789999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=302.82 Aligned_cols=249 Identities=25% Similarity=0.306 Sum_probs=190.2
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCC--CCCchhHHHHHHHHHhcCCCceeeEecccCC-------c
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS--LQGPSEFQQEIDILSKIRHPNLVTLVGACPE-------V 531 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~--~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~~-------~ 531 (824)
...|...+.||+|+||.||+|... +..||||.+.... ......+.+|+.+++.++||||+++++++.. .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 346888999999999999999875 5889999987532 2234467789999999999999999998732 3
Q ss_pred eEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccc
Q 003384 532 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR 611 (824)
Q Consensus 532 ~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~ 611 (824)
.++||||+. ++|.+++. ....+++..+..++.|++.||.|||+ ++++||||||+|||++.++.+||+|||++.
T Consensus 84 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIR---SSQTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 689999995 68888874 33569999999999999999999999 899999999999999999999999999998
Q ss_pred ccccccccCCCccccccCCCCCCcccCChhhhcc-CCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHh--------
Q 003384 612 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALD-------- 682 (824)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~-------- 682 (824)
........ .....|+..|+|||.+.. ..++.++|||||||++|+|++|++||...+.......
T Consensus 157 ~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 228 (337)
T cd07858 157 TTSEKGDF--------MTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSP 228 (337)
T ss_pred ccCCCccc--------ccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCC
Confidence 65432111 123357899999998865 4688999999999999999999999975432211000
Q ss_pred ---------hhcccccc-------CCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHH
Q 003384 683 ---------TGKLKNLL-------DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD 726 (824)
Q Consensus 683 ---------~~~~~~~l-------d~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~ 726 (824)
.......+ .+.........+..+.+++.+||+.+|.+||++.+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~el 288 (337)
T cd07858 229 SEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEA 288 (337)
T ss_pred ChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHH
Confidence 00000000 000001112345678999999999999999998443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=294.18 Aligned_cols=250 Identities=27% Similarity=0.351 Sum_probs=190.6
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHHhcCCCceeeEecccCC--------
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACPE-------- 530 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~~-------- 530 (824)
..+|+....||.|+||.||+|... +..||||.+..... .....+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~ 85 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK 85 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence 457888999999999999999985 57899999875432 223467889999999999999999998732
Q ss_pred ----ceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeec
Q 003384 531 ----VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSD 606 (824)
Q Consensus 531 ----~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~D 606 (824)
..++|+||+++ +|.+.+... ...+++..+..++.+++.||.|||+ .+|+||||||+||+++.++.+||+|
T Consensus 86 ~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 86 KDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred ccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEEeCc
Confidence 57899999976 677766432 3468999999999999999999999 8999999999999999999999999
Q ss_pred cccccccccccccCCCccccccCCCCCCcccCChhhhccC-CCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhc
Q 003384 607 FGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK 685 (824)
Q Consensus 607 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~ 685 (824)
||++..+....... .....++..|+|||.+.+. .++.++|||||||++|+|++|++||..............
T Consensus 160 fg~~~~~~~~~~~~-------~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~ 232 (302)
T cd07864 160 FGLARLYNSEESRP-------YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISR 232 (302)
T ss_pred ccccccccCCcccc-------cccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 99998665432110 0223468899999988653 578899999999999999999999976544332211110
Q ss_pred c-----cc----c--------cCCCC------CCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 686 L-----KN----L--------LDPLA------GDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 686 ~-----~~----~--------ld~~~------~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
. .. + .++.. .......+..+.+++.+||+.+|.+||++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~ 295 (302)
T cd07864 233 LCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEE 295 (302)
T ss_pred HhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence 0 00 0 00000 0001123678999999999999999999843
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=295.56 Aligned_cols=257 Identities=25% Similarity=0.311 Sum_probs=189.7
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCC--chhHHHHHHHHHhcCCCceeeEecccC---------
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACP--------- 529 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~L~g~~~--------- 529 (824)
.++|...++||.|+||.||+|... +..||||.+......+ ...+.+|+++++.++||||+++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 458999999999999999999875 5789999886543222 345789999999999999999998762
Q ss_pred -CceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccc
Q 003384 530 -EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFG 608 (824)
Q Consensus 530 -~~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFG 608 (824)
...++||||+.+ +|...+.. ....+++..+..++.+++.||.|||. ++|+||||||+|||++.++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcCc
Confidence 136899999965 67666642 34569999999999999999999999 899999999999999999999999999
Q ss_pred cccccccccccCCCc---cccccCCCCCCcccCChhhhccC-CCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhh
Q 003384 609 ISRFLSQNEISSNNT---TLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG 684 (824)
Q Consensus 609 la~~~~~~~~~~~~~---~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~ 684 (824)
++............. .....+...|++.|+|||++.+. .++.++|||||||++|+|++|++||.............
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 998654432211110 00111344678999999988654 58899999999999999999999997554332111100
Q ss_pred cc---------------ccccC-CCCCCCC-------hhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 685 KL---------------KNLLD-PLAGDWP-------FVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 685 ~~---------------~~~ld-~~~~~~p-------~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
.. ....+ ......+ ......+.+++.+||+.+|.+||++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~e 304 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASD 304 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHH
Confidence 00 00000 0000011 112257889999999999999999843
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=316.90 Aligned_cols=196 Identities=34% Similarity=0.541 Sum_probs=170.2
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCC-CCCchhHHHHHHHHHhcCCCceeeEecccC--------CceE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS-LQGPSEFQQEIDILSKIRHPNLVTLVGACP--------EVWT 533 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~-~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--------~~~~ 533 (824)
.+.....||+||||.||+|+.+ |..||||.++... ....+...+|+++|++|+|||||+++++=. ....
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 3455667999999999999875 6889999998753 344567889999999999999999998753 3457
Q ss_pred EEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEec--CCC--cceeecccc
Q 003384 534 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD--ANF--VSKLSDFGI 609 (824)
Q Consensus 534 LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld--~~~--~vKL~DFGl 609 (824)
+|||||.||||+..|....+...|+....+.+..++..||.|||. +|||||||||.||++- .+| .-||+|||.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 999999999999999888888889999999999999999999998 8999999999999994 334 459999999
Q ss_pred ccccccccccCCCccccccCCCCCCcccCChhhhcc-CCCCcchhHHhHHHHHHHHHhCCCCCC
Q 003384 610 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALG 672 (824)
Q Consensus 610 a~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDVwSlGvvL~ELltG~~Pf~ 672 (824)
|+-+.++.. .++.+||..|++||.+.. ..|+..+|.|||||++|+++||..||-
T Consensus 171 Arel~d~s~---------~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~ 225 (732)
T KOG4250|consen 171 ARELDDNSL---------FTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFI 225 (732)
T ss_pred cccCCCCCe---------eeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCC
Confidence 998776541 256789999999999984 788999999999999999999999984
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=312.62 Aligned_cols=197 Identities=30% Similarity=0.395 Sum_probs=167.2
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcC-C-----CceeeEeccc--CCceEE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-H-----PNLVTLVGAC--PEVWTL 534 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~-H-----pnIv~L~g~~--~~~~~L 534 (824)
+|.+...||+|.||.|.++.+. +..||||+++.... -..+-..|+.||..|+ | -|+|+++++| .++.||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 7888999999999999999886 47899999986432 1345667999999997 3 4899999987 678999
Q ss_pred EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCC--Ccceeeccccccc
Q 003384 535 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN--FVSKLSDFGISRF 612 (824)
Q Consensus 535 V~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~--~~vKL~DFGla~~ 612 (824)
|+|.+ ..+|+++|... ...+|+...+..|+.||+.||.+||. .+|||+||||+||||..- ..+||+|||.|+.
T Consensus 266 VfELL-~~NLYellK~n-~f~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNN-KFRGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eehhh-hhhHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEecccccc
Confidence 99999 56999999654 34569999999999999999999999 899999999999999643 3799999999997
Q ss_pred cccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHH
Q 003384 613 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 678 (824)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~ 678 (824)
...... ...-+..|.|||++.+.+|+.+.||||||||++||+||.|.|.+.+++.
T Consensus 341 ~~q~vy-----------tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~D 395 (586)
T KOG0667|consen 341 ESQRVY-----------TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYD 395 (586)
T ss_pred cCCcce-----------eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHH
Confidence 665432 1235789999999999999999999999999999999999998766543
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=302.12 Aligned_cols=254 Identities=28% Similarity=0.392 Sum_probs=190.7
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCC--CCCCchhHHHHHHHHHhc-CCCceeeEecccCC----ceE
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH--SLQGPSEFQQEIDILSKI-RHPNLVTLVGACPE----VWT 533 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~--~~~~~~~f~~Ei~iL~~l-~HpnIv~L~g~~~~----~~~ 533 (824)
..+|...+.||+|+||.||+|.+. +..||||.+... .......+.+|+.+++++ +||||++++|+|.. ..+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 346888889999999999999875 578999988542 222334577899999999 99999999998732 478
Q ss_pred EEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccc
Q 003384 534 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 613 (824)
Q Consensus 534 LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~ 613 (824)
+||||++ ++|..++.. ..+++..+..++.+++.||.|||+ +||+||||||+|||++.++.+||+|||++..+
T Consensus 86 lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 86 LVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 9999997 589888742 268889999999999999999999 89999999999999999999999999999876
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhcc-CCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhh---------
Q 003384 614 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT--------- 683 (824)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~--------- 683 (824)
.......... ......||..|+|||++.+ ..++.++|||||||++|+|+||++||............
T Consensus 158 ~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07852 158 SELEENPENP---VLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSA 234 (337)
T ss_pred ccccccccCc---chhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 5433211101 1123468999999998765 46788999999999999999999999654322110000
Q ss_pred --------hccccccCCC-------CCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 003384 684 --------GKLKNLLDPL-------AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 727 (824)
Q Consensus 684 --------~~~~~~ld~~-------~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 727 (824)
.....+++.. ........+..+.+++.+||+.+|.+||++.+.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il 293 (337)
T cd07852 235 EDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEAL 293 (337)
T ss_pred HHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHh
Confidence 0000000000 0011112456899999999999999999995443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=291.93 Aligned_cols=230 Identities=26% Similarity=0.334 Sum_probs=177.8
Q ss_pred eeeecCceEEEEEEEC--CeEEEEEEecCCCCCC---chhHHHHHHH---HHhcCCCceeeEecccC--CceEEEEEecC
Q 003384 471 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---PSEFQQEIDI---LSKIRHPNLVTLVGACP--EVWTLVYEYLP 540 (824)
Q Consensus 471 ~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~---~~~f~~Ei~i---L~~l~HpnIv~L~g~~~--~~~~LV~Ey~~ 540 (824)
.||+|+||.||+|... +..||+|.+....... ...+..|..+ ++...||||+++++++. +..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999764 5789999987543221 1224445443 44457999999999874 46889999999
Q ss_pred CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccC
Q 003384 541 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 620 (824)
Q Consensus 541 ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 620 (824)
||+|.+++. ....+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++..+....
T Consensus 81 g~~L~~~l~---~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--- 151 (278)
T cd05606 81 GGDLHYHLS---QHGVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (278)
T ss_pred CCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence 999999884 33569999999999999999999999 889999999999999999999999999987543221
Q ss_pred CCccccccCCCCCCcccCChhhhccC-CCCcchhHHhHHHHHHHHHhCCCCCCCchHHHH-HHhhhccccccCCCCCCCC
Q 003384 621 NNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQY-ALDTGKLKNLLDPLAGDWP 698 (824)
Q Consensus 621 ~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~-~~~~~~~~~~ld~~~~~~p 698 (824)
.....|+..|+|||++.++ .++.++|||||||++|+|++|+.||........ ..... .......+|
T Consensus 152 -------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~ 219 (278)
T cd05606 152 -------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM-----TLTMAVELP 219 (278)
T ss_pred -------CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHH-----hhccCCCCC
Confidence 0223589999999998755 689999999999999999999999975421110 01111 001112234
Q ss_pred hhhHHHHHHHHHHHhhhccCCCC
Q 003384 699 FVQAEQLANLAMRCCEMSRKSRP 721 (824)
Q Consensus 699 ~~~~~~l~~Li~~Cl~~~P~~RP 721 (824)
...+..+.+++.+|+..+|.+||
T Consensus 220 ~~~s~~~~~li~~~l~~~p~~R~ 242 (278)
T cd05606 220 DSFSPELRSLLEGLLQRDVNRRL 242 (278)
T ss_pred CcCCHHHHHHHHHHhhcCHHhcc
Confidence 44567899999999999999999
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=297.11 Aligned_cols=238 Identities=23% Similarity=0.304 Sum_probs=192.1
Q ss_pred CCCCccceeeecCceEEEEEEECC--eEEEEEEecCCCC---CCchhHHHHHHHHHhc-CCCceeeEeccc--CCceEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSL---QGPSEFQQEIDILSKI-RHPNLVTLVGAC--PEVWTLV 535 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~~--~~VAvK~l~~~~~---~~~~~f~~Ei~iL~~l-~HpnIv~L~g~~--~~~~~LV 535 (824)
.+|+...+||+|+||.|..|..++ ..+|||++++... .+.+--..|-.+|... +-|.+++|..+| .+.+|.|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 478999999999999999998876 4599999987532 2223334677777766 467888888887 4689999
Q ss_pred EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccc
Q 003384 536 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 615 (824)
Q Consensus 536 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~ 615 (824)
|||+.||+|.-++.. -+.+.+.....+|.+||-||-|||+ +|||.||||.+|||||..|++||+|||+++----
T Consensus 429 MEyvnGGDLMyhiQQ---~GkFKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQ---VGKFKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred EEEecCchhhhHHHH---hcccCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeeccccccccc
Confidence 999999999988843 3457778889999999999999999 9999999999999999999999999999974221
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCC
Q 003384 616 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG 695 (824)
Q Consensus 616 ~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~ 695 (824)
.. .+ ..+..|||.|+|||++..++|+..+|||||||+||||+.|+|||++.++.......... .-
T Consensus 503 ~~----~T----TkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~eh-------nv 567 (683)
T KOG0696|consen 503 DG----VT----TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEH-------NV 567 (683)
T ss_pred CC----cc----eeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc-------cC
Confidence 11 11 13456999999999999999999999999999999999999999987654422211111 12
Q ss_pred CCChhhHHHHHHHHHHHhhhccCCCCC
Q 003384 696 DWPFVQAEQLANLAMRCCEMSRKSRPE 722 (824)
Q Consensus 696 ~~p~~~~~~l~~Li~~Cl~~~P~~RPt 722 (824)
.+|...+.+...+....+...|.+|-.
T Consensus 568 syPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 568 SYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred cCcccccHHHHHHHHHHhhcCCccccC
Confidence 356777889999999999999999854
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=336.62 Aligned_cols=248 Identities=25% Similarity=0.321 Sum_probs=195.9
Q ss_pred hhcCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHHhcCCCceeeEeccc--CCceEE
Q 003384 461 GATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTL 534 (824)
Q Consensus 461 ~~~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~L 534 (824)
..+-++.....||.|.||.||.|... |.-.|+|-++.... .....+.+|+.+|..|+|||+|++||+= .+..+|
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence 44557788889999999999999865 56689997765432 2345688999999999999999999974 567889
Q ss_pred EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccc
Q 003384 535 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 614 (824)
Q Consensus 535 V~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~ 614 (824)
.||||.+|+|.+++.. +.-.++.....+..|++.||+|||+ +|||||||||+||||+.+|.+|++|||.|..+.
T Consensus 1312 FMEyC~~GsLa~ll~~---gri~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEH---GRIEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred HHHHhccCcHHHHHHh---cchhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeEec
Confidence 9999999999999953 3446667777889999999999999 899999999999999999999999999998776
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccC---CCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccC
Q 003384 615 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASG---ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD 691 (824)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~---~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld 691 (824)
....... ..-...+||+.|||||++.+. +...+.||||+|||.+||+||+.||...+.-...+.. ..-
T Consensus 1386 ~~~~~~~----~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~-----V~~ 1456 (1509)
T KOG4645|consen 1386 NNAQTMP----GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYH-----VAA 1456 (1509)
T ss_pred CchhcCC----HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhH-----Hhc
Confidence 5521111 112456899999999999763 5667899999999999999999999644332221111 111
Q ss_pred CCCCCCChhhHHHHHHHHHHHhhhccCCCCCh
Q 003384 692 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 723 (824)
Q Consensus 692 ~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 723 (824)
.-.+..|...+.+-.+++.+||+.||+.|-+.
T Consensus 1457 gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~ 1488 (1509)
T KOG4645|consen 1457 GHKPQIPERLSSEGRDFLEHCLEQDPKMRWTA 1488 (1509)
T ss_pred cCCCCCchhhhHhHHHHHHHHHhcCchhhhHH
Confidence 12234566678889999999999999999554
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=293.52 Aligned_cols=245 Identities=25% Similarity=0.347 Sum_probs=186.0
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC-CchhHHHHHHHHHhcC-CCceeeEecccC--CceEEEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIR-HPNLVTLVGACP--EVWTLVYE 537 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l~-HpnIv~L~g~~~--~~~~LV~E 537 (824)
++|.....||.|+||.||+|.+. +..||||.+...... ....+..|+.++.++. ||||++++|+|. ...++|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 46788899999999999999987 688999998754322 2345677887777775 999999999984 46889999
Q ss_pred ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccc
Q 003384 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 617 (824)
Q Consensus 538 y~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 617 (824)
|+. ++|.+++... ..++++..+..++.+++.||.|||+. .+|+||||+|+||+++.++.+||+|||++..+....
T Consensus 95 ~~~-~~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 95 LMS-TCLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK 169 (296)
T ss_pred ccC-cCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence 985 5777766432 23789999999999999999999972 379999999999999999999999999987654322
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCC----CCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCC
Q 003384 618 ISSNNTTLCCRTDPKGTFAYMDPEFLASGE----LTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPL 693 (824)
Q Consensus 618 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~----~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~ 693 (824)
.. ....|+..|+|||++.+.. ++.++|||||||++|+|++|+.||.........+.. .+.... +.
T Consensus 170 ~~---------~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~-~~~~~~-~~ 238 (296)
T cd06618 170 AK---------TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTK-ILQEEP-PS 238 (296)
T ss_pred cc---------cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHH-HhcCCC-CC
Confidence 11 2234788999999987553 788999999999999999999999653221111111 000000 00
Q ss_pred CCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 694 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 694 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
.......+..+.+|+.+||+.+|.+||++.+
T Consensus 239 -~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ 269 (296)
T cd06618 239 -LPPNEGFSPDFCSFVDLCLTKDHRKRPKYRE 269 (296)
T ss_pred -CCCCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence 1111234678999999999999999999943
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=295.49 Aligned_cols=248 Identities=25% Similarity=0.334 Sum_probs=191.3
Q ss_pred CCCccceeeecCceEEEEEEEC-----CeEEEEEEecCCCC----CCchhHHHHHHHHHhc-CCCceeeEecccC--Cce
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR-----HMQVAIKMLHPHSL----QGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVW 532 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~-----~~~VAvK~l~~~~~----~~~~~f~~Ei~iL~~l-~HpnIv~L~g~~~--~~~ 532 (824)
+|...+.||+|+||.||++... +..||||++..... .....+.+|+.++.++ +||||+++++.+. ...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 3677789999999999998753 46799999864321 2234688999999999 5999999998874 467
Q ss_pred EEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccc
Q 003384 533 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 612 (824)
Q Consensus 533 ~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~ 612 (824)
++||||+++|+|.+++.. ...+++.....++.|++.||.|||. .+++||||+|.||+++.++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECccccc
Confidence 899999999999998843 3468899999999999999999999 8999999999999999999999999999876
Q ss_pred cccccccCCCccccccCCCCCCcccCChhhhccCC--CCcchhHHhHHHHHHHHHhCCCCCCCchHH--HHHHhhhcccc
Q 003384 613 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE--LTPKSDVYSFGIILLRLLTGRPALGITKEV--QYALDTGKLKN 688 (824)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~--~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~--~~~~~~~~~~~ 688 (824)
+....... .....|+..|+|||.+.+.. ++.++||||||+++|+|+||..||...... ...+......
T Consensus 155 ~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~- 226 (288)
T cd05583 155 FLAEEEER-------AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK- 226 (288)
T ss_pred cccccccc-------cccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHc-
Confidence 54332110 12345899999999987654 788999999999999999999999643211 1111111111
Q ss_pred ccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHH
Q 003384 689 LLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVL 731 (824)
Q Consensus 689 ~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L 731 (824)
.....+...+..+.+++.+||+.+|.+||++ ..+.+.|
T Consensus 227 ----~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~-~~~~~~l 264 (288)
T cd05583 227 ----SKPPFPKTMSAEARDFIQKLLEKDPKKRLGA-NGADEIK 264 (288)
T ss_pred ----cCCCCCcccCHHHHHHHHHHhcCCHhhccCc-chHHHHh
Confidence 1112233455688999999999999999998 4554444
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=301.12 Aligned_cols=243 Identities=23% Similarity=0.345 Sum_probs=185.2
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHHhcCCCceeeEecccCC--------c
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACPE--------V 531 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~~--------~ 531 (824)
.+|.....||+|+||.||+|... +..||||++..... .....+.+|+.+++.++||||++++++|.. .
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 57888899999999999999864 68899999865321 123457899999999999999999998732 3
Q ss_pred eEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccc
Q 003384 532 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR 611 (824)
Q Consensus 532 ~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~ 611 (824)
+++|+||+. ++|..++ ...+++..+..++.+++.||.|||. ++|+||||||+|||++.++.+||+|||+++
T Consensus 95 ~~lv~e~~~-~~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~~~ 165 (342)
T cd07879 95 FYLVMPYMQ-TDLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLAR 165 (342)
T ss_pred EEEEecccc-cCHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence 589999996 4776655 2358899999999999999999999 899999999999999999999999999987
Q ss_pred ccccccccCCCccccccCCCCCCcccCChhhhcc-CCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhc-----
Q 003384 612 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK----- 685 (824)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~----- 685 (824)
...... ....||..|+|||++.+ ..++.++|||||||++|||++|+.||..............
T Consensus 166 ~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 234 (342)
T cd07879 166 HADAEM-----------TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVP 234 (342)
T ss_pred CCCCCC-----------CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 542211 23357889999999876 4688999999999999999999999976543221110000
Q ss_pred ------------cccccC--CC--CCCC---ChhhHHHHHHHHHHHhhhccCCCCChHHH
Q 003384 686 ------------LKNLLD--PL--AGDW---PFVQAEQLANLAMRCCEMSRKSRPELGKD 726 (824)
Q Consensus 686 ------------~~~~ld--~~--~~~~---p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~ 726 (824)
...... +. ...+ ....+..+.+|+.+||+.+|.+||++.+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~ 294 (342)
T cd07879 235 GPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEA 294 (342)
T ss_pred CHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 000000 00 0000 01234578899999999999999999433
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-32 Score=285.27 Aligned_cols=242 Identities=31% Similarity=0.415 Sum_probs=195.0
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEe
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY 538 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey 538 (824)
+|+...+||.|+||.||++... +..+++|.+...... ....+.+|+.+++.++||||+++++++. ...++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4677889999999999999875 578999998754322 2346788999999999999999998873 468899999
Q ss_pred cCCCChhhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccc
Q 003384 539 LPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 617 (824)
Q Consensus 539 ~~ggsL~~~L~~~-~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 617 (824)
+++++|.+++... .....+++..+..++.+++.||.|||+ .|++||||+|.||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 9999999988542 223568999999999999999999999 899999999999999999999999999998765431
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCC
Q 003384 618 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 697 (824)
Q Consensus 618 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~ 697 (824)
. ....|++.|++||.+.+..++.++|+||||+++|+|++|++||............ ... .....
T Consensus 158 ~----------~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~--~~~----~~~~~ 221 (256)
T cd08530 158 A----------KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKV--QRG----KYPPI 221 (256)
T ss_pred c----------ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--hcC----CCCCC
Confidence 1 1234789999999999888999999999999999999999999765533221111 111 11122
Q ss_pred ChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 698 PFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 698 p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
+...+.++.+++.+|++.+|.+||++.+
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 249 (256)
T cd08530 222 PPIYSQDLQNFIRSMLQVKPKLRPNCDK 249 (256)
T ss_pred chhhCHHHHHHHHHHcCCCcccCCCHHH
Confidence 3345678999999999999999999943
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=287.80 Aligned_cols=246 Identities=29% Similarity=0.380 Sum_probs=186.9
Q ss_pred CCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCC--chhHHHHHHHHHhc---CCCceeeEecccC--Cc-----
Q 003384 466 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKI---RHPNLVTLVGACP--EV----- 531 (824)
Q Consensus 466 f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~--~~~f~~Ei~iL~~l---~HpnIv~L~g~~~--~~----- 531 (824)
|+....||.|+||.||+|.+. +..||+|++....... ...+.+|+.++.++ +||||++++++|. +.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 566788999999999999986 5889999997543221 23567788887766 5999999999883 33
Q ss_pred eEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccc
Q 003384 532 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR 611 (824)
Q Consensus 532 ~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~ 611 (824)
.+++|||+.+ +|.+++.... ...+++..+..++.+++.||.|||+ ++++|+||+|+|||++.++.+||+|||++.
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhccc-CHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCcce
Confidence 7899999974 8988885432 2358999999999999999999999 889999999999999999999999999987
Q ss_pred ccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccc----
Q 003384 612 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLK---- 687 (824)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~---- 687 (824)
.+...... ....++..|+|||++.+..++.++|||||||++|+|+||++||............-...
T Consensus 156 ~~~~~~~~---------~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (287)
T cd07838 156 IYSFEMAL---------TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPS 226 (287)
T ss_pred eccCCccc---------ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCC
Confidence 76433211 12347889999999998899999999999999999999999997654332211100000
Q ss_pred ------------cccCCCCC----CCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 688 ------------NLLDPLAG----DWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 688 ------------~~ld~~~~----~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
..+..... ......+..+.+++.+||+.+|.+||++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~ 280 (287)
T cd07838 227 EEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFE 280 (287)
T ss_pred hHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHH
Confidence 00000000 001123467889999999999999999943
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-32 Score=287.10 Aligned_cols=243 Identities=24% Similarity=0.349 Sum_probs=190.0
Q ss_pred CCCccceeeecCceEEEEEEECC--eEEEEEEecCCCC-----CCchhHHHHHHHHHhcCCCceeeEecccC--CceEEE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSL-----QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLV 535 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~~--~~VAvK~l~~~~~-----~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV 535 (824)
+|.+.+.||+|+||.||++.+.. ..+++|+++.... .....+..|+.+++.++||||+++++++. +..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 36777899999999999998764 4466666654221 12235778999999999999999999884 468899
Q ss_pred EEecCCCChhhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccc
Q 003384 536 YEYLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 614 (824)
Q Consensus 536 ~Ey~~ggsL~~~L~~~-~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~ 614 (824)
|||+++++|.+++... .....+++..+..++.+++.||.|||+ +|++|+||+|+||+++. +.+||+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999988542 234579999999999999999999999 89999999999999985 569999999988654
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCC
Q 003384 615 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 694 (824)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~ 694 (824)
..... .....|++.|+|||.+.+..++.++||||||+++|+|++|..||............ .....
T Consensus 157 ~~~~~--------~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~------~~~~~ 222 (260)
T cd08222 157 GSCDL--------ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRI------VEGPT 222 (260)
T ss_pred CCccc--------ccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH------HcCCC
Confidence 32211 12345889999999998888999999999999999999999999754433221111 11112
Q ss_pred CCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 695 GDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 695 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
...+...+..+.+++.+||..+|.+||++.+
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 253 (260)
T cd08222 223 PSLPETYSRQLNSIMQSMLNKDPSLRPSAAE 253 (260)
T ss_pred CCCcchhcHHHHHHHHHHhcCChhhCcCHHH
Confidence 2234456678999999999999999999943
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=311.22 Aligned_cols=238 Identities=21% Similarity=0.373 Sum_probs=186.4
Q ss_pred ccceeeecCceEEEEEEECCe--EEE---EEEecCC-CCCCchhHHHHHHHHHhcCCCceeeEecccCC----ceEEEEE
Q 003384 468 PSLKIGEGGYGSIYKGLLRHM--QVA---IKMLHPH-SLQGPSEFQQEIDILSKIRHPNLVTLVGACPE----VWTLVYE 537 (824)
Q Consensus 468 ~~~~LG~G~fG~Vykg~~~~~--~VA---vK~l~~~-~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~~----~~~LV~E 537 (824)
...+||+|+|-+||+|.+... .|| ||.-... .......|..|+.+|+.|+|||||++|+++.+ ...+|.|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 345699999999999988643 343 2322111 12223679999999999999999999999843 3678999
Q ss_pred ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecC-CCcceeeccccccccccc
Q 003384 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA-NFVSKLSDFGISRFLSQN 616 (824)
Q Consensus 538 y~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~-~~~vKL~DFGla~~~~~~ 616 (824)
.+..|+|..++.+ ...++...+..|+.||++||.|||+..| ||||||||.+||||+. -|.|||+|+|||......
T Consensus 124 L~TSGtLr~Y~kk---~~~vn~kaik~W~RQILkGL~yLHs~~P-PIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 124 LFTSGTLREYRKK---HRRVNIKAIKSWCRQILKGLVYLHSQDP-PIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred cccCCcHHHHHHH---hccCCHHHHHHHHHHHHHHhhhhhcCCC-CccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 9999999999953 3457788999999999999999999775 8999999999999975 589999999999987654
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCch---HHHHHHhhhccccccCCC
Q 003384 617 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITK---EVQYALDTGKLKNLLDPL 693 (824)
Q Consensus 617 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~---~~~~~~~~~~~~~~ld~~ 693 (824)
.. ....|||.|||||++. ..|+..+||||||++|+||+|+..||.--. .+...+..|..-..+.
T Consensus 200 ~a----------ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~-- 266 (632)
T KOG0584|consen 200 HA----------KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALS-- 266 (632)
T ss_pred cc----------ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhh--
Confidence 31 3457999999999987 789999999999999999999999995322 2333333333222221
Q ss_pred CCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHH
Q 003384 694 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVW 728 (824)
Q Consensus 694 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~ 728 (824)
....+++.+||.+|+.. ..+||+..+.+.
T Consensus 267 -----kV~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 267 -----KVKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred -----ccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 22245899999999999 999999955443
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=290.61 Aligned_cols=246 Identities=25% Similarity=0.361 Sum_probs=187.6
Q ss_pred CCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC-CchhHHHHHHHHHhcC-CCceeeEeccc--CCceEEEEEec
Q 003384 466 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIR-HPNLVTLVGAC--PEVWTLVYEYL 539 (824)
Q Consensus 466 f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l~-HpnIv~L~g~~--~~~~~LV~Ey~ 539 (824)
|...+.||.|+||+||+|... +..|+||.+...... ......+|+..+++++ ||||+++++++ .+..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 556778999999999999985 578999998654321 2234567999999999 99999999988 34689999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccccc
Q 003384 540 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 619 (824)
Q Consensus 540 ~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 619 (824)
+|+|.+++.... ...+++..+..++.+++.+|.|||+ ++++|+||+|.||+++.++.++|+|||++.........
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY 155 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCc
Confidence 889998885433 3468999999999999999999999 89999999999999999999999999998765432111
Q ss_pred CCCccccccCCCCCCcccCChhhhcc-CCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhc-------------
Q 003384 620 SNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK------------- 685 (824)
Q Consensus 620 ~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~------------- 685 (824)
....|+..|+|||++.. ..++.++||||||+++|+|++|++||..............
T Consensus 156 ---------~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (283)
T cd07830 156 ---------TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEG 226 (283)
T ss_pred ---------CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhH
Confidence 22357899999998854 4578999999999999999999999975543322111100
Q ss_pred ------cccccCCC----CCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 686 ------LKNLLDPL----AGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 686 ------~~~~ld~~----~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
....+... ........+..+.+++.+||+.+|.+||++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~e 276 (283)
T cd07830 227 YKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQ 276 (283)
T ss_pred hhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHH
Confidence 00000000 00111112467999999999999999999943
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-32 Score=296.30 Aligned_cols=252 Identities=21% Similarity=0.241 Sum_probs=184.8
Q ss_pred eeeec--CceEEEEEEE--CCeEEEEEEecCCCCCC--chhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEecCCC
Q 003384 471 KIGEG--GYGSIYKGLL--RHMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNG 542 (824)
Q Consensus 471 ~LG~G--~fG~Vykg~~--~~~~VAvK~l~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey~~gg 542 (824)
.||+| +||+||++.+ .++.||||++....... .+.+.+|+.+++.++||||++++++|. +..++||||+.+|
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 46666 9999999987 46899999987543222 356889999999999999999999984 4678999999999
Q ss_pred ChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCCC
Q 003384 543 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 622 (824)
Q Consensus 543 sL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~ 622 (824)
+|.+++.... ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+|++|||.+............
T Consensus 85 ~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 85 SANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 9999886432 2358899999999999999999999 89999999999999999999999999876543322111100
Q ss_pred ccccccCCCCCCcccCChhhhccC--CCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccc-------------
Q 003384 623 TTLCCRTDPKGTFAYMDPEFLASG--ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLK------------- 687 (824)
Q Consensus 623 ~~~~~~~~~~GT~~Y~APE~l~~~--~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~------------- 687 (824)
.........++..|+|||++.+. .++.++|||||||++|+|++|++||............-...
T Consensus 161 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd08226 161 -VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE 239 (328)
T ss_pred -cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh
Confidence 00000112356789999999764 57899999999999999999999997543322211100000
Q ss_pred --------------------------ccc-CCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 003384 688 --------------------------NLL-DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 727 (824)
Q Consensus 688 --------------------------~~l-d~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 727 (824)
... .......+...+..+.+|+.+||+.+|.+||++.+.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l 306 (328)
T cd08226 240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLL 306 (328)
T ss_pred hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHh
Confidence 000 0001111223466899999999999999999995443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-32 Score=299.94 Aligned_cols=246 Identities=23% Similarity=0.329 Sum_probs=189.3
Q ss_pred hcCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEecccCC-------
Q 003384 462 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACPE------- 530 (824)
Q Consensus 462 ~~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~L~g~~~~------- 530 (824)
..++|...+.||+|+||.||+|... +..||||++...... ....+.+|+.+|+.++||||+++++++..
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 4567999999999999999999875 578999998643211 23457899999999999999999998732
Q ss_pred -ceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccc
Q 003384 531 -VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI 609 (824)
Q Consensus 531 -~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGl 609 (824)
.+++||||+ +++|.+++. ...+++..+..++.|++.||.|||. .||+||||||+|||++.++.+||+|||+
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~dfg~ 164 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGL 164 (343)
T ss_pred ceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeccc
Confidence 358999999 779988873 2468999999999999999999999 8999999999999999999999999999
Q ss_pred ccccccccccCCCccccccCCCCCCcccCChhhhcc-CCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhcc--
Q 003384 610 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL-- 686 (824)
Q Consensus 610 a~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~-- 686 (824)
+....... ....+++.|+|||.+.+ ..++.++|||||||++|+|++|++||...............
T Consensus 165 ~~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~ 233 (343)
T cd07880 165 ARQTDSEM-----------TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTG 233 (343)
T ss_pred ccccccCc-----------cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 87543211 23357899999999876 45889999999999999999999999765432211110000
Q ss_pred ---------------ccccCCC-------CCCCChhhHHHHHHHHHHHhhhccCCCCChHHH
Q 003384 687 ---------------KNLLDPL-------AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD 726 (824)
Q Consensus 687 ---------------~~~ld~~-------~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~ 726 (824)
....... ........+..+.+++.+|++.+|.+||++.+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~ 295 (343)
T cd07880 234 TPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEA 295 (343)
T ss_pred CCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHH
Confidence 0000000 000112334578999999999999999999443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=320.26 Aligned_cols=198 Identities=21% Similarity=0.279 Sum_probs=152.0
Q ss_pred CCCCccceeeecCceEEEEEEECC---eEEEEEEec--------------C---CCCCCchhHHHHHHHHHhcCCCceee
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLRH---MQVAIKMLH--------------P---HSLQGPSEFQQEIDILSKIRHPNLVT 523 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~~---~~VAvK~l~--------------~---~~~~~~~~f~~Ei~iL~~l~HpnIv~ 523 (824)
.+|.+..+||+|+||+||++.++. ..+++|.+. . ........+.+|+.+|+.++||||++
T Consensus 148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 227 (501)
T PHA03210 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK 227 (501)
T ss_pred hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence 479999999999999999986542 112222110 0 01111245789999999999999999
Q ss_pred Eeccc--CCceEEEEEecCCCChhhhhhccCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCC
Q 003384 524 LVGAC--PEVWTLVYEYLPNGSLEDRLSCKDN--SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN 599 (824)
Q Consensus 524 L~g~~--~~~~~LV~Ey~~ggsL~~~L~~~~~--~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~ 599 (824)
+++++ .+..++|++++. ++|.+++..... ...........|+.||+.||.|||+ ++||||||||+||||+.+
T Consensus 228 l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl~~~ 303 (501)
T PHA03210 228 IEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNCD 303 (501)
T ss_pred EeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCC
Confidence 99988 456889999985 567776643211 1223355677899999999999999 899999999999999999
Q ss_pred CcceeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCC-CCC
Q 003384 600 FVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP-ALG 672 (824)
Q Consensus 600 ~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~-Pf~ 672 (824)
+.+||+|||+++.+....... .....||+.|+|||++.+..++.++|||||||+||||++|.. ||.
T Consensus 304 ~~vkL~DFGla~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~ 370 (501)
T PHA03210 304 GKIVLGDFGTAMPFEKEREAF-------DYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIG 370 (501)
T ss_pred CCEEEEeCCCceecCcccccc-------cccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCcc
Confidence 999999999998764332111 123469999999999999999999999999999999999874 453
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=300.50 Aligned_cols=250 Identities=22% Similarity=0.298 Sum_probs=188.6
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccCC----------
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPE---------- 530 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~~---------- 530 (824)
..+|...+.||.|+||.||+|... +..||+|.+........+.+.+|+++++.++||||+++++++..
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 357899999999999999999875 57899999876655555678899999999999999999987632
Q ss_pred ------ceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEec-CCCcce
Q 003384 531 ------VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD-ANFVSK 603 (824)
Q Consensus 531 ------~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld-~~~~vK 603 (824)
..++||||+. ++|.+++. ...+++..+..++.|++.||.|||+ .||+||||||+|||++ .++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceEE
Confidence 3689999997 58888773 2358899999999999999999999 8999999999999997 566889
Q ss_pred eeccccccccccccccCCCccccccCCCCCCcccCChhhhcc-CCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHh
Q 003384 604 LSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALD 682 (824)
Q Consensus 604 L~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~ 682 (824)
|+|||++..+........ ......|+..|+|||++.. ..++.++|||||||++|+|++|++||...........
T Consensus 156 l~dfg~~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~ 230 (342)
T cd07854 156 IGDFGLARIVDPHYSHKG-----YLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQL 230 (342)
T ss_pred ECCcccceecCCcccccc-----ccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 999999976532211110 0122357899999998755 4688899999999999999999999975443221111
Q ss_pred hhcc---------ccc--------c-CCCCCCC-----ChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 683 TGKL---------KNL--------L-DPLAGDW-----PFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 683 ~~~~---------~~~--------l-d~~~~~~-----p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
.... ... . ....... ....+..+.+|+.+||+.+|.+||++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e 296 (342)
T cd07854 231 ILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEE 296 (342)
T ss_pred HHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHH
Confidence 0000 000 0 0000001 1123467889999999999999999843
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=298.05 Aligned_cols=249 Identities=25% Similarity=0.329 Sum_probs=192.1
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCC--CCCchhHHHHHHHHHhcCCCceeeEecccCC-------ceE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS--LQGPSEFQQEIDILSKIRHPNLVTLVGACPE-------VWT 533 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~--~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~~-------~~~ 533 (824)
+|...+.||.|+||.||+|... +..||||.+.... ....+.+.+|+.+++.++||||+++++++.. ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4777889999999999999875 5889999987643 2334578999999999999999999998732 478
Q ss_pred EEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccc
Q 003384 534 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 613 (824)
Q Consensus 534 LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~ 613 (824)
+||||++ ++|.+++.. ..++++..+..++.+++.||.|||+ +||+||||||.|||++.++.++|+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999997 588888842 3479999999999999999999999 89999999999999999999999999999876
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhccC-CCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhc-------
Q 003384 614 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK------- 685 (824)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~------- 685 (824)
....... .......||+.|+|||++.+. .++.++|||||||++|+|++|++||............-.
T Consensus 154 ~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 228 (330)
T cd07834 154 DPDEDEK-----GFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSE 228 (330)
T ss_pred ccccccc-----ccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCCh
Confidence 5432110 011334589999999999887 789999999999999999999999976543221110000
Q ss_pred ----------cccccCCCC-------CCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 686 ----------LKNLLDPLA-------GDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 686 ----------~~~~ld~~~-------~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
....+.... .......+..+.+++.+||+.+|.+||++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ 285 (330)
T cd07834 229 EDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADE 285 (330)
T ss_pred hHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHH
Confidence 000000000 0001123567899999999999999999843
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.9e-33 Score=286.18 Aligned_cols=252 Identities=25% Similarity=0.355 Sum_probs=190.1
Q ss_pred CCCccceeeecCceEEEEEEECC------eEEEEEEecCCCCCC--chhHHHHHHHHHhcCCCceeeEecccC---CceE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLRH------MQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACP---EVWT 533 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~~------~~VAvK~l~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~L~g~~~---~~~~ 533 (824)
.|+....||+|.||.||++...+ ..+|||.++...... .....+|+.+++.|+||||+.|..+|- ...+
T Consensus 25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~ 104 (438)
T KOG0666|consen 25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVW 104 (438)
T ss_pred HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEE
Confidence 57888899999999999996532 368999998653322 235789999999999999999988873 3678
Q ss_pred EEEEecCCCChhhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCC----Ccceeecc
Q 003384 534 LVYEYLPNGSLEDRLSCK--DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN----FVSKLSDF 607 (824)
Q Consensus 534 LV~Ey~~ggsL~~~L~~~--~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~----~~vKL~DF 607 (824)
+++||.+. +|..++... .....++......|+.||+.|+.|||+ +-|+||||||+|||+..+ |.+||+||
T Consensus 105 l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 105 LLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred EEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEeecc
Confidence 99999986 787777543 233578889999999999999999999 889999999999999877 89999999
Q ss_pred ccccccccccccCCCccccccCCCCCCcccCChhhhccC-CCCcchhHHhHHHHHHHHHhCCCCCCCchH-------HHH
Q 003384 608 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKE-------VQY 679 (824)
Q Consensus 608 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~-------~~~ 679 (824)
|+++.+...-... .....++-|++|.|||.+.+. .||++.|||+.|||+.||+|-.|.|.+... +..
T Consensus 181 GlaR~~~~plkpl-----~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~ 255 (438)
T KOG0666|consen 181 GLARLFNNPLKPL-----ASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQH 255 (438)
T ss_pred cHHHHhhcccccc-----ccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchH
Confidence 9999876543211 112345579999999999885 799999999999999999999998854321 111
Q ss_pred HHhhhccccccCCCCCCCChhh--------------------------------HHHHHHHHHHHhhhccCCCCChHH
Q 003384 680 ALDTGKLKNLLDPLAGDWPFVQ--------------------------------AEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 680 ~~~~~~~~~~ld~~~~~~p~~~--------------------------------~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
.-....+.-+..|...+||... ++...+|+..+|++||.+|.|..+
T Consensus 256 dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~q 333 (438)
T KOG0666|consen 256 DQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQ 333 (438)
T ss_pred HHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHH
Confidence 1111112222223333333211 224678899999999999999844
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.6e-32 Score=296.74 Aligned_cols=248 Identities=24% Similarity=0.305 Sum_probs=190.1
Q ss_pred HhhhcCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHHhcCCCceeeEecccC---Cc
Q 003384 459 IEGATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP---EV 531 (824)
Q Consensus 459 i~~~~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~---~~ 531 (824)
+...+++|...+.||.|+||.||+|... +..||||.+..... .....+..|+.+++.++||||++++++|. ..
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 3446778999999999999999999865 57899998764321 22456889999999999999999999873 35
Q ss_pred eEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccc
Q 003384 532 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR 611 (824)
Q Consensus 532 ~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~ 611 (824)
.++||||+ +++|.+++. ..+++......++.+++.||.|||+ ++|+||||+|+|||++.++.+||+|||++.
T Consensus 85 ~~lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 85 IYFVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred EEEEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCcccccc
Confidence 78999998 568988873 2357888888999999999999999 899999999999999999999999999987
Q ss_pred ccccccccCCCccccccCCCCCCcccCChhhhcc-CCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhh-------
Q 003384 612 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT------- 683 (824)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~------- 683 (824)
...... ....++..|+|||++.+ ..++.++|||||||++|+|+||++||............
T Consensus 157 ~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~ 225 (328)
T cd07856 157 IQDPQM-----------TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTP 225 (328)
T ss_pred ccCCCc-----------CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 532211 22357889999998766 56899999999999999999999999754432111000
Q ss_pred ----------hccccccCCC--CCCCC-----hhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 684 ----------GKLKNLLDPL--AGDWP-----FVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 684 ----------~~~~~~ld~~--~~~~p-----~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
+.....+... ....| ...+..+.+++.+||+.+|.+||++.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~e 284 (328)
T cd07856 226 PDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAE 284 (328)
T ss_pred CHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHH
Confidence 0000000000 00111 123568999999999999999999843
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=292.54 Aligned_cols=237 Identities=28% Similarity=0.389 Sum_probs=185.9
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC---CchhHHHHHHHHHhcCCCceeeEeccc--CCceEEEEE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYE 537 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~---~~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~E 537 (824)
.|...+.||.|+||.||+|... +..||+|.+...... ....+.+|+.+++.++|||++++++++ ....++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 4667788999999999999875 578999988643222 234577899999999999999999987 446789999
Q ss_pred ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccc
Q 003384 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 617 (824)
Q Consensus 538 y~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 617 (824)
|+. |+|.+.+... ..++++..+..++.+++.||.|||+ .+++||||+|+|||++.++.+||+|||++......
T Consensus 96 ~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~- 168 (308)
T cd06634 96 YCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (308)
T ss_pred ccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence 996 5787776422 3458899999999999999999999 89999999999999999999999999998764321
Q ss_pred ccCCCccccccCCCCCCcccCChhhhc---cCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHH--HhhhccccccCC
Q 003384 618 ISSNNTTLCCRTDPKGTFAYMDPEFLA---SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA--LDTGKLKNLLDP 692 (824)
Q Consensus 618 ~~~~~~~~~~~~~~~GT~~Y~APE~l~---~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~--~~~~~~~~~ld~ 692 (824)
....|++.|+|||.+. ...++.++|||||||++|+|++|.+||......... ...+.. +
T Consensus 169 -----------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-----~ 232 (308)
T cd06634 169 -----------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-----P 232 (308)
T ss_pred -----------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCC-----C
Confidence 2235789999999975 346788999999999999999999998654332211 111111 1
Q ss_pred CCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 003384 693 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 727 (824)
Q Consensus 693 ~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 727 (824)
. ..+...+..+.+|+.+||..+|.+||++ +++
T Consensus 233 ~--~~~~~~~~~~~~li~~cl~~~P~~Rp~~-~~l 264 (308)
T cd06634 233 A--LQSGHWSEYFRNFVDSCLQKIPQDRPTS-EVL 264 (308)
T ss_pred C--cCcccccHHHHHHHHHHhhCCcccCCCH-HHH
Confidence 0 0122345679999999999999999998 444
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=295.29 Aligned_cols=254 Identities=22% Similarity=0.280 Sum_probs=187.0
Q ss_pred CCC-ccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCC--------------chhHHHHHHHHHhcCCCceeeEecc
Q 003384 465 NFD-PSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--------------PSEFQQEIDILSKIRHPNLVTLVGA 527 (824)
Q Consensus 465 ~f~-~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~--------------~~~f~~Ei~iL~~l~HpnIv~L~g~ 527 (824)
+|. ....||.|+||.||+|... +..||||.+....... ...+.+|+.+++.++||||++++++
T Consensus 9 ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 88 (335)
T PTZ00024 9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDV 88 (335)
T ss_pred chhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEE
Confidence 454 3467999999999999865 5789999986543221 1247789999999999999999998
Q ss_pred c--CCceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceee
Q 003384 528 C--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLS 605 (824)
Q Consensus 528 ~--~~~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~ 605 (824)
+ .+..++||||+. |+|.+++. ....+++.....++.|++.||.|||. ++|+||||+|+|||++.++.+||+
T Consensus 89 ~~~~~~~~lv~e~~~-~~l~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~kl~ 161 (335)
T PTZ00024 89 YVEGDFINLVMDIMA-SDLKKVVD---RKIRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIA 161 (335)
T ss_pred EecCCcEEEEEeccc-cCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEEEC
Confidence 7 456889999996 68988884 33468899999999999999999999 899999999999999999999999
Q ss_pred ccccccccccccccCC-----C-ccccccCCCCCCcccCChhhhccC-CCCcchhHHhHHHHHHHHHhCCCCCCCchHHH
Q 003384 606 DFGISRFLSQNEISSN-----N-TTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 678 (824)
Q Consensus 606 DFGla~~~~~~~~~~~-----~-~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~ 678 (824)
|||++........... . ..........+++.|+|||++.+. .++.++|||||||++|+|+||.+||...+...
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~ 241 (335)
T PTZ00024 162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID 241 (335)
T ss_pred CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999986642211100 0 000011234578899999998764 47899999999999999999999997655432
Q ss_pred HHHhhhc---------ccccc-----CCCCC-------CCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 679 YALDTGK---------LKNLL-----DPLAG-------DWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 679 ~~~~~~~---------~~~~l-----d~~~~-------~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
....... +.... .+... ......+..+.+++.+||+.+|.+||++.+
T Consensus 242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~ 309 (335)
T PTZ00024 242 QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKE 309 (335)
T ss_pred HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHH
Confidence 1111000 00000 00000 001123567899999999999999999843
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=295.42 Aligned_cols=250 Identities=23% Similarity=0.266 Sum_probs=186.0
Q ss_pred CCCccceeeecCceEEEEEEEC----CeEEEEEEecCCCCC--CchhHHHHHHHHHhc-CCCceeeEecccC------Cc
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR----HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKI-RHPNLVTLVGACP------EV 531 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~----~~~VAvK~l~~~~~~--~~~~f~~Ei~iL~~l-~HpnIv~L~g~~~------~~ 531 (824)
+|...+.||+|+||.||++... +..||||.+...... ....+.+|+.+++++ +||||+++++.+. ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4677889999999999999876 457999988643211 234678899999999 5999999998641 24
Q ss_pred eEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccc
Q 003384 532 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR 611 (824)
Q Consensus 532 ~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~ 611 (824)
.+++++|+. ++|.+.+. ....+++..+..++.|++.||.|||. +||+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 678888885 68988884 34568999999999999999999999 899999999999999999999999999998
Q ss_pred ccccccccCCCccccccCCCCCCcccCChhhhcc-CCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHh--------
Q 003384 612 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALD-------- 682 (824)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~-------- 682 (824)
.+........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...+.......
T Consensus 154 ~~~~~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 229 (332)
T cd07857 154 GFSENPGENA----GFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTP 229 (332)
T ss_pred eccccccccc----ccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCC
Confidence 6653322111 01133468999999998766 4689999999999999999999999975432110000
Q ss_pred ---------hhc---cccccC----CCCCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 683 ---------TGK---LKNLLD----PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 683 ---------~~~---~~~~ld----~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
... ....+. ..........+..+.+++.+|++.+|.+||++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ 288 (332)
T cd07857 230 DEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEE 288 (332)
T ss_pred CHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence 000 000000 0000001123567999999999999999999844
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=286.70 Aligned_cols=246 Identities=28% Similarity=0.400 Sum_probs=190.2
Q ss_pred CCccceeeecCceEEEEEEEC--CeEEEEEEecCCC--CCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEec
Q 003384 466 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS--LQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL 539 (824)
Q Consensus 466 f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~--~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey~ 539 (824)
|+....||.|+||.||+|... +..||+|++.... ......+..|+.+++.++||||+++++++. +..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 455678999999999999886 5889999988653 223456889999999999999999999874 4688999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccccc
Q 003384 540 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 619 (824)
Q Consensus 540 ~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 619 (824)
+ ++|.+++.... ..+++..+..++.+++.||.|||. ++|+||||+|+||+++.++.+||+|||++.........
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 154 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT 154 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCccc
Confidence 7 58999985332 468999999999999999999999 89999999999999999999999999999865432211
Q ss_pred CCCccccccCCCCCCcccCChhhhccC-CCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhc---------c---
Q 003384 620 SNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK---------L--- 686 (824)
Q Consensus 620 ~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~---------~--- 686 (824)
.....++..|+|||++.+. .++.++|||||||++|||++|++||.............. +
T Consensus 155 --------~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (282)
T cd07829 155 --------YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGV 226 (282)
T ss_pred --------cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhh
Confidence 1223467889999998776 789999999999999999999999976554322111000 0
Q ss_pred ccc--cCCCCCCC--------ChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 687 KNL--LDPLAGDW--------PFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 687 ~~~--ld~~~~~~--------p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
..+ .+.....+ ....+..+.+++.+||..+|.+||++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ 275 (282)
T cd07829 227 TKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKE 275 (282)
T ss_pred cccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHH
Confidence 000 00000000 0112568999999999999999999843
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-32 Score=279.31 Aligned_cols=238 Identities=25% Similarity=0.368 Sum_probs=181.8
Q ss_pred cceeeecCceEEEEEEECC--eEEEEEEecCCCC-CCchhHHHHHHHHHhcC-CCceeeEecccC--CceEEEEEecCCC
Q 003384 469 SLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSL-QGPSEFQQEIDILSKIR-HPNLVTLVGACP--EVWTLVYEYLPNG 542 (824)
Q Consensus 469 ~~~LG~G~fG~Vykg~~~~--~~VAvK~l~~~~~-~~~~~f~~Ei~iL~~l~-HpnIv~L~g~~~--~~~~LV~Ey~~gg 542 (824)
...||.|..|.|++.+++. .-.|||.+..... ...+++...++++.+.+ .|+||+.+|+|- ....+.||.|. .
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs-~ 175 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS-T 175 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-H
Confidence 3459999999999999875 7899999876543 23456788888877765 899999999983 34567788873 3
Q ss_pred ChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCCC
Q 003384 543 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 622 (824)
Q Consensus 543 sL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~ 622 (824)
-++.+|.. -..++++...-++..-+..||.||..- ++|||||+||+|||+|..|.+||||||++..+......
T Consensus 176 C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh--- 248 (391)
T KOG0983|consen 176 CAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH--- 248 (391)
T ss_pred HHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccccceeeccccc---
Confidence 45555532 245688888889999999999999885 57999999999999999999999999999877654321
Q ss_pred ccccccCCCCCCcccCChhhhcc---CCCCcchhHHhHHHHHHHHHhCCCCCCCch-HHHHHHhhhccccccCCCCCCCC
Q 003384 623 TTLCCRTDPKGTFAYMDPEFLAS---GELTPKSDVYSFGIILLRLLTGRPALGITK-EVQYALDTGKLKNLLDPLAGDWP 698 (824)
Q Consensus 623 ~~~~~~~~~~GT~~Y~APE~l~~---~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~-~~~~~~~~~~~~~~ld~~~~~~p 698 (824)
+...|.+.|||||.+.. ..|+..+||||||+.|+||.||+.||.+.+ ++.. ....+.+ ..|.. +.-
T Consensus 249 ------trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~--ltkvln~-ePP~L-~~~ 318 (391)
T KOG0983|consen 249 ------TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEV--LTKVLNE-EPPLL-PGH 318 (391)
T ss_pred ------ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHH--HHHHHhc-CCCCC-Ccc
Confidence 34569999999999864 368999999999999999999999997632 2221 1111111 11111 111
Q ss_pred hhhHHHHHHHHHHHhhhccCCCCChH
Q 003384 699 FVQAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 699 ~~~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
..-+..+.+++..||..|+.+||.+.
T Consensus 319 ~gFSp~F~~fv~~CL~kd~r~RP~Y~ 344 (391)
T KOG0983|consen 319 MGFSPDFQSFVKDCLTKDHRKRPKYN 344 (391)
T ss_pred cCcCHHHHHHHHHHhhcCcccCcchH
Confidence 12467999999999999999999984
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-31 Score=290.08 Aligned_cols=237 Identities=27% Similarity=0.373 Sum_probs=184.5
Q ss_pred CCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCC---chhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEe
Q 003384 466 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY 538 (824)
Q Consensus 466 f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~---~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey 538 (824)
|.....||+|+||.||+|... +..|++|.+....... ...+.+|+.+++.++|||++++++++. +..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555677999999999999874 5789999986543322 245788999999999999999999884 468899999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccc
Q 003384 539 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 618 (824)
Q Consensus 539 ~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 618 (824)
+. |+|.+++... ..++++..+..++.+++.||.|||. +|++||||+|+||+++.++.+||+|||++......
T Consensus 103 ~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~-- 174 (313)
T cd06633 103 CL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA-- 174 (313)
T ss_pred CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCCC--
Confidence 96 5777777432 3468999999999999999999999 89999999999999999999999999987532211
Q ss_pred cCCCccccccCCCCCCcccCChhhhc---cCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCC
Q 003384 619 SSNNTTLCCRTDPKGTFAYMDPEFLA---SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG 695 (824)
Q Consensus 619 ~~~~~~~~~~~~~~GT~~Y~APE~l~---~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~ 695 (824)
....|+..|+|||++. .+.++.++|||||||++|+|++|.+||............... . . +..
T Consensus 175 ----------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~-~-~-~~~- 240 (313)
T cd06633 175 ----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-D-S-PTL- 240 (313)
T ss_pred ----------CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc-C-C-CCC-
Confidence 2345899999999984 356888999999999999999999999655433222111110 0 0 100
Q ss_pred CCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 696 DWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 696 ~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
.....+..+.+|+.+||+.+|.+||++.+
T Consensus 241 -~~~~~~~~l~~li~~~l~~~P~~Rp~~~~ 269 (313)
T cd06633 241 -QSNEWTDSFRGFVDYCLQKIPQERPASAE 269 (313)
T ss_pred -CccccCHHHHHHHHHHccCChhhCcCHHH
Confidence 11123457899999999999999999943
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=281.01 Aligned_cols=232 Identities=30% Similarity=0.385 Sum_probs=189.4
Q ss_pred eeecCceEEEEEEEC--CeEEEEEEecCCCCC---CchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEecCCCCh
Q 003384 472 IGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNGSL 544 (824)
Q Consensus 472 LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~---~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey~~ggsL 544 (824)
||.|+||.||++... +..||+|++...... ....+..|+.+++.++||||+++++.+. ...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999886 588999998765432 2347889999999999999999999874 467899999999999
Q ss_pred hhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCCCcc
Q 003384 545 EDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 624 (824)
Q Consensus 545 ~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~ 624 (824)
.+++.. ...+++..+..++.+++.||.|||. .+++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~------ 148 (250)
T cd05123 81 FSHLSK---EGRFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS------ 148 (250)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCCC------
Confidence 999853 3368999999999999999999999 8899999999999999999999999999876543310
Q ss_pred ccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCChhhHHH
Q 003384 625 LCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQ 704 (824)
Q Consensus 625 ~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~ 704 (824)
......|+..|++||.+.+..++.++|+||||+++|+|++|+.||......... .. ... .....+...+..
T Consensus 149 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~-~~--~~~----~~~~~~~~~~~~ 219 (250)
T cd05123 149 --RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIY-EK--ILK----DPLRFPEFLSPE 219 (250)
T ss_pred --cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHH-HH--Hhc----CCCCCCCCCCHH
Confidence 013345899999999998888899999999999999999999999765432111 11 000 112334445678
Q ss_pred HHHHHHHHhhhccCCCCChH
Q 003384 705 LANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 705 l~~Li~~Cl~~~P~~RPt~~ 724 (824)
+.+++.+||..+|.+||++.
T Consensus 220 l~~~i~~~l~~~p~~R~~~~ 239 (250)
T cd05123 220 ARDLISGLLQKDPTKRLGSG 239 (250)
T ss_pred HHHHHHHHhcCCHhhCCCcc
Confidence 99999999999999999984
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-32 Score=320.76 Aligned_cols=255 Identities=26% Similarity=0.384 Sum_probs=185.8
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCC-CCCchhHHHHHHHHHhcCCCceeeEeccc-----------
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS-LQGPSEFQQEIDILSKIRHPNLVTLVGAC----------- 528 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~-~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~----------- 528 (824)
..+|+....||+||||.||+++.+ |..||||++.... ...-..+.+|+.+|++|+|||||++|.++
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 346888889999999999999764 8999999987653 22235688999999999999999986432
Q ss_pred -----------C--------------------------------------------------------------------
Q 003384 529 -----------P-------------------------------------------------------------------- 529 (824)
Q Consensus 529 -----------~-------------------------------------------------------------------- 529 (824)
.
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence 0
Q ss_pred -------------------------------CceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhh
Q 003384 530 -------------------------------EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 578 (824)
Q Consensus 530 -------------------------------~~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~ 578 (824)
-..||=||||+..+|.+++..+... -.....++++.+|++||.|+|+
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~--~~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN--SQRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc--hhhHHHHHHHHHHHHHHHHHHh
Confidence 0024567788777777776432111 0345678999999999999999
Q ss_pred cCCCceEeccccCCcEEecCCCcceeeccccccccc------ccccc----CCCccccccCCCCCCcccCChhhhccC--
Q 003384 579 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS------QNEIS----SNNTTLCCRTDPKGTFAYMDPEFLASG-- 646 (824)
Q Consensus 579 ~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~------~~~~~----~~~~~~~~~~~~~GT~~Y~APE~l~~~-- 646 (824)
+|||||||||.||+||++..|||+|||+|+... ..... .........++.+||.-|+|||++.+.
T Consensus 716 ---~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~ 792 (1351)
T KOG1035|consen 716 ---QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS 792 (1351)
T ss_pred ---CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence 899999999999999999999999999998722 00000 011111123677999999999999765
Q ss_pred -CCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 647 -ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 647 -~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
.|+.|+|+|||||||+||+. ||+...+-...+ ..+...--|...++.......-+.+|.++++.||.+|||+.+
T Consensus 793 ~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL--~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~e 867 (1351)
T KOG1035|consen 793 NKYNSKIDMYSLGIVLFEMLY---PFGTSMERASIL--TNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATE 867 (1351)
T ss_pred ccccchhhhHHHHHHHHHHhc---cCCchHHHHHHH--HhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHH
Confidence 49999999999999999986 475443322211 112221112223445556667889999999999999999955
Q ss_pred HH
Q 003384 726 DV 727 (824)
Q Consensus 726 ~v 727 (824)
.+
T Consensus 868 LL 869 (1351)
T KOG1035|consen 868 LL 869 (1351)
T ss_pred Hh
Confidence 44
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-32 Score=303.13 Aligned_cols=244 Identities=25% Similarity=0.385 Sum_probs=199.1
Q ss_pred hhcCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCc--hhHHHHHHHHHhcCCCceeeEeccc--CCceEE
Q 003384 461 GATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGP--SEFQQEIDILSKIRHPNLVTLVGAC--PEVWTL 534 (824)
Q Consensus 461 ~~~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~--~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~L 534 (824)
.....|.+...||+|.|++|..|+.. +..||||++........ ..+.+|+++|+.|+|||||+|+.+. +...|+
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 34567999999999999999999765 68999999987654432 4588999999999999999999986 567999
Q ss_pred EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccc
Q 003384 535 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 614 (824)
Q Consensus 535 V~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~ 614 (824)
||||+.+|.++++|.... .+.......++.|+..|++|||+ ++|||||||.+||||+.+..+||+|||++.++.
T Consensus 133 V~eya~~ge~~~yl~~~g---r~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHG---RMKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEEeccCchhHHHHHhcc---cchhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeec
Confidence 999999999999996443 34557888899999999999999 899999999999999999999999999999886
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCC-CcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCC
Q 003384 615 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL-TPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPL 693 (824)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~ 693 (824)
..... .+..|++.|.|||++.+..| ++.+|+||+|++||-|+.|..||++..-.. +....+..
T Consensus 207 ~~~~l---------qt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~--Lr~rvl~g----- 270 (596)
T KOG0586|consen 207 YGLML---------QTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE--LRPRVLRG----- 270 (596)
T ss_pred ccccc---------cccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc--ccchheee-----
Confidence 44321 34469999999999999876 578999999999999999999998653211 11111100
Q ss_pred CCCCChhhHHHHHHHHHHHhhhccCCCCChHHH
Q 003384 694 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD 726 (824)
Q Consensus 694 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~ 726 (824)
.-..|.....+..+++++++-.+|.+|+++.+.
T Consensus 271 k~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqi 303 (596)
T KOG0586|consen 271 KYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQI 303 (596)
T ss_pred eecccceeechhHHHHHHhhccCccccCCHHHh
Confidence 112344556688999999999999999998443
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=304.43 Aligned_cols=251 Identities=25% Similarity=0.429 Sum_probs=205.0
Q ss_pred CCccceeeecCceEEEEEEEC------CeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccC-CceEEEEE
Q 003384 466 FDPSLKIGEGGYGSIYKGLLR------HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVYE 537 (824)
Q Consensus 466 f~~~~~LG~G~fG~Vykg~~~------~~~VAvK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~-~~~~LV~E 537 (824)
....++||.|+||+||+|.|- +-+||||++..... ....+|..|+-+|..++|||+++|+|+|. ....||.+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~~qlvtq 777 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLSTLQLVTQ 777 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccchHHHHHH
Confidence 344678999999999999873 25799999876433 33567999999999999999999999995 45779999
Q ss_pred ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccc
Q 003384 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 617 (824)
Q Consensus 538 y~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 617 (824)
|+++|+|.|++.. .+.++..+..+.|..|||+|+.|||. +.++||||-..|||+..-.++||.|||+++++..+.
T Consensus 778 ~mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 778 LMPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred hcccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 9999999999964 45678889999999999999999998 899999999999999999999999999999887665
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchH--HHHHHhhhccccccCCCC
Q 003384 618 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKE--VQYALDTGKLKNLLDPLA 694 (824)
Q Consensus 618 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~--~~~~~~~~~~~~~ld~~~ 694 (824)
..-.. ....-.+-|||=|.+....|+.++|||||||++||++| |..|+.+... +...++.| ..
T Consensus 853 ~ey~~------~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~g--------eR 918 (1177)
T KOG1025|consen 853 KEYSA------PGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKG--------ER 918 (1177)
T ss_pred ccccc------cccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcc--------cc
Confidence 33211 22234678999999999999999999999999999998 8888865432 22222222 22
Q ss_pred CCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHh
Q 003384 695 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 736 (824)
Q Consensus 695 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~ 736 (824)
...|...+.++..++.+||..++..||++ +++...+..+..
T Consensus 919 LsqPpiCtiDVy~~mvkCwmid~~~rp~f-kel~~~fs~~ar 959 (1177)
T KOG1025|consen 919 LSQPPICTIDVYMVMVKCWMIDADSRPTF-KELAEEFSRMAR 959 (1177)
T ss_pred CCCCCCccHHHHHHHHHHhccCcccCccH-HHHHHHHHHHhc
Confidence 45678888999999999999999999999 566666655543
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=297.06 Aligned_cols=245 Identities=22% Similarity=0.309 Sum_probs=188.9
Q ss_pred hcCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCC--CCCchhHHHHHHHHHhcCCCceeeEecccC--C-----
Q 003384 462 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS--LQGPSEFQQEIDILSKIRHPNLVTLVGACP--E----- 530 (824)
Q Consensus 462 ~~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~--~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~----- 530 (824)
..++|.....||.|+||.||+|... +..||||++.... ......+.+|+.+++.++||||+++++++. +
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4567999999999999999999885 5789999986532 122345778999999999999999998763 2
Q ss_pred -ceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccc
Q 003384 531 -VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI 609 (824)
Q Consensus 531 -~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGl 609 (824)
..++|+||+ +++|.+++.. .++++..+..++.+++.||.|||+ +||+||||||+||+++.++.+||+|||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEccccc
Confidence 278999998 6799998842 468999999999999999999999 8999999999999999999999999999
Q ss_pred ccccccccccCCCccccccCCCCCCcccCChhhhccC-CCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhcccc
Q 003384 610 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKN 688 (824)
Q Consensus 610 a~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~ 688 (824)
+....... ....++..|+|||.+.+. .++.++|||||||++|+|+||++||.................
T Consensus 165 ~~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~ 233 (343)
T cd07851 165 ARHTDDEM-----------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVG 233 (343)
T ss_pred cccccccc-----------cCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Confidence 87653221 223578899999998653 678899999999999999999999975543221111000000
Q ss_pred -----------------ccCCC----CCC---CChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 689 -----------------LLDPL----AGD---WPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 689 -----------------~ld~~----~~~---~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
.+... ... .....+..+.+++.+||+.+|.+||++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~e 294 (343)
T cd07851 234 TPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAE 294 (343)
T ss_pred CCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHH
Confidence 00000 000 01123568999999999999999999843
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=290.08 Aligned_cols=257 Identities=27% Similarity=0.419 Sum_probs=197.3
Q ss_pred CCCccceeeecCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhc--CCCceeeEecccC------CceEEEE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKI--RHPNLVTLVGACP------EVWTLVY 536 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l--~HpnIv~L~g~~~------~~~~LV~ 536 (824)
......+||+|.||.||||.+.++.||||++... ....|.+|.+|.+.. .|+||++++++-. ..+.||+
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt 287 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT 287 (534)
T ss_pred chhhHHHhhcCccceeehhhccCceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence 4456678999999999999999999999999754 345799999998875 7999999999752 2578999
Q ss_pred EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC------CCceEeccccCCcEEecCCCcceeeccccc
Q 003384 537 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK------PHSIVHGDLKPANILLDANFVSKLSDFGIS 610 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~------~~giiHrDLKp~NILld~~~~vKL~DFGla 610 (824)
+|-+.|+|.++|. ...++|....+|+..+++||+|||.-. ..+|+|||||+.||||.++++.-|+|||||
T Consensus 288 ~fh~kGsL~dyL~----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA 363 (534)
T KOG3653|consen 288 EFHPKGSLCDYLK----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA 363 (534)
T ss_pred eeccCCcHHHHHH----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence 9999999999994 345899999999999999999999733 357999999999999999999999999999
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccC-CCC-----cchhHHhHHHHHHHHHhCCCCC--CCc--------
Q 003384 611 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELT-----PKSDVYSFGIILLRLLTGRPAL--GIT-------- 674 (824)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t-----~ksDVwSlGvvL~ELltG~~Pf--~~~-------- 674 (824)
..+........ . .+.+||.+|||||++.+. .+. .+.||||+|.|||||+++-.-+ +..
T Consensus 364 l~~~p~~~~~d--~----~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe 437 (534)
T KOG3653|consen 364 LRLEPGKPQGD--T----HGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFE 437 (534)
T ss_pred EEecCCCCCcc--h----hhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchh
Confidence 98874432211 1 336899999999999764 232 3689999999999999865433 111
Q ss_pred ---------hHHHHHHhhhccccccCCCCCCCCh-hhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhhC
Q 003384 675 ---------KEVQYALDTGKLKNLLDPLAGDWPF-VQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC 738 (824)
Q Consensus 675 ---------~~~~~~~~~~~~~~~ld~~~~~~p~-~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~~~ 738 (824)
+.++..+...+.... +...|.. ....-+.+.+..||+.|++-|-|. .-|.+++..+....
T Consensus 438 ~evG~hPt~e~mq~~VV~kK~RP~---~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA-~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 438 AEVGNHPTLEEMQELVVRKKQRPK---IPDAWRKHAGMAVLCETIEECWDHDAEARLTA-GCVEERMAELMMLW 507 (534)
T ss_pred HHhcCCCCHHHHHHHHHhhccCCC---ChhhhhcCccHHHHHHHHHHHcCCchhhhhhh-HHHHHHHHHHhccC
Confidence 111111111111111 1122221 235578999999999999999998 88888888876654
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-33 Score=299.90 Aligned_cols=238 Identities=21% Similarity=0.297 Sum_probs=198.6
Q ss_pred CCccceeeecCceEEEEEEECCeE--EEEEEecCCCC---CCchhHHHHHHHHHhcCCCceeeEecccCC--ceEEEEEe
Q 003384 466 FDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVYEY 538 (824)
Q Consensus 466 f~~~~~LG~G~fG~Vykg~~~~~~--VAvK~l~~~~~---~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~~--~~~LV~Ey 538 (824)
+.....||-||||.|=.+..++.. +|+|++++... ...+++..|-+||..++.|.||+||-.|.+ ..|+.||-
T Consensus 422 l~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEa 501 (732)
T KOG0614|consen 422 LKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEA 501 (732)
T ss_pred hhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHh
Confidence 344556999999999998887655 78888876433 334678899999999999999999999955 57889999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccc
Q 003384 539 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 618 (824)
Q Consensus 539 ~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 618 (824)
|-||.|...|. .++.|+..+...++..+.+|+.|||. +|||.|||||+|++||.+|.+||.|||+|+.+....
T Consensus 502 ClGGElWTiLr---dRg~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~- 574 (732)
T KOG0614|consen 502 CLGGELWTILR---DRGSFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR- 574 (732)
T ss_pred hcCchhhhhhh---hcCCcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhccCC-
Confidence 99999999994 44568888899999999999999999 899999999999999999999999999999876543
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCC
Q 003384 619 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWP 698 (824)
Q Consensus 619 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p 698 (824)
.. .+..|||.|.|||++.+.+++.++|.||||+++|||+||.|||.+.+.+......- .-+| .-.||
T Consensus 575 --KT------wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~IL---kGid--~i~~P 641 (732)
T KOG0614|consen 575 --KT------WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLIL---KGID--KIEFP 641 (732)
T ss_pred --ce------eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH---hhhh--hhhcc
Confidence 11 34569999999999999999999999999999999999999999887654321110 1111 12467
Q ss_pred hhhHHHHHHHHHHHhhhccCCCCCh
Q 003384 699 FVQAEQLANLAMRCCEMSRKSRPEL 723 (824)
Q Consensus 699 ~~~~~~l~~Li~~Cl~~~P~~RPt~ 723 (824)
........+|+.+.|..+|.+|-..
T Consensus 642 r~I~k~a~~Lik~LCr~~P~ERLG~ 666 (732)
T KOG0614|consen 642 RRITKTATDLIKKLCRDNPTERLGY 666 (732)
T ss_pred cccchhHHHHHHHHHhcCcHhhhcc
Confidence 7788899999999999999999863
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-31 Score=315.01 Aligned_cols=143 Identities=29% Similarity=0.435 Sum_probs=126.0
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCC---chhHHHHHHHHHhcCCCceeeEeccc--CCceEEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVY 536 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~---~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~ 536 (824)
.+|.+.++||+|+||.||+|.+. +..||||++....... ...+..|+.++..++||||+++++++ ....+|||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 46888999999999999999987 6889999987643322 24688999999999999999999887 35689999
Q ss_pred EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccc
Q 003384 537 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 612 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~ 612 (824)
||+.|++|.+++.. ...+++..++.|+.||+.||.|||. ++||||||||+||||+.++.+||+|||+++.
T Consensus 84 Ey~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~~ 153 (669)
T cd05610 84 EYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153 (669)
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCcc
Confidence 99999999999843 3458889999999999999999999 7999999999999999999999999999873
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=278.02 Aligned_cols=248 Identities=23% Similarity=0.361 Sum_probs=191.3
Q ss_pred ceeeecCceEEEEEE--ECCeEEEEEEecCCCCCCchhHHHHHHHHHhcC-CCceeeEecccCC--ceEEEEEecCCCCh
Q 003384 470 LKIGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVGACPE--VWTLVYEYLPNGSL 544 (824)
Q Consensus 470 ~~LG~G~fG~Vykg~--~~~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~-HpnIv~L~g~~~~--~~~LV~Ey~~ggsL 544 (824)
..||+|+|+.|-.++ .++..+|||++.+........+.+|++++.+.+ |+||+.|+.+|++ .+|||||-|.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 469999999998664 567899999999887777888999999999995 9999999999954 79999999999999
Q ss_pred hhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCC---CcceeeccccccccccccccCC
Q 003384 545 EDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN---FVSKLSDFGISRFLSQNEISSN 621 (824)
Q Consensus 545 ~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~---~~vKL~DFGla~~~~~~~~~~~ 621 (824)
..++.. ...|++....++..+|+.||.|||. +||.||||||+|||.... ..+||+||.|...+.....-..
T Consensus 164 LshI~~---~~~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 164 LSHIQK---RKHFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred HHHHHH---hhhccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 999853 4568999999999999999999999 999999999999999643 3689999999875443322221
Q ss_pred CccccccCCCCCCcccCChhhhc---c--CCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhc--------ccc
Q 003384 622 NTTLCCRTDPKGTFAYMDPEFLA---S--GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK--------LKN 688 (824)
Q Consensus 622 ~~~~~~~~~~~GT~~Y~APE~l~---~--~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~--------~~~ 688 (824)
. ......+++|+..|||||+.. + ..|+.++|.||||||||-||+|.+||.+.......++.|. +.+
T Consensus 238 a-stP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFe 316 (463)
T KOG0607|consen 238 A-STPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFE 316 (463)
T ss_pred C-CCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHH
Confidence 1 112235678999999999753 2 3689999999999999999999999965422222222111 111
Q ss_pred -----ccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 689 -----LLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 689 -----~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
.+.....+| ...+.+..+++...+-.++.+|-+..+
T Consensus 317 sIQEGkYeFPdkdW-ahIS~eakdlisnLlvrda~~rlsa~~ 357 (463)
T KOG0607|consen 317 SIQEGKYEFPDKDW-AHISSEAKDLISNLLVRDAKQRLSAAQ 357 (463)
T ss_pred HHhccCCcCChhhh-HHhhHHHHHHHHHHHhccHHhhhhhhh
Confidence 111122233 245677889999999999999988743
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=277.11 Aligned_cols=217 Identities=24% Similarity=0.213 Sum_probs=175.0
Q ss_pred cCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEecCCCChhhhhhc
Q 003384 475 GGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNGSLEDRLSC 550 (824)
Q Consensus 475 G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey~~ggsL~~~L~~ 550 (824)
|.||.||++.+. +..||+|.+.... .+.+|...+....||||+++++++. +..++||||++||+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999875 5789999987543 3445666666678999999999874 468899999999999999853
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCCCccccccCC
Q 003384 551 KDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTD 630 (824)
Q Consensus 551 ~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~ 630 (824)
. .++++..+..++.+++.||.|||. ++|+||||||+||+++.++.++|+|||++....... ..
T Consensus 79 ~---~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----------~~ 141 (237)
T cd05576 79 F---LNIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----------DG 141 (237)
T ss_pred h---cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----------cc
Confidence 2 458999999999999999999999 899999999999999999999999999876543221 12
Q ss_pred CCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCChhhHHHHHHHHH
Q 003384 631 PKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAM 710 (824)
Q Consensus 631 ~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~ 710 (824)
..++..|+|||++.+..++.++|||||||++|+|++|++||....... . .......|...+..+.+++.
T Consensus 142 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~---~--------~~~~~~~~~~~~~~~~~li~ 210 (237)
T cd05576 142 EAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI---N--------THTTLNIPEWVSEEARSLLQ 210 (237)
T ss_pred CCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc---c--------cccccCCcccCCHHHHHHHH
Confidence 346778999999988889999999999999999999998875432110 0 00011233445678999999
Q ss_pred HHhhhccCCCCChH
Q 003384 711 RCCEMSRKSRPELG 724 (824)
Q Consensus 711 ~Cl~~~P~~RPt~~ 724 (824)
+|++.+|.+||++.
T Consensus 211 ~~l~~dp~~R~~~~ 224 (237)
T cd05576 211 QLLQFNPTERLGAG 224 (237)
T ss_pred HHccCCHHHhcCCC
Confidence 99999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=284.97 Aligned_cols=259 Identities=22% Similarity=0.336 Sum_probs=192.4
Q ss_pred CCCCccceeeecCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHh--cCCCceeeEecccC------CceEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSK--IRHPNLVTLVGACP------EVWTLV 535 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~--l~HpnIv~L~g~~~------~~~~LV 535 (824)
......+.||+|.||+||+|.|+|..||||+|.... ...+.+|.+|++. |+|+||+.++++-. ...+||
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLv 287 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLV 287 (513)
T ss_pred heeEEEEEecCccccceeeccccCCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEe
Confidence 456677889999999999999999999999997644 3468899999876 59999999998752 247899
Q ss_pred EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhh-----cCCCceEeccccCCcEEecCCCcceeeccccc
Q 003384 536 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS-----CKPHSIVHGDLKPANILLDANFVSKLSDFGIS 610 (824)
Q Consensus 536 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~-----~~~~giiHrDLKp~NILld~~~~vKL~DFGla 610 (824)
.+|-+.|||.|+|. ...++....++++..+|.||++||. .....|.|||||+.|||+..||..-|+|+|||
T Consensus 288 TdYHe~GSL~DyL~----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLA 363 (513)
T KOG2052|consen 288 TDYHEHGSLYDYLN----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 363 (513)
T ss_pred eecccCCcHHHHHh----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceee
Confidence 99999999999993 3568899999999999999999995 22246999999999999999999999999999
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccC----CCC--cchhHHhHHHHHHHHHhC----------CCCCCCc
Q 003384 611 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG----ELT--PKSDVYSFGIILLRLLTG----------RPALGIT 674 (824)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~----~~t--~ksDVwSlGvvL~ELltG----------~~Pf~~~ 674 (824)
-........ .....+..+||.+|||||++... .+. ..+||||||.|+||+... ++||...
T Consensus 364 v~h~~~t~~----idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~ 439 (513)
T KOG2052|consen 364 VRHDSDTDT----IDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV 439 (513)
T ss_pred EEecccCCc----ccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence 866544211 11223567899999999998653 121 358999999999999752 2676422
Q ss_pred ----hHHHHHHhhhccccccCCCCCCCC-hhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHH
Q 003384 675 ----KEVQYALDTGKLKNLLDPLAGDWP-FVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 734 (824)
Q Consensus 675 ----~~~~~~~~~~~~~~~ld~~~~~~p-~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l 734 (824)
+.++.-.+.--...+-......|. ......+.+|+..||..+|.-|-+.. -+-..|..+
T Consensus 440 Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltAL-riKKtl~~l 503 (513)
T KOG2052|consen 440 VPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTAL-RIKKTLAKL 503 (513)
T ss_pred CCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHH-HHHHHHHHH
Confidence 111111111111111112223333 23456889999999999999999873 344444444
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=299.54 Aligned_cols=254 Identities=28% Similarity=0.391 Sum_probs=205.9
Q ss_pred hhhHhhhcCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhc-CCCceeeEeccc----
Q 003384 456 FSEIEGATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGAC---- 528 (824)
Q Consensus 456 ~~ei~~~~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l-~HpnIv~L~g~~---- 528 (824)
++-+...+..|.+...||.|.||.||+++.. ++.+|+|++..... ..+++..|.+||+.+ +|||++.+||++
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 4445556778999999999999999988654 68899999877543 345788999999988 699999999987
Q ss_pred ---CCceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceee
Q 003384 529 ---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLS 605 (824)
Q Consensus 529 ---~~~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~ 605 (824)
.+.++||||||.|||..|++.... +..+.|..+..|+.+++.||.+||. +.+||||||-.||||+.++.+||+
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEEe
Confidence 467899999999999999996655 6779999999999999999999999 779999999999999999999999
Q ss_pred ccccccccccccccCCCccccccCCCCCCcccCChhhhccC-----CCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHH
Q 003384 606 DFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-----ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA 680 (824)
Q Consensus 606 DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-----~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~ 680 (824)
|||++..+... ...+.+.+||+.|||||++... .|+..+|+||||++..||.-|.||+.....+...
T Consensus 166 DFGvSaQldsT--------~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraL 237 (953)
T KOG0587|consen 166 DFGVSAQLDST--------VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRAL 237 (953)
T ss_pred eeeeeeeeecc--------cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhh
Confidence 99998765432 1223567899999999998643 4778999999999999999999999766554432
Q ss_pred HhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHH
Q 003384 681 LDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD 726 (824)
Q Consensus 681 ~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~ 726 (824)
...-+- .|.....|..-+..+.++|..||..+..+||++.+.
T Consensus 238 F~IpRN----PPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~l 279 (953)
T KOG0587|consen 238 FLIPRN----PPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEEL 279 (953)
T ss_pred ccCCCC----CCccccchhhHHHHHHHHHHHHHhhccccCcchhhh
Confidence 221100 112223355667899999999999999999998543
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=274.62 Aligned_cols=244 Identities=22% Similarity=0.360 Sum_probs=190.0
Q ss_pred hcCCCCcc-ceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhc-CCCceeeEecccCC------c
Q 003384 462 ATHNFDPS-LKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGACPE------V 531 (824)
Q Consensus 462 ~~~~f~~~-~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l-~HpnIv~L~g~~~~------~ 531 (824)
.+.+|.+. ++||-|-.|.|.....+ +..+|+|++.. ....++|++..-.. .|||||.+++++.+ .
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 34456543 57999999999888765 56799999853 34678899886655 59999999998843 3
Q ss_pred eEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEec---CCCcceeeccc
Q 003384 532 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD---ANFVSKLSDFG 608 (824)
Q Consensus 532 ~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld---~~~~vKL~DFG 608 (824)
+.+|||+|+||.|...+..+ ....|++.+...|..+|+.|+.|||+ .+|.||||||+|+|.. .|-.+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEecccc
Confidence 56899999999999999654 34569999999999999999999999 8899999999999996 45689999999
Q ss_pred cccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHH--HHHHhhhcc
Q 003384 609 ISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEV--QYALDTGKL 686 (824)
Q Consensus 609 la~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~--~~~~~~~~~ 686 (824)
+|+...... .. .+..-|+.|.|||++....|+..+|+||+||++|-|++|.|||...... ...+.....
T Consensus 210 FAK~t~~~~---~L------~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~ 280 (400)
T KOG0604|consen 210 FAKETQEPG---DL------MTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIR 280 (400)
T ss_pred cccccCCCc---cc------cCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhh
Confidence 998654322 11 3345799999999999999999999999999999999999999643221 111111111
Q ss_pred ccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChH
Q 003384 687 KNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 687 ~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
..-++....+| ...++...++|+.+|..+|.+|-|+.
T Consensus 281 ~gqy~FP~pEW-s~VSe~aKdlIR~LLkt~PteRlTI~ 317 (400)
T KOG0604|consen 281 TGQYEFPEPEW-SCVSEAAKDLIRKLLKTEPTERLTIE 317 (400)
T ss_pred ccCccCCChhH-hHHHHHHHHHHHHHhcCCchhheeHH
Confidence 12222233344 34678899999999999999999993
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=307.68 Aligned_cols=252 Identities=29% Similarity=0.478 Sum_probs=201.7
Q ss_pred CCCCccceeeecCceEEEEEEEC---------CeEEEEEEecCCCCC-CchhHHHHHHHHHhc-CCCceeeEecccCC--
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR---------HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKI-RHPNLVTLVGACPE-- 530 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~---------~~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l-~HpnIv~L~g~~~~-- 530 (824)
.+..+.+.||.|.||.|++|... ...||||.++..... ..+.+..|+++|+.+ .||||+.|+|+|..
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~ 375 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG 375 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence 34455568999999999999753 246999999865433 356799999999999 59999999999954
Q ss_pred ceEEEEEecCCCChhhhhhccC-----CC--------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEec
Q 003384 531 VWTLVYEYLPNGSLEDRLSCKD-----NS--------PPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD 597 (824)
Q Consensus 531 ~~~LV~Ey~~ggsL~~~L~~~~-----~~--------~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld 597 (824)
..++|+||+..|+|.++|.... .. ..|+....+.++.|||.|+.||++ .++|||||-..|||+.
T Consensus 376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAARNVLIT 452 (609)
T ss_pred ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhhhEEec
Confidence 6789999999999999997554 00 248899999999999999999999 8899999999999999
Q ss_pred CCCcceeeccccccccccccccCCCccccccCCCCC--CcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCc
Q 003384 598 ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG--TFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGIT 674 (824)
Q Consensus 598 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~G--T~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~ 674 (824)
.+..+||+|||+|+.......... ....| ...|||||.+....|+.++|||||||+||||+| |..|+.+.
T Consensus 453 ~~~~~kIaDFGlar~~~~~~~y~~-------~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~ 525 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKDYYRT-------KSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI 525 (609)
T ss_pred CCCEEEEccccceeccCCCCceEe-------cCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC
Confidence 999999999999996554432211 11122 346999999999999999999999999999998 88999763
Q ss_pred h---HHHHHHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHH
Q 003384 675 K---EVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 734 (824)
Q Consensus 675 ~---~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l 734 (824)
. .+...+..| .....|..+..++.+++..||+.+|.+||++ .++.+.++..
T Consensus 526 ~~~~~l~~~l~~G--------~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F-~~~~~~~~~~ 579 (609)
T KOG0200|consen 526 PPTEELLEFLKEG--------NRMEQPEHCSDEIYDLMKSCWNADPEDRPTF-SECVEFFEKH 579 (609)
T ss_pred CcHHHHHHHHhcC--------CCCCCCCCCCHHHHHHHHHHhCCCcccCCCH-HHHHHHHHHH
Confidence 2 221122222 2334577788899999999999999999999 5666666653
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-32 Score=272.24 Aligned_cols=252 Identities=25% Similarity=0.433 Sum_probs=192.8
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCC--CCCCchhHHHHHHHHHhcCCCceeeEecccC----------
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH--SLQGPSEFQQEIDILSKIRHPNLVTLVGACP---------- 529 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~--~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~---------- 529 (824)
+.|....+||+|.||+||++... ++.||+|++-.. ...-+....+|+.+|..|.|+|++.|+..|.
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 45667778999999999999876 467898865432 2222456789999999999999999999882
Q ss_pred CceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccc
Q 003384 530 EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI 609 (824)
Q Consensus 530 ~~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGl 609 (824)
..+|+||.+|+. +|..+|. +....++..++.+++.++..||.|+|. +.|+|||+|++|+||+.+|.+||+|||+
T Consensus 97 ~t~ylVf~~ceh-DLaGlLs--n~~vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLS--NRKVRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhc--CccccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeecccc
Confidence 138999999976 7888884 333578999999999999999999999 7899999999999999999999999999
Q ss_pred ccccccccccCCCccccccCCCCCCcccCChhhhccC-CCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHh----hh
Q 003384 610 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALD----TG 684 (824)
Q Consensus 610 a~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~----~~ 684 (824)
++.+.......... .+..+-|.+|.+||.+.+. .|+++.|||.-|||+.||+||.|.|.+..+...... .|
T Consensus 171 ar~fs~~~n~~kpr----ytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcG 246 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPR----YTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCG 246 (376)
T ss_pred ccceecccccCCCC----cccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhc
Confidence 98876554332221 2556679999999998875 799999999999999999999999976654332211 11
Q ss_pred cccc-------------cc--CCCCCC---------CChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 685 KLKN-------------LL--DPLAGD---------WPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 685 ~~~~-------------~l--d~~~~~---------~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
.+.. .+ .|+... .|........+|+.+++..||.+||+..+
T Consensus 247 s~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~ 311 (376)
T KOG0669|consen 247 SITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQ 311 (376)
T ss_pred cCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHh
Confidence 1111 11 111000 01122346789999999999999999843
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=287.18 Aligned_cols=238 Identities=27% Similarity=0.440 Sum_probs=193.6
Q ss_pred cceeeecCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHHhcCCCceeeEeccc--CCceEEEEEecCCC
Q 003384 469 SLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNG 542 (824)
Q Consensus 469 ~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~Ey~~gg 542 (824)
.+.||.|.||+||-|+++ |+.||||++.+... .....+++|+.||..++||.||.|---| ++..+.|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 467999999999999886 68999999976433 2346799999999999999999998777 56889999999765
Q ss_pred ChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCC---Ccceeecccccccccccccc
Q 003384 543 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN---FVSKLSDFGISRFLSQNEIS 619 (824)
Q Consensus 543 sL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~---~~vKL~DFGla~~~~~~~~~ 619 (824)
-|+-+|.. ..+.|+......++.||+.||.|||. ++|+|.||||+||||... -.+||||||+|+.+.+..+
T Consensus 649 MLEMILSs--EkgRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF- 722 (888)
T KOG4236|consen 649 MLEMILSS--EKGRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF- 722 (888)
T ss_pred HHHHHHHh--hcccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchhhh-
Confidence 55555542 34568888888999999999999999 899999999999999643 4799999999999876543
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCCh
Q 003384 620 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPF 699 (824)
Q Consensus 620 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~ 699 (824)
+...+|||.|+|||++.+.+|+..-|+||.|||+|--++|.-||.-+.++...+.+..+.. ...+|.
T Consensus 723 --------RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMy----Pp~PW~- 789 (888)
T KOG4236|consen 723 --------RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMY----PPNPWS- 789 (888)
T ss_pred --------hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhcccccc----CCCchh-
Confidence 2456799999999999999999999999999999999999999977665554443322211 122332
Q ss_pred hhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 700 VQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 700 ~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
..+....+||...|+..-.+|-+..+
T Consensus 790 eis~~AidlIn~LLqVkm~kRysvdk 815 (888)
T KOG4236|consen 790 EISPEAIDLINNLLQVKMRKRYSVDK 815 (888)
T ss_pred hcCHHHHHHHHHHHHHHHHHhcchHh
Confidence 34567889999999999999988744
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=250.34 Aligned_cols=199 Identities=31% Similarity=0.433 Sum_probs=165.8
Q ss_pred CCCccceeeecCceEEEEEEECC--eEEEEEEecCCCC--CCchhHHHHHHHHHhcCCCceeeEeccc--CCceEEEEEe
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 538 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~~--~~VAvK~l~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~Ey 538 (824)
+|+..++||+|.||+||+|+.+. .-||+|.++.... .-+....+|+.+|+.++|.|||+|++.. .....+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 45666789999999999998764 6799999876533 2356789999999999999999999976 4568899999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccc
Q 003384 539 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 618 (824)
Q Consensus 539 ~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 618 (824)
|. .+|..++... .+.++.+....++.|+++||.|+|+ ++++||||||.|+||+.||.+||+|||+++-+.-..
T Consensus 83 cd-qdlkkyfdsl--ng~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgipv- 155 (292)
T KOG0662|consen 83 CD-QDLKKYFDSL--NGDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV- 155 (292)
T ss_pred hh-HHHHHHHHhc--CCcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCce-
Confidence 95 4777776432 4568889999999999999999999 889999999999999999999999999999765332
Q ss_pred cCCCccccccCCCCCCcccCChhhhccC-CCCcchhHHhHHHHHHHHHh-CCCCCCCchHH
Q 003384 619 SSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLT-GRPALGITKEV 677 (824)
Q Consensus 619 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~ 677 (824)
.+....+-|.+|.+|.++.+. -|++..|+||-|||+.|+.. |+|.|.+.+-.
T Consensus 156 -------rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvd 209 (292)
T KOG0662|consen 156 -------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD 209 (292)
T ss_pred -------EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHH
Confidence 122345579999999999886 48889999999999999985 88888766543
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-32 Score=275.26 Aligned_cols=241 Identities=26% Similarity=0.308 Sum_probs=184.8
Q ss_pred ccceeeecCceEEEEEEEC--CeEEEEEEecCCCC-CCchhHHHHHHHHHhc-CCCceeeEeccc-C-CceEEEEEecCC
Q 003384 468 PSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKI-RHPNLVTLVGAC-P-EVWTLVYEYLPN 541 (824)
Q Consensus 468 ~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~-~~~~~f~~Ei~iL~~l-~HpnIv~L~g~~-~-~~~~LV~Ey~~g 541 (824)
....||.|+||+|+|-.++ ++..|||.+..... ....++..|.++..+- +.||||++||++ . ...++.||+|.
T Consensus 68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd- 146 (361)
T KOG1006|consen 68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD- 146 (361)
T ss_pred HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-
Confidence 3456999999999998876 57899999987544 3456788899877665 689999999986 3 35678999984
Q ss_pred CChhhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccccc
Q 003384 542 GSLEDRLSCK--DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 619 (824)
Q Consensus 542 gsL~~~L~~~--~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 619 (824)
.||..+...- .....+++...-.|......||.||... ..||||||||+|||||..|.+||||||++..+.....
T Consensus 147 ~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiA- 223 (361)
T KOG1006|consen 147 ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIA- 223 (361)
T ss_pred hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHHHHH-
Confidence 5765544211 2234588888888888999999999875 4699999999999999999999999999987654321
Q ss_pred CCCccccccCCCCCCcccCChhhhcc--CCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCC
Q 003384 620 SNNTTLCCRTDPKGTFAYMDPEFLAS--GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 697 (824)
Q Consensus 620 ~~~~~~~~~~~~~GT~~Y~APE~l~~--~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~ 697 (824)
.+..+|...|||||.+.. .+|+.+|||||||++|||+.||+-|+...+.+-..+. .....||.....
T Consensus 224 --------kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~---~Vv~gdpp~l~~ 292 (361)
T KOG1006|consen 224 --------KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLC---QVVIGDPPILLF 292 (361)
T ss_pred --------hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHH---HHHcCCCCeecC
Confidence 244578999999999864 3699999999999999999999999875544322221 112223322222
Q ss_pred C---hhhHHHHHHHHHHHhhhccCCCCCh
Q 003384 698 P---FVQAEQLANLAMRCCEMSRKSRPEL 723 (824)
Q Consensus 698 p---~~~~~~l~~Li~~Cl~~~P~~RPt~ 723 (824)
+ ...+..+..++..|+..+..+||.+
T Consensus 293 ~~~~~~~s~~~~~fintCl~Kd~~~Rpky 321 (361)
T KOG1006|consen 293 DKECVHYSFSMVRFINTCLIKDRSDRPKY 321 (361)
T ss_pred cccccccCHHHHHHHHHHhhcccccCcch
Confidence 2 3367799999999999999999998
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=260.10 Aligned_cols=230 Identities=32% Similarity=0.425 Sum_probs=185.5
Q ss_pred CceEEEEEEECC--eEEEEEEecCCCCCC-chhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEecCCCChhhhhhc
Q 003384 476 GYGSIYKGLLRH--MQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNGSLEDRLSC 550 (824)
Q Consensus 476 ~fG~Vykg~~~~--~~VAvK~l~~~~~~~-~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey~~ggsL~~~L~~ 550 (824)
+||.||+|...+ ..+++|++....... ...+.+|+.++++++|+||+++++++. ...++||||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 689999999864 889999998765544 578999999999999999999999884 568899999999999999853
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCCCccccccCC
Q 003384 551 KDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTD 630 (824)
Q Consensus 551 ~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~ 630 (824)
. ..+++..+..++.+++.+|.+||. .+++|+||+|.||+++.++.++|+|||++........ ...
T Consensus 81 ~---~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~---------~~~ 145 (244)
T smart00220 81 R---GRLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGL---------LTT 145 (244)
T ss_pred c---cCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeeccccc---------ccc
Confidence 2 238899999999999999999999 7999999999999999999999999999987654320 123
Q ss_pred CCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCChh--hHHHHHHH
Q 003384 631 PKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV--QAEQLANL 708 (824)
Q Consensus 631 ~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~--~~~~l~~L 708 (824)
..|+..|++||.+.+..++.++||||||+++|+|++|.+||............- ........+.. .+..+.++
T Consensus 146 ~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 220 (244)
T smart00220 146 FVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKI-----GKPKPPFPPPEWKISPEAKDL 220 (244)
T ss_pred ccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH-----hccCCCCccccccCCHHHHHH
Confidence 458899999999998889999999999999999999999997632222111110 00000000111 45689999
Q ss_pred HHHHhhhccCCCCChHH
Q 003384 709 AMRCCEMSRKSRPELGK 725 (824)
Q Consensus 709 i~~Cl~~~P~~RPt~~~ 725 (824)
+.+|+..+|.+||++.+
T Consensus 221 i~~~l~~~p~~Rp~~~~ 237 (244)
T smart00220 221 IRKLLVKDPEKRLTAEE 237 (244)
T ss_pred HHHHccCCchhccCHHH
Confidence 99999999999999943
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-30 Score=267.48 Aligned_cols=243 Identities=23% Similarity=0.306 Sum_probs=189.8
Q ss_pred CCCCccceeeecCceEEEEEEECC--eEEEEEEecCC---CCCCchhHHHHHHHHHhc-CCCceeeEecccC--CceEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPH---SLQGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTLV 535 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~~--~~VAvK~l~~~---~~~~~~~f~~Ei~iL~~l-~HpnIv~L~g~~~--~~~~LV 535 (824)
.+|+...+||+|+|.+|..+.+.. +-+|+|++++. ...+.+-++.|-.+..+. +||.+|-|..+|. ...++|
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv 329 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV 329 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence 468899999999999999887764 67999998764 233445577888888776 7999999999884 468899
Q ss_pred EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccc
Q 003384 536 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 615 (824)
Q Consensus 536 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~ 615 (824)
.||++||+|.-++ .....|++.....+..+|.-||.|||+ +|||.||||.+|||||..|++||.|+|+++---.
T Consensus 330 ieyv~ggdlmfhm---qrqrklpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 330 IEYVNGGDLMFHM---QRQRKLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred EEEecCcceeeeh---hhhhcCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcCCC
Confidence 9999999998887 345669999999999999999999999 9999999999999999999999999999984332
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchH--HHHHHhhhccccccCCC
Q 003384 616 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE--VQYALDTGKLKNLLDPL 693 (824)
Q Consensus 616 ~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~--~~~~~~~~~~~~~ld~~ 693 (824)
.+. . ..+..|||.|+|||++.+..|+..+|+|+|||+++||+.|+.||+...- .....+ .-+..++-..
T Consensus 404 ~gd----~----tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~nte-dylfqvilek 474 (593)
T KOG0695|consen 404 PGD----T----TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTE-DYLFQVILEK 474 (593)
T ss_pred CCc----c----cccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchh-HHHHHHHhhh
Confidence 221 1 1345699999999999999999999999999999999999999974321 000000 0011111111
Q ss_pred CCCCChhhHHHHHHHHHHHhhhccCCCC
Q 003384 694 AGDWPFVQAEQLANLAMRCCEMSRKSRP 721 (824)
Q Consensus 694 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RP 721 (824)
....|...+-....++...|+.+|.+|-
T Consensus 475 qiriprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 475 QIRIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred cccccceeehhhHHHHHHhhcCCcHHhc
Confidence 1223455556778888999999999885
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-30 Score=287.16 Aligned_cols=233 Identities=27% Similarity=0.373 Sum_probs=185.8
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhc-CCCceeeEecccCC--ceEEEEE
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGACPE--VWTLVYE 537 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l-~HpnIv~L~g~~~~--~~~LV~E 537 (824)
+..|.....+|.|+|+.|-.+... ++..++|++.... ....+|+.++... +||||+++.+.|.+ ..|+|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 556778888999999999888765 5789999987652 2456788777666 69999999999965 5789999
Q ss_pred ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEe-cCCCcceeeccccccccccc
Q 003384 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL-DANFVSKLSDFGISRFLSQN 616 (824)
Q Consensus 538 y~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILl-d~~~~vKL~DFGla~~~~~~ 616 (824)
++.||-|.+.+... +.....+..|+.+|+.|+.|||. +|+|||||||+|||+ +..|+++|+|||.++.....
T Consensus 397 ~l~g~ell~ri~~~----~~~~~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSK----PEFCSEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred hccccHHHHHHHhc----chhHHHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 99999887777422 22236777899999999999999 899999999999999 68999999999999876544
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCC
Q 003384 617 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 696 (824)
Q Consensus 617 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~ 696 (824)
. ...+-|..|.|||++...+|+.+|||||||++||+||+|+.||.....-..... .+. .+.
T Consensus 470 ~-----------~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~-----~i~---~~~ 530 (612)
T KOG0603|consen 470 C-----------DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHT-----RIQ---MPK 530 (612)
T ss_pred h-----------cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHH-----hhc---CCc
Confidence 1 223458899999999999999999999999999999999999965432211110 111 112
Q ss_pred CChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 697 WPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 697 ~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
+....+....+|+.+||+.+|.+||++.+
T Consensus 531 ~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~ 559 (612)
T KOG0603|consen 531 FSECVSDEAKDLLQQLLQVDPALRLGADE 559 (612)
T ss_pred cccccCHHHHHHHHHhccCChhhCcChhh
Confidence 22556789999999999999999999943
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.5e-29 Score=290.63 Aligned_cols=250 Identities=21% Similarity=0.215 Sum_probs=161.5
Q ss_pred hcCCCCccceeeecCceEEEEEEEC------CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecc--------
Q 003384 462 ATHNFDPSLKIGEGGYGSIYKGLLR------HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGA-------- 527 (824)
Q Consensus 462 ~~~~f~~~~~LG~G~fG~Vykg~~~------~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~-------- 527 (824)
..++|...++||+|+||.||+|.+. +..||||.+..... .+.+..+ .+....+.+++.++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 5668999999999999999999875 45799998764321 1111111 1222223333332221
Q ss_pred cCCceEEEEEecCCCChhhhhhccCCC-----------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccc
Q 003384 528 CPEVWTLVYEYLPNGSLEDRLSCKDNS-----------------PPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLK 590 (824)
Q Consensus 528 ~~~~~~LV~Ey~~ggsL~~~L~~~~~~-----------------~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLK 590 (824)
.....+|||||+.+++|.+++...... .......+..|+.|++.||.|||+ ++|||||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCC
Confidence 134688999999999999988533210 011123456799999999999999 899999999
Q ss_pred CCcEEecC-CCcceeeccccccccccccccCCCccccccCCCCCCcccCChhhhccC----------------------C
Q 003384 591 PANILLDA-NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG----------------------E 647 (824)
Q Consensus 591 p~NILld~-~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~----------------------~ 647 (824)
|+||||+. ++.+||+|||+|+.+....... .....||+.|+|||.+... .
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~-------~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~ 355 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYI-------PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLN 355 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccC-------CcccccCCCccChHHhhccCCCCCCccccccccccchhcccc
Confidence 99999985 6899999999998654322111 1335689999999976432 2
Q ss_pred CCcchhHHhHHHHHHHHHhCCCCCCCchH-HHHHHhhh-----ccccccCCCC-CC------CChhhHHHHHHHHHHHhh
Q 003384 648 LTPKSDVYSFGIILLRLLTGRPALGITKE-VQYALDTG-----KLKNLLDPLA-GD------WPFVQAEQLANLAMRCCE 714 (824)
Q Consensus 648 ~t~ksDVwSlGvvL~ELltG~~Pf~~~~~-~~~~~~~~-----~~~~~ld~~~-~~------~p~~~~~~l~~Li~~Cl~ 714 (824)
++.++|||||||+||||+++..+++.... +...+... .+...+.+.. .+ ..........+|+.+||+
T Consensus 356 ~~~k~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~ 435 (566)
T PLN03225 356 LPDRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMR 435 (566)
T ss_pred CCCCcccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHcc
Confidence 34567999999999999997766542211 11111110 0011111110 00 000112345689999999
Q ss_pred hccCCCCChHH
Q 003384 715 MSRKSRPELGK 725 (824)
Q Consensus 715 ~~P~~RPt~~~ 725 (824)
.+|.+||++.+
T Consensus 436 ~dP~kR~ta~e 446 (566)
T PLN03225 436 FKGRQRISAKA 446 (566)
T ss_pred CCcccCCCHHH
Confidence 99999999843
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-28 Score=278.94 Aligned_cols=254 Identities=20% Similarity=0.236 Sum_probs=175.9
Q ss_pred hcCCCCccceeeecCceEEEEEEE------------------CCeEEEEEEecCCCCCCch--------------hHHHH
Q 003384 462 ATHNFDPSLKIGEGGYGSIYKGLL------------------RHMQVAIKMLHPHSLQGPS--------------EFQQE 509 (824)
Q Consensus 462 ~~~~f~~~~~LG~G~fG~Vykg~~------------------~~~~VAvK~l~~~~~~~~~--------------~f~~E 509 (824)
..++|...++||+|+||.||+|.+ .+..||||.+......... .+..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 456899999999999999999964 1356999998754322222 23457
Q ss_pred HHHHHhcCCCce-----eeEecccC----------CceEEEEEecCCCChhhhhhccCC---------------------
Q 003384 510 IDILSKIRHPNL-----VTLVGACP----------EVWTLVYEYLPNGSLEDRLSCKDN--------------------- 553 (824)
Q Consensus 510 i~iL~~l~HpnI-----v~L~g~~~----------~~~~LV~Ey~~ggsL~~~L~~~~~--------------------- 553 (824)
+.++.+++|.++ ++++|+|. ...+|||||+++|+|.++|.....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777778876654 66777763 246899999999999999864211
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCCCccccccCCCCC
Q 003384 554 SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 633 (824)
Q Consensus 554 ~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~G 633 (824)
...+++..+..++.+++.||.|||. ++|+||||||+|||++.++.+||+|||++......... . .....+
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~---~----~~~g~~ 372 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF---N----PLYGML 372 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc---C----ccccCC
Confidence 1235677888999999999999999 88999999999999999999999999999755332111 0 012345
Q ss_pred CcccCChhhhccCC--------------------C--CcchhHHhHHHHHHHHHhCCC-CCCCchHHHHHHhh--hcccc
Q 003384 634 TFAYMDPEFLASGE--------------------L--TPKSDVYSFGIILLRLLTGRP-ALGITKEVQYALDT--GKLKN 688 (824)
Q Consensus 634 T~~Y~APE~l~~~~--------------------~--t~ksDVwSlGvvL~ELltG~~-Pf~~~~~~~~~~~~--~~~~~ 688 (824)
|+.|+|||.+.... | ..+.||||+||+||+|++|.. ||.....+...... .....
T Consensus 373 tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~ 452 (507)
T PLN03224 373 DPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNR 452 (507)
T ss_pred CcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHH
Confidence 89999999875432 1 124799999999999999975 77533222211110 00000
Q ss_pred --ccCCCCCCC--ChhhHHHHHHHHHHHhhhcc---CCCCChHH
Q 003384 689 --LLDPLAGDW--PFVQAEQLANLAMRCCEMSR---KSRPELGK 725 (824)
Q Consensus 689 --~ld~~~~~~--p~~~~~~l~~Li~~Cl~~~P---~~RPt~~~ 725 (824)
.......++ .........+|+.+++..+| .+|+++.+
T Consensus 453 ~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~e 496 (507)
T PLN03224 453 WRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQ 496 (507)
T ss_pred HHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHH
Confidence 000001111 12245688999999999766 68999843
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=288.77 Aligned_cols=245 Identities=28% Similarity=0.375 Sum_probs=186.7
Q ss_pred CCCccceeeecCceE-EEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhc-CCCceeeEecccC--CceEEEEEecC
Q 003384 465 NFDPSLKIGEGGYGS-IYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTLVYEYLP 540 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~-Vykg~~~~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l-~HpnIv~L~g~~~--~~~~LV~Ey~~ 540 (824)
-|...+.+|.|+-|+ ||+|.+.++.||||++-... .....+|+..|+.- +|||||++|+.-. ...||..|.|.
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eeccHHHcccCCCCcEEEEEeeCCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 356667799999875 79999999999999986533 23578999999998 5999999998753 46889999995
Q ss_pred CCChhhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecC---C--Ccceeeccccccccc
Q 003384 541 NGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA---N--FVSKLSDFGISRFLS 614 (824)
Q Consensus 541 ggsL~~~L~~~-~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~---~--~~vKL~DFGla~~~~ 614 (824)
.+|.+++... .......-...+.+..|++.||++||+ .+||||||||.||||+. + ..++|+|||+|+.+.
T Consensus 587 -~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 -CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred -hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 5999999653 111111113456788999999999999 67999999999999975 2 478999999999887
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhC-CCCCCCchHHHHHHhhhccccccCCC
Q 003384 615 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG-RPALGITKEVQYALDTGKLKNLLDPL 693 (824)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG-~~Pf~~~~~~~~~~~~~~~~~~ld~~ 693 (824)
.+..+... ..+..||-+|+|||++....-+.++||||||||+|+.++| ..||+..-.-+..+..|...- ..+
T Consensus 663 ~~~sS~~r-----~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L--~~L 735 (903)
T KOG1027|consen 663 GGKSSFSR-----LSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTL--VHL 735 (903)
T ss_pred CCcchhhc-----ccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccce--eee
Confidence 66543322 2567799999999999998888899999999999999996 899986654433333332211 111
Q ss_pred CCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 003384 694 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 727 (824)
Q Consensus 694 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 727 (824)
.. .. .....+||.+|++.+|..||++.+++
T Consensus 736 ~~---~~-d~eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 736 EP---LP-DCEAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred cc---Cc-hHHHHHHHHHhcCCCcccCCCHHHHh
Confidence 11 11 11789999999999999999995443
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-29 Score=248.44 Aligned_cols=260 Identities=22% Similarity=0.387 Sum_probs=196.6
Q ss_pred CCCCCccCCCChhhHh-hhcCCCCccceeeecCceEEEEEE--ECCeEEEEEEecCCCCCCchhHHHHHHHHHhcC-CCc
Q 003384 445 SHMPQFFSDFSFSEIE-GATHNFDPSLKIGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HPN 520 (824)
Q Consensus 445 ~~~~~~~~~~~~~ei~-~~~~~f~~~~~LG~G~fG~Vykg~--~~~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~-Hpn 520 (824)
...+..+++|.--.+. +...+|++.+++|+|.|++||.|. .++..++||++++.. .+.+.+|+.||..|. |||
T Consensus 18 ~~rp~eYWdYE~~~i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~N 94 (338)
T KOG0668|consen 18 EERPREYWDYESLVIDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPN 94 (338)
T ss_pred ccCchhhcchhheeeeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCC
Confidence 3345556666543332 456789999999999999999997 456889999998753 357999999999997 999
Q ss_pred eeeEecccCC----ceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEe
Q 003384 521 LVTLVGACPE----VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL 596 (824)
Q Consensus 521 Iv~L~g~~~~----~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILl 596 (824)
|++|++...+ ...||+||+.+.++..+. +.|+...+..++.+++.||.|+|+ +||+|||+||.|++|
T Consensus 95 Ii~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmI 165 (338)
T KOG0668|consen 95 IIKLLDIVKDPESKTPSLIFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMI 165 (338)
T ss_pred eeehhhhhcCccccCchhHhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeee
Confidence 9999998844 467999999998887765 457777889999999999999999 999999999999999
Q ss_pred cC-CCcceeeccccccccccccccCCCccccccCCCCCCcccCChhhhccC-CCCcchhHHhHHHHHHHHHhCCCCCC-C
Q 003384 597 DA-NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALG-I 673 (824)
Q Consensus 597 d~-~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDVwSlGvvL~ELltG~~Pf~-~ 673 (824)
|. .-.++|+|+|||.++...... +-.+.+..|..||.+... .|+..-|+|||||+|..|+..+.||- +
T Consensus 166 dh~~rkLrlIDWGLAEFYHp~~eY---------nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG 236 (338)
T KOG0668|consen 166 DHELRKLRLIDWGLAEFYHPGKEY---------NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 236 (338)
T ss_pred chhhceeeeeecchHhhcCCCcee---------eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCC
Confidence 95 457999999999988765432 223467789999998764 68888999999999999999998873 2
Q ss_pred chHHHHHHhh-------------hccccccCCC---------CCCC--------ChhhHHHHHHHHHHHhhhccCCCCCh
Q 003384 674 TKEVQYALDT-------------GKLKNLLDPL---------AGDW--------PFVQAEQLANLAMRCCEMSRKSRPEL 723 (824)
Q Consensus 674 ~~~~~~~~~~-------------~~~~~~ld~~---------~~~~--------p~~~~~~l~~Li~~Cl~~~P~~RPt~ 723 (824)
.+...+.+.. ++..-.++|. ...| .....++..+|+...|..|-.+|||.
T Consensus 237 ~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTa 316 (338)
T KOG0668|consen 237 HDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTA 316 (338)
T ss_pred CCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccch
Confidence 2221111110 1111112221 1111 11224678899999999999999998
Q ss_pred HH
Q 003384 724 GK 725 (824)
Q Consensus 724 ~~ 725 (824)
.+
T Consensus 317 kE 318 (338)
T KOG0668|consen 317 KE 318 (338)
T ss_pred HH
Confidence 43
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.5e-29 Score=263.15 Aligned_cols=248 Identities=27% Similarity=0.365 Sum_probs=187.6
Q ss_pred cCCCCccceeeecCceEEEEEEECC--eEEEEEEecCCCCCCchhHHHHHHHHHhcC--CCc----eeeEecccC--Cce
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIR--HPN----LVTLVGACP--EVW 532 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~~--~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~--Hpn----Iv~L~g~~~--~~~ 532 (824)
+.+|.+..++|+|.||.|-...++. ..||||+++..... .+...-|+++|.++. .|+ +|.+.++|+ ...
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 6689999999999999999988764 68999998754321 334667999999994 233 677777774 568
Q ss_pred EEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecC--------------
Q 003384 533 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA-------------- 598 (824)
Q Consensus 533 ~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~-------------- 598 (824)
+||+|.+ |-|+.++|.. ++..+++...+..|+.|++++++|||+ .+++|.||||+|||+-.
T Consensus 167 Civfell-G~S~~dFlk~-N~y~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKE-NNYIPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred EEEEecc-ChhHHHHhcc-CCccccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEEeccCCccc
Confidence 8999998 6699999953 355789999999999999999999999 88999999999999932
Q ss_pred ------CCcceeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCC
Q 003384 599 ------NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALG 672 (824)
Q Consensus 599 ------~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~ 672 (824)
+..+||+|||.|.+..+.. ...+.|..|.|||++.+-+++.++||||+||||+|+.||...|.
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~h-----------s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFq 310 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEHH-----------STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQ 310 (415)
T ss_pred eeccCCCcceEEEecCCcceeccCc-----------ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecc
Confidence 3457999999988655443 23457999999999999999999999999999999999999886
Q ss_pred CchHHHH-HHhhhcc-------------ccccCCCCCCCC-------------------------hhhHHHHHHHHHHHh
Q 003384 673 ITKEVQY-ALDTGKL-------------KNLLDPLAGDWP-------------------------FVQAEQLANLAMRCC 713 (824)
Q Consensus 673 ~~~~~~~-~~~~~~~-------------~~~ld~~~~~~p-------------------------~~~~~~l~~Li~~Cl 713 (824)
..+..+- ++.+..+ ...+.....+|| .....+|.+|+.++|
T Consensus 311 tHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL 390 (415)
T KOG0671|consen 311 THENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRML 390 (415)
T ss_pred cCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHH
Confidence 5432110 1100000 000000011111 123457999999999
Q ss_pred hhccCCCCChHHHH
Q 003384 714 EMSRKSRPELGKDV 727 (824)
Q Consensus 714 ~~~P~~RPt~~~~v 727 (824)
..||.+|+|+.+.+
T Consensus 391 ~fDP~~RiTl~EAL 404 (415)
T KOG0671|consen 391 EFDPARRITLREAL 404 (415)
T ss_pred ccCccccccHHHHh
Confidence 99999999996554
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.1e-29 Score=277.61 Aligned_cols=249 Identities=28% Similarity=0.362 Sum_probs=205.8
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--CCceEEEEEe
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 538 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~Ey 538 (824)
..+|.....+|.|.||.|||+++. +...|+|+++.....+...+++|+-+++..+|||||.++|.+ .+..++.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 457889999999999999999875 578999999988777778899999999999999999999988 4678999999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccc
Q 003384 539 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 618 (824)
Q Consensus 539 ~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 618 (824)
|.||+|.+..+ ...+|++.++..++.+..+||+|||+ +|-+|||||-.|||++..|.+|++|||.+..+.
T Consensus 94 cgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqit---- 163 (829)
T KOG0576|consen 94 CGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQIT---- 163 (829)
T ss_pred cCCCcccceee---ecccchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhh----
Confidence 99999999874 46789999999999999999999999 889999999999999999999999999876543
Q ss_pred cCCCccccccCCCCCCcccCChhhh---ccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCC
Q 003384 619 SSNNTTLCCRTDPKGTFAYMDPEFL---ASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG 695 (824)
Q Consensus 619 ~~~~~~~~~~~~~~GT~~Y~APE~l---~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~ 695 (824)
.+...+....||+.|||||+. ..+.|...+|||++|+...|+---+||.-.....+..... ....++|...
T Consensus 164 ----ati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~Lm--TkS~~qpp~l 237 (829)
T KOG0576|consen 164 ----ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLM--TKSGFQPPTL 237 (829)
T ss_pred ----hhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHh--hccCCCCCcc
Confidence 233445678899999999986 3578999999999999999999988886443333222111 1223344333
Q ss_pred CCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 003384 696 DWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 727 (824)
Q Consensus 696 ~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 727 (824)
.-+......+.+|++.|+..+|++||+..+.+
T Consensus 238 kDk~kws~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 238 KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred cCCccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence 33445577899999999999999999985443
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=253.62 Aligned_cols=262 Identities=24% Similarity=0.378 Sum_probs=208.1
Q ss_pred hHhhhcCCCCccceeeecCceEEEEEEECC-------eEEEEEEecCCC-CCCchhHHHHHHHHHhcCCCceeeEecccC
Q 003384 458 EIEGATHNFDPSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHS-LQGPSEFQQEIDILSKIRHPNLVTLVGACP 529 (824)
Q Consensus 458 ei~~~~~~f~~~~~LG~G~fG~Vykg~~~~-------~~VAvK~l~~~~-~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~ 529 (824)
++.....+++...++-+|.||.||.|+|+. +.|.+|.++... .-....+..|.-.+..+.|||++.+.|.+.
T Consensus 278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~i 357 (563)
T KOG1024|consen 278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSI 357 (563)
T ss_pred hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence 344445567777789999999999997753 347778776542 223456888999999999999999999883
Q ss_pred ---CceEEEEEecCCCChhhhhh-----ccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCc
Q 003384 530 ---EVWTLVYEYLPNGSLEDRLS-----CKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV 601 (824)
Q Consensus 530 ---~~~~LV~Ey~~ggsL~~~L~-----~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~ 601 (824)
+..+.+|.++.-|+|..+|. .......++..+...++.|++.|+.|||. ++|||.||...|.+||+...
T Consensus 358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd~Lq 434 (563)
T KOG1024|consen 358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDDQLQ 434 (563)
T ss_pred eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehhhee
Confidence 35678899999999999997 22334567788889999999999999999 89999999999999999999
Q ss_pred ceeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHHH
Q 003384 602 SKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYA 680 (824)
Q Consensus 602 vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~ 680 (824)
+||+|=.|++.+...+.. |...+......||+||.+.+..|+.++|||||||+||||+| |+.|+...+.++..
T Consensus 435 VkltDsaLSRDLFP~DYh------cLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~ 508 (563)
T KOG1024|consen 435 VKLTDSALSRDLFPGDYH------CLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME 508 (563)
T ss_pred EEeccchhccccCccccc------ccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH
Confidence 999999999976555432 22223345778999999999999999999999999999998 99999766555432
Q ss_pred HhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHH
Q 003384 681 LDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 735 (824)
Q Consensus 681 ~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~ 735 (824)
. .+.|......|..+++++..+...||...|++||++ +.+..-|.++.
T Consensus 509 ~------ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf-~Qlv~cLseF~ 556 (563)
T KOG1024|consen 509 H------YLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSF-SQLVICLSEFH 556 (563)
T ss_pred H------HHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCH-HHHHHHHHHHH
Confidence 1 233444445688899999999999999999999999 56666665543
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-28 Score=238.42 Aligned_cols=197 Identities=27% Similarity=0.363 Sum_probs=157.6
Q ss_pred CCCccceeeecCceEEEE--EEECCeEEEEEEecCCCC-CCchhHHHHHHHHHhc-CCCceeeEecccC--CceEEEEEe
Q 003384 465 NFDPSLKIGEGGYGSIYK--GLLRHMQVAIKMLHPHSL-QGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTLVYEY 538 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vyk--g~~~~~~VAvK~l~~~~~-~~~~~f~~Ei~iL~~l-~HpnIv~L~g~~~--~~~~LV~Ey 538 (824)
....+..||+|+||.|-+ -...|+-.|+|.+...-. +..++..+|+++..+. ..|.+|.+||... ....+.||.
T Consensus 47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~ 126 (282)
T KOG0984|consen 47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMEL 126 (282)
T ss_pred hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHH
Confidence 445566799999998754 445678899999876532 2345678899887665 6899999999753 357789999
Q ss_pred cCCCChhhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccc
Q 003384 539 LPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 617 (824)
Q Consensus 539 ~~ggsL~~~L~~~-~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 617 (824)
|. .||..+...- +.+..+++..+-+|+..+..||.|||+. ..+||||+||+||||+.+|++||||||++..+.+.-
T Consensus 127 M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi 203 (282)
T KOG0984|consen 127 MD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI 203 (282)
T ss_pred hh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhhh
Confidence 84 5776655322 4456788899999999999999999995 569999999999999999999999999998776542
Q ss_pred ccCCCccccccCCCCCCcccCChhhhcc----CCCCcchhHHhHHHHHHHHHhCCCCCCC
Q 003384 618 ISSNNTTLCCRTDPKGTFAYMDPEFLAS----GELTPKSDVYSFGIILLRLLTGRPALGI 673 (824)
Q Consensus 618 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~----~~~t~ksDVwSlGvvL~ELltG~~Pf~~ 673 (824)
.. +-..|...|||||.+.. ..|+.++||||||+.++||.+++.|++.
T Consensus 204 Ak---------t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 204 AK---------TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred HH---------HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 11 22458889999999854 3799999999999999999999999853
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-26 Score=231.66 Aligned_cols=204 Identities=39% Similarity=0.605 Sum_probs=175.9
Q ss_pred eeecCceEEEEEEEC--CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccCC--ceEEEEEecCCCChhh
Q 003384 472 IGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVYEYLPNGSLED 546 (824)
Q Consensus 472 LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~L~g~~~~--~~~LV~Ey~~ggsL~~ 546 (824)
||.|++|.||++... +..+++|++...... ....+.+|+.+++.+.|++|+++++++.. ..+++|||+.|++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999987 789999998765432 23579999999999999999999999854 7889999999999999
Q ss_pred hhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecC-CCcceeeccccccccccccccCCCccc
Q 003384 547 RLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA-NFVSKLSDFGISRFLSQNEISSNNTTL 625 (824)
Q Consensus 547 ~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~-~~~vKL~DFGla~~~~~~~~~~~~~~~ 625 (824)
++.... ..+++..+..++.+++.+|.+||. .+++|+||+|.||+++. ++.++|+|||.+........
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~------- 148 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS------- 148 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-------
Confidence 985322 468899999999999999999999 79999999999999999 89999999999986654321
Q ss_pred cccCCCCCCcccCChhhhccC-CCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCChhhHHH
Q 003384 626 CCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQ 704 (824)
Q Consensus 626 ~~~~~~~GT~~Y~APE~l~~~-~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~ 704 (824)
......+...|++||.+... .++.+.|+|+||+++++| ..
T Consensus 149 -~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------~~ 189 (215)
T cd00180 149 -LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------PE 189 (215)
T ss_pred -hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------HH
Confidence 01234578899999999887 888999999999999999 47
Q ss_pred HHHHHHHHhhhccCCCCChHHHH
Q 003384 705 LANLAMRCCEMSRKSRPELGKDV 727 (824)
Q Consensus 705 l~~Li~~Cl~~~P~~RPt~~~~v 727 (824)
+.+++..|++.+|.+||++ .++
T Consensus 190 ~~~~l~~~l~~~p~~R~~~-~~l 211 (215)
T cd00180 190 LKDLIRKMLQKDPEKRPSA-KEI 211 (215)
T ss_pred HHHHHHHHhhCCcccCcCH-HHH
Confidence 8999999999999999998 444
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-26 Score=234.27 Aligned_cols=196 Identities=37% Similarity=0.553 Sum_probs=166.9
Q ss_pred CCccceeeecCceEEEEEEECC--eEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEecC
Q 003384 466 FDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLP 540 (824)
Q Consensus 466 f~~~~~LG~G~fG~Vykg~~~~--~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey~~ 540 (824)
|.....||.|++|.||+|...+ ..+++|.+...... ....+.+|+..+..++|+|++++++++. ...++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4566789999999999999864 88999999876544 4668899999999999999999999874 57889999999
Q ss_pred CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccC
Q 003384 541 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 620 (824)
Q Consensus 541 ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 620 (824)
+++|.+++..... .+++.....++.+++.+|.+||. .+++|+||+|.||+++.++.++|+|||++.........
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~- 154 (225)
T smart00221 81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA- 154 (225)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-
Confidence 9999999853221 17889999999999999999999 79999999999999999999999999999876544200
Q ss_pred CCccccccCCCCCCcccCChhhh-ccCCCCcchhHHhHHHHHHHHHhCCCCCCC
Q 003384 621 NNTTLCCRTDPKGTFAYMDPEFL-ASGELTPKSDVYSFGIILLRLLTGRPALGI 673 (824)
Q Consensus 621 ~~~~~~~~~~~~GT~~Y~APE~l-~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~ 673 (824)
......++..|++||.+ ....++.++|||+||+++++|++|++||..
T Consensus 155 ------~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 ------LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ------cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 01234578899999998 666788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-27 Score=259.64 Aligned_cols=192 Identities=24% Similarity=0.414 Sum_probs=163.8
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC------CC--chhHHHHHHHHHhcC---CCceeeEecccCC-
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL------QG--PSEFQQEIDILSKIR---HPNLVTLVGACPE- 530 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~------~~--~~~f~~Ei~iL~~l~---HpnIv~L~g~~~~- 530 (824)
+|...+.+|.|+||.|+.++++ +..|+||.+.+... .+ ...+-.|+.||..|+ |+||++++++|++
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd 641 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD 641 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence 5888999999999999999987 37799999876421 11 224667999999997 9999999999954
Q ss_pred -ceEEEEEec-CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccc
Q 003384 531 -VWTLVYEYL-PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFG 608 (824)
Q Consensus 531 -~~~LV~Ey~-~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFG 608 (824)
.+||+||-- +|.+|.+++ ...+.+++....-|+.|++.|+++||. .||||||||-+||.++.+|.+||+|||
T Consensus 642 d~yyl~te~hg~gIDLFd~I---E~kp~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 642 DYYYLETEVHGEGIDLFDFI---EFKPRMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred CeeEEEecCCCCCcchhhhh---hccCccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEeecc
Confidence 688999874 566899998 455679999999999999999999999 899999999999999999999999999
Q ss_pred cccccccccccCCCccccccCCCCCCcccCChhhhccCCC-CcchhHHhHHHHHHHHHhCCCCCC
Q 003384 609 ISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL-TPKSDVYSFGIILLRLLTGRPALG 672 (824)
Q Consensus 609 la~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-t~ksDVwSlGvvL~ELltG~~Pf~ 672 (824)
.|.+.....+ ...+||..|.|||++.+..| +..-|||++|++||.++....||.
T Consensus 716 saa~~ksgpf----------d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 716 SAAYTKSGPF----------DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred chhhhcCCCc----------ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9876654432 34579999999999999876 566899999999999999998884
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.4e-28 Score=246.43 Aligned_cols=199 Identities=25% Similarity=0.395 Sum_probs=162.5
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCC--CCCCchhHHHHHHHHHhcCCCceeeEecccCC-------ceE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH--SLQGPSEFQQEIDILSKIRHPNLVTLVGACPE-------VWT 533 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~--~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~~-------~~~ 533 (824)
+.++.+.||-|+||.||..++. ++.||+|++... ....-+.+.+|+.+|.-++|.|++..+++... ..|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 4567788999999999998875 588999987542 22234578899999999999999999887632 356
Q ss_pred EEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccc
Q 003384 534 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 613 (824)
Q Consensus 534 LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~ 613 (824)
.|.|+|. .+|..++. ...+|+-..+.-+..||++||.|||+ .+|+||||||.|+|++.|..+||+||||++..
T Consensus 134 V~TELmQ-SDLHKIIV---SPQ~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARve 206 (449)
T KOG0664|consen 134 VLTELMQ-SDLHKIIV---SPQALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTW 206 (449)
T ss_pred HHHHHHH-hhhhheec---cCCCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEeccccccccc
Confidence 7888884 57888773 44568888888899999999999999 88999999999999999999999999999976
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhccC-CCCcchhHHhHHHHHHHHHhCCCCCCCchHH
Q 003384 614 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEV 677 (824)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~ 677 (824)
........ +..+-|..|.|||++++. .|+.+.||||.|||+.||+..+..|...+.+
T Consensus 207 e~d~~~hM-------TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~Pi 264 (449)
T KOG0664|consen 207 DQRDRLNM-------THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPI 264 (449)
T ss_pred chhhhhhh-------HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChH
Confidence 65542221 233458899999999985 7999999999999999999999888654443
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-26 Score=252.26 Aligned_cols=198 Identities=25% Similarity=0.333 Sum_probs=166.3
Q ss_pred hcCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcC------CCceeeEeccc--CCc
Q 003384 462 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIR------HPNLVTLVGAC--PEV 531 (824)
Q Consensus 462 ~~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~------HpnIv~L~g~~--~~~ 531 (824)
....|.+....|+|-|++|.+|.+. +..||||++...... .+.=..|++||++|+ --|+++|+-.| ..+
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH 508 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH 508 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence 3456777778899999999999875 578999999765322 234568999999995 34789998877 467
Q ss_pred eEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCC-Ccceeeccccc
Q 003384 532 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN-FVSKLSDFGIS 610 (824)
Q Consensus 532 ~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~-~~vKL~DFGla 610 (824)
+|||+|-+ ..+|.++|...+....|....+..++.|++-||..|.. -||+|.||||+|||++++ ..+||||||.|
T Consensus 509 LClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 509 LCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred eEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccceEeccCcceeeeccCccc
Confidence 99999988 46999999877777788889999999999999999999 579999999999999875 57899999999
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCc
Q 003384 611 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGIT 674 (824)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~ 674 (824)
.....++.... .-+..|.|||++.+..|+...|+||.||+||||.||+..|.+.
T Consensus 585 ~~~~eneitPY----------LVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~ 638 (752)
T KOG0670|consen 585 SFASENEITPY----------LVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGR 638 (752)
T ss_pred cccccccccHH----------HHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCC
Confidence 87776653322 1356799999999999999999999999999999999988654
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.6e-26 Score=235.44 Aligned_cols=242 Identities=21% Similarity=0.272 Sum_probs=183.5
Q ss_pred CCCCccceeeecCceEEEEEEE--CCeEEEEEEecCC--CCCCchhHHHHHHHHHhcCCCceeeEecccCC--------c
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPH--SLQGPSEFQQEIDILSKIRHPNLVTLVGACPE--------V 531 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~--~~~~VAvK~l~~~--~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~~--------~ 531 (824)
.+|.....+|.|.- .|..+.+ .+.+||+|.+... .....+...+|..++..++|+||++++.+|.. .
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 46777778898888 5555544 3789999987543 22334568899999999999999999999832 4
Q ss_pred eEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccc
Q 003384 532 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR 611 (824)
Q Consensus 532 ~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~ 611 (824)
+|+|||||. ++|...+. ..++-.+...|+.|+++|+.|||+ .||+||||||+||++..+..+||.|||+|+
T Consensus 96 ~y~v~e~m~-~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 96 VYLVMELMD-ANLCQVIL-----MELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHHHHhhh-hHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchhhc
Confidence 789999995 58888774 346667889999999999999999 899999999999999999999999999998
Q ss_pred ccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHh---------
Q 003384 612 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALD--------- 682 (824)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~--------- 682 (824)
..... ...+..+.|..|.|||++.+-+|...+||||+||++.||++|...|.+.+.+.....
T Consensus 167 ~e~~~---------~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd 237 (369)
T KOG0665|consen 167 TEDTD---------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPD 237 (369)
T ss_pred ccCcc---------cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCC
Confidence 54332 112445679999999999998899999999999999999999988865433221110
Q ss_pred ---------hh-------------cccccc-C---CCCCCCChhhHHHHHHHHHHHhhhccCCCCChH
Q 003384 683 ---------TG-------------KLKNLL-D---PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 683 ---------~~-------------~~~~~l-d---~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
.+ .+...+ | +...+.+...+..+.+++.+||-.+|++|.+..
T Consensus 238 ~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~ 305 (369)
T KOG0665|consen 238 PSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVD 305 (369)
T ss_pred HHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHH
Confidence 00 000111 0 011111223356789999999999999999983
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-25 Score=240.24 Aligned_cols=199 Identities=28% Similarity=0.430 Sum_probs=162.0
Q ss_pred cCCCCccceeeecCceEEEEEEEC-----CeEEEEEEecCCCCCCchhHHHHHHHHHhcC-CCceeeEeccc--CCceEE
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR-----HMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVGAC--PEVWTL 534 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~-----~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~-HpnIv~L~g~~--~~~~~L 534 (824)
.+.|....+||.|.|++||++++. +..||+|.+... ..+..+.+|+++|..+. +.||+++.+++ .+...+
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~i 112 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAI 112 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEE
Confidence 346788889999999999999754 367999998764 34678999999999995 99999999998 567899
Q ss_pred EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecC-CCcceeecccccccc
Q 003384 535 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA-NFVSKLSDFGISRFL 613 (824)
Q Consensus 535 V~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~-~~~vKL~DFGla~~~ 613 (824)
|+||+++....+++. .++...+..++..++.||.++|. +|||||||||+|||.+. -+.-.|.|||||...
T Consensus 113 vlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~ 183 (418)
T KOG1167|consen 113 VLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRY 183 (418)
T ss_pred EecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechhHHHH
Confidence 999999999999883 36678999999999999999999 99999999999999985 467789999999722
Q ss_pred cccc------------ccC------------------------CCccccccCCCCCCcccCChhhhcc-CCCCcchhHHh
Q 003384 614 SQNE------------ISS------------------------NNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYS 656 (824)
Q Consensus 614 ~~~~------------~~~------------------------~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDVwS 656 (824)
.... ... +...........||++|.|||++.. +..++++||||
T Consensus 184 d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws 263 (418)
T KOG1167|consen 184 DGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWS 263 (418)
T ss_pred HhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceee
Confidence 1100 000 0000112335589999999999876 46889999999
Q ss_pred HHHHHHHHHhCCCCCC
Q 003384 657 FGIILLRLLTGRPALG 672 (824)
Q Consensus 657 lGvvL~ELltG~~Pf~ 672 (824)
.||||+-+++++.||-
T Consensus 264 ~GVI~Lslls~~~PFf 279 (418)
T KOG1167|consen 264 AGVILLSLLSRRYPFF 279 (418)
T ss_pred ccceeehhhccccccc
Confidence 9999999999999984
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-24 Score=234.43 Aligned_cols=130 Identities=23% Similarity=0.336 Sum_probs=107.7
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcC-----C---CceeeEecccC---
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-----H---PNLVTLVGACP--- 529 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~-----H---pnIv~L~g~~~--- 529 (824)
..+|-..++||.|-|++||++.+. .+.||+|+.+.... -.+....||.+|++++ | .+||+|++.|.
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh-YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH-YTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH-HHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 457889999999999999999886 47899999875432 2345678999999983 3 46999999982
Q ss_pred ---CceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEec
Q 003384 530 ---EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD 597 (824)
Q Consensus 530 ---~~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld 597 (824)
.+.++|+|++ |.+|..++.... ...++...+..|+.||+.||.|||.. -||||.||||+||||.
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~-YrGlpl~~VK~I~~qvL~GLdYLH~e--cgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSN-YRGLPLSCVKEICRQVLTGLDYLHRE--CGIIHTDLKPENVLLC 222 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhC-CCCCcHHHHHHHHHHHHHHHHHHHHh--cCccccCCCcceeeee
Confidence 3689999999 778888886543 45588999999999999999999995 4799999999999994
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=7e-25 Score=269.11 Aligned_cols=199 Identities=16% Similarity=0.187 Sum_probs=138.8
Q ss_pred hcCC-CceeeEeccc---------CCceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCce
Q 003384 515 KIRH-PNLVTLVGAC---------PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 584 (824)
Q Consensus 515 ~l~H-pnIv~L~g~~---------~~~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~gi 584 (824)
.++| +||++++++| .+.++++|||+ +++|.++|.. ....+++..++.|+.||+.||.|||+ +||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~---~gI 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN--PDRSVDAFECFHVFRQIVEIVNAAHS---QGI 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc--ccccccHHHHHHHHHHHHHHHHHHHh---CCe
Confidence 4556 5888888877 12466788887 6699999952 23569999999999999999999999 899
Q ss_pred EeccccCCcEEecC-------------------CCcceeecccccccccccccc--------CCCccccccCCCCCCccc
Q 003384 585 VHGDLKPANILLDA-------------------NFVSKLSDFGISRFLSQNEIS--------SNNTTLCCRTDPKGTFAY 637 (824)
Q Consensus 585 iHrDLKp~NILld~-------------------~~~vKL~DFGla~~~~~~~~~--------~~~~~~~~~~~~~GT~~Y 637 (824)
|||||||+||||+. ++.+||+|||+++........ .............||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 445666666666542210000 000000001224689999
Q ss_pred CChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhcc
Q 003384 638 MDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSR 717 (824)
Q Consensus 638 ~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P 717 (824)
||||++.+..|+.++|||||||+||||++|.+|+.........+... .+.+ ...........++.+||+.+|
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~~~----~~~~----~~~~~~~~~~~~~~~~L~~~P 253 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLRHR----VLPP----QILLNWPKEASFCLWLLHPEP 253 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHHHh----hcCh----hhhhcCHHHHHHHHHhCCCCh
Confidence 99999999999999999999999999999999985432221111111 1111 011123356788899999999
Q ss_pred CCCCChHHHH
Q 003384 718 KSRPELGKDV 727 (824)
Q Consensus 718 ~~RPt~~~~v 727 (824)
.+||++.+.+
T Consensus 254 ~~Rps~~eil 263 (793)
T PLN00181 254 SCRPSMSELL 263 (793)
T ss_pred hhCcChHHHh
Confidence 9999995543
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-22 Score=223.64 Aligned_cols=263 Identities=23% Similarity=0.288 Sum_probs=195.3
Q ss_pred CCCccceeeecCceEEEEEEECC---eEEEEEEecCCCCCCchhHHHHHHHHHhcCC----CceeeEeccc---CCceEE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLRH---MQVAIKMLHPHSLQGPSEFQQEIDILSKIRH----PNLVTLVGAC---PEVWTL 534 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~~---~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~H----pnIv~L~g~~---~~~~~L 534 (824)
+|.+.++||+|+||.||.|.... ..+|+|............+..|+.++..+.. +++..+++.. ....++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 79999999999999999998765 3689998776544433478899999999973 5788887766 235789
Q ss_pred EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCC-----Ccceeecccc
Q 003384 535 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN-----FVSKLSDFGI 609 (824)
Q Consensus 535 V~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~-----~~vKL~DFGl 609 (824)
||+.+ |.+|.++..... ...++..+.+.|+.|++.+|.+||+ .|+|||||||+|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99988 889999874443 5679999999999999999999999 899999999999999865 4689999999
Q ss_pred cc--ccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHH--HHHHhhhc
Q 003384 610 SR--FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEV--QYALDTGK 685 (824)
Q Consensus 610 a~--~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~--~~~~~~~~ 685 (824)
++ .+...................||..|+++.+..+...+.+.|+||++.++.+|+.|..||...... ...+....
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 99 332222111011100013456999999999999999999999999999999999999999543321 11111111
Q ss_pred cccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhh
Q 003384 686 LKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 737 (824)
Q Consensus 686 ~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~~ 737 (824)
....... .....+..+..+...+-..+...+|.+ ..+...|......
T Consensus 254 ~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~Pdy-~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 254 RKLLTDR----FGDLKPEEFAKILEYIDSLDYEDKPDY-EKLAELLKDVFDS 300 (322)
T ss_pred hhhcccc----ccCCChHHHHHHHHHhhccCCcCCCCH-HHHHHHHHHHHHh
Confidence 1111111 223345677888888888999999999 6666666665443
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-23 Score=207.23 Aligned_cols=165 Identities=22% Similarity=0.259 Sum_probs=123.3
Q ss_pred CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCC
Q 003384 542 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 621 (824)
Q Consensus 542 gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 621 (824)
|+|.+++... ..++++..++.|+.|++.||.|||+ ++ ||+|||++.++.+|+ ||++......
T Consensus 1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~----- 62 (176)
T smart00750 1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPE----- 62 (176)
T ss_pred CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeeccc-----
Confidence 7899998532 4569999999999999999999999 44 999999999999999 9998765432
Q ss_pred CccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhh--hccccccCCCCCCCCh
Q 003384 622 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT--GKLKNLLDPLAGDWPF 699 (824)
Q Consensus 622 ~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~--~~~~~~ld~~~~~~p~ 699 (824)
...||+.|+|||++.+..++.++|||||||++|||+||++||............ ..... ..+.....+.
T Consensus 63 --------~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 133 (176)
T smart00750 63 --------QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPA-DDPRDRSNLE 133 (176)
T ss_pred --------cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhcc-CCccccccHH
Confidence 124899999999999999999999999999999999999999654332111111 00111 1111111122
Q ss_pred hhHH--HHHHHHHHHhhhccCCCCChHHHHHHHHHHH
Q 003384 700 VQAE--QLANLAMRCCEMSRKSRPELGKDVWRVLEPM 734 (824)
Q Consensus 700 ~~~~--~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l 734 (824)
.... .+.+++.+||+.+|.+||++ .+++..+..+
T Consensus 134 ~~~~~~~~~~~i~~cl~~~p~~Rp~~-~~ll~~~~~~ 169 (176)
T smart00750 134 SVSAARSFADFMRVCASRLPQRREAA-NHYLAHCRAL 169 (176)
T ss_pred HHHhhhhHHHHHHHHHhcccccccCH-HHHHHHHHHH
Confidence 2233 69999999999999999999 5565555443
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.8e-24 Score=217.51 Aligned_cols=234 Identities=22% Similarity=0.326 Sum_probs=172.4
Q ss_pred CCCCccceeeecCceEEEEEEECC--eEEEEEEecCCCCCCchhHHHHHHHHHhc-CCCceeeEecc-c--CCceEEEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGA-C--PEVWTLVYE 537 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~~--~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l-~HpnIv~L~g~-~--~~~~~LV~E 537 (824)
..|++.+.||+|.||.+..+.+++ +.+++|.+.... ....+|.+|..---.| .|.||+.-|+. | .+.++.++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 468999999999999999999885 679999886543 3456899988765555 48999988764 3 356778999
Q ss_pred ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEe-c-CCCcceeecccccccccc
Q 003384 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL-D-ANFVSKLSDFGISRFLSQ 615 (824)
Q Consensus 538 y~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILl-d-~~~~vKL~DFGla~~~~~ 615 (824)
|+|.|+|..-+. ...+.+....+++.|++.||.|+|+ +++||||||.+|||| + +...+||||||+.+....
T Consensus 103 ~aP~gdL~snv~----~~GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 103 FAPRGDLRSNVE----AAGIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred cCccchhhhhcC----cccccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 999999998773 2346777888999999999999999 899999999999999 3 345899999999874432
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccC-----CCCcchhHHhHHHHHHHHHhCCCCCCCc-----hHH-HHHHhhh
Q 003384 616 NEISSNNTTLCCRTDPKGTFAYMDPEFLASG-----ELTPKSDVYSFGIILLRLLTGRPALGIT-----KEV-QYALDTG 684 (824)
Q Consensus 616 ~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-----~~t~ksDVwSlGvvL~ELltG~~Pf~~~-----~~~-~~~~~~~ 684 (824)
.. ....-+..|.+||..... ...+.+|||.||+|+|.++||.+||... ... ...+..+
T Consensus 176 tV-----------~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~r 244 (378)
T KOG1345|consen 176 TV-----------KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKR 244 (378)
T ss_pred ee-----------hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcc
Confidence 11 112246679999977542 2467899999999999999999999621 111 1112222
Q ss_pred ccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCC
Q 003384 685 KLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 721 (824)
Q Consensus 685 ~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RP 721 (824)
... ..+......++.+..+..+-+..+|++|=
T Consensus 245 k~~-----~~P~~F~~fs~~a~r~Fkk~lt~~~~drc 276 (378)
T KOG1345|consen 245 KNP-----ALPKKFNPFSEKALRLFKKSLTPRFKDRC 276 (378)
T ss_pred cCc-----cCchhhcccCHHHHHHHHHhcCCcccccc
Confidence 221 11111222345677888888888998883
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.7e-23 Score=229.24 Aligned_cols=172 Identities=16% Similarity=0.120 Sum_probs=130.4
Q ss_pred hhhcCCCCccceeeecCceEEEEEEEC---CeEEEEEEecCCCC-----CCchhHHHHHHHHHhcCCCceee-EecccCC
Q 003384 460 EGATHNFDPSLKIGEGGYGSIYKGLLR---HMQVAIKMLHPHSL-----QGPSEFQQEIDILSKIRHPNLVT-LVGACPE 530 (824)
Q Consensus 460 ~~~~~~f~~~~~LG~G~fG~Vykg~~~---~~~VAvK~l~~~~~-----~~~~~f~~Ei~iL~~l~HpnIv~-L~g~~~~ 530 (824)
......|.....||+|+||+||+|.+. +..||||++..... .....|.+|+++|+.++|+|++. +++. .
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--~ 91 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--G 91 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--C
Confidence 345567999999999999999999874 46689998753311 11345899999999999999985 5443 4
Q ss_pred ceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccc-cCCcEEecCCCcceeecccc
Q 003384 531 VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDL-KPANILLDANFVSKLSDFGI 609 (824)
Q Consensus 531 ~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDL-Kp~NILld~~~~vKL~DFGl 609 (824)
..+|||||++|++|.... . .. ...++.+++.||.|||+ +||+|||| ||+|||++.++.+||+|||+
T Consensus 92 ~~~LVmE~~~G~~L~~~~---~----~~---~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiDFGl 158 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLAR---P----HG---DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVIDFQL 158 (365)
T ss_pred CcEEEEEccCCCCHHHhC---c----cc---hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEECcc
Confidence 578999999999996321 1 11 14678899999999999 89999999 99999999999999999999
Q ss_pred ccccccccccCCCccccccCCCCCCcccCChhhhccC
Q 003384 610 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG 646 (824)
Q Consensus 610 a~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~ 646 (824)
|+.+..............-....|++.|+|||++...
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 9987654322221111111356789999999998653
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3e-23 Score=211.29 Aligned_cols=248 Identities=23% Similarity=0.403 Sum_probs=195.3
Q ss_pred CCccceeeecCceEEEEEEECCeEEEEEEecCCCCCC--chhHHHHHHHHHhcCCCceeeEeccc--CCceEEEEEecCC
Q 003384 466 FDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPN 541 (824)
Q Consensus 466 f~~~~~LG~G~fG~Vykg~~~~~~VAvK~l~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~Ey~~g 541 (824)
.+...+|.+...|+.|+|++.+..+++|+++...... ...|..|.-.|+-+.||||+.++|.| +....++..||+.
T Consensus 192 lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~ 271 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF 271 (448)
T ss_pred hhhhhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence 3455678899999999999999999999987654332 35799999999999999999999999 4568899999999
Q ss_pred CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCC
Q 003384 542 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 621 (824)
Q Consensus 542 gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 621 (824)
|||+..|+.. .....+..+..+++.++++|++|||+..+. |.---|.+..|++|++.+++|+= +-+++ +..
T Consensus 272 gslynvlhe~-t~vvvd~sqav~faldiargmaflhslep~-ipr~~lns~hvmidedltarism-ad~kf------sfq 342 (448)
T KOG0195|consen 272 GSLYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSLEPM-IPRFYLNSKHVMIDEDLTARISM-ADTKF------SFQ 342 (448)
T ss_pred hHHHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhcchh-hhhhhcccceEEecchhhhheec-cccee------eee
Confidence 9999999644 334566778999999999999999998752 34447899999999999888742 11111 100
Q ss_pred CccccccCCCCCCcccCChhhhccCCCC---cchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCC
Q 003384 622 NTTLCCRTDPKGTFAYMDPEFLASGELT---PKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWP 698 (824)
Q Consensus 622 ~~~~~~~~~~~GT~~Y~APE~l~~~~~t---~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p 698 (824)
..+..-.|.||+||.+...+-+ .++|+|||+++||||.|...||..-...+..+. -.++.+....|
T Consensus 343 ------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmk-----ialeglrv~ip 411 (448)
T KOG0195|consen 343 ------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMK-----IALEGLRVHIP 411 (448)
T ss_pred ------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhh-----hhhccccccCC
Confidence 0223458899999999876543 468999999999999999999976655544332 23445556677
Q ss_pred hhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHH
Q 003384 699 FVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 734 (824)
Q Consensus 699 ~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l 734 (824)
...+..+.+|+.-|++.||.+||.+ ..++.+|+.+
T Consensus 412 pgis~hm~klm~icmnedpgkrpkf-dmivpilekm 446 (448)
T KOG0195|consen 412 PGISRHMNKLMNICMNEDPGKRPKF-DMIVPILEKM 446 (448)
T ss_pred CCccHHHHHHHHHHhcCCCCcCCCc-ceehhhHHHh
Confidence 8888999999999999999999999 7788888875
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.88 E-value=6e-21 Score=202.79 Aligned_cols=258 Identities=33% Similarity=0.475 Sum_probs=192.4
Q ss_pred CCccceeeecCceEEEEEEECCeEEEEEEecCCCCCC---chhHHHHHHHHHhcCCC-ceeeEecccCC--ceEEEEEec
Q 003384 466 FDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHP-NLVTLVGACPE--VWTLVYEYL 539 (824)
Q Consensus 466 f~~~~~LG~G~fG~Vykg~~~~~~VAvK~l~~~~~~~---~~~f~~Ei~iL~~l~Hp-nIv~L~g~~~~--~~~LV~Ey~ 539 (824)
|.....||.|+||.||++... ..+++|.+....... ...+.+|+.++..+.|+ +|+++++.+.. ..+++++|+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 566778999999999999888 788999987654432 56799999999999988 79999988743 358999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCC-cceeeccccccccccccc
Q 003384 540 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF-VSKLSDFGISRFLSQNEI 618 (824)
Q Consensus 540 ~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~-~vKL~DFGla~~~~~~~~ 618 (824)
.+++|.+++........++......++.+++.+|.|+|. .+++||||||+|||++..+ .++++|||+++.+.....
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence 999999766322111368888999999999999999999 7899999999999999988 799999999985544332
Q ss_pred cCCCccccccCCCCCCcccCChhhhcc---CCCCcchhHHhHHHHHHHHHhCCCCCCCchH---HHHHHh---hhccccc
Q 003384 619 SSNNTTLCCRTDPKGTFAYMDPEFLAS---GELTPKSDVYSFGIILLRLLTGRPALGITKE---VQYALD---TGKLKNL 689 (824)
Q Consensus 619 ~~~~~~~~~~~~~~GT~~Y~APE~l~~---~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~---~~~~~~---~~~~~~~ 689 (824)
..... .......||..|+|||.+.+ ..++...|+||+|++++++++|..||..... ...... .......
T Consensus 158 ~~~~~--~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (384)
T COG0515 158 TSSIP--ALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235 (384)
T ss_pred ccccc--ccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccc
Confidence 11100 01245679999999999987 5788899999999999999999999876542 111111 1110000
Q ss_pred cCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHH
Q 003384 690 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWR 729 (824)
Q Consensus 690 ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~ 729 (824)
........+......+.+++..|+..+|..|.+.......
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0001111111123578999999999999999998655443
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.5e-21 Score=201.55 Aligned_cols=261 Identities=19% Similarity=0.249 Sum_probs=196.3
Q ss_pred hcCCCCccceeeecCceEEEEEE--ECCeEEEEEEecCCCCCCchhHHHHHHHHHhcC-CCceeeEecccC--CceEEEE
Q 003384 462 ATHNFDPSLKIGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVGACP--EVWTLVY 536 (824)
Q Consensus 462 ~~~~f~~~~~LG~G~fG~Vykg~--~~~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~-HpnIv~L~g~~~--~~~~LV~ 536 (824)
..-+|.++++||+|+||+++.|. +++.+||||.-...+ ...++..|....+.|. .++|...|.+-+ -...||+
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 34589999999999999999995 568999999754332 2347899999999985 578877765544 4566999
Q ss_pred EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCC-----cceeecccccc
Q 003384 537 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF-----VSKLSDFGISR 611 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~-----~vKL~DFGla~ 611 (824)
|++ |.||+|++.-.+ ..|+..++..||.|++.-+.|+|. +.+|.|||||+|+||..-+ .+.|+|||+|+
T Consensus 104 dLL-GPSLEDLFD~Cg--R~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 104 DLL-GPSLEDLFDLCG--RRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred hhh-CcCHHHHHHHhc--CcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 998 889999886443 458999999999999999999999 8899999999999997533 57899999999
Q ss_pred ccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHH---HHHHhhhcccc
Q 003384 612 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEV---QYALDTGKLKN 688 (824)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~---~~~~~~~~~~~ 688 (824)
.+.+..+..... ........||..||+=-...+...+...|+-|||-||++.|-|..||.+-... +.--..|....
T Consensus 178 ~YrDp~TkqHIP-YrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr 256 (449)
T KOG1165|consen 178 EYRDPKTKQHIP-YREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKR 256 (449)
T ss_pred hhcCccccccCc-cccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccc
Confidence 887776554332 23346678999999998888999999999999999999999999999653211 11111121111
Q ss_pred ccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHH
Q 003384 689 LLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 734 (824)
Q Consensus 689 ~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l 734 (824)
.. ++ ...-...+.++...+.-....+..+-|+. +-+...+..+
T Consensus 257 ~T-~i-~~Lc~g~P~efa~Yl~yvR~L~F~E~PDY-dylr~Lf~dv 299 (449)
T KOG1165|consen 257 ST-PI-EVLCEGFPEEFATYLRYVRRLDFFETPDY-DYLRKLFDDV 299 (449)
T ss_pred cC-CH-HHHHhcCHHHHHHHHHHHHhcCcccCCCH-HHHHHHHHHH
Confidence 10 00 00112235688888888889999999998 4444444443
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.2e-21 Score=194.10 Aligned_cols=248 Identities=20% Similarity=0.289 Sum_probs=189.0
Q ss_pred cCCCCccceeeecCceEEEEEEE--CCeEEEEEEecCCCCCCchhHHHHHHHHHhcCC-CceeeEeccc--CCceEEEEE
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRH-PNLVTLVGAC--PEVWTLVYE 537 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~--~~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~H-pnIv~L~g~~--~~~~~LV~E 537 (824)
.++|...++||.|+||.+|.|.. .+..||||+-..... ..++..|..+...|++ ..|..+.-+. .+...+||+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 45799999999999999999975 468999998654432 2468899999999975 4555555454 345679999
Q ss_pred ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCC---Ccceeeccccccccc
Q 003384 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN---FVSKLSDFGISRFLS 614 (824)
Q Consensus 538 y~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~---~~vKL~DFGla~~~~ 614 (824)
.+ |.||++++... ...++..+.+-++-|++.-++|+|. +++|||||||+|+|..-+ ..+.|+|||||+.+.
T Consensus 92 LL-GPsLEdLfnfC--~R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFC--SRRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred cc-CccHHHHHHHH--hhhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchhhhc
Confidence 98 88999988533 3458889999999999999999999 899999999999999744 467899999999876
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHH-----HHhhhccccc
Q 003384 615 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQY-----ALDTGKLKNL 689 (824)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~-----~~~~~~~~~~ 689 (824)
+..+...... .......||..|.+--.+.+...+...|+-|+|.+|.++.-|..||.+...... -+.+.++...
T Consensus 166 d~~t~~HIpy-re~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ 244 (341)
T KOG1163|consen 166 DIRTRQHIPY-REDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTP 244 (341)
T ss_pred cccccccCcc-ccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCC
Confidence 5543322211 122456799999998888888889999999999999999999999975433211 1122222222
Q ss_pred cCCCCCCCChhhHHHHHHHHHHHhhhccCCCCCh
Q 003384 690 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 723 (824)
Q Consensus 690 ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 723 (824)
+..+...+ +.++.-.+.-|-..-.++-|+.
T Consensus 245 ie~LC~G~----P~EF~myl~Y~R~L~F~E~Pdy 274 (341)
T KOG1163|consen 245 IEVLCKGF----PAEFAMYLNYCRGLGFEEKPDY 274 (341)
T ss_pred HHHHhCCC----cHHHHHHHHHHhhcCCCCCCcH
Confidence 22233333 4578889999999999999987
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.3e-21 Score=223.86 Aligned_cols=247 Identities=23% Similarity=0.335 Sum_probs=180.7
Q ss_pred CCCccceeeecCceEEEEEEECCeEEEEEEecCCC-CCCchhHHHHHHH--HHhcCCCceeeEeccc--CCceEEEEEec
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHS-LQGPSEFQQEIDI--LSKIRHPNLVTLVGAC--PEVWTLVYEYL 539 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~~~~VAvK~l~~~~-~~~~~~f~~Ei~i--L~~l~HpnIv~L~g~~--~~~~~LV~Ey~ 539 (824)
+|...+.||.+.|=+|.+|+++...|+||++-... ..+...|.+.+.- ...++|||++++.-.- ....|||-+|+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyv 103 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYV 103 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHH
Confidence 56777889999999999999998889999987654 3344555554433 3445899999886543 34567888998
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccccc
Q 003384 540 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 619 (824)
Q Consensus 540 ~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 619 (824)
.+ +|+|+| ..++.|...+...|+.|++.||.-+|. .||+|||||.+||||+.-..+.|+||.--+...-.+..
T Consensus 104 kh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 104 KH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred hh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 55 899999 455678888899999999999999999 89999999999999999999999999876643322222
Q ss_pred CCCccccccCCCCCCcccCChhhhccC----------C-CCcchhHHhHHHHHHHHHh-CCCCCCCchHHHHHHhhhc--
Q 003384 620 SNNTTLCCRTDPKGTFAYMDPEFLASG----------E-LTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGK-- 685 (824)
Q Consensus 620 ~~~~~~~~~~~~~GT~~Y~APE~l~~~----------~-~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~~~~~-- 685 (824)
...-... ..+...-.+|+|||.|... . .++++||||+||+++||++ |+|||....-..+ ..|.
T Consensus 177 Padf~fF-FDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aY--r~~~~~ 253 (1431)
T KOG1240|consen 177 PADFTFF-FDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAY--RSGNAD 253 (1431)
T ss_pred cccceEE-EecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhH--hccCcc
Confidence 2111111 1222345589999988542 2 6789999999999999998 8999976544333 2221
Q ss_pred -cccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHH
Q 003384 686 -LKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWR 729 (824)
Q Consensus 686 -~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~ 729 (824)
....+. ......+++|++.|++.+|..|-+. +++++
T Consensus 254 ~~e~~Le-------~Ied~~~Rnlil~Mi~rdPs~RlSA-edyL~ 290 (1431)
T KOG1240|consen 254 DPEQLLE-------KIEDVSLRNLILSMIQRDPSKRLSA-EDYLQ 290 (1431)
T ss_pred CHHHHHH-------hCcCccHHHHHHHHHccCchhccCH-HHHHH
Confidence 111111 1122378999999999999999998 44433
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.5e-20 Score=194.97 Aligned_cols=170 Identities=16% Similarity=0.175 Sum_probs=133.0
Q ss_pred hcCCCCccceeeecCceEEEEEEECCeEEEEEEecCCCCCCchh---------HHHHHHHHHhcCCCceeeEecccC---
Q 003384 462 ATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSE---------FQQEIDILSKIRHPNLVTLVGACP--- 529 (824)
Q Consensus 462 ~~~~f~~~~~LG~G~fG~Vykg~~~~~~VAvK~l~~~~~~~~~~---------f~~Ei~iL~~l~HpnIv~L~g~~~--- 529 (824)
..++|...++||.|+||.||.....+..+|||++.+........ +.+|+..+.++.||+|..+.+++.
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 46789999999999999999977777889999998654433322 678999999999999998877642
Q ss_pred -------CceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcc
Q 003384 530 -------EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS 602 (824)
Q Consensus 530 -------~~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~v 602 (824)
...+|||||++|.+|.++.. ++. ....+++.+|..+|. .|++|||++|+||+++++| +
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~~~g-i 173 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVSKNG-L 173 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEeCCC-E
Confidence 24789999999999988641 222 245689999999999 8999999999999999998 9
Q ss_pred eeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh
Q 003384 603 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 666 (824)
Q Consensus 603 KL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt 666 (824)
+|+|||.......... ..-++....|+.++|+|||||.|.-+..
T Consensus 174 ~liDfg~~~~~~e~~a--------------------~d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 174 RIIDLSGKRCTAQRKA--------------------KDRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred EEEECCCcccccchhh--------------------HHHHHHHhHhcccccccceeEeehHHHH
Confidence 9999998764422110 0113445567789999999999876543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=5.7e-20 Score=187.16 Aligned_cols=137 Identities=18% Similarity=0.197 Sum_probs=105.7
Q ss_pred ceeeecCceEEEEEEEC-CeEEEEEEecCCCCC--C-------chhH-----------------HHHHHHHHhcCCCcee
Q 003384 470 LKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQ--G-------PSEF-----------------QQEIDILSKIRHPNLV 522 (824)
Q Consensus 470 ~~LG~G~fG~Vykg~~~-~~~VAvK~l~~~~~~--~-------~~~f-----------------~~Ei~iL~~l~HpnIv 522 (824)
..||+|+||.||+|... +..||||+++..... . ...| ..|+.+|.++.++++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 56999999999999875 789999999764221 1 1122 3499999999877764
Q ss_pred eEecccCCceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHH-hhcCCCceEeccccCCcEEecCCCc
Q 003384 523 TLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFL-HSCKPHSIVHGDLKPANILLDANFV 601 (824)
Q Consensus 523 ~L~g~~~~~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~L-H~~~~~giiHrDLKp~NILld~~~~ 601 (824)
..........+|||||++|++|...+. ...+++......++.+++.+|.+| |. .||+||||||+|||++ ++.
T Consensus 83 ~p~~~~~~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 83 CPEPILLKSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCcEEEecCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEE-CCc
Confidence 332222233489999999887765432 234688899999999999999999 57 7899999999999998 478
Q ss_pred ceeecccccccc
Q 003384 602 SKLSDFGISRFL 613 (824)
Q Consensus 602 vKL~DFGla~~~ 613 (824)
++|+|||+|...
T Consensus 156 v~LiDFG~a~~~ 167 (190)
T cd05147 156 LYIIDVSQSVEH 167 (190)
T ss_pred EEEEEccccccC
Confidence 999999998744
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.7e-20 Score=220.82 Aligned_cols=247 Identities=22% Similarity=0.305 Sum_probs=175.3
Q ss_pred CccceeeecCceEEEEEEEC--CeEEEEEEecCC--CCCCc----hhHHHHHHHHHhcCCCceeeEecccCC--ceEEEE
Q 003384 467 DPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH--SLQGP----SEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVY 536 (824)
Q Consensus 467 ~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~--~~~~~----~~f~~Ei~iL~~l~HpnIv~L~g~~~~--~~~LV~ 536 (824)
.....+|.|+||.|+..... ...++.|.+... ..... ..+..|+.+-..|.|||++..+..+.+ ..+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 45678999999977766543 233444433211 11111 125567888888999999887776633 333459
Q ss_pred EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccc
Q 003384 537 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 616 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 616 (824)
|||++ +|..++... ..+....+-.++.|+..||.|+|. .||.||||||+|++++.+|.+||+|||.+..+...
T Consensus 401 E~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hcccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 99999 999998532 457778889999999999999999 89999999999999999999999999999876544
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCcc-hhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCC
Q 003384 617 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPK-SDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG 695 (824)
Q Consensus 617 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~k-sDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~ 695 (824)
... ......+..|+..|+|||.+.+..|++. .||||.|+++..|++|+.||.......................+
T Consensus 474 ~e~----~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~ 549 (601)
T KOG0590|consen 474 WEK----NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEG 549 (601)
T ss_pred cch----hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccC
Confidence 321 1122356789999999999999999875 79999999999999999999543221110000000000000111
Q ss_pred CC--ChhhHHHHHHHHHHHhhhccCCCCChH
Q 003384 696 DW--PFVQAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 696 ~~--p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
.+ ....+..-..++.++|+.+|.+|.++.
T Consensus 550 ~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~ 580 (601)
T KOG0590|consen 550 PNRLLSLLPRETRIIIYRMLQLDPTKRITIE 580 (601)
T ss_pred hHHHHHhchhhHHHHHHHHccCChhheecHH
Confidence 11 123456778999999999999999994
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=2e-19 Score=183.26 Aligned_cols=192 Identities=15% Similarity=0.054 Sum_probs=140.9
Q ss_pred CccceeeecCceEEEEEEECCeEEEEEEecCCCCCC----chhHHHHHHHHHhcC-CCceeeEecccCCceEEEEEecCC
Q 003384 467 DPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQG----PSEFQQEIDILSKIR-HPNLVTLVGACPEVWTLVYEYLPN 541 (824)
Q Consensus 467 ~~~~~LG~G~fG~Vykg~~~~~~VAvK~l~~~~~~~----~~~f~~Ei~iL~~l~-HpnIv~L~g~~~~~~~LV~Ey~~g 541 (824)
.....||+|+||+||.+...+.+++.+.+.....-. ...|.+|+++|++|. |++|++++++ +..+++|||+.|
T Consensus 5 ~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~--~~~~lvmeyI~G 82 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW--DGRHLDRSYLAG 82 (218)
T ss_pred ccceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE--cCEEEEEeeecC
Confidence 455689999999999877777888888776543311 124789999999995 5889999886 457899999999
Q ss_pred CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccc-cCCcEEecCCCcceeecccccccccccccc-
Q 003384 542 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDL-KPANILLDANFVSKLSDFGISRFLSQNEIS- 619 (824)
Q Consensus 542 gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDL-Kp~NILld~~~~vKL~DFGla~~~~~~~~~- 619 (824)
.+|...+. . ....++.+++.+|.++|. +||+|||| ||+|||++.++.++|+|||+|.........
T Consensus 83 ~~L~~~~~----~------~~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 83 AAMYQRPP----R------GDLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred ccHHhhhh----h------hhHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence 99875441 0 123577899999999999 89999999 799999999999999999999855432210
Q ss_pred ---CC-CccccccCCCCCCcccCChhhhccC-CCC-cchhHHhHHHHHHHHHhCCCCCCC
Q 003384 620 ---SN-NTTLCCRTDPKGTFAYMDPEFLASG-ELT-PKSDVYSFGIILLRLLTGRPALGI 673 (824)
Q Consensus 620 ---~~-~~~~~~~~~~~GT~~Y~APE~l~~~-~~t-~ksDVwSlGvvL~ELltG~~Pf~~ 673 (824)
.. ........-..+++.|++|+-..-- ..+ ...++++.|+-+|.++||+.++-.
T Consensus 150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 00 0000000112378889999754322 233 567999999999999999987643
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.8e-20 Score=210.02 Aligned_cols=221 Identities=27% Similarity=0.324 Sum_probs=176.6
Q ss_pred eeecCceEEEEE-----EECCeEEEEEEecCCCCCC--chhHHHHHHHHHhcC-CCceeeEecccC--CceEEEEEecCC
Q 003384 472 IGEGGYGSIYKG-----LLRHMQVAIKMLHPHSLQG--PSEFQQEIDILSKIR-HPNLVTLVGACP--EVWTLVYEYLPN 541 (824)
Q Consensus 472 LG~G~fG~Vykg-----~~~~~~VAvK~l~~~~~~~--~~~f~~Ei~iL~~l~-HpnIv~L~g~~~--~~~~LV~Ey~~g 541 (824)
+|+|.||.|+.+ ...+.-+|+|+++...... ......|..++..++ ||.+|++...+. ...+++++|..|
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 799999999863 3446778999887653322 124567889999997 999999998874 468899999999
Q ss_pred CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCC
Q 003384 542 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 621 (824)
Q Consensus 542 gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 621 (824)
|.|...+. ....+.......+...++-++.++|. .+|+|||+|++||+++.+|++|+.|||+++..-....
T Consensus 82 g~lft~l~---~~~~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~--- 152 (612)
T KOG0603|consen 82 GDLFTRLS---KEVMFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI--- 152 (612)
T ss_pred chhhhccc---cCCchHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhhh---
Confidence 99988884 44556777777788889999999999 8999999999999999999999999999986654321
Q ss_pred CccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCChhh
Q 003384 622 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQ 701 (824)
Q Consensus 622 ~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~ 701 (824)
..||..|||||++. ++...+|+||||++++||+||..||.. +. ...+.......|...
T Consensus 153 ---------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~--~~---------~~~Il~~~~~~p~~l 210 (612)
T KOG0603|consen 153 ---------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG--DT---------MKRILKAELEMPREL 210 (612)
T ss_pred ---------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch--HH---------HHHHhhhccCCchhh
Confidence 15899999999998 667889999999999999999999976 11 111111223456777
Q ss_pred HHHHHHHHHHHhhhccCCCCCh
Q 003384 702 AEQLANLAMRCCEMSRKSRPEL 723 (824)
Q Consensus 702 ~~~l~~Li~~Cl~~~P~~RPt~ 723 (824)
...+..++.+++..+|.+|--.
T Consensus 211 ~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 211 SAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred hHHHHHHHHHHHhhCHHHHhcc
Confidence 7889999999999999998754
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=1e-18 Score=177.85 Aligned_cols=140 Identities=18% Similarity=0.191 Sum_probs=108.5
Q ss_pred cceeeecCceEEEEEEEC-CeEEEEEEecCCCCC---------------------Cc-----hhHHHHHHHHHhcCCCce
Q 003384 469 SLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQ---------------------GP-----SEFQQEIDILSKIRHPNL 521 (824)
Q Consensus 469 ~~~LG~G~fG~Vykg~~~-~~~VAvK~l~~~~~~---------------------~~-----~~f~~Ei~iL~~l~HpnI 521 (824)
...||+|+||.||+|... +..||||+++..... .. ..+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 357999999999999875 789999999865321 00 113578999999999987
Q ss_pred eeEecccCCceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCc
Q 003384 522 VTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV 601 (824)
Q Consensus 522 v~L~g~~~~~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~ 601 (824)
.....+.....+|||||++|+++...+. ...+++......++.+++.+|.+||+. .||+||||||.|||++ ++.
T Consensus 82 ~~p~~~~~~~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~--~givHrDlkP~NIll~-~~~ 155 (190)
T cd05145 82 PVPEPILLKKNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQE--AGLVHGDLSEYNILYH-DGK 155 (190)
T ss_pred CCceEEEecCCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHh--CCEecCCCChhhEEEE-CCC
Confidence 4433322234589999999886543321 124577788999999999999999983 4899999999999999 889
Q ss_pred ceeeccccccccc
Q 003384 602 SKLSDFGISRFLS 614 (824)
Q Consensus 602 vKL~DFGla~~~~ 614 (824)
++|+|||++....
T Consensus 156 ~~liDFG~a~~~~ 168 (190)
T cd05145 156 PYIIDVSQAVELD 168 (190)
T ss_pred EEEEEcccceecC
Confidence 9999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=8.8e-18 Score=173.34 Aligned_cols=134 Identities=18% Similarity=0.233 Sum_probs=103.0
Q ss_pred CccceeeecCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhc-----CCCceeeEecccCCc------eEEE
Q 003384 467 DPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKI-----RHPNLVTLVGACPEV------WTLV 535 (824)
Q Consensus 467 ~~~~~LG~G~fG~Vykg~~~~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l-----~HpnIv~L~g~~~~~------~~LV 535 (824)
.....||+|+||.||..... ...+||++........+.+.+|+.+++.+ +||||++++|++... +.+|
T Consensus 5 ~~~~~LG~G~~~~Vy~hp~~-~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 5 SEQSPLGTGRHRKCYAHPED-AQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred CCcceecCCCceEEEECCCC-cCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 44568999999999962222 33479988765444566799999999999 579999999998442 2378
Q ss_pred EEe--cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHH-HHHhhcCCCceEeccccCCcEEecC----CCcceeeccc
Q 003384 536 YEY--LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVL-IFLHSCKPHSIVHGDLKPANILLDA----NFVSKLSDFG 608 (824)
Q Consensus 536 ~Ey--~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL-~~LH~~~~~giiHrDLKp~NILld~----~~~vKL~DFG 608 (824)
+|| +++|+|.+++.. ..++.. ..++.+++.++ .|||+ ++||||||||+|||++. ++.++|+||+
T Consensus 84 ~e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred ecCCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 999 667999999943 235544 35677888777 89999 89999999999999974 3489999955
Q ss_pred cc
Q 003384 609 IS 610 (824)
Q Consensus 609 la 610 (824)
.+
T Consensus 155 G~ 156 (210)
T PRK10345 155 GE 156 (210)
T ss_pred CC
Confidence 33
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.7e-17 Score=174.64 Aligned_cols=230 Identities=21% Similarity=0.288 Sum_probs=147.1
Q ss_pred CCCccceeeecCceEEEEEEECC--eEEEEEEecCCCCC---CchhHHHHHHHHHhcCC----------Cc------eee
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRH----------PN------LVT 523 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~~--~~VAvK~l~~~~~~---~~~~f~~Ei~iL~~l~H----------pn------Iv~ 523 (824)
.+.....||.|+|+.||.+++.. ..+|+|++...... ..+.+.+|.-....+.+ -. +++
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 34456789999999999999874 89999998654422 23456666644444322 11 222
Q ss_pred Eecc---c---C--C-----ceEEEEEecCCCChhhhhhc---cCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEe
Q 003384 524 LVGA---C---P--E-----VWTLVYEYLPNGSLEDRLSC---KDN-SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 586 (824)
Q Consensus 524 L~g~---~---~--~-----~~~LV~Ey~~ggsL~~~L~~---~~~-~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiH 586 (824)
+-+- + . . ..+++|.-+ .++|.+++.. ... ...+....++.+..|+.+.+++||. .|++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEe
Confidence 2210 0 0 1 235677766 4688776532 111 2335556777888999999999999 89999
Q ss_pred ccccCCcEEecCCCcceeeccccccccccccccCCCccccccCCCCCCcccCChhhhccC--------CCCcchhHHhHH
Q 003384 587 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG--------ELTPKSDVYSFG 658 (824)
Q Consensus 587 rDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~--------~~t~ksDVwSlG 658 (824)
+||+|+|+|++.+|.++|+||+........... ...+..|.+||..... .++.+.|.|+||
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----------~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG 237 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----------SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLG 237 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----------GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCceeec-----------cCCCcccCChhhhhhhcccCcccceeeeccCHHHHH
Confidence 999999999999999999999977654432211 1245789999977442 478889999999
Q ss_pred HHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCC
Q 003384 659 IILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSR 720 (824)
Q Consensus 659 vvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~R 720 (824)
+++|.|++|+.||+....... .+.....+. ..++.+..||..+|+.+|.+|
T Consensus 238 ~~ly~lWC~~lPf~~~~~~~~----------~~~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 238 ITLYSLWCGRLPFGLSSPEAD----------PEWDFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHHHSS-STCCCGGGST----------SGGGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHHHccCCCCCCCcccc----------ccccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999999999999986532110 000223344 678899999999999999987
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.72 E-value=8.8e-18 Score=197.88 Aligned_cols=216 Identities=24% Similarity=0.297 Sum_probs=147.6
Q ss_pred hcCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccCCceEEEEEec
Q 003384 462 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTLVYEYL 539 (824)
Q Consensus 462 ~~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~~~~~LV~Ey~ 539 (824)
...+|+.++.|-.|+||-||...++ .+++|+|+ +.... +.+- |+.....|.+ |
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l-----ilRn--ilt~a~npfv-------------v---- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL-----ILRN--ILTFAGNPFV-------------V---- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhcc-cccch-----hhhc--cccccCCcce-------------e----
Confidence 3458999999999999999999776 57899854 32211 1110 2222233333 2
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccccc
Q 003384 540 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 619 (824)
Q Consensus 540 ~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 619 (824)
|+-.+.+ .+-++++... +.+++|||+ .||+|||+||+|+||+.-|++|+.|||+++........
T Consensus 136 --gDc~tll---k~~g~lPvdm--------vla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 --GDCATLL---KNIGPLPVDM--------VLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred --chhhhhc---ccCCCCcchh--------hHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 4555555 3334455432 678999999 89999999999999999999999999999743221111
Q ss_pred CC-------CccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHH-HHHHhhhccccccC
Q 003384 620 SN-------NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEV-QYALDTGKLKNLLD 691 (824)
Q Consensus 620 ~~-------~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~-~~~~~~~~~~~~ld 691 (824)
.. ...........||+.|+|||++..++|+..+|||++|+|+||.+.|..||.++..- ......+....+.+
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE 279 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 279 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccc
Confidence 00 01111224557999999999999999999999999999999999999999766321 11111111111111
Q ss_pred CCCCCCChhhHHHHHHHHHHHhhhccCCCCCh
Q 003384 692 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 723 (824)
Q Consensus 692 ~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 723 (824)
. ....+.++++++.+.|+.+|..|--.
T Consensus 280 ---~--dea~p~Ea~dli~~LL~qnp~~Rlgt 306 (1205)
T KOG0606|consen 280 ---E--DEALPPEAQDLIEQLLRQNPLCRLGT 306 (1205)
T ss_pred ---c--CcCCCHHHHHHHHHHHHhChHhhccc
Confidence 1 12235689999999999999999644
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.71 E-value=5e-17 Score=165.94 Aligned_cols=128 Identities=27% Similarity=0.407 Sum_probs=105.5
Q ss_pred eeeecCceEEEEEEECCeEEEEEEecCCCCCC--------chhHHHHHHHHHhcCCCce--eeEecccCCceEEEEEecC
Q 003384 471 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQG--------PSEFQQEIDILSKIRHPNL--VTLVGACPEVWTLVYEYLP 540 (824)
Q Consensus 471 ~LG~G~fG~Vykg~~~~~~VAvK~l~~~~~~~--------~~~f~~Ei~iL~~l~HpnI--v~L~g~~~~~~~LV~Ey~~ 540 (824)
.||+|+||.||+|.+.+..|++|......... ...+.+|+.++..+.|+++ ..+++...+..++||||++
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 38999999999999999999999876433211 1457789999999988754 4555555667799999999
Q ss_pred CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccc
Q 003384 541 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 612 (824)
Q Consensus 541 ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~ 612 (824)
|++|.+.+... . ..++.+++.+|.+||. .|++|||++|.|||++ ++.++++|||++..
T Consensus 81 g~~l~~~~~~~---~-------~~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 81 GKPLKDVIEEG---N-------DELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CccHHHHHhhc---H-------HHHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999887321 1 1789999999999999 8999999999999999 88999999998875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.3e-17 Score=167.15 Aligned_cols=132 Identities=27% Similarity=0.438 Sum_probs=109.8
Q ss_pred ceeeecCceEEEEEEECCeEEEEEEecCCCCCCc--------hhHHHHHHHHHhcCCCceeeEecc--cCCceEEEEEec
Q 003384 470 LKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGP--------SEFQQEIDILSKIRHPNLVTLVGA--CPEVWTLVYEYL 539 (824)
Q Consensus 470 ~~LG~G~fG~Vykg~~~~~~VAvK~l~~~~~~~~--------~~f~~Ei~iL~~l~HpnIv~L~g~--~~~~~~LV~Ey~ 539 (824)
+.||+|++|.||+|.+.+..|++|+......... ..+.+|+.++..+.|+||.....+ ..+..++||||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 4699999999999999989999998765433221 347789999999999887655444 456788999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccc
Q 003384 540 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 612 (824)
Q Consensus 540 ~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~ 612 (824)
+|++|.+++... .. .+..++.+++.+|.+||. .+++|||++|.|||++ ++.++|+|||++..
T Consensus 82 ~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSN------GM-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999988421 12 788999999999999999 8999999999999999 78999999998764
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.9e-17 Score=185.84 Aligned_cols=208 Identities=27% Similarity=0.455 Sum_probs=151.8
Q ss_pred HHhcCCCceeeEeccc--CCceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCce-Eeccc
Q 003384 513 LSKIRHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI-VHGDL 589 (824)
Q Consensus 513 L~~l~HpnIv~L~g~~--~~~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~gi-iHrDL 589 (824)
|+.+.|.|+.+++|.| ....++|.+||..|+|.|.+.. ....+++.-...+..+|+.||.|||.. +| .|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeee
Confidence 4578999999999988 4467889999999999999964 356688889999999999999999993 34 99999
Q ss_pred cCCcEEecCCCcceeeccccccccccccccCCCccccccCCCCCCcccCChhhhccC---C----CCcchhHHhHHHHHH
Q 003384 590 KPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG---E----LTPKSDVYSFGIILL 662 (824)
Q Consensus 590 Kp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~---~----~t~ksDVwSlGvvL~ 662 (824)
++.|.++|..+.+||+|||+............. ....-...|.|||.+... . .+.+.||||||++++
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~------~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ 149 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAH------HPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMY 149 (484)
T ss_pred ccccceeeeeEEEEechhhhccccccccccccc------chhHHHHhccCHHHhcccccccccccccccCCeehHHHHHH
Confidence 999999999999999999998876531101000 111135679999998763 2 466799999999999
Q ss_pred HHHhCCCCCCCchH------HHHHHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHH
Q 003384 663 RLLTGRPALGITKE------VQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 734 (824)
Q Consensus 663 ELltG~~Pf~~~~~------~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l 734 (824)
|+++...||+.... +...+.. .....+-|...... ...+.+..++.+||..+|.+||++ +.+...++.+
T Consensus 150 ei~~r~~~~~~~~~~~~~~eii~~~~~-~~~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~-~~i~~~~~~~ 224 (484)
T KOG1023|consen 150 EILFRSGPFDLRNLVEDPDEIILRVKK-GGSNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSI-EQIRSKLLTI 224 (484)
T ss_pred HHHhccCccccccccCChHHHHHHHHh-cCCCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccH-HHHHhhhhhh
Confidence 99999999975322 1111111 01111112111111 233479999999999999999999 5555555443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.70 E-value=5.5e-17 Score=170.92 Aligned_cols=140 Identities=19% Similarity=0.194 Sum_probs=109.3
Q ss_pred CCCccceeeecCceEEEEEE-E--CCeEEEEEEecCCCCC-------------------Cc-----hhHHHHHHHHHhcC
Q 003384 465 NFDPSLKIGEGGYGSIYKGL-L--RHMQVAIKMLHPHSLQ-------------------GP-----SEFQQEIDILSKIR 517 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~-~--~~~~VAvK~l~~~~~~-------------------~~-----~~f~~Ei~iL~~l~ 517 (824)
-|.+...||+|+||.||+|. . .+..||||++...... .. ..+..|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 46777889999999999998 2 4689999998754211 00 12568999999997
Q ss_pred CC--ceeeEecccCCceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCc-eEeccccCCcE
Q 003384 518 HP--NLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS-IVHGDLKPANI 594 (824)
Q Consensus 518 Hp--nIv~L~g~~~~~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~g-iiHrDLKp~NI 594 (824)
+. .+.++++. ...++||||++|++|...+. ...++.......++.+++.+|.+||. .| |+||||||+||
T Consensus 109 ~~~i~~p~~~~~--~~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dikp~NI 180 (237)
T smart00090 109 EAGVPVPKPIAW--RRNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYK---EGELVHGDLSEYNI 180 (237)
T ss_pred hcCCCCCeeeEe--cCceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCChhhE
Confidence 53 34455543 23579999999988876542 22345666678999999999999999 88 99999999999
Q ss_pred EecCCCcceeecccccccc
Q 003384 595 LLDANFVSKLSDFGISRFL 613 (824)
Q Consensus 595 Lld~~~~vKL~DFGla~~~ 613 (824)
|++ ++.++|+|||++...
T Consensus 181 li~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 181 LVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred EEE-CCCEEEEEChhhhcc
Confidence 999 889999999988754
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.4e-16 Score=170.31 Aligned_cols=200 Identities=22% Similarity=0.242 Sum_probs=139.8
Q ss_pred CCCceeeEecccC-----------------------------CceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHH
Q 003384 517 RHPNLVTLVGACP-----------------------------EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIAT 567 (824)
Q Consensus 517 ~HpnIv~L~g~~~-----------------------------~~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~ 567 (824)
+|||||+++++|- ...|+||.-.+. +|+.+|... ..+.....-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~----~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR----HRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC----CCchHHHHHHHH
Confidence 5999999988761 025788877654 888888432 345567788999
Q ss_pred HHHHHHHHHhhcCCCceEeccccCCcEEe--cCCC--cceeeccccccccccccccCCCccccccCCCCCCcccCChhhh
Q 003384 568 ELCSVLIFLHSCKPHSIVHGDLKPANILL--DANF--VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 643 (824)
Q Consensus 568 qia~aL~~LH~~~~~giiHrDLKp~NILl--d~~~--~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l 643 (824)
|+++|+.|||. +||.|||+|++|||| |.++ .+.|+|||+|---...+...... .......|....||||+.
T Consensus 349 QlLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~--S~~Vd~GGNa~lmAPEi~ 423 (598)
T KOG4158|consen 349 QLLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYE--SDEVDLGGNAKLMAPEIA 423 (598)
T ss_pred HHHHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccc--cccccCCCcceecchhhh
Confidence 99999999999 899999999999999 4444 56899999874322211111111 111344588899999998
Q ss_pred ccCC--C----CcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhcc
Q 003384 644 ASGE--L----TPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSR 717 (824)
Q Consensus 644 ~~~~--~----t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P 717 (824)
...+ . -.++|.|+.|.+.||+++...||....+.... .....+ ...+..|...+..+.+++...|+.+|
T Consensus 424 ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~--~r~Yqe---~qLPalp~~vpp~~rqlV~~lL~r~p 498 (598)
T KOG4158|consen 424 TAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLD--TRTYQE---SQLPALPSRVPPVARQLVFDLLKRDP 498 (598)
T ss_pred hcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheec--hhhhhh---hhCCCCcccCChHHHHHHHHHhcCCc
Confidence 6532 1 24799999999999999999999764432211 111111 12233455667789999999999999
Q ss_pred CCCCChHHHHHHHHH
Q 003384 718 KSRPELGKDVWRVLE 732 (824)
Q Consensus 718 ~~RPt~~~~v~~~Le 732 (824)
.+||+. .+...+|.
T Consensus 499 skRvsp-~iAANvl~ 512 (598)
T KOG4158|consen 499 SKRVSP-NIAANVLN 512 (598)
T ss_pred cccCCc-cHHHhHHH
Confidence 999997 55544443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.69 E-value=2e-16 Score=190.17 Aligned_cols=195 Identities=26% Similarity=0.334 Sum_probs=154.1
Q ss_pred hHhhhcCCCCccceeeecCceEEEEEEEC-CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCcee----eEecc--cCC
Q 003384 458 EIEGATHNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLV----TLVGA--CPE 530 (824)
Q Consensus 458 ei~~~~~~f~~~~~LG~G~fG~Vykg~~~-~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv----~L~g~--~~~ 530 (824)
+++.....|.+.+.||+|+||.||+|... ++.||+|+-++... =+|.--.+++.+|+ |-++ .+..+ +.+
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~---WEfYI~~q~~~RLk-~~~~~~~~~~~~a~~~~~ 767 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP---WEFYICLQVMERLK-PQMLPSIMHISSAHVFQN 767 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc---eeeeehHHHHHhhc-hhhhcchHHHHHHHccCC
Confidence 34445557888999999999999999875 58899999776542 24544556666776 3333 33322 367
Q ss_pred ceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecC-------CCcce
Q 003384 531 VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA-------NFVSK 603 (824)
Q Consensus 531 ~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~-------~~~vK 603 (824)
..+||+||.+.|+|.+++. ....+++...+.++.+++..+..||. .+||||||||+|+||.. +.-++
T Consensus 768 ~S~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~ 841 (974)
T KOG1166|consen 768 ASVLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLY 841 (974)
T ss_pred cceeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceE
Confidence 8889999999999999994 66779999999999999999999999 78999999999999942 34689
Q ss_pred eeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCC
Q 003384 604 LSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR 668 (824)
Q Consensus 604 L~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~ 668 (824)
|+|||.+..+.--.. .. ......+|-.+-.+|+..|..++...|.|.|+.+++-||.|+
T Consensus 842 lIDfG~siDm~lfp~---~~---~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 842 LIDFGRSIDMKLFPD---GT---KFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred EEecccceeeeEcCC---Cc---EEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHH
Confidence 999999874432111 11 114556899999999999999999999999999999999996
|
|
| >PF04564 U-box: U-box domain; InterPro: IPR003613 Quality control of intracellular proteins is essential for cellular homeostasis | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.4e-17 Score=142.58 Aligned_cols=71 Identities=44% Similarity=0.843 Sum_probs=63.1
Q ss_pred CCCCCcccchhhhccCCccccCCccchhhhhhhhhcCCCCCCCCCCCCCCCCCCCchHHHHHHHHHHHHhC
Q 003384 754 PPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWLQQH 824 (824)
Q Consensus 754 ~P~~f~cPi~~evm~dPvi~~~g~tye~~~i~~wl~~~~~t~p~t~~~l~~~~l~pn~~lr~~i~~~~~~~ 824 (824)
+|++|.|||+.++|.|||++++|+|||+++|..|+..++.+||+|++++...+|+||.+||++|++|+.+|
T Consensus 1 iP~~f~CpIt~~lM~dPVi~~~G~tyer~~I~~~l~~~~~~~P~t~~~l~~~~l~pn~~Lk~~I~~~~~~~ 71 (73)
T PF04564_consen 1 IPDEFLCPITGELMRDPVILPSGHTYERSAIERWLEQNGGTDPFTRQPLSESDLIPNRALKSAIEEWCAEN 71 (73)
T ss_dssp SSGGGB-TTTSSB-SSEEEETTSEEEEHHHHHHHHCTTSSB-TTT-SB-SGGGSEE-HHHHHHHHHHHHHC
T ss_pred CCcccCCcCcCcHhhCceeCCcCCEEcHHHHHHHHHcCCCCCCCCCCcCCcccceECHHHHHHHHHHHHHc
Confidence 58999999999999999999999999999999999998999999999999999999999999999999986
|
Molecular chaperones recognise and contribute to the refolding of misfolded or unfolded proteins, whereas the ubiquitin-proteasome system mediates the degradation of such abnormal proteins. Ubiquitin-protein ligases (E3s) determine the substrate specificity for ubiquitylation and have been classified into HECT and RING-finger families. More recently, however, U-box proteins, which contain a domain (the U box) of about 70 amino acids that is conserved from yeast to humans, have been identified as a new type of E3 []. Members of the U-box family of proteins constitute a class of ubiquitin-protein ligases (E3s) distinct from the HECT-type and RING finger-containing E3 families []. Using yeast two-hybrid technology, all mammalian U-box proteins have been reported to interact with molecular chaperones or co-chaperones, including Hsp90, Hsp70, DnaJc7, EKN1, CRN, and VCP. This suggests that the function of U box-type E3s is to mediate the degradation of unfolded or misfolded proteins in conjunction with molecular chaperones as receptors that recognise such abnormal proteins [, ]. Unlike the RING finger domain, IPR001841 from INTERPRO, that is stabilised by Zn2+ ions coordinated by the cysteines and a histidine, the U-box scaffold is probably stabilised by a system of salt-bridges and hydrogen bonds. The charged and polar residues that participate in this network of bonds are more strongly conserved in the U-box proteins than in classic RING fingers, which supports their role in maintaining the stability of the U box. Thus, the U box appears to have evolved from a RING finger domain by appropriation of a new set of residues required to stabilise its structure, concomitant with the loss of the original, metal-chelating residues [].; GO: 0004842 ubiquitin-protein ligase activity, 0016567 protein ubiquitination, 0000151 ubiquitin ligase complex; PDB: 1T1H_A 2C2L_D 2C2V_V 1WGM_A 2KR4_A 3L1Z_B 3L1X_A 2KRE_A 3M63_A 2QIZ_A .... |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.3e-16 Score=185.58 Aligned_cols=136 Identities=28% Similarity=0.378 Sum_probs=111.1
Q ss_pred hcCCCCccceeeecCceEEEEEEECCeEEEEEEecCCCCC--------CchhHHHHHHHHHhcCCCceeeEeccc--CCc
Q 003384 462 ATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQ--------GPSEFQQEIDILSKIRHPNLVTLVGAC--PEV 531 (824)
Q Consensus 462 ~~~~f~~~~~LG~G~fG~Vykg~~~~~~VAvK~l~~~~~~--------~~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~ 531 (824)
....|...+.||+|+||+||+|.+.+..+++|+....... ....+.+|++++..++|+|++..+.++ .+.
T Consensus 331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 331 VKRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred cccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 3445677889999999999999998777766654322111 124578999999999999988765544 456
Q ss_pred eEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccc
Q 003384 532 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR 611 (824)
Q Consensus 532 ~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~ 611 (824)
.++||||++|++|.+++. ....++.+++.+|.+||+ .+++||||||+|||+ .++.++|+|||+++
T Consensus 411 ~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFGla~ 475 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFGLGK 475 (535)
T ss_pred CEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCcccc
Confidence 789999999999999883 457789999999999999 899999999999999 57799999999987
Q ss_pred c
Q 003384 612 F 612 (824)
Q Consensus 612 ~ 612 (824)
.
T Consensus 476 ~ 476 (535)
T PRK09605 476 Y 476 (535)
T ss_pred c
Confidence 5
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.5e-17 Score=181.12 Aligned_cols=176 Identities=22% Similarity=0.335 Sum_probs=133.5
Q ss_pred ceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccc
Q 003384 531 VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS 610 (824)
Q Consensus 531 ~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla 610 (824)
.+||.|++|.-.+|.++|.++......++.....++.|++.|+.| ++.+|+|+||.||++..+..+||+|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence 478999999999999999877777778888999999999999999 57999999999999999999999999998
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHHHHhhhccccc
Q 003384 611 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNL 689 (824)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~~~~~~~~~ 689 (824)
............ ....+..+||..||+||.+.+..|+.++||||||+||+|+++ =..+|. ..+.+..+
T Consensus 404 ts~~~~~~~~~~--~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e---------r~~t~~d~ 472 (516)
T KOG1033|consen 404 TSQDKDETVAPA--AASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE---------RIATLTDI 472 (516)
T ss_pred eecccCCcccch--hhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH---------HHHhhhhh
Confidence 866555421111 112356789999999999999999999999999999999998 333331 11111121
Q ss_pred cCCCCCCCChhhHHHHHHHHHHHhhhccCCCCCh
Q 003384 690 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 723 (824)
Q Consensus 690 ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 723 (824)
-+...++......+.-..|+.+++.+.|.+||+.
T Consensus 473 r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~ 506 (516)
T KOG1033|consen 473 RDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSA 506 (516)
T ss_pred hcCCCChHHhhcCcHHHHHHHHhcCCCcccCchH
Confidence 1111110011112355689999999999999954
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.7e-16 Score=159.19 Aligned_cols=136 Identities=20% Similarity=0.179 Sum_probs=107.2
Q ss_pred CCCccceeeecCceEEEEEEEC-CeEEEEEEecCCCCC----------------------CchhHHHHHHHHHhcCCC--
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQ----------------------GPSEFQQEIDILSKIRHP-- 519 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~-~~~VAvK~l~~~~~~----------------------~~~~f~~Ei~iL~~l~Hp-- 519 (824)
.|...+.||+|+||.||+|... +..||||++...... ....+..|+.++..+.|+
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 4677788999999999999874 789999987653210 011256789999999877
Q ss_pred ceeeEecccCCceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCC
Q 003384 520 NLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN 599 (824)
Q Consensus 520 nIv~L~g~~~~~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~ 599 (824)
.+...++. ...++||||++|++|...... .....++.+++.++.++|. .||+||||||.||+++.+
T Consensus 96 ~v~~~~~~--~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~p~Nill~~~ 161 (198)
T cd05144 96 PVPKPIDW--NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYK---HGIIHGDLSEFNILVDDD 161 (198)
T ss_pred CCCceeec--CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHH---CCCCcCCCCcccEEEcCC
Confidence 44555543 345899999999999775420 2346788999999999999 899999999999999999
Q ss_pred Ccceeeccccccccc
Q 003384 600 FVSKLSDFGISRFLS 614 (824)
Q Consensus 600 ~~vKL~DFGla~~~~ 614 (824)
+.++|+|||++....
T Consensus 162 ~~~~liDfg~~~~~~ 176 (198)
T cd05144 162 EKIYIIDWPQMVSTD 176 (198)
T ss_pred CcEEEEECCccccCC
Confidence 999999999986443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.61 E-value=4.7e-15 Score=142.04 Aligned_cols=132 Identities=20% Similarity=0.278 Sum_probs=112.3
Q ss_pred cceeeecCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhcCC--CceeeEecccCC--ceEEEEEecCCCCh
Q 003384 469 SLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRH--PNLVTLVGACPE--VWTLVYEYLPNGSL 544 (824)
Q Consensus 469 ~~~LG~G~fG~Vykg~~~~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~H--pnIv~L~g~~~~--~~~LV~Ey~~ggsL 544 (824)
.+.||.|+++.||++...+..+++|....... ...+..|+.++..+.| ++++++++++.. ..+++|||++|+++
T Consensus 3 ~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~ 80 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKDEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL 80 (155)
T ss_pred ceecccccccceEEEEecCCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence 45799999999999999888999999865432 4579999999999976 588888887743 68999999998877
Q ss_pred hhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccc
Q 003384 545 EDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 612 (824)
Q Consensus 545 ~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~ 612 (824)
..+ +......++.+++.+|.+||.....+++|+||+|.|||++.++.++++|||++..
T Consensus 81 ~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 81 DEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 543 4467778899999999999997656899999999999999989999999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.53 E-value=4.6e-14 Score=148.97 Aligned_cols=132 Identities=20% Similarity=0.218 Sum_probs=103.7
Q ss_pred ceee-ecCceEEEEEEECCeEEEEEEecCCCC-------------CCchhHHHHHHHHHhcCCCce--eeEecccCC---
Q 003384 470 LKIG-EGGYGSIYKGLLRHMQVAIKMLHPHSL-------------QGPSEFQQEIDILSKIRHPNL--VTLVGACPE--- 530 (824)
Q Consensus 470 ~~LG-~G~fG~Vykg~~~~~~VAvK~l~~~~~-------------~~~~~f~~Ei~iL~~l~HpnI--v~L~g~~~~--- 530 (824)
..|| .||.|+||.+...+..++||.+..... .....+.+|+.++..|.|++| +..++++..
T Consensus 37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~ 116 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG 116 (239)
T ss_pred ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence 4688 899999999988889999998853210 122457889999999998875 666665421
Q ss_pred ---ceEEEEEecCC-CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeec
Q 003384 531 ---VWTLVYEYLPN-GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSD 606 (824)
Q Consensus 531 ---~~~LV~Ey~~g-gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~D 606 (824)
..++||||++| .+|.+++.. .+++.. .+.+++.+|.+||. +||+||||||.|||++.++.++|+|
T Consensus 117 ~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v~LID 185 (239)
T PRK01723 117 LFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKFWLID 185 (239)
T ss_pred cceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCEEEEE
Confidence 23599999997 689888742 234443 35689999999999 8999999999999999999999999
Q ss_pred cccccc
Q 003384 607 FGISRF 612 (824)
Q Consensus 607 FGla~~ 612 (824)
||.+..
T Consensus 186 fg~~~~ 191 (239)
T PRK01723 186 FDRGEL 191 (239)
T ss_pred CCCccc
Confidence 998764
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.53 E-value=3.1e-14 Score=143.76 Aligned_cols=137 Identities=18% Similarity=0.189 Sum_probs=96.4
Q ss_pred cceeeecCceEEEEEEEC-CeEEEEEEecCCCCCC--chh----------------------HHHHHHHHHhcCCCc--e
Q 003384 469 SLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQG--PSE----------------------FQQEIDILSKIRHPN--L 521 (824)
Q Consensus 469 ~~~LG~G~fG~Vykg~~~-~~~VAvK~l~~~~~~~--~~~----------------------f~~Ei~iL~~l~Hpn--I 521 (824)
.+.||+|+||.||+|... +..||||++....... ... ...|...+..+.+.+ +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 357999999999999887 7899999987542211 111 135666666664432 4
Q ss_pred eeEecccCCceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCc
Q 003384 522 VTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV 601 (824)
Q Consensus 522 v~L~g~~~~~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~ 601 (824)
.+.+++ ...++||||++|+++........ ... .....++.+++.++.++|.. .+|+||||||+||+++ ++.
T Consensus 82 ~~~~~~--~~~~lv~e~~~g~~~~~~~l~~~---~~~-~~~~~~~~~~~~~l~~lh~~--~~ivH~Dl~p~Nili~-~~~ 152 (187)
T cd05119 82 PKPIDL--NRHVLVMEFIGGDGIPAPRLKDV---RLL-EDPEELYDQILELMRKLYRE--AGLVHGDLSEYNILVD-DGK 152 (187)
T ss_pred CceEec--CCCEEEEEEeCCCCccChhhhhh---hhc-ccHHHHHHHHHHHHHHHhhc--cCcCcCCCChhhEEEE-CCc
Confidence 444443 24589999999965432111000 011 46778899999999999973 4799999999999999 899
Q ss_pred ceeeccccccccc
Q 003384 602 SKLSDFGISRFLS 614 (824)
Q Consensus 602 vKL~DFGla~~~~ 614 (824)
++|+|||.+....
T Consensus 153 ~~liDfg~a~~~~ 165 (187)
T cd05119 153 VYIIDVPQAVEID 165 (187)
T ss_pred EEEEECccccccc
Confidence 9999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.45 E-value=9.5e-15 Score=172.38 Aligned_cols=244 Identities=26% Similarity=0.372 Sum_probs=178.1
Q ss_pred CCCCccceeeecCceEEEEEEEC---CeEEEEEEecCCC--CCCchhHHHHHHHHHhcC-CCceeeEeccc--CCceEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR---HMQVAIKMLHPHS--LQGPSEFQQEIDILSKIR-HPNLVTLVGAC--PEVWTLV 535 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~---~~~VAvK~l~~~~--~~~~~~f~~Ei~iL~~l~-HpnIv~L~g~~--~~~~~LV 535 (824)
..|...+.||+|+|+.|-..... ...+|+|.+.... .........|..+-..+. |+|++.+++.. .+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 35777788999999999766543 3457777665443 222334556888888887 99999999987 4567899
Q ss_pred EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHh-hcCCCceEeccccCCcEEecCCC-cceeecccccccc
Q 003384 536 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH-SCKPHSIVHGDLKPANILLDANF-VSKLSDFGISRFL 613 (824)
Q Consensus 536 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH-~~~~~giiHrDLKp~NILld~~~-~vKL~DFGla~~~ 613 (824)
++|..||++.+.+... .....+....-.++.++..+|.|+| . .++.||||||+|.+++.++ .+|++|||+|..+
T Consensus 100 ~~~s~g~~~f~~i~~~-~~~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHP-DSTGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cCcccccccccccccC-CccCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhccc
Confidence 9999999998887311 1113444566788999999999999 6 7899999999999999999 9999999999877
Q ss_pred cc-ccccCCCccccccCCCCC-CcccCChhhhccC-CCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhcccccc
Q 003384 614 SQ-NEISSNNTTLCCRTDPKG-TFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLL 690 (824)
Q Consensus 614 ~~-~~~~~~~~~~~~~~~~~G-T~~Y~APE~l~~~-~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~l 690 (824)
.. .+.... .....| ++.|+|||.+.+. ...+..|+||.|+++.-+++|..|+....... +....+.
T Consensus 176 ~~~~g~~~~------~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~-----~~~~~~~ 244 (601)
T KOG0590|consen 176 RNKNGAERS------LKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD-----GRYSSWK 244 (601)
T ss_pred cccCCccee------eecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc-----ccceeec
Confidence 65 321111 133457 9999999999885 45677899999999999999999986543221 1111111
Q ss_pred CC----CCCCCChhhHHHHHHHHHHHhhhccCCCCCh
Q 003384 691 DP----LAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 723 (824)
Q Consensus 691 d~----~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 723 (824)
.. ....| ........+++..++..+|..|.+.
T Consensus 245 ~~~~~~~~~~~-~~~~~~~~~~l~k~l~~~~~~r~s~ 280 (601)
T KOG0590|consen 245 SNKGRFTQLPW-NSISDQAHDLLHKILKENPSNRLSI 280 (601)
T ss_pred ccccccccCcc-ccCChhhhhcccccccCCchhcccc
Confidence 11 01111 2334567788888888999999987
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.35 E-value=2.8e-12 Score=127.08 Aligned_cols=129 Identities=18% Similarity=0.144 Sum_probs=99.1
Q ss_pred ceeeecCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCce-eeEecccCCceEEEEEecCCCChhhhh
Q 003384 470 LKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNL-VTLVGACPEVWTLVYEYLPNGSLEDRL 548 (824)
Q Consensus 470 ~~LG~G~fG~Vykg~~~~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnI-v~L~g~~~~~~~LV~Ey~~ggsL~~~L 548 (824)
+.|+.|.++.||++...+..|++|+...... ....+..|+.++..+.+.++ .++++.+....++||||++|.++.+..
T Consensus 4 ~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~~~~lv~e~i~G~~l~~~~ 82 (170)
T cd05151 4 SPLKGGMTNKNYRVEVANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDPETGVLITEFIEGSELLTED 82 (170)
T ss_pred eecCCcccCceEEEEECCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeCCCCeEEEEecCCCcccccc
Confidence 4689999999999999899999998765432 22357899999999865444 456666665678999999998876431
Q ss_pred hccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CCceEeccccCCcEEecCCCcceeecccccc
Q 003384 549 SCKDNSPPLSWQTRIRIATELCSVLIFLHSCK--PHSIVHGDLKPANILLDANFVSKLSDFGISR 611 (824)
Q Consensus 549 ~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~--~~giiHrDLKp~NILld~~~~vKL~DFGla~ 611 (824)
. ....++.+++.+|..||... +.+++|+|++|.||+++ ++.++++|||.+.
T Consensus 83 --------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 83 --------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred --------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 0 11345678999999999943 23469999999999999 6689999999765
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.32 E-value=3.3e-12 Score=146.32 Aligned_cols=137 Identities=23% Similarity=0.284 Sum_probs=96.4
Q ss_pred ceeeecCceEEEEEEEC-CeEEEEEEecCCCCCC--------------------------c--------------hhHHH
Q 003384 470 LKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQG--------------------------P--------------SEFQQ 508 (824)
Q Consensus 470 ~~LG~G~fG~Vykg~~~-~~~VAvK~l~~~~~~~--------------------------~--------------~~f~~ 508 (824)
..||.|++|.||+|++. |..||||+.++..... . -.|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 57999999999999885 7899999987642110 0 02445
Q ss_pred HHHHHHhcC-----CCce--eeEecccCCceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHH-HHHHHhhcC
Q 003384 509 EIDILSKIR-----HPNL--VTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCS-VLIFLHSCK 580 (824)
Q Consensus 509 Ei~iL~~l~-----HpnI--v~L~g~~~~~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~-aL~~LH~~~ 580 (824)
|...+.++. +++| .+++..+....+|||||++|++|.+++..... .+ .+..++..++. .+..+|.
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~-- 275 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLR-- 275 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHh--
Confidence 665555552 3332 23333333457899999999999887642211 12 23456666655 4667777
Q ss_pred CCceEeccccCCcEEecCCCcceeeccccccccc
Q 003384 581 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 614 (824)
Q Consensus 581 ~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~ 614 (824)
.|++|+|++|.||+++.++.++|+|||++..+.
T Consensus 276 -~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 276 -DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred -CCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 899999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.8e-12 Score=136.56 Aligned_cols=209 Identities=23% Similarity=0.323 Sum_probs=143.9
Q ss_pred HHHHHHHHhcCCCceeeEecccCC-------ceEEEEEecCCCChhhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHhh
Q 003384 507 QQEIDILSKIRHPNLVTLVGACPE-------VWTLVYEYLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHS 578 (824)
Q Consensus 507 ~~Ei~iL~~l~HpnIv~L~g~~~~-------~~~LV~Ey~~ggsL~~~L~~~-~~~~~l~~~~~~~ia~qia~aL~~LH~ 578 (824)
..-..-|-++.|.|||+++.++.+ ...++.||+..|+|..+|... .....+......+|+.||..||.|||+
T Consensus 115 ~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs 194 (458)
T KOG1266|consen 115 RAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS 194 (458)
T ss_pred HHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc
Confidence 334455667789999999998843 345889999999999999653 345567788888999999999999999
Q ss_pred cCCCceEeccccCCcEEecCCCcceeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHH
Q 003384 579 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFG 658 (824)
Q Consensus 579 ~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlG 658 (824)
+.| +|+|+++..+-|++..+|-+||+--.-.. .. ..........+....|-++|.+||+-.....+.++|||+||
T Consensus 195 ~~P-piihgnlTc~tifiq~ngLIkig~~ap~s-~h---~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fg 269 (458)
T KOG1266|consen 195 CDP-PIIHGNLTCDTIFIQHNGLIKIGSVAPDS-TH---PSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFG 269 (458)
T ss_pred cCC-ccccCCcchhheeecCCceEEecccCccc-cc---hhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhh
Confidence 885 89999999999999999998875322111 00 01111111222345678999999997777788899999999
Q ss_pred HHHHHHHhCCCCC-CCchHHHHHHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHH
Q 003384 659 IILLRLLTGRPAL-GITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRV 730 (824)
Q Consensus 659 vvL~ELltG~~Pf-~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~ 730 (824)
+..++|..|..-- .....+.. .. .....+-.+ ....-+.++..|++..|..||+++..++..
T Consensus 270 mcAlemailEiq~tnseS~~~~--ee-~ia~~i~~l-------en~lqr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 270 MCALEMAILEIQSTNSESKVEV--EE-NIANVIIGL-------ENGLQRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred HHHHHHHHheeccCCCcceeeh--hh-hhhhheeec-------cCccccCcCcccccCCCCCCcchhhhhcCc
Confidence 9999999876432 11111110 00 011111001 111235677899999999999997666443
|
|
| >cd01989 STK_N The N-terminal domain of Eukaryotic Serine Threonine kinases | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.2e-10 Score=112.91 Aligned_cols=96 Identities=33% Similarity=0.560 Sum_probs=81.9
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHhhcCeeeEEEEeecCchHHHHHHHHHHcCCCEEEeccCcCccchhhhcccchhhHH
Q 003384 38 KVQAYREIERQDMHNHLDMCLLICRQMGVRAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAI 117 (824)
Q Consensus 38 ~v~~~~~~e~~~~~~~l~~~~~~C~~~~V~~~~~~ie~~dv~~~i~e~i~~~~i~~LV~Ga~~~~~~~~~~~~~~s~~a~ 117 (824)
....+..+.+++.+++|+++...|...+++++..+++.++++++|++++.+++++.+|||++..+...+.. +.|.-|.
T Consensus 51 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~g~~~~~~I~~~a~~~~~dlIV~Gs~g~~~l~~~~--~gssva~ 128 (146)
T cd01989 51 VASAYKQEEDKEAKELLLPYRCFCSRKGVQCEDVVLEDDDVAKAIVEYVADHGITKLVMGASSDNHFSMKF--KKSDVAS 128 (146)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHhhcCCeEEEEEEeCCcHHHHHHHHHHHcCCCEEEEeccCCCceeecc--cCCchhH
Confidence 34567777888899999999999999999999999998899999999999999999999999444443332 2234677
Q ss_pred hhhccCCCccEEEEEecC
Q 003384 118 SVRQQAPASCHIWFICNG 135 (824)
Q Consensus 118 ~v~~~a~~~C~v~~i~~g 135 (824)
.|++++|++|.|.+|++|
T Consensus 129 ~Vi~~a~~~c~Vlvv~~~ 146 (146)
T cd01989 129 SVLKEAPDFCTVYVVSKG 146 (146)
T ss_pred HHHhcCCCCceEEEEeCc
Confidence 999999999999999998
|
The Serine Threonine kinases are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. The N-terminal domain is homologous to the USP family which has a ATP binding fold. The N-terminal domain is predicted to be involved in ATP binding. |
| >smart00504 Ubox Modified RING finger domain | Back alignment and domain information |
|---|
Probab=99.16 E-value=2.1e-11 Score=101.23 Aligned_cols=63 Identities=57% Similarity=0.993 Sum_probs=60.4
Q ss_pred CCcccchhhhccCCccccCCccchhhhhhhhhcCCCCCCCCCCCCCCCCCCCchHHHHHHHHHH
Q 003384 757 YFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEW 820 (824)
Q Consensus 757 ~f~cPi~~evm~dPvi~~~g~tye~~~i~~wl~~~~~t~p~t~~~l~~~~l~pn~~lr~~i~~~ 820 (824)
+|.|||+.++|.||+++..|++|++..|.+|+.. +.+||+|+.++...+|+||.+||++|++|
T Consensus 1 ~~~Cpi~~~~~~~Pv~~~~G~v~~~~~i~~~~~~-~~~cP~~~~~~~~~~l~~~~~l~~~i~~~ 63 (63)
T smart00504 1 EFLCPISLEVMKDPVILPSGQTYERRAIEKWLLS-HGTDPVTGQPLTHEDLIPNLALKSAIQEW 63 (63)
T ss_pred CcCCcCCCCcCCCCEECCCCCEEeHHHHHHHHHH-CCCCCCCcCCCChhhceeCHHHHHHHHhC
Confidence 4789999999999999999999999999999988 77999999999999999999999999998
|
Modified RING finger domain, without the full complement of Zn2+-binding ligands. Probable involvement in E2-dependent ubiquitination. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.14 E-value=2.6e-11 Score=144.09 Aligned_cols=251 Identities=22% Similarity=0.221 Sum_probs=169.3
Q ss_pred CCCCccceeeecCceEEEEEEECC--eEEEEEEecCCC---CCCchhHHHHHHHHHhcCCCceeeEecc--cCCceEEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHS---LQGPSEFQQEIDILSKIRHPNLVTLVGA--CPEVWTLVY 536 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~~--~~VAvK~l~~~~---~~~~~~f~~Ei~iL~~l~HpnIv~L~g~--~~~~~~LV~ 536 (824)
..|.+.+-+-.|.||.++.+.-.+ ...++|+..... ....+....+-.++-.-++|-++..+.. |....+||+
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~ 883 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVG 883 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhh
Confidence 345666678889999998765432 334444332211 1112233444444444456777777666 566789999
Q ss_pred EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccc
Q 003384 537 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 616 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 616 (824)
+|+.|++|...|+.. +..+..........+..++++||. ..++|+|++|.|+|...+|+.+++|||+.......
T Consensus 884 ~~~~~~~~~Skl~~~---~~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~ 957 (1205)
T KOG0606|consen 884 HYLNGGDLPSKLHNS---GCLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI 957 (1205)
T ss_pred HHhccCCchhhhhcC---CCcccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCccccccccccc
Confidence 999999999988533 345544555566778889999999 56899999999999999999999999944322110
Q ss_pred ----cc----c-------------CCCcc--ccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCC
Q 003384 617 ----EI----S-------------SNNTT--LCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGI 673 (824)
Q Consensus 617 ----~~----~-------------~~~~~--~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~ 673 (824)
.. . ..... ........||+.|.+||.+.+...+..+|+|++|++++|.++|.+||..
T Consensus 958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen 958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence 00 0 00000 0112456799999999999999999999999999999999999999976
Q ss_pred chHHHHHHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChH
Q 003384 674 TKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 674 ~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
...-+.. .+ +... +.....-+...+....+++.+.+..+|.+|-.+.
T Consensus 1038 ~tpq~~f--~n-i~~~-~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1038 ETPQQIF--EN-ILNR-DIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred cchhhhh--hc-cccC-CCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 5432221 11 1111 1112223444567889999999999999998873
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.11 E-value=6.4e-10 Score=114.69 Aligned_cols=139 Identities=22% Similarity=0.324 Sum_probs=109.0
Q ss_pred ceeeecCceEEEEEEECC-eEEEEEEecCCCC-CCchhHHHHHHHHHhcCC--CceeeEecccCC-----ceEEEEEecC
Q 003384 470 LKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSL-QGPSEFQQEIDILSKIRH--PNLVTLVGACPE-----VWTLVYEYLP 540 (824)
Q Consensus 470 ~~LG~G~fG~Vykg~~~~-~~VAvK~l~~~~~-~~~~~f~~Ei~iL~~l~H--pnIv~L~g~~~~-----~~~LV~Ey~~ 540 (824)
..||.|.++.||++...+ ..+++|+...... .....+..|+.++..+.+ .++.++++++.+ ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 468999999999998876 8899999765432 134578999999999975 345667777644 4589999999
Q ss_pred CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC----------------------------------------
Q 003384 541 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK---------------------------------------- 580 (824)
Q Consensus 541 ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~---------------------------------------- 580 (824)
|.+|.+.+.. ..++...+..++.+++.+|..||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9988776521 34677788888889999999998531
Q ss_pred -------------CCceEeccccCCcEEecC--CCcceeeccccccc
Q 003384 581 -------------PHSIVHGDLKPANILLDA--NFVSKLSDFGISRF 612 (824)
Q Consensus 581 -------------~~giiHrDLKp~NILld~--~~~vKL~DFGla~~ 612 (824)
+..++|+|+.|.|||++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 246799999999999998 66789999997653
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.10 E-value=8.8e-11 Score=133.64 Aligned_cols=242 Identities=25% Similarity=0.274 Sum_probs=169.2
Q ss_pred CCCccceeee--cCceEEEEEEE--C--CeEEEEEEecCC--CCCCchhHHHHHHHHHhcC-CCceeeEecccCC--ceE
Q 003384 465 NFDPSLKIGE--GGYGSIYKGLL--R--HMQVAIKMLHPH--SLQGPSEFQQEIDILSKIR-HPNLVTLVGACPE--VWT 533 (824)
Q Consensus 465 ~f~~~~~LG~--G~fG~Vykg~~--~--~~~VAvK~l~~~--~~~~~~~f~~Ei~iL~~l~-HpnIv~L~g~~~~--~~~ 533 (824)
.|.....+|. |.+|.||.+.. . ...+|+|.-+.. .......=.+|+....+++ |+|.++.+..+.. ..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4566677999 99999999887 3 367898874332 2223333456777777774 9999997777743 456
Q ss_pred EEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHH----HHHHHhhcCCCceEeccccCCcEEecCC-Ccceeeccc
Q 003384 534 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCS----VLIFLHSCKPHSIVHGDLKPANILLDAN-FVSKLSDFG 608 (824)
Q Consensus 534 LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~----aL~~LH~~~~~giiHrDLKp~NILld~~-~~vKL~DFG 608 (824)
+-.|++ +.+|..+.+... ..++....+.+..+... ||.++|. .+++|-|+||.||++..+ ...+++|||
T Consensus 195 iqtE~~-~~sl~~~~~~~~--~~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 195 IQTELC-GESLQSYCHTPC--NFLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred eeeccc-cchhHHhhhccc--ccCCchhhhhHHhhhhhcccccccccCC---CcccccccchhheecccccceeecCCcc
Confidence 667777 578877775332 23555666777777777 9999999 789999999999999998 789999999
Q ss_pred cccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCc-hHHHHHHhhhccc
Q 003384 609 ISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGIT-KEVQYALDTGKLK 687 (824)
Q Consensus 609 la~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~-~~~~~~~~~~~~~ 687 (824)
+...+........... .....|...|++||.+. +-++...|+|++|.++++-.+|..+.... ...+..++.+
T Consensus 269 ~v~~i~~~~~~~~~~~---~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~--- 341 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKV---SKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG--- 341 (524)
T ss_pred eeEEccCCccccceee---eecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc---
Confidence 9998877664433221 13446888999999864 56788999999999999999987655322 1111111111
Q ss_pred cccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCCh
Q 003384 688 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 723 (824)
Q Consensus 688 ~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 723 (824)
+.+ .++-......+...+.++++.+|..|++.
T Consensus 342 --~ip--~e~~~~~s~~l~~~~~~~~d~~~~~~~~~ 373 (524)
T KOG0601|consen 342 --YIP--LEFCEGGSSSLRSVTSQMLDEDPRLRLTA 373 (524)
T ss_pred --cCc--hhhhcCcchhhhhHHHHhcCcchhhhhHH
Confidence 111 11222234456668899999999998886
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.10 E-value=5.9e-10 Score=110.52 Aligned_cols=128 Identities=28% Similarity=0.397 Sum_probs=101.5
Q ss_pred eeeecCceEEEEEEECCeEEEEEEecCCCCCCc--------hhHHHHHHHHHhcCC--CceeeEecccCCceEEEEEecC
Q 003384 471 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGP--------SEFQQEIDILSKIRH--PNLVTLVGACPEVWTLVYEYLP 540 (824)
Q Consensus 471 ~LG~G~fG~Vykg~~~~~~VAvK~l~~~~~~~~--------~~f~~Ei~iL~~l~H--pnIv~L~g~~~~~~~LV~Ey~~ 540 (824)
.|++|+-+.+|.+.+.+.++++|.-.+.....+ ..-.+|..+|.+++- -+...++++.++...|+|||++
T Consensus 3 ~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~ 82 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIE 82 (204)
T ss_pred hhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeC
Confidence 588999999999988887888886554433322 235679999998853 3445567777788889999999
Q ss_pred CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccc
Q 003384 541 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 612 (824)
Q Consensus 541 ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~ 612 (824)
|..|.+.+... ...++..+-.-+.-||. .||||+||.++||++..+. +.++||||+.+
T Consensus 83 G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 83 GELLKDALEEA----------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred ChhHHHHHHhc----------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999888422 35677788888999999 8999999999999998765 89999999874
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.09 E-value=2.1e-10 Score=133.42 Aligned_cols=144 Identities=19% Similarity=0.269 Sum_probs=90.1
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC--------------------------Cc--------h----
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--------------------------GP--------S---- 504 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~--------------------------~~--------~---- 504 (824)
.|+. ..||.|++|.||+|+++ |+.||||+.++.... +. +
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 4565 67999999999999885 689999999864210 00 0
Q ss_pred --hHHHHHHHHHhcC----CCcee---eEecccCCceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHH
Q 003384 505 --EFQQEIDILSKIR----HPNLV---TLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIF 575 (824)
Q Consensus 505 --~f~~Ei~iL~~l~----HpnIv---~L~g~~~~~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~ 575 (824)
.|.+|+..+.++. +.+.+ ++|.-+....+|||||+.|+.|.++-.-... ..+. ..++...+. .|
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~--g~d~---~~la~~~v~--~~ 272 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAA--GTDM---KLLAERGVE--VF 272 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhc--CCCH---HHHHHHHHH--HH
Confidence 1344554444442 33222 2333223456799999999999774211111 1111 112222221 12
Q ss_pred HhhcCCCceEeccccCCcEEecCCC----cceeeccccccccccc
Q 003384 576 LHSCKPHSIVHGDLKPANILLDANF----VSKLSDFGISRFLSQN 616 (824)
Q Consensus 576 LH~~~~~giiHrDLKp~NILld~~~----~vKL~DFGla~~~~~~ 616 (824)
+++....|++|+|++|.||+++.+| .++++|||++..+...
T Consensus 273 ~~Qif~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 273 FTQVFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred HHHHHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 2222227899999999999999888 9999999999877543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.1e-09 Score=111.67 Aligned_cols=134 Identities=16% Similarity=0.142 Sum_probs=95.9
Q ss_pred ceeeecCceEEEEEEEC--------CeEEEEEEecCCCC--C-------------------C-chhHH----HHHHHHHh
Q 003384 470 LKIGEGGYGSIYKGLLR--------HMQVAIKMLHPHSL--Q-------------------G-PSEFQ----QEIDILSK 515 (824)
Q Consensus 470 ~~LG~G~fG~Vykg~~~--------~~~VAvK~l~~~~~--~-------------------~-~~~f~----~Ei~iL~~ 515 (824)
..||.|--+.||.|... +..+|||+.+.... . + ...+. +|+..|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 35899999999999754 26899999754210 0 0 11233 79999999
Q ss_pred cCC--CceeeEecccCCceEEEEEecCCCChhh-hhhccCCCCCCCHHHHHHHHHHHHHHHHHH-hhcCCCceEeccccC
Q 003384 516 IRH--PNLVTLVGACPEVWTLVYEYLPNGSLED-RLSCKDNSPPLSWQTRIRIATELCSVLIFL-HSCKPHSIVHGDLKP 591 (824)
Q Consensus 516 l~H--pnIv~L~g~~~~~~~LV~Ey~~ggsL~~-~L~~~~~~~~l~~~~~~~ia~qia~aL~~L-H~~~~~giiHrDLKp 591 (824)
+.. -++.+++++ ...+|||||+.++.+.. .|. ...++......+..+++.+|..| |. .|||||||++
T Consensus 83 l~~~Gv~vP~pi~~--~~~~lvME~Ig~~~~~~~~Lk----d~~~~~~~~~~i~~~i~~~l~~l~H~---~glVHGDLs~ 153 (197)
T cd05146 83 MQKAGIPCPEVVVL--KKHVLVMSFIGDDQVPAPKLK----DAKLNDEEMKNAYYQVLSMMKQLYKE---CNLVHADLSE 153 (197)
T ss_pred HHHcCCCCCeEEEe--cCCEEEEEEcCCCCccchhhh----ccccCHHHHHHHHHHHHHHHHHHHHh---CCeecCCCCH
Confidence 853 455556654 56789999997654422 221 12344456677889999999988 77 7899999999
Q ss_pred CcEEecCCCcceeecccccccc
Q 003384 592 ANILLDANFVSKLSDFGISRFL 613 (824)
Q Consensus 592 ~NILld~~~~vKL~DFGla~~~ 613 (824)
.|||++ ++.++|+|||.+-..
T Consensus 154 ~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 154 YNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred HHEEEE-CCcEEEEECCCceeC
Confidence 999997 467999999987644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.98 E-value=4.8e-09 Score=103.64 Aligned_cols=141 Identities=21% Similarity=0.245 Sum_probs=102.5
Q ss_pred ccceeeecCceEEEEEEECCeEEEEEEecCCCCCC--------chhHHHHHHHHHhcCCCc--eeeEecccCCceEEEEE
Q 003384 468 PSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQG--------PSEFQQEIDILSKIRHPN--LVTLVGACPEVWTLVYE 537 (824)
Q Consensus 468 ~~~~LG~G~fG~Vykg~~~~~~VAvK~l~~~~~~~--------~~~f~~Ei~iL~~l~Hpn--Iv~L~g~~~~~~~LV~E 537 (824)
....|-+|+-+.|+++.+.|..+.||.-....... .....+|+.+|.++.--. ..+++-+-.....|+||
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 45679999999999999999998888654332222 234678999999886322 23333333456789999
Q ss_pred ecCC-CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCC---cceeeccccccc
Q 003384 538 YLPN-GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF---VSKLSDFGISRF 612 (824)
Q Consensus 538 y~~g-gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~---~vKL~DFGla~~ 612 (824)
|++| .++.+++......... ......++..|-+.|.-||. ++||||||..+||+|..++ .+.++|||++..
T Consensus 91 ~~~g~~~vk~~i~~~~~~~~~-d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMEDESE-DEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred eccchhHHHHHHHHHccCccc-chhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 9987 3777777544333222 23346788899999999999 8899999999999996544 458999999753
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.96 E-value=5.3e-10 Score=127.37 Aligned_cols=235 Identities=24% Similarity=0.252 Sum_probs=163.6
Q ss_pred hcCCCCccceeeecCceEEEEEEEC---CeEEEEEEecCCCCCCchhH--HHHHHHHHhc-CCCceeeEeccc--CCceE
Q 003384 462 ATHNFDPSLKIGEGGYGSIYKGLLR---HMQVAIKMLHPHSLQGPSEF--QQEIDILSKI-RHPNLVTLVGAC--PEVWT 533 (824)
Q Consensus 462 ~~~~f~~~~~LG~G~fG~Vykg~~~---~~~VAvK~l~~~~~~~~~~f--~~Ei~iL~~l-~HpnIv~L~g~~--~~~~~ 533 (824)
.+.+|..+..||.|.|+.||+...+ +..+++|.+.........++ ..|+-+...+ -|.+++..+..+ .+..|
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 3557888999999999999987654 46788887765433322222 3466666665 488888877766 34677
Q ss_pred EEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCC-Ccceeeccccccc
Q 003384 534 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN-FVSKLSDFGISRF 612 (824)
Q Consensus 534 LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~-~~vKL~DFGla~~ 612 (824)
+=-|||.++++...+. ....+....++++..+++.++.++|+ +.++|+|+||+||++..+ +..+++|||+...
T Consensus 343 ip~e~~~~~s~~l~~~---~~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSV---TSQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred CchhhhcCcchhhhhH---HHHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhccccccccc
Confidence 8899999998876652 22346667788999999999999998 899999999999999886 7889999999864
Q ss_pred cccccccCCCccccccCCCCCCcccC--ChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhcccccc
Q 003384 613 LSQNEISSNNTTLCCRTDPKGTFAYM--DPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLL 690 (824)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~GT~~Y~--APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~l 690 (824)
+.-.. ....++-++. +|.......+..+.|++|||.-+.+.++|.+.-..... ...+.
T Consensus 417 ~~~~~-----------~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~---------~~~i~ 476 (524)
T KOG0601|consen 417 LAFSS-----------GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ---------SLTIR 476 (524)
T ss_pred cceec-----------ccccccccccccchhhccccccccccccccccccccccccCcccCccccc---------ceeee
Confidence 22111 1112333444 55555566788999999999999999999753321111 01111
Q ss_pred CCCCCCCChhhHHHHHHHHHHHhhhccCCCCCh
Q 003384 691 DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 723 (824)
Q Consensus 691 d~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 723 (824)
.......+..- ..+..+...+...++..||.+
T Consensus 477 ~~~~p~~~~~~-~~~q~~~kv~~~~~~~~~~l~ 508 (524)
T KOG0601|consen 477 SGDTPNLPGLK-LQLQVLLKVMINPDRKRRPSA 508 (524)
T ss_pred cccccCCCchH-HhhhhhhhhhcCCccccchhh
Confidence 11111122222 678888888889999999987
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.96 E-value=5.7e-09 Score=120.09 Aligned_cols=161 Identities=19% Similarity=0.232 Sum_probs=117.7
Q ss_pred CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccCC--ceEEEEEecCCCChhhhhhccCCCCCCCHHHHHH
Q 003384 487 HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIR 564 (824)
Q Consensus 487 ~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~~--~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ 564 (824)
+.+|.|...............+-+..|+.++||||++++..+.. ..|||.|-+. .|..+|.. ++......
T Consensus 37 ~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~v~~ 108 (690)
T KOG1243|consen 37 GGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEEVCL 108 (690)
T ss_pred CCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHHHHH
Confidence 56777777765544334557888999999999999999998854 5799999883 56666632 22345556
Q ss_pred HHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCCCccccccCCCCCCcccCChhhhc
Q 003384 565 IATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 644 (824)
Q Consensus 565 ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~ 644 (824)
.+.||+.||.|||.- .+++|++|.-+.|+++..|..||++|.++......... .. ...--..|..|+.+.
T Consensus 109 Gl~qIl~AL~FL~~d--~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~--~~------~~~~~~s~~~P~~~~ 178 (690)
T KOG1243|consen 109 GLFQILAALSFLNDD--CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAP--AK------SLYLIESFDDPEEID 178 (690)
T ss_pred HHHHHHHHHHHHhcc--CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc--cc------cchhhhcccChhhcC
Confidence 788999999999863 46999999999999999999999999988644322110 00 001122456666544
Q ss_pred cCCCCcchhHHhHHHHHHHHHhC
Q 003384 645 SGELTPKSDVYSFGIILLRLLTG 667 (824)
Q Consensus 645 ~~~~t~ksDVwSlGvvL~ELltG 667 (824)
... ...|.|-|||++++++.|
T Consensus 179 ~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 179 PSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred ccc--cchhhhhHHHHHHHHhCc
Confidence 332 346999999999999999
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.92 E-value=4.6e-08 Score=106.88 Aligned_cols=254 Identities=21% Similarity=0.295 Sum_probs=165.7
Q ss_pred CccceeeecCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhc-CCCceee--------EecccCC-ceEEEE
Q 003384 467 DPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVT--------LVGACPE-VWTLVY 536 (824)
Q Consensus 467 ~~~~~LG~G~fG~Vykg~~~~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l-~HpnIv~--------L~g~~~~-~~~LV~ 536 (824)
.++..||+||-+.+|.----+. .+.|+++..... .-.+-+..|... .||-+-. |+|.-.. ...+.|
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~d-~VAKIYh~Pppa---~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVRD-QVAKIYHAPPPA---AQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCCccccCCccceeeecchhhc-hhheeecCCCch---HHHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 4567799999999995322222 344777654322 112233334333 4554332 2333222 255677
Q ss_pred EecCCC-Chhhhhh---ccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccc
Q 003384 537 EYLPNG-SLEDRLS---CKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 612 (824)
Q Consensus 537 Ey~~gg-sL~~~L~---~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~ 612 (824)
..+.|. ....++. .+...+...|.-.++.+..++.+.+-||. .|.+-||+.++|+|+..++.+.|.|-..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEcccceee
Confidence 777664 2333332 23445678999999999999999999999 8999999999999999999999987542211
Q ss_pred cccccccCCCccccccCCCCCCcccCChhhhc-----cCCCCcchhHHhHHHHHHHHHhC-CCCCCCc-------hHHHH
Q 003384 613 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA-----SGELTPKSDVYSFGIILLRLLTG-RPALGIT-------KEVQY 679 (824)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~-----~~~~t~ksDVwSlGvvL~ELltG-~~Pf~~~-------~~~~~ 679 (824)
- .+... ....+|...|.+||... +..-+...|.|.|||++++++.| +.||.+. +..+.
T Consensus 167 ~------~ng~~---~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~ 237 (637)
T COG4248 167 N------ANGTL---HLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET 237 (637)
T ss_pred c------cCCce---EecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh
Confidence 1 11111 13467999999999764 33456789999999999999986 9999643 22233
Q ss_pred HHhhhcccccc------CCCCCCCChh-hHHHHHHHHHHHhhhc--cCCCCChHHHHHHHHHHHHhh
Q 003384 680 ALDTGKLKNLL------DPLAGDWPFV-QAEQLANLAMRCCEMS--RKSRPELGKDVWRVLEPMRAS 737 (824)
Q Consensus 680 ~~~~~~~~~~l------d~~~~~~p~~-~~~~l~~Li~~Cl~~~--P~~RPt~~~~v~~~Le~l~~~ 737 (824)
.+..|.+...- .+....||.. .+..+..|..+|+... +.-||+. +..+..|..+++.
T Consensus 238 ~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a-~aW~aAl~al~~~ 303 (637)
T COG4248 238 DIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTA-KAWVAALDALRQQ 303 (637)
T ss_pred hhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCH-HHHHHHHHHHHHh
Confidence 34444433222 2334455544 3568899999999863 5689998 7787888777664
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.8e-07 Score=104.76 Aligned_cols=164 Identities=23% Similarity=0.303 Sum_probs=128.1
Q ss_pred eEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC------CceEEEEEecCC-CChhhhh
Q 003384 478 GSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP------EVWTLVYEYLPN-GSLEDRL 548 (824)
Q Consensus 478 G~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~------~~~~LV~Ey~~g-gsL~~~L 548 (824)
.+.||+... |..|++|+++............-+++++++.|+|||++..+|. ...++||+|.|+ ++|.++.
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 567888654 7889999997766666656667789999999999999987763 247899999886 4788766
Q ss_pred hccC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccc
Q 003384 549 SCKD------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 616 (824)
Q Consensus 549 ~~~~------------~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 616 (824)
+... .....++..++.++.|+..||.++|+ .|+..+-|.|.+||++.+..++|+..|+..++..+
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 4321 23356778999999999999999999 78999999999999999999999999987765443
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCC
Q 003384 617 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 669 (824)
Q Consensus 617 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~ 669 (824)
.. +-+.. -.+-|.=-||.+++.|.||..
T Consensus 447 ~~----------------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 447 PT----------------------EPLES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CC----------------------cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence 20 00111 125688899999999999964
|
|
| >KOG4642 consensus Chaperone-dependent E3 ubiquitin protein ligase (contains TPR repeats) [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.72 E-value=7.1e-09 Score=105.39 Aligned_cols=73 Identities=32% Similarity=0.587 Sum_probs=69.8
Q ss_pred CCCCCCCcccchhhhccCCccccCCccchhhhhhhhhcCCCCCCCCCCCCCCCCCCCchHHHHHHHHHHHHhC
Q 003384 752 CEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWLQQH 824 (824)
Q Consensus 752 ~~~P~~f~cPi~~evm~dPvi~~~g~tye~~~i~~wl~~~~~t~p~t~~~l~~~~l~pn~~lr~~i~~~~~~~ 824 (824)
.++|+|.+|.|+.++|++|||+++|.||+|..|.+++..-+-.+|.|+.+|...+++||.+|+..|..|+..|
T Consensus 206 rEvpd~lcgkIt~el~~~pvi~psgIty~ra~I~Ehl~rvghfdpvtr~~Lte~q~ipN~alkevIa~fl~~n 278 (284)
T KOG4642|consen 206 REVPDYLCGKITLELMREPVITPSGITYDRADIEEHLQRVGHFDPVTRWPLTEYQLIPNLALKEVIAAFLKEN 278 (284)
T ss_pred ccccchhhhhhhHHhhcCCccCccccchhHHHHHHHHHHhccCCchhcccCCHHhhccchHHHHHHHHHHHhc
Confidence 4789999999999999999999999999999999999998889999999999999999999999999998765
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.4e-07 Score=101.34 Aligned_cols=137 Identities=15% Similarity=0.070 Sum_probs=97.8
Q ss_pred eeeecCceEEEEEEECCeEEEEEEecCCCCC-----------CchhHHHHHHHHHhcCCCce--eeEeccc-------CC
Q 003384 471 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQ-----------GPSEFQQEIDILSKIRHPNL--VTLVGAC-------PE 530 (824)
Q Consensus 471 ~LG~G~fG~Vykg~~~~~~VAvK~l~~~~~~-----------~~~~f~~Ei~iL~~l~HpnI--v~L~g~~-------~~ 530 (824)
.+-......|+++.+.|..|.||........ ....+.+|...+.+|..-+| ..++++. ..
T Consensus 29 ~v~~~~~rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~ 108 (268)
T PRK15123 29 VFRELEGRRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR 108 (268)
T ss_pred EEecCCCceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence 3444444557788888889999977543311 11147899999988843222 2333332 12
Q ss_pred ceEEEEEecCCC-ChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecC-------CCcc
Q 003384 531 VWTLVYEYLPNG-SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA-------NFVS 602 (824)
Q Consensus 531 ~~~LV~Ey~~gg-sL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~-------~~~v 602 (824)
..+||+|++++. +|.+++.... ..+.+...+..++.+++..+.-||. .||+|+|+++.|||++. ++.+
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~~~~~ 184 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREEDLKL 184 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCCCceE
Confidence 367999999886 8998874221 2344556777899999999999999 89999999999999975 4688
Q ss_pred eeecccccc
Q 003384 603 KLSDFGISR 611 (824)
Q Consensus 603 KL~DFGla~ 611 (824)
.|+||+.+.
T Consensus 185 ~LIDl~r~~ 193 (268)
T PRK15123 185 SVIDLHRAQ 193 (268)
T ss_pred EEEECCccc
Confidence 999999875
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.67 E-value=8.3e-08 Score=97.48 Aligned_cols=124 Identities=23% Similarity=0.253 Sum_probs=78.6
Q ss_pred EEEEEEEC-CeEEEEEEecCCCCC---------------------Cc-----hhHHHHHHHHHhcCCC--ceeeEecccC
Q 003384 479 SIYKGLLR-HMQVAIKMLHPHSLQ---------------------GP-----SEFQQEIDILSKIRHP--NLVTLVGACP 529 (824)
Q Consensus 479 ~Vykg~~~-~~~VAvK~l~~~~~~---------------------~~-----~~f~~Ei~iL~~l~Hp--nIv~L~g~~~ 529 (824)
.||.|... +..+|||+.+..... .. ....+|.+.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999874 688999997642110 00 1256899999999755 456666542
Q ss_pred CceEEEEEecC--CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHH-HhhcCCCceEeccccCCcEEecCCCcceeec
Q 003384 530 EVWTLVYEYLP--NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIF-LHSCKPHSIVHGDLKPANILLDANFVSKLSD 606 (824)
Q Consensus 530 ~~~~LV~Ey~~--ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~-LH~~~~~giiHrDLKp~NILld~~~~vKL~D 606 (824)
..+|||||++ |..+..+.... ++......++.+++..+.. +|. .|||||||.+.|||++.+ .+.|+|
T Consensus 80 -~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~~iID 149 (188)
T PF01163_consen 80 -RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KVYIID 149 (188)
T ss_dssp -TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CEEE--
T ss_pred -CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eEEEEe
Confidence 4579999998 65554433211 1123455677777775555 567 799999999999999988 899999
Q ss_pred ccccccc
Q 003384 607 FGISRFL 613 (824)
Q Consensus 607 FGla~~~ 613 (824)
||.+...
T Consensus 150 f~qav~~ 156 (188)
T PF01163_consen 150 FGQAVDS 156 (188)
T ss_dssp GTTEEET
T ss_pred cCcceec
Confidence 9987643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.44 E-value=6.2e-08 Score=112.14 Aligned_cols=151 Identities=21% Similarity=0.287 Sum_probs=102.2
Q ss_pred HHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCCC-ccccccCCCCCCcccCChhhhccC
Q 003384 568 ELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN-TTLCCRTDPKGTFAYMDPEFLASG 646 (824)
Q Consensus 568 qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~-~~~~~~~~~~GT~~Y~APE~l~~~ 646 (824)
+++.||.|+|.. .++||++|.|++|.++.++.+||++|+++............ ......--..-...|.|||++.+.
T Consensus 107 ~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 455899999985 46999999999999999999999999998654331111100 000000111346689999999998
Q ss_pred CCCcchhHHhHHHHHHHHH-hCCCCCCCchHHHHHHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCCh
Q 003384 647 ELTPKSDVYSFGIILLRLL-TGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 723 (824)
Q Consensus 647 ~~t~ksDVwSlGvvL~ELl-tG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 723 (824)
..++++|+||+||++|.+. .|++-+...+........+. ..+.....+....+.++.+-+.+.+..+..-||++
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~---~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~ 259 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRN---LLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTL 259 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhc---ccccccccccccCcHHHHHHHHHHhcCCcccCcch
Confidence 8899999999999999999 56655543322211111111 11111112234556788999999999999999976
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.44 E-value=8.9e-07 Score=91.47 Aligned_cols=104 Identities=30% Similarity=0.342 Sum_probs=79.7
Q ss_pred chhHHHHHHHHHhcCCCc--eeeEecccC------CceEEEEEecCCC-ChhhhhhccCCCCCCCHHHHHHHHHHHHHHH
Q 003384 503 PSEFQQEIDILSKIRHPN--LVTLVGACP------EVWTLVYEYLPNG-SLEDRLSCKDNSPPLSWQTRIRIATELCSVL 573 (824)
Q Consensus 503 ~~~f~~Ei~iL~~l~Hpn--Iv~L~g~~~------~~~~LV~Ey~~gg-sL~~~L~~~~~~~~l~~~~~~~ia~qia~aL 573 (824)
.....+|...+..|..-+ +.+.+++.. ...+||+|++++. +|.+++.... .++......++.+++..+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~---~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE---QLDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc---ccchhhHHHHHHHHHHHH
Confidence 346888999888875322 233344332 2357999999985 8999885322 155567788999999999
Q ss_pred HHHhhcCCCceEeccccCCcEEecCCC---cceeeccccccc
Q 003384 574 IFLHSCKPHSIVHGDLKPANILLDANF---VSKLSDFGISRF 612 (824)
Q Consensus 574 ~~LH~~~~~giiHrDLKp~NILld~~~---~vKL~DFGla~~ 612 (824)
.-||. .||+|+|+++.|||++.++ .+.|+||+-++.
T Consensus 132 ~~lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 132 AKLHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999 8999999999999999877 899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.40 E-value=3.3e-06 Score=86.76 Aligned_cols=135 Identities=16% Similarity=0.133 Sum_probs=102.0
Q ss_pred eeecCceEEEEEEECCeEEEEEEecCCC------CCCchhHHHHHHHHHhcCCC--ceeeEecccC-------CceEEEE
Q 003384 472 IGEGGYGSIYKGLLRHMQVAIKMLHPHS------LQGPSEFQQEIDILSKIRHP--NLVTLVGACP-------EVWTLVY 536 (824)
Q Consensus 472 LG~G~fG~Vykg~~~~~~VAvK~l~~~~------~~~~~~f~~Ei~iL~~l~Hp--nIv~L~g~~~-------~~~~LV~ 536 (824)
-|+||.+-|++-.+.+..+-+|.-...- ......|.+|+..|.+|..- .+.+.+ ++. -..+||+
T Consensus 26 ~~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence 4779999999988888888888754221 12346799999999998532 244444 221 1357999
Q ss_pred EecCC-CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCc--ceeecccccc
Q 003384 537 EYLPN-GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV--SKLSDFGISR 611 (824)
Q Consensus 537 Ey~~g-gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~--vKL~DFGla~ 611 (824)
|-+.| -+|.+++... ...+.+...+..+..+++..|.-||. .|+.|+|+-+.|||++.++. ++++||.-++
T Consensus 105 e~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 98865 4888887432 22356777788999999999999999 89999999999999986666 9999999665
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.35 E-value=1.9e-06 Score=90.52 Aligned_cols=133 Identities=20% Similarity=0.189 Sum_probs=90.9
Q ss_pred CCccceeeecCceEEEEEEEC-CeEEEEEEecCCCC--C--------------------CchhHHHHHHHHHhcCCC--c
Q 003384 466 FDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSL--Q--------------------GPSEFQQEIDILSKIRHP--N 520 (824)
Q Consensus 466 f~~~~~LG~G~fG~Vykg~~~-~~~VAvK~l~~~~~--~--------------------~~~~f~~Ei~iL~~l~Hp--n 520 (824)
..++..||-|--+.||.|... +.++|||.-+.... . +.....+|.++|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 456678999999999999986 78999997432110 0 012256899999988654 4
Q ss_pred eeeEecccCCceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCC
Q 003384 521 LVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF 600 (824)
Q Consensus 521 Iv~L~g~~~~~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~ 600 (824)
|.+.++. +...+||||++|-.|...- ++....-.|+..|++-+.-+-. .||||+|+++-|||++++|
T Consensus 173 VP~P~~~--nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV~~dg 239 (304)
T COG0478 173 VPKPIAW--NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILVTEDG 239 (304)
T ss_pred CCCcccc--ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEEecCC
Confidence 4444443 4567999999987665432 1112222333334333333334 6899999999999999999
Q ss_pred cceeecccccc
Q 003384 601 VSKLSDFGISR 611 (824)
Q Consensus 601 ~vKL~DFGla~ 611 (824)
.+.++||--+.
T Consensus 240 ~~~vIDwPQ~v 250 (304)
T COG0478 240 DIVVIDWPQAV 250 (304)
T ss_pred CEEEEeCcccc
Confidence 99999998654
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.21 E-value=1e-05 Score=84.83 Aligned_cols=131 Identities=18% Similarity=0.249 Sum_probs=81.3
Q ss_pred cceeeecCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCce--eeEeccc--CCceEEEEEecCCCC-
Q 003384 469 SLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNL--VTLVGAC--PEVWTLVYEYLPNGS- 543 (824)
Q Consensus 469 ~~~LG~G~fG~Vykg~~~~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnI--v~L~g~~--~~~~~LV~Ey~~ggs- 543 (824)
...||+|..+.||+. .+..+++|...... ......+|.++++.+..-++ .+.++++ .+...+|||+++|.+
T Consensus 6 ~~~i~~G~t~~~y~~--~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 6 WTQTGEGGNGESYTH--KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred heeecCCCCcceeEe--cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 357999999999984 35567889876532 34567899999998863333 4455554 345678999999863
Q ss_pred hhhhhhccCCCCCCCHHHHHHHHHHHHHH---------------------------------------HHHHhhc-CCCc
Q 003384 544 LEDRLSCKDNSPPLSWQTRIRIATELCSV---------------------------------------LIFLHSC-KPHS 583 (824)
Q Consensus 544 L~~~L~~~~~~~~l~~~~~~~ia~qia~a---------------------------------------L~~LH~~-~~~g 583 (824)
+...+. .+......++..++.. ..+|... .+..
T Consensus 82 ~~~~~~-------~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~ 154 (226)
T TIGR02172 82 FSRIIS-------DNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTST 154 (226)
T ss_pred hhhhhc-------CCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCc
Confidence 221110 0001111111112221 2222211 1235
Q ss_pred eEeccccCCcEEecCCCcceeecccccc
Q 003384 584 IVHGDLKPANILLDANFVSKLSDFGISR 611 (824)
Q Consensus 584 iiHrDLKp~NILld~~~~vKL~DFGla~ 611 (824)
++|+|+.|.||++++++ +.|+||+.+.
T Consensus 155 ~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 155 CLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred eEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 78999999999999888 9999999764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.19 E-value=1.1e-05 Score=83.39 Aligned_cols=140 Identities=21% Similarity=0.302 Sum_probs=84.7
Q ss_pred ceeeecCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhcCCC--ceeeEeccc-----CCceEEEEEecCCC
Q 003384 470 LKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHP--NLVTLVGAC-----PEVWTLVYEYLPNG 542 (824)
Q Consensus 470 ~~LG~G~fG~Vykg~~~~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~Hp--nIv~L~g~~-----~~~~~LV~Ey~~gg 542 (824)
+.|+.|..+.||+....+..+++|..... .....+.+|..++..+... .+.+++..+ ....+++|+|++|.
T Consensus 3 ~~l~~G~~n~~~~v~~~~~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~ 80 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDDGRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR 80 (239)
T ss_dssp EEEEESSSSEEEEEEETTSEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred ccCCCCCeeeEEEEEECCcEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence 56999999999999988889999997654 2345788999999888533 345566533 22368999999998
Q ss_pred Chhh----------------hhh---cc-CCCCCCCHHHH---------HHH------------HHHHHH-HHHHHhh--
Q 003384 543 SLED----------------RLS---CK-DNSPPLSWQTR---------IRI------------ATELCS-VLIFLHS-- 578 (824)
Q Consensus 543 sL~~----------------~L~---~~-~~~~~l~~~~~---------~~i------------a~qia~-aL~~LH~-- 578 (824)
++.. .+. .. ....++..... ... ...+.. .+..++.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (239)
T PF01636_consen 81 PLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALL 160 (239)
T ss_dssp EHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhh
Confidence 8777 111 11 11111111110 000 111222 3334443
Q ss_pred --cCCCceEeccccCCcEEec-CCCcceeecccccc
Q 003384 579 --CKPHSIVHGDLKPANILLD-ANFVSKLSDFGISR 611 (824)
Q Consensus 579 --~~~~giiHrDLKp~NILld-~~~~vKL~DFGla~ 611 (824)
..+..++|+|+.|.|||++ .++.+-|+||+.+.
T Consensus 161 ~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 161 PKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred ccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 1346799999999999999 66666899999764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.14 E-value=8.9e-06 Score=83.96 Aligned_cols=135 Identities=19% Similarity=0.211 Sum_probs=91.5
Q ss_pred hcCCCCccceeeecCceEEEEEEECCeEEEEEEecCCCCCCchh---------HHHHHHHHHhcCCCc---eeeEeccc-
Q 003384 462 ATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSE---------FQQEIDILSKIRHPN---LVTLVGAC- 528 (824)
Q Consensus 462 ~~~~f~~~~~LG~G~fG~Vykg~~~~~~VAvK~l~~~~~~~~~~---------f~~Ei~iL~~l~Hpn---Iv~L~g~~- 528 (824)
...+|...+++-......|.+-...+..+.+|............ ..+.+..+..+...+ ...++.+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 35577777778877778888888889999999887644322222 223444444443222 22222211
Q ss_pred ------CCceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcc
Q 003384 529 ------PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS 602 (824)
Q Consensus 529 ------~~~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~v 602 (824)
....+|||||++|..|.+... ++. .++..+..++.-||. .|++|+|..|.|++++.++ +
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~~~-i 173 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSNNG-I 173 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEECCc-E
Confidence 234568999999988876541 221 345667788999999 8999999999999999665 8
Q ss_pred eeecccccc
Q 003384 603 KLSDFGISR 611 (824)
Q Consensus 603 KL~DFGla~ 611 (824)
+++||+..+
T Consensus 174 ~iID~~~k~ 182 (229)
T PF06176_consen 174 RIIDTQGKR 182 (229)
T ss_pred EEEECcccc
Confidence 999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.04 E-value=1.5e-05 Score=92.73 Aligned_cols=139 Identities=21% Similarity=0.302 Sum_probs=90.2
Q ss_pred ceeeecCceEEEEEEEC-CeEEEEEEecCCCCCCc------------------------------h----------hHHH
Q 003384 470 LKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGP------------------------------S----------EFQQ 508 (824)
Q Consensus 470 ~~LG~G~fG~Vykg~~~-~~~VAvK~l~~~~~~~~------------------------------~----------~f~~ 508 (824)
..|+.++-|.||+|++. |+.||||+.++.-.... + .+.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 46999999999999998 79999999876432110 0 1234
Q ss_pred HHHHHHhcC-----CCce--eeEecccCCceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 003384 509 EIDILSKIR-----HPNL--VTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 581 (824)
Q Consensus 509 Ei~iL~~l~-----HpnI--v~L~g~~~~~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~ 581 (824)
|..-+.+++ .|+| .++|--+.....|+|||++|..+.+...... ..++. ..++..++++ |+-+.-.
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~---k~ia~~~~~~--f~~q~~~ 283 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDR---KELAELLVRA--FLRQLLR 283 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCH---HHHHHHHHHH--HHHHHHh
Confidence 444444442 3332 2233223345679999999999988753222 22332 2333333332 1111111
Q ss_pred CceEeccccCCcEEecCCCcceeecccccccccc
Q 003384 582 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 615 (824)
Q Consensus 582 ~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~ 615 (824)
.|++|.|..|.||+++.+|.+-+.|||+...+..
T Consensus 284 dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 284 DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred cCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 5899999999999999999999999999876654
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.04 E-value=1.7e-05 Score=80.86 Aligned_cols=106 Identities=23% Similarity=0.228 Sum_probs=84.8
Q ss_pred HHHHHHHHhcCC-CceeeEecccCCceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceE
Q 003384 507 QQEIDILSKIRH-PNLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 585 (824)
Q Consensus 507 ~~Ei~iL~~l~H-pnIv~L~g~~~~~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~gii 585 (824)
..|.-+|+.+.+ +++.+++|+|.. .+|.||+..+++............-+|..|.+||.++++.+.+|++.....+.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~--~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~ 84 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR--FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFY 84 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC--EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEE
Confidence 458888999976 699999999965 56999998776643210001223468999999999999999999987666688
Q ss_pred eccccCCcEEecCCCcceeeccccccccc
Q 003384 586 HGDLKPANILLDANFVSKLSDFGISRFLS 614 (824)
Q Consensus 586 HrDLKp~NILld~~~~vKL~DFGla~~~~ 614 (824)
-.|++|+|+-++.+|.+|++|...+....
T Consensus 85 lcDv~~~nfgv~~~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 85 LCDVSPDNFGVNDDGRLKLIDLDDVFVED 113 (188)
T ss_pred EeecchHHeEEeCCCcEEEEechhcchhH
Confidence 89999999999999999999999776543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.00 E-value=1.2e-06 Score=100.59 Aligned_cols=191 Identities=18% Similarity=0.149 Sum_probs=132.8
Q ss_pred HhhhcCCCCccceeeecCceEEEEEEECCe-EEEEEEecCCCCCCchhHHHHHHHHHhcCCCc-eeeEecccC--CceEE
Q 003384 459 IEGATHNFDPSLKIGEGGYGSIYKGLLRHM-QVAIKMLHPHSLQGPSEFQQEIDILSKIRHPN-LVTLVGACP--EVWTL 534 (824)
Q Consensus 459 i~~~~~~f~~~~~LG~G~fG~Vykg~~~~~-~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~Hpn-Iv~L~g~~~--~~~~L 534 (824)
++..+.-+...+.+++|+++++||.+.... ....+.+.. .....-++++|.+++||| .+..++.+. +...+
T Consensus 237 lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~-----~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i 311 (829)
T KOG0576|consen 237 LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ-----TLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWI 311 (829)
T ss_pred ccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeecc-----chhhHHHHHHHHHccCCCCcccccccCCcccccch
Confidence 334455556667799999999999876532 222444322 245677999999999999 666666663 45678
Q ss_pred EEEecCCC-ChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccc
Q 003384 535 VYEYLPNG-SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 613 (824)
Q Consensus 535 V~Ey~~gg-sL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~ 613 (824)
+++|+.+| +-..... .....+...+...+...-.++|++||+ -.-+|+| |||..+ +..|.+||+....+
T Consensus 312 ~~~i~s~~rs~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L 381 (829)
T KOG0576|consen 312 PMRICSTGRSSALEMT--VSEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQL 381 (829)
T ss_pred hhhhhcCCccccccCC--hhhHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCccc
Confidence 99999877 2222110 111112223444556667788999998 3348998 887766 57899999988766
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCC
Q 003384 614 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGI 673 (824)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~ 673 (824)
.... ......+|+.++|||+.....+....|+|++|+--.+|.-|-+|-..
T Consensus 382 ~~~~---------~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 382 TRTM---------KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred Cccc---------ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 5442 12445699999999999999999999999999988888888877643
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.98 E-value=4.3e-05 Score=80.73 Aligned_cols=137 Identities=16% Similarity=0.169 Sum_probs=82.9
Q ss_pred eeecCc-eEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhcC-CCceeeEecccCC--ceEEEEEecCCCChhhh
Q 003384 472 IGEGGY-GSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVGACPE--VWTLVYEYLPNGSLEDR 547 (824)
Q Consensus 472 LG~G~f-G~Vykg~~~~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~-HpnIv~L~g~~~~--~~~LV~Ey~~ggsL~~~ 547 (824)
|-.|.. ..||+....+..+.||+..... ...+.+|+.++..+. +--+.++++++.. ..++||||++|.+|...
T Consensus 6 ~~~g~~~~~v~~~~~~~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 6 VTEGQSGATVYRLDGKNPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred cCCCCCcCeEEEEcCCCCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 445555 7899987766788889875443 346788999998884 3335566666543 47899999999877643
Q ss_pred h-------------------hccC-CCCCCCH--HHHHHHHH--------------------HHHHHHHHHhh----cCC
Q 003384 548 L-------------------SCKD-NSPPLSW--QTRIRIAT--------------------ELCSVLIFLHS----CKP 581 (824)
Q Consensus 548 L-------------------~~~~-~~~~l~~--~~~~~ia~--------------------qia~aL~~LH~----~~~ 581 (824)
. +... ...++.. ........ .+...+..|-. ..+
T Consensus 83 ~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 162 (244)
T cd05150 83 WEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEED 162 (244)
T ss_pred hcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCc
Confidence 2 1110 0111110 01110000 01111222211 122
Q ss_pred CceEeccccCCcEEecCCCcceeecccccc
Q 003384 582 HSIVHGDLKPANILLDANFVSKLSDFGISR 611 (824)
Q Consensus 582 ~giiHrDLKp~NILld~~~~vKL~DFGla~ 611 (824)
..++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred eEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 458999999999999998888999999654
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.89 E-value=4.6e-05 Score=75.64 Aligned_cols=128 Identities=18% Similarity=0.188 Sum_probs=89.3
Q ss_pred CccceeeecCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceee-EecccCCceEEEEEecCCCChh
Q 003384 467 DPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVT-LVGACPEVWTLVYEYLPNGSLE 545 (824)
Q Consensus 467 ~~~~~LG~G~fG~Vykg~~~~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~-L~g~~~~~~~LV~Ey~~ggsL~ 545 (824)
...+.||+|.+|.||+|.+++..+|+|+-..++ ....+..|+++|..+.--++.+ +|.+..+ .+.|||+.|-+|.
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg~~--~i~me~i~G~~L~ 100 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWRGGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYGED--FIRMEYIDGRPLG 100 (201)
T ss_pred hhhhhhhcccccEEEEeeccCceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEechh--hhhhhhhcCcchh
Confidence 445679999999999999999999999876543 3467999999999987665543 3333322 2459999998887
Q ss_pred hhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccc-CCcEEecCCCcceeecccccc
Q 003384 546 DRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLK-PANILLDANFVSKLSDFGISR 611 (824)
Q Consensus 546 ~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLK-p~NILld~~~~vKL~DFGla~ 611 (824)
+.-... +-.+ ...+++.-.-|.. .||-|+.|. |..++|.+++.+.|+||.-|.
T Consensus 101 ~~~~~~------~rk~----l~~vlE~a~~LD~---~GI~H~El~~~~k~vlv~~~~~~iIDFd~At 154 (201)
T COG2112 101 KLEIGG------DRKH----LLRVLEKAYKLDR---LGIEHGELSRPWKNVLVNDRDVYIIDFDSAT 154 (201)
T ss_pred hhhhcc------cHHH----HHHHHHHHHHHHH---hccchhhhcCCceeEEecCCcEEEEEccchh
Confidence 765211 1122 2334455444555 788888886 444444445599999999876
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00011 Score=91.20 Aligned_cols=145 Identities=19% Similarity=0.321 Sum_probs=90.4
Q ss_pred cceeeecCceEEEEEEECC----eEEEEEEecCCCC-CCchhHHHHHHHHHhcC-CCce--eeEecccCC-----ceEEE
Q 003384 469 SLKIGEGGYGSIYKGLLRH----MQVAIKMLHPHSL-QGPSEFQQEIDILSKIR-HPNL--VTLVGACPE-----VWTLV 535 (824)
Q Consensus 469 ~~~LG~G~fG~Vykg~~~~----~~VAvK~l~~~~~-~~~~~f~~Ei~iL~~l~-HpnI--v~L~g~~~~-----~~~LV 535 (824)
...|+.|.++.+|+....+ ..+++|+...... .....+.+|+.+|+.+. |+++ .+++++|.+ ..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 4568999999999877654 4677787544321 23356889999999995 6665 777887754 46899
Q ss_pred EEecCCCChhhh-----------------------hhccCC--------CCCCCH--HHHHHHH---------------H
Q 003384 536 YEYLPNGSLEDR-----------------------LSCKDN--------SPPLSW--QTRIRIA---------------T 567 (824)
Q Consensus 536 ~Ey~~ggsL~~~-----------------------L~~~~~--------~~~l~~--~~~~~ia---------------~ 567 (824)
|||++|..+.+. |+.... ..+..+ .++..+. -
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 999998654321 111110 011111 1111111 1
Q ss_pred HHHHHHHHHhhcCC--------CceEeccccCCcEEecCC-C-cceeecccccccc
Q 003384 568 ELCSVLIFLHSCKP--------HSIVHGDLKPANILLDAN-F-VSKLSDFGISRFL 613 (824)
Q Consensus 568 qia~aL~~LH~~~~--------~giiHrDLKp~NILld~~-~-~vKL~DFGla~~~ 613 (824)
.+...+.+|....| ..+||+|+++.|||++.+ + .+-|.||+++..-
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 13344566654333 249999999999999853 3 3579999998654
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.88 E-value=6.3e-05 Score=79.14 Aligned_cols=71 Identities=11% Similarity=0.165 Sum_probs=45.6
Q ss_pred ceeeecCce-EEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhcCCC---ceeeEecccCC-----ceEEEEEecC
Q 003384 470 LKIGEGGYG-SIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHP---NLVTLVGACPE-----VWTLVYEYLP 540 (824)
Q Consensus 470 ~~LG~G~fG-~Vykg~~~~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~Hp---nIv~L~g~~~~-----~~~LV~Ey~~ 540 (824)
..|+.||.. .||+. +..+++|+.... .....+.+|..+|..+... -+.++++.+.. ..++||++++
T Consensus 3 ~~~~~gG~~n~vy~~---~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~ 77 (235)
T cd05155 3 EPVDSGGTDNATFRL---GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE 77 (235)
T ss_pred eeccCCCcccceEEc---CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence 457877776 48864 345777875432 2345789999999887531 23344444322 3478999999
Q ss_pred CCChh
Q 003384 541 NGSLE 545 (824)
Q Consensus 541 ggsL~ 545 (824)
|.++.
T Consensus 78 G~~l~ 82 (235)
T cd05155 78 GETAT 82 (235)
T ss_pred CCCCC
Confidence 97774
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG2042 consensus Ubiquitin fusion degradation protein-2 [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=97.79 E-value=1.4e-05 Score=96.17 Aligned_cols=74 Identities=27% Similarity=0.474 Sum_probs=68.9
Q ss_pred CCCCCCCCCcccchhhhccCCcccc-CCccchhhhhhhhhcCCCCCCCCCCCCCCCCCCCchHHHHHHHHHHHHhC
Q 003384 750 ERCEPPPYFTCPIFQEVMQDPHVAA-DGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWLQQH 824 (824)
Q Consensus 750 ~~~~~P~~f~cPi~~evm~dPvi~~-~g~tye~~~i~~wl~~~~~t~p~t~~~l~~~~l~pn~~lr~~i~~~~~~~ 824 (824)
...++|++|..|+...+|.|||+.+ +|.+.+|+.|..|+.+ ..|||+.|.+|+..+++||-+||+.|+.|..++
T Consensus 863 ~l~dvpdef~DPlm~Tlm~dPV~LP~Srv~vDRsti~rhlLs-~~tdPFNR~pLt~d~v~pn~eLK~kI~~~~~ek 937 (943)
T KOG2042|consen 863 ELGDVPDEFLDPLMSTLMSDPVVLPSSRVTVDRSTIERHLLS-DCTDPFNREPLTEDMVSPNEELKAKIRCWIKEK 937 (943)
T ss_pred HhccCchhhhCccccccCCCCccCCcccccccHHHHHHHHhc-CCCCccccccCchhhcCCCHHHHHHHHHHHHHh
Confidence 3457999999999999999999999 8899999999999988 669999999999999999999999999998753
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00018 Score=75.31 Aligned_cols=135 Identities=19% Similarity=0.200 Sum_probs=81.8
Q ss_pred eeeecCceEEEEEEEC-CeEEEEEEecCCCCCCc-------------------hh-----HHHHHHHHHhcCC--Cceee
Q 003384 471 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGP-------------------SE-----FQQEIDILSKIRH--PNLVT 523 (824)
Q Consensus 471 ~LG~G~fG~Vykg~~~-~~~VAvK~l~~~~~~~~-------------------~~-----f~~Ei~iL~~l~H--pnIv~ 523 (824)
.|..|--+.||+|... +..||||++......-. .. ..+|+.-|.++.. -.+.+
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 3556677789998764 68899999875422110 00 2346666666532 22222
Q ss_pred EecccCCceEEEEEecCCC-ChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcc
Q 003384 524 LVGACPEVWTLVYEYLPNG-SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS 602 (824)
Q Consensus 524 L~g~~~~~~~LV~Ey~~gg-sL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~v 602 (824)
-+++. ...|||||+... .-.-.| ...++.......+..++.+.+.-|-.- .++||+||+.=|||+. ++.+
T Consensus 135 Pi~~~--~nVLvMEfIg~~g~pAP~L----kDv~~e~~e~~~~~~~~v~~~~~l~~~--a~LVHgDLSEyNiL~~-~~~p 205 (268)
T COG1718 135 PIAFR--NNVLVMEFIGDDGLPAPRL----KDVPLELEEAEGLYEDVVEYMRRLYKE--AGLVHGDLSEYNILVH-DGEP 205 (268)
T ss_pred ceeec--CCeEEEEeccCCCCCCCCc----ccCCcCchhHHHHHHHHHHHHHHHHHh--cCcccccchhhheEEE-CCeE
Confidence 23222 346999998543 111112 111222224555666666666655442 4799999999999999 8899
Q ss_pred eeeccccccccc
Q 003384 603 KLSDFGISRFLS 614 (824)
Q Consensus 603 KL~DFGla~~~~ 614 (824)
.|+|||-|....
T Consensus 206 ~iID~~QaV~~~ 217 (268)
T COG1718 206 YIIDVSQAVTID 217 (268)
T ss_pred EEEECccccccC
Confidence 999999776443
|
|
| >cd01987 USP_OKCHK USP domain is located between the N-terminal sensor domain and C-terminal catalytic domain of this Osmosensitive K+ channel histidine kinase family | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00011 Score=68.87 Aligned_cols=77 Identities=10% Similarity=0.296 Sum_probs=61.7
Q ss_pred HHHHHHHHHHHHhhcCeeeEEEEeecCchHHHHHHHHHHcCCCEEEeccCcCccchhhhcccchhhHHhhhccCCCccEE
Q 003384 50 MHNHLDMCLLICRQMGVRAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAPASCHI 129 (824)
Q Consensus 50 ~~~~l~~~~~~C~~~~V~~~~~~ie~~dv~~~i~e~i~~~~i~~LV~Ga~~~~~~~~~~~~~~s~~a~~v~~~a~~~C~v 129 (824)
.++.|+.+...+.+.++. ..++.+++++++|++++..++|+.||||++..+..++. +....+..|+..+ .-|.|
T Consensus 47 ~~~~l~~~~~~~~~~~~~--~~~~~~~~~~~~I~~~~~~~~~dllviG~~~~~~~~~~---~~Gs~~~~v~~~a-~~~~v 120 (124)
T cd01987 47 ERRRLAEALRLAEELGAE--VVTLPGDDVAEAIVEFAREHNVTQIVVGKSRRSRWREL---FRGSLVDRLLRRA-GNIDV 120 (124)
T ss_pred HHHHHHHHHHHHHHcCCE--EEEEeCCcHHHHHHHHHHHcCCCEEEeCCCCCchHHHH---hcccHHHHHHHhC-CCCeE
Confidence 456788888888887764 45667789999999999999999999999955555444 3344677899998 89999
Q ss_pred EEE
Q 003384 130 WFI 132 (824)
Q Consensus 130 ~~i 132 (824)
+++
T Consensus 121 ~v~ 123 (124)
T cd01987 121 HIV 123 (124)
T ss_pred EEe
Confidence 997
|
The family of KdpD sensor kinase proteins regulates the kdpFABC operon responsible for potassium transport. The USP domain is homologous to the universal stress protein Usp Usp is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. Usp enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00014 Score=77.57 Aligned_cols=137 Identities=17% Similarity=0.138 Sum_probs=80.3
Q ss_pred eeecCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCce-eeEecccCCceEEEEEecCCCChhhh---
Q 003384 472 IGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNL-VTLVGACPEVWTLVYEYLPNGSLEDR--- 547 (824)
Q Consensus 472 LG~G~fG~Vykg~~~~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnI-v~L~g~~~~~~~LV~Ey~~ggsL~~~--- 547 (824)
+..|-.+.+|+....+..+++|+.......-.-...+|..+++.+..-++ .++++.+. .++||||++|..+...
T Consensus 4 ~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~--~~~v~e~i~G~~~~~~~~~ 81 (256)
T TIGR02721 4 LSGGLTNRSWRIEHPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE--HWLLVEWLEGEVITLDQFV 81 (256)
T ss_pred CCCcCcCCeEEEEeCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC--CEEEEEeccCccccccccc
Confidence 55677789998887778899997654322111246789999999864323 33444443 3689999998765421
Q ss_pred --------------hhccC-CCCCCCHHHH-HHHHHH---------HHHHHHHHhhc-----CCCceEeccccCCcEEec
Q 003384 548 --------------LSCKD-NSPPLSWQTR-IRIATE---------LCSVLIFLHSC-----KPHSIVHGDLKPANILLD 597 (824)
Q Consensus 548 --------------L~~~~-~~~~l~~~~~-~~ia~q---------ia~aL~~LH~~-----~~~giiHrDLKp~NILld 597 (824)
|+... ...+++.... ..+..+ +...+..+-.. .+..++|+|+.|.|||++
T Consensus 82 ~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Nil~~ 161 (256)
T TIGR02721 82 ALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNLVVT 161 (256)
T ss_pred CchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcEEEe
Confidence 11111 1122232211 111111 11112222111 123589999999999999
Q ss_pred CCCcceeecccccc
Q 003384 598 ANFVSKLSDFGISR 611 (824)
Q Consensus 598 ~~~~vKL~DFGla~ 611 (824)
+++ +.|+||+.|.
T Consensus 162 ~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 162 PQG-LKLIDWEYAS 174 (256)
T ss_pred CCC-CEEEeccccC
Confidence 887 7899999765
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00014 Score=84.50 Aligned_cols=139 Identities=19% Similarity=0.250 Sum_probs=92.0
Q ss_pred ceeeecCceEEEEEEEC-CeEEEEEEecCCCCCCc---------------------------h----------hHHHHHH
Q 003384 470 LKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGP---------------------------S----------EFQQEID 511 (824)
Q Consensus 470 ~~LG~G~fG~Vykg~~~-~~~VAvK~l~~~~~~~~---------------------------~----------~f~~Ei~ 511 (824)
+.||.-+.|.||+|+.+ |..||||+-++.-.... + .|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 35899999999999987 57899999776422110 0 1344544
Q ss_pred HHHhc----CCCc------eeeEecccCCceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 003384 512 ILSKI----RHPN------LVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 581 (824)
Q Consensus 512 iL~~l----~Hpn------Iv~L~g~~~~~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~ 581 (824)
-..++ .|-+ |.++|-.+.....|+||||+|..+.|.-.-... .++.. .|+..+.++ |++....
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~--gi~~~---~i~~~l~~~--~~~qIf~ 319 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKR--GISPH---DILNKLVEA--YLEQIFK 319 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHc--CCCHH---HHHHHHHHH--HHHHHHh
Confidence 43333 3444 555666666678899999999988776532222 23333 333333332 3333333
Q ss_pred CceEeccccCCcEEecC----CCcceeecccccccccc
Q 003384 582 HSIVHGDLKPANILLDA----NFVSKLSDFGISRFLSQ 615 (824)
Q Consensus 582 ~giiHrDLKp~NILld~----~~~vKL~DFGla~~~~~ 615 (824)
.|++|+|-.|.|||+.. ++.+.+.|||+...+..
T Consensus 320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 68999999999999983 67899999999876654
|
|
| >COG5113 UFD2 Ubiquitin fusion degradation protein 2 [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=97.64 E-value=7.1e-05 Score=85.00 Aligned_cols=75 Identities=27% Similarity=0.473 Sum_probs=66.9
Q ss_pred CCCCCCCCCCCcccchhhhccCCcccc-CCccchhhhhhhhhcCCCCCCCCCCCCCCCCCCCchHHHHHHHHHHHHh
Q 003384 748 SEERCEPPPYFTCPIFQEVMQDPHVAA-DGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWLQQ 823 (824)
Q Consensus 748 ~e~~~~~P~~f~cPi~~evm~dPvi~~-~g~tye~~~i~~wl~~~~~t~p~t~~~l~~~~l~pn~~lr~~i~~~~~~ 823 (824)
.+...++|++|..|.+..+|.|||+.+ ++.+.+|+.|..|+.+ +.|||..+.||.-.+++||-.||+.|..|...
T Consensus 845 eED~GDvPDeFlDPLmftimkdPV~Lp~S~i~IDRSTikahlls-d~tDPFNRmPLtlddVtpn~eLrekIn~f~k~ 920 (929)
T COG5113 845 EEDMGDVPDEFLDPLMFTIMKDPVKLPTSRITIDRSTIKAHLLS-DGTDPFNRMPLTLDDVTPNAELREKINRFYKC 920 (929)
T ss_pred hhhccCCchhhhCchhhhcccCCeecccccccccHHHHHHHHhc-CCCCccccCCCchhhcCCCHHHHHHHHHHHhc
Confidence 344668999999999999999999975 4579999999999988 55999999999999999999999999988753
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.00054 Score=75.41 Aligned_cols=139 Identities=19% Similarity=0.248 Sum_probs=78.4
Q ss_pred ceeeecCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhcC-----CCceeeE-----ecccCCceEEEEEec
Q 003384 470 LKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-----HPNLVTL-----VGACPEVWTLVYEYL 539 (824)
Q Consensus 470 ~~LG~G~fG~Vykg~~~~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~-----HpnIv~L-----~g~~~~~~~LV~Ey~ 539 (824)
+.|+.|....+|+....+..+++|++.. .....+..|+.++..|. -|.++.- +.......+++++|+
T Consensus 28 ~~l~~G~~n~~y~v~t~~g~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~l 104 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQGEYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTFL 104 (319)
T ss_pred chhccccccceEEEEeCCCcEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEec
Confidence 4466777788999877767899998762 23345556667766663 2333321 111234568999999
Q ss_pred CCCChhh-----------hh---hccCC--------CCCCCH-HHHHHH------------H-HHHHHHHHHHhh----c
Q 003384 540 PNGSLED-----------RL---SCKDN--------SPPLSW-QTRIRI------------A-TELCSVLIFLHS----C 579 (824)
Q Consensus 540 ~ggsL~~-----------~L---~~~~~--------~~~l~~-~~~~~i------------a-~qia~aL~~LH~----~ 579 (824)
+|..+.. .| +.... ...+.| .....- . ..+...+..+.. .
T Consensus 105 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 184 (319)
T PRK05231 105 EGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWPA 184 (319)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccccc
Confidence 9875421 11 11000 011112 111110 0 111122233321 1
Q ss_pred CCCceEeccccCCcEEecCCCcceeecccccc
Q 003384 580 KPHSIVHGDLKPANILLDANFVSKLSDFGISR 611 (824)
Q Consensus 580 ~~~giiHrDLKp~NILld~~~~vKL~DFGla~ 611 (824)
-+.++||+|+.|.|||++.+...-|+||+.+.
T Consensus 185 lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 185 LPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred CCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 35689999999999999977666899999764
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.00063 Score=74.44 Aligned_cols=73 Identities=22% Similarity=0.132 Sum_probs=55.0
Q ss_pred ceeeecCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhcCC---CceeeEecccC-----CceEEEEEecCC
Q 003384 470 LKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRH---PNLVTLVGACP-----EVWTLVYEYLPN 541 (824)
Q Consensus 470 ~~LG~G~fG~Vykg~~~~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~H---pnIv~L~g~~~-----~~~~LV~Ey~~g 541 (824)
..||.|..+.||+-...+..+.+|..+. ......|..|...|+.|.- -.+.++++.|. ...+||||+++|
T Consensus 20 ~~i~~G~~~~vy~~~~~~~~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G 97 (297)
T PRK10593 20 ECISEQPYAALWALYDSQGNPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRG 97 (297)
T ss_pred eecCCccceeEEEEEcCCCCEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCC
Confidence 4599999999999876656677887543 1234589999999998853 35777887663 347999999998
Q ss_pred CCh
Q 003384 542 GSL 544 (824)
Q Consensus 542 gsL 544 (824)
+++
T Consensus 98 ~~~ 100 (297)
T PRK10593 98 VSV 100 (297)
T ss_pred Eec
Confidence 765
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.00032 Score=73.50 Aligned_cols=139 Identities=19% Similarity=0.279 Sum_probs=81.3
Q ss_pred ceeeecCceEEEEEEEC---CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCc-eeeEecccCCceEEEEEecCCCChh
Q 003384 470 LKIGEGGYGSIYKGLLR---HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPN-LVTLVGACPEVWTLVYEYLPNGSLE 545 (824)
Q Consensus 470 ~~LG~G~fG~Vykg~~~---~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~Hpn-Iv~L~g~~~~~~~LV~Ey~~ggsL~ 545 (824)
+.|..|-...+|+.... +..|++|+...... ..-...+|+.++..+...+ ..++++.+.. .+||||++|.++.
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~~--~~l~e~i~G~~l~ 80 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQN--GLIYEFIPGRTLE 80 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeCC--cEEEEeeCCCcCC
Confidence 45777778899988765 46788997654321 1123457999999885333 3445554443 4799999997763
Q ss_pred hh-----------------hhccCCC--------CCCC-HHHHHHHHH----------------------HHHHHHHHH-
Q 003384 546 DR-----------------LSCKDNS--------PPLS-WQTRIRIAT----------------------ELCSVLIFL- 576 (824)
Q Consensus 546 ~~-----------------L~~~~~~--------~~l~-~~~~~~ia~----------------------qia~aL~~L- 576 (824)
.. |+..... .... +..+..+.. .+...+..|
T Consensus 81 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~ 160 (235)
T cd05157 81 PEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISWLK 160 (235)
T ss_pred HHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHHHH
Confidence 21 0111111 1111 222112211 111111122
Q ss_pred ---hhc-CCCceEeccccCCcEEecC-CCcceeecccccc
Q 003384 577 ---HSC-KPHSIVHGDLKPANILLDA-NFVSKLSDFGISR 611 (824)
Q Consensus 577 ---H~~-~~~giiHrDLKp~NILld~-~~~vKL~DFGla~ 611 (824)
... .+..++|+|+.+.|||++. ++.+.|+||..|.
T Consensus 161 ~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 161 ELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred HHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 111 2357999999999999998 5789999999765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.00045 Score=75.05 Aligned_cols=140 Identities=16% Similarity=0.177 Sum_probs=86.5
Q ss_pred cceeeecCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCc--eeeEeccc--------CCceEEEEEe
Q 003384 469 SLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPN--LVTLVGAC--------PEVWTLVYEY 538 (824)
Q Consensus 469 ~~~LG~G~fG~Vykg~~~~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~Hpn--Iv~L~g~~--------~~~~~LV~Ey 538 (824)
...|..|....+|+....+..+++|+... .....+..|+.++..|.+-+ +.+++... .+..++|++|
T Consensus 19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~ 95 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEF 95 (296)
T ss_pred eecccCccccceEEEEeCCCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEe
Confidence 34577777789999877777899998764 23456778888888885322 44444322 2345789999
Q ss_pred cCCCChhh----hh----------hcc----CC----CCCCCHHHHH----------HHHHHHHHHHHHHhh----cCCC
Q 003384 539 LPNGSLED----RL----------SCK----DN----SPPLSWQTRI----------RIATELCSVLIFLHS----CKPH 582 (824)
Q Consensus 539 ~~ggsL~~----~L----------~~~----~~----~~~l~~~~~~----------~ia~qia~aL~~LH~----~~~~ 582 (824)
++|..+.. .+ +.. .. .....|.... .....+..++.++.. ..+.
T Consensus 96 i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~ 175 (296)
T cd05153 96 LAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPR 175 (296)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCC
Confidence 99877532 00 100 00 0111222111 011113334444443 2346
Q ss_pred ceEeccccCCcEEecCCCcceeecccccc
Q 003384 583 SIVHGDLKPANILLDANFVSKLSDFGISR 611 (824)
Q Consensus 583 giiHrDLKp~NILld~~~~vKL~DFGla~ 611 (824)
+++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 176 ~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 176 GVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred cCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 79999999999999998778899999764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.0008 Score=76.22 Aligned_cols=74 Identities=16% Similarity=0.096 Sum_probs=56.1
Q ss_pred ceeeecCceEEEEEEECC--eEEEEEEecCCC-------CCCchhHHHHHHHHHhcC---CCceeeEecccCCceEEEEE
Q 003384 470 LKIGEGGYGSIYKGLLRH--MQVAIKMLHPHS-------LQGPSEFQQEIDILSKIR---HPNLVTLVGACPEVWTLVYE 537 (824)
Q Consensus 470 ~~LG~G~fG~Vykg~~~~--~~VAvK~l~~~~-------~~~~~~f~~Ei~iL~~l~---HpnIv~L~g~~~~~~~LV~E 537 (824)
+.||.|.+..||++...+ +.|+||.-.+.. ....+.+..|.+.|..+. ..++.+++.+..+..++|||
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~~~~~lVME 111 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDEELAVTVME 111 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECCCCCEEEEe
Confidence 469999999999998875 389999854221 123456788999988873 35678888888888899999
Q ss_pred ecCCCC
Q 003384 538 YLPNGS 543 (824)
Q Consensus 538 y~~ggs 543 (824)
|+++..
T Consensus 112 ~L~~~~ 117 (401)
T PRK09550 112 DLSDHK 117 (401)
T ss_pred cCCCcc
Confidence 998743
|
|
| >cd01988 Na_H_Antiporter_C The C-terminal domain of a subfamily of Na+ /H+ antiporter existed in bacteria and archea | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.00092 Score=62.92 Aligned_cols=82 Identities=18% Similarity=0.234 Sum_probs=67.6
Q ss_pred HHHHHHHHHHHHHHHHhhcCeeeEEEEeecCchHHHHHHHHHHcCCCEEEeccCcCccchhhhcccchhhHHhhhccCCC
Q 003384 46 ERQDMHNHLDMCLLICRQMGVRAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAPA 125 (824)
Q Consensus 46 e~~~~~~~l~~~~~~C~~~~V~~~~~~ie~~dv~~~i~e~i~~~~i~~LV~Ga~~~~~~~~~~~~~~s~~a~~v~~~a~~ 125 (824)
+....++.+..+...+...++.++.+++.++++.++|++++..++++.+|||.+....+.+ .+-+..+..|.+.++
T Consensus 50 ~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~I~~~a~~~~~dlIV~G~~~~~~~~~---~~lGs~~~~v~~~~~- 125 (132)
T cd01988 50 NVQRARKLLRQAERIAASLGVPVHTIIRIDHDIASGILRTAKERQADLIIMGWHGSTSLRD---RLFGGVIDQVLESAP- 125 (132)
T ss_pred HHHHHHHHHHHHHHHhhhcCCceEEEEEecCCHHHHHHHHHHhcCCCEEEEecCCCCCccc---eecCchHHHHHhcCC-
Confidence 4456789999999999999999999998888999999999999999999999995544422 222346778999977
Q ss_pred ccEEEEE
Q 003384 126 SCHIWFI 132 (824)
Q Consensus 126 ~C~v~~i 132 (824)
|.|.+|
T Consensus 126 -~pvlvv 131 (132)
T cd01988 126 -CDVAVV 131 (132)
T ss_pred -CCEEEe
Confidence 999876
|
Na+/H+ exchange proteins eject protons from cells, effectively eliminating excess acid from actively metabolising cells. Na+ /H+ exchange activity is also crucial for the regulation of cell volume, and for the reabsorption of NaCl across renal, intestinal, and other epithelia. These antiports exchange Na+ for H+ in an electroneutral manner, and this activity is carried out by a family of Na+ /H+ exchangers, or NHEs, which are known to be present in both prokaryotic and eukaryotic cells. These exchangers are highly-regulated (glyco)phosphoproteins, which, based on their primary structure, appear to contain 10-12 membrane-spanning regions (M) at the N-terminus and a large cytoplasmic region at the C-terminus. The transmembrane regions M3-M12 share identity wit h other members of the family. The M6 and M7 regions are highly conserved. Thus, this is thought to be the regio |
| >PRK15118 universal stress global response regulator UspA; Provisional | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.00067 Score=65.46 Aligned_cols=80 Identities=13% Similarity=0.222 Sum_probs=58.7
Q ss_pred HHHHHHHHHHHHHHHHHHHHhhcCeeeEEEEeecCchHHHHHHHHHHcCCCEEEeccCcCccchhhhcccchhhHHhhhc
Q 003384 42 YREIERQDMHNHLDMCLLICRQMGVRAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQ 121 (824)
Q Consensus 42 ~~~~e~~~~~~~l~~~~~~C~~~~V~~~~~~ie~~dv~~~i~e~i~~~~i~~LV~Ga~~~~~~~~~~~~~~s~~a~~v~~ 121 (824)
+++..+....+.|+. ++...++.+...++..++++++|++++.+++++.+|||++ .+.. + .+- ..|..|+.
T Consensus 58 ~~~~~~~~~~~~l~~---~~~~~~~~~~~~~~~~G~p~~~I~~~a~~~~~DLIV~Gs~-~~~~-~---~lg-Sva~~v~~ 128 (144)
T PRK15118 58 MQKRISEETHHALTE---LSTNAGYPITETLSGSGDLGQVLVDAIKKYDMDLVVCGHH-QDFW-S---KLM-SSARQLIN 128 (144)
T ss_pred HHHHHHHHHHHHHHH---HHHhCCCCceEEEEEecCHHHHHHHHHHHhCCCEEEEeCc-ccHH-H---HHH-HHHHHHHh
Confidence 344344444444544 3466788887777777999999999999999999999999 2221 2 233 47889999
Q ss_pred cCCCccEEEEE
Q 003384 122 QAPASCHIWFI 132 (824)
Q Consensus 122 ~a~~~C~v~~i 132 (824)
+++ |.|.+|
T Consensus 129 ~a~--~pVLvv 137 (144)
T PRK15118 129 TVH--VDMLIV 137 (144)
T ss_pred hCC--CCEEEe
Confidence 977 999998
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.0017 Score=66.45 Aligned_cols=123 Identities=25% Similarity=0.372 Sum_probs=89.1
Q ss_pred CCCCccceeeecCc-eEEEEEEECCeEEEEEEecC---CCC------------------CCchhHHHHHHHHHhcC---C
Q 003384 464 HNFDPSLKIGEGGY-GSIYKGLLRHMQVAIKMLHP---HSL------------------QGPSEFQQEIDILSKIR---H 518 (824)
Q Consensus 464 ~~f~~~~~LG~G~f-G~Vykg~~~~~~VAvK~l~~---~~~------------------~~~~~f~~Ei~iL~~l~---H 518 (824)
.+++..+.||.|.- |.||++...+..+|+|++.. ... .-...|..|.+...+|+ +
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 67888999999999 99999999999999999322 110 00124788998888874 4
Q ss_pred Cce--eeEeccc--C------------------CceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHH
Q 003384 519 PNL--VTLVGAC--P------------------EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFL 576 (824)
Q Consensus 519 pnI--v~L~g~~--~------------------~~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~L 576 (824)
.++ |+++|+. . ..+.||.||++... .+. .+-+.+|.+-|..+
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~----~~~~~~~~~dl~~~ 180 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQ----IRDIPQMLRDLKIL 180 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccc----hhHHHHHHHHHHHH
Confidence 455 8888875 1 12468888886543 122 22344566777788
Q ss_pred hhcCCCceEeccccCCcEEecCCCcceeeccccc
Q 003384 577 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS 610 (824)
Q Consensus 577 H~~~~~giiHrDLKp~NILld~~~~vKL~DFGla 610 (824)
|. .||+-+|+++.|.. .-||+|||.+
T Consensus 181 ~k---~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HK---LGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HH---CCeeeccCcccccc-----CCEEEecccC
Confidence 88 89999999999987 2389999964
|
|
| >PF00582 Usp: Universal stress protein family; InterPro: IPR006016 The universal stress protein UspA P28242 from SWISSPROT [] is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.00056 Score=63.99 Aligned_cols=69 Identities=19% Similarity=0.237 Sum_probs=56.6
Q ss_pred HHHhhcCeeeEEEEeecCchHHHHHHHHHHcCCCEEEeccCcCccchhhhcccchhhHHhhhccCCCccEEEEE
Q 003384 59 LICRQMGVRAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAPASCHIWFI 132 (824)
Q Consensus 59 ~~C~~~~V~~~~~~ie~~dv~~~i~e~i~~~~i~~LV~Ga~~~~~~~~~~~~~~s~~a~~v~~~a~~~C~v~~i 132 (824)
..+...+.......+..++++++|++++..++++.+|||++..+...+ -.-+..+..|++.+| |.|++|
T Consensus 71 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~dliv~G~~~~~~~~~---~~~gs~~~~l~~~~~--~pVlvv 139 (140)
T PF00582_consen 71 EEAEAEGGIVIEVVIESGDVADAIIEFAEEHNADLIVMGSRGRSGLER---LLFGSVAEKLLRHAP--CPVLVV 139 (140)
T ss_dssp HHHHHHTTSEEEEEEEESSHHHHHHHHHHHTTCSEEEEESSSTTSTTT---SSSHHHHHHHHHHTS--SEEEEE
T ss_pred HHHhhhccceeEEEEEeeccchhhhhccccccceeEEEeccCCCCccC---CCcCCHHHHHHHcCC--CCEEEe
Confidence 677888888888888899999999999999999999999994333333 234556779999988 999886
|
UspA enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae UspA [] reveals an alpha/beta fold similar to that of the Methanocaldococcus jannaschii (Methanococcus jannaschii) MJ0577 protein, which binds ATP [], though UspA lacks ATP-binding activity.; GO: 0006950 response to stress; PDB: 3DLO_C 3QTB_A 2PFS_A 3TNJ_A 1JMV_D 3FH0_B 3FDX_B 3AB7_A 3AB8_A 2GM3_F .... |
| >cd00293 USP_Like Usp: Universal stress protein family | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0014 Score=60.64 Aligned_cols=86 Identities=21% Similarity=0.299 Sum_probs=65.6
Q ss_pred HHHHHHHHHHHHHHHHHHHHHhhcCeeeEEEEeecCchHHHHHHHHHHcCCCEEEeccCcCccchhhhcccchhhHHhhh
Q 003384 41 AYREIERQDMHNHLDMCLLICRQMGVRAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVR 120 (824)
Q Consensus 41 ~~~~~e~~~~~~~l~~~~~~C~~~~V~~~~~~ie~~dv~~~i~e~i~~~~i~~LV~Ga~~~~~~~~~~~~~~s~~a~~v~ 120 (824)
.+...+..+.++.|+.|...|...+|.+...+.. ++.+++|++++..++++.||||+...+.+.+ ...+..+..++
T Consensus 45 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~i~~~~~~~~~dlvvig~~~~~~~~~---~~~~~~~~~ll 120 (130)
T cd00293 45 ELAELLEEEARALLEALREALAEAGVKVETVVLE-GDPAEAILEAAEELGADLIVMGSRGRSGLRR---LLLGSVAERVL 120 (130)
T ss_pred hHHHHHHHHHHHHHHHHHHHHhcCCCceEEEEec-CCCHHHHHHHHHHcCCCEEEEcCCCCCccce---eeeccHHHHHH
Confidence 4445566777899999999999999999888776 5569999999999999999999995544322 23344566787
Q ss_pred ccCCCccEEEEE
Q 003384 121 QQAPASCHIWFI 132 (824)
Q Consensus 121 ~~a~~~C~v~~i 132 (824)
+. .-|.|+++
T Consensus 121 ~~--~~~pvliv 130 (130)
T cd00293 121 RH--APCPVLVV 130 (130)
T ss_pred hC--CCCCEEeC
Confidence 77 34777653
|
The universal stress protein Usp is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. Usp enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae Usp reveals an alpha/beta fold similar to that of the Methanococcus jannaschii MJ0577 protein, which binds ATP, athough Usp lacks ATP-binding activity. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.27 E-value=9.3e-05 Score=92.04 Aligned_cols=175 Identities=15% Similarity=0.040 Sum_probs=122.7
Q ss_pred EEEEEEecCCCCCCchh-----HHHHHHHHHhcCCCceeeEecccC----CceEEEEEecCCCChhhhhhcc-CCCCCCC
Q 003384 489 QVAIKMLHPHSLQGPSE-----FQQEIDILSKIRHPNLVTLVGACP----EVWTLVYEYLPNGSLEDRLSCK-DNSPPLS 558 (824)
Q Consensus 489 ~VAvK~l~~~~~~~~~~-----f~~Ei~iL~~l~HpnIv~L~g~~~----~~~~LV~Ey~~ggsL~~~L~~~-~~~~~l~ 558 (824)
.+.+|+.+....+...+ ...|.+-++...|+++...+.-.+ ..-+.+++|+.+|.+.+.|.+. ...+++.
T Consensus 1254 ~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld 1333 (2724)
T KOG1826|consen 1254 WFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLD 1333 (2724)
T ss_pred eeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcch
Confidence 35666665544333222 334555566678999887665442 2457899999999999988654 3344444
Q ss_pred HHHHHHHHHHHHHHHHHHhhcCC--CceEeccccCCcEEecCCCcceeeccccccccccccccCCCccccccCCCCCCcc
Q 003384 559 WQTRIRIATELCSVLIFLHSCKP--HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 636 (824)
Q Consensus 559 ~~~~~~ia~qia~aL~~LH~~~~--~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~ 636 (824)
..-......+......-+|.... +--+|++||+.|.+|..++.+|++++|+.+...... ...+...+++.
T Consensus 1334 ~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~--------sf~Gl~l~sp~ 1405 (2724)
T KOG1826|consen 1334 RSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVL--------SFFGLELCSPI 1405 (2724)
T ss_pred hchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCchH--------hhhhhhhCCHH
Confidence 44444333333455555555332 236899999999999999999999999998322211 11245568899
Q ss_pred cCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCC
Q 003384 637 YMDPEFLASGELTPKSDVYSFGIILLRLLTGRPAL 671 (824)
Q Consensus 637 Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf 671 (824)
|+.|++...-.++.++|+|..|+-+|+.--|.++|
T Consensus 1406 ~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1406 YVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred HHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence 99999998889998999999999999999999888
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0046 Score=67.77 Aligned_cols=141 Identities=18% Similarity=0.211 Sum_probs=83.8
Q ss_pred cceeeecCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCc--eeeEeccc--------CCceEEEEEe
Q 003384 469 SLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPN--LVTLVGAC--------PEVWTLVYEY 538 (824)
Q Consensus 469 ~~~LG~G~fG~Vykg~~~~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~Hpn--Iv~L~g~~--------~~~~~LV~Ey 538 (824)
...|+.|-...+|+....+..+++|+.+... ....+..|++++..|...+ +.+++... .+..+++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~ 104 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVGRYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEF 104 (307)
T ss_pred ccccCCccccceEEEEeCCCcEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEe
Confidence 3456777778999887666678889875421 2446677888888774222 34444332 2346789999
Q ss_pred cCCCChhh-----------h---hhccCCC--CC-------CCHHHHHH------------HHHHHHHHHHHHhh----c
Q 003384 539 LPNGSLED-----------R---LSCKDNS--PP-------LSWQTRIR------------IATELCSVLIFLHS----C 579 (824)
Q Consensus 539 ~~ggsL~~-----------~---L~~~~~~--~~-------l~~~~~~~------------ia~qia~aL~~LH~----~ 579 (824)
++|..+.. . ++..... .+ -.|..... ....+...+.++.. .
T Consensus 105 i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~ 184 (307)
T TIGR00938 105 LQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRD 184 (307)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhc
Confidence 99865421 0 1110000 00 11111100 01123334555532 2
Q ss_pred CCCceEeccccCCcEEecCCCcceeecccccc
Q 003384 580 KPHSIVHGDLKPANILLDANFVSKLSDFGISR 611 (824)
Q Consensus 580 ~~~giiHrDLKp~NILld~~~~vKL~DFGla~ 611 (824)
.+.+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 185 ~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 185 LPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 35789999999999999998877899999754
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK15456 universal stress protein UspG; Provisional | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0022 Score=61.75 Aligned_cols=86 Identities=16% Similarity=0.166 Sum_probs=66.5
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHhhcCeeeEEEEeecCchHHHHHHHHHHcCCCEEEeccCcCccchhhhcccchhhHHhh
Q 003384 40 QAYREIERQDMHNHLDMCLLICRQMGVRAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISV 119 (824)
Q Consensus 40 ~~~~~~e~~~~~~~l~~~~~~C~~~~V~~~~~~ie~~dv~~~i~e~i~~~~i~~LV~Ga~~~~~~~~~~~~~~s~~a~~v 119 (824)
+.|.+..++..++.|+++.......+++++..+.+ +++++.|++++.+++++.+|||++.. +..+ -+-...|..|
T Consensus 56 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~v~~~v~~-G~~~~~I~~~a~~~~~DLIVmG~~g~-~~~~---~llGS~a~~v 130 (142)
T PRK15456 56 RRFEEHLQHEAEERLQTMVSHFTIDPSRIKQHVRF-GSVRDEVNELAEELGADVVVIGSRNP-SIST---HLLGSNASSV 130 (142)
T ss_pred hhHHHHHHHHHHHHHHHHHHHhCCCCcceEEEEcC-CChHHHHHHHHhhcCCCEEEEcCCCC-Cccc---eecCccHHHH
Confidence 34666667777888888888877778888877666 79999999999999999999999942 2222 1223467789
Q ss_pred hccCCCccEEEEE
Q 003384 120 RQQAPASCHIWFI 132 (824)
Q Consensus 120 ~~~a~~~C~v~~i 132 (824)
.+.++ |.|.+|
T Consensus 131 ~~~a~--~pVLvV 141 (142)
T PRK15456 131 IRHAN--LPVLVV 141 (142)
T ss_pred HHcCC--CCEEEe
Confidence 99976 999886
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.0015 Score=71.31 Aligned_cols=138 Identities=22% Similarity=0.290 Sum_probs=81.8
Q ss_pred eeeecCceEEEEEEECC--------eEEEEEEecCCCCCCchhHHHHHHHHHhcCCCc-eeeEecccCCceEEEEEecCC
Q 003384 471 KIGEGGYGSIYKGLLRH--------MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPN-LVTLVGACPEVWTLVYEYLPN 541 (824)
Q Consensus 471 ~LG~G~fG~Vykg~~~~--------~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~Hpn-Iv~L~g~~~~~~~LV~Ey~~g 541 (824)
.|..|--..||+....+ ..+++|+..... .......+|..++..+...+ ..++++++.+ .+|+||++|
T Consensus 5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~--~~v~e~i~G 81 (302)
T cd05156 5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN--GRIEEFIPS 81 (302)
T ss_pred EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC--CchhheeCC
Confidence 45556667888877653 678999876533 22345678999998885332 3355666543 368999998
Q ss_pred CChhhh-----------------hhccCCCC------CCC--HHHHHHH--------------------------HHHHH
Q 003384 542 GSLEDR-----------------LSCKDNSP------PLS--WQTRIRI--------------------------ATELC 570 (824)
Q Consensus 542 gsL~~~-----------------L~~~~~~~------~l~--~~~~~~i--------------------------a~qia 570 (824)
..+... |+...... ..+ +.....+ ...+.
T Consensus 82 ~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (302)
T cd05156 82 RTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLEDEA 161 (302)
T ss_pred CcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHHHH
Confidence 776431 11111110 111 1111110 11122
Q ss_pred HHHHHHhh------cCCCceEeccccCCcEEecCC----Ccceeecccccc
Q 003384 571 SVLIFLHS------CKPHSIVHGDLKPANILLDAN----FVSKLSDFGISR 611 (824)
Q Consensus 571 ~aL~~LH~------~~~~giiHrDLKp~NILld~~----~~vKL~DFGla~ 611 (824)
..+.+|-. ..+..++|+|+.|.|||++.+ +.++|+||+.|.
T Consensus 162 ~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 162 KYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 22334432 134679999999999999985 889999999764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK15005 universal stress protein F; Provisional | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.0022 Score=61.59 Aligned_cols=81 Identities=16% Similarity=0.194 Sum_probs=62.3
Q ss_pred HHHHHHHHHHHHHHHHHhhcCeeeEEEEeecCchHHHHHHHHHHcCCCEEEeccCcCccchhhhcccchhhHHhhhccCC
Q 003384 45 IERQDMHNHLDMCLLICRQMGVRAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAP 124 (824)
Q Consensus 45 ~e~~~~~~~l~~~~~~C~~~~V~~~~~~ie~~dv~~~i~e~i~~~~i~~LV~Ga~~~~~~~~~~~~~~s~~a~~v~~~a~ 124 (824)
..++...+.|..+...+...+++++..+.+ +++++.|++++.+++++.+|||++ .++..+. +-...+..|++++|
T Consensus 63 ~~~~~~~~~l~~~~~~~~~~~~~~~~~v~~-G~p~~~I~~~a~~~~~DLIV~Gs~-~~~~~~~---llGS~a~~vl~~a~ 137 (144)
T PRK15005 63 DLKAEAKSQLEEIIKKFKLPTDRVHVHVEE-GSPKDRILELAKKIPADMIIIASH-RPDITTY---LLGSNAAAVVRHAE 137 (144)
T ss_pred HHHHHHHHHHHHHHHHhCCCCCceEEEEeC-CCHHHHHHHHHHHcCCCEEEEeCC-CCCchhe---eecchHHHHHHhCC
Confidence 344555677778877777788888877766 899999999999999999999988 3333222 22346789999987
Q ss_pred CccEEEEE
Q 003384 125 ASCHIWFI 132 (824)
Q Consensus 125 ~~C~v~~i 132 (824)
|.|++|
T Consensus 138 --cpVlvV 143 (144)
T PRK15005 138 --CSVLVV 143 (144)
T ss_pred --CCEEEe
Confidence 999987
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.0068 Score=62.27 Aligned_cols=126 Identities=24% Similarity=0.272 Sum_probs=83.6
Q ss_pred ccceeeecCceEEEEEEEC-CeEEEEEEecCCC----------------CCCchhHHHHHHHHHhcC------CCceeeE
Q 003384 468 PSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHS----------------LQGPSEFQQEIDILSKIR------HPNLVTL 524 (824)
Q Consensus 468 ~~~~LG~G~fG~Vykg~~~-~~~VAvK~l~~~~----------------~~~~~~f~~Ei~iL~~l~------HpnIv~L 524 (824)
....||+|+.=.||. +. +....||+..+.. ....+++.+|+.-...+. +.+|.++
T Consensus 5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 345799999999994 33 3557889887655 122356778888777766 7889999
Q ss_pred ecccCC--ceEEEEEecCC------CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEe
Q 003384 525 VGACPE--VWTLVYEYLPN------GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL 596 (824)
Q Consensus 525 ~g~~~~--~~~LV~Ey~~g------gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILl 596 (824)
+|.... +..+|+|.+.+ .+|.+++.. ..++. ..... +-.-..||-. +.|+.+||+|.||++
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~----~~~~~-~~~~~---L~~f~~~l~~---~~Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKE----GGLTE-ELRQA---LDEFKRYLLD---HHIVIRDLNPHNIVV 151 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHc----CCccH-HHHHH---HHHHHHHHHH---cCCeecCCCcccEEE
Confidence 998743 56788888643 257777732 23443 33333 3334445555 679999999999999
Q ss_pred cCC--C--cceeec
Q 003384 597 DAN--F--VSKLSD 606 (824)
Q Consensus 597 d~~--~--~vKL~D 606 (824)
..+ + .+.|+|
T Consensus 152 ~~~~~~~~~lvlID 165 (199)
T PF10707_consen 152 QRRDSGEFRLVLID 165 (199)
T ss_pred EecCCCceEEEEEe
Confidence 643 2 455665
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK11175 universal stress protein UspE; Provisional | Back alignment and domain information |
|---|
Probab=96.82 E-value=0.0073 Score=65.92 Aligned_cols=94 Identities=11% Similarity=0.055 Sum_probs=71.8
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHhhcCeeeEEEEeecCchHHHHHHHHHHcCCCEEEeccCcCccchhhhcccchhh
Q 003384 36 EEKVQAYREIERQDMHNHLDMCLLICRQMGVRAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKK 115 (824)
Q Consensus 36 ~e~v~~~~~~e~~~~~~~l~~~~~~C~~~~V~~~~~~ie~~dv~~~i~e~i~~~~i~~LV~Ga~~~~~~~~~~~~~~s~~ 115 (824)
.+..+.++++..++.++.|+.+...|...+++++..++..+++.++|++++..++++.+|||++.. +...+-+-...
T Consensus 53 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~v~~~g~~~~~i~~~a~~~~~DLiV~G~~~~---~~~~~~~~gs~ 129 (305)
T PRK11175 53 PDEREAMRQGVISQRTAWIREQAKPYLDAGIPIEIKVVWHNRPFEAIIQEVIAGGHDLVVKMTHQH---DKLESVIFTPT 129 (305)
T ss_pred hhHHHHHHHHHHHHHHHHHHHHHHHHhhcCCceEEEEecCCCcHHHHHHHHHhcCCCEEEEeCCCC---cHHHhhccChh
Confidence 333444555555567788999999999999999998887799999999999999999999999933 33332222335
Q ss_pred HHhhhccCCCccEEEEEec
Q 003384 116 AISVRQQAPASCHIWFICN 134 (824)
Q Consensus 116 a~~v~~~a~~~C~v~~i~~ 134 (824)
+..|+..+| |-|++|-.
T Consensus 130 ~~~l~~~~~--~pvlvv~~ 146 (305)
T PRK11175 130 DWHLLRKCP--CPVLMVKD 146 (305)
T ss_pred HHHHHhcCC--CCEEEecc
Confidence 667888876 99999943
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.82 E-value=0.0066 Score=67.86 Aligned_cols=138 Identities=16% Similarity=0.184 Sum_probs=80.9
Q ss_pred eeeecCceEEEEEEEC------CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCce-eeEecccCCceEEEEEecCCCC
Q 003384 471 KIGEGGYGSIYKGLLR------HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNL-VTLVGACPEVWTLVYEYLPNGS 543 (824)
Q Consensus 471 ~LG~G~fG~Vykg~~~------~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnI-v~L~g~~~~~~~LV~Ey~~ggs 543 (824)
.|-.|-.-.+|+..+. +..|++|+.........+ -.+|..++..+..-++ .++++.+... .|++|+++.+
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g--~v~efi~g~~ 119 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG--RVEEFIHART 119 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc--eEEEeeCCCC
Confidence 4545667789987653 257899987654322222 3679999988854333 3456666544 6899998877
Q ss_pred hhhh-----------------hhccCC-C-C-CCCHHHHHHHHHH-----------------HHHHHHHH----hh-cCC
Q 003384 544 LEDR-----------------LSCKDN-S-P-PLSWQTRIRIATE-----------------LCSVLIFL----HS-CKP 581 (824)
Q Consensus 544 L~~~-----------------L~~~~~-~-~-~l~~~~~~~ia~q-----------------ia~aL~~L----H~-~~~ 581 (824)
|... |+.... . . +..+.....+..+ +...+..| .. ..+
T Consensus 120 l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~~ 199 (344)
T PLN02236 120 LSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQE 199 (344)
T ss_pred CCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCCC
Confidence 6421 111110 0 1 1122333233211 11112222 21 223
Q ss_pred CceEeccccCCcEEecC-CCcceeecccccc
Q 003384 582 HSIVHGDLKPANILLDA-NFVSKLSDFGISR 611 (824)
Q Consensus 582 ~giiHrDLKp~NILld~-~~~vKL~DFGla~ 611 (824)
..++|+|+++.|||+++ ++.+.|+||..|.
T Consensus 200 ~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 200 IGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred ceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 57899999999999986 4789999999765
|
|
| >PRK10116 universal stress protein UspC; Provisional | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.0091 Score=57.23 Aligned_cols=86 Identities=13% Similarity=0.191 Sum_probs=64.2
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHhhcCeeeEEEEeecCchHHHHHHHHHHcCCCEEEeccCcCccchhhhcccchhhH
Q 003384 37 EKVQAYREIERQDMHNHLDMCLLICRQMGVRAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKA 116 (824)
Q Consensus 37 e~v~~~~~~e~~~~~~~l~~~~~~C~~~~V~~~~~~ie~~dv~~~i~e~i~~~~i~~LV~Ga~~~~~~~~~~~~~~s~~a 116 (824)
...+.+++..++...+.|..+ +.+.++..+...++.+++.++|++++.+.+++.+|||++.+.+..+.. | .|
T Consensus 52 ~~~~~~~~~~~~~~~~~l~~~---~~~~~~~~~~~~~~~G~~~~~I~~~a~~~~~DLiV~g~~~~~~~~~~~----s-~a 123 (142)
T PRK10116 52 PMLEDLRSVMQEETQSFLDKL---IQDADYPIEKTFIAYGELSEHILEVCRKHHFDLVICGNHNHSFFSRAS----C-SA 123 (142)
T ss_pred HHHHHHHHHHHHHHHHHHHHH---HHhcCCCeEEEEEecCCHHHHHHHHHHHhCCCEEEEcCCcchHHHHHH----H-HH
Confidence 344556666666666666655 456788877778888999999999999999999999999544443332 3 47
Q ss_pred HhhhccCCCccEEEEE
Q 003384 117 ISVRQQAPASCHIWFI 132 (824)
Q Consensus 117 ~~v~~~a~~~C~v~~i 132 (824)
..|+..+ -|.|.+|
T Consensus 124 ~~v~~~~--~~pVLvv 137 (142)
T PRK10116 124 KRVIASS--EVDVLLV 137 (142)
T ss_pred HHHHhcC--CCCEEEE
Confidence 7888884 5999987
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.018 Score=65.34 Aligned_cols=79 Identities=14% Similarity=0.053 Sum_probs=57.0
Q ss_pred cceeeecCceEEEEEEECCeEEEEEEecCCCC-------CCchhHHHHHHHHHhcC---CCceeeEecccCCceEEEEEe
Q 003384 469 SLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSL-------QGPSEFQQEIDILSKIR---HPNLVTLVGACPEVWTLVYEY 538 (824)
Q Consensus 469 ~~~LG~G~fG~Vykg~~~~~~VAvK~l~~~~~-------~~~~~f~~Ei~iL~~l~---HpnIv~L~g~~~~~~~LV~Ey 538 (824)
.+.||.|....||+....+..|+||.-.+... .+...-..|...|+.+. ..++.+++.+|.+..++||||
T Consensus 37 ~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~~vlvME~ 116 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTMALIGMRY 116 (418)
T ss_pred EEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCCCEEEEee
Confidence 45689999999999887777799997542111 13345556677777664 357888999999989999999
Q ss_pred cCC--CChhhh
Q 003384 539 LPN--GSLEDR 547 (824)
Q Consensus 539 ~~g--gsL~~~ 547 (824)
+++ ..+.+.
T Consensus 117 L~~~~~ilr~~ 127 (418)
T PLN02756 117 LEPPHIILRKG 127 (418)
T ss_pred cCCcceehhhh
Confidence 977 345443
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.65 E-value=0.0047 Score=76.27 Aligned_cols=188 Identities=24% Similarity=0.241 Sum_probs=126.9
Q ss_pred HHHHHHHHhcCCCceeeEecccCCc------eEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 003384 507 QQEIDILSKIRHPNLVTLVGACPEV------WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 580 (824)
Q Consensus 507 ~~Ei~iL~~l~HpnIv~L~g~~~~~------~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~ 580 (824)
..|...+.++.|+|++.++++.-+. ..+..+||..-++...+. .-..++..+.+.+..++.+||.|+|..
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q---~v~~i~~~~~r~~~~~~~~GL~~~h~~- 305 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ---SVGSIPLETLRILHQKLLEGLAYLHSL- 305 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh---hccccCHHHHHHHHHHHhhhHHHHHHh-
Confidence 4577778888999999998876321 123457888888888884 445677888888999999999999994
Q ss_pred CCceEeccccCC---cEEecCCCcceee--ccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcc--hh
Q 003384 581 PHSIVHGDLKPA---NILLDANFVSKLS--DFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPK--SD 653 (824)
Q Consensus 581 ~~giiHrDLKp~---NILld~~~~vKL~--DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~k--sD 653 (824)
...|.-|..+ +...+..+.+.++ ||+.+..+........ ..-+..|.+||......++.+ .|
T Consensus 306 --~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~---------~~~~~~~~~~e~~~~~~~~~~r~~d 374 (1351)
T KOG1035|consen 306 --SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS---------DLLAEIRNADEDLKENTAKKSRLTD 374 (1351)
T ss_pred --ccceeEEecccccccccCccceeecchhhhcccccCCCcccchh---------hcCccccccccccccccchhhhhhH
Confidence 3444444444 4445566677776 8888876655443221 123556778887766655544 69
Q ss_pred HHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 654 VYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 654 VwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
+|.+|..+..+..|..+-...... ..+++. .....+.+....|+..++++|+...+
T Consensus 375 L~~lgll~~~~~~~~~i~~~~~~~---------~~~l~~-------~~~~~~~d~~~~~~~~~~~~Rl~~~~ 430 (1351)
T KOG1035|consen 375 LWCLGLLLLQLSQGEDISEKSAVP---------VSLLDV-------LSTSELLDALPKCLDEDSEERLSALE 430 (1351)
T ss_pred HHHHHHHHhhhhhcCcccccccch---------hhhhcc-------ccchhhhhhhhhhcchhhhhccchhh
Confidence 999999999999987554221111 111111 11115677888999999999999843
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.54 E-value=0.019 Score=64.07 Aligned_cols=78 Identities=15% Similarity=0.114 Sum_probs=54.2
Q ss_pred eeeecCceEEEEEEECC--eEEEEEEecCC-------CCCCchhHHHHHHHHHhcC--CC-ceeeEecccCCceEEEEEe
Q 003384 471 KIGEGGYGSIYKGLLRH--MQVAIKMLHPH-------SLQGPSEFQQEIDILSKIR--HP-NLVTLVGACPEVWTLVYEY 538 (824)
Q Consensus 471 ~LG~G~fG~Vykg~~~~--~~VAvK~l~~~-------~~~~~~~f~~Ei~iL~~l~--Hp-nIv~L~g~~~~~~~LV~Ey 538 (824)
.||.|....||++...+ +.|+||.-.+. ...+.++..-|...|+... -| .+.++|.+-++...+|||+
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D~e~~~~vMEd 81 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFDTEMAVTVMED 81 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEccccceehHhh
Confidence 47999999999998764 57999964321 1233456778888887764 34 4666777777778899999
Q ss_pred cCCC-Chhhhh
Q 003384 539 LPNG-SLEDRL 548 (824)
Q Consensus 539 ~~gg-sL~~~L 548 (824)
++.. .|.+.|
T Consensus 82 L~~~~ilR~~L 92 (370)
T TIGR01767 82 LSHHKIARKGL 92 (370)
T ss_pred CccchHHHHHH
Confidence 9543 344433
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.52 E-value=0.019 Score=63.18 Aligned_cols=132 Identities=19% Similarity=0.352 Sum_probs=79.0
Q ss_pred ecCce-EEEEEEECCeEEEEEEecC--CCCCCchhHHHHHHHHHhcCC--CceeeEecccCCce----EEEEEecCCCCh
Q 003384 474 EGGYG-SIYKGLLRHMQVAIKMLHP--HSLQGPSEFQQEIDILSKIRH--PNLVTLVGACPEVW----TLVYEYLPNGSL 544 (824)
Q Consensus 474 ~G~fG-~Vykg~~~~~~VAvK~l~~--~~~~~~~~f~~Ei~iL~~l~H--pnIv~L~g~~~~~~----~LV~Ey~~ggsL 544 (824)
.||+. .+|.....++.+++. ... ..........+|..+|+.+.- .-+...+++|.+.. +.||+|+.|..+
T Consensus 34 ~~G~sn~t~~~~~~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~ 112 (321)
T COG3173 34 SGGWSNDTFRLGDTGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVV 112 (321)
T ss_pred cCCcccceEEEecCCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceec
Confidence 34443 344444446677777 221 122223456788888888753 23455678886655 899999998544
Q ss_pred hhhhhccCCCCCCCHHHHHHHH-HHHHHHHHHHh----------------------------------------------
Q 003384 545 EDRLSCKDNSPPLSWQTRIRIA-TELCSVLIFLH---------------------------------------------- 577 (824)
Q Consensus 545 ~~~L~~~~~~~~l~~~~~~~ia-~qia~aL~~LH---------------------------------------------- 577 (824)
.+.+.. .+.. .+++ ..++..|+-||
T Consensus 113 ~~~~~~------~~~~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~ 184 (321)
T COG3173 113 WSALPP------ESLG--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLI 184 (321)
T ss_pred cCcCCc------ccch--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHH
Confidence 333310 0000 0111 13333333333
Q ss_pred ----hcC-----CCceEeccccCCcEEecCCCcceeeccccccccc
Q 003384 578 ----SCK-----PHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 614 (824)
Q Consensus 578 ----~~~-----~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~ 614 (824)
... +..++|+|+.+.||+++.++.+=|.||+++.+-.
T Consensus 185 ~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 185 KWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred HHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 311 2468999999999999999889999999987543
|
|
| >PF11789 zf-Nse: Zinc-finger of the MIZ type in Nse subunit; PDB: 2YU4_A 3HTK_C | Back alignment and domain information |
|---|
Probab=96.46 E-value=0.0011 Score=53.71 Aligned_cols=43 Identities=28% Similarity=0.597 Sum_probs=30.9
Q ss_pred CCcccchhhhccCCccc-cCCccchhhhhhhhh-cCCCCCCCCCC
Q 003384 757 YFTCPIFQEVMQDPHVA-ADGFTYEAEALKGWL-DSGHETSPMTN 799 (824)
Q Consensus 757 ~f~cPi~~evm~dPvi~-~~g~tye~~~i~~wl-~~~~~t~p~t~ 799 (824)
.+.|||+...+.|||.. .-|++|++++|.+|| +.+...||+++
T Consensus 11 ~~~CPiT~~~~~~PV~s~~C~H~fek~aI~~~i~~~~~~~CPv~G 55 (57)
T PF11789_consen 11 SLKCPITLQPFEDPVKSKKCGHTFEKEAILQYIQRNGSKRCPVAG 55 (57)
T ss_dssp -SB-TTTSSB-SSEEEESSS--EEEHHHHHHHCTTTS-EE-SCCC
T ss_pred ccCCCCcCChhhCCcCcCCCCCeecHHHHHHHHHhcCCCCCCCCC
Confidence 47899999999999997 449999999999999 44556798865
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.26 E-value=0.003 Score=68.32 Aligned_cols=148 Identities=15% Similarity=0.191 Sum_probs=95.0
Q ss_pred cCCCChhhHhhhcC---CCCccceeeecCceEEEEEEEC-CeEEEEEEecCC--CCC----------------C----ch
Q 003384 451 FSDFSFSEIEGATH---NFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPH--SLQ----------------G----PS 504 (824)
Q Consensus 451 ~~~~~~~ei~~~~~---~f~~~~~LG~G~fG~Vykg~~~-~~~VAvK~l~~~--~~~----------------~----~~ 504 (824)
+.-|.+--|+...+ -+..+..||-|--+.||.+-+. |++.++|.-... +.. + .-
T Consensus 76 y~GyDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRl 155 (465)
T KOG2268|consen 76 YAGYDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRL 155 (465)
T ss_pred eccchHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHH
Confidence 34445544443333 3677889999999999999887 788888853211 000 0 01
Q ss_pred hHHHHHHHHHhcCCC--ceeeEecccCCceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 003384 505 EFQQEIDILSKIRHP--NLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 582 (824)
Q Consensus 505 ~f~~Ei~iL~~l~Hp--nIv~L~g~~~~~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~ 582 (824)
...+|...|+.|... -+.+.+++ ...++|||++.|-.|...-+- .+..+ +...+...+--|-. +
T Consensus 156 aa~kEfafmkaL~e~gfpVPkpiD~--~RH~Vvmelv~g~Pl~~v~~v------~d~~~---ly~~lm~~Iv~la~---~ 221 (465)
T KOG2268|consen 156 AATKEFAFMKALYERGFPVPKPIDH--NRHCVVMELVDGYPLRQVRHV------EDPPT---LYDDLMGLIVRLAN---H 221 (465)
T ss_pred HHHHHHHHHHHHHHcCCCCCCcccc--cceeeHHHhhcccceeeeeec------CChHH---HHHHHHHHHHHHHH---c
Confidence 134688888887431 13333443 346789999998887654321 11122 33334444444545 8
Q ss_pred ceEeccccCCcEEecCCCcceeeccccccc
Q 003384 583 SIVHGDLKPANILLDANFVSKLSDFGISRF 612 (824)
Q Consensus 583 giiHrDLKp~NILld~~~~vKL~DFGla~~ 612 (824)
|+||+|..-=||+++.++.++++||--+..
T Consensus 222 GlIHgDFNEFNimv~dd~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 222 GLIHGDFNEFNIMVKDDDKIVVIDFPQMVS 251 (465)
T ss_pred CceecccchheeEEecCCCEEEeechHhhc
Confidence 999999999999999999999999986653
|
|
| >PRK11175 universal stress protein UspE; Provisional | Back alignment and domain information |
|---|
Probab=96.14 E-value=0.017 Score=62.97 Aligned_cols=84 Identities=17% Similarity=0.242 Sum_probs=59.3
Q ss_pred HHHHHHHHHHHHHHHHHHHHhhcCeeeEEEEeecCchHHHHHHHHHHcCCCEEEeccCcCccchhhhcccchhhHHhhhc
Q 003384 42 YREIERQDMHNHLDMCLLICRQMGVRAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQ 121 (824)
Q Consensus 42 ~~~~e~~~~~~~l~~~~~~C~~~~V~~~~~~ie~~dv~~~i~e~i~~~~i~~LV~Ga~~~~~~~~~~~~~~s~~a~~v~~ 121 (824)
|.+..+....+.|.++.. ..++..+...+..++++++|++++..++++.||||++.++...+. +-...|..|+.
T Consensus 216 ~~~~~~~~~~~~l~~~~~---~~~~~~~~~~v~~G~~~~~I~~~a~~~~~DLIVmG~~~~~~~~~~---llGS~a~~v~~ 289 (305)
T PRK11175 216 YNDAIRGQHLLAMKALRQ---KFGIDEEQTHVEEGLPEEVIPDLAEHLDAELVILGTVGRTGLSAA---FLGNTAEHVID 289 (305)
T ss_pred HHHHHHHHHHHHHHHHHH---HhCCChhheeeccCCHHHHHHHHHHHhCCCEEEECCCccCCCcce---eecchHHHHHh
Confidence 333333344445555543 447776666677799999999999999999999999944444333 33446779999
Q ss_pred cCCCccEEEEEe
Q 003384 122 QAPASCHIWFIC 133 (824)
Q Consensus 122 ~a~~~C~v~~i~ 133 (824)
.++ |.|.+|.
T Consensus 290 ~~~--~pVLvv~ 299 (305)
T PRK11175 290 HLN--CDLLAIK 299 (305)
T ss_pred cCC--CCEEEEc
Confidence 987 9999983
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 824 | ||||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-49 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-48 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-48 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-45 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-43 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-43 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-37 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 9e-37 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 6e-24 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-23 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-22 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-22 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 7e-22 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-21 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-21 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-21 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-21 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-21 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-21 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-21 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-21 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-21 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-21 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-21 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 7e-21 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 8e-21 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 8e-21 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 8e-21 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 8e-21 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 9e-21 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-20 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-20 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-20 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-20 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-20 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-20 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-20 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-20 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-20 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-20 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-20 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-20 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-20 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-20 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-20 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-19 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-19 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-19 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-19 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-19 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-19 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-19 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-19 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-19 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-19 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-19 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-19 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-19 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-19 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 5e-19 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-19 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 7e-19 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-18 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-18 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-18 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-18 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-18 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-18 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-18 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-18 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-18 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-18 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-18 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-18 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-18 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-18 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-18 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-18 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 6e-18 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 6e-18 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-18 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 7e-18 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 9e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 9e-18 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 9e-18 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-17 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-17 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-17 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-17 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-17 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-17 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-17 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-17 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-17 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-17 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-17 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-17 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-17 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-17 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-17 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-17 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-17 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 5e-17 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 6e-17 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 8e-17 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 9e-17 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-16 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-16 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-16 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-16 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-16 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-16 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-16 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-16 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-16 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-16 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-16 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-16 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-16 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-16 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-16 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-16 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 6e-16 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 6e-16 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-16 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 6e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-16 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 6e-16 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 6e-16 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 6e-16 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-16 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 7e-16 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 7e-16 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-16 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 7e-16 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-16 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-16 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 8e-16 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-16 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 8e-16 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 8e-16 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 8e-16 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 8e-16 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 8e-16 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 9e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 9e-16 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-16 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 9e-16 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 9e-16 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-15 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-15 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-15 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-15 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-15 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-15 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-15 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-15 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-15 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-15 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-15 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-15 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-15 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-15 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-15 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-15 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-15 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-15 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-15 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-15 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-15 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-15 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-15 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-15 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-15 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-15 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-15 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-15 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-15 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-15 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-15 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-15 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-15 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-15 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-15 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-15 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-15 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-15 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 5e-15 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-15 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-15 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-15 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-15 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-15 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-15 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-15 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 7e-15 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 7e-15 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 7e-15 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-15 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 7e-15 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 7e-15 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 8e-15 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 8e-15 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 8e-15 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 9e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 9e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-14 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-14 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-14 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-14 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-14 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-14 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-14 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-14 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-14 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-14 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-14 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-14 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-14 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-14 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-14 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-14 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-14 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-14 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-14 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-14 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-14 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-14 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-14 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-14 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 5e-14 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 5e-14 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-14 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-14 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 6e-14 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 7e-14 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 7e-14 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 7e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-14 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 9e-14 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-13 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-13 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-13 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-13 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-13 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-13 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-13 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-13 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-13 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-13 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-13 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-13 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-13 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-13 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-13 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-13 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-13 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-13 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 5e-13 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-13 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-13 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-13 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 6e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-13 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 6e-13 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-13 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 7e-13 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 7e-13 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 8e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 9e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 9e-13 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-12 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-12 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-12 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-12 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-12 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-12 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-12 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-12 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-12 | ||
| 1t1h_A | 78 | Nmr Solution Structure Of The U Box Domain From Atp | 4e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-12 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-12 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-12 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 7e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-12 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 8e-12 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-12 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 9e-12 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 9e-12 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-11 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-11 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-11 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-11 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-11 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-11 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-11 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-11 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-11 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-11 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-11 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-11 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-11 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-11 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 5e-11 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 6e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-11 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 6e-11 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 6e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 6e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 6e-11 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 7e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 7e-11 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-11 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 7e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 7e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 7e-11 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 7e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 7e-11 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 7e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 7e-11 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 7e-11 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 8e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 8e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 8e-11 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 8e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 8e-11 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 8e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 8e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 8e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-11 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 8e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 8e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 8e-11 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 9e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 9e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 9e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 9e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 9e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-11 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 9e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 9e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-10 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-10 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-10 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-10 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-10 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-10 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-10 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-10 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-10 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-10 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-10 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-10 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-10 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-10 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-10 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-10 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-10 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 5e-10 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 5e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-10 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 5e-10 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 6e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 6e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 6e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 6e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 6e-10 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 6e-10 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 7e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 7e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 7e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 8e-10 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-10 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 9e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 9e-10 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-09 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-09 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-09 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-09 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-09 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-09 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-09 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-09 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-09 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-09 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-09 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-09 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 6e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 7e-09 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-09 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-09 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 8e-09 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-08 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-08 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-08 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-08 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-08 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-08 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-08 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-08 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-08 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-08 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-08 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-08 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-08 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-08 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-08 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-08 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-08 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-08 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-08 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-08 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-08 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-08 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-08 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 5e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-08 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 5e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 5e-08 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 5e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 5e-08 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 5e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 6e-08 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 6e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 7e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 7e-08 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 7e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 7e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 7e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 7e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 8e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 8e-08 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 8e-08 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-08 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 8e-08 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 8e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 8e-08 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 8e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 9e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 9e-08 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 9e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 9e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 9e-08 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 9e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 9e-08 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-07 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-07 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-07 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-07 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-07 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-07 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-07 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-07 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-07 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-07 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-07 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-07 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-07 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-07 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-07 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-07 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-07 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-07 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-07 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-07 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-07 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-07 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-07 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 5e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 5e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 6e-07 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 6e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 6e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 6e-07 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 6e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 7e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 7e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 7e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 7e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 8e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 8e-07 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 8e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 9e-07 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 9e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 9e-07 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-06 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-06 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-06 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-06 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-06 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-06 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-06 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-06 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-06 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-06 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-06 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-06 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-06 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-06 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-06 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-06 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-06 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-06 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-06 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-06 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 4e-06 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-06 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 6e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 6e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 6e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 6e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 6e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 6e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 7e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 7e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 7e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 7e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 7e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 9e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-05 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-05 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-05 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-05 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-05 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-05 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-05 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-05 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-05 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-05 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-05 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-05 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-05 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-05 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-05 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-05 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-05 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-05 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-05 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-05 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-05 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-05 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-05 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-05 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-05 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-05 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-05 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-05 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-05 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-05 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-05 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-05 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-05 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-05 | ||
| 2oxq_C | 80 | Structure Of The Ubch5 :chip U-Box Complex Length = | 2e-05 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-05 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-05 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-05 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-05 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-05 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-05 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-05 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-05 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-05 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-05 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-05 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-05 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-05 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-05 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-05 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-05 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-05 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-05 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-05 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-05 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-05 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-05 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-05 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-05 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-05 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-05 | ||
| 2f42_A | 179 | Dimerization And U-Box Domains Of Zebrafish C-Termi | 4e-05 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 4e-05 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 5e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 6e-05 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-05 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-05 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 6e-05 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-05 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 7e-05 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 7e-05 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 8e-05 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 9e-05 | ||
| 2csn_A | 297 | Binary Complex Of Casein Kinase-1 With Cki7 Length | 1e-04 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 1e-04 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-04 | ||
| 1eh4_A | 298 | Binary Complex Of Casein Kinase-1 From S. Pombe Wit | 1e-04 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-04 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-04 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-04 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-04 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-04 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-04 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-04 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-04 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-04 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-04 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-04 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-04 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-04 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-04 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-04 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-04 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-04 | ||
| 2c2l_A | 281 | Crystal Structure Of The Chip U-Box E3 Ubiquitin Li | 3e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-04 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-04 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-04 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-04 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-04 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-04 |
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1T1H|A Chain A, Nmr Solution Structure Of The U Box Domain From Atpub14, An Armadillo Repeat Containing Protein From Arabidopsis Thaliana Length = 78 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2OXQ|C Chain C, Structure Of The Ubch5 :chip U-Box Complex Length = 80 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2F42|A Chain A, Dimerization And U-Box Domains Of Zebrafish C-Terminal Of Hsp70 Interacting Protein Length = 179 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2C2L|A Chain A, Crystal Structure Of The Chip U-Box E3 Ubiquitin Ligase Length = 281 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 311 bits (798), Expect = 1e-99
Identities = 118/314 (37%), Positives = 176/314 (56%), Gaps = 31/314 (9%)
Query: 437 SRKEASSSSHMPQFFS-DFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH-MQVAIKM 494
S +A SSS++ F S ++E AT+NFD IG G +G +YKG+LR +VA+K
Sbjct: 11 SINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR 70
Query: 495 LHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVYEYLPNGSLEDRLSCKD 552
P S QG EF+ EI+ LS RHP+LV+L+G C E L+Y+Y+ NG+L+ L D
Sbjct: 71 RTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSD 130
Query: 553 N-SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR 611
+ +SW+ R+ I L +LH+ +I+H D+K NILLD NFV K++DFGIS+
Sbjct: 131 LPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISK 187
Query: 612 FLSQNE---ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR 668
++ + +S T KGT Y+DPE+ G LT KSDVYSFG++L +L R
Sbjct: 188 KGTELDQTHLS---------TVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR 238
Query: 669 PALGITKE------VQYA---LDTGKLKNLLDP-LAGDWPFVQAEQLANLAMRCCEMSRK 718
A+ + ++A + G+L+ ++DP LA + + A++C +S +
Sbjct: 239 SAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSE 298
Query: 719 SRPELGKDVWRVLE 732
RP +G DV LE
Sbjct: 299 DRPSMG-DVLWKLE 311
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 308 bits (791), Expect = 1e-98
Identities = 114/304 (37%), Positives = 171/304 (56%), Gaps = 31/304 (10%)
Query: 454 FSFSEIEGATHNFDPSL------KIGEGGYGSIYKGLLRHMQVAIKMLHPH----SLQGP 503
FSF E++ T+NFD K+GEGG+G +YKG + + VA+K L + +
Sbjct: 15 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 74
Query: 504 SEFQQEIDILSKIRHPNLVTLVGACPEVWT--LVYEYLPNGSLEDRLSCKDNSPPLSWQT 561
+F QEI +++K +H NLV L+G + LVY Y+PNGSL DRLSC D +PPLSW
Sbjct: 75 QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHM 134
Query: 562 RIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 621
R +IA + + FLH + +H D+K ANILLD F +K+SDFG++R + +
Sbjct: 135 RCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVM 191
Query: 622 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYAL 681
+ + GT AYM PE L GE+TPKSD+YSFG++LL ++TG PA+ +E Q L
Sbjct: 192 TSRI------VGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL 244
Query: 682 --------DTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP 733
+ +++ +D D E + ++A +C + RP++ V ++L+
Sbjct: 245 DIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIK-KVQQLLQE 303
Query: 734 MRAS 737
M AS
Sbjct: 304 MTAS 307
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 276 bits (708), Expect = 3e-86
Identities = 101/299 (33%), Positives = 161/299 (53%), Gaps = 31/299 (10%)
Query: 454 FSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGP-SEFQQEID 511
FS E++ A+ NF +G GG+G +YKG L VA+K L QG +FQ E++
Sbjct: 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79
Query: 512 ILSKIRHPNLVTLVGACPE--VWTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATE 568
++S H NL+ L G C LVY Y+ NGS+ L ++ PPL W R RIA
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 569 LCSVLIFLH-SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE--ISSNNTTL 625
L +LH C P I+H D+K ANILLD F + + DFG+++ + + ++
Sbjct: 140 SARGLAYLHDHCDPK-IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT------ 192
Query: 626 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE--------V 677
T +GT ++ PE+L++G+ + K+DV+ +G++LL L+TG+ A + + +
Sbjct: 193 ---TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 249
Query: 678 QYA---LDTGKLKNLLDP-LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 732
+ L KL+ L+D L G++ + EQL +A+ C + S RP++ +V R+LE
Sbjct: 250 DWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMS-EVVRMLE 307
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 1e-67
Identities = 77/273 (28%), Positives = 124/273 (45%), Gaps = 21/273 (7%)
Query: 471 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPE 530
+G G +G + K R VAIK + S + F E+ LS++ HPN+V L GAC
Sbjct: 15 VVGRGAFGVVCKAKWRAKDVAIKQIESESERK--AFIVELRQLSRVNHPNIVKLYGACLN 72
Query: 531 VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLK 590
LV EY GSL + L + P + + + + +LHS +P +++H DLK
Sbjct: 73 PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLK 132
Query: 591 PANILLDANF-VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELT 649
P N+LL A V K+ DFG + + + T+ KG+ A+M PE +
Sbjct: 133 PPNLLLVAGGTVLKICDFGTACDIQTH-----------MTNNKGSAAWMAPEVFEGSNYS 181
Query: 650 PKSDVYSFGIILLRLLTGR-PALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANL 708
K DV+S+GIIL ++T R P I + PL + P + + +L
Sbjct: 182 EKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVH-NGTRPPLIKNLP----KPIESL 236
Query: 709 AMRCCEMSRKSRPELGKDVWRVLEPMRASCGGS 741
RC RP + +++ +++ + G+
Sbjct: 237 MTRCWSKDPSQRPSM-EEIVKIMTHLMRYFPGA 268
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 222 bits (569), Expect = 2e-66
Identities = 83/315 (26%), Positives = 134/315 (42%), Gaps = 21/315 (6%)
Query: 428 VKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH 487
+K ++ F +++ + + KIG G +G++++
Sbjct: 1 MKHHHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHG 60
Query: 488 MQVAIKMLHPHSLQGPS--EFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNGS 543
VA+K+L EF +E+ I+ ++RHPN+V +GA P ++V EYL GS
Sbjct: 61 SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGS 120
Query: 544 LEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSK 603
L L L + R+ +A ++ + +LH+ P IVH +LK N+L+D + K
Sbjct: 121 LYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP-PIVHRNLKSPNLLVDKKYTVK 179
Query: 604 LSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLR 663
+ DFG+SR + +SS GT +M PE L KSDVYSFG+IL
Sbjct: 180 VCDFGLSRLKASTFLSS--------KSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWE 231
Query: 664 LLTGR-PALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPE 722
L T + P + Q G K + + Q+A + C RP
Sbjct: 232 LATLQQPWGNLN-PAQVVAAVGF-KCKRLEIPRNLN----PQVAAIIEGCWTNEPWKRPS 285
Query: 723 LGKDVWRVLEPMRAS 737
+ +L P+ S
Sbjct: 286 F-ATIMDLLRPLIKS 299
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 5e-63
Identities = 67/319 (21%), Positives = 115/319 (36%), Gaps = 53/319 (16%)
Query: 437 SRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLH 496
SS D + + G +G ++K L + VA+K+
Sbjct: 3 HHHHHHSSG------VDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFP 56
Query: 497 PHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC---PEVWT---LVYEYLPNGSLEDRLSC 550
Q + + E+ L ++H N++ +GA V L+ + GSL D L
Sbjct: 57 IQDKQS-WQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-- 113
Query: 551 KDNSPPLSWQTRIRIATELCSVLIFLHS--------CKPHSIVHGDLKPANILLDANFVS 602
+ +SW IA + L +LH KP I H D+K N+LL N +
Sbjct: 114 --KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA-ISHRDIKSKNVLLKNNLTA 170
Query: 603 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-----ELTPKSDVYSF 657
++DFG++ + + + GT YM PE L + + D+Y+
Sbjct: 171 CIADFGLALKFEAGKSAGDTHGQV------GTRRYMAPEVLEGAINFQRDAFLRIDMYAM 224
Query: 658 GIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSR 717
G++L L + A + +Y L + + M+ + +
Sbjct: 225 GLVLWELASRCTAADGPVD-EYML------PFEEEIGQHPSLED--------MQEVVVHK 269
Query: 718 KSRPELGKDVWRVLEPMRA 736
K RP L +D W+ M
Sbjct: 270 KKRPVL-RDYWQKHAGMAM 287
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 9e-62
Identities = 74/279 (26%), Positives = 118/279 (42%), Gaps = 36/279 (12%)
Query: 471 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPS----EFQQEIDILSKIRHPNLVTLVG 526
IG GG+G +Y+ +VA+K + S +QE + + ++HPN++ L G
Sbjct: 14 IIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 527 AC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 584
C LV E+ G L LS K + + A ++ + +LH I
Sbjct: 74 VCLKEPNLCLVMEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEAIVPI 129
Query: 585 VHGDLKPANILLD--------ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 636
+H DLK +NIL+ +N + K++DFG++R + S G +A
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA----------AGAYA 179
Query: 637 YMDPEFLASGELTPKSDVYSFGIILLRLLTGR-PALGITKEVQYALDTGKLKNLLDPLAG 695
+M PE + + + SDV+S+G++L LLTG P GI + A L P+
Sbjct: 180 WMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID-GLAVAYGVAM-NKLALPIPS 237
Query: 696 DWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 734
P E A L C SRP ++ L +
Sbjct: 238 TCP----EPFAKLMEDCWNPDPHSRPSF-TNILDQLTTI 271
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 5e-61
Identities = 72/273 (26%), Positives = 121/273 (44%), Gaps = 26/273 (9%)
Query: 471 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPS--EFQQEIDILSKIRHPNLVTLVGAC 528
+IG G +G++YKG H VA+KML+ + F+ E+ +L K RH N++ +G
Sbjct: 31 RIGSGSFGTVYKGKW-HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 529 -PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 587
+V ++ SL L + + I IA + + +LH+ I+H
Sbjct: 90 TAPQLAIVTQWCEGSSLYHHL--HASETKFEMKKLIDIARQTARGMDYLHAKS---IIHR 144
Query: 588 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 647
DLK NI L + K+ DFG++ S+ S G+ +M PE + +
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQ------LSGSILWMAPEVIRMQD 198
Query: 648 LTP---KSDVYSFGIILLRLLTGR-PALGIT--KEVQYALDTGKLKNLLDPLAGDWPFVQ 701
P +SDVY+FGI+L L+TG+ P I ++ + G L L + + P
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCP--- 255
Query: 702 AEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 734
+++ L C + R RP + +E +
Sbjct: 256 -KRMKRLMAECLKKKRDERPSF-PRILAEIEEL 286
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 4e-60
Identities = 80/282 (28%), Positives = 135/282 (47%), Gaps = 38/282 (13%)
Query: 471 KIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPS-------EFQQEIDILSKIRHPNL 521
+IG+GG+G ++KG + VAIK L +G + EFQ+E+ I+S + HPN+
Sbjct: 26 QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 522 VTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 581
V L G +V E++P G L RL D + P+ W ++R+ ++ + ++ + P
Sbjct: 86 VKLYGLMHNPPRMVMEFVPCGDLYHRL--LDKAHPIKWSVKLRLMLDIALGIEYMQNQNP 143
Query: 582 HSIVHGDLKPANILLD-----ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 636
IVH DL+ NI L A +K++DFG+S+ S ++ + G F
Sbjct: 144 -PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-------SVHSV----SGLLGNFQ 191
Query: 637 YMDPEFLASGEL--TPKSDVYSFGIILLRLLTGR-PALGIT-KEVQYALDTGKLKNLLDP 692
+M PE + + E T K+D YSF +IL +LTG P + ++++ + + L
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE-EGLRPT 250
Query: 693 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 734
+ D P +L N+ C K RP + + L +
Sbjct: 251 IPEDCP----PRLRNVIELCWSGDPKKRPHF-SYIVKELSEL 287
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 6e-60
Identities = 62/281 (22%), Positives = 109/281 (38%), Gaps = 20/281 (7%)
Query: 471 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 528
+G+G +G K R + +K L + F +E+ ++ + HPN++ +G
Sbjct: 17 VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 529 --PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 586
+ + EY+ G+L + K W R+ A ++ S + +LHS I+H
Sbjct: 77 YKDKRLNFITEYIKGGTLRGII--KSMDSQYPWSQRVSFAKDIASGMAYLHSMN---IIH 131
Query: 587 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK------GTFAYMDP 640
DL N L+ N ++DFG++R + + + D K G +M P
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
Query: 641 EFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV 700
E + K DV+SFGI+L ++ A L + P
Sbjct: 192 EMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCP-- 249
Query: 701 QAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGS 741
+ +RCC++ + RP + LE +R G
Sbjct: 250 --PSFFPITVRCCDLDPEKRPSF-VKLEHWLETLRMHLAGH 287
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 201 bits (512), Expect = 2e-58
Identities = 58/279 (20%), Positives = 109/279 (39%), Gaps = 33/279 (11%)
Query: 471 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPS--EFQQEIDILSKIRHPNLVTLVGAC 528
IG+G +G +Y G H +VAI+++ F++E+ + RH N+V +GAC
Sbjct: 40 LIGKGRFGQVYHGRW-HGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98
Query: 529 --PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 586
P ++ +L + +D L +IA E+ + +LH+ I+H
Sbjct: 99 MSPPHLAIITSLCKGRTLYSVV--RDAKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILH 153
Query: 587 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG 646
DLK N+ D V ++DFG+ + L G ++ PE +
Sbjct: 154 KDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKL---RIQNGWLCHLAPEIIRQL 209
Query: 647 EL---------TPKSDVYSFGIILLRLLTGR-PALGITKE-VQYALDTGKLKNLLDPLAG 695
+ SDV++ G I L P E + + + TG +
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGM---KPNLSQI 266
Query: 696 DWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 734
++++++ + C ++ RP + +LE +
Sbjct: 267 GMG----KEISDILLFCWAFEQEERPTF-TKLMDMLEKL 300
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 1e-57
Identities = 51/275 (18%), Positives = 108/275 (39%), Gaps = 32/275 (11%)
Query: 471 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPS--EFQQEIDILSKIRHPNLVTLVGAC 528
K+ E G ++KG + + +K+L +F +E L HPN++ ++GAC
Sbjct: 17 KLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 529 --PEVWTL--VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 584
P + ++P GSL + L + + + ++ A ++ + FLH+ +P I
Sbjct: 77 QSPPAPHPTLITHWMPYGSLYNVLH-EGTNFVVDQSQAVKFALDMARGMAFLHTLEP-LI 134
Query: 585 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL- 643
L ++++D + +++S + A++ PE L
Sbjct: 135 PRHALNSRSVMIDEDMTARISMADVKFSFQS-------------PGRMYAPAWVAPEALQ 181
Query: 644 --ASGELTPKSDVYSFGIILLRLLTGR-PALGITKEVQYALDTGKLKNLLDPLAGDWPFV 700
+D++SF ++L L+T P ++ ++ + L+ L +
Sbjct: 182 KKPEDTNRRSADMWSFAVLLWELVTREVPFADLS-NMEIGMKVA-LEGLRPTIPPGIS-- 237
Query: 701 QAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 735
++ L C RP+ + +LE M+
Sbjct: 238 --PHVSKLMKICMNEDPAKRPKF-DMIVPILEKMQ 269
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 5e-54
Identities = 65/248 (26%), Positives = 96/248 (38%), Gaps = 31/248 (12%)
Query: 453 DFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDI 512
+ + SE N IG G YG++YKG L VA+K+ + Q F E +I
Sbjct: 2 EAAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQ---NFINEKNI 58
Query: 513 --LSKIRHPNLVTLVGAC--------PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTR 562
+ + H N+ + E LV EY PNGSL L + W +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYL-LVMEYYPNGSLXKYL----SLHTSDWVSS 113
Query: 563 IRIATELCSVLIFLHSCKPHS------IVHGDLKPANILLDANFVSKLSDFGISRFLSQN 616
R+A + L +LH+ P I H DL N+L+ + +SDFG+S L+ N
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173
Query: 617 EISSNNTTLCCRTDPKGTFAYMDPEFL-------ASGELTPKSDVYSFGIILLRLLTGRP 669
+ GT YM PE L + D+Y+ G+I +
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233
Query: 670 ALGITKEV 677
L + V
Sbjct: 234 DLFPGESV 241
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 2e-51
Identities = 56/229 (24%), Positives = 99/229 (43%), Gaps = 34/229 (14%)
Query: 471 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDI--LSKIRHPNLVTLVGAC 528
+G+G YG +++G + VA+K+ + + +E ++ +RH N++ + +
Sbjct: 15 CVGKGRYGEVWRGSWQGENVAVKIFSSRDEK---SWFRETELYNTVMLRHENILGFIASD 71
Query: 529 -------PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS--- 578
++W L+ Y GSL D L L + +RI + S L LH
Sbjct: 72 MTSRHSSTQLW-LITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 579 ---CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 635
KP +I H DLK NIL+ N ++D G++ SQ+ N GT
Sbjct: 127 GTQGKP-AIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQST----NQLDVGNNPRVGTK 181
Query: 636 AYMDPEFL------ASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 678
YM PE L + + D+++FG++L + + GI ++ +
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK 230
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 2e-49
Identities = 63/229 (27%), Positives = 102/229 (44%), Gaps = 34/229 (14%)
Query: 471 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDI--LSKIRHPNLVTLVGAC 528
+IG+G YG ++ G R +VA+K+ + +E +I +RH N++ + A
Sbjct: 44 QIGKGRYGEVWMGKWRGEKVAVKVFFTTEEA---SWFRETEIYQTVLMRHENILGFIAAD 100
Query: 529 -------PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS--- 578
+++ L+ +Y NGSL D L S L ++ +++A S L LH+
Sbjct: 101 IKGTGSWTQLY-LITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLCHLHTEIF 155
Query: 579 ---CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 635
KP +I H DLK NIL+ N ++D G++ + N GT
Sbjct: 156 STQGKP-AIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDT----NEVDIPPNTRVGTK 210
Query: 636 AYMDPEFLA------SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 678
YM PE L + +D+YSFG+IL + + GI +E Q
Sbjct: 211 RYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 1e-47
Identities = 66/284 (23%), Positives = 111/284 (39%), Gaps = 41/284 (14%)
Query: 416 EQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEG 475
E L ++L + S S +P I IG+G
Sbjct: 1 EDPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQE-------SIGKG 53
Query: 476 GYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDI--LSKIRHPNLVTLVGAC----- 528
+G +++G R +VA+K+ + + +E +I +RH N++ + A
Sbjct: 54 RFGEVWRGKWRGEEVAVKIFSSREER---SWFREAEIYQTVMLRHENILGFIAADNKDNG 110
Query: 529 --PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS------CK 580
++W LV +Y +GSL D L N ++ + I++A S L LH K
Sbjct: 111 TWTQLW-LVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 165
Query: 581 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 640
P +I H DLK NIL+ N ++D G++ +T GT YM P
Sbjct: 166 P-AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA----TDTIDIAPNHRVGTKRYMAP 220
Query: 641 EFL------ASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 678
E L E ++D+Y+ G++ + GI ++ Q
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 264
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 4e-39
Identities = 58/221 (26%), Positives = 93/221 (42%), Gaps = 37/221 (16%)
Query: 471 KIGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQGPSE-FQQEIDILSKIRHPNLVTLV 525
+G+G ++++G RH AIK+ + S P + +E ++L K+ H N+V L
Sbjct: 16 ILGQGATANVFRG--RHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 526 GACPEVWT-----LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 580
A E T L+ E+ P GSL L N+ L + + ++ + L
Sbjct: 74 -AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE-- 130
Query: 581 PHSIVHGDLKPANILL----DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 636
+ IVH ++KP NI+ D V KL+DFG +R L +E +L GT
Sbjct: 131 -NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF---VSLY------GTEE 180
Query: 637 YMDPEFLASGEL--------TPKSDVYSFGIILLRLLTGRP 669
Y+ P+ L D++S G+ TG
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 5e-38
Identities = 78/285 (27%), Positives = 132/285 (46%), Gaps = 40/285 (14%)
Query: 471 KIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPS---EFQQEIDILSKIRHPNLVTL- 524
K+G GG ++Y + +++VAIK + + F++E+ S++ H N+V++
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 525 -VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 583
V + + LV EY+ +L + + ++ PLS T I ++ + H
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAHD---MR 131
Query: 584 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 643
IVH D+KP NIL+D+N K+ DFGI++ LS+ ++ N L GT Y PE
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVL-------GTVQYFSPEQA 184
Query: 644 ASGELTPKSDVYSFGIILLRLLTGRP------ALGI-TKEVQYALDTGKLKNLLDPLAGD 696
+D+YS GI+L +L G P A+ I K +Q + + D
Sbjct: 185 KGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQD--SVPNVTTDVRK---D 239
Query: 697 WPFVQAEQLANLAMRCCEMSRKSRP----ELGKDVWRVLEPMRAS 737
P + L+N+ +R E + +R E+ D+ VL RA+
Sbjct: 240 IP----QSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRAN 280
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-37
Identities = 64/262 (24%), Positives = 112/262 (42%), Gaps = 33/262 (12%)
Query: 471 KIGEGGYGSIYKGLLR--HMQVAIKMLHPH-SLQGPSEFQQEIDILSKIRHPNLVTLVGA 527
+IG G +G ++ G LR + VA+K ++F QE IL + HPN+V L+G
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 528 CPE---VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 584
C + ++ +V E + G L + L +T +++ + + + +L S
Sbjct: 181 CTQKQPIY-IVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAAAGMEYLES---KCC 234
Query: 585 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY--MDPEF 642
+H DL N L+ V K+SDFG+SR + + + PE
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA--------ASGGLRQVPVKWTAPEA 286
Query: 643 LASGELTPKSDVYSFGIILLRLLT-GR-PALGIT-KEVQYALDTGKLKNLLDPLAGDWPF 699
L G + +SDV+SFGI+L + G P ++ ++ + ++ G L P
Sbjct: 287 LNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG---GRLPC-----PE 338
Query: 700 VQAEQLANLAMRCCEMSRKSRP 721
+ + + L +C RP
Sbjct: 339 LCPDAVFRLMEQCWAYEPGQRP 360
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-37
Identities = 58/221 (26%), Positives = 93/221 (42%), Gaps = 37/221 (16%)
Query: 471 KIGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQGPSE-FQQEIDILSKIRHPNLVTLV 525
+G+G ++++G RH AIK+ + S P + +E ++L K+ H N+V L
Sbjct: 16 ILGQGATANVFRG--RHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 526 GACPEVWT-----LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 580
A E T L+ E+ P GSL L N+ L + + ++ + L
Sbjct: 74 -AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE-- 130
Query: 581 PHSIVHGDLKPANILL----DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 636
+ IVH ++KP NI+ D V KL+DFG +R L +E +L GT
Sbjct: 131 -NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF---VSLY------GTEE 180
Query: 637 YMDPEFLASGEL--------TPKSDVYSFGIILLRLLTGRP 669
Y+ P+ L D++S G+ TG
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221
|
| >1t1h_A Gspef-atpub14, armadillo repeat containing protein; ubiquitin ligase, E3 ligase, U-BOX,; NMR {Arabidopsis thaliana} SCOP: g.44.1.2 Length = 78 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 6e-37
Identities = 31/72 (43%), Positives = 44/72 (61%)
Query: 753 EPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLA 812
E P YF CPI E+M+DP + + G TYE +++ WLD+GH+T P + L H L PN
Sbjct: 4 EFPEYFRCPISLELMKDPVIVSTGQTYERSSIQKWLDAGHKTCPKSQETLLHAGLTPNYV 63
Query: 813 LRSAIQEWLQQH 824
L+S I W + +
Sbjct: 64 LKSLIALWCESN 75
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-36
Identities = 51/206 (24%), Positives = 88/206 (42%), Gaps = 20/206 (9%)
Query: 471 KIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPS---EFQQEIDILSKIRHPNLVTL- 524
+G GG G +Y+ +R VA+K++ P Q+E +++ P++V +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 525 -VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 583
G + + L L PL+ + I ++ S L H+
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSALDAAHA---AG 154
Query: 584 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 643
H D+KP NIL+ A+ + L DFGI+ + +++ T+ GT YM PE
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-------GTLYYMAPERF 207
Query: 644 ASGELTPKSDVYSFGIILLRLLTGRP 669
+ T ++D+Y+ +L LTG P
Sbjct: 208 SESHATYRADIYALTCVLYECLTGSP 233
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 3e-36
Identities = 56/228 (24%), Positives = 102/228 (44%), Gaps = 28/228 (12%)
Query: 471 KIGEGGYGSIYKGLLR------HMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVT 523
+G G +G++YKGL + VAIK L S + E E +++ + +P++
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 524 LVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 581
L+G C V L+ + +P G L D + +++ + Q + ++ + +L
Sbjct: 82 LLGICLTSTVQ-LITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYLED--- 135
Query: 582 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF--AYMD 639
+VH DL N+L+ K++DFG+++ L E G +M
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK--------EYHAEGGKVPIKWMA 187
Query: 640 PEFLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 684
E + T +SDV+S+G+ + L+T +P GI E+ L+ G
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 235
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 8e-36
Identities = 56/217 (25%), Positives = 90/217 (41%), Gaps = 32/217 (14%)
Query: 471 KIGEGGYGSIYKGLLRHMQ-VAIKMLHPHSLQGPS--EFQQEIDILSKIRHPNL--VTLV 525
+IG GG +++ L Q AIK ++ + ++ EI L+K++ + + L
Sbjct: 35 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 526 GAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 583
+ +V E N L L K + R + + +H H
Sbjct: 95 DYEITDQYIYMVMEC-GNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQ---HG 147
Query: 584 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 643
IVH DLKPAN L+ + KL DFGI+ + + S + GT YM PE +
Sbjct: 148 IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQV------GTVNYMPPEAI 200
Query: 644 -----------ASGELTPKSDVYSFGIILLRLLTGRP 669
+ +++PKSDV+S G IL + G+
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 237
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 62/214 (28%), Positives = 92/214 (42%), Gaps = 25/214 (11%)
Query: 471 KIGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQGPSEFQ---QEIDILSKIRHPNLVT 523
IG G YG K R + K L S+ +E Q E+++L +++HPN+V
Sbjct: 13 TIGTGSYGRCQKI--RRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVR 69
Query: 524 LVGACPEVWT----LVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHS 578
+ +V EY G L + L + +R+ T+L L H
Sbjct: 70 YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 129
Query: 579 CK--PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 636
H+++H DLKPAN+ LD KL DFG++R L+ + +S T GT
Sbjct: 130 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD--TSFAKTFV------GTPY 181
Query: 637 YMDPEFLASGELTPKSDVYSFGIILLRLLTGRPA 670
YM PE + KSD++S G +L L P
Sbjct: 182 YMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 19/208 (9%)
Query: 471 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSE---FQQEIDILSKIRHPNLVTLV 525
KIG G + +Y+ + VA+K + L +EID+L ++ HPN++
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 526 GACPEVWTL--VYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 582
+ E L V E G L + K + +T + +LCS L +HS
Sbjct: 99 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---R 155
Query: 583 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 642
++H D+KPAN+ + A V KL D G+ RF ++ GT YM PE
Sbjct: 156 RVMHRDIKPANVFITATGVVKLGDLGLGRFF--------SSKTTAAHSLVGTPYYMSPER 207
Query: 643 LASGELTPKSDVYSFGIILLRLLTGRPA 670
+ KSD++S G +L + +
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 59/252 (23%), Positives = 97/252 (38%), Gaps = 22/252 (8%)
Query: 434 LRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIY--KGLLRHMQVA 491
+ S SS + F + ++ K+GEGG+ + +GL A
Sbjct: 1 MGSSHHHHHHSS--GRENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYA 58
Query: 492 IKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC-------PEVWTLVYEYLPNGSL 544
+K + H Q E Q+E D+ HPN++ LV C E W L+ + G+L
Sbjct: 59 LKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW-LLLPFFKRGTL 117
Query: 545 EDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSK 603
+ + KD L+ + + +C L +H+ H DLKP NILL
Sbjct: 118 WNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPV 174
Query: 604 LSDFGISRFLSQNEISSNNTTLCCRTDPK--GTFAYMDPEFLAS---GELTPKSDVYSFG 658
L D G + + L + T +Y PE + + ++DV+S G
Sbjct: 175 LMDLGSMNQAC-IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLG 233
Query: 659 IILLRLLTGRPA 670
+L ++ G
Sbjct: 234 CVLYAMMFGEGP 245
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-35
Identities = 56/217 (25%), Positives = 90/217 (41%), Gaps = 32/217 (14%)
Query: 471 KIGEGGYGSIYKGLLRHMQ-VAIKMLHPHSLQGPS--EFQQEIDILSKIRHPNL--VTLV 525
+IG GG +++ L Q AIK ++ + ++ EI L+K++ + + L
Sbjct: 16 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 526 GAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 583
+ +V E N L L K + R + + +H H
Sbjct: 76 DYEITDQYIYMVMEC-GNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQ---HG 128
Query: 584 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 643
IVH DLKPAN L+ + KL DFGI+ + + S + GT YM PE +
Sbjct: 129 IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQV------GTVNYMPPEAI 181
Query: 644 -----------ASGELTPKSDVYSFGIILLRLLTGRP 669
+ +++PKSDV+S G IL + G+
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 218
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 57/207 (27%), Positives = 99/207 (47%), Gaps = 21/207 (10%)
Query: 471 KIGEGGYGSIYKGLLR------HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVT 523
+GEG +G + QVA+K L P S ++ ++EI+IL + H N+V
Sbjct: 28 DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 87
Query: 524 LVGAC----PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 579
G C L+ E+LP+GSL++ L N ++ + +++ A ++C + +L S
Sbjct: 88 YKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLGS- 144
Query: 580 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 639
VH DL N+L+++ K+ DFG+++ + ++ + D +
Sbjct: 145 --RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK-----EYYTVKDDRDSPVFWYA 197
Query: 640 PEFLASGELTPKSDVYSFGIILLRLLT 666
PE L + SDV+SFG+ L LLT
Sbjct: 198 PECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-35
Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 20/206 (9%)
Query: 471 KIGEGGYGSIYKGLLR------HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL 524
++G+G +GS+ VA+K L + + +F++EI+IL ++H N+V
Sbjct: 17 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 525 VGAC----PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 580
G C L+ EYLP GSL D L + + + ++ +++C + +L +
Sbjct: 77 KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGT-- 132
Query: 581 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 640
+H DL NIL++ K+ DFG+++ L Q++ + + + P
Sbjct: 133 -KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-----EFFKVKEPGESPIFWYAP 186
Query: 641 EFLASGELTPKSDVYSFGIILLRLLT 666
E L + + SDV+SFG++L L T
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFT 212
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 5e-35
Identities = 55/223 (24%), Positives = 97/223 (43%), Gaps = 24/223 (10%)
Query: 465 NFDPSLKIGEGGYGSIYKGLLRH--MQVAIKML-HPHSLQGPSEFQQEIDILSKIRHPNL 521
+F+P +G GG+G +++ + AIK + P+ + +E+ L+K+ HP +
Sbjct: 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 522 VTLVGACPEVWT--------------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIAT 567
V A E T + + +L+D ++ + + I
Sbjct: 66 VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFL 125
Query: 568 ELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE----ISSNNT 623
++ + FLHS ++H DLKP+NI + V K+ DFG+ + Q+E + +
Sbjct: 126 QIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 624 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 666
T GT YM PE + + K D++S G+IL LL
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 6e-35
Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 20/206 (9%)
Query: 471 KIGEGGYGSIYKGLLR------HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL 524
++G+G +GS+ VA+K L + + +F++EI+IL ++H N+V
Sbjct: 48 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 107
Query: 525 VGAC----PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 580
G C L+ EYLP GSL D L + + + ++ +++C + +L +
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGT-- 163
Query: 581 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 640
+H DL NIL++ K+ DFG+++ L Q++ + + + P
Sbjct: 164 -KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-----EYYKVKEPGESPIFWYAP 217
Query: 641 EFLASGELTPKSDVYSFGIILLRLLT 666
E L + + SDV+SFG++L L T
Sbjct: 218 ESLTESKFSVASDVWSFGVVLYELFT 243
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 6e-35
Identities = 59/235 (25%), Positives = 95/235 (40%), Gaps = 24/235 (10%)
Query: 443 SSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSL 500
SS + + F +E + KIGEG +G Q IK + S
Sbjct: 7 HSSGVDLGTENLYFQSME----KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEI-NISR 61
Query: 501 QGPSEFQ---QEIDILSKIRHPNLVTLVGACPEVWTL--VYEYLPNGSLEDRLSCKDNSP 555
E + +E+ +L+ ++HPN+V + E +L V +Y G L R++
Sbjct: 62 MSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRIN-AQKGV 120
Query: 556 PLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 615
+ ++C L +H K I+H D+K NI L + +L DFGI+R L+
Sbjct: 121 LFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS 177
Query: 616 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPA 670
GT Y+ PE + KSD+++ G +L L T + A
Sbjct: 178 T--VELARACI------GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA 224
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 7e-35
Identities = 65/286 (22%), Positives = 99/286 (34%), Gaps = 52/286 (18%)
Query: 471 KIGEGGYGSIYKGL---LRHMQVAIKMLHPHSLQGPSE-FQQEIDILSKIRHPNLVTL-- 524
I GG G IY L + V +K L E L+++ HP++V +
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 525 VGACPEVWT-----LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 579
+ +V EY+ SL+ L I E+ L +LHS
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKG-----QKLPVAEAIAYLLEILPALSYLHS- 200
Query: 580 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 639
+V+ DLKP NI+L + KL D G I+S GT +
Sbjct: 201 --IGLVYNDLKPENIMLTEEQL-KLIDLGAVS-----RINSFGYLY-------GTPGFQA 245
Query: 640 PEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPF 699
PE + T +D+Y+ G L L P G+ +D L D P
Sbjct: 246 PE-IVRTGPTVATDIYTVGRTLAALTLDLPT-----------RNGR---YVDGLPEDDPV 290
Query: 700 VQA-EQLANLAMRCCEMSRKSRP----ELGKDVWRVLEPMRASCGG 740
++ + L R + + R E+ + VL + A G
Sbjct: 291 LKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREVVAQDTG 336
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 7e-35
Identities = 55/206 (26%), Positives = 93/206 (45%), Gaps = 20/206 (9%)
Query: 471 KIGEGGYGSIYKGLLR------HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL 524
++G+G +GS+ VA+K L +FQ+EI IL + +V
Sbjct: 30 QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 89
Query: 525 VGACPEVWT----LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 580
G LV EYLP+G L D L + + L + ++++C + +L S
Sbjct: 90 RGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLGS-- 145
Query: 581 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 640
VH DL NIL+++ K++DFG+++ L ++ R + + P
Sbjct: 146 -RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK-----DYYVVREPGQSPIFWYAP 199
Query: 641 EFLASGELTPKSDVYSFGIILLRLLT 666
E L+ + +SDV+SFG++L L T
Sbjct: 200 ESLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 9e-35
Identities = 61/222 (27%), Positives = 109/222 (49%), Gaps = 23/222 (10%)
Query: 471 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 529
+IG G +G ++ G +VAIK + ++ +F +E +++ K+ HP LV L G C
Sbjct: 15 EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCL 73
Query: 530 E---VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 586
E + LV E++ +G L D L + + +T + + ++C + +L ++H
Sbjct: 74 EQAPIC-LVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIH 127
Query: 587 GDLKPANILLDANFVSKLSDFGISRFLSQNE-ISSNNTTLCCRTDPKGTFAYMDPEFLAS 645
DL N L+ N V K+SDFG++RF+ ++ SS T + + PE +
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK--------WASPEVFSF 179
Query: 646 GELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 684
+ KSDV+SFG+++ + + P + EV + TG
Sbjct: 180 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG 221
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 1e-34
Identities = 64/281 (22%), Positives = 103/281 (36%), Gaps = 41/281 (14%)
Query: 413 YKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHN---FDPS 469
+ + R +KE + R+ S S S E + +
Sbjct: 2 HHHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSIL 61
Query: 470 LKIGEGGYGSIYKGLLRHMQ-VAIKM-----LHPHSLQGPSEFQQEIDILSKIRHPNL-- 521
+IG GG +++ L Q AIK +L ++ EI L+K++ +
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDS---YRNEIAYLNKLQQHSDKI 118
Query: 522 VTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 579
+ L + +V E N L L K + R + + +H
Sbjct: 119 IRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQ- 173
Query: 580 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 639
H IVH DLKPAN L+ + KL DFGI+ + + S + G YM
Sbjct: 174 --HGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQV------GAVNYMP 224
Query: 640 PEFL-----------ASGELTPKSDVYSFGIILLRLLTGRP 669
PE + + +++PKSDV+S G IL + G+
Sbjct: 225 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 265
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-34
Identities = 72/220 (32%), Positives = 112/220 (50%), Gaps = 19/220 (8%)
Query: 471 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 529
K+G+G +G ++ G +VAIK L P ++ P F QE ++ K+RH LV L
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 530 E--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 587
E ++ +V EY+ GSL D L + L + +A ++ S + ++ + VH
Sbjct: 250 EEPIY-IVTEYMSKGSLLDFLK-GETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 304
Query: 588 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 647
DL+ ANIL+ N V K++DFG++R + NE ++ R K + PE G
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTA-------RQGAKFPIKWTAPEAALYGR 357
Query: 648 LTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 684
T KSDV+SFGI+L L T P G+ +EV ++ G
Sbjct: 358 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 397
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 62/222 (27%), Positives = 107/222 (48%), Gaps = 23/222 (10%)
Query: 471 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 529
++G G +G + G + VA+KM+ S+ EF QE + K+ HP LV G C
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 530 E---VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 586
+ ++ +V EY+ NG L + L + + L + + ++C + FL S H +H
Sbjct: 74 KEYPIY-IVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFLES---HQFIH 127
Query: 587 GDLKPANILLDANFVSKLSDFGISRFLSQNE-ISSNNTTLCCRTDPKGTFAYMDPEFLAS 645
DL N L+D + K+SDFG++R++ ++ +SS T + + PE
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVK--------WSAPEVFHY 179
Query: 646 GELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 684
+ + KSDV++FGI++ + + P T EV + G
Sbjct: 180 FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQG 221
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-34
Identities = 63/222 (28%), Positives = 116/222 (52%), Gaps = 21/222 (9%)
Query: 471 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 528
K+G G YG +Y+G+ + + VA+K L +++ EF +E ++ +I+HPNLV L+G C
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 285
Query: 529 PE---VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 585
+ ++ E++ G+L D L + N +S + +AT++ S + +L + +
Sbjct: 286 TREPPFY-IITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQISSAMEYLEK---KNFI 340
Query: 586 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS 645
H +L N L+ N + K++DFG+SR ++ + ++ K + PE LA
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTA-------HAGAKFPIKWTAPESLAY 393
Query: 646 GELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 684
+ + KSDV++FG++L + T P GI +V L+
Sbjct: 394 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD 435
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 4e-34
Identities = 61/216 (28%), Positives = 92/216 (42%), Gaps = 32/216 (14%)
Query: 471 KIGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQGPSE-FQQEIDILSKIRHPNLVTLV 525
++G GG+G + + H QVAIK E + EI I+ K+ HPN+V+
Sbjct: 21 RLGTGGFGYVLRW--IHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR 78
Query: 526 GACPEVWT---------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFL 576
P+ L EY G L L+ +N L + +++ S L +L
Sbjct: 79 -EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL 137
Query: 577 HSCKPHSIVHGDLKPANILLDAN---FVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 633
H + I+H DLKP NI+L + K+ D G ++ L Q E+ T G
Sbjct: 138 HE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC---TEFV------G 185
Query: 634 TFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 669
T Y+ PE L + T D +SFG + +TG
Sbjct: 186 TLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-34
Identities = 49/210 (23%), Positives = 85/210 (40%), Gaps = 26/210 (12%)
Query: 471 KIGEGGYGSIYKGLLRH--MQVAIK--MLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVG 526
+IG G + ++YKGL ++VA + F++E ++L ++HPN+V
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 527 ACPEVWT------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 580
+ LV E + +G+L+ L + + ++ L FLH+
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT 149
Query: 581 PHSIVHGDLKPANILLDA-NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 639
P I+H DLK NI + K+ D G++ + + GT +M
Sbjct: 150 P-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV----------IGTPEFMA 198
Query: 640 PEFLASGELTPKSDVYSFGIILLRLLTGRP 669
PE DVY+FG+ +L + T
Sbjct: 199 PEMYEEK-YDESVDVYAFGMCMLEMATSEY 227
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 5e-34
Identities = 61/223 (27%), Positives = 104/223 (46%), Gaps = 29/223 (13%)
Query: 471 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC-- 528
IG+G +G + G R +VA+K + + F E +++++RH NLV L+G
Sbjct: 200 TIGKGEFGDVMLGDYRGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 529 --PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 586
++ +V EY+ GSL D L L ++ + ++C + +L ++ VH
Sbjct: 258 EKGGLY-IVTEYMAKGSLVDYLR-SRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVH 312
Query: 587 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY--MDPEFLA 644
DL N+L+ + V+K+SDFG+++ S T G PE L
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTKEAS-------------STQDTGKLPVKWTAPEALR 359
Query: 645 SGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 684
+ + KSDV+SFGI+L + + P I K+V ++ G
Sbjct: 360 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG 402
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 5e-34
Identities = 65/220 (29%), Positives = 112/220 (50%), Gaps = 19/220 (8%)
Query: 471 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 529
++G G +G ++ G H +VA+K L S+ P F E +++ +++H LV L
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 530 E--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 587
+ ++ ++ EY+ NGSL D L + L+ + +A ++ + F+ + +H
Sbjct: 79 QEPIY-IITEYMENGSLVDFLK-TPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHR 133
Query: 588 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 647
DL+ ANIL+ K++DFG++R + NE ++ R K + PE + G
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTA-------REGAKFPIKWTAPEAINYGT 186
Query: 648 LTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 684
T KSDV+SFGI+L ++T P G+T EV L+ G
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 226
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 6e-34
Identities = 52/231 (22%), Positives = 95/231 (41%), Gaps = 34/231 (14%)
Query: 463 THNFDPSLKIGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQGPSEFQQEIDILSKIRH 518
+F+ +G+G +G + K R+ AIK + H+ + S E+ +L+ + H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKA--RNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNH 61
Query: 519 PNLVTLVGA------------CPEVWTLVY---EYLPNGSLEDRLSCKDNSPPLSWQTRI 563
+V A + + ++ EY NG+L D + +
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI--HSENLNQQRDEYW 119
Query: 564 RIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT 623
R+ ++ L ++HS I+H DLKP NI +D + K+ DFG+++ + ++
Sbjct: 120 RLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 624 TLCCRTDPK------GTFAYMDPEFLA-SGELTPKSDVYSFGIILLRLLTG 667
+ GT Y+ E L +G K D+YS GII ++
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 7e-34
Identities = 56/228 (24%), Positives = 102/228 (44%), Gaps = 28/228 (12%)
Query: 471 KIGEGGYGSIYKGLLR------HMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVT 523
+G G +G++YKGL + VAIK L S + E E +++ + +P++
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 524 LVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 581
L+G C V L+ + +P G L D + +++ + Q + ++ + +L
Sbjct: 82 LLGICLTSTVQ-LITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYLED--- 135
Query: 582 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF--AYMD 639
+VH DL N+L+ K++DFG+++ L E G +M
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK--------EYHAEGGKVPIKWMA 187
Query: 640 PEFLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 684
E + T +SDV+S+G+ + L+T +P GI E+ L+ G
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 235
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 7e-34
Identities = 53/227 (23%), Positives = 99/227 (43%), Gaps = 25/227 (11%)
Query: 470 LKIGEGGYGSIYKGLLRH----MQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTL 524
+++G G +GS+ +G+ R + VAIK+L E +E I+ ++ +P +V L
Sbjct: 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 75
Query: 525 VGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 582
+G C + LV E G L L + + ++ + +L
Sbjct: 76 IGVCQAEALM-LVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLEE---K 129
Query: 583 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF--AYMDP 640
+ VH DL N+LL +K+SDFG+S+ L ++ G + + P
Sbjct: 130 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD-------SYYTARSAGKWPLKWYAP 182
Query: 641 EFLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 684
E + + + +SDV+S+G+ + L+ +P + EV ++ G
Sbjct: 183 ECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG 229
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 8e-34
Identities = 62/221 (28%), Positives = 109/221 (49%), Gaps = 21/221 (9%)
Query: 471 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 529
K+G G +G ++ H +VA+K + P S+ F E +++ ++H LV L
Sbjct: 195 KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVVT 253
Query: 530 E--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 587
+ ++ ++ E++ GSL D L D I + ++ + F+ + +H
Sbjct: 254 KEPIY-IITEFMAKGSLLDFLK-SDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHR 308
Query: 588 DLKPANILLDANFVSKLSDFGISRFLSQNE-ISSNNTTLCCRTDPKGTFAYMDPEFLASG 646
DL+ ANIL+ A+ V K++DFG++R + NE + + + PE + G
Sbjct: 309 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK--------WTAPEAINFG 360
Query: 647 ELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 684
T KSDV+SFGI+L+ ++T P G++ EV AL+ G
Sbjct: 361 SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG 401
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 9e-34
Identities = 61/223 (27%), Positives = 104/223 (46%), Gaps = 29/223 (13%)
Query: 471 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC-- 528
IG+G +G + G R +VA+K + + F E +++++RH NLV L+G
Sbjct: 28 TIGKGEFGDVMLGDYRGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 529 --PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 586
++ +V EY+ GSL D L L ++ + ++C + +L ++ VH
Sbjct: 86 EKGGLY-IVTEYMAKGSLVDYLR-SRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVH 140
Query: 587 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY--MDPEFLA 644
DL N+L+ + V+K+SDFG+++ S T G PE L
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTKEAS-------------STQDTGKLPVKWTAPEALR 187
Query: 645 SGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 684
+ + KSDV+SFGI+L + + P I K+V ++ G
Sbjct: 188 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG 230
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 59/222 (26%), Positives = 105/222 (47%), Gaps = 23/222 (10%)
Query: 471 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 529
++G G +G + G R VAIKM+ S+ EF +E ++ + H LV L G C
Sbjct: 31 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 530 E---VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 586
+ ++ ++ EY+ NG L + L ++ Q + + ++C + +L S +H
Sbjct: 90 KQRPIF-IITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLH 143
Query: 587 GDLKPANILLDANFVSKLSDFGISRFLSQNE-ISSNNTTLCCRTDPKGTFAYMDPEFLAS 645
DL N L++ V K+SDFG+SR++ +E SS + R + PE L
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR--------WSPPEVLMY 195
Query: 646 GELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 684
+ + KSD+++FG+++ + + P T E + G
Sbjct: 196 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG 237
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-33
Identities = 72/220 (32%), Positives = 112/220 (50%), Gaps = 19/220 (8%)
Query: 471 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 529
K+G+G +G ++ G +VAIK L P ++ P F QE ++ K+RH LV L
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 530 E--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 587
E ++ +V EY+ GSL D L + L + +A ++ S + ++ + VH
Sbjct: 333 EEPIY-IVTEYMSKGSLLDFLK-GETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 387
Query: 588 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 647
DL+ ANIL+ N V K++DFG++R + NE ++ R K + PE G
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNEYTA-------RQGAKFPIKWTAPEAALYGR 440
Query: 648 LTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 684
T KSDV+SFGI+L L T P G+ +EV ++ G
Sbjct: 441 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 480
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 53/227 (23%), Positives = 95/227 (41%), Gaps = 41/227 (18%)
Query: 465 NFDPSLKIGEGGYGSIYKGLLRHM----QVAIKMLHPHSLQGPSEFQQEIDILSKIRHPN 520
+F IG GG+G ++K +H IK + ++ + + ++E+ L+K+ H N
Sbjct: 12 DFKEIELIGSGGFGQVFKA--KHRIDGKTYVIKRV-KYNNE---KAEREVKALAKLDHVN 65
Query: 521 LVTLVGA---------------CPEVWTLVY---EYLPNGSLEDRLSCKDNSPPLSWQTR 562
+V G ++ E+ G+LE + K L
Sbjct: 66 IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE-KRRGEKLDKVLA 124
Query: 563 IRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 622
+ + ++ + ++HS K +++ DLKP+NI L K+ DFG+ L +
Sbjct: 125 LELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND---GKR 178
Query: 623 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 669
T GT YM PE ++S + + D+Y+ G+IL LL
Sbjct: 179 TRSK------GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD 219
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 64/224 (28%), Positives = 116/224 (51%), Gaps = 25/224 (11%)
Query: 471 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 528
K+G G YG +Y+G+ + + VA+K L +++ EF +E ++ +I+HPNLV L+G C
Sbjct: 20 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 529 PE---VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 585
+ ++ E++ G+L D L + N +S + +AT++ S + +L + +
Sbjct: 79 TREPPFY-IITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQISSAMEYLEK---KNFI 133
Query: 586 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY--MDPEFL 643
H DL N L+ N + K++DFG+SR ++ + +++ F PE L
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA---------GAKFPIKWTAPESL 184
Query: 644 ASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 684
A + + KSDV++FG++L + T P GI +V L+
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD 228
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 21/201 (10%)
Query: 471 KIGEGGYGSIYKGLLR-----HMQVAIKMLHPHSLQGPS---EFQQEIDILSKIRHPNLV 522
K+G+G +G + +G + VA+K L P L P +F +E++ + + H NL+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 523 TLVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 580
L G + +V E P GSL DRL + + T R A ++ + +L S
Sbjct: 85 RLYGVVLTPPMK-MVTELAPLGSLLDRL--RKHQGHFLLGTLSRYAVQVAEGMGYLES-- 139
Query: 581 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 640
+H DL N+LL + K+ DFG+ R L QN+ + K FA+ P
Sbjct: 140 -KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND-----DHYVMQEHRKVPFAWCAP 193
Query: 641 EFLASGELTPKSDVYSFGIIL 661
E L + + SD + FG+ L
Sbjct: 194 ESLKTRTFSHASDTWMFGVTL 214
|
| >2f42_A STIP1 homology and U-box containing protein 1; chaperone; 2.50A {Danio rerio} PDB: 2c2v_S 2oxq_C Length = 179 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-33
Identities = 22/77 (28%), Positives = 40/77 (51%)
Query: 748 SEERCEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNL 807
++ E P Y I E+M++P + G TY+ + ++ L P+T PL L
Sbjct: 97 KRKKREIPDYLCGKISFELMREPCITPSGITYDRKDIEEHLQRVGHFDPVTRSPLTQDQL 156
Query: 808 VPNLALRSAIQEWLQQH 824
+PNLA++ I ++Q++
Sbjct: 157 IPNLAMKEVIDAFIQEN 173
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 2e-33
Identities = 50/229 (21%), Positives = 90/229 (39%), Gaps = 46/229 (20%)
Query: 471 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEF-----------------QQEIDIL 513
+ +G + I + A+K L+ +F + E+ I+
Sbjct: 38 TLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 514 SKIRHPNLVTLVGACPEVWT------LVYEYLPNGSLEDRLSC-----KDNSPPLSWQTR 562
+ I++ +T + T ++YEY+ N S+ K+ + + Q
Sbjct: 98 TDIKNEYCLTCE----GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVI 153
Query: 563 IRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 622
I + + ++H+ K +I H D+KP+NIL+D N KLSDFG S+ +
Sbjct: 154 KCIIKSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFG----ESEYMVDKKI 207
Query: 623 TTLCCRTDPKGTFAYMDPEFLASGELT--PKSDVYSFGIILLRLLTGRP 669
GT+ +M PEF ++ K D++S GI L +
Sbjct: 208 KGSR------GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVV 250
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-33
Identities = 57/229 (24%), Positives = 97/229 (42%), Gaps = 27/229 (11%)
Query: 471 KIGEGGYGSIYKGLLR-----HMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTL 524
IG+G +G +Y G +Q AIK L +Q F +E ++ + HPN++ L
Sbjct: 28 VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87
Query: 525 VGAC----PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 580
+G ++ Y+ +G L + + + + I ++ + +L
Sbjct: 88 IGIMLPPEGLPH-VLLPYMCHGDLLQFI--RSPQRNPTVKDLISFGLQVARGMEYLAE-- 142
Query: 581 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF--AYM 638
VH DL N +LD +F K++DFG++R + E S + +
Sbjct: 143 -QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYS------VQQHRHARLPVKWT 195
Query: 639 DPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 684
E L + T KSDV+SFG++L LLT P I ++ + L G
Sbjct: 196 ALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQG 244
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-33
Identities = 70/308 (22%), Positives = 125/308 (40%), Gaps = 32/308 (10%)
Query: 442 SSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH-----MQVAIKMLH 496
S+ P+ I ++ + IG G +G +Y G L + A+K L+
Sbjct: 3 DLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN 62
Query: 497 P-HSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTLVY---EYLPNGSLEDRLSCKD 552
+ S+F E I+ HPN+++L+G C Y+ +G L + + ++
Sbjct: 63 RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RN 120
Query: 553 NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 612
+ + + I ++ + +L S VH DL N +LD F K++DFG++R
Sbjct: 121 ETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARD 177
Query: 613 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPA 670
+ E S + + K +M E L + + T KSDV+SFG++L L+T P
Sbjct: 178 MYDKEYYSVHNKTGAKLPVK----WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 233
Query: 671 LGIT-KEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP---ELGKD 726
+ ++ L G L P + L + ++C + RP EL
Sbjct: 234 PDVNTFDITVYLLQG---RRLLQ-----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 285
Query: 727 VWRVLEPM 734
+ +
Sbjct: 286 ISAIFSTF 293
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-33
Identities = 63/207 (30%), Positives = 97/207 (46%), Gaps = 27/207 (13%)
Query: 472 IGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTL 524
+G+G +G++Y L R Q +A+K+L L+ Q E++I S +RHPN++ L
Sbjct: 17 LGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 525 VG--ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 582
G L+ EY P G++ L Q TEL + L + HS
Sbjct: 75 YGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCHS---K 128
Query: 583 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 642
++H D+KP N+LL + K++DFG S + SS T LC GT Y+ PE
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLC------GTLDYLPPEM 178
Query: 643 LASGELTPKSDVYSFGIILLRLLTGRP 669
+ K D++S G++ L G+P
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKP 205
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 5e-33
Identities = 56/226 (24%), Positives = 105/226 (46%), Gaps = 24/226 (10%)
Query: 471 KIGEGGYGSIYKGLLR------HMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVT 523
+G G +G+++KG+ + V IK++ Q + + + H ++V
Sbjct: 20 VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVR 79
Query: 524 LVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 581
L+G CP + LV +YLP GSL D + + + L Q + ++ + +L
Sbjct: 80 LLGLCPGSSLQ-LVTQYLPLGSLLDHV--RQHRGALGPQLLLNWGVQIAKGMYYLEE--- 133
Query: 582 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 641
H +VH +L N+LL + +++DFG++ L ++ ++ K +M E
Sbjct: 134 HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLL------YSEAKTPIKWMALE 187
Query: 642 FLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 684
+ G+ T +SDV+S+G+ + L+T P G+ EV L+ G
Sbjct: 188 SIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG 233
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 5e-33
Identities = 61/207 (29%), Positives = 94/207 (45%), Gaps = 23/207 (11%)
Query: 471 KIGEGGYGSIYKGLLR------HMQVAIKMLHPH-SLQGPSEFQQEIDILSKIRHPNLVT 523
+GEG +G + VA+K L Q S ++QEIDIL + H +++
Sbjct: 38 DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIK 97
Query: 524 LVGAC----PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 579
G C LV EY+P GSL D L +S L+ + A ++C + +LH+
Sbjct: 98 YKGCCEDAGAASLQLVMEYVPLGSLRDYL--PRHSIGLAQL--LLFAQQICEGMAYLHAQ 153
Query: 580 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 639
+H DL N+LLD + + K+ DFG+++ + + R D +
Sbjct: 154 H---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH-----EYYRVREDGDSPVFWYA 205
Query: 640 PEFLASGELTPKSDVYSFGIILLRLLT 666
PE L + SDV+SFG+ L LLT
Sbjct: 206 PECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 6e-33
Identities = 59/225 (26%), Positives = 104/225 (46%), Gaps = 24/225 (10%)
Query: 471 KIGEGGYGSIYKGLLRH-----MQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTL 524
+GEG +G +Y+G+ + + VA+K +L +F E I+ + HP++V L
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 525 VGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 582
+G E W ++ E P G L L + N L T + + ++C + +L S
Sbjct: 79 IGIIEEEPTW-IIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAYLES---I 132
Query: 583 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 642
+ VH D+ NIL+ + KL DFG+SR++ + + T + +M PE
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVT-------RLPIKWMSPES 185
Query: 643 LASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 684
+ T SDV+ F + + +L+ +P + K+V L+ G
Sbjct: 186 INFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG 230
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 6e-33
Identities = 61/225 (27%), Positives = 100/225 (44%), Gaps = 24/225 (10%)
Query: 471 KIGEGGYGSIYKGLLR-----HMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTL 524
IGEG +G +++G+ + VAIK S +F QE + + HP++V L
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 525 VGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 582
+G E VW ++ E G L L + L + I A +L + L +L S
Sbjct: 82 IGVITENPVW-IIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLES---K 135
Query: 583 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 642
VH D+ N+L+ +N KL DFG+SR++ + + K +M PE
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK-------ASKGKLPIKWMAPES 188
Query: 643 LASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 684
+ T SDV+ FG+ + +L +P G+ +V ++ G
Sbjct: 189 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG 233
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 8e-33
Identities = 55/238 (23%), Positives = 98/238 (41%), Gaps = 42/238 (17%)
Query: 471 KIGEGGYGSIYKGLLR---------HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNL 521
+G+G + I+KG+ R +V +K+L F + ++SK+ H +L
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 522 VTLVGAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 578
V G C E LV E++ GSL+ L K N ++ ++ +A +L + + FL
Sbjct: 75 VLNYGVCVCGDENI-LVQEFVKFGSLDTYL--KKNKNCINILWKLEVAKQLAAAMHFLEE 131
Query: 579 CKPHSIVHGDLKPANILLDA--------NFVSKLSDFGISRFLSQNEISSNNTTLCCRTD 630
++++HG++ NILL KLSD GIS + +I
Sbjct: 132 ---NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDIL----------- 177
Query: 631 PKGTFAYMDPE-FLASGELTPKSDVYSFGIILLRLLTG--RPALGIT-KEVQYALDTG 684
+ ++ PE L +D +SFG L + +G +P + + +
Sbjct: 178 -QERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDR 234
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 9e-33
Identities = 58/202 (28%), Positives = 93/202 (46%), Gaps = 24/202 (11%)
Query: 471 KIGEGGYGSIYKGLLR-----HMQVAIKMLHPH-SLQGPSEFQQEIDILSKIRHPNLVTL 524
IG G G + G LR + VAIK L + + +F E I+ + HPN++ L
Sbjct: 56 IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115
Query: 525 VGACPE---VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 581
G +V EY+ NGSL+ L + + + + + + + + +L
Sbjct: 116 EGVVTRGRLAM-IVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRYLSD--- 169
Query: 582 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY--MD 639
VH DL N+L+D+N V K+SDFG+SR L + ++ TT G
Sbjct: 170 LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTT-------GGKIPIRWTA 222
Query: 640 PEFLASGELTPKSDVYSFGIIL 661
PE +A + SDV+SFG+++
Sbjct: 223 PEAIAFRTFSSASDVWSFGVVM 244
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 1e-32
Identities = 46/262 (17%), Positives = 87/262 (33%), Gaps = 35/262 (13%)
Query: 434 LRKSRKEASSSSHMPQFFSDFS----FSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH-- 487
L K SS + ++ +E + + +GEG + +Y+
Sbjct: 31 LSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLN 90
Query: 488 -----MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLP 540
+ +K+ P + Q ++ L + A LV E
Sbjct: 91 DAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYS 150
Query: 541 NGSLEDRLSCKDNSP--PLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA 598
G+L + ++ N+P + I A + ++ +H C+ I+HGD+KP N +L
Sbjct: 151 YGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGN 207
Query: 599 NFVS-----------KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 647
F+ L D G S + + T C T + E L++
Sbjct: 208 GFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKC------ETSGFQCVEMLSNKP 261
Query: 648 LTPKSDVYSFGIILLRLLTGRP 669
+ D + + +L G
Sbjct: 262 WNYQIDYFGVAATVYCMLFGTY 283
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 57/214 (26%), Positives = 97/214 (45%), Gaps = 30/214 (14%)
Query: 471 KIGEGGYGSIYKG----LLRHMQVAIKMLHPHSLQGPS---EFQQEIDILSKIRHPNLVT 523
+G GG ++ R VA+K+L + PS F++E + + HP +V
Sbjct: 19 ILGFGGMSEVHLARDLRDHR--DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 524 L------VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 577
+ + +V EY+ +L D + P++ + I + + C L F H
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQALNFSH 133
Query: 578 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE--ISSNNTTLCCRTDPKGTF 635
+ I+H D+KPANI++ A K+ DFGI+R ++ + ++ + GT
Sbjct: 134 Q---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI-------GTA 183
Query: 636 AYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 669
Y+ PE + +SDVYS G +L +LTG P
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 217
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 4e-32
Identities = 64/228 (28%), Positives = 110/228 (48%), Gaps = 27/228 (11%)
Query: 471 KIGEGGYGSIYKGLL-----RHMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTL 524
+G G +G + G L + + VAIK L ++ + +F E I+ + HPN++ L
Sbjct: 52 VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 525 VGACPE---VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 581
G + V +V EY+ NGSL+ L + + + + + + S + +L
Sbjct: 112 EGVVTKSKPVM-IVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKYLSD--- 165
Query: 582 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY--MD 639
VH DL NIL+++N V K+SDFG+ R L + ++ T G
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR-------GGKIPIRWTS 218
Query: 640 PEFLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 684
PE +A + T SDV+S+GI+L +++ RP ++ ++V A+D G
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 266
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 4e-32
Identities = 68/301 (22%), Positives = 119/301 (39%), Gaps = 33/301 (10%)
Query: 435 RKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH-----MQ 489
+ S+ P+ I ++ + IG G +G +Y G L +
Sbjct: 60 GANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIH 119
Query: 490 VAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTLVY---EYLPNGSLE 545
A+K L+ + S+F E I+ HPN+++L+G C Y+ +G L
Sbjct: 120 CAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 179
Query: 546 DRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLS 605
+ + ++ + + + I ++ + FL S VH DL N +LD F K++
Sbjct: 180 NFI--RNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVA 234
Query: 606 DFGISRFLSQNEISSNNTTLCCRTDPKGTFA--YMDPEFLASGELTPKSDVYSFGIILLR 663
DFG++R + E S +M E L + + T KSDV+SFG++L
Sbjct: 235 DFGLARDMYDKEFDS------VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE 288
Query: 664 LLT--GRPALGIT-KEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSR 720
L+T P + ++ L G L P + L + ++C + R
Sbjct: 289 LMTRGAPPYPDVNTFDITVYLLQG---RRLLQ-----PEYCPDPLYEVMLKCWHPKAEMR 340
Query: 721 P 721
P
Sbjct: 341 P 341
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 5e-32
Identities = 54/219 (24%), Positives = 90/219 (41%), Gaps = 20/219 (9%)
Query: 471 KIGEGGYGSIY--KGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVGA 527
+ EGG+ +Y + + + A+K L + + QE+ + K+ HPN+V A
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 528 CPEVWT---------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 578
L+ L G L + L ++ PLS T ++I + C + +H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154
Query: 579 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK----GT 634
KP I+H DLK N+LL KL DFG + +S S + + + T
Sbjct: 155 QKP-PIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 635 FAYMDPE---FLASGELTPKSDVYSFGIILLRLLTGRPA 670
Y PE ++ + K D+++ G IL L +
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 5e-32
Identities = 57/203 (28%), Positives = 101/203 (49%), Gaps = 25/203 (12%)
Query: 471 KIGEGGYGSIYKGLLR------HMQVAIKMLHPH-SLQGPSEFQQEIDILSKIRHPNLVT 523
IG G +G +YKG+L+ + VAIK L + + +F E I+ + H N++
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 524 LVGACPE---VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 580
L G + + ++ EY+ NG+L+ L ++ S + + + + + +L +
Sbjct: 111 LEGVISKYKPMM-IITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMKYLAN-- 165
Query: 581 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY--M 638
+ VH DL NIL+++N V K+SDFG+SR L + ++ T+ G
Sbjct: 166 -MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS-------GGKIPIRWT 217
Query: 639 DPEFLASGELTPKSDVYSFGIIL 661
PE ++ + T SDV+SFGI++
Sbjct: 218 APEAISYRKFTSASDVWSFGIVM 240
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 6e-32
Identities = 61/234 (26%), Positives = 102/234 (43%), Gaps = 18/234 (7%)
Query: 443 SSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSL 500
S + + E + + +G+G YG +Y G Q +AIK +
Sbjct: 1 SMRSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS 60
Query: 501 QGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTL--VYEYLPNGSLEDRLSCKDNSPPLS 558
+ +EI + ++H N+V +G+ E + E +P GSL L K +
Sbjct: 61 RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDN 120
Query: 559 WQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA-NFVSKLSDFGISRFLSQNE 617
QT ++ L +LH + IVH D+K N+L++ + V K+SDFG S+ L+
Sbjct: 121 EQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLA--G 175
Query: 618 ISSNNTTLCCRTDPKGTFAYMDPEFLASGEL--TPKSDVYSFGIILLRLLTGRP 669
I+ T GT YM PE + G +D++S G ++ + TG+P
Sbjct: 176 INPCTETF------TGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKP 223
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 8e-32
Identities = 69/262 (26%), Positives = 109/262 (41%), Gaps = 32/262 (12%)
Query: 471 KIGEGGYGSIYKGLLR-----HMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTL 524
IGEG +G +++G+ M VAIK S +F QE + + HP++V L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 525 VGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 582
+G E VW ++ E G L L + L + I A +L + L +L S
Sbjct: 457 IGVITENPVW-IIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLES---K 510
Query: 583 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 642
VH D+ N+L+ +N KL DFG+SR++ + + K +M PE
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK-------ASKGKLPIKWMAPES 563
Query: 643 LASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTGKLKNLLDPLAGDWPF 699
+ T SDV+ FG+ + +L +P G+ +V ++ G L P
Sbjct: 564 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG---ERLPM-----PP 615
Query: 700 VQAEQLANLAMRCCEMSRKSRP 721
L +L +C RP
Sbjct: 616 NCPPTLYSLMTKCWAYDPSRRP 637
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 32/211 (15%)
Query: 472 IGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTL 524
+G+G + +Y + VAIKM+ ++ Q+ E+ I +++HP+++ L
Sbjct: 19 LGKGSFAGVY--RAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILEL 76
Query: 525 VGACPEVWT------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 578
+ LV E NG + L K+ P S ++ + +++LHS
Sbjct: 77 Y----NYFEDSNYVYLVLEMCHNGEMNRYL--KNRVKPFSENEARHFMHQIITGMLYLHS 130
Query: 579 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 638
H I+H DL +N+LL N K++DFG++ L + TLC GT Y+
Sbjct: 131 ---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP--HEKHYTLC------GTPNYI 179
Query: 639 DPEFLASGELTPKSDVYSFGIILLRLLTGRP 669
PE +SDV+S G + LL GRP
Sbjct: 180 SPEIATRSAHGLESDVWSLGCMFYTLLIGRP 210
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 35/215 (16%)
Query: 471 KIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVT 523
++GEG +G ++ M VA+K L +L +FQ+E ++L+ ++H ++V
Sbjct: 22 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 81
Query: 524 LVGACPEV--WTLVYEYLPNGSLEDRL-------------SCKDNSPPLSWQTRIRIATE 568
G C + +V+EY+ +G L L + L + IA++
Sbjct: 82 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 141
Query: 569 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCR 628
+ S +++L S VH DL N L+ AN + K+ DFG+SR + + R
Sbjct: 142 IASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY--------YR 190
Query: 629 TDPKGTF--AYMDPEFLASGELTPKSDVYSFGIIL 661
+M PE + + T +SDV+SFG+IL
Sbjct: 191 VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVIL 225
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 130 bits (327), Expect = 2e-31
Identities = 55/224 (24%), Positives = 101/224 (45%), Gaps = 19/224 (8%)
Query: 471 KIGEGGYGSIYKGLLR----HMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTLV 525
++G G +GS+ +G+ R + VAIK+L E +E I+ ++ +P +V L+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 526 GAC-PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 584
G C E LV E G L L + + ++ + +L +
Sbjct: 403 GVCQAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLEE---KNF 457
Query: 585 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 644
VH +L N+LL +K+SDFG+S+ L ++ + R+ K + PE +
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSKALGADD-----SYYTARSAGKWPLKWYAPECIN 512
Query: 645 SGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTGK 685
+ + +SDV+S+G+ + L+ +P + EV ++ GK
Sbjct: 513 FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK 556
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 56/207 (27%), Positives = 89/207 (42%), Gaps = 27/207 (13%)
Query: 472 IGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTL 524
+G+G +G++Y L R Q +A+K+L L+ Q EI+I S +RHPN++ +
Sbjct: 22 LGKGKFGNVY--LAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 79
Query: 525 VG--ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 582
+ L+ E+ P G L L Q EL L + H
Sbjct: 80 YNYFHDRKRIYLMLEFAPRGELYKELQ---KHGRFDEQRSATFMEELADALHYCHE---R 133
Query: 583 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 642
++H D+KP N+L+ K++DFG S + S T+C GT Y+ PE
Sbjct: 134 KVIHRDIKPENLLMGYKGELKIADFG----WSVHAPSLRRRTMC------GTLDYLPPEM 183
Query: 643 LASGELTPKSDVYSFGIILLRLLTGRP 669
+ K D++ G++ L G P
Sbjct: 184 IEGKTHDEKVDLWCAGVLCYEFLVGMP 210
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-31
Identities = 64/277 (23%), Positives = 117/277 (42%), Gaps = 45/277 (16%)
Query: 471 KIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVT 523
++GEG +G ++ + M VA+K L S +FQ+E ++L+ ++H ++V
Sbjct: 48 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 524 LVGACPEV--WTLVYEYLPNGSLEDRL------------SCKDNSPPLSWQTRIRIATEL 569
G C E +V+EY+ +G L L PL + +A+++
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 570 CSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRT 629
+ +++L VH DL N L+ V K+ DFG+SR +I S + R
Sbjct: 168 AAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIGDFGMSR-----DIYSTDYY---RV 216
Query: 630 DPKGTFA--YMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 684
+ +M PE + + T +SDV+SFG++L + T +P ++ E + G
Sbjct: 217 GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQG 276
Query: 685 KLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 721
L+ P ++ + C + + R
Sbjct: 277 ---RELER-----PRACPPEVYAIMRGCWQREPQQRH 305
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 4e-31
Identities = 52/252 (20%), Positives = 95/252 (37%), Gaps = 24/252 (9%)
Query: 424 RDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKG 483
+ K ++ D+ + E H ++G G +G +++
Sbjct: 21 SSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYRE---EVHWMTHQPRVGRGSFGEVHRM 77
Query: 484 LLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC---PEVWTLVYEY 538
+ Q A+K + + +E+ + + P +V L GA P V + E
Sbjct: 78 KDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVN-IFMEL 131
Query: 539 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA 598
L GSL + L + + L +LH+ + I+HGD+K N+LL +
Sbjct: 132 LEGGSLGQLIK---QMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSS 185
Query: 599 NFVS-KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSF 657
+ L DFG + L + + +L GT +M PE + K D++S
Sbjct: 186 DGSRAALCDFGHALCLQPDGLG---KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSS 242
Query: 658 GIILLRLLTGRP 669
++L +L G
Sbjct: 243 CCMMLHMLNGCH 254
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 4e-31
Identities = 53/218 (24%), Positives = 93/218 (42%), Gaps = 27/218 (12%)
Query: 465 NFDPSLKIGEGGYGSI-YKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLV 522
+F P +G G G+I Y+G+ + VA+K + P +E+ +L + HPN++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFA---DREVQLLRESDEHPNVI 81
Query: 523 TLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 580
+ + E +L++ + KD + I + + S L LHS
Sbjct: 82 RYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFA--HLGLEPITLLQQTTSGLAHLHS-- 136
Query: 581 PHSIVHGDLKPANILL-----DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 635
+IVH DLKP NIL+ + +SDFG+ + L+ S + + GT
Sbjct: 137 -LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP-----GTE 190
Query: 636 AYMDPEFL---ASGELTPKSDVYSFGIILLRLLT-GRP 669
++ PE L T D++S G + +++ G
Sbjct: 191 GWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-31
Identities = 51/236 (21%), Positives = 96/236 (40%), Gaps = 33/236 (13%)
Query: 471 KIGEGGYGSIYKGLLRH-----MQVAIKMLHP--HSLQGPSEFQQEIDILSKIRHPNLVT 523
+GEG +GS+ +G L+ ++VA+K + S + EF E + HPN++
Sbjct: 41 ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100
Query: 524 LVGAC----PEVWTLVY---EYLPNGSLEDRL---SCKDNSPPLSWQTRIRIATELCSVL 573
L+G C + ++ G L L + + QT ++ ++ +
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160
Query: 574 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 633
+L + + +H DL N +L + ++DFG+S+ + +
Sbjct: 161 EYLSN---RNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGR--------IA 209
Query: 634 TFA--YMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 684
++ E LA T KSDV++FG+ + + T P G+ E+ L G
Sbjct: 210 KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHG 265
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-31
Identities = 56/226 (24%), Positives = 103/226 (45%), Gaps = 25/226 (11%)
Query: 471 KIGEGGYGSIYKGLLR----HMQVAIKMLHPHSLQGPS--EFQQEIDILSKIRHPNLVTL 524
++G G +G++ KG + VA+K+L + E E +++ ++ +P +V +
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 525 VGACP-EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 583
+G C E W LV E G L L + + + I + ++ + +L +
Sbjct: 84 IGICEAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEE---SN 137
Query: 584 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF--AYMDPE 641
VH DL N+LL +K+SDFG+S+ L +E + G + + PE
Sbjct: 138 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE-------NYYKAQTHGKWPVKWYAPE 190
Query: 642 FLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 684
+ + + KSDV+SFG+++ + +P G+ EV L+ G
Sbjct: 191 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG 236
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 70/310 (22%), Positives = 133/310 (42%), Gaps = 42/310 (13%)
Query: 471 KIGEGGYGSIYKGLLRH-------MQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLV 522
++G+G +G +Y+G+ + +VAIK ++ S++ EF E ++ + ++V
Sbjct: 32 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 523 TLVGACPEV--WTLVYEYLPNGSLED-------RLSCKDNSPPLSWQTRIRIATELCSVL 573
L+G + ++ E + G L+ ++ P S I++A E+ +
Sbjct: 92 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151
Query: 574 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 633
+L++ + VH DL N ++ +F K+ DFG++R + + + R KG
Sbjct: 152 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY--------YRKGGKG 200
Query: 634 TFA--YMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTGKLKN 688
+M PE L G T SDV+SFG++L + T +P G++ ++V + G
Sbjct: 201 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG---G 257
Query: 689 LLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGS 748
LLD P + L L C + + K RP ++ ++ S+
Sbjct: 258 LLDK-----PDNCPDMLFELMRMCWQYNPKMRPSF-LEIISSIKEEMEPGFREVSFYYSE 311
Query: 749 EERCEPPPYF 758
E + P
Sbjct: 312 ENKLPEPEEL 321
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 59/264 (22%), Positives = 89/264 (33%), Gaps = 43/264 (16%)
Query: 418 DELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGY 477
+ + + V E ++ + P+ F SF + ++G G Y
Sbjct: 21 QSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLS----------RLGHGSY 70
Query: 478 GSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQ---QEIDILSKI-RHPNLVTLVGACPEV 531
G ++K + A+K +GP + E+ K+ +HP V L A
Sbjct: 71 GEVFKVRSKEDGRLYAVKRS-MSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQA---- 125
Query: 532 WT------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 585
W L E SL+ C+ L + L LHS +V
Sbjct: 126 WEEGGILYLQTELC-GPSLQQH--CEAWGASLPEAQVWGYLRDTLLALAHLHS---QGLV 179
Query: 586 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS 645
H D+KPANI L KL DFG+ L G YM PE L
Sbjct: 180 HLDVKPANIFLGPRGRCKLGDFGLLVELGTA---GAGEVQE------GDPRYMAPELLQG 230
Query: 646 GELTPKSDVYSFGIILLRLLTGRP 669
+DV+S G+ +L +
Sbjct: 231 S-YGTAADVFSLGLTILEVACNME 253
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 55/237 (23%), Positives = 100/237 (42%), Gaps = 34/237 (14%)
Query: 471 KIGEGGYGSIYKGLLRH-----MQVAIKMLHP--HSLQGPSEFQQEIDILSKIRHPNLVT 523
+G+G +GS+ + L+ ++VA+KML + EF +E + + HP++
Sbjct: 30 MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAK 89
Query: 524 LVGAC----PEVWT----LVYEYLPNGSLEDRL---SCKDNSPPLSWQTRIRIATELCSV 572
LVG + ++ ++ +G L L +N L QT +R ++
Sbjct: 90 LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149
Query: 573 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 632
+ +L S + +H DL N +L + ++DFG+SR + + R
Sbjct: 150 MEYLSS---RNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDY--------YRQGCA 198
Query: 633 GTFA--YMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 684
++ E LA T SDV++FG+ + ++T P GI E+ L G
Sbjct: 199 SKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGG 255
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 43/345 (12%), Positives = 87/345 (25%), Gaps = 60/345 (17%)
Query: 420 LQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGS 479
+ +EA + + EA +++ PQ S + + G
Sbjct: 18 EEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSV 77
Query: 480 IYKGLLRH--MQVAIKMLHPHSLQGPSE---FQQEIDILSKIRHPNLVTLVGACPEVWT- 533
++ A+K+ + SE + +++ + +
Sbjct: 78 VFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPS 137
Query: 534 ---------------------------LVYEYLPNGSLEDRLSCKDNSP----PLSWQTR 562
L+ + LE S D
Sbjct: 138 DAVAVQSQPPFAQLSPGQDDYAVANYLLLMP-AASVDLELLFSTLDFVYVFRGDEGILAL 196
Query: 563 IRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 622
+ +L + L S +VHG P N+ + + L D ++ +
Sbjct: 197 HILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSALW-----KVGTRG 248
Query: 623 TTLCCRTDPKGTFAYMDPEFLASGEL--TPKSDVYSFGIILLRLLTGRPALGITKEVQYA 680
Y EFL + T + + G+ + R+ G+
Sbjct: 249 PASS------VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI-- 300
Query: 681 LDTGKLKNLLDPLAGDWPFVQA----EQLANLAMRCCEMSRKSRP 721
+ K +L P F + + L R R+ R
Sbjct: 301 KGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRL 345
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 48/208 (23%), Positives = 84/208 (40%), Gaps = 27/208 (12%)
Query: 472 IGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPS---EFQQEIDILSKIRHPNLVTL 524
+G+GG+ + + A K++ L P + EI I + H ++V
Sbjct: 23 LGKGGFAKCF--EISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80
Query: 525 VGACPEVWTLVY---EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 581
G E V+ E SL + + L+ ++ +LH
Sbjct: 81 HG-FFEDNDFVFVVLELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHR--- 133
Query: 582 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 641
+ ++H DLK N+ L+ + K+ DFG++ + + LC GT Y+ PE
Sbjct: 134 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD--GERKKVLC------GTPNYIAPE 185
Query: 642 FLASGELTPKSDVYSFGIILLRLLTGRP 669
L+ + + DV+S G I+ LL G+P
Sbjct: 186 VLSKKGHSFEVDVWSIGCIMYTLLVGKP 213
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-30
Identities = 60/273 (21%), Positives = 108/273 (39%), Gaps = 41/273 (15%)
Query: 471 KIGEGGYGSIYKGLLRH-------MQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLV 522
+G G +G +Y+G + +QVA+K L S Q +F E I+SK H N+V
Sbjct: 37 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 96
Query: 523 TLVGACPEV--WTLVYEYLPNGSLED----RLSCKDNSPPLSWQTRIRIATELCSVLIFL 576
+G + ++ E + G L+ L+ + +A ++ +L
Sbjct: 97 RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 577 HSCKPHSIVHGDLKPANILLDA---NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 633
+ +H D+ N LL V+K+ DFG++R + + R
Sbjct: 157 EE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS--------YYRKGGCA 205
Query: 634 TFA--YMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTGKLKN 688
+M PE G T K+D +SFG++L + + P + +EV + +G
Sbjct: 206 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG---G 262
Query: 689 LLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 721
+DP P + + +C + + RP
Sbjct: 263 RMDP-----PKNCPGPVYRIMTQCWQHQPEDRP 290
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 6e-30
Identities = 52/246 (21%), Positives = 95/246 (38%), Gaps = 35/246 (14%)
Query: 435 RKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQ----V 490
+ A + +P+ D + + +G+GG+ + +
Sbjct: 18 PGAPAAAPPAKEIPEVLVD------PRSRRRYVRGRFLGKGGFAKCF--EISDADTKEVF 69
Query: 491 AIKMLHPHSLQGPS---EFQQEIDILSKIRHPNLVTLVGACPEVWTLVY---EYLPNGSL 544
A K++ L P + EI I + H ++V G E V+ E SL
Sbjct: 70 AGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG-FFEDNDFVFVVLELCRRRSL 128
Query: 545 EDRLSCKDNSPPLS-WQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSK 603
+ + L+ + R ++ +LH + ++H DLK N+ L+ + K
Sbjct: 129 LELHKRRK---ALTEPEAR-YYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVK 181
Query: 604 LSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLR 663
+ DFG++ + + LC GT Y+ PE L+ + + DV+S G I+
Sbjct: 182 IGDFGLATKVEYD--GERKKVLC------GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYT 233
Query: 664 LLTGRP 669
LL G+P
Sbjct: 234 LLVGKP 239
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 54/219 (24%), Positives = 88/219 (40%), Gaps = 39/219 (17%)
Query: 471 KIGEGGYGSIYKGLLRH-------MQVAIKMLHP-HSLQGPSEFQQEIDILSKI-RHPNL 521
+G G +G + + M VA+KML P L E+ +LS + H N+
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 522 VTLVGAC--PEVWTLVYEYLPNGSLEDRL---------------SCKDNSPPLSWQTRIR 564
V L+GAC ++ EY G L + L +D+ L + +
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 565 IATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 624
+ ++ + FL S +H DL NILL ++K+ DFG++R + +
Sbjct: 150 FSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG- 205
Query: 625 LCCRTDPKGTFAY--MDPEFLASGELTPKSDVYSFGIIL 661
M PE + + T +SDV+S+GI L
Sbjct: 206 -------NARLPVKWMAPESIFNCVYTFESDVWSYGIFL 237
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-29
Identities = 71/321 (22%), Positives = 125/321 (38%), Gaps = 43/321 (13%)
Query: 426 KAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLL 485
K ++E E + RK + Q + + E + ++G G G ++K
Sbjct: 2 KKLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKIS-------ELGAGNGGVVFKVSH 54
Query: 486 RHMQ--VAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTLVGAC---PEVWTLVYE 537
+ +A K++H P+ Q E+ +L + P +V GA E+ + E
Sbjct: 55 KPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS-ICME 111
Query: 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD 597
++ GSL+ L + + Q +++ + L +L H I+H D+KP+NIL++
Sbjct: 112 HMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVN 166
Query: 598 ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSF 657
+ KL DFG+S L S N+ + GT +YM PE L + +SD++S
Sbjct: 167 SRGEIKLCDFGVSGQLID---SMANSFV-------GTRSYMSPERLQGTHYSVQSDIWSM 216
Query: 658 GIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMS- 716
G+ L+ + GR + + L G P L M
Sbjct: 217 GLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMA 276
Query: 717 ---------RKSRPELGKDVW 728
+ P+L V+
Sbjct: 277 IFELLDYIVNEPPPKLPSGVF 297
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-29
Identities = 61/273 (22%), Positives = 109/273 (39%), Gaps = 41/273 (15%)
Query: 471 KIGEGGYGSIYKGLLRH-------MQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLV 522
+G G +G +Y+G + +QVA+K L S Q +F E I+SK H N+V
Sbjct: 78 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 137
Query: 523 TLVGACPEV--WTLVYEYLPNGSLEDRL----SCKDNSPPLSWQTRIRIATELCSVLIFL 576
+G + ++ E + G L+ L L+ + +A ++ +L
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197
Query: 577 HSCKPHSIVHGDLKPANILLDA---NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 633
+ +H D+ N LL V+K+ DFG++R + + R
Sbjct: 198 EE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG--------YYRKGGCA 246
Query: 634 TFA--YMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTGKLKN 688
+M PE G T K+D +SFG++L + + P + +EV + +G
Sbjct: 247 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG---G 303
Query: 689 LLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 721
+DP P + + +C + + RP
Sbjct: 304 RMDP-----PKNCPGPVYRIMTQCWQHQPEDRP 331
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 4e-29
Identities = 50/218 (22%), Positives = 93/218 (42%), Gaps = 40/218 (18%)
Query: 471 KIGEGGYGSIYKGLLRH-------MQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLV 522
++GE +G +YKG L VAIK L EF+ E + ++++HPN+V
Sbjct: 16 ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 75
Query: 523 TLVGAC----PEVWTLVYEYLPNGSLEDRL-------------SCKDNSPPLSWQTRIRI 565
L+G P ++++ Y +G L + L + L + +
Sbjct: 76 CLLGVVTKDQP--LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 566 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 625
++ + + +L S H +VH DL N+L+ K+SD G+ R + +
Sbjct: 134 VAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADY------- 183
Query: 626 CCRTDPKGTFA--YMDPEFLASGELTPKSDVYSFGIIL 661
+ +M PE + G+ + SD++S+G++L
Sbjct: 184 -YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVL 220
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 4e-29
Identities = 58/204 (28%), Positives = 98/204 (48%), Gaps = 21/204 (10%)
Query: 471 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 528
KIG+G G++Y + +VAI+ ++ EI ++ + ++PN+V + +
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 529 ---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 585
E+W +V EYL GSL D ++ + + E L FLHS + ++
Sbjct: 87 LVGDELW-VVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHS---NQVI 138
Query: 586 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS 645
H D+K NILL + KL+DFG ++ E S +T + GT +M PE +
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQIT-PEQSKRSTMV-------GTPYWMAPEVVTR 190
Query: 646 GELTPKSDVYSFGIILLRLLTGRP 669
PK D++S GI+ + ++ G P
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEP 214
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 5e-29
Identities = 52/219 (23%), Positives = 97/219 (44%), Gaps = 39/219 (17%)
Query: 471 KIGEGGYGSIYKGLLRH---------MQVAIKMLHP-HSLQGPSEFQQEIDILSKI-RHP 519
+GEG +G + + VA+KML + + S+ E++++ I +H
Sbjct: 42 PLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 520 NLVTLVGAC--PEVWTLVYEYLPNGSLEDRL-------------SCKDNSPPLSWQTRIR 564
N++ L+GAC ++ EY G+L + L + ++++ +
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 565 IATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 624
+L + +L S K +H DL N+L+ N V K++DFG++R ++ + T
Sbjct: 162 CTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT- 217
Query: 625 LCCRTDPKGTFA--YMDPEFLASGELTPKSDVYSFGIIL 661
G +M PE L T +SDV+SFG+++
Sbjct: 218 -------NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 249
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 5e-29
Identities = 32/295 (10%), Positives = 78/295 (26%), Gaps = 53/295 (17%)
Query: 418 DELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSF-SEIEGATHNFDPSLKIGEGG 476
+ V+ E +S ++ S+ + F SE+ +G+
Sbjct: 31 ELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQED 90
Query: 477 YGSIYKG--LLRHMQVAIKML----------------------------HPHSLQGPSEF 506
+ + + + + + F
Sbjct: 91 PYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRF 150
Query: 507 QQEIDILSKIRHPNLVTLVGACPEVWTLVY---EYLPNGSLEDRL----SCKDNSPPLSW 559
D++ + ++ + ++W L +L+ S L
Sbjct: 151 IFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVH 210
Query: 560 QTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 619
R+++ ++ +L LH + +VH L+P +I+LD L+ F
Sbjct: 211 HARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLV-------R 260
Query: 620 SNNTTLCCRTDPKGTFAYMDPEFLAS-----GELTPKSDVYSFGIILLRLLTGRP 669
+ + L +T D ++ G+ + +
Sbjct: 261 DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 7e-29
Identities = 54/204 (26%), Positives = 97/204 (47%), Gaps = 21/204 (10%)
Query: 471 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 528
KIGEG G + +H QVA+KM+ Q E+ I+ +H N+V + +
Sbjct: 52 KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111
Query: 529 ---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 585
E+W ++ E+L G+L D +S L+ + + + L +LH+ ++
Sbjct: 112 LVGEELW-VLMEFLQGGALTDIVSQV----RLNEEQIATVCEAVLQALAYLHA---QGVI 163
Query: 586 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS 645
H D+K +ILL + KLSDFG +S ++ + + GT +M PE ++
Sbjct: 164 HRDIKSDSILLTLDGRVKLSDFGFCAQIS-KDVPKRKSLV-------GTPYWMAPEVISR 215
Query: 646 GELTPKSDVYSFGIILLRLLTGRP 669
+ D++S GI+++ ++ G P
Sbjct: 216 SLYATEVDIWSLGIMVIEMVDGEP 239
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 8e-29
Identities = 59/245 (24%), Positives = 96/245 (39%), Gaps = 42/245 (17%)
Query: 471 KIGEGGYGSIYKGLLRH-------MQVAIKMLHP-HSLQGPSEFQQEIDILSKI-RHPNL 521
+G G +G + + VA+KML + E+ IL I H N+
Sbjct: 34 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 93
Query: 522 VTLVGACPEV---WTLVYEYLPNGSLEDRL-------------SCKDNSPPLSWQTRIRI 565
V L+GAC + ++ E+ G+L L L+ + I
Sbjct: 94 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153
Query: 566 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 625
+ ++ + FL S K +H DL NILL V K+ DFG++R + ++
Sbjct: 154 SFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG-- 208
Query: 626 CCRTDPKGTFA--YMDPEFLASGELTPKSDVYSFGIILLRLLT-GR---PALGITKEVQY 679
+M PE + T +SDV+SFG++L + + G P + I +E
Sbjct: 209 ------DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 262
Query: 680 ALDTG 684
L G
Sbjct: 263 RLKEG 267
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 8e-29
Identities = 68/238 (28%), Positives = 108/238 (45%), Gaps = 36/238 (15%)
Query: 471 KIGEGGYGSIYKGLLR----HMQVAIKMLHP-HSLQGPSEFQQEIDILSKI-RHPNLVTL 524
IGEG +G + K ++ M AIK + S +F E+++L K+ HPN++ L
Sbjct: 32 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91
Query: 525 VGAC--PEVWTLVYEYLPNGSLEDRL-------------SCKDNSPPLSWQTRIRIATEL 569
+GAC L EY P+G+L D L + LS Q + A ++
Sbjct: 92 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 151
Query: 570 CSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRT 629
+ +L +H DL NIL+ N+V+K++DFG+SR + + L R
Sbjct: 152 ARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRG-QEVYVKKTMGRLPVR- 206
Query: 630 DPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 684
+M E L T SDV+S+G++L +++ G P G+T E+ L G
Sbjct: 207 -------WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 257
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 57/230 (24%), Positives = 109/230 (47%), Gaps = 32/230 (13%)
Query: 457 SEIEGATHNFDPSL------KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQ 508
E E + DP+ ++G+G +G +YK + A K++ S + ++
Sbjct: 6 REYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIV 65
Query: 509 EIDILSKIRHPNLVTLVGAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIR- 564
EI+IL+ HP +V L+GA ++W ++ E+ P G+++ + + L+ + +I+
Sbjct: 66 EIEILATCDHPYIVKLLGAYYHDGKLW-IMIEFCPGGAVDAIM--LELDRGLT-EPQIQV 121
Query: 565 IATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 624
+ ++ L FLHS I+H DLK N+L+ +L+DFG+S + ++
Sbjct: 122 VCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL-KTLQKRDSF 177
Query: 625 LCCRTDPKGTFAYMDPEFLASGELT-----PKSDVYSFGIILLRLLTGRP 669
+ GT +M PE + + K+D++S GI L+ + P
Sbjct: 178 I-------GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP 220
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-28
Identities = 58/262 (22%), Positives = 98/262 (37%), Gaps = 41/262 (15%)
Query: 471 KIGEGGYGSI-YKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGAC 528
+G G G++ ++G + VA+K + EI +L++ HPN++ +
Sbjct: 22 ILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCD---IALMEIKLLTESDDHPNVIRYYCSE 78
Query: 529 --PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATEL----CSVLIFLHSCKPH 582
+ E N +L+D + K+ S + L S + LHS
Sbjct: 79 TTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---L 134
Query: 583 SIVHGDLKPANILLD-------------ANFVSKLSDFGISRFLSQNEISSNNTTLCCRT 629
I+H DLKP NIL+ N +SDFG+ + L + S
Sbjct: 135 KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL----N 190
Query: 630 DPKGTFAYMDPEFLASGE-------LTPKSDVYSFGIILLRLLT-GRPALGITKEVQYAL 681
+P GT + PE L LT D++S G + +L+ G+ G + +
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNI 250
Query: 682 DTGKLKNLLDPLAGDWPFVQAE 703
G +L + + AE
Sbjct: 251 IRGIF-SLDEMKCLHDRSLIAE 271
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 33/288 (11%), Positives = 79/288 (27%), Gaps = 63/288 (21%)
Query: 430 EAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH-- 487
+E ++ + S+S SE+ +G+ + + +
Sbjct: 39 TSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETG 98
Query: 488 MQVAIKML----------------------------HPHSLQGPSEFQQEIDILSKIRHP 519
+ + + + F D++ +
Sbjct: 99 ESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKK 158
Query: 520 NLVTLVGACPEVWTLVY---EYLPNGSLEDRL----SCKDNSPPLSWQTRIRIATELCSV 572
++ + ++W L +L+ S L R+++ ++ +
Sbjct: 159 KMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRL 218
Query: 573 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 632
L LH + +VH L+P +I+LD L+ F R
Sbjct: 219 LASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA------------RVVSS 263
Query: 633 GTFAYMDPEFLAS-----------GELTPKSDVYSFGIILLRLLTGRP 669
+ + PE A +T D ++ G+++ +
Sbjct: 264 VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 471 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSE-FQQEIDILSKIRHPNLVTLVGA 527
K+G G +G ++ R ++ IK ++ Q P E + EI++L + HPN++ +
Sbjct: 29 KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 528 C--PEVWTLVYEYLPNGSLEDRLSCKDNSP-PLSWQTRIRIATELCSVLIFLHSCKPHSI 584
+V E G L +R+ LS + ++ + L + HS +
Sbjct: 89 FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHV 145
Query: 585 VHGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 641
VH DLKP NIL + K+ DFG++ +E S T GT YM PE
Sbjct: 146 VHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS---TNAA------GTALYMAPE 196
Query: 642 FLASGELTPKSDVYSFGIILLRLLTGRP 669
++T K D++S G+++ LLTG
Sbjct: 197 VF-KRDVTFKCDIWSAGVVMYFLLTGCL 223
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-28
Identities = 53/219 (24%), Positives = 96/219 (43%), Gaps = 39/219 (17%)
Query: 471 KIGEGGYGSIYKGLLR---------HMQVAIKMLHP-HSLQGPSEFQQEIDILSKI-RHP 519
+GEG +G + +VA+KML + + S+ E++++ I +H
Sbjct: 76 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 135
Query: 520 NLVTLVGAC--PEVWTLVYEYLPNGSLEDRL-------------SCKDNSPPLSWQTRIR 564
N++ L+GAC ++ EY G+L + L + LS + +
Sbjct: 136 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 195
Query: 565 IATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 624
A ++ + +L S K +H DL N+L+ + V K++DFG++R + +
Sbjct: 196 CAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY------ 246
Query: 625 LCCRTDPKGTFA--YMDPEFLASGELTPKSDVYSFGIIL 661
+ G +M PE L T +SDV+SFG++L
Sbjct: 247 --YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLL 283
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 52/215 (24%), Positives = 93/215 (43%), Gaps = 35/215 (16%)
Query: 471 KIGEGGYGSIYKGLLR-------HMQVAIKMLHP-HSLQGPSEFQQEIDILSKI-RHPNL 521
+G G +G + + ++VA+KML E+ I+S + +H N+
Sbjct: 53 TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 112
Query: 522 VTLVGAC--PEVWTLVYEYLPNGSL-----------EDRLSCKDNSPPLSWQTRIRIATE 568
V L+GAC ++ EY G L E + + S + + +++
Sbjct: 113 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQ 172
Query: 569 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE--ISSNNTTLC 626
+ + FL S + +H D+ N+LL V+K+ DFG++R + + I N L
Sbjct: 173 VAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP 229
Query: 627 CRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIIL 661
+ +M PE + T +SDV+S+GI+L
Sbjct: 230 VK--------WMAPESIFDCVYTVQSDVWSYGILL 256
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 56/206 (27%), Positives = 91/206 (44%), Gaps = 23/206 (11%)
Query: 471 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGA- 527
+G G + ++ R A+K + S + EI +L KI+H N+VTL
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 528 -CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 586
+ LV + + G L DR+ + + + + ++ S + +LH + IVH
Sbjct: 76 ESTTHYYLVMQLVSGGELFDRILERGV---YTEKDASLVIQQVLSAVKYLHE---NGIVH 129
Query: 587 GDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 643
DLKP N+L + N ++DFG+S+ + +T C GT Y+ PE L
Sbjct: 130 RDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM----STAC------GTPGYVAPEVL 179
Query: 644 ASGELTPKSDVYSFGIILLRLLTGRP 669
A + D +S G+I LL G P
Sbjct: 180 AQKPYSKAVDCWSIGVITYILLCGYP 205
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-28
Identities = 56/262 (21%), Positives = 104/262 (39%), Gaps = 32/262 (12%)
Query: 414 KKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIG 473
K + + K E++ K + + E ++G
Sbjct: 13 KVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILE------------ELG 60
Query: 474 EGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--P 529
G +G +++ + + K ++ + EI I++++ HP L+ L A
Sbjct: 61 SGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK 120
Query: 530 EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDL 589
L+ E+L G L DR++ +D +S I + C L +H HSIVH D+
Sbjct: 121 YEMVLILEFLSGGELFDRIAAEDYK--MSEAEVINYMRQACEGLKHMHE---HSIVHLDI 175
Query: 590 KPANILLDANFVS--KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 647
KP NI+ + S K+ DFG++ L+ +EI T + PE +
Sbjct: 176 KPENIMCETKKASSVKIIDFGLATKLNPDEIV---KVTT------ATAEFAAPEIVDREP 226
Query: 648 LTPKSDVYSFGIILLRLLTGRP 669
+ +D+++ G++ LL+G
Sbjct: 227 VGFYTDMWAIGVLGYVLLSGLS 248
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-28
Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 26/209 (12%)
Query: 471 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSE---FQQEIDILSKIRHPNLVTLV 525
+G+G +G + + + A+K++ ++ ++ +E+ +L ++ HPN++ L
Sbjct: 33 VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92
Query: 526 GAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 583
+ LV E G L D + + S RI ++ S + ++H +
Sbjct: 93 EFFEDKGYFYLVGEVYTGGELFDEIISRKR---FSEVDAARIIRQVLSGITYMHK---NK 146
Query: 584 IVHGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 640
IVH DLKP N+LL + ++ DFG+S ++ D GT Y+ P
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK---------MKDKIGTAYYIAP 197
Query: 641 EFLASGELTPKSDVYSFGIILLRLLTGRP 669
E L G K DV+S G+IL LL+G P
Sbjct: 198 EVL-HGTYDEKCDVWSTGVILYILLSGCP 225
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 58/224 (25%), Positives = 91/224 (40%), Gaps = 44/224 (19%)
Query: 471 KIGEGGYGSIYKGLLRH-------MQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLV 522
+GEG +G + K H VA+KML S + E ++L ++ HP+++
Sbjct: 30 TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89
Query: 523 TLVGAC--PEVWTLVYEYLPNGSLEDRL---------------------SCKDNSPPLSW 559
L GAC L+ EY GSL L + L+
Sbjct: 90 KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149
Query: 560 QTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 619
I A ++ + +L K +VH DL NIL+ K+SDFG+SR + + +
Sbjct: 150 GDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY 206
Query: 620 SNNTTLCCRTDPKGTF--AYMDPEFLASGELTPKSDVYSFGIIL 661
+ +G +M E L T +SDV+SFG++L
Sbjct: 207 VKRS--------QGRIPVKWMAIESLFDHIYTTQSDVWSFGVLL 242
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 60/211 (28%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 471 KIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGP-SEFQQEIDILSKIRHPNLVTLVGA 527
IG G + + +VAIK ++ Q E +EI +S+ HPN+V+ +
Sbjct: 22 VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81
Query: 528 ---CPEVWTLVYEYLPNGSLED--RLSCKDNSPPLSWQTRIRIAT---ELCSVLIFLHSC 579
E+W LV + L GS+ D + IAT E+ L +LH
Sbjct: 82 FVVKDELW-LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK- 139
Query: 580 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 639
+ +H D+K NILL + +++DFG+S FL+ + T R GT +M
Sbjct: 140 --NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLAT---GGDITRNKVRKTFVGTPCWMA 194
Query: 640 PEFLASGEL-TPKSDVYSFGIILLRLLTGRP 669
PE + K+D++SFGI + L TG
Sbjct: 195 PEVMEQVRGYDFKADIWSFGITAIELATGAA 225
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 27/207 (13%)
Query: 471 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 528
K+GEG YGS+YK + + VAIK + E +EI I+ + P++V G+
Sbjct: 36 KLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSY 93
Query: 529 ---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIAT---ELCSVLIFLHSCKPH 582
++W +V EY GS+ D + + + L T IAT L +LH
Sbjct: 94 FKNTDLW-IVMEYCGAGSVSDII--RLRNKTL---TEDEIATILQSTLKGLEYLHF---M 144
Query: 583 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 642
+H D+K NILL+ +KL+DFG++ L+ + ++ NT + GT +M PE
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADFGVAGQLT-DTMAKRNTVI-------GTPFWMAPEV 196
Query: 643 LASGELTPKSDVYSFGIILLRLLTGRP 669
+ +D++S GI + + G+P
Sbjct: 197 IQEIGYNCVADIWSLGITAIEMAEGKP 223
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 66/208 (31%), Positives = 101/208 (48%), Gaps = 28/208 (13%)
Query: 471 KIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGP-SEFQQEIDILSKIRHPNLVTLVGA 527
KIG+G +G ++KG+ Q VAIK++ + + QQEI +LS+ P + G+
Sbjct: 29 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 88
Query: 528 ---CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIAT---ELCSVLIFLHSCKP 581
++W ++ EYL GS D L PL +IAT E+ L +LHS
Sbjct: 89 YLKDTKLW-IIMEYLGGGSALDLLEPG----PL---DETQIATILREILKGLDYLHS--- 137
Query: 582 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 641
+H D+K AN+LL + KL+DFG++ L+ NT + GT +M PE
Sbjct: 138 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT-QIKRNTFV-------GTPFWMAPE 189
Query: 642 FLASGELTPKSDVYSFGIILLRLLTGRP 669
+ K+D++S GI + L G P
Sbjct: 190 VIKQSAYDSKADIWSLGITAIELARGEP 217
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 5e-28
Identities = 59/271 (21%), Positives = 113/271 (41%), Gaps = 26/271 (9%)
Query: 411 QNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNF---- 466
Q+ + +E + A KS++ ++ + +P + F +
Sbjct: 30 QDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFY 89
Query: 467 --DPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLV 522
+ +G G +G ++K +++A K++ ++ E + EI +++++ H NL+
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 523 TLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 580
L A LV EY+ G L DR+ + + L+ I ++C + +H
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRIIDESYN--LTELDTILFMKQICEGIRHMHQ-- 205
Query: 581 PHSIVHGDLKPANILLDANFVS--KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 638
I+H DLKP NIL K+ DFG++R E GT ++
Sbjct: 206 -MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLKVNF------GTPEFL 255
Query: 639 DPEFLASGELTPKSDVYSFGIILLRLLTGRP 669
PE + ++ +D++S G+I LL+G
Sbjct: 256 APEVVNYDFVSFPTDMWSVGVIAYMLLSGLS 286
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 6e-28
Identities = 60/208 (28%), Positives = 95/208 (45%), Gaps = 25/208 (12%)
Query: 471 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSE--FQQEIDILSKIRHPNLVTLVG 526
K+G G YG + + H++ AIK++ S+ S +E+ +L + HPN++ L
Sbjct: 44 KLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYD 103
Query: 527 AC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 584
+ LV E G L D + + + I ++ S + +LH H+I
Sbjct: 104 FFEDKRNYYLVMECYKGGELFDEIIHRMK---FNEVDAAVIIKQVLSGVTYLHK---HNI 157
Query: 585 VHGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 641
VH DLKP N+LL + + + K+ DFG+S + + GT Y+ PE
Sbjct: 158 VHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK---------MKERLGTAYYIAPE 208
Query: 642 FLASGELTPKSDVYSFGIILLRLLTGRP 669
L + K DV+S G+IL LL G P
Sbjct: 209 VL-RKKYDEKCDVWSIGVILFILLAGYP 235
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 6e-28
Identities = 54/224 (24%), Positives = 91/224 (40%), Gaps = 44/224 (19%)
Query: 471 KIGEGGYGSIYKGLLRH-------MQVAIKMLHP-HSLQGPSEFQQEIDILSKI-RHPNL 521
+G G +G + +QVA+KML E+ +++++ H N+
Sbjct: 52 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 111
Query: 522 VTLVGAC--PEVWTLVYEYLPNGSL--------------------EDRLSCKDNSPPLSW 559
V L+GAC L++EY G L + RL +++ L++
Sbjct: 112 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171
Query: 560 QTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 619
+ + A ++ + FL VH DL N+L+ V K+ DFG++R + +
Sbjct: 172 EDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 228
Query: 620 SNNTTLCCRTDPKGTF--AYMDPEFLASGELTPKSDVYSFGIIL 661
+M PE L G T KSDV+S+GI+L
Sbjct: 229 VVRG--------NARLPVKWMAPESLFEGIYTIKSDVWSYGILL 264
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 7e-28
Identities = 60/241 (24%), Positives = 99/241 (41%), Gaps = 38/241 (15%)
Query: 451 FSDFSFSEIEGATHNF----DPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPS 504
F D + + S +G G G + R +VAI+++ S
Sbjct: 118 FFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGS 177
Query: 505 E--------FQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNS 554
+ EI+IL K+ HP ++ + + + +V E + G L D++
Sbjct: 178 AREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKR- 235
Query: 555 PPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL---DANFVSKLSDFGISR 611
L T ++ + +LH + I+H DLKP N+LL + + + K++DFG S+
Sbjct: 236 --LKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290
Query: 612 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL---TPKSDVYSFGIILLRLLTGR 668
L + + TLC GT Y+ PE L S D +S G+IL L+G
Sbjct: 291 ILGETSLM---RTLC------GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGY 341
Query: 669 P 669
P
Sbjct: 342 P 342
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 9e-28
Identities = 51/219 (23%), Positives = 97/219 (44%), Gaps = 39/219 (17%)
Query: 471 KIGEGGYGSIYKGLLRH---------MQVAIKMLHP-HSLQGPSEFQQEIDILSKI-RHP 519
+GEG +G + + VA+KML + + S+ E++++ I +H
Sbjct: 88 PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 147
Query: 520 NLVTLVGAC--PEVWTLVYEYLPNGSLEDRL-------------SCKDNSPPLSWQTRIR 564
N++ L+GAC ++ EY G+L + L + ++++ +
Sbjct: 148 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 207
Query: 565 IATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 624
+L + +L S K +H DL N+L+ N V K++DFG++R ++ +
Sbjct: 208 CTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDY------ 258
Query: 625 LCCRTDPKGTFA--YMDPEFLASGELTPKSDVYSFGIIL 661
+ G +M PE L T +SDV+SFG+++
Sbjct: 259 --YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 295
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 1e-27
Identities = 53/262 (20%), Positives = 106/262 (40%), Gaps = 20/262 (7%)
Query: 414 KKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIG 473
+K + ++ + + S + Q++ + + ++D ++G
Sbjct: 107 RKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELG 166
Query: 474 EGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--P 529
G +G +++ R A K + ++EI +S +RHP LV L A
Sbjct: 167 TGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD 226
Query: 530 EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDL 589
++YE++ G L ++++ + N +S + ++C L +H ++ VH DL
Sbjct: 227 NEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMHE---NNYVHLDL 281
Query: 590 KPANILLDANFVS--KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 647
KP NI+ + KL DFG++ L + GT + PE
Sbjct: 282 KPENIMFTTKRSNELKLIDFGLTAHLDPKQSV---KVTT------GTAEFAAPEVAEGKP 332
Query: 648 LTPKSDVYSFGIILLRLLTGRP 669
+ +D++S G++ LL+G
Sbjct: 333 VGYYTDMWSVGVLSYILLSGLS 354
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 115 bits (288), Expect = 1e-27
Identities = 46/243 (18%), Positives = 80/243 (32%), Gaps = 23/243 (9%)
Query: 441 ASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEG--GYGSIYKGLLRHMQ--VAIKM-- 494
A H + S ++ IG+G ++ + V ++
Sbjct: 2 AHHHHHHMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRIN 61
Query: 495 LHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGA---CPEVWTLVYEYLPNGSLEDRLSCK 551
L S + + Q E+ + HPN+V E+W +V ++ GS +D +
Sbjct: 62 LEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW-VVTSFMAYGSAKDLICTH 120
Query: 552 DNSPPLSWQTRIRIATELCSVLI---FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFG 608
+ IA L VL ++H VH +K ++IL+ + LS
Sbjct: 121 FMDG----MNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLR 173
Query: 609 ISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL--TPKSDVYSFGIILLRLLT 666
+ + + ++ PE L KSD+YS GI L
Sbjct: 174 SNLSMI-SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELAN 232
Query: 667 GRP 669
G
Sbjct: 233 GHV 235
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 58/207 (28%), Positives = 90/207 (43%), Gaps = 28/207 (13%)
Query: 472 IGEGGYGSIYKGLLRHM----QVAIKMLHPHSLQGPSE--FQQEIDILSKIRHPNLVTL- 524
IG+G + + RH+ +VAIK++ L S +E+ I+ + HPN+V L
Sbjct: 23 IGKGNFAKVKLA--RHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 80
Query: 525 -VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 583
V + L+ EY G + D L + + ++ S + + H
Sbjct: 81 EVIETEKTLYLIMEYASGGEVFDYLVAHG---RMKEKEARSKFRQIVSAVQYCHQ---KR 134
Query: 584 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 643
IVH DLK N+LLDA+ K++DFG S + C G Y PE
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLD---AFC------GAPPYAAPELF 185
Query: 644 ASGEL--TPKSDVYSFGIILLRLLTGR 668
G+ P+ DV+S G+IL L++G
Sbjct: 186 -QGKKYDGPEVDVWSLGVILYTLVSGS 211
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 1e-27
Identities = 53/206 (25%), Positives = 89/206 (43%), Gaps = 23/206 (11%)
Query: 471 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 528
IG G +G + + + ++ A K + + ++ F+QEI+I+ + HPN++ L
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 529 --PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 586
LV E G L +R+ K RI ++ S + + H ++ H
Sbjct: 76 EDNTDIYLVMELCTGGELFERVVHKRV---FRESDAARIMKDVLSAVAYCHK---LNVAH 129
Query: 587 GDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 643
DLKP N L + KL DFG++ ++ T GT Y+ P+ L
Sbjct: 130 RDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM---RTKV------GTPYYVSPQVL 180
Query: 644 ASGELTPKSDVYSFGIILLRLLTGRP 669
G P+ D +S G+++ LL G P
Sbjct: 181 -EGLYGPECDEWSAGVMMYVLLCGYP 205
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 61/240 (25%), Positives = 96/240 (40%), Gaps = 66/240 (27%)
Query: 472 IGEGGYGSIYKGLLRHM----QVAIKMLHPHSLQGPSEF--------------------- 506
IG+G YG + + A+K+L L + F
Sbjct: 21 IGKGSYGVVKLA--YNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78
Query: 507 -----QQEIDILSKIRHPNLVTLVGACPEVWT--------LVYEYLPNGSLEDRLSCKDN 553
QEI IL K+ HPN+V LV EV +V+E + G + + + K
Sbjct: 79 PIEQVYQEIAILKKLDHPNVVKLV----EVLDDPNEDHLYMVFELVNQGPVMEVPTLK-- 132
Query: 554 SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 613
PLS +L + +LH I+H D+KP+N+L+ + K++DFG+S
Sbjct: 133 --PLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVS--- 184
Query: 614 SQNEISSNNTTL--CCRTDPKGTFAYMDPEFLASGELT---PKSDVYSFGIILLRLLTGR 668
NE ++ L GT A+M PE L+ DV++ G+ L + G+
Sbjct: 185 --NEFKGSDALLSNTV-----GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 3e-27
Identities = 56/218 (25%), Positives = 86/218 (39%), Gaps = 41/218 (18%)
Query: 472 IGEGGYGSIYKGLLRHM----QVAIKMLHPHSLQGPSEFQQ----EIDILSKIRHPNLVT 523
+GEG YG + + + A+K+L L+ + EI +L ++RH N++
Sbjct: 13 LGEGSYGKVKEV--LDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70
Query: 524 LVGACPEVWT--------LVYEYLPNGSLE--DRLSCKDNSPPLS-WQTRIRIATELCSV 572
LV +V +V EY G E D + K Q +L
Sbjct: 71 LV----DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK----RFPVCQAH-GYFCQLIDG 121
Query: 573 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 632
L +LHS IVH D+KP N+LL K+S G++ L T
Sbjct: 122 LEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ------ 172
Query: 633 GTFAYMDPEFLASGEL--TPKSDVYSFGIILLRLLTGR 668
G+ A+ PE + K D++S G+ L + TG
Sbjct: 173 GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-27
Identities = 63/208 (30%), Positives = 98/208 (47%), Gaps = 25/208 (12%)
Query: 471 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGP--SEFQQEIDILSKIRHPNLVTLVG 526
+G+G +G + K R + A+K+++ S + S +E+++L K+ HPN++ L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 527 AC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 584
+ +V E G L D + + S RI ++ S + ++H H+I
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEIIKRKR---FSEHDAARIIKQVFSGITYMHK---HNI 142
Query: 585 VHGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 641
VH DLKP NILL + + K+ DFG+S QN GT Y+ PE
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---KDRI------GTAYYIAPE 193
Query: 642 FLASGELTPKSDVYSFGIILLRLLTGRP 669
L G K DV+S G+IL LL+G P
Sbjct: 194 VL-RGTYDEKCDVWSAGVILYILLSGTP 220
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-27
Identities = 60/219 (27%), Positives = 94/219 (42%), Gaps = 36/219 (16%)
Query: 471 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPS-------------EFQQEIDILSK 515
K+G G YG + + H + AIK++ E EI +L
Sbjct: 43 KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 516 IRHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVL 573
+ HPN++ L + + LV E+ G L +++ + I ++ S +
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK---FDECDAANIMKQILSGI 159
Query: 574 IFLHSCKPHSIVHGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTD 630
+LH H+IVH D+KP NILL ++ K+ DFG+S F S++
Sbjct: 160 CYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL---RDRL---- 209
Query: 631 PKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 669
GT Y+ PE L + K DV+S G+I+ LL G P
Sbjct: 210 --GTAYYIAPEVL-KKKYNEKCDVWSCGVIMYILLCGYP 245
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 4e-27
Identities = 58/217 (26%), Positives = 94/217 (43%), Gaps = 34/217 (15%)
Query: 471 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSE--------FQQEIDILSKIRHPN 520
+G G G + R +VAIK++ S + EI+IL K+ HP
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 521 LVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 578
++ + + + +V E + G L D++ L T ++ + +LH
Sbjct: 77 IIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKR---LKEATCKLYFYQMLLAVQYLHE 132
Query: 579 CKPHSIVHGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 635
+ I+H DLKP N+LL + + + K++DFG S+ L + + TLC GT
Sbjct: 133 ---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM---RTLC------GTP 180
Query: 636 AYMDPEFLASGEL---TPKSDVYSFGIILLRLLTGRP 669
Y+ PE L S D +S G+IL L+G P
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 217
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 5e-27
Identities = 57/224 (25%), Positives = 98/224 (43%), Gaps = 44/224 (19%)
Query: 471 KIGEGGYGSIYKGLLRH-------MQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLV 522
IGEG +G +++ VA+KML S ++FQ+E ++++ +PN+V
Sbjct: 54 DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 113
Query: 523 TLVGACPEV--WTLVYEYLPNGSLEDRL---------------------SCKDNSPPLSW 559
L+G C L++EY+ G L + L PPLS
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173
Query: 560 QTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 619
++ IA ++ + + +L VH DL N L+ N V K++DFG+SR + +
Sbjct: 174 AEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY- 229
Query: 620 SNNTTLCCRTDPKGTF--AYMDPEFLASGELTPKSDVYSFGIIL 661
+ D +M PE + T +SDV+++G++L
Sbjct: 230 -------YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVL 266
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 9e-27
Identities = 64/208 (30%), Positives = 102/208 (49%), Gaps = 29/208 (13%)
Query: 472 IGEGGYGSIYKGLLRHM----QVAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTL 524
+G G +G + G H +VA+K+L+ ++ + EI L RHP+++ L
Sbjct: 19 LGVGTFGKVKIG--EHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 525 --VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 582
V + P + +V EY+ G L D + + R+ ++ S + + H H
Sbjct: 77 YQVISTPTDFFMVMEYVSGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCHR---H 130
Query: 583 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 642
+VH DLKP N+LLDA+ +K++DFG+S +S E T C G+ Y PE
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR---TSC------GSPNYAAPEV 181
Query: 643 LASGEL--TPKSDVYSFGIILLRLLTGR 668
+ SG L P+ D++S G+IL LL G
Sbjct: 182 I-SGRLYAGPEVDIWSCGVILYALLCGT 208
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 70/246 (28%), Positives = 105/246 (42%), Gaps = 35/246 (14%)
Query: 443 SSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQ----VAIKMLHPH 498
+S + + S + F+ +G G YG +YKG RH++ AIK++
Sbjct: 3 ASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKG--RHVKTGQLAAIKVMDVT 60
Query: 499 SLQGPSEFQQEIDILSKI-RHPNLVTLVGA---------CPEVWTLVYEYLPNGSLEDRL 548
E +QEI++L K H N+ T GA ++W LV E+ GS+ D +
Sbjct: 61 G-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW-LVMEFCGAGSVTDLI 118
Query: 549 SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFG 608
+ I E+ L LH H ++H D+K N+LL N KL DFG
Sbjct: 119 KNTKGNTLKEEWIAY-ICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFG 174
Query: 609 ISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELT-----PKSDVYSFGIILLR 663
+S L + NT + GT +M PE +A E KSD++S GI +
Sbjct: 175 VSAQLD-RTVGRRNTFI-------GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 226
Query: 664 LLTGRP 669
+ G P
Sbjct: 227 MAEGAP 232
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 25/208 (12%)
Query: 471 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSE--FQQEIDILSKIRHPNLVTLVG 526
+G+G +G + K R + A+K+++ S + +E+++L K+ HPN++ L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 527 AC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 584
+ +V E G L D + + S RI ++ S + ++H H+I
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEIIKRKR---FSEHDAARIIKQVFSGITYMHK---HNI 142
Query: 585 VHGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 641
VH DLKP NILL + + K+ DFG+S QN GT Y+ PE
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---KDRI------GTAYYIAPE 193
Query: 642 FLASGELTPKSDVYSFGIILLRLLTGRP 669
L G K DV+S G+IL LL+G P
Sbjct: 194 VL-RGTYDEKCDVWSAGVILYILLSGTP 220
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 50/213 (23%), Positives = 91/213 (42%), Gaps = 29/213 (13%)
Query: 471 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPS------EFQQEIDILSKIRHPNLV 522
++G G + + K + ++ A K + + E ++E+ IL ++ H N++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 523 TLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 580
TL L+ E + G L D L+ K++ LS + ++ + +LH+
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQILDGVNYLHT-- 133
Query: 581 PHSIVHGDLKPANILL----DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 636
I H DLKP NI+L KL DFG++ + + GT
Sbjct: 134 -KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIF------GTPE 183
Query: 637 YMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 669
++ PE + L ++D++S G+I LL+G
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 216
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 56/213 (26%), Positives = 94/213 (44%), Gaps = 29/213 (13%)
Query: 471 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPS------EFQQEIDILSKIRHPNLV 522
++G G + + K + + A K + L E ++E++IL +IRHPN++
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 523 TLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 580
TL L+ E + G L D L+ K++ L+ + ++ + +LHS
Sbjct: 72 TLHDIFENKTDVVLILELVSGGELFDFLAEKES---LTEDEATQFLKQILDGVHYLHS-- 126
Query: 581 PHSIVHGDLKPANILL----DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 636
I H DLKP NI+L N KL DFGI+ + + GT
Sbjct: 127 -KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIF------GTPE 176
Query: 637 YMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 669
++ PE + L ++D++S G+I LL+G
Sbjct: 177 FVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 209
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 57/210 (27%), Positives = 84/210 (40%), Gaps = 32/210 (15%)
Query: 472 IGEGGYGSIYKGLLRHM----QVAIKMLHPHSLQGPSE-FQQEIDILSKIRHPNLVTLVG 526
+GEG YG + L + VA+K++ E ++EI I + H N+V
Sbjct: 15 LGEGAYGEVQ--LAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY- 71
Query: 527 ACPEVWT------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 580
L EY G L DR+ + R +L + +++LH
Sbjct: 72 ---GHRREGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHG-- 123
Query: 581 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 640
I H D+KP N+LLD K+SDFG++ N +C GT Y+ P
Sbjct: 124 -IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC------GTLPYVAP 176
Query: 641 EFLASGEL--TPKSDVYSFGIILLRLLTGR 668
E L DV+S GI+L +L G
Sbjct: 177 ELL-KRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 57/214 (26%), Positives = 85/214 (39%), Gaps = 30/214 (14%)
Query: 471 KIGEGGYGSIYKGLLRHMQ----VAIKMLHP-HSLQGPSEFQQEIDI-LSKIRHPNLVTL 524
+IG G YGS+ K H +A+K + + + ++D+ + P +V
Sbjct: 29 EIGRGAYGSVNKM--VHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQF 86
Query: 525 VGAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRI--RIATELCSVLIFLHSC 579
GA + W + E + + S + + I +I L L
Sbjct: 87 YGALFREGDCW-ICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE- 143
Query: 580 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 639
I+H D+KP+NILLD + KL DFGIS L + I+ G YM
Sbjct: 144 -NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV-DSIAKTRDA--------GCRPYMA 193
Query: 640 PEFLASGELTP----KSDVYSFGIILLRLLTGRP 669
PE + +SDV+S GI L L TGR
Sbjct: 194 PERIDPSASRQGYDVRSDVWSLGITLYELATGRF 227
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 5e-26
Identities = 58/213 (27%), Positives = 93/213 (43%), Gaps = 29/213 (13%)
Query: 471 KIGEGGYGSIYKGLLRHMQ----VAIKMLHP-HSLQGPSEFQQEIDI-LSKIRHPNLVTL 524
++G G YG + K RH+ +A+K + + Q ++DI + + P VT
Sbjct: 14 ELGRGAYGVVEKM--RHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTF 71
Query: 525 VGAC---PEVWTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 580
GA +VW + E + + SL+ D + +IA + L LHS
Sbjct: 72 YGALFREGDVW-ICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS-- 127
Query: 581 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 640
S++H D+KP+N+L++A K+ DFGIS +L + D G YM P
Sbjct: 128 KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV--------DDVAKDID-AGCKPYMAP 178
Query: 641 EFLASGELTP----KSDVYSFGIILLRLLTGRP 669
E + KSD++S GI ++ L R
Sbjct: 179 ERINPELNQKGYSVKSDIWSLGITMIELAILRF 211
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 41/175 (23%), Positives = 70/175 (40%), Gaps = 9/175 (5%)
Query: 499 SLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTL--VYEYLPNGSLEDRLSCKDNSPP 556
S +I + N V + L + +L+D ++ + +
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160
Query: 557 LSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 616
+ I ++ + FLHS ++H DLKP+NI + V K+ DFG+ + Q+
Sbjct: 161 REHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217
Query: 617 E----ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG 667
E + + T GT YM PE + + K D++S G+IL LL
Sbjct: 218 EEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS 272
|
| >2kr4_A Ubiquitin conjugation factor E4 B; U-BOX, UFD2, ring, E3 ligase, UBL conjugation pathway; NMR {Mus musculus} Length = 85 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 7e-26
Identities = 17/76 (22%), Positives = 28/76 (36%), Gaps = 1/76 (1%)
Query: 749 EERCEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLV 808
+ + P F P+ +M DP G + + L + T P L L
Sbjct: 6 IDYSDAPDEFRDPLMDTLMTDPVRLPSGTVMDRSIILRHLLNSP-TDPFNRQMLTESMLE 64
Query: 809 PNLALRSAIQEWLQQH 824
P L+ IQ W+++
Sbjct: 65 PVPELKEQIQAWMREK 80
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 49/208 (23%), Positives = 94/208 (45%), Gaps = 24/208 (11%)
Query: 471 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSE--FQQEIDILSKIRHPNLVTLVG 526
++G+G + + + + + ++ A K+++ L ++E I K++HPN+V L
Sbjct: 13 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 72
Query: 527 AC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 584
+ LV++ + G L + + ++ S ++ + + HS + I
Sbjct: 73 SIQEESFHYLVFDLVTGGELFEDIVAREF---YSEADASHCIQQILESIAYCHS---NGI 126
Query: 585 VHGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 641
VH +LKP N+LL KL+DFG++ ++ +E GT Y+ PE
Sbjct: 127 VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW---HGFA------GTPGYLSPE 177
Query: 642 FLASGELTPKSDVYSFGIILLRLLTGRP 669
L + D+++ G+IL LL G P
Sbjct: 178 VLKKDPYSKPVDIWACGVILYILLVGYP 205
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 52/211 (24%), Positives = 92/211 (43%), Gaps = 27/211 (12%)
Query: 471 KIGEGGYGSIYKGLLRHMQ--VAIKMLHP-HSLQGPSEFQQEIDILSK-IRHPNLVTLVG 526
++G G G ++K R +A+K + + + ++D++ K P +V G
Sbjct: 32 EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91
Query: 527 AC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 583
+V+ + E + E K P+ + ++ + L +L H
Sbjct: 92 TFITNTDVF-IAMELM-GTCAEKLK--KRMQGPIPERILGKMTVAIVKALYYLKE--KHG 145
Query: 584 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 643
++H D+KP+NILLD KL DFGIS L ++ + + + G AYM PE +
Sbjct: 146 VIHRDVKPSNILLDERGQIKLCDFGISGRLV-DDKAKDRSA--------GCAAYMAPERI 196
Query: 644 ASGEL-----TPKSDVYSFGIILLRLLTGRP 669
+ ++DV+S GI L+ L TG+
Sbjct: 197 DPPDPTKPDYDIRADVWSLGISLVELATGQF 227
|
| >2kre_A Ubiquitin conjugation factor E4 B; U-box domain, E3 ubiquitin ligase, E4 polyubiquitin chain EL factor, phosphoprotein, UBL conjugation pathway; NMR {Homo sapiens} PDB: 3l1x_A 3l1z_B Length = 100 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-25
Identities = 17/82 (20%), Positives = 28/82 (34%), Gaps = 1/82 (1%)
Query: 743 SYRLGSEERCEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPL 802
+ + P F P+ +M DP G + + L + T P L
Sbjct: 15 KNARAEIDYSDAPDEFRDPLMDTLMTDPVRLPSGTIMDRSIILRHLLNSP-TDPFNRQTL 73
Query: 803 AHKNLVPNLALRSAIQEWLQQH 824
L P L+ IQ W+++
Sbjct: 74 TESMLEPVPELKEQIQAWMREK 95
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 51/213 (23%), Positives = 94/213 (44%), Gaps = 29/213 (13%)
Query: 471 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPS------EFQQEIDILSKIRHPNLV 522
++G G + + K + +Q A K + + + ++E+ IL +I+HPN++
Sbjct: 18 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 523 TLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 580
TL L+ E + G L D L+ K++ L+ + ++ + + +LHS
Sbjct: 78 TLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGVYYLHS-- 132
Query: 581 PHSIVHGDLKPANILL----DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 636
I H DLKP NI+L K+ DFG++ + + GT
Sbjct: 133 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIF------GTPE 182
Query: 637 YMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 669
++ PE + L ++D++S G+I LL+G
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 215
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 44/207 (21%), Positives = 88/207 (42%), Gaps = 25/207 (12%)
Query: 471 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 528
+G G +G +++ + K + ++EI IL+ RH N++ L +
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF 70
Query: 529 --PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 586
E +++E++ + +R++ L+ + + ++C L FLHS H+I H
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFE--LNEREIVSYVHQVCEALQFLHS---HNIGH 125
Query: 587 GDLKPANILL----DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 642
D++P NI+ + K+ +FG +R L + L Y PE
Sbjct: 126 FDIRPENIIYQTRRSSTI--KIIEFGQARQLKPGDNF---RLLF------TAPEYYAPEV 174
Query: 643 LASGELTPKSDVYSFGIILLRLLTGRP 669
++ +D++S G ++ LL+G
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGIN 201
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 61/283 (21%), Positives = 101/283 (35%), Gaps = 64/283 (22%)
Query: 439 KEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLH 496
SS +F S E+ + IG+G YG + + AIK+++
Sbjct: 4 HHHHSSGRENLYFQGGSLLEL---QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMN 60
Query: 497 PHSLQGPSE-----FQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLS 549
+ ++ + + E+ ++ K+ HPN+ L + LV E G L D+L+
Sbjct: 61 KNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLN 120
Query: 550 CKDNSPPLSWQTRI-------------------------------------RIATELCSV 572
+ + I ++ S
Sbjct: 121 VFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180
Query: 573 LIFLHSCKPHSIVHGDLKPANILL--DANFVSKLSDFGISRFLSQNEISSNN--TTLCCR 628
L +LH+ I H D+KP N L + +F KL DFG+S+ + TT
Sbjct: 181 LHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-- 235
Query: 629 TDPKGTFAYMDPEFLASGEL--TPKSDVYSFGIILLRLLTGRP 669
GT ++ PE L + PK D +S G++L LL G
Sbjct: 236 ----GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAV 274
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 57/210 (27%), Positives = 84/210 (40%), Gaps = 32/210 (15%)
Query: 472 IGEGGYGSIYKGLLRHM----QVAIKMLHPHSLQGPSE-FQQEIDILSKIRHPNLVTLVG 526
+GEG YG + L + VA+K++ E ++EI I + H N+V
Sbjct: 15 LGEGAYGEVQ--LAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY- 71
Query: 527 ACPEVWT------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 580
L EY G L DR+ + R +L + +++LH
Sbjct: 72 ---GHRREGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHG-- 123
Query: 581 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 640
I H D+KP N+LLD K+SDFG++ N +C GT Y+ P
Sbjct: 124 -IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC------GTLPYVAP 176
Query: 641 EFLASGEL--TPKSDVYSFGIILLRLLTGR 668
E L DV+S GI+L +L G
Sbjct: 177 ELL-KRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 51/213 (23%), Positives = 92/213 (43%), Gaps = 29/213 (13%)
Query: 471 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPS------EFQQEIDILSKIRHPNLV 522
++G G + + K + ++ A K + + E ++E+ IL ++ HPN++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78
Query: 523 TLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 580
TL L+ E + G L D L+ K++ LS + ++ + +LH+
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQILDGVNYLHT-- 133
Query: 581 PHSIVHGDLKPANILL----DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 636
I H DLKP NI+L KL DFG++ + + GT
Sbjct: 134 -KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIF------GTPE 183
Query: 637 YMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 669
++ PE + L ++D++S G+I LL+G
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 216
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 49/208 (23%), Positives = 94/208 (45%), Gaps = 24/208 (11%)
Query: 471 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSE--FQQEIDILSKIRHPNLVTLVG 526
++G+G + + + + + ++ A K+++ L ++E I K++HPN+V L
Sbjct: 36 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95
Query: 527 AC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 584
+ LV++ + G L + + ++ S ++ + + HS + I
Sbjct: 96 SIQEESFHYLVFDLVTGGELFEDIVAREF---YSEADASHCIQQILESIAYCHS---NGI 149
Query: 585 VHGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 641
VH +LKP N+LL KL+DFG++ ++ +E GT Y+ PE
Sbjct: 150 VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFA------GTPGYLSPE 200
Query: 642 FLASGELTPKSDVYSFGIILLRLLTGRP 669
L + D+++ G+IL LL G P
Sbjct: 201 VLKKDPYSKPVDIWACGVILYILLVGYP 228
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 49/229 (21%), Positives = 85/229 (37%), Gaps = 45/229 (19%)
Query: 471 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQ---QEIDILSKI-RHPNLVTL 524
KIG G +GS++K + R AIK L G + Q +E+ + + +H ++V
Sbjct: 18 KIGSGEFGSVFKCVKRLDGCIYAIKRS-KKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 76
Query: 525 VGACPEVWTL--VYEYLPNGSLEDRLS-CKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 581
A E + EY GSL D +S + ++ L ++HS
Sbjct: 77 FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS- 135
Query: 582 HSIVHGDLKPANILLDAN-------------------FVSKLSDFGISRFLSQNEISSNN 622
+VH D+KP+NI + + K+ D G ISS
Sbjct: 136 --LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT-----RISSPQ 188
Query: 623 TTLCCRTDPKGTFAYMDPEFLA-SGELTPKSDVYSFGIILLRLLTGRPA 670
+G ++ E L + PK+D+++ + ++ P
Sbjct: 189 VE-------EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 62/219 (28%), Positives = 96/219 (43%), Gaps = 35/219 (15%)
Query: 471 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSE---------FQQEIDILSKI-RH 518
+G G + + + + + A+K++ S +E+DIL K+ H
Sbjct: 24 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83
Query: 519 PNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFL 576
PN++ L + LV++ + G L D L+ K LS + +I L V+ L
Sbjct: 84 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRALLEVICAL 140
Query: 577 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 636
H +IVH DLKP NILLD + KL+DFG S L E +C GT +
Sbjct: 141 HK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL---REVC------GTPS 188
Query: 637 YMDPEFLASGEL------TPKSDVYSFGIILLRLLTGRP 669
Y+ PE + + D++S G+I+ LL G P
Sbjct: 189 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 227
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 8e-25
Identities = 55/231 (23%), Positives = 100/231 (43%), Gaps = 29/231 (12%)
Query: 461 GATHNFDPSLK---------IGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQE 509
G+T +F + +GEG + + + + A+K++ S +E
Sbjct: 1 GSTDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFRE 60
Query: 510 IDILSKIR-HPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIA 566
+++L + + H N++ L+ + + LV+E + GS+ + + + + +
Sbjct: 61 VEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRH---FNELEASVVV 117
Query: 567 TELCSVLIFLHSCKPHSIVHGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNT 623
++ S L FLH+ I H DLKP NIL + K+ DF + + N S +
Sbjct: 118 QDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIS 174
Query: 624 TLCCRTDPKGTFAYMDPEFLASGELTPKS-----DVYSFGIILLRLLTGRP 669
T T P G+ YM PE + + D++S G+IL LL+G P
Sbjct: 175 TPELLT-PCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYP 224
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 71/309 (22%), Positives = 119/309 (38%), Gaps = 34/309 (11%)
Query: 380 DQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRK 439
+ + + + + L ++ K+ + +
Sbjct: 10 GVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGT 69
Query: 440 EASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHP 497
E M ++ + +DP IG G + + + R + A+K++
Sbjct: 70 ENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEV 129
Query: 498 HSLQGPSE--------FQQEIDILSKIR-HPNLVTLVGAC--PEVWTLVYEYLPNGSLED 546
+ + E ++E IL ++ HP+++TL+ + LV++ + G L D
Sbjct: 130 TAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFD 189
Query: 547 RLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSD 606
L+ K LS + I L + FLH+ ++IVH DLKP NILLD N +LSD
Sbjct: 190 YLTEKVA---LSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSD 243
Query: 607 FGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL------TPKSDVYSFGII 660
FG S L E LC GT Y+ PE L + D+++ G+I
Sbjct: 244 FGFSCHLEPGEKL---RELC------GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVI 294
Query: 661 LLRLLTGRP 669
L LL G P
Sbjct: 295 LFTLLAGSP 303
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 51/209 (24%), Positives = 86/209 (41%), Gaps = 23/209 (11%)
Query: 471 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGP--SEFQQEIDILSKIRH-PNLVTLV 525
++G G + + + + + + A K L +E EI +L + P ++ L
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 526 GA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 583
L+ EY G + + + +S IR+ ++ + +LH ++
Sbjct: 96 EVYENTSEIILILEYAAGGEIFSLC-LPELAEMVSENDVIRLIKQILEGVYYLHQ---NN 151
Query: 584 IVHGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 640
IVH DLKP NILL K+ DFG+SR + + GT Y+ P
Sbjct: 152 IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL---REIM------GTPEYLAP 202
Query: 641 EFLASGELTPKSDVYSFGIILLRLLTGRP 669
E L +T +D+++ GII LLT
Sbjct: 203 EILNYDPITTATDMWNIGIIAYMLLTHTS 231
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-24
Identities = 43/208 (20%), Positives = 85/208 (40%), Gaps = 23/208 (11%)
Query: 471 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSE--FQQEIDILSKIRHPNLVTLVG 526
++G+G + + + + + A +++ L ++E I ++HPN+V L
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77
Query: 527 AC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 584
+ L+++ + G L + + ++ S ++ ++ H +
Sbjct: 78 SISEEGHHYLIFDLVTGGELFEDIVAREY---YSEADASHCIQQILEAVLHCHQ---MGV 131
Query: 585 VHGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 641
VH +LKP N+LL KL+DFG++ + + GT Y+ PE
Sbjct: 132 VHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ--QAWFGFA------GTPGYLSPE 183
Query: 642 FLASGELTPKSDVYSFGIILLRLLTGRP 669
L D+++ G+IL LL G P
Sbjct: 184 VLRKDPYGKPVDLWACGVILYILLVGYP 211
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 46/247 (18%), Positives = 94/247 (38%), Gaps = 30/247 (12%)
Query: 436 KSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIK 493
+ D F ++ ++ IG+G + + + + R Q A+K
Sbjct: 2 SPGISGGGGGILDMADDDVLFEDV------YELCEVIGKGPFSVVRRCINRETGQQFAVK 55
Query: 494 M-----LHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNGSLED 546
+ + ++E I ++HP++V L+ + +V+E++ L
Sbjct: 56 IVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCF 115
Query: 547 RLSCKDNSP-PLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL---DANFVS 602
+ + ++ S ++ L + H ++I+H D+KP +LL + +
Sbjct: 116 EIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPV 172
Query: 603 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILL 662
KL FG++ L ++ GT +M PE + DV+ G+IL
Sbjct: 173 KLGGFGVAIQLGES--GLVAGGRV------GTPHFMAPEVVKREPYGKPVDVWGCGVILF 224
Query: 663 RLLTGRP 669
LL+G
Sbjct: 225 ILLSGCL 231
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 50/214 (23%), Positives = 83/214 (38%), Gaps = 35/214 (16%)
Query: 472 IGEGGYGSIYKGLLRHM----QVAIKML------HPHSLQGPSEFQQEIDILSKIRH--P 519
+G GG+GS+Y G + VAIK + L + E+ +L K+
Sbjct: 51 LGSGGFGSVYSG--IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 108
Query: 520 NLVTL--VGACPEVWTLVYEY-LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFL 576
++ L P+ + L+ E P L D ++ + L + ++ +
Sbjct: 109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRHC 165
Query: 577 HSCKPHSIVHGDLKPANILLDANFVS-KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 635
H+ ++H D+K NIL+D N KL DFG L T GT
Sbjct: 166 HN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY----TDFD------GTR 212
Query: 636 AYMDPEFLASGELT-PKSDVYSFGIILLRLLTGR 668
Y PE++ + V+S GI+L ++ G
Sbjct: 213 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 246
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-24
Identities = 61/267 (22%), Positives = 112/267 (41%), Gaps = 26/267 (9%)
Query: 410 LQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPS 469
+ ++ + + + ++ + ++S +P ++ D S + + F+
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGS--NRDALSDFFEVE 58
Query: 470 LKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGA 527
++G G +Y+ + A+K+L + EI +L ++ HPN++ L
Sbjct: 59 SELGRGATSIVYRCKQKGTQKPYALKVLK--KTVDKKIVRTEIGVLLRLSHPNIIKLKEI 116
Query: 528 C--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 585
P +LV E + G L DR+ K S + ++ + +LH + IV
Sbjct: 117 FETPTEISLVLELVTGGELFDRIVEKGY---YSERDAADAVKQILEAVAYLHE---NGIV 170
Query: 586 HGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 642
H DLKP N+L + K++DFG+S+ + + T+C GT Y PE
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM---KTVC------GTPGYCAPEI 221
Query: 643 LASGELTPKSDVYSFGIILLRLLTGRP 669
L P+ D++S GII LL G
Sbjct: 222 LRGCAYGPEVDMWSVGIITYILLCGFE 248
|
| >1wgm_A Ubiquitin conjugation factor E4A; ubiquitinating enzyme, KIAA0126, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: g.44.1.2 Length = 98 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 7e-24
Identities = 22/77 (28%), Positives = 29/77 (37%), Gaps = 2/77 (2%)
Query: 749 EERCEPPPYFTCPIFQEVMQDPHVAADG-FTYEAEALKGWLDSGHETSPMTNLPLAHKNL 807
E + F PI +M DP V T + + L S T P PL +
Sbjct: 14 ETYADACDEFLDPIMSTLMCDPVVLPSSRVTVDRSTIARHLLSDQ-TDPFNRSPLTMDQI 72
Query: 808 VPNLALRSAIQEWLQQH 824
PN L+ IQ WL +
Sbjct: 73 RPNTELKEKIQRWLAER 89
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 8e-24
Identities = 63/213 (29%), Positives = 96/213 (45%), Gaps = 36/213 (16%)
Query: 471 KIGEGGYGSIYKGLLRH--MQVAIKML---HPHSLQGPSEFQQEIDILSKIRHPNLVTLV 525
+IG G +G++Y VAIK + S + + +E+ L K+RHPN +
Sbjct: 61 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 120
Query: 526 GAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIAT---ELCSVLIFLHSC 579
G W LV EY GS D L + + PL + IA L +LHS
Sbjct: 121 GCYLREHTAW-LVMEYCL-GSASDLL--EVHKKPL---QEVEIAAVTHGALQGLAYLHS- 172
Query: 580 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 639
H+++H D+K NILL + KL DFG + + ++ N+ + GT +M
Sbjct: 173 --HNMIHRDVKAGNILLSEPGLVKLGDFGSA-----SIMAPANSFV-------GTPYWMA 218
Query: 640 PEFLAS---GELTPKSDVYSFGIILLRLLTGRP 669
PE + + G+ K DV+S GI + L +P
Sbjct: 219 PEVILAMDEGQYDGKVDVWSLGITCIELAERKP 251
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 9e-24
Identities = 64/212 (30%), Positives = 103/212 (48%), Gaps = 37/212 (17%)
Query: 472 IGEGGYGSIYKGLLRHM----QVAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTL 524
+G G +G + G +H +VA+K+L+ ++ + EI L RHP+++ L
Sbjct: 24 LGVGTFGKVKVG--KHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 525 VGACPEVWT------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 578
+V + +V EY+ G L D + L + R+ ++ S + + H
Sbjct: 82 Y----QVISTPSDIFMVMEYVSGGELFDYICKNG---RLDEKESRRLFQQILSGVDYCHR 134
Query: 579 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 638
H +VH DLKP N+LLDA+ +K++DFG+S +S E T C G+ Y
Sbjct: 135 ---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR---TSC------GSPNYA 182
Query: 639 DPEFLASGEL--TPKSDVYSFGIILLRLLTGR 668
PE + SG L P+ D++S G+IL LL G
Sbjct: 183 APEVI-SGRLYAGPEVDIWSSGVILYALLCGT 213
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 52/211 (24%), Positives = 95/211 (45%), Gaps = 31/211 (14%)
Query: 471 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGA 527
+G G G + + R + A+K+L+ +QE+D + P++V ++
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-----ARQEVDHHWQASGGPHIVCILDV 90
Query: 528 CPEVWT------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 581
+ ++ E + G L R+ + + + + I ++ + + FLHS
Sbjct: 91 YENMHHGKRCLLIIMECMEGGELFSRIQERGDQA-FTEREAAEIMRDIGTAIQFLHS--- 146
Query: 582 HSIVHGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 638
H+I H D+KP N+L + + V KL+DFG ++ +QN + T C T Y+
Sbjct: 147 HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL----QTPC------YTPYYV 196
Query: 639 DPEFLASGELTPKSDVYSFGIILLRLLTGRP 669
PE L + D++S G+I+ LL G P
Sbjct: 197 APEVLGPEKYDKSCDMWSLGVIMYILLCGFP 227
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 59/207 (28%), Positives = 93/207 (44%), Gaps = 23/207 (11%)
Query: 472 IGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTL 524
+GEG + ++ L R + AIK+L + ++ E D++S++ HP V L
Sbjct: 38 LGEGSFSTVV--LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 525 VGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 582
E Y NG L + K S + TR A E+ S L +LH
Sbjct: 96 YFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDET-CTRFYTA-EIVSALEYLHG---K 149
Query: 583 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 642
I+H DLKP NILL+ + +++DFG ++ LS + + GT Y+ PE
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV------GTAQYVSPEL 203
Query: 643 LASGELTPKSDVYSFGIILLRLLTGRP 669
L SD+++ G I+ +L+ G P
Sbjct: 204 LTEKSACKSSDLWALGCIIYQLVAGLP 230
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 63/208 (30%), Positives = 97/208 (46%), Gaps = 30/208 (14%)
Query: 472 IGEGGYGSIYKGLLRHM----QVAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTL 524
+GEG +G + H +VA+K + L+ + EI L +RHP+++ L
Sbjct: 17 LGEGSFGKVKLA--THYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74
Query: 525 --VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 582
V P +V EY G L D + K ++ R ++ + + H H
Sbjct: 75 YDVITTPTDIVMVIEYA-GGELFDYIVEKK---RMTEDEGRRFFQQIICAIEYCHR---H 127
Query: 583 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 642
IVH DLKP N+LLD N K++DFG+S ++ T C G+ Y PE
Sbjct: 128 KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLK---TSC------GSPNYAAPEV 178
Query: 643 LASGEL--TPKSDVYSFGIILLRLLTGR 668
+ +G+L P+ DV+S GI+L +L GR
Sbjct: 179 I-NGKLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 49/214 (22%), Positives = 86/214 (40%), Gaps = 35/214 (16%)
Query: 472 IGEGGYGSIYKGLLRHM----QVAIKM-----LHPHSLQGPSEFQQ---EIDILSKIRHP 519
+G G +G ++ +V +K + + + EI ILS++ H
Sbjct: 32 LGSGAFGFVWTA--VDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89
Query: 520 NLVTL--VGACPEVWTLVYEYLPNGS-LEDRLSCKDNSPPLSWQTRIRIATELCSVLIFL 576
N++ + + + LV E +G L + L I +L S + +L
Sbjct: 90 NIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR---LDEPLASYIFRQLVSAVGYL 146
Query: 577 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 636
I+H D+K NI++ +F KL DFG + +L + ++ T C GT
Sbjct: 147 RL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFY---TFC------GTIE 194
Query: 637 YMDPEFLASGEL--TPKSDVYSFGIILLRLLTGR 668
Y PE L G P+ +++S G+ L L+
Sbjct: 195 YCAPEVL-MGNPYRGPELEMWSLGVTLYTLVFEE 227
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 34/208 (16%), Positives = 56/208 (26%), Gaps = 54/208 (25%)
Query: 471 KIGEGGYGSIYKG----LLRHMQVAIKMLHPHSLQGPS---EFQQEIDILSKIRHPNLVT 523
G ++ L R QVA+ + P + E LS+I P +
Sbjct: 38 FHGGVPPLQFWQALDTALDR--QVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 524 L--VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 581
+ V +V E++ GSL++ + P IR L + H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVAD----TSPSPVGA-IRAMQSLAAAADAAHR--- 147
Query: 582 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 641
+ P+ + + + L A M
Sbjct: 148 AGVALSIDHPSRVRVSIDGDVVL----------------------------AYPATMPDA 179
Query: 642 FLASGELTPKSDVYSFGIILLRLLTGRP 669
P+ D+ G L LL R
Sbjct: 180 -------NPQDDIRGIGASLYALLVNRW 200
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 55/216 (25%), Positives = 89/216 (41%), Gaps = 37/216 (17%)
Query: 472 IGEGGYGSIYKGLLRHM----QVAIKML------HPHSLQGPSEFQQEIDILSKIR---- 517
+G+GG+G+++ G + QVAIK++ L E+ +L K+
Sbjct: 39 LGKGGFGTVFAG--HRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96
Query: 518 HPNLVTL--VGACPEVWTLVYEY-LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLI 574
HP ++ L E + LV E LP L D ++ K L ++ + +
Sbjct: 97 HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP---LGEGPSRCFFGQVVAAIQ 153
Query: 575 FLHSCKPHSIVHGDLKPANILLDA-NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 633
HS +VH D+K NIL+D +KL DFG L T G
Sbjct: 154 HCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY----TDFD------G 200
Query: 634 TFAYMDPEFLASGELT-PKSDVYSFGIILLRLLTGR 668
T Y PE+++ + + V+S GI+L ++ G
Sbjct: 201 TRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD 236
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 57/207 (27%), Positives = 85/207 (41%), Gaps = 25/207 (12%)
Query: 471 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVGA 527
+GEG + K + + + A+K++ Q+EI L HPN+V L
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANT---QKEITALKLCEGHPNIVKLHEV 74
Query: 528 C--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 585
LV E L G L +R+ K + S I +L S + +H +V
Sbjct: 75 FHDQLHTFLVMELLNGGELFERIKKKKH---FSETEASYIMRKLVSAVSHMHD---VGVV 128
Query: 586 HGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 642
H DLKP N+L + N K+ DFG +R +N L P T Y PE
Sbjct: 129 HRDLKPENLLFTDENDNLEIKIIDFGFARL-----KPPDNQPL---KTPCFTLHYAAPEL 180
Query: 643 LASGELTPKSDVYSFGIILLRLLTGRP 669
L D++S G+IL +L+G+
Sbjct: 181 LNQNGYDESCDLWSLGVILYTMLSGQV 207
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 5e-22
Identities = 50/209 (23%), Positives = 91/209 (43%), Gaps = 29/209 (13%)
Query: 471 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSK-IRHPNLVTLVGA 527
IG G Y + + + +M+ A+K++ +EI+IL + +HPN++TL
Sbjct: 29 DIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDP----TEEIEILLRYGQHPNIITLKDV 84
Query: 528 C--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 585
+ +V E + G L D++ + S + + + + +LH+ +V
Sbjct: 85 YDDGKYVYVVTELMKGGELLDKILRQKF---FSEREASAVLFTITKTVEYLHA---QGVV 138
Query: 586 HGDLKPANILL-----DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 640
H DLKP+NIL + + ++ DFG ++ L T C T ++ P
Sbjct: 139 HRDLKPSNILYVDESGNPESI-RICDFGFAKQLRAEN--GLLMTPC------YTANFVAP 189
Query: 641 EFLASGELTPKSDVYSFGIILLRLLTGRP 669
E L D++S G++L +LTG
Sbjct: 190 EVLERQGYDAACDIWSLGVLLYTMLTGYT 218
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 2e-21
Identities = 50/211 (23%), Positives = 92/211 (43%), Gaps = 30/211 (14%)
Query: 471 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGA 527
+G G G + + + + A+KML ++E+++ + + P++V +V
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIVDV 123
Query: 528 CPEVWT------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 581
++ +V E L G L R+ + + + + I + + +LHS
Sbjct: 124 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMKSIGEAIQYLHS--- 179
Query: 582 HSIVHGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 638
+I H D+KP N+L N + KL+DFG ++ + + TT C T Y+
Sbjct: 180 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL---TTPC------YTPYYV 230
Query: 639 DPEFLASGELTPKSDVYSFGIILLRLLTGRP 669
PE L + D++S G+I+ LL G P
Sbjct: 231 APEVLGPEKYDKSCDMWSLGVIMYILLCGYP 261
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 57/207 (27%), Positives = 83/207 (40%), Gaps = 29/207 (14%)
Query: 472 IGEGGYGSIYKGLLRHM----QVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL--V 525
IG G +G L+R VA+K + + Q+EI +RHPN+V V
Sbjct: 28 IGSGNFGVAR--LMRDKLTKELVAVKYIERGAAI-DENVQREIINHRSLRHPNIVRFKEV 84
Query: 526 GACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 585
P ++ EY G L +R+ S +L S + + HS I
Sbjct: 85 ILTPTHLAIIMEYASGGELYERICNAGR---FSEDEARFFFQQLLSGVSYCHS---MQIC 138
Query: 586 HGDLKPANILLDANFVS--KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 643
H DLK N LLD + K+ DFG S+ + + GT AY+ PE L
Sbjct: 139 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STV------GTPAYIAPEVL 189
Query: 644 ASGEL--TPKSDVYSFGIILLRLLTGR 668
+ +DV+S G+ L +L G
Sbjct: 190 -LRQEYDGKIADVWSCGVTLYVMLVGA 215
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 3e-21
Identities = 63/280 (22%), Positives = 103/280 (36%), Gaps = 46/280 (16%)
Query: 407 VELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNF 466
++LL +E ++ +DK V A+ L+ + + DF
Sbjct: 18 LDLLLGVHQELGASELAQDKYV--ADFLQWAEPIVVRLKEVRLQRDDFEI---------- 65
Query: 467 DPSLK-IGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSE---FQQEIDILSKIRH 518
LK IG G + + +++ Q A+K+++ + E F++E D+L
Sbjct: 66 ---LKVIGRGAFSEVA--VVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 519 PNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFL 576
+ L A LV EY G L LS P R +A E+ + +
Sbjct: 121 RWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEM-ARFYLA-EIVMAIDSV 178
Query: 577 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 636
H VH D+KP NILLD +L+DFG L + + GT
Sbjct: 179 HR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSL-VAV------GTPD 228
Query: 637 YMDPEFLASGELTPKSDVY-------SFGIILLRLLTGRP 669
Y+ PE L + P + Y + G+ + G+
Sbjct: 229 YLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQT 268
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 3e-21
Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 25/208 (12%)
Query: 471 KIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTL 524
+GEG YG + K R+ VAIK +EI +L ++RH NLV L
Sbjct: 32 LVGEGSYGMVMKC--RNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNL 89
Query: 525 VGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 582
+ C + W LV+E++ + ++ D L + L +Q + ++ + + F HS H
Sbjct: 90 LEVCKKKKRWYLVFEFVDH-TILDDL--ELFPNGLDYQVVQKYLFQIINGIGFCHS---H 143
Query: 583 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 642
+I+H D+KP NIL+ + V KL DFG +R +++ D T Y PE
Sbjct: 144 NIIHRDIKPENILVSQSGVVKLCDFGFAR-----TLAAPGEVY---DDEVATRWYRAPEL 195
Query: 643 L-ASGELTPKSDVYSFGIILLRLLTGRP 669
L + DV++ G ++ + G P
Sbjct: 196 LVGDVKYGKAVDVWAIGCLVTEMFMGEP 223
|
| >2c2l_A CHIP, carboxy terminus of HSP70-interacting protein; chaperone, E3 ligase, ubiquitinylation, TPR, heat-shock protein complex; 3.3A {Mus musculus} SCOP: a.118.8.1 g.44.1.2 Length = 281 | Back alignment and structure |
|---|
Score = 93.1 bits (231), Expect = 5e-21
Identities = 20/77 (25%), Positives = 41/77 (53%)
Query: 748 SEERCEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNL 807
++ + P Y I E+M++P + G TY+ + ++ L +P+T PL + L
Sbjct: 199 KRKKRDIPDYLCGKISFELMREPCITPSGITYDRKDIEEHLQRVGHFNPVTRSPLTQEQL 258
Query: 808 VPNLALRSAIQEWLQQH 824
+PNLA++ I ++ ++
Sbjct: 259 IPNLAMKEVIDAFISEN 275
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 5e-21
Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 37/216 (17%)
Query: 471 KIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTL- 524
K+G G Y ++YKG + VA+K + S +G PS +EI ++ +++H N+V L
Sbjct: 12 KLGNGTYATVYKG--LNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLY 69
Query: 525 -VGACPEVWTLVYEYLPN--GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 581
V TLV+E++ N D + + L +L L F H
Sbjct: 70 DVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE--- 126
Query: 582 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA----- 636
+ I+H DLKP N+L++ KL DFG++R P TF+
Sbjct: 127 NKILHRDLKPQNLLINKRGQLKLGDFGLARAFG---------------IPVNTFSSEVVT 171
Query: 637 --YMDPE-FLASGELTPKSDVYSFGIILLRLLTGRP 669
Y P+ + S + D++S G IL ++TG+P
Sbjct: 172 LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKP 207
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 5e-21
Identities = 69/303 (22%), Positives = 116/303 (38%), Gaps = 46/303 (15%)
Query: 383 SLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEAS 442
LE I + + + +++L E + + R+K + E L ++ S
Sbjct: 7 RQLEQFILDGPAQTNGQCFSVETLLDILICLYDECNNSPLRREKNI--LEYLEWAKPFTS 64
Query: 443 SSSHMPQFFSDFSFSEIEGATHNFDPSLK-IGEGGYGSIYKGLLRHMQ----VAIKMLHP 497
M DF LK IG G +G + +++ A+K+L+
Sbjct: 65 KVKQMRLHREDFEI-------------LKVIGRGAFGEVA--VVKLKNADKVFAMKILNK 109
Query: 498 HSLQGPSE---FQQEIDILSKIRHPNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKD 552
+ +E F++E D+L + TL A LV +Y G L LS +
Sbjct: 110 WEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFE 169
Query: 553 NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS-R 611
+ P R +A E+ + +H VH D+KP NIL+D N +L+DFG +
Sbjct: 170 DRLPEEM-ARFYLA-EMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLK 224
Query: 612 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKS-----DVYSFGIILLRLLT 666
+ + S+ GT Y+ PE L + E D +S G+ + +L
Sbjct: 225 LMEDGTVQSS--VAV------GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLY 276
Query: 667 GRP 669
G
Sbjct: 277 GET 279
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 5e-20
Identities = 51/229 (22%), Positives = 92/229 (40%), Gaps = 50/229 (21%)
Query: 470 LKIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLV 525
K+G G YG +YK + + A+K + + +EI +L +++HPN+++L
Sbjct: 27 CKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQ 84
Query: 526 GACPE-----VWTLVYEYLPN---GSLEDRLSCKDNSP--PLSWQTRIRIATELCSVLIF 575
VW L+++Y + ++ + K N L + ++ + +
Sbjct: 85 KVFLSHADRKVW-LLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 143
Query: 576 LHSCKPHSIVHGDLKPANILLDANFVS----KLSDFGISRFLSQNEISSNNTTLCCRTDP 631
LH+ + ++H DLKPANIL+ K++D G +R + P
Sbjct: 144 LHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN---------------SP 185
Query: 632 KGTFAYMDPE-----------FLASGELTPKSDVYSFGIILLRLLTGRP 669
A +DP L + T D+++ G I LLT P
Sbjct: 186 LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 234
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 9e-20
Identities = 59/208 (28%), Positives = 88/208 (42%), Gaps = 25/208 (12%)
Query: 471 KIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTL 524
KIGEG YG ++K R+ VAIK +EI +L +++HPNLV L
Sbjct: 10 KIGEGSYGVVFKC--RNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNL 67
Query: 525 VGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 582
+ LV+EY + ++ L + I + + F H H
Sbjct: 68 LEVFRRKRRLHLVFEYCDH-TVLHEL--DRYQRGVPEHLVKSITWQTLQAVNFCHK---H 121
Query: 583 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 642
+ +H D+KP NIL+ + V KL DFG +R ++ + D T Y PE
Sbjct: 122 NCIHRDVKPENILITKHSVIKLCDFGFAR-----LLTGPSDYY---DDEVATRWYRSPEL 173
Query: 643 LASGEL-TPKSDVYSFGIILLRLLTGRP 669
L P DV++ G + LL+G P
Sbjct: 174 LVGDTQYGPPVDVWAIGCVFAELLSGVP 201
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 88.3 bits (220), Expect = 2e-19
Identities = 55/212 (25%), Positives = 91/212 (42%), Gaps = 34/212 (16%)
Query: 471 KIGEGGYGSIYKGLLRHMQ-VAIKMLHPHSLQ-G-PSEFQQEIDILSKIRHPNLVTL--V 525
KIGEG YG +YK + + A+K + G PS +EI IL +++H N+V L V
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 526 GACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 585
+ LV+E+L L+ L L T +L + + + H ++
Sbjct: 69 IHTKKRLVLVFEHLDQ-DLKKLL--DVCEGGLESVTAKSFLLQLLNGIAYCHD---RRVL 122
Query: 586 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA-------YM 638
H DLKP N+L++ K++DFG++R P + Y
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFG---------------IPVRKYTHEIVTLWYR 167
Query: 639 DPE-FLASGELTPKSDVYSFGIILLRLLTGRP 669
P+ + S + + D++S G I ++ G P
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNGTP 199
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 2e-19
Identities = 59/218 (27%), Positives = 97/218 (44%), Gaps = 34/218 (15%)
Query: 465 NFDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNL 521
+ K+GEG Y ++YKG + VA+K + +G P +E+ +L ++H N+
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 62
Query: 522 VTL--VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 579
VTL + + TLV+EYL L+ L D ++ +L L + H
Sbjct: 63 VTLHDIIHTEKSLTLVFEYLDK-DLKQYL--DDCGNIINMHNVKLFLFQLLRGLAYCHR- 118
Query: 580 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA--- 636
++H DLKP N+L++ KL+DFG++R S P T+
Sbjct: 119 --QKVLHRDLKPQNLLINERGELKLADFGLARAKS---------------IPTKTYDNEV 161
Query: 637 ----YMDPE-FLASGELTPKSDVYSFGIILLRLLTGRP 669
Y P+ L S + + + D++ G I + TGRP
Sbjct: 162 VTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRP 199
|
| >3m62_A Ubiquitin conjugation factor E4; armadillo-like repeats, UBL conjugation pathway, DNA damage, nucleus, phosphoprotein; HET: 1PE; 2.40A {Saccharomyces cerevisiae} PDB: 3m63_A* 2qiz_A 2qj0_A Length = 968 | Back alignment and structure |
|---|
Score = 92.1 bits (228), Expect = 3e-19
Identities = 25/123 (20%), Positives = 45/123 (36%), Gaps = 8/123 (6%)
Query: 703 EQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGSEERCEPPPYFTCPI 762
+ ++ R ++ E + E R + E + P F P+
Sbjct: 843 VRAVDILGRKTGLASPEFIEKLLNFANKAEEQRKAD------EEEDLEYGDVPDEFLDPL 896
Query: 763 FQEVMQDPHV-AADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWL 821
+M+DP + A + +K L S T P +PL +++ PN LR I +
Sbjct: 897 MYTIMKDPVILPASKMNIDRSTIKAHLLS-DSTDPFNRMPLKLEDVTPNEELRQKILCFK 955
Query: 822 QQH 824
+Q
Sbjct: 956 KQK 958
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 4e-19
Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 34/212 (16%)
Query: 471 KIGEGGYGSIYKGLLRHMQ-VAIKMLHPHSLQ-G-PSEFQQEIDILSKIRHPNLVTL--V 525
K+GEG YG +YK + VA+K + + G PS +EI +L ++ HPN+V+L V
Sbjct: 28 KVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 526 GACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 585
TLV+E++ L+ L +N L +L + H H I+
Sbjct: 88 IHSERCLTLVFEFMEK-DLKKVL--DENKTGLQDSQIKIYLYQLLRGVAHCHQ---HRIL 141
Query: 586 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA-------YM 638
H DLKP N+L++++ KL+DFG++R P ++ Y
Sbjct: 142 HRDLKPQNLLINSDGALKLADFGLARAFG---------------IPVRSYTHEVVTLWYR 186
Query: 639 DPE-FLASGELTPKSDVYSFGIILLRLLTGRP 669
P+ + S + + D++S G I ++TG+P
Sbjct: 187 APDVLMGSKKYSTSVDIWSIGCIFAEMITGKP 218
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 5e-19
Identities = 66/268 (24%), Positives = 109/268 (40%), Gaps = 45/268 (16%)
Query: 416 EQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLK-IGE 474
+ D + ++K + L + + + + D+ +K IG
Sbjct: 35 DLDFPALRKNKNI--DNFLSRYKDTINKIRDLRMKAEDYEV-------------VKVIGR 79
Query: 475 GGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSE---FQQEIDILSKIRHPNLVTLVGA 527
G +G + L+RH A+K+L + S+ F +E DI++ P +V L A
Sbjct: 80 GAFGEVQ--LVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYA 137
Query: 528 --CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 585
+V EY+P G L + +S D R A E+ L +HS +
Sbjct: 138 FQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK---WARFYTA-EVVLALDAIHS---MGFI 190
Query: 586 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS 645
H D+KP N+LLD + KL+DFG +++ + + T GT Y+ PE L S
Sbjct: 191 HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCD-TAV------GTPDYISPEVLKS 243
Query: 646 ----GELTPKSDVYSFGIILLRLLTGRP 669
G + D +S G+ L +L G
Sbjct: 244 QGGDGYYGRECDWWSVGVFLYEMLVGDT 271
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 7e-19
Identities = 56/221 (25%), Positives = 91/221 (41%), Gaps = 51/221 (23%)
Query: 472 IGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSEFQ---QEIDILSKIRHPNLVTL 524
IG+G +G + +++ A+K ++ +E + +E+ I+ + HP LV L
Sbjct: 23 IGKGSFGKVC--IVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 525 VGA--CPEVWTLVYEYLPNGSL-----------EDRLSCKDNSPPLSWQTRIRIATELCS 571
+ E +V + L G L E+ ++ I EL
Sbjct: 81 WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEET-------------VKLFIC-ELVM 126
Query: 572 VLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDP 631
L +L + I+H D+KP NILLD + ++DF I+ L + TT+
Sbjct: 127 ALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI---TTMA----- 175
Query: 632 KGTFAYMDPEFLASGELTPKS---DVYSFGIILLRLLTGRP 669
GT YM PE +S + S D +S G+ LL GR
Sbjct: 176 -GTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 8e-19
Identities = 58/220 (26%), Positives = 88/220 (40%), Gaps = 45/220 (20%)
Query: 471 KIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQ-G-PSEFQQEIDILSKIRHPNLVTL 524
K+GEG YG +YK VAIK + + G P +E+ +L +++H N++ L
Sbjct: 41 KLGEGTYGEVYKA--IDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIEL 98
Query: 525 --VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 582
V L++EY N D D +P +S + +L + + F HS
Sbjct: 99 KSVIHHNHRLHLIFEYAEN----DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHS---R 151
Query: 583 SIVHGDLKPANILLDANFVS-----KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA- 636
+H DLKP N+LL + S K+ DFG++R P F
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG---------------IPIRQFTH 196
Query: 637 ------YMDPEFL-ASGELTPKSDVYSFGIILLRLLTGRP 669
Y PE L S + D++S I +L P
Sbjct: 197 EIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTP 236
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 86.4 bits (215), Expect = 1e-18
Identities = 55/217 (25%), Positives = 93/217 (42%), Gaps = 39/217 (17%)
Query: 471 KIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQ-G-PSEFQQEIDILSKIRHPNLVTL 524
KIGEG YG+++K ++ + VA+K + G PS +EI +L +++H N+V L
Sbjct: 9 KIGEGTYGTVFKA--KNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRL 66
Query: 525 --VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 582
V + TLV+E+ L+ + L + +L L F HS
Sbjct: 67 HDVLHSDKKLTLVFEFCDQ-DLKKYF--DSCNGDLDPEIVKSFLFQLLKGLGFCHS---R 120
Query: 583 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA------ 636
+++H DLKP N+L++ N KL++FG++R P ++
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFG---------------IPVRCYSAEVVTL 165
Query: 637 -YMDPE-FLASGELTPKSDVYSFGIILLRLLTGRPAL 671
Y P+ + + D++S G I L L
Sbjct: 166 WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 89.6 bits (222), Expect = 1e-18
Identities = 78/344 (22%), Positives = 131/344 (38%), Gaps = 47/344 (13%)
Query: 342 EELKRRKEFEEALAN-GKLEL-ERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKEL 399
EE K EF E + KLE E E+ + + + + L
Sbjct: 77 EEAKPLVEFYEEIKKYEKLETEEERLVCSREIFDTYIMKELLACSHPFSKSAIEHVQGHL 136
Query: 400 EQKIISAVELLQNYKKEQ-DELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSE 458
+K + +L Q Y +E L+ + + E+++ + + + ++ +DFS
Sbjct: 137 VKKQVPP-DLFQPYIEEICQNLRGDVFQKFIESDKFTRFCQWKNVELNIHLTMNDFSV-- 193
Query: 459 IEGATHNFDPSLK-IGEGGYGSIYKGLLRHMQV--AIKMLHPHSLQGPSEFQ---QEIDI 512
+ IG GG+G +Y A+K L ++ E +
Sbjct: 194 -----------HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIM 242
Query: 513 LSKI---RHPNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-A 566
LS + P +V + A P+ + + + + G L LS + +R A
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS----EADMRFYA 298
Query: 567 TELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLC 626
E+ L +H+ +V+ DLKPANILLD + ++SD G++ + S
Sbjct: 299 AEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLAC-----DFSKKKPHAS 350
Query: 627 CRTDPKGTFAYMDPEFLASGELTPKS-DVYSFGIILLRLLTGRP 669
GT YM PE L G S D +S G +L +LL G
Sbjct: 351 V-----GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 389
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 2e-18
Identities = 65/289 (22%), Positives = 117/289 (40%), Gaps = 45/289 (15%)
Query: 394 QTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSD 453
+T +E ++ +A++ + + K+Q +M+ + + + + ++
Sbjct: 91 ETPEE-REEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNE 149
Query: 454 FSFSEIEGATHNFDPSLK-IGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSEFQQ 508
F + LK +G+G +G + L++ A+K+L + E
Sbjct: 150 FEY-------------LKLLGKGTFGKVI--LVKEKATGRYYAMKILKKEVIVAKDEVAH 194
Query: 509 ---EIDILSKIRHPNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRI 563
E +L RHP L L + + V EY G L LS + + R
Sbjct: 195 TLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFS----EDRA 250
Query: 564 RI-ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 622
R E+ S L +LHS ++V+ DLK N++LD + K++DFG L + I
Sbjct: 251 RFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFG----LCKEGIKDGA 304
Query: 623 T--TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 669
T T C GT Y+ PE L + D + G+++ ++ GR
Sbjct: 305 TMKTFC------GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 347
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 4e-18
Identities = 62/221 (28%), Positives = 93/221 (42%), Gaps = 48/221 (21%)
Query: 471 KIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQ--------EIDILSKIRH 518
+GEG + ++YK R VAIK + L SE + EI +L ++ H
Sbjct: 17 FLGEGQFATVYKA--RDKNTNQIVAIKKIK---LGHRSEAKDGINRTALREIKLLQELSH 71
Query: 519 PNLVTLVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFL 576
PN++ L+ A +LV++++ LE + KDNS L+ L +L
Sbjct: 72 PNIIGLLDAFGHKSNISLVFDFMET-DLEVII--KDNSLVLTPSHIKAYMLMTLQGLEYL 128
Query: 577 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 636
H H I+H DLKP N+LLD N V KL+DFG+++ P +
Sbjct: 129 HQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFG---------------SPNRAYT 170
Query: 637 -------YMDPE-FLASGELTPKSDVYSFGIILLRLLTGRP 669
Y PE + D+++ G IL LL P
Sbjct: 171 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVP 211
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 7e-18
Identities = 62/218 (28%), Positives = 93/218 (42%), Gaps = 43/218 (19%)
Query: 471 KIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL----- 524
IG G +G +++ L +VAIK + LQ +E+ I+ ++HPN+V L
Sbjct: 47 VIGNGSFGVVFQAKLVESDEVAIKKV----LQDKRFKNRELQIMRIVKHPNVVDLKAFFY 102
Query: 525 --VGACPEVW-TLVYEYLP---NGSLEDRLSCKDNSPPL-----SWQTRIRIATELCSVL 573
EV+ LV EY+P + K P L +Q L L
Sbjct: 103 SNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQ--------LLRSL 154
Query: 574 IFLHSCKPHSIVHGDLKPANILLDAN-FVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 632
++HS I H D+KP N+LLD V KL DFG ++ L E N + C
Sbjct: 155 AYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP---NVSYIC----- 203
Query: 633 GTFAYMDPEF-LASGELTPKSDVYSFGIILLRLLTGRP 669
+ Y PE + T D++S G ++ L+ G+P
Sbjct: 204 -SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQP 240
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 9e-18
Identities = 65/230 (28%), Positives = 100/230 (43%), Gaps = 55/230 (23%)
Query: 465 NFDPSLK-IGEGGYGSIYKGLLRHMQV-------AIKMLHPHSLQGPSEFQ--QEIDILS 514
F+ LK +G+G +G ++ L++ + A+K+L +L+ + E DIL
Sbjct: 25 QFEL-LKVLGQGSFGKVF--LVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILV 81
Query: 515 KIRHPNLVTLVGA--CPEVWTLVYEYLPNGSL-----------EDRLSCKDNSPPLSWQT 561
++ HP +V L A L+ ++L G L E+
Sbjct: 82 EVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEED-------------V 128
Query: 562 RIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 621
+ +A EL L LHS I++ DLKP NILLD KL+DFG LS+ I
Sbjct: 129 KFYLA-ELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFG----LSKESIDHE 180
Query: 622 NT--TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 669
+ C GT YM PE + T +D +SFG+++ +LTG
Sbjct: 181 KKAYSFC------GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTL 224
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 2e-17
Identities = 71/335 (21%), Positives = 120/335 (35%), Gaps = 27/335 (8%)
Query: 347 RKEFEEALANGKLELERMKKQHDEVME-ELQIALDQKSLLESQIAESDQTAKELEQKIIS 405
R F E A + EL R D V E E+ +K+ + +
Sbjct: 64 RLLFREFCAT-RPELSRCVAFLDGVAEYEVTPDDKRKACGRNLTQNFLSHTGPDLIPEVP 122
Query: 406 --AVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGAT 463
V ++ + ++ E L + S F + + E + T
Sbjct: 123 RQLVTNCTQRLEQGPCKDLFQELTRLTHEYLSVAPFADYLDSIYFNRFLQWKWLERQPVT 182
Query: 464 -HNFDPSLKIGEGGYGSIYKGLLRHMQV--AIKMLHPHSLQGPSEFQQ---EIDILSKIR 517
+ F +G+GG+G + +R A K L ++ E IL K+
Sbjct: 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN 242
Query: 518 HPNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-ATELCSVLI 574
+V+L A + LV + G L+ + + R A E+C L
Sbjct: 243 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY-HMGQAGFP-EARAVFYAAEICCGLE 300
Query: 575 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 634
LH IV+ DLKP NILLD + ++SD G++ + + + GT
Sbjct: 301 DLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK---GRV------GT 348
Query: 635 FAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 669
YM PE + + T D ++ G +L ++ G+
Sbjct: 349 VGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQS 383
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 60/222 (27%), Positives = 92/222 (41%), Gaps = 43/222 (19%)
Query: 471 KIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQG-----PSEFQQEIDIL---SKIRH 518
+IG G YG++YK R VA+K + + G P +E+ +L H
Sbjct: 16 EIGVGAYGTVYKA--RDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEH 73
Query: 519 PNLVTLV-------GACPEVWTLVYEYLPN---GSLEDRLSCKDNSPPLSWQTRIRIATE 568
PN+V L+ TLV+E++ L+ P L +T + +
Sbjct: 74 PNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKA-----PPPGLPAETIKDLMRQ 128
Query: 569 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR-FLSQNEISSNNTTLCC 627
L FLH+ + IVH DLKP NIL+ + KL+DFG++R + Q ++ TL
Sbjct: 129 FLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLW- 184
Query: 628 RTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 669
Y PE L D++S G I + +P
Sbjct: 185 ---------YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKP 217
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 2e-17
Identities = 66/265 (24%), Positives = 103/265 (38%), Gaps = 54/265 (20%)
Query: 425 DKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGL 484
V ++ K ++ P + S+++ + IG G +G +Y+
Sbjct: 25 SMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTK----------VIGNGSFGVVYQAK 74
Query: 485 LRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWT--------L 534
L VAIK + LQ +E+ I+ K+ H N+V L L
Sbjct: 75 LCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130
Query: 535 VYEYLP---NGSLEDRLSCKDNSPPL-----SWQTRIRIATELCSVLIFLHSCKPHSIVH 586
V +Y+P K P + +Q L L ++HS I H
Sbjct: 131 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ--------LFRSLAYIHS---FGICH 179
Query: 587 GDLKPANILLDAN-FVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE-FLA 644
D+KP N+LLD + V KL DFG ++ L + E N + C + Y PE
Sbjct: 180 RDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYIC------SRYYRAPELIFG 230
Query: 645 SGELTPKSDVYSFGIILLRLLTGRP 669
+ + T DV+S G +L LL G+P
Sbjct: 231 ATDYTSSIDVWSAGCVLAELLLGQP 255
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 2e-17
Identities = 60/249 (24%), Positives = 106/249 (42%), Gaps = 48/249 (19%)
Query: 447 MPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQ- 501
M + + + + ++ KIG+G +G ++K RH + VA+K + + +
Sbjct: 1 MAKQYDSVECPFCDEVS-KYEKLAKIGQGTFGEVFKA--RHRKTGQKVALKKVLMENEKE 57
Query: 502 G-PSEFQQEIDILSKIRHPNLVTLVGACPEVWT----------LVYEYLPN---GSLEDR 547
G P +EI IL ++H N+V L+ C + LV+++ + G L +
Sbjct: 58 GFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV 117
Query: 548 LSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDF 607
+ R+ L + L ++H + I+H D+K AN+L+ + V KL+DF
Sbjct: 118 ------LVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADF 168
Query: 608 GISRFLSQNEISSNNT------TLCCRTDPKGTFAYMDPE-FLASGELTPKSDVYSFGII 660
G++R S + S N TL Y PE L + P D++ G I
Sbjct: 169 GLARAFSLAKNSQPNRYTNRVVTLW----------YRPPELLLGERDYGPPIDLWGAGCI 218
Query: 661 LLRLLTGRP 669
+ + T P
Sbjct: 219 MAEMWTRSP 227
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 2e-17
Identities = 64/340 (18%), Positives = 120/340 (35%), Gaps = 42/340 (12%)
Query: 341 AEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELE 400
E+ + + + + +D + L+ Q ++ L+
Sbjct: 79 HEQHGPALQLWKDIED-----------YDTADDALRPQKAQALRAAYLEPQAQLFCSFLD 127
Query: 401 QKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIE 460
+ ++ D L +AV L ++ + S F + + E +
Sbjct: 128 AETVARAR-----AGAGDGLFQPLLRAVLA--HLGQAPFQEFLDSLYFLRFLQWKWLEAQ 180
Query: 461 GAT-HNFDPSLKIGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSEFQ---QEIDI 512
F +G GG+G ++ + A K L+ L+ +Q E I
Sbjct: 181 PMGEDWFLDFRVLGRGGFGEVF--ACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKI 238
Query: 513 LSKIRHPNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-ATEL 569
L+K+ +V+L A LV + G + + D P + R ++
Sbjct: 239 LAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQI 298
Query: 570 CSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRT 629
S L LH +I++ DLKP N+LLD + ++SD G++ L + +
Sbjct: 299 VSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK--GYA--- 350
Query: 630 DPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 669
GT +M PE L E D ++ G+ L ++ R
Sbjct: 351 ---GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARG 387
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 3e-17
Identities = 53/268 (19%), Positives = 104/268 (38%), Gaps = 50/268 (18%)
Query: 414 KKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIG 473
KK ++ ++ A + + L+K + +++ + F + +G
Sbjct: 7 KKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQL----DQFDRIKT------------LG 50
Query: 474 EGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQ---QEIDILSKIRHPNLVTLVG 526
G +G + L++H + A+K+L + + + E IL + P LV L
Sbjct: 51 TGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 527 AC--PEVWTLVYEYLPNGSLEDRLSCK---DNSPPLSWQTRIRIATELCSVLIFLHSCKP 581
+ +V EY+ G + L R A ++ +LHS
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-----HARFYAA-QIVLTFEYLHS--- 159
Query: 582 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 641
+++ DLKP N+L+D +++DFG ++ + TLC GT + PE
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLC------GTPEALAPE 208
Query: 642 FLASGELTPKSDVYSFGIILLRLLTGRP 669
+ S D ++ G+++ + G P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYP 236
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 3e-17
Identities = 63/232 (27%), Positives = 95/232 (40%), Gaps = 57/232 (24%)
Query: 465 NFDPSLK-IGEGGYGSIYKGLLRHMQV-------AIKMLH-PHSLQGPSEFQQ---EIDI 512
F+ L+ +G+GGYG ++ +R + A+K+L ++ + E +I
Sbjct: 18 CFEL-LRVLGKGGYGKVF--QVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNI 74
Query: 513 LSKIRHPNLVTLVGA--CPEVWTLVYEYLPNGSL-----------EDRLSCKDNSPPLSW 559
L +++HP +V L+ A L+ EYL G L ED
Sbjct: 75 LEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDT------------ 122
Query: 560 QTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 619
+A E+ L LH I++ DLKP NI+L+ KL+DFG L + I
Sbjct: 123 -ACFYLA-EISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFG----LCKESIH 173
Query: 620 SNNT--TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 669
T C GT YM PE L D +S G ++ +LTG P
Sbjct: 174 DGTVTHTFC------GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAP 219
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 5e-17
Identities = 53/247 (21%), Positives = 106/247 (42%), Gaps = 33/247 (13%)
Query: 436 KSRKEASSSSHMPQFFSDFSFSEIE-GATHNFDPSLKIGEGGYGSIYKGL--LRHMQVAI 492
++R ++H P+ + D+ +E G ++ K+G G Y +++ + + +V +
Sbjct: 7 RARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVV 66
Query: 493 KMLHPHSLQGPSEFQQEIDILSKIR-HPNLVTL--VGACPEVWTLVY--EYLPNGSLEDR 547
K+L P + + ++EI IL +R PN++TL + P T E++ N
Sbjct: 67 KILKPVKKK---KIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF--- 120
Query: 548 LSCKDNSPPLSWQTRIR-IATELCSVLIFLHSCKPHSIVHGDLKPANILLD-ANFVSKLS 605
K L+ IR E+ L + HS I+H D+KP N+++D + +L
Sbjct: 121 ---KQLYQTLT-DYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLI 173
Query: 606 DFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL-TPKSDVYSFGIILLRL 664
D+G++ F + + + PE L ++ D++S G +L +
Sbjct: 174 DWGLAEFYHPGQ---------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASM 224
Query: 665 LTGRPAL 671
+ +
Sbjct: 225 IFRKEPF 231
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 6e-17
Identities = 62/220 (28%), Positives = 97/220 (44%), Gaps = 41/220 (18%)
Query: 471 KIGEGGYGSIYKGLLRHMQ-----VAIKMLHPHSLQG--PSEFQQEIDIL---SKIRHPN 520
+IGEG YG ++K R ++ VA+K + + + P +E+ +L HPN
Sbjct: 18 EIGEGAYGKVFKA--RDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPN 75
Query: 521 LVTLVGACPEVW-------TLVYEYLPN---GSLEDRLSCKDNSPPLSWQTRIRIATELC 570
+V L C TLV+E++ L+ P + +T + +L
Sbjct: 76 VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV-----PEPGVPTETIKDMMFQLL 130
Query: 571 SVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR-FLSQNEISSNNTTLCCRT 629
L FLHS H +VH DLKP NIL+ ++ KL+DFG++R + Q ++S TL
Sbjct: 131 RGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLW--- 184
Query: 630 DPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 669
Y PE L D++S G I + +P
Sbjct: 185 -------YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 217
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 81.9 bits (201), Expect = 6e-17
Identities = 50/265 (18%), Positives = 79/265 (29%), Gaps = 59/265 (22%)
Query: 444 SSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSL--- 500
S P FS T KIGEG +G +++ + H VAIK++
Sbjct: 6 SQKGPVPFSHCL------PTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLV 59
Query: 501 -----QGPSEFQQEIDILSKI---------RHPNLVTLV------GACPEVWTLVYEYLP 540
+ E EI I ++ R + L G+ P + +++
Sbjct: 60 NGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYN 119
Query: 541 --NGSLEDRLS--------------------CKDNSPPLSWQTRIRIATELCSVLIFLHS 578
GS DR + + S T I +L + L
Sbjct: 120 STKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAE- 178
Query: 579 CKPHSIVHGDLKPANILLDANFVSKLSDFGISR---FLSQNEISSNNTTLCCRTDPKGTF 635
H DL N+LL + KL + S S R + G
Sbjct: 179 -ASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIV 237
Query: 636 AYMDPEF---LASGELTPKSDVYSF 657
+ D L +G+ + D+Y
Sbjct: 238 VFCDVSMDEDLFTGDGDYQFDIYRL 262
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 81.4 bits (202), Expect = 6e-17
Identities = 55/214 (25%), Positives = 93/214 (43%), Gaps = 42/214 (19%)
Query: 472 IGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQ---QEIDILSKIRHPNLVTL 524
+G G +G ++ L+R A+K+L + + + E +LS + HP ++ +
Sbjct: 14 LGTGSFGRVH--LIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 71
Query: 525 VGAC--PEVWTLVYEYLPNGSL------EDRLSCKDNSPPLSWQTRIRI-ATELCSVLIF 575
G + ++ +Y+ G L R + A E+C L +
Sbjct: 72 WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFP----------NPVAKFYAAEVCLALEY 121
Query: 576 LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 635
LHS I++ DLKP NILLD N K++DFG ++ + TLC GT
Sbjct: 122 LHS---KDIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLC------GTP 167
Query: 636 AYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 669
Y+ PE +++ D +SFGI++ +L G
Sbjct: 168 DYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYT 201
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 4e-16
Identities = 56/221 (25%), Positives = 87/221 (39%), Gaps = 53/221 (23%)
Query: 472 IGEGGYGSIYKGLLRHMQV---------AIKMLHPHSLQGPSEF---QQEIDILSKIRHP 519
+G+G +G + + V A+K+L + E E +L RHP
Sbjct: 13 LGKGTFGKV-------ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 520 NLVTLVGA--CPEVWTLVYEYLPNGSL------EDRLSCKDNSPPLSWQTRIRI-ATELC 570
L L A + V EY G L E + + R R E+
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFT----------EERARFYGAEIV 115
Query: 571 SVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT--TLCCR 628
S L +LHS +V+ D+K N++LD + K++DFG L + IS T T C
Sbjct: 116 SALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFG----LCKEGISDGATMKTFC-- 166
Query: 629 TDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 669
GT Y+ PE L + D + G+++ ++ GR
Sbjct: 167 ----GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 203
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 43/211 (20%), Positives = 80/211 (37%), Gaps = 51/211 (24%)
Query: 471 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGA 527
+G G G + + + + A+KML ++E+++ + + P++V +V
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIVDV 79
Query: 528 CPEVWT------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 581
++ +V E L G L R+ + + + + I + + +LHS
Sbjct: 80 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMKSIGEAIQYLHS--- 135
Query: 582 HSIVHGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 638
+I H D+KP N+L N + KL+DFG +
Sbjct: 136 INIAHRDVKPENLLYTSKRPNAILKLTDFGFA---------------------------- 167
Query: 639 DPEFLASGELTPKSDVYSFGIILLRLLTGRP 669
E D++S G+I+ LL G P
Sbjct: 168 -KETTGEK-YDKSCDMWSLGVIMYILLCGYP 196
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 52/246 (21%), Positives = 91/246 (36%), Gaps = 40/246 (16%)
Query: 441 ASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPH 498
S S F+S + IG G G + VAIK L
Sbjct: 2 GSRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKL-SR 60
Query: 499 SLQGPSEFQQ---EIDILSKIRHPNLVTL---------VGACPEVWTLVYEYLP---NGS 543
Q + ++ E+ ++ + H N++ L + +V+ +V E +
Sbjct: 61 PFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY-IVMELMDANLCQV 119
Query: 544 LEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSK 603
++ L + L +Q LC + LHS I+H DLKP+NI++ ++ K
Sbjct: 120 IQMELD-HERMSYLLYQM-------LCG-IKHLHSA---GIIHRDLKPSNIVVKSDCTLK 167
Query: 604 LSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLR 663
+ DFG++R + + T T Y PE + D++S G I+
Sbjct: 168 ILDFGLARTAGTSFMM---------TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 218
Query: 664 LLTGRP 669
++ G
Sbjct: 219 MIKGGV 224
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 4e-15
Identities = 49/242 (20%), Positives = 81/242 (33%), Gaps = 39/242 (16%)
Query: 452 SDFSFSEIEGATHN----FDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSE- 505
+ + ++ H + I G YG++ G+ + VAIK + G +
Sbjct: 6 GEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVN 65
Query: 506 -FQQ---------EIDILSKIRHPNLVTLVGA-CPEVWT------LVYEYLPNGSLEDRL 548
EI +L+ HPN++ L LV E + L +
Sbjct: 66 ILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVI 124
Query: 549 SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFG 608
D +S Q + L LH +VH DL P NILL N + DF
Sbjct: 125 --HDQRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFN 179
Query: 609 ISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE-FLASGELTPKSDVYSFGIILLRLLTG 667
++R + + T Y PE + T D++S G ++ +
Sbjct: 180 LAREDTADANK---------THYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR 230
Query: 668 RP 669
+
Sbjct: 231 KA 232
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 6e-15
Identities = 63/286 (22%), Positives = 107/286 (37%), Gaps = 74/286 (25%)
Query: 416 EQDELQMERDKAVKEAEELRKSRKEASSSSHMPQF-FSDFSFSEIEGATHNFDPSLK-IG 473
+ ++ ++ + A+ + H + +F LK +G
Sbjct: 17 GAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFEL-------------LKVLG 63
Query: 474 EGGYGSIYKGLLRHMQV-------AIKMLHPHSLQGPSEFQQ----EIDILSKIRH-PNL 521
G YG ++ L+R + A+K+L ++ ++ + E +L IR P L
Sbjct: 64 TGAYGKVF--LVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 522 VTLVGA--CPEVWTLVYEYLPNGSL-----------EDRLSCKDNSPPLSWQTRIRIATE 568
VTL A L+ +Y+ G L E +I + E
Sbjct: 122 VTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHE-------------VQIYVG-E 167
Query: 569 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT---TL 625
+ L LH I++ D+K NILLD+N L+DFG LS+ ++
Sbjct: 168 IVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFG----LSKEFVADETERAYDF 220
Query: 626 CCRTDPKGTFAYMDPEFLASGEL--TPKSDVYSFGIILLRLLTGRP 669
C GT YM P+ + G+ D +S G+++ LLTG
Sbjct: 221 C------GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 260
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 8e-15
Identities = 54/220 (24%), Positives = 90/220 (40%), Gaps = 40/220 (18%)
Query: 471 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPS----EFQQEIDILSKIRHPNLVTL 524
G+G +G++ G + M VAIK + +Q P E Q + L+ + HPN+V L
Sbjct: 30 MAGQGTFGTVQLGKEKSTGMSVAIKKV----IQDPRFRNRELQ-IMQDLAVLHHPNIVQL 84
Query: 525 --------VGACPEVW-TLVYEYLPNGSLED--RL--SCKDNSPPLSWQTRIRIATELCS 571
+++ +V EY+P + R + +L
Sbjct: 85 QSYFYTLGERDRRDIYLNVVMEYVP----DTLHRCCRNYYRRQVAPPPILIKVFLFQLIR 140
Query: 572 VLIFLHSCKPHSIVHGDLKPANILLD-ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTD 630
+ LH ++ H D+KP N+L++ A+ KL DFG ++ LS +E N C
Sbjct: 141 SIGCLH-LPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE---PNVAYIC--- 193
Query: 631 PKGTFAYMDPE-FLASGELTPKSDVYSFGIILLRLLTGRP 669
+ Y PE + T D++S G I ++ G P
Sbjct: 194 ---SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEP 230
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 9e-15
Identities = 61/255 (23%), Positives = 104/255 (40%), Gaps = 46/255 (18%)
Query: 435 RKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGL--LRHMQVAI 492
A++++ P+ F ++ + IGEG YG + L ++VAI
Sbjct: 2 HHHHHMAAAAAAGPEMVRGQVF-DV---GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAI 57
Query: 493 KMLHPHSLQGPSEFQQ---------EIDILSKIRHPNLVTLVGACP--------EVWTLV 535
K + P F+ EI IL + RH N++ + +V+ +V
Sbjct: 58 KKISP--------FEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY-IV 108
Query: 536 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANIL 595
+ + E L + LS ++ L ++HS +++H DLKP+N+L
Sbjct: 109 QDLM-----ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLL 160
Query: 596 LDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE-FLASGELTPKSDV 654
L+ K+ DFG++R + + T+ T Y PE L S T D+
Sbjct: 161 LNTTCDLKICDFGLARVADPDHDHTGFL-----TEYVATRWYRAPEIMLNSKGYTKSIDI 215
Query: 655 YSFGIILLRLLTGRP 669
+S G IL +L+ RP
Sbjct: 216 WSVGCILAEMLSNRP 230
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 1e-14
Identities = 59/281 (20%), Positives = 103/281 (36%), Gaps = 61/281 (21%)
Query: 411 QNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQF-FSDFSFSEIEGATHNFDPS 469
+Y E + EE +++ S DF
Sbjct: 10 HDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDL------------- 56
Query: 470 LK-IGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSEF---QQEIDILSKI-RHPN 520
L+ IG G Y + L+R + A++++ + + Q E + + HP
Sbjct: 57 LRVIGRGSYAKVL--LVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPF 114
Query: 521 LVTLVGAC---PEVWTLVYEYLPNGSL------EDRLSCKDNSPPLSWQTRIRI-ATELC 570
LV L +C V EY+ G L + +L + R + E+
Sbjct: 115 LVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP----------EEHARFYSAEIS 163
Query: 571 SVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT--TLCCR 628
L +LH I++ DLK N+LLD+ KL+D+G + + + +T T C
Sbjct: 164 LALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYG----MCKEGLRPGDTTSTFC-- 214
Query: 629 TDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 669
GT Y+ PE L + D ++ G+++ ++ GR
Sbjct: 215 ----GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS 251
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 1e-14
Identities = 60/320 (18%), Positives = 108/320 (33%), Gaps = 78/320 (24%)
Query: 414 KKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIG 473
++ + ++ + RK + ++ MP+ SD+ + ++ IG
Sbjct: 9 AQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPD------RYEIRHLIG 62
Query: 474 EGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQ---------EIDILSKIRHPNLV 522
G YG + + + VAIK + F+ EI IL+++ H ++V
Sbjct: 63 TGSYGHVCEAYDKLEKRVVAIKKIL-------RVFEDLIDCKRILREIAILNRLNHDHVV 115
Query: 523 TLVGACP--------EVWTLVYEYLP---------NGSLEDRLSCKDNSPPLSWQTRIRI 565
++ E++ +V E L + L +
Sbjct: 116 KVLDIVIPKDVEKFDELY-VVLEIADSDFKKLFRTPVYLTELHIKT-----LLYNL---- 165
Query: 566 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 625
L + ++HS I+H DLKPAN L++ + K+ DFG++R + E ++ +
Sbjct: 166 ---LVG-VKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPI 218
Query: 626 CCRTDPKGTFAYMD-------------------PE-FLASGELTPKSDVYSFGIILLRLL 665
R D + PE L T DV+S G I LL
Sbjct: 219 SPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278
Query: 666 TGRPALGITKEVQYALDTGK 685
+ L G
Sbjct: 279 NMIKENVAYHADRGPLFPGS 298
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 77.2 bits (189), Expect = 1e-14
Identities = 86/587 (14%), Positives = 177/587 (30%), Gaps = 198/587 (33%)
Query: 28 KFPASSLEEEKVQ------AYREIERQDMHNHLDMCLLICRQMGV-RAEKLDTESESTEK 80
KF S ++ E+ Q Y E +R ++N + + V R + +
Sbjct: 92 KFLMSPIKTEQRQPSMMTRMYIE-QRDRLYNDNQ----VFAKYNVSRLQPY----LKLRQ 142
Query: 81 GILELISH-----YGIR---K--LVMGAAADKHYKKKM------MDL---KSKKAISVRQ 121
+LEL G+ K + + + KM ++L S + +
Sbjct: 143 ALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEML 202
Query: 122 QAPASCHIWFICNGNLIYTREGSLDGIDPEISSPSFQASHNTENR---------HPNCLR 172
Q L+Y + + + SS H+ + + NCL
Sbjct: 203 Q-------------KLLYQIDPNWT-SRSDHSSNIKLRIHSIQAELRRLLKSKPYENCL- 247
Query: 173 SQSVVLRHNRPMKLTNPVQDLFHRVRSMNFDRNVGNVMTSQD-SIGGLSSPASRSDAEVS 231
+VL + VQ+ + N + ++T++ + S A+ + +S
Sbjct: 248 ---LVLLN---------VQNAKA-WNAFNLSCKI--LLTTRFKQVTDFLSAATTT--HIS 290
Query: 232 SDECTTGRSTSQGSLSSCSSRGVIDVAMIPLIRTEGVSTLPPSKEDLQSSPPSVLDGSVD 291
D + + + S +D LP E L ++P
Sbjct: 291 LDHHSMTLTPDE-VKSLLLK--YLDCR---------PQDLPR--EVLTTNP--------- 327
Query: 292 DNLYDQLAQAMAEAENSRREAFEEALRRGKA--------EKDAIESIRRAKAS-ESLYAE 342
++ E++R G A D + +I ++S L
Sbjct: 328 ------RRLSI----------IAESIRDGLATWDNWKHVNCDKLTTII--ESSLNVLEPA 369
Query: 343 ELKRRKEFEEALA----NGKLE---LERM--KKQHDEVMEELQIALDQKSLLESQIAES- 392
E ++ F+ L+ + + L + +VM + L + SL+E Q ES
Sbjct: 370 EYRKM--FDR-LSVFPPSAHIPTILLSLIWFDVIKSDVMVVVN-KLHKYSLVEKQPKEST 425
Query: 393 --------DQTAK-----ELEQKIISAVELLQNYKKEQDELQMERD-----------KAV 428
+ K L + I+ + + + + D + D K +
Sbjct: 426 ISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSD-DLIPPYLDQYFYSHIGHHLKNI 484
Query: 429 KEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHM 488
+ E + + F DF F +E KI G + +
Sbjct: 485 EHPERM----------TLFRMVFLDFRF--LEQ---------KIRHDSTAWNASGSILNT 523
Query: 489 QVAIKMLHPHSLQGPSEFQQEIDILSK---------IRHP--NLVTL 524
+K P+ ++++ ++ + I +L+ +
Sbjct: 524 LQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLRI 570
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 54.9 bits (131), Expect = 1e-07
Identities = 74/556 (13%), Positives = 149/556 (26%), Gaps = 162/556 (29%)
Query: 311 EAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDE 370
FE+A KD + + + E + + + K+ + + +E
Sbjct: 23 SVFEDAFVDNFDCKDVQDMPKSILSKEEI--DHIIMSKDAVSGT---LRLFWTLLSKQEE 77
Query: 371 VMEELQIALDQK--SLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAV 428
++++ + + L S I + + + I + L N + + + R +
Sbjct: 78 MVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPY 137
Query: 429 KEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHM 488
+LR++ E + ++ G G G K +
Sbjct: 138 L---KLRQALLELRPAKNV--------------LID--------GVLGSG---KTWV--- 166
Query: 489 QVAIKMLHPHSLQGPSEFQQEIDI----LSKIRHPNLVTLVGACPEVWTLVYEYLPNGSL 544
A+ + + +Q +F+ I L P V + + L+Y+ PN +
Sbjct: 167 --ALDVCLSYKVQCKMDFK----IFWLNLKNCNSPETVLEM-----LQKLLYQIDPNWTS 215
Query: 545 EDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS-IVHGDLKPANILLDANFVSK 603
S S Q +R + + +V +++ A +A F
Sbjct: 216 RSDHSSNIKLRIHSIQAELRR--------LLKSKPYENCLLVLLNVQNAKA-WNA-F--- 262
Query: 604 LSDFG-----ISRFLS-QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSF 657
+ +RF + +S+ TT T E L K
Sbjct: 263 --NLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLT--PDEVK---SLLLK----YL 311
Query: 658 GIILLRL----LTGRP-ALG-ITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMR 711
L LT P L I + ++ L T N W V ++L +
Sbjct: 312 DCRPQDLPREVLTTNPRRLSIIAESIRDGLAT--WDN--------WKHVNCDKLTTIIES 361
Query: 712 CCEMSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGSEERCEPPPYFTCPIFQEVMQDPH 771
VLEP +E R + +F H
Sbjct: 362 SLN---------------VLEP--------------AEYR---KMFDRLSVFPP---SAH 386
Query: 772 VAA--------DGFTYEAE----------ALKGWLDSG----H-----ETSPMTNLPLAH 804
+ D + ++ + N H
Sbjct: 387 IPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALH 446
Query: 805 KNLVPNLALRSAIQEW 820
+++V + +
Sbjct: 447 RSIVDHYNIPKTFDSD 462
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 49/243 (20%), Positives = 84/243 (34%), Gaps = 60/243 (24%)
Query: 471 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL---- 524
+G G +G + + + A+K + P +E+DI+ + H N++ L
Sbjct: 14 TLGTGSFGIVCEVFDIESGKRFALKKVLQD----PRYKNRELDIMKVLDHVNIIKLVDYF 69
Query: 525 -----VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATE----------- 568
P + L + K S + + E
Sbjct: 70 YTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLK 129
Query: 569 --------------------LCSVLIFLHSCKPHSIVHGDLKPANILLDAN-FVSKLSDF 607
L + F+HS I H D+KP N+L+++ KL DF
Sbjct: 130 SFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSKDNTLKLCDF 186
Query: 608 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE-FLASGELTPKSDVYSFGIILLRLLT 666
G ++ L +E + C + Y PE L + E TP D++S G + L+
Sbjct: 187 GSAKKLIPSE---PSVAYIC------SRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL 237
Query: 667 GRP 669
G+P
Sbjct: 238 GKP 240
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 78/280 (27%), Positives = 112/280 (40%), Gaps = 69/280 (24%)
Query: 414 KKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLK-I 472
+ Q+ M + A A + + +S+ P SDF F LK I
Sbjct: 3 SQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKP---SDFHF-------------LKVI 46
Query: 473 GEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSEF---QQEIDILSK-IRHPNLVTL 524
G+G +G + L RH A+K+L ++ E E ++L K ++HP LV L
Sbjct: 47 GKGSFGKVL--LARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104
Query: 525 VGA--CPEVWTLVYEYLPNGSL-----------EDRLSCKDNSPPLSWQTRIRIATELCS 571
+ + V +Y+ G L E R R A E+ S
Sbjct: 105 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPR-------------ARFYAA-EIAS 150
Query: 572 VLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT--TLCCRT 629
L +LHS +IV+ DLKP NILLD+ L+DFG L + I N+T T C
Sbjct: 151 ALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFG----LCKENIEHNSTTSTFC--- 200
Query: 630 DPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 669
GT Y+ PE L D + G +L +L G P
Sbjct: 201 ---GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLP 237
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 57/217 (26%), Positives = 84/217 (38%), Gaps = 44/217 (20%)
Query: 472 IGEGGYGSIYKGLLRHMQV---------AIKMLHPHSLQGPSEF---QQEIDILSK-IRH 518
+G+G +G + AIK L + + E +LS H
Sbjct: 25 LGKGSFGKV-------FLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 77
Query: 519 PNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-ATELCSVLIF 575
P L + E V EYL G L + +R A E+ L F
Sbjct: 78 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFD----LSRATFYAAEIILGLQF 133
Query: 576 LHSCKPHSIVHGDLKPANILLDAN-FVSKLSDFGISRFLSQNEISSNNT--TLCCRTDPK 632
LHS IV+ DLK NILLD + + K++DFG + + + + T C
Sbjct: 134 LHS---KGIVYRDLKLDNILLDKDGHI-KIADFG----MCKENMLGDAKTNTFC------ 179
Query: 633 GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 669
GT Y+ PE L + D +SFG++L +L G+
Sbjct: 180 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQS 216
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 2e-14
Identities = 49/236 (20%), Positives = 86/236 (36%), Gaps = 22/236 (9%)
Query: 442 SSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHS 499
S S QF+S + IG G G + VAIK L
Sbjct: 40 SKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL-SRP 98
Query: 500 LQGPSEFQQ---EIDILSKIRHPNLVTL---VGACPEVWTLVYEYLPNGSLEDRLSCKDN 553
Q + ++ E+ ++ + H N+++L + YL ++ L
Sbjct: 99 FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ 158
Query: 554 SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 613
+ + LC + LHS I+H DLKP+NI++ ++ K+ DFG++R
Sbjct: 159 MELDHERMSYLLYQMLCG-IKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 214
Query: 614 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 669
+ + T T Y PE + D++S G I+ ++ +
Sbjct: 215 GTSFMM---------TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 261
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 60/234 (25%), Positives = 98/234 (41%), Gaps = 55/234 (23%)
Query: 466 FDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQ---------EIDILS 514
F +GEG YG + + VAIK + P F + EI IL
Sbjct: 13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLREIKILK 64
Query: 515 KIRHPNLVTLVGACP--------EVWTLVYEYLPNGSLEDRLSCKDNSPPLS-------- 558
+H N++T+ EV+ ++ E + L +S + LS
Sbjct: 65 HFKHENIITIFNIQRPDSFENFNEVY-IIQELMQT-DLHRVIS----TQMLSDDHIQYFI 118
Query: 559 WQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 618
+QT L + + LH +++H DLKP+N+L+++N K+ DFG++R + ++
Sbjct: 119 YQT-------LRA-VKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA 167
Query: 619 SSNNTTLCCR--TDPKGTFAYMDPE-FLASGELTPKSDVYSFGIILLRLLTGRP 669
++ T + T Y PE L S + + DV+S G IL L RP
Sbjct: 168 DNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRP 221
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 51/223 (22%), Positives = 87/223 (39%), Gaps = 56/223 (25%)
Query: 472 IGEGGYGSIYKGLLRHMQV---------AIKMLHPHSLQGPSEF---QQEIDILSKI-RH 518
IG G Y + + V A+K++ + + Q E + + H
Sbjct: 17 IGRGSYAKV-------LLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 69
Query: 519 PNLVTLVGAC---PEVWTLVYEYLPNGSL------EDRLSCKDNSPPLSWQTRIRI-ATE 568
P LV L +C V EY+ G L + +L + R + E
Sbjct: 70 PFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP----------EEHARFYSAE 118
Query: 569 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT--TLC 626
+ L +LH I++ DLK N+LLD+ KL+D+G + + + +T T C
Sbjct: 119 ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYG----MCKEGLRPGDTTSTFC 171
Query: 627 CRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 669
GT Y+ PE L + D ++ G+++ ++ GR
Sbjct: 172 ------GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS 208
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 3e-14
Identities = 59/222 (26%), Positives = 86/222 (38%), Gaps = 54/222 (24%)
Query: 472 IGEGGYGSIYKGLLRHMQV---------AIKMLHPHSLQGPSEF---QQEIDILSKI-RH 518
+G+G +G + M A+K+L + + E ILS H
Sbjct: 31 LGKGSFGKV-------MLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNH 83
Query: 519 PNLVTLVGAC--PEVWTLVYEYLPNGSL------EDRLSCKDNSPPLSWQTRIRI-ATEL 569
P L L P+ V E++ G L R + R R A E+
Sbjct: 84 PFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD----------EARARFYAAEI 133
Query: 570 CSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT--TLCC 627
S L+FLH I++ DLK N+LLD KL+DFG + + I + T T C
Sbjct: 134 ISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFG----MCKEGICNGVTTATFC- 185
Query: 628 RTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 669
GT Y+ PE L P D ++ G++L +L G
Sbjct: 186 -----GTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHA 222
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 3e-14
Identities = 51/222 (22%), Positives = 83/222 (37%), Gaps = 54/222 (24%)
Query: 472 IGEGGYGSIYKGLLRHMQV---------AIKMLHPHSLQGPSEF---QQEIDILSKI-RH 518
+G+G +G + M A+K+L + + E +L+ +
Sbjct: 28 LGKGSFGKV-------MLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP 80
Query: 519 PNLVTLVGA--CPEVWTLVYEYLPNGSL------EDRLSCKDNSPPLSWQTRIRI-ATEL 569
P L L + V EY+ G L R + A E+
Sbjct: 81 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK----------EPHAVFYAAEI 130
Query: 570 CSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT--TLCC 627
L FL S I++ DLK N++LD+ K++DFG + + I T T C
Sbjct: 131 AIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFG----MCKENIWDGVTTKTFC- 182
Query: 628 RTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 669
GT Y+ PE +A D ++FG++L +L G+
Sbjct: 183 -----GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 219
|
| >2yu4_A E3 SUMO-protein ligase NSE2; SP-ring domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} Length = 94 | Back alignment and structure |
|---|
Score = 68.1 bits (166), Expect = 3e-14
Identities = 21/76 (27%), Positives = 36/76 (47%), Gaps = 9/76 (11%)
Query: 758 FTCPIFQEVMQDPHVAAD-GFTYEAEALKGWLDSGHETS-----PMT---NLPLAHKNLV 808
FTCPI +E M+ P G TYE +A+ ++S + P + + +L+
Sbjct: 8 FTCPITKEEMKKPVKNKVCGHTYEEDAIVRMIESRQKRKKKAYCPQIGCSHTDIRKSDLI 67
Query: 809 PNLALRSAIQEWLQQH 824
+ ALR AI+ ++
Sbjct: 68 QDEALRRAIENHNKKR 83
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 7e-14
Identities = 53/290 (18%), Positives = 97/290 (33%), Gaps = 73/290 (25%)
Query: 435 RKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHM--QVAI 492
+ + Q + + N+ IG G YG +Y ++ VAI
Sbjct: 3 HHHHHSSGRENLYFQGIKNVHVPD------NYIIKHLIGRGSYGYVYLAYDKNTEKNVAI 56
Query: 493 KMLHPHSLQGPSEFQQ---------EIDILSKIRHPNLVTLVGACP--------EVWTLV 535
K ++ F+ EI IL++++ ++ L E++ +V
Sbjct: 57 KKVN-------RMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELY-IV 108
Query: 536 YEYLP---------NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 586
E L + ++ + + L F+H I+H
Sbjct: 109 LEIADSDLKKLFKTPIFLTE-----EHIKTILYNL-------LLG-ENFIHES---GIIH 152
Query: 587 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD------- 639
DLKPAN LL+ + K+ DFG++R ++ + ++ L +P +
Sbjct: 153 RDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHV 212
Query: 640 -------PE-FLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYAL 681
PE L T D++S G I LL + ++ L
Sbjct: 213 VTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPL 262
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 2e-13
Identities = 52/225 (23%), Positives = 91/225 (40%), Gaps = 29/225 (12%)
Query: 463 THNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQ---EIDILSKIR 517
+ +G GG G ++ + +VAIK + L P + EI I+ ++
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI---VLTDPQSVKHALREIKIIRRLD 66
Query: 518 HPNLVTLVGA-CPEVWTLVYEYLPNGSLED-----RLSCKD-----NSPPLSWQTRIRIA 566
H N+V + P L + L D PL +
Sbjct: 67 HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFM 126
Query: 567 TELCSVLIFLHSCKPHSIVHGDLKPANILLDA-NFVSKLSDFGISRFLSQNEISSNNTTL 625
+L L ++HS +++H DLKPAN+ ++ + V K+ DFG++R + + S+ L
Sbjct: 127 YQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHY--SHKGHL 181
Query: 626 CCRTDPKGTFAYMDPE-FLASGELTPKSDVYSFGIILLRLLTGRP 669
++ T Y P L+ T D+++ G I +LTG+
Sbjct: 182 ---SEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKT 223
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 3e-13
Identities = 52/247 (21%), Positives = 96/247 (38%), Gaps = 43/247 (17%)
Query: 441 ASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPH 498
+ S F+ + +G G YGS+ + + +VAIK L
Sbjct: 1 SLSLIRKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL-SR 59
Query: 499 SLQGPSEFQQ---EIDILSKIRHPNLVTL---------VGACPEVWTLVYEYLP---NGS 543
Q ++ E+ +L ++H N++ L + + + LV ++
Sbjct: 60 PFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFY-LVMPFMQTDLQKI 118
Query: 544 LEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSK 603
+ + S ++ L +Q L L ++HS +VH DLKP N+ ++ + K
Sbjct: 119 MGLKFS-EEKIQYLVYQM-------LKG-LKYIHSA---GVVHRDLKPGNLAVNEDCELK 166
Query: 604 LSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE-FLASGELTPKSDVYSFGIILL 662
+ DFG++R + + T T Y PE L+ D++S G I+
Sbjct: 167 ILDFGLAR--------HADAEM---TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMA 215
Query: 663 RLLTGRP 669
+LTG+
Sbjct: 216 EMLTGKT 222
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 72.4 bits (177), Expect = 3e-13
Identities = 57/284 (20%), Positives = 105/284 (36%), Gaps = 56/284 (19%)
Query: 405 SAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATH 464
E + +++ + ++ + E + K ++ + +DF+F
Sbjct: 294 EGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNF-------- 345
Query: 465 NFDPSLK-IGEGGYGSIYKGLLRHMQV---------AIKMLHPHSLQGPSEFQQ---EID 511
L +G+G +G + M A+K+L + + + E
Sbjct: 346 -----LMVLGKGSFGKV-------MLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKR 393
Query: 512 ILSKI-RHPNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-AT 567
+L+ + P L L + V EY+ G L + + A
Sbjct: 394 VLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK----EPHAVFYAA 449
Query: 568 ELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT--TL 625
E+ L FL S I++ DLK N++LD+ K++DFG + + I T T
Sbjct: 450 EIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFG----MCKENIWDGVTTKTF 502
Query: 626 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 669
C GT Y+ PE +A D ++FG++L +L G+
Sbjct: 503 C------GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 540
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 9e-13
Identities = 62/221 (28%), Positives = 88/221 (39%), Gaps = 51/221 (23%)
Query: 472 IGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPSEFQQ---EIDILSKIRH------PN 520
IG+G +G + K H VA+KM+ +Q EI IL +R N
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMN 160
Query: 521 LVTLVGA-------CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVL 573
++ ++ C + +E L + +L + L K+ S + A + L
Sbjct: 161 VIHMLENFTFRNHIC-----MTFELL-SMNLYE-LIKKNKFQGFSLPLVRKFAHSILQCL 213
Query: 574 IFLHSCKPHSIVHGDLKPANILLDANFVS--KLSDFGISRFLSQN---EISSNNTTLCCR 628
LH + I+H DLKP NILL S K+ DFG S + Q I S R
Sbjct: 214 DALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQS-------R 263
Query: 629 TDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 669
F Y PE + D++S G IL LLTG P
Sbjct: 264 ------F-YRAPEVILGARYGMPIDMWSLGCILAELLTGYP 297
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 51/241 (21%), Positives = 90/241 (37%), Gaps = 40/241 (16%)
Query: 448 PQFFSDFSFSEIEGA----THNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQ 501
P S F E+ + +G G YG++ + +VAIK L Q
Sbjct: 5 PPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL-YRPFQ 63
Query: 502 GPSEFQQ---EIDILSKIRHPNLVTL---------VGACPEVWTLVYEYLPNGSLEDRLS 549
++ E+ +L +RH N++ L + + + LV ++ L
Sbjct: 64 SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFY-LVMPFM-----GTDLG 117
Query: 550 CKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI 609
L + ++ L ++H+ I+H DLKP N+ ++ + K+ DFG+
Sbjct: 118 KLMKHEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 174
Query: 610 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE-FLASGELTPKSDVYSFGIILLRLLTGR 668
+R T T Y PE L T D++S G I+ ++TG+
Sbjct: 175 ARQADSE-----------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
Query: 669 P 669
Sbjct: 224 T 224
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 3e-12
Identities = 54/243 (22%), Positives = 93/243 (38%), Gaps = 36/243 (14%)
Query: 442 SSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHS 499
S P F+ I + +G G YGS+ ++VA+K L
Sbjct: 7 HHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRP 65
Query: 500 LQGPSEFQQ---EIDILSKIRHPNLVTL---------VGACPEVWTLVYEYLPNGSLEDR 547
Q ++ E+ +L ++H N++ L + +V+ LV +
Sbjct: 66 FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY-LVTHLM-----GAD 119
Query: 548 LSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDF 607
L+ L+ + ++ L ++HS I+H DLKP+N+ ++ + K+ DF
Sbjct: 120 LNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDF 176
Query: 608 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE-FLASGELTPKSDVYSFGIILLRLLT 666
G++R + T T Y PE L D++S G I+ LLT
Sbjct: 177 GLARHTADE-----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225
Query: 667 GRP 669
GR
Sbjct: 226 GRT 228
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 6e-12
Identities = 62/246 (25%), Positives = 102/246 (41%), Gaps = 63/246 (25%)
Query: 463 THNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQ---------EID 511
++ K+G+G YG ++K + R VA+K + FQ EI
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIF-------DAFQNSTDAQRTFREIM 60
Query: 512 ILSKIR-HPNLVTLVGACP-----EVWTLVYEYLPNGSLEDRLSCKDNSPPLS------- 558
IL+++ H N+V L+ +V+ LV++Y+ E L + L
Sbjct: 61 ILTELSGHENIVNLLNVLRADNDRDVY-LVFDYM-----ETDLHAVIRANILEPVHKQYV 114
Query: 559 -WQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 617
+Q + + +LHS ++H D+KP+NILL+A K++DFG+SR
Sbjct: 115 VYQL-------IKV-IKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163
Query: 618 ISSNNTTLCCRTDPKGTFAYMD-------------PE-FLASGELTPKSDVYSFGIILLR 663
+NN L + + PE L S + T D++S G IL
Sbjct: 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGE 223
Query: 664 LLTGRP 669
+L G+P
Sbjct: 224 ILCGKP 229
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 65.7 bits (160), Expect = 2e-11
Identities = 56/268 (20%), Positives = 101/268 (37%), Gaps = 32/268 (11%)
Query: 436 KSRKEASSSSHMPQFFSDFSF----------SEIEGA-THNFDPSLKIGE-GGYGSIYKG 483
K KE ++ S S+ + GA T P + I E +G++
Sbjct: 58 KMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTY 117
Query: 484 LLRHMQVAIK-MLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTLVYEYLPNG 542
L + + ++ I + K R ++ + + V E +
Sbjct: 118 LRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASS--GFVEEKSLSD 175
Query: 543 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS 602
E+ L+ + I + ++ + FL S K +H DL NILL V
Sbjct: 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVV 232
Query: 603 KLSDFGISRFLSQNE--ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGII 660
K+ DFG++R + ++ + + L + +M PE + T +SDV+SFG++
Sbjct: 233 KICDFGLARDIYKDPDYVRKGDARLPLK--------WMAPETIFDRVYTIQSDVWSFGVL 284
Query: 661 LLRLLT-GR---PALGITKEVQYALDTG 684
L + + G P + I +E L G
Sbjct: 285 LWEIFSLGASPYPGVKIDEEFCRRLKEG 312
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 43/195 (22%), Positives = 65/195 (33%), Gaps = 32/195 (16%)
Query: 471 KIGEGGYGSIYKGLLRHM-------QVAIKMLHP-HSLQGPSEFQQEIDILSKI-RHPNL 521
+G G +G + + + VA+KML + E+ IL I H N+
Sbjct: 29 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 88
Query: 522 VTLVGAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 578
V L+GAC ++ E+ G+L L K N R V
Sbjct: 89 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYV------ 142
Query: 579 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG---TF 635
+ DLK + ++ S S F + LS E L +
Sbjct: 143 ----GAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICY 198
Query: 636 AY-----MDPEFLAS 645
++ M EFLAS
Sbjct: 199 SFQVAKGM--EFLAS 211
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 41/239 (17%), Positives = 91/239 (38%), Gaps = 71/239 (29%)
Query: 471 KIGEGGYGSIYKG--LLRHMQVAIKML------HPHSLQGPSEFQQEIDILSKIR----- 517
K+G G + +++ ++ + VA+K++ + + EI +L ++
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAA-------EDEIKLLQRVNDADNT 78
Query: 518 ------HPNLVTLVGA-----------CPEVWTLVYEYLPNGSLEDRLSCKDNSP-PLSW 559
+++ L+ +V+E L +L + ++ PL
Sbjct: 79 KEDSMGANHILKLLDHFNHKGPNGVHVV-----MVFEVL-GENLLALIKKYEHRGIPLI- 131
Query: 560 QTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS------KLSDFGISRFL 613
+ +I+ +L L ++H + I+H D+KP N+L++ K++D G + +
Sbjct: 132 YVK-QISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY 188
Query: 614 SQ---NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 669
+ N I + Y PE L +D++S ++ L+TG
Sbjct: 189 DEHYTNSIQTR--------------EYRSPEVLLGAPWGCGADIWSTACLIFELITGDF 233
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 59/220 (26%), Positives = 91/220 (41%), Gaps = 45/220 (20%)
Query: 471 KIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPSEFQQ---EIDILSKIRHP------ 519
IG+G +G + K + VAIK++ + Q E+ +L +
Sbjct: 61 LIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKY 116
Query: 520 NLVTLVGA-------CPEVWTLVYEYLPNGSLEDRLSCKDNS-PPLSWQTRIRIATELCS 571
+V L C LV+E L + +L D L ++ + +S + A ++C+
Sbjct: 117 YIVHLKRHFMFRNHLC-----LVFEML-SYNLYDLL--RNTNFRGVSLNLTRKFAQQMCT 168
Query: 572 VLIFLHSCKPHSIVHGDLKPANILL--DANFVSKLSDFGISRFLSQNEISSNNTTLCCRT 629
L+FL + + I+H DLKP NILL K+ DFG S L Q + R
Sbjct: 169 ALLFLATPELS-IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR----IYQYIQSR- 222
Query: 630 DPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 669
F Y PE L D++S G IL+ + TG P
Sbjct: 223 -----F-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEP 256
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 51/211 (24%), Positives = 90/211 (42%), Gaps = 27/211 (12%)
Query: 471 KIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLV--- 525
KIG G +G IY G + +VAIK+ + + E I ++ + +
Sbjct: 16 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWC 73
Query: 526 GACPEVWTLVYEYLPNG-SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 584
GA + +V E L G SLED + S +T + +A ++ S + ++HS +
Sbjct: 74 GAEGDYNVMVMELL--GPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIHS---KNF 126
Query: 585 VHGDLKPANILL----DANFVSKLSDFGIS-RFLSQNEISSNNTTLCCRTDPK--GTFAY 637
+H D+KP N L+ N V + DFG++ ++ + + + R + GT Y
Sbjct: 127 IHRDVKPDNFLMGLGKKGNLVY-IIDFGLAKKYRD----ARTHQHIPYRENKNLTGTARY 181
Query: 638 MDPEFLASGELTPKSDVYSFGIILLRLLTGR 668
E + + D+ S G +L+ G
Sbjct: 182 ASINTHLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 4e-11
Identities = 43/245 (17%), Positives = 90/245 (36%), Gaps = 47/245 (19%)
Query: 471 KIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQGPSEFQ-----QEIDILSKIRH 518
IG+GG+G IY + +K+ + +E + + + + K
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 519 PNLVTLVGACPEVWT------------LVYEYLPNG-SLEDRLSCKDNSPPLSWQTRIRI 565
+ +G + ++ + G L+ + N+ S +T +++
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIY--EANAKRFSRKTVLQL 157
Query: 566 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSK--LSDFGISRFLSQNEISSNNT 623
+ + +L ++H H VHGD+K +N+LL+ + L D+G++
Sbjct: 158 SLRILDILEYIHE---HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY-----RYCPEGV 209
Query: 624 TLCCRTDPK----GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR-PALGI---TK 675
DPK GT + + + + D+ G +++ LTG P K
Sbjct: 210 HKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK 269
Query: 676 EVQYA 680
V+ +
Sbjct: 270 YVRDS 274
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 40/244 (16%), Positives = 78/244 (31%), Gaps = 45/244 (18%)
Query: 471 KIGEGGYGSIYKG----------LLRHMQVAIKMLHPHS-LQGPSEFQQEIDILSKIRHP 519
G +Y+ + + ++K+ L F Q ++
Sbjct: 49 FQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKW 108
Query: 520 NLVTLVGAC--PEVWT----------LVYEYLPNG-SLEDRLSCKDNSPPLSWQTRIRIA 566
+ P LV L G SL+ LS ++ +++A
Sbjct: 109 KKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQS-ALDVSPKHVLSERSVLQVA 165
Query: 567 TELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSK--LSDFGISRFLSQNEISSNNTT 624
L L FLH + VHG++ NI +D S+ L+ +G + +
Sbjct: 166 CRLLDALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF-----RYCPSGKH 217
Query: 625 LCCRTDPK----GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR-PALGI---TKE 676
+ + G ++ + + +SD+ S G +L+ L G P T++
Sbjct: 218 VAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTED 277
Query: 677 VQYA 680
+
Sbjct: 278 IMKQ 281
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 5e-10
Identities = 47/228 (20%), Positives = 84/228 (36%), Gaps = 44/228 (19%)
Query: 471 KIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 528
KIG GG+G IY + + A ++ + F E+ ++ + +
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFS-ELKFYQRVAKKDCIKKWIER 102
Query: 529 --------PEVW-------------TLVYEYLPNG-SLEDRLSCKDNSPPLSWQTRIRIA 566
P + +V E L G L+ + T +++
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQ---NGTFKKSTVLQLG 157
Query: 567 TELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSK--LSDFGISRFLSQNEISSNNTT 624
+ VL ++H + VHGD+K AN+LL + L+D+G+S N
Sbjct: 158 IRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLSY-----RYCPNGNH 209
Query: 625 LCCRTDPK----GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR 668
+ +P+ GT + + L+ +SDV G +LR L G+
Sbjct: 210 KQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGK 257
|
| >1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 1e-09
Identities = 31/156 (19%), Positives = 69/156 (44%), Gaps = 14/156 (8%)
Query: 296 DQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALA 355
+++ +A + E E R + E++ + ++ K +L+ + E EE A
Sbjct: 912 EEMRVRLAAKKQELEEILHEMEARIEEEEERSQQLQAEKKKMQQQMLDLEEQLE-EEEAA 970
Query: 356 NGKLELERMKKQHDEVMEELQIALD-----------QKSLLESQIAESDQTAKELEQKII 404
KL+LE K D +++++ + ++ LLE ++++ E E+K
Sbjct: 971 RQKLQLE--KVTADGKIKKMEDDILIMEDQNNKLTKERKLLEERVSDLTTNLAEEEEKAK 1028
Query: 405 SAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKE 440
+ +L ++ EL++ K K +EL K +++
Sbjct: 1029 NLTKLKNKHESMISELEVRLKKEEKSRQELEKIKRK 1064
|
| >1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 6e-09
Identities = 25/148 (16%), Positives = 57/148 (38%), Gaps = 4/148 (2%)
Query: 297 QLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKAS----ESLYAEELKRRKEFEE 352
+ + E+ ++ + K K E + + E K + + E
Sbjct: 980 TADGKIKKMEDDILIMEDQNNKLTKERKLLEERVSDLTTNLAEEEEKAKNLTKLKNKHES 1039
Query: 353 ALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQN 412
++ ++ L++ +K E+ + + + S L QIAE EL+ ++ E LQ
Sbjct: 1040 MISELEVRLKKEEKSRQELEKIKRKLEGESSDLHEQIAELQAQIAELKAQLAKKEEELQA 1099
Query: 413 YKKEQDELQMERDKAVKEAEELRKSRKE 440
++ +++ A+K+ EL +
Sbjct: 1100 ALARLEDETSQKNNALKKIRELESHISD 1127
|
| >1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 2e-07
Identities = 29/154 (18%), Positives = 62/154 (40%), Gaps = 11/154 (7%)
Query: 292 DNLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFE 351
++ ++L + E E + E++ +++ + K EL+ R + E
Sbjct: 996 EDQNNKLTKERKLLE----ERVSDLTTNLAEEEEKAKNLTKLKNKHESMISELEVRLKKE 1051
Query: 352 EA----LANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAV 407
E L K +LE E + ELQ Q + L++Q+A+ ++ + ++
Sbjct: 1052 EKSRQELEKIKRKLEGESSDLHEQIAELQ---AQIAELKAQLAKKEEELQAALARLEDET 1108
Query: 408 ELLQNYKKEQDELQMERDKAVKEAEELRKSRKEA 441
N K+ EL+ ++ E + +R +A
Sbjct: 1109 SQKNNALKKIRELESHISDLQEDLESEKAARNKA 1142
|
| >1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 2e-07
Identities = 26/144 (18%), Positives = 56/144 (38%)
Query: 299 AQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGK 358
Q E + + E +AE+ + + + E + E R +E EE +
Sbjct: 888 TQLCEEKNLLQEKLQAETELYAEAEEMRVRLAAKKQELEEILHEMEARIEEEEERSQQLQ 947
Query: 359 LELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQD 418
E ++M++Q ++ E+L+ + L+ + +D K++E I+ + KE+
Sbjct: 948 AEKKKMQQQMLDLEEQLEEEEAARQKLQLEKVTADGKIKKMEDDILIMEDQNNKLTKERK 1007
Query: 419 ELQMERDKAVKEAEELRKSRKEAS 442
L+ E + K +
Sbjct: 1008 LLEERVSDLTTNLAEEEEKAKNLT 1031
|
| >1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 5e-07
Identities = 24/161 (14%), Positives = 63/161 (39%), Gaps = 7/161 (4%)
Query: 292 DNLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFE 351
L ++++ +A + K E E R K E E K +++ E
Sbjct: 1007 KLLEERVSDLTTNLAEEEEKAKNLTKLKNKHESMISELEVRLKKEEKSRQELEKIKRKLE 1066
Query: 352 EALANGKLELERMKKQHDEVMEELQIALDQKSLLESQI-------AESDQTAKELEQKII 404
++ ++ ++ Q E+ +L ++ +++ + + +ELE I
Sbjct: 1067 GESSDLHEQIAELQAQIAELKAQLAKKEEELQAALARLEDETSQKNNALKKIRELESHIS 1126
Query: 405 SAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSS 445
E L++ K +++ + ++ +E E L+ ++ ++
Sbjct: 1127 DLQEDLESEKAARNKAEKQKRDLSEELEALKTELEDTLDTT 1167
|
| >1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 3e-06
Identities = 27/140 (19%), Positives = 54/140 (38%), Gaps = 18/140 (12%)
Query: 304 EAENSRREAFEEALRRGKAE-KDAIESIRRAKASESLYAEELKRRKEFEEALANGKLELE 362
+ E R+ E+ R+ + E D E I +A + +L + KE E A +LE E
Sbjct: 1049 KKEEKSRQELEKIKRKLEGESSDLHEQIAELQAQIAELKAQLAK-KEEELQAALARLEDE 1107
Query: 363 R------------MKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELL 410
++ ++ E+L+ ++ E Q + + + L+ ++ E
Sbjct: 1108 TSQKNNALKKIRELESHISDLQEDLESEKAARNKAEKQKRDLSEELEALKTEL----EDT 1163
Query: 411 QNYKKEQDELQMERDKAVKE 430
+ Q EL+ K +
Sbjct: 1164 LDTTATQQELRGSDYKDDDD 1183
|
| >1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 5e-06
Identities = 20/127 (15%), Positives = 51/127 (40%)
Query: 315 EALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEE 374
L+ + E++ + ++ + KE E+ E ++++ E
Sbjct: 848 PLLKVTRQEEEMQAKDEELQRTKERQQKAEAELKELEQKHTQLCEEKNLLQEKLQAETEL 907
Query: 375 LQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEEL 434
A + + L ++ E ++ E+E +I E Q + E+ ++Q + ++ EE
Sbjct: 908 YAEAEEMRVRLAAKKQELEEILHEMEARIEEEEERSQQLQAEKKKMQQQMLDLEEQLEEE 967
Query: 435 RKSRKEA 441
+R++
Sbjct: 968 EAARQKL 974
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 53/213 (24%), Positives = 85/213 (39%), Gaps = 29/213 (13%)
Query: 471 KIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLV--- 525
+IGEG +G I++G LL + QVAIK S + + E + + V
Sbjct: 17 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYF 74
Query: 526 GACPEVWTLVYEYLPNG-SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 584
G LV + L G SLED L S +T A ++ + + +H S+
Sbjct: 75 GQEGLHNVLVIDLL--GPSLEDLL--DLCGRKFSVKTVAMAAKQMLARVQSIHE---KSL 127
Query: 585 VHGDLKPANILL------DANFVSKLSDFGIS-RFLSQNEISSNNTTLCCRTDPK--GTF 635
V+ D+KP N L+ +AN + + DFG+ + + R GT
Sbjct: 128 VYRDIKPDNFLIGRPNSKNANMIY-VVDFGMVKFYRD----PVTKQHIPYREKKNLSGTA 182
Query: 636 AYMDPEFLASGELTPKSDVYSFGIILLRLLTGR 668
YM E + + D+ + G + + L G
Sbjct: 183 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 50/213 (23%), Positives = 85/213 (39%), Gaps = 29/213 (13%)
Query: 471 KIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRH----PNLVTL 524
KIG G +G + G L + VAIK+ S + E ++ P +
Sbjct: 16 KIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYF 73
Query: 525 VGACPEVWTLVYEYLPNG-SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 583
G C + +V E L G SLED D + S +T + IA +L S + ++HS +
Sbjct: 74 -GPCGKYNAMVLELL--GPSLEDLFDLCDRT--FSLKTVLMIAIQLISRMEYVHS---KN 125
Query: 584 IVHGDLKPANILLDANFVSK-----LSDFGIS-RFLSQNEISSNNTTLCCRTDPK--GTF 635
+++ D+KP N L+ + DF ++ ++ + R GT
Sbjct: 126 LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPE----TKKHIPYREHKSLTGTA 181
Query: 636 AYMDPEFLASGELTPKSDVYSFGIILLRLLTGR 668
YM E + + D+ + G + + L G
Sbjct: 182 RYMSINTHLGKEQSRRDDLEALGHMFMYFLRGS 214
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 25/210 (11%)
Query: 471 KIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLV--- 525
KIG G +G IY G + + +VAIK+ + + + E I ++ + V
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWF 71
Query: 526 GACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 585
G + LV + L SLED S LS +T + +A ++ + + F+HS S +
Sbjct: 72 GVEGDYNVLVMDLLGP-SLEDLF--NFCSRKLSLKTVLMLADQMINRVEFVHS---KSFL 125
Query: 586 HGDLKPANILL----DANFVSKLSDFGIS-RFLSQNEISSNNTTLCCRTDPK--GTFAYM 638
H D+KP N L+ AN V + DFG++ ++ + + + R + GT Y
Sbjct: 126 HRDIKPDNFLMGLGRRANQVY-IIDFGLAKKYRDTS----THQHIPYRENKNLTGTARYA 180
Query: 639 DPEFLASGELTPKSDVYSFGIILLRLLTGR 668
E + + D+ S G +L+ L G
Sbjct: 181 SVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >2dfs_A Myosin-5A; myosin-V, inhibited state, cryoelectron tomograp contractIle protein-transport protein complex; 24.00A {Gallus gallus} Length = 1080 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 8e-09
Identities = 24/149 (16%), Positives = 61/149 (40%), Gaps = 1/149 (0%)
Query: 297 QLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRR-KEFEEALA 355
L + RR + L++ K E ++E ++ +L+R+ E +
Sbjct: 886 TLKAIVYLQCCYRRMMAKRELKKLKIEARSVERYKKLHIGLENKIMQLQRKIDEQNKEYK 945
Query: 356 NGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKK 415
+ ++ ++ + E+L+ +++ + E + + L+++I + L +
Sbjct: 946 SLLEKMNNLEITYSTETEKLRSDVERLRMSEEEAKNATNRVLSLQEEIAKLRKELHQTQT 1005
Query: 416 EQDELQMERDKAVKEAEELRKSRKEASSS 444
E+ ++ DK E E+L KE ++
Sbjct: 1006 EKKTIEEWADKYKHETEQLVSELKEQNTL 1034
|
| >2dfs_A Myosin-5A; myosin-V, inhibited state, cryoelectron tomograp contractIle protein-transport protein complex; 24.00A {Gallus gallus} Length = 1080 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 2e-07
Identities = 26/158 (16%), Positives = 57/158 (36%), Gaps = 14/158 (8%)
Query: 297 QLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALAN 356
+ + E E +++ E ++ R+ Y L++ E +
Sbjct: 903 KRELKKLKIEARSVERYKKL--HIGLENKIMQLQRKIDEQNKEYKSLLEKMNNLEITYST 960
Query: 357 GKLEL----ERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQN 412
+L ER++ EE + A ++ L+ +IA+ + + + + + E
Sbjct: 961 ETEKLRSDVERLRMS----EEEAKNATNRVLSLQEEIAKLRKELHQTQTEKKTIEEWADK 1016
Query: 413 YKKEQDELQMERDKAV----KEAEELRKSRKEASSSSH 446
YK E ++L E + E EEL + + +
Sbjct: 1017 YKHETEQLVSELKEQNTLLKTEKEELNRRIHDQAKEIT 1054
|
| >2dfs_A Myosin-5A; myosin-V, inhibited state, cryoelectron tomograp contractIle protein-transport protein complex; 24.00A {Gallus gallus} Length = 1080 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 5e-07
Identities = 24/147 (16%), Positives = 58/147 (39%), Gaps = 3/147 (2%)
Query: 297 QLAQAMAEAENSRREAFEEALRRGKAEKDAIES-IRRAKASESLYAEELKRRKEFEEALA 355
+ +++ ++ R R ++ RR A L +++ R
Sbjct: 863 REHKSIIIQKHVRGWLARVHYHRTLKAIVYLQCCYRRMMAKRELKKLKIEARSVERYKKL 922
Query: 356 NGKLE--LERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNY 413
+ LE + +++++ DE +E + L++ + LE + + + +++ + E +N
Sbjct: 923 HIGLENKIMQLQRKIDEQNKEYKSLLEKMNNLEITYSTETEKLRSDVERLRMSEEEAKNA 982
Query: 414 KKEQDELQMERDKAVKEAEELRKSRKE 440
LQ E K KE + + +K
Sbjct: 983 TNRVLSLQEEIAKLRKELHQTQTEKKT 1009
|
| >2dfs_A Myosin-5A; myosin-V, inhibited state, cryoelectron tomograp contractIle protein-transport protein complex; 24.00A {Gallus gallus} Length = 1080 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 9e-07
Identities = 29/173 (16%), Positives = 59/173 (34%), Gaps = 14/173 (8%)
Query: 278 LQSSPPSVLDGSVDDNLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASE 337
+Q + + D A + + R I+ R +
Sbjct: 822 IQKFQRMYVVRKRYQCMRDATIALQALLRGYLVRNKYQMMLREHKSI-IIQKHVRGWLAR 880
Query: 338 SLYAEELKRR----KEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESD 393
Y LK + +A K EL+++K + V ++ LE++I +
Sbjct: 881 VHYHRTLKAIVYLQCCYRRMMA--KRELKKLKIEARSVERYKKL----HIGLENKIMQLQ 934
Query: 394 QTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSH 446
+ E ++ LL+ + E +K + E LR S +EA ++++
Sbjct: 935 RKIDEQNKEY---KSLLEKMNNLEITYSTETEKLRSDVERLRMSEEEAKNATN 984
|
| >2dfs_A Myosin-5A; myosin-V, inhibited state, cryoelectron tomograp contractIle protein-transport protein complex; 24.00A {Gallus gallus} Length = 1080 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 6e-06
Identities = 14/145 (9%), Positives = 50/145 (34%), Gaps = 7/145 (4%)
Query: 300 QAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGKL 359
+ + ++ +R A +++ + Y + +R+ + + +
Sbjct: 857 KYQMMLREHKSIIIQKHVRGWLARVHYHRTLKAIVYLQCCYRRMMAKRELKKLKIEARSV 916
Query: 360 E-LERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQD 418
E +++ + + +LQ +D+ + + LE + + + +
Sbjct: 917 ERYKKLHIGLENKIMQLQRKIDE---QNKEYKSLLEKMNNLEITY---STETEKLRSDVE 970
Query: 419 ELQMERDKAVKEAEELRKSRKEASS 443
L+M ++A + ++E +
Sbjct: 971 RLRMSEEEAKNATNRVLSLQEEIAK 995
|
| >2dfs_A Myosin-5A; myosin-V, inhibited state, cryoelectron tomograp contractIle protein-transport protein complex; 24.00A {Gallus gallus} Length = 1080 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 3e-05
Identities = 20/134 (14%), Positives = 52/134 (38%), Gaps = 9/134 (6%)
Query: 300 QAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGKL 359
+ E + + E LR + E + + EE+ + ++ K
Sbjct: 955 EITYSTETEKLRSDVERLRMSEEEAKNATNRVLSLQ------EEIAKLRKELHQTQTEKK 1008
Query: 360 ELERMKKQHDEVMEELQIALD-QKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQD 418
+E ++ E+L L Q +LL+++ E ++ + ++I +E + +E
Sbjct: 1009 TIEEWADKYKHETEQLVSELKEQNTLLKTEKEELNRRIHDQAKEITETME--KKLVEETK 1066
Query: 419 ELQMERDKAVKEAE 432
+L+++ + +
Sbjct: 1067 QLELDLNDERLRYQ 1080
|
| >1c1g_A Tropomyosin; contractIle protein; 7.00A {Sus scrofa} SCOP: h.1.5.1 PDB: 2tma_A 2w49_A 2w4u_A Length = 284 | Back alignment and structure |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 25/145 (17%), Positives = 55/145 (37%)
Query: 296 DQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALA 355
++LA A+ + E + + A E E A + + + E E ++ +
Sbjct: 104 ERLATALQKLEEAEKAADESERGMKVIESRAQKDEEKMEIQEIQLKEAKHIAEDADRKYE 163
Query: 356 NGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKK 415
+L ++ + E +++ + + LE +I K LE + + Y++
Sbjct: 164 EVARKLVIIESDLERAEERAELSEGKCAELEEEIKTVTNNLKSLEAQAEKYSQKEDKYEE 223
Query: 416 EQDELQMERDKAVKEAEELRKSRKE 440
E L + +A AE +S +
Sbjct: 224 EIKVLSDKLKEAETRAEFAERSVTK 248
|
| >1c1g_A Tropomyosin; contractIle protein; 7.00A {Sus scrofa} SCOP: h.1.5.1 PDB: 2tma_A 2w49_A 2w4u_A Length = 284 | Back alignment and structure |
|---|
Score = 52.0 bits (124), Expect = 3e-07
Identities = 32/143 (22%), Positives = 66/143 (46%)
Query: 292 DNLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFE 351
+ QL +A AE++ R+ E A + E D + RA+ SE AE + K
Sbjct: 142 EIQEIQLKEAKHIAEDADRKYEEVARKLVIIESDLERAEERAELSEGKCAELEEEIKTVT 201
Query: 352 EALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQ 411
L + + + E+ ++ D+ EE+++ D+ E++ ++++ +LE+ I + L
Sbjct: 202 NNLKSLEAQAEKYSQKEDKYEEEIKVLSDKLKEAETRAEFAERSVTKLEKSIDDLEDELY 261
Query: 412 NYKKEQDELQMERDKAVKEAEEL 434
K + + E D A+ + +
Sbjct: 262 AQKLKYKAISEELDHALNDMTSI 284
|
| >1c1g_A Tropomyosin; contractIle protein; 7.00A {Sus scrofa} SCOP: h.1.5.1 PDB: 2tma_A 2w49_A 2w4u_A Length = 284 | Back alignment and structure |
|---|
Score = 51.6 bits (123), Expect = 3e-07
Identities = 22/147 (14%), Positives = 62/147 (42%), Gaps = 2/147 (1%)
Query: 297 QLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALAN 356
A+A +A R + E+ L + + A E + ++ + E+ +
Sbjct: 23 DEAEADKKAAEDRSKQLEDELVSLQKKLKATED--ELDKYSEALKDAQEKLELAEKKATD 80
Query: 357 GKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKE 416
+ ++ + ++ EEL A ++ + ++ E+++ A E E+ + Q +++
Sbjct: 81 AEADVASLNRRIQLFEEELDRAQERLATALQKLEEAEKAADESERGMKVIESRAQKDEEK 140
Query: 417 QDELQMERDKAVKEAEELRKSRKEASS 443
+ +++ +A AE+ + +E +
Sbjct: 141 MEIQEIQLKEAKHIAEDADRKYEEVAR 167
|
| >1c1g_A Tropomyosin; contractIle protein; 7.00A {Sus scrofa} SCOP: h.1.5.1 PDB: 2tma_A 2w49_A 2w4u_A Length = 284 | Back alignment and structure |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 22/146 (15%), Positives = 50/146 (34%)
Query: 296 DQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALA 355
+ + + E + E A++ E R+ ES +R + E A
Sbjct: 132 SRAQKDEEKMEIQEIQLKEAKHIAEDADRKYEEVARKLVIIESDLERAEERAELSEGKCA 191
Query: 356 NGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKK 415
+ E++ + + + + ++ E +I KE E + A + +K
Sbjct: 192 ELEEEIKTVTNNLKSLEAQAEKYSQKEDKYEEEIKVLSDKLKEAETRAEFAERSVTKLEK 251
Query: 416 EQDELQMERDKAVKEAEELRKSRKEA 441
D+L+ E + + + + A
Sbjct: 252 SIDDLEDELYAQKLKYKAISEELDHA 277
|
| >1c1g_A Tropomyosin; contractIle protein; 7.00A {Sus scrofa} SCOP: h.1.5.1 PDB: 2tma_A 2w49_A 2w4u_A Length = 284 | Back alignment and structure |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 22/148 (14%), Positives = 54/148 (36%)
Query: 297 QLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALAN 356
++ + EN+ A E + AE + + + + ++ EAL +
Sbjct: 7 KMQMLKLDKENALDRADEAEADKKAAEDRSKQLEDELVSLQKKLKATEDELDKYSEALKD 66
Query: 357 GKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKE 416
+ +LE +K+ + ++ + L E ++ + + QK+ A + ++
Sbjct: 67 AQEKLELAEKKATDAEADVASLNRRIQLFEEELDRAQERLATALQKLEEAEKAADESERG 126
Query: 417 QDELQMERDKAVKEAEELRKSRKEASSS 444
++ K ++ E KEA
Sbjct: 127 MKVIESRAQKDEEKMEIQEIQLKEAKHI 154
|
| >1c1g_A Tropomyosin; contractIle protein; 7.00A {Sus scrofa} SCOP: h.1.5.1 PDB: 2tma_A 2w49_A 2w4u_A Length = 284 | Back alignment and structure |
|---|
Score = 48.1 bits (114), Expect = 5e-06
Identities = 20/151 (13%), Positives = 55/151 (36%)
Query: 293 NLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEE 352
D+L + ++++ + + AE D RR + E +R +
Sbjct: 52 ATEDELDKYSEALKDAQEKLELAEKKATDAEADVASLNRRIQLFEEELDRAQERLATALQ 111
Query: 353 ALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQN 412
L + + ++ + Q ++ + E Q+ E+ A++ ++K L
Sbjct: 112 KLEEAEKAADESERGMKVIESRAQKDEEKMEIQEIQLKEAKHIAEDADRKYEEVARKLVI 171
Query: 413 YKKEQDELQMERDKAVKEAEELRKSRKEASS 443
+ + + + + + + EL + K ++
Sbjct: 172 IESDLERAEERAELSEGKCAELEEEIKTVTN 202
|
| >1c1g_A Tropomyosin; contractIle protein; 7.00A {Sus scrofa} SCOP: h.1.5.1 PDB: 2tma_A 2w49_A 2w4u_A Length = 284 | Back alignment and structure |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 20/146 (13%), Positives = 51/146 (34%), Gaps = 2/146 (1%)
Query: 297 QLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALAN 356
++ ++ A+ + + E E L+ K + + R+ + + EE
Sbjct: 128 KVIESRAQKDEEKMEIQEIQLKEAKHIAEDAD--RKYEEVARKLVIIESDLERAEERAEL 185
Query: 357 GKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKE 416
+ + ++++ V L+ Q + + ++ K L K+ A + ++
Sbjct: 186 SEGKCAELEEEIKTVTNNLKSLEAQAEKYSQKEDKYEEEIKVLSDKLKEAETRAEFAERS 245
Query: 417 QDELQMERDKAVKEAEELRKSRKEAS 442
+L+ D E + K S
Sbjct: 246 VTKLEKSIDDLEDELYAQKLKYKAIS 271
|
| >1c1g_A Tropomyosin; contractIle protein; 7.00A {Sus scrofa} SCOP: h.1.5.1 PDB: 2tma_A 2w49_A 2w4u_A Length = 284 | Back alignment and structure |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 22/148 (14%), Positives = 63/148 (42%), Gaps = 3/148 (2%)
Query: 296 DQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALA 355
L + + E+ + EAL+ + + + E ++A +E+ A +R + FEE L
Sbjct: 44 VSLQKKLKATEDELDKY-SEALKDAQEKLELAE--KKATDAEADVASLNRRIQLFEEELD 100
Query: 356 NGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKK 415
+ L ++ +E + + ++ES+ + ++ + E ++ A + ++ +
Sbjct: 101 RAQERLATALQKLEEAEKAADESERGMKVIESRAQKDEEKMEIQEIQLKEAKHIAEDADR 160
Query: 416 EQDELQMERDKAVKEAEELRKSRKEASS 443
+ +E+ + + E + + +
Sbjct: 161 KYEEVARKLVIIESDLERAEERAELSEG 188
|
| >1c1g_A Tropomyosin; contractIle protein; 7.00A {Sus scrofa} SCOP: h.1.5.1 PDB: 2tma_A 2w49_A 2w4u_A Length = 284 | Back alignment and structure |
|---|
Score = 45.0 bits (106), Expect = 5e-05
Identities = 17/83 (20%), Positives = 41/83 (49%)
Query: 361 LERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDEL 420
++ +KK+ + + + ALD+ E+ ++ +K+LE +++S + L+ + E D+
Sbjct: 1 MDAIKKKMQMLKLDKENALDRADEAEADKKAAEDRSKQLEDELVSLQKKLKATEDELDKY 60
Query: 421 QMERDKAVKEAEELRKSRKEASS 443
A ++ E K +A +
Sbjct: 61 SEALKDAQEKLELAEKKATDAEA 83
|
| >1c1g_A Tropomyosin; contractIle protein; 7.00A {Sus scrofa} SCOP: h.1.5.1 PDB: 2tma_A 2w49_A 2w4u_A Length = 284 | Back alignment and structure |
|---|
Score = 41.9 bits (98), Expect = 5e-04
Identities = 22/159 (13%), Positives = 60/159 (37%), Gaps = 7/159 (4%)
Query: 292 DNLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFE 351
+ + A A+ + R +A++ ++++ + +E E + K E
Sbjct: 72 ELAEKKATDAEADVASLNRRIQLFEEELDRAQERLATALQKLEEAEKAADESERGMKVIE 131
Query: 352 EALANGKLELERMKKQHDEV---MEELQIALD----QKSLLESQIAESDQTAKELEQKII 404
+ ++E + Q E E+ + + ++ES + +++ A+ E K
Sbjct: 132 SRAQKDEEKMEIQEIQLKEAKHIAEDADRKYEEVARKLVIIESDLERAEERAELSEGKCA 191
Query: 405 SAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASS 443
E ++ L+ + +K ++ ++ + K S
Sbjct: 192 ELEEEIKTVTNNLKSLEAQAEKYSQKEDKYEEEIKVLSD 230
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 57/246 (23%), Positives = 90/246 (36%), Gaps = 77/246 (31%)
Query: 471 KIGEGGYGSIYKG--LLRHMQVAIKML---HPHSLQGPSEFQQEIDILSKIRH-----PN 520
K+G+G +G + + A+K++ ++ + E DIL KI++ N
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA----KIEADILKKIQNDDINNNN 97
Query: 521 LVTLVGA-------CPEVWTLVYEYLPNGSLEDRLSCKDNS-PPLSWQTRIR-IATELCS 571
+V G C L++E L SL + + N+ + I+ E+
Sbjct: 98 IVKYHGKFMYYDHMC-----LIFEPL-GPSLYEII--TRNNYNGFHIE-DIKLYCIEILK 148
Query: 572 VLIFLHSCKPHSIVHGDLKPANILLDANFVS-------------------------KLSD 606
L +L + H DLKP NILLD + KL D
Sbjct: 149 ALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLID 205
Query: 607 FGISRFLSQNE---ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLR 663
FG + F S I++ R Y PE + + SD++SFG +L
Sbjct: 206 FGCATFKSDYHGSIINT-------RQ-------YRAPEVILNLGWDVSSDMWSFGCVLAE 251
Query: 664 LLTGRP 669
L TG
Sbjct: 252 LYTGSL 257
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 51/271 (18%), Positives = 86/271 (31%), Gaps = 95/271 (35%)
Query: 471 KIGEGGYGSIY--KGLLRHMQVAIKMLHPHSLQGPSEF-QQEIDILSKIR-----HPN-- 520
K+G G + +++ + VA+K++ S + +E EI +L +R PN
Sbjct: 44 KLGWGHFSTVWLSWDIQGKKFVAMKVVK--SAEHYTETALDEIRLLKSVRNSDPNDPNRE 101
Query: 521 -LVTLVGA-----------CPEVWTLVYEYLPNG-SLEDRLSCKDNSPPLSWQTRIRIAT 567
+V L+ C +V+E L G L K N L +I
Sbjct: 102 MVVQLLDDFKISGVNGTHIC-----MVFEVL--GHHLLK-WIIKSNYQGLPLPCVKKIIQ 153
Query: 568 ELCSVLIFLHSCKPHSIVHGDLKPANILL------------------------------- 596
++ L +LH+ I+H D+KP NILL
Sbjct: 154 QVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVS 211
Query: 597 ------------------DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 638
K++D G + ++ + T+ T Y
Sbjct: 212 TAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK-----------HFTEDIQTRQYR 260
Query: 639 DPEFLASGELTPKSDVYSFGIILLRLLTGRP 669
E L +D++S + L TG
Sbjct: 261 SLEVLIGSGYNTPADIWSTACMAFELATGDY 291
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 3e-07
Identities = 57/240 (23%), Positives = 89/240 (37%), Gaps = 69/240 (28%)
Query: 471 KIGEGGYGSIYKGLLRHMQ---VAIKMLHPHSLQGPSEFQQ---EIDILSKIRHP----- 519
+GEG +G + + + VA+K++ + EI +L +
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNST 76
Query: 520 -NLVTLVGA-------CPEVWTLVYEYLPNGSLEDRLSCKDNS-PPLSWQTRIR-IATEL 569
V ++ C +V+E L S D + K+N P IR +A ++
Sbjct: 77 FRCVQMLEWFEHHGHIC-----IVFELL-GLSTYDFI--KENGFLPFRLD-HIRKMAYQI 127
Query: 570 CSVLIFLHSCKPHSIVHGDLKPANILLDANFVS-------------------KLSDFGIS 610
C + FLHS K + H DLKP NIL + + K+ DFG +
Sbjct: 128 CKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA 184
Query: 611 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPE-FLASGELTPKSDVYSFGIILLRLLTGRP 669
+ ++ T + R Y PE LA G P DV+S G IL+ G
Sbjct: 185 TYDDEHHS----TLVSTR------H-YRAPEVILALGWSQP-CDVWSIGCILIEYYLGFT 232
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 5e-07
Identities = 50/240 (20%), Positives = 84/240 (35%), Gaps = 69/240 (28%)
Query: 471 KIGEGGYGSIYKGLLR---HMQVAIKMLHPHSLQGPSEFQQ---EIDILSKIRHP----- 519
+GEG +G + + L QVA+K++ + EI++L KI+
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENK 81
Query: 520 -NLVTLVGA-------CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCS 571
V + C + +E L + + ++N P +A +LC
Sbjct: 82 FLCVLMSDWFNFHGHMC-----IAFELL-GKNTFE-FLKENNFQPYPLPHVRHMAYQLCH 134
Query: 572 VLIFLHSCKPHSIVHGDLKPANILLDANFVS-------------------KLSDFGISRF 612
L FLH + + H DLKP NIL + +++DFG + F
Sbjct: 135 ALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF 191
Query: 613 LSQNE---ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 669
++ +++ R Y PE + DV+S G IL G
Sbjct: 192 DHEHHTTIVAT-------R------H-YRPPEVILELGWAQPCDVWSIGCILFEYYRGFT 237
|
| >3lvg_D LCB, clathrin light chain B; SELF assembly, coated PIT, cytoplasmic vesicle, membrane, Ca structural protein; 7.94A {Bos taurus} Length = 190 | Back alignment and structure |
|---|
Score = 49.0 bits (116), Expect = 9e-07
Identities = 15/77 (19%), Positives = 33/77 (42%), Gaps = 4/77 (5%)
Query: 367 QHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIIS-AVELLQNYKKEQDELQMERD 425
Q D + +E + + ++ E D +K +EQ+ A + L+ + + Q E Q+E++
Sbjct: 76 QADRLTQEPESIRKWREEQRKRLQELDAASKVMEQEWREKAKKDLEEWNQRQSE-QVEKN 134
Query: 426 KAV--KEAEELRKSRKE 440
K + +
Sbjct: 135 KINNRIADKAFYQQPDA 151
|
| >3lvg_D LCB, clathrin light chain B; SELF assembly, coated PIT, cytoplasmic vesicle, membrane, Ca structural protein; 7.94A {Bos taurus} Length = 190 | Back alignment and structure |
|---|
Score = 47.8 bits (113), Expect = 3e-06
Identities = 23/110 (20%), Positives = 42/110 (38%), Gaps = 33/110 (30%)
Query: 297 QLAQAMAEAENSR--REAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEAL 354
Q + E E+ R RE + L E DA + +E + E+A
Sbjct: 76 QADRLTQEPESIRKWREEQRKRL----QELDAASKVME---------QEWR-----EKA- 116
Query: 355 ANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKII 404
K +LE ++ E +E K+ + ++IA+ ++ + II
Sbjct: 117 ---KKDLEEWNQRQSEQVE--------KNKINNRIAD-KAFYQQPDADII 154
|
| >2bay_A PRE-mRNA splicing factor PRP19; U-BOX, ubiquitin ligase, E3 ligase; 1.50A {Saccharomyces cerevisiae} SCOP: g.44.1.2 PDB: 1n87_A Length = 61 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 1e-06
Identities = 12/54 (22%), Positives = 25/54 (46%), Gaps = 2/54 (3%)
Query: 757 YFTCPIFQEVMQDPHVA-ADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVP 809
+ C I +V + P ++ +E L+ ++ P+TN PL+ + +V
Sbjct: 3 HMLCAISGKVPRRPVLSPKSRTIFEKSLLEQYVKD-TGNDPITNEPLSIEEIVE 55
|
| >2zuo_A MVP, major vault protein; repeat domains, protein-protein complex, cytoplasm, ribonucleoprotein, structural protein; 3.50A {Rattus norvegicus} PDB: 2zv4_N 2zv5_a 2qzv_A Length = 861 | Back alignment and structure |
|---|
Score = 50.2 bits (119), Expect = 2e-06
Identities = 26/140 (18%), Positives = 54/140 (38%), Gaps = 8/140 (5%)
Query: 297 QLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALAN 356
Q +EAE +R+E E +A A+ES AKA AE R E E ++
Sbjct: 691 QKILDQSEAEKARKELLEL-----EAMSMAVESTGNAKAEAESRAEA--ARIEGEGSVLQ 743
Query: 357 GKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQT-AKELEQKIISAVELLQNYKK 415
KL+ + + + + +E ++ + + + E + + A++L + +
Sbjct: 744 AKLKAQALAIETEAELERVKKVREMELIYARAQLELEVSKAQQLANVEAKKFKEMTEALG 803
Query: 416 EQDELQMERDKAVKEAEELR 435
+ + + L+
Sbjct: 804 PGTIRDLAVAGPEMQVKLLQ 823
|
| >2efr_A General control protein GCN4 and tropomyosin 1 Al; destabilizing cluster, hydrophobic core, contractIle protein; 1.80A {Saccharomyces cerevisiae} PDB: 2efs_A 2d3e_A Length = 155 | Back alignment and structure |
|---|
Score = 45.0 bits (106), Expect = 1e-05
Identities = 26/145 (17%), Positives = 60/145 (41%)
Query: 297 QLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALAN 356
++ Q + E + + + +K + RA+ SE AE + K L +
Sbjct: 1 RMKQLEDKVEELLSKNYHLENEVARLKKLLERAEERAELSEGKSAELEEELKTVTNNLKS 60
Query: 357 GKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKE 416
+ + E+ ++ D+ EE+++ D+ E++ ++++ +LE+ I + L K +
Sbjct: 61 LEAQAEKYSQKEDKYEEEIKVLSDKLKEAETRAEFAERSVTKLEKSIDDLEDELYAQKLK 120
Query: 417 QDELQMERDKAVKEAEELRKSRKEA 441
+ E + + EEL
Sbjct: 121 YKAISEEMKQLEDKVEELLSKNYHL 145
|
| >1w1w_A Structural maintenance of chromosome 1; cohesin, chromosome segregation, cell adhesion, kleisin, MIT cell cycle; HET: ATG; 2.90A {Saccharomyces cerevisiae} SCOP: c.37.1.12 Length = 430 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 18/144 (12%), Positives = 50/144 (34%), Gaps = 9/144 (6%)
Query: 306 ENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANG---KLELE 362
+ + + L A + E + A+ E ++ K E E
Sbjct: 124 KTVSYKDYSIFLENENILIKAKNFLVFQGDVEQIAAQSPVELSRMFEEVSGSIQYKKEYE 183
Query: 363 RMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVEL------LQNYKKE 416
+K++ +++ + ++ + + ++ E+ + + E
Sbjct: 184 ELKEKIEKLSKSATESIKNRRRIHGELKTYKSPGLEVLFQGPRGSRYDEAEGRFEVINNE 243
Query: 417 QDELQMERDKAVKEAEELRKSRKE 440
++L+ E K + + +++K RKE
Sbjct: 244 TEQLKAEEKKILNQFLKIKKKRKE 267
|
| >1cii_A Colicin IA; bacteriocin, ION channel formation, transmembrane protein; 3.00A {Escherichia coli} SCOP: f.1.1.1 h.4.3.1 Length = 602 | Back alignment and structure |
|---|
Score = 45.5 bits (106), Expect = 6e-05
Identities = 22/151 (14%), Positives = 48/151 (31%), Gaps = 1/151 (0%)
Query: 292 DNLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKR-RKEF 350
+ L+ E EN R EA + A + +++ +A + A+ ++ +
Sbjct: 56 TAYKNTLSAQQKENENKRTEAGKRLSAAIAAREKDENTLKTLRAGNADAADITRQEFRLL 115
Query: 351 EEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELL 410
+ L E + E ++ L E+ ++ E++ A
Sbjct: 116 QAELREYGFRTEIAGYDALRLHTESRMLFADADSLRISPREARSLIEQAEKRQKDAQNAD 175
Query: 411 QNYKKEQDELQMERDKAVKEAEELRKSRKEA 441
+ E + + EL K+ A
Sbjct: 176 KKAADMLAEYERRKGILDTRLSELEKNGGAA 206
|
| >3htk_C E3 SUMO-protein ligase MMS21; SUMO E3 ligase, SPL-ring, ring, ATP-binding, chromosomal protein, coiled coil, DNA damage; 2.31A {Saccharomyces cerevisiae} Length = 267 | Back alignment and structure |
|---|
Score = 43.4 bits (101), Expect = 1e-04
Identities = 8/71 (11%), Positives = 27/71 (38%), Gaps = 4/71 (5%)
Query: 758 FTCPIFQEVMQDPHVAAD-GFTYEAEALKGWLDSGHETS-PMT--NLPLAHKNLVPNLAL 813
TCPI + + P ++ ++ + ++ +L P + ++ ++ V + +
Sbjct: 182 LTCPITCKPYEAPLISRKCNHVFDRDGIQNYLQGYTTRDCPQAACSQVVSMRDFVRDPIM 241
Query: 814 RSAIQEWLQQH 824
+ +
Sbjct: 242 ELRCKIAKMKE 252
|
| >2v71_A Nuclear distribution protein NUDE-like 1; developmental protein, nuclear protein, neurogenesis, cytosk LIS1 binding, differentiation; 2.24A {Rattus norvegicus} Length = 189 | Back alignment and structure |
|---|
Score = 42.4 bits (99), Expect = 2e-04
Identities = 24/155 (15%), Positives = 62/155 (40%), Gaps = 7/155 (4%)
Query: 295 YDQLAQAMAEAENSRREAFEEAL-----RRGKAEKDAIESIRRAKA-SESLYAEELKRRK 348
+ + + E + RE E L + + +D +R K E+L + +
Sbjct: 26 FQEARDELVEFQEGSRE-LEAELEAQLVQAEQRNRDLQADNQRLKYEVEALKEKLEHQYA 84
Query: 349 EFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVE 408
+ + ++ + +L + + +++ + ++ LE + + ++ EQ++ A+E
Sbjct: 85 QSYKQVSVLEDDLSQTRAIKEQLHKYVRELEQANDDLERAKRATIMSLEDFEQRLNQAIE 144
Query: 409 LLQNYKKEQDELQMERDKAVKEAEELRKSRKEASS 443
+ E DE + + +E R R+E +
Sbjct: 145 RNAFLESELDEKESLLVSVQRLKDEARDLRQELAV 179
|
| >1f5n_A Interferon-induced guanylate-binding protein 1; GBP, GTP hydrolysis, GDP, GMP, dynamin related, large GTPase family. GMPPNP, GPPNHP.; HET: GNP; 1.70A {Homo sapiens} SCOP: a.114.1.1 c.37.1.8 PDB: 1dg3_A* 2b8w_A* 2b92_A* 2bc9_A* 2d4h_A* Length = 592 | Back alignment and structure |
|---|
Score = 43.8 bits (102), Expect = 2e-04
Identities = 21/164 (12%), Positives = 60/164 (36%), Gaps = 13/164 (7%)
Query: 292 DNLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFE 351
Y Q + + + + +EE + +AE+ ++ ++ + + E E
Sbjct: 430 PGGYRLFVQKLQDLKK---KYYEEPRKGIQAEEILQTYLKSKESMTDAILQTDQTLTEKE 486
Query: 352 EALANGKLELERMKKQHDEVMEELQ-----IALDQKSLLESQIAESDQTAKELEQKIISA 406
+ + +++ E + + E + + ++S E +++ + Q +
Sbjct: 487 KEIEVERVKAESAQASAKMLHEMQRKNEQMMEQKERSYQEHLKQLTEKMENDRVQLLKEQ 546
Query: 407 VELLQNYKKEQDEL-----QMERDKAVKEAEELRKSRKEASSSS 445
L +EQ++L Q E E ++L+ + + +
Sbjct: 547 ERTLALKLQEQEQLLKEGFQKESRIMKNEIQDLQTKMRRRKACT 590
|
| >2xs1_A Programmed cell death 6-interacting protein; protein transport-viral protein complex, cell cycle; 2.30A {Homo sapiens} PDB: 2xs8_A 2oev_A 2r05_A 2r02_A 2r03_A 2oex_A 2ojq_A Length = 704 | Back alignment and structure |
|---|
Score = 43.4 bits (101), Expect = 3e-04
Identities = 28/157 (17%), Positives = 55/157 (35%), Gaps = 12/157 (7%)
Query: 296 DQLAQAMAEAENSRREAFE---------EALRRGKAE-KDAIESIRRAKASESLYAEELK 345
+ +A + + E L + + E AI S AK + +E +
Sbjct: 499 TNFRTVLDKAVQADGQVKECYQSHRDTIVLLCKPEPELNAAIPSANPAKTMQG--SEVVN 556
Query: 346 RRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIIS 405
K L K E E ++ V ++ + I E + EL++
Sbjct: 557 VLKSLLSNLDEVKKEREGLENDLKSVNFDMTSKFLTALAQDGVINEEALSVTELDRVYGG 616
Query: 406 AVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEAS 442
+Q K+Q+ L + +E ++++S EA+
Sbjct: 617 LTTKVQESLKKQEGLLKNIQVSHQEFSKMKQSNNEAN 653
|
| >3haj_A Human pacsin2 F-BAR; pacsin,syndapin,FAP52,F-BAR, alternative splicing, coiled coil, cytoplasmic vesicle, endocytosis, phosphoprotein, polymorphism; 2.78A {Homo sapiens} Length = 486 | Back alignment and structure |
|---|
Score = 42.8 bits (99), Expect = 4e-04
Identities = 28/166 (16%), Positives = 51/166 (30%), Gaps = 8/166 (4%)
Query: 291 DDNLYDQLAQAMAEAENSRREAFEEALR-RGKAEKDAIESIRRAKASESLYAEELKRRKE 349
+ Y + + + + + L R + EK + + E+ +
Sbjct: 20 EVGNYKRTVKRIDDGHRLCSD-LMNCLHERARIEKAYAQQLTEWARRWRQLVEKGPQYGT 78
Query: 350 FEEALANGKLELERMKKQHDEVMEELQ------IALDQKSLLESQIAESDQTAKELEQKI 403
E+A E ER+ + H EV L I QK Q+ + KE E
Sbjct: 79 VEKAWMAFMSEAERVSELHLEVKASLMNDDFEKIKNWQKEAFHKQMMGGFKETKEAEDGF 138
Query: 404 ISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQ 449
A + KE + + A KE + + + +
Sbjct: 139 RKAQKPWAKKLKEVEAAKKAHHAACKEEKLAISREANSKADPSLNP 184
|
| >2fxo_A Myosin heavy chain, cardiac muscle beta isoform; coiled coil (dimeric, parallel), familial hypertrophic cardiomyopathy, FHC-associated mutant E924K; 2.50A {Homo sapiens} SCOP: h.1.26.1 PDB: 2fxm_A Length = 129 | Back alignment and structure |
|---|
Score = 39.9 bits (93), Expect = 5e-04
Identities = 22/121 (18%), Positives = 52/121 (42%), Gaps = 7/121 (5%)
Query: 317 LRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQ 376
L+ + EK+ + + RRKE EE ++ + ++ +++ ++Q
Sbjct: 6 LKSAEREKEMASMKEEFTRLKEALEKSEARRKELEE-------KMVSLLQEKNDLQLQVQ 58
Query: 377 IALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRK 436
D + E + + + +LE K+ + L++ ++ EL ++ K E EL++
Sbjct: 59 AEQDNLADAEERCDQLIKNKIQLEAKVKEMNKRLEDEEEMNAELTAKKRKLEDECSELKR 118
Query: 437 S 437
Sbjct: 119 D 119
|
| >3auy_A DNA double-strand break repair RAD50 ATPase; DNA repair, ABC transporter ATPase domain-like; HET: DNA ADP; 2.70A {Methanocaldococcus jannaschii} PDB: 3aux_A* 3av0_B* Length = 371 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 5e-04
Identities = 21/143 (14%), Positives = 48/143 (33%), Gaps = 12/143 (8%)
Query: 302 MAEAENSRREAFEEAL----------RRGKAEKDAIESIRRAKASESLYAEELKRRKEFE 351
++ + + E + L + G+ K+ + + R + + E LK R +
Sbjct: 141 LSLKPSEKLETVAKLLGIDEFEKCYQKMGEIVKEYEKRLERIEGELNYKEESLKARLKEM 200
Query: 352 EALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQ 411
L K +L + + D+V Q L E + + E + ++
Sbjct: 201 SNLEKEKEKLTKFVEYLDKVRRIFGRNGFQAYLREKYVPLIQKYLNEAFSEFDLPYSFVE 260
Query: 412 NYKKEQDELQMERDKAVKEAEEL 434
+ E+++ V + L
Sbjct: 261 --LTKDFEVRVHAPNGVLTIDNL 281
|
| >3na7_A HP0958; flagellar biogenesis, flagellum export, C4 Zn-ribbon, coiled post-transcriptional, gene regulation, chaperone; HET: EPE; 2.20A {Helicobacter pylori} Length = 256 | Back alignment and structure |
|---|
Score = 41.6 bits (97), Expect = 5e-04
Identities = 15/97 (15%), Positives = 35/97 (36%), Gaps = 5/97 (5%)
Query: 345 KRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKII 404
+E + L + E K + EE Q S E + +++ +++K+
Sbjct: 25 PLIREKRKDLDKALNDKEAKNKAILNLEEEKLALKLQVSKNEQTLQDTNAKIASIQKKMS 84
Query: 405 SAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEA 441
++E L +E D A + + + + +
Sbjct: 85 EIKS-----ERELRSLNIEEDIAKERSNQANREIENL 116
|
| >3qwe_A GMIP, GEM-interacting protein; structural genomics consortium, SGC, protein binding; 2.40A {Homo sapiens} Length = 279 | Back alignment and structure |
|---|
Score = 41.4 bits (96), Expect = 6e-04
Identities = 27/144 (18%), Positives = 61/144 (42%), Gaps = 16/144 (11%)
Query: 294 LYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEA 353
Y LA E E R+E E+ ++ K +A++++RRA+ +E+L+ R +
Sbjct: 99 YYQPLAAKRTEIEKWRKEFKEQWMKEQKRMNEAVQALRRAQLQYVQRSEDLRARSQGSPE 158
Query: 354 LANGKLE------LERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAV 407
+ + ER ++ +E + Q A ++ + E++ ++LE V
Sbjct: 159 DSAPQASPGPSKQQERRRRSREEAQAKAQEAEAL---YQACVREANARQQDLEIAKQRIV 215
Query: 408 ELLQNYKKEQDELQMERDKAVKEA 431
++ +L + D+ ++
Sbjct: 216 SHVR-------KLVFQGDEVLRRV 232
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 824 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.77 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.58 | |
| 1wgm_A | 98 | Ubiquitin conjugation factor E4A; ubiquitinating e | 99.51 | |
| 2kre_A | 100 | Ubiquitin conjugation factor E4 B; U-box domain, E | 99.49 | |
| 2kr4_A | 85 | Ubiquitin conjugation factor E4 B; U-BOX, UFD2, ri | 99.49 | |
| 2f42_A | 179 | STIP1 homology and U-box containing protein 1; cha | 99.43 | |
| 3m62_A | 968 | Ubiquitin conjugation factor E4; armadillo-like re | 99.4 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.23 | |
| 2yu4_A | 94 | E3 SUMO-protein ligase NSE2; SP-ring domain, struc | 99.21 | |
| 2c2l_A | 281 | CHIP, carboxy terminus of HSP70-interacting protei | 99.18 | |
| 2bay_A | 61 | PRE-mRNA splicing factor PRP19; U-BOX, ubiquitin l | 99.08 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.07 | |
| 1t1h_A | 78 | Gspef-atpub14, armadillo repeat containing protein | 99.04 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.02 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.86 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.56 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.38 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.3 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.28 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.23 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.12 | |
| 3s3t_A | 146 | Nucleotide-binding protein, universal stress PROT | 98.06 | |
| 3htk_C | 267 | E3 SUMO-protein ligase MMS21; SUMO E3 ligase, SPL- | 98.03 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.97 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.96 | |
| 3ztg_A | 92 | E3 ubiquitin-protein ligase RBBP6; PACT, U-BOX, mR | 97.94 | |
| 3idf_A | 138 | USP-like protein; universal, stress, PSI, MCSG, st | 97.83 | |
| 1mjh_A | 162 | Protein (ATP-binding domain of protein MJ0577); hy | 97.83 | |
| 2gm3_A | 175 | Unknown protein; AT3G01520, putative ethylene-resp | 97.82 | |
| 3fg9_A | 156 | Protein of universal stress protein USPA family; A | 97.78 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.78 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.63 | |
| 3hgm_A | 147 | Universal stress protein TEAD; rossman fold, signa | 97.56 | |
| 1tq8_A | 163 | Hypothetical protein RV1636; MTCY01B2.28, structur | 97.53 | |
| 2dum_A | 170 | Hypothetical protein PH0823; conserved hypothetica | 97.5 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.48 | |
| 3fl2_A | 124 | E3 ubiquitin-protein ligase UHRF1; cell cycle, DNA | 97.47 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.46 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.46 | |
| 1z6u_A | 150 | NP95-like ring finger protein isoform B; structura | 97.42 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.35 | |
| 3dlo_A | 155 | Universal stress protein; unknown function, struct | 97.33 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.33 | |
| 3tnj_A | 150 | Universal stress protein (USP); structural genomic | 97.32 | |
| 3fdx_A | 143 | Putative filament protein / universal stress PROT; | 97.28 | |
| 3olq_A | 319 | Universal stress protein E; structural genomics, P | 97.16 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.15 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.12 | |
| 2z08_A | 137 | Universal stress protein family; uncharacterized c | 97.12 | |
| 2y43_A | 99 | E3 ubiquitin-protein ligase RAD18; DNA repair, met | 97.02 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.92 | |
| 1jm7_B | 117 | BARD1, BRCA1-associated ring domain protein 1; rin | 96.91 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.88 | |
| 3hct_A | 118 | TNF receptor-associated factor 6; cross-brace, bet | 96.84 | |
| 3loq_A | 294 | Universal stress protein; structural genomics, PSI | 96.81 | |
| 3cis_A | 309 | Uncharacterized protein; alpha/beta hydrolase, ATP | 96.71 | |
| 3ab8_A | 268 | Putative uncharacterized protein TTHA0350; tandem- | 96.68 | |
| 2ckl_A | 108 | Polycomb group ring finger protein 4; BMI1, RING1B | 96.67 | |
| 2ecw_A | 85 | Tripartite motif-containing protein 30; metal bind | 96.66 | |
| 2ckl_B | 165 | Ubiquitin ligase protein RING2; BMI1, RING1B, poly | 96.57 | |
| 2egp_A | 79 | Tripartite motif-containing protein 34; ZF-C3HC4 d | 96.56 | |
| 1q77_A | 138 | Hypothetical protein AQ_178; structural genomics, | 96.55 | |
| 2ecv_A | 85 | Tripartite motif-containing protein 5; metal bindi | 96.52 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.51 | |
| 3hcs_A | 170 | TNF receptor-associated factor 6; cross-brace, bet | 96.41 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.32 | |
| 1jmv_A | 141 | USPA, universal stress protein A; chaperone; 1.85A | 96.21 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.03 | |
| 3mt0_A | 290 | Uncharacterized protein PA1789; structural genomic | 96.02 | |
| 1jm7_A | 112 | BRCA1, breast cancer type 1 susceptibility protein | 96.0 | |
| 3l11_A | 115 | E3 ubiquitin-protein ligase RNF168; E3 ligase, rin | 96.0 | |
| 2csy_A | 81 | Zinc finger protein 183-like 1; ring finger protei | 95.71 | |
| 3lrq_A | 100 | E3 ubiquitin-protein ligase TRIM37; structural gen | 95.65 | |
| 3loq_A | 294 | Universal stress protein; structural genomics, PSI | 95.63 | |
| 2ecy_A | 66 | TNF receptor-associated factor 3; metal binding pr | 95.63 | |
| 3olq_A | 319 | Universal stress protein E; structural genomics, P | 95.56 | |
| 3mt0_A | 290 | Uncharacterized protein PA1789; structural genomic | 95.46 | |
| 2yur_A | 74 | Retinoblastoma-binding protein 6; P53-associated c | 95.45 | |
| 1rmd_A | 116 | RAG1; V(D)J recombination, antibody, MAD, ring fin | 95.38 | |
| 3knv_A | 141 | TNF receptor-associated factor 2; cross-brace, alt | 95.22 | |
| 3cis_A | 309 | Uncharacterized protein; alpha/beta hydrolase, ATP | 94.79 | |
| 4ayc_A | 138 | E3 ubiquitin-protein ligase RNF8; DNA damage, K63 | 94.69 | |
| 2djb_A | 72 | Polycomb group ring finger protein 6; PCGF6, ring | 94.55 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 94.4 | |
| 2ysl_A | 73 | Tripartite motif-containing protein 31; ring-type | 94.06 | |
| 1g25_A | 65 | CDK-activating kinase assembly factor MAT1; ring f | 92.33 | |
| 3ng2_A | 71 | RNF4, snurf, ring finger protein 4; ring domain, E | 92.03 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.76 | |
| 3ab8_A | 268 | Putative uncharacterized protein TTHA0350; tandem- | 90.26 | |
| 2ysj_A | 63 | Tripartite motif-containing protein 31; ring-type | 90.07 | |
| 2xeu_A | 64 | Ring finger protein 4; transcription, zinc-finger, | 90.02 | |
| 3vkg_A | 3245 | Dynein heavy chain, cytoplasmic; AAA+ protein, mol | 89.74 | |
| 2fxo_A | 129 | Myosin heavy chain, cardiac muscle beta isoform; c | 89.44 | |
| 2ct2_A | 88 | Tripartite motif protein 32; zinc-finger protein H | 88.99 | |
| 2ect_A | 78 | Ring finger protein 126; metal binding protein, st | 88.64 | |
| 2ecj_A | 58 | Tripartite motif-containing protein 39; TRIM39, ri | 87.4 | |
| 3vkg_A | 3245 | Dynein heavy chain, cytoplasmic; AAA+ protein, mol | 87.17 | |
| 2d8t_A | 71 | Dactylidin, ring finger protein 146; RNF146, ring | 86.53 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 86.31 | |
| 3qwe_A | 279 | GMIP, GEM-interacting protein; structural genomics | 84.78 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 84.03 | |
| 2ea6_A | 69 | Ring finger protein 4; RNF4, RES4-26, ring domain, | 83.8 | |
| 1i84_S | 1184 | Smooth muscle myosin heavy chain; muscle protein, | 83.61 | |
| 2dfs_A | 1080 | Myosin-5A; myosin-V, inhibited state, cryoelectron | 83.52 | |
| 4ap4_A | 133 | E3 ubiquitin ligase RNF4; ligase-signalling protei | 82.34 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 82.3 | |
| 2i1j_A | 575 | Moesin; FERM, coiled-coil, C-ermad, ERM, radixin, | 82.2 | |
| 3ol1_A | 119 | Vimentin; structural genomics, PSI-2, protein stru | 81.99 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=447.39 Aligned_cols=256 Identities=25% Similarity=0.451 Sum_probs=205.4
Q ss_pred CCCCccceeeecCceEEEEEEECCeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEecccC-CceEEEEEecC
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVYEYLP 540 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~~~~VAvK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~L~g~~~-~~~~LV~Ey~~ 540 (824)
.+|.+.++||+|+||+||+|.+++ .||||+++..... ..+.|.+|+.+|++++|||||+++|+|. +..+||||||+
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~iVmEy~~ 114 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCE 114 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEECCS
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECCeEEEEEEcCC
Confidence 467788899999999999998765 5999998754322 2356999999999999999999999984 56899999999
Q ss_pred CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccC
Q 003384 541 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 620 (824)
Q Consensus 541 ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 620 (824)
||+|.++|... ..++++..++.|+.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+.........
T Consensus 115 gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~ 189 (307)
T 3omv_A 115 GSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQ 189 (307)
T ss_dssp SCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC--------
T ss_pred CCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccCCcce
Confidence 99999999633 3569999999999999999999999 899999999999999999999999999998765432211
Q ss_pred CCccccccCCCCCCcccCChhhhcc---CCCCcchhHHhHHHHHHHHHhCCCCCCCchHHH---HHHhhhccccccCCCC
Q 003384 621 NNTTLCCRTDPKGTFAYMDPEFLAS---GELTPKSDVYSFGIILLRLLTGRPALGITKEVQ---YALDTGKLKNLLDPLA 694 (824)
Q Consensus 621 ~~~~~~~~~~~~GT~~Y~APE~l~~---~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~---~~~~~~~~~~~ld~~~ 694 (824)
. .....||+.|||||++.+ +.|+.++|||||||+||||+||++||....... ..+..+ ...|..
T Consensus 190 ~------~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~----~~~p~~ 259 (307)
T 3omv_A 190 Q------VEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRG----YASPDL 259 (307)
T ss_dssp ----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTT----CCCCCS
T ss_pred e------ecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcC----CCCCCc
Confidence 1 134579999999999964 468999999999999999999999997543222 222222 222333
Q ss_pred CCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHh
Q 003384 695 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 736 (824)
Q Consensus 695 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~ 736 (824)
...+...+..+.+|+.+||+.+|.+||++ .+|++.|+.++.
T Consensus 260 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~-~ei~~~Le~l~~ 300 (307)
T 3omv_A 260 SKLYKNCPKAMKRLVADCVKKVKEERPLF-PQILSSIELLQH 300 (307)
T ss_dssp TTSCTTSCHHHHHHHHHHTCSSSTTSCCH-HHHHHHHHHHHT
T ss_pred ccccccchHHHHHHHHHHcCCCHhHCcCH-HHHHHHHHHHhc
Confidence 34455667899999999999999999999 778888887764
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-52 Score=450.06 Aligned_cols=256 Identities=24% Similarity=0.462 Sum_probs=211.0
Q ss_pred CCCCccceeeecCceEEEEEEEC-------CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC--CceEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTL 534 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~-------~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~L 534 (824)
.+|.+.+.||+|+||+||+|.+. +..||||+++.......+.|.+|+.+|++|+|||||+++|+|. +..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 36778899999999999999874 4679999998655444567999999999999999999999994 46899
Q ss_pred EEEecCCCChhhhhhcc----------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCccee
Q 003384 535 VYEYLPNGSLEDRLSCK----------DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKL 604 (824)
Q Consensus 535 V~Ey~~ggsL~~~L~~~----------~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL 604 (824)
|||||+||+|.++|... .....|+|..++.|+.||+.||.|||+ ++||||||||+||||+.++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcEEE
Confidence 99999999999999643 234579999999999999999999999 89999999999999999999999
Q ss_pred eccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHH--HHH
Q 003384 605 SDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--YAL 681 (824)
Q Consensus 605 ~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~--~~~ 681 (824)
+|||+|+.......... .....||+.|||||++.+..|+.++|||||||+||||+| |++||....... ..+
T Consensus 170 ~DFGla~~~~~~~~~~~------~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i 243 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRV------GGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI 243 (299)
T ss_dssp CCCSCHHHHTGGGCEEE------TTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred CCcccceecCCCCceee------cCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 99999987654332111 123458999999999999999999999999999999999 999997654332 222
Q ss_pred hhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhh
Q 003384 682 DTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 737 (824)
Q Consensus 682 ~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~~ 737 (824)
..+. ....|...+..+.+|+.+||+.+|.+||++ ++|.+.|+.+...
T Consensus 244 ~~~~--------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~-~~i~~~L~~~~~~ 290 (299)
T 4asz_A 244 TQGR--------VLQRPRTCPQEVYELMLGCWQREPHMRKNI-KGIHTLLQNLAKA 290 (299)
T ss_dssp HHTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHH
T ss_pred HcCC--------CCCCCccchHHHHHHHHHHcCCChhHCcCH-HHHHHHHHHHHhc
Confidence 2221 123455667899999999999999999999 6788899887654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-51 Score=451.05 Aligned_cols=255 Identities=24% Similarity=0.451 Sum_probs=205.2
Q ss_pred CCCCccceeeecCceEEEEEEEC-------CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC--CceEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTL 534 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~-------~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~L 534 (824)
.+|.+.++||+|+||+||+|.++ +..||||+++.......+.|.+|+.+|++|+|||||+++|+|. +..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 35677789999999999999875 4679999998655444567999999999999999999999995 46899
Q ss_pred EEEecCCCChhhhhhccC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcc
Q 003384 535 VYEYLPNGSLEDRLSCKD------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS 602 (824)
Q Consensus 535 V~Ey~~ggsL~~~L~~~~------------~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~v 602 (824)
|||||++|+|.++|.... ...+++|..++.|+.||+.||.|||+ ++||||||||+||||+.++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCcE
Confidence 999999999999996532 13569999999999999999999999 889999999999999999999
Q ss_pred eeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHH--
Q 003384 603 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQY-- 679 (824)
Q Consensus 603 KL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~-- 679 (824)
||+|||+|+.+........ .+...||+.|||||++.+..|+.++|||||||+||||+| |++||........
T Consensus 198 Ki~DFGla~~~~~~~~~~~------~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~ 271 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRV------GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID 271 (329)
T ss_dssp EECCCC----------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHH
T ss_pred EEcccccceeccCCCccee------cCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999987654322111 134569999999999999999999999999999999999 9999976544322
Q ss_pred HHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHh
Q 003384 680 ALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 736 (824)
Q Consensus 680 ~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~ 736 (824)
.+..+ .....|...+..+.+|+.+||+.+|.+||++ ++|++.|+.+..
T Consensus 272 ~i~~g--------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~-~ei~~~L~~l~~ 319 (329)
T 4aoj_A 272 CITQG--------RELERPRACPPEVYAIMRGCWQREPQQRHSI-KDVHARLQALAQ 319 (329)
T ss_dssp HHHHT--------CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCH-HHHHHHHHHHHH
T ss_pred HHHcC--------CCCCCcccccHHHHHHHHHHcCcChhHCcCH-HHHHHHHHHHhh
Confidence 22222 1223455667899999999999999999999 778888988765
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-51 Score=445.26 Aligned_cols=251 Identities=23% Similarity=0.387 Sum_probs=206.5
Q ss_pred CCCccceeeecCceEEEEEEEC-------CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccC--CceEE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTL 534 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~-------~~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~L 534 (824)
++.+.++||+|+||+||+|.+. +..||||+++..... ..+.|.+|+.+|++++|||||+++|+|. +..+|
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 3556788999999999999873 367999999765332 3467999999999999999999999994 46899
Q ss_pred EEEecCCCChhhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCc
Q 003384 535 VYEYLPNGSLEDRLSCKDN-------------SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV 601 (824)
Q Consensus 535 V~Ey~~ggsL~~~L~~~~~-------------~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~ 601 (824)
|||||++|+|.++|..... ...+++..++.|+.|||.||.|||+ ++||||||||+||||+.++.
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceEECCCCC
Confidence 9999999999999964321 2469999999999999999999999 88999999999999999999
Q ss_pred ceeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHH--
Q 003384 602 SKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ-- 678 (824)
Q Consensus 602 vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~-- 678 (824)
+||+|||+|+.+........ .+...||+.|||||++.++.|+.++|||||||+||||+| |++||.......
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~------~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~ 257 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKL------LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVV 257 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCS------SSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHH
T ss_pred EEECCcccceeccCCCceeE------ecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999987654332211 134579999999999999999999999999999999999 899997654432
Q ss_pred HHHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHH
Q 003384 679 YALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP 733 (824)
Q Consensus 679 ~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~ 733 (824)
..+..+ ...+.|...+..+.+|+.+||+.+|.+||++ ++|++.|+.
T Consensus 258 ~~i~~~--------~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~-~ei~~~L~a 303 (308)
T 4gt4_A 258 EMIRNR--------QVLPCPDDCPAWVYALMIECWNEFPSRRPRF-KDIHSRLRA 303 (308)
T ss_dssp HHHHTT--------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHT
T ss_pred HHHHcC--------CCCCCcccchHHHHHHHHHHcCCChhHCcCH-HHHHHHHHh
Confidence 222222 1223455667889999999999999999999 677777764
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=436.39 Aligned_cols=242 Identities=24% Similarity=0.334 Sum_probs=203.6
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--CCceEEEEEec
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 539 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~Ey~ 539 (824)
..|+..++||+|+||+||+|.+. +..||||++........+.+.+|+.+|+.++|||||+++++| .+..|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 35888899999999999999986 688999999876666667899999999999999999999998 45789999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccccc
Q 003384 540 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 619 (824)
Q Consensus 540 ~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 619 (824)
+||+|.+++.. ..+++..+..|+.||+.||.|||+ ++||||||||+||||+.+|.+||+|||+|+.+......
T Consensus 154 ~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 226 (346)
T 4fih_A 154 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 226 (346)
T ss_dssp TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred CCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCc
Confidence 99999999853 359999999999999999999999 89999999999999999999999999999876543211
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCCh
Q 003384 620 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPF 699 (824)
Q Consensus 620 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~ 699 (824)
....+||+.|||||++.+..|+.++|||||||+||||+||++||............ .....+. ...+.
T Consensus 227 --------~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i---~~~~~~~-~~~~~ 294 (346)
T 4fih_A 227 --------RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---RDNLPPR-LKNLH 294 (346)
T ss_dssp --------BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---HHSSCCC-CSCGG
T ss_pred --------ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH---HcCCCCC-CCccc
Confidence 14467999999999999999999999999999999999999999776544322111 1111111 12234
Q ss_pred hhHHHHHHHHHHHhhhccCCCCChH
Q 003384 700 VQAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 700 ~~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
..+..+.+|+.+||+.||.+||++.
T Consensus 295 ~~s~~~~dli~~~L~~dP~~R~ta~ 319 (346)
T 4fih_A 295 KVSPSLKGFLDRLLVRDPAQRATAA 319 (346)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHH
Confidence 5677899999999999999999983
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=438.47 Aligned_cols=245 Identities=23% Similarity=0.352 Sum_probs=197.0
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCC--chhHHHHHHHHHhcCCCceeeEecccC--CceEEEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE 537 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~E 537 (824)
++|...+.||+|+||+||+|.+. ++.||||++....... .+.|.+|+.+|++|+|||||++++++. +..|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 47999999999999999999986 6899999997654322 356899999999999999999999984 46899999
Q ss_pred ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccc
Q 003384 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 617 (824)
Q Consensus 538 y~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 617 (824)
||+||+|.++|... ....+++..++.|+.||+.||.|||+ +|||||||||+||||+.+|.+||+|||+|+.+....
T Consensus 104 y~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp CCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred CCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 99999999999643 34568899999999999999999999 899999999999999999999999999998765432
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCC
Q 003384 618 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 697 (824)
Q Consensus 618 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~ 697 (824)
.. .+..+||+.|||||++.+..|+.++|||||||+||||+||++||...+........ ..... ...
T Consensus 180 ~~--------~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i--~~~~~----~~~ 245 (350)
T 4b9d_A 180 EL--------ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKI--ISGSF----PPV 245 (350)
T ss_dssp HH--------HHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH--HHTCC----CCC
T ss_pred cc--------ccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH--HcCCC----CCC
Confidence 11 12235999999999999999999999999999999999999999876543322111 11111 123
Q ss_pred ChhhHHHHHHHHHHHhhhccCCCCChHHH
Q 003384 698 PFVQAEQLANLAMRCCEMSRKSRPELGKD 726 (824)
Q Consensus 698 p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~ 726 (824)
+...+.++.+|+.+||+.||.+||++.+.
T Consensus 246 ~~~~s~~~~~li~~~L~~dP~~R~s~~e~ 274 (350)
T 4b9d_A 246 SLHYSYDLRSLVSQLFKRNPRDRPSVNSI 274 (350)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CccCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 34556789999999999999999999443
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=438.65 Aligned_cols=265 Identities=25% Similarity=0.369 Sum_probs=214.7
Q ss_pred CChhhHhhhcCCCCccceeeecCceEEEEEEECC-------eEEEEEEecCCCCCC-chhHHHHHHHHHhcCC-CceeeE
Q 003384 454 FSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQG-PSEFQQEIDILSKIRH-PNLVTL 524 (824)
Q Consensus 454 ~~~~ei~~~~~~f~~~~~LG~G~fG~Vykg~~~~-------~~VAvK~l~~~~~~~-~~~f~~Ei~iL~~l~H-pnIv~L 524 (824)
|..++++...++|.+.+.||+|+||+||+|.+.+ +.||||++....... .+.|.+|+.+|++++| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 3444555556789999999999999999998753 579999997653322 3568999999999965 999999
Q ss_pred ecccC---CceEEEEEecCCCChhhhhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecc
Q 003384 525 VGACP---EVWTLVYEYLPNGSLEDRLSCKD-------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGD 588 (824)
Q Consensus 525 ~g~~~---~~~~LV~Ey~~ggsL~~~L~~~~-------------~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrD 588 (824)
+|+|. ..++||||||++|+|.++|.... ....+++..++.|+.|||.||.|||+ ++|||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCc
Confidence 99983 25799999999999999996432 13468999999999999999999999 8999999
Q ss_pred ccCCcEEecCCCcceeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-C
Q 003384 589 LKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-G 667 (824)
Q Consensus 589 LKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G 667 (824)
|||+||||+.++.+||+|||+|+.+....... ..+...||+.|||||++.+..|+.++|||||||+||||+| |
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~------~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G 284 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYV------RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG 284 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSE------EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTS
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCce------eeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCC
Confidence 99999999999999999999999765432211 1134468999999999999999999999999999999998 9
Q ss_pred CCCCCCch---HHHHHHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHh
Q 003384 668 RPALGITK---EVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 736 (824)
Q Consensus 668 ~~Pf~~~~---~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~ 736 (824)
++||.... .+...+..+. ....|...+.++.+|+.+||+.+|.+||++ .++++.|+.+..
T Consensus 285 ~~Pf~~~~~~~~~~~~i~~g~--------~~~~p~~~~~~~~~li~~c~~~dP~~RPt~-~eil~~L~~llq 347 (353)
T 4ase_A 285 ASPYPGVKIDEEFCRRLKEGT--------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTF-SELVEHLGNLLQ 347 (353)
T ss_dssp CCSSTTCCCSHHHHHHHHHTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCC--------CCCCCccCCHHHHHHHHHHcCcChhHCcCH-HHHHHHHHHHHH
Confidence 99997543 2222223321 223455667899999999999999999999 778888887654
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-49 Score=432.68 Aligned_cols=253 Identities=21% Similarity=0.246 Sum_probs=201.2
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEe
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY 538 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey 538 (824)
...|...++||+|+||+||+|.+. +..||||+++.... +.+|+.+|+.|+|||||+++++|. +..||||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 346788889999999999999986 68899999976432 357999999999999999999984 468999999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCC-cceeecccccccccccc
Q 003384 539 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF-VSKLSDFGISRFLSQNE 617 (824)
Q Consensus 539 ~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~-~vKL~DFGla~~~~~~~ 617 (824)
|+||+|.++|... .+|++..+..|+.||+.||.|||+ ++||||||||+||||+.+| .+||+|||+|+.+....
T Consensus 132 ~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 132 LEGGSLGQLIKQM---GCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp CTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 9999999999543 469999999999999999999999 8999999999999999987 69999999999776543
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHH--HHHHhhhccccccCCCCC
Q 003384 618 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEV--QYALDTGKLKNLLDPLAG 695 (824)
Q Consensus 618 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~--~~~~~~~~~~~~ld~~~~ 695 (824)
..... ......+||+.|||||++.+..|+.++|||||||+||||+||++||...... ...+..+. +...
T Consensus 206 ~~~~~---~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~------~~~~ 276 (336)
T 4g3f_A 206 LGKSL---LTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEP------PPIR 276 (336)
T ss_dssp -----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSC------CGGG
T ss_pred cccce---ecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCC------CCch
Confidence 22111 1123457999999999999999999999999999999999999999654321 11111111 1111
Q ss_pred CCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHh
Q 003384 696 DWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 736 (824)
Q Consensus 696 ~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~ 736 (824)
..|...+..+.+|+.+||+.+|.+||++ .++++.|.....
T Consensus 277 ~~~~~~s~~~~~li~~~L~~dP~~R~sa-~el~~~l~~~l~ 316 (336)
T 4g3f_A 277 EIPPSCAPLTAQAIQEGLRKEPVHRASA-MELRRKVGKALQ 316 (336)
T ss_dssp GSCTTSCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHH
T ss_pred hcCccCCHHHHHHHHHHccCCHhHCcCH-HHHHHHHHHHHh
Confidence 2345567889999999999999999999 566666665443
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-49 Score=427.61 Aligned_cols=242 Identities=24% Similarity=0.343 Sum_probs=202.5
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCC---CCCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH---SLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 536 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~---~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~ 536 (824)
.+|.+.+.||+|+||+||+|... ++.||||++... .......+.+|+++|+.|+|||||++++++. +..||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 36999999999999999999986 578999999643 2234567999999999999999999999984 4689999
Q ss_pred EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccc
Q 003384 537 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 616 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 616 (824)
|||+||+|.++|... ..+++.....|+.||+.||.|||+ ++||||||||+||||+.+|.+||+|||+|+.+...
T Consensus 112 Ey~~gG~L~~~i~~~---~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 999999999999543 469999999999999999999999 89999999999999999999999999999977543
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCC
Q 003384 617 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 696 (824)
Q Consensus 617 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~ 696 (824)
..... ....+||+.|||||++.+..|+.++|||||||+||+|+||++||...+......... .. ...
T Consensus 186 ~~~~~------~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~--~~-----~~~ 252 (311)
T 4aw0_A 186 SKQAR------ANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKII--KL-----EYD 252 (311)
T ss_dssp TTCCC------BCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HT-----CCC
T ss_pred CCccc------ccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--cC-----CCC
Confidence 22111 134579999999999999999999999999999999999999998665433211111 10 113
Q ss_pred CChhhHHHHHHHHHHHhhhccCCCCChH
Q 003384 697 WPFVQAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 697 ~p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
+|...+.++.+|+.+||+.||.+||++.
T Consensus 253 ~p~~~s~~~~dli~~lL~~dp~~R~t~~ 280 (311)
T 4aw0_A 253 FPEKFFPKARDLVEKLLVLDATKRLGCE 280 (311)
T ss_dssp CCTTCCHHHHHHHHHHSCSSGGGSTTSG
T ss_pred CCcccCHHHHHHHHHHccCCHhHCcChH
Confidence 4455677899999999999999999983
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=422.12 Aligned_cols=237 Identities=23% Similarity=0.399 Sum_probs=189.6
Q ss_pred CccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEecccC------CceEEEE
Q 003384 467 DPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP------EVWTLVY 536 (824)
Q Consensus 467 ~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~L~g~~~------~~~~LV~ 536 (824)
...++||+|+||+||+|.+. +..||||++...... ....|.+|+.+|++|+|||||+++++|. ..+||||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 55678999999999999987 578999998754322 2356899999999999999999999873 2478999
Q ss_pred EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCc--eEeccccCCcEEec-CCCcceeecccccccc
Q 003384 537 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS--IVHGDLKPANILLD-ANFVSKLSDFGISRFL 613 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~g--iiHrDLKp~NILld-~~~~vKL~DFGla~~~ 613 (824)
|||+||+|.++|.. ..++++..+..|+.||+.||.|||+ ++ ||||||||+||||+ .+|.+||+|||+|+..
T Consensus 109 Ey~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 109 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 99999999999954 3569999999999999999999999 55 99999999999998 4899999999999854
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCC
Q 003384 614 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPL 693 (824)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~ 693 (824)
.... ....+||+.|||||++.+ .|+.++|||||||+||||+||++||............ +.....+
T Consensus 183 ~~~~----------~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~--i~~~~~~- 248 (290)
T 3fpq_A 183 RASF----------AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR--VTSGVKP- 248 (290)
T ss_dssp CTTS----------BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHH--HTTTCCC-
T ss_pred CCCc----------cCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHH--HHcCCCC-
Confidence 3221 123569999999998864 6999999999999999999999999654332221111 0010111
Q ss_pred CCCCChhhHHHHHHHHHHHhhhccCCCCChH
Q 003384 694 AGDWPFVQAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 694 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
..++...++++.+|+.+||+.+|.+|||+.
T Consensus 249 -~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ 278 (290)
T 3fpq_A 249 -ASFDKVAIPEVKEIIEGCIRQNKDERYSIK 278 (290)
T ss_dssp -GGGGGCCCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred -CCCCccCCHHHHHHHHHHccCChhHCcCHH
Confidence 112333456899999999999999999984
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=438.00 Aligned_cols=242 Identities=24% Similarity=0.339 Sum_probs=203.8
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--CCceEEEEEec
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 539 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~Ey~ 539 (824)
..|+..++||+|+||.||+|.+. +..||||++........+.+.+|+.+|+.++|||||+++++| .+.+|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 46888999999999999999986 688999999877666677899999999999999999999998 45789999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccccc
Q 003384 540 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 619 (824)
Q Consensus 540 ~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 619 (824)
+||+|.+++.. ..+++..+..|+.||+.||.|||+ +|||||||||+||||+.+|.+||+|||+|+.+......
T Consensus 231 ~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 303 (423)
T 4fie_A 231 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 303 (423)
T ss_dssp TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC
T ss_pred CCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCCCCcc
Confidence 99999999853 358999999999999999999999 89999999999999999999999999999876543211
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCCh
Q 003384 620 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPF 699 (824)
Q Consensus 620 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~ 699 (824)
....+||+.|||||++.+..|+.++|||||||+||||++|++||............ .....+.. ..+.
T Consensus 304 --------~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i---~~~~~~~~-~~~~ 371 (423)
T 4fie_A 304 --------RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---RDNLPPRL-KNLH 371 (423)
T ss_dssp --------BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---HHSCCCCC-SCTT
T ss_pred --------ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH---HcCCCCCC-cccc
Confidence 13456999999999999999999999999999999999999999766544322111 11111111 1233
Q ss_pred hhHHHHHHHHHHHhhhccCCCCChH
Q 003384 700 VQAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 700 ~~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
..+..+.+|+.+||..||.+||++.
T Consensus 372 ~~s~~~~dli~~~L~~dP~~R~ta~ 396 (423)
T 4fie_A 372 KVSPSLKGFLDRLLVRDPAQRATAA 396 (423)
T ss_dssp SSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHH
Confidence 4567899999999999999999983
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=429.80 Aligned_cols=261 Identities=23% Similarity=0.336 Sum_probs=196.2
Q ss_pred CCCccceeeecCceEEEEEEECCeEEEEEEecCCCCCCchhHH--HHHHHHHhcCCCceeeEecccCC------ceEEEE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQ--QEIDILSKIRHPNLVTLVGACPE------VWTLVY 536 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~~~~VAvK~l~~~~~~~~~~f~--~Ei~iL~~l~HpnIv~L~g~~~~------~~~LV~ 536 (824)
+|.+.++||+|+||+||+|.++++.||||++.... ...+. .|+.++.+++|||||+++|+|.+ ..+|||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 46677899999999999999999999999996532 23344 45555678899999999999842 468999
Q ss_pred EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhc-----CCCceEeccccCCcEEecCCCcceeecccccc
Q 003384 537 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC-----KPHSIVHGDLKPANILLDANFVSKLSDFGISR 611 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~-----~~~giiHrDLKp~NILld~~~~vKL~DFGla~ 611 (824)
|||+||+|.++|.. .+++|..+++|+.|++.||.|||+. +..+||||||||+||||+.++++||+|||+|+
T Consensus 81 Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 99999999999953 3589999999999999999999973 23489999999999999999999999999998
Q ss_pred ccccccccCCCccccccCCCCCCcccCChhhhccC------CCCcchhHHhHHHHHHHHHhCCCCCCCchHH--------
Q 003384 612 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG------ELTPKSDVYSFGIILLRLLTGRPALGITKEV-------- 677 (824)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~------~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~-------- 677 (824)
........... ......||+.|||||++.+. .|+.++|||||||+||||+||.+||+.....
T Consensus 157 ~~~~~~~~~~~----~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~ 232 (303)
T 3hmm_A 157 RHDSATDTIDI----APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232 (303)
T ss_dssp EEETTTTEESC----C-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred cccCCCCceee----ecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcc
Confidence 76543221111 11345799999999999764 3677999999999999999998877432110
Q ss_pred -----HHHHhhhccccccCCCCCC-C-ChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhh
Q 003384 678 -----QYALDTGKLKNLLDPLAGD-W-PFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 737 (824)
Q Consensus 678 -----~~~~~~~~~~~~ld~~~~~-~-p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~~ 737 (824)
...+........+.|.... + +...+..+.+|+.+||+.+|.+|||+ .+|.+.|+.+...
T Consensus 233 ~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 233 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA-LRIKKTLSQLSQQ 298 (303)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCH-HHHHHHHHHHHHC
T ss_pred cccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCH-HHHHHHHHHHHHH
Confidence 0011111111122221111 1 22345689999999999999999999 7788889887653
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-48 Score=411.64 Aligned_cols=237 Identities=26% Similarity=0.412 Sum_probs=185.9
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHHhcCCCceeeEeccc--CCceEEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVY 536 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~---~~~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~ 536 (824)
++|.+.+.||+|+||+||+|... ++.||||++..... .....+.+|+.+|+.++|||||++++++ .+..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 47999999999999999999875 68999999976432 2245689999999999999999999998 45689999
Q ss_pred EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccc
Q 003384 537 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 616 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 616 (824)
||| +|+|.+++.. ..++++..+..++.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHHH---SCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 6899999853 3569999999999999999999999 89999999999999999999999999999865433
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCC-CcchhHHhHHHHHHHHHhCCCCCCCchHHHHH--HhhhccccccCCC
Q 003384 617 EISSNNTTLCCRTDPKGTFAYMDPEFLASGEL-TPKSDVYSFGIILLRLLTGRPALGITKEVQYA--LDTGKLKNLLDPL 693 (824)
Q Consensus 617 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~--~~~~~~~~~ld~~ 693 (824)
.. .....||+.|||||++.+..| +.++|||||||+||+|+||++||......... +..+
T Consensus 166 ~~---------~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~--------- 227 (275)
T 3hyh_A 166 NF---------LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNG--------- 227 (275)
T ss_dssp ------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT---------
T ss_pred Cc---------cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC---------
Confidence 21 134569999999999998876 57999999999999999999999865443221 1111
Q ss_pred CCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 694 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 694 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
...+|...+..+.+|+.+||+.||.+|||+.+
T Consensus 228 ~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~e 259 (275)
T 3hyh_A 228 VYTLPKFLSPGAAGLIKRMLIVNPLNRISIHE 259 (275)
T ss_dssp CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhHCcCHHH
Confidence 11234556788999999999999999999843
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=424.36 Aligned_cols=239 Identities=27% Similarity=0.326 Sum_probs=192.5
Q ss_pred CCCCccceeeecCceEEEEEEEC-----CeEEEEEEecCCCC--CCchhHHHHHHHHHhcCCCceeeEeccc--CCceEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR-----HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTL 534 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~-----~~~VAvK~l~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~L 534 (824)
++|++.+.||+|+||+||+|... ++.||||+++.... .....+.+|+.+|++++|||||++++++ .+..||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 46999999999999999999862 46899999975422 1234688999999999999999999998 456899
Q ss_pred EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccc
Q 003384 535 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 614 (824)
Q Consensus 535 V~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~ 614 (824)
|||||+||+|.++|.. ...+++..+..|+.||+.||.|||+ ++||||||||+|||++.+|.+||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 9999999999999954 3469999999999999999999999 899999999999999999999999999998654
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCC
Q 003384 615 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 694 (824)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~ 694 (824)
..... .....||+.|||||++.+..|+.++|||||||+||||+||++||...+......... .. .
T Consensus 178 ~~~~~--------~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~--~~-----~ 242 (304)
T 3ubd_A 178 DHEKK--------AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMIL--KA-----K 242 (304)
T ss_dssp ---CC--------CCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HC-----C
T ss_pred CCCcc--------ccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHH--cC-----C
Confidence 33211 134579999999999999999999999999999999999999998765433221111 11 1
Q ss_pred CCCChhhHHHHHHHHHHHhhhccCCCCCh
Q 003384 695 GDWPFVQAEQLANLAMRCCEMSRKSRPEL 723 (824)
Q Consensus 695 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 723 (824)
..+|...+.++.+|+.+||+.||.+||+.
T Consensus 243 ~~~p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 243 LGMPQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred CCCCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 23455567899999999999999999996
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-47 Score=409.49 Aligned_cols=250 Identities=24% Similarity=0.356 Sum_probs=184.3
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccCC-----------
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACPE----------- 530 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~L~g~~~~----------- 530 (824)
+|+..+.||+|+||+||+|.+. +..||||++...... ..+.+.+|+.+|++|+|||||+++++|.+
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~ 85 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS 85 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence 5888999999999999999986 689999998754322 23568899999999999999999998732
Q ss_pred ---ceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecc
Q 003384 531 ---VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDF 607 (824)
Q Consensus 531 ---~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DF 607 (824)
..|+|||||+||+|.+++.........++..++.|+.||+.||.|||+ ++||||||||+||||+.+|.+||+||
T Consensus 86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 86 PKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp -CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred CCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEEccC
Confidence 268999999999999999765544556777889999999999999999 89999999999999999999999999
Q ss_pred ccccccccccccCCC----ccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhh
Q 003384 608 GISRFLSQNEISSNN----TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT 683 (824)
Q Consensus 608 Gla~~~~~~~~~~~~----~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~ 683 (824)
|+|+.+......... ......+..+||+.|||||++.+..|+.++|||||||+||||++ ||.........+..
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~ 239 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTD 239 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHH
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHH
Confidence 999977654322111 00111244679999999999999999999999999999999997 77654332221111
Q ss_pred hccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 684 GKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 684 ~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
. .. ......+....+.+.+|+.+||+.+|.+||++.+
T Consensus 240 ~--~~---~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~e 276 (299)
T 4g31_A 240 V--RN---LKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAIN 276 (299)
T ss_dssp H--HT---TCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred H--hc---CCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHH
Confidence 0 00 0001111223356788999999999999999843
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-45 Score=408.57 Aligned_cols=251 Identities=24% Similarity=0.315 Sum_probs=194.8
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEecccC--------C
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP--------E 530 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--------~ 530 (824)
.++|.+.+.||+|+||+||+|.+. +..||||++...... ....+.+|+.+|+.|+|||||++++++. .
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 357999999999999999999986 689999999754322 2346889999999999999999999863 3
Q ss_pred ceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccc
Q 003384 531 VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS 610 (824)
Q Consensus 531 ~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla 610 (824)
..|||||||. |+|.+++. ...++++..+..|+.||+.||.|||+ +|||||||||+|||++.+|.+||+|||+|
T Consensus 133 ~~~ivmE~~~-g~L~~~i~---~~~~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIH---SSQPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp CEEEEEECCS-EEHHHHHT---SSSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEeCCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeeccee
Confidence 5799999996 67999984 34579999999999999999999999 89999999999999999999999999999
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccC-CCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhh----hc
Q 003384 611 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT----GK 685 (824)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~----~~ 685 (824)
+.+......... .....+||+.|+|||++.+. .|+.++||||+|||||||+||++||.+.+........ +.
T Consensus 206 ~~~~~~~~~~~~----~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~ 281 (398)
T 4b99_A 206 RGLCTSPAEHQY----FMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGT 281 (398)
T ss_dssp BCC-------CC----CCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCC
T ss_pred eecccCcccccc----ccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCC
Confidence 876543221111 12456799999999998875 5799999999999999999999999876554322211 10
Q ss_pred ccc-------------ccC--CCCCCCC-----hhhHHHHHHHHHHHhhhccCCCCChH
Q 003384 686 LKN-------------LLD--PLAGDWP-----FVQAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 686 ~~~-------------~ld--~~~~~~p-----~~~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
... .+. +.....+ ...+.++.+|+.+||..||.+|||+.
T Consensus 282 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~ 340 (398)
T 4b99_A 282 PSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAA 340 (398)
T ss_dssp CCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred CChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHH
Confidence 000 000 0000001 12356789999999999999999984
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=390.92 Aligned_cols=201 Identities=28% Similarity=0.379 Sum_probs=166.3
Q ss_pred hhcCCCCccceeeecCceEEEEEEEC-----CeEEEEEEecCCCCCCchhHHHHHHHHHhc-CCCceeeEeccc--CCce
Q 003384 461 GATHNFDPSLKIGEGGYGSIYKGLLR-----HMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGAC--PEVW 532 (824)
Q Consensus 461 ~~~~~f~~~~~LG~G~fG~Vykg~~~-----~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l-~HpnIv~L~g~~--~~~~ 532 (824)
...+.|.+.++||+|+||+||+|..+ +..||||++.... ....+.+|+++|+.+ +|||||++++++ .+..
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 34567999999999999999999763 4679999986542 345788999999998 699999999988 4578
Q ss_pred EEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCC-Ccceeecccccc
Q 003384 533 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN-FVSKLSDFGISR 611 (824)
Q Consensus 533 ~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~-~~vKL~DFGla~ 611 (824)
|||||||+||+|.+++ ..+++..+..++.|++.||.|||+ +|||||||||+||||+.+ +.+||+|||+|+
T Consensus 96 ~lvmE~~~g~~L~~~~------~~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 96 VIAMPYLEHESFLDIL------NSLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp EEEEECCCCCCHHHHH------TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEeCCCcccHHHHH------cCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 9999999999999998 248999999999999999999999 899999999999999876 899999999998
Q ss_pred ccccccccCCC--------------------ccccccCCCCCCcccCChhhhccC-CCCcchhHHhHHHHHHHHHhCCCC
Q 003384 612 FLSQNEISSNN--------------------TTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPA 670 (824)
Q Consensus 612 ~~~~~~~~~~~--------------------~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDVwSlGvvL~ELltG~~P 670 (824)
........... ......+..+||+.|+|||++.+. .|+.++||||+||+||||+||++|
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence 65433211000 000112345799999999999875 589999999999999999999999
Q ss_pred CC
Q 003384 671 LG 672 (824)
Q Consensus 671 f~ 672 (824)
|.
T Consensus 247 f~ 248 (361)
T 4f9c_A 247 FY 248 (361)
T ss_dssp SS
T ss_pred CC
Confidence 94
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=413.37 Aligned_cols=245 Identities=21% Similarity=0.335 Sum_probs=201.2
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEec
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL 539 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey~ 539 (824)
++|.+.+.||+|+||.||+|..+ +..||||++..........+.+|+.+|+.|+|||||+|+++|. ...|||||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 47999999999999999999986 5889999997655444567899999999999999999999984 4689999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCC--Ccceeecccccccccccc
Q 003384 540 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN--FVSKLSDFGISRFLSQNE 617 (824)
Q Consensus 540 ~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~--~~vKL~DFGla~~~~~~~ 617 (824)
+||+|.++|.. ....|++..+..|+.||+.||.|||+ ++|+||||||+||||+.+ +.+||+|||+|+.+....
T Consensus 237 ~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 237 SGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp CCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred CCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 99999999853 33569999999999999999999999 899999999999999854 899999999999765432
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCC
Q 003384 618 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 697 (824)
Q Consensus 618 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~ 697 (824)
.. ....||+.|||||++.+..|+.++|||||||+||||++|++||..................+ ....
T Consensus 312 ~~---------~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~---~~~~ 379 (573)
T 3uto_A 312 SV---------KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNM---DDSA 379 (573)
T ss_dssp EE---------EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCC---CSGG
T ss_pred ce---------eeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCC---Cccc
Confidence 11 23469999999999999999999999999999999999999998765543322211111101 1111
Q ss_pred ChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 698 PFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 698 p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
+...+..+.+|+.+||+.||.+||++.+
T Consensus 380 ~~~~s~~~~dli~~~L~~dp~~R~t~~e 407 (573)
T 3uto_A 380 FSGISEDGKDFIRKLLLADPNTRMTIHQ 407 (573)
T ss_dssp GTTSCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHH
Confidence 2234678999999999999999999843
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=414.25 Aligned_cols=239 Identities=26% Similarity=0.345 Sum_probs=192.4
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCC---CCCchhHHHH---HHHHHhcCCCceeeEecccC--CceE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQE---IDILSKIRHPNLVTLVGACP--EVWT 533 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~---~~~~~~f~~E---i~iL~~l~HpnIv~L~g~~~--~~~~ 533 (824)
++|.+.++||+|+||+||+|... +..||||++.... ......+.+| +.+++.++|||||+|+++|. +..|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 36899999999999999999986 5889999996431 1223334444 56667779999999999984 5789
Q ss_pred EEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccc
Q 003384 534 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 613 (824)
Q Consensus 534 LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~ 613 (824)
||||||+||+|.++|... ..|++..+..|+.||+.||.|||+ +|||||||||+||||+.+|++||+|||+|+.+
T Consensus 269 lVmEy~~GGdL~~~l~~~---~~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEECCCCSCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceeeec
Confidence 999999999999999643 469999999999999999999999 89999999999999999999999999999876
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhcc-CCCCcchhHHhHHHHHHHHHhCCCCCCCchHH-HHHHhhhccccccC
Q 003384 614 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEV-QYALDTGKLKNLLD 691 (824)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~-~~~~~~~~~~~~ld 691 (824)
..... ...+||+.|||||++.. ..|+.++|||||||+||||+||++||...... ...+......
T Consensus 343 ~~~~~----------~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~---- 408 (689)
T 3v5w_A 343 SKKKP----------HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT---- 408 (689)
T ss_dssp SSCCC----------CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHH----
T ss_pred CCCCC----------CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcC----
Confidence 53321 34579999999999975 57999999999999999999999999653211 0111111111
Q ss_pred CCCCCCChhhHHHHHHHHHHHhhhccCCCCCh
Q 003384 692 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 723 (824)
Q Consensus 692 ~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 723 (824)
....+|...+.++.+|+.+||+.||.+|++.
T Consensus 409 -~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~ 439 (689)
T 3v5w_A 409 -MAVELPDSFSPELRSLLEGLLQRDVNRRLGC 439 (689)
T ss_dssp -CCCCCCTTSCHHHHHHHHHHTCSCGGGCTTC
T ss_pred -CCCCCCccCCHHHHHHHHHHccCCHhHCCCC
Confidence 1123455667899999999999999999984
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=373.12 Aligned_cols=275 Identities=39% Similarity=0.656 Sum_probs=223.9
Q ss_pred CCCChhhHhhhcCCCCccceeeecCceEEEEEEEC-CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC-
Q 003384 452 SDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP- 529 (824)
Q Consensus 452 ~~~~~~ei~~~~~~f~~~~~LG~G~fG~Vykg~~~-~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~- 529 (824)
..+.+.++...+++|...+.||+|+||.||+|.+. +..||||++..........+.+|+.+++.++||||++++++|.
T Consensus 27 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 106 (321)
T 2qkw_B 27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE 106 (321)
T ss_dssp ---CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred eeecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 34556677888999999999999999999999976 6889999988765555678999999999999999999999984
Q ss_pred -CceEEEEEecCCCChhhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecc
Q 003384 530 -EVWTLVYEYLPNGSLEDRLSCKD-NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDF 607 (824)
Q Consensus 530 -~~~~LV~Ey~~ggsL~~~L~~~~-~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DF 607 (824)
+..++||||+++|+|.+++.... ....+++..++.++.+++.||.|||+ +||+||||||+|||++.++.+||+||
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Df 183 (321)
T 2qkw_B 107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDF 183 (321)
T ss_dssp TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCC
T ss_pred CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeec
Confidence 46899999999999999996442 23469999999999999999999999 89999999999999999999999999
Q ss_pred ccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchH---------HH
Q 003384 608 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE---------VQ 678 (824)
Q Consensus 608 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~---------~~ 678 (824)
|+++.......... .....||+.|+|||++.+..++.++|||||||++|+|+||++||..... ..
T Consensus 184 g~~~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~ 257 (321)
T 2qkw_B 184 GISKKGTELDQTHL------STVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAV 257 (321)
T ss_dssp TTCEECSSSSCCCC------BCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTH
T ss_pred cccccccccccccc------ccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhh
Confidence 99986543221111 1234589999999999999999999999999999999999999964321 11
Q ss_pred HHHhhhccccccCCC-CCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHh
Q 003384 679 YALDTGKLKNLLDPL-AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 736 (824)
Q Consensus 679 ~~~~~~~~~~~ld~~-~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~ 736 (824)
.....+.+...+++. ....+...+..+.+++.+||+.+|.+||++ .++++.|+.+..
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-~ell~~L~~~l~ 315 (321)
T 2qkw_B 258 ESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSM-GDVLWKLEYALR 315 (321)
T ss_dssp HHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHH
T ss_pred hccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCH-HHHHHHHHHHhh
Confidence 122233344444442 334566778899999999999999999999 778888887755
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=367.85 Aligned_cols=276 Identities=41% Similarity=0.702 Sum_probs=226.6
Q ss_pred ccCCCChhhHhhhcCCCCcc------ceeeecCceEEEEEEECCeEEEEEEecCCCC----CCchhHHHHHHHHHhcCCC
Q 003384 450 FFSDFSFSEIEGATHNFDPS------LKIGEGGYGSIYKGLLRHMQVAIKMLHPHSL----QGPSEFQQEIDILSKIRHP 519 (824)
Q Consensus 450 ~~~~~~~~ei~~~~~~f~~~------~~LG~G~fG~Vykg~~~~~~VAvK~l~~~~~----~~~~~f~~Ei~iL~~l~Hp 519 (824)
.+..|++.++..++.+|+.. +.||+|+||.||+|.+.+..||||++..... .....+.+|+.+++.++||
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 35678999999999999887 8999999999999999999999999875422 1235688999999999999
Q ss_pred ceeeEecccC--CceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEec
Q 003384 520 NLVTLVGACP--EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD 597 (824)
Q Consensus 520 nIv~L~g~~~--~~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld 597 (824)
||+++++++. +..++||||+++|+|.+++.......++++..+..++.+++.||.|||+ +||+||||||+|||++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nili~ 167 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLD 167 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEC
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEEEc
Confidence 9999999984 4689999999999999999765556679999999999999999999999 8999999999999999
Q ss_pred CCCcceeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchH-
Q 003384 598 ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE- 676 (824)
Q Consensus 598 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~- 676 (824)
.++.+||+|||++.......... ......||+.|+|||++.+ .++.++|||||||++|+|+||++||.....
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~~~~~------~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 240 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKFAQTV------MTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREP 240 (307)
T ss_dssp TTCCEEECCCTTCEECCSCSSCE------ECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSS
T ss_pred CCCcEEEeecccccccccccccc------cccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcch
Confidence 99999999999998654322110 1133569999999998864 588999999999999999999999975322
Q ss_pred -----HHHHHh--hhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHh
Q 003384 677 -----VQYALD--TGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 736 (824)
Q Consensus 677 -----~~~~~~--~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~ 736 (824)
...... ...+...++......+...+..+.+++.+||+.+|.+||++ .++++.|+.+.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~-~~l~~~L~~l~~ 306 (307)
T 2nru_A 241 QLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDI-KKVQQLLQEMTA 306 (307)
T ss_dssp SBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCH-HHHHHHHHHHC-
T ss_pred HHHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCH-HHHHHHHHHHhc
Confidence 111111 11233444444556677788899999999999999999999 788888888754
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=372.84 Aligned_cols=264 Identities=30% Similarity=0.475 Sum_probs=206.1
Q ss_pred hhHhhhcCCCCccceeeecCceEEEEEEECCeEEEEEEecCCCCCC--chhHHHHHHHHHhcCCCceeeEecccC--Cce
Q 003384 457 SEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACP--EVW 532 (824)
Q Consensus 457 ~ei~~~~~~f~~~~~LG~G~fG~Vykg~~~~~~VAvK~l~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~ 532 (824)
.++.....+|...+.||+|+||.||+|.+.+..||||++....... ...+.+|+.+|++++||||+++++++. ...
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL 109 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence 3444455688999999999999999999999999999997654322 246889999999999999999999984 467
Q ss_pred EEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCc--eEeccccCCcEEecCCCcceeeccccc
Q 003384 533 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS--IVHGDLKPANILLDANFVSKLSDFGIS 610 (824)
Q Consensus 533 ~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~g--iiHrDLKp~NILld~~~~vKL~DFGla 610 (824)
++||||+++|+|.+++........+++..++.++.|++.||.|||+ ++ |+||||||+|||++.++.+||+|||++
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a 186 (309)
T 3p86_A 110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS 186 (309)
T ss_dssp EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC--
T ss_pred EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCCC
Confidence 9999999999999999644333358999999999999999999999 77 999999999999999999999999999
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhcccccc
Q 003384 611 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLL 690 (824)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~l 690 (824)
+........ .....||+.|+|||++.+..++.++|||||||++|+|+||+.||..............
T Consensus 187 ~~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~----- 253 (309)
T 3p86_A 187 RLKASTFLS--------SKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGF----- 253 (309)
T ss_dssp -----------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHH-----
T ss_pred ccccccccc--------cccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-----
Confidence 854432211 1334699999999999999999999999999999999999999986654332221110
Q ss_pred CCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhh
Q 003384 691 DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 737 (824)
Q Consensus 691 d~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~~ 737 (824)
.......+...+..+.+|+.+||+.+|.+||++ .++++.|+.+...
T Consensus 254 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-~~ll~~L~~~~~~ 299 (309)
T 3p86_A 254 KCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSF-ATIMDLLRPLIKS 299 (309)
T ss_dssp SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHC-
T ss_pred cCCCCCCCccCCHHHHHHHHHHccCChhhCcCH-HHHHHHHHHHHHh
Confidence 111223445567789999999999999999999 7788888887653
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=372.15 Aligned_cols=276 Identities=36% Similarity=0.638 Sum_probs=221.9
Q ss_pred ccCCCChhhHhhhcCCCCccceeeecCceEEEEEEEC-CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecc
Q 003384 450 FFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGA 527 (824)
Q Consensus 450 ~~~~~~~~ei~~~~~~f~~~~~LG~G~fG~Vykg~~~-~~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~L~g~ 527 (824)
....|++.++...+++|...+.||+|+||.||+|... +..||||++...... ....+.+|+.+++.++||||++++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 3567889999999999999999999999999999875 688999998765332 23479999999999999999999999
Q ss_pred cC--CceEEEEEecCCCChhhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCccee
Q 003384 528 CP--EVWTLVYEYLPNGSLEDRLSCKD-NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKL 604 (824)
Q Consensus 528 ~~--~~~~LV~Ey~~ggsL~~~L~~~~-~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL 604 (824)
|. ...++||||+++|+|.+++.... ...++++..+..|+.+++.||.|||+.+..||+||||||+|||++.++.+||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence 84 46789999999999999996543 3456999999999999999999999933339999999999999999999999
Q ss_pred eccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchH--------
Q 003384 605 SDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE-------- 676 (824)
Q Consensus 605 ~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~-------- 676 (824)
+|||++......... ......||+.|+|||++.+..++.++|||||||++|+|+||++||.....
T Consensus 176 ~Dfg~~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 248 (326)
T 3uim_A 176 GDFGLAKLMDYKDTH-------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 248 (326)
T ss_dssp CCCSSCEECCSSSSC-------EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBH
T ss_pred ccCccccccCccccc-------ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhH
Confidence 999999876433211 11344699999999999999999999999999999999999999952211
Q ss_pred ---HHHHHhhhccccccCC-CCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHH
Q 003384 677 ---VQYALDTGKLKNLLDP-LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP 733 (824)
Q Consensus 677 ---~~~~~~~~~~~~~ld~-~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~ 733 (824)
..............+. ....++...+..+.+++.+||+.+|.+||++ ++|++.|+.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-~ell~~L~~ 308 (326)
T 3uim_A 249 LDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKM-SEVVRMLEG 308 (326)
T ss_dssp HHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCH-HHHHHHHHT
T ss_pred HHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCH-HHHHHHhcC
Confidence 0000111222222222 2345567778899999999999999999999 777777764
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=366.43 Aligned_cols=257 Identities=27% Similarity=0.440 Sum_probs=205.6
Q ss_pred CCCCccceeeecCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccCCceEEEEEecCCCC
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTLVYEYLPNGS 543 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~~~~~LV~Ey~~ggs 543 (824)
++|...+.||+|+||.||+|.+.+..||||++... .....|.+|+.+|++++||||++++|++.+..++||||+++|+
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~lv~e~~~~~~ 85 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLNPVCLVMEYAEGGS 85 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTTTTEEEEECCTTCB
T ss_pred hHeeeeeEeecCCCceEEEEEECCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCcEEEEEcCCCCC
Confidence 46788899999999999999999999999998643 2346799999999999999999999999888999999999999
Q ss_pred hhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCc-ceeeccccccccccccccCCC
Q 003384 544 LEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV-SKLSDFGISRFLSQNEISSNN 622 (824)
Q Consensus 544 L~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~-vKL~DFGla~~~~~~~~~~~~ 622 (824)
|.+++........+++..++.++.+++.||.|||+.+++||+||||||+|||++.++. +||+|||++.......
T Consensus 86 L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~----- 160 (307)
T 2eva_A 86 LYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM----- 160 (307)
T ss_dssp HHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------------
T ss_pred HHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc-----
Confidence 9999976554456889999999999999999999977678999999999999998886 7999999997543221
Q ss_pred ccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCChhhH
Q 003384 623 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQA 702 (824)
Q Consensus 623 ~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~ 702 (824)
....||+.|+|||++.+..++.++|||||||++|+|+||++||............... .......+...+
T Consensus 161 ------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~ 230 (307)
T 2eva_A 161 ------TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVH----NGTRPPLIKNLP 230 (307)
T ss_dssp ----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHH----TTCCCCCBTTCC
T ss_pred ------ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHh----cCCCCCcccccC
Confidence 2335899999999999999999999999999999999999999743211111100000 011112233456
Q ss_pred HHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhhC
Q 003384 703 EQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC 738 (824)
Q Consensus 703 ~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~~~ 738 (824)
..+.+++.+||+.+|.+||++ +++++.|+.+....
T Consensus 231 ~~l~~li~~~l~~dp~~Rps~-~ell~~L~~~~~~~ 265 (307)
T 2eva_A 231 KPIESLMTRCWSKDPSQRPSM-EEIVKIMTHLMRYF 265 (307)
T ss_dssp HHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHGGGC
T ss_pred HHHHHHHHHHhcCChhhCcCH-HHHHHHHHHHHHhc
Confidence 789999999999999999999 78888888876543
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=373.55 Aligned_cols=292 Identities=22% Similarity=0.361 Sum_probs=215.2
Q ss_pred CCCCccceeeecCceEEEEEEECC------eEEEEEEecCCC-CCCchhHHHHHHHHHhcCCCceeeEecccC-CceEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLRH------MQVAIKMLHPHS-LQGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLV 535 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~~------~~VAvK~l~~~~-~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~-~~~~LV 535 (824)
.+|...+.||+|+||.||+|.+.. ..||+|.+.... ......|.+|+.++++++||||++++++|. ...++|
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~v 94 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 94 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSSEEEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEE
Confidence 468899999999999999998742 247889886533 234567999999999999999999999984 467899
Q ss_pred EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccc
Q 003384 536 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 615 (824)
Q Consensus 536 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~ 615 (824)
|||+++|+|.+++... ...+++..++.|+.+++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.+..
T Consensus 95 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 95 TQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred EEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 9999999999999643 3569999999999999999999999 8999999999999999999999999999987654
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchH--HHHHHhhhccccccCC
Q 003384 616 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKE--VQYALDTGKLKNLLDP 692 (824)
Q Consensus 616 ~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~--~~~~~~~~~~~~~ld~ 692 (824)
...... .....||+.|+|||++.+..++.++|||||||++|||+| |++||..... ....+..+
T Consensus 170 ~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-------- 235 (327)
T 3poz_A 170 EEKEYH------AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-------- 235 (327)
T ss_dssp TCC-------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT--------
T ss_pred Cccccc------ccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcC--------
Confidence 332111 123457899999999999999999999999999999999 9999975432 21212211
Q ss_pred CCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhhC----CCCCCccCCCCCCCCCCCCCcccchhhhcc
Q 003384 693 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC----GGSTSYRLGSEERCEPPPYFTCPIFQEVMQ 768 (824)
Q Consensus 693 ~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~~~----~~~~~~~~~~e~~~~~P~~f~cPi~~evm~ 768 (824)
.....+...+..+.+++.+||+.+|.+||++ .++++.|+.+.... ....... .......++.|.+++..+.+.
T Consensus 236 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-~ell~~l~~~~~~~~~~~~~~~~~~--~~~~~p~~~~~~~~~~~~~~~ 312 (327)
T 3poz_A 236 ERLPQPPICTIDVYMIMVKCWMIDADSRPKF-RELIIEFSKMARDPQRYLVIQGDER--MHLPSPTDSNFYRALMDEEDM 312 (327)
T ss_dssp CCCCCCTTBCHHHHHHHHHHTCSCGGGSCCH-HHHHHHHHHHHTSHHHHBCCTTGGG--CCCCCTTTCHHHHHHHC----
T ss_pred CCCCCCccCCHHHHHHHHHHcCCChhhCCCH-HHHHHHHHHHHhhhhhhhhhcCCCc--cCCCCCCchHHHHhccccccc
Confidence 1122345566789999999999999999999 67778887765421 1111100 011112234456777777777
Q ss_pred CCccccCCc
Q 003384 769 DPHVAADGF 777 (824)
Q Consensus 769 dPvi~~~g~ 777 (824)
|+++..|++
T Consensus 313 ~~~~~~d~~ 321 (327)
T 3poz_A 313 DDVVDADEY 321 (327)
T ss_dssp --CCCHHHH
T ss_pred ccccCHHHc
Confidence 887766654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=362.15 Aligned_cols=244 Identities=25% Similarity=0.379 Sum_probs=202.9
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--CCceEEEEEe
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 538 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~Ey 538 (824)
.++|...+.||+|+||.||+|.+. +..||||++........+.+.+|+.+++.++||||++++++| .+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 357999999999999999999864 688999999776655667799999999999999999999987 4578999999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccc
Q 003384 539 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 618 (824)
Q Consensus 539 ~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 618 (824)
++||+|.+++.. ..+++..+..++.+++.||.|||+ +||+||||||+|||++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp CTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence 999999999853 258899999999999999999999 8999999999999999999999999999986654321
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCC
Q 003384 619 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWP 698 (824)
Q Consensus 619 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p 698 (824)
. .....||+.|+|||++.+..++.++|||||||++|+|+||++||................ ......+
T Consensus 172 ~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~----~~~~~~~ 239 (297)
T 3fxz_A 172 K--------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG----TPELQNP 239 (297)
T ss_dssp C--------BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC----SCCCSCG
T ss_pred c--------cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC----CCCCCCc
Confidence 1 134569999999999999999999999999999999999999997665433222111000 0111234
Q ss_pred hhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 699 FVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 699 ~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
...+..+.+|+.+||+.+|.+||++.+
T Consensus 240 ~~~~~~~~~li~~~l~~dp~~Rps~~e 266 (297)
T 3fxz_A 240 EKLSAIFRDFLNRCLEMDVEKRGSAKE 266 (297)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred cccCHHHHHHHHHHccCChhHCcCHHH
Confidence 456678999999999999999999943
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=368.25 Aligned_cols=259 Identities=27% Similarity=0.420 Sum_probs=207.6
Q ss_pred cCCCCccceeeecCceEEEEEEEC-----CeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccCC--ceEE
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR-----HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTL 534 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~-----~~~VAvK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~~--~~~L 534 (824)
..+|.+.+.||+|+||.||+|.+. +..||||++..... .....|.+|+.+|+.++||||++++++|.+ ..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 346888999999999999999984 35699999975432 223568999999999999999999999854 5889
Q ss_pred EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccc
Q 003384 535 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 614 (824)
Q Consensus 535 V~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~ 614 (824)
||||+++|+|.+++.. ....+++..++.|+.+++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.+.
T Consensus 128 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 128 VTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeeCCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 9999999999999953 33569999999999999999999999 899999999999999999999999999998765
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHHHHhhhccccccCCC
Q 003384 615 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPL 693 (824)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~~~~~~~~~ld~~ 693 (824)
...... .......||+.|+|||++.+..++.++|||||||++|+|++ |++||............. ...
T Consensus 203 ~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~------~~~ 271 (325)
T 3kul_A 203 DDPDAA-----YTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE------EGY 271 (325)
T ss_dssp ----CC-----EECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH------TTC
T ss_pred cCccce-----eeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH------cCC
Confidence 432211 11133457889999999999999999999999999999999 999997654332211111 111
Q ss_pred CCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhhC
Q 003384 694 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC 738 (824)
Q Consensus 694 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~~~ 738 (824)
....+...+..+.+|+.+||..+|.+||++ .++++.|+.+....
T Consensus 272 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~eil~~L~~l~~~~ 315 (325)
T 3kul_A 272 RLPAPMGCPHALHQLMLDCWHKDRAQRPRF-SQIVSVLDALIRSP 315 (325)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHSC
T ss_pred CCCCCCCcCHHHHHHHHHHccCChhhCcCH-HHHHHHHHHHHhCc
Confidence 122344566789999999999999999999 78889999887643
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=361.97 Aligned_cols=264 Identities=23% Similarity=0.393 Sum_probs=206.6
Q ss_pred cCCCCccceeeecCceEEEEEEE------CCeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC----Cce
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLL------RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP----EVW 532 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~------~~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~----~~~ 532 (824)
.++|...+.||+|+||.||+|.+ .+..||||++..........+.+|+.+|+.++||||++++++|. ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 35788999999999999999985 35789999997654434467899999999999999999999873 347
Q ss_pred EEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccc
Q 003384 533 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 612 (824)
Q Consensus 533 ~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~ 612 (824)
++||||+++|+|.+++... ...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++..
T Consensus 89 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 9999999999999999643 2358999999999999999999999 8999999999999999999999999999987
Q ss_pred cccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHH-hhh-------
Q 003384 613 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYAL-DTG------- 684 (824)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~-~~~------- 684 (824)
......... ......||..|+|||++.+..++.++|||||||++|+|+||..||.......... ...
T Consensus 164 ~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (295)
T 3ugc_A 164 LPQDKEFFK-----VKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 238 (295)
T ss_dssp -----------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHH
T ss_pred ccCCcceee-----eccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhH
Confidence 654322111 1133457889999999999999999999999999999999999987543221110 000
Q ss_pred --ccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhh
Q 003384 685 --KLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 737 (824)
Q Consensus 685 --~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~~ 737 (824)
....+........+...+..+.+|+.+||+.+|.+||++ +++++.|+.+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~el~~~L~~l~~~ 292 (295)
T 3ugc_A 239 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSF-RDLALRVDQIRDN 292 (295)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCH-HHHHHHHHHHHHC
T ss_pred HHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCH-HHHHHHHHHHHHh
Confidence 001111112233455667899999999999999999999 7888999888653
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=361.97 Aligned_cols=257 Identities=23% Similarity=0.330 Sum_probs=198.7
Q ss_pred cCCCCccceeeecCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHh--cCCCceeeEecccC------CceEE
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSK--IRHPNLVTLVGACP------EVWTL 534 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~--l~HpnIv~L~g~~~------~~~~L 534 (824)
.++|...+.||+|+||.||+|.+.+..||||++... ....+..|.+++.. ++||||+++++++. ...++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~l 83 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL 83 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEE
Confidence 457899999999999999999999999999998653 34567778888877 79999999999862 24789
Q ss_pred EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHh--------hcCCCceEeccccCCcEEecCCCcceeec
Q 003384 535 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH--------SCKPHSIVHGDLKPANILLDANFVSKLSD 606 (824)
Q Consensus 535 V~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH--------~~~~~giiHrDLKp~NILld~~~~vKL~D 606 (824)
||||+++|+|.+++. ...+++..++.++.+++.||.||| + ++|+||||||+|||++.++.+||+|
T Consensus 84 v~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 84 ITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK---PAIAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp EECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB---CEEECSCCCGGGEEECTTSCEEECC
T ss_pred ehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCC---CCeecCCCChHhEEEcCCCCEEEee
Confidence 999999999999993 346999999999999999999999 6 8999999999999999999999999
Q ss_pred cccccccccccccCCCccccccCCCCCCcccCChhhhccC------CCCcchhHHhHHHHHHHHHhC----------CCC
Q 003384 607 FGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG------ELTPKSDVYSFGIILLRLLTG----------RPA 670 (824)
Q Consensus 607 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~------~~t~ksDVwSlGvvL~ELltG----------~~P 670 (824)
||+++.......... .......||+.|+|||++.+. .++.++|||||||++|||+|| ++|
T Consensus 157 fg~a~~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~p 232 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLD----VGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP 232 (301)
T ss_dssp CTTCEEEETTTTEEE----CCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred CCCeeeccccccccc----ccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccc
Confidence 999986654322111 111344799999999999876 455789999999999999999 888
Q ss_pred CCCchH---HHHHHhhhccccccCCC-C-CCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHH
Q 003384 671 LGITKE---VQYALDTGKLKNLLDPL-A-GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 734 (824)
Q Consensus 671 f~~~~~---~~~~~~~~~~~~~ld~~-~-~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l 734 (824)
|..... ...............+. . ...+...+..+.+|+.+||+.+|.+||++ .++++.|+.+
T Consensus 233 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-~~i~~~L~~i 300 (301)
T 3q4u_A 233 FYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTA-LRIKKTLTKI 300 (301)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCH-HHHHHHHHHH
T ss_pred ccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCH-HHHHHHHhcc
Confidence 843210 00000000000001111 1 01123466789999999999999999999 7788888764
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=360.60 Aligned_cols=241 Identities=25% Similarity=0.361 Sum_probs=199.7
Q ss_pred CCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--CCceEEEEEecCC
Q 003384 466 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPN 541 (824)
Q Consensus 466 f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~Ey~~g 541 (824)
|+....||+|+||.||+|... +..||||++........+.+.+|+.+++.++||||++++++| .+..++||||++|
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 126 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG 126 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence 666778999999999999885 689999999876666667899999999999999999999988 4578999999999
Q ss_pred CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCC
Q 003384 542 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 621 (824)
Q Consensus 542 gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 621 (824)
|+|.+++. ...+++..+..++.+++.||.|||+ +||+||||||+|||++.++.+||+|||++.........
T Consensus 127 ~~L~~~l~----~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~-- 197 (321)
T 2c30_A 127 GALTDIVS----QVRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-- 197 (321)
T ss_dssp CBHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC--
T ss_pred CCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccc--
Confidence 99999984 2469999999999999999999999 89999999999999999999999999999876543211
Q ss_pred CccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCChhh
Q 003384 622 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQ 701 (824)
Q Consensus 622 ~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~ 701 (824)
.....||+.|+|||++.+..++.++|||||||++|+|+||++||........... +.....+. ...+...
T Consensus 198 ------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~---~~~~~~~~-~~~~~~~ 267 (321)
T 2c30_A 198 ------RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR---LRDSPPPK-LKNSHKV 267 (321)
T ss_dssp ------BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH---HHHSSCCC-CTTGGGS
T ss_pred ------cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HhcCCCCC-cCccccC
Confidence 1345699999999999999999999999999999999999999976544332111 11111111 1122345
Q ss_pred HHHHHHHHHHHhhhccCCCCChHH
Q 003384 702 AEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 702 ~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
+..+.+++.+||+.+|.+||++.+
T Consensus 268 ~~~l~~li~~~l~~dp~~Rps~~e 291 (321)
T 2c30_A 268 SPVLRDFLERMLVRDPQERATAQE 291 (321)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred CHHHHHHHHHHccCChhhCcCHHH
Confidence 678999999999999999999943
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=371.95 Aligned_cols=257 Identities=24% Similarity=0.412 Sum_probs=208.5
Q ss_pred cCCCCccceeeecCceEEEEEEEC---------CeEEEEEEecCCCC-CCchhHHHHHHHHHhc-CCCceeeEecccC--
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR---------HMQVAIKMLHPHSL-QGPSEFQQEIDILSKI-RHPNLVTLVGACP-- 529 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~---------~~~VAvK~l~~~~~-~~~~~f~~Ei~iL~~l-~HpnIv~L~g~~~-- 529 (824)
..+|...+.||+|+||.||+|.+. +..||||++..... .....+.+|+.+|+.+ +||||++++++|.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 357888999999999999999863 24699999975432 1234688999999999 8999999999984
Q ss_pred CceEEEEEecCCCChhhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEe
Q 003384 530 EVWTLVYEYLPNGSLEDRLSCKDN-------------SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL 596 (824)
Q Consensus 530 ~~~~LV~Ey~~ggsL~~~L~~~~~-------------~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILl 596 (824)
+..++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEEE
Confidence 468999999999999999965431 2458999999999999999999999 899999999999999
Q ss_pred cCCCcceeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCch
Q 003384 597 DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITK 675 (824)
Q Consensus 597 d~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~ 675 (824)
+.++.+||+|||+++.+........ .....||+.|+|||++.+..++.++|||||||++|||+| |++||....
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~ 310 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKK------TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 310 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCT------TTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred CCCCCEEEccccCCcccCcccceec------ccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 9999999999999986654322111 133457899999999999999999999999999999999 999997543
Q ss_pred HH--HHHHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhh
Q 003384 676 EV--QYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 737 (824)
Q Consensus 676 ~~--~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~~ 737 (824)
.. ...+..+ .....|...+..+.+|+.+||+.+|.+||++ .++++.|+.+...
T Consensus 311 ~~~~~~~~~~~--------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~-~ell~~L~~il~~ 365 (370)
T 2psq_A 311 VEELFKLLKEG--------HRMDKPANCTNELYMMMRDCWHAVPSQRPTF-KQLVEDLDRILTL 365 (370)
T ss_dssp GGGHHHHHHTT--------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHH
T ss_pred HHHHHHHHhcC--------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCH-HHHHHHHHHHHHH
Confidence 21 1111111 1223345567789999999999999999999 7888888887654
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=351.32 Aligned_cols=254 Identities=25% Similarity=0.463 Sum_probs=209.7
Q ss_pred CCCCccceeeecCceEEEEEEEC-CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEecC
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLP 540 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~-~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey~~ 540 (824)
.+|...+.||+|+||.||+|.+. +..||||++.... ...+.+.+|+.++++++||||+++++++. ...++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 46888999999999999999985 5789999997643 34567999999999999999999999984 46899999999
Q ss_pred CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccC
Q 003384 541 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 620 (824)
Q Consensus 541 ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 620 (824)
+|+|.+++.. ....+++..++.++.+++.||.|||+ ++|+||||||+|||++.++.+||+|||++..........
T Consensus 89 ~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (269)
T 4hcu_A 89 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 163 (269)
T ss_dssp TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred CCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEecccccccccccccccc
Confidence 9999999953 33568999999999999999999999 899999999999999999999999999998665432211
Q ss_pred CCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHHHHhhhccccccCCCCCCCCh
Q 003384 621 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPF 699 (824)
Q Consensus 621 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~ 699 (824)
.....||+.|+|||++.+..++.++|||||||++|+|+| |++||............. .......+.
T Consensus 164 -------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~------~~~~~~~~~ 230 (269)
T 4hcu_A 164 -------STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS------TGFRLYKPR 230 (269)
T ss_dssp -------TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH------TTCCCCCCT
T ss_pred -------ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh------cCccCCCCC
Confidence 133457889999999999999999999999999999999 999997654433211111 111122344
Q ss_pred hhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhh
Q 003384 700 VQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 737 (824)
Q Consensus 700 ~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~~ 737 (824)
..+..+.+++.+||+.+|.+||++ +++++.|+.+...
T Consensus 231 ~~~~~~~~li~~~l~~~p~~Rps~-~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 231 LASTHVYQIMNHCWRERPEDRPAF-SRLLRQLAEIAES 267 (269)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHC
T ss_pred cCCHHHHHHHHHHccCCcccCcCH-HHHHHHHHHHHHc
Confidence 456789999999999999999999 7888888887653
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=368.30 Aligned_cols=265 Identities=22% Similarity=0.347 Sum_probs=203.6
Q ss_pred hhcCCCCccceeeecCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccCC------ceEE
Q 003384 461 GATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPE------VWTL 534 (824)
Q Consensus 461 ~~~~~f~~~~~LG~G~fG~Vykg~~~~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~~------~~~L 534 (824)
-..++|...++||+|+||.||+|.+.+..||||++.... .....+..|+.+|++++||||++++++|.+ .+++
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cchhhchhhheecccCceEEEEEEECCCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 344579999999999999999999999999999986532 122346678889999999999999999843 2689
Q ss_pred EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhc-------CCCceEeccccCCcEEecCCCcceeecc
Q 003384 535 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC-------KPHSIVHGDLKPANILLDANFVSKLSDF 607 (824)
Q Consensus 535 V~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~-------~~~giiHrDLKp~NILld~~~~vKL~DF 607 (824)
||||+++|+|.+++.. ..+++..+..++.|++.||.|||+. +..+|+||||||+|||++.++.+||+||
T Consensus 100 v~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF 175 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175 (322)
T ss_dssp EEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred EEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence 9999999999999953 3489999999999999999999992 1129999999999999999999999999
Q ss_pred ccccccccccccCCCccccccCCCCCCcccCChhhhccC-----CCCcchhHHhHHHHHHHHHhCCCCCCCchH-----H
Q 003384 608 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-----ELTPKSDVYSFGIILLRLLTGRPALGITKE-----V 677 (824)
Q Consensus 608 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-----~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~-----~ 677 (824)
|+++.+........ .....||+.|+|||++.+. .++.++|||||||++|||+||++||..... .
T Consensus 176 g~a~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~ 249 (322)
T 3soc_A 176 GLALKFEAGKSAGD------THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249 (322)
T ss_dssp TTCEEECTTSCCCC------CTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTT
T ss_pred CcccccccccCccc------cccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccch
Confidence 99987654332111 1335699999999999863 456688999999999999999999964211 0
Q ss_pred H---------HHHhhhccccccCCCCCC-C-ChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhh
Q 003384 678 Q---------YALDTGKLKNLLDPLAGD-W-PFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 737 (824)
Q Consensus 678 ~---------~~~~~~~~~~~ld~~~~~-~-p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~~ 737 (824)
. ..+..........+.... + +...+..+.+|+.+||+.+|.+||++ .++++.|+.+...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-~ell~~L~~l~~~ 319 (322)
T 3soc_A 250 EEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA-GCVGERITQMQRL 319 (322)
T ss_dssp HHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHH
T ss_pred hhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCH-HHHHHHHHHHHHH
Confidence 0 000000011111111111 1 12345679999999999999999999 7888999988764
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=359.16 Aligned_cols=258 Identities=26% Similarity=0.436 Sum_probs=203.9
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCC---chhHHHHHHHHHhcCCCceeeEecccC--CceEEE
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLV 535 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~---~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV 535 (824)
.++|...+.||+|+||.||+|.+. +..||||++....... ...+.+|+.+++.++||||+++++++. +..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 457999999999999999999875 5789999986544333 246889999999999999999999984 468899
Q ss_pred EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccc
Q 003384 536 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 615 (824)
Q Consensus 536 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~ 615 (824)
|||++||+|.+++... .++++..+..++.+++.||.|||+ +||+||||||+|||++.++.+||+|||+++.+..
T Consensus 90 ~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 9999999999999543 469999999999999999999999 8999999999999999999999999999987643
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCC
Q 003384 616 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG 695 (824)
Q Consensus 616 ~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~ 695 (824)
..... .....||+.|+|||++.+..++.++|||||||++|+|+||++||............ +.........
T Consensus 164 ~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~--~~~~~~~~~~ 234 (294)
T 4eqm_A 164 TSLTQ-------TNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKH--IQDSVPNVTT 234 (294)
T ss_dssp ------------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHH--HSSCCCCHHH
T ss_pred ccccc-------cCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH--hhccCCCcch
Confidence 32111 12346999999999999999999999999999999999999999876554332221 1111111111
Q ss_pred CCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHH
Q 003384 696 DWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 735 (824)
Q Consensus 696 ~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~ 735 (824)
..+...+..+.+++.+||+.+|.+||+..+++.+.|+.+.
T Consensus 235 ~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 235 DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 2233456789999999999999999966588877777543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=368.66 Aligned_cols=266 Identities=25% Similarity=0.367 Sum_probs=213.1
Q ss_pred CCChhhHhhhcCCCCccceeeecCceEEEEEEEC-------CeEEEEEEecCCCCC-CchhHHHHHHHHHhc-CCCceee
Q 003384 453 DFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKI-RHPNLVT 523 (824)
Q Consensus 453 ~~~~~ei~~~~~~f~~~~~LG~G~fG~Vykg~~~-------~~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l-~HpnIv~ 523 (824)
.+....+....++|...+.||+|+||.||+|.+. +..||||++...... ....+.+|+.++.++ +||||++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 3455666677789999999999999999999853 267999999754322 134689999999999 7999999
Q ss_pred EecccCC---ceEEEEEecCCCChhhhhhccCC-----------------------------------------------
Q 003384 524 LVGACPE---VWTLVYEYLPNGSLEDRLSCKDN----------------------------------------------- 553 (824)
Q Consensus 524 L~g~~~~---~~~LV~Ey~~ggsL~~~L~~~~~----------------------------------------------- 553 (824)
++++|.+ ..++||||+++|+|.+++.....
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 9999843 48899999999999999965432
Q ss_pred ----------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccc
Q 003384 554 ----------------SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 617 (824)
Q Consensus 554 ----------------~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 617 (824)
...+++..++.|+.|++.||.|||+ ++|+||||||+||||+.++.+||+|||+++.+....
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 1228999999999999999999999 899999999999999999999999999998664332
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchH---HHHHHhhhccccccCCC
Q 003384 618 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKE---VQYALDTGKLKNLLDPL 693 (824)
Q Consensus 618 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~---~~~~~~~~~~~~~ld~~ 693 (824)
... ......||+.|+|||++.+..++.++|||||||++|+|+| |++||..... ....+..+ .
T Consensus 248 ~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~--------~ 313 (359)
T 3vhe_A 248 DYV------RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG--------T 313 (359)
T ss_dssp TCE------EC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHT--------C
T ss_pred cch------hccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcC--------C
Confidence 111 1134458999999999999999999999999999999998 9999975432 22222221 1
Q ss_pred CCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHh
Q 003384 694 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 736 (824)
Q Consensus 694 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~ 736 (824)
....+...+..+.+++.+||+.+|.+||++ +++++.|+.+..
T Consensus 314 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-~ell~~L~~~~~ 355 (359)
T 3vhe_A 314 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTF-SELVEHLGNLLQ 355 (359)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCCCH-HHHHHHHHHHHH
Confidence 122344556789999999999999999999 788888887764
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=361.90 Aligned_cols=265 Identities=23% Similarity=0.406 Sum_probs=206.6
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEe
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY 538 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey 538 (824)
.++|...+.||+|+||.||+|.+. +..||+|++..........|.+|+.+++.++||||++++++|. ...++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 346888999999999999999986 5889999986654444567999999999999999999999984 568899999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccc
Q 003384 539 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 618 (824)
Q Consensus 539 ~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 618 (824)
+++|+|.+++... ...+++..+..|+.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 89 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 89 IKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp CTTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 9999999999643 3569999999999999999999999 8999999999999999999999999999987654432
Q ss_pred cCCCc------cccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCC
Q 003384 619 SSNNT------TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDP 692 (824)
Q Consensus 619 ~~~~~------~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~ 692 (824)
..... .........||+.|+|||++.+..++.++|||||||++|+|++|.+||........... ......++
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~-~~~~~~~~- 241 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG-LNVRGFLD- 241 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS-BCHHHHHH-
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh-hhhhcccc-
Confidence 21100 00011245799999999999999999999999999999999999999853211000000 00000000
Q ss_pred CCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhh
Q 003384 693 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 737 (824)
Q Consensus 693 ~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~~ 737 (824)
...+...+..+.+++.+||+.+|.+||++ .++.+.|+.+...
T Consensus 242 --~~~~~~~~~~l~~li~~~l~~dP~~Rps~-~~l~~~L~~l~~~ 283 (310)
T 3s95_A 242 --RYCPPNCPPSFFPITVRCCDLDPEKRPSF-VKLEHWLETLRMH 283 (310)
T ss_dssp --HTCCTTCCTTHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHH
T ss_pred --ccCCCCCCHHHHHHHHHHccCChhhCcCH-HHHHHHHHHHHHh
Confidence 11233445679999999999999999999 7888999988764
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=363.91 Aligned_cols=261 Identities=26% Similarity=0.464 Sum_probs=211.3
Q ss_pred hHhhhcCCCCccceeeecCceEEEEEEECC-------eEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccC
Q 003384 458 EIEGATHNFDPSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP 529 (824)
Q Consensus 458 ei~~~~~~f~~~~~LG~G~fG~Vykg~~~~-------~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~L~g~~~ 529 (824)
.+....++|...+.||+|+||.||+|.+.+ ..||||++...... ....|.+|+.+++.++||||++++++|.
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 344456789999999999999999998864 78999999754322 1356899999999999999999999984
Q ss_pred --CceEEEEEecCCCChhhhhhccCC---------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEe
Q 003384 530 --EVWTLVYEYLPNGSLEDRLSCKDN---------------------SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 586 (824)
Q Consensus 530 --~~~~LV~Ey~~ggsL~~~L~~~~~---------------------~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiH 586 (824)
+..++||||+++|+|.+++..... ...+++..++.|+.||+.||.|||+ ++|+|
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH 197 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVH 197 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeec
Confidence 468999999999999999965321 2579999999999999999999999 89999
Q ss_pred ccccCCcEEecCCCcceeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh
Q 003384 587 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 666 (824)
Q Consensus 587 rDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt 666 (824)
|||||+|||++.++.+||+|||+++.......... .....||+.|+|||++.+..++.++|||||||++|+|+|
T Consensus 198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t 271 (343)
T 1luf_A 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA------DGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271 (343)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----------CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred CCCCcceEEECCCCeEEEeecCCCcccccCccccc------cCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHh
Confidence 99999999999999999999999986644321111 133468999999999999999999999999999999999
Q ss_pred -CCCCCCCchHHHH--HHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHh
Q 003384 667 -GRPALGITKEVQY--ALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 736 (824)
Q Consensus 667 -G~~Pf~~~~~~~~--~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~ 736 (824)
|..||........ .+..+. ....+...+..+.+|+.+||+.+|.+||++ .++++.|+.+..
T Consensus 272 ~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-~~~~~~L~~~~~ 335 (343)
T 1luf_A 272 YGLQPYYGMAHEEVIYYVRDGN--------ILACPENCPLELYNLMRLCWSKLPADRPSF-CSIHRILQRMCE 335 (343)
T ss_dssp TTCCTTTTSCHHHHHHHHHTTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHTTC
T ss_pred cCCCcCCCCChHHHHHHHhCCC--------cCCCCCCCCHHHHHHHHHHcccCcccCCCH-HHHHHHHHHHHh
Confidence 9999976543221 122221 122344556789999999999999999999 778888887643
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=376.78 Aligned_cols=249 Identities=27% Similarity=0.461 Sum_probs=207.3
Q ss_pred cCCCCccceeeecCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC---CceEEEEEec
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP---EVWTLVYEYL 539 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~---~~~~LV~Ey~ 539 (824)
..+|...+.||+|+||.||+|.+.+..||||+++... ....|.+|+.+|++++||||++++|+|. ...++||||+
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~ 269 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 269 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred hHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence 3468888999999999999999999999999997653 4578999999999999999999999872 2589999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccccc
Q 003384 540 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 619 (824)
Q Consensus 540 ~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 619 (824)
++|+|.+++.... ...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 270 ~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-- 343 (450)
T 1k9a_A 270 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 343 (450)
T ss_dssp TTCBHHHHHHHHC-TTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc--
Confidence 9999999996542 3347899999999999999999999 899999999999999999999999999998543211
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchH--HHHHHhhhccccccCCCCCC
Q 003384 620 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKE--VQYALDTGKLKNLLDPLAGD 696 (824)
Q Consensus 620 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~--~~~~~~~~~~~~~ld~~~~~ 696 (824)
....+|+.|+|||++.+..++.++|||||||+||||+| |+.||..... +...+..+ ....
T Consensus 344 ---------~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~--------~~~~ 406 (450)
T 1k9a_A 344 ---------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG--------YKMD 406 (450)
T ss_dssp ------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTT--------CCCC
T ss_pred ---------cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--------CCCC
Confidence 12357899999999999999999999999999999998 9999975432 22222222 1123
Q ss_pred CChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhh
Q 003384 697 WPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 737 (824)
Q Consensus 697 ~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~~ 737 (824)
.|...+..+.+|+.+||+.+|.+||++ .++.+.|+.+...
T Consensus 407 ~p~~~~~~l~~li~~cl~~dp~~Rpt~-~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 407 APDGCPPAVYDVMKNCWHLDAATRPTF-LQLREQLEHIRTH 446 (450)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHT
T ss_pred CCCcCCHHHHHHHHHHcCCChhHCcCH-HHHHHHHHHHHHh
Confidence 355667899999999999999999999 7788888887653
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=364.93 Aligned_cols=240 Identities=25% Similarity=0.381 Sum_probs=199.7
Q ss_pred hcCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEecccC--CceEEE
Q 003384 462 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLV 535 (824)
Q Consensus 462 ~~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV 535 (824)
..++|...+.||+|+||.||+|.+. +..||||++...... ....+.+|+.+|+.++||||+++++++. ...++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 4568999999999999999999974 689999998754322 2346889999999999999999999984 468999
Q ss_pred EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccc
Q 003384 536 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 615 (824)
Q Consensus 536 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~ 615 (824)
|||++||+|.+++... ..+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++.....
T Consensus 93 ~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp ECCCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred EECCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 9999999999998543 458999999999999999999999 8999999999999999999999999999986543
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCC-cchhHHhHHHHHHHHHhCCCCCCCchHHHHH--HhhhccccccCC
Q 003384 616 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELT-PKSDVYSFGIILLRLLTGRPALGITKEVQYA--LDTGKLKNLLDP 692 (824)
Q Consensus 616 ~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t-~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~--~~~~~~~~~ld~ 692 (824)
... .....||+.|+|||++.+..++ .++|||||||++|+|+||++||......... +..+
T Consensus 167 ~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~-------- 229 (328)
T 3fe3_A 167 GGK---------LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG-------- 229 (328)
T ss_dssp SCG---------GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--------
T ss_pred CCc---------cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------
Confidence 321 1345699999999999988775 7899999999999999999999876543221 1111
Q ss_pred CCCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 693 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 693 ~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
....|...+..+.+|+.+||..+|.+||++.+
T Consensus 230 -~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e 261 (328)
T 3fe3_A 230 -KYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQ 261 (328)
T ss_dssp -CCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHH
T ss_pred -CCCCCCCCCHHHHHHHHHHCCCChhHCcCHHH
Confidence 11234556778999999999999999999943
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=348.17 Aligned_cols=248 Identities=27% Similarity=0.467 Sum_probs=195.0
Q ss_pred cCCCCccceeeecCceEEEEEEECCeEEEEEEecCCCCC----CchhHHHHHHHHHhcCCCceeeEecccC--CceEEEE
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQ----GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 536 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~~~~VAvK~l~~~~~~----~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~ 536 (824)
..+|...+.||+|+||.||+|.+.+..||||++...... ..+.+.+|+.+++.++||||++++++|. +..++||
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 357888999999999999999999999999998754322 2457889999999999999999999984 4578999
Q ss_pred EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCc---eEeccccCCcEEecC--------CCcceee
Q 003384 537 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS---IVHGDLKPANILLDA--------NFVSKLS 605 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~g---iiHrDLKp~NILld~--------~~~vKL~ 605 (824)
||+++++|.+++. ...+++..+..++.+++.||.|||+ ++ |+||||||+|||++. ++.+||+
T Consensus 86 e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~---~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~ 158 (271)
T 3dtc_A 86 EFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHD---EAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158 (271)
T ss_dssp ECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHH---SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred EcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence 9999999999983 3468999999999999999999999 66 999999999999986 7789999
Q ss_pred ccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhc
Q 003384 606 DFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK 685 (824)
Q Consensus 606 DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~ 685 (824)
|||++........ ....||+.|+|||++.+..++.++|||||||++|+|+||++||..............
T Consensus 159 Dfg~~~~~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 228 (271)
T 3dtc_A 159 DFGLAREWHRTTK----------MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAM 228 (271)
T ss_dssp CCCC-----------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHT
T ss_pred cCCcccccccccc----------cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhc
Confidence 9999986543221 234589999999999999999999999999999999999999976554332221110
Q ss_pred cccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHH
Q 003384 686 LKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP 733 (824)
Q Consensus 686 ~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~ 733 (824)
.......+...+..+.+++.+||+.+|.+||++ .++++.|+.
T Consensus 229 -----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-~e~l~~L~~ 270 (271)
T 3dtc_A 229 -----NKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSF-TNILDQLTT 270 (271)
T ss_dssp -----SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHC
T ss_pred -----CCCCCCCCcccCHHHHHHHHHHhcCCcccCcCH-HHHHHHHhc
Confidence 111222345556789999999999999999999 677777764
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=356.43 Aligned_cols=261 Identities=20% Similarity=0.232 Sum_probs=205.4
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhc-CCCceeeEeccc--CCceEEEEE
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGAC--PEVWTLVYE 537 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l-~HpnIv~L~g~~--~~~~~LV~E 537 (824)
..+|...+.||+|+||.||+|... +..||||++.... ....+.+|+.+++.+ +||||+++++++ .+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 457999999999999999999964 6899999987543 234699999999999 999999999987 456789999
Q ss_pred ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCc-----ceeeccccccc
Q 003384 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV-----SKLSDFGISRF 612 (824)
Q Consensus 538 y~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~-----vKL~DFGla~~ 612 (824)
|+ +|+|.+++... ...+++..++.|+.|++.||.|||+ ++|+||||||+|||++.++. +||+|||+++.
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 99999999643 3579999999999999999999999 89999999999999998887 99999999987
Q ss_pred cccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchH--HH---HHHhhhccc
Q 003384 613 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE--VQ---YALDTGKLK 687 (824)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~--~~---~~~~~~~~~ 687 (824)
+.......... ........||+.|+|||++.+..++.++|||||||+||||+||++||..... .. ..+......
T Consensus 160 ~~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~ 238 (330)
T 2izr_A 160 YIDPETKKHIP-YREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA 238 (330)
T ss_dssp SBCTTTCCBCC-CCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH
T ss_pred eecCCCCcccc-ccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc
Confidence 65443221110 0112456799999999999999999999999999999999999999975321 11 111111111
Q ss_pred cccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhhC
Q 003384 688 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC 738 (824)
Q Consensus 688 ~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~~~ 738 (824)
....... ...+ .+.+++.+||+.+|.+||++ +.+.+.|+.+....
T Consensus 239 ~~~~~~~----~~~p-~~~~li~~~l~~~p~~RP~~-~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 239 TPIEVLC----ENFP-EMATYLRYVRRLDFFEKPDY-DYLRKLFTDLFDRK 283 (330)
T ss_dssp SCHHHHT----TTCH-HHHHHHHHHHHCCTTCCCCH-HHHHHHHHHHHHHT
T ss_pred CCHHHHh----ccCh-HHHHHHHHHHhCCCCCCCCH-HHHHHHHHHHHHHc
Confidence 0000001 1123 89999999999999999999 78888888776654
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=351.11 Aligned_cols=251 Identities=29% Similarity=0.475 Sum_probs=202.0
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCc-------hhHHHHHHHHHhcCCCceeeEecccCCceE
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGP-------SEFQQEIDILSKIRHPNLVTLVGACPEVWT 533 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~-------~~f~~Ei~iL~~l~HpnIv~L~g~~~~~~~ 533 (824)
.++|...+.||+|+||.||+|.+. +..||||++........ ..+.+|+.+++.++||||+++++++.+..+
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 97 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR 97 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTTE
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCCe
Confidence 457999999999999999999985 68899999876543322 568899999999999999999999988889
Q ss_pred EEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCc--eEeccccCCcEEecCCCc-----ceeec
Q 003384 534 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS--IVHGDLKPANILLDANFV-----SKLSD 606 (824)
Q Consensus 534 LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~g--iiHrDLKp~NILld~~~~-----vKL~D 606 (824)
+||||+++|+|.+.+.. ...++++..+..++.+++.||.|||+ ++ |+||||||+|||++.++. +||+|
T Consensus 98 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 98 MVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp EEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred EEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 99999999999988853 34579999999999999999999999 67 999999999999988776 99999
Q ss_pred cccccccccccccCCCccccccCCCCCCcccCChhhhc--cCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhh
Q 003384 607 FGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA--SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG 684 (824)
Q Consensus 607 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~--~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~ 684 (824)
||+++...... ....||+.|+|||++. ...++.++|||||||++|+|++|++||.............
T Consensus 173 fg~~~~~~~~~-----------~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 241 (287)
T 4f0f_A 173 FGLSQQSVHSV-----------SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINM 241 (287)
T ss_dssp CTTCBCCSSCE-----------ECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHH
T ss_pred CCccccccccc-----------cccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHH
Confidence 99987443211 3346899999999984 4567899999999999999999999997543211111100
Q ss_pred ccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHH
Q 003384 685 KLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP 733 (824)
Q Consensus 685 ~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~ 733 (824)
... .......+...+..+.+|+.+||+.+|.+||++ +++++.|+.
T Consensus 242 ~~~---~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~~ll~~L~~ 286 (287)
T 4f0f_A 242 IRE---EGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHF-SYIVKELSE 286 (287)
T ss_dssp HHH---SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHT
T ss_pred Hhc---cCCCCCCCcccCHHHHHHHHHHhcCChhhCcCH-HHHHHHHHh
Confidence 000 111223345567789999999999999999999 677777764
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=363.68 Aligned_cols=245 Identities=22% Similarity=0.326 Sum_probs=199.0
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC------CchhHHHHHHHHHhcCCCceeeEecccC--Cce
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ------GPSEFQQEIDILSKIRHPNLVTLVGACP--EVW 532 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~------~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~ 532 (824)
.+.|.+.+.||+|+||.||+|... +..||||++...... ....+.+|+.+|+.++||||++++++|. ...
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 347899999999999999999986 688999999765332 2357899999999999999999999984 468
Q ss_pred EEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCC----cceeeccc
Q 003384 533 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF----VSKLSDFG 608 (824)
Q Consensus 533 ~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~----~vKL~DFG 608 (824)
++||||++||+|.+++. ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 91 VLILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EEEEECCCSCBHHHHHT---TCSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEEEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 99999999999999994 34579999999999999999999999 8999999999999998776 79999999
Q ss_pred cccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhcccc
Q 003384 609 ISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKN 688 (824)
Q Consensus 609 la~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~ 688 (824)
++..+..... .....||+.|+|||++.+..++.++|||||||++|+|++|.+||................
T Consensus 165 ~a~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~- 234 (361)
T 2yab_A 165 LAHEIEDGVE---------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVS- 234 (361)
T ss_dssp SCEECCTTCC---------CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTC-
T ss_pred CceEcCCCCc---------cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-
Confidence 9987654321 133569999999999999999999999999999999999999997665433221111100
Q ss_pred ccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 689 LLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 689 ~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
.+ ....++...+..+.+|+.+||..+|.+||++.+
T Consensus 235 -~~-~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e 269 (361)
T 2yab_A 235 -YD-FDEEFFSQTSELAKDFIRKLLVKETRKRLTIQE 269 (361)
T ss_dssp -CC-CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred -CC-CCchhccCCCHHHHHHHHHHCCCChhHCcCHHH
Confidence 00 000111234568999999999999999999943
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=370.66 Aligned_cols=256 Identities=27% Similarity=0.465 Sum_probs=195.9
Q ss_pred cCCCCccceeeecCceEEEEEEEC-----CeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccC--CceEE
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR-----HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTL 534 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~-----~~~VAvK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~L 534 (824)
..+|...+.||+|+||.||+|.+. +..||||++..... .....|.+|+.+|++++||||++++|+|. ...++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 347999999999999999999875 46799999975432 12346899999999999999999999984 46899
Q ss_pred EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccc
Q 003384 535 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 614 (824)
Q Consensus 535 V~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~ 614 (824)
||||+++|+|.+++.. ....+++..++.|+.+++.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 124 v~e~~~~~sL~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 124 VTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 9999999999999953 34569999999999999999999999 899999999999999999999999999998765
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHH--HHhhhccccccC
Q 003384 615 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQY--ALDTGKLKNLLD 691 (824)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~--~~~~~~~~~~ld 691 (824)
........ .....+|+.|+|||++.+..++.++|||||||+||||++ |++||........ .+..+
T Consensus 199 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~------- 266 (373)
T 2qol_A 199 DDPEAAYT-----TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG------- 266 (373)
T ss_dssp --------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTT-------
T ss_pred cCCcccee-----ccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-------
Confidence 43211111 122346889999999999999999999999999999998 9999975543221 11111
Q ss_pred CCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhh
Q 003384 692 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 737 (824)
Q Consensus 692 ~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~~ 737 (824)
.....+...+..+.+|+.+||+.+|.+||++ .++++.|+.+...
T Consensus 267 -~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~-~~i~~~L~~~~~~ 310 (373)
T 2qol_A 267 -YRLPPPMDCPAALYQLMLDCWQKDRNNRPKF-EQIVSILDKLIRN 310 (373)
T ss_dssp -EECCCCTTCBHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHC
T ss_pred -CCCCCCccccHHHHHHHHHHhCcChhhCcCH-HHHHHHHHHHHhC
Confidence 1112234556789999999999999999999 7788899887653
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=361.00 Aligned_cols=263 Identities=23% Similarity=0.373 Sum_probs=196.3
Q ss_pred HhhhcCCCCccceeeecCceEEEEEEECCe-----EEEEEEecCCCC--CCchhHHHHHHHHHhcCCCceeeEecccCC-
Q 003384 459 IEGATHNFDPSLKIGEGGYGSIYKGLLRHM-----QVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACPE- 530 (824)
Q Consensus 459 i~~~~~~f~~~~~LG~G~fG~Vykg~~~~~-----~VAvK~l~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~~- 530 (824)
+....++|...+.||+|+||.||+|.+... .||||++..... .....+.+|+.+++.++||||+++++++..
T Consensus 18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS 97 (323)
T ss_dssp TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence 344556899999999999999999987642 799999976532 224578999999999999999999998732
Q ss_pred -c------eEEEEEecCCCChhhhhhccC---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCC
Q 003384 531 -V------WTLVYEYLPNGSLEDRLSCKD---NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF 600 (824)
Q Consensus 531 -~------~~LV~Ey~~ggsL~~~L~~~~---~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~ 600 (824)
. .++||||+++|+|.+++.... ....+++..+..|+.|++.||.|||+ +||+||||||+|||++.++
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~ 174 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDM 174 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTS
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCC
Confidence 2 389999999999999985432 23369999999999999999999999 8999999999999999999
Q ss_pred cceeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHH
Q 003384 601 VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQY 679 (824)
Q Consensus 601 ~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~ 679 (824)
.+||+|||+++.......... .....||+.|+|||.+.+..++.++|||||||++|+|+| |++||........
T Consensus 175 ~~kl~Dfg~a~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~ 248 (323)
T 3qup_A 175 TVCVADFGLSRKIYSGDYYRQ------GCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI 248 (323)
T ss_dssp CEEECCCCC-----------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH
T ss_pred CEEEeeccccccccccccccc------cccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH
Confidence 999999999987654322111 123457889999999999999999999999999999999 9999975433211
Q ss_pred HHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhh
Q 003384 680 ALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 737 (824)
Q Consensus 680 ~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~~ 737 (824)
.. .+........+...+..+.+|+.+||+.+|.+||++ .++.+.|+.+...
T Consensus 249 ~~------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~~l~~~l~~~l~~ 299 (323)
T 3qup_A 249 YN------YLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSF-TCLRMELENILGH 299 (323)
T ss_dssp HH------HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCH-HHHHHHHHHHHHC
T ss_pred HH------HHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCH-HHHHHHHHHHHHH
Confidence 11 011111122344556789999999999999999999 7888888887653
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=372.20 Aligned_cols=255 Identities=25% Similarity=0.416 Sum_probs=206.9
Q ss_pred hcCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccC--CceEEEE
Q 003384 462 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 536 (824)
Q Consensus 462 ~~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~ 536 (824)
...+|...+.||+|+||.||+|.+. +..||||++...... ....|.+|+.+|+.++||||++++|+|. +..++||
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 3457888999999999999999986 688999998754221 1246889999999999999999999984 4689999
Q ss_pred EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccc
Q 003384 537 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 616 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 616 (824)
||+++|+|.+++... ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 192 e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 192 ELVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp ECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred EcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 999999999999633 3458899999999999999999999 89999999999999999999999999999865432
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHH--HHhhhccccccCCC
Q 003384 617 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQY--ALDTGKLKNLLDPL 693 (824)
Q Consensus 617 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~--~~~~~~~~~~ld~~ 693 (824)
..... .....+++.|+|||++.++.++.++|||||||+||||+| |.+||........ .+..+ .
T Consensus 267 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~--------~ 332 (377)
T 3cbl_A 267 VYAAS------GGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG--------G 332 (377)
T ss_dssp EEECC------SSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTT--------C
T ss_pred ceeec------CCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--------C
Confidence 21111 012235788999999999999999999999999999998 9999976543221 11111 1
Q ss_pred CCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHh
Q 003384 694 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 736 (824)
Q Consensus 694 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~ 736 (824)
....|...+..+.+|+.+||+.+|.+||++ +++++.|+.+..
T Consensus 333 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-~~i~~~L~~i~~ 374 (377)
T 3cbl_A 333 RLPCPELCPDAVFRLMEQCWAYEPGQRPSF-STIYQELQSIRK 374 (377)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCchhCcCH-HHHHHHHHHHHh
Confidence 122344566789999999999999999999 788888888764
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=362.06 Aligned_cols=253 Identities=24% Similarity=0.415 Sum_probs=203.0
Q ss_pred CCCCccceeeecCceEEEEEEECC--e----EEEEEEecCCC-CCCchhHHHHHHHHHhcCCCceeeEecccC-CceEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLRH--M----QVAIKMLHPHS-LQGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLV 535 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~~--~----~VAvK~l~~~~-~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~-~~~~LV 535 (824)
.+|...+.||+|+||.||+|.+.. . .||+|.+.... ......+.+|+.+++.++||||++++++|. ...++|
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v 92 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQLV 92 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECBSSEEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCccEEE
Confidence 468889999999999999998753 2 38889886543 233457889999999999999999999985 468899
Q ss_pred EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccc
Q 003384 536 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 615 (824)
Q Consensus 536 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~ 615 (824)
|||+++|+|.+++... ...+++..+..|+.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.+..
T Consensus 93 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 93 TQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp EECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred EEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 9999999999999533 3468889999999999999999999 8999999999999999999999999999987654
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchH--HHHHHhhhccccccCC
Q 003384 616 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKE--VQYALDTGKLKNLLDP 692 (824)
Q Consensus 616 ~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~--~~~~~~~~~~~~~ld~ 692 (824)
...... .....||+.|+|||++.+..++.++|||||||++|+|+| |++||..... ....+..+.
T Consensus 168 ~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~------- 234 (325)
T 3kex_A 168 DDKQLL------YSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE------- 234 (325)
T ss_dssp CTTCCC-----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTC-------
T ss_pred cccccc------ccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCC-------
Confidence 432111 133458889999999999999999999999999999999 9999975432 222222211
Q ss_pred CCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHh
Q 003384 693 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 736 (824)
Q Consensus 693 ~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~ 736 (824)
....+...+..+.+++.+||+.+|.+||++ .++++.|+.+..
T Consensus 235 -~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-~el~~~l~~~~~ 276 (325)
T 3kex_A 235 -RLAQPQICTIDVYMVMVKCWMIDENIRPTF-KELANEFTRMAR 276 (325)
T ss_dssp -BCCCCTTBCTTTTHHHHHHTCSCTTTSCCH-HHHHHHHHHHTT
T ss_pred -CCCCCCcCcHHHHHHHHHHcCCChhhCcCH-HHHHHHHHHHHh
Confidence 112233445578999999999999999999 778888877643
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=346.77 Aligned_cols=253 Identities=26% Similarity=0.495 Sum_probs=208.2
Q ss_pred cCCCCccceeeecCceEEEEEEECC-eEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccCC--ceEEEEEec
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVYEYL 539 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~~-~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~~--~~~LV~Ey~ 539 (824)
.++|...+.||+|+||.||+|.+.+ ..||||++..... ....+.+|+.++..++||||++++++|.+ ..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 4578899999999999999998875 5799999976442 45679999999999999999999999853 578999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccccc
Q 003384 540 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 619 (824)
Q Consensus 540 ~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 619 (824)
++|+|.+++... ...+++..+..++.+++.||.|||+ +||+||||||+|||++.++.+||+|||++.........
T Consensus 86 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 86 SNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp TTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred CCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence 999999999543 3458999999999999999999999 89999999999999999999999999999866543221
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHHHHhhhccccccCCCCCCCC
Q 003384 620 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWP 698 (824)
Q Consensus 620 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p 698 (824)
. .....||+.|+|||++.+..++.++|||||||++|+|+| |++||................ ....|
T Consensus 161 ~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~------~~~~~ 227 (268)
T 3sxs_A 161 S-------SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGH------RLYRP 227 (268)
T ss_dssp E-------CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC------CCCCC
T ss_pred c-------ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCC------CCCCC
Confidence 1 133457889999999999899999999999999999999 999997655433222211111 11223
Q ss_pred hhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHH
Q 003384 699 FVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 735 (824)
Q Consensus 699 ~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~ 735 (824)
...+..+.+++.+||+.+|.+||++ .++++.|+.+.
T Consensus 228 ~~~~~~l~~li~~~l~~~p~~Rps~-~~ll~~L~~l~ 263 (268)
T 3sxs_A 228 HLASDTIYQIMYSCWHELPEKRPTF-QQLLSSIEPLR 263 (268)
T ss_dssp TTSCHHHHHHHHHTTCSSGGGSCCH-HHHHHHHGGGC
T ss_pred CcChHHHHHHHHHHcCCChhhCcCH-HHHHHHHHHhh
Confidence 4456789999999999999999999 77888887764
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=359.25 Aligned_cols=260 Identities=27% Similarity=0.432 Sum_probs=207.0
Q ss_pred HhhhcCCCCccceeeecCceEEEEEEEC-------CeEEEEEEecCCC-CCCchhHHHHHHHHHhc-CCCceeeEecccC
Q 003384 459 IEGATHNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHS-LQGPSEFQQEIDILSKI-RHPNLVTLVGACP 529 (824)
Q Consensus 459 i~~~~~~f~~~~~LG~G~fG~Vykg~~~-------~~~VAvK~l~~~~-~~~~~~f~~Ei~iL~~l-~HpnIv~L~g~~~ 529 (824)
......+|...+.||+|+||.||+|.+. +..||||++.... ......+.+|+.+|.++ +||||++++++|.
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 3445678999999999999999999872 3579999997543 23356799999999999 8999999999984
Q ss_pred --CceEEEEEecCCCChhhhhhccCCC--------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEec
Q 003384 530 --EVWTLVYEYLPNGSLEDRLSCKDNS--------------------PPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 587 (824)
Q Consensus 530 --~~~~LV~Ey~~ggsL~~~L~~~~~~--------------------~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHr 587 (824)
+..++||||+++|+|.+++...... ..+++..++.++.+|+.||.|||+ +||+||
T Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~ 196 (344)
T 1rjb_A 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHR 196 (344)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEET
T ss_pred eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccC
Confidence 4689999999999999999654321 348999999999999999999999 899999
Q ss_pred cccCCcEEecCCCcceeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-
Q 003384 588 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT- 666 (824)
Q Consensus 588 DLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt- 666 (824)
||||+|||++.++.+||+|||++.......... ......||+.|+|||++.+..++.++|||||||+||+|+|
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~ 270 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYV------VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL 270 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSE------EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTT
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccce------eccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcC
Confidence 999999999999999999999998665432111 1133457889999999999999999999999999999998
Q ss_pred CCCCCCCchH---HHHHHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHh
Q 003384 667 GRPALGITKE---VQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 736 (824)
Q Consensus 667 G~~Pf~~~~~---~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~ 736 (824)
|.+||..... ....+..+ .....+...+..+.+|+.+||+.+|.+||++ .++++.|+.+.+
T Consensus 271 g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~~l~~~l~~~~~ 334 (344)
T 1rjb_A 271 GVNPYPGIPVDANFYKLIQNG--------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSF-PNLTSFLGCQLA 334 (344)
T ss_dssp SCCSSTTCCCSHHHHHHHHTT--------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHC-
T ss_pred CCCCcccCCcHHHHHHHHhcC--------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCH-HHHHHHHHHHHH
Confidence 9999975432 22211211 1122344557789999999999999999999 778888877644
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=354.78 Aligned_cols=259 Identities=28% Similarity=0.398 Sum_probs=208.8
Q ss_pred hhhcCCCCccceeeecCceEEEEEEEC-------CeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccC--
Q 003384 460 EGATHNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP-- 529 (824)
Q Consensus 460 ~~~~~~f~~~~~LG~G~fG~Vykg~~~-------~~~VAvK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~-- 529 (824)
.....+|...+.||+|+||.||+|.+. +..||||++..... .....+.+|+.+++.++||||+++++++.
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 98 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD 98 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Confidence 334567899999999999999999862 26799999875432 12356889999999999999999999984
Q ss_pred CceEEEEEecCCCChhhhhhccCC---------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecc
Q 003384 530 EVWTLVYEYLPNGSLEDRLSCKDN---------------------SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGD 588 (824)
Q Consensus 530 ~~~~LV~Ey~~ggsL~~~L~~~~~---------------------~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrD 588 (824)
...++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+ ++|+|||
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~d 175 (314)
T 2ivs_A 99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRD 175 (314)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCC
T ss_pred CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccc
Confidence 468999999999999999965432 2348999999999999999999999 8999999
Q ss_pred ccCCcEEecCCCcceeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-C
Q 003384 589 LKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-G 667 (824)
Q Consensus 589 LKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G 667 (824)
|||+|||++.++.+||+|||++.......... ......||+.|+|||++.+..++.++|||||||++|+|+| |
T Consensus 176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g 249 (314)
T 2ivs_A 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYV------KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLG 249 (314)
T ss_dssp CSGGGEEEETTTEEEECCCTTCEECTTTSCEE------CSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTS
T ss_pred cchheEEEcCCCCEEEccccccccccccccce------eccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCC
Confidence 99999999999999999999998664432111 1133457899999999999999999999999999999999 9
Q ss_pred CCCCCCchHH--HHHHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHh
Q 003384 668 RPALGITKEV--QYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 736 (824)
Q Consensus 668 ~~Pf~~~~~~--~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~ 736 (824)
.+||...... ...+..+ .....+...+..+.+++.+||+.+|.+||++ .++++.|+.+..
T Consensus 250 ~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-~~l~~~l~~~~~ 311 (314)
T 2ivs_A 250 GNPYPGIPPERLFNLLKTG--------HRMERPDNCSEEMYRLMLQCWKQEPDKRPVF-ADISKDLEKMMV 311 (314)
T ss_dssp CCSSTTCCGGGHHHHHHTT--------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHhhcC--------CcCCCCccCCHHHHHHHHHHccCChhhCcCH-HHHHHHHHHHHh
Confidence 9999754321 1111111 1122344567789999999999999999999 778888887654
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=378.59 Aligned_cols=258 Identities=29% Similarity=0.498 Sum_probs=211.7
Q ss_pred hHhhhcCCCCccceeeecCceEEEEEEEC-CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC-CceEEE
Q 003384 458 EIEGATHNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLV 535 (824)
Q Consensus 458 ei~~~~~~f~~~~~LG~G~fG~Vykg~~~-~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~-~~~~LV 535 (824)
.+.....+|...+.||+|+||.||+|.+. +..||||+++... ...+.|.+|+.+|+.++||||+++++++. +..++|
T Consensus 182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~lv 260 (454)
T 1qcf_A 182 AWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYII 260 (454)
T ss_dssp CSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEE
T ss_pred ceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEeCCccEEE
Confidence 34445667899999999999999999987 5789999998644 34678999999999999999999999985 468999
Q ss_pred EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccc
Q 003384 536 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 615 (824)
Q Consensus 536 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~ 615 (824)
|||+++|+|.++|.... ...+++..++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++....
T Consensus 261 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 261 TEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp ECCCTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred EeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 99999999999995331 2358889999999999999999999 8999999999999999999999999999987654
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHH--HHhhhccccccCC
Q 003384 616 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQY--ALDTGKLKNLLDP 692 (824)
Q Consensus 616 ~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~--~~~~~~~~~~ld~ 692 (824)
..... .....+|+.|+|||++..+.++.++|||||||+||||+| |++||........ .+..+
T Consensus 337 ~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~-------- 401 (454)
T 1qcf_A 337 NEYTA-------REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-------- 401 (454)
T ss_dssp HHHHT-------TCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHT--------
T ss_pred Cceec-------cCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--------
Confidence 32111 123347889999999999999999999999999999999 9999976543321 22221
Q ss_pred CCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHh
Q 003384 693 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 736 (824)
Q Consensus 693 ~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~ 736 (824)
.....|...+..+.+|+.+||+.+|.+||++ ++|.+.|+.+..
T Consensus 402 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~-~~i~~~L~~~~~ 444 (454)
T 1qcf_A 402 YRMPRPENCPEELYNIMMRCWKNRPEERPTF-EYIQSVLDDFYT 444 (454)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHTSSS
T ss_pred CCCCCCCCCCHHHHHHHHHHccCChhHCcCH-HHHHHHHHHHHh
Confidence 1112344566789999999999999999999 778888877543
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=351.41 Aligned_cols=254 Identities=25% Similarity=0.387 Sum_probs=196.1
Q ss_pred hcCCCCccceeeecCceEEEEEEECC-----eEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccC-CceEE
Q 003384 462 ATHNFDPSLKIGEGGYGSIYKGLLRH-----MQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTL 534 (824)
Q Consensus 462 ~~~~f~~~~~LG~G~fG~Vykg~~~~-----~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~L~g~~~-~~~~L 534 (824)
..++|...+.||+|+||.||+|.+.. ..||||++...... ....+.+|+.+++.++||||+++++++. +..++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~l 92 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWI 92 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEccCccEE
Confidence 34578999999999999999998752 46999998754321 2346889999999999999999999984 46789
Q ss_pred EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccc
Q 003384 535 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 614 (824)
Q Consensus 535 V~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~ 614 (824)
||||+++|+|.+++... ...+++..++.++.+++.||.|||+ +||+||||||+|||++.++.+||+|||+++...
T Consensus 93 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp EEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECccccccccC
Confidence 99999999999999643 3468999999999999999999999 899999999999999999999999999998765
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHH--HHHHhhhccccccC
Q 003384 615 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEV--QYALDTGKLKNLLD 691 (824)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~--~~~~~~~~~~~~ld 691 (824)
...... .....||+.|+|||++.+..++.++|||||||++|+|++ |.+||...... ...+..+
T Consensus 168 ~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~------- 233 (281)
T 1mp8_A 168 DSTYYK-------ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG------- 233 (281)
T ss_dssp ------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT-------
T ss_pred cccccc-------cccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcC-------
Confidence 432111 123457889999999999999999999999999999997 99999754321 1111111
Q ss_pred CCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHh
Q 003384 692 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 736 (824)
Q Consensus 692 ~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~ 736 (824)
.....+...+..+.+++.+||+.+|.+||++ .++++.|+.+..
T Consensus 234 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-~~l~~~l~~~~~ 276 (281)
T 1mp8_A 234 -ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRF-TELKAQLSTILE 276 (281)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHH
T ss_pred -CCCCCCCCCCHHHHHHHHHHccCChhhCcCH-HHHHHHHHHHHH
Confidence 1122344566789999999999999999999 778888877643
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=350.56 Aligned_cols=256 Identities=27% Similarity=0.450 Sum_probs=196.3
Q ss_pred hcCCCCccceeeecCceEEEEEEECCeEEEEEEecCCCCCC--chhHHHHHHHHHhcCCCceeeEecccC-CceEEEEEe
Q 003384 462 ATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVYEY 538 (824)
Q Consensus 462 ~~~~f~~~~~LG~G~fG~Vykg~~~~~~VAvK~l~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~L~g~~~-~~~~LV~Ey 538 (824)
..++|...++||+|+||.||+|.+.+ .||||+++...... ...|.+|+.+++.++||||+++++++. ...++||||
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~lv~e~ 100 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQW 100 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEEC
T ss_pred CccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccCCccEEEEEe
Confidence 45679999999999999999998765 59999997654322 356899999999999999999999874 467899999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccc
Q 003384 539 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 618 (824)
Q Consensus 539 ~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 618 (824)
+++++|.+++.. ....+++..++.++.+++.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 101 ~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 175 (289)
T 3og7_A 101 CEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175 (289)
T ss_dssp CCEEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred cCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceeccccccccc
Confidence 999999999853 34569999999999999999999999 8999999999999999999999999999986543221
Q ss_pred cCCCccccccCCCCCCcccCChhhhc---cCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHH---HHHhhhccccccCC
Q 003384 619 SSNNTTLCCRTDPKGTFAYMDPEFLA---SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ---YALDTGKLKNLLDP 692 (824)
Q Consensus 619 ~~~~~~~~~~~~~~GT~~Y~APE~l~---~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~---~~~~~~~~~~~ld~ 692 (824)
... .....||+.|+|||++. +..++.++|||||||++|+|++|+.||....... .....+.. .+
T Consensus 176 ~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~----~~ 245 (289)
T 3og7_A 176 SHQ------FEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSL----SP 245 (289)
T ss_dssp --------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSC----CC
T ss_pred ccc------ccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhccccc----Cc
Confidence 111 12346999999999986 5678889999999999999999999997543322 22222222 12
Q ss_pred CCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHH
Q 003384 693 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 734 (824)
Q Consensus 693 ~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l 734 (824)
.....+...+..+.+|+.+||+.+|.+||++ .++++.|+.+
T Consensus 246 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-~ell~~L~~l 286 (289)
T 3og7_A 246 DLSKVRSNCPKRMKRLMAECLKKKRDERPSF-PRILAEIEEL 286 (289)
T ss_dssp CTTSSCTTSCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHT
T ss_pred chhhccccCCHHHHHHHHHHccCChhhCCCH-HHHHHHHHHH
Confidence 2222334556789999999999999999999 7788888765
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=364.26 Aligned_cols=259 Identities=25% Similarity=0.407 Sum_probs=211.4
Q ss_pred hcCCCCccceeeecCceEEEEEEECC---------eEEEEEEecCCCCC-CchhHHHHHHHHHhc-CCCceeeEecccC-
Q 003384 462 ATHNFDPSLKIGEGGYGSIYKGLLRH---------MQVAIKMLHPHSLQ-GPSEFQQEIDILSKI-RHPNLVTLVGACP- 529 (824)
Q Consensus 462 ~~~~f~~~~~LG~G~fG~Vykg~~~~---------~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l-~HpnIv~L~g~~~- 529 (824)
..++|...+.||+|+||.||+|.+.+ ..||||++...... ....+.+|+.+++.+ +||||++++++|.
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 34578999999999999999998632 57999999765322 235688999999999 9999999999984
Q ss_pred -CceEEEEEecCCCChhhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEE
Q 003384 530 -EVWTLVYEYLPNGSLEDRLSCKDN-------------SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANIL 595 (824)
Q Consensus 530 -~~~~LV~Ey~~ggsL~~~L~~~~~-------------~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NIL 595 (824)
+..++||||+++|+|.+++..... ...+++..++.|+.|++.||.|||+ ++|+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcceEE
Confidence 468999999999999999965431 2469999999999999999999999 89999999999999
Q ss_pred ecCCCcceeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCc
Q 003384 596 LDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGIT 674 (824)
Q Consensus 596 ld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~ 674 (824)
|+.++.+||+|||+++.......... .....||+.|+|||++.+..++.++|||||||++|+|+| |..||...
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~ 297 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKK------TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 297 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCC------CTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred EcCCCcEEEcccCccccccccccccc------ccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999986654322111 133468899999999999999999999999999999999 99999765
Q ss_pred hHHHH--HHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhhC
Q 003384 675 KEVQY--ALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC 738 (824)
Q Consensus 675 ~~~~~--~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~~~ 738 (824)
..... .+..+ .....+...+..+.+|+.+||+.+|.+||++ +++++.|+.+.+..
T Consensus 298 ~~~~~~~~~~~~--------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-~ell~~L~~~~~~~ 354 (382)
T 3tt0_A 298 PVEELFKLLKEG--------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTF-KQLVEDLDRIVALT 354 (382)
T ss_dssp CHHHHHHHHHTT--------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHHS
T ss_pred CHHHHHHHHHcC--------CCCCCCccCCHHHHHHHHHHcCCChhhCcCH-HHHHHHHHHHHHHH
Confidence 43221 11111 1222344566789999999999999999999 78889999887754
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=358.12 Aligned_cols=259 Identities=24% Similarity=0.399 Sum_probs=199.6
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCc---hhHHHHHHHHHhcCCCceeeEecccCC------c
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGP---SEFQQEIDILSKIRHPNLVTLVGACPE------V 531 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~---~~f~~Ei~iL~~l~HpnIv~L~g~~~~------~ 531 (824)
.++|...+.||+|+||.||+|.+. +..||||++........ ..+.+|+.+++.++||||+++++++.. .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 457999999999999999999974 58899999987544332 368899999999999999999998743 2
Q ss_pred eEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccc
Q 003384 532 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR 611 (824)
Q Consensus 532 ~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~ 611 (824)
.++||||++||+|.+++... .++++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred cEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 38999999999999999533 468999999999999999999999 899999999999999999999999999998
Q ss_pred ccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccC
Q 003384 612 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD 691 (824)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld 691 (824)
.+........ ......||+.|+|||++.+..++.++|||||||++|+|+||++||............... ....
T Consensus 165 ~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~-~~~~ 238 (311)
T 3ork_A 165 AIADSGNSVT-----QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE-DPIP 238 (311)
T ss_dssp ----------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC-CCCC
T ss_pred cccccccccc-----cccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcC-CCCC
Confidence 7654322111 113346899999999999999999999999999999999999999876544322221110 0000
Q ss_pred CCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHH
Q 003384 692 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 735 (824)
Q Consensus 692 ~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~ 735 (824)
+ ...+...+..+.+|+.+||+.+|.+||+..+++...+..+.
T Consensus 239 ~--~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 239 P--SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp H--HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred c--ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 0 00112345689999999999999999999888877776553
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=360.97 Aligned_cols=237 Identities=23% Similarity=0.289 Sum_probs=196.5
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCC---CCCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH---SLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 536 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~---~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~ 536 (824)
++|...+.||+|+||.||+|... +..||||++... .......+.+|+.+|+.++||||+++++++. +..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 46889999999999999999886 688999998653 2234567889999999999999999999984 5689999
Q ss_pred EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccc
Q 003384 537 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 616 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 616 (824)
||++||+|.+++... ..+++..+..++.+|+.||.|||+ +||+||||||+|||++.+|.+||+|||+++.....
T Consensus 85 E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 85 EYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 999999999998533 468999999999999999999999 89999999999999999999999999999854322
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCC
Q 003384 617 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 696 (824)
Q Consensus 617 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~ 696 (824)
... .....||+.|+|||++.+..++.++|||||||++|||++|++||...+........ .. ....
T Consensus 159 ~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i--~~-----~~~~ 223 (337)
T 1o6l_A 159 GAT--------MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI--LM-----EEIR 223 (337)
T ss_dssp TCC--------BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--HH-----CCCC
T ss_pred CCc--------ccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHH--Hc-----CCCC
Confidence 111 13346999999999999999999999999999999999999999765432211111 00 0122
Q ss_pred CChhhHHHHHHHHHHHhhhccCCCC
Q 003384 697 WPFVQAEQLANLAMRCCEMSRKSRP 721 (824)
Q Consensus 697 ~p~~~~~~l~~Li~~Cl~~~P~~RP 721 (824)
+|...+..+.+|+.+||+.+|.+||
T Consensus 224 ~p~~~s~~~~~li~~lL~~dP~~R~ 248 (337)
T 1o6l_A 224 FPRTLSPEAKSLLAGLLKKDPKQRL 248 (337)
T ss_dssp CCTTSCHHHHHHHHHHTCSSTTTST
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHhc
Confidence 4555678999999999999999999
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=368.21 Aligned_cols=258 Identities=22% Similarity=0.335 Sum_probs=205.9
Q ss_pred cCCCCccceeeecCceEEEEEEEC-------CeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccC--Cce
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVW 532 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~-------~~~VAvK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~ 532 (824)
..+|...+.||+|+||.||+|.+. +..||||++..... .....+.+|+.++++++||||++++++|. ...
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 357889999999999999999854 35799999865322 22346889999999999999999999984 467
Q ss_pred EEEEEecCCCChhhhhhccC----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCC---cceee
Q 003384 533 TLVYEYLPNGSLEDRLSCKD----NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF---VSKLS 605 (824)
Q Consensus 533 ~LV~Ey~~ggsL~~~L~~~~----~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~---~vKL~ 605 (824)
++||||++||+|.+++.... ....+++..++.++.||+.||.|||+ +||+||||||+||||+.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999996543 22469999999999999999999999 8999999999999999554 59999
Q ss_pred ccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHHHHhhh
Q 003384 606 DFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTG 684 (824)
Q Consensus 606 DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~~~~ 684 (824)
|||+++.+......... ....||+.|+|||++.+..++.++|||||||++|||+| |.+||............
T Consensus 227 DFG~a~~~~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i- 299 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKG------GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV- 299 (367)
T ss_dssp CCHHHHHHHHHSSCTTC------CGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH-
T ss_pred CCccccccccccccccC------CCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-
Confidence 99999865433221111 22357999999999999999999999999999999998 99999765443221111
Q ss_pred ccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHh
Q 003384 685 KLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 736 (824)
Q Consensus 685 ~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~ 736 (824)
........+...+..+.+|+.+||+.+|.+||++ .++++.|+.+..
T Consensus 300 -----~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-~eil~~l~~~~~ 345 (367)
T 3l9p_A 300 -----TSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNF-AIILERIEYCTQ 345 (367)
T ss_dssp -----HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHH
T ss_pred -----HcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCH-HHHHHHHHHHhh
Confidence 0111122344556789999999999999999999 778888887765
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=343.62 Aligned_cols=249 Identities=20% Similarity=0.357 Sum_probs=203.2
Q ss_pred CCCCccceeeecCceEEEEEEECCeEEEEEEecCCCCCC--chhHHHHHHHHHhcCCCceeeEecccC----CceEEEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACP----EVWTLVYE 537 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~~~~VAvK~l~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~L~g~~~----~~~~LV~E 537 (824)
++|...+.||+|+||.||+|.+.+..||||++....... ...|.+|+.++++++||||++++++|. ...++|||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 89 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITH 89 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeec
Confidence 468888999999999999999999999999998654322 346899999999999999999999984 45789999
Q ss_pred ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCc--eEeccccCCcEEecCCCcceeecccccccccc
Q 003384 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS--IVHGDLKPANILLDANFVSKLSDFGISRFLSQ 615 (824)
Q Consensus 538 y~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~g--iiHrDLKp~NILld~~~~vKL~DFGla~~~~~ 615 (824)
|+++|+|.+++... ....+++..++.|+.|++.||.|||+ ++ |+||||||+|||++.++.++|+|||++.....
T Consensus 90 ~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 90 WMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp CCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred ccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 99999999999643 23469999999999999999999999 67 99999999999999999999999998654221
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCc---chhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCC
Q 003384 616 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTP---KSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDP 692 (824)
Q Consensus 616 ~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~---ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~ 692 (824)
....||+.|+|||++.+..++. ++|||||||++|+|+||++||............ . ...
T Consensus 166 -------------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~--~---~~~ 227 (271)
T 3kmu_A 166 -------------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKV--A---LEG 227 (271)
T ss_dssp -------------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHH--H---HSC
T ss_pred -------------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHH--H---hcC
Confidence 2235899999999998765544 799999999999999999999765443321111 0 011
Q ss_pred CCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHH
Q 003384 693 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 735 (824)
Q Consensus 693 ~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~ 735 (824)
.....+...+..+.+++.+||+.+|.+||++ +++++.|+.+.
T Consensus 228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-~~il~~L~~l~ 269 (271)
T 3kmu_A 228 LRPTIPPGISPHVSKLMKICMNEDPAKRPKF-DMIVPILEKMQ 269 (271)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHC
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhhCcCH-HHHHHHHHHhh
Confidence 1223445567789999999999999999999 77888887763
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=355.77 Aligned_cols=251 Identities=24% Similarity=0.347 Sum_probs=194.8
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccCC----------
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACPE---------- 530 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~L~g~~~~---------- 530 (824)
.+|...+.||+|+||.||+|.+. +..||||++...... ..+.+.+|+.+|++++||||++++++|.+
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 36888999999999999999986 688999999754332 34679999999999999999999998621
Q ss_pred -------------------------------------------------ceEEEEEecCCCChhhhhhccCCCCCCCHHH
Q 003384 531 -------------------------------------------------VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQT 561 (824)
Q Consensus 531 -------------------------------------------------~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~ 561 (824)
..++||||+++|+|.+++.........++..
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence 2689999999999999997665556677888
Q ss_pred HHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCCCc----cccccCCCCCCccc
Q 003384 562 RIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT----TLCCRTDPKGTFAY 637 (824)
Q Consensus 562 ~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~----~~~~~~~~~GT~~Y 637 (824)
++.++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+++............ .........||+.|
T Consensus 166 ~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred HHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 99999999999999999 899999999999999999999999999998776543211100 00112345799999
Q ss_pred CChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhcc
Q 003384 638 MDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSR 717 (824)
Q Consensus 638 ~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P 717 (824)
+|||++.+..++.++|||||||++|+|++|..|+............+. ....+......+.+|+.+||+.+|
T Consensus 243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~li~~~l~~~p 314 (332)
T 3qd2_B 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLK--------FPLLFTQKYPQEHMMVQDMLSPSP 314 (332)
T ss_dssp SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHHHHHHHHTTC--------CCHHHHHHCHHHHHHHHHHHCSSG
T ss_pred cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHHHHHHhhccC--------CCcccccCChhHHHHHHHHccCCC
Confidence 999999999999999999999999999999887632222111111111 111112334678999999999999
Q ss_pred CCCCChHH
Q 003384 718 KSRPELGK 725 (824)
Q Consensus 718 ~~RPt~~~ 725 (824)
.+||++.+
T Consensus 315 ~~Rps~~~ 322 (332)
T 3qd2_B 315 TERPEATD 322 (332)
T ss_dssp GGSCCHHH
T ss_pred CcCCCHHH
Confidence 99999943
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=345.28 Aligned_cols=260 Identities=27% Similarity=0.448 Sum_probs=211.5
Q ss_pred hhhcCCCCccceeeecCceEEEEEEECC-eEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC-CceEEEEE
Q 003384 460 EGATHNFDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVYE 537 (824)
Q Consensus 460 ~~~~~~f~~~~~LG~G~fG~Vykg~~~~-~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~-~~~~LV~E 537 (824)
....++|...+.||+|+||.||+|.+.+ ..||||++.... ...+.+.+|+.+++.++||||+++++++. +..++|||
T Consensus 9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e 87 (279)
T 1qpc_A 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITE 87 (279)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEE
T ss_pred ccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcCCCcEEEEe
Confidence 3345678999999999999999999875 689999997543 34678999999999999999999999884 46889999
Q ss_pred ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccc
Q 003384 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 617 (824)
Q Consensus 538 y~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 617 (824)
|+++|+|.+++.... ...+++..++.++.+++.||.|||+ +||+||||||+|||++.++.+||+|||++.......
T Consensus 88 ~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T 1qpc_A 88 YMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (279)
T ss_dssp CCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred cCCCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccCcc
Confidence 999999999984321 1268999999999999999999999 899999999999999999999999999998765432
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHHHHhhhccccccCCCCCC
Q 003384 618 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGD 696 (824)
Q Consensus 618 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~ 696 (824)
... .....||+.|+|||++.+..++.++|||||||++|+|+| |++||............. ......
T Consensus 164 ~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~------~~~~~~ 230 (279)
T 1qpc_A 164 YTA-------REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE------RGYRMV 230 (279)
T ss_dssp EEC-------CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH------TTCCCC
T ss_pred ccc-------ccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHh------cccCCC
Confidence 111 123457889999999998899999999999999999999 999997654322111110 011112
Q ss_pred CChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhhC
Q 003384 697 WPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC 738 (824)
Q Consensus 697 ~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~~~ 738 (824)
.+...+..+.+++.+||..+|.+||++ +++.+.|+.+....
T Consensus 231 ~~~~~~~~l~~li~~~l~~~p~~Rps~-~~l~~~l~~~~~~~ 271 (279)
T 1qpc_A 231 RPDNCPEELYQLMRLCWKERPEDRPTF-DYLRSVLEDFFTAT 271 (279)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHHC
T ss_pred CcccccHHHHHHHHHHhccChhhCCCH-HHHHHHHHHHHHhc
Confidence 334556789999999999999999999 78889998876653
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=348.06 Aligned_cols=255 Identities=25% Similarity=0.437 Sum_probs=206.0
Q ss_pred hcCCCCccceeeecCceEEEEEEECC-eEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEe
Q 003384 462 ATHNFDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY 538 (824)
Q Consensus 462 ~~~~f~~~~~LG~G~fG~Vykg~~~~-~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey 538 (824)
..++|...+.||+|+||.||+|.+.+ ..||||++.... .....+.+|+.++..++||||++++++|. ...++||||
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 34578899999999999999998875 579999997643 23567999999999999999999999985 457999999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccc
Q 003384 539 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 618 (824)
Q Consensus 539 ~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 618 (824)
+++|+|.+++... ...+++..+..++.+++.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 101 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 175 (283)
T 3gen_A 101 MANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 175 (283)
T ss_dssp CTTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred cCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence 9999999999542 3459999999999999999999999 8999999999999999999999999999986654322
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHHHHhhhccccccCCCCCCC
Q 003384 619 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDW 697 (824)
Q Consensus 619 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~ 697 (824)
.. .....||+.|+|||++.+..++.++|||||||++|+|+| |++||............. .......
T Consensus 176 ~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~------~~~~~~~ 242 (283)
T 3gen_A 176 TS-------SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA------QGLRLYR 242 (283)
T ss_dssp HS-------TTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH------TTCCCCC
T ss_pred cc-------ccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHh------cccCCCC
Confidence 11 123457889999999999999999999999999999998 999997654433221111 1111223
Q ss_pred ChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHh
Q 003384 698 PFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 736 (824)
Q Consensus 698 p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~ 736 (824)
+...+..+.+++.+||+.+|.+||++ +++++.|..+..
T Consensus 243 ~~~~~~~l~~li~~~l~~~p~~Rps~-~~ll~~L~~~~~ 280 (283)
T 3gen_A 243 PHLASEKVYTIMYSCWHEKADERPTF-KILLSNILDVMD 280 (283)
T ss_dssp CTTCCHHHHHHHHHTTCSSGGGSCCH-HHHHHHHHHHHH
T ss_pred CCcCCHHHHHHHHHHccCChhHCcCH-HHHHHHHHHHhh
Confidence 44456789999999999999999999 677777776643
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=354.48 Aligned_cols=244 Identities=22% Similarity=0.333 Sum_probs=197.7
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC------CchhHHHHHHHHHhcCCCceeeEecccC--CceE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ------GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWT 533 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~------~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~ 533 (824)
+.|...+.||+|+||.||+|... +..||||++...... ....+.+|+.+|+.++||||++++++|. ...+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 36889999999999999999986 688999998764322 2457999999999999999999999884 4689
Q ss_pred EEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCC----cceeecccc
Q 003384 534 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF----VSKLSDFGI 609 (824)
Q Consensus 534 LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~----~vKL~DFGl 609 (824)
+||||+++|+|.+++. ....+++..+..++.|++.||.|||+ ++|+||||||+|||++.++ .+||+|||+
T Consensus 91 lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 91 LILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp EEEECCCSCBHHHHHT---TSSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEcCCCCCHHHHHH---hcCCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 9999999999999994 34569999999999999999999999 8999999999999999877 899999999
Q ss_pred ccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccc
Q 003384 610 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNL 689 (824)
Q Consensus 610 a~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ 689 (824)
++....... .....||+.|+|||++.+..++.++|||||||++|+|++|++||.................
T Consensus 165 a~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~- 234 (326)
T 2y0a_A 165 AHKIDFGNE---------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY- 234 (326)
T ss_dssp CEECCTTSC---------CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCC-
T ss_pred CeECCCCCc---------cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCC-
Confidence 987643221 1234699999999999999999999999999999999999999976544322111111100
Q ss_pred cCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 690 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 690 ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
......+...+..+.+|+.+||+.+|.+||++.+
T Consensus 235 --~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 268 (326)
T 2y0a_A 235 --EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQD 268 (326)
T ss_dssp --CCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred --CcCccccccCCHHHHHHHHHHccCChhhCCCHHH
Confidence 0000111234568899999999999999999943
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=359.70 Aligned_cols=264 Identities=24% Similarity=0.384 Sum_probs=211.8
Q ss_pred CCChhhHhhhcCCCCccceeeecCceEEEEEEEC-------CeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeE
Q 003384 453 DFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTL 524 (824)
Q Consensus 453 ~~~~~ei~~~~~~f~~~~~LG~G~fG~Vykg~~~-------~~~VAvK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~L 524 (824)
.+..+++....++|...+.||+|+||.||+|.+. +..||||++..... .....+.+|+.+++.++||||+++
T Consensus 14 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 93 (322)
T 1p4o_A 14 VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRL 93 (322)
T ss_dssp CCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCE
T ss_pred ccChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeee
Confidence 3445566677788999999999999999999765 46799999875432 123458899999999999999999
Q ss_pred ecccC--CceEEEEEecCCCChhhhhhccC-------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEE
Q 003384 525 VGACP--EVWTLVYEYLPNGSLEDRLSCKD-------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANIL 595 (824)
Q Consensus 525 ~g~~~--~~~~LV~Ey~~ggsL~~~L~~~~-------~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NIL 595 (824)
++++. +..++||||+++|+|.+++.... ...++++..++.++.+++.||.|||+ +||+||||||+|||
T Consensus 94 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIl 170 (322)
T 1p4o_A 94 LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCM 170 (322)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEE
T ss_pred EEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEE
Confidence 99984 46899999999999999986421 12567899999999999999999999 89999999999999
Q ss_pred ecCCCcceeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCc
Q 003384 596 LDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGIT 674 (824)
Q Consensus 596 ld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~ 674 (824)
++.++.+||+|||+++......... ......||+.|+|||++.+..++.++|||||||++|+|+| |++||...
T Consensus 171 i~~~~~~kl~Dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 244 (322)
T 1p4o_A 171 VAEDFTVKIGDFGMTRDIYETDYYR------KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 244 (322)
T ss_dssp ECTTCCEEECCTTCCCGGGGGGCEE------GGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS
T ss_pred EcCCCeEEECcCccccccccccccc------cccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccC
Confidence 9999999999999998664432111 1123457899999999999999999999999999999999 89999765
Q ss_pred hHHHH--HHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHH
Q 003384 675 KEVQY--ALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 734 (824)
Q Consensus 675 ~~~~~--~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l 734 (824)
..... .+..+. ....+...+..+.+|+.+||+.+|.+||++ .++++.|+.+
T Consensus 245 ~~~~~~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~e~l~~L~~~ 297 (322)
T 1p4o_A 245 SNEQVLRFVMEGG--------LLDKPDNCPDMLFELMRMCWQYNPKMRPSF-LEIISSIKEE 297 (322)
T ss_dssp CHHHHHHHHHTTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHGGG
T ss_pred CHHHHHHHHHcCC--------cCCCCCCCCHHHHHHHHHHcCCCcccCcCH-HHHHHHHHHh
Confidence 43221 111111 122344556789999999999999999999 6777777665
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=350.75 Aligned_cols=255 Identities=25% Similarity=0.326 Sum_probs=202.6
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCC-CCCchhHHHHHHHHHhcCCCceeeEecccCC----ceEEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS-LQGPSEFQQEIDILSKIRHPNLVTLVGACPE----VWTLVY 536 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~-~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~~----~~~LV~ 536 (824)
++|...+.||+|+||.||+|.+. +..||||++.... ......+.+|+.+|++++||||+++++++.. ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 46889999999999999999987 6889999997543 2335678899999999999999999998732 578999
Q ss_pred EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEe----cCCCcceeeccccccc
Q 003384 537 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL----DANFVSKLSDFGISRF 612 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILl----d~~~~vKL~DFGla~~ 612 (824)
||+++|+|.+++........+++..++.|+.|++.||.|||+ ++|+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 999999999999765555569999999999999999999999 899999999999999 7888999999999987
Q ss_pred cccccccCCCccccccCCCCCCcccCChhhhc--------cCCCCcchhHHhHHHHHHHHHhCCCCCCCch------HHH
Q 003384 613 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA--------SGELTPKSDVYSFGIILLRLLTGRPALGITK------EVQ 678 (824)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~--------~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~------~~~ 678 (824)
....... ....||+.|+|||++. +..++.++|||||||++|||+||++||.... ...
T Consensus 166 ~~~~~~~---------~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~ 236 (319)
T 4euu_A 166 LEDDEQF---------VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236 (319)
T ss_dssp CCTTCCB---------CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHH
T ss_pred cCCCCce---------eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHH
Confidence 6543211 2346999999999986 4678999999999999999999999995321 111
Q ss_pred HHHhhhccccc----------------cCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHH
Q 003384 679 YALDTGKLKNL----------------LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVL 731 (824)
Q Consensus 679 ~~~~~~~~~~~----------------ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~L 731 (824)
..+..+..... ..+.....+...+..+.+|+.+||+.+|.+||++ +++++..
T Consensus 237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~-~ell~h~ 304 (319)
T 4euu_A 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF-DQFFAET 304 (319)
T ss_dssp HHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCH-HHHHHHH
T ss_pred HHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccH-HHhhhcc
Confidence 11111111000 0011123445677899999999999999999999 4454443
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=347.56 Aligned_cols=242 Identities=26% Similarity=0.343 Sum_probs=191.1
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC--------------------------CchhHHHHHHHHH
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--------------------------GPSEFQQEIDILS 514 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~--------------------------~~~~f~~Ei~iL~ 514 (824)
.++|...+.||+|+||.||+|... +..||||++...... ..+.+.+|+.+|+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 357899999999999999999875 588999998754321 1356899999999
Q ss_pred hcCCCceeeEecccC----CceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccc
Q 003384 515 KIRHPNLVTLVGACP----EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLK 590 (824)
Q Consensus 515 ~l~HpnIv~L~g~~~----~~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLK 590 (824)
.++||||+++++++. ...++||||+++|+|.+++. ..++++..+..++.|++.||.|||+ ++|+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT----LKPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC----SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCC
Confidence 999999999999874 35789999999999988762 3569999999999999999999999 899999999
Q ss_pred CCcEEecCCCcceeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCC---CCcchhHHhHHHHHHHHHhC
Q 003384 591 PANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE---LTPKSDVYSFGIILLRLLTG 667 (824)
Q Consensus 591 p~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~---~t~ksDVwSlGvvL~ELltG 667 (824)
|+|||++.++.+||+|||+++.+...... .....||+.|+|||++.+.. ++.++|||||||++|+|++|
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g 236 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDAL--------LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFG 236 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSCE--------ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHS
T ss_pred HHHEEECCCCCEEEecCCCcccccccccc--------ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHC
Confidence 99999999999999999999866433211 13456999999999997765 37789999999999999999
Q ss_pred CCCCCCchHHHHHHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChH
Q 003384 668 RPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 668 ~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
++||............. ...+. ...+...+..+.+|+.+||+.+|.+||++.
T Consensus 237 ~~pf~~~~~~~~~~~~~--~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~R~s~~ 288 (298)
T 2zv2_A 237 QCPFMDERIMCLHSKIK--SQALE---FPDQPDIAEDLKDLITRMLDKNPESRIVVP 288 (298)
T ss_dssp SCSSCCSSHHHHHHHHH--HCCCC---CCSSSCCCHHHHHHHHHHTCSCTTTSCCHH
T ss_pred CCCCCCccHHHHHHHHh--cccCC---CCCccccCHHHHHHHHHHhhcChhhCCCHH
Confidence 99997654332211110 01010 011223457899999999999999999984
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=347.44 Aligned_cols=259 Identities=25% Similarity=0.392 Sum_probs=204.3
Q ss_pred cCCCCccceeeecCceEEEEEEECC-----eEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEeccc---CCceE
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLRH-----MQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGAC---PEVWT 533 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~~-----~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~L~g~~---~~~~~ 533 (824)
...|...+.||+|+||.||+|.+.. ..||+|.+...... ....+.+|+.++++++||||++++++| ....+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 3468888999999999999998642 35899998753321 235688999999999999999999986 33678
Q ss_pred EEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccc
Q 003384 534 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 613 (824)
Q Consensus 534 LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~ 613 (824)
+||||+++|+|.+++.. ....+++..++.++.+++.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 104 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECcccccccc
Confidence 99999999999999953 34568999999999999999999999 89999999999999999999999999999876
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHHHHhhhccccccCC
Q 003384 614 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDP 692 (824)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~~~~~~~~~ld~ 692 (824)
......... ......||+.|+|||.+.+..++.++|||||||++|+|++ |.+||............. ..
T Consensus 179 ~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~------~~ 248 (298)
T 3f66_A 179 YDKEYYSVH----NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL------QG 248 (298)
T ss_dssp SCGGGCBC---------CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHH------TT
T ss_pred cccchhccc----cccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh------cC
Confidence 544322111 1234568899999999999999999999999999999999 677776543322111110 01
Q ss_pred CCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhh
Q 003384 693 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 737 (824)
Q Consensus 693 ~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~~ 737 (824)
.....+...+..+.+++.+||+.+|.+||++ +++++.|+.+...
T Consensus 249 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-~ell~~L~~~~~~ 292 (298)
T 3f66_A 249 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSF-SELVSRISAIFST 292 (298)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHT
T ss_pred CCCCCCccCCHHHHHHHHHHcCCChhhCcCH-HHHHHHHHHHHHh
Confidence 1112234456789999999999999999999 7888888887664
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=356.08 Aligned_cols=245 Identities=26% Similarity=0.351 Sum_probs=194.1
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEe
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY 538 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey 538 (824)
++|...+.||+|+||.||+|.+. +..||||++..... ...+.+.+|+.+++.++||||+++++++. ...++||||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 47899999999999999999886 58899999875432 22457899999999999999999999984 467899999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccc
Q 003384 539 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 618 (824)
Q Consensus 539 ~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 618 (824)
++||+|.+++. ....+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+++.+.....
T Consensus 87 ~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 160 (323)
T 3tki_A 87 CSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (323)
T ss_dssp CTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred CCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence 99999999984 34569999999999999999999999 8999999999999999999999999999986643321
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCCC-CcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCC
Q 003384 619 SSNNTTLCCRTDPKGTFAYMDPEFLASGEL-TPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 697 (824)
Q Consensus 619 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~ 697 (824)
... .....||+.|+|||++.+..+ +.++|||||||++|+|+||++||................. .....
T Consensus 161 ~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~----~~~~~ 230 (323)
T 3tki_A 161 ERL------LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK----TYLNP 230 (323)
T ss_dssp ECC------BCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTC----TTSTT
T ss_pred ccc------cCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccc----ccCCc
Confidence 111 134569999999999988775 7789999999999999999999975432111111100000 00011
Q ss_pred ChhhHHHHHHHHHHHhhhccCCCCChH
Q 003384 698 PFVQAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 698 p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
....+..+.+|+.+||+.+|.+||++.
T Consensus 231 ~~~~~~~~~~li~~~L~~dP~~R~t~~ 257 (323)
T 3tki_A 231 WKKIDSAPLALLHKILVENPSARITIP 257 (323)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHH
Confidence 234567889999999999999999984
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=350.39 Aligned_cols=259 Identities=24% Similarity=0.390 Sum_probs=208.6
Q ss_pred hhcCCCCccceeeecCceEEEEEEEC-------CeEEEEEEecCCCCC-CchhHHHHHHHHHhc-CCCceeeEecccC--
Q 003384 461 GATHNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKI-RHPNLVTLVGACP-- 529 (824)
Q Consensus 461 ~~~~~f~~~~~LG~G~fG~Vykg~~~-------~~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l-~HpnIv~L~g~~~-- 529 (824)
...++|...+.||+|+||.||+|.+. +..||||++...... ....+.+|+.+++++ +||||++++++|.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 99 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence 34567999999999999999999852 368999999765321 235688999999999 9999999999984
Q ss_pred CceEEEEEecCCCChhhhhhccCC---------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcE
Q 003384 530 EVWTLVYEYLPNGSLEDRLSCKDN---------------SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANI 594 (824)
Q Consensus 530 ~~~~LV~Ey~~ggsL~~~L~~~~~---------------~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NI 594 (824)
+..++||||+++|+|.+++..... ...+++..++.++.+++.||.|||+ +||+||||||+||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Ni 176 (313)
T 1t46_A 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNI 176 (313)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGE
T ss_pred CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceE
Confidence 468999999999999999965432 2358999999999999999999999 8999999999999
Q ss_pred EecCCCcceeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCC
Q 003384 595 LLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGI 673 (824)
Q Consensus 595 Lld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~ 673 (824)
|++.++.+||+|||++.......... ......||+.|+|||++.+..++.++|||||||++|+|+| |++||..
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 250 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKNDSNYV------VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG 250 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSE------ECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred EEcCCCCEEEccccccccccccccce------eccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 99999999999999998765432111 1123457889999999999999999999999999999999 9999975
Q ss_pred chH---HHHHHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhh
Q 003384 674 TKE---VQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 737 (824)
Q Consensus 674 ~~~---~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~~ 737 (824)
... .......+ . ....+...+..+.+|+.+||+.+|.+||++ .++++.|+.+...
T Consensus 251 ~~~~~~~~~~~~~~-----~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~ell~~L~~~~~~ 308 (313)
T 1t46_A 251 MPVDSKFYKMIKEG-----F---RMLSPEHAPAEMYDIMKTCWDADPLKRPTF-KQIVQLIEKQISE 308 (313)
T ss_dssp CCSSHHHHHHHHHT-----C---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHH
T ss_pred ccchhHHHHHhccC-----C---CCCCcccCCHHHHHHHHHHcCCCchhCcCH-HHHHHHHHHHHHH
Confidence 432 11111111 1 111234456789999999999999999999 7788888876654
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=368.17 Aligned_cols=246 Identities=22% Similarity=0.277 Sum_probs=195.3
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCC---CCCchhHHHHHHHHHhc-CCCceeeEecccC--CceEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTLV 535 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~---~~~~~~f~~Ei~iL~~l-~HpnIv~L~g~~~--~~~~LV 535 (824)
.+|...++||+|+||.||+|... +..||||++.... ......+..|..+|.++ +||||++++++|. +..++|
T Consensus 52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV 131 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 131 (396)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence 46889999999999999999886 5789999997542 22345688999999887 8999999999984 468999
Q ss_pred EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccc
Q 003384 536 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 615 (824)
Q Consensus 536 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~ 615 (824)
|||++||+|.+++... ..+++..+..++.||+.||.|||+ ++||||||||+||||+.+|.+||+|||+|+....
T Consensus 132 ~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 132 IEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEcCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 9999999999998543 469999999999999999999999 8999999999999999999999999999985332
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHH--hhhccccccCCC
Q 003384 616 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYAL--DTGKLKNLLDPL 693 (824)
Q Consensus 616 ~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~--~~~~~~~~ld~~ 693 (824)
.... .....||+.|+|||++.+..|+.++|||||||++|||++|++||.......... ....+...+...
T Consensus 206 ~~~~--------~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~ 277 (396)
T 4dc2_A 206 PGDT--------TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK 277 (396)
T ss_dssp TTCC--------BCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC
T ss_pred CCCc--------cccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc
Confidence 2111 134569999999999999999999999999999999999999996431110000 000000001011
Q ss_pred CCCCChhhHHHHHHHHHHHhhhccCCCCCh
Q 003384 694 AGDWPFVQAEQLANLAMRCCEMSRKSRPEL 723 (824)
Q Consensus 694 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 723 (824)
...+|...+..+.+|+.+||+.+|.+||+.
T Consensus 278 ~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 278 QIRIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred ccCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 223455667889999999999999999985
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=362.50 Aligned_cols=267 Identities=16% Similarity=0.231 Sum_probs=201.6
Q ss_pred hcCCCCccceeeecCceEEEEEEECC-------eEEEEEEecCCCCCC-----------chhHHHHHHHHHhcCCCceee
Q 003384 462 ATHNFDPSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQG-----------PSEFQQEIDILSKIRHPNLVT 523 (824)
Q Consensus 462 ~~~~f~~~~~LG~G~fG~Vykg~~~~-------~~VAvK~l~~~~~~~-----------~~~f~~Ei~iL~~l~HpnIv~ 523 (824)
..++|...+.||+|+||.||+|.+.. ..||||++....... ...+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 45589999999999999999998853 579999987543110 112334555666778999999
Q ss_pred EecccCC------ceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEec
Q 003384 524 LVGACPE------VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD 597 (824)
Q Consensus 524 L~g~~~~------~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld 597 (824)
+++++.. ..+|||||+ ||+|.+++.. ....+++..++.|+.||+.||.|||+ ++|+||||||+||||+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEEe
Confidence 9998843 378999999 9999999964 23569999999999999999999999 8999999999999999
Q ss_pred --CCCcceeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCch
Q 003384 598 --ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITK 675 (824)
Q Consensus 598 --~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~ 675 (824)
.++.+||+|||+++.+.......... ........||+.|+|||++.+..++.++|||||||+||||+||+.||....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYA-ADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSS-CCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred cCCCCeEEEEECCcceecccCCcccccc-cCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 88999999999998776543221111 111134569999999999999999999999999999999999999997421
Q ss_pred H---HHHHHh---hhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhhC
Q 003384 676 E---VQYALD---TGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC 738 (824)
Q Consensus 676 ~---~~~~~~---~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~~~ 738 (824)
. ...... ...+..+++.... +...+..+.+++..||+.+|.+||++ +.+.+.|+.+....
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~RP~~-~~l~~~l~~~~~~~ 331 (364)
T 3op5_A 266 KDPKYVRDSKIRYRENIASLMDKCFP--AANAPGEIAKYMETVKLLDYTEKPLY-ENLRDILLQGLKAI 331 (364)
T ss_dssp TCHHHHHHHHHHHHHCHHHHHHHHSC--TTCCCHHHHHHHHHHHTCCTTCCCCH-HHHHHHHHHHHHHT
T ss_pred cCHHHHHHHHHHhhhhHHHHHHHhcc--cccCHHHHHHHHHHHhcCCCCCCCCH-HHHHHHHHHHHHHc
Confidence 1 111011 1111222211110 12335689999999999999999999 78888888876654
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=341.32 Aligned_cols=253 Identities=25% Similarity=0.459 Sum_probs=208.2
Q ss_pred CCCCccceeeecCceEEEEEEEC-CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEecC
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLP 540 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~-~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey~~ 540 (824)
++|...+.||+|+||.||+|.+. +..||+|++..... ..+.+.+|+.+++.++||||+++++++. +..++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 46888999999999999999985 57899999976542 3467999999999999999999999984 46899999999
Q ss_pred CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccC
Q 003384 541 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 620 (824)
Q Consensus 541 ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 620 (824)
+|+|.+++... ...+++..+..++.+++.||.|||+ ++|+||||||+|||++.++.+||+|||++..........
T Consensus 87 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 161 (267)
T 3t9t_A 87 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 161 (267)
T ss_dssp TCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred CCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEcccccccccccccccc
Confidence 99999999543 3468999999999999999999999 899999999999999999999999999998664332111
Q ss_pred CCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHHHHhhhccccccCCCCCCCCh
Q 003384 621 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPF 699 (824)
Q Consensus 621 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~ 699 (824)
.....||+.|+|||++.+..++.++||||||+++|+|+| |++||............. .......+.
T Consensus 162 -------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~------~~~~~~~~~ 228 (267)
T 3t9t_A 162 -------STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS------TGFRLYKPR 228 (267)
T ss_dssp -------TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH------TTCCCCCCT
T ss_pred -------cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHh------cCCcCCCCc
Confidence 123457889999999999999999999999999999999 899997654332211111 011112234
Q ss_pred hhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHh
Q 003384 700 VQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 736 (824)
Q Consensus 700 ~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~ 736 (824)
..+..+.+++.+||+.+|.+||++ .++++.|+.+..
T Consensus 229 ~~~~~l~~li~~~l~~~p~~Rps~-~~ll~~L~~l~~ 264 (267)
T 3t9t_A 229 LASTHVYQIMNHCWRERPEDRPAF-SRLLRQLAEIAE 264 (267)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHH
T ss_pred cCcHHHHHHHHHHccCChhhCcCH-HHHHHHHHHHHh
Confidence 456789999999999999999999 778888888765
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=363.27 Aligned_cols=240 Identities=24% Similarity=0.286 Sum_probs=195.2
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCC---CCCCchhHHHHHHHHHhc-CCCceeeEecccC--CceEE
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH---SLQGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTL 534 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~---~~~~~~~f~~Ei~iL~~l-~HpnIv~L~g~~~--~~~~L 534 (824)
.++|...+.||+|+||.||+|... +..||||++... .......+.+|..+|..+ +||||+++++++. +..++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 357999999999999999999886 578999998753 122345688999999998 7999999999984 46899
Q ss_pred EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccc
Q 003384 535 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 614 (824)
Q Consensus 535 V~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~ 614 (824)
||||++||+|.+++... ..+++..+..++.+|+.||.|||+ +||+||||||+||||+.+|.+||+|||+|+...
T Consensus 102 v~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 99999999999999543 458999999999999999999999 899999999999999999999999999998543
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCC
Q 003384 615 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 694 (824)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~ 694 (824)
..... .....||+.|+|||++.+..|+.++|||||||++|||+||++||............. . ..
T Consensus 176 ~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~--~-----~~ 240 (353)
T 3txo_A 176 CNGVT--------TATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL--N-----DE 240 (353)
T ss_dssp C-----------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--H-----CC
T ss_pred cCCcc--------ccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHH--c-----CC
Confidence 22111 134569999999999999899999999999999999999999998665432211110 0 11
Q ss_pred CCCChhhHHHHHHHHHHHhhhccCCCCCh
Q 003384 695 GDWPFVQAEQLANLAMRCCEMSRKSRPEL 723 (824)
Q Consensus 695 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 723 (824)
..+|...+..+.+|+.+||+.+|.+||+.
T Consensus 241 ~~~p~~~~~~~~~li~~lL~~dP~~R~~~ 269 (353)
T 3txo_A 241 VVYPTWLHEDATGILKSFMTKNPTMRLGS 269 (353)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred CCCCCCCCHHHHHHHHHHhhhCHHHccCC
Confidence 22345567789999999999999999997
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=378.06 Aligned_cols=253 Identities=27% Similarity=0.487 Sum_probs=208.9
Q ss_pred hhcCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEE
Q 003384 461 GATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 536 (824)
Q Consensus 461 ~~~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~ 536 (824)
....+|...+.||+|+||.||+|.+. +..||||++.... ...+.|.+|+.+|++++||||++++|+|. +..+|||
T Consensus 217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 295 (495)
T 1opk_A 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 295 (495)
T ss_dssp CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence 34557888999999999999999987 5789999997643 34678999999999999999999999984 4689999
Q ss_pred EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccc
Q 003384 537 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 616 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 616 (824)
||+++|+|.++|... ....+++..++.|+.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++.....
T Consensus 296 E~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 371 (495)
T 1opk_A 296 EFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371 (495)
T ss_dssp ECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred EccCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence 999999999999643 23568999999999999999999999 89999999999999999999999999999876533
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHH--HHHHhhhccccccCCC
Q 003384 617 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEV--QYALDTGKLKNLLDPL 693 (824)
Q Consensus 617 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~--~~~~~~~~~~~~ld~~ 693 (824)
.... .....+|+.|+|||++.+..++.++|||||||+||||+| |++||...... ...+..+ .
T Consensus 372 ~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~--------~ 436 (495)
T 1opk_A 372 TYTA-------HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD--------Y 436 (495)
T ss_dssp CEEC-------CTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT--------C
T ss_pred ceee-------cCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--------C
Confidence 2111 123457889999999999999999999999999999999 99999754321 1111111 1
Q ss_pred CCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHH
Q 003384 694 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 734 (824)
Q Consensus 694 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l 734 (824)
....|...+..+.+|+.+||+.+|.+||++ .++++.|+.+
T Consensus 437 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-~el~~~L~~~ 476 (495)
T 1opk_A 437 RMERPEGCPEKVYELMRACWQWNPSDRPSF-AEIHQAFETM 476 (495)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHTS
T ss_pred CCCCCCCCCHHHHHHHHHHcCcChhHCcCH-HHHHHHHHHH
Confidence 223345567889999999999999999999 6777777654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=353.77 Aligned_cols=234 Identities=26% Similarity=0.381 Sum_probs=196.1
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCC---CCCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH---SLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 536 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~---~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~ 536 (824)
.+|...+.||+|+||.||+|... +..||||++... .......+.+|+.+++.++||||+++++++. ...++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 46888999999999999999885 688999998653 2234567889999999999999999999984 4689999
Q ss_pred EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccc
Q 003384 537 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 616 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 616 (824)
||++||+|.+++.. ...+++..+..++.+|+.||.|||+ +||+||||||+|||++.+|.+||+|||+++.....
T Consensus 86 e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~ 159 (318)
T 1fot_A 86 DYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 159 (318)
T ss_dssp CCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence 99999999999953 3468999999999999999999999 89999999999999999999999999999865422
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCC
Q 003384 617 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 696 (824)
Q Consensus 617 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~ 696 (824)
. ....||+.|+|||++.+..++.++|||||||++|||++|++||............ ... ...
T Consensus 160 ~-----------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i--~~~-----~~~ 221 (318)
T 1fot_A 160 T-----------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI--LNA-----ELR 221 (318)
T ss_dssp B-----------CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH--HHC-----CCC
T ss_pred c-----------ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH--HhC-----CCC
Confidence 1 2346999999999999999999999999999999999999999765443221111 001 112
Q ss_pred CChhhHHHHHHHHHHHhhhccCCCC
Q 003384 697 WPFVQAEQLANLAMRCCEMSRKSRP 721 (824)
Q Consensus 697 ~p~~~~~~l~~Li~~Cl~~~P~~RP 721 (824)
+|...+..+.+|+.+||..+|.+||
T Consensus 222 ~p~~~~~~~~~li~~lL~~dp~~R~ 246 (318)
T 1fot_A 222 FPPFFNEDVKDLLSRLITRDLSQRL 246 (318)
T ss_dssp CCTTSCHHHHHHHHHHTCSCTTTCT
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcC
Confidence 4455667899999999999999999
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=372.79 Aligned_cols=256 Identities=31% Similarity=0.488 Sum_probs=205.5
Q ss_pred HhhhcCCCCccceeeecCceEEEEEEECC-eEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC-CceEEEE
Q 003384 459 IEGATHNFDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVY 536 (824)
Q Consensus 459 i~~~~~~f~~~~~LG~G~fG~Vykg~~~~-~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~-~~~~LV~ 536 (824)
......+|...+.||+|+||.||+|.+.+ ..||||+++... ...+.|.+|+.+|++++||||++++++|. +..++||
T Consensus 179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~iv~ 257 (452)
T 1fmk_A 179 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVT 257 (452)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEE
T ss_pred cccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcCCceEEEe
Confidence 33445678899999999999999999986 679999998654 34578999999999999999999999985 4688999
Q ss_pred EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccc
Q 003384 537 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 616 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 616 (824)
||+++|+|.++|... ....+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 258 e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 258 EYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 333 (452)
T ss_dssp CCCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred hhhcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence 999999999999532 22458999999999999999999999 89999999999999999999999999999876543
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHH--HHHhhhccccccCCC
Q 003384 617 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--YALDTGKLKNLLDPL 693 (824)
Q Consensus 617 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~--~~~~~~~~~~~ld~~ 693 (824)
.... .....+|+.|+|||++.++.++.++|||||||+||||+| |++||....... ..+..+ .
T Consensus 334 ~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~--------~ 398 (452)
T 1fmk_A 334 EYTA-------RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG--------Y 398 (452)
T ss_dssp ----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT--------C
T ss_pred ceec-------ccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--------C
Confidence 2111 123457889999999999999999999999999999999 999997654322 112221 1
Q ss_pred CCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHH
Q 003384 694 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 735 (824)
Q Consensus 694 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~ 735 (824)
....|...+..+.+|+.+||+.+|.+||++ +++.+.|+.+.
T Consensus 399 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~-~~l~~~L~~~~ 439 (452)
T 1fmk_A 399 RMPCPPECPESLHDLMCQCWRKEPEERPTF-EYLQAFLEDYF 439 (452)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHTTT
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCcCH-HHHHHHHHHHh
Confidence 122344567789999999999999999999 77878887654
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=359.01 Aligned_cols=242 Identities=24% Similarity=0.302 Sum_probs=199.3
Q ss_pred hcCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCC---CCCchhHHHHHHHHHhc-CCCceeeEecccC--CceE
Q 003384 462 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWT 533 (824)
Q Consensus 462 ~~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~---~~~~~~f~~Ei~iL~~l-~HpnIv~L~g~~~--~~~~ 533 (824)
...+|...+.||+|+||.||+|... +..||||+++... ......+..|..++..+ +||||+++++++. +..+
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 4467999999999999999999986 5889999997531 23455688999999987 8999999999984 4689
Q ss_pred EEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccc
Q 003384 534 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 613 (824)
Q Consensus 534 LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~ 613 (824)
+||||++||+|.+++... ..+++..+..++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||+++..
T Consensus 95 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp EEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 999999999999999543 458999999999999999999999 89999999999999999999999999999854
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCC
Q 003384 614 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPL 693 (824)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~ 693 (824)
...... .....||+.|+|||++.+..++.++|||||||++|||++|++||............. . .
T Consensus 169 ~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~--~-----~ 233 (345)
T 1xjd_A 169 MLGDAK--------TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR--M-----D 233 (345)
T ss_dssp CCTTCC--------BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--H-----C
T ss_pred ccCCCc--------ccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH--h-----C
Confidence 322111 134569999999999999999999999999999999999999997655432211110 0 0
Q ss_pred CCCCChhhHHHHHHHHHHHhhhccCCCCChH
Q 003384 694 AGDWPFVQAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 694 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
...+|...+..+.+|+.+||..+|.+||++.
T Consensus 234 ~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~ 264 (345)
T 1xjd_A 234 NPFYPRWLEKEAKDLLVKLFVREPEKRLGVR 264 (345)
T ss_dssp CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTB
T ss_pred CCCCCcccCHHHHHHHHHHhcCCHhHcCCCh
Confidence 1224455678899999999999999999983
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=340.76 Aligned_cols=262 Identities=19% Similarity=0.232 Sum_probs=206.6
Q ss_pred cCCCCccceeeecCceEEEEEEE--CCeEEEEEEecCCCCCCchhHHHHHHHHHhc-CCCceeeEecccC--CceEEEEE
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTLVYE 537 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~--~~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l-~HpnIv~L~g~~~--~~~~LV~E 537 (824)
.++|...+.||+|+||.||+|.. .+..||||++.... ....+.+|+.++..+ +|||++++++++. ...++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 45799999999999999999996 46899999986543 345789999999999 7999999999884 46789999
Q ss_pred ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCc-----ceeeccccccc
Q 003384 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV-----SKLSDFGISRF 612 (824)
Q Consensus 538 y~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~-----vKL~DFGla~~ 612 (824)
|+ +++|.+++... ..++++..+..++.|++.||.|||+ +||+||||||+|||++.++. +||+|||+++.
T Consensus 87 ~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 87 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 99 99999999643 3469999999999999999999999 89999999999999987765 99999999987
Q ss_pred cccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchH-----HHHHHhhhccc
Q 003384 613 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE-----VQYALDTGKLK 687 (824)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~-----~~~~~~~~~~~ 687 (824)
........... ........||+.|+|||++.+..++.++|||||||++|+|+||++||..... ....+..+...
T Consensus 161 ~~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T 1csn_A 161 YRDPVTKQHIP-YREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 239 (298)
T ss_dssp SBCTTTCCBCC-CCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred ccccccccccc-ccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence 65443221111 0112456799999999999999999999999999999999999999975321 11111111110
Q ss_pred cccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhhC
Q 003384 688 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC 738 (824)
Q Consensus 688 ~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~~~ 738 (824)
... .......+..+.+|+.+||+.+|.+||++ +++.+.|+.+....
T Consensus 240 ~~~----~~~~~~~~~~l~~li~~~l~~dp~~RP~~-~~l~~~l~~~~~~~ 285 (298)
T 1csn_A 240 TPL----RELCAGFPEEFYKYMHYARNLAFDATPDY-DYLQGLFSKVLERL 285 (298)
T ss_dssp SCH----HHHTTTSCHHHHHHHHHHHHCCTTCCCCH-HHHHHHHHHHHHHT
T ss_pred ccH----HHHHhhCcHHHHHHHHHHhcCCcccCCCH-HHHHHHHHHHHHhc
Confidence 100 00112345689999999999999999999 78889998876643
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=364.47 Aligned_cols=243 Identities=26% Similarity=0.360 Sum_probs=197.8
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCC---CCCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH---SLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 536 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~---~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~ 536 (824)
++|...+.||+|+||.||+|... +..||||++... .......+.+|+.+|+.++|||||+++++|. +..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 46889999999999999999886 478999998643 2233467889999999999999999999984 4689999
Q ss_pred EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccc
Q 003384 537 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 616 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 616 (824)
||+.||+|.+++.. ...+++..+..++.+|+.||.|||+ +||+||||||+||||+.+|.+||+|||+++.+...
T Consensus 95 e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp CCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 99999999999953 4569999999999999999999999 89999999999999999999999999999876432
Q ss_pred cccCCCccccccCCCCCCcccCChhhhcc---CCCCcchhHHhHHHHHHHHHhCCCCCCCchHH--HHHHhhhccccccC
Q 003384 617 EISSNNTTLCCRTDPKGTFAYMDPEFLAS---GELTPKSDVYSFGIILLRLLTGRPALGITKEV--QYALDTGKLKNLLD 691 (824)
Q Consensus 617 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~---~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~--~~~~~~~~~~~~ld 691 (824)
.. .....||+.|+|||++.+ ..|+.++|||||||++|+|+||++||...... ...... + .
T Consensus 169 ~~---------~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~--~----~ 233 (384)
T 4fr4_A 169 TQ---------ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT--F----E 233 (384)
T ss_dssp CC---------BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHH--H----H
T ss_pred Cc---------eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHH--H----h
Confidence 21 134569999999999864 46899999999999999999999999643211 111111 0 0
Q ss_pred CCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 003384 692 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 727 (824)
Q Consensus 692 ~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 727 (824)
.....+|...+..+.+|+.+||+.+|.+||+..+++
T Consensus 234 ~~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l 269 (384)
T 4fr4_A 234 TTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDV 269 (384)
T ss_dssp HCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHH
T ss_pred hcccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHH
Confidence 112234555678999999999999999999953444
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=346.24 Aligned_cols=256 Identities=25% Similarity=0.411 Sum_probs=207.8
Q ss_pred CCCCccc-eeeecCceEEEEEEEC----CeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccC-CceEEEE
Q 003384 464 HNFDPSL-KIGEGGYGSIYKGLLR----HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVY 536 (824)
Q Consensus 464 ~~f~~~~-~LG~G~fG~Vykg~~~----~~~VAvK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~-~~~~LV~ 536 (824)
.+|.... .||+|+||.||+|.+. +..||||++..... .....+.+|+.+++.++||||+++++++. +..++||
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~lv~ 88 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVM 88 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecCCCcEEEE
Confidence 3555555 8999999999999863 56799999976432 22456889999999999999999999984 4688999
Q ss_pred EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccc
Q 003384 537 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 616 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 616 (824)
||+++|+|.+++.. ....+++..+..++.+++.||.|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 89 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 163 (287)
T 1u59_A 89 EMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163 (287)
T ss_dssp ECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence 99999999999853 34569999999999999999999999 89999999999999999999999999999876543
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHH--HHHhhhccccccCCC
Q 003384 617 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--YALDTGKLKNLLDPL 693 (824)
Q Consensus 617 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~--~~~~~~~~~~~ld~~ 693 (824)
..... ......||+.|+|||++.+..++.++|||||||++|+|+| |++||....... ..+..+ .
T Consensus 164 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~--------~ 230 (287)
T 1u59_A 164 DSYYT-----ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG--------K 230 (287)
T ss_dssp SCEEC-----CCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT--------C
T ss_pred cceee-----ccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcC--------C
Confidence 21111 1133457899999999998899999999999999999998 999997544322 112221 1
Q ss_pred CCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhhC
Q 003384 694 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC 738 (824)
Q Consensus 694 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~~~ 738 (824)
....+...+..+.+++.+||+.+|.+||++ .++++.|+.+..+.
T Consensus 231 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-~~l~~~l~~~~~~~ 274 (287)
T 1u59_A 231 RMECPPECPPELYALMSDCWIYKWEDRPDF-LTVEQRMRACYYSL 274 (287)
T ss_dssp CCCCCTTCCHHHHHHHHHTTCSSGGGSCCH-HHHHHHHHHHHHHH
T ss_pred cCCCCCCcCHHHHHHHHHHcCCChhhCcCH-HHHHHHHHHHHHhc
Confidence 123345567799999999999999999999 77888888887654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=355.20 Aligned_cols=246 Identities=20% Similarity=0.279 Sum_probs=197.6
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEe
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY 538 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey 538 (824)
.++|...+.||+|+||.||+|... +..||+|++.... .....+.+|+.+|+.++||||+++++++. +..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 457899999999999999999986 5789999987532 23456889999999999999999999984 568999999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecC--CCcceeeccccccccccc
Q 003384 539 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA--NFVSKLSDFGISRFLSQN 616 (824)
Q Consensus 539 ~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~--~~~vKL~DFGla~~~~~~ 616 (824)
++||+|.+++.. ....+++..+..++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||++..+...
T Consensus 83 ~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 999999999943 23469999999999999999999999 89999999999999987 789999999999876543
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCC
Q 003384 617 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 696 (824)
Q Consensus 617 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~ 696 (824)
... ....||+.|+|||++.+..++.++|||||||++|+|++|.+||............. ........ .
T Consensus 158 ~~~---------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~--~~~~~~~~-~ 225 (321)
T 1tki_A 158 DNF---------RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIM--NAEYTFDE-E 225 (321)
T ss_dssp CEE---------EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--HTCCCCCH-H
T ss_pred Ccc---------ccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHH--cCCCCCCh-h
Confidence 211 12348999999999998889999999999999999999999997654432211110 00010000 0
Q ss_pred CChhhHHHHHHHHHHHhhhccCCCCChHHH
Q 003384 697 WPFVQAEQLANLAMRCCEMSRKSRPELGKD 726 (824)
Q Consensus 697 ~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~ 726 (824)
.....+..+.+|+.+||..+|.+||++.+.
T Consensus 226 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~ 255 (321)
T 1tki_A 226 AFKEISIEAMDFVDRLLVKERKSRMTASEA 255 (321)
T ss_dssp HHTTSCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred hhccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 011345689999999999999999999443
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=347.02 Aligned_cols=254 Identities=25% Similarity=0.424 Sum_probs=203.3
Q ss_pred hcCCCCccceeeecCceEEEEEEECC-----eEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccC-CceEE
Q 003384 462 ATHNFDPSLKIGEGGYGSIYKGLLRH-----MQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTL 534 (824)
Q Consensus 462 ~~~~f~~~~~LG~G~fG~Vykg~~~~-----~~VAvK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~-~~~~L 534 (824)
..++|...+.||+|+||.||+|.+.+ ..||||++..... .....+.+|+.+++.++||||+++++++. +..++
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 89 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWI 89 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSSSCEE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCEE
Confidence 34578899999999999999998643 3599999876532 22456889999999999999999999985 45789
Q ss_pred EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccc
Q 003384 535 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 614 (824)
Q Consensus 535 V~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~ 614 (824)
||||+++|+|.+++... ...+++..+..++.+++.||.|||+ +||+||||||+|||++.++.+||+|||++....
T Consensus 90 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 90 IMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp EEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred EEecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 99999999999999643 3458999999999999999999999 899999999999999999999999999998765
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchH--HHHHHhhhccccccC
Q 003384 615 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKE--VQYALDTGKLKNLLD 691 (824)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~--~~~~~~~~~~~~~ld 691 (824)
...... .....||+.|+|||++.+..++.++|||||||++|+|+| |++||..... ....+..+.
T Consensus 165 ~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~------ 231 (281)
T 3cc6_A 165 DEDYYK-------ASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGD------ 231 (281)
T ss_dssp ---------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTC------
T ss_pred cccccc-------cccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCC------
Confidence 432111 123457899999999999999999999999999999998 9999964322 222222211
Q ss_pred CCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHh
Q 003384 692 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 736 (824)
Q Consensus 692 ~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~ 736 (824)
....+...+..+.+++.+||..+|.+||++ .++++.|+.+..
T Consensus 232 --~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-~ell~~L~~~~~ 273 (281)
T 3cc6_A 232 --RLPKPDLCPPVLYTLMTRCWDYDPSDRPRF-TELVCSLSDVYQ 273 (281)
T ss_dssp --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHH
T ss_pred --CCCCCCCCCHHHHHHHHHHccCCchhCcCH-HHHHHHHHHHHH
Confidence 112234456789999999999999999999 778888887654
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=352.96 Aligned_cols=262 Identities=25% Similarity=0.332 Sum_probs=199.0
Q ss_pred hhcCCCCccceeeecCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhc--CCCceeeEecccC------Cce
Q 003384 461 GATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKI--RHPNLVTLVGACP------EVW 532 (824)
Q Consensus 461 ~~~~~f~~~~~LG~G~fG~Vykg~~~~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l--~HpnIv~L~g~~~------~~~ 532 (824)
...++|...+.||+|+||.||+|.+++..||||++... ....+..|.+++..+ +||||+++++++. ...
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 110 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL 110 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred ccccceEEEeEeecCCCeEEEEEEECCceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence 34457999999999999999999999999999998643 234566777777665 8999999999873 457
Q ss_pred EEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhc-----CCCceEeccccCCcEEecCCCcceeecc
Q 003384 533 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC-----KPHSIVHGDLKPANILLDANFVSKLSDF 607 (824)
Q Consensus 533 ~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~-----~~~giiHrDLKp~NILld~~~~vKL~DF 607 (824)
++||||+++|+|.+++.. ..+++..++.++.+++.||.|||+. +..+|+||||||+|||++.++.+||+||
T Consensus 111 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 186 (337)
T 3mdy_A 111 YLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL 186 (337)
T ss_dssp EEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeC
Confidence 899999999999999953 3589999999999999999999982 0128999999999999999999999999
Q ss_pred ccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcc------hhHHhHHHHHHHHHhC----------CCCC
Q 003384 608 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPK------SDVYSFGIILLRLLTG----------RPAL 671 (824)
Q Consensus 608 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~k------sDVwSlGvvL~ELltG----------~~Pf 671 (824)
|+++.+......... ......||+.|+|||++.+..++.. +|||||||++|||+|| +.||
T Consensus 187 g~a~~~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~ 262 (337)
T 3mdy_A 187 GLAVKFISDTNEVDI----PPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262 (337)
T ss_dssp TTCEECC-------------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred CCceeeccccccccC----CCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence 999866543321111 1134569999999999988766655 9999999999999999 6666
Q ss_pred CCchH---HHHHHhhhccccccCCCCCCCC-----hhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhh
Q 003384 672 GITKE---VQYALDTGKLKNLLDPLAGDWP-----FVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 737 (824)
Q Consensus 672 ~~~~~---~~~~~~~~~~~~~ld~~~~~~p-----~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~~ 737 (824)
..... ............ ......+ ...+..+.+|+.+||+.+|.+||++ .++++.|+.+...
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-~ell~~L~~l~~~ 332 (337)
T 3mdy_A 263 HDLVPSDPSYEDMREIVCIK---KLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTA-LRVKKTLAKMSES 332 (337)
T ss_dssp TTTSCSSCCHHHHHHHHTTS---CCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCH-HHHHHHHHHHHHT
T ss_pred hhhcCCCCchhhhHHHHhhh---ccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCH-HHHHHHHHHHHhh
Confidence 43210 000001100011 1111222 2567789999999999999999999 7888999888764
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=370.20 Aligned_cols=254 Identities=23% Similarity=0.259 Sum_probs=201.0
Q ss_pred hhHhhhcCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCC---CCCCchhHHHHHHHHHhcCCCceeeEecccC--
Q 003384 457 SEIEGATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH---SLQGPSEFQQEIDILSKIRHPNLVTLVGACP-- 529 (824)
Q Consensus 457 ~ei~~~~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~---~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~-- 529 (824)
.++.....+|...++||+|+||+||+|.+. +..||||++... .......+.+|+.++..++||||++++++|.
T Consensus 67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 146 (437)
T 4aw2_A 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDD 146 (437)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred hcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC
Confidence 344555678999999999999999999986 478999998642 1222345899999999999999999999984
Q ss_pred CceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccc
Q 003384 530 EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI 609 (824)
Q Consensus 530 ~~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGl 609 (824)
+..+|||||++||+|.++|... ...+++..+..++.+++.||.|||+ ++||||||||+||||+.+|.+||+|||+
T Consensus 147 ~~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~DFGl 221 (437)
T 4aw2_A 147 NNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGS 221 (437)
T ss_dssp SEEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEcchhh
Confidence 4689999999999999999642 3569999999999999999999999 8999999999999999999999999999
Q ss_pred ccccccccccCCCccccccCCCCCCcccCChhhhc-----cCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhh
Q 003384 610 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA-----SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG 684 (824)
Q Consensus 610 a~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~-----~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~ 684 (824)
|+........ ......||+.|+|||++. ...|+.++|||||||++|||+||++||............-
T Consensus 222 a~~~~~~~~~-------~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~ 294 (437)
T 4aw2_A 222 CLKLMEDGTV-------QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 294 (437)
T ss_dssp CEECCTTSCE-------ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred hhhcccCCCc-------ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhh
Confidence 9865443211 113356999999999987 4578999999999999999999999998765433221111
Q ss_pred ccccccCCCCCCCChhhHHHHHHHHHHHhhhccCC--CCChH
Q 003384 685 KLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKS--RPELG 724 (824)
Q Consensus 685 ~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~--RPt~~ 724 (824)
.....+ .........+..+.+|+.+||..+|++ ||++.
T Consensus 295 ~~~~~~--~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~ 334 (437)
T 4aw2_A 295 NHKERF--QFPTQVTDVSENAKDLIRRLICSREHRLGQNGIE 334 (437)
T ss_dssp THHHHC--CCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTH
T ss_pred hccccc--cCCcccccCCHHHHHHHHHHhcccccccCCCCHH
Confidence 100001 111112235678999999999888887 99983
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=356.13 Aligned_cols=244 Identities=23% Similarity=0.411 Sum_probs=197.8
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEecccC--CceEEEE
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 536 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~ 536 (824)
..+|...+.||+|+||.||+|... +..||||++...... ....+.+|+.+++.++||||++++++|. ...++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 347899999999999999999986 578999999765432 2346889999999999999999999984 4688999
Q ss_pred EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCC---Ccceeecccccccc
Q 003384 537 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN---FVSKLSDFGISRFL 613 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~---~~vKL~DFGla~~~ 613 (824)
||++||+|.+.+. ....+++..+..++.||+.||.|||+ ++|+||||||+|||++.+ +.+||+|||++...
T Consensus 108 e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 108 DLVTGGELFEDIV---AREFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp CCCCSCBHHHHHT---TCSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred ecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 9999999999884 34568999999999999999999999 899999999999999864 46999999999866
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHH--HHhhhccccccC
Q 003384 614 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQY--ALDTGKLKNLLD 691 (824)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~--~~~~~~~~~~ld 691 (824)
..... .....||+.|+|||++.+..|+.++|||||||++|+|++|++||........ .+..+.. .
T Consensus 182 ~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~----~ 248 (362)
T 2bdw_A 182 NDSEA---------WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY----D 248 (362)
T ss_dssp TTCCS---------CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC----C
T ss_pred cCCcc---------cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC----C
Confidence 53221 1234699999999999999999999999999999999999999976544322 1122211 1
Q ss_pred CCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHH
Q 003384 692 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD 726 (824)
Q Consensus 692 ~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~ 726 (824)
.....| ...+..+.+|+.+||+.+|.+||++.+.
T Consensus 249 ~~~~~~-~~~~~~~~~li~~~L~~dP~~R~t~~e~ 282 (362)
T 2bdw_A 249 YPSPEW-DTVTPEAKSLIDSMLTVNPKKRITADQA 282 (362)
T ss_dssp CCTTGG-GGSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred CCcccc-cCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 111111 2346789999999999999999999443
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=355.46 Aligned_cols=263 Identities=24% Similarity=0.356 Sum_probs=207.7
Q ss_pred CCCCccceeeecCceEEEEEEE------CCeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC----CceE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLL------RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP----EVWT 533 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~------~~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~----~~~~ 533 (824)
.+|...+.||+|+||.||+|.+ .+..||||++..........+.+|+.++++++||||+++++++. ...+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 4788999999999999999985 35789999998654444456899999999999999999999872 3478
Q ss_pred EEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccc
Q 003384 534 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 613 (824)
Q Consensus 534 LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~ 613 (824)
+||||+++|+|.+++... ...+++..++.|+.+++.||.|||+ ++|+||||||+|||++.++.+||+|||++...
T Consensus 103 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEcccccceec
Confidence 999999999999999643 2358999999999999999999999 89999999999999999999999999999876
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHh---------hh
Q 003384 614 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALD---------TG 684 (824)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~---------~~ 684 (824)
....... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||........... ..
T Consensus 178 ~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 252 (327)
T 3lxl_A 178 PLDKDYY-----VVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR 252 (327)
T ss_dssp CTTCSEE-----ECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHH
T ss_pred ccCCccc-----eeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHH
Confidence 5332111 112345689999999999999999999999999999999999999865432211000 00
Q ss_pred ccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhh
Q 003384 685 KLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 737 (824)
Q Consensus 685 ~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~~ 737 (824)
....+........+...+..+.+|+.+||+.+|.+||++ .++++.|+.+...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-~ell~~L~~~~~~ 304 (327)
T 3lxl_A 253 LLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSF-SALGPQLDMLWSG 304 (327)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHC---
T ss_pred HHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCH-HHHHHHHHHHHhh
Confidence 000111112233455667889999999999999999999 7787888876543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=361.96 Aligned_cols=256 Identities=27% Similarity=0.419 Sum_probs=195.4
Q ss_pred CCCccceeeecCceEEEEEEEC--C---eEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccC---CceEEE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--H---MQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP---EVWTLV 535 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~---~~VAvK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~---~~~~LV 535 (824)
.|...+.||+|+||.||+|.+. + ..||||.+..... .....|.+|+.++++++||||++++++|. ...++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4677789999999999999863 2 3589999875432 22457899999999999999999999862 367899
Q ss_pred EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccc
Q 003384 536 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 615 (824)
Q Consensus 536 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~ 615 (824)
|||+++|+|.+++.. ....+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.+..
T Consensus 170 ~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp EECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeeccccccccc
Confidence 999999999999953 34568899999999999999999999 8999999999999999999999999999986644
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHH--HHHHhhhccccccCC
Q 003384 616 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEV--QYALDTGKLKNLLDP 692 (824)
Q Consensus 616 ~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~--~~~~~~~~~~~~ld~ 692 (824)
...... .......||+.|+|||++.+..++.++|||||||++|||+| |.+||...... ...+..+.
T Consensus 245 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~------- 313 (373)
T 3c1x_A 245 KEFDSV----HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR------- 313 (373)
T ss_dssp -----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTC-------
T ss_pred cccccc----cccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCC-------
Confidence 322111 11133457899999999999999999999999999999999 78888654321 11112211
Q ss_pred CCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhhC
Q 003384 693 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC 738 (824)
Q Consensus 693 ~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~~~ 738 (824)
....|...+..+.+++.+||+.+|.+||++ .++++.|+.+....
T Consensus 314 -~~~~p~~~~~~l~~li~~cl~~dp~~RPs~-~ell~~L~~i~~~~ 357 (373)
T 3c1x_A 314 -RLLQPEYCPDPLYEVMLKCWHPKAEMRPSF-SELVSRISAIFSTF 357 (373)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHTC
T ss_pred -CCCCCCCCCHHHHHHHHHHcCCChhhCcCH-HHHHHHHHHHHHhc
Confidence 112244556789999999999999999999 78888888887654
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=342.22 Aligned_cols=256 Identities=25% Similarity=0.371 Sum_probs=203.9
Q ss_pred CCCccceeeecCceEEEEEEECC-----eEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccC--Cc-eEEE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLRH-----MQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EV-WTLV 535 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~~-----~~VAvK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~-~~LV 535 (824)
.|...++||+|+||.||+|.+.. ..||+|++..... ...+.+.+|+.+++.++||||+++++++. +. .++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 46667899999999999998632 3699999875332 12356889999999999999999999984 33 4899
Q ss_pred EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccc
Q 003384 536 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 615 (824)
Q Consensus 536 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~ 615 (824)
|||+.+|+|.+++.. ....+++..+..++.+++.||.|||+ +||+||||||+|||++.++.+||+|||+++.+..
T Consensus 102 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 999999999999953 34568999999999999999999999 8999999999999999999999999999986654
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHH--HHHhhhccccccCC
Q 003384 616 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--YALDTGKLKNLLDP 692 (824)
Q Consensus 616 ~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~--~~~~~~~~~~~ld~ 692 (824)
........ .....||+.|+|||.+.+..++.++|||||||++|+|+| |.+||....... ..+..+
T Consensus 177 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~-------- 244 (298)
T 3pls_A 177 REYYSVQQ----HRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQG-------- 244 (298)
T ss_dssp GGGGCSCC----SSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTT--------
T ss_pred Cccccccc----CcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcC--------
Confidence 33221111 134568999999999999999999999999999999999 556665433221 111111
Q ss_pred CCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhhC
Q 003384 693 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC 738 (824)
Q Consensus 693 ~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~~~ 738 (824)
.....+...+..+.+++.+||+.+|.+||++ +++++.|+.+....
T Consensus 245 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-~~ll~~l~~~~~~l 289 (298)
T 3pls_A 245 RRLPQPEYCPDSLYQVMQQCWEADPAVRPTF-RVLVGEVEQIVSAL 289 (298)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHHC
T ss_pred CCCCCCccchHHHHHHHHHHccCChhhCcCH-HHHHHHHHHHHHHH
Confidence 1122344456789999999999999999999 78888888887654
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=346.64 Aligned_cols=256 Identities=28% Similarity=0.489 Sum_probs=209.8
Q ss_pred hhhcCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEE
Q 003384 460 EGATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLV 535 (824)
Q Consensus 460 ~~~~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV 535 (824)
.....+|...+.||+|+||.||+|.+. +..||||++.... .....+.+|+.+++.++||||+++++++. ...++|
T Consensus 9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v 87 (288)
T 3kfa_A 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 87 (288)
T ss_dssp BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEE
Confidence 345568999999999999999999987 5789999997543 33567999999999999999999999984 468999
Q ss_pred EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccc
Q 003384 536 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 615 (824)
Q Consensus 536 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~ 615 (824)
|||+++|+|.+++... ....+++..++.++.+++.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 88 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 163 (288)
T 3kfa_A 88 TEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 163 (288)
T ss_dssp EECCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred EEcCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence 9999999999999643 34569999999999999999999999 7899999999999999999999999999987653
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHH--HHHhhhccccccCC
Q 003384 616 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--YALDTGKLKNLLDP 692 (824)
Q Consensus 616 ~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~--~~~~~~~~~~~ld~ 692 (824)
..... .....||+.|+|||++.+..++.++|||||||++|+|++ |.+||....... ..+.. .
T Consensus 164 ~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~--------~ 228 (288)
T 3kfa_A 164 DTYTA-------HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK--------D 228 (288)
T ss_dssp SSSEE-------ETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT--------T
T ss_pred Ccccc-------ccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc--------c
Confidence 32111 123347889999999999999999999999999999999 999997543221 11111 1
Q ss_pred CCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHh
Q 003384 693 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 736 (824)
Q Consensus 693 ~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~ 736 (824)
.....+...+..+.+|+.+||..+|.+||++ .++++.|+.+..
T Consensus 229 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~~~~~~l~~~~~ 271 (288)
T 3kfa_A 229 YRMERPEGCPEKVYELMRACWQWNPSDRPSF-AEIHQAFETMFQ 271 (288)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHhCCChhhCcCH-HHHHHHHHHHHH
Confidence 1122344556789999999999999999999 677888876644
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=352.38 Aligned_cols=265 Identities=25% Similarity=0.389 Sum_probs=196.0
Q ss_pred cCCCCccceeeecCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHH--hcCCCceeeEeccc-----C--CceE
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILS--KIRHPNLVTLVGAC-----P--EVWT 533 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~~~~VAvK~l~~~~~~~~~~f~~Ei~iL~--~l~HpnIv~L~g~~-----~--~~~~ 533 (824)
.++|...+.||+|+||.||+|.+.+..||||++... ....+..|.+++. .++||||+++++.+ . ..++
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 88 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL 88 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred hHHhheeeecccCCCeEEEEEEECCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence 357889999999999999999999999999998643 2345566666644 58999999999744 1 2468
Q ss_pred EEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC------CCceEeccccCCcEEecCCCcceeecc
Q 003384 534 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK------PHSIVHGDLKPANILLDANFVSKLSDF 607 (824)
Q Consensus 534 LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~------~~giiHrDLKp~NILld~~~~vKL~DF 607 (824)
+||||+++|+|.+++... .+++..+..|+.|++.||.|||+.. ..+|+||||||+||||+.++.+||+||
T Consensus 89 lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DF 164 (336)
T 3g2f_A 89 LVMEYYPNGSLXKYLSLH----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDF 164 (336)
T ss_dssp EEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCC
T ss_pred EEEecCCCCcHHHHHhhc----ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeec
Confidence 999999999999999532 3588999999999999999999921 019999999999999999999999999
Q ss_pred ccccccccccccCCCccccccCCCCCCcccCChhhhcc-------CCCCcchhHHhHHHHHHHHHhCCCCCC-Cch----
Q 003384 608 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-------GELTPKSDVYSFGIILLRLLTGRPALG-ITK---- 675 (824)
Q Consensus 608 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-------~~~t~ksDVwSlGvvL~ELltG~~Pf~-~~~---- 675 (824)
|+++.+...................||+.|+|||++.+ ..++.++|||||||++|||+||..||. ...
T Consensus 165 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~ 244 (336)
T 3g2f_A 165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY 244 (336)
T ss_dssp TTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCC
T ss_pred cceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHH
Confidence 99987654332211111111234569999999999976 356678999999999999999976552 111
Q ss_pred ---------------HHHHHHhhhccccccCCCCCCC--ChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhhC
Q 003384 676 ---------------EVQYALDTGKLKNLLDPLAGDW--PFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC 738 (824)
Q Consensus 676 ---------------~~~~~~~~~~~~~~ld~~~~~~--p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~~~ 738 (824)
............. .....+ ....+..+.+|+.+||+.+|.+||++ +++++.|+.+....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-~e~l~~L~~ll~~~ 320 (336)
T 3g2f_A 245 QMAFQTEVGNHPTFEDMQVLVSREKQRP---KFPEAWKENSLAVRSLKETIEDCWDQDAEARLTA-QXAEERMAELMMIW 320 (336)
T ss_dssp CCTTHHHHCSSCCHHHHHHHHTTSCCCC---CCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCH-HHHHHHHHHHHHCC
T ss_pred HHhhhcccCCCchHHHHHhhhcccccCC---CCCcccccccchHHHHHHHHHHHhcCChhhCcch-HHHHHHHHHHHHHH
Confidence 0000011110001 111111 22356789999999999999999999 78889999887654
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=366.73 Aligned_cols=249 Identities=24% Similarity=0.272 Sum_probs=198.7
Q ss_pred HhhhcCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCC---CCCCchhHHHHHHHHHhcCCCceeeEecccC--Cc
Q 003384 459 IEGATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH---SLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EV 531 (824)
Q Consensus 459 i~~~~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~---~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~ 531 (824)
+.....+|...+.||+|+||.||+|... +..||+|++... .......+.+|+.+++.++||||++++++|. ..
T Consensus 64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 143 (410)
T 3v8s_A 64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 143 (410)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence 3344567999999999999999999986 578999998642 1233456899999999999999999999984 46
Q ss_pred eEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccc
Q 003384 532 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR 611 (824)
Q Consensus 532 ~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~ 611 (824)
.++||||++||+|.+++.. ..+++..+..++.+|+.||.|||+ +|||||||||+||||+.+|.+||+|||+|+
T Consensus 144 ~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFG~a~ 216 (410)
T 3v8s_A 144 LYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCM 216 (410)
T ss_dssp EEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEeccceeE
Confidence 8999999999999999853 358899999999999999999999 899999999999999999999999999998
Q ss_pred ccccccccCCCccccccCCCCCCcccCChhhhccCC----CCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccc
Q 003384 612 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE----LTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLK 687 (824)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~----~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~ 687 (824)
........ ......||+.|+|||++.+.. |+.++|||||||+||||+||++||................
T Consensus 217 ~~~~~~~~-------~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~ 289 (410)
T 3v8s_A 217 KMNKEGMV-------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK 289 (410)
T ss_dssp ECCTTSEE-------ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH
T ss_pred eeccCCcc-------cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcc
Confidence 66543211 113457999999999998765 7899999999999999999999998665433221111100
Q ss_pred cccCCCCCCCChhhHHHHHHHHHHHhhhccCC--CCChH
Q 003384 688 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKS--RPELG 724 (824)
Q Consensus 688 ~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~--RPt~~ 724 (824)
..+. .......+..+.+|+.+||..+|.+ ||++.
T Consensus 290 ~~~~---~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ 325 (410)
T 3v8s_A 290 NSLT---FPDDNDISKEAKNLICAFLTDREVRLGRNGVE 325 (410)
T ss_dssp HHCC---CCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHH
T ss_pred cccc---CCCcccccHHHHHHHHHHccChhhhCCCCCHH
Confidence 0010 0111235678999999999999988 99983
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=346.09 Aligned_cols=249 Identities=26% Similarity=0.447 Sum_probs=200.4
Q ss_pred cCCCCccceeeecCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC---CceEEEEEec
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP---EVWTLVYEYL 539 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~---~~~~LV~Ey~ 539 (824)
.++|...+.||+|+||.||+|.+.+..||||++.... ..+.+.+|+.+++.++||||+++++++. ...++||||+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 97 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 97 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred hhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence 4578999999999999999999999999999987543 4567999999999999999999999863 3579999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccccc
Q 003384 540 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 619 (824)
Q Consensus 540 ~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 619 (824)
++|+|.+++.... ...+++..+..++.+++.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 98 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 171 (278)
T 1byg_A 98 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 171 (278)
T ss_dssp TTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeeccccccccccc--
Confidence 9999999995431 2237889999999999999999999 899999999999999999999999999987544321
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHH--HHHHhhhccccccCCCCCC
Q 003384 620 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEV--QYALDTGKLKNLLDPLAGD 696 (824)
Q Consensus 620 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~--~~~~~~~~~~~~ld~~~~~ 696 (824)
....+|+.|+|||++.+..++.++|||||||++|+|+| |++||...... ...+..+ ....
T Consensus 172 ---------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~--------~~~~ 234 (278)
T 1byg_A 172 ---------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG--------YKMD 234 (278)
T ss_dssp -------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT--------CCCC
T ss_pred ---------cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC--------CCCC
Confidence 12347899999999999999999999999999999998 99999754321 1111111 1122
Q ss_pred CChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhh
Q 003384 697 WPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 737 (824)
Q Consensus 697 ~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~~ 737 (824)
.+...+..+.+++.+||+.+|.+||++ .++++.|+.+...
T Consensus 235 ~~~~~~~~l~~li~~~l~~~p~~Rps~-~~l~~~L~~i~~~ 274 (278)
T 1byg_A 235 APDGCPPAVYEVMKNCWHLDAAMRPSF-LQLREQLEHIKTH 274 (278)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHH
T ss_pred CcccCCHHHHHHHHHHhcCChhhCCCH-HHHHHHHHHHHhh
Confidence 344567789999999999999999999 7888888887653
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=347.03 Aligned_cols=260 Identities=24% Similarity=0.416 Sum_probs=204.3
Q ss_pred CCCCccceeeecCceEEEEEEE------CCeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccC----Cce
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLL------RHMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP----EVW 532 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~------~~~~VAvK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~----~~~ 532 (824)
..|...+.||+|+||.||+|.+ .+..||||++..... .....+.+|+.+++.++||||+++++++. ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4588899999999999999985 358899999975432 33467999999999999999999999883 347
Q ss_pred EEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccc
Q 003384 533 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 612 (824)
Q Consensus 533 ~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~ 612 (824)
++||||+++|+|.+++... ...+++..++.++.+++.||.|||+ ++|+||||||+|||++.++.+||+|||++..
T Consensus 101 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKN--KNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECccccccc
Confidence 8999999999999999543 3458999999999999999999999 8999999999999999999999999999987
Q ss_pred cccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHh--------hh
Q 003384 613 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALD--------TG 684 (824)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~--------~~ 684 (824)
........ .......||..|+|||++.+..++.++|||||||++|+|+||.+|+........... ..
T Consensus 176 ~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (302)
T 4e5w_A 176 IETDKEYY-----TVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVT 250 (302)
T ss_dssp CCTTCCEE-----ECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHH
T ss_pred ccCCCcce-----eccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHH
Confidence 65432111 112345689999999999999999999999999999999999998753321110000 00
Q ss_pred c-cccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHH
Q 003384 685 K-LKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 734 (824)
Q Consensus 685 ~-~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l 734 (824)
. ...+........+...+..+.+|+.+||+.+|.+||++ +++++.|+.+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~~ll~~L~~l 300 (302)
T 4e5w_A 251 RLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSF-QNLIEGFEAL 300 (302)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCH-HHHHHHHHHH
T ss_pred HHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHHH
Confidence 0 00111112223455567899999999999999999999 7788888765
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=351.94 Aligned_cols=254 Identities=23% Similarity=0.389 Sum_probs=200.0
Q ss_pred cCCCCccceeeecCceEEEEEEEC--Ce----EEEEEEecCCC-CCCchhHHHHHHHHHhcCCCceeeEecccC-CceEE
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HM----QVAIKMLHPHS-LQGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTL 534 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~----~VAvK~l~~~~-~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~-~~~~L 534 (824)
..+|...+.||+|+||.||+|.+. +. .||+|.+.... ......+.+|+.+++.++||||++++++|. ...++
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 93 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL 93 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSSEEE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCCceE
Confidence 357999999999999999999875 32 46888876542 334567999999999999999999999984 46789
Q ss_pred EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccc
Q 003384 535 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 614 (824)
Q Consensus 535 V~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~ 614 (824)
|++|+.+|+|.+++... ...+++..++.|+.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.+.
T Consensus 94 v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred EEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 99999999999999643 3568999999999999999999999 899999999999999999999999999998765
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHH--HHHHhhhccccccC
Q 003384 615 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEV--QYALDTGKLKNLLD 691 (824)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~--~~~~~~~~~~~~ld 691 (824)
....... .....||+.|+|||++.+..++.++|||||||++|+|+| |++||...... ...+..+
T Consensus 169 ~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~------- 235 (327)
T 3lzb_A 169 AEEKEYH------AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG------- 235 (327)
T ss_dssp -----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT-------
T ss_pred Ccccccc------ccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-------
Confidence 4322111 123457889999999999999999999999999999999 99999764332 1111111
Q ss_pred CCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHh
Q 003384 692 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 736 (824)
Q Consensus 692 ~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~ 736 (824)
.....+...+..+.+|+.+||+.+|.+||++ .++++.|+.+..
T Consensus 236 -~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~ell~~L~~~~~ 278 (327)
T 3lzb_A 236 -ERLPQPPICTIDVYMIMRKCWMIDADSRPKF-RELIIEFSKMAR 278 (327)
T ss_dssp -CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHT
T ss_pred -CCCCCCccCCHHHHHHHHHHcCCChhHCcCH-HHHHHHHHHHHh
Confidence 1122344566789999999999999999999 778888887753
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=352.98 Aligned_cols=247 Identities=22% Similarity=0.304 Sum_probs=197.3
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCC-----CCCCchhHHHHHHHHHhcCCCceeeEecccC--CceEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH-----SLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTL 534 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~-----~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~L 534 (824)
+.|...+.||+|+||.||+|... +..||||++... .....+.+.+|+.+++.++||||+++++++. ...++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 36889999999999999999886 588999998532 1224567999999999999999999999884 46899
Q ss_pred EEEecCCCChhhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCc---ceeeccccc
Q 003384 535 VYEYLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV---SKLSDFGIS 610 (824)
Q Consensus 535 V~Ey~~ggsL~~~L~~~-~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~---vKL~DFGla 610 (824)
||||++||+|.+.+... .....+++..+..++.||+.||.|||+ ++|+||||||+|||++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 99999999998887543 234468999999999999999999999 89999999999999986554 999999999
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHH-HHHhhhccccc
Q 003384 611 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ-YALDTGKLKNL 689 (824)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~-~~~~~~~~~~~ 689 (824)
......... .....||+.|+|||++.+..++.++|||||||++|+|+||++||....... ..+..+..
T Consensus 181 ~~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~i~~~~~--- 249 (351)
T 3c0i_A 181 IQLGESGLV--------AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKY--- 249 (351)
T ss_dssp EECCTTSCB--------CCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHHHHHTCC---
T ss_pred eEecCCCee--------ecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHHHHcCCC---
Confidence 876543211 134569999999999999999999999999999999999999997754321 11111111
Q ss_pred cCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHH
Q 003384 690 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD 726 (824)
Q Consensus 690 ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~ 726 (824)
..... .....+..+.+|+.+||+.+|.+||++.+.
T Consensus 250 -~~~~~-~~~~~s~~~~~li~~~L~~dP~~R~s~~e~ 284 (351)
T 3c0i_A 250 -KMNPR-QWSHISESAKDLVRRMLMLDPAERITVYEA 284 (351)
T ss_dssp -CCCHH-HHTTSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred -CCCcc-ccccCCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 00000 001345689999999999999999999543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=356.12 Aligned_cols=246 Identities=24% Similarity=0.357 Sum_probs=184.6
Q ss_pred hhcCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEE
Q 003384 461 GATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 536 (824)
Q Consensus 461 ~~~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~ 536 (824)
...+.|...+.||+|+||.||+|.+. +..||||++.... ..+.+.+|+.+|++++||||++++++|. ...++||
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 127 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL 127 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence 44567999999999999999999986 4789999997643 3456889999999999999999999984 4688999
Q ss_pred EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecC---CCcceeecccccccc
Q 003384 537 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA---NFVSKLSDFGISRFL 613 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~---~~~vKL~DFGla~~~ 613 (824)
||+++|+|.+++. ....+++..+..++.|++.||.|||+ ++|+||||||+|||++. ++.+||+|||+++..
T Consensus 128 e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 128 ELVTGGELFDRIV---EKGYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp CCCCSCBHHHHHT---TCSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred EeCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 9999999999984 34568999999999999999999999 89999999999999975 889999999999865
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCC
Q 003384 614 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPL 693 (824)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~ 693 (824)
..... .....||+.|+|||++.+..++.++|||||||++|+|+||+.||............- ..... ..
T Consensus 202 ~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i-~~~~~-~~ 270 (349)
T 2w4o_A 202 EHQVL---------MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRI-LNCEY-YF 270 (349)
T ss_dssp --------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHH-HTTCC-CC
T ss_pred Ccccc---------cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHH-HhCCC-cc
Confidence 43221 123468999999999999999999999999999999999999996543322111110 00000 11
Q ss_pred CCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 694 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 694 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
...+....+..+.+|+.+||+.+|.+||++.+
T Consensus 271 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 302 (349)
T 2w4o_A 271 ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQ 302 (349)
T ss_dssp CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred CCchhhhCCHHHHHHHHHHccCChhhCcCHHH
Confidence 12223345678999999999999999999943
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=347.19 Aligned_cols=255 Identities=24% Similarity=0.406 Sum_probs=203.8
Q ss_pred cCCCCccc-eeeecCceEEEEEEEC----CeEEEEEEecCCCCCC--chhHHHHHHHHHhcCCCceeeEecccC-CceEE
Q 003384 463 THNFDPSL-KIGEGGYGSIYKGLLR----HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACP-EVWTL 534 (824)
Q Consensus 463 ~~~f~~~~-~LG~G~fG~Vykg~~~----~~~VAvK~l~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~L~g~~~-~~~~L 534 (824)
..+|.... .||+|+||.||+|.+. +..||||++....... ...+.+|+.+++.++||||+++++++. +..++
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~l 94 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWML 94 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECCCCcEE
Confidence 45677777 8999999999999653 3779999997653322 356899999999999999999999984 46789
Q ss_pred EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccc
Q 003384 535 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 614 (824)
Q Consensus 535 V~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~ 614 (824)
||||+++|+|.+++.. ...+++..++.++.+++.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 95 v~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 95 VMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 168 (291)
T ss_dssp EEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence 9999999999999954 3458999999999999999999999 899999999999999999999999999998765
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHH--HHhhhccccccC
Q 003384 615 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQY--ALDTGKLKNLLD 691 (824)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~--~~~~~~~~~~ld 691 (824)
....... ......||+.|+|||++.+..++.++|||||||++|+|+| |++||........ .+..+
T Consensus 169 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~------- 236 (291)
T 1xbb_A 169 ADENYYK-----AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG------- 236 (291)
T ss_dssp TTCSEEE-----C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-------
T ss_pred cCCCccc-----ccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-------
Confidence 4321111 1123457899999999998889999999999999999999 9999976543221 11111
Q ss_pred CCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhh
Q 003384 692 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 737 (824)
Q Consensus 692 ~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~~ 737 (824)
.....+...+..+.+++.+||+.+|.+||++ .++++.|+.+-..
T Consensus 237 -~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 237 -ERMGCPAGCPREMYDLMNLCWTYDVENRPGF-AAVELRLRNYYYD 280 (291)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCH-HHHHHHHHHHHHH
T ss_pred -CCCCCCCCCCHHHHHHHHHHcCCChhhCcCH-HHHHHHHHHHHHH
Confidence 1122345567789999999999999999999 7788888877543
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=349.54 Aligned_cols=266 Identities=25% Similarity=0.379 Sum_probs=211.9
Q ss_pred CChhhHhhhcCCCCccceeeecCceEEEEEEEC-------CeEEEEEEecCCCCC-CchhHHHHHHHHHhc-CCCceeeE
Q 003384 454 FSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKI-RHPNLVTL 524 (824)
Q Consensus 454 ~~~~ei~~~~~~f~~~~~LG~G~fG~Vykg~~~-------~~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l-~HpnIv~L 524 (824)
+...+.....++|...+.||+|+||.||+|.+. +..||||++...... ....+.+|+.++.++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 344555666778999999999999999999852 378999999764322 234688999999999 79999999
Q ss_pred ecccCC---ceEEEEEecCCCChhhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecc
Q 003384 525 VGACPE---VWTLVYEYLPNGSLEDRLSCKDN-------------SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGD 588 (824)
Q Consensus 525 ~g~~~~---~~~LV~Ey~~ggsL~~~L~~~~~-------------~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrD 588 (824)
+++|.. ..++||||+++|+|.+++..... ...+++..++.++.+++.||.|||+ +||+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCccccc
Confidence 999843 48999999999999999965432 1238899999999999999999999 8999999
Q ss_pred ccCCcEEecCCCcceeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-C
Q 003384 589 LKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-G 667 (824)
Q Consensus 589 LKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G 667 (824)
|||+|||++.++.+||+|||+++......... ......||+.|+|||++.+..++.++|||||||++|+|+| |
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g 247 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYV------RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG 247 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSE------EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred CccceEEECCCCCEEECCCccccccccCccce------eccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCC
Confidence 99999999999999999999998664332111 1123457899999999999999999999999999999998 9
Q ss_pred CCCCCCch---HHHHHHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhh
Q 003384 668 RPALGITK---EVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 737 (824)
Q Consensus 668 ~~Pf~~~~---~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~~ 737 (824)
++||.... .....+..+. ....+...+..+.+++.+||+.+|.+||++ .++++.|+.+...
T Consensus 248 ~~p~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~ell~~L~~~~~~ 311 (316)
T 2xir_A 248 ASPYPGVKIDEEFCRRLKEGT--------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTF-SELVEHLGNLLQA 311 (316)
T ss_dssp CCSSTTCCCSHHHHHHHHHTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHH
T ss_pred CCCCcccchhHHHHHHhccCc--------cCCCCCCCCHHHHHHHHHHcCCChhhCcCH-HHHHHHHHHHHhh
Confidence 99996543 2222222221 112234456789999999999999999999 7788888877653
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=351.82 Aligned_cols=239 Identities=26% Similarity=0.343 Sum_probs=187.8
Q ss_pred CCCCccceeeecCceEEEEEEE-----CCeEEEEEEecCCCC----CCchhHHHHHHHHHhcCCCceeeEecccC--Cce
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLL-----RHMQVAIKMLHPHSL----QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVW 532 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~-----~~~~VAvK~l~~~~~----~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~ 532 (824)
.+|...+.||+|+||.||++.. .+..||||++..... .....+.+|+.+|+.++||||+++++++. +..
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 4689999999999999999987 368899999976432 23446889999999999999999999984 468
Q ss_pred EEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccc
Q 003384 533 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 612 (824)
Q Consensus 533 ~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~ 612 (824)
++||||++||+|.+++... ..+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++.
T Consensus 97 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 97 YLILEYLSGGELFMQLERE---GIFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp EEEEECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EEEEeCCCCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 9999999999999999533 458899999999999999999999 8999999999999999999999999999875
Q ss_pred cccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCC
Q 003384 613 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDP 692 (824)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~ 692 (824)
....... .....||+.|+|||++.+..++.++|||||||++|+|++|++||............. ..
T Consensus 171 ~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~--~~---- 236 (327)
T 3a62_A 171 SIHDGTV--------THTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKIL--KC---- 236 (327)
T ss_dssp ----------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH--HT----
T ss_pred cccCCcc--------ccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHH--hC----
Confidence 4322211 123469999999999999999999999999999999999999997654432211110 00
Q ss_pred CCCCCChhhHHHHHHHHHHHhhhccCCCCCh
Q 003384 693 LAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 723 (824)
Q Consensus 693 ~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 723 (824)
...+|...+..+.+|+.+||..+|.+||++
T Consensus 237 -~~~~p~~~~~~~~~li~~~L~~dp~~R~~~ 266 (327)
T 3a62_A 237 -KLNLPPYLTQEARDLLKKLLKRNAASRLGA 266 (327)
T ss_dssp -CCCCCTTSCHHHHHHHHHHSCSCGGGSTTS
T ss_pred -CCCCCCCCCHHHHHHHHHHHhcCHhhccCC
Confidence 112344566789999999999999999953
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=357.68 Aligned_cols=233 Identities=22% Similarity=0.322 Sum_probs=197.2
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCC---CCCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH---SLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 536 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~---~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~ 536 (824)
++|...+.||+|+||.||+|... +..||||++... .......+.+|+.+|+.++||||+++++++. ...++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 46888999999999999999986 688999998643 2234567889999999999999999999984 4689999
Q ss_pred EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccc
Q 003384 537 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 616 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 616 (824)
||++||+|.+++... ..+++..+..++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceeccCC
Confidence 999999999999643 458999999999999999999999 89999999999999999999999999999865432
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHH--HhhhccccccCCCC
Q 003384 617 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA--LDTGKLKNLLDPLA 694 (824)
Q Consensus 617 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~--~~~~~~~~~ld~~~ 694 (824)
. ....||+.|+|||++.+..++.++|||||||++|+|++|++||......... +..+.
T Consensus 195 ~-----------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--------- 254 (350)
T 1rdq_E 195 T-----------WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--------- 254 (350)
T ss_dssp B-----------CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------
T ss_pred c-----------ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCC---------
Confidence 1 2345899999999999999999999999999999999999999765443221 11211
Q ss_pred CCCChhhHHHHHHHHHHHhhhccCCCCC
Q 003384 695 GDWPFVQAEQLANLAMRCCEMSRKSRPE 722 (824)
Q Consensus 695 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt 722 (824)
..+|...+..+.+|+.+||+.+|.+||+
T Consensus 255 ~~~p~~~~~~~~~li~~lL~~dp~~R~~ 282 (350)
T 1rdq_E 255 VRFPSHFSSDLKDLLRNLLQVDLTKRFG 282 (350)
T ss_dssp CCCCTTCCHHHHHHHHHHSCSCTTTCTT
T ss_pred CCCCCCCCHHHHHHHHHHhhcCHHhccC
Confidence 1234556778999999999999999998
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=357.50 Aligned_cols=246 Identities=22% Similarity=0.285 Sum_probs=195.6
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCC---chhHHHHHHHHHhc-CCCceeeEecccC--CceEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---PSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTLV 535 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~---~~~f~~Ei~iL~~l-~HpnIv~L~g~~~--~~~~LV 535 (824)
.+|...+.||+|+||.||+|... +..||||++....... ...+.+|+.++.++ +||||+++++++. ...++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 46888999999999999999986 5889999997653332 24578999999988 8999999999984 468999
Q ss_pred EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccc
Q 003384 536 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 615 (824)
Q Consensus 536 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~ 615 (824)
|||++||+|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.+|.+||+|||+++....
T Consensus 89 ~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 9999999999998543 468999999999999999999999 8999999999999999999999999999985432
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHH--HhhhccccccCCC
Q 003384 616 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA--LDTGKLKNLLDPL 693 (824)
Q Consensus 616 ~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~--~~~~~~~~~ld~~ 693 (824)
.... .....||+.|+|||++.+..++.++|||||||++|||++|++||......... .....+...+...
T Consensus 163 ~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~ 234 (345)
T 3a8x_A 163 PGDT--------TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK 234 (345)
T ss_dssp TTCC--------BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC
T ss_pred CCCc--------ccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC
Confidence 2111 13456999999999999999999999999999999999999999642110000 0000000000011
Q ss_pred CCCCChhhHHHHHHHHHHHhhhccCCCCCh
Q 003384 694 AGDWPFVQAEQLANLAMRCCEMSRKSRPEL 723 (824)
Q Consensus 694 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 723 (824)
...+|...+..+.+|+.+||+.+|.+||+.
T Consensus 235 ~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 235 QIRIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred CCCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 123455567789999999999999999995
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=348.90 Aligned_cols=248 Identities=25% Similarity=0.391 Sum_probs=198.4
Q ss_pred CCCCccceeeecCceEEEEEEECC---------eEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC--Cce
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLRH---------MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVW 532 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~~---------~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~ 532 (824)
.+|...+.||+|+||.||+|.+.. ..||+|++........+.+.+|+.+++.++||||++++++|. +..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 468889999999999999998753 469999997655445567999999999999999999999984 468
Q ss_pred EEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCc--------cee
Q 003384 533 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV--------SKL 604 (824)
Q Consensus 533 ~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~--------vKL 604 (824)
++||||+++|+|.+++... ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++. +||
T Consensus 88 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp EEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred EEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCcccccccceeee
Confidence 8999999999999999643 3348999999999999999999999 89999999999999998887 999
Q ss_pred eccccccccccccccCCCccccccCCCCCCcccCChhhhcc-CCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHHHHh
Q 003384 605 SDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALD 682 (824)
Q Consensus 605 ~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~~ 682 (824)
+|||++....... ...||+.|+|||++.+ ..++.++|||||||++|+|+| |.+||...........
T Consensus 163 ~Dfg~~~~~~~~~------------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~ 230 (289)
T 4fvq_A 163 SDPGISITVLPKD------------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF 230 (289)
T ss_dssp CCCCSCTTTSCHH------------HHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH
T ss_pred ccCcccccccCcc------------ccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHH
Confidence 9999987543321 1237889999999987 679999999999999999999 5566654433221111
Q ss_pred hhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhh
Q 003384 683 TGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 737 (824)
Q Consensus 683 ~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~~ 737 (824)
... ....+...+..+.+|+.+||+.+|.+||++ +++++.|+.+...
T Consensus 231 ~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~~ll~~l~~l~~p 276 (289)
T 4fvq_A 231 YED--------RHQLPAPKAAELANLINNCMDYEPDHRPSF-RAIIRDLNSLFTP 276 (289)
T ss_dssp HHT--------TCCCCCCSSCTTHHHHHHHSCSSGGGSCCH-HHHHHHHHTCC--
T ss_pred hhc--------cCCCCCCCCHHHHHHHHHHcCCChhHCcCH-HHHHHHHHHhcCC
Confidence 110 111222334578999999999999999999 7788888776543
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=349.66 Aligned_cols=259 Identities=27% Similarity=0.419 Sum_probs=204.9
Q ss_pred CCccceeeecCceEEEEEEE------CCeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccC----CceEE
Q 003384 466 FDPSLKIGEGGYGSIYKGLL------RHMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP----EVWTL 534 (824)
Q Consensus 466 f~~~~~LG~G~fG~Vykg~~------~~~~VAvK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~----~~~~L 534 (824)
|...+.||+|+||.||++.+ .+..||||++..... .....+.+|+.+|+.++||||+++++++. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 48889999999999999876 357899999976432 12346899999999999999999999984 35789
Q ss_pred EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccc
Q 003384 535 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 614 (824)
Q Consensus 535 V~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~ 614 (824)
||||+++|+|.+++.. ..+++..++.++.+++.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 113 v~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 9999999999999953 248999999999999999999999 899999999999999999999999999998765
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHH--------hhhcc
Q 003384 615 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYAL--------DTGKL 686 (824)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~--------~~~~~ 686 (824)
...... .......||+.|+|||++.+..++.++|||||||++|+|+||..||.......... ....+
T Consensus 186 ~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 260 (318)
T 3lxp_A 186 EGHEYY-----RVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRL 260 (318)
T ss_dssp TTCSEE-----EC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHH
T ss_pred cccccc-----ccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHH
Confidence 432111 11134568999999999999999999999999999999999999997543211100 00001
Q ss_pred cccc-CCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhh
Q 003384 687 KNLL-DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 737 (824)
Q Consensus 687 ~~~l-d~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~~ 737 (824)
...+ .......+...+..+.+|+.+||+.+|.+||++ +++++.|+.+...
T Consensus 261 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-~ell~~L~~l~~~ 311 (318)
T 3lxp_A 261 TELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTF-ENLIPILKTVHEK 311 (318)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHH
T ss_pred HHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCH-HHHHHHHHHHHHh
Confidence 1111 112233455567899999999999999999999 7788899887654
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=348.71 Aligned_cols=264 Identities=22% Similarity=0.345 Sum_probs=200.8
Q ss_pred hHhhhcCCCCccceeeecCceEEEEEEECC-----eEEEEEEecCCCCCC--chhHHHHHHHHHhcCCCceeeEecccCC
Q 003384 458 EIEGATHNFDPSLKIGEGGYGSIYKGLLRH-----MQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACPE 530 (824)
Q Consensus 458 ei~~~~~~f~~~~~LG~G~fG~Vykg~~~~-----~~VAvK~l~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~L~g~~~~ 530 (824)
++....++|...+.||+|+||.||+|.+.. ..||||++....... ...+.+|+.++++++||||++++++|.+
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 107 (313)
T 3brb_A 28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE 107 (313)
T ss_dssp TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred hcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence 344455689999999999999999997642 479999987653322 3468899999999999999999998843
Q ss_pred -------ceEEEEEecCCCChhhhhhcc---CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCC
Q 003384 531 -------VWTLVYEYLPNGSLEDRLSCK---DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF 600 (824)
Q Consensus 531 -------~~~LV~Ey~~ggsL~~~L~~~---~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~ 600 (824)
..++||||+++|+|.+++... .....+++..++.++.+++.||.|||+ ++|+||||||+|||++.++
T Consensus 108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~ 184 (313)
T 3brb_A 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDM 184 (313)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTTS
T ss_pred ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCC
Confidence 348999999999999998432 234579999999999999999999999 8999999999999999999
Q ss_pred cceeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHH
Q 003384 601 VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQY 679 (824)
Q Consensus 601 ~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~ 679 (824)
.+||+|||++..+........ .....|++.|+|||.+.+..++.++|||||||++|+|+| |.+||........
T Consensus 185 ~~kl~Dfg~~~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 258 (313)
T 3brb_A 185 TVCVADFGLSKKIYSGDYYRQ------GRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM 258 (313)
T ss_dssp CEEECSCSCC----------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred cEEEeecCcceecccccccCc------ccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH
Confidence 999999999987654321111 123457889999999999999999999999999999999 9999975432211
Q ss_pred HHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhh
Q 003384 680 ALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 737 (824)
Q Consensus 680 ~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~~ 737 (824)
.. .+........+...+..+.+++.+||..+|.+||++ .++.+.|+.+...
T Consensus 259 ~~------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~~l~~~L~~l~~~ 309 (313)
T 3brb_A 259 YD------YLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTF-SVLRLQLEKLLES 309 (313)
T ss_dssp HH------HHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCH-HHHHHHHHHHHHH
T ss_pred HH------HHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCH-HHHHHHHHHHHHh
Confidence 10 011111122344556789999999999999999999 7888888887653
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=353.44 Aligned_cols=261 Identities=23% Similarity=0.391 Sum_probs=208.7
Q ss_pred hHhhhcCCCCccceeeecCceEEEEEEECC-------eEEEEEEecCCCCC-CchhHHHHHHHHHhc-CCCceeeEeccc
Q 003384 458 EIEGATHNFDPSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQ-GPSEFQQEIDILSKI-RHPNLVTLVGAC 528 (824)
Q Consensus 458 ei~~~~~~f~~~~~LG~G~fG~Vykg~~~~-------~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l-~HpnIv~L~g~~ 528 (824)
++....++|...+.||+|+||.||+|.+.+ ..||+|++...... ....+.+|+.+++.+ +||||++++++|
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 344556789999999999999999998753 37999999764322 235688999999999 899999999998
Q ss_pred C--CceEEEEEecCCCChhhhhhccC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEE
Q 003384 529 P--EVWTLVYEYLPNGSLEDRLSCKD-----------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANIL 595 (824)
Q Consensus 529 ~--~~~~LV~Ey~~ggsL~~~L~~~~-----------~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NIL 595 (824)
. +..++||||+++|+|.+++.... ....+++..++.++.+++.||.|||+ +||+||||||+|||
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl 196 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVL 196 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCE
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEE
Confidence 4 46899999999999999986432 13468999999999999999999999 89999999999999
Q ss_pred ecCCCcceeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCc
Q 003384 596 LDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGIT 674 (824)
Q Consensus 596 ld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~ 674 (824)
++.++.+||+|||++.......... ......||+.|+|||++.+..++.++|||||||++|+|+| |.+||...
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 270 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYI------VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGI 270 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSE------ECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ECCCCeEEECcccccccccccccee------ecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCccc
Confidence 9999999999999998664432111 1133457889999999999999999999999999999999 99999754
Q ss_pred hH---HHHHHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHh
Q 003384 675 KE---VQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 736 (824)
Q Consensus 675 ~~---~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~ 736 (824)
.. .......+ .....+...+..+.+|+.+||+.+|.+||++ .++++.|+.+..
T Consensus 271 ~~~~~~~~~~~~~--------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-~~l~~~L~~~~~ 326 (333)
T 2i1m_A 271 LVNSKFYKLVKDG--------YQMAQPAFAPKNIYSIMQACWALEPTHRPTF-QQICSFLQEQAQ 326 (333)
T ss_dssp CSSHHHHHHHHHT--------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHH
T ss_pred chhHHHHHHHhcC--------CCCCCCCCCCHHHHHHHHHHhccChhhCcCH-HHHHHHHHHHHH
Confidence 22 11111111 1112234456789999999999999999999 778888877654
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=342.51 Aligned_cols=248 Identities=24% Similarity=0.335 Sum_probs=192.5
Q ss_pred CCCCccceeeecCceEEEEEEEC-CeEEEEEEecCCCC--CCchhHHHHHHHHHhcCCCceeeEeccc--CCceEEEEEe
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 538 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~-~~~VAvK~l~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~Ey 538 (824)
.+|...+.||+|+||.||+|... +..||||++..... .....+.+|+.+++.++||||+++++++ .+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 36888999999999999999886 68899999865432 2246788999999999999999999998 3568999999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccc
Q 003384 539 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 618 (824)
Q Consensus 539 ~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 618 (824)
+++ +|.+++... ...+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp CSE-EHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 975 898888532 3568999999999999999999999 8999999999999999999999999999986543211
Q ss_pred cCCCccccccCCCCCCcccCChhhhccC-CCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccc----------
Q 003384 619 SSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLK---------- 687 (824)
Q Consensus 619 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~---------- 687 (824)
. .....||+.|+|||++.+. .++.++|||||||++|+|+||++||................
T Consensus 156 ~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (288)
T 1ob3_A 156 K--------YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN 227 (288)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred c--------cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchh
Confidence 1 1234689999999999764 58999999999999999999999998655433221110000
Q ss_pred ----cccCCCC--------CCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 688 ----NLLDPLA--------GDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 688 ----~~ld~~~--------~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
...++.. .......+..+.+|+.+||+.+|.+||++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 277 (288)
T 1ob3_A 228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQ 277 (288)
T ss_dssp GGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred hhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHH
Confidence 0000000 0111234678899999999999999999943
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=347.01 Aligned_cols=249 Identities=26% Similarity=0.380 Sum_probs=191.6
Q ss_pred hhcCCCCccceeeecCceEEEEEEEC-CeEEEEEEecCCCCCC--chhHHHHHHHHHhcCCCceeeEecccC--CceEEE
Q 003384 461 GATHNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLV 535 (824)
Q Consensus 461 ~~~~~f~~~~~LG~G~fG~Vykg~~~-~~~VAvK~l~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV 535 (824)
...++|...++||+|+||.||+|.+. +..||||++....... ...+.+|+.+++.++||||+++++++. ...++|
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 97 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV 97 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred chHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence 34567999999999999999999985 6889999997543222 356889999999999999999999984 468999
Q ss_pred EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccc
Q 003384 536 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 615 (824)
Q Consensus 536 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~ 615 (824)
|||+++ +|.+.+.. ....+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+++....
T Consensus 98 ~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 98 FEFMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp EECCSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred EcCCCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 999975 78887753 34568999999999999999999999 8999999999999999999999999999986643
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhcc-CCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCC
Q 003384 616 NEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 694 (824)
Q Consensus 616 ~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~ 694 (824)
.... .....||+.|+|||++.+ ..++.++|||||||++|+|+||++||............... +..+..
T Consensus 172 ~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~--~~~~~~ 241 (311)
T 3niz_A 172 PVRS--------YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSI--LGTPNP 241 (311)
T ss_dssp CCC-----------CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHH--HCCCCT
T ss_pred Cccc--------ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH--HCCCCh
Confidence 2211 133468999999999876 56899999999999999999999999754321111110000 000000
Q ss_pred CCC-------------------------ChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 695 GDW-------------------------PFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 695 ~~~-------------------------p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
..| ....+.++.+|+.+||+.+|.+||++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 297 (311)
T 3niz_A 242 REWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARD 297 (311)
T ss_dssp TTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHH
T ss_pred HHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHH
Confidence 000 1123467899999999999999999943
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=355.99 Aligned_cols=240 Identities=20% Similarity=0.283 Sum_probs=198.0
Q ss_pred cCCCCccceeeecCceEEEEEEECC--eEEEEEEecCC---CCCCchhHHHHHHHHHhc-CCCceeeEecccC--CceEE
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPH---SLQGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTL 534 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~~--~~VAvK~l~~~---~~~~~~~f~~Ei~iL~~l-~HpnIv~L~g~~~--~~~~L 534 (824)
..+|...+.||+|+||.||+|.... ..||||++... .......+..|..+|..+ +||||+++++++. +..|+
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 3578999999999999999999874 67999998753 223455688999999988 7999999999884 46899
Q ss_pred EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccc
Q 003384 535 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 614 (824)
Q Consensus 535 V~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~ 614 (824)
||||++||+|.+++... ..+++..+..++.||+.||.|||+ +||+||||||+||||+.+|.+||+|||+++...
T Consensus 99 v~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 99999999999999543 458999999999999999999999 899999999999999999999999999998543
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCC
Q 003384 615 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 694 (824)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~ 694 (824)
..... .....||+.|+|||++.+..++.++|||||||++|||++|++||............ .. ..
T Consensus 173 ~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i--~~-----~~ 237 (353)
T 2i0e_A 173 WDGVT--------TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI--ME-----HN 237 (353)
T ss_dssp CTTCC--------BCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--HH-----CC
T ss_pred cCCcc--------cccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHH--Hh-----CC
Confidence 22111 13456999999999999999999999999999999999999999765443221111 00 11
Q ss_pred CCCChhhHHHHHHHHHHHhhhccCCCCCh
Q 003384 695 GDWPFVQAEQLANLAMRCCEMSRKSRPEL 723 (824)
Q Consensus 695 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 723 (824)
..+|...+..+.+|+.+||..+|.+||+.
T Consensus 238 ~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 266 (353)
T 2i0e_A 238 VAYPKSMSKEAVAICKGLMTKHPGKRLGC 266 (353)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSCTTSCTTC
T ss_pred CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 22455567899999999999999999974
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=357.32 Aligned_cols=240 Identities=25% Similarity=0.374 Sum_probs=196.8
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCC---CCCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEE
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH---SLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLV 535 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~---~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV 535 (824)
.++|.+.+.||+|+||.||+|.+. +..||||++... .......+.+|+.+|+.++||||+++++++. ...++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 357899999999999999999984 688999998642 1223457899999999999999999999984 468999
Q ss_pred EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccc
Q 003384 536 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 615 (824)
Q Consensus 536 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~ 615 (824)
|||+ +|+|.+++... ..+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++.....
T Consensus 88 ~E~~-~g~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEK---KRMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp ECCC-CEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred EECC-CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 9999 78998888543 468999999999999999999999 7899999999999999999999999999986654
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCC-CcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCC
Q 003384 616 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL-TPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 694 (824)
Q Consensus 616 ~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~ 694 (824)
... .....||+.|+|||++.+..+ +.++|||||||++|+|++|++||..... ..+...+....
T Consensus 161 ~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~-------~~~~~~i~~~~ 224 (336)
T 3h4j_B 161 GNF---------LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFI-------PNLFKKVNSCV 224 (336)
T ss_dssp SBT---------TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSS-------TTCBCCCCSSC
T ss_pred Ccc---------cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccH-------HHHHHHHHcCC
Confidence 321 133469999999999988776 6899999999999999999999965321 11111122222
Q ss_pred CCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 695 GDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 695 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
...|...+..+.+|+.+||+.+|.+||++.+
T Consensus 225 ~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~e 255 (336)
T 3h4j_B 225 YVMPDFLSPGAQSLIRRMIVADPMQRITIQE 255 (336)
T ss_dssp CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred CCCcccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 3345566788999999999999999999943
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=360.45 Aligned_cols=246 Identities=21% Similarity=0.335 Sum_probs=199.3
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEe
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY 538 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey 538 (824)
.+.|...+.||+|+||.||+|... +..||+|++..........+.+|+.+|+.++||||++++++|. ...++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 357999999999999999999886 5789999987654333457899999999999999999999984 468999999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecC--CCcceeeccccccccccc
Q 003384 539 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA--NFVSKLSDFGISRFLSQN 616 (824)
Q Consensus 539 ~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~--~~~vKL~DFGla~~~~~~ 616 (824)
++||+|.+++.. ....+++..+..++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||+++.....
T Consensus 130 ~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 999999999853 23468999999999999999999999 89999999999999974 578999999999876433
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCC
Q 003384 617 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 696 (824)
Q Consensus 617 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~ 696 (824)
... ....||+.|+|||++.+..++.++|||||||++|+|+||++||.................. ....
T Consensus 205 ~~~---------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~---~~~~ 272 (387)
T 1kob_A 205 EIV---------KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWE---FDED 272 (387)
T ss_dssp SCE---------EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCC---CCSS
T ss_pred cce---------eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---CCcc
Confidence 211 1235899999999999999999999999999999999999999876543322211111111 1111
Q ss_pred CChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 697 WPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 697 ~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
.....+..+.+|+.+||+.+|.+||++.+
T Consensus 273 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~e 301 (387)
T 1kob_A 273 AFSSVSPEAKDFIKNLLQKEPRKRLTVHD 301 (387)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 22345678999999999999999999943
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=351.20 Aligned_cols=256 Identities=27% Similarity=0.473 Sum_probs=199.9
Q ss_pred cCCCCccceeeecCceEEEEEEECC------eEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccC--CceE
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLRH------MQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWT 533 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~~------~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~ 533 (824)
..+|...+.||+|+||.||+|.+.. ..||||++...... ....+.+|+.+++.++||||+++++++. ...+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 3467778999999999999998753 35999999754321 2346889999999999999999999985 4689
Q ss_pred EEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccc
Q 003384 534 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 613 (824)
Q Consensus 534 LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~ 613 (824)
+||||+++|+|.+++... ...+++..++.++.+++.||.|||+ +||+||||||+|||++.++.+||+|||+++..
T Consensus 123 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 123 IITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 999999999999999643 3568999999999999999999999 89999999999999999999999999999876
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHH--HHhhhcccccc
Q 003384 614 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQY--ALDTGKLKNLL 690 (824)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~--~~~~~~~~~~l 690 (824)
........ ......||+.|+|||++.+..++.++|||||||++|+|+| |+.||........ .+..+
T Consensus 198 ~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~------ 266 (333)
T 1mqb_A 198 EDDPEATY-----TTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG------ 266 (333)
T ss_dssp ------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT------
T ss_pred cccccccc-----ccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCC------
Confidence 54321111 1123457889999999999999999999999999999999 9999975543221 11111
Q ss_pred CCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhh
Q 003384 691 DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 737 (824)
Q Consensus 691 d~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~~ 737 (824)
.....+...+..+.+++.+||+.+|.+||++ .++++.|+.+...
T Consensus 267 --~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 267 --FRLPTPMDCPSAIYQLMMQCWQQERARRPKF-ADIVSILDKLIRA 310 (333)
T ss_dssp --CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCH-HHHHHHHHHHHHS
T ss_pred --CcCCCcccCCHHHHHHHHHHcCCChhhCcCH-HHHHHHHHHHHhc
Confidence 1112244556789999999999999999999 7788888877653
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=351.37 Aligned_cols=259 Identities=24% Similarity=0.419 Sum_probs=208.4
Q ss_pred hcCCCCccceeeecCceEEEEEEEC---------CeEEEEEEecCCCC-CCchhHHHHHHHHHhc-CCCceeeEecccC-
Q 003384 462 ATHNFDPSLKIGEGGYGSIYKGLLR---------HMQVAIKMLHPHSL-QGPSEFQQEIDILSKI-RHPNLVTLVGACP- 529 (824)
Q Consensus 462 ~~~~f~~~~~LG~G~fG~Vykg~~~---------~~~VAvK~l~~~~~-~~~~~f~~Ei~iL~~l-~HpnIv~L~g~~~- 529 (824)
..++|...+.||+|+||.||+|.+. +..||||++..... .....+.+|+.+++.+ +||||++++++|.
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 3457899999999999999999864 35799999875432 1234688999999999 8999999999984
Q ss_pred -CceEEEEEecCCCChhhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEE
Q 003384 530 -EVWTLVYEYLPNGSLEDRLSCKDN-------------SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANIL 595 (824)
Q Consensus 530 -~~~~LV~Ey~~ggsL~~~L~~~~~-------------~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NIL 595 (824)
+..++||||+++|+|.+++..... ...+++..++.++.+++.||.|||+ ++|+||||||+|||
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceEE
Confidence 468999999999999999965432 2348999999999999999999999 89999999999999
Q ss_pred ecCCCcceeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCc
Q 003384 596 LDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGIT 674 (824)
Q Consensus 596 ld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~ 674 (824)
++.++.+||+|||+++......... ......||+.|+|||++.+..++.++|||||||++|+|+| |++||...
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 263 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYK------KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 263 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEE------CCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred EcCCCCEEEcccccccccccccccc------ccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcC
Confidence 9999999999999998665432111 1133457899999999999899999999999999999999 99999765
Q ss_pred hHHHH--HHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhhC
Q 003384 675 KEVQY--ALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC 738 (824)
Q Consensus 675 ~~~~~--~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~~~ 738 (824)
..... .+..+. ....+...+..+.+++.+||+.+|.+||++ .++++.|+.+....
T Consensus 264 ~~~~~~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~ell~~L~~l~~~~ 320 (334)
T 2pvf_A 264 PVEELFKLLKEGH--------RMDKPANCTNELYMMMRDCWHAVPSQRPTF-KQLVEDLDRILTLT 320 (334)
T ss_dssp CHHHHHHHHHHTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHHH
T ss_pred CHHHHHHHHhcCC--------CCCCCccCCHHHHHHHHHHccCChhhCcCH-HHHHHHHHHHHhcc
Confidence 43221 111111 112344556789999999999999999999 78888888876643
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=379.24 Aligned_cols=254 Identities=25% Similarity=0.419 Sum_probs=202.4
Q ss_pred CCCccc-eeeecCceEEEEEEEC----CeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccC-CceEEEEE
Q 003384 465 NFDPSL-KIGEGGYGSIYKGLLR----HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVYE 537 (824)
Q Consensus 465 ~f~~~~-~LG~G~fG~Vykg~~~----~~~VAvK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~-~~~~LV~E 537 (824)
++.... .||+|+||.||+|.+. +..||||+++.... ...+.|.+|+.+|++++|||||+++|+|. +..++|||
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv~E 415 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVME 415 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESSSEEEEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccCCeEEEEE
Confidence 344444 7999999999999874 35699999986532 34568999999999999999999999984 56899999
Q ss_pred ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccc
Q 003384 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 617 (824)
Q Consensus 538 y~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 617 (824)
|+++|+|.++|.. ....+++..+..|+.||+.||.|||+ ++||||||||+||||+.++.+||+|||+++.+....
T Consensus 416 ~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~ 490 (613)
T 2ozo_A 416 MAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490 (613)
T ss_dssp CCTTCBHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---
T ss_pred eCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCC
Confidence 9999999999953 34569999999999999999999999 899999999999999999999999999998765432
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHH--HHHhhhccccccCCCC
Q 003384 618 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--YALDTGKLKNLLDPLA 694 (824)
Q Consensus 618 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~--~~~~~~~~~~~ld~~~ 694 (824)
.... ......+|+.|+|||++.+..++.++|||||||+||||+| |++||....... ..+..+. .
T Consensus 491 ~~~~-----~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~--------~ 557 (613)
T 2ozo_A 491 SYYT-----ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK--------R 557 (613)
T ss_dssp ----------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTC--------C
T ss_pred ceee-----eccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC--------C
Confidence 1111 1123346789999999999999999999999999999998 999997654322 2222221 1
Q ss_pred CCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhh
Q 003384 695 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 737 (824)
Q Consensus 695 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~~ 737 (824)
...|...+..+.+|+.+||+.+|.+||++ .++.+.|+.+...
T Consensus 558 ~~~p~~~~~~l~~li~~cl~~dP~~RPs~-~~l~~~L~~~~~~ 599 (613)
T 2ozo_A 558 MECPPECPPELYALMSDCWIYKWEDRPDF-LTVEQRMRACYYS 599 (613)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSTTTSCCH-HHHHHHHHHHHHH
T ss_pred CCCCCcCCHHHHHHHHHHcCCChhHCcCH-HHHHHHHHHHHHH
Confidence 23445567899999999999999999999 7788888876554
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=365.73 Aligned_cols=245 Identities=20% Similarity=0.354 Sum_probs=197.3
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEecccC--CceEEEE
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 536 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~ 536 (824)
.++|...+.||+|+||.||+|... +..||+|++...... ....+.+|+.+|+.++||||+++++++. ...++||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 346889999999999999999875 688999999765432 2346889999999999999999999984 4689999
Q ss_pred EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEec---CCCcceeecccccccc
Q 003384 537 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD---ANFVSKLSDFGISRFL 613 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld---~~~~vKL~DFGla~~~ 613 (824)
||++||+|.+.+... ..+++..+..++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||++...
T Consensus 90 E~~~gg~L~~~i~~~---~~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 90 DLVTGGELFEDIVAR---EYYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp CCCBCCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 999999999998543 469999999999999999999999 8999999999999998 4688999999999866
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHH--HHhhhccccccC
Q 003384 614 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQY--ALDTGKLKNLLD 691 (824)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~--~~~~~~~~~~ld 691 (824)
...... .....||+.|+|||++.+..|+.++|||||||++|+|++|++||........ .+..+.. +
T Consensus 164 ~~~~~~--------~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~----~ 231 (444)
T 3soa_A 164 EGEQQA--------WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAY----D 231 (444)
T ss_dssp CTTCCB--------CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC----C
T ss_pred cCCCce--------eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCC----C
Confidence 533211 1345699999999999999999999999999999999999999976544322 2222211 1
Q ss_pred CCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHH
Q 003384 692 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD 726 (824)
Q Consensus 692 ~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~ 726 (824)
.....| ...+..+.+|+.+||+.+|.+||++.+.
T Consensus 232 ~~~~~~-~~~s~~~~~li~~~L~~dP~~Rpta~e~ 265 (444)
T 3soa_A 232 FPSPEW-DTVTPEAKDLINKMLTINPSKRITAAEA 265 (444)
T ss_dssp CCTTTT-TTSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred CCcccc-ccCCHHHHHHHHHHcCCChhHCCCHHHH
Confidence 111112 2446789999999999999999999543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=357.41 Aligned_cols=259 Identities=17% Similarity=0.237 Sum_probs=197.4
Q ss_pred hcCCCCccceeeec--CceEEEEEEEC--CeEEEEEEecCCCCCC--chhHHHHHHHHHhcCCCceeeEeccc--CCceE
Q 003384 462 ATHNFDPSLKIGEG--GYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGAC--PEVWT 533 (824)
Q Consensus 462 ~~~~f~~~~~LG~G--~fG~Vykg~~~--~~~VAvK~l~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~ 533 (824)
..++|...++||+| +||.||+|.+. +..||||++....... ...+.+|+.+++.++|||||+++++| ....+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 45679999999999 99999999986 6889999997643222 34678899999999999999999998 45689
Q ss_pred EEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccc
Q 003384 534 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 613 (824)
Q Consensus 534 LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~ 613 (824)
+||||+++|+|.+++.... ...+++..+..|+.||+.||.|||+ ++|+||||||+||||+.++.+||+|||++...
T Consensus 103 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEEECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 9999999999999986432 3459999999999999999999999 89999999999999999999999999998765
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhcc--CCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHh--hhccccc
Q 003384 614 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS--GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALD--TGKLKNL 689 (824)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~--~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~--~~~~~~~ 689 (824)
.......... ........||+.|+|||++.+ ..++.++|||||||++|+|+||++||........... .+....+
T Consensus 179 ~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 257 (389)
T 3gni_B 179 ISHGQRQRVV-HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL 257 (389)
T ss_dssp EETTEECSCB-CCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------
T ss_pred cccccccccc-ccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcc
Confidence 4332111111 111133579999999999987 5799999999999999999999999965432211111 1111100
Q ss_pred cCC-------------------------------------CCCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 690 LDP-------------------------------------LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 690 ld~-------------------------------------~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
++. ....++...+..+.+|+.+||+.+|.+||++.+
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e 330 (389)
T 3gni_B 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSAST 330 (389)
T ss_dssp ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHH
T ss_pred ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHH
Confidence 000 011123345668999999999999999999843
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=345.24 Aligned_cols=249 Identities=25% Similarity=0.381 Sum_probs=182.6
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEe
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY 538 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey 538 (824)
.+|...+.||+|+||.||+|... +..||||++..... .....+.+|+.+++.++||||+++++++. +..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 84 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEF 84 (317)
T ss_dssp --------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEEC
T ss_pred cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEe
Confidence 47888999999999999999875 68899999976532 23467899999999999999999999984 468999999
Q ss_pred cCCCChhhhhhcc---CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccc
Q 003384 539 LPNGSLEDRLSCK---DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 615 (824)
Q Consensus 539 ~~ggsL~~~L~~~---~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~ 615 (824)
++ |+|.+++... .....+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+++....
T Consensus 85 ~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 85 MD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp CC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred cC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 98 5999888543 223458999999999999999999999 8999999999999999999999999999986643
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccC-CCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhh----hccc---
Q 003384 616 NEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT----GKLK--- 687 (824)
Q Consensus 616 ~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~----~~~~--- 687 (824)
.... .....||+.|+|||++.+. .++.++|||||||++|+|+||++||............ +...
T Consensus 161 ~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 232 (317)
T 2pmi_A 161 PVNT--------FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESL 232 (317)
T ss_dssp CCCC--------CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTT
T ss_pred Cccc--------CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhH
Confidence 2111 1334689999999999764 6899999999999999999999999766543221111 0000
Q ss_pred -----cc--cCCC-------------CCCCChhhHHHHHHHHHHHhhhccCCCCChH
Q 003384 688 -----NL--LDPL-------------AGDWPFVQAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 688 -----~~--ld~~-------------~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
.. ..+. ....+...+..+.+|+.+||+.+|.+||++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ 289 (317)
T 2pmi_A 233 WPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAK 289 (317)
T ss_dssp CGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred hhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHH
Confidence 00 0000 0001113456899999999999999999984
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=340.28 Aligned_cols=248 Identities=25% Similarity=0.297 Sum_probs=190.5
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCC--chhHHHHHHHHHhcCCCceeeEeccc--CCceEEEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYE 537 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~E 537 (824)
++|...+.||+|+||+||+|.+. +..||||++....... ...+.+|+.++++++||||+++++++ ....++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 46888999999999999999985 5789999997654322 35688999999999999999999998 446899999
Q ss_pred ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccc
Q 003384 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 617 (824)
Q Consensus 538 y~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 617 (824)
|+++ +|.+.+.. ....+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~-~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 82 FCDQ-DLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSE-EHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred cCCC-CHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 9976 55555532 23569999999999999999999999 899999999999999999999999999998664322
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCC-CCcchhHHhHHHHHHHHHhCCCCC-CCchHHHHHHhhhcc---------
Q 003384 618 ISSNNTTLCCRTDPKGTFAYMDPEFLASGE-LTPKSDVYSFGIILLRLLTGRPAL-GITKEVQYALDTGKL--------- 686 (824)
Q Consensus 618 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~t~ksDVwSlGvvL~ELltG~~Pf-~~~~~~~~~~~~~~~--------- 686 (824)
.. .....||+.|+|||++.+.. ++.++|||||||++|+|+||..|| ...............
T Consensus 156 ~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~ 227 (292)
T 3o0g_A 156 RC--------YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQW 227 (292)
T ss_dssp SC--------CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTC
T ss_pred cc--------ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhh
Confidence 11 13456899999999998765 899999999999999999887764 433222111110000
Q ss_pred ---ccccC----------CCCCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 687 ---KNLLD----------PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 687 ---~~~ld----------~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
....+ ..........+..+.+|+.+||+.+|.+||++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e 279 (292)
T 3o0g_A 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEE 279 (292)
T ss_dssp TTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred hhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHH
Confidence 00000 0001112235678999999999999999999843
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=352.46 Aligned_cols=258 Identities=23% Similarity=0.293 Sum_probs=195.8
Q ss_pred HhhhcCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCC-----CCCCchhHHHHHHHHHhcCCCceeeEecccC--
Q 003384 459 IEGATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH-----SLQGPSEFQQEIDILSKIRHPNLVTLVGACP-- 529 (824)
Q Consensus 459 i~~~~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~-----~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~-- 529 (824)
+....++|...+.||+|+||.||+|... +..||||++... .......+.+|+.+++.++||||++++++|.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 4455668999999999999999999886 478999998643 2233467899999999999999999999984
Q ss_pred CceEEEEEecCCCChhhhhhccC-------------------------------------CCCCCCHHHHHHHHHHHHHH
Q 003384 530 EVWTLVYEYLPNGSLEDRLSCKD-------------------------------------NSPPLSWQTRIRIATELCSV 572 (824)
Q Consensus 530 ~~~~LV~Ey~~ggsL~~~L~~~~-------------------------------------~~~~l~~~~~~~ia~qia~a 572 (824)
+..++||||++||+|.+++.... ....+++..+..|+.|++.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 45789999999999999884210 01224567788999999999
Q ss_pred HHHHhhcCCCceEeccccCCcEEecCCC--cceeeccccccccccccccCCCccccccCCCCCCcccCChhhhcc--CCC
Q 003384 573 LIFLHSCKPHSIVHGDLKPANILLDANF--VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS--GEL 648 (824)
Q Consensus 573 L~~LH~~~~~giiHrDLKp~NILld~~~--~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~--~~~ 648 (824)
|.|||+ ++|+||||||+|||++.++ .+||+|||+++.+........ .......||+.|+|||++.+ ..+
T Consensus 181 l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~ 253 (345)
T 3hko_A 181 LHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEY----YGMTTKAGTPYFVAPEVLNTTNESY 253 (345)
T ss_dssp HHHHHH---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC------------CCCGGGCCHHHHTCSSSCC
T ss_pred HHHHHH---CCccccCCChhhEEEecCCCceEEEeeccccccccccCcccc----ccccccCCCccccCchhhccCCCCC
Confidence 999999 8999999999999998776 899999999986644321111 11134569999999999975 678
Q ss_pred CcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHH
Q 003384 649 TPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD 726 (824)
Q Consensus 649 t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~ 726 (824)
+.++|||||||++|+|++|++||.............. ... ..........+..+.+|+.+||+.+|.+||++.+.
T Consensus 254 ~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~--~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 328 (345)
T 3hko_A 254 GPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLN--KKL-CFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRA 328 (345)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCC-CTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred CcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHh--ccc-ccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHH
Confidence 9999999999999999999999976654332211110 000 01111112346789999999999999999999443
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=343.21 Aligned_cols=257 Identities=27% Similarity=0.415 Sum_probs=196.7
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCC---chhHHHHHHHHHhcCCCceeeEeccc--CCceEEE
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLV 535 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~---~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV 535 (824)
..+|...+.||+|+||.||+|... +..||||++....... ...+.+|+.+++.++||||++++++| .+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 347899999999999999999874 6899999997643333 34688999999999999999999988 4568899
Q ss_pred EEecCCCChhhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccc
Q 003384 536 YEYLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 614 (824)
Q Consensus 536 ~Ey~~ggsL~~~L~~~-~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~ 614 (824)
|||+++|+|.+++... .....+++..++.++.+++.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 9999999999998542 234568999999999999999999999 899999999999999999999999999998654
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHH----HHHHhhhcccccc
Q 003384 615 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEV----QYALDTGKLKNLL 690 (824)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~----~~~~~~~~~~~~l 690 (824)
..... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ...+..+..
T Consensus 188 ~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---- 255 (310)
T 2wqm_A 188 SKTTA--------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDY---- 255 (310)
T ss_dssp -------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCS----
T ss_pred CCCcc--------ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccC----
Confidence 33211 12345899999999999999999999999999999999999999653211 111111111
Q ss_pred CCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhhC
Q 003384 691 DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC 738 (824)
Q Consensus 691 d~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~~~ 738 (824)
.+. .+...+..+.+|+.+||+.+|.+||++ .++++.|+.+.+..
T Consensus 256 ~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~-~~il~~l~~l~~~~ 299 (310)
T 2wqm_A 256 PPL---PSDHYSEELRQLVNMCINPDPEKRPDV-TYVYDVAKRMHACT 299 (310)
T ss_dssp CCC---CTTTSCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHHH
T ss_pred CCC---cccccCHHHHHHHHHHcCCChhhCCCH-HHHHHHHHHHHHhh
Confidence 111 123446789999999999999999999 78889999998765
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=353.67 Aligned_cols=257 Identities=16% Similarity=0.173 Sum_probs=206.1
Q ss_pred hhHhhhcCCCCccceeeecCceEEEEEE-------ECCeEEEEEEecCCCCCCchhHHHHHHHHHhcC---CCceeeEec
Q 003384 457 SEIEGATHNFDPSLKIGEGGYGSIYKGL-------LRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIR---HPNLVTLVG 526 (824)
Q Consensus 457 ~ei~~~~~~f~~~~~LG~G~fG~Vykg~-------~~~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~---HpnIv~L~g 526 (824)
.++.....+|...+.||+|+||.||+|. ..+..||||++... ....+..|+.++..++ |+||+++++
T Consensus 58 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~ 134 (365)
T 3e7e_A 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYS 134 (365)
T ss_dssp CEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred eeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence 3444556789999999999999999994 23578999999753 3567899999999997 999999999
Q ss_pred cc--CCceEEEEEecCCCChhhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecC----
Q 003384 527 AC--PEVWTLVYEYLPNGSLEDRLSCK--DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA---- 598 (824)
Q Consensus 527 ~~--~~~~~LV~Ey~~ggsL~~~L~~~--~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~---- 598 (824)
++ .+..++||||++||+|.+++... .....+++..++.|+.||+.||.|||+ ++||||||||+||||+.
T Consensus 135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~ 211 (365)
T 3e7e_A 135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLE 211 (365)
T ss_dssp EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTC
T ss_pred eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccC
Confidence 87 45789999999999999999642 134579999999999999999999999 89999999999999998
Q ss_pred -------CCcceeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCC
Q 003384 599 -------NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPAL 671 (824)
Q Consensus 599 -------~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf 671 (824)
++.+||+|||+|+.+...... .......||+.|+|||++.+..|+.++|||||||++|||+||++||
T Consensus 212 ~~~~~~~~~~~kl~DFG~a~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 285 (365)
T 3e7e_A 212 QDDEDDLSAGLALIDLGQSIDMKLFPKG------TIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMK 285 (365)
T ss_dssp C------CTTEEECCCTTCEEGGGSCTT------EEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCC
T ss_pred ccccccccCCEEEeeCchhhhhhccCCC------ceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcc
Confidence 899999999999765422111 0124457999999999999999999999999999999999999999
Q ss_pred CCchHHHHHHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHh
Q 003384 672 GITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 736 (824)
Q Consensus 672 ~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~ 736 (824)
..... +. ..+....... .....+.+++..|++.+|.+||+..+.+.+.|+.+..
T Consensus 286 ~~~~~-------~~--~~~~~~~~~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~ 339 (365)
T 3e7e_A 286 VKNEG-------GE--CKPEGLFRRL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ 339 (365)
T ss_dssp EEEET-------TE--EEECSCCTTC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred ccCCC-------Cc--eeechhcccc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence 53221 11 1111111111 2366889999999999999997766888887776644
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=339.46 Aligned_cols=244 Identities=25% Similarity=0.399 Sum_probs=202.4
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC------------
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP------------ 529 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~------------ 529 (824)
.+|...+.||+|+||.||+|.+. +..||||++.... ..+.+|+.+++.++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 86 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN 86 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence 46888999999999999999986 6899999987542 46889999999999999999999873
Q ss_pred ------CceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcce
Q 003384 530 ------EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSK 603 (824)
Q Consensus 530 ------~~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vK 603 (824)
...++||||+++|+|.+++.... ...+++..++.++.+++.||.|||+ ++|+||||||+|||++.++.+|
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~k 162 (284)
T 2a19_B 87 SSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVK 162 (284)
T ss_dssp --CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEE
T ss_pred ccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEcCCCCEE
Confidence 23689999999999999996432 3568999999999999999999999 8999999999999999999999
Q ss_pred eeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhh
Q 003384 604 LSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT 683 (824)
Q Consensus 604 L~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~ 683 (824)
|+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|+||..||............
T Consensus 163 l~Dfg~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~ 233 (284)
T 2a19_B 163 IGDFGLVTSLKNDGK---------RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRD 233 (284)
T ss_dssp ECCCTTCEESSCCSC---------CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHHHHHHHT
T ss_pred ECcchhheecccccc---------ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHHHHHhhc
Confidence 999999987654321 12346899999999999999999999999999999999999988433222221111
Q ss_pred hccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHh
Q 003384 684 GKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 736 (824)
Q Consensus 684 ~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~ 736 (824)
+ ..+...+..+.+++.+||+.+|.+||++ .++++.|..+..
T Consensus 234 ~-----------~~~~~~~~~~~~li~~~l~~dp~~Rps~-~e~l~~l~~~~~ 274 (284)
T 2a19_B 234 G-----------IISDIFDKKEKTLLQKLLSKKPEDRPNT-SEILRTLTVWKK 274 (284)
T ss_dssp T-----------CCCTTSCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHTC
T ss_pred c-----------cccccCCHHHHHHHHHHccCChhhCcCH-HHHHHHHHHHhh
Confidence 1 1223345689999999999999999999 778888877654
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=355.43 Aligned_cols=263 Identities=19% Similarity=0.245 Sum_probs=194.5
Q ss_pred cCCCCccceeeecCceEEEEEEEC-----CeEEEEEEecCCCCC-----------CchhHHHHHHHHHhcCCCceeeEec
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR-----HMQVAIKMLHPHSLQ-----------GPSEFQQEIDILSKIRHPNLVTLVG 526 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~-----~~~VAvK~l~~~~~~-----------~~~~f~~Ei~iL~~l~HpnIv~L~g 526 (824)
.++|...+.||+|+||.||+|.+. +..||||++...... ....+.+|+.+++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 357999999999999999999984 467999998764321 1224667888899999999999999
Q ss_pred ccC------CceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCC
Q 003384 527 ACP------EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF 600 (824)
Q Consensus 527 ~~~------~~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~ 600 (824)
++. ...++||||+ +++|.+++... ..+++..++.|+.||+.||.|||+ ++|+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN---GTFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGG---GBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEccCC
Confidence 873 3578999999 99999999533 379999999999999999999999 8999999999999999887
Q ss_pred --cceeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCc--hH
Q 003384 601 --VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGIT--KE 676 (824)
Q Consensus 601 --~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~--~~ 676 (824)
.+||+|||+++.+.......... ........||+.|+|||++.+..++.++|||||||++|||+||+.||... ..
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~ 267 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQ-ENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP 267 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCC-CCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred CCcEEEEeCCCceecccccccccch-hccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence 99999999998775443211111 11123457999999999999999999999999999999999999999532 11
Q ss_pred HHHHHhhhccccccCCCCCC--CChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHH
Q 003384 677 VQYALDTGKLKNLLDPLAGD--WPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 734 (824)
Q Consensus 677 ~~~~~~~~~~~~~ld~~~~~--~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l 734 (824)
.............+...... .+...+..+.+++.+||..+|.+||++ +++++.|+.+
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~~l~~~L~~~ 326 (345)
T 2v62_A 268 VAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNY-QALKKILNPH 326 (345)
T ss_dssp HHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCH-HHHHHHHCTT
T ss_pred HHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCH-HHHHHHHhcc
Confidence 11111111111111100000 011345689999999999999999999 7777777654
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=376.14 Aligned_cols=256 Identities=31% Similarity=0.492 Sum_probs=209.9
Q ss_pred hHhhhcCCCCccceeeecCceEEEEEEECC-eEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC-CceEEE
Q 003384 458 EIEGATHNFDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLV 535 (824)
Q Consensus 458 ei~~~~~~f~~~~~LG~G~fG~Vykg~~~~-~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~-~~~~LV 535 (824)
.+.....+|.+.++||+|+||.||+|.+.+ ..||||+++... ...+.|.+|+.+|++++||||++++++|. +..+||
T Consensus 261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~lv 339 (535)
T 2h8h_A 261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIV 339 (535)
T ss_dssp CSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEE
T ss_pred ceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEeeccceEe
Confidence 334455678899999999999999999986 679999998654 34578999999999999999999999985 468899
Q ss_pred EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccc
Q 003384 536 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 615 (824)
Q Consensus 536 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~ 615 (824)
|||+.+|+|.++|... ....+++..++.|+.||+.||.|||+ ++||||||||+||||+.++.+||+|||+++.+..
T Consensus 340 ~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 340 TEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp ECCCTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred eehhcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 9999999999999532 12458999999999999999999999 8999999999999999999999999999987653
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHH--HHHhhhccccccCC
Q 003384 616 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--YALDTGKLKNLLDP 692 (824)
Q Consensus 616 ~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~--~~~~~~~~~~~ld~ 692 (824)
..... .....+|+.|+|||++.+..++.++|||||||+||||+| |+.||....... ..+..+
T Consensus 416 ~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~-------- 480 (535)
T 2h8h_A 416 NEYTA-------RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-------- 480 (535)
T ss_dssp HHHHT-------TCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTT--------
T ss_pred Cceec-------ccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--------
Confidence 32111 123457889999999999999999999999999999999 999997654322 222221
Q ss_pred CCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHH
Q 003384 693 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 734 (824)
Q Consensus 693 ~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l 734 (824)
.....+...+..+.+|+.+||+.+|.+||++ ++|.+.|+.+
T Consensus 481 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-~~l~~~L~~~ 521 (535)
T 2h8h_A 481 YRMPCPPECPESLHDLMCQCWRKEPEERPTF-EYLQAFLEDY 521 (535)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHTS
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhHCcCH-HHHHHHHHHH
Confidence 1112344566789999999999999999999 7777777765
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=352.94 Aligned_cols=209 Identities=27% Similarity=0.344 Sum_probs=177.8
Q ss_pred cCCCChhhHhhhcCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcC-----CCceee
Q 003384 451 FSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-----HPNLVT 523 (824)
Q Consensus 451 ~~~~~~~ei~~~~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~-----HpnIv~ 523 (824)
...|++.+.....++|...++||+|+||.||+|.+. +..||||++.... .....+..|+.+++.+. ||||++
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK-KYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH-HHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch-hhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 445566666667789999999999999999999984 6889999986421 22346788999999996 999999
Q ss_pred Eeccc--CCceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecC---
Q 003384 524 LVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA--- 598 (824)
Q Consensus 524 L~g~~--~~~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~--- 598 (824)
+++++ .+..++||||+ +++|.+++.... ...+++..+..++.||+.||.|||+ +||+||||||+||||+.
T Consensus 101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNN-YNGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYF 175 (360)
T ss_dssp EEEEEEETTEEEEEECCC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTC
T ss_pred ccceeeECCeeEEEEcCC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEccccc
Confidence 99988 45789999999 999999996443 3458999999999999999999999 89999999999999975
Q ss_pred ----------------------CCcceeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHh
Q 003384 599 ----------------------NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYS 656 (824)
Q Consensus 599 ----------------------~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwS 656 (824)
++.+||+|||+++...... ....||+.|+|||++.+..++.++||||
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----------~~~~gt~~y~aPE~~~~~~~~~~~Diws 244 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----------GSIINTRQYRAPEVILNLGWDVSSDMWS 244 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----------CSCCSCGGGCCHHHHTTCCCCTTHHHHH
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCCCC-----------cCccCcccccCcHHHcCCCCCCccchHH
Confidence 7899999999998643321 2346899999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCchH
Q 003384 657 FGIILLRLLTGRPALGITKE 676 (824)
Q Consensus 657 lGvvL~ELltG~~Pf~~~~~ 676 (824)
|||++|+|+||++||.....
T Consensus 245 lG~il~ell~g~~pf~~~~~ 264 (360)
T 3llt_A 245 FGCVLAELYTGSLLFRTHEH 264 (360)
T ss_dssp HHHHHHHHHHSSCSCCCSSH
T ss_pred HHHHHHHHHHCCCCCCCCcH
Confidence 99999999999999976543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=358.17 Aligned_cols=241 Identities=23% Similarity=0.305 Sum_probs=190.0
Q ss_pred cceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEecCCCCh
Q 003384 469 SLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNGSL 544 (824)
Q Consensus 469 ~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey~~ggsL 544 (824)
.+.||+|+||.||+|... +..||||++..........+.+|+.+|++++||||++++++|. +..+|||||+++|+|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 567999999999999875 6889999998755445567999999999999999999999984 468999999999999
Q ss_pred hhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEe--cCCCcceeeccccccccccccccCCC
Q 003384 545 EDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL--DANFVSKLSDFGISRFLSQNEISSNN 622 (824)
Q Consensus 545 ~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILl--d~~~~vKL~DFGla~~~~~~~~~~~~ 622 (824)
.+++... ...+++..++.++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||+++.+......
T Consensus 174 ~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~--- 245 (373)
T 2x4f_A 174 FDRIIDE--SYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL--- 245 (373)
T ss_dssp HHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC---
T ss_pred HHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc---
Confidence 9988532 3468999999999999999999999 899999999999999 56789999999999876543211
Q ss_pred ccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCChhhH
Q 003384 623 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQA 702 (824)
Q Consensus 623 ~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~ 702 (824)
....||+.|+|||++.+..++.++|||||||+||+|+||++||............-. ...... .......+
T Consensus 246 ------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~--~~~~~~-~~~~~~~~ 316 (373)
T 2x4f_A 246 ------KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILA--CRWDLE-DEEFQDIS 316 (373)
T ss_dssp ------CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH--TCCCSC-SGGGTTSC
T ss_pred ------ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--ccCCCC-hhhhccCC
Confidence 234599999999999988999999999999999999999999976654332211110 001110 11112345
Q ss_pred HHHHHHHHHHhhhccCCCCChHHH
Q 003384 703 EQLANLAMRCCEMSRKSRPELGKD 726 (824)
Q Consensus 703 ~~l~~Li~~Cl~~~P~~RPt~~~~ 726 (824)
..+.+|+.+||+.+|.+||++.+.
T Consensus 317 ~~~~~li~~~L~~dp~~Rps~~e~ 340 (373)
T 2x4f_A 317 EEAKEFISKLLIKEKSWRISASEA 340 (373)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred HHHHHHHHHHcCCChhhCCCHHHH
Confidence 789999999999999999999443
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=335.64 Aligned_cols=262 Identities=20% Similarity=0.269 Sum_probs=205.7
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc---CCceEEEEE
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC---PEVWTLVYE 537 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~---~~~~~LV~E 537 (824)
.++|...+.||+|+||.||+|... +..||||++..... ...+.+|+.+++.++|++++..++.+ ....++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 468999999999999999999964 68999999876432 35799999999999998877777665 446789999
Q ss_pred ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEe---cCCCcceeeccccccccc
Q 003384 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL---DANFVSKLSDFGISRFLS 614 (824)
Q Consensus 538 y~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILl---d~~~~vKL~DFGla~~~~ 614 (824)
|+ +++|.+++... ...+++..+..++.|++.||.|||+ ++|+||||||+|||+ +.++.+||+|||++....
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 86 LL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred ec-CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 99 99999999532 3469999999999999999999999 899999999999999 488999999999998765
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchH-----HHHHHhhhccccc
Q 003384 615 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE-----VQYALDTGKLKNL 689 (824)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~-----~~~~~~~~~~~~~ 689 (824)
......... ........||+.|+|||++.+..++.++|||||||++|+|+||++||..... ....+..+.....
T Consensus 160 ~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 3uzp_A 160 DARTHQHIP-YRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp CTTTCCBCC-CCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred ccccccccc-cccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence 543211110 0112345799999999999999999999999999999999999999975321 1111111111111
Q ss_pred cCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhhC
Q 003384 690 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC 738 (824)
Q Consensus 690 ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~~~ 738 (824)
... .+...+..+.+++.+||+.+|.+||++ +++.+.|+.+....
T Consensus 239 ~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~-~~l~~~l~~~~~~~ 282 (296)
T 3uzp_A 239 IEV----LCKGYPSEFATYLNFCRSLRFDDKPDY-SYLRQLFRNLFHRQ 282 (296)
T ss_dssp HHH----HTTTSCHHHHHHHHHHHTSCTTCCCCH-HHHHHHHHHHHHHT
T ss_pred hHH----HHhhCCHHHHHHHHHHHhcCcCcCCCH-HHHHHHHHHHHHhc
Confidence 000 112335689999999999999999999 78889998877654
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=348.30 Aligned_cols=263 Identities=24% Similarity=0.397 Sum_probs=208.5
Q ss_pred cCCCCccceeeecCceEEEEEEE------CCeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccCC----ce
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLL------RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPE----VW 532 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~------~~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~~----~~ 532 (824)
..+|...+.||+|+||.||+|.+ .+..||||++..........+.+|+.+++.++||||+++++++.. ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 34688899999999999999985 357899999987544445679999999999999999999998732 57
Q ss_pred EEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccc
Q 003384 533 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 612 (824)
Q Consensus 533 ~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~ 612 (824)
++||||+++|+|.+++... ...+++..++.++.+++.||.|||+ ++|+||||||+|||++.++.+||+|||++..
T Consensus 120 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 8999999999999999643 3458999999999999999999999 8999999999999999999999999999987
Q ss_pred cccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHH-HHhh--------
Q 003384 613 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQY-ALDT-------- 683 (824)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~-~~~~-------- 683 (824)
........ .......||..|+|||++.+..++.++|||||||++|+|+||..||........ ....
T Consensus 195 ~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (326)
T 2w1i_A 195 LPQDKEYY-----KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 269 (326)
T ss_dssp CCSSCSEE-----ECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHH
T ss_pred cccccccc-----ccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhH
Confidence 65432111 011334578899999999998899999999999999999999999864321110 0000
Q ss_pred hcccccc-CCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHh
Q 003384 684 GKLKNLL-DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 736 (824)
Q Consensus 684 ~~~~~~l-d~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~ 736 (824)
..+...+ .......+...+..+.+|+.+||+.+|.+||++ .++++.|+.+..
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-~el~~~L~~l~~ 322 (326)
T 2w1i_A 270 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSF-RDLALRVDQIRD 322 (326)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCH-HHHHHHHHHHHH
T ss_pred HHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCH-HHHHHHHHHHHH
Confidence 0000111 111122345567889999999999999999999 788888888765
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=359.05 Aligned_cols=242 Identities=24% Similarity=0.314 Sum_probs=189.7
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHH-HHhcCCCceeeEecccC--CceEE
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDI-LSKIRHPNLVTLVGACP--EVWTL 534 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~---~~~~~f~~Ei~i-L~~l~HpnIv~L~g~~~--~~~~L 534 (824)
..+|...+.||+|+||.||+|... +..||||++..... .....+..|..+ ++.++||||++++++|. +..|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 357999999999999999999986 47899999976432 223456677777 56789999999999984 56899
Q ss_pred EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccc
Q 003384 535 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 614 (824)
Q Consensus 535 V~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~ 614 (824)
||||++||+|.+++... ..+++..+..++.+|+.||.|||+ +||+||||||+||||+.+|++||+|||+++...
T Consensus 117 v~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRE---RCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 99999999999999543 458899999999999999999999 899999999999999999999999999998543
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCC
Q 003384 615 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 694 (824)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~ 694 (824)
..... .....||+.|+|||++.+..|+.++|||||||++|||++|++||...+........ +.. .
T Consensus 191 ~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i--~~~-----~ 255 (373)
T 2r5t_A 191 EHNST--------TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI--LNK-----P 255 (373)
T ss_dssp CCCCC--------CCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHH--HHS-----C
T ss_pred cCCCc--------cccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHH--Hhc-----c
Confidence 22111 13346999999999999999999999999999999999999999765543221111 111 1
Q ss_pred CCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 695 GDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 695 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
..++...+..+.+|+.+||+.+|.+||++.+
T Consensus 256 ~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 256 LQLKPNITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred cCCCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 1234455678999999999999999999843
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=335.40 Aligned_cols=240 Identities=25% Similarity=0.367 Sum_probs=197.5
Q ss_pred CCCCccceeeecCceEEEEEEECC--eEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEec
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL 539 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~~--~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey~ 539 (824)
++|...+.||+|+||.||+|.+.+ ..||+|++........+.+.+|+.+++.++||||++++++|. ...++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELC 88 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEecc
Confidence 468889999999999999999874 689999998765566778999999999999999999999984 4578999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEe---cCCCcceeeccccccccccc
Q 003384 540 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL---DANFVSKLSDFGISRFLSQN 616 (824)
Q Consensus 540 ~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILl---d~~~~vKL~DFGla~~~~~~ 616 (824)
++++|.+++... ..+++..+..++.+++.||.|||+ ++|+||||||+|||+ +.++.+||+|||++..+...
T Consensus 89 ~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~ 162 (277)
T 3f3z_A 89 TGGELFERVVHK---RVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 162 (277)
T ss_dssp CSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred CCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence 999999988543 458999999999999999999999 899999999999999 78899999999999866533
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCC
Q 003384 617 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 696 (824)
Q Consensus 617 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~ 696 (824)
.. .....||+.|+|||++.+. ++.++|||||||++|+|+||++||............... . ..
T Consensus 163 ~~---------~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~-----~~ 225 (277)
T 3f3z_A 163 KM---------MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREG--T-----FT 225 (277)
T ss_dssp SC---------BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--C-----CC
T ss_pred cc---------hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC--C-----CC
Confidence 21 1334689999999998654 899999999999999999999999765443222111100 0 01
Q ss_pred CCh----hhHHHHHHHHHHHhhhccCCCCChHHH
Q 003384 697 WPF----VQAEQLANLAMRCCEMSRKSRPELGKD 726 (824)
Q Consensus 697 ~p~----~~~~~l~~Li~~Cl~~~P~~RPt~~~~ 726 (824)
.+. ..+..+.+|+.+||+.+|.+||++.+.
T Consensus 226 ~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~ 259 (277)
T 3f3z_A 226 FPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQA 259 (277)
T ss_dssp CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred CCchhhhcCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 111 345789999999999999999999443
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=381.55 Aligned_cols=246 Identities=25% Similarity=0.424 Sum_probs=198.3
Q ss_pred ceeeecCceEEEEEEEC----CeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEecccC-CceEEEEEecCCC
Q 003384 470 LKIGEGGYGSIYKGLLR----HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVYEYLPNG 542 (824)
Q Consensus 470 ~~LG~G~fG~Vykg~~~----~~~VAvK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~L~g~~~-~~~~LV~Ey~~gg 542 (824)
++||+|+||.||+|.+. +..||||+++..... ....|.+|+.+|++++|||||+++++|. +..++||||+++|
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~lv~E~~~~g 454 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG 454 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEEEccCCC
Confidence 47999999999999763 367999999764322 2467999999999999999999999984 4678999999999
Q ss_pred ChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCCC
Q 003384 543 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 622 (824)
Q Consensus 543 sL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~ 622 (824)
+|.+++.. ...+++..++.|+.||+.||.|||+ ++||||||||+||||+.++.+||+|||+++.+........
T Consensus 455 ~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~- 527 (635)
T 4fl3_A 455 PLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK- 527 (635)
T ss_dssp EHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred CHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc-
Confidence 99999953 3568999999999999999999999 8999999999999999999999999999987654332111
Q ss_pred ccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHH--HHHhhhccccccCCCCCCCCh
Q 003384 623 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--YALDTGKLKNLLDPLAGDWPF 699 (824)
Q Consensus 623 ~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~~p~ 699 (824)
......||+.|+|||++.+..++.++|||||||+||||+| |++||....... ..+..+ .....|.
T Consensus 528 ----~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~--------~~~~~p~ 595 (635)
T 4fl3_A 528 ----AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG--------ERMGCPA 595 (635)
T ss_dssp -----------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT--------CCCCCCT
T ss_pred ----cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--------CCCCCCC
Confidence 1133457899999999999999999999999999999998 999997654432 222222 1223355
Q ss_pred hhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHH
Q 003384 700 VQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 735 (824)
Q Consensus 700 ~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~ 735 (824)
..+..+.+|+.+||+.+|.+||++ .+|.+.|+.+-
T Consensus 596 ~~~~~l~~li~~cl~~dP~~RPs~-~~l~~~L~~~~ 630 (635)
T 4fl3_A 596 GCPREMYDLMNLCWTYDVENRPGF-AAVELRLRNYY 630 (635)
T ss_dssp TCCHHHHHHHHHHTCSSTTTSCCH-HHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHcCCCHhHCcCH-HHHHHHHHHHH
Confidence 567899999999999999999999 77878887654
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=357.05 Aligned_cols=260 Identities=25% Similarity=0.329 Sum_probs=206.4
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCC-CCCchhHHHHHHHHHhcCCCceeeEecccCC----ceEEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS-LQGPSEFQQEIDILSKIRHPNLVTLVGACPE----VWTLVY 536 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~-~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~~----~~~LV~ 536 (824)
++|...+.||+|+||.||+|.+. +..||||++.... ......+.+|+.+|++++||||+++++++.+ ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 46889999999999999999987 6889999997543 2334678899999999999999999998732 578999
Q ss_pred EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEe----cCCCcceeeccccccc
Q 003384 537 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL----DANFVSKLSDFGISRF 612 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILl----d~~~~vKL~DFGla~~ 612 (824)
||+++|+|.+++........+++..++.++.+++.||.|||+ +||+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 999999999999755445559999999999999999999999 899999999999999 7888899999999987
Q ss_pred cccccccCCCccccccCCCCCCcccCChhhhcc--------CCCCcchhHHhHHHHHHHHHhCCCCCCCc------hHHH
Q 003384 613 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS--------GELTPKSDVYSFGIILLRLLTGRPALGIT------KEVQ 678 (824)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~--------~~~t~ksDVwSlGvvL~ELltG~~Pf~~~------~~~~ 678 (824)
....... ....||+.|+|||++.+ ..++.++|||||||++|||+||++||... ....
T Consensus 166 ~~~~~~~---------~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~ 236 (396)
T 4eut_A 166 LEDDEQF---------VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236 (396)
T ss_dssp CCCGGGS---------SCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHH
T ss_pred ccCCCcc---------ccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHH
Confidence 6543211 23469999999999865 56778999999999999999999999532 1222
Q ss_pred HHHhhhcccccc----------------CCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHh
Q 003384 679 YALDTGKLKNLL----------------DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 736 (824)
Q Consensus 679 ~~~~~~~~~~~l----------------d~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~ 736 (824)
..+..+.....+ .+.....+......+.+++.+||+.+|.+||++ +++++.+..+..
T Consensus 237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~-~e~l~~l~~il~ 309 (396)
T 4eut_A 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF-DQFFAETSDILH 309 (396)
T ss_dssp HHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCH-HHHHHHHHHHHT
T ss_pred HHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccH-HHHHHHHHHHhh
Confidence 222222111000 011223345677899999999999999999999 667777776643
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=338.10 Aligned_cols=246 Identities=25% Similarity=0.384 Sum_probs=196.0
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEecC
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLP 540 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey~~ 540 (824)
.|.....||+|+||.||+|.+. +..||||.+..........+.+|+.+++.++||||+++++++. ...++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 4555668999999999999985 5789999998765555678999999999999999999999984 46889999999
Q ss_pred CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecC-CCcceeecccccccccccccc
Q 003384 541 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA-NFVSKLSDFGISRFLSQNEIS 619 (824)
Q Consensus 541 ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~-~~~vKL~DFGla~~~~~~~~~ 619 (824)
+++|.+++........+++..+..++.+++.||.|||+ +||+||||||+|||++. ++.+||+|||++.........
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~ 179 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC 179 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCc
Confidence 99999999765555567899999999999999999999 89999999999999987 899999999999865432211
Q ss_pred CCCccccccCCCCCCcccCChhhhccCC--CCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCC
Q 003384 620 SNNTTLCCRTDPKGTFAYMDPEFLASGE--LTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 697 (824)
Q Consensus 620 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~--~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~ 697 (824)
.....||+.|+|||++.+.. ++.++|||||||++|+|+||++||................ ......
T Consensus 180 --------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~----~~~~~~ 247 (295)
T 2clq_A 180 --------TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMF----KVHPEI 247 (295)
T ss_dssp ---------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHH----CCCCCC
T ss_pred --------ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccc----cccccc
Confidence 12346899999999997653 8899999999999999999999996433222111111011 111233
Q ss_pred ChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 698 PFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 698 p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
+...+..+.+|+.+||+.+|.+||++.+
T Consensus 248 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ 275 (295)
T 2clq_A 248 PESMSAEAKAFILKCFEPDPDKRACAND 275 (295)
T ss_dssp CTTSCHHHHHHHHHTTCSSTTTSCCHHH
T ss_pred cccCCHHHHHHHHHHccCChhhCCCHHH
Confidence 4556678999999999999999999944
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=336.35 Aligned_cols=263 Identities=21% Similarity=0.282 Sum_probs=202.7
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc---CCceEEEEE
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC---PEVWTLVYE 537 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~---~~~~~LV~E 537 (824)
.++|...+.||+|+||.||+|.+. +..||||++..... ...+.+|+.+++.++|+|++..++.+ .+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence 467999999999999999999964 68999998765432 34689999999999998888877766 456789999
Q ss_pred ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEe---cCCCcceeeccccccccc
Q 003384 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL---DANFVSKLSDFGISRFLS 614 (824)
Q Consensus 538 y~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILl---d~~~~vKL~DFGla~~~~ 614 (824)
|+ +|+|.+++... ...+++..+..++.|++.||.|||+ ++|+||||||+|||+ +.++.+||+|||+++...
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 86 LL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred cc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 99 99999998532 3469999999999999999999999 899999999999999 789999999999998765
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchH-----HHHHHhhhccccc
Q 003384 615 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE-----VQYALDTGKLKNL 689 (824)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~-----~~~~~~~~~~~~~ 689 (824)
......... ........||+.|+|||++.+..++.++|||||||++|+|+||++||..... .............
T Consensus 160 ~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 4hgt_A 160 DARTHQHIP-YRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp CTTTCCBCC-CCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred CcccCccCC-CCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence 443211110 0112345799999999999999999999999999999999999999964321 1111111111110
Q ss_pred cCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhhCC
Q 003384 690 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCG 739 (824)
Q Consensus 690 ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~~~~ 739 (824)
.... ....+..+.+|+.+||+.+|.+||++ +++++.|+.+....+
T Consensus 239 ~~~~----~~~~~~~l~~li~~~l~~~p~~Rpt~-~~l~~~l~~~~~~~~ 283 (296)
T 4hgt_A 239 IEVL----CKGYPSEFATYLNFCRSLRFDDKPDY-SYLRQLFRNLFHRQG 283 (296)
T ss_dssp HHHH----TTTSCHHHHHHHHHHHTSCTTCCCCH-HHHHHHHHHHHHHHT
T ss_pred hhhh----hccCCHHHHHHHHHHHhcCCCCCCCH-HHHHHHHHHHHHHhC
Confidence 0000 12235689999999999999999999 788899988776543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=342.27 Aligned_cols=247 Identities=29% Similarity=0.388 Sum_probs=193.2
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC-----CCchhHHHHHHHHHhcC---CCceeeEecccCC--
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-----QGPSEFQQEIDILSKIR---HPNLVTLVGACPE-- 530 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~-----~~~~~f~~Ei~iL~~l~---HpnIv~L~g~~~~-- 530 (824)
.++|...+.||+|+||.||+|.+. +..||||++..... .....+.+|+.+++.+. ||||++++++|..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 568999999999999999999964 68899999864321 12346788998888775 9999999998832
Q ss_pred -----ceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceee
Q 003384 531 -----VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLS 605 (824)
Q Consensus 531 -----~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~ 605 (824)
..++||||+. |+|.+++.... ...+++..+..|+.|++.||.|||+ ++|+||||||+|||++.++.+||+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 88 TDREIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp SSSEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSCEEEC
T ss_pred CCCceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEEe
Confidence 3689999996 59999986432 3349999999999999999999999 899999999999999999999999
Q ss_pred ccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhc
Q 003384 606 DFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK 685 (824)
Q Consensus 606 DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~ 685 (824)
|||+++........ ....||+.|+|||++.+..++.++|||||||++|+|++|++||............-.
T Consensus 163 Dfg~a~~~~~~~~~---------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~ 233 (308)
T 3g33_A 163 DFGLARIYSYQMAL---------TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFD 233 (308)
T ss_dssp SCSCTTTSTTCCCS---------GGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHH
T ss_pred eCccccccCCCccc---------CCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 99999865432211 223589999999999999999999999999999999999999976654332211110
Q ss_pred cccccCCCCCCC----------------------ChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 686 LKNLLDPLAGDW----------------------PFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 686 ~~~~ld~~~~~~----------------------p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
.. ..+....| ....+..+.+|+.+||+.+|.+||++.+
T Consensus 234 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e 293 (308)
T 3g33_A 234 LI--GLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFR 293 (308)
T ss_dssp HH--CCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred Hh--CCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHH
Confidence 00 00000111 1134568899999999999999999943
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=350.15 Aligned_cols=271 Identities=23% Similarity=0.293 Sum_probs=192.6
Q ss_pred CChhhHhhhcCCCCccceeeecCceEEEEEEE--CCeEEEEEEecCCCCCCchhHHHHHHHHHhcC-CCceeeEeccc--
Q 003384 454 FSFSEIEGATHNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVGAC-- 528 (824)
Q Consensus 454 ~~~~ei~~~~~~f~~~~~LG~G~fG~Vykg~~--~~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~-HpnIv~L~g~~-- 528 (824)
+....+.....+|...+.||+|+||.||+|.+ .+..||||++..........+.+|+.++.++. ||||+++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 97 (337)
T 3ll6_A 18 FVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASI 97 (337)
T ss_dssp STTCEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred hhcceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccc
Confidence 33344455566899999999999999999998 46899999986554334557889999999996 99999999987
Q ss_pred ------C--CceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCc--eEeccccCCcEEecC
Q 003384 529 ------P--EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS--IVHGDLKPANILLDA 598 (824)
Q Consensus 529 ------~--~~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~g--iiHrDLKp~NILld~ 598 (824)
. ..+++||||+. |+|.+++.......++++..++.|+.+++.||.|||+ ++ |+||||||+||||+.
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~ 173 (337)
T 3ll6_A 98 GKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSN 173 (337)
T ss_dssp CTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECT
T ss_pred cccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECC
Confidence 1 13789999995 7999988654445679999999999999999999999 67 999999999999999
Q ss_pred CCcceeeccccccccccccccCCCc----cccccCCCCCCcccCChhhh---ccCCCCcchhHHhHHHHHHHHHhCCCCC
Q 003384 599 NFVSKLSDFGISRFLSQNEISSNNT----TLCCRTDPKGTFAYMDPEFL---ASGELTPKSDVYSFGIILLRLLTGRPAL 671 (824)
Q Consensus 599 ~~~vKL~DFGla~~~~~~~~~~~~~----~~~~~~~~~GT~~Y~APE~l---~~~~~t~ksDVwSlGvvL~ELltG~~Pf 671 (824)
++.+||+|||+++............ .........||+.|+|||++ .+..++.++|||||||++|+|+||++||
T Consensus 174 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~ 253 (337)
T 3ll6_A 174 QGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF 253 (337)
T ss_dssp TSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC
T ss_pred CCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCC
Confidence 9999999999998765432211000 00011234589999999998 5667899999999999999999999999
Q ss_pred CCchHHHHHHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhhC
Q 003384 672 GITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC 738 (824)
Q Consensus 672 ~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~~~ 738 (824)
........ ..+.. ....+...+..+.+|+.+||+.+|.+||++ .++++.|..+....
T Consensus 254 ~~~~~~~~--~~~~~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-~e~l~~l~~~~~~~ 310 (337)
T 3ll6_A 254 EDGAKLRI--VNGKY-------SIPPHDTQYTVFHSLIRAMLQVNPEERLSI-AEVVHQLQEIAAAR 310 (337)
T ss_dssp --------------C-------CCCTTCCSSGGGHHHHHHHSCSSGGGSCCH-HHHHHHHHHHHHHT
T ss_pred cchhHHHh--hcCcc-------cCCcccccchHHHHHHHHHccCChhhCcCH-HHHHHHHHHHHhcc
Confidence 65432211 11111 011122233468899999999999999999 77888888887643
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=345.92 Aligned_cols=238 Identities=24% Similarity=0.280 Sum_probs=186.7
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCC--chhHHHHHHHHHhc-CCCceeeEecccC--CceEEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTLVY 536 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~--~~~f~~Ei~iL~~l-~HpnIv~L~g~~~--~~~~LV~ 536 (824)
++|...++||+|+||+||+|.+. +..||||++....... ...+..|+..+..+ +||||++++++|. ...++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 46888999999999999999986 6889999987543322 22355566666555 8999999999984 4689999
Q ss_pred EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccc
Q 003384 537 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 616 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 616 (824)
||+ +|+|.+++... ...+++..+..|+.+++.||.|||+ ++|+||||||+||||+.++.+||+|||++......
T Consensus 137 e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp ECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred ecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence 999 67999888644 3469999999999999999999999 89999999999999999999999999998865433
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCC
Q 003384 617 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 696 (824)
Q Consensus 617 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~ 696 (824)
.. .....||+.|+|||++.+ .++.++|||||||++|||++|.+|+........ +..+.. ...
T Consensus 211 ~~---------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~-~~~~~~-------~~~ 272 (311)
T 3p1a_A 211 GA---------GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQ-LRQGYL-------PPE 272 (311)
T ss_dssp -------------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHH-HTTTCC-------CHH
T ss_pred CC---------CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH-HhccCC-------Ccc
Confidence 21 123459999999999875 799999999999999999999776654433221 122111 011
Q ss_pred CChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 697 WPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 697 ~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
++...+..+.+|+.+||+.+|.+||++.+
T Consensus 273 ~~~~~~~~l~~li~~~L~~dP~~Rpt~~e 301 (311)
T 3p1a_A 273 FTAGLSSELRSVLVMMLEPDPKLRATAEA 301 (311)
T ss_dssp HHTTSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred cccCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 12334578999999999999999999943
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=364.17 Aligned_cols=250 Identities=22% Similarity=0.234 Sum_probs=196.5
Q ss_pred HhhhcCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCC---CCCchhHHHHHHHHHhcCCCceeeEecccC--Cc
Q 003384 459 IEGATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDILSKIRHPNLVTLVGACP--EV 531 (824)
Q Consensus 459 i~~~~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~---~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~ 531 (824)
+....++|...+.||+|+||.||+|... +..||||++.... ......+.+|+.++..++||||++++++|. +.
T Consensus 56 ~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~ 135 (412)
T 2vd5_A 56 VRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENY 135 (412)
T ss_dssp HSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred ccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence 3445568999999999999999999985 6889999986421 112345889999999999999999999984 46
Q ss_pred eEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccc
Q 003384 532 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR 611 (824)
Q Consensus 532 ~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~ 611 (824)
.|+||||++||+|.+++... ...+++..+..++.+|+.||.|||+ ++||||||||+||||+.+|++||+|||+++
T Consensus 136 ~~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~DFGla~ 210 (412)
T 2vd5_A 136 LYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCL 210 (412)
T ss_dssp EEEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEeechhhe
Confidence 89999999999999999643 2368999999999999999999999 899999999999999999999999999998
Q ss_pred ccccccccCCCccccccCCCCCCcccCChhhhc-------cCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhh
Q 003384 612 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA-------SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG 684 (824)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~-------~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~ 684 (824)
.+...... ......||+.|+|||++. +..|+.++|||||||++|||+||++||.............
T Consensus 211 ~~~~~~~~-------~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~ 283 (412)
T 2vd5_A 211 KLRADGTV-------RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIV 283 (412)
T ss_dssp ECCTTSCE-------ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred eccCCCcc-------ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 76543211 113356999999999997 3568999999999999999999999997665433211111
Q ss_pred ccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCC---Ch
Q 003384 685 KLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP---EL 723 (824)
Q Consensus 685 ~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RP---t~ 723 (824)
.....+. ....+...+..+.+|+.+||. +|.+|+ ++
T Consensus 284 ~~~~~~~--~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~ 322 (412)
T 2vd5_A 284 HYKEHLS--LPLVDEGVPEEARDFIQRLLC-PPETRLGRGGA 322 (412)
T ss_dssp THHHHCC--CC----CCCHHHHHHHHTTSS-CGGGCTTTTTH
T ss_pred hcccCcC--CCccccCCCHHHHHHHHHHcC-ChhhcCCCCCH
Confidence 1111110 111123456789999999999 999984 66
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=352.22 Aligned_cols=265 Identities=17% Similarity=0.234 Sum_probs=204.1
Q ss_pred cCCCCccceeeecCceEEEEEEEC----------CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeE--------
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR----------HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL-------- 524 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~----------~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L-------- 524 (824)
.++|...+.||+|+||.||+|.+. +..||||++... ..+.+|+.++++++||||+++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 357999999999999999999875 467999998754 468999999999999999984
Q ss_pred -------eccc---CCceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcE
Q 003384 525 -------VGAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANI 594 (824)
Q Consensus 525 -------~g~~---~~~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NI 594 (824)
++++ ....++||||+ +|+|.+++... ....+++..++.|+.||+.||.|||+ ++|+||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHE
Confidence 4443 34678999999 99999999643 13569999999999999999999999 8999999999999
Q ss_pred EecCCC--cceeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCC
Q 003384 595 LLDANF--VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALG 672 (824)
Q Consensus 595 Lld~~~--~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~ 672 (824)
|++.++ .+||+|||+++.+.......... ........||+.|+|||++.+..++.++|||||||+||+|+||+.||.
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYV-EGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCC-TTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEcCCCCceEEEecCcceeeccCCCcccccc-ccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 999998 99999999998766443221111 111234579999999999999999999999999999999999999997
Q ss_pred Cch-HHHHHH-hhhccccccCCCCCCC--ChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhhCC
Q 003384 673 ITK-EVQYAL-DTGKLKNLLDPLAGDW--PFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCG 739 (824)
Q Consensus 673 ~~~-~~~~~~-~~~~~~~~ld~~~~~~--p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~~~~ 739 (824)
... ...... ....+........... ....+..+.+|+.+||+.+|.+||++ +++++.|+.+.....
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 270 NCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPY-AMLRNNLEALLQDLR 339 (352)
T ss_dssp GGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCH-HHHHHHHHHHHHHTT
T ss_pred cCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCH-HHHHHHHHHHHHhcC
Confidence 542 111111 1111111111111100 11335789999999999999999998 788889988876543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=344.59 Aligned_cols=244 Identities=21% Similarity=0.299 Sum_probs=197.8
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC------CchhHHHHHHHHHhcCCCceeeEecccC--CceE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ------GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWT 533 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~------~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~ 533 (824)
+.|...+.||+|+||.||+|... +..||||++...... ....+.+|+.+++.++||||+++++++. ...+
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 46889999999999999999986 578999999764332 2456999999999999999999999984 4689
Q ss_pred EEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCC----cceeecccc
Q 003384 534 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF----VSKLSDFGI 609 (824)
Q Consensus 534 LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~----~vKL~DFGl 609 (824)
+||||+++++|.+++.. ...+++..+..++.+++.||.|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus 92 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~ 165 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (321)
T ss_dssp EEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred EEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence 99999999999999953 3568999999999999999999999 8999999999999999887 799999999
Q ss_pred ccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccc
Q 003384 610 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNL 689 (824)
Q Consensus 610 a~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ 689 (824)
+........ .....||+.|+|||++.+..++.++|||||||++|+|+||++||..................
T Consensus 166 ~~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 236 (321)
T 2a2a_A 166 AHEIEDGVE---------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYD 236 (321)
T ss_dssp CEECCTTCC---------CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC
T ss_pred ceecCcccc---------ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccc
Confidence 986654321 12346999999999999999999999999999999999999999765443322111111000
Q ss_pred cCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 690 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 690 ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
.....+...+..+.+|+.+||+.+|.+||++.+
T Consensus 237 ---~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e 269 (321)
T 2a2a_A 237 ---FDEEFFSHTSELAKDFIRKLLVKETRKRLTIQE 269 (321)
T ss_dssp ---CCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHH
T ss_pred ---cChhhhcccCHHHHHHHHHHcCCChhhCcCHHH
Confidence 000011234568999999999999999999943
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=338.66 Aligned_cols=242 Identities=27% Similarity=0.442 Sum_probs=196.2
Q ss_pred hcCCCCccceeeecCceEEEEEEECC--eEEEEEEecCCC---CCCchhHHHHHHHHHhcCCCceeeEecccC--CceEE
Q 003384 462 ATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHS---LQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTL 534 (824)
Q Consensus 462 ~~~~f~~~~~LG~G~fG~Vykg~~~~--~~VAvK~l~~~~---~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~L 534 (824)
..++|...+.||+|+||.||+|.+.. ..||||++.... ......+.+|+.+++.++||||++++++|. ...++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 34578899999999999999998874 679999985431 122456889999999999999999999984 45789
Q ss_pred EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccc
Q 003384 535 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 614 (824)
Q Consensus 535 V~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~ 614 (824)
||||+++|+|.+++... ..+++..+..++.+++.||.|||+ +||+||||||+|||++.++.+||+|||++....
T Consensus 87 v~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp EECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 99999999999998533 458999999999999999999999 899999999999999999999999999986543
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCC
Q 003384 615 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 694 (824)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~ 694 (824)
... .....||+.|+|||++.+..++.++||||||+++|+|++|++||.............. ..
T Consensus 161 ~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------~~ 223 (279)
T 3fdn_A 161 SSR----------RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR-------VE 223 (279)
T ss_dssp -----------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH-------TC
T ss_pred ccc----------ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHh-------CC
Confidence 321 1234689999999999999999999999999999999999999986554332211111 11
Q ss_pred CCCChhhHHHHHHHHHHHhhhccCCCCChHHH
Q 003384 695 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKD 726 (824)
Q Consensus 695 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~ 726 (824)
..+|...+..+.+|+.+||+.+|.+||++.+.
T Consensus 224 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~ 255 (279)
T 3fdn_A 224 FTFPDFVTEGARDLISRLLKHNPSQRPMLREV 255 (279)
T ss_dssp CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred CCCCCcCCHHHHHHHHHHhccChhhCCCHHHH
Confidence 22344566789999999999999999999433
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=344.70 Aligned_cols=255 Identities=26% Similarity=0.425 Sum_probs=202.4
Q ss_pred CCCCccceeeecCceEEEEEEEC--Ce--EEEEEEecCCC-CCCchhHHHHHHHHHhc-CCCceeeEecccC--CceEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HM--QVAIKMLHPHS-LQGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTLV 535 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~--~VAvK~l~~~~-~~~~~~f~~Ei~iL~~l-~HpnIv~L~g~~~--~~~~LV 535 (824)
++|...+.||+|+||.||+|.+. +. .||||.+.... ......+.+|+.+++++ +||||+++++++. +..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 46888999999999999999875 44 45999887532 23356799999999999 8999999999984 468899
Q ss_pred EEecCCCChhhhhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcc
Q 003384 536 YEYLPNGSLEDRLSCKD-------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS 602 (824)
Q Consensus 536 ~Ey~~ggsL~~~L~~~~-------------~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~v 602 (824)
|||+++|+|.+++.... ....+++..++.++.+++.||.|||+ +||+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCeE
Confidence 99999999999996432 23479999999999999999999999 899999999999999999999
Q ss_pred eeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHHHH
Q 003384 603 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYAL 681 (824)
Q Consensus 603 KL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~ 681 (824)
||+|||+++....... .....+|+.|+|||++.+..++.++|||||||++|+|+| |++||..........
T Consensus 182 kL~Dfg~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~ 252 (327)
T 1fvr_A 182 KIADFGLSRGQEVYVK---------KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 252 (327)
T ss_dssp EECCTTCEESSCEECC---------C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred EEcccCcCcccccccc---------ccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHH
Confidence 9999999874332211 123357899999999998889999999999999999998 999997654432211
Q ss_pred hhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhh
Q 003384 682 DTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 737 (824)
Q Consensus 682 ~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~~ 737 (824)
.. ........+...+..+.+|+.+||..+|.+||++ +++++.|..+...
T Consensus 253 ~~------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~ell~~L~~~~~~ 301 (327)
T 1fvr_A 253 KL------PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSF-AQILVSLNRMLEE 301 (327)
T ss_dssp HG------GGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHS
T ss_pred Hh------hcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCH-HHHHHHHHHHHHh
Confidence 11 1111122344566789999999999999999999 7788888877653
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=335.57 Aligned_cols=243 Identities=23% Similarity=0.375 Sum_probs=196.7
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEecccC--CceEEEE
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 536 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~ 536 (824)
.++|...+.||+|+||.||+|.+. +..||+|++...... ....+.+|+.++++++||||+++++++. ...++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 457999999999999999999886 578999998754332 2346889999999999999999999984 4578999
Q ss_pred EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCc---ceeecccccccc
Q 003384 537 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV---SKLSDFGISRFL 613 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~---vKL~DFGla~~~ 613 (824)
||+++|+|.+.+... ..+++..+..++.+++.||.|||+ ++|+||||||+|||++.++. +||+|||++...
T Consensus 85 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp CCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 999999999888543 468999999999999999999999 89999999999999986654 999999999765
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHH--hhhccccccC
Q 003384 614 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYAL--DTGKLKNLLD 691 (824)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~--~~~~~~~~ld 691 (824)
..... .....||+.|+|||++.+..++.++|||||||++|+|++|++||.......... ..+.. .
T Consensus 159 ~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~----~ 225 (284)
T 3kk8_A 159 NDSEA---------WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY----D 225 (284)
T ss_dssp CSSCB---------CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC----C
T ss_pred ccCcc---------ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccc----c
Confidence 43321 123468999999999999999999999999999999999999997654432211 11111 1
Q ss_pred CCCCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 692 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 692 ~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
. ........+..+.+|+.+||+.+|.+||++.+
T Consensus 226 ~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ 258 (284)
T 3kk8_A 226 Y-PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQ 258 (284)
T ss_dssp C-CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred C-CchhhcccCHHHHHHHHHHcccChhhCCCHHH
Confidence 1 11111244578999999999999999999943
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=339.28 Aligned_cols=248 Identities=27% Similarity=0.361 Sum_probs=190.7
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCC--chhHHHHHHHHHhcCCCceeeEecccC--CceEEEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE 537 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~E 537 (824)
++|...+.||+|+||.||+|.+. +..||||++....... ...+.+|+.++++++||||+++++++. ...++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 46888999999999999999986 6889999986653322 345789999999999999999999984 46889999
Q ss_pred ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccc
Q 003384 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 617 (824)
Q Consensus 538 y~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 617 (824)
|+++++|.+++. ....+++..+..++.+++.||.|||+ +||+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~~~~~l~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 83 YCDHTVLHELDR---YQRGVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp CCSEEHHHHHHH---TSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred eCCCchHHHHHh---hhcCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 999999998874 23568999999999999999999999 899999999999999999999999999998765332
Q ss_pred ccCCCccccccCCCCCCcccCChhhhcc-CCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhcc-c--------
Q 003384 618 ISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL-K-------- 687 (824)
Q Consensus 618 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~-~-------- 687 (824)
.. .....||+.|+|||++.+ ..++.++|||||||++|+|+||++||............... .
T Consensus 157 ~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (311)
T 4agu_A 157 DY--------YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQ 228 (311)
T ss_dssp -----------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred cc--------cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccc
Confidence 11 123468999999999976 57899999999999999999999999766443322111000 0
Q ss_pred -----cccC----CCCCCC------ChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 688 -----NLLD----PLAGDW------PFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 688 -----~~ld----~~~~~~------p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
.... +..... ....+..+.+|+.+||+.+|.+||++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 281 (311)
T 4agu_A 229 VFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQ 281 (311)
T ss_dssp HHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHH
T ss_pred ccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHH
Confidence 0000 000000 0134567899999999999999999943
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=352.00 Aligned_cols=239 Identities=23% Similarity=0.395 Sum_probs=192.3
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhc-CCCceeeEecccC--CceEEEEEe
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTLVYEY 538 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l-~HpnIv~L~g~~~--~~~~LV~Ey 538 (824)
++|...+.||+|+||.||++... +..||||++..... .+.+|++++.++ +||||+++++++. ...++||||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 97 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL 97 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeC
Confidence 46888999999999999999986 58899999976432 356799999888 7999999999984 468899999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecC-C---Ccceeeccccccccc
Q 003384 539 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA-N---FVSKLSDFGISRFLS 614 (824)
Q Consensus 539 ~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~-~---~~vKL~DFGla~~~~ 614 (824)
++||+|.+++.. ...+++..+..++.+|+.||.|||+ +||+||||||+|||+.. + +.+||+|||+++.+.
T Consensus 98 ~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 98 MKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp CCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred CCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 999999999853 3569999999999999999999999 89999999999999843 2 359999999998764
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCch-----HHHHHHhhhccccc
Q 003384 615 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITK-----EVQYALDTGKLKNL 689 (824)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~-----~~~~~~~~~~~~~~ 689 (824)
..... .....||+.|+|||++.+..|+.++|||||||++|+|++|++||.... .+...+..+..
T Consensus 172 ~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~--- 240 (342)
T 2qr7_A 172 AENGL--------LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKF--- 240 (342)
T ss_dssp CTTCC--------BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCC---
T ss_pred CCCCc--------eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCc---
Confidence 33211 133468999999999988889999999999999999999999997421 12222222221
Q ss_pred cCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 690 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 690 ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
. .....+...+..+.+|+.+||..+|.+||++.+
T Consensus 241 -~-~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~ 274 (342)
T 2qr7_A 241 -S-LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAAL 274 (342)
T ss_dssp -C-CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred -c-cCccccccCCHHHHHHHHHHCCCChhHCcCHHH
Confidence 1 111223345678999999999999999999843
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=350.88 Aligned_cols=247 Identities=25% Similarity=0.380 Sum_probs=191.2
Q ss_pred hcCCCCccceeeecCceEEEEEEEC-CeEEEEEEecCCCCCC--chhHHHHHHHHHhcCC--CceeeEecccC--CceEE
Q 003384 462 ATHNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRH--PNLVTLVGACP--EVWTL 534 (824)
Q Consensus 462 ~~~~f~~~~~LG~G~fG~Vykg~~~-~~~VAvK~l~~~~~~~--~~~f~~Ei~iL~~l~H--pnIv~L~g~~~--~~~~L 534 (824)
..+.|.+.+.||+|+||.||+|... +..||||++....... ...+.+|+.+|..++| |||+++++++. ...++
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 4557999999999999999999876 4789999987653322 3568899999999986 99999999984 46889
Q ss_pred EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccc
Q 003384 535 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 614 (824)
Q Consensus 535 V~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~ 614 (824)
||| +.+|+|.+++.. ...+++..+..|+.|++.||.|||+ ++|+||||||+||||+ ++.+||+|||+++.+.
T Consensus 87 v~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EEC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred EEe-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 999 558899999964 3568999999999999999999999 8999999999999997 6789999999998765
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhcc-----------CCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhh
Q 003384 615 QNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-----------GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT 683 (824)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-----------~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~ 683 (824)
...... ......||+.|+|||++.+ ..++.++|||||||+||+|++|++||.........
T Consensus 159 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--- 229 (343)
T 3dbq_A 159 PDTTSV------VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK--- 229 (343)
T ss_dssp -----------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH---
T ss_pred cccccc------cCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHH---
Confidence 432211 1134569999999999865 67889999999999999999999999753221111
Q ss_pred hccccccCC-CCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 003384 684 GKLKNLLDP-LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 727 (824)
Q Consensus 684 ~~~~~~ld~-~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 727 (824)
+...+++ ....+|...+..+.+|+.+||+.+|.+||++.+.+
T Consensus 230 --~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l 272 (343)
T 3dbq_A 230 --LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 272 (343)
T ss_dssp --HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred --HHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHH
Confidence 1111111 22344555567899999999999999999995443
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=346.06 Aligned_cols=249 Identities=27% Similarity=0.351 Sum_probs=189.9
Q ss_pred hhcCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCC-----chhHHHHHHHHHhcCCCceeeEecccC--Cc
Q 003384 461 GATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG-----PSEFQQEIDILSKIRHPNLVTLVGACP--EV 531 (824)
Q Consensus 461 ~~~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~-----~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~ 531 (824)
...++|...+.||+|+||.||+|.+. +..||||++....... ...+.+|+.+++.++||||++++++|. ..
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34567999999999999999999886 5789999987532211 346889999999999999999999984 46
Q ss_pred eEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccc
Q 003384 532 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR 611 (824)
Q Consensus 532 ~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~ 611 (824)
.++||||+.+ +|.+++.. ....+++..+..++.+++.||.|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 87 ~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CEEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred eEEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEecccce
Confidence 8999999986 88888843 34568888999999999999999999 899999999999999999999999999998
Q ss_pred ccccccccCCCccccccCCCCCCcccCChhhhccC-CCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhcccccc
Q 003384 612 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLL 690 (824)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~l 690 (824)
.+...... .....||+.|+|||++.+. .++.++|||||||++|+|++|.+||............- ....
T Consensus 161 ~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~--~~~~ 230 (346)
T 1ua2_A 161 SFGSPNRA--------YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIF--ETLG 230 (346)
T ss_dssp TTTSCCCC--------CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HHHC
T ss_pred eccCCccc--------CCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHH--HHcC
Confidence 76433211 1345689999999999764 58999999999999999999999998765433221110 0000
Q ss_pred CCCCCCC------------------C-----hhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 691 DPLAGDW------------------P-----FVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 691 d~~~~~~------------------p-----~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
.+....| + ...+..+.+|+.+||..+|.+||++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 288 (346)
T 1ua2_A 231 TPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQ 288 (346)
T ss_dssp CCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHH
T ss_pred CCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHH
Confidence 0100111 1 233578999999999999999999943
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=349.92 Aligned_cols=235 Identities=23% Similarity=0.406 Sum_probs=194.6
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC--------CchhHHHHHHHHHhcCCCceeeEecccC--C
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--------GPSEFQQEIDILSKIRHPNLVTLVGACP--E 530 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~--------~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~ 530 (824)
.++|...+.||+|+||.||+|.+. +..||||++...... ....+.+|+.+|+.++||||++++++|. .
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 457899999999999999999875 688999999765322 2346788999999999999999999984 4
Q ss_pred ceEEEEEecCCC-ChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccc
Q 003384 531 VWTLVYEYLPNG-SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI 609 (824)
Q Consensus 531 ~~~LV~Ey~~gg-sL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGl 609 (824)
..++||||+.+| +|.+++. ....+++..+..|+.+++.||.|||. ++|+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 176 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFID---RHPRLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGS 176 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHH---TCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEEEEeCCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEeeccc
Confidence 678999999777 9999984 34569999999999999999999999 8999999999999999999999999999
Q ss_pred ccccccccccCCCccccccCCCCCCcccCChhhhccCCC-CcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhcccc
Q 003384 610 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL-TPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKN 688 (824)
Q Consensus 610 a~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~ 688 (824)
+......... ....||+.|+|||++.+..+ +.++|||||||++|+|++|++||...... ...
T Consensus 177 a~~~~~~~~~---------~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------~~~ 239 (335)
T 3dls_A 177 AAYLERGKLF---------YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET--------VEA 239 (335)
T ss_dssp CEECCTTCCB---------CEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG--------TTT
T ss_pred ceECCCCCce---------eccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH--------Hhh
Confidence 9876543211 22458999999999988876 78999999999999999999999653211 111
Q ss_pred ccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 689 LLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 689 ~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
....|...+..+.+|+.+||+.+|.+||++.+
T Consensus 240 -----~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e 271 (335)
T 3dls_A 240 -----AIHPPYLVSKELMSLVSGLLQPVPERRTTLEK 271 (335)
T ss_dssp -----CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred -----ccCCCcccCHHHHHHHHHHccCChhhCcCHHH
Confidence 11223345678999999999999999999943
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=365.07 Aligned_cols=238 Identities=22% Similarity=0.263 Sum_probs=186.4
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCC---CCCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH---SLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 536 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~---~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~ 536 (824)
++|...+.||+|+||.||+|... +..||||++... .......+.+|+.+|+.++||||++++++|. +..++||
T Consensus 148 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 227 (446)
T 4ejn_A 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM 227 (446)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEE
T ss_pred HHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEE
Confidence 46889999999999999999875 578999998753 2233456789999999999999999999984 5689999
Q ss_pred EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccc
Q 003384 537 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 616 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 616 (824)
||++||+|.+++... ..+++..+..++.||+.||.|||+. +|||||||||+||||+.++.+||+|||+++.....
T Consensus 228 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~--~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 302 (446)
T 4ejn_A 228 EYANGGELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 302 (446)
T ss_dssp CCCSSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHH--TCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred eeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhc--CCEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence 999999999998543 4689999999999999999999962 57999999999999999999999999999854332
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCC
Q 003384 617 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 696 (824)
Q Consensus 617 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~ 696 (824)
... .....||+.|+|||++.+..|+.++|||||||+||||++|++||............. . ....
T Consensus 303 ~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~--~-----~~~~ 367 (446)
T 4ejn_A 303 GAT--------MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL--M-----EEIR 367 (446)
T ss_dssp ------------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--H-----CCCC
T ss_pred Ccc--------cccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHH--h-----CCCC
Confidence 211 134569999999999999999999999999999999999999997654432211110 0 1112
Q ss_pred CChhhHHHHHHHHHHHhhhccCCCC
Q 003384 697 WPFVQAEQLANLAMRCCEMSRKSRP 721 (824)
Q Consensus 697 ~p~~~~~~l~~Li~~Cl~~~P~~RP 721 (824)
+|...+..+.+|+.+||+.+|.+||
T Consensus 368 ~p~~~~~~~~~li~~~L~~dP~~R~ 392 (446)
T 4ejn_A 368 FPRTLGPEAKSLLSGLLKKDPKQRL 392 (446)
T ss_dssp CCTTSCHHHHHHHHHHTCSSTTTST
T ss_pred CCccCCHHHHHHHHHHcccCHHHhC
Confidence 3455667899999999999999999
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=363.62 Aligned_cols=239 Identities=26% Similarity=0.401 Sum_probs=198.3
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCC---CCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEE
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLV 535 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~---~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV 535 (824)
.++|...+.||+|+||.||+|.+. +..||||++.... ......+.+|+.+|+.++||||+++++++. +..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 357889999999999999999886 6899999986432 223457899999999999999999999984 568999
Q ss_pred EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccc
Q 003384 536 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 615 (824)
Q Consensus 536 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~ 615 (824)
|||++||+|.+++. ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++.....
T Consensus 95 ~E~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 95 MEYVSGGELFDYIC---KNGRLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EECCSSEEHHHHTT---SSSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred EeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 99999999999994 34569999999999999999999999 8999999999999999999999999999987654
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCC-CcchhHHhHHHHHHHHHhCCCCCCCchHHHH--HHhhhccccccCC
Q 003384 616 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL-TPKSDVYSFGIILLRLLTGRPALGITKEVQY--ALDTGKLKNLLDP 692 (824)
Q Consensus 616 ~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~--~~~~~~~~~~ld~ 692 (824)
... .....||+.|+|||++.+..+ +.++|||||||++|+|++|++||........ .+..+.
T Consensus 169 ~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~------- 232 (476)
T 2y94_A 169 GEF---------LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI------- 232 (476)
T ss_dssp TCC---------BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTC-------
T ss_pred ccc---------ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-------
Confidence 321 133469999999999988765 6899999999999999999999976543221 111111
Q ss_pred CCCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 693 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 693 ~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
...|...+..+.+|+.+||+.+|.+||++.+
T Consensus 233 --~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~e 263 (476)
T 2y94_A 233 --FYTPQYLNPSVISLLKHMLQVDPMKRATIKD 263 (476)
T ss_dssp --CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred --cCCCccCCHHHHHHHHHHcCCCchhCcCHHH
Confidence 1224445678999999999999999999944
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=353.61 Aligned_cols=244 Identities=25% Similarity=0.307 Sum_probs=186.3
Q ss_pred hcCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--CCceEEEEE
Q 003384 462 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYE 537 (824)
Q Consensus 462 ~~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~E 537 (824)
..++|...+.||+|+||.||++... +..||||++..... ....+.+|+.+++.++||||+++++++ ....++|||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 3457999999999999999999986 57899999975432 346789999999999999999999998 456899999
Q ss_pred ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCc--ceeecccccccccc
Q 003384 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV--SKLSDFGISRFLSQ 615 (824)
Q Consensus 538 y~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~--vKL~DFGla~~~~~ 615 (824)
|+++|+|.+++... ..+++..+..++.|++.||.|||+ +||+||||||+|||++.++. +||+|||+++....
T Consensus 97 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 97 YASGGELYERICNA---GRFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp CCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred eCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 99999999998533 458999999999999999999999 89999999999999987765 99999999874332
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCcc-hhHHhHHHHHHHHHhCCCCCCCchHH---HHHHhhhccccccC
Q 003384 616 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPK-SDVYSFGIILLRLLTGRPALGITKEV---QYALDTGKLKNLLD 691 (824)
Q Consensus 616 ~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~k-sDVwSlGvvL~ELltG~~Pf~~~~~~---~~~~~~~~~~~~ld 691 (824)
... .....||+.|+|||++.+..++.+ +|||||||++|+|++|++||...... ...+.. ....
T Consensus 171 ~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~-~~~~--- 237 (361)
T 3uc3_A 171 HSQ---------PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQR-ILSV--- 237 (361)
T ss_dssp -------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHH-HHTT---
T ss_pred cCC---------CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHH-HhcC---
Confidence 211 123469999999999988887665 89999999999999999999754321 111110 0000
Q ss_pred CCCCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 692 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 692 ~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
..........+..+.+|+.+||+.+|.+||++.+
T Consensus 238 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e 271 (361)
T 3uc3_A 238 KYSIPDDIRISPECCHLISRIFVADPATRISIPE 271 (361)
T ss_dssp CCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHH
T ss_pred CCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHH
Confidence 0001111234578999999999999999999944
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=335.40 Aligned_cols=245 Identities=24% Similarity=0.356 Sum_probs=191.9
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEe
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY 538 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey 538 (824)
+.|...+.||+|+||.||++... +..||+|++..... .....+.+|+.+|+.++||||++++++|. ...++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 36888999999999999999886 57899999876532 34567999999999999999999999984 467899999
Q ss_pred cCCCChhhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEe---cCCCcceeeccccccccc
Q 003384 539 LPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL---DANFVSKLSDFGISRFLS 614 (824)
Q Consensus 539 ~~ggsL~~~L~~~-~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILl---d~~~~vKL~DFGla~~~~ 614 (824)
+++|+|.+.+... .....+++..+..|+.+++.||.|||+ ++|+||||||+|||+ +.++.+||+|||++..+.
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999988543 224569999999999999999999999 899999999999999 456889999999998654
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCC
Q 003384 615 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 694 (824)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~ 694 (824)
.... .....||+.|+|||++. +.++.++|||||||++|+|++|+.||................ +..
T Consensus 179 ~~~~---------~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~----~~~ 244 (285)
T 3is5_A 179 SDEH---------STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKE----PNY 244 (285)
T ss_dssp -----------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC----CCC
T ss_pred Cccc---------CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCC----ccc
Confidence 3321 12345899999999975 578999999999999999999999997654332211111111 100
Q ss_pred CCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 695 GDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 695 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
.......+..+.+|+.+||+.+|.+||++.+
T Consensus 245 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e 275 (285)
T 3is5_A 245 AVECRPLTPQAVDLLKQMLTKDPERRPSAAQ 275 (285)
T ss_dssp CC--CCCCHHHHHHHHHHTCSCTTTSCCHHH
T ss_pred ccccCcCCHHHHHHHHHHccCChhhCcCHHH
Confidence 1111123568899999999999999999943
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=347.05 Aligned_cols=264 Identities=22% Similarity=0.314 Sum_probs=202.8
Q ss_pred hcCCCCccceeeecCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHh--cCCCceeeEecccCC------ceE
Q 003384 462 ATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSK--IRHPNLVTLVGACPE------VWT 533 (824)
Q Consensus 462 ~~~~f~~~~~LG~G~fG~Vykg~~~~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~--l~HpnIv~L~g~~~~------~~~ 533 (824)
..++|...+.||+|+||.||+|.+++..||||++... ....+.+|++++.. ++||||+++++++.. ..+
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~ 116 (342)
T 1b6c_B 40 IARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 116 (342)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEE
T ss_pred ccccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeE
Confidence 4457999999999999999999999999999998643 24568899999988 789999999998832 578
Q ss_pred EEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhc-----CCCceEeccccCCcEEecCCCcceeeccc
Q 003384 534 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC-----KPHSIVHGDLKPANILLDANFVSKLSDFG 608 (824)
Q Consensus 534 LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~-----~~~giiHrDLKp~NILld~~~~vKL~DFG 608 (824)
+||||+++|+|.+++.. ..+++..++.++.+++.||.|||.. +.++|+||||||+||||+.++.+||+|||
T Consensus 117 lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg 192 (342)
T 1b6c_B 117 LVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 192 (342)
T ss_dssp EEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCT
T ss_pred EEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECC
Confidence 99999999999999953 3589999999999999999999921 01799999999999999999999999999
Q ss_pred cccccccccccCCCccccccCCCCCCcccCChhhhccCC------CCcchhHHhHHHHHHHHHhC----------CCCCC
Q 003384 609 ISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE------LTPKSDVYSFGIILLRLLTG----------RPALG 672 (824)
Q Consensus 609 la~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~------~t~ksDVwSlGvvL~ELltG----------~~Pf~ 672 (824)
++........... .......||+.|+|||++.+.. ++.++|||||||++|+|+|| +.||.
T Consensus 193 ~~~~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~ 268 (342)
T 1b6c_B 193 LAVRHDSATDTID----IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 268 (342)
T ss_dssp TCEEEETTTTEEE----ECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred Cceeccccccccc----cccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcc
Confidence 9986654321110 0113456999999999997752 33689999999999999999 67875
Q ss_pred CchH---HHHHHhhhccccccCCCCC-CC-ChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhh
Q 003384 673 ITKE---VQYALDTGKLKNLLDPLAG-DW-PFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 737 (824)
Q Consensus 673 ~~~~---~~~~~~~~~~~~~ld~~~~-~~-p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~~ 737 (824)
.... ....+........+.+... .+ ....+..+.+|+.+||+.+|.+||++ +++++.|+.+...
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~-~~i~~~L~~i~~~ 337 (342)
T 1b6c_B 269 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA-LRIKKTLSQLSQQ 337 (342)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCH-HHHHHHHHHHHHT
T ss_pred ccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCH-HHHHHHHHHHHHH
Confidence 4210 0000111111111111111 11 23456789999999999999999999 7888899887654
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-38 Score=336.42 Aligned_cols=242 Identities=28% Similarity=0.411 Sum_probs=200.0
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEeccc--CCceEEEEE
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYE 537 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~E 537 (824)
...|...+.||+|+||.||+|... +..||||++..... .....+.+|+.+++.++||||+++++++ ....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 346889999999999999999875 57899999976543 3356799999999999999999999988 356889999
Q ss_pred ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccc
Q 003384 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 617 (824)
Q Consensus 538 y~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 617 (824)
|+++++|.+++. ..++++..+..++.+++.||.|||+ +||+||||||+|||++.++.+||+|||++.......
T Consensus 101 ~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 101 YLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CCTTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred eCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 999999999984 2468999999999999999999999 899999999999999999999999999998765432
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCC
Q 003384 618 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 697 (824)
Q Consensus 618 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~ 697 (824)
.. .....||+.|+|||++.+..++.++|||||||++|+|++|++||.............. ......
T Consensus 174 ~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------~~~~~~ 239 (303)
T 3a7i_A 174 IK--------RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPK------NNPPTL 239 (303)
T ss_dssp CC--------BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH------SCCCCC
T ss_pred cc--------cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhc------CCCCCC
Confidence 11 1345689999999999999999999999999999999999999976544332211110 011122
Q ss_pred ChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 698 PFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 698 p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
+...+..+.+|+.+||+.+|.+||++.+
T Consensus 240 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ 267 (303)
T 3a7i_A 240 EGNYSKPLKEFVEACLNKEPSFRPTAKE 267 (303)
T ss_dssp CSSCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred ccccCHHHHHHHHHHcCCChhhCcCHHH
Confidence 3445678999999999999999999943
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=346.63 Aligned_cols=257 Identities=23% Similarity=0.362 Sum_probs=201.4
Q ss_pred hcCCCCccceeeecCceEEEEEEEC-------CeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccC--Cc
Q 003384 462 ATHNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EV 531 (824)
Q Consensus 462 ~~~~f~~~~~LG~G~fG~Vykg~~~-------~~~VAvK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~ 531 (824)
..++|...+.||+|+||.||+|.+. +..||||++..... .....+.+|+.++++++||||+++++++. ..
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 3457999999999999999999843 35799999864322 22346889999999999999999999984 46
Q ss_pred eEEEEEecCCCChhhhhhccCC----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecC---CCccee
Q 003384 532 WTLVYEYLPNGSLEDRLSCKDN----SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA---NFVSKL 604 (824)
Q Consensus 532 ~~LV~Ey~~ggsL~~~L~~~~~----~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~---~~~vKL 604 (824)
.++||||+++|+|.+++..... ...+++..++.++.+++.||.|||+ +||+||||||+|||++. ++.+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEEE
Confidence 7999999999999999965432 2458999999999999999999999 89999999999999984 456999
Q ss_pred eccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHH--HH
Q 003384 605 SDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQY--AL 681 (824)
Q Consensus 605 ~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~--~~ 681 (824)
+|||++........... .....||+.|+|||++.+..++.++|||||||++|+|+| |++||........ .+
T Consensus 185 ~Dfg~~~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 258 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRK------GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 258 (327)
T ss_dssp CCCHHHHHHHC------------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred Ccccccccccccccccc------CCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHH
Confidence 99999986543321111 122357999999999999999999999999999999998 9999976543221 11
Q ss_pred hhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHh
Q 003384 682 DTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 736 (824)
Q Consensus 682 ~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~ 736 (824)
..+ .....+...+..+.+|+.+||+.+|.+||++ .++++.|+.+..
T Consensus 259 ~~~--------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~~ll~~l~~~~~ 304 (327)
T 2yfx_A 259 TSG--------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNF-AIILERIEYCTQ 304 (327)
T ss_dssp HTT--------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHH
T ss_pred hcC--------CCCCCCCCCCHHHHHHHHHHhcCChhhCcCH-HHHHHHHHHHhc
Confidence 111 1112234456789999999999999999999 778888887654
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=345.89 Aligned_cols=251 Identities=26% Similarity=0.394 Sum_probs=194.8
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEecccCC--------
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACPE-------- 530 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~L~g~~~~-------- 530 (824)
.++|...+.||+|+||.||+|... +..||||++...... ....+.+|+.+|+.++||||++++++|..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 357999999999999999999985 588999998654332 24568899999999999999999998732
Q ss_pred --ceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccc
Q 003384 531 --VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFG 608 (824)
Q Consensus 531 --~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFG 608 (824)
..++||||+.+ +|.+.+.. ....+++..+..|+.|++.||.|||+ +||+||||||+|||++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCC-CHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccch
Confidence 47899999975 77777743 33469999999999999999999999 899999999999999999999999999
Q ss_pred cccccccccccCCCccccccCCCCCCcccCChhhhcc-CCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccc
Q 003384 609 ISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLK 687 (824)
Q Consensus 609 la~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~ 687 (824)
+++.+......... ......||+.|+|||++.+ ..++.++|||||||++|+|+||++||................
T Consensus 170 ~a~~~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 245 (351)
T 3mi9_A 170 LARAFSLAKNSQPN----RYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 245 (351)
T ss_dssp TCEECCCCSSSSCC----CCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred hccccccccccccc----ccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 99876533222111 1134578999999999876 468999999999999999999999998765433222111111
Q ss_pred cccCCCCCCCChh---------------------------hHHHHHHHHHHHhhhccCCCCChHH
Q 003384 688 NLLDPLAGDWPFV---------------------------QAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 688 ~~ld~~~~~~p~~---------------------------~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
....+ ..|+.. .+..+.+|+.+||+.+|.+||++.+
T Consensus 246 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e 308 (351)
T 3mi9_A 246 GSITP--EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDD 308 (351)
T ss_dssp CCCCT--TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred CCCCh--hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHH
Confidence 11100 001110 1456889999999999999999943
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=363.65 Aligned_cols=246 Identities=20% Similarity=0.256 Sum_probs=188.0
Q ss_pred hcCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHHhcCCCceeeEecccCC-------
Q 003384 462 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACPE------- 530 (824)
Q Consensus 462 ~~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~~------- 530 (824)
..++|...+.||+|+||.||+|... +..||||++..... .....+.+|+.+|+.++||||+++++++..
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 3568999999999999999999876 58899999975421 223568899999999999999999998832
Q ss_pred -ceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccc
Q 003384 531 -VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI 609 (824)
Q Consensus 531 -~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGl 609 (824)
..++||||+.++ |.+.+. ..+++..+..++.||+.||.|||+ +||+||||||+||||+.++.+||+|||+
T Consensus 140 ~~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 140 QDVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp CEEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred CeEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEEe
Confidence 369999999764 666662 248899999999999999999999 8999999999999999999999999999
Q ss_pred ccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhcc---
Q 003384 610 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL--- 686 (824)
Q Consensus 610 a~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~--- 686 (824)
++....... .....||+.|+|||++.+..|+.++|||||||+||||++|++||.+.+........-..
T Consensus 211 a~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~ 281 (464)
T 3ttj_A 211 ARTAGTSFM---------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 281 (464)
T ss_dssp C-----CCC---------C----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCS
T ss_pred eeecCCCcc---------cCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 986543211 13456999999999999999999999999999999999999999876543321111000
Q ss_pred -------------ccccC--CCCCC------C-----------ChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 687 -------------KNLLD--PLAGD------W-----------PFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 687 -------------~~~ld--~~~~~------~-----------p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
...+. +.... + ....+..+.+|+.+||..||.+|||+.+
T Consensus 282 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e 352 (464)
T 3ttj_A 282 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 352 (464)
T ss_dssp CCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred CCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHH
Confidence 00000 00000 0 0112567999999999999999999943
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=342.29 Aligned_cols=256 Identities=27% Similarity=0.393 Sum_probs=197.7
Q ss_pred CCCChhhHhhhcCCCCccceeeecCceEEEEEEE--CCeEEEEEEecCCCCCCchhHHHHHHHHHhc-CCCceeeEeccc
Q 003384 452 SDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGAC 528 (824)
Q Consensus 452 ~~~~~~ei~~~~~~f~~~~~LG~G~fG~Vykg~~--~~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l-~HpnIv~L~g~~ 528 (824)
..+.+.++....++|...+.||+|+||.||+|.+ .+..||||++.... .....+.+|+.+++++ +||||+++++++
T Consensus 12 ~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 90 (326)
T 2x7f_A 12 DEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAF 90 (326)
T ss_dssp ----CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred hhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEE
Confidence 4455666777888999999999999999999998 46899999987543 3456799999999999 799999999987
Q ss_pred C--------CceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCC
Q 003384 529 P--------EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF 600 (824)
Q Consensus 529 ~--------~~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~ 600 (824)
. ...++||||+++|+|.+++.... ...+++..+..++.+++.||.|||. +||+||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~ 166 (326)
T 2x7f_A 91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENA 166 (326)
T ss_dssp EECC--CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTC
T ss_pred eeccCccccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCC
Confidence 2 35789999999999999996432 3468999999999999999999999 8999999999999999999
Q ss_pred cceeeccccccccccccccCCCccccccCCCCCCcccCChhhhc-----cCCCCcchhHHhHHHHHHHHHhCCCCCCCch
Q 003384 601 VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA-----SGELTPKSDVYSFGIILLRLLTGRPALGITK 675 (824)
Q Consensus 601 ~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~-----~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~ 675 (824)
.+||+|||++......... .....||+.|+|||++. +..++.++|||||||++|+|+||++||....
T Consensus 167 ~~kl~Dfg~~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 238 (326)
T 2x7f_A 167 EVKLVDFGVSAQLDRTVGR--------RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 238 (326)
T ss_dssp CEEECCCTTTC---------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred CEEEeeCcCceecCcCccc--------cccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence 9999999998865432111 12346899999999987 5678999999999999999999999997655
Q ss_pred HHHHHHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 676 EVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 676 ~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
.......... .+.....+...+..+.+|+.+||..+|.+||++.+
T Consensus 239 ~~~~~~~~~~-----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 283 (326)
T 2x7f_A 239 PMRALFLIPR-----NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQ 283 (326)
T ss_dssp HHHHHHHHHH-----SCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred HHHHHHHhhc-----CccccCCccccCHHHHHHHHHHhccChhhCCCHHH
Confidence 4332211110 01111112334578999999999999999999943
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=341.07 Aligned_cols=256 Identities=20% Similarity=0.271 Sum_probs=195.2
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCC---chhHHHHHHHHHhcCCCceeeEeccc--CCceEEE
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLV 535 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~---~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV 535 (824)
.++|...+.||+|+||.||+|.+. +..||||++....... ...+.+|+.+++.++||||+++++++ ....++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 357999999999999999999975 6889999987543322 25688999999999999999999988 4568899
Q ss_pred EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccc
Q 003384 536 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 615 (824)
Q Consensus 536 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~ 615 (824)
|||+++++|.+++... .++++..+..++.+++.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 113 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 9999999999999543 468999999999999999999999 8999999999999999999999999999986544
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCC
Q 003384 616 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG 695 (824)
Q Consensus 616 ~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~ 695 (824)
..... .....||+.|+|||++.+..++.++|||||||++|+|+||++||............ .... +...
T Consensus 187 ~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~-~~~~ 255 (309)
T 2h34_A 187 EKLTQ-------LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHI---NQAI-PRPS 255 (309)
T ss_dssp -----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHH---HSCC-CCGG
T ss_pred ccccc-------ccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHh---ccCC-CCcc
Confidence 32111 12346899999999999999999999999999999999999999876543211111 1111 1111
Q ss_pred CCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHH
Q 003384 696 DWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 735 (824)
Q Consensus 696 ~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~ 735 (824)
..+...+..+.+++.+||+.+|.+||+..+++.+.|+.+.
T Consensus 256 ~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l 295 (309)
T 2h34_A 256 TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAAL 295 (309)
T ss_dssp GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTC
T ss_pred ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHH
Confidence 2233455689999999999999999943378877777643
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=347.32 Aligned_cols=239 Identities=28% Similarity=0.389 Sum_probs=192.8
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCC---chhHHHHHHHHHhcCCCceeeEeccc--CCceEEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVY 536 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~---~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~ 536 (824)
..|...+.||+|+||.||+|... +..||||++....... ...+.+|+.+|+.++||||++++++| .+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 35888899999999999999864 6889999997654332 24588999999999999999999988 45688999
Q ss_pred EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccc
Q 003384 537 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 616 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 616 (824)
||+. |+|.+++... ..++++..+..++.+++.||.|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 134 e~~~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 207 (348)
T ss_dssp ECCS-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred ecCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence 9997 6788877432 3568999999999999999999999 89999999999999999999999999999765422
Q ss_pred cccCCCccccccCCCCCCcccCChhhhc---cCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCC
Q 003384 617 EISSNNTTLCCRTDPKGTFAYMDPEFLA---SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPL 693 (824)
Q Consensus 617 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~---~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~ 693 (824)
....||+.|+|||++. .+.++.++|||||||++|||+||++||.............. . ..+
T Consensus 208 ------------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~--~-~~~- 271 (348)
T 1u5q_A 208 ------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--N-ESP- 271 (348)
T ss_dssp ------------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH--S-CCC-
T ss_pred ------------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh--c-CCC-
Confidence 2346899999999985 46789999999999999999999999976544332211110 0 011
Q ss_pred CCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 694 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 694 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
...+...+..+.+|+.+||+.+|.+||++.+
T Consensus 272 -~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ 302 (348)
T 1u5q_A 272 -ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEV 302 (348)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred -CCCCCCCCHHHHHHHHHHcccChhhCcCHHH
Confidence 1112334568999999999999999999943
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=335.15 Aligned_cols=242 Identities=25% Similarity=0.395 Sum_probs=177.4
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCC---CCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEE
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLV 535 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~---~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV 535 (824)
..+|...+.||+|+||.||+|... +..||||++.... ......+.+|+.+++.++||||+++++++. +..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 346889999999999999999874 6889999986431 122457899999999999999999999984 467899
Q ss_pred EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccc
Q 003384 536 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 615 (824)
Q Consensus 536 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~ 615 (824)
|||+++++|.+++.. ...++++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 90 LEMCHNGEMNRYLKN--RVKPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EECCTTEEHHHHHHT--CSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EecCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 999999999999853 33578999999999999999999999 8999999999999999999999999999986543
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCC
Q 003384 616 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG 695 (824)
Q Consensus 616 ~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~ 695 (824)
.... .....||+.|+|||++.+..++.++|||||||++|+|+||++||........ +.... ....
T Consensus 165 ~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~-~~~~ 229 (278)
T 3cok_A 165 PHEK--------HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT------LNKVV-LADY 229 (278)
T ss_dssp -----------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------CC-SSCC
T ss_pred CCCc--------ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH------HHHHh-hccc
Confidence 2211 1234589999999999988999999999999999999999999975432111 00111 0112
Q ss_pred CCChhhHHHHHHHHHHHhhhccCCCCChH
Q 003384 696 DWPFVQAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 696 ~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
..|...+..+.+|+.+||+.+|.+||++.
T Consensus 230 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~ 258 (278)
T 3cok_A 230 EMPSFLSIEAKDLIHQLLRRNPADRLSLS 258 (278)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred CCccccCHHHHHHHHHHcccCHhhCCCHH
Confidence 23455677899999999999999999994
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=333.49 Aligned_cols=238 Identities=22% Similarity=0.305 Sum_probs=193.8
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCC--chhHHHHHHHHHhc-CCCceeeEeccc--CCceEEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKI-RHPNLVTLVGAC--PEVWTLVY 536 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~--~~~f~~Ei~iL~~l-~HpnIv~L~g~~--~~~~~LV~ 536 (824)
.+|...+.||+|+||.||+|.+. +..||||++....... ...+.+|+.++..+ +||||+++++++ .+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~ 90 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN 90 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 46888999999999999999986 6899999997653322 34688999999999 999999999998 45688999
Q ss_pred EecCCCChhhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCC----------------
Q 003384 537 EYLPNGSLEDRLSCKD-NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN---------------- 599 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~~-~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~---------------- 599 (824)
||+++|+|.+++.... ....+++..+..|+.|++.||.|||+ ++|+||||||+|||++.+
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~ 167 (289)
T 1x8b_A 91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167 (289)
T ss_dssp ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC------------------
T ss_pred EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence 9999999999996432 12568999999999999999999999 899999999999999844
Q ss_pred ---CcceeeccccccccccccccCCCccccccCCCCCCcccCChhhhccC-CCCcchhHHhHHHHHHHHHhCCCCCCCch
Q 003384 600 ---FVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITK 675 (824)
Q Consensus 600 ---~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDVwSlGvvL~ELltG~~Pf~~~~ 675 (824)
+.+||+|||++...... ....||+.|+|||++.+. .++.++|||||||++|+|++|.+|+....
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~------------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~ 235 (289)
T 1x8b_A 168 SNKVMFKIGDLGHVTRISSP------------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD 235 (289)
T ss_dssp --CCCEEECCCTTCEETTCS------------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH
T ss_pred CCceEEEEcccccccccCCc------------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh
Confidence 47899999998865432 123489999999999876 56789999999999999999998876554
Q ss_pred HHHHHHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 676 EVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 676 ~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
.... +..+.. ...+...+..+.+|+.+||+.+|.+||++.+
T Consensus 236 ~~~~-~~~~~~--------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ 276 (289)
T 1x8b_A 236 QWHE-IRQGRL--------PRIPQVLSQEFTELLKVMIHPDPERRPSAMA 276 (289)
T ss_dssp HHHH-HHTTCC--------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHH-HHcCCC--------CCCCcccCHHHHHHHHHHhCCCcccCCCHHH
Confidence 3322 222211 2234455678999999999999999999943
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=346.88 Aligned_cols=234 Identities=24% Similarity=0.363 Sum_probs=170.8
Q ss_pred cceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcC-CCceeeEecccC--CceEEEEEecCCCC
Q 003384 469 SLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVGACP--EVWTLVYEYLPNGS 543 (824)
Q Consensus 469 ~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~-HpnIv~L~g~~~--~~~~LV~Ey~~ggs 543 (824)
.+.||+|+||.||+|.+. +..||||++... ....+.+|+.+++.+. ||||++++++|. ...++||||++||+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 367999999999999986 588999998643 2457889999999997 999999999984 46889999999999
Q ss_pred hhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCC---cceeeccccccccccccccC
Q 003384 544 LEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF---VSKLSDFGISRFLSQNEISS 620 (824)
Q Consensus 544 L~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~---~vKL~DFGla~~~~~~~~~~ 620 (824)
|.+++.. ...+++..+..|+.+++.||.|||+ ++|+||||||+|||++.++ .+||+|||+++........
T Consensus 93 L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~- 165 (325)
T 3kn6_A 93 LFERIKK---KKHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP- 165 (325)
T ss_dssp HHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred HHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc-
Confidence 9999954 3569999999999999999999999 8999999999999997665 8999999999865433211
Q ss_pred CCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHH---------HHHHhhhccccccC
Q 003384 621 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEV---------QYALDTGKLKNLLD 691 (824)
Q Consensus 621 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~---------~~~~~~~~~~~~ld 691 (824)
.....||+.|+|||++.+..++.++|||||||++|+|++|++||...... ...+..+..
T Consensus 166 -------~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~----- 233 (325)
T 3kn6_A 166 -------LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF----- 233 (325)
T ss_dssp -------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC-----
T ss_pred -------ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC-----
Confidence 13345899999999999999999999999999999999999999754321 111111110
Q ss_pred CCCCCCChhhHHHHHHHHHHHhhhccCCCCChH
Q 003384 692 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 692 ~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
..........+..+.+|+.+||+.+|.+||++.
T Consensus 234 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ 266 (325)
T 3kn6_A 234 SFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMS 266 (325)
T ss_dssp CCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTT
T ss_pred CCCcccccCCCHHHHHHHHHHCCCChhHCCCHH
Confidence 000000123467899999999999999999983
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=360.56 Aligned_cols=243 Identities=25% Similarity=0.403 Sum_probs=186.5
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCC--------CCCchhHHHHHHHHHhcCCCceeeEecccC-Cc
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS--------LQGPSEFQQEIDILSKIRHPNLVTLVGACP-EV 531 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~--------~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~-~~ 531 (824)
.++|...+.||+|+||.||+|... +..||||++.... ......+.+|+.+|++++||||+++++++. +.
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 213 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 213 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESSE
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecCc
Confidence 457899999999999999999886 4789999986532 112235889999999999999999999984 46
Q ss_pred eEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCC---Ccceeeccc
Q 003384 532 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN---FVSKLSDFG 608 (824)
Q Consensus 532 ~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~---~~vKL~DFG 608 (824)
.++||||+++|+|.+++. ....+++..+..++.|++.||.|||+ ++|+||||||+|||++.+ +.+||+|||
T Consensus 214 ~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kl~DFG 287 (419)
T 3i6u_A 214 YYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFG 287 (419)
T ss_dssp EEEEEECCTTCBGGGGTS---SSCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred eEEEEEcCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEEEeecc
Confidence 789999999999999884 34569999999999999999999999 899999999999999754 459999999
Q ss_pred cccccccccccCCCccccccCCCCCCcccCChhhhcc---CCCCcchhHHhHHHHHHHHHhCCCCCCCchH---HHHHHh
Q 003384 609 ISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS---GELTPKSDVYSFGIILLRLLTGRPALGITKE---VQYALD 682 (824)
Q Consensus 609 la~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~---~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~---~~~~~~ 682 (824)
+++....... .....||+.|+|||++.+ ..|+.++|||||||+||+|+||++||..... ....+.
T Consensus 288 ~a~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~ 358 (419)
T 3i6u_A 288 HSKILGETSL---------MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT 358 (419)
T ss_dssp TTTSCC--------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHH
T ss_pred cceecCCCcc---------ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHh
Confidence 9987653321 123469999999999864 5788899999999999999999999964321 112222
Q ss_pred hhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 683 TGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 683 ~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
.+.... ........+..+.+|+.+||+.+|.+||++.+
T Consensus 359 ~~~~~~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e 396 (419)
T 3i6u_A 359 SGKYNF-----IPEVWAEVSEKALDLVKKLLVVDPKARFTTEE 396 (419)
T ss_dssp TTCCCC-----CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred cCCCCC-----CchhhcccCHHHHHHHHHHccCChhHCcCHHH
Confidence 221110 00001124568999999999999999999943
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=338.27 Aligned_cols=245 Identities=26% Similarity=0.419 Sum_probs=196.7
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEeccc----CCceEE
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGAC----PEVWTL 534 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~L~g~~----~~~~~L 534 (824)
.++|...+.||+|+||.||+|... +..||+|++...... ....+.+|+.+++.++||||+++++++ ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 347888999999999999999985 588999999765432 234688999999999999999999977 346789
Q ss_pred EEEecCCCChhhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCc-----eEeccccCCcEEecCCCcceeeccc
Q 003384 535 VYEYLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPHS-----IVHGDLKPANILLDANFVSKLSDFG 608 (824)
Q Consensus 535 V~Ey~~ggsL~~~L~~~-~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~g-----iiHrDLKp~NILld~~~~vKL~DFG 608 (824)
||||+++|+|.+++... .....+++..++.++.+++.||.|||+ ++ |+||||||+|||++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 99999999999999643 234569999999999999999999999 56 9999999999999999999999999
Q ss_pred cccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHH--HHHhhhcc
Q 003384 609 ISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ--YALDTGKL 686 (824)
Q Consensus 609 la~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~--~~~~~~~~ 686 (824)
++.......... ....||+.|+|||++.+..++.++|||||||++|+|+||++||....... ..+..+..
T Consensus 162 ~~~~~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~ 233 (279)
T 2w5a_A 162 LARILNHDTSFA--------KTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF 233 (279)
T ss_dssp HHHHC---CHHH--------HHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred hheeeccccccc--------cccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccc
Confidence 998654322110 12248999999999999999999999999999999999999998654322 12222211
Q ss_pred ccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 003384 687 KNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 727 (824)
Q Consensus 687 ~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 727 (824)
...+...+..+.+++.+||+.+|.+||++ .++
T Consensus 234 --------~~~~~~~~~~l~~li~~~l~~~p~~Rps~-~~l 265 (279)
T 2w5a_A 234 --------RRIPYRYSDELNEIITRMLNLKDYHRPSV-EEI 265 (279)
T ss_dssp --------CCCCTTSCHHHHHHHHHHTCSSGGGSCCH-HHH
T ss_pred --------ccCCcccCHHHHHHHHHHcCCCcccCCCH-HHH
Confidence 12344556789999999999999999999 444
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=344.85 Aligned_cols=246 Identities=23% Similarity=0.318 Sum_probs=188.5
Q ss_pred CCCCcc-ceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhc-CCCceeeEeccc--CCceEEEEE
Q 003384 464 HNFDPS-LKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGAC--PEVWTLVYE 537 (824)
Q Consensus 464 ~~f~~~-~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l-~HpnIv~L~g~~--~~~~~LV~E 537 (824)
..|.+. +.||+|+||.||+|... +..||||++..........+.+|+.+|.++ +||||+++++++ .+..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 356663 67999999999999874 688999999876555567899999999985 799999999998 456899999
Q ss_pred ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCc---ceeeccccccccc
Q 003384 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV---SKLSDFGISRFLS 614 (824)
Q Consensus 538 y~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~---vKL~DFGla~~~~ 614 (824)
|+++|+|.+++... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++. +||+|||++....
T Consensus 92 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 92 KMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp CCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred cCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 99999999999643 468999999999999999999999 89999999999999988765 9999999998654
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhcc-----CCCCcchhHHhHHHHHHHHHhCCCCCCCchH-------------
Q 003384 615 QNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-----GELTPKSDVYSFGIILLRLLTGRPALGITKE------------- 676 (824)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-----~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~------------- 676 (824)
......... ........||+.|+|||++.+ ..++.++|||||||++|+|+||++||.....
T Consensus 166 ~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 166 LNGDCSPIS-TPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred cCCcccccc-ccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 322111100 001123469999999999875 4588999999999999999999999965321
Q ss_pred ----HHHHHhhhccccccCCCCCCCCh----hhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 677 ----VQYALDTGKLKNLLDPLAGDWPF----VQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 677 ----~~~~~~~~~~~~~ld~~~~~~p~----~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
....+..+. ..+|. ..+..+.+|+.+||+.+|.+||++.+
T Consensus 245 ~~~~~~~~i~~~~---------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e 292 (316)
T 2ac3_A 245 CQNMLFESIQEGK---------YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQ 292 (316)
T ss_dssp HHHHHHHHHHHCC---------CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred HHHHHHHHHhccC---------cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHH
Confidence 111111111 11221 24568999999999999999999943
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=335.52 Aligned_cols=246 Identities=24% Similarity=0.342 Sum_probs=195.7
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC------CchhHHHHHHHHHhcCCCceeeEecccC--CceE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ------GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWT 533 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~------~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~ 533 (824)
++|...+.||+|+||.||+|... +..||+|++...... ....+.+|+.++++++||||+++++++. ...+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 35888999999999999999986 689999998764322 2467999999999999999999999984 4688
Q ss_pred EEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCC----cceeecccc
Q 003384 534 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF----VSKLSDFGI 609 (824)
Q Consensus 534 LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~----~vKL~DFGl 609 (824)
+||||+++++|.+++.. ...+++..+..++.+++.||.|||+ ++|+||||||+|||++.++ .+||+|||+
T Consensus 85 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 85 LILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 99999999999999953 3468999999999999999999999 8999999999999998877 899999999
Q ss_pred ccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccc
Q 003384 610 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNL 689 (824)
Q Consensus 610 a~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ 689 (824)
+........ .....||+.|+|||++.+..++.++||||||+++|+|++|++||..................
T Consensus 159 ~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 229 (283)
T 3bhy_A 159 AHKIEAGNE---------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYD 229 (283)
T ss_dssp CEECC-----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC
T ss_pred ceeccCCCc---------ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccC
Confidence 986543321 12345899999999999999999999999999999999999999765443222111111000
Q ss_pred cCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 003384 690 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 727 (824)
Q Consensus 690 ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 727 (824)
.....+...+..+.+|+.+||..+|.+||++.+.+
T Consensus 230 ---~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l 264 (283)
T 3bhy_A 230 ---FDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSL 264 (283)
T ss_dssp ---CCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred ---CcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHH
Confidence 00001123456899999999999999999995443
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=345.03 Aligned_cols=247 Identities=25% Similarity=0.375 Sum_probs=186.8
Q ss_pred hcCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCC--chhHHHHHHHHHhcCCCceeeEeccc--CCceEEE
Q 003384 462 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLV 535 (824)
Q Consensus 462 ~~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV 535 (824)
..++|...+.||+|+||.||+|... +..||||++....... ...+.+|+.+|+.++||||+++++++ ....++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 3457999999999999999999875 6889999997543222 34678999999999999999999998 4568999
Q ss_pred EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEe-----cCCCcceeeccccc
Q 003384 536 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL-----DANFVSKLSDFGIS 610 (824)
Q Consensus 536 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILl-----d~~~~vKL~DFGla 610 (824)
|||++ |+|.+++.. ...+++..+..|+.||+.||.|||+ ++|+||||||+|||| +.++.+||+|||++
T Consensus 112 ~e~~~-~~L~~~~~~---~~~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 112 FEYAE-NDLKKYMDK---NPDVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp EECCS-EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred EecCC-CCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 99997 499998853 3458999999999999999999999 899999999999999 45566999999999
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccC-CCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccc
Q 003384 611 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNL 689 (824)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ 689 (824)
+.+...... .....||+.|+|||++.+. .++.++|||||||++|+|++|++||..................
T Consensus 185 ~~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 256 (329)
T 3gbz_A 185 RAFGIPIRQ--------FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGL 256 (329)
T ss_dssp HHHC-------------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred cccCCcccc--------cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCC
Confidence 866432211 1334589999999999875 5899999999999999999999999876554332221111000
Q ss_pred cCCCCCCC-------------------------ChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 690 LDPLAGDW-------------------------PFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 690 ld~~~~~~-------------------------p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
+....| +...+..+.+|+.+||+.+|.+||++.+
T Consensus 257 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e 315 (329)
T 3gbz_A 257 --PDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKN 315 (329)
T ss_dssp --CCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred --CchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHH
Confidence 000001 0113568899999999999999999943
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=344.25 Aligned_cols=245 Identities=25% Similarity=0.380 Sum_probs=187.1
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEeccc--CCceEEEEEe
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 538 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~Ey 538 (824)
++|...+.||+|+||.||+|... +..||||++...... ....+.+|+.+|+.++||||+++++++ ....++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 36888999999999999999986 578999998754322 123466899999999999999999998 4468999999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccc
Q 003384 539 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 618 (824)
Q Consensus 539 ~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 618 (824)
++ |+|.+++... ...+++..+..++.+++.||.|||+ +||+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 155 (324)
T 3mtl_A 82 LD-KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 155 (324)
T ss_dssp CS-EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence 97 5888888543 3468999999999999999999999 8999999999999999999999999999986543221
Q ss_pred cCCCccccccCCCCCCcccCChhhhcc-CCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCC
Q 003384 619 SSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 697 (824)
Q Consensus 619 ~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~ 697 (824)
. .....||+.|+|||++.+ ..++.++|||||||++|+|+||++||............... +..+....|
T Consensus 156 ~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~ 225 (324)
T 3mtl_A 156 T--------YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRI--LGTPTEETW 225 (324)
T ss_dssp ---------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH--HCCCCTTTS
T ss_pred c--------cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH--hCCCChHhc
Confidence 1 123468999999999876 56899999999999999999999999876543322111100 000111111
Q ss_pred C-------------------------hhhHHHHHHHHHHHhhhccCCCCChH
Q 003384 698 P-------------------------FVQAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 698 p-------------------------~~~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
+ ...+..+.+|+.+||+.+|.+||++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 277 (324)
T 3mtl_A 226 PGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAE 277 (324)
T ss_dssp TTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred hhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHH
Confidence 1 12356789999999999999999984
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=338.52 Aligned_cols=245 Identities=24% Similarity=0.356 Sum_probs=194.7
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEe
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY 538 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey 538 (824)
...|...+.||+|+||.||+|.+. +..||+|++..........+.+|+.+++.++||||+++++++. +..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 457999999999999999999986 5789999998766666678999999999999999999999883 468999999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccc
Q 003384 539 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 618 (824)
Q Consensus 539 ~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 618 (824)
+++|+|.+++... ...+++..+..++.+++.||.|||+ +||+||||||+|||++.++.+||+|||++........
T Consensus 98 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 172 (302)
T 2j7t_A 98 CPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ 172 (302)
T ss_dssp CTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH
T ss_pred CCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCcccccccc
Confidence 9999999988543 3458999999999999999999999 8999999999999999999999999999864332211
Q ss_pred cCCCccccccCCCCCCcccCChhhhc-----cCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCC
Q 003384 619 SSNNTTLCCRTDPKGTFAYMDPEFLA-----SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPL 693 (824)
Q Consensus 619 ~~~~~~~~~~~~~~GT~~Y~APE~l~-----~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~ 693 (824)
. .....||+.|+|||++. +..++.++|||||||++|+|+||++||............... .+.
T Consensus 173 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----~~~ 240 (302)
T 2j7t_A 173 K--------RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS----DPP 240 (302)
T ss_dssp C-------------CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS----CCC
T ss_pred c--------cccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhcc----CCc
Confidence 1 12345899999999984 567899999999999999999999999865543322211110 111
Q ss_pred CCCCChhhHHHHHHHHHHHhhhccCCCCChH
Q 003384 694 AGDWPFVQAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 694 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
....+...+..+.+++.+||+.+|.+||++.
T Consensus 241 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 271 (302)
T 2j7t_A 241 TLLTPSKWSVEFRDFLKIALDKNPETRPSAA 271 (302)
T ss_dssp CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHH
T ss_pred ccCCccccCHHHHHHHHHHcccChhhCCCHH
Confidence 1112344567899999999999999999984
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=352.72 Aligned_cols=239 Identities=23% Similarity=0.385 Sum_probs=185.2
Q ss_pred CCCCcc-ceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHh-cCCCceeeEecccC------CceE
Q 003384 464 HNFDPS-LKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSK-IRHPNLVTLVGACP------EVWT 533 (824)
Q Consensus 464 ~~f~~~-~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~-l~HpnIv~L~g~~~------~~~~ 533 (824)
.+|... +.||+|+||+||+|.+. +..||||++.. ...+.+|+.++.+ ++||||++++++|. ...+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 356655 68999999999999986 57899999863 3468899999854 58999999999873 3478
Q ss_pred EEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecC---CCcceeeccccc
Q 003384 534 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA---NFVSKLSDFGIS 610 (824)
Q Consensus 534 LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~---~~~vKL~DFGla 610 (824)
|||||++||+|.+++... ....+++..+..|+.||+.||.|||+ ++|+||||||+||||+. ++.+||+|||++
T Consensus 136 lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEecccc
Confidence 999999999999999643 23469999999999999999999999 89999999999999997 789999999999
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchH------HHHHHhhh
Q 003384 611 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE------VQYALDTG 684 (824)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~------~~~~~~~~ 684 (824)
+....... .....||+.|+|||++.+..|+.++|||||||+||+|+||++||..... ....+..+
T Consensus 212 ~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~ 282 (400)
T 1nxk_A 212 KETTSHNS---------LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG 282 (400)
T ss_dssp EECC--------------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHT
T ss_pred cccCCCCc---------cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcC
Confidence 86543211 1344689999999999999999999999999999999999999965432 11222222
Q ss_pred ccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 685 KLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 685 ~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
... .....| ...+..+.+|+.+||+.+|.+||++.+
T Consensus 283 ~~~----~~~~~~-~~~s~~~~~li~~~L~~dP~~Rpt~~e 318 (400)
T 1nxk_A 283 QYE----FPNPEW-SEVSEEVKMLIRNLLKTEPTQRMTITE 318 (400)
T ss_dssp CCC----CCTTTT-TTSCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred ccc----CCCccc-ccCCHHHHHHHHHHCCCChhHCcCHHH
Confidence 111 111111 235678999999999999999999943
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=365.59 Aligned_cols=244 Identities=23% Similarity=0.314 Sum_probs=199.2
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCC---CCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 536 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~---~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~ 536 (824)
.+|...+.||+|+||.||+|... +..||||++.... ......+.+|+.+|+.++||||++++++|. ...|+||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 46888899999999999999985 6889999986432 233457889999999999999999999884 4689999
Q ss_pred EecCCCChhhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccc
Q 003384 537 EYLPNGSLEDRLSCKD-NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 615 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~~-~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~ 615 (824)
||++||+|.+++.... ....+++..+..++.||+.||.|||+ +||+||||||+||||+.+|++||+|||+++.+..
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 9999999999986542 24569999999999999999999999 8999999999999999999999999999987653
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHH--HHHHhhhccccccCCC
Q 003384 616 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEV--QYALDTGKLKNLLDPL 693 (824)
Q Consensus 616 ~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~--~~~~~~~~~~~~ld~~ 693 (824)
.... .....||+.|+|||++.+..|+.++|||||||++|||+||++||...... ...+...... .
T Consensus 342 ~~~~--------~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~-----~ 408 (543)
T 3c4z_A 342 GQTK--------TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLE-----Q 408 (543)
T ss_dssp TCCC--------BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHH-----C
T ss_pred CCcc--------cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhh-----c
Confidence 3211 12346999999999999999999999999999999999999999754210 0011111111 1
Q ss_pred CCCCChhhHHHHHHHHHHHhhhccCCCCCh
Q 003384 694 AGDWPFVQAEQLANLAMRCCEMSRKSRPEL 723 (824)
Q Consensus 694 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 723 (824)
...+|...+..+.+|+.+||+.+|.+||++
T Consensus 409 ~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 409 AVTYPDKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp CCCCCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred ccCCCcccCHHHHHHHHHhccCCHhHCCCC
Confidence 123455667899999999999999999986
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-38 Score=333.78 Aligned_cols=239 Identities=23% Similarity=0.389 Sum_probs=197.7
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCC---CCCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH---SLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 536 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~---~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~ 536 (824)
++|...+.||+|+||.||+|... +..||||++... .......+.+|+.+++.++||||+++++++. ...++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999986 478999998643 1223457899999999999999999999984 4688999
Q ss_pred EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccc
Q 003384 537 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 616 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 616 (824)
||+++|+|.+++... ..+++..+..++.+++.||.|||+ +||+||||||+|||++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 94 EFAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 999999999998543 358999999999999999999999 89999999999999999999999999998754322
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCC
Q 003384 617 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 696 (824)
Q Consensus 617 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~ 696 (824)
. .....||+.|+|||++.+..++.++||||||+++|+|++|++||.............. ....
T Consensus 168 ~----------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-------~~~~ 230 (284)
T 2vgo_A 168 R----------RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVN-------VDLK 230 (284)
T ss_dssp C----------BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT-------TCCC
T ss_pred c----------cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhc-------cccC
Confidence 1 1234689999999999999999999999999999999999999976544322111100 1122
Q ss_pred CChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 697 WPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 697 ~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
+|...+..+.+++.+||+.+|.+||++.+
T Consensus 231 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 259 (284)
T 2vgo_A 231 FPPFLSDGSKDLISKLLRYHPPQRLPLKG 259 (284)
T ss_dssp CCTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred CCCcCCHHHHHHHHHHhhcCHhhCCCHHH
Confidence 34456678999999999999999999943
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=371.53 Aligned_cols=242 Identities=24% Similarity=0.342 Sum_probs=198.1
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCC---CCCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEE
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH---SLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLV 535 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~---~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV 535 (824)
.++|...+.||+|+||.||+|... +..||||++... .......+.+|+.+|+.++||||+++++++. +..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 456889999999999999999985 688999998643 2233456889999999999999999999884 468999
Q ss_pred EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccc
Q 003384 536 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 615 (824)
Q Consensus 536 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~ 615 (824)
|||++||+|.+++.... ...+++..+..++.||+.||.|||+ +|||||||||+||||+.+|.+||+|||+++.+..
T Consensus 263 mEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp ECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 99999999999986432 3459999999999999999999999 8999999999999999999999999999987643
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHH--HHHHhhhccccccCCC
Q 003384 616 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEV--QYALDTGKLKNLLDPL 693 (824)
Q Consensus 616 ~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~--~~~~~~~~~~~~ld~~ 693 (824)
... .....||+.|+|||++.+..|+.++|||||||++|||++|++||...... ...+.. .+...
T Consensus 339 ~~~---------~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~-----~i~~~ 404 (576)
T 2acx_A 339 GQT---------IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER-----LVKEV 404 (576)
T ss_dssp TCC---------EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHH-----HHHHC
T ss_pred Ccc---------ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHH-----Hhhcc
Confidence 321 12346999999999999989999999999999999999999999754210 000000 01111
Q ss_pred CCCCChhhHHHHHHHHHHHhhhccCCCCC
Q 003384 694 AGDWPFVQAEQLANLAMRCCEMSRKSRPE 722 (824)
Q Consensus 694 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt 722 (824)
...++...+..+.+|+.+||+.+|.+||+
T Consensus 405 ~~~~p~~~s~~~~dLI~~lL~~dP~~R~g 433 (576)
T 2acx_A 405 PEEYSERFSPQARSLCSQLLCKDPAERLG 433 (576)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSTT
T ss_pred cccCCccCCHHHHHHHHHhccCCHHHcCC
Confidence 22345556789999999999999999994
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=347.58 Aligned_cols=245 Identities=21% Similarity=0.287 Sum_probs=189.4
Q ss_pred hcCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEecccCC-------
Q 003384 462 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACPE------- 530 (824)
Q Consensus 462 ~~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~L~g~~~~------- 530 (824)
...+|...+.||+|+||.||+|.+. +..||||++...... ....+.+|+.+|+.++||||+++++++..
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 3568999999999999999999975 688999998654322 13468899999999999999999998842
Q ss_pred -ceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccc
Q 003384 531 -VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI 609 (824)
Q Consensus 531 -~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGl 609 (824)
.+++||||+ +++|.+++.. ..+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeec
Confidence 359999999 8899999853 458999999999999999999999 8999999999999999999999999999
Q ss_pred ccccccccccCCCccccccCCCCCCcccCChhhhcc-CCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhh----h
Q 003384 610 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT----G 684 (824)
Q Consensus 610 a~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~----~ 684 (824)
++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|++||...+........ |
T Consensus 175 a~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g 243 (367)
T 1cm8_A 175 ARQADSE-----------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 243 (367)
T ss_dssp CEECCSS-----------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred ccccccc-----------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 9865422 133468999999999887 68999999999999999999999999876543321111 0
Q ss_pred cc----------------ccccC----CCCCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 685 KL----------------KNLLD----PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 685 ~~----------------~~~ld----~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
.. ...+. ..........+..+.+|+.+||..+|.+||++.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e 304 (367)
T 1cm8_A 244 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGE 304 (367)
T ss_dssp CCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred CCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHH
Confidence 00 00000 0011122344678999999999999999999943
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=337.81 Aligned_cols=241 Identities=25% Similarity=0.364 Sum_probs=194.8
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEec
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL 539 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey~ 539 (824)
++|...+.||+|+||.||+|... +..||||++..........+.+|+.+++.++||||+++++++. ...++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV 88 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence 46888999999999999999985 6889999998655444567899999999999999999999884 4688999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEe---cCCCcceeeccccccccccc
Q 003384 540 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL---DANFVSKLSDFGISRFLSQN 616 (824)
Q Consensus 540 ~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILl---d~~~~vKL~DFGla~~~~~~ 616 (824)
++|+|.+++... ..+++..+..++.+++.||.|||+ +||+||||||+|||+ +.++.+||+|||++......
T Consensus 89 ~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 162 (304)
T 2jam_A 89 SGGELFDRILER---GVYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG 162 (304)
T ss_dssp CSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred CCccHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence 999999988533 468999999999999999999999 899999999999999 78899999999998754322
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHH--HHhhhccccccCCCC
Q 003384 617 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQY--ALDTGKLKNLLDPLA 694 (824)
Q Consensus 617 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~--~~~~~~~~~~ld~~~ 694 (824)
.. ....||+.|+|||++.+..++.++|||||||++|+|++|++||........ .+..+.. ...
T Consensus 163 ~~----------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~-----~~~ 227 (304)
T 2jam_A 163 IM----------STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYY-----EFE 227 (304)
T ss_dssp TT----------HHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCC-----CCC
T ss_pred cc----------ccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC-----CCC
Confidence 10 112489999999999999999999999999999999999999976543221 1112111 111
Q ss_pred CCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 695 GDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 695 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
...+...+..+.+|+.+||..+|.+||++.+
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ 258 (304)
T 2jam_A 228 SPFWDDISESAKDFICHLLEKDPNERYTCEK 258 (304)
T ss_dssp TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHH
T ss_pred ccccccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 1223345678999999999999999999943
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=359.10 Aligned_cols=205 Identities=24% Similarity=0.330 Sum_probs=156.4
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEecccC-------Cc
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP-------EV 531 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~L~g~~~-------~~ 531 (824)
..+|.+.+.||+|+||.||+|.+. +..||||++...... ....+.+|+.+|+.++|||||+++++|. ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 357999999999999999999876 578999998654222 2356889999999999999999999882 34
Q ss_pred eEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccc
Q 003384 532 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR 611 (824)
Q Consensus 532 ~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~ 611 (824)
.|+||||+ +|+|.+++. ....+++..+..|+.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+
T Consensus 132 ~~lv~e~~-~~~L~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFR---TPVYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCC-SEEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEecc-ccchhhhcc---cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccch
Confidence 79999998 578999884 33569999999999999999999999 899999999999999999999999999998
Q ss_pred ccccccccCCC-------------------ccccccCCCCCCcccCChhhh-ccCCCCcchhHHhHHHHHHHHHh-----
Q 003384 612 FLSQNEISSNN-------------------TTLCCRTDPKGTFAYMDPEFL-ASGELTPKSDVYSFGIILLRLLT----- 666 (824)
Q Consensus 612 ~~~~~~~~~~~-------------------~~~~~~~~~~GT~~Y~APE~l-~~~~~t~ksDVwSlGvvL~ELlt----- 666 (824)
........... ......+..+||+.|+|||++ .+..|+.++||||||||||||+|
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~ 284 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccc
Confidence 76533211000 000112455789999999986 45679999999999999999999
Q ss_pred ------CCCCCCCc
Q 003384 667 ------GRPALGIT 674 (824)
Q Consensus 667 ------G~~Pf~~~ 674 (824)
|+++|.+.
T Consensus 285 ~~~~~~~~p~f~g~ 298 (458)
T 3rp9_A 285 VAYHADRGPLFPGS 298 (458)
T ss_dssp CSSGGGCCCSCC--
T ss_pred ccccccccccCCCC
Confidence 77777554
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=350.66 Aligned_cols=254 Identities=25% Similarity=0.331 Sum_probs=184.5
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHHhcC-CCceeeEecccC--C--ceE
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIR-HPNLVTLVGACP--E--VWT 533 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~--~~~~f~~Ei~iL~~l~-HpnIv~L~g~~~--~--~~~ 533 (824)
.++|...+.||+|+||.||+|.+. +..||||++...... ....+.+|+.+|..+. ||||+++++++. + ..|
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 457999999999999999999876 688999998654222 2345789999999997 999999999883 2 579
Q ss_pred EEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccc
Q 003384 534 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 613 (824)
Q Consensus 534 LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~ 613 (824)
+||||+. |+|.+++.. ..+++..+..++.|++.||.|||+ +||+||||||+||||+.++.+||+|||+|+.+
T Consensus 88 lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 88 LVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSF 159 (388)
T ss_dssp EEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred EEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence 9999997 589988853 368899999999999999999999 89999999999999999999999999999876
Q ss_pred ccccccCCC-------------ccccccCCCCCCcccCChhhhcc-CCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHH
Q 003384 614 SQNEISSNN-------------TTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQY 679 (824)
Q Consensus 614 ~~~~~~~~~-------------~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~ 679 (824)
......... ......+...||+.|+|||++.+ ..|+.++|||||||+||||++|++||.+......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~ 239 (388)
T 3oz6_A 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ 239 (388)
T ss_dssp SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 432111000 00011244579999999999987 6799999999999999999999999987654332
Q ss_pred HHhhhcccccc---------------------------C-CCCCC------------CChhhHHHHHHHHHHHhhhccCC
Q 003384 680 ALDTGKLKNLL---------------------------D-PLAGD------------WPFVQAEQLANLAMRCCEMSRKS 719 (824)
Q Consensus 680 ~~~~~~~~~~l---------------------------d-~~~~~------------~p~~~~~~l~~Li~~Cl~~~P~~ 719 (824)
....-...... . ..... .+...+..+.+|+.+||..+|.+
T Consensus 240 ~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~ 319 (388)
T 3oz6_A 240 LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNK 319 (388)
T ss_dssp HHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCccc
Confidence 21110000000 0 00000 00133568999999999999999
Q ss_pred CCChH
Q 003384 720 RPELG 724 (824)
Q Consensus 720 RPt~~ 724 (824)
||++.
T Consensus 320 R~t~~ 324 (388)
T 3oz6_A 320 RISAN 324 (388)
T ss_dssp SCCHH
T ss_pred CCCHH
Confidence 99984
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=344.21 Aligned_cols=262 Identities=23% Similarity=0.309 Sum_probs=201.2
Q ss_pred hcCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC------CceE
Q 003384 462 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP------EVWT 533 (824)
Q Consensus 462 ~~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~------~~~~ 533 (824)
..++|...+.||+|+||.||++... +..||||++..........+.+|+.+++.++||||+++++++. ...+
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 4467999999999999999999974 6889999986644444567899999999999999999999873 2578
Q ss_pred EEEEecCCCChhhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccc
Q 003384 534 LVYEYLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 612 (824)
Q Consensus 534 LV~Ey~~ggsL~~~L~~~-~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~ 612 (824)
+||||+++|+|.+++... .....+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++..
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 999999999999998642 234679999999999999999999999 8999999999999999999999999999876
Q ss_pred cccccccCCCc-cccccCCCCCCcccCChhhhccCC---CCcchhHHhHHHHHHHHHhCCCCCCCchH----HHHHHhhh
Q 003384 613 LSQNEISSNNT-TLCCRTDPKGTFAYMDPEFLASGE---LTPKSDVYSFGIILLRLLTGRPALGITKE----VQYALDTG 684 (824)
Q Consensus 613 ~~~~~~~~~~~-~~~~~~~~~GT~~Y~APE~l~~~~---~t~ksDVwSlGvvL~ELltG~~Pf~~~~~----~~~~~~~~ 684 (824)
........... .........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||..... .......
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~- 262 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN- 262 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC-
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc-
Confidence 54221110000 000001234799999999987654 68899999999999999999999953211 1111111
Q ss_pred ccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHH
Q 003384 685 KLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 735 (824)
Q Consensus 685 ~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~ 735 (824)
......+...+..+.+|+.+||+.+|.+||++ .++++.|+.+.
T Consensus 263 -------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~~ll~~L~~~~ 305 (317)
T 2buj_A 263 -------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHI-PLLLSQLEALQ 305 (317)
T ss_dssp -------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHTC
T ss_pred -------cCCCCccccCCHHHHHHHHHHhhcChhhCCCH-HHHHHHhhhcC
Confidence 11111223456789999999999999999999 77878877653
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=338.15 Aligned_cols=257 Identities=26% Similarity=0.384 Sum_probs=195.5
Q ss_pred cCCCCccceeeecCceEEEEEEEC---C--eEEEEEEecCCCCC---CchhHHHHHHHHHhcCCCceeeEecccC-CceE
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR---H--MQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGACP-EVWT 533 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~---~--~~VAvK~l~~~~~~---~~~~f~~Ei~iL~~l~HpnIv~L~g~~~-~~~~ 533 (824)
.++|...+.||+|+||.||+|.+. + ..||||++...... ....+.+|+.+++.++||||+++++++. +..+
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK 96 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCE
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCCce
Confidence 357899999999999999999863 2 36999998765322 2356889999999999999999999884 4588
Q ss_pred EEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccc
Q 003384 534 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 613 (824)
Q Consensus 534 LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~ 613 (824)
+||||+++|+|.+++... ...+++..+..++.+++.||.|||+ ++|+||||||+|||++.++.+||+|||++...
T Consensus 97 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp EEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEccccccccc
Confidence 999999999999998643 2458899999999999999999999 89999999999999999999999999999876
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHHHHhhhccccccCC
Q 003384 614 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDP 692 (824)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~~~~~~~~~ld~ 692 (824)
....... .......||+.|+|||++.+..++.++|||||||++|+|++ |++||............... .
T Consensus 172 ~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-----~ 241 (291)
T 1u46_A 172 PQNDDHY-----VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE-----G 241 (291)
T ss_dssp CC-CCEE-----EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTS-----C
T ss_pred cccccch-----hhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHcc-----C
Confidence 5432111 11133458889999999998889999999999999999999 99999765443221111100 0
Q ss_pred CCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHH
Q 003384 693 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 735 (824)
Q Consensus 693 ~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~ 735 (824)
.....+...+..+.+++.+||..+|.+||++ .++++.|+.+.
T Consensus 242 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-~~l~~~l~~~~ 283 (291)
T 1u46_A 242 ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTF-VALRDFLLEAQ 283 (291)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHC
T ss_pred CCCCCCcCcCHHHHHHHHHHccCCcccCcCH-HHHHHHHHHhC
Confidence 1112234556789999999999999999999 67778887654
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=334.91 Aligned_cols=241 Identities=21% Similarity=0.283 Sum_probs=198.5
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCC---chhHHHHHHHHHhcCCCceeeEecccC--CceEEE
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLV 535 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~---~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV 535 (824)
.++|...+.||+|+||.||+|... +..||+|++....... ...+.+|+.+++.++||||+++++++. +..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 457889999999999999999986 5789999987543322 346889999999999999999999984 457899
Q ss_pred EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccc
Q 003384 536 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 615 (824)
Q Consensus 536 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~ 615 (824)
|||+++++|.+++... ..+++..+..++.+++.||.|||+ +||+||||||+|||++.++.+||+|||++.....
T Consensus 94 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 94 LELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EECCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 9999999999988532 468999999999999999999999 8999999999999999999999999999986643
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCC
Q 003384 616 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG 695 (824)
Q Consensus 616 ~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~ 695 (824)
.... .....||+.|+|||++.+..++.++||||||+++|+|+||++||............... ..
T Consensus 168 ~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-------~~ 232 (294)
T 2rku_A 168 DGER--------KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN-------EY 232 (294)
T ss_dssp TTCC--------BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-------CC
T ss_pred Cccc--------cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc-------cC
Confidence 2211 12346899999999999889999999999999999999999999865433221111100 11
Q ss_pred CCChhhHHHHHHHHHHHhhhccCCCCChH
Q 003384 696 DWPFVQAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 696 ~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
..|...+..+.+++.+||+.+|.+||++.
T Consensus 233 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 261 (294)
T 2rku_A 233 SIPKHINPVAASLIQKMLQTDPTARPTIN 261 (294)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCGG
T ss_pred CCccccCHHHHHHHHHHcccChhhCcCHH
Confidence 23445567899999999999999999994
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=335.74 Aligned_cols=243 Identities=26% Similarity=0.383 Sum_probs=195.3
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--CCceEEEEEe
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 538 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~Ey 538 (824)
...|...+.||+|+||.||+|.+. +..||||++.... ....+.+|+.+++.++||||+++++++ ....++||||
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEY 105 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeec
Confidence 457899999999999999999986 6889999997643 456799999999999999999999988 3568999999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccc
Q 003384 539 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 618 (824)
Q Consensus 539 ~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 618 (824)
+++|+|.+++... ...+++..+..++.+++.||.|||. +||+||||||+|||++.++.+||+|||++........
T Consensus 106 ~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 106 CGAGSVSDIIRLR--NKTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA 180 (314)
T ss_dssp CTTEEHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred CCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence 9999999998532 3568999999999999999999999 8999999999999999999999999999986643321
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCC
Q 003384 619 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWP 698 (824)
Q Consensus 619 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p 698 (824)
. .....||+.|+|||++.+..++.++|||||||++|+|++|++||............... .+.....+
T Consensus 181 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~ 248 (314)
T 3com_A 181 K--------RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN----PPPTFRKP 248 (314)
T ss_dssp C--------BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS----CCCCCSSG
T ss_pred c--------cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcC----CCcccCCc
Confidence 1 13346899999999999999999999999999999999999999765543322211100 01111123
Q ss_pred hhhHHHHHHHHHHHhhhccCCCCChH
Q 003384 699 FVQAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 699 ~~~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
...+..+.+|+.+||..+|.+||++.
T Consensus 249 ~~~~~~l~~li~~~l~~dp~~Rpt~~ 274 (314)
T 3com_A 249 ELWSDNFTDFVKQCLVKSPEQRATAT 274 (314)
T ss_dssp GGSCHHHHHHHHHHTCSCTTTSCCHH
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHH
Confidence 44567899999999999999999994
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-38 Score=330.94 Aligned_cols=245 Identities=25% Similarity=0.349 Sum_probs=195.2
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEe
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY 538 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey 538 (824)
++|...+.||+|+||.||+|... +..||||++..... .....+.+|+.+++.++||||+++++++. ...++||||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 36888899999999999999886 68899999875432 23467899999999999999999999884 467899999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccc
Q 003384 539 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 618 (824)
Q Consensus 539 ~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 618 (824)
+++|+|.+++. ....+++..+..++.+++.||.|||+ +||+||||||+|||++.++.+||+|||++..+.....
T Consensus 87 ~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 87 CSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp CTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 99999999984 34568999999999999999999999 8999999999999999999999999999986643321
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCCC-CcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCC
Q 003384 619 SSNNTTLCCRTDPKGTFAYMDPEFLASGEL-TPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 697 (824)
Q Consensus 619 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~ 697 (824)
.. ......||+.|+|||++.+..+ +.++|||||||++|+|+||+.||............. ... ......
T Consensus 161 ~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~--~~~~~~ 230 (276)
T 2yex_A 161 ER------LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW--KEK--KTYLNP 230 (276)
T ss_dssp EC------CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHH--HTT--CTTSTT
T ss_pred hh------cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHh--hhc--ccccCc
Confidence 11 1134568999999999987765 678999999999999999999997543211111100 000 000011
Q ss_pred ChhhHHHHHHHHHHHhhhccCCCCChH
Q 003384 698 PFVQAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 698 p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
....+..+.+|+.+||+.+|.+||++.
T Consensus 231 ~~~~~~~~~~li~~~l~~~p~~Rps~~ 257 (276)
T 2yex_A 231 WKKIDSAPLALLHKILVENPSARITIP 257 (276)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred hhhcCHHHHHHHHHHCCCCchhCCCHH
Confidence 234567899999999999999999984
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=352.10 Aligned_cols=245 Identities=25% Similarity=0.382 Sum_probs=190.0
Q ss_pred cCCCCccceeeecCceEEEEEEEC-CeEEEEEEecCCCCC--CchhHHHHHHHHHhcC--CCceeeEeccc--CCceEEE
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIR--HPNLVTLVGAC--PEVWTLV 535 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~-~~~VAvK~l~~~~~~--~~~~f~~Ei~iL~~l~--HpnIv~L~g~~--~~~~~LV 535 (824)
...|...+.||+|+||.||+|... +..||||++...... ....+.+|+.+|..+. ||||+++++++ .+..++|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 345999999999999999999876 578999999765332 2356899999999996 59999999987 4568999
Q ss_pred EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccc
Q 003384 536 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 615 (824)
Q Consensus 536 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~ 615 (824)
|| +.+++|.+++... ..+++..+..|+.||+.||.|||+ ++|+||||||+||||+ ++.+||+|||+++.+..
T Consensus 135 ~E-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EE-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred Ee-cCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 99 5688999999643 468899999999999999999999 8999999999999996 57999999999987654
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhcc-----------CCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhh
Q 003384 616 NEISSNNTTLCCRTDPKGTFAYMDPEFLAS-----------GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG 684 (824)
Q Consensus 616 ~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-----------~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~ 684 (824)
..... ......||+.|+|||++.+ ..++.++|||||||+||||++|++||.........
T Consensus 207 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~---- 276 (390)
T 2zmd_A 207 DTTSV------VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK---- 276 (390)
T ss_dssp -------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH----
T ss_pred CCccc------cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHH----
Confidence 32111 1134569999999999875 36889999999999999999999999753221111
Q ss_pred ccccccCC-CCCCCChhhHHHHHHHHHHHhhhccCCCCChHHH
Q 003384 685 KLKNLLDP-LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD 726 (824)
Q Consensus 685 ~~~~~ld~-~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~ 726 (824)
+..++++ ....+|...+..+.+|+.+||+.+|.+||++.+.
T Consensus 277 -~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~el 318 (390)
T 2zmd_A 277 -LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 318 (390)
T ss_dssp -HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred -HHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHH
Confidence 1111111 1223344446789999999999999999999543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=344.83 Aligned_cols=255 Identities=21% Similarity=0.263 Sum_probs=191.4
Q ss_pred hhhHhhhcCCCCccceeeecCceEEEEEEEC-CeEEEEEEecCCCCCC-----------chhHHHHHHHHHhcCCCceee
Q 003384 456 FSEIEGATHNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQG-----------PSEFQQEIDILSKIRHPNLVT 523 (824)
Q Consensus 456 ~~ei~~~~~~f~~~~~LG~G~fG~Vykg~~~-~~~VAvK~l~~~~~~~-----------~~~f~~Ei~iL~~l~HpnIv~ 523 (824)
+.++....++|...+.||+|+||.||+|... +..||||++....... ...+.+|+.+++.++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 3456667789999999999999999999875 5889999986543222 156899999999999999999
Q ss_pred Eeccc-----C--CceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEe
Q 003384 524 LVGAC-----P--EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL 596 (824)
Q Consensus 524 L~g~~-----~--~~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILl 596 (824)
+++++ . ...++||||+. |+|.+.+. .....+++..+..++.|++.||.|||+ ++|+||||||+|||+
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIH--DQRIVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILL 167 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHH--CTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEE
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHHEEE
Confidence 99987 2 14789999997 58888875 334579999999999999999999999 899999999999999
Q ss_pred cCCCcceeeccccccccccccccCCCccccccCCCCCCcccCChhhhcc-CCCCcchhHHhHHHHHHHHHhCCCCCCCch
Q 003384 597 DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITK 675 (824)
Q Consensus 597 d~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~ 675 (824)
+.++.+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|+|+||++||....
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 238 (362)
T 3pg1_A 168 ADNNDITICDFNLAREDTADAN---------KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST 238 (362)
T ss_dssp CTTCCEEECCTTC------------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cCCCCEEEEecCcccccccccc---------cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999975433221 123468999999999887 678999999999999999999999998654
Q ss_pred HHHHHHhhhc-----------------cccccCCCCC--------CCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 676 EVQYALDTGK-----------------LKNLLDPLAG--------DWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 676 ~~~~~~~~~~-----------------~~~~ld~~~~--------~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
.......... ....+..... ..+...+..+.+|+.+||+.+|.+||++.+
T Consensus 239 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 313 (362)
T 3pg1_A 239 FYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQ 313 (362)
T ss_dssp HHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHH
Confidence 3222111000 0000000000 011223567999999999999999999943
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=358.90 Aligned_cols=238 Identities=12% Similarity=0.112 Sum_probs=183.5
Q ss_pred hcCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHH---HHHHhcCCCceeeEecccC----
Q 003384 462 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEI---DILSKIRHPNLVTLVGACP---- 529 (824)
Q Consensus 462 ~~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~---~~~~~f~~Ei---~iL~~l~HpnIv~L~g~~~---- 529 (824)
..++|...+.||+|+||.||+|.+. +..||||++..... ...+.|.+|+ .+|+.++|||||++++.+.
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 4567889999999999999999864 68999999975422 2346788999 4555568999999985442
Q ss_pred ---C-------------------ceEEEEEecCCCChhhhhhccCC----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCc
Q 003384 530 ---E-------------------VWTLVYEYLPNGSLEDRLSCKDN----SPPLSWQTRIRIATELCSVLIFLHSCKPHS 583 (824)
Q Consensus 530 ---~-------------------~~~LV~Ey~~ggsL~~~L~~~~~----~~~l~~~~~~~ia~qia~aL~~LH~~~~~g 583 (824)
+ ..++||||+ +|+|.+++..... ...+++..++.|+.||+.||.|||+ +|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ 226 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YG 226 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TT
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CC
Confidence 1 278999999 6899999964311 1234568888999999999999999 89
Q ss_pred eEeccccCCcEEecCCCcceeeccccccccccccccCCCccccccCCCCCCcccCChhhhccC-----------CCCcch
Q 003384 584 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-----------ELTPKS 652 (824)
Q Consensus 584 iiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-----------~~t~ks 652 (824)
|+||||||+||||+.++.+||+|||+++..... .....| +.|+|||++.+. .++.++
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~ 294 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR-----------VVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSF 294 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTCE-----------EECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHH
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecCCc-----------ccCCCC-cCccChhhhcccccccccccccccCChhh
Confidence 999999999999999999999999999853321 123457 999999999887 899999
Q ss_pred hHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHH
Q 003384 653 DVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD 726 (824)
Q Consensus 653 DVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~ 726 (824)
|||||||+||||+||++||....... ....+.. . +...+..+.+|+.+||+.+|.+||++.+.
T Consensus 295 DvwSlG~il~elltg~~Pf~~~~~~~------~~~~~~~-~----~~~~~~~~~~li~~~L~~dp~~Rpt~~e~ 357 (377)
T 3byv_A 295 DAWALGLVIYWIWCADLPITKDAALG------GSEWIFR-S----CKNIPQPVRALLEGFLRYPKEDRLLPLQA 357 (377)
T ss_dssp HHHHHHHHHHHHHHSSCCC------C------CSGGGGS-S----CCCCCHHHHHHHHHHTCSSGGGCCCHHHH
T ss_pred hHHHHHHHHHHHHHCCCCCccccccc------chhhhhh-h----ccCCCHHHHHHHHHHcCCCchhCCCHHHH
Confidence 99999999999999999996433211 1111111 1 12345789999999999999999999543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=339.35 Aligned_cols=249 Identities=22% Similarity=0.287 Sum_probs=196.3
Q ss_pred hhhcCCCCcc-ceeeecCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHHhcC-CCceeeEecccC--Cc
Q 003384 460 EGATHNFDPS-LKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIR-HPNLVTLVGACP--EV 531 (824)
Q Consensus 460 ~~~~~~f~~~-~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~--~~~~f~~Ei~iL~~l~-HpnIv~L~g~~~--~~ 531 (824)
....+.|... +.||+|+||.||+|... +..||||++...... ....+.+|+.++..+. ||||+++++++. ..
T Consensus 24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~ 103 (327)
T 3lm5_A 24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE 103 (327)
T ss_dssp HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence 3334456666 78999999999999886 689999998764322 2457899999999995 699999999984 46
Q ss_pred eEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecC---CCcceeeccc
Q 003384 532 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA---NFVSKLSDFG 608 (824)
Q Consensus 532 ~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~---~~~vKL~DFG 608 (824)
.++||||+++|+|.+++... ....+++..++.++.|++.||.|||. +||+||||||+|||++. ++.+||+|||
T Consensus 104 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~~kL~Dfg 179 (327)
T 3lm5_A 104 IILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFG 179 (327)
T ss_dssp EEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCCEEECCGG
T ss_pred EEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCcEEEeeCc
Confidence 88999999999999998432 24569999999999999999999999 89999999999999987 7899999999
Q ss_pred cccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhcccc
Q 003384 609 ISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKN 688 (824)
Q Consensus 609 la~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~ 688 (824)
+++....... .....||+.|+|||++.+..++.++|||||||++|+|+||++||...............
T Consensus 180 ~a~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~-- 248 (327)
T 3lm5_A 180 MSRKIGHACE---------LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV-- 248 (327)
T ss_dssp GCEEC------------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--
T ss_pred cccccCCccc---------cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhc--
Confidence 9987643321 12346999999999999999999999999999999999999999766543332221111
Q ss_pred ccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChH
Q 003384 689 LLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 689 ~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
........+...+..+.+|+.+||+.+|.+||++.
T Consensus 249 -~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 283 (327)
T 3lm5_A 249 -NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAE 283 (327)
T ss_dssp -CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred -ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHH
Confidence 11111222334567899999999999999999984
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=351.85 Aligned_cols=240 Identities=27% Similarity=0.365 Sum_probs=191.6
Q ss_pred CCCCccceeeecCceEEEEEEE-----CCeEEEEEEecCCC----CCCchhHHHHHHHHHhc-CCCceeeEecccC--Cc
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLL-----RHMQVAIKMLHPHS----LQGPSEFQQEIDILSKI-RHPNLVTLVGACP--EV 531 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~-----~~~~VAvK~l~~~~----~~~~~~f~~Ei~iL~~l-~HpnIv~L~g~~~--~~ 531 (824)
.+|...+.||+|+||.||+|.. .+..||||++.... ......+.+|+.+|+.+ +||||+++++++. ..
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 5799999999999999999987 46899999987532 12345678899999999 6999999999883 46
Q ss_pred eEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccc
Q 003384 532 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR 611 (824)
Q Consensus 532 ~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~ 611 (824)
.++||||+++|+|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred EEEEeecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 88999999999999999643 468999999999999999999999 899999999999999999999999999998
Q ss_pred ccccccccCCCccccccCCCCCCcccCChhhhccC--CCCcchhHHhHHHHHHHHHhCCCCCCCchHH--HHHHhhhccc
Q 003384 612 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG--ELTPKSDVYSFGIILLRLLTGRPALGITKEV--QYALDTGKLK 687 (824)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~--~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~--~~~~~~~~~~ 687 (824)
.+....... .....||+.|+|||++.+. .++.++|||||||+||+|+||++||...... ...+.....
T Consensus 208 ~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~- 279 (355)
T 1vzo_A 208 EFVADETER-------AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL- 279 (355)
T ss_dssp ECCGGGGGG-------GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH-
T ss_pred ecccCCCCc-------ccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHh-
Confidence 664332211 1223589999999999863 5789999999999999999999999643210 011111101
Q ss_pred cccCCCCCCCChhhHHHHHHHHHHHhhhccCCCC
Q 003384 688 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 721 (824)
Q Consensus 688 ~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RP 721 (824)
.....++...+..+.+|+.+||..+|.+||
T Consensus 280 ----~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 309 (355)
T 1vzo_A 280 ----KSEPPYPQEMSALAKDLIQRLLMKDPKKRL 309 (355)
T ss_dssp ----HCCCCCCTTSCHHHHHHHHHHTCSSGGGST
T ss_pred ----ccCCCCCcccCHHHHHHHHHHhhhCHHHhc
Confidence 011234455667899999999999999999
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=341.74 Aligned_cols=243 Identities=21% Similarity=0.284 Sum_probs=199.2
Q ss_pred hcCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCC---chhHHHHHHHHHhcCCCceeeEecccC--CceEE
Q 003384 462 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTL 534 (824)
Q Consensus 462 ~~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~---~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~L 534 (824)
...+|...+.||+|+||.||++.+. +..||+|++....... ...+.+|+.+++.++||||++++++|. +..++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 3457899999999999999999986 4789999987543222 356889999999999999999999984 45889
Q ss_pred EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccc
Q 003384 535 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 614 (824)
Q Consensus 535 V~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~ 614 (824)
||||+.+++|.+++... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 119 v~e~~~~~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 119 VLELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp EECCCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 99999999999988533 468999999999999999999999 899999999999999999999999999998764
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCC
Q 003384 615 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 694 (824)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~ 694 (824)
..... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||............... .
T Consensus 193 ~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-------~ 257 (335)
T 2owb_A 193 YDGER--------KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN-------E 257 (335)
T ss_dssp STTCC--------BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT-------C
T ss_pred cCccc--------ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC-------C
Confidence 32211 12346899999999999999999999999999999999999999765433221111100 1
Q ss_pred CCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 695 GDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 695 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
...+...+..+.+|+.+||+.+|.+||++.+
T Consensus 258 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e 288 (335)
T 2owb_A 258 YSIPKHINPVAASLIQKMLQTDPTARPTINE 288 (335)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGG
T ss_pred CCCCccCCHHHHHHHHHHccCChhHCcCHHH
Confidence 1223445678999999999999999999943
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=358.65 Aligned_cols=243 Identities=28% Similarity=0.462 Sum_probs=192.4
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCC--CCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS--LQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE 537 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~--~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~E 537 (824)
..|...+.||+|+||.||+|... +..||||++.... ......+.+|+.+|+.++||||++++++|. ...++|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 46999999999999999999986 5789999987643 233567899999999999999999999984 46889999
Q ss_pred ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecC---CCcceeeccccccccc
Q 003384 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA---NFVSKLSDFGISRFLS 614 (824)
Q Consensus 538 y~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~---~~~vKL~DFGla~~~~ 614 (824)
|+++|+|.+.+... ..+++..+..|+.||+.||.|||+ +||+||||||+|||++. ++.+||+|||++..+.
T Consensus 117 ~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 117 CYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp CCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred cCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 99999999988543 468999999999999999999999 89999999999999976 4569999999998765
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHH--HhhhccccccCC
Q 003384 615 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA--LDTGKLKNLLDP 692 (824)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~--~~~~~~~~~ld~ 692 (824)
.... .....||+.|+|||++. +.|+.++|||||||++|+|++|++||......... +..+... .
T Consensus 191 ~~~~---------~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~----~ 256 (494)
T 3lij_A 191 NQKK---------MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYT----F 256 (494)
T ss_dssp TTBC---------BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC----C
T ss_pred CCcc---------ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC----C
Confidence 4321 13456999999999986 56999999999999999999999999866543221 2222111 1
Q ss_pred CCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 003384 693 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 727 (824)
Q Consensus 693 ~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 727 (824)
....| ...+..+.+|+.+||+.+|.+||++.+.+
T Consensus 257 ~~~~~-~~~s~~~~~li~~~L~~dp~~R~s~~e~l 290 (494)
T 3lij_A 257 DSPEW-KNVSEGAKDLIKQMLQFDSQRRISAQQAL 290 (494)
T ss_dssp CSGGG-TTSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred Cchhc-ccCCHHHHHHHHHHCCCChhhCccHHHHh
Confidence 11111 23457899999999999999999995433
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=336.29 Aligned_cols=242 Identities=21% Similarity=0.341 Sum_probs=191.2
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcC-CCceeeEecccCC----ceEEE
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVGACPE----VWTLV 535 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~-HpnIv~L~g~~~~----~~~LV 535 (824)
.++|...+.||+|+||.||+|... +..||||++... ....+.+|+.+|+.++ ||||+++++++.+ ..++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 457999999999999999999874 588999998743 3567999999999997 9999999998843 47899
Q ss_pred EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCC-cceeeccccccccc
Q 003384 536 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF-VSKLSDFGISRFLS 614 (824)
Q Consensus 536 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~-~vKL~DFGla~~~~ 614 (824)
|||+.+++|.+++. .++...+..++.|++.||.|||+ +||+||||||+|||++.++ .+||+|||+++...
T Consensus 112 ~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 99999999999883 38889999999999999999999 8999999999999999776 89999999998665
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhcc-CCCCcchhHHhHHHHHHHHHhCCCCCCCch-HHHHHHh------hhcc
Q 003384 615 QNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITK-EVQYALD------TGKL 686 (824)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~-~~~~~~~------~~~~ 686 (824)
..... ....||+.|+|||++.+ ..++.++|||||||++|+|+||+.||.... ....... ...+
T Consensus 183 ~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~ 253 (330)
T 3nsz_A 183 PGQEY---------NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDL 253 (330)
T ss_dssp TTCCC---------CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHH
T ss_pred CCCcc---------ccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchh
Confidence 43211 23468999999999987 678999999999999999999999994321 1110000 0000
Q ss_pred ccc-------cC-----------------CCCCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 687 KNL-------LD-----------------PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 687 ~~~-------ld-----------------~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
... ++ ......+...+..+.+|+.+||+.+|.+||++.+
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e 316 (330)
T 3nsz_A 254 YDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 316 (330)
T ss_dssp HHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred hhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHH
Confidence 000 00 0111112235678999999999999999999943
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=332.61 Aligned_cols=240 Identities=22% Similarity=0.373 Sum_probs=190.3
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEecccC------CceEE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP------EVWTL 534 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~L~g~~~------~~~~L 534 (824)
.|...+.||+|+||.||+|.+. +..||+|++...... ....+.+|+.+++.++||||++++++|. ...++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 4777888999999999999886 467999998754322 2356889999999999999999999873 24789
Q ss_pred EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCc--eEeccccCCcEEec-CCCcceeecccccc
Q 003384 535 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS--IVHGDLKPANILLD-ANFVSKLSDFGISR 611 (824)
Q Consensus 535 V~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~g--iiHrDLKp~NILld-~~~~vKL~DFGla~ 611 (824)
||||+++|+|.+++... ..+++..+..|+.+++.||.|||+ ++ |+||||||+|||++ .++.+||+|||++.
T Consensus 107 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 99999999999999533 468999999999999999999999 66 99999999999998 78999999999997
Q ss_pred ccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccC
Q 003384 612 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD 691 (824)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld 691 (824)
....... ....||+.|+|||++. +.++.++|||||||++|+|+||+.||.............. ....
T Consensus 181 ~~~~~~~----------~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~--~~~~ 247 (290)
T 1t4h_A 181 LKRASFA----------KAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT--SGVK 247 (290)
T ss_dssp GCCTTSB----------EESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHT--TTCC
T ss_pred ccccccc----------ccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHh--ccCC
Confidence 5433211 2245899999999876 4689999999999999999999999976433222221110 0000
Q ss_pred CCCCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 692 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 692 ~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
....+...+..+.+|+.+||+.+|.+||++.+
T Consensus 248 --~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e 279 (290)
T 1t4h_A 248 --PASFDKVAIPEVKEIIEGCIRQNKDERYSIKD 279 (290)
T ss_dssp --CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred --ccccCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence 11122333468999999999999999999943
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=359.26 Aligned_cols=243 Identities=25% Similarity=0.376 Sum_probs=197.6
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 536 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~---~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~ 536 (824)
.+|...+.||+|+||.||+|... +..||||++..... .....+.+|+.+|++++||||++++++|. ...++||
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 105 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG 105 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 46889999999999999999986 68899999865432 34567999999999999999999999984 4688999
Q ss_pred EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEe---cCCCcceeecccccccc
Q 003384 537 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL---DANFVSKLSDFGISRFL 613 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILl---d~~~~vKL~DFGla~~~ 613 (824)
||+.+|+|.+++.. ...+++..+..|+.|++.||.|||+ +||+||||||+|||+ +.++.+||+|||+++.+
T Consensus 106 e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 106 EVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp CCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred ecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 99999999998853 3569999999999999999999999 899999999999999 56789999999999866
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHH--HhhhccccccC
Q 003384 614 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA--LDTGKLKNLLD 691 (824)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~--~~~~~~~~~ld 691 (824)
...... ....||+.|+|||++.+ .|+.++|||||||++|+|++|++||......... +..+...
T Consensus 180 ~~~~~~---------~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~---- 245 (484)
T 3nyv_A 180 EASKKM---------KDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYT---- 245 (484)
T ss_dssp CCCCSH---------HHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC----
T ss_pred cccccc---------ccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC----
Confidence 433210 22359999999999875 6999999999999999999999999876543322 2222111
Q ss_pred CCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 003384 692 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 727 (824)
Q Consensus 692 ~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 727 (824)
... +.....+..+.+|+.+||+.+|.+||++.+.+
T Consensus 246 ~~~-~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l 280 (484)
T 3nyv_A 246 FEL-PQWKKVSESAKDLIRKMLTYVPSMRISARDAL 280 (484)
T ss_dssp CCS-GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCC-cccccCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 011 11134567899999999999999999995443
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=348.15 Aligned_cols=246 Identities=24% Similarity=0.358 Sum_probs=194.3
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEeccc--CCceEEEEEe
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 538 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~Ey 538 (824)
++|...+.||+|+||.||+|.+. +..||+|++...... ....+.+|+.+++.++||||++++++| ....++||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 46888999999999999999987 688999999765321 235688999999999999999999988 4568999999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-ceEeccccCCcEEecCCCcceeecccccccccccc
Q 003384 539 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH-SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 617 (824)
Q Consensus 539 ~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~-giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 617 (824)
+++|+|.+++... ..+++..+..++.+++.||.|||+ . ||+||||||+|||++.++.+||+|||++.......
T Consensus 113 ~~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 186 (360)
T 3eqc_A 113 MDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 186 (360)
T ss_dssp CTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH---HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC
T ss_pred CCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---hCCEEcCCccHHHEEECCCCCEEEEECCCCccccccc
Confidence 9999999999543 458899999999999999999998 4 79999999999999999999999999987653321
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhc------------
Q 003384 618 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK------------ 685 (824)
Q Consensus 618 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~------------ 685 (824)
.....||+.|+|||++.+..++.++|||||||++|+|+||+.||............+.
T Consensus 187 ----------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (360)
T 3eqc_A 187 ----------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 256 (360)
T ss_dssp --------------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------
T ss_pred ----------ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCC
Confidence 1234689999999999999999999999999999999999999975433221110000
Q ss_pred ------------------------cccccCCCCCC-CChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 686 ------------------------LKNLLDPLAGD-WPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 686 ------------------------~~~~ld~~~~~-~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
........... .+...+..+.+|+.+||+.+|.+||++.+
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 321 (360)
T 3eqc_A 257 PRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 321 (360)
T ss_dssp -----------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHH
T ss_pred cccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHH
Confidence 00000000011 11224568999999999999999999943
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=337.23 Aligned_cols=258 Identities=24% Similarity=0.335 Sum_probs=181.8
Q ss_pred hcCCCCccceeeecCceEEEEEEE--CCeEEEEEEecCCC-CCCchhHHHHHHHHHhcCCCceeeEeccc--CCceEEEE
Q 003384 462 ATHNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHS-LQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVY 536 (824)
Q Consensus 462 ~~~~f~~~~~LG~G~fG~Vykg~~--~~~~VAvK~l~~~~-~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~ 536 (824)
..++|...+.||+|+||.||+|.+ .+..||||++.... ......+.+|+.+++.++||||+++++++ .+..++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 346799999999999999999987 46889999986543 22345788999999999999999999988 45789999
Q ss_pred EecCCCChhhhhhcc-----CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccc
Q 003384 537 EYLPNGSLEDRLSCK-----DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR 611 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~-----~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~ 611 (824)
||+++|+|.+++... .....+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++.
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 999999999998531 124568999999999999999999999 899999999999999999999999999998
Q ss_pred ccccccccCCCccccccCCCCCCcccCChhhhcc-CCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHh--hhcccc
Q 003384 612 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALD--TGKLKN 688 (824)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~--~~~~~~ 688 (824)
........... .......||+.|+|||++.+ ..++.++|||||||++|+|+||++||........... .+....
T Consensus 170 ~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 246 (303)
T 2vwi_A 170 FLATGGDITRN---KVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPS 246 (303)
T ss_dssp HCC------------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCC
T ss_pred eeccCCCccch---hhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCc
Confidence 66543211110 01133569999999999876 5789999999999999999999999976433221111 111111
Q ss_pred ccCC-CCCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 689 LLDP-LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 689 ~ld~-~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
.... .........+..+.+|+.+||+.+|.+||++.+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ 284 (303)
T 2vwi_A 247 LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAE 284 (303)
T ss_dssp TTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred cccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHH
Confidence 0000 011122334568999999999999999999943
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=340.46 Aligned_cols=264 Identities=20% Similarity=0.332 Sum_probs=200.0
Q ss_pred hhHhhhcCCCCccceeeecCceEEEEEEECCeEEEEEEecCCCC--CCchhHHHHHHHHHhcCCCceeeEecccC--Cce
Q 003384 457 SEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVW 532 (824)
Q Consensus 457 ~ei~~~~~~f~~~~~LG~G~fG~Vykg~~~~~~VAvK~l~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~ 532 (824)
.+.....++|...+.||+|+||.||+|.+.+ .||+|++..... .....+.+|+.+++.++||||+++++++. +..
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHL 104 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCE
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCce
Confidence 3444456789999999999999999999876 599999875432 23456889999999999999999999984 468
Q ss_pred EEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccc
Q 003384 533 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 612 (824)
Q Consensus 533 ~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~ 612 (824)
++||||+++++|.+++.. ....+++..+..++.+++.||.|||+ ++|+||||||+|||++ ++.+||+|||++..
T Consensus 105 ~iv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~ 178 (319)
T 2y4i_B 105 AIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSI 178 (319)
T ss_dssp EEECBCCCSEEHHHHTTS--SCCCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC-
T ss_pred EEEeecccCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCccc
Confidence 999999999999999953 23468899999999999999999999 8999999999999998 67999999999876
Q ss_pred cccccccCCCccccccCCCCCCcccCChhhhcc---------CCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhh
Q 003384 613 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS---------GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT 683 (824)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~---------~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~ 683 (824)
........... ......||+.|+|||++.+ ..++.++|||||||++|+|+||+.||............
T Consensus 179 ~~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~ 255 (319)
T 2y4i_B 179 SGVLQAGRRED---KLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM 255 (319)
T ss_dssp ---------CC---SCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHH
T ss_pred ccccccccccc---ccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Confidence 54222111111 1133468999999999864 45788999999999999999999999765433222111
Q ss_pred hccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHh
Q 003384 684 GKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 736 (824)
Q Consensus 684 ~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~ 736 (824)
... ..+.. .+...+..+.+++.+||..+|.+||++ .++++.|+.+..
T Consensus 256 ~~~---~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~-~~l~~~l~~l~~ 302 (319)
T 2y4i_B 256 GTG---MKPNL--SQIGMGKEISDILLFCWAFEQEERPTF-TKLMDMLEKLPK 302 (319)
T ss_dssp HTT---CCCCC--CCSSCCTTHHHHHHHHHCSSTTTSCCH-HHHHHHHTTC--
T ss_pred ccC---CCCCC--CcCCCCHHHHHHHHHHhcCChhhCcCH-HHHHHHHHHHHH
Confidence 110 11111 111234579999999999999999999 778888887654
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=359.42 Aligned_cols=245 Identities=28% Similarity=0.428 Sum_probs=194.6
Q ss_pred hhcCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC-------------CCchhHHHHHHHHHhcCCCceeeEe
Q 003384 461 GATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-------------QGPSEFQQEIDILSKIRHPNLVTLV 525 (824)
Q Consensus 461 ~~~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~-------------~~~~~f~~Ei~iL~~l~HpnIv~L~ 525 (824)
.....|...++||+|+||+||+|... +..||||++..... .....+.+|+.+|+.++||||++++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 34568999999999999999999986 47899999875432 2235688999999999999999999
Q ss_pred cccC--CceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCC---
Q 003384 526 GACP--EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF--- 600 (824)
Q Consensus 526 g~~~--~~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~--- 600 (824)
++|. ...++|||||+||+|.+++... ..+++..+..|+.||+.||.|||+ ++|+||||||+|||++.++
T Consensus 113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 113 DVFEDKKYFYLVTEFYEGGELFEQIINR---HKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCS
T ss_pred EEEEcCCEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCc
Confidence 9984 4688999999999999988543 469999999999999999999999 8999999999999998776
Q ss_pred cceeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHH-
Q 003384 601 VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQY- 679 (824)
Q Consensus 601 ~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~- 679 (824)
.+||+|||++..+..... .....||+.|+|||++. +.++.++|||||||++|+|++|++||........
T Consensus 187 ~~kl~Dfg~a~~~~~~~~---------~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 256 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKDYK---------LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDII 256 (504)
T ss_dssp SEEECCCTTCEECCTTSC---------BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred cEEEEECCCCEEcCCCCc---------cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 699999999987654321 13346999999999986 5699999999999999999999999987654322
Q ss_pred -HHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHH
Q 003384 680 -ALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD 726 (824)
Q Consensus 680 -~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~ 726 (824)
.+..+.... + ... ....+..+.+|+.+||+.+|.+||++.+.
T Consensus 257 ~~i~~~~~~~--~--~~~-~~~~s~~~~~li~~~L~~dp~~R~t~~e~ 299 (504)
T 3q5i_A 257 KKVEKGKYYF--D--FND-WKNISDEAKELIKLMLTYDYNKRCTAEEA 299 (504)
T ss_dssp HHHHHCCCCC--C--HHH-HTTSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred HHHHcCCCCC--C--ccc-cCCCCHHHHHHHHHHcCCChhHCCCHHHH
Confidence 122221100 0 000 02345689999999999999999999543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=355.11 Aligned_cols=248 Identities=14% Similarity=0.103 Sum_probs=176.4
Q ss_pred hcCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCC---chhHHHHHHHHHhc--CCCceeeEecccC-----
Q 003384 462 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---PSEFQQEIDILSKI--RHPNLVTLVGACP----- 529 (824)
Q Consensus 462 ~~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~---~~~f~~Ei~iL~~l--~HpnIv~L~g~~~----- 529 (824)
...+|...+.||+|+||.||+|.+. +..||||++....... ...+.+|+.+++.| +||||++++..+.
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 60 GERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp CEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEE
T ss_pred CceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehh
Confidence 3446889999999999999999975 5889999998754322 34577886555555 6999888653321
Q ss_pred ---------------------CceEEEEEecCCCChhhhhhccCCCCCCCHHHH------HHHHHHHHHHHHHHhhcCCC
Q 003384 530 ---------------------EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTR------IRIATELCSVLIFLHSCKPH 582 (824)
Q Consensus 530 ---------------------~~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~------~~ia~qia~aL~~LH~~~~~ 582 (824)
...+|||||++ |+|.+++.... ..+.+..+ ..++.||+.||.|||+ +
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~ 213 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD--FVYVFRGDEGILALHILTAQLIRLAANLQS---K 213 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH--HSCCCCHHHHHHHHHHHHHHHHHHHHHHHH---T
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc--cccchhhhhhhhhHHHHHHHHHHHHHHHHH---C
Confidence 33799999998 89999996532 23344556 7888999999999999 8
Q ss_pred ceEeccccCCcEEecCCCcceeeccccccccccccccCCCccccccCCCCCCcccCChhhhcc--CCCCcchhHHhHHHH
Q 003384 583 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS--GELTPKSDVYSFGII 660 (824)
Q Consensus 583 giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~--~~~t~ksDVwSlGvv 660 (824)
+||||||||+||||+.++.+||+|||+++...... ....||+.|+|||++.+ ..++.++|||||||+
T Consensus 214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----------~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~i 282 (371)
T 3q60_A 214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----------PASSVPVTYAPREFLNASTATFTHALNAWQLGLS 282 (371)
T ss_dssp TEEETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----------EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHH
T ss_pred CCccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----------cCccCCcCCcChhhccCCCCCcCccccHHHHHHH
Confidence 99999999999999999999999999998654321 12236799999999987 679999999999999
Q ss_pred HHHHHhCCCCCCCchHHHHHHhhh-cccccc-CCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHH
Q 003384 661 LLRLLTGRPALGITKEVQYALDTG-KLKNLL-DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD 726 (824)
Q Consensus 661 L~ELltG~~Pf~~~~~~~~~~~~~-~~~~~l-d~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~ 726 (824)
||+|+||++||............. ...... .......+...+..+.+|+.+||+.+|.+||++.+.
T Consensus 283 l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~ 350 (371)
T 3q60_A 283 IYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEA 350 (371)
T ss_dssp HHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHH
T ss_pred HHHHHhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 999999999997542110000000 000000 001111123457799999999999999999999443
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=329.90 Aligned_cols=241 Identities=26% Similarity=0.398 Sum_probs=189.8
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCC---CCCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEE
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH---SLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLV 535 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~---~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV 535 (824)
.++|...+.||+|+||.||+|.+. +..||||++... .......+.+|+.+++.++||||+++++++. +..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 357889999999999999999986 689999998643 2233457899999999999999999999884 468999
Q ss_pred EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccc
Q 003384 536 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 615 (824)
Q Consensus 536 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~ 615 (824)
|||+++++|.+++... ..+++..+..++.+++.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 90 MEYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 9999999999999543 458999999999999999999999 7899999999999999999999999999986644
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCC-CcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCC
Q 003384 616 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL-TPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 694 (824)
Q Consensus 616 ~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~ 694 (824)
.... ....||+.|+|||++.+..+ +.++||||||+++|+|++|+.||............. . ..
T Consensus 164 ~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~---~----~~ 227 (276)
T 2h6d_A 164 GEFL---------RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIR---G----GV 227 (276)
T ss_dssp ----------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---H----CC
T ss_pred Ccce---------ecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhh---c----Cc
Confidence 3211 23458999999999988765 689999999999999999999997654322111110 0 01
Q ss_pred CCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 695 GDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 695 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
...|...+..+.+++.+||+.+|.+||++.+
T Consensus 228 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 258 (276)
T 2h6d_A 228 FYIPEYLNRSVATLLMHMLQVDPLKRATIKD 258 (276)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ccCchhcCHHHHHHHHHHccCChhhCCCHHH
Confidence 1224445678999999999999999999943
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=343.91 Aligned_cols=246 Identities=20% Similarity=0.257 Sum_probs=185.6
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEecccCC--------
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACPE-------- 530 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~L~g~~~~-------- 530 (824)
.++|...+.||+|+||.||+|... +..||||++...... ....+.+|+.+++.++||||+++++++..
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 468999999999999999999875 688999998754322 13468899999999999999999998732
Q ss_pred ceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccc
Q 003384 531 VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS 610 (824)
Q Consensus 531 ~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla 610 (824)
..++||||+.+ +|.+.+. ..+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeecc
Confidence 46899999975 7888774 348899999999999999999999 89999999999999999999999999999
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccc---
Q 003384 611 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLK--- 687 (824)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~--- 687 (824)
+....... .....||+.|+|||++.+..++.++|||||||++|+|+||++||...+........-...
T Consensus 175 ~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 245 (371)
T 2xrw_A 175 RTAGTSFM---------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP 245 (371)
T ss_dssp ------------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCC
T ss_pred cccccccc---------cCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 86543211 123468999999999999999999999999999999999999998765433211110000
Q ss_pred ----------------------------ccc----CCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHH
Q 003384 688 ----------------------------NLL----DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD 726 (824)
Q Consensus 688 ----------------------------~~l----d~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~ 726 (824)
..+ .+.....+...+..+.+|+.+||..+|.+|||+.+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~ 316 (371)
T 2xrw_A 246 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 316 (371)
T ss_dssp CHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred CHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHH
Confidence 000 000000011236789999999999999999999443
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=343.19 Aligned_cols=247 Identities=27% Similarity=0.408 Sum_probs=190.7
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCC--chhHHHHHHHHHhcCCCceeeEecccC--CceEEEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE 537 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~E 537 (824)
++|...+.||+|+||.||+|... +..||||++....... ...+.+|+.+++.++||||++++++|. ...++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 46889999999999999999986 6789999986553322 235779999999999999999999984 46889999
Q ss_pred ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccc
Q 003384 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 617 (824)
Q Consensus 538 y~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 617 (824)
|+++++|.+++. ....+++..+..++.+++.||.|||+ +||+||||||+|||++.++.+||+|||++..+....
T Consensus 105 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 105 FVDHTILDDLEL---FPNGLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp CCSEEHHHHHHH---STTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred cCCcchHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence 999999988764 23469999999999999999999999 899999999999999999999999999998654332
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccC-CCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhh----c-------
Q 003384 618 ISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG----K------- 685 (824)
Q Consensus 618 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~----~------- 685 (824)
.. .....||+.|+|||++.+. .++.++|||||||++|+|+||++||............. .
T Consensus 179 ~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (331)
T 4aaa_A 179 EV--------YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQE 250 (331)
T ss_dssp -------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred cc--------cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Confidence 11 1234689999999999875 78999999999999999999999997665433211110 0
Q ss_pred -------cccccCC-CCCCC-----ChhhHHHHHHHHHHHhhhccCCCCChH
Q 003384 686 -------LKNLLDP-LAGDW-----PFVQAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 686 -------~~~~ld~-~~~~~-----p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
......+ ..... ....+..+.+|+.+||+.+|.+||++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ 302 (331)
T 4aaa_A 251 LFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCA 302 (331)
T ss_dssp HHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGG
T ss_pred HhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHH
Confidence 0000000 00000 113467899999999999999999983
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=357.94 Aligned_cols=242 Identities=28% Similarity=0.418 Sum_probs=195.4
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCC--CCCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH--SLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE 537 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~--~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~E 537 (824)
.+|.+.++||+|+||+||+|... +..||||++... .......+.+|+.+|++++||||+++++++. ...++|||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 101 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence 46899999999999999999986 688999998643 2234567999999999999999999999984 46889999
Q ss_pred ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEec---CCCcceeeccccccccc
Q 003384 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD---ANFVSKLSDFGISRFLS 614 (824)
Q Consensus 538 y~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld---~~~~vKL~DFGla~~~~ 614 (824)
|+.+|+|.+.+... ..+++..+..|+.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++.+.
T Consensus 102 ~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 102 LYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp CCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred cCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 99999999988543 468999999999999999999999 8999999999999995 45689999999998654
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHH--HHhhhccccccCC
Q 003384 615 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQY--ALDTGKLKNLLDP 692 (824)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~--~~~~~~~~~~ld~ 692 (824)
.... .....||+.|+|||++.+ .|+.++|||||||++|+|++|++||........ .+..+....
T Consensus 176 ~~~~---------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~---- 241 (486)
T 3mwu_A 176 QNTK---------MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAF---- 241 (486)
T ss_dssp CC-------------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCS----
T ss_pred CCCc---------cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC----
Confidence 3321 133469999999999875 599999999999999999999999976654332 222221111
Q ss_pred CCCCCChhhHHHHHHHHHHHhhhccCCCCChHHH
Q 003384 693 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD 726 (824)
Q Consensus 693 ~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~ 726 (824)
.. +.....+..+.+|+.+||+.+|.+||++.+.
T Consensus 242 ~~-~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~ 274 (486)
T 3mwu_A 242 DL-PQWRTISDDAKDLIRKMLTFHPSLRITATQC 274 (486)
T ss_dssp CS-GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred CC-cccCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 11 1113456789999999999999999999443
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=346.66 Aligned_cols=249 Identities=22% Similarity=0.320 Sum_probs=191.6
Q ss_pred hhcCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccCC--------
Q 003384 461 GATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPE-------- 530 (824)
Q Consensus 461 ~~~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~~-------- 530 (824)
....+|...+.||+|+||.||+|.+. +..||||++.... ....+|+.+|+.++||||++++++|..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 44568999999999999999999875 6899999986542 234589999999999999999998721
Q ss_pred --------------------------------ceEEEEEecCCCChhhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHh
Q 003384 531 --------------------------------VWTLVYEYLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLH 577 (824)
Q Consensus 531 --------------------------------~~~LV~Ey~~ggsL~~~L~~~-~~~~~l~~~~~~~ia~qia~aL~~LH 577 (824)
..++||||++ |+|.+.+... .....+++..+..++.||+.||.|||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp ------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 2779999998 5877776432 23467999999999999999999999
Q ss_pred hcCCCceEeccccCCcEEec-CCCcceeeccccccccccccccCCCccccccCCCCCCcccCChhhhccC-CCCcchhHH
Q 003384 578 SCKPHSIVHGDLKPANILLD-ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVY 655 (824)
Q Consensus 578 ~~~~~giiHrDLKp~NILld-~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDVw 655 (824)
+ +||+||||||+|||++ .++.+||+|||+++.+...... ....||+.|+|||++.+. .++.++|||
T Consensus 159 ~---~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~---------~~~~~t~~y~aPE~~~~~~~~~~~~Diw 226 (383)
T 3eb0_A 159 S---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS---------VAYICSRFYRAPELMLGATEYTPSIDLW 226 (383)
T ss_dssp T---TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC---------CCCCCCSSCCCHHHHTTCSSCCTHHHHH
T ss_pred H---CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC---------cCcccCCCccCHHHhcCCCCCCcchhhh
Confidence 9 8999999999999998 6899999999999866443211 234689999999998775 589999999
Q ss_pred hHHHHHHHHHhCCCCCCCchHHHHHHhhhcc----------------ccccCCC--CCC----CChhhHHHHHHHHHHHh
Q 003384 656 SFGIILLRLLTGRPALGITKEVQYALDTGKL----------------KNLLDPL--AGD----WPFVQAEQLANLAMRCC 713 (824)
Q Consensus 656 SlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~----------------~~~ld~~--~~~----~p~~~~~~l~~Li~~Cl 713 (824)
||||++|+|++|++||............-.. ....-+. ... .+...+..+.+|+.+||
T Consensus 227 slG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 306 (383)
T 3eb0_A 227 SIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQIL 306 (383)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHC
T ss_pred hHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHc
Confidence 9999999999999999876543322211000 0000000 001 23335678999999999
Q ss_pred hhccCCCCChHHH
Q 003384 714 EMSRKSRPELGKD 726 (824)
Q Consensus 714 ~~~P~~RPt~~~~ 726 (824)
..+|.+||++.+.
T Consensus 307 ~~dP~~R~t~~e~ 319 (383)
T 3eb0_A 307 RYEPDLRINPYEA 319 (383)
T ss_dssp CSSGGGSCCHHHH
T ss_pred cCChhhCCCHHHH
Confidence 9999999999543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=340.54 Aligned_cols=254 Identities=22% Similarity=0.275 Sum_probs=184.7
Q ss_pred hHhhhcCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccCC-----
Q 003384 458 EIEGATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPE----- 530 (824)
Q Consensus 458 ei~~~~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~~----- 530 (824)
......++|...+.||+|+||.||+|.+. +..||||++.... .....+.+++..+..++||||++++++|..
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 34455678999999999999999999986 6889999986543 334567888999999999999999998721
Q ss_pred ----ceEEEEEecCCCChhhhhh-ccCCCCCCCHHHHHHHHHHHHHHHHHHh--hcCCCceEeccccCCcEEecC-CCcc
Q 003384 531 ----VWTLVYEYLPNGSLEDRLS-CKDNSPPLSWQTRIRIATELCSVLIFLH--SCKPHSIVHGDLKPANILLDA-NFVS 602 (824)
Q Consensus 531 ----~~~LV~Ey~~ggsL~~~L~-~~~~~~~l~~~~~~~ia~qia~aL~~LH--~~~~~giiHrDLKp~NILld~-~~~v 602 (824)
..++||||++++ |.+.+. .......+++..+..++.+++.||.||| + +||+||||||+||||+. ++.+
T Consensus 96 ~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp TTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEETTTTEE
T ss_pred ccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeCCCCcE
Confidence 278999999864 444332 2244567899999999999999999999 6 89999999999999996 8999
Q ss_pred eeeccccccccccccccCCCccccccCCCCCCcccCChhhhccC-CCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHH
Q 003384 603 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYAL 681 (824)
Q Consensus 603 KL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~ 681 (824)
||+|||+++.+...... ....||+.|+|||++.+. .++.++|||||||++|+|+||++||..........
T Consensus 172 kl~Dfg~a~~~~~~~~~---------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~ 242 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSEPN---------VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLH 242 (360)
T ss_dssp EECCCTTCBCCCTTSCC---------CSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred EEeeCCCceecCCCCCc---------ccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHH
Confidence 99999999876543211 234689999999998765 48999999999999999999999998654432211
Q ss_pred hhhcc------------------ccccCC-------CCCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 682 DTGKL------------------KNLLDP-------LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 682 ~~~~~------------------~~~ld~-------~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
..... ...... .....+...+..+.+|+.+||+.+|.+||++.+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 311 (360)
T 3e3p_A 243 EIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYE 311 (360)
T ss_dssp HHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHH
Confidence 11000 000000 011122235678999999999999999999943
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=331.32 Aligned_cols=246 Identities=23% Similarity=0.308 Sum_probs=179.3
Q ss_pred cCCCCccceeeecCceEEEEEEE--CCeEEEEEEecCCCCCC--chhHHHHHHHHHhcCCCceeeEeccc--CCceEEEE
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVY 536 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~--~~~~VAvK~l~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~ 536 (824)
.++|...+.||+|+||.||+|.. .+..||||++....... ...+..+...++.++||||+++++++ ....++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 45789999999999999999998 46899999997543221 12244555567888999999999988 44689999
Q ss_pred EecCCCChhhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-ceEeccccCCcEEecCCCcceeeccccccccc
Q 003384 537 EYLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPH-SIVHGDLKPANILLDANFVSKLSDFGISRFLS 614 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~-~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~-giiHrDLKp~NILld~~~~vKL~DFGla~~~~ 614 (824)
||++ |+|.+++... .....+++..+..|+.|++.||.|||+ + ||+||||||+|||++.++.+||+|||++....
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9997 4887777432 234679999999999999999999999 6 89999999999999999999999999998664
Q ss_pred cccccCCCccccccCCCCCCcccCChhhh----ccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhcccccc
Q 003384 615 QNEISSNNTTLCCRTDPKGTFAYMDPEFL----ASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLL 690 (824)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~l----~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~l 690 (824)
..... ....||+.|+|||++ .+..++.++|||||||++|+|+||+.||............. ...
T Consensus 162 ~~~~~---------~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~-- 229 (290)
T 3fme_A 162 DDVAK---------DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV-VEE-- 229 (290)
T ss_dssp -----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHH-HHS--
T ss_pred ccccc---------cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHH-hcc--
Confidence 43211 223589999999996 45678999999999999999999999997532211111111 000
Q ss_pred CCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 691 DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 691 d~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
......+...+..+.+|+.+||+.+|.+||++.+
T Consensus 230 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e 263 (290)
T 3fme_A 230 -PSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPE 263 (290)
T ss_dssp -CCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred -CCCCcccccCCHHHHHHHHHHhhcChhhCcCHHH
Confidence 0111112345678999999999999999999943
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=349.25 Aligned_cols=246 Identities=26% Similarity=0.337 Sum_probs=189.0
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC------C--ceE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP------E--VWT 533 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~------~--~~~ 533 (824)
..|...+.||+|+||.||+|.+. +..||||++.... ..+.+|+++|+.++|||||+++++|. + ..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 36888999999999999999985 6889999986532 23457999999999999999998872 1 257
Q ss_pred EEEEecCCCChhhhhhc-cCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCC-Ccceeecccccc
Q 003384 534 LVYEYLPNGSLEDRLSC-KDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN-FVSKLSDFGISR 611 (824)
Q Consensus 534 LV~Ey~~ggsL~~~L~~-~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~-~~vKL~DFGla~ 611 (824)
+||||+++ +|.+.+.. ......+++..+..++.||+.||.|||+ ++|+||||||+||||+.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 89999976 56655532 1234679999999999999999999999 899999999999999955 678999999998
Q ss_pred ccccccccCCCccccccCCCCCCcccCChhhhccC-CCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhc-----
Q 003384 612 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK----- 685 (824)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~----- 685 (824)
.+...... ....||+.|+|||++.+. .|+.++|||||||+||||++|++||............-.
T Consensus 206 ~~~~~~~~---------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p 276 (420)
T 1j1b_A 206 QLVRGEPN---------VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 276 (420)
T ss_dssp ECCTTCCC---------CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSC
T ss_pred hcccCCCc---------eeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 76433211 234689999999998765 799999999999999999999999987654332221100
Q ss_pred ----c-------ccccCCCC--CC----CChhhHHHHHHHHHHHhhhccCCCCChHHH
Q 003384 686 ----L-------KNLLDPLA--GD----WPFVQAEQLANLAMRCCEMSRKSRPELGKD 726 (824)
Q Consensus 686 ----~-------~~~ld~~~--~~----~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~ 726 (824)
+ .....+.. .. ++...+..+.+|+.+||..+|.+||++.+.
T Consensus 277 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~ 334 (420)
T 1j1b_A 277 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 334 (420)
T ss_dssp CHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred CHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHH
Confidence 0 00000000 00 122345789999999999999999999543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=343.46 Aligned_cols=244 Identities=28% Similarity=0.448 Sum_probs=195.6
Q ss_pred hcCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCC--------chhHHHHHHHHHhc-CCCceeeEecccC-
Q 003384 462 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--------PSEFQQEIDILSKI-RHPNLVTLVGACP- 529 (824)
Q Consensus 462 ~~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~--------~~~f~~Ei~iL~~l-~HpnIv~L~g~~~- 529 (824)
...+|.....||+|+||.||+|.+. +..||||++....... ...+.+|+.++.++ +||||+++++++.
T Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 171 (365)
T 2y7j_A 92 FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES 171 (365)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB
T ss_pred hhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee
Confidence 3456889999999999999999986 6899999997654221 23578999999999 7999999999884
Q ss_pred -CceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccc
Q 003384 530 -EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFG 608 (824)
Q Consensus 530 -~~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFG 608 (824)
...++||||++||+|.+++.. ...+++..+..++.||+.||.|||+ .||+||||||+|||++.+|.+||+|||
T Consensus 172 ~~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~ikl~DfG 245 (365)
T 2y7j_A 172 SSFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFG 245 (365)
T ss_dssp SSEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred CCEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEEecC
Confidence 568999999999999999853 2468999999999999999999999 899999999999999999999999999
Q ss_pred cccccccccccCCCccccccCCCCCCcccCChhhhcc------CCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHH--
Q 003384 609 ISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS------GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA-- 680 (824)
Q Consensus 609 la~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~------~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~-- 680 (824)
++..+..... .....||+.|+|||++.+ ..++.++|||||||++|+|+||++||.........
T Consensus 246 ~~~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~ 316 (365)
T 2y7j_A 246 FSCHLEPGEK---------LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRM 316 (365)
T ss_dssp TCEECCTTCC---------BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred cccccCCCcc---------cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 9987654321 133569999999999864 35888999999999999999999999765433221
Q ss_pred HhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 681 LDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 681 ~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
+..+... .....| ...+..+.+|+.+||+.+|.+||++.+
T Consensus 317 i~~~~~~----~~~~~~-~~~~~~~~~li~~~L~~dP~~Rps~~e 356 (365)
T 2y7j_A 317 IMEGQYQ----FSSPEW-DDRSSTVKDLISRLLQVDPEARLTAEQ 356 (365)
T ss_dssp HHHTCCC----CCHHHH-SSSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred HHhCCCC----CCCccc-ccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 1111110 000000 123467999999999999999999943
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=348.62 Aligned_cols=248 Identities=24% Similarity=0.345 Sum_probs=189.9
Q ss_pred cCCCCccceeeecCceEEEEEEEC-CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC------C--ceE
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP------E--VWT 533 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~-~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~------~--~~~ 533 (824)
..+|...+.||+|+||.||+|.+. +..||+|++..... ...+|+.+|+.++||||++++++|. + ..+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 346999999999999999999985 46699998764322 2347999999999999999999872 1 267
Q ss_pred EEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEec-CCCcceeeccccccc
Q 003384 534 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD-ANFVSKLSDFGISRF 612 (824)
Q Consensus 534 LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld-~~~~vKL~DFGla~~ 612 (824)
+||||++++.+............+++..+..++.||+.||.|||+ +||+||||||+||||+ .++.+||+|||+++.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 999999876544433323335679999999999999999999999 8999999999999999 799999999999987
Q ss_pred cccccccCCCccccccCCCCCCcccCChhhhccC-CCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhcc-----
Q 003384 613 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL----- 686 (824)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~----- 686 (824)
+...... ....||+.|+|||++.+. .|+.++|||||||+||||++|++||............-..
T Consensus 192 ~~~~~~~---------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~ 262 (394)
T 4e7w_A 192 LIAGEPN---------VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPS 262 (394)
T ss_dssp CCTTCCC---------CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred ccCCCCC---------cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 6433211 234689999999998765 5999999999999999999999999876543322211000
Q ss_pred --------ccccC---CCCC------CCChhhHHHHHHHHHHHhhhccCCCCChHHH
Q 003384 687 --------KNLLD---PLAG------DWPFVQAEQLANLAMRCCEMSRKSRPELGKD 726 (824)
Q Consensus 687 --------~~~ld---~~~~------~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~ 726 (824)
..... +... .++...+..+.+|+.+||+.+|.+||++.+.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~ 319 (394)
T 4e7w_A 263 REQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEA 319 (394)
T ss_dssp HHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred HHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHH
Confidence 00000 0000 1122355789999999999999999998443
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=371.97 Aligned_cols=239 Identities=21% Similarity=0.290 Sum_probs=199.1
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCC---CCCCchhHHHHHHHHHhc-CCCceeeEecccC--CceEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH---SLQGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTLV 535 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~---~~~~~~~f~~Ei~iL~~l-~HpnIv~L~g~~~--~~~~LV 535 (824)
.+|...+.||+|+||.||+|... +..||||++... .......+..|..+|..+ +||||+++++++. +..|||
T Consensus 341 ~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV 420 (674)
T 3pfq_A 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV 420 (674)
T ss_dssp TTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEE
T ss_pred cceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEE
Confidence 46889999999999999999986 467999998743 223456788999999988 7999999999884 468999
Q ss_pred EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccc
Q 003384 536 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 615 (824)
Q Consensus 536 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~ 615 (824)
|||++||+|.+++... ..+++..+..|+.||+.||.|||+ ++||||||||+||||+.+|++||+|||+|+....
T Consensus 421 ~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 494 (674)
T 3pfq_A 421 MEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 494 (674)
T ss_dssp EECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred EeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence 9999999999999643 458999999999999999999999 8999999999999999999999999999985432
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCC
Q 003384 616 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG 695 (824)
Q Consensus 616 ~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~ 695 (824)
.... .....||+.|+|||++.+..|+.++|||||||+||||+||++||...+........ +. ...
T Consensus 495 ~~~~--------~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i------~~-~~~ 559 (674)
T 3pfq_A 495 DGVT--------TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI------ME-HNV 559 (674)
T ss_dssp TTCC--------BCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HS-SCC
T ss_pred CCcc--------cccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHH------Hh-CCC
Confidence 2211 13456999999999999999999999999999999999999999876543221111 10 112
Q ss_pred CCChhhHHHHHHHHHHHhhhccCCCCCh
Q 003384 696 DWPFVQAEQLANLAMRCCEMSRKSRPEL 723 (824)
Q Consensus 696 ~~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 723 (824)
.+|...+..+.+|+.+||+.+|.+||++
T Consensus 560 ~~p~~~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 560 AYPKSMSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred CCCccCCHHHHHHHHHHccCCHHHCCCC
Confidence 3455677899999999999999999997
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=339.10 Aligned_cols=243 Identities=25% Similarity=0.398 Sum_probs=190.2
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC--------CCchhHHHHHHHHHhcCCCceeeEecccC-Cce
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--------QGPSEFQQEIDILSKIRHPNLVTLVGACP-EVW 532 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~--------~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~-~~~ 532 (824)
++|...+.||+|+||.||+|... +..||||++..... .....+.+|+.+|+.++||||+++++++. +..
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 89 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY 89 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSSE
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCce
Confidence 46889999999999999999886 57899999875421 12245889999999999999999999884 458
Q ss_pred EEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCc---ceeecccc
Q 003384 533 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV---SKLSDFGI 609 (824)
Q Consensus 533 ~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~---vKL~DFGl 609 (824)
++||||+++|+|.+++. ....+++..+..++.|++.||.|||+ ++|+||||||+|||++.++. +||+|||+
T Consensus 90 ~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 90 YIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp EEEEECCTTEETHHHHS---TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred EEEEecCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 99999999999999884 34579999999999999999999999 89999999999999987654 99999999
Q ss_pred ccccccccccCCCccccccCCCCCCcccCChhhhc---cCCCCcchhHHhHHHHHHHHHhCCCCCCCchH---HHHHHhh
Q 003384 610 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA---SGELTPKSDVYSFGIILLRLLTGRPALGITKE---VQYALDT 683 (824)
Q Consensus 610 a~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~---~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~---~~~~~~~ 683 (824)
+......... ....||+.|+|||++. ...++.++|||||||++|+|++|++||..... ....+..
T Consensus 164 ~~~~~~~~~~---------~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (322)
T 2ycf_A 164 SKILGETSLM---------RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS 234 (322)
T ss_dssp CEECCCCHHH---------HHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHH
T ss_pred ceeccccccc---------ccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHh
Confidence 9876433210 1224899999999974 45789999999999999999999999964321 1222222
Q ss_pred hccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHH
Q 003384 684 GKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD 726 (824)
Q Consensus 684 ~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~ 726 (824)
+.... ....+...+..+.+|+.+||+.+|.+||++.+.
T Consensus 235 ~~~~~-----~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~ 272 (322)
T 2ycf_A 235 GKYNF-----IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEA 272 (322)
T ss_dssp TCCCC-----CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred Ccccc-----CchhhhhcCHHHHHHHHHHcccCHhhCCCHHHH
Confidence 21110 000012245689999999999999999999443
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-37 Score=332.59 Aligned_cols=251 Identities=27% Similarity=0.363 Sum_probs=197.0
Q ss_pred hhcCCCCccceeeecCceEEEEEEEC---CeEEEEEEecCCCC--CCchhHHHHHHHHHhc---CCCceeeEecccC---
Q 003384 461 GATHNFDPSLKIGEGGYGSIYKGLLR---HMQVAIKMLHPHSL--QGPSEFQQEIDILSKI---RHPNLVTLVGACP--- 529 (824)
Q Consensus 461 ~~~~~f~~~~~LG~G~fG~Vykg~~~---~~~VAvK~l~~~~~--~~~~~f~~Ei~iL~~l---~HpnIv~L~g~~~--- 529 (824)
...++|...+.||+|+||.||+|.+. +..||||++..... .....+.+|+.+++.+ +||||++++++|.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 34568999999999999999999873 57899999865322 2244688899888877 8999999999874
Q ss_pred ----CceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceee
Q 003384 530 ----EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLS 605 (824)
Q Consensus 530 ----~~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~ 605 (824)
...++||||+. |+|.+++.... ...+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEEe
Confidence 35789999997 69999986432 3458999999999999999999999 899999999999999999999999
Q ss_pred ccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhc
Q 003384 606 DFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK 685 (824)
Q Consensus 606 DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~ 685 (824)
|||+++....... .....||+.|+|||++.+..++.++|||||||++|+|+||++||............-.
T Consensus 163 Dfg~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~ 233 (326)
T 1blx_A 163 DFGLARIYSFQMA---------LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD 233 (326)
T ss_dssp SCCSCCCCCGGGG---------GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cCcccccccCCCC---------ccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 9999986543221 1345689999999999999999999999999999999999999986654332111100
Q ss_pred ---------ccc-------cc----CCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 686 ---------LKN-------LL----DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 686 ---------~~~-------~l----d~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
+.. .+ .......+...+..+.+|+.+||+.+|.+||++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 293 (326)
T 1blx_A 234 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYS 293 (326)
T ss_dssp HHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred HcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHH
Confidence 000 00 00001122345678999999999999999999943
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=343.63 Aligned_cols=253 Identities=24% Similarity=0.299 Sum_probs=194.7
Q ss_pred hhhcCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccC-------
Q 003384 460 EGATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP------- 529 (824)
Q Consensus 460 ~~~~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~L~g~~~------- 529 (824)
.....+|...+.||+|+||.||+|... +..||||++...... ....+.+|+.+|++++||||+++++++.
T Consensus 23 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 102 (364)
T 3qyz_A 23 FDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM 102 (364)
T ss_dssp CCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred ccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCcccc
Confidence 344568999999999999999999876 578999999753322 1256889999999999999999999873
Q ss_pred CceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccc
Q 003384 530 EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI 609 (824)
Q Consensus 530 ~~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGl 609 (824)
...++||||+. |+|.+++.. ..+++..+..|+.|++.||.|||+ +||+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 174 (364)
T 3qyz_A 103 KDVYIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGL 174 (364)
T ss_dssp CCEEEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcc
Confidence 24789999997 589998843 358999999999999999999999 8999999999999999999999999999
Q ss_pred ccccccccccCCCccccccCCCCCCcccCChhhhcc-CCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhh----h
Q 003384 610 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT----G 684 (824)
Q Consensus 610 a~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~----~ 684 (824)
+........... ......||+.|+|||++.+ ..++.++|||||||++|+|+||++||............ +
T Consensus 175 a~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 249 (364)
T 3qyz_A 175 ARVADPDHDHTG-----FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG 249 (364)
T ss_dssp CEECCGGGCBCC-----TTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHC
T ss_pred eEecCCCCCccc-----cccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhC
Confidence 987654332111 1134579999999998765 45899999999999999999999999765322111000 0
Q ss_pred c-----------------cccccCCCCCC---CChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 685 K-----------------LKNLLDPLAGD---WPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 685 ~-----------------~~~~ld~~~~~---~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
. ........... .....+..+.+|+.+||+.+|.+||++.+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e 310 (364)
T 3qyz_A 250 SPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQ 310 (364)
T ss_dssp SCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred CCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHH
Confidence 0 00000000000 01233568999999999999999999943
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=346.48 Aligned_cols=245 Identities=22% Similarity=0.339 Sum_probs=177.9
Q ss_pred hcCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEecccC--------
Q 003384 462 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP-------- 529 (824)
Q Consensus 462 ~~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~L~g~~~-------- 529 (824)
...+|...+.||+|+||.||+|.+. +..||||++...... ....+.+|+.+|+.++||||+++++++.
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 4568999999999999999999875 688999998754221 2346889999999999999999999873
Q ss_pred CceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccc
Q 003384 530 EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI 609 (824)
Q Consensus 530 ~~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGl 609 (824)
...++||||+ +++|.+++.. ..+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC---
T ss_pred CeEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeeccc
Confidence 3468999999 7899998842 469999999999999999999999 8999999999999999999999999999
Q ss_pred ccccccccccCCCccccccCCCCCCcccCChhhhcc-CCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhcc--
Q 003384 610 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL-- 686 (824)
Q Consensus 610 a~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~-- 686 (824)
++...... ....||+.|+|||++.+ ..++.++|||||||++|+|+||++||...+........-..
T Consensus 179 a~~~~~~~-----------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g 247 (367)
T 2fst_X 179 ARHTADEM-----------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 247 (367)
T ss_dssp -----------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred cccccccC-----------CCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 98654221 23468999999999887 67999999999999999999999999876543321111000
Q ss_pred ---------------ccccCCC--CCCCC-----hhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 687 ---------------KNLLDPL--AGDWP-----FVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 687 ---------------~~~ld~~--~~~~p-----~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
...+... ....+ ...+..+.+|+.+||..+|.+||++.+
T Consensus 248 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e 308 (367)
T 2fst_X 248 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 308 (367)
T ss_dssp SCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred CCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHH
Confidence 0000000 00000 123567899999999999999999944
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=326.99 Aligned_cols=242 Identities=27% Similarity=0.400 Sum_probs=195.6
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCC---------chhHHHHHHHHHhcC-CCceeeEecccC-
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---------PSEFQQEIDILSKIR-HPNLVTLVGACP- 529 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~---------~~~f~~Ei~iL~~l~-HpnIv~L~g~~~- 529 (824)
..+|...+.||+|+||.||+|... +..||||++....... ...+.+|+.+++++. ||||+++++++.
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 457899999999999999999985 5889999997653211 235779999999995 999999999984
Q ss_pred -CceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccc
Q 003384 530 -EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFG 608 (824)
Q Consensus 530 -~~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFG 608 (824)
...++||||+++|+|.+++.. ...+++..+..++.+++.||.|||+ +||+||||||+|||++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred CCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEeccc
Confidence 468899999999999999954 3468999999999999999999999 899999999999999999999999999
Q ss_pred cccccccccccCCCccccccCCCCCCcccCChhhhc------cCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHH--
Q 003384 609 ISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA------SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA-- 680 (824)
Q Consensus 609 la~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~------~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~-- 680 (824)
++........ .....||+.|+|||++. ...++.++|||||||++|+|++|++||.........
T Consensus 170 ~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 240 (298)
T 1phk_A 170 FSCQLDPGEK---------LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM 240 (298)
T ss_dssp TCEECCTTCC---------BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred chhhcCCCcc---------cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHH
Confidence 9986643321 13346899999999985 456889999999999999999999999765443221
Q ss_pred HhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChH
Q 003384 681 LDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 681 ~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
+..+.. .. ........+..+.+|+.+||+.+|.+||++.
T Consensus 241 ~~~~~~----~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 279 (298)
T 1phk_A 241 IMSGNY----QF-GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAE 279 (298)
T ss_dssp HHHTCC----CC-CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred HhcCCc----cc-CcccccccCHHHHHHHHHHccCCcccCCCHH
Confidence 111111 10 1111134567899999999999999999984
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=369.48 Aligned_cols=257 Identities=25% Similarity=0.388 Sum_probs=205.4
Q ss_pred HhhhcCCCCccceeeecCceEEEEEEEC-----CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccC-Cc
Q 003384 459 IEGATHNFDPSLKIGEGGYGSIYKGLLR-----HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP-EV 531 (824)
Q Consensus 459 i~~~~~~f~~~~~LG~G~fG~Vykg~~~-----~~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~L~g~~~-~~ 531 (824)
......+|...+.||+|+||.||+|.+. +..||||++...... ....|.+|+.+|++++||||++++|++. +.
T Consensus 385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 464 (656)
T 2j0j_A 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP 464 (656)
T ss_dssp TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCc
Confidence 3344567889999999999999999875 256999998754321 1356899999999999999999999984 46
Q ss_pred eEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccc
Q 003384 532 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR 611 (824)
Q Consensus 532 ~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~ 611 (824)
.++||||+++|+|.+++... ...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 465 ~~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a~ 539 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSR 539 (656)
T ss_dssp CEEEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred eEEEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCCe
Confidence 88999999999999999633 3468999999999999999999999 899999999999999999999999999998
Q ss_pred ccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHH--HHhhhcccc
Q 003384 612 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQY--ALDTGKLKN 688 (824)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~--~~~~~~~~~ 688 (824)
......... .....||+.|+|||++.+..++.++|||||||++|||++ |.+||........ .+..+
T Consensus 540 ~~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~---- 608 (656)
T 2j0j_A 540 YMEDSTYYK-------ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG---- 608 (656)
T ss_dssp SCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHT----
T ss_pred ecCCCccee-------ccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC----
Confidence 764432111 123457889999999999999999999999999999997 9999976543322 11111
Q ss_pred ccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHh
Q 003384 689 LLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 736 (824)
Q Consensus 689 ~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~ 736 (824)
.....|...+..+.+|+.+||+.+|.+||++ .++++.|+.+..
T Consensus 609 ----~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~-~el~~~L~~il~ 651 (656)
T 2j0j_A 609 ----ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRF-TELKAQLSTILE 651 (656)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHH
T ss_pred ----CCCCCCccccHHHHHHHHHHcCCChhHCcCH-HHHHHHHHHHHH
Confidence 1122344566789999999999999999999 778888877643
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=353.62 Aligned_cols=261 Identities=22% Similarity=0.280 Sum_probs=201.9
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCcee-eEecc--cCCceEEEEE
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLV-TLVGA--CPEVWTLVYE 537 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv-~L~g~--~~~~~~LV~E 537 (824)
.++|.+.++||+|+||.||+|.+. +..||||++..... ...+.+|+.+++.|.|++++ .+..+ ..+..+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 457999999999999999999975 68999999875432 34689999999999875444 33333 3567899999
Q ss_pred ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEe---cCCCcceeeccccccccc
Q 003384 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL---DANFVSKLSDFGISRFLS 614 (824)
Q Consensus 538 y~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILl---d~~~~vKL~DFGla~~~~ 614 (824)
|+ +++|.+++... ...+++..++.|+.||+.||.|||. ++||||||||+|||| +.++.+||+|||+++.+.
T Consensus 84 ~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 99999999633 3469999999999999999999999 899999999999999 688999999999998766
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchH-----HHHHHhhhccccc
Q 003384 615 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE-----VQYALDTGKLKNL 689 (824)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~-----~~~~~~~~~~~~~ 689 (824)
........ .........||+.|+|||++.+..++.++|||||||+||||++|+.||..... ....+....+...
T Consensus 158 ~~~~~~~~-~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (483)
T 3sv0_A 158 DTSTHQHI-PYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS 236 (483)
T ss_dssp CTTTCCBC-CCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred CCcccccc-ccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence 54322111 01112356799999999999999999999999999999999999999975321 1111111111111
Q ss_pred cCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhh
Q 003384 690 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 737 (824)
Q Consensus 690 ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~~ 737 (824)
+... +...+..+.+|+.+||+.+|.+||++ +.|.+.|+.+...
T Consensus 237 ~~~l----~~~~p~~l~~li~~cl~~dP~~RPs~-~el~~~L~~l~~~ 279 (483)
T 3sv0_A 237 IEAL----CRGYPTEFASYFHYCRSLRFDDKPDY-SYLKRLFRDLFIR 279 (483)
T ss_dssp HHHH----HTTSCHHHHHHHHHHHTCCTTCCCCH-HHHHHHHHHHHHH
T ss_pred HHHH----hcCCcHHHHHHHHHHhcCChhhCcCH-HHHHHHHHHHHHH
Confidence 1111 12235689999999999999999999 7888888887553
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-37 Score=329.00 Aligned_cols=245 Identities=24% Similarity=0.311 Sum_probs=195.0
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCC----CCCchhHHHHHHHHHhcCCCceeeEeccc--C--CceE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS----LQGPSEFQQEIDILSKIRHPNLVTLVGAC--P--EVWT 533 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~----~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~--~--~~~~ 533 (824)
++|...+.||+|+||.||+|... +..||||++.... ......+.+|+.+++.++||||+++++++ . ...+
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY 84 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence 57999999999999999999985 5789999987532 22345789999999999999999999987 3 3679
Q ss_pred EEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccc
Q 003384 534 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 613 (824)
Q Consensus 534 LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~ 613 (824)
+||||+.+| |.+++... ....+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++...
T Consensus 85 lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 85 MVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence 999999877 77776543 24569999999999999999999999 89999999999999999999999999999866
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhccCC--CCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccC
Q 003384 614 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE--LTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD 691 (824)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~--~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld 691 (824)
....... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...............
T Consensus 160 ~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~----- 228 (305)
T 2wtk_C 160 HPFAADD------TCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG----- 228 (305)
T ss_dssp CTTCSSC------EECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC-----
T ss_pred Ccccccc------ccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcC-----
Confidence 4322111 113456999999999997654 377999999999999999999999865443221111110
Q ss_pred CCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHH
Q 003384 692 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD 726 (824)
Q Consensus 692 ~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~ 726 (824)
....+...+..+.+|+.+||+.+|.+||++.+.
T Consensus 229 --~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 261 (305)
T 2wtk_C 229 --SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQI 261 (305)
T ss_dssp --CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred --CCCCCCccCHHHHHHHHHHccCChhhCCCHHHH
Confidence 112344556789999999999999999999443
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=350.09 Aligned_cols=200 Identities=26% Similarity=0.314 Sum_probs=160.9
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEecccC-------Cc
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP-------EV 531 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~L~g~~~-------~~ 531 (824)
.++|...+.||+|+||.||+|.+. +..||||++...... ....+.+|+.+|+.++||||+++++++. ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 458999999999999999999886 578999999754322 2356889999999999999999999883 34
Q ss_pred eEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccc
Q 003384 532 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR 611 (824)
Q Consensus 532 ~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~ 611 (824)
.|+||||+. |+|.+++. ....+++..+..++.||+.||.|||+ +||+||||||+||||+.++.+||+|||+++
T Consensus 105 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFK---TPIFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCS-EEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCC-cCHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 799999986 59999985 33569999999999999999999999 899999999999999999999999999998
Q ss_pred ccccccccCCC--------------ccccccCCCCCCcccCChhhh-ccCCCCcchhHHhHHHHHHHHHhCCC
Q 003384 612 FLSQNEISSNN--------------TTLCCRTDPKGTFAYMDPEFL-ASGELTPKSDVYSFGIILLRLLTGRP 669 (824)
Q Consensus 612 ~~~~~~~~~~~--------------~~~~~~~~~~GT~~Y~APE~l-~~~~~t~ksDVwSlGvvL~ELltG~~ 669 (824)
........... ......+...||+.|+|||++ ....|+.++|||||||+||||++|..
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~ 250 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQ 250 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCT
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccc
Confidence 76543211000 000112456799999999986 45679999999999999999998433
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=337.77 Aligned_cols=250 Identities=22% Similarity=0.330 Sum_probs=197.4
Q ss_pred cCCCCccceeeecCceEEEEEEECCeEEEEEEecCCCCCCc-----------------hhHHHHHHHHHhcCCCceeeEe
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGP-----------------SEFQQEIDILSKIRHPNLVTLV 525 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~~~~VAvK~l~~~~~~~~-----------------~~f~~Ei~iL~~l~HpnIv~L~ 525 (824)
.++|...+.||+|+||.||+|.+.+..||||++........ ..+.+|+.+++.++||||++++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 109 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE 109 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred cCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence 46899999999999999999999889999999865322111 6799999999999999999999
Q ss_pred cccC--CceEEEEEecCCCChhhh------hhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEec
Q 003384 526 GACP--EVWTLVYEYLPNGSLEDR------LSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD 597 (824)
Q Consensus 526 g~~~--~~~~LV~Ey~~ggsL~~~------L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld 597 (824)
+++. +..++||||+++|+|.++ +.. .....+++..+..++.+++.||.|||+. +||+||||||+|||++
T Consensus 110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dl~p~Nil~~ 186 (348)
T 2pml_X 110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNE--KNICHRDVKPSNILMD 186 (348)
T ss_dssp EEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHT--SCEECCCCCGGGEEEC
T ss_pred EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhcc--CCEeecCCChHhEEEc
Confidence 9984 568999999999999998 532 1256799999999999999999999972 5799999999999999
Q ss_pred CCCcceeeccccccccccccccCCCccccccCCCCCCcccCChhhhccC-CCCc-chhHHhHHHHHHHHHhCCCCCCCch
Q 003384 598 ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTP-KSDVYSFGIILLRLLTGRPALGITK 675 (824)
Q Consensus 598 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~-ksDVwSlGvvL~ELltG~~Pf~~~~ 675 (824)
.++.+||+|||++....... .....||+.|+|||++.+. .++. ++|||||||++|+|+||++||....
T Consensus 187 ~~~~~kl~dfg~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 256 (348)
T 2pml_X 187 KNGRVKLSDFGESEYMVDKK----------IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256 (348)
T ss_dssp TTSCEEECCCTTCEECBTTE----------ECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCCcEEEecccccccccccc----------ccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999998754331 1334689999999999887 6766 9999999999999999999997653
Q ss_pred H---HHHHHhhhccccccCC------C----CCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 676 E---VQYALDTGKLKNLLDP------L----AGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 676 ~---~~~~~~~~~~~~~ld~------~----~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
. ....+..+......+. . ....+...+..+.+|+.+||+.+|.+||++.+
T Consensus 257 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e 319 (348)
T 2pml_X 257 SLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSED 319 (348)
T ss_dssp CSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred cHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHH
Confidence 3 2222222211100000 0 00001345678999999999999999999943
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=335.48 Aligned_cols=250 Identities=22% Similarity=0.321 Sum_probs=187.0
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC-----------
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP----------- 529 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~----------- 529 (824)
.++|...+.||+|+||.||+|... +..||||++..........+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 357899999999999999999987 6899999987654444567889999999999999999998762
Q ss_pred -----CceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEec-CCCcce
Q 003384 530 -----EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD-ANFVSK 603 (824)
Q Consensus 530 -----~~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld-~~~~vK 603 (824)
...++||||+. |+|.+++. ..++++..+..++.|++.||.|||+ +||+||||||+|||++ .++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCeEE
Confidence 35789999997 69999984 3468999999999999999999999 8999999999999997 577999
Q ss_pred eeccccccccccccccCCCccccccCCCCCCcccCChhhhcc-CCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHh
Q 003384 604 LSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALD 682 (824)
Q Consensus 604 L~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~ 682 (824)
|+|||+++........... .....||..|+|||.+.+ ..++.++|||||||++|+|+||++||...........
T Consensus 162 l~Dfg~~~~~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 236 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGH-----LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQL 236 (320)
T ss_dssp ECCCTTCBCC--------C-----CCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred EccCccccccCCCcccccc-----cccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9999999876432211110 122357999999998876 6789999999999999999999999986654322111
Q ss_pred hhcc---------ccc------------cCCCC--CCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 683 TGKL---------KNL------------LDPLA--GDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 683 ~~~~---------~~~------------ld~~~--~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
.... ..+ ..+.. ...+...+..+.+|+.+||+.+|.+||++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 302 (320)
T 2i6l_A 237 ILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEE 302 (320)
T ss_dssp HHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred HHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHH
Confidence 0000 000 00000 0011234678999999999999999999943
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-37 Score=332.68 Aligned_cols=245 Identities=22% Similarity=0.306 Sum_probs=192.7
Q ss_pred cCCCCccceeeecCceEEEEEEE---CCeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCc------eeeEeccc--CCc
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLL---RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPN------LVTLVGAC--PEV 531 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~---~~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~Hpn------Iv~L~g~~--~~~ 531 (824)
.++|...+.||+|+||.||+|.. .+..||||++.... .....+.+|+.+++.++|+| |+++++++ .+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 35799999999999999999987 35889999986432 22356889999999987654 99999988 456
Q ss_pred eEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecC-------------
Q 003384 532 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA------------- 598 (824)
Q Consensus 532 ~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~------------- 598 (824)
.++||||+ +++|.+++... ...++++..+..++.|++.||.|||+ ++|+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCcccc
Confidence 89999999 88999998643 23468999999999999999999999 89999999999999987
Q ss_pred ------CCcceeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCC
Q 003384 599 ------NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALG 672 (824)
Q Consensus 599 ------~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~ 672 (824)
++.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|||+||++||.
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~~-----------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 235 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEHH-----------STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFP 235 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSCC-----------CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccCCCceEeeCcccccCcccc-----------ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 6789999999997643221 23468999999999999999999999999999999999999997
Q ss_pred CchHHHHHHhhhcccc--------------cc---------------------CC--CCCCCChhhHHHHHHHHHHHhhh
Q 003384 673 ITKEVQYALDTGKLKN--------------LL---------------------DP--LAGDWPFVQAEQLANLAMRCCEM 715 (824)
Q Consensus 673 ~~~~~~~~~~~~~~~~--------------~l---------------------d~--~~~~~p~~~~~~l~~Li~~Cl~~ 715 (824)
................ .. .+ .....+...+..+.+|+.+||+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 315 (339)
T 1z57_A 236 THDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEY 315 (339)
T ss_dssp CSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred CCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCc
Confidence 6543221111000000 00 00 00112334567899999999999
Q ss_pred ccCCCCChH
Q 003384 716 SRKSRPELG 724 (824)
Q Consensus 716 ~P~~RPt~~ 724 (824)
+|.+||++.
T Consensus 316 dP~~Rpt~~ 324 (339)
T 1z57_A 316 DPAKRITLR 324 (339)
T ss_dssp STTTSCCHH
T ss_pred CcccccCHH
Confidence 999999994
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=345.39 Aligned_cols=198 Identities=25% Similarity=0.402 Sum_probs=150.8
Q ss_pred CCc-cceeeecCceEEEEEEEC----CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc----CCceEEEE
Q 003384 466 FDP-SLKIGEGGYGSIYKGLLR----HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC----PEVWTLVY 536 (824)
Q Consensus 466 f~~-~~~LG~G~fG~Vykg~~~----~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~----~~~~~LV~ 536 (824)
|.. .++||+|+||.||+|.+. +..||||++.... ....+.+|+.+|+.++||||++++++| ....++||
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~ 99 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 99 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence 444 457999999999999965 4679999997543 235789999999999999999999988 34689999
Q ss_pred EecCCCChhhhhhcc------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEe----cCCCcceeec
Q 003384 537 EYLPNGSLEDRLSCK------DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL----DANFVSKLSD 606 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~------~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILl----d~~~~vKL~D 606 (824)
||+. |+|.+++... .....+++..+..|+.||+.||.|||+ ++|+||||||+|||| +.++.+||+|
T Consensus 100 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 100 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp ECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred eCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 9996 4787777422 123359999999999999999999999 899999999999999 7789999999
Q ss_pred cccccccccccccCCCccccccCCCCCCcccCChhhhccC-CCCcchhHHhHHHHHHHHHhCCCCCCCc
Q 003384 607 FGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGIT 674 (824)
Q Consensus 607 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDVwSlGvvL~ELltG~~Pf~~~ 674 (824)
||+++.+....... .......||+.|+|||++.+. .++.++|||||||+||+|+||++||...
T Consensus 176 fg~a~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 176 MGFARLFNSPLKPL-----ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp TTCCC---------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred CCCceecCCCCccc-----ccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 99998765332111 111345699999999999874 5899999999999999999999999644
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=347.20 Aligned_cols=246 Identities=21% Similarity=0.306 Sum_probs=191.9
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcC--------CCceeeEecccC---
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIR--------HPNLVTLVGACP--- 529 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~--------HpnIv~L~g~~~--- 529 (824)
.++|...++||+|+||.||+|... +..||||++.... .....+.+|+.+|+.++ ||||++++++|.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE-HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC-cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 467999999999999999999875 5889999997432 22456889999999995 788999999874
Q ss_pred ---CceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-ceEeccccCCcEEecCCC-----
Q 003384 530 ---EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH-SIVHGDLKPANILLDANF----- 600 (824)
Q Consensus 530 ---~~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~-giiHrDLKp~NILld~~~----- 600 (824)
...++||||+ +|+|.+.+... ....+++..+..|+.||+.||.|||+ + ||+||||||+||||+.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCCHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEeccchhhhh
Confidence 3578999999 56666666433 23569999999999999999999999 7 899999999999999775
Q ss_pred --------------------------------------------cceeeccccccccccccccCCCccccccCCCCCCcc
Q 003384 601 --------------------------------------------VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 636 (824)
Q Consensus 601 --------------------------------------------~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~ 636 (824)
.+||+|||++....... ....||+.
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~-----------~~~~gt~~ 258 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-----------TEDIQTRQ 258 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS-----------CSCCSCGG
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC-----------ccCCCCCc
Confidence 79999999998654321 23468999
Q ss_pred cCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCch------HHHH---HHh-hhc----------cc-cccCC---
Q 003384 637 YMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITK------EVQY---ALD-TGK----------LK-NLLDP--- 692 (824)
Q Consensus 637 Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~------~~~~---~~~-~~~----------~~-~~ld~--- 692 (824)
|+|||++.+..++.++|||||||+||+|+||++||.... .... ... .+. .. ..+..
T Consensus 259 y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 338 (397)
T 1wak_A 259 YRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGD 338 (397)
T ss_dssp GCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSS
T ss_pred ccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccc
Confidence 999999999999999999999999999999999996432 1110 000 000 00 00000
Q ss_pred -----------------CCCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 693 -----------------LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 693 -----------------~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
....++...+..+.+|+.+||+.+|.+||++.+
T Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 388 (397)
T 1wak_A 339 LKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAE 388 (397)
T ss_dssp BSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHH
T ss_pred cccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHH
Confidence 011345666788999999999999999999943
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=334.74 Aligned_cols=256 Identities=22% Similarity=0.277 Sum_probs=193.1
Q ss_pred hcCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccC-------Cc
Q 003384 462 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP-------EV 531 (824)
Q Consensus 462 ~~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~L~g~~~-------~~ 531 (824)
..++|...+.||+|+||.||+|.+. +..||||++...... ....+.+|+.+++.++||||+++++++. ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 3468999999999999999999986 688999999653221 1345789999999999999999999873 35
Q ss_pred eEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccc
Q 003384 532 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR 611 (824)
Q Consensus 532 ~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~ 611 (824)
.++||||+. |+|.+++.. ..+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++.
T Consensus 89 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 789999997 589998853 358999999999999999999999 899999999999999999999999999998
Q ss_pred ccccccccCCC--ccccccCCCCCCcccCChhhhcc-CCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccc-
Q 003384 612 FLSQNEISSNN--TTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLK- 687 (824)
Q Consensus 612 ~~~~~~~~~~~--~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~- 687 (824)
.+......... ..........||+.|+|||++.+ ..++.++|||||||++|+|++|++||................
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 240 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG 240 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Confidence 76543221110 00011134578999999998765 678999999999999999999999998765432211110000
Q ss_pred -----------------cccCCC--CC-----CCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 688 -----------------NLLDPL--AG-----DWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 688 -----------------~~ld~~--~~-----~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
..+... .. ..+...+..+.+|+.+||+.+|.+||++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 302 (353)
T 2b9h_A 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKE 302 (353)
T ss_dssp CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHH
Confidence 000000 00 001234568899999999999999999943
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-37 Score=339.70 Aligned_cols=244 Identities=23% Similarity=0.319 Sum_probs=190.0
Q ss_pred hcCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCC--chhHHHHHHHHHhcCCCceeeEecccCC--c----
Q 003384 462 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACPE--V---- 531 (824)
Q Consensus 462 ~~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~L~g~~~~--~---- 531 (824)
..++|...+.||+|+||.||+|.+. +..||||++....... ...+.+|+.+++.++||||++++++|.. .
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 4568999999999999999999876 6899999997643222 3568899999999999999999998843 2
Q ss_pred --eEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccc
Q 003384 532 --WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI 609 (824)
Q Consensus 532 --~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGl 609 (824)
+++||||+. |+|.+.+. ..+++..+..++.+++.||.|||+ +||+||||||+|||++.++.+||+|||+
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eeEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecCc
Confidence 389999997 68888772 348999999999999999999999 8999999999999999999999999999
Q ss_pred ccccccccccCCCccccccCCCCCCcccCChhhhcc-CCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhcc--
Q 003384 610 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL-- 686 (824)
Q Consensus 610 a~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~-- 686 (824)
++...... ....||+.|+|||++.+ ..++.++|||||||++|+|+||++||............-..
T Consensus 191 a~~~~~~~-----------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~ 259 (371)
T 4exu_A 191 ARHADAEM-----------TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG 259 (371)
T ss_dssp C-------------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred ccccccCc-----------CCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 98553221 33468999999999987 68999999999999999999999999866543222111000
Q ss_pred -------------------ccccCCCCCC---CChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 687 -------------------KNLLDPLAGD---WPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 687 -------------------~~~ld~~~~~---~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
..+....... .+...+..+.+|+.+||+.+|.+||++.+
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 320 (371)
T 4exu_A 260 VPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQ 320 (371)
T ss_dssp CCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHH
T ss_pred CCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHH
Confidence 0000000000 11234578999999999999999999943
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=333.91 Aligned_cols=243 Identities=22% Similarity=0.307 Sum_probs=190.4
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCC--chhHHHHHHHHHhcCCCceeeEecccCC--------
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACPE-------- 530 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~L~g~~~~-------- 530 (824)
..+|.....||+|+||.||+|.+. +..||||++....... ...+.+|+.+++.++||||+++++++..
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 467999999999999999999875 6899999997643221 3468899999999999999999998843
Q ss_pred ceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccc
Q 003384 531 VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS 610 (824)
Q Consensus 531 ~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla 610 (824)
.+++||||+. |+|.+++. ..+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeecccc
Confidence 2489999997 68888772 348999999999999999999999 89999999999999999999999999999
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhcc-CCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhcc---
Q 003384 611 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL--- 686 (824)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~--- 686 (824)
+...... ....||+.|+|||++.+ ..++.++|||||||++|+|+||++||............-..
T Consensus 174 ~~~~~~~-----------~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~ 242 (353)
T 3coi_A 174 RHADAEM-----------TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGV 242 (353)
T ss_dssp TC-------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCB
T ss_pred cCCCCCc-----------cccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 7643221 23468999999999887 67899999999999999999999999765433211110000
Q ss_pred ------------------ccc---cCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 687 ------------------KNL---LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 687 ------------------~~~---ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
..+ ........+...+..+.+|+.+||+.+|.+||++.+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e 302 (353)
T 3coi_A 243 PGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQ 302 (353)
T ss_dssp CCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHH
T ss_pred CCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHH
Confidence 000 000111223345778999999999999999999943
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=345.41 Aligned_cols=197 Identities=27% Similarity=0.366 Sum_probs=167.7
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhc------CCCceeeEeccc--CCce
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKI------RHPNLVTLVGAC--PEVW 532 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l------~HpnIv~L~g~~--~~~~ 532 (824)
..+|...+.||+|+||.||+|.+. +..||||++.... .....+.+|+.++..+ +||||++++++| ....
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 457999999999999999999886 5889999997532 1234678899999887 578999999988 4578
Q ss_pred EEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCc--ceeeccccc
Q 003384 533 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV--SKLSDFGIS 610 (824)
Q Consensus 533 ~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~--vKL~DFGla 610 (824)
++||||+. ++|.+++.... ...+++..+..|+.||+.||.|||+ ++||||||||+||||+.++. +||+|||++
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNK-FQGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEeccC-CCHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence 99999995 68999886443 3458999999999999999999999 78999999999999999887 999999999
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchH
Q 003384 611 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE 676 (824)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~ 676 (824)
+...... ....||+.|+|||++.+..++.++|||||||+||||+||++||.....
T Consensus 250 ~~~~~~~-----------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~ 304 (429)
T 3kvw_A 250 CYEHQRV-----------YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE 304 (429)
T ss_dssp EETTCCC-----------CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred eecCCcc-----------cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 7543221 234689999999999999999999999999999999999999976654
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=326.29 Aligned_cols=251 Identities=22% Similarity=0.327 Sum_probs=186.7
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC------------
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP------------ 529 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~------------ 529 (824)
++|...+.||+|+||.||+|... +..||||++.... .....+.+|+.+++.++||||++++++|.
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH-HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 46888999999999999999975 6889999986421 22356889999999999999999999762
Q ss_pred ---CceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeec
Q 003384 530 ---EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSD 606 (824)
Q Consensus 530 ---~~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~D 606 (824)
...++||||+++|+|.+++... ...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHHS--CGGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECC
T ss_pred ccCCceEEEEecCCCCCHHHhhhcc--ccccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCCEEEee
Confidence 3578999999999999999643 3457888999999999999999999 8999999999999999999999999
Q ss_pred cccccccccccccCC------CccccccCCCCCCcccCChhhhccC-CCCcchhHHhHHHHHHHHHhCCCCCCCchHHHH
Q 003384 607 FGISRFLSQNEISSN------NTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQY 679 (824)
Q Consensus 607 FGla~~~~~~~~~~~------~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~ 679 (824)
||++........... ...........||+.|+|||++.+. .++.++|||||||++|+|++ ||........
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~ 236 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN 236 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence 999986643211000 0000111345689999999999864 78999999999999999999 4543222111
Q ss_pred HHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 680 ALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 680 ~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
.... +..........++...+..+.+++.+||+.+|.+||++.+
T Consensus 237 ~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ 280 (303)
T 1zy4_A 237 ILKK--LRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGART 280 (303)
T ss_dssp HHHH--HHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHh--ccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHH
Confidence 1111 1111111223345556678999999999999999999943
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=339.75 Aligned_cols=246 Identities=19% Similarity=0.309 Sum_probs=191.1
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcC-----------CCceeeEecccC
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-----------HPNLVTLVGACP 529 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~-----------HpnIv~L~g~~~ 529 (824)
..+|...+.||+|+||.||+|.+. +..||||++.... .....+.+|+.++++++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 357999999999999999999974 6899999987432 12356889999999886 899999999874
Q ss_pred C------ceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-ceEeccccCCcEEec-----
Q 003384 530 E------VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH-SIVHGDLKPANILLD----- 597 (824)
Q Consensus 530 ~------~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~-giiHrDLKp~NILld----- 597 (824)
. ..++||||+ +++|.+++.... ...+++..+..|+.||+.||.|||+ + ||+||||||+||||+
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEeccCCC
Confidence 2 578999999 899999986432 3458999999999999999999999 7 899999999999994
Q ss_pred -CCCcceeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchH
Q 003384 598 -ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE 676 (824)
Q Consensus 598 -~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~ 676 (824)
..+.+||+|||++....... ....||+.|+|||++.+..++.++|||||||+||+|+||++||.....
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~~-----------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 240 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEHY-----------TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEG 240 (373)
T ss_dssp TTEEEEEECCCTTCEETTBCC-----------CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred cCcceEEEcccccccccCCCC-----------CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcc
Confidence 44589999999998654321 234689999999999999999999999999999999999999975431
Q ss_pred HH---------HHHh-hhccc-----------c------ccC--------------CCCCCCChhhHHHHHHHHHHHhhh
Q 003384 677 VQ---------YALD-TGKLK-----------N------LLD--------------PLAGDWPFVQAEQLANLAMRCCEM 715 (824)
Q Consensus 677 ~~---------~~~~-~~~~~-----------~------~ld--------------~~~~~~p~~~~~~l~~Li~~Cl~~ 715 (824)
.. .... .+... . .+. .....++...+..+.+|+.+||+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 320 (373)
T 1q8y_A 241 HSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL 320 (373)
T ss_dssp ----CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCS
T ss_pred cccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhcc
Confidence 10 0000 00000 0 000 001134556778999999999999
Q ss_pred ccCCCCChHH
Q 003384 716 SRKSRPELGK 725 (824)
Q Consensus 716 ~P~~RPt~~~ 725 (824)
+|.+||++.+
T Consensus 321 dP~~Rpt~~e 330 (373)
T 1q8y_A 321 DPRKRADAGG 330 (373)
T ss_dssp STTTCBCHHH
T ss_pred CccccCCHHH
Confidence 9999999943
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=328.85 Aligned_cols=236 Identities=28% Similarity=0.437 Sum_probs=190.1
Q ss_pred hhcCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC------CchhHHHHHHHHHhc----CCCceeeEeccc
Q 003384 461 GATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ------GPSEFQQEIDILSKI----RHPNLVTLVGAC 528 (824)
Q Consensus 461 ~~~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~------~~~~f~~Ei~iL~~l----~HpnIv~L~g~~ 528 (824)
...++|...+.||+|+||.||+|.+. +..||||++...... ....+.+|+.++.++ +||||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 34568999999999999999999874 578999999765332 223467899999999 899999999988
Q ss_pred C--CceEEEEEe-cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEec-CCCccee
Q 003384 529 P--EVWTLVYEY-LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD-ANFVSKL 604 (824)
Q Consensus 529 ~--~~~~LV~Ey-~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld-~~~~vKL 604 (824)
. +..++|||| +.+++|.+++... ..+++..+..++.+++.||.|||+ ++|+||||||+|||++ .++.+||
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITEK---GPLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTTEEEE
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCCeEEE
Confidence 4 468899999 7899999999643 458999999999999999999999 7899999999999999 8899999
Q ss_pred eccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCC-cchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhh
Q 003384 605 SDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELT-PKSDVYSFGIILLRLLTGRPALGITKEVQYALDT 683 (824)
Q Consensus 605 ~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t-~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~ 683 (824)
+|||++........ ....||+.|+|||++.+..+. .++|||||||++|+|++|+.||........
T Consensus 182 ~dfg~~~~~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---- 247 (312)
T 2iwi_A 182 IDFGSGALLHDEPY----------TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILE---- 247 (312)
T ss_dssp CCCSSCEECCSSCB----------CCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHH----
T ss_pred EEcchhhhcccCcc----------cccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHHhh----
Confidence 99999987653321 234589999999999877664 589999999999999999999976543211
Q ss_pred hccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 684 GKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 684 ~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
. ...++...+..+.+|+.+||+.+|.+||++.+
T Consensus 248 ~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e 280 (312)
T 2iwi_A 248 A---------ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEE 280 (312)
T ss_dssp T---------CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred h---------ccCCcccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 1 11234455678999999999999999999943
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=330.20 Aligned_cols=256 Identities=25% Similarity=0.374 Sum_probs=193.3
Q ss_pred CCCChhhHhhhcCCCCccceeeecCceEEEEEEEC-CeEEEEEEecCCCCC--CchhHHHHHHHHHhcC--CCceeeEec
Q 003384 452 SDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIR--HPNLVTLVG 526 (824)
Q Consensus 452 ~~~~~~ei~~~~~~f~~~~~LG~G~fG~Vykg~~~-~~~VAvK~l~~~~~~--~~~~f~~Ei~iL~~l~--HpnIv~L~g 526 (824)
..+.+..+.....+|...+.||+|+||.||++... +..||||++...... ....+.+|+.++.+++ ||||+++++
T Consensus 16 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~ 95 (313)
T 3cek_A 16 ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95 (313)
T ss_dssp ----CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEE
T ss_pred CCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEE
Confidence 44555666667778999999999999999999876 578999999754332 2356889999999997 599999999
Q ss_pred ccC--CceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCccee
Q 003384 527 ACP--EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKL 604 (824)
Q Consensus 527 ~~~--~~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL 604 (824)
++. ...++||| +.+++|.+++... ..+++..+..++.+++.||.|||+ ++|+||||||+|||++. +.+||
T Consensus 96 ~~~~~~~~~lv~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~~kL 167 (313)
T 3cek_A 96 YEITDQYIYMVME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GMLKL 167 (313)
T ss_dssp EEECSSEEEEEEC-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TEEEE
T ss_pred EeecCCEEEEEEe-cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-CeEEE
Confidence 883 46789999 5688999999543 468999999999999999999999 89999999999999964 89999
Q ss_pred eccccccccccccccCCCccccccCCCCCCcccCChhhhcc-----------CCCCcchhHHhHHHHHHHHHhCCCCCCC
Q 003384 605 SDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-----------GELTPKSDVYSFGIILLRLLTGRPALGI 673 (824)
Q Consensus 605 ~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-----------~~~t~ksDVwSlGvvL~ELltG~~Pf~~ 673 (824)
+|||++..+....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..
T Consensus 168 ~Dfg~~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 241 (313)
T 3cek_A 168 IDFGIANQMQPDTTSV------VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 241 (313)
T ss_dssp CCCSSSCC--------------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred eeccccccccCccccc------cccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhh
Confidence 9999998765432111 1123468999999999875 4688899999999999999999999965
Q ss_pred chHHHHHHhhhccccccCC-CCCCCChhhHHHHHHHHHHHhhhccCCCCChHHH
Q 003384 674 TKEVQYALDTGKLKNLLDP-LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD 726 (824)
Q Consensus 674 ~~~~~~~~~~~~~~~~ld~-~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~ 726 (824)
......... ..+++ ....++...+..+.+++.+||+.+|.+||++.+.
T Consensus 242 ~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el 290 (313)
T 3cek_A 242 IINQISKLH-----AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 290 (313)
T ss_dssp CCSHHHHHH-----HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred HHHHHHHHH-----HHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHH
Confidence 422111111 11111 1123344446789999999999999999999443
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=334.71 Aligned_cols=207 Identities=29% Similarity=0.378 Sum_probs=170.5
Q ss_pred ChhhHhhhcCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcC-CC-----ceeeEec
Q 003384 455 SFSEIEGATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HP-----NLVTLVG 526 (824)
Q Consensus 455 ~~~ei~~~~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~-Hp-----nIv~L~g 526 (824)
.+.......++|...+.||+|+||.||+|... +..||||++.... .....+..|+.++..++ |+ +|+++++
T Consensus 45 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~ 123 (382)
T 2vx3_A 45 IVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKR 123 (382)
T ss_dssp CCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEE
T ss_pred EeecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeee
Confidence 33444455678999999999999999999886 5789999997432 12346778999998885 55 4899998
Q ss_pred cc--CCceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEec--CCCcc
Q 003384 527 AC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD--ANFVS 602 (824)
Q Consensus 527 ~~--~~~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld--~~~~v 602 (824)
++ .+..++||||+. |+|.+++.... ...+++..+..++.|++.||.|||.. ..|||||||||+||||+ .++.+
T Consensus 124 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~ 200 (382)
T 2vx3_A 124 HFMFRNHLCLVFEMLS-YNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAI 200 (382)
T ss_dssp EEEETTEEEEEEECCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCE
T ss_pred eeccCCceEEEEecCC-CCHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcE
Confidence 87 457899999996 59999986442 24589999999999999999999952 26899999999999995 57889
Q ss_pred eeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchH
Q 003384 603 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE 676 (824)
Q Consensus 603 KL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~ 676 (824)
||+|||+++...... ....||+.|+|||++.+..++.++|||||||+||||+||++||.....
T Consensus 201 kL~DFG~a~~~~~~~-----------~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~ 263 (382)
T 2vx3_A 201 KIVDFGSSCQLGQRI-----------YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263 (382)
T ss_dssp EECCCTTCEETTCCC-----------CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EEEeccCceeccccc-----------ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999998664321 234689999999999999999999999999999999999999986544
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=330.19 Aligned_cols=249 Identities=25% Similarity=0.320 Sum_probs=172.3
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC-CchhHHHHHH-HHHhcCCCceeeEeccc--CCceEEEE
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEID-ILSKIRHPNLVTLVGAC--PEVWTLVY 536 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~-~~~~f~~Ei~-iL~~l~HpnIv~L~g~~--~~~~~LV~ 536 (824)
..+|...+.||+|+||.||+|... +..||||++...... ....+..|+. +++.++||||+++++++ .+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 457889999999999999999986 689999999764321 1234556665 67778999999999988 45688999
Q ss_pred EecCCCChhhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-ceEeccccCCcEEecCCCcceeecccccccc
Q 003384 537 EYLPNGSLEDRLSCK--DNSPPLSWQTRIRIATELCSVLIFLHSCKPH-SIVHGDLKPANILLDANFVSKLSDFGISRFL 613 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~--~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~-giiHrDLKp~NILld~~~~vKL~DFGla~~~ 613 (824)
||+.+ +|.+++... .....+++..+..++.+++.||.|||+ + ||+||||||+|||++.++.+||+|||+++.+
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99975 787776421 224678999999999999999999999 7 8999999999999999999999999999866
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhh----ccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccc
Q 003384 614 SQNEISSNNTTLCCRTDPKGTFAYMDPEFL----ASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNL 689 (824)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l----~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ 689 (824)
..... .....||+.|+|||++ .+..++.++|||||||++|+|+||+.||............ .....
T Consensus 177 ~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~ 246 (327)
T 3aln_A 177 VDSIA---------KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQ-VVKGD 246 (327)
T ss_dssp --------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CC-CCCSC
T ss_pred ccccc---------cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHH-HhcCC
Confidence 43321 1233589999999998 4567899999999999999999999999764432111111 00000
Q ss_pred cCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 690 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 690 ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
............+..+.+|+.+||+.+|.+||++.+
T Consensus 247 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e 282 (327)
T 3aln_A 247 PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKE 282 (327)
T ss_dssp CCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHH
Confidence 001111112345678999999999999999999943
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=321.65 Aligned_cols=242 Identities=29% Similarity=0.434 Sum_probs=193.5
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCC--CCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS--LQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE 537 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~--~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~E 537 (824)
++|...+.||+|+||.||+|... +..||||++.... ......+.+|+.++++++||||+++++++. ...++|||
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence 46889999999999999999985 6889999986542 234567999999999999999999999884 46889999
Q ss_pred ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCC---Ccceeeccccccccc
Q 003384 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN---FVSKLSDFGISRFLS 614 (824)
Q Consensus 538 y~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~---~~vKL~DFGla~~~~ 614 (824)
|+++++|.+.+... ..+++..+..++.+++.||.|||. +||+||||||+|||++.+ +.+||+|||++....
T Consensus 102 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 102 LYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp CCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred ccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 99999999988543 358999999999999999999999 899999999999999754 479999999998654
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHH--HHhhhccccccCC
Q 003384 615 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQY--ALDTGKLKNLLDP 692 (824)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~--~~~~~~~~~~ld~ 692 (824)
..... ....||+.|+|||++.+ .++.++||||||+++|+|++|++||........ .+..+.... +
T Consensus 176 ~~~~~---------~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~- 242 (287)
T 2wei_A 176 QNTKM---------KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAF--D- 242 (287)
T ss_dssp CCSSC---------SCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--C-
T ss_pred CCCcc---------ccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC--C-
Confidence 33211 12247999999999865 489999999999999999999999976544322 112221110 0
Q ss_pred CCCCCChhhHHHHHHHHHHHhhhccCCCCChHHH
Q 003384 693 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD 726 (824)
Q Consensus 693 ~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~ 726 (824)
. ......+..+.+++.+||..+|.+||++.+.
T Consensus 243 -~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~el 274 (287)
T 2wei_A 243 -L-PQWRTISDDAKDLIRKMLTFHPSLRITATQC 274 (287)
T ss_dssp -S-GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred -c-hhhhhcCHHHHHHHHHHcccChhhCcCHHHH
Confidence 0 0012345689999999999999999999443
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=332.13 Aligned_cols=236 Identities=23% Similarity=0.367 Sum_probs=193.9
Q ss_pred hhhcCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC------CchhHHHHHHHHHhcC--CCceeeEecccC
Q 003384 460 EGATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ------GPSEFQQEIDILSKIR--HPNLVTLVGACP 529 (824)
Q Consensus 460 ~~~~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~------~~~~f~~Ei~iL~~l~--HpnIv~L~g~~~ 529 (824)
....++|...+.||+|+||.||+|... +..||||++...... ....+.+|+.++++++ ||||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 344568999999999999999999874 688999999764332 2346788999999996 599999999984
Q ss_pred --CceEEEEEecCC-CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEec-CCCcceee
Q 003384 530 --EVWTLVYEYLPN-GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD-ANFVSKLS 605 (824)
Q Consensus 530 --~~~~LV~Ey~~g-gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld-~~~~vKL~ 605 (824)
+..++||||+.+ ++|.+++.. ...+++..+..++.|++.||.|||+ ++|+||||||+|||++ .++.+||+
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~kL~ 192 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLI 192 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEEC
T ss_pred cCCcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCEEEe
Confidence 568899999976 899999854 3468999999999999999999999 8999999999999999 78999999
Q ss_pred ccccccccccccccCCCccccccCCCCCCcccCChhhhccCCC-CcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhh
Q 003384 606 DFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL-TPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG 684 (824)
Q Consensus 606 DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~ 684 (824)
|||+++....... ....||+.|+|||++.+..+ +.++|||||||++|+|+||+.||....... .+
T Consensus 193 Dfg~~~~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~----~~ 258 (320)
T 3a99_A 193 DFGSGALLKDTVY----------TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII----RG 258 (320)
T ss_dssp CCTTCEECCSSCB----------CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH----HC
T ss_pred eCccccccccccc----------cCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhh----cc
Confidence 9999987653211 23468999999999987765 678999999999999999999997654321 11
Q ss_pred ccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChH
Q 003384 685 KLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 685 ~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
. ..++...+..+.+|+.+||+.+|.+||++.
T Consensus 259 ~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ 289 (320)
T 3a99_A 259 Q---------VFFRQRVSSECQHLIRWCLALRPSDRPTFE 289 (320)
T ss_dssp C---------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred c---------ccccccCCHHHHHHHHHHccCChhhCcCHH
Confidence 1 112334457899999999999999999994
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-36 Score=327.03 Aligned_cols=245 Identities=25% Similarity=0.333 Sum_probs=189.9
Q ss_pred cCCCCccceeeecCceEEEEEEEC--C-eEEEEEEecCCCCCCchhHHHHHHHHHhcCCCc------eeeEeccc--CCc
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--H-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPN------LVTLVGAC--PEV 531 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~-~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~Hpn------Iv~L~g~~--~~~ 531 (824)
.++|...+.||+|+||.||+|... + ..||||++.... .....+.+|+.+++.++|+| ++.+++++ ...
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 458999999999999999999875 3 689999996432 22356889999999997666 88888877 457
Q ss_pred eEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEe---------------
Q 003384 532 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL--------------- 596 (824)
Q Consensus 532 ~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILl--------------- 596 (824)
.++||||+ +++|.+.+... ...++++..+..++.||+.||.|||+ +||+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecccccccccccccc
Confidence 89999999 66777766433 23469999999999999999999999 899999999999999
Q ss_pred ----cCCCcceeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCC
Q 003384 597 ----DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALG 672 (824)
Q Consensus 597 ----d~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~ 672 (824)
+.++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||+||++||.
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~~-----------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 240 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEHH-----------TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQ 240 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSCC-----------CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccCCCcEEEeecCccccccccc-----------cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCC
Confidence 567899999999997643221 23468999999999999999999999999999999999999997
Q ss_pred CchHHHHHHhhhcccc--------------cc---------------------CC--CCCCCChhhHHHHHHHHHHHhhh
Q 003384 673 ITKEVQYALDTGKLKN--------------LL---------------------DP--LAGDWPFVQAEQLANLAMRCCEM 715 (824)
Q Consensus 673 ~~~~~~~~~~~~~~~~--------------~l---------------------d~--~~~~~p~~~~~~l~~Li~~Cl~~ 715 (824)
................ .. .+ .........+..+.+|+.+||+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 320 (355)
T 2eu9_A 241 THENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEF 320 (355)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred CCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcC
Confidence 6543321111000000 00 00 00011223456899999999999
Q ss_pred ccCCCCChH
Q 003384 716 SRKSRPELG 724 (824)
Q Consensus 716 ~P~~RPt~~ 724 (824)
+|.+||++.
T Consensus 321 dP~~Rpt~~ 329 (355)
T 2eu9_A 321 DPAQRITLA 329 (355)
T ss_dssp STTTSCCHH
T ss_pred ChhhCcCHH
Confidence 999999994
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=342.22 Aligned_cols=249 Identities=24% Similarity=0.318 Sum_probs=180.5
Q ss_pred CCCccceeeecCceEEE-EEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhc-CCCceeeEecccC--CceEEEEEecC
Q 003384 465 NFDPSLKIGEGGYGSIY-KGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTLVYEYLP 540 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vy-kg~~~~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l-~HpnIv~L~g~~~--~~~~LV~Ey~~ 540 (824)
.|...+.||+|+||+|| .+...+..||||++... ..+.+.+|+.+|.++ +||||+++++++. ...++||||+.
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 34556789999999996 45666899999998653 234678999999987 8999999999884 46789999995
Q ss_pred CCChhhhhhccCCCC-C---CCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCC-------------Ccce
Q 003384 541 NGSLEDRLSCKDNSP-P---LSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN-------------FVSK 603 (824)
Q Consensus 541 ggsL~~~L~~~~~~~-~---l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~-------------~~vK 603 (824)
|+|.+++....... . .++..++.|+.||+.||.|||+ ++|+||||||+||||+.+ +.+|
T Consensus 93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 69999996442211 1 1233457899999999999999 899999999999999754 4899
Q ss_pred eeccccccccccccccCCCccccccCCCCCCcccCChhhhcc-------CCCCcchhHHhHHHHHHHHHh-CCCCCCCch
Q 003384 604 LSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-------GELTPKSDVYSFGIILLRLLT-GRPALGITK 675 (824)
Q Consensus 604 L~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-------~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~ 675 (824)
|+|||+++.+......... ......||+.|+|||++.+ ..++.++|||||||++|||+| |++||+...
T Consensus 169 L~DFG~a~~~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 244 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRT----NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244 (434)
T ss_dssp ECCCTTCEECCC------------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred EcccccceecCCCCcccee----eecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence 9999999876543221110 1134569999999999975 578999999999999999999 999997543
Q ss_pred HHHHHHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHH
Q 003384 676 EVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD 726 (824)
Q Consensus 676 ~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~ 726 (824)
.....+..+... ........+...+..+.+|+.+||+.+|.+||++.+.
T Consensus 245 ~~~~~i~~~~~~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ei 293 (434)
T 2rio_A 245 SRESNIIRGIFS--LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV 293 (434)
T ss_dssp THHHHHHHTCCC--CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred hhHHHHhcCCCC--cccccccccccchHHHHHHHHHHhhCChhhCCCHHHH
Confidence 332222222111 1111111234567889999999999999999999543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=330.58 Aligned_cols=244 Identities=23% Similarity=0.342 Sum_probs=167.5
Q ss_pred cCCCCccc-eeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHH-HHHHhcCCCceeeEecccCC------ce
Q 003384 463 THNFDPSL-KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEI-DILSKIRHPNLVTLVGACPE------VW 532 (824)
Q Consensus 463 ~~~f~~~~-~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei-~iL~~l~HpnIv~L~g~~~~------~~ 532 (824)
.++|...+ .||+|+||.||+|.+. +..||||++... ....+|+ ..++.+.||||+++++++.. ..
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 34788854 6999999999999987 689999998642 2333444 44567799999999998732 37
Q ss_pred EEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecC---CCcceeecccc
Q 003384 533 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA---NFVSKLSDFGI 609 (824)
Q Consensus 533 ~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~---~~~vKL~DFGl 609 (824)
++||||++||+|.+++.... ...+++..+..++.|++.||.|||. +||+||||||+|||++. ++.+||+|||+
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEecccc
Confidence 89999999999999996432 3469999999999999999999999 89999999999999976 45699999999
Q ss_pred ccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhh-hcccc
Q 003384 610 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT-GKLKN 688 (824)
Q Consensus 610 a~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~-~~~~~ 688 (824)
++....... ....||+.|+|||++.+..++.++|||||||++|+|+||++||............ .....
T Consensus 178 ~~~~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 247 (336)
T 3fhr_A 178 AKETTQNAL----------QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL 247 (336)
T ss_dssp CEEC--------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------
T ss_pred ceecccccc----------ccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhc
Confidence 986543211 2345899999999998888999999999999999999999999654322110000 00000
Q ss_pred ccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 689 LLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 689 ~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
.............+..+.+|+.+||+.+|.+||++.+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 284 (336)
T 3fhr_A 248 GQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQ 284 (336)
T ss_dssp ---CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred cccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHH
Confidence 0000111112345678999999999999999999943
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=341.37 Aligned_cols=248 Identities=25% Similarity=0.346 Sum_probs=184.4
Q ss_pred hcCCCCccceeeecCceE-EEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhc-CCCceeeEecccC--CceEEEEE
Q 003384 462 ATHNFDPSLKIGEGGYGS-IYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTLVYE 537 (824)
Q Consensus 462 ~~~~f~~~~~LG~G~fG~-Vykg~~~~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l-~HpnIv~L~g~~~--~~~~LV~E 537 (824)
...+|...+.||+|+||+ ||++...+..||||++.... ...+.+|+.+|+.+ +|||||++++++. ...++|||
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 345688899999999998 56777788999999986532 34578999999999 7999999999884 45789999
Q ss_pred ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecC---C--Ccceeeccccccc
Q 003384 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA---N--FVSKLSDFGISRF 612 (824)
Q Consensus 538 y~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~---~--~~vKL~DFGla~~ 612 (824)
|+. |+|.+++.... ..+....+..++.||+.||.|||+ ++|+||||||+||||+. + ..+||+|||+++.
T Consensus 99 ~~~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 99 LCA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp CCS-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred CCC-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 996 59999986443 234444567899999999999999 89999999999999953 2 3577999999987
Q ss_pred cccccccCCCccccccCCCCCCcccCChhhhc---cCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHHHHhhhcccc
Q 003384 613 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA---SGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKN 688 (824)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~---~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~~~~~~~~ 688 (824)
+........ ......||+.|+|||++. ...++.++|||||||++|||+| |.+||+...........+..
T Consensus 173 ~~~~~~~~~-----~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~-- 245 (432)
T 3p23_A 173 LAVGRHSFS-----RRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGAC-- 245 (432)
T ss_dssp C-----------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCC--
T ss_pred ccCCCccee-----eccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccC--
Confidence 654321111 113456999999999997 4567889999999999999999 99999755433222221111
Q ss_pred ccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 003384 689 LLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 727 (824)
Q Consensus 689 ~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 727 (824)
.......+...+..+.+|+.+||+.+|.+||++.+.+
T Consensus 246 --~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl 282 (432)
T 3p23_A 246 --SLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVL 282 (432)
T ss_dssp --CCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred --CccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHH
Confidence 0111112234566789999999999999999995443
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=320.38 Aligned_cols=246 Identities=23% Similarity=0.336 Sum_probs=172.7
Q ss_pred hcCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCC--chhHHHHHHHHHhcCCCceeeEeccc--CCceEEE
Q 003384 462 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLV 535 (824)
Q Consensus 462 ~~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV 535 (824)
...+|...+.||+|+||.||+|.+. +..||||++....... ...+..+..+++.++||||+++++++ .+..++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 3457888999999999999999985 6899999997643221 12244455678888999999999988 3468999
Q ss_pred EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-ceEeccccCCcEEecCCCcceeeccccccccc
Q 003384 536 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH-SIVHGDLKPANILLDANFVSKLSDFGISRFLS 614 (824)
Q Consensus 536 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~-giiHrDLKp~NILld~~~~vKL~DFGla~~~~ 614 (824)
|||+ ++.+..++... ...+++..+..++.+++.||.|||+ + ||+||||||+|||++.++.+||+|||++..+.
T Consensus 103 ~e~~-~~~~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 103 MELM-GTCAEKLKKRM--QGPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp ECCC-SEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred Eecc-CCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 9999 55565555322 3568999999999999999999998 5 89999999999999999999999999997654
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhc-----cCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccc
Q 003384 615 QNEISSNNTTLCCRTDPKGTFAYMDPEFLA-----SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNL 689 (824)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~-----~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ 689 (824)
.... .....||+.|+|||++. ...++.++|||||||++|+|+||+.||............. ....
T Consensus 177 ~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-~~~~ 246 (318)
T 2dyl_A 177 DDKA---------KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKV-LQEE 246 (318)
T ss_dssp -------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH-HHSC
T ss_pred CCcc---------ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHH-hccC
Confidence 3321 12345899999999994 4578899999999999999999999997532211111110 0000
Q ss_pred cCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 690 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 690 ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
.+.. ......+..+.+|+.+||+.+|.+||++.+
T Consensus 247 -~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 280 (318)
T 2dyl_A 247 -PPLL-PGHMGFSGDFQSFVKDCLTKDHRKRPKYNK 280 (318)
T ss_dssp -CCCC-CSSSCCCHHHHHHHHHHTCSCTTTSCCHHH
T ss_pred -CCCC-CccCCCCHHHHHHHHHHccCChhHCcCHHH
Confidence 0111 111234578999999999999999999943
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=352.53 Aligned_cols=237 Identities=25% Similarity=0.305 Sum_probs=191.2
Q ss_pred cCCCCccceeeecCceEEEEEEEC---CeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccCC--c-----
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR---HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACPE--V----- 531 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~---~~~VAvK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~~--~----- 531 (824)
.++|.+.+.||+|+||.||+|.+. +..||||++..... .....+.+|+.+|++++||||++++++|.. .
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 468999999999999999999874 58899999865322 123468899999999999999999998842 2
Q ss_pred eEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccc
Q 003384 532 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR 611 (824)
Q Consensus 532 ~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~ 611 (824)
.||||||++|++|.+++. ..+++..++.|+.||+.||.|||+ +|||||||||+||||+.+ .+||+|||+++
T Consensus 159 ~~lv~E~~~g~~L~~~~~-----~~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKG-----QKLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEECCCCEECC---------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecccch
Confidence 699999999999998773 269999999999999999999999 899999999999999986 89999999998
Q ss_pred ccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccC
Q 003384 612 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD 691 (824)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld 691 (824)
..... ....||+.|+|||++.++. +.++|||||||+||+|++|.+||.... .+
T Consensus 230 ~~~~~------------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~--------------~~ 282 (681)
T 2pzi_A 230 RINSF------------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRY--------------VD 282 (681)
T ss_dssp ETTCC------------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEE--------------CS
T ss_pred hcccC------------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccc--------------cc
Confidence 65432 2345999999999987654 889999999999999999999985321 01
Q ss_pred CCCCCC-ChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHH
Q 003384 692 PLAGDW-PFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 735 (824)
Q Consensus 692 ~~~~~~-p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~ 735 (824)
...... ....+..+.+|+.+||+.+|.+||+..+++...|..+.
T Consensus 283 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 283 GLPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp SCCTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred cccccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 111111 11234679999999999999999988788877776553
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=349.14 Aligned_cols=260 Identities=24% Similarity=0.344 Sum_probs=198.2
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccC--------Cce
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--------EVW 532 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--------~~~ 532 (824)
++|...+.||+|+||.||+|.+. +..||||++..... .....+.+|+.++++++||||+++++++. +..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 57999999999999999999874 58899999875421 12346889999999999999999999863 346
Q ss_pred EEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCc---ceeecccc
Q 003384 533 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV---SKLSDFGI 609 (824)
Q Consensus 533 ~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~---vKL~DFGl 609 (824)
++||||++||+|.+++........+++..+..|+.+++.||.|||+ +||+||||||+|||++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 8999999999999999765555678999999999999999999999 89999999999999997664 89999999
Q ss_pred ccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHH--------
Q 003384 610 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYAL-------- 681 (824)
Q Consensus 610 a~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~-------- 681 (824)
+......... ....||+.|+|||++.+..++.++|||||||++|+|+||+.||..........
T Consensus 171 a~~~~~~~~~---------~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~ 241 (676)
T 3qa8_A 171 AKELDQGELC---------TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSN 241 (676)
T ss_dssp CCBTTSCCCC---------CCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC----
T ss_pred cccccccccc---------ccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccc
Confidence 9876443211 33569999999999999999999999999999999999999996542221100
Q ss_pred hhhccccc---------cCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHH----HHHHHHHHH
Q 003384 682 DTGKLKNL---------LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD----VWRVLEPMR 735 (824)
Q Consensus 682 ~~~~~~~~---------ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~----v~~~Le~l~ 735 (824)
........ ..+.....+...+..+.+|+.+||..+|.+||++.+. ++..+..+.
T Consensus 242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL 308 (676)
T 3qa8_A 242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSIL 308 (676)
T ss_dssp --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHH
T ss_pred hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHH
Confidence 00000000 0011223445578899999999999999999998431 344555444
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-35 Score=314.73 Aligned_cols=227 Identities=17% Similarity=0.124 Sum_probs=178.4
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCC---chhHHHHHHHHHhcCCCceeeEeccc--CCceEEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVY 536 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~---~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~ 536 (824)
++|...+.||+|+||.||+|.+. +..||||++....... ...+.+|+.++..++||||+++++++ .+..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 57999999999999999999987 6899999998754433 25689999999999999999999988 44689999
Q ss_pred EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccc
Q 003384 537 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 616 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 616 (824)
||++|++|.+++.. . ........|+.|++.||.|||+ +||+||||||+||||+.+|.+||+++|
T Consensus 111 e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~~-------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPA-------- 174 (286)
T ss_dssp ECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred EecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEecc--------
Confidence 99999999999832 2 3455788999999999999999 899999999999999999999998544
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCC---
Q 003384 617 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPL--- 693 (824)
Q Consensus 617 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~--- 693 (824)
|++ .++.++|||||||+||+|+||+.||......... . .....+...
T Consensus 175 --------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~-~--~~~~~~~~~~~~ 224 (286)
T 3uqc_A 175 --------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL-A--PAERDTAGQPIE 224 (286)
T ss_dssp --------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCS-E--ECCBCTTSCBCC
T ss_pred --------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhh-H--HHHHHhccCCCC
Confidence 233 3688999999999999999999999754321000 0 000000000
Q ss_pred CCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhhC
Q 003384 694 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC 738 (824)
Q Consensus 694 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~~~ 738 (824)
....+...+..+.+|+.+||+.+|.+| ++ .++++.|+.+....
T Consensus 225 ~~~~~~~~~~~l~~li~~~l~~dP~~R-s~-~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 225 PADIDRDIPFQISAVAARSVQGDGGIR-SA-STLLNLMQQATAVA 267 (286)
T ss_dssp HHHHCTTSCHHHHHHHHHHHCTTSSCC-CH-HHHHHHHHHHHC--
T ss_pred hhhcccCCCHHHHHHHHHHcccCCccC-CH-HHHHHHHHHHhccC
Confidence 001123356789999999999999999 88 78888888876543
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=316.72 Aligned_cols=232 Identities=19% Similarity=0.183 Sum_probs=177.2
Q ss_pred cCCCCccceeeecCceEEEEEEECCeEEEEEEecCCCCC--------CchhHHHHHHHHHhcC---------CCceeeEe
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQ--------GPSEFQQEIDILSKIR---------HPNLVTLV 525 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~~~~VAvK~l~~~~~~--------~~~~f~~Ei~iL~~l~---------HpnIv~L~ 525 (824)
.++|...+.||+|+||.||+|.+++..||||++...... ....+.+|+.+|+.++ |||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred cccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 346888999999999999999999999999999765321 2267899999999986 66665555
Q ss_pred cc-----------------c---------------CCceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHH
Q 003384 526 GA-----------------C---------------PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVL 573 (824)
Q Consensus 526 g~-----------------~---------------~~~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL 573 (824)
+. + ....+|||||+++|++.+.+. ...+++..+..|+.||+.||
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~----~~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR----TKLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT----TTCCCHHHHHHHHHHHHHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH----hcCCCHHHHHHHHHHHHHHH
Confidence 43 3 356899999999997777663 24589999999999999999
Q ss_pred HHHh-hcCCCceEeccccCCcEEecCCC--------------------cceeeccccccccccccccCCCccccccCCCC
Q 003384 574 IFLH-SCKPHSIVHGDLKPANILLDANF--------------------VSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 632 (824)
Q Consensus 574 ~~LH-~~~~~giiHrDLKp~NILld~~~--------------------~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~ 632 (824)
.||| + ++||||||||+||||+.++ .+||+|||+|+..... ...
T Consensus 175 ~~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------------~~~ 238 (336)
T 2vuw_A 175 AVAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------------IVV 238 (336)
T ss_dssp HHHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------------EEE
T ss_pred HHHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------------cEE
Confidence 9999 8 7899999999999999887 9999999999866432 124
Q ss_pred CCcccCChhhhccCCCCcchhHHhHHHH-HHHHHhCCCCCCCchHHHHHHhhhcccc-ccC-CCCCCCChhhHHHHHHHH
Q 003384 633 GTFAYMDPEFLASGELTPKSDVYSFGII-LLRLLTGRPALGITKEVQYALDTGKLKN-LLD-PLAGDWPFVQAEQLANLA 709 (824)
Q Consensus 633 GT~~Y~APE~l~~~~~t~ksDVwSlGvv-L~ELltG~~Pf~~~~~~~~~~~~~~~~~-~ld-~~~~~~p~~~~~~l~~Li 709 (824)
||+.|+|||++.+.. +.++||||||++ .+++++|.+||....+....... .... ... ......+...+..+.+|+
T Consensus 239 gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~s~~~~dli 316 (336)
T 2vuw_A 239 FCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDK-MLKQMTFKTKCNTPAMKQIKRKIQEFH 316 (336)
T ss_dssp CCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHH-HHHTCCCSSCCCSHHHHHHHHHHHHHH
T ss_pred EeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHh-hhhhhccCcccchhhhhhcCHHHHHHH
Confidence 899999999998766 889999998777 77899999999543222211111 0000 000 111112235678899999
Q ss_pred HHHhhhc
Q 003384 710 MRCCEMS 716 (824)
Q Consensus 710 ~~Cl~~~ 716 (824)
.+||+.+
T Consensus 317 ~~~L~~d 323 (336)
T 2vuw_A 317 RTMLNFS 323 (336)
T ss_dssp HHGGGSS
T ss_pred HHHhccC
Confidence 9999965
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=325.04 Aligned_cols=240 Identities=13% Similarity=0.117 Sum_probs=180.5
Q ss_pred HhhhcCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC---CchhHHHHHHHHHhcCC-Ccee----------
Q 003384 459 IEGATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRH-PNLV---------- 522 (824)
Q Consensus 459 i~~~~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~---~~~~f~~Ei~iL~~l~H-pnIv---------- 522 (824)
+...+.+|...+.||+|+||.||+|.+. +..||||++...... ..+.|.+|+.+++.+.| +|..
T Consensus 73 ~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~ 152 (413)
T 3dzo_A 73 LGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIF 152 (413)
T ss_dssp SSSCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCC
T ss_pred CCCCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhccccc
Confidence 3344556888899999999999999987 789999998844322 25679999999999987 3221
Q ss_pred -----eE------eccc-------CCceEEEEEecCCCChhhhhhc----cCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 003384 523 -----TL------VGAC-------PEVWTLVYEYLPNGSLEDRLSC----KDNSPPLSWQTRIRIATELCSVLIFLHSCK 580 (824)
Q Consensus 523 -----~L------~g~~-------~~~~~LV~Ey~~ggsL~~~L~~----~~~~~~l~~~~~~~ia~qia~aL~~LH~~~ 580 (824)
.+ +.++ ....+++|+++ +++|.+++.. .....++++..++.|+.|++.||.|||+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-- 229 (413)
T 3dzo_A 153 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH-- 229 (413)
T ss_dssp CCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH--
T ss_pred chhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh--
Confidence 11 1111 11245666655 6899988842 1234568888999999999999999999
Q ss_pred CCceEeccccCCcEEecCCCcceeeccccccccccccccCCCccccccCCCCCCcccCChhhh----------ccCCCCc
Q 003384 581 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL----------ASGELTP 650 (824)
Q Consensus 581 ~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l----------~~~~~t~ 650 (824)
++||||||||+||||+.++.+||+|||+++..... .....| +.|+|||++ .+..++.
T Consensus 230 -~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~ 296 (413)
T 3dzo_A 230 -YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTF 296 (413)
T ss_dssp -TTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECH
T ss_pred -CCcccCCcccceEEEecCCeEEEEeccceeecCCc-----------cccCCC-CceeCchhhhccccccccccCcCCCc
Confidence 89999999999999999999999999998865432 133457 999999999 4456888
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 651 KSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 651 ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
++|||||||+||||+||+.||...... ......+ ..+ ...+..+.+|+.+||+.+|.+||++.+
T Consensus 297 ~~DvwSlGvil~elltg~~Pf~~~~~~------~~~~~~~----~~~-~~~~~~~~~li~~~l~~dP~~Rpt~~~ 360 (413)
T 3dzo_A 297 AFDTWTLGLAIYWIWCADLPNTDDAAL------GGSEWIF----RSC-KNIPQPVRALLEGFLRYPKEDRLLPLQ 360 (413)
T ss_dssp HHHHHHHHHHHHHHHHSSCCCCTTGGG------SCSGGGG----SSC-CCCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred hhhHHHHHHHHHHHHHCCCCCCCcchh------hhHHHHH----hhc-ccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 999999999999999999999754321 1111111 111 133578999999999999999999743
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=302.18 Aligned_cols=220 Identities=21% Similarity=0.368 Sum_probs=172.2
Q ss_pred CCCCcc-ceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHH-HhcCCCceeeEecccC------CceE
Q 003384 464 HNFDPS-LKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDIL-SKIRHPNLVTLVGACP------EVWT 533 (824)
Q Consensus 464 ~~f~~~-~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL-~~l~HpnIv~L~g~~~------~~~~ 533 (824)
.+|... +.||+|+||.||+|... +..||||++.. ...+.+|+.++ +.++||||+++++++. ...+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 356666 77999999999999885 57899999863 34788999998 5568999999999873 3478
Q ss_pred EEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecC---CCcceeeccccc
Q 003384 534 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA---NFVSKLSDFGIS 610 (824)
Q Consensus 534 LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~---~~~vKL~DFGla 610 (824)
+||||+++|+|.+++.... ...+++..+..++.+++.||.|||+ ++|+||||||+|||++. ++.+||+|||++
T Consensus 92 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEECCCCSCBHHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 9999999999999996532 3469999999999999999999999 89999999999999998 789999999988
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhcccccc
Q 003384 611 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLL 690 (824)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~l 690 (824)
.... +..++.++|||||||++|+|+||++||......... . .....+
T Consensus 168 ~~~~------------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~--~-~~~~~~ 214 (299)
T 3m2w_A 168 KETT------------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS--P-GMKTRI 214 (299)
T ss_dssp EECT------------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC---------C-CSCCSS
T ss_pred cccc------------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh--H-HHHHHH
Confidence 6432 234677999999999999999999999755432211 0 011111
Q ss_pred CCCCCCCC----hhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 691 DPLAGDWP----FVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 691 d~~~~~~p----~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
......++ ...+..+.+|+.+||+.+|.+||++.+
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e 253 (299)
T 3m2w_A 215 RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITE 253 (299)
T ss_dssp CTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred hhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHH
Confidence 11111222 234678999999999999999999943
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-28 Score=289.90 Aligned_cols=181 Identities=20% Similarity=0.156 Sum_probs=123.8
Q ss_pred eeecCceEEEEEE--ECCeEEEEEEecCCCCCC----------chhHHHHHHHHHhc-CCCceeeEecccCC--ceEEEE
Q 003384 472 IGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQG----------PSEFQQEIDILSKI-RHPNLVTLVGACPE--VWTLVY 536 (824)
Q Consensus 472 LG~G~fG~Vykg~--~~~~~VAvK~l~~~~~~~----------~~~f~~Ei~iL~~l-~HpnIv~L~g~~~~--~~~LV~ 536 (824)
++.|++|.+..++ +-+..||+|++....... .++|.+|+++|+++ .|+||+++++++.+ ..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 3455555554432 346789999997653221 24589999999999 69999999999854 689999
Q ss_pred EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccc
Q 003384 537 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 616 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 616 (824)
||++||+|.++|.. ..+++.. +|+.||+.||.|||+ +|||||||||+||||+.+|.+||+|||+|+.....
T Consensus 322 Eyv~G~~L~d~i~~---~~~l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 322 EKLPGRLLSDMLAA---GEEIDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp ECCCSEEHHHHHHT---TCCCCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred ecCCCCcHHHHHHh---CCCCCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 99999999999953 3456654 588999999999999 89999999999999999999999999999876543
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCC
Q 003384 617 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPA 670 (824)
Q Consensus 617 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~P 670 (824)
... .+..+||+.|||||++.+ .+..++|+||+|+++++|.+|..+
T Consensus 393 ~~~--------~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 393 CSW--------PTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp -CC--------SHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred Ccc--------ccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 211 123459999999999865 466789999999999888776544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=5.2e-26 Score=265.72 Aligned_cols=188 Identities=16% Similarity=0.218 Sum_probs=146.3
Q ss_pred CccceeeecCceEEEEEEECCeEEEEEEecCCCCCC--------chhHHHHHHHHHhcCCCcee--eEecccCCceEEEE
Q 003384 467 DPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQG--------PSEFQQEIDILSKIRHPNLV--TLVGACPEVWTLVY 536 (824)
Q Consensus 467 ~~~~~LG~G~fG~Vykg~~~~~~VAvK~l~~~~~~~--------~~~f~~Ei~iL~~l~HpnIv--~L~g~~~~~~~LV~ 536 (824)
...++||+|+||.||+|...+..+++|......... .+.+.+|+.+|++++||||+ .+++...+..+|||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp ---------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 445689999999999998889999999876543322 13478999999999999999 66777677889999
Q ss_pred EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccc
Q 003384 537 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 616 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 616 (824)
||++||+|.+++.. +..|+.|++.||.|||+ ++|+||||||+|||++. .+||+|||+++.....
T Consensus 419 E~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 419 SYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp ECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred ECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 99999999999942 56899999999999999 89999999999999999 9999999999977543
Q ss_pred cccCCCccccccCCCCCCcccCChhhhcc--CCCCcchhHHhHHHHHHHHHhCCCCC
Q 003384 617 EISSNNTTLCCRTDPKGTFAYMDPEFLAS--GELTPKSDVYSFGIILLRLLTGRPAL 671 (824)
Q Consensus 617 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~--~~~t~ksDVwSlGvvL~ELltG~~Pf 671 (824)
....... ........||+.|+|||++.. ..|+..+|+||.++-.++.+.++.+|
T Consensus 483 ~~~~~~~-~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 483 EDKAVDL-IVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHH-HHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccccch-hhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 2211000 000123358999999999987 57888899999999999988887766
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.2e-22 Score=218.08 Aligned_cols=147 Identities=16% Similarity=0.107 Sum_probs=117.0
Q ss_pred hhcCCCCccceeeecCceEEEEEEEC-CeEEEEEEecCCCCC------------------CchhHHHHHHHHHhcCCCce
Q 003384 461 GATHNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQ------------------GPSEFQQEIDILSKIRHPNL 521 (824)
Q Consensus 461 ~~~~~f~~~~~LG~G~fG~Vykg~~~-~~~VAvK~l~~~~~~------------------~~~~f~~Ei~iL~~l~HpnI 521 (824)
.....|...+.||+|+||.||+|.+. +..||||++...... ....+.+|+.+|++++ |
T Consensus 87 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~- 163 (282)
T 1zar_A 87 RSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G- 163 (282)
T ss_dssp HTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-
T ss_pred hCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-
Confidence 34556777799999999999999984 689999999653211 1245889999999999 4
Q ss_pred eeEeccc-CCceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCC
Q 003384 522 VTLVGAC-PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF 600 (824)
Q Consensus 522 v~L~g~~-~~~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~ 600 (824)
+++++++ .+..++||||++||+|.+ +.. .....++.+++.||.|||+ +||+||||||+|||++ ++
T Consensus 164 ~~v~~~~~~~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~NILl~-~~ 229 (282)
T 1zar_A 164 LAVPKVYAWEGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVS-EE 229 (282)
T ss_dssp SSSCCEEEEETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEE-TT
T ss_pred CCcCeEEeccceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHHEEEE-CC
Confidence 5555544 245799999999999998 521 1345799999999999999 8999999999999999 99
Q ss_pred cceeeccccccccccccccCCCccccccCCCCCCcccCChhhhcc
Q 003384 601 VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS 645 (824)
Q Consensus 601 ~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~ 645 (824)
.+||+|||+|+. +..|+|||++..
T Consensus 230 ~vkl~DFG~a~~---------------------~~~~~a~e~l~r 253 (282)
T 1zar_A 230 GIWIIDFPQSVE---------------------VGEEGWREILER 253 (282)
T ss_dssp EEEECCCTTCEE---------------------TTSTTHHHHHHH
T ss_pred cEEEEECCCCeE---------------------CCCCCHHHHHHH
Confidence 999999999862 445789998853
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=3.8e-19 Score=188.05 Aligned_cols=135 Identities=16% Similarity=0.072 Sum_probs=104.2
Q ss_pred CCccceeeecCceEEEEEEE--CCeE--EEEEEecCCCCCC------------------------chhHHHHHHHHHhcC
Q 003384 466 FDPSLKIGEGGYGSIYKGLL--RHMQ--VAIKMLHPHSLQG------------------------PSEFQQEIDILSKIR 517 (824)
Q Consensus 466 f~~~~~LG~G~fG~Vykg~~--~~~~--VAvK~l~~~~~~~------------------------~~~f~~Ei~iL~~l~ 517 (824)
|.....||+|+||.||+|.+ .+.. ||||+++...... ...+.+|+.+|..+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56678899999999999988 6788 9999976532110 025789999999998
Q ss_pred CCce--eeEecccCCceEEEEEecCC-C----ChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHh-hcCCCceEeccc
Q 003384 518 HPNL--VTLVGACPEVWTLVYEYLPN-G----SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH-SCKPHSIVHGDL 589 (824)
Q Consensus 518 HpnI--v~L~g~~~~~~~LV~Ey~~g-g----sL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH-~~~~~giiHrDL 589 (824)
|+|+ ..+++. ...+|||||+.+ | +|.+.... +++.....++.+++.||.||| . .|||||||
T Consensus 129 ~~~i~~p~~~~~--~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~---~givHrDl 197 (258)
T 1zth_A 129 EAGVSVPQPYTY--MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQE---AELVHADL 197 (258)
T ss_dssp HTTCCCCCEEEE--ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHT---SCEECSSC
T ss_pred hCCCCCCeEEEc--CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHH---CCEEeCCC
Confidence 8764 333432 467899999942 4 66665421 223456789999999999999 8 79999999
Q ss_pred cCCcEEecCCCcceeecccccccc
Q 003384 590 KPANILLDANFVSKLSDFGISRFL 613 (824)
Q Consensus 590 Kp~NILld~~~~vKL~DFGla~~~ 613 (824)
||.|||++. .++|+|||+|...
T Consensus 198 kp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 198 SEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp STTSEEESS--SEEECCCTTCEET
T ss_pred CHHHEEEcC--cEEEEECcccccC
Confidence 999999998 9999999998754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.58 E-value=1.1e-15 Score=169.82 Aligned_cols=139 Identities=14% Similarity=0.169 Sum_probs=98.1
Q ss_pred hhcCCCCccceeeecCceEEEEEEEC-CeEEEEEEecCCCC--CC------------chhHHHHHHHHHhcCCCceeeEe
Q 003384 461 GATHNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSL--QG------------PSEFQQEIDILSKIRHPNLVTLV 525 (824)
Q Consensus 461 ~~~~~f~~~~~LG~G~fG~Vykg~~~-~~~VAvK~l~~~~~--~~------------~~~f~~Ei~iL~~l~HpnIv~L~ 525 (824)
....-|.+...||.|+||.||+|... |..||||+++.... .. ......++.+.....|+|+.+++
T Consensus 92 ~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~ 171 (397)
T 4gyi_A 92 ARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALY 171 (397)
T ss_dssp HTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHH
Confidence 33445899999999999999999875 68999999864311 00 11122333333333444544443
Q ss_pred ccc--------CCceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEec
Q 003384 526 GAC--------PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD 597 (824)
Q Consensus 526 g~~--------~~~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld 597 (824)
... ....+|||||++|++|..+.. . .....++.|++.+|.+||. .|||||||||.||||+
T Consensus 172 ~~gv~vp~p~~~~~~~LVME~i~G~~L~~l~~-------~--~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NILl~ 239 (397)
T 4gyi_A 172 EEGFPVPEPIAQSRHTIVMSLVDALPMRQVSS-------V--PDPASLYADLIALILRLAK---HGLIHGDFNEFNILIR 239 (397)
T ss_dssp HTTCSCCCEEEEETTEEEEECCSCEEGGGCCC-------C--SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEE
T ss_pred hcCCCCCeeeeccCceEEEEecCCccHhhhcc-------c--HHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEe
Confidence 321 123469999999999876542 1 1235678999999999999 8999999999999998
Q ss_pred CCC----------cceeecccccc
Q 003384 598 ANF----------VSKLSDFGISR 611 (824)
Q Consensus 598 ~~~----------~vKL~DFGla~ 611 (824)
++| .+.|+||+-+.
T Consensus 240 ~dgd~~d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 240 EEKDAEDPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp EEECSSCTTSEEEEEEECCCTTCE
T ss_pred CCCCcccccccccceEEEEeCCcc
Confidence 876 37899999664
|
| >1wgm_A Ubiquitin conjugation factor E4A; ubiquitinating enzyme, KIAA0126, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: g.44.1.2 | Back alignment and structure |
|---|
Probab=99.51 E-value=2e-14 Score=129.07 Aligned_cols=73 Identities=29% Similarity=0.483 Sum_probs=68.7
Q ss_pred CCCCCCCCcccchhhhccCCccccCC-ccchhhhhhhhhcCCCCCCCCCCCCCCCCCCCchHHHHHHHHHHHHhC
Q 003384 751 RCEPPPYFTCPIFQEVMQDPHVAADG-FTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWLQQH 824 (824)
Q Consensus 751 ~~~~P~~f~cPi~~evm~dPvi~~~g-~tye~~~i~~wl~~~~~t~p~t~~~l~~~~l~pn~~lr~~i~~~~~~~ 824 (824)
...+|++|.|||+.++|.|||++..| ++|++..|..|+.. +.+||+|+.+|...+|+||++||++|++|+.++
T Consensus 16 ~~~~p~~~~CpI~~~~m~dPV~~~cG~htf~r~cI~~~l~~-~~~cP~~~~~l~~~~L~pn~~Lk~~I~~~~~~~ 89 (98)
T 1wgm_A 16 YADACDEFLDPIMSTLMCDPVVLPSSRVTVDRSTIARHLLS-DQTDPFNRSPLTMDQIRPNTELKEKIQRWLAER 89 (98)
T ss_dssp CCSCCTTTBCTTTCSBCSSEEECTTTCCEEEHHHHHHHTTT-SCBCTTTCSBCCTTTSEECHHHHHHHHHHHHHS
T ss_pred hhcCcHhcCCcCccccccCCeECCCCCeEECHHHHHHHHHh-CCCCCCCCCCCChhhceEcHHHHHHHHHHHHHc
Confidence 34679999999999999999999999 99999999999987 679999999999999999999999999999875
|
| >2kre_A Ubiquitin conjugation factor E4 B; U-box domain, E3 ubiquitin ligase, E4 polyubiquitin chain EL factor, phosphoprotein, UBL conjugation pathway; NMR {Homo sapiens} PDB: 3l1x_A 3l1z_B | Back alignment and structure |
|---|
Probab=99.49 E-value=2e-14 Score=129.47 Aligned_cols=73 Identities=23% Similarity=0.430 Sum_probs=68.8
Q ss_pred CCCCCCCCcccchhhhccCCccccCCccchhhhhhhhhcCCCCCCCCCCCCCCCCCCCchHHHHHHHHHHHHhC
Q 003384 751 RCEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWLQQH 824 (824)
Q Consensus 751 ~~~~P~~f~cPi~~evm~dPvi~~~g~tye~~~i~~wl~~~~~t~p~t~~~l~~~~l~pn~~lr~~i~~~~~~~ 824 (824)
...+|++|.|||+.++|.|||++.+|++|++..|..|+.. +.+||+|+.++...+|+||++||++|+.|+.+|
T Consensus 23 ~~~~p~~~~CpI~~~~m~dPV~~~cGhtf~r~~I~~~l~~-~~~cP~~~~~l~~~~L~pn~~Lk~~I~~~~~~~ 95 (100)
T 2kre_A 23 YSDAPDEFRDPLMDTLMTDPVRLPSGTIMDRSIILRHLLN-SPTDPFNRQTLTESMLEPVPELKEQIQAWMREK 95 (100)
T ss_dssp CSSCSTTTBCTTTCSBCSSEEEETTTEEEEHHHHHHHTTS-CSBCSSSCCBCCTTSSEECHHHHHHHHHHHHTT
T ss_pred hccCcHhhCCcCccCcccCCeECCCCCEEchHHHHHHHHc-CCCCCCCCCCCChhhceECHHHHHHHHHHHHHh
Confidence 4467999999999999999999999999999999999985 789999999999999999999999999999875
|
| >2kr4_A Ubiquitin conjugation factor E4 B; U-BOX, UFD2, ring, E3 ligase, UBL conjugation pathway; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=99.49 E-value=1.2e-14 Score=127.13 Aligned_cols=72 Identities=24% Similarity=0.435 Sum_probs=68.0
Q ss_pred CCCCCCCcccchhhhccCCccccCCccchhhhhhhhhcCCCCCCCCCCCCCCCCCCCchHHHHHHHHHHHHhC
Q 003384 752 CEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWLQQH 824 (824)
Q Consensus 752 ~~~P~~f~cPi~~evm~dPvi~~~g~tye~~~i~~wl~~~~~t~p~t~~~l~~~~l~pn~~lr~~i~~~~~~~ 824 (824)
..+|++|.|||+.++|.|||++..|++|++..|..|+.. +.+||+|+.++...+|+||++||++|++|+.+|
T Consensus 9 ~~~p~~~~CpI~~~~m~dPV~~~cGhtf~r~~I~~~l~~-~~~cP~~~~~l~~~~l~pn~~L~~~i~~~~~~~ 80 (85)
T 2kr4_A 9 SDAPDEFRDPLMDTLMTDPVRLPSGTVMDRSIILRHLLN-SPTDPFNRQMLTESMLEPVPELKEQIQAWMREK 80 (85)
T ss_dssp TTCCTTTBCTTTCSBCSSEEECTTSCEEEHHHHHHHHHH-CSBCTTTCCBCCGGGCEECHHHHHHHHHHHHHH
T ss_pred hcCchheECcccCchhcCCeECCCCCEECHHHHHHHHhc-CCCCCCCcCCCChHhcchHHHHHHHHHHHHHHh
Confidence 467999999999999999999999999999999999985 789999999999999999999999999999764
|
| >2f42_A STIP1 homology and U-box containing protein 1; chaperone; 2.50A {Danio rerio} PDB: 2c2v_S 2oxq_C | Back alignment and structure |
|---|
Probab=99.43 E-value=3.6e-14 Score=140.28 Aligned_cols=73 Identities=30% Similarity=0.593 Sum_probs=68.9
Q ss_pred CCCCCCCcccchhhhccCCccccCCccchhhhhhhhhcCCCCCCCCCCCCCCCCCCCchHHHHHHHHHHHHhC
Q 003384 752 CEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWLQQH 824 (824)
Q Consensus 752 ~~~P~~f~cPi~~evm~dPvi~~~g~tye~~~i~~wl~~~~~t~p~t~~~l~~~~l~pn~~lr~~i~~~~~~~ 824 (824)
..+|++|.|||+.++|.|||++++|+||++.+|..|+..++.+||+|+.+|...+|+||++||++|++|+.+|
T Consensus 101 ~~ip~~f~CPI~~elm~DPV~~~~Ghtfer~~I~~~l~~~~~tcP~t~~~l~~~~L~pN~~Lk~~Ie~~~~~~ 173 (179)
T 2f42_A 101 REIPDYLCGKISFELMREPCITPSGITYDRKDIEEHLQRVGHFDPVTRSPLTQDQLIPNLAMKEVIDAFIQEN 173 (179)
T ss_dssp CCCCGGGBCTTTCSBCSSEEECTTSCEEEHHHHHHHHHHTCSBCTTTCCBCCGGGCEECHHHHHHHHHHHHHC
T ss_pred cCCcHhhcccCccccCCCCeECCCCCEECHHHHHHHHHhCCCCCCCCcCCCChhhCcchHHHHHHHHHHHHHC
Confidence 4679999999999999999999999999999999999876668999999999999999999999999999875
|
| >3m62_A Ubiquitin conjugation factor E4; armadillo-like repeats, UBL conjugation pathway, DNA damage, nucleus, phosphoprotein; HET: 1PE; 2.40A {Saccharomyces cerevisiae} PDB: 3m63_A* 2qiz_A 2qj0_A | Back alignment and structure |
|---|
Probab=99.40 E-value=7.1e-14 Score=167.03 Aligned_cols=73 Identities=26% Similarity=0.464 Sum_probs=68.9
Q ss_pred CCCCCCCCcccchhhhccCCccccCC-ccchhhhhhhhhcCCCCCCCCCCCCCCCCCCCchHHHHHHHHHHHHhC
Q 003384 751 RCEPPPYFTCPIFQEVMQDPHVAADG-FTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWLQQH 824 (824)
Q Consensus 751 ~~~~P~~f~cPi~~evm~dPvi~~~g-~tye~~~i~~wl~~~~~t~p~t~~~l~~~~l~pn~~lr~~i~~~~~~~ 824 (824)
..++|++|.|||+.++|.|||++++| +||||++|.+|+.+ +.|||+|+++|.+.+|+||++||++|++||.++
T Consensus 885 ~~~iP~~F~cPIs~~lM~DPVilpsG~~TydR~~I~~wl~~-~~tdP~Tr~~L~~~~liPN~~Lk~~I~~w~~~~ 958 (968)
T 3m62_A 885 YGDVPDEFLDPLMYTIMKDPVILPASKMNIDRSTIKAHLLS-DSTDPFNRMPLKLEDVTPNEELRQKILCFKKQK 958 (968)
T ss_dssp HCCSCGGGBCTTTCSBCSSEEECTTTCCEEEHHHHHHHHTT-CCBCTTTCCBCCGGGCEECHHHHHHHHHHHHHH
T ss_pred ccCCcHHhCCcchhhHHhCCeEcCCCCEEECHHHHHHHHhc-CCCCCCCCCCCCcccccccHHHHHHHHHHHHHH
Confidence 35799999999999999999999998 79999999999988 779999999999999999999999999999864
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.23 E-value=1.7e-11 Score=128.59 Aligned_cols=140 Identities=16% Similarity=0.140 Sum_probs=109.2
Q ss_pred CCCCccceeeecCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhcC-CCceeeEecccC--CceEEEEEecC
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVGACP--EVWTLVYEYLP 540 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~-HpnIv~L~g~~~--~~~~LV~Ey~~ 540 (824)
..|.....+|.|+++.||+....+..+++|+...........+.+|+.+|+.+. +.++.++++++. ...++||||++
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~ 93 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEAD 93 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCS
T ss_pred ccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecC
Confidence 457777778888999999998778899999987532233457999999999995 667778887763 45789999999
Q ss_pred CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC----------------------------------------
Q 003384 541 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK---------------------------------------- 580 (824)
Q Consensus 541 ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~---------------------------------------- 580 (824)
|.+|.+.+. +......++.+++.+|..||...
T Consensus 94 G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (263)
T 3tm0_A 94 GVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK 165 (263)
T ss_dssp SEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSS
T ss_pred CeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCC
Confidence 999987641 11223478889999999999821
Q ss_pred ----------------CCceEeccccCCcEEecCCCcceeecccccc
Q 003384 581 ----------------PHSIVHGDLKPANILLDANFVSKLSDFGISR 611 (824)
Q Consensus 581 ----------------~~giiHrDLKp~NILld~~~~vKL~DFGla~ 611 (824)
+..++|+|++|.|||++.++.+.|+||+.+.
T Consensus 166 ~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred CHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1459999999999999877667799999764
|
| >2yu4_A E3 SUMO-protein ligase NSE2; SP-ring domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.21 E-value=3.9e-12 Score=113.31 Aligned_cols=72 Identities=29% Similarity=0.472 Sum_probs=64.8
Q ss_pred CCCCCCcccchhhhccCCcccc-CCccchhhhhhhhhcCC-----CCCCCCCCCC---CCCCCCCchHHHHHHHHHHHHh
Q 003384 753 EPPPYFTCPIFQEVMQDPHVAA-DGFTYEAEALKGWLDSG-----HETSPMTNLP---LAHKNLVPNLALRSAIQEWLQQ 823 (824)
Q Consensus 753 ~~P~~f~cPi~~evm~dPvi~~-~g~tye~~~i~~wl~~~-----~~t~p~t~~~---l~~~~l~pn~~lr~~i~~~~~~ 823 (824)
..+..|.|||+.++|.|||+++ .|++|++..|..|+..+ ..+||+|+.+ +...+|+||.+||++|++|+.+
T Consensus 3 ~~~~~~~CPI~~~~~~dPV~~~~cGh~f~r~cI~~~l~~~~~~~~~~~CP~tgc~~~~l~~~~L~pn~~L~~~I~~~~~~ 82 (94)
T 2yu4_A 3 SGSSGFTCPITKEEMKKPVKNKVCGHTYEEDAIVRMIESRQKRKKKAYCPQIGCSHTDIRKSDLIQDEALRRAIENHNKK 82 (94)
T ss_dssp SCSSCCBCTTTCSBCSSEEEESSSCCEEEHHHHHHHHHHHHTTTCCBCCCSTTCCCCCBCGGGEEECHHHHHHHHHHHTT
T ss_pred CCCcEeECcCcCchhcCCEEcCCCCCeecHHHHHHHHHHccCcCCCCCCCcCcCcccccCHhhCcCCHHHHHHHHHHHHH
Confidence 3578899999999999999995 99999999999999864 4699998877 8889999999999999999875
Q ss_pred C
Q 003384 824 H 824 (824)
Q Consensus 824 ~ 824 (824)
+
T Consensus 83 ~ 83 (94)
T 2yu4_A 83 R 83 (94)
T ss_dssp C
T ss_pred h
Confidence 3
|
| >2c2l_A CHIP, carboxy terminus of HSP70-interacting protein; chaperone, E3 ligase, ubiquitinylation, TPR, heat-shock protein complex; 3.3A {Mus musculus} SCOP: a.118.8.1 g.44.1.2 | Back alignment and structure |
|---|
Probab=99.18 E-value=9.3e-12 Score=132.50 Aligned_cols=73 Identities=27% Similarity=0.583 Sum_probs=69.4
Q ss_pred CCCCCCCcccchhhhccCCccccCCccchhhhhhhhhcCCCCCCCCCCCCCCCCCCCchHHHHHHHHHHHHhC
Q 003384 752 CEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWLQQH 824 (824)
Q Consensus 752 ~~~P~~f~cPi~~evm~dPvi~~~g~tye~~~i~~wl~~~~~t~p~t~~~l~~~~l~pn~~lr~~i~~~~~~~ 824 (824)
..+|++|.|||+.++|.|||+++.|+||++..|..|+..++.+||+|+.++...+|+||++||++|++|+.+|
T Consensus 203 ~~~~~~~~c~i~~~~~~dPv~~~~gh~f~~~~i~~~~~~~~~~cP~~~~~~~~~~l~~n~~l~~~i~~~~~~~ 275 (281)
T 2c2l_A 203 RDIPDYLCGKISFELMREPCITPSGITYDRKDIEEHLQRVGHFNPVTRSPLTQEQLIPNLAMKEVIDAFISEN 275 (281)
T ss_dssp CCCCSTTBCTTTCSBCSSEEECSSCCEEETTHHHHHHHHTCSSCTTTCCCCCGGGCEECHHHHHHHHHHHTTC
T ss_pred CCCCcccCCcCcCCHhcCCeECCCCCEECHHHHHHHHHHCCCCCcCCCCCCchhcCcccHHHHHHHHHHHHHC
Confidence 4789999999999999999999999999999999999987778999999999999999999999999999875
|
| >2bay_A PRE-mRNA splicing factor PRP19; U-BOX, ubiquitin ligase, E3 ligase; 1.50A {Saccharomyces cerevisiae} SCOP: g.44.1.2 PDB: 1n87_A | Back alignment and structure |
|---|
Probab=99.08 E-value=6.5e-12 Score=102.38 Aligned_cols=56 Identities=21% Similarity=0.392 Sum_probs=51.6
Q ss_pred CCcccchhhhccCCccc-cCCccchhhhhhhhhcCCCCCCCCCCCCCCCCCCCchHHH
Q 003384 757 YFTCPIFQEVMQDPHVA-ADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLAL 813 (824)
Q Consensus 757 ~f~cPi~~evm~dPvi~-~~g~tye~~~i~~wl~~~~~t~p~t~~~l~~~~l~pn~~l 813 (824)
.|.|||+.++|.|||++ .+|++|++.+|.+|+.. +.+||+|+++|.+.+|+||+.-
T Consensus 3 ~~~CpIs~~~m~dPV~~~~sG~~yer~~I~~~l~~-~~~cP~t~~~L~~~~Lip~~~~ 59 (61)
T 2bay_A 3 HMLCAISGKVPRRPVLSPKSRTIFEKSLLEQYVKD-TGNDPITNEPLSIEEIVEIVPS 59 (61)
T ss_dssp -CCCTTTCSCCSSEEEETTTTEEEEHHHHHHHHHH-HSBCTTTCCBCCGGGCEECCCC
T ss_pred eEEecCCCCCCCCCEEeCCCCcEEcHHHHHHHHHh-CCCCcCCcCCCChhhcEECccC
Confidence 58999999999999999 99999999999999987 5689999999999999999753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.07 E-value=4.3e-10 Score=123.81 Aligned_cols=140 Identities=17% Similarity=0.261 Sum_probs=107.3
Q ss_pred cceeeecCceEEEEEEECCeEEEEEEec--CCC-CCCchhHHHHHHHHHhcC--CCceeeEecccCCc-----eEEEEEe
Q 003384 469 SLKIGEGGYGSIYKGLLRHMQVAIKMLH--PHS-LQGPSEFQQEIDILSKIR--HPNLVTLVGACPEV-----WTLVYEY 538 (824)
Q Consensus 469 ~~~LG~G~fG~Vykg~~~~~~VAvK~l~--~~~-~~~~~~f~~Ei~iL~~l~--HpnIv~L~g~~~~~-----~~LV~Ey 538 (824)
...|+.|.++.||+....+..+++|+.. ... ......+.+|+.+++.|. +..+.++++++.+. .++||||
T Consensus 43 ~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~ 122 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF 122 (359)
T ss_dssp EEECCC-CCSCEEEEECSSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred EEEcCCcccceEEEEEECCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence 4568999999999998888889999876 322 122357889999999997 45578888887543 7899999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC--------------------------------------
Q 003384 539 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK-------------------------------------- 580 (824)
Q Consensus 539 ~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~-------------------------------------- 580 (824)
++|..+.+.. ...++...+..++.+++.+|..||...
T Consensus 123 v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (359)
T 3dxp_A 123 VSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM 197 (359)
T ss_dssp CCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred cCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence 9998885432 134677888999999999999999831
Q ss_pred -----------------CCceEeccccCCcEEecCCCc--ceeecccccccc
Q 003384 581 -----------------PHSIVHGDLKPANILLDANFV--SKLSDFGISRFL 613 (824)
Q Consensus 581 -----------------~~giiHrDLKp~NILld~~~~--vKL~DFGla~~~ 613 (824)
+..++|||++|.|||++.++. +.|+||+.+..-
T Consensus 198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 357999999999999997753 689999998753
|
| >1t1h_A Gspef-atpub14, armadillo repeat containing protein; ubiquitin ligase, E3 ligase, U-BOX,; NMR {Arabidopsis thaliana} SCOP: g.44.1.2 | Back alignment and structure |
|---|
Probab=99.04 E-value=1.1e-10 Score=99.88 Aligned_cols=72 Identities=43% Similarity=0.845 Sum_probs=68.8
Q ss_pred CCCCCCcccchhhhccCCccccCCccchhhhhhhhhcCCCCCCCCCCCCCCCCCCCchHHHHHHHHHHHHhC
Q 003384 753 EPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWLQQH 824 (824)
Q Consensus 753 ~~P~~f~cPi~~evm~dPvi~~~g~tye~~~i~~wl~~~~~t~p~t~~~l~~~~l~pn~~lr~~i~~~~~~~ 824 (824)
.+|+.|.|||+.++|.||+++.-|++|.+..|.+|+..++.+||+++.++....|+||.+|+++|++|+.+|
T Consensus 4 ~~~~~~~C~IC~~~~~~Pv~~~CgH~fc~~Ci~~~~~~~~~~CP~C~~~~~~~~l~~n~~l~~~i~~~~~~~ 75 (78)
T 1t1h_A 4 EFPEYFRCPISLELMKDPVIVSTGQTYERSSIQKWLDAGHKTCPKSQETLLHAGLTPNYVLKSLIALWCESN 75 (78)
T ss_dssp CCSSSSSCTTTSCCCSSEEEETTTEEEEHHHHHHHHTTTCCBCTTTCCBCSSCCCEECTTTHHHHHHHHHHS
T ss_pred CCcccCCCCCccccccCCEEcCCCCeecHHHHHHHHHHCcCCCCCCcCCCChhhCccCHHHHHHHHHHHHHc
Confidence 578999999999999999999999999999999999988899999999999999999999999999999875
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.02 E-value=5.4e-10 Score=116.09 Aligned_cols=127 Identities=17% Similarity=0.147 Sum_probs=93.7
Q ss_pred eee-ecCceEEEEEEEC-CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCc--eeeEecccC--CceEEEEEecCCCCh
Q 003384 471 KIG-EGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPN--LVTLVGACP--EVWTLVYEYLPNGSL 544 (824)
Q Consensus 471 ~LG-~G~fG~Vykg~~~-~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~Hpn--Iv~L~g~~~--~~~~LV~Ey~~ggsL 544 (824)
.++ .|..+.||+.... +..+++|+.... ....+.+|+.+++.+.+.+ +.++++++. +..++||||++|.+|
T Consensus 26 ~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l 102 (264)
T 1nd4_A 26 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 102 (264)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred ecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCccc
Confidence 344 5556999998765 467999997654 2356899999999996544 455777663 357899999999888
Q ss_pred hhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC--------------------------------------------
Q 003384 545 EDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK-------------------------------------------- 580 (824)
Q Consensus 545 ~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~-------------------------------------------- 580 (824)
. +. . .+ ...++.+++..|..||...
T Consensus 103 ~--~~---~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (264)
T 1nd4_A 103 L--SS---H---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 171 (264)
T ss_dssp T--TS---C---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred C--cC---c---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHH
Confidence 4 31 1 11 2356778888888888743
Q ss_pred -----------CCceEeccccCCcEEecCCCcceeecccccc
Q 003384 581 -----------PHSIVHGDLKPANILLDANFVSKLSDFGISR 611 (824)
Q Consensus 581 -----------~~giiHrDLKp~NILld~~~~vKL~DFGla~ 611 (824)
+..++|+|++|.|||++.++.+.|+|||.+.
T Consensus 172 ~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 172 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1239999999999999887777899999765
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.86 E-value=1.1e-09 Score=117.72 Aligned_cols=181 Identities=21% Similarity=0.223 Sum_probs=121.5
Q ss_pred cceeeecCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhcC-CCc--eeeEecccC--C---ceEEEEEecC
Q 003384 469 SLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HPN--LVTLVGACP--E---VWTLVYEYLP 540 (824)
Q Consensus 469 ~~~LG~G~fG~Vykg~~~~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~-Hpn--Iv~L~g~~~--~---~~~LV~Ey~~ 540 (824)
...++.|.+..||+.. ..+++|+.... .....+.+|..+|+.+. +.. +.++++.+. + ..|+||+|++
T Consensus 25 i~~~~~G~~n~v~~v~---~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN---RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CCEEEECSSEEEEEST---TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred eEecCCCCcceEEEEC---CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 3458999999999753 56889986432 22356889999998883 322 334444432 2 2478999999
Q ss_pred CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC----------------------------------------
Q 003384 541 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK---------------------------------------- 580 (824)
Q Consensus 541 ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~---------------------------------------- 580 (824)
|.+|.+... ..++...+..++.+++..|..||...
T Consensus 100 G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 100 GVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred CeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 988875432 23667778888889999998888621
Q ss_pred ---------------CCceEeccccCCcEEecC--CCcceeeccccccccccccccCCCccccccCCCCCCccc---CCh
Q 003384 581 ---------------PHSIVHGDLKPANILLDA--NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY---MDP 640 (824)
Q Consensus 581 ---------------~~giiHrDLKp~NILld~--~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y---~AP 640 (824)
+..++|+|++|.|||++. ++.+.|+||+.+........... ...+ ..|
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~------------~~~~~~~~~~ 242 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFIS------------LMEDDEEYGM 242 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHT------------TCCTTTSCCH
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHH------------HHhhccccCH
Confidence 135899999999999998 56788999998875432111000 1111 233
Q ss_pred hhhcc-----CCCC---------cchhHHhHHHHHHHHHhCCCCC
Q 003384 641 EFLAS-----GELT---------PKSDVYSFGIILLRLLTGRPAL 671 (824)
Q Consensus 641 E~l~~-----~~~t---------~ksDVwSlGvvL~ELltG~~Pf 671 (824)
+.... +..+ ...+.|++|.++|.+.+|.++|
T Consensus 243 ~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 243 EFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 32211 1111 1368999999999999998776
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.30 E-value=2.5e-06 Score=91.85 Aligned_cols=134 Identities=20% Similarity=0.215 Sum_probs=92.3
Q ss_pred cceeeecCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhcCCC---ceeeEeccc---CCceEEEEEecCCC
Q 003384 469 SLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHP---NLVTLVGAC---PEVWTLVYEYLPNG 542 (824)
Q Consensus 469 ~~~LG~G~fG~Vykg~~~~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~Hp---nIv~L~g~~---~~~~~LV~Ey~~gg 542 (824)
...++.|....||+. +..+++|+... ......+.+|..+|..|.+. .+.+.+.++ ....++||||++|.
T Consensus 24 v~~l~~G~~n~v~~v---g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 24 VESLGEGFRNYAILV---NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEEECSSEEEEEE---TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eeecCCCcceeEEEE---CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 345888888999987 67788898532 11235688999999999642 244445444 23467999999998
Q ss_pred ChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhc-------------------------------------------
Q 003384 543 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC------------------------------------------- 579 (824)
Q Consensus 543 sL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~------------------------------------------- 579 (824)
+|.+... ..++...+..++.+++..|..||..
T Consensus 99 ~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 99 ILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp ECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred ECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 8876321 1234455566666666666666642
Q ss_pred --------------CCCceEeccccCCcEEecC---CCc-ceeeccccccc
Q 003384 580 --------------KPHSIVHGDLKPANILLDA---NFV-SKLSDFGISRF 612 (824)
Q Consensus 580 --------------~~~giiHrDLKp~NILld~---~~~-vKL~DFGla~~ 612 (824)
.+..++|+|+.|.|||++. ++. +.|+||+.+..
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2235799999999999987 344 58999997653
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.28 E-value=2e-06 Score=94.15 Aligned_cols=77 Identities=5% Similarity=0.027 Sum_probs=54.5
Q ss_pred cee-eecCceEEEEEEEC--------CeEEEEEEecCCC---CCCchhHHHHHHHHHhcC-C--CceeeEecccCC----
Q 003384 470 LKI-GEGGYGSIYKGLLR--------HMQVAIKMLHPHS---LQGPSEFQQEIDILSKIR-H--PNLVTLVGACPE---- 530 (824)
Q Consensus 470 ~~L-G~G~fG~Vykg~~~--------~~~VAvK~l~~~~---~~~~~~f~~Ei~iL~~l~-H--pnIv~L~g~~~~---- 530 (824)
+.| +.|....+|+.... +..+++|+..... ......+.+|+.+|+.|. + -.+.++++++.+
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 457 78888999987765 6678999865432 112356889999998884 2 346677776643
Q ss_pred -ceEEEEEecCCCChhh
Q 003384 531 -VWTLVYEYLPNGSLED 546 (824)
Q Consensus 531 -~~~LV~Ey~~ggsL~~ 546 (824)
..++||||++|.++.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 3579999999877654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.12 E-value=7.3e-06 Score=91.19 Aligned_cols=74 Identities=18% Similarity=0.132 Sum_probs=52.2
Q ss_pred cceeeecCceEEEEEEE--CCeEEEEEEecCCCC-------CCchhHHHHHHHHHhcCC--C-ceeeEecccCCceEEEE
Q 003384 469 SLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSL-------QGPSEFQQEIDILSKIRH--P-NLVTLVGACPEVWTLVY 536 (824)
Q Consensus 469 ~~~LG~G~fG~Vykg~~--~~~~VAvK~l~~~~~-------~~~~~f~~Ei~iL~~l~H--p-nIv~L~g~~~~~~~LV~ 536 (824)
...||.|.++.||++.. .+..|+||...+... .....+..|.++|..+.. | .+.+++.+..+..++||
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d~~~~~lvm 114 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTEMAVTVM 114 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETTTTEEEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEcCCccEEEE
Confidence 45699999999999964 357899998654211 223567889999988742 3 34466666666778999
Q ss_pred EecCCC
Q 003384 537 EYLPNG 542 (824)
Q Consensus 537 Ey~~gg 542 (824)
||++|.
T Consensus 115 E~l~g~ 120 (397)
T 2olc_A 115 EDLSHL 120 (397)
T ss_dssp CCCTTS
T ss_pred EeCCCc
Confidence 999874
|
| >3s3t_A Nucleotide-binding protein, universal stress PROT family; structural genomics, PSI-biology, midwest center for structu genomics, MCSG; HET: ATP; 1.90A {Lactobacillus plantarum} SCOP: c.26.2.0 | Back alignment and structure |
|---|
Probab=98.06 E-value=1.1e-05 Score=76.04 Aligned_cols=89 Identities=13% Similarity=0.150 Sum_probs=72.8
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHhhcCe-eeEEEEeecCchHHHHHH-HHHHcCCCEEEeccCcCccchhhhcccchhh
Q 003384 38 KVQAYREIERQDMHNHLDMCLLICRQMGV-RAEKLDTESESTEKGILE-LISHYGIRKLVMGAAADKHYKKKMMDLKSKK 115 (824)
Q Consensus 38 ~v~~~~~~e~~~~~~~l~~~~~~C~~~~V-~~~~~~ie~~dv~~~i~e-~i~~~~i~~LV~Ga~~~~~~~~~~~~~~s~~ 115 (824)
....+.+..++..++.|+.+...|...|| +++..+.+ ++++++|++ ++.+++++.+|||++..+...+ -+-...
T Consensus 55 ~~~~~~~~~~~~~~~~l~~~~~~~~~~g~~~~~~~~~~-g~~~~~I~~~~a~~~~~dliV~G~~~~~~~~~---~~~Gs~ 130 (146)
T 3s3t_A 55 VLSELLDAEAAHAKDAMRQRQQFVATTSAPNLKTEISY-GIPKHTIEDYAKQHPEIDLIVLGATGTNSPHR---VAVGST 130 (146)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHTTSSCCCCEEEEEE-ECHHHHHHHHHHHSTTCCEEEEESCCSSCTTT---CSSCHH
T ss_pred ccHHHHHHHHHHHHHHHHHHHHHHHhcCCcceEEEEec-CChHHHHHHHHHhhcCCCEEEECCCCCCCcce---EEEcch
Confidence 33556677788889999999999999999 99988877 689999999 9999999999999994433332 233446
Q ss_pred HHhhhccCCCccEEEEE
Q 003384 116 AISVRQQAPASCHIWFI 132 (824)
Q Consensus 116 a~~v~~~a~~~C~v~~i 132 (824)
+..|+.+++ |.|++|
T Consensus 131 ~~~vl~~~~--~pVlvV 145 (146)
T 3s3t_A 131 TSYVVDHAP--CNVIVI 145 (146)
T ss_dssp HHHHHHHCS--SEEEEE
T ss_pred HHHHhccCC--CCEEEe
Confidence 779999987 999987
|
| >3htk_C E3 SUMO-protein ligase MMS21; SUMO E3 ligase, SPL-ring, ring, ATP-binding, chromosomal protein, coiled coil, DNA damage; 2.31A {Saccharomyces cerevisiae} | Back alignment and structure |
|---|
Probab=98.03 E-value=1.5e-06 Score=89.98 Aligned_cols=70 Identities=11% Similarity=0.254 Sum_probs=62.3
Q ss_pred CCCCCcccchhhhccCCccc-cCCccchhhhhhhhhcC-CCCCCCC--CCCCCCCCCCCchHHHHHHHHHHHHh
Q 003384 754 PPPYFTCPIFQEVMQDPHVA-ADGFTYEAEALKGWLDS-GHETSPM--TNLPLAHKNLVPNLALRSAIQEWLQQ 823 (824)
Q Consensus 754 ~P~~f~cPi~~evm~dPvi~-~~g~tye~~~i~~wl~~-~~~t~p~--t~~~l~~~~l~pn~~lr~~i~~~~~~ 823 (824)
....|.|||+.++|.|||+. .-|++|++.+|..|+.. +..+||+ ++.++...+|+||.+|+..|+.|..+
T Consensus 178 ~~~el~CPIcl~~f~DPVts~~CGHsFcR~cI~~~~~~~~~~~CPvtGCr~~l~~~dL~pN~~L~~lve~~k~r 251 (267)
T 3htk_C 178 GKIELTCPITCKPYEAPLISRKCNHVFDRDGIQNYLQGYTTRDCPQAACSQVVSMRDFVRDPIMELRCKIAKMK 251 (267)
T ss_dssp SBCCSBCTTTSSBCSSEEEESSSCCEEEHHHHHHHSTTCSCEECSGGGCSCEECGGGEEECHHHHHHHHHHHHH
T ss_pred CceeeECcCccCcccCCeeeCCCCCcccHHHHHHHHHhCCCCCCCcccccCcCchhhCCcCHHHHHHHHHHHHH
Confidence 46778999999999999985 88999999999999986 3468999 55999999999999999999999763
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.97 E-value=1.9e-05 Score=85.11 Aligned_cols=138 Identities=14% Similarity=0.109 Sum_probs=81.6
Q ss_pred ceeeecCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhcCC--CceeeEecc--------cCCceEEEEEec
Q 003384 470 LKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRH--PNLVTLVGA--------CPEVWTLVYEYL 539 (824)
Q Consensus 470 ~~LG~G~fG~Vykg~~~~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~H--pnIv~L~g~--------~~~~~~LV~Ey~ 539 (824)
..|+.|..+.||+....+..+++|+... ....+..|+.++..|.. -.+.+++.. ..+..++||+|+
T Consensus 38 ~~l~gG~~n~~~~v~~~~~~~vlk~~~~----~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i 113 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSGAVCLKRIHR----PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI 113 (346)
T ss_dssp EECC----CEEEEEEETTEEEEEEEECS----CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred eeccccccCcEEEEEeCCCCEEEEecCC----CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence 3566677899999888777799999875 23455667777766631 123333321 234578999999
Q ss_pred CCCChh-----------h---hhhcc-C-C--C-------CCCCHHHHH-------------------------------
Q 003384 540 PNGSLE-----------D---RLSCK-D-N--S-------PPLSWQTRI------------------------------- 563 (824)
Q Consensus 540 ~ggsL~-----------~---~L~~~-~-~--~-------~~l~~~~~~------------------------------- 563 (824)
+|.++. . .|+.. . - . ..-.|...+
T Consensus 114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 193 (346)
T 2q83_A 114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID 193 (346)
T ss_dssp CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence 987552 0 11111 0 0 0 011232110
Q ss_pred HHHHHHHHHHHHHhh----------cCCCceEeccccCCcEEecCCCcceeecccccc
Q 003384 564 RIATELCSVLIFLHS----------CKPHSIVHGDLKPANILLDANFVSKLSDFGISR 611 (824)
Q Consensus 564 ~ia~qia~aL~~LH~----------~~~~giiHrDLKp~NILld~~~~vKL~DFGla~ 611 (824)
.+...+..++.+|+. ..+..++|+|+.+.|||++.++.+.|+||+.+.
T Consensus 194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 011123345666653 134789999999999999888889999999764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.96 E-value=1.3e-05 Score=83.86 Aligned_cols=131 Identities=20% Similarity=0.178 Sum_probs=90.1
Q ss_pred eeeecCce-EEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcC-CCceeeEeccc--CCceEEEEEecCCCCh
Q 003384 471 KIGEGGYG-SIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVGAC--PEVWTLVYEYLPNGSL 544 (824)
Q Consensus 471 ~LG~G~fG-~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~-HpnIv~L~g~~--~~~~~LV~Ey~~ggsL 544 (824)
.+..|..| .||+.... +..+.+|+-... ....+.+|..+|+.|. +--+.++++++ .+..++|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 45556555 68986554 457899986532 2346889999999885 22255666665 4567899999999888
Q ss_pred hhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC--------------------------------------------
Q 003384 545 EDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK-------------------------------------------- 580 (824)
Q Consensus 545 ~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~-------------------------------------------- 580 (824)
.+..... ......++.+++..|..||...
T Consensus 108 ~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 108 FQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred cccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 7655211 1233455666666777776421
Q ss_pred -----------CCceEeccccCCcEEecCCCcceeecccccc
Q 003384 581 -----------PHSIVHGDLKPANILLDANFVSKLSDFGISR 611 (824)
Q Consensus 581 -----------~~giiHrDLKp~NILld~~~~vKL~DFGla~ 611 (824)
+..++|+|+.+.|||++.++.+-|+||+.+.
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1137999999999999988777899999765
|
| >3ztg_A E3 ubiquitin-protein ligase RBBP6; PACT, U-BOX, mRNA processing, mRNA splicing; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.94 E-value=8.9e-06 Score=71.35 Aligned_cols=71 Identities=24% Similarity=0.352 Sum_probs=63.7
Q ss_pred CCCCCCcccchhhhccCCcccc-CCccchhhhhhhhhcC-CCCCCCCCCCCC-CCCCCCchHHHHHHHHHHHHh
Q 003384 753 EPPPYFTCPIFQEVMQDPHVAA-DGFTYEAEALKGWLDS-GHETSPMTNLPL-AHKNLVPNLALRSAIQEWLQQ 823 (824)
Q Consensus 753 ~~P~~f~cPi~~evm~dPvi~~-~g~tye~~~i~~wl~~-~~~t~p~t~~~l-~~~~l~pn~~lr~~i~~~~~~ 823 (824)
..++.+.|||+.+++.||+++. =|++|-...|..|+.. ++.+||+.+.++ ....+.||..|+++|+.|...
T Consensus 9 ~~~~~~~C~IC~~~~~~p~~~~~CgH~fC~~Ci~~~~~~~~~~~CP~Cr~~~~~~~~~~~n~~l~~~i~~~~~~ 82 (92)
T 3ztg_A 9 PIPDELLCLICKDIMTDAVVIPCCGNSYCDECIRTALLESDEHTCPTCHQNDVSPDALIANKFLRQAVNNFKNE 82 (92)
T ss_dssp CCCTTTEETTTTEECSSCEECTTTCCEECHHHHHHHHHHCTTCCCTTTCCSSCCTTSCEECHHHHHHHHHHHHH
T ss_pred cCCcCCCCCCCChhhcCceECCCCCCHHHHHHHHHHHHhcCCCcCcCCCCcCCCccccCcCHHHHHHHHHHHHH
Confidence 5678999999999999999998 5999999999999964 457999999997 567999999999999999864
|
| >3idf_A USP-like protein; universal, stress, PSI, MCSG, structural genomics, midwest center for structural genomics structure initiative; 2.00A {Wolinella succinogenes} | Back alignment and structure |
|---|
Probab=97.83 E-value=3.6e-05 Score=71.79 Aligned_cols=82 Identities=12% Similarity=0.125 Sum_probs=66.0
Q ss_pred HHHHHH-HHHHHHHHHHHHHHhhcCeeeEEEEeecCchHHHHHHHHHHcCCCEEEeccCcCccchhhhcccchhhHHhhh
Q 003384 42 YREIER-QDMHNHLDMCLLICRQMGVRAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVR 120 (824)
Q Consensus 42 ~~~~e~-~~~~~~l~~~~~~C~~~~V~~~~~~ie~~dv~~~i~e~i~~~~i~~LV~Ga~~~~~~~~~~~~~~s~~a~~v~ 120 (824)
+.+..+ +..++.|+++...|...|++++..+.+ ++++++|++++. +++.+|||++..+.. .+-+ ...+..|+
T Consensus 55 ~~~~~~~~~~~~~l~~~~~~~~~~g~~~~~~v~~-g~~~~~I~~~a~--~~dliV~G~~~~~~~---~~~~-Gs~~~~vl 127 (138)
T 3idf_A 55 EIEMKEEEKAKLLTQKFSTFFTEKGINPFVVIKE-GEPVEMVLEEAK--DYNLLIIGSSENSFL---NKIF-ASHQDDFI 127 (138)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHTTTCCCEEEEEE-SCHHHHHHHHHT--TCSEEEEECCTTSTT---SSCC-CCTTCHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHCCCCeEEEEec-CChHHHHHHHHh--cCCEEEEeCCCcchH---HHHh-CcHHHHHH
Confidence 344445 788999999999999999999988877 789999999999 999999999943333 2223 44566899
Q ss_pred ccCCCccEEEEE
Q 003384 121 QQAPASCHIWFI 132 (824)
Q Consensus 121 ~~a~~~C~v~~i 132 (824)
.+++ |-|++|
T Consensus 128 ~~~~--~pVlvv 137 (138)
T 3idf_A 128 QKAP--IPVLIV 137 (138)
T ss_dssp HHCS--SCEEEE
T ss_pred hcCC--CCEEEe
Confidence 9987 999987
|
| >1mjh_A Protein (ATP-binding domain of protein MJ0577); hypothetical protein, structural genomics, functional assignment; HET: ATP; 1.70A {Methanocaldococcus jannaschii} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=97.83 E-value=9.2e-05 Score=71.10 Aligned_cols=89 Identities=10% Similarity=0.175 Sum_probs=72.5
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHhhcCeeeEEEEeecCchHHHHHHHHHHcCCCEEEeccCcCccchhhhcccchhhHHh
Q 003384 39 VQAYREIERQDMHNHLDMCLLICRQMGVRAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAIS 118 (824)
Q Consensus 39 v~~~~~~e~~~~~~~l~~~~~~C~~~~V~~~~~~ie~~dv~~~i~e~i~~~~i~~LV~Ga~~~~~~~~~~~~~~s~~a~~ 118 (824)
...+.+..++..++.|+.+...|...||+++..+.+ ++++++|++++.+++++.+|||++......+ -+-+..+..
T Consensus 70 ~~~~~~~~~~~~~~~l~~~~~~~~~~g~~~~~~v~~-G~~~~~I~~~a~~~~~dlIV~G~~g~~~~~~---~~~GSv~~~ 145 (162)
T 1mjh_A 70 ENELKNKLTEEAKNKMENIKKELEDVGFKVKDIIVV-GIPHEEIVKIAEDEGVDIIIMGSHGKTNLKE---ILLGSVTEN 145 (162)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHTTCEEEEEEEE-ECHHHHHHHHHHHTTCSEEEEESCCSSCCTT---CSSCHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHcCCceEEEEcC-CCHHHHHHHHHHHcCCCEEEEcCCCCCCccc---eEecchHHH
Confidence 445667777888999999999999999999988766 8999999999999999999999994433322 233446778
Q ss_pred hhccCCCccEEEEEe
Q 003384 119 VRQQAPASCHIWFIC 133 (824)
Q Consensus 119 v~~~a~~~C~v~~i~ 133 (824)
|+.+++ |.|.+|-
T Consensus 146 vl~~~~--~pVlvv~ 158 (162)
T 1mjh_A 146 VIKKSN--KPVLVVK 158 (162)
T ss_dssp HHHHCC--SCEEEEC
T ss_pred HHHhCC--CCEEEEe
Confidence 999975 9999984
|
| >2gm3_A Unknown protein; AT3G01520, putative ethylene-responsive protein, USP domain, nucleotide binding domain, AMP; HET: MSE AMP; 2.46A {Arabidopsis thaliana} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=97.82 E-value=5.7e-05 Score=73.74 Aligned_cols=94 Identities=16% Similarity=0.217 Sum_probs=72.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHHHHHHHhhcCeeeEEEEeecCchHHHHHHHHHHcCCCEEEeccCcCccchhhhcccch
Q 003384 34 LEEEKVQAYREIERQDMHNHLDMCLLICRQMGVRAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKS 113 (824)
Q Consensus 34 ~~~e~v~~~~~~e~~~~~~~l~~~~~~C~~~~V~~~~~~ie~~dv~~~i~e~i~~~~i~~LV~Ga~~~~~~~~~~~~~~s 113 (824)
..++.+..+.++.++..++.|+.+...|...+|.++..+.+ ++++++|++++.+++++.+|||++..+...+. +-.
T Consensus 69 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~g~~~~~~v~~-G~~~~~I~~~a~~~~~DLIVmG~~g~~~~~~~---~~G 144 (175)
T 2gm3_A 69 ASPEDFRDMRQSNKAKGLHLLEFFVNKCHEIGVGCEAWIKT-GDPKDVICQEVKRVRPDFLVVGSRGLGRFQKV---FVG 144 (175)
T ss_dssp CSHHHHHHHTTSHHHHHHHHHHHHHHHHHHHTCEEEEEEEE-SCHHHHHHHHHHHHCCSEEEEEECCCC-----------
T ss_pred CCHHHHHHHHHHHHHHHHHHHHHHHHHHHHCCCceEEEEec-CCHHHHHHHHHHHhCCCEEEEeCCCCChhhhh---hcC
Confidence 34555666666667778889999999999999999887776 79999999999999999999999944333332 223
Q ss_pred hhHHhhhccCCCccEEEEEe
Q 003384 114 KKAISVRQQAPASCHIWFIC 133 (824)
Q Consensus 114 ~~a~~v~~~a~~~C~v~~i~ 133 (824)
..|..|+.+++ |.|++|.
T Consensus 145 sva~~vl~~a~--~pVlvv~ 162 (175)
T 2gm3_A 145 TVSAFCVKHAE--CPVMTIK 162 (175)
T ss_dssp CHHHHHHHHCS--SCEEEEE
T ss_pred chHHHHHhCCC--CCEEEEc
Confidence 46779999987 9999984
|
| >3fg9_A Protein of universal stress protein USPA family; APC60691, nucleotide- binding, lactobacillus plantarum WCFS1, structural genomics PSI-2; 1.47A {Lactobacillus plantarum} | Back alignment and structure |
|---|
Probab=97.78 E-value=0.0001 Score=70.44 Aligned_cols=86 Identities=20% Similarity=0.264 Sum_probs=70.4
Q ss_pred HHHHHHHHHHHHHHHHHHHHHhhcCee-eEEEEeecCchHHHHHHH-HHHcCCCEEEeccCcCccchhhhcccchhhHHh
Q 003384 41 AYREIERQDMHNHLDMCLLICRQMGVR-AEKLDTESESTEKGILEL-ISHYGIRKLVMGAAADKHYKKKMMDLKSKKAIS 118 (824)
Q Consensus 41 ~~~~~e~~~~~~~l~~~~~~C~~~~V~-~~~~~ie~~dv~~~i~e~-i~~~~i~~LV~Ga~~~~~~~~~~~~~~s~~a~~ 118 (824)
.+.+..++..++.|+.+...+...||+ ++..+.++++++++|+++ +..++++.+|||++..+... + +-+..+..
T Consensus 68 ~~~~~~~~~~~~~l~~~~~~~~~~g~~~~~~~v~~~g~~~~~I~~~~a~~~~~DlIV~G~~g~~~~~---~-~~Gs~~~~ 143 (156)
T 3fg9_A 68 SKIQAKRKHVEDVVAEYVQLAEQRGVNQVEPLVYEGGDVDDVILEQVIPEFKPDLLVTGADTEFPHS---K-IAGAIGPR 143 (156)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHTCSSEEEEEEECSCHHHHHHHTHHHHHCCSEEEEETTCCCTTS---S-SCSCHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHcCCCceEEEEEeCCCHHHHHHHHHHHhcCCCEEEECCCCCCccc---e-eecchHHH
Confidence 355667778899999999999999994 888887779999999999 99999999999999544443 2 33346778
Q ss_pred hhccCCCccEEEEE
Q 003384 119 VRQQAPASCHIWFI 132 (824)
Q Consensus 119 v~~~a~~~C~v~~i 132 (824)
|+.+++ |-|.+|
T Consensus 144 vl~~a~--~PVlvV 155 (156)
T 3fg9_A 144 LARKAP--ISVIVV 155 (156)
T ss_dssp HHHHCS--SEEEEE
T ss_pred HHHhCC--CCEEEe
Confidence 999987 999987
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.78 E-value=5.8e-05 Score=84.71 Aligned_cols=73 Identities=15% Similarity=0.109 Sum_probs=47.2
Q ss_pred cceeeecCceEEEEEEECCeEEEEEEecCCCC----C---CchhHHHHHHHHHhc---CCCceeeEecccCCceEEEEEe
Q 003384 469 SLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSL----Q---GPSEFQQEIDILSKI---RHPNLVTLVGACPEVWTLVYEY 538 (824)
Q Consensus 469 ~~~LG~G~fG~Vykg~~~~~~VAvK~l~~~~~----~---~~~~f~~Ei~iL~~l---~HpnIv~L~g~~~~~~~LV~Ey 538 (824)
...||.|..+.||+....+..++||...+... . .......|.+++..+ ....+.+++++..+..++||||
T Consensus 39 i~~l~~G~~n~vyrv~~~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~~~~~~lv~e~ 118 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVGSSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFDRTMALIGMRY 118 (420)
T ss_dssp EEECCCSSSCEEEEEECSSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEETTTTEEEECC
T ss_pred EEEccCCCcEEEEEEEcCCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEECCCccEEEEee
Confidence 45689999999999977677899995432111 1 112333344444333 2345667777767778999999
Q ss_pred c-CC
Q 003384 539 L-PN 541 (824)
Q Consensus 539 ~-~g 541 (824)
+ +|
T Consensus 119 l~~g 122 (420)
T 2pyw_A 119 LEPP 122 (420)
T ss_dssp CCTT
T ss_pred cCCc
Confidence 9 77
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00019 Score=76.92 Aligned_cols=140 Identities=14% Similarity=0.171 Sum_probs=82.1
Q ss_pred ceeeecCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCc--eeeEecc--------cCCceEEEEEec
Q 003384 470 LKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPN--LVTLVGA--------CPEVWTLVYEYL 539 (824)
Q Consensus 470 ~~LG~G~fG~Vykg~~~~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~Hpn--Iv~L~g~--------~~~~~~LV~Ey~ 539 (824)
+.|+.|....+|+....+..+++|+.... .....+..|+.++..|...+ +.+++.. ..+..++||+|+
T Consensus 28 ~~i~~G~~n~~~~v~~~~g~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l 105 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKDPLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL 105 (322)
T ss_dssp EEECC---EEEEEEEESSCCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred eccCCCcccceEEEEeCCccEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeC
Confidence 45677888899998877678999998753 23456778898888774212 2333322 124467899999
Q ss_pred CCCChhh--------------hhhcc--C-CCC---CC---CHHHHHH------------HHHHHHHHHHHHhhc----C
Q 003384 540 PNGSLED--------------RLSCK--D-NSP---PL---SWQTRIR------------IATELCSVLIFLHSC----K 580 (824)
Q Consensus 540 ~ggsL~~--------------~L~~~--~-~~~---~l---~~~~~~~------------ia~qia~aL~~LH~~----~ 580 (824)
+|..+.. .|+.. . ... .. .|...+. +...+...+.+|+.. .
T Consensus 106 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~ 185 (322)
T 2ppq_A 106 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDL 185 (322)
T ss_dssp CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSS
T ss_pred CCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccC
Confidence 9865421 01111 0 000 01 1222110 001234455566532 2
Q ss_pred CCceEeccccCCcEEecCCCcceeecccccc
Q 003384 581 PHSIVHGDLKPANILLDANFVSKLSDFGISR 611 (824)
Q Consensus 581 ~~giiHrDLKp~NILld~~~~vKL~DFGla~ 611 (824)
+.+++|+|+.+.|||++.++.+.|+||+.+.
T Consensus 186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 186 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 4679999999999999987666899999764
|
| >3hgm_A Universal stress protein TEAD; rossman fold, signaling protein; HET: ATP; 1.90A {Halomonas elongata} SCOP: c.26.2.0 | Back alignment and structure |
|---|
Probab=97.56 E-value=0.00014 Score=68.29 Aligned_cols=84 Identities=15% Similarity=0.150 Sum_probs=67.1
Q ss_pred HHHHHHHHHHHHHHHHHHHhhcCeee---EEEEeecCchHHHHHHHHHHcCCCEEEeccCcCccchhhhcccchhhHHhh
Q 003384 43 REIERQDMHNHLDMCLLICRQMGVRA---EKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISV 119 (824)
Q Consensus 43 ~~~e~~~~~~~l~~~~~~C~~~~V~~---~~~~ie~~dv~~~i~e~i~~~~i~~LV~Ga~~~~~~~~~~~~~~s~~a~~v 119 (824)
.+..++..++.|+.+...|...||.+ +..+.+ ++++++|++++.+++++.+|||++..+...+ -+-...+..|
T Consensus 61 ~~~~~~~~~~~l~~~~~~~~~~g~~~~~~~~~~~~-g~~~~~I~~~a~~~~~dliV~G~~~~~~~~~---~~~Gs~~~~v 136 (147)
T 3hgm_A 61 DDALKDYATEIAVQAKTRATELGVPADKVRAFVKG-GRPSRTIVRFARKRECDLVVIGAQGTNGDKS---LLLGSVAQRV 136 (147)
T ss_dssp TTHHHHHHHHHHHHHHHHHHHTTCCGGGEEEEEEE-SCHHHHHHHHHHHTTCSEEEECSSCTTCCSC---CCCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHhcCCCccceEEEEec-CCHHHHHHHHHHHhCCCEEEEeCCCCccccc---eeeccHHHHH
Confidence 44456777899999999999999999 866666 7999999999999999999999994333322 2334467799
Q ss_pred hccCCCccEEEEE
Q 003384 120 RQQAPASCHIWFI 132 (824)
Q Consensus 120 ~~~a~~~C~v~~i 132 (824)
+.+++ |.|.+|
T Consensus 137 l~~~~--~pVlvV 147 (147)
T 3hgm_A 137 AGSAH--CPVLVV 147 (147)
T ss_dssp HHHCS--SCEEEC
T ss_pred HhhCC--CCEEEC
Confidence 99987 999875
|
| >1tq8_A Hypothetical protein RV1636; MTCY01B2.28, structural target, NYSGXRC, PSI, protein structure initiative; 2.40A {Mycobacterium tuberculosis} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=97.53 E-value=0.00013 Score=70.80 Aligned_cols=86 Identities=13% Similarity=0.152 Sum_probs=66.5
Q ss_pred HHHHHHHHHHHHHHHHHHHHhhcCee-eEEEEeecCchHHHHHHHHHHcCCCEEEeccCcCccchhhhcccchhhHHhhh
Q 003384 42 YREIERQDMHNHLDMCLLICRQMGVR-AEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVR 120 (824)
Q Consensus 42 ~~~~e~~~~~~~l~~~~~~C~~~~V~-~~~~~ie~~dv~~~i~e~i~~~~i~~LV~Ga~~~~~~~~~~~~~~s~~a~~v~ 120 (824)
+.+..++..++.|+++...|...+|. ++..+.+ ++++++|++++...+++.+|||++......+. +-...|..|+
T Consensus 71 ~~~~~~~~~~~~l~~~~~~~~~~gv~~v~~~v~~-G~~~~~I~~~a~~~~~DLIV~G~~g~~~~~~~---~lGSva~~vl 146 (163)
T 1tq8_A 71 YKVTGTAPIYEILHDAKERAHNAGAKNVEERPIV-GAPVDALVNLADEEKADLLVVGNVGLSTIAGR---LLGSVPANVS 146 (163)
T ss_dssp -----CCTHHHHHHHHHHHHHTTTCCEEEEEEEC-SSHHHHHHHHHHHTTCSEEEEECCCCCSHHHH---HTBBHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHHcCCCeEEEEEec-CCHHHHHHHHHHhcCCCEEEECCCCCCcccce---eeccHHHHHH
Confidence 33445566788999999999999998 8888776 79999999999999999999999954444333 2233577899
Q ss_pred ccCCCccEEEEEe
Q 003384 121 QQAPASCHIWFIC 133 (824)
Q Consensus 121 ~~a~~~C~v~~i~ 133 (824)
.+++ |.|.+|-
T Consensus 147 ~~a~--~PVlvV~ 157 (163)
T 1tq8_A 147 RRAK--VDVLIVH 157 (163)
T ss_dssp HHTT--CEEEEEC
T ss_pred HhCC--CCEEEEe
Confidence 9987 9999983
|
| >2dum_A Hypothetical protein PH0823; conserved hypothetical protein, putative universal protein A structural genomics, NPPSFA; 2.75A {Pyrococcus horikoshii} | Back alignment and structure |
|---|
Probab=97.50 E-value=0.00025 Score=68.66 Aligned_cols=85 Identities=6% Similarity=0.037 Sum_probs=66.9
Q ss_pred HHHHHHHHHHHHHHHHHHHhhcCeeeEE--EEeecCchHHHHHHHHHHcCCCEEEeccCcCccchhhhcccchhhHHhhh
Q 003384 43 REIERQDMHNHLDMCLLICRQMGVRAEK--LDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVR 120 (824)
Q Consensus 43 ~~~e~~~~~~~l~~~~~~C~~~~V~~~~--~~ie~~dv~~~i~e~i~~~~i~~LV~Ga~~~~~~~~~~~~~~s~~a~~v~ 120 (824)
.+..++..++.|+.+...|...+|+++. .+.+ ++++++|++++.+++++.+|||++......+ -+-...+..|+
T Consensus 69 ~~~~~~~~~~~l~~~~~~~~~~g~~~~~~~~~~~-g~~~~~I~~~a~~~~~DlIV~G~~g~~~~~~---~~~Gsv~~~vl 144 (170)
T 2dum_A 69 KEKLKEEASRKLQEKAEEVKRAFRAKNVRTIIRF-GIPWDEIVKVAEEENVSLIILPSRGKLSLSH---EFLGSTVMRVL 144 (170)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHTTCSEEEEEEEE-ECHHHHHHHHHHHTTCSEEEEESCCCCC--T---TCCCHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHcCCceeeeeEEec-CChHHHHHHHHHHcCCCEEEECCCCCCcccc---ceechHHHHHH
Confidence 3445667788999999999999999987 5555 8999999999999999999999994433322 23344677899
Q ss_pred ccCCCccEEEEEe
Q 003384 121 QQAPASCHIWFIC 133 (824)
Q Consensus 121 ~~a~~~C~v~~i~ 133 (824)
.+++ |.|++|-
T Consensus 145 ~~~~--~PVlvv~ 155 (170)
T 2dum_A 145 RKTK--KPVLIIK 155 (170)
T ss_dssp HHCS--SCEEEEC
T ss_pred HhCC--CCEEEEc
Confidence 9987 9999984
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.48 E-value=0.00035 Score=74.48 Aligned_cols=71 Identities=8% Similarity=0.104 Sum_probs=48.6
Q ss_pred cceeeecCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCce-eeEecccCCceEEEEEec-CCCCh
Q 003384 469 SLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNL-VTLVGACPEVWTLVYEYL-PNGSL 544 (824)
Q Consensus 469 ~~~LG~G~fG~Vykg~~~~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnI-v~L~g~~~~~~~LV~Ey~-~ggsL 544 (824)
...|+.|....+|+. ..+++|+....... .-...+|+.+++.+..-++ .++++.+.+..++|+||+ +|.+|
T Consensus 23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVDPATGVMVTRYIAGAQTM 95 (301)
T ss_dssp CEEEESCSSEEEEEE----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEECTTTCCEEEECCTTCEEC
T ss_pred eeEcCCcccccccee----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEECCCCEEEEeecCCCccC
Confidence 567999999999988 56888987653211 1234678888887742222 466777776678999999 66555
|
| >3fl2_A E3 ubiquitin-protein ligase UHRF1; cell cycle, DNA damage, DNA repair, ring finger domain, metal binding, DNA replication; 1.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.47 E-value=7.4e-05 Score=69.35 Aligned_cols=68 Identities=15% Similarity=0.201 Sum_probs=62.3
Q ss_pred CCCCcccchhhhccCCccccCCccchhhhhhhhhcCCCCCCCCCCCCCCC-CCCCchHHHHHHHHHHHH
Q 003384 755 PPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAH-KNLVPNLALRSAIQEWLQ 822 (824)
Q Consensus 755 P~~f~cPi~~evm~dPvi~~~g~tye~~~i~~wl~~~~~t~p~t~~~l~~-~~l~pn~~lr~~i~~~~~ 822 (824)
++.+.|||+.+++.+|+++.=|++|-+..|..|+..+..+||+.+.++.. ..+.||..|+++|..|+-
T Consensus 50 ~~~~~C~IC~~~~~~p~~~~CgH~fC~~Ci~~~~~~~~~~CP~Cr~~~~~~~~~~~n~~l~~~i~~~~p 118 (124)
T 3fl2_A 50 EETFQCICCQELVFRPITTVCQHNVCKDCLDRSFRAQVFSCPACRYDLGRSYAMQVNQPLQTVLNQLFP 118 (124)
T ss_dssp HHHTBCTTTSSBCSSEEECTTSCEEEHHHHHHHHHTTCCBCTTTCCBCCTTCCCCCCHHHHHHHHHHST
T ss_pred ccCCCCCcCChHHcCcEEeeCCCcccHHHHHHHHhHCcCCCCCCCccCCCCCCCCCCHHHHHHHHHHcc
Confidence 35688999999999999999999999999999999767799999999987 789999999999999864
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.46 E-value=0.0006 Score=72.15 Aligned_cols=77 Identities=16% Similarity=0.088 Sum_probs=55.7
Q ss_pred CCccceeeecCceEEEEEEEC-CeEEEEEEecCCCCCCchhHHHHHHHHHhcCC---CceeeEecccCCceEEEEEecCC
Q 003384 466 FDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRH---PNLVTLVGACPEVWTLVYEYLPN 541 (824)
Q Consensus 466 f~~~~~LG~G~fG~Vykg~~~-~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~H---pnIv~L~g~~~~~~~LV~Ey~~g 541 (824)
......+|.|..+.||+.... |+.|.+|+...........|..|+..|+.|.- --+.++++.. ..++||||+++
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~~~lv~e~l~~ 94 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD--DRTLAMEWVDE 94 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--TTEEEEECCCC
T ss_pred eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc--CceEEEEeecc
Confidence 344567999999999999876 68899998765544444568999999998842 1244455543 34789999987
Q ss_pred CCh
Q 003384 542 GSL 544 (824)
Q Consensus 542 gsL 544 (824)
+..
T Consensus 95 ~~~ 97 (288)
T 3f7w_A 95 RPP 97 (288)
T ss_dssp CCC
T ss_pred cCC
Confidence 754
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.46 E-value=0.00051 Score=74.10 Aligned_cols=73 Identities=21% Similarity=0.105 Sum_probs=56.5
Q ss_pred cceeeecCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhcC---CCceeeEeccc--CCceEEEEEecCCCC
Q 003384 469 SLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIR---HPNLVTLVGAC--PEVWTLVYEYLPNGS 543 (824)
Q Consensus 469 ~~~LG~G~fG~Vykg~~~~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~---HpnIv~L~g~~--~~~~~LV~Ey~~ggs 543 (824)
...|+.|.+..+|+....+..+++|+.... ....+..|...|+.|. ...+.++++.+ ....++||||++|..
T Consensus 41 ~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~ 117 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDEVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSK 117 (312)
T ss_dssp EEEECCSSSSEEEEEESSSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCC
T ss_pred eEEeCCccceeeeEEEECCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCC
Confidence 356899999999998877788999987542 2456889999998884 24566777665 356889999999986
Q ss_pred h
Q 003384 544 L 544 (824)
Q Consensus 544 L 544 (824)
+
T Consensus 118 ~ 118 (312)
T 3jr1_A 118 N 118 (312)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >1z6u_A NP95-like ring finger protein isoform B; structural genomics consortium, ligase, ubiquitin-protein ligase, cell cycle regulation, SGC; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.42 E-value=9.2e-05 Score=71.25 Aligned_cols=68 Identities=16% Similarity=0.249 Sum_probs=62.8
Q ss_pred CCCCcccchhhhccCCccccCCccchhhhhhhhhcCCCCCCCCCCCCCCCC-CCCchHHHHHHHHHHHH
Q 003384 755 PPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHK-NLVPNLALRSAIQEWLQ 822 (824)
Q Consensus 755 P~~f~cPi~~evm~dPvi~~~g~tye~~~i~~wl~~~~~t~p~t~~~l~~~-~l~pn~~lr~~i~~~~~ 822 (824)
++.+.|||+.+++.+|+++.=|++|-...|..|+..+..+||+.+.++... .|.||..|+++|..|+.
T Consensus 76 ~~~~~C~IC~~~~~~pv~~~CgH~fC~~Ci~~~~~~~~~~CP~Cr~~~~~~~~l~~n~~l~~lv~~~~p 144 (150)
T 1z6u_A 76 EQSFMCVCCQELVYQPVTTECFHNVCKDCLQRSFKAQVFSCPACRHDLGQNYIMIPNEILQTLLDLFFP 144 (150)
T ss_dssp HHHTBCTTTSSBCSSEEECTTSCEEEHHHHHHHHHTTCCBCTTTCCBCCTTCCCCBCHHHHHHHHHHST
T ss_pred ccCCEeecCChhhcCCEEcCCCCchhHHHHHHHHHhCCCcCCCCCccCCCCCCCCCCHHHHHHHHHHhh
Confidence 456899999999999999999999999999999998777999999999977 99999999999999864
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.35 E-value=0.00031 Score=79.21 Aligned_cols=71 Identities=20% Similarity=0.254 Sum_probs=50.6
Q ss_pred ceeeecCceEEEEEEEC---------CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCce-eeEecccCCceEEEEEec
Q 003384 470 LKIGEGGYGSIYKGLLR---------HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNL-VTLVGACPEVWTLVYEYL 539 (824)
Q Consensus 470 ~~LG~G~fG~Vykg~~~---------~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnI-v~L~g~~~~~~~LV~Ey~ 539 (824)
..|+.|....||+.... +..+++|+.... .....+..|..++..|...++ .++++.+.+. +||||+
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~g--~v~e~l 154 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSGG--RLEEYI 154 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETTE--EEECCC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCCC--EEEEEe
Confidence 45888888999998764 367999988432 112567789999998853333 5677777653 899999
Q ss_pred CCCCh
Q 003384 540 PNGSL 544 (824)
Q Consensus 540 ~ggsL 544 (824)
+|.+|
T Consensus 155 ~G~~l 159 (429)
T 1nw1_A 155 PSRPL 159 (429)
T ss_dssp CEEEC
T ss_pred CCccc
Confidence 87544
|
| >3dlo_A Universal stress protein; unknown function, structural genomics, PSI-2, protein struct initiative, midwest center for structural genomics; HET: MSE; 1.97A {Archaeoglobus fulgidus} PDB: 3qtb_A* | Back alignment and structure |
|---|
Probab=97.33 E-value=0.00074 Score=64.72 Aligned_cols=82 Identities=15% Similarity=0.126 Sum_probs=64.7
Q ss_pred HHHHHHHHHHHHHHHHhhcCeeeEEE-EeecCchHHHHHHHHHHcCCCEEEeccCcCccchhhhcccchhhHHhhhccCC
Q 003384 46 ERQDMHNHLDMCLLICRQMGVRAEKL-DTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAP 124 (824)
Q Consensus 46 e~~~~~~~l~~~~~~C~~~~V~~~~~-~ie~~dv~~~i~e~i~~~~i~~LV~Ga~~~~~~~~~~~~~~s~~a~~v~~~a~ 124 (824)
.++..++.|+.+...+...++.++.. .+..++++++|++++.+++++.+|||++..... .+-+-...+..|+..++
T Consensus 72 ~~~~~~~~l~~~~~~~~~~g~~~~~~~~v~~G~~~~~I~~~a~~~~~DLIV~G~~g~~~~---~~~~lGSv~~~vl~~a~ 148 (155)
T 3dlo_A 72 DIIEAKETLSWAVSIIRKEGAEGEEHLLVRGKEPPDDIVDFADEVDAIAIVIGIRKRSPT---GKLIFGSVARDVILKAN 148 (155)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCEEEEEEESSSCHHHHHHHHHHHTTCSEEEEECCEECTT---SCEECCHHHHHHHHHCS
T ss_pred HHHHHHHHHHHHHHHHHhcCCCceEEEEecCCCHHHHHHHHHHHcCCCEEEECCCCCCCC---CCEEeccHHHHHHHhCC
Confidence 44567888999999999999998864 467799999999999999999999999933322 22233446778999876
Q ss_pred CccEEEEE
Q 003384 125 ASCHIWFI 132 (824)
Q Consensus 125 ~~C~v~~i 132 (824)
|-|.+|
T Consensus 149 --~PVLvV 154 (155)
T 3dlo_A 149 --KPVICI 154 (155)
T ss_dssp --SCEEEE
T ss_pred --CCEEEe
Confidence 999887
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.33 E-value=0.0008 Score=76.47 Aligned_cols=73 Identities=14% Similarity=0.059 Sum_probs=49.9
Q ss_pred cceeeecCceEEEEEEECC--eEEEEEEecCCCCCCchhHHHHHHHHHhcCCCce-eeEecccCCceEEEEEecCCCCh
Q 003384 469 SLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNL-VTLVGACPEVWTLVYEYLPNGSL 544 (824)
Q Consensus 469 ~~~LG~G~fG~Vykg~~~~--~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnI-v~L~g~~~~~~~LV~Ey~~ggsL 544 (824)
...|+.|-...+|+....+ ..+++|+....... .-...+|..++..|...++ .++++.+.+. +||||++|.+|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~~G--~v~e~I~G~~l 188 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFTNG--RIEEFMDGYAL 188 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEETTE--EEEECCCSEEC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeCCe--EEEEeeCCccC
Confidence 3468888889999998876 78999987543211 1123689999999975444 5677777543 59999998554
|
| >3tnj_A Universal stress protein (USP); structural genomics, PSI-biology, midwest center for structu genomics, MCSG, chaperone; HET: AMP; 2.00A {Nitrosomonas europaea} PDB: 2pfs_A* | Back alignment and structure |
|---|
Probab=97.32 E-value=0.00029 Score=66.54 Aligned_cols=80 Identities=14% Similarity=0.183 Sum_probs=54.8
Q ss_pred HHHHHHHHHHHHHHHHHHhhcCeee-EEEEeecCchHHHHHHHHHHcCCCEEEeccCcCccchhhhcccchhhHHhhhcc
Q 003384 44 EIERQDMHNHLDMCLLICRQMGVRA-EKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQ 122 (824)
Q Consensus 44 ~~e~~~~~~~l~~~~~~C~~~~V~~-~~~~ie~~dv~~~i~e~i~~~~i~~LV~Ga~~~~~~~~~~~~~~s~~a~~v~~~ 122 (824)
+..++..++.|+.+ |.+.++.. +.. +..++++++|++++..++++.+|||++..+... -+-...+..|+.+
T Consensus 66 ~~~~~~~~~~l~~~---~~~~~~~~~~~~-~~~g~~~~~I~~~a~~~~~dliV~G~~~~~~~~----~~~Gs~~~~vl~~ 137 (150)
T 3tnj_A 66 DAMLDVEKQKLSQI---GNTLGIDPAHRW-LVWGEPREEIIRIAEQENVDLIVVGSHGRHGLA----LLLGSTANSVLHY 137 (150)
T ss_dssp HHHHHHHHHHHHHH---HHHHTCCGGGEE-EEESCHHHHHHHHHHHTTCSEEEEEEC------------CCCHHHHHHHH
T ss_pred HHHHHHHHHHHHHH---HHHcCCCcceEE-EecCCHHHHHHHHHHHcCCCEEEEecCCCCCcC----eEecchHHHHHHh
Confidence 34445556666665 44457774 554 455899999999999999999999999433332 2333467789999
Q ss_pred CCCccEEEEEe
Q 003384 123 APASCHIWFIC 133 (824)
Q Consensus 123 a~~~C~v~~i~ 133 (824)
++ |.|.+|-
T Consensus 138 ~~--~pVlvv~ 146 (150)
T 3tnj_A 138 AK--CDVLAVR 146 (150)
T ss_dssp CS--SEEEEEE
T ss_pred CC--CCEEEEe
Confidence 87 9999984
|
| >3fdx_A Putative filament protein / universal stress PROT; structural genomics, APC60640.1, universal protein F, PSI-2; HET: MSE ATP; 1.58A {Klebsiella pneumoniae subsp} PDB: 3fh0_A* | Back alignment and structure |
|---|
Probab=97.28 E-value=0.00061 Score=63.63 Aligned_cols=77 Identities=16% Similarity=0.152 Sum_probs=56.6
Q ss_pred HHHHHHHHHHHHHhhcC---eeeEEEEeecCchHHHHHHHHHHcCCCEEEeccCcCccchhhhcccchhhHHhhhccCCC
Q 003384 49 DMHNHLDMCLLICRQMG---VRAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAPA 125 (824)
Q Consensus 49 ~~~~~l~~~~~~C~~~~---V~~~~~~ie~~dv~~~i~e~i~~~~i~~LV~Ga~~~~~~~~~~~~~~s~~a~~v~~~a~~ 125 (824)
...+.+..+..++.+.+ ++++..+.+ ++++++|++++.+++++.+|||++ .+...+ -+-...+..|+.+++
T Consensus 63 ~~~~~~~~l~~~~~~~~~~~~~v~~~~~~-g~~~~~I~~~a~~~~~dliV~G~~-~~~~~~---~~~Gs~~~~v~~~~~- 136 (143)
T 3fdx_A 63 LREGSETQLKEIAKKFSIPEDRMHFHVAE-GSPKDKILALAKSLPADLVIIASH-RPDITT---YLLGSNAAAVVRHAE- 136 (143)
T ss_dssp HHHHHHHHHHHHHTTSCCCGGGEEEEEEE-SCHHHHHHHHHHHTTCSEEEEESS-CTTCCS---CSSCHHHHHHHHHCS-
T ss_pred HHHHHHHHHHHHHHHcCCCCCceEEEEEe-cChHHHHHHHHHHhCCCEEEEeCC-CCCCee---eeeccHHHHHHHhCC-
Confidence 34455666666777765 456777666 799999999999999999999998 333222 233446778999977
Q ss_pred ccEEEEE
Q 003384 126 SCHIWFI 132 (824)
Q Consensus 126 ~C~v~~i 132 (824)
|-|++|
T Consensus 137 -~pVlvv 142 (143)
T 3fdx_A 137 -CSVLVV 142 (143)
T ss_dssp -SEEEEE
T ss_pred -CCEEEe
Confidence 999987
|
| >3olq_A Universal stress protein E; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: UNL; 1.82A {Proteus mirabilis} | Back alignment and structure |
|---|
Probab=97.16 E-value=0.0024 Score=68.21 Aligned_cols=96 Identities=10% Similarity=0.084 Sum_probs=76.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHHHHHHHhhcCeeeEEEEeecCchHHHHHHHHHHcCCCEEEeccCcCccchhhhcccch
Q 003384 34 LEEEKVQAYREIERQDMHNHLDMCLLICRQMGVRAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKS 113 (824)
Q Consensus 34 ~~~e~v~~~~~~e~~~~~~~l~~~~~~C~~~~V~~~~~~ie~~dv~~~i~e~i~~~~i~~LV~Ga~~~~~~~~~~~~~~s 113 (824)
+.++..+.+++...+..++.|+.+...|...+|.++..+...+++..+|++++..++++.+|||++..... .+-+-+
T Consensus 55 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~v~~~~~~~~~g~~~~~i~~~a~~~~~DLiV~G~~g~~~~---~~~~~G 131 (319)
T 3olq_A 55 LSPDERNAMRKGVINQKTAWIKQQARYYLEAGIQIDIKVIWHNRPYEAIIEEVITDKHDLLIKMAHQHDKL---GSLIFT 131 (319)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHHHHHHHHHTTCCEEEEEEECSCHHHHHHHHHHHHTCSEEEEEEBCC--C---CSCBCC
T ss_pred cChhhHHHHHHHHHHHHHHHHHHHHHHHhhcCCeEEEEEEecCChHHHHHHHHHhcCCCEEEEecCcCchh---hccccc
Confidence 44566666777777788899999999999999999999986699999999999999999999999943322 222234
Q ss_pred hhHHhhhccCCCccEEEEEec
Q 003384 114 KKAISVRQQAPASCHIWFICN 134 (824)
Q Consensus 114 ~~a~~v~~~a~~~C~v~~i~~ 134 (824)
..+..|+..++ |-|++|-.
T Consensus 132 s~~~~vl~~~~--~PVlvv~~ 150 (319)
T 3olq_A 132 PLDWQLLRKCP--APVWMVKD 150 (319)
T ss_dssp HHHHHHHHHCS--SCEEEEES
T ss_pred ccHHHHHhcCC--CCEEEecC
Confidence 45778999876 99999853
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.15 E-value=0.0007 Score=75.02 Aligned_cols=139 Identities=21% Similarity=0.253 Sum_probs=83.3
Q ss_pred ceeeecCceEEEEEEEC---------CeEEEEEEecCCCCCCchhHHHHHHHHHhcC-CCceeeEecccCCceEEEEEec
Q 003384 470 LKIGEGGYGSIYKGLLR---------HMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVGACPEVWTLVYEYL 539 (824)
Q Consensus 470 ~~LG~G~fG~Vykg~~~---------~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~-HpnIv~L~g~~~~~~~LV~Ey~ 539 (824)
..|..|-...+|+.... +..+++|+... .......+.+|..+++.|. +.-..++++.|.+. +||||+
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g--~v~e~i 132 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPEG--RLEQYI 132 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE--EEEECC
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc--cEEEEe
Confidence 35766777889988763 36789998633 2233456779999998884 32235677777764 899999
Q ss_pred CCCChhhh-----------------hhccC--CCCCCC--HHHHHHHHHHHHH-------------------HHHHHh--
Q 003384 540 PNGSLEDR-----------------LSCKD--NSPPLS--WQTRIRIATELCS-------------------VLIFLH-- 577 (824)
Q Consensus 540 ~ggsL~~~-----------------L~~~~--~~~~l~--~~~~~~ia~qia~-------------------aL~~LH-- 577 (824)
+|.+|... |+... ...+.. +.++.++..++.. .+..|.
T Consensus 133 ~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~ 212 (379)
T 3feg_A 133 PSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKL 212 (379)
T ss_dssp SEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHH
T ss_pred cCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHH
Confidence 98665321 11111 011122 3444445443321 223332
Q ss_pred --h-cCCCceEeccccCCcEEecCC----Ccceeecccccc
Q 003384 578 --S-CKPHSIVHGDLKPANILLDAN----FVSKLSDFGISR 611 (824)
Q Consensus 578 --~-~~~~giiHrDLKp~NILld~~----~~vKL~DFGla~ 611 (824)
. ..+..++|+|+.+.|||++.+ +.+.|+||..+.
T Consensus 213 L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 213 LESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 2 123579999999999999876 789999999775
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.12 E-value=0.0015 Score=70.47 Aligned_cols=139 Identities=12% Similarity=0.053 Sum_probs=74.1
Q ss_pred eeeecCceE-EEEEEEC-CeEEEEEEecCCCCCCchhHHHHHHHHHhcCC--CceeeEecccCCceEEEEEecCCCChhh
Q 003384 471 KIGEGGYGS-IYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRH--PNLVTLVGACPEVWTLVYEYLPNGSLED 546 (824)
Q Consensus 471 ~LG~G~fG~-Vykg~~~-~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~H--pnIv~L~g~~~~~~~LV~Ey~~ggsL~~ 546 (824)
.|+.|+... +|+.... +..+++|...+... ..+..|+.++..|.. -.+.+++.++.+..++|||++.+..+.+
T Consensus 25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g~ll~e~l~~~~l~~ 101 (333)
T 3csv_A 25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARGLLLIEDLGDALFTE 101 (333)
T ss_dssp C--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTTEEEECCCCSCBHHH
T ss_pred ECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCCEEEEeeCCCcchHH
Confidence 465555444 6676654 66777776543321 345678888877742 2345566655444478999997766654
Q ss_pred hhhcc---------------------C--CCCCCCHHHHH-------HH-------------HHHHHHHHHHHh---hcC
Q 003384 547 RLSCK---------------------D--NSPPLSWQTRI-------RI-------------ATELCSVLIFLH---SCK 580 (824)
Q Consensus 547 ~L~~~---------------------~--~~~~l~~~~~~-------~i-------------a~qia~aL~~LH---~~~ 580 (824)
.+... . ..+.++..... .+ ...+...+..|. ...
T Consensus 102 ~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~~~ 181 (333)
T 3csv_A 102 VINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQLEG 181 (333)
T ss_dssp HHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHCCS
T ss_pred HhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcccC
Confidence 33210 0 01112221110 00 001112222221 123
Q ss_pred CCceEeccccCCcEEecCC----Ccceeeccccccc
Q 003384 581 PHSIVHGDLKPANILLDAN----FVSKLSDFGISRF 612 (824)
Q Consensus 581 ~~giiHrDLKp~NILld~~----~~vKL~DFGla~~ 612 (824)
+..++|||+.+.|||++.+ +.+.|+||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 4689999999999999874 6789999998764
|
| >2z08_A Universal stress protein family; uncharacterized conserved protein, structural genomics, unknown function, NPPSFA; HET: ATP; 1.55A {Thermus thermophilus} SCOP: c.26.2.4 PDB: 1wjg_A* 2z09_A* 2z3v_A | Back alignment and structure |
|---|
Probab=97.12 E-value=0.001 Score=61.83 Aligned_cols=81 Identities=17% Similarity=0.220 Sum_probs=59.8
Q ss_pred HHHHHHHHHHHHHHHHHHHhhcCe-eeEEEEeecCchHHHHHHHHHHcCCCEEEeccCcCccchhhhcccchhhHHhhhc
Q 003384 43 REIERQDMHNHLDMCLLICRQMGV-RAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQ 121 (824)
Q Consensus 43 ~~~e~~~~~~~l~~~~~~C~~~~V-~~~~~~ie~~dv~~~i~e~i~~~~i~~LV~Ga~~~~~~~~~~~~~~s~~a~~v~~ 121 (824)
.+..++..++.|+++... .|+ +++..+.+ ++++++|++++.+++++.+|||++..+...+ -+-...+..|+.
T Consensus 55 ~~~~~~~~~~~l~~~~~~---~g~~~~~~~~~~-g~~~~~I~~~a~~~~~dliV~G~~~~~~~~~---~~~Gs~~~~vl~ 127 (137)
T 2z08_A 55 LRRRLERAEGVLEEARAL---TGVPKEDALLLE-GVPAEAILQAARAEKADLIVMGTRGLGALGS---LFLGSQSQRVVA 127 (137)
T ss_dssp -CHHHHHHHHHHHHHHHH---HCCCGGGEEEEE-SSHHHHHHHHHHHTTCSEEEEESSCTTCCSC---SSSCHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHH---cCCCccEEEEEe-cCHHHHHHHHHHHcCCCEEEECCCCCchhhh---hhhccHHHHHHh
Confidence 344455667777776554 788 88877665 7999999999999999999999994333322 223446778999
Q ss_pred cCCCccEEEEE
Q 003384 122 QAPASCHIWFI 132 (824)
Q Consensus 122 ~a~~~C~v~~i 132 (824)
+++ |.|++|
T Consensus 128 ~~~--~pVlvv 136 (137)
T 2z08_A 128 EAP--CPVLLV 136 (137)
T ss_dssp HCS--SCEEEE
T ss_pred cCC--CCEEEe
Confidence 976 999987
|
| >2y43_A E3 ubiquitin-protein ligase RAD18; DNA repair, metal-binding, translesion synthesis, UB conjugation pathway; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.02 E-value=0.00045 Score=61.27 Aligned_cols=67 Identities=13% Similarity=0.200 Sum_probs=61.2
Q ss_pred CCCCcccchhhhccCCccc-cCCccchhhhhhhhhcCCCCCCCCCCCCCCCCCCCchHHHHHHHHHHHH
Q 003384 755 PPYFTCPIFQEVMQDPHVA-ADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWLQ 822 (824)
Q Consensus 755 P~~f~cPi~~evm~dPvi~-~~g~tye~~~i~~wl~~~~~t~p~t~~~l~~~~l~pn~~lr~~i~~~~~ 822 (824)
++.+.|||+.+.+.+|++. .=|++|=...|..|+.. ..+||+.+.++....+.||..|++.|..|..
T Consensus 20 ~~~~~C~IC~~~~~~p~~~~~CgH~fC~~Ci~~~~~~-~~~CP~Cr~~~~~~~l~~n~~l~~~i~~~~~ 87 (99)
T 2y43_A 20 DDLLRCGICFEYFNIAMIIPQCSHNYCSLCIRKFLSY-KTQCPTCCVTVTEPDLKNNRILDELVKSLNF 87 (99)
T ss_dssp HHHTBCTTTCSBCSSEEECTTTCCEEEHHHHHHHHTT-CCBCTTTCCBCCGGGCEECHHHHHHHHHHHH
T ss_pred CCCCCcccCChhhCCcCEECCCCCHhhHHHHHHHHHC-CCCCCCCCCcCChhhCCcCHHHHHHHHHHHH
Confidence 4568899999999999988 89999999999999986 5799999999998899999999999999875
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.92 E-value=0.0012 Score=72.54 Aligned_cols=72 Identities=14% Similarity=0.135 Sum_probs=44.6
Q ss_pred ceeeecCceEEEEEEECC----------eEEEEEEecCCCCCCchhHHHHHHHHHhcCCCc-eeeEecccCCceEEEEEe
Q 003384 470 LKIGEGGYGSIYKGLLRH----------MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPN-LVTLVGACPEVWTLVYEY 538 (824)
Q Consensus 470 ~~LG~G~fG~Vykg~~~~----------~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~Hpn-Iv~L~g~~~~~~~LV~Ey 538 (824)
..|+.|....+|+....+ ..+++|+...... .......|..++..|...+ +.++++.+. .++||||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~~--~~~v~e~ 115 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTFN--GGRIEEW 115 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEET--TEEEEEC
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEecC--CcEEEEE
Confidence 457778888999987754 6788898654211 1113468898888885333 346665543 3689999
Q ss_pred cCCCCh
Q 003384 539 LPNGSL 544 (824)
Q Consensus 539 ~~ggsL 544 (824)
++|.++
T Consensus 116 i~G~~l 121 (369)
T 3c5i_A 116 LYGDPL 121 (369)
T ss_dssp CCSEEC
T ss_pred ecCCcC
Confidence 998554
|
| >1jm7_B BARD1, BRCA1-associated ring domain protein 1; ring finger, zinc-binding protein, heterodimer, ubiquitin ligase, antitumor; NMR {Homo sapiens} SCOP: g.44.1.1 | Back alignment and structure |
|---|
Probab=96.91 E-value=0.0011 Score=60.85 Aligned_cols=64 Identities=16% Similarity=0.248 Sum_probs=59.3
Q ss_pred CCCcccchhhhccCCccc-cCCccchhhhhhhhhcCCCCCCCCCCCCCCCCCCCchHHHHHHHHHHHH
Q 003384 756 PYFTCPIFQEVMQDPHVA-ADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWLQ 822 (824)
Q Consensus 756 ~~f~cPi~~evm~dPvi~-~~g~tye~~~i~~wl~~~~~t~p~t~~~l~~~~l~pn~~lr~~i~~~~~ 822 (824)
..+.|||+.+++.+|+++ .=|++|=...|..|+. .+||+.+.++....+.||..|++.|..|..
T Consensus 21 ~~~~C~IC~~~~~~pv~~~~CgH~fC~~Ci~~~~~---~~CP~Cr~~~~~~~~~~n~~l~~l~~~~~~ 85 (117)
T 1jm7_B 21 KLLRCSRCTNILREPVCLGGCEHIFCSNCVSDCIG---TGCPVCYTPAWIQDLKINRQLDSMIQLCSK 85 (117)
T ss_dssp HTTSCSSSCSCCSSCBCCCSSSCCBCTTTGGGGTT---TBCSSSCCBCSCSSCCCCHHHHHHHHHHHH
T ss_pred hCCCCCCCChHhhCccEeCCCCCHHHHHHHHHHhc---CCCcCCCCcCccccccccHHHHHHHHHHHH
Confidence 468899999999999999 8999999999999997 689999999988899999999999998864
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.88 E-value=0.0033 Score=67.32 Aligned_cols=139 Identities=12% Similarity=0.155 Sum_probs=81.1
Q ss_pred ceeeecCceEEEEEEEC-CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCc--eeeEecc-------cCCceEEEEEec
Q 003384 470 LKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPN--LVTLVGA-------CPEVWTLVYEYL 539 (824)
Q Consensus 470 ~~LG~G~fG~Vykg~~~-~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~Hpn--Iv~L~g~-------~~~~~~LV~Ey~ 539 (824)
..|+ |....||+.... +..+++|+..+.. .....+..|..++..|.... +.+++.. .....++||+|+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4577 778899987664 4579999987432 24567888999988874222 3444433 123457899999
Q ss_pred CCCChhh-----------h---hhcc---C---CCCCCCHHHH----HHH---------------HHHHHHHHHHHhhc-
Q 003384 540 PNGSLED-----------R---LSCK---D---NSPPLSWQTR----IRI---------------ATELCSVLIFLHSC- 579 (824)
Q Consensus 540 ~ggsL~~-----------~---L~~~---~---~~~~l~~~~~----~~i---------------a~qia~aL~~LH~~- 579 (824)
+|..+.. . |+.. . ....+++... ..+ ...+...+..+...
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 8855421 0 1110 0 0112232211 001 11111223333321
Q ss_pred ---CCCceEeccccCCcEEecCCCcceeeccccccc
Q 003384 580 ---KPHSIVHGDLKPANILLDANFVSKLSDFGISRF 612 (824)
Q Consensus 580 ---~~~giiHrDLKp~NILld~~~~vKL~DFGla~~ 612 (824)
.+..++|||+++.|||++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 346789999999999999 4 789999997653
|
| >3hct_A TNF receptor-associated factor 6; cross-brace, beta-BETA-alpha, coiled coil, cytoplasm, metal- binding, UBL conjugation, UBL conjugation pathway; 2.10A {Homo sapiens} PDB: 3hcu_A 2eci_A 2jmd_A | Back alignment and structure |
|---|
Probab=96.84 E-value=0.00042 Score=63.67 Aligned_cols=68 Identities=15% Similarity=0.256 Sum_probs=62.7
Q ss_pred CCCCCCcccchhhhccCCccccCCccchhhhhhhhhcCCCCCCCCCCCCCCCCCCCchHHHHHHHHHH
Q 003384 753 EPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEW 820 (824)
Q Consensus 753 ~~P~~f~cPi~~evm~dPvi~~~g~tye~~~i~~wl~~~~~t~p~t~~~l~~~~l~pn~~lr~~i~~~ 820 (824)
..++.+.|||..+++.+|+++.=|++|=...|..|+..+..+||+.+.++....++||..++..|.++
T Consensus 14 ~~~~~~~C~IC~~~~~~p~~~~CgH~fC~~Ci~~~~~~~~~~CP~Cr~~~~~~~~~~~~~l~~~i~~l 81 (118)
T 3hct_A 14 PLESKYECPICLMALREAVQTPCGHRFCKACIIKSIRDAGHKCPVDNEILLENQLFPDNFAKREILSL 81 (118)
T ss_dssp CCCGGGBCTTTCSBCSSEEECTTSCEEEHHHHHHHHHHHCSBCTTTCCBCCGGGCEECHHHHHHHHTS
T ss_pred CCCCCCCCCcCChhhcCeEECCcCChhhHHHHHHHHhhCCCCCCCCCCCcCHHhcccCHHHHHHHccc
Confidence 56778999999999999999999999999999999988777999999999999999999999998764
|
| >3loq_A Universal stress protein; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: AMP; 2.32A {Archaeoglobus fulgidus} | Back alignment and structure |
|---|
Probab=96.81 E-value=0.00081 Score=71.20 Aligned_cols=84 Identities=14% Similarity=0.167 Sum_probs=66.5
Q ss_pred HHHHHHHHHHHHHHHHHHHHhhcCeeeEE-EEeecCchHHHHHHHHHHcCCCEEEeccCcCccchhhhcccchhhHHhhh
Q 003384 42 YREIERQDMHNHLDMCLLICRQMGVRAEK-LDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVR 120 (824)
Q Consensus 42 ~~~~e~~~~~~~l~~~~~~C~~~~V~~~~-~~ie~~dv~~~i~e~i~~~~i~~LV~Ga~~~~~~~~~~~~~~s~~a~~v~ 120 (824)
+.+..++..++.|+.+...|...||.++. .+.+.++++++| ++...+++.+|||++..+...+. +-+..+..|+
T Consensus 76 ~~~~~~~~~~~~l~~~~~~~~~~g~~~~~~~v~~~g~~~~~I--~a~~~~~DliV~G~~g~~~~~~~---~~Gs~~~~vl 150 (294)
T 3loq_A 76 YIDEMSEKAEEVLPEVAQKIEAAGIKAEVIKPFPAGDPVVEI--IKASENYSFIAMGSRGASKFKKI---LLGSVSEGVL 150 (294)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHTTCEEEECSSCCEECHHHHH--HHHHTTSSEEEEECCCCCHHHHH---HHCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHHcCCCcceeEeeccCChhHhe--eeccCCCCEEEEcCCCCccccce---eeccHHHHHH
Confidence 34556667888999999999999999998 566469999999 99999999999999944333322 2233567899
Q ss_pred ccCCCccEEEEE
Q 003384 121 QQAPASCHIWFI 132 (824)
Q Consensus 121 ~~a~~~C~v~~i 132 (824)
..++ |.|++|
T Consensus 151 ~~~~--~PVlvv 160 (294)
T 3loq_A 151 HDSK--VPVYIF 160 (294)
T ss_dssp HHCS--SCEEEE
T ss_pred hcCC--CCEEEe
Confidence 9987 999998
|
| >3cis_A Uncharacterized protein; alpha/beta hydrolase, ATP, universal stress protein, unknown function; HET: ATP; 2.90A {Mycobacterium tuberculosis} PDB: 2jax_A* | Back alignment and structure |
|---|
Probab=96.71 E-value=0.0046 Score=65.85 Aligned_cols=83 Identities=11% Similarity=0.134 Sum_probs=64.2
Q ss_pred HHHHHHHHHHHHHHHHHHHhhc-----CeeeEEEEeecCchHHHHHHHHHHcCCCEEEeccCcCccchhhhcccchhhHH
Q 003384 43 REIERQDMHNHLDMCLLICRQM-----GVRAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAI 117 (824)
Q Consensus 43 ~~~e~~~~~~~l~~~~~~C~~~-----~V~~~~~~ie~~dv~~~i~e~i~~~~i~~LV~Ga~~~~~~~~~~~~~~s~~a~ 117 (824)
.+..++..++.|+++...|... +|+++..+.+ ++++++|++++. +++.+|||++..+.. .+-+-...+.
T Consensus 73 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~-g~~~~~I~~~a~--~~DliV~G~~g~~~~---~~~~~Gs~~~ 146 (309)
T 3cis_A 73 LRWQQDHGRHLIDDALKVVEQASLRAGPPTVHSEIVP-AAAVPTLVDMSK--DAVLMVVGCLGSGRW---PGRLLGSVSS 146 (309)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHCSSSCCSCEEEEEES-SCHHHHHHHHGG--GEEEEEEESSCTTCC---TTCCSCHHHH
T ss_pred hHHHHHHHHHHHHHHHHHHHHhcccCCCceEEEEEec-CCHHHHHHHHhc--CCCEEEECCCCCccc---cccccCcHHH
Confidence 3445566788899999999876 9999988776 899999999986 899999999933332 2223344677
Q ss_pred hhhccCCCccEEEEEe
Q 003384 118 SVRQQAPASCHIWFIC 133 (824)
Q Consensus 118 ~v~~~a~~~C~v~~i~ 133 (824)
.|+..+ .|.|++|-
T Consensus 147 ~vl~~~--~~PVlvv~ 160 (309)
T 3cis_A 147 GLLRHA--HCPVVIIH 160 (309)
T ss_dssp HHHHHC--SSCEEEEC
T ss_pred HHHHhC--CCCEEEEc
Confidence 899997 59999984
|
| >3ab8_A Putative uncharacterized protein TTHA0350; tandem-type universal stress protein, unknown function; HET: ATP; 1.70A {Thermus thermophilus} PDB: 3ab7_A* | Back alignment and structure |
|---|
Probab=96.68 E-value=0.0063 Score=63.18 Aligned_cols=83 Identities=16% Similarity=0.067 Sum_probs=66.2
Q ss_pred HHHHHHHHHHHHHHHHHHHhhcCeeeEEEEeecCchHHHHHHHHHHcCCCEEEeccCcCc-cchhhhcccchhhHHhhhc
Q 003384 43 REIERQDMHNHLDMCLLICRQMGVRAEKLDTESESTEKGILELISHYGIRKLVMGAAADK-HYKKKMMDLKSKKAISVRQ 121 (824)
Q Consensus 43 ~~~e~~~~~~~l~~~~~~C~~~~V~~~~~~ie~~dv~~~i~e~i~~~~i~~LV~Ga~~~~-~~~~~~~~~~s~~a~~v~~ 121 (824)
.+..++..++.|+.+...|...||.++..+.+ ++++++|+++ .++++.+|||++..+ ...+ -+-...+..|+.
T Consensus 65 ~~~~~~~~~~~l~~~~~~~~~~g~~~~~~~~~-g~~~~~I~~~--~~~~dliV~G~~g~~~~~~~---~~~Gs~~~~v~~ 138 (268)
T 3ab8_A 65 ERALALRGEAVLERVRQSALAAGVAVEAVLEE-GVPHEAILRR--ARAADLLVLGRSGEAHGDGF---GGLGSTADRVLR 138 (268)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTTCCEEEEEEE-ECHHHHHHHH--HTTCSEEEEESSCTTSCTTC---CSCCHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHhCCCCeEEEEec-CCHHHHHHhh--ccCCCEEEEeccCCCccccc---cccchhHHHHHH
Confidence 44556778899999999999999999988775 8999999999 999999999999433 2222 223346778999
Q ss_pred cCCCccEEEEEe
Q 003384 122 QAPASCHIWFIC 133 (824)
Q Consensus 122 ~a~~~C~v~~i~ 133 (824)
.++ |-|++|-
T Consensus 139 ~a~--~PVlvv~ 148 (268)
T 3ab8_A 139 ASP--VPVLLAP 148 (268)
T ss_dssp HCS--SCEEEEC
T ss_pred hCC--CCEEEEC
Confidence 977 9999983
|
| >2ckl_A Polycomb group ring finger protein 4; BMI1, RING1B, polycomb, E3-ligase, nuclear protein, chromosomal protein, transcription regulation; 2.0A {Mus musculus} PDB: 3rpg_B 2h0d_A | Back alignment and structure |
|---|
Probab=96.67 E-value=0.001 Score=60.00 Aligned_cols=68 Identities=10% Similarity=0.264 Sum_probs=60.9
Q ss_pred CCCCCcccchhhhccCCccc-cCCccchhhhhhhhhcCCCCCCCCCCCCCCCC----CCCchHHHHHHHHHHHH
Q 003384 754 PPPYFTCPIFQEVMQDPHVA-ADGFTYEAEALKGWLDSGHETSPMTNLPLAHK----NLVPNLALRSAIQEWLQ 822 (824)
Q Consensus 754 ~P~~f~cPi~~evm~dPvi~-~~g~tye~~~i~~wl~~~~~t~p~t~~~l~~~----~l~pn~~lr~~i~~~~~ 822 (824)
.++.+.|||+.+++.+|++. .=|++|=...|..|+..+ .+||+.+.++... .+.+|..|++.|..|..
T Consensus 12 ~~~~~~C~IC~~~~~~p~~~~~CgH~fC~~Ci~~~~~~~-~~CP~Cr~~~~~~~~~~~l~~n~~l~~~i~~~~~ 84 (108)
T 2ckl_A 12 LNPHLMCVLCGGYFIDATTIIECLHSFCKTCIVRYLETS-KYCPICDVQVHKTRPLLNIRSDKTLQDIVYKLVP 84 (108)
T ss_dssp HGGGTBCTTTSSBCSSEEEETTTCCEEEHHHHHHHHTSC-SBCTTTCCBSCSSCGGGGEEECHHHHHHHHHHST
T ss_pred cCCcCCCccCChHHhCcCEeCCCCChhhHHHHHHHHHhC-CcCcCCCccccccCcccccCcCHHHHHHHHHHhh
Confidence 35678999999999999997 999999999999999874 7999999998865 88999999999998853
|
| >2ecw_A Tripartite motif-containing protein 30; metal binding protein, structural genomics, NPPSFA; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=96.66 E-value=0.00039 Score=59.34 Aligned_cols=66 Identities=24% Similarity=0.410 Sum_probs=58.1
Q ss_pred CCCCCCCcccchhhhccCCccccCCccchhhhhhhhhcC-----CCCCCCCCCCCCCCCCCCchHHHHHHH
Q 003384 752 CEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDS-----GHETSPMTNLPLAHKNLVPNLALRSAI 817 (824)
Q Consensus 752 ~~~P~~f~cPi~~evm~dPvi~~~g~tye~~~i~~wl~~-----~~~t~p~t~~~l~~~~l~pn~~lr~~i 817 (824)
......+.|||..+.+.+|++..=|++|=...|..|+.. +..+||+.+.++....+.||..|++.|
T Consensus 14 ~~~~~~~~C~IC~~~~~~p~~~~CgH~fC~~Ci~~~~~~~~~~~~~~~CP~Cr~~~~~~~~~~n~~l~~~v 84 (85)
T 2ecw_A 14 EMIKEEVTCPICLELLKEPVSADCNHSFCRACITLNYESNRNTDGKGNCPVCRVPYPFGNLKPNLHVANIV 84 (85)
T ss_dssp CCCCTTTSCTTTCSCCSSCEECTTSCCBCHHHHHHHHHHSBCTTSCBCCTTTCCCCCTTCCEECSCCCSSC
T ss_pred HhCccCCCCcCCChhhCcceeCCCCCHHHHHHHHHHHHhccCCCCCCCCCCCCCcCCHHhCCcCHHHHHhh
Confidence 345678999999999999999999999999999999987 367899999999999999998876543
|
| >2ckl_B Ubiquitin ligase protein RING2; BMI1, RING1B, polycomb, E3-ligase, nuclear protein, chromosomal protein, transcription regulation; 2.0A {Mus musculus} PDB: 3rpg_C 2h0d_B | Back alignment and structure |
|---|
Probab=96.57 E-value=0.00095 Score=64.97 Aligned_cols=67 Identities=18% Similarity=0.332 Sum_probs=60.7
Q ss_pred CCCCcccchhhhccCCccc-cCCccchhhhhhhhhcCCCCCCCCCCCCCC-CCCCCchHHHHHHHHHHH
Q 003384 755 PPYFTCPIFQEVMQDPHVA-ADGFTYEAEALKGWLDSGHETSPMTNLPLA-HKNLVPNLALRSAIQEWL 821 (824)
Q Consensus 755 P~~f~cPi~~evm~dPvi~-~~g~tye~~~i~~wl~~~~~t~p~t~~~l~-~~~l~pn~~lr~~i~~~~ 821 (824)
.+.+.|||+.+.+.+|++. .=|++|=...|..|+..++.+||+.+.++. ...|.||..|+.+|..|.
T Consensus 52 ~~~~~C~IC~~~~~~p~~~~~CgH~fC~~Ci~~~~~~~~~~CP~Cr~~~~~~~~l~~~~~l~~~i~~~~ 120 (165)
T 2ckl_B 52 HSELMCPICLDMLKNTMTTKECLHRFCADCIITALRSGNKECPTCRKKLVSKRSLRPDPNFDALISKIY 120 (165)
T ss_dssp HHHHBCTTTSSBCSSEEEETTTCCEEEHHHHHHHHHTTCCBCTTTCCBCCSGGGEEECHHHHHHHHHHC
T ss_pred CCCCCCcccChHhhCcCEeCCCCChhHHHHHHHHHHhCcCCCCCCCCcCCCcccCCcCHHHHHHHHHHH
Confidence 4567899999999999987 889999999999999988889999999985 467999999999999884
|
| >2egp_A Tripartite motif-containing protein 34; ZF-C3HC4 domain, tripartite motif protein 34, interferon- responsive finger protein 1; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.56 E-value=0.00034 Score=59.05 Aligned_cols=65 Identities=17% Similarity=0.300 Sum_probs=57.7
Q ss_pred CCCCCCcccchhhhccCCccccCCccchhhhhhhhhcCC------CCCCCCCCCCCCCCCCCchHHHHHHH
Q 003384 753 EPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSG------HETSPMTNLPLAHKNLVPNLALRSAI 817 (824)
Q Consensus 753 ~~P~~f~cPi~~evm~dPvi~~~g~tye~~~i~~wl~~~------~~t~p~t~~~l~~~~l~pn~~lr~~i 817 (824)
...+.+.|||..+.+.+|++..=|++|=...|..|+... ..+||+.+.++....+.||..|++.|
T Consensus 8 ~~~~~~~C~IC~~~~~~p~~l~CgH~fC~~Ci~~~~~~~~~~~~~~~~CP~Cr~~~~~~~l~~n~~l~~lv 78 (79)
T 2egp_A 8 NVQEEVTCPICLELLTEPLSLDCGHSLCRACITVSNKEAVTSMGGKSSCPVCGISYSFEHLQANQHLANIV 78 (79)
T ss_dssp CCCCCCEETTTTEECSSCCCCSSSCCCCHHHHSCCCCCCSSSCCCCCCCSSSCCCCCSSGGGTCSSSCCCC
T ss_pred hcccCCCCcCCCcccCCeeECCCCCHHHHHHHHHHHHhcccCCCCCCcCCCCCCcCCHhhCCcCHHHHHhh
Confidence 456789999999999999999999999999999999863 67999999999999999999886543
|
| >1q77_A Hypothetical protein AQ_178; structural genomics, universal stress protein, PSI, protein structure initiative; 2.70A {Aquifex aeolicus} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=96.55 E-value=0.0059 Score=56.51 Aligned_cols=73 Identities=7% Similarity=-0.024 Sum_probs=57.2
Q ss_pred HHHHHHHHHHHHHHHHHHH--hhcCeeeEEEEeecCchHHHHHHHHHHcCCCEEEeccCcCccchhhhcccchhhHHhhh
Q 003384 43 REIERQDMHNHLDMCLLIC--RQMGVRAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVR 120 (824)
Q Consensus 43 ~~~e~~~~~~~l~~~~~~C--~~~~V~~~~~~ie~~dv~~~i~e~i~~~~i~~LV~Ga~~~~~~~~~~~~~~s~~a~~v~ 120 (824)
.+..++..++.|+++ ..| ...+ +++..+.+ ++++++|++++.+++++.+|||++ + + ..+..|+
T Consensus 63 ~~~~~~~~~~~l~~~-~~~~~~~~~-~~~~~~~~-g~~~~~I~~~a~~~~~dliV~G~~---g--~-------sv~~~vl 127 (138)
T 1q77_A 63 KEESKKRIERRLREV-WEKLTGSTE-IPGVEYRI-GPLSEEVKKFVEGKGYELVVWACY---P--S-------AYLCKVI 127 (138)
T ss_dssp HHHHHHHHHHHHHHH-HHHHHSCCC-CCCEEEEC-SCHHHHHHHHHTTSCCSEEEECSC---C--G-------GGTHHHH
T ss_pred HHHHHHHHHHHHHHH-HHHhhccCC-cceEEEEc-CCHHHHHHHHHHhcCCCEEEEeCC---C--C-------chHHHHH
Confidence 344556677888888 775 5566 77776555 899999999999999999999998 2 2 2456899
Q ss_pred ccCCCccEEEEE
Q 003384 121 QQAPASCHIWFI 132 (824)
Q Consensus 121 ~~a~~~C~v~~i 132 (824)
..++ |-|++|
T Consensus 128 ~~a~--~PVlvv 137 (138)
T 1q77_A 128 DGLN--LASLIV 137 (138)
T ss_dssp HHSS--SEEEEC
T ss_pred HhCC--CceEee
Confidence 9987 999986
|
| >2ecv_A Tripartite motif-containing protein 5; metal binding protein, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.52 E-value=0.00063 Score=58.03 Aligned_cols=66 Identities=20% Similarity=0.386 Sum_probs=58.0
Q ss_pred CCCCCCCcccchhhhccCCccccCCccchhhhhhhhhcC-----CCCCCCCCCCCCCCCCCCchHHHHHHH
Q 003384 752 CEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDS-----GHETSPMTNLPLAHKNLVPNLALRSAI 817 (824)
Q Consensus 752 ~~~P~~f~cPi~~evm~dPvi~~~g~tye~~~i~~wl~~-----~~~t~p~t~~~l~~~~l~pn~~lr~~i 817 (824)
....+.+.|||..+.+.+|++..=|++|=...|..|+.. +..+||+.+.++....+.||+.|++.|
T Consensus 14 ~~~~~~~~C~IC~~~~~~p~~~~CgH~fC~~Ci~~~~~~~~~~~~~~~CP~Cr~~~~~~~~~~n~~l~~~v 84 (85)
T 2ecv_A 14 VNVKEEVTCPICLELLTQPLSLDCGHSFCQACLTANHKKSMLDKGESSCPVCRISYQPENIRPNRHVANIV 84 (85)
T ss_dssp CCCCCCCCCTTTCSCCSSCBCCSSSCCBCTTHHHHHHHHHHHTTSCCCCTTTCCSSCSSSCCCSCCCCCCC
T ss_pred HHccCCCCCCCCCcccCCceeCCCCCHHHHHHHHHHHHHhhcCCCCCcCCCCCCccCHHhcCccHHHHHhh
Confidence 356778999999999999999999999999999999976 467999999999999999998876543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.51 E-value=0.006 Score=66.23 Aligned_cols=33 Identities=15% Similarity=0.255 Sum_probs=28.5
Q ss_pred CCceEeccccCCcEEecCCCcceeecccccccc
Q 003384 581 PHSIVHGDLKPANILLDANFVSKLSDFGISRFL 613 (824)
Q Consensus 581 ~~giiHrDLKp~NILld~~~~vKL~DFGla~~~ 613 (824)
+..++|+|+.+.|||++.++.+.|+||+.+...
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 357999999999999998888999999877643
|
| >3hcs_A TNF receptor-associated factor 6; cross-brace, beta-BETA-alpha, coiled coil, cytoplasm, metal- binding, UBL conjugation, UBL conjugation pathway; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.41 E-value=0.001 Score=65.02 Aligned_cols=67 Identities=15% Similarity=0.263 Sum_probs=62.2
Q ss_pred CCCCCCcccchhhhccCCccccCCccchhhhhhhhhcCCCCCCCCCCCCCCCCCCCchHHHHHHHHH
Q 003384 753 EPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQE 819 (824)
Q Consensus 753 ~~P~~f~cPi~~evm~dPvi~~~g~tye~~~i~~wl~~~~~t~p~t~~~l~~~~l~pn~~lr~~i~~ 819 (824)
.+++.|.|||..+++.+|+.+.=|++|=...|.+|+..+..+||+.+.++....++||.+++..|.+
T Consensus 14 ~~~~~~~C~IC~~~~~~pv~~~CgH~fC~~Ci~~~~~~~~~~CP~Cr~~~~~~~~~~~~~~~~~i~~ 80 (170)
T 3hcs_A 14 PLESKYECPICLMALREAVQTPCGHRFCKACIIKSIRDAGHKCPVDNEILLENQLFPDNFAKREILS 80 (170)
T ss_dssp CCCGGGBCTTTCSBCSSEEECTTSCEEEHHHHHHHHHHHCSBCTTTCCBCCGGGCEECHHHHHHHHT
T ss_pred CCCCCCCCCCCChhhcCcEECCCCCHHHHHHHHHHHHhCCCCCCCCccCcchhhhhhhHHHHHHHhh
Confidence 5678899999999999999999999999999999998877799999999999999999999998875
|
| >1jmv_A USPA, universal stress protein A; chaperone; 1.85A {Haemophilus influenzae} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=96.21 E-value=0.012 Score=54.65 Aligned_cols=76 Identities=12% Similarity=0.128 Sum_probs=57.6
Q ss_pred HHHHHHHHHHHHHHhhcCeeeEEEEeecCchHHHHHHHHHHcCCCEEEeccCcCccchhhhcccchhhHHhhhccCCCcc
Q 003384 48 QDMHNHLDMCLLICRQMGVRAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAPASC 127 (824)
Q Consensus 48 ~~~~~~l~~~~~~C~~~~V~~~~~~ie~~dv~~~i~e~i~~~~i~~LV~Ga~~~~~~~~~~~~~~s~~a~~v~~~a~~~C 127 (824)
+..++.|+.+ +.+.++.+....+..++++++|++++..++++.+|||++ .+...+ + ...+..|+.+++ |
T Consensus 63 ~~~~~~l~~~---~~~~~~~~~~~~~~~g~~~~~I~~~a~~~~~dliV~G~~-~~~~~~-l----gs~~~~vl~~~~--~ 131 (141)
T 1jmv_A 63 TETQKALLDL---AESVDYPISEKLSGSGDLGQVLSDAIEQYDVDLLVTGHH-QDFWSK-L----MSSTRQVMNTIK--I 131 (141)
T ss_dssp CHHHHHHHHH---HHHSSSCCCCEEEEEECHHHHHHHHHHHTTCCEEEEEEC-CCCHHH-H----HHHHHHHHTTCC--S
T ss_pred HHHHHHHHHH---HHHcCCCceEEEEecCCHHHHHHHHHHhcCCCEEEEeCC-Cchhhh-h----cchHHHHHhcCC--C
Confidence 4455666654 445688875455566899999999999999999999999 655544 2 235778999987 9
Q ss_pred EEEEEec
Q 003384 128 HIWFICN 134 (824)
Q Consensus 128 ~v~~i~~ 134 (824)
.|++|-.
T Consensus 132 pVlvv~~ 138 (141)
T 1jmv_A 132 DMLVVPL 138 (141)
T ss_dssp EEEEEEC
T ss_pred CEEEeeC
Confidence 9999853
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.03 E-value=0.011 Score=66.35 Aligned_cols=139 Identities=14% Similarity=0.190 Sum_probs=84.2
Q ss_pred ceeeecCceEEEEEEEC---------CeEEEEEEecCCCCCCchhHHHHHHHHHhcC-CCceeeEecccCCceEEEEEec
Q 003384 470 LKIGEGGYGSIYKGLLR---------HMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVGACPEVWTLVYEYL 539 (824)
Q Consensus 470 ~~LG~G~fG~Vykg~~~---------~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~-HpnIv~L~g~~~~~~~LV~Ey~ 539 (824)
..|..|-...+|+.... +..+++++..... ...-...+|..+++.|. +.-..++++.+. .++||||+
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~--~~~I~efI 152 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP--EGRIEEFI 152 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET--TEEEEECC
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC--CCEEEEEe
Confidence 45777777889998776 5779999864432 11223468999998884 322345565544 36899999
Q ss_pred CCCChhhh--------------h---hcc-------C---CCCCCCHHHHHHHHHHH-------------------HHHH
Q 003384 540 PNGSLEDR--------------L---SCK-------D---NSPPLSWQTRIRIATEL-------------------CSVL 573 (824)
Q Consensus 540 ~ggsL~~~--------------L---~~~-------~---~~~~l~~~~~~~ia~qi-------------------a~aL 573 (824)
+|.+|... | +.. . ...+..+.++.++..++ ...+
T Consensus 153 ~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~e~ 232 (424)
T 3mes_A 153 DGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILEEI 232 (424)
T ss_dssp CSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHHHH
T ss_pred CCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHHHH
Confidence 98664210 0 000 0 11222344444443222 1223
Q ss_pred HHHhh---------------------cCCCceEeccccCCcEEecCCCcceeeccccccc
Q 003384 574 IFLHS---------------------CKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 612 (824)
Q Consensus 574 ~~LH~---------------------~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~ 612 (824)
.+|.. ..+..++|+|+.+.||+ +.++.+.|+||..|..
T Consensus 233 ~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 233 DQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 33321 12356899999999999 7788999999998753
|
| >3mt0_A Uncharacterized protein PA1789; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: MSE; 1.58A {Pseudomonas aeruginosa} | Back alignment and structure |
|---|
Probab=96.02 E-value=0.016 Score=60.92 Aligned_cols=83 Identities=14% Similarity=0.101 Sum_probs=57.6
Q ss_pred HHHHHHHHHHHHHHHHHHHhhcCeeeEEEEeecCchHHHHHHHHHHcCCCEEEeccCcCccchhhhcccchhhHHhhhcc
Q 003384 43 REIERQDMHNHLDMCLLICRQMGVRAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQ 122 (824)
Q Consensus 43 ~~~e~~~~~~~l~~~~~~C~~~~V~~~~~~ie~~dv~~~i~e~i~~~~i~~LV~Ga~~~~~~~~~~~~~~s~~a~~v~~~ 122 (824)
.+..++...+.|..+ +.+.++......+..++++++|++++..++++.||||++..+...+. +-...+..|+.+
T Consensus 193 ~~~~~~~~~~~l~~~---~~~~g~~~~~~~v~~g~~~~~I~~~a~~~~~dLiVmG~~g~~~~~~~---~~Gsv~~~vl~~ 266 (290)
T 3mt0_A 193 SETIEARYREACRTF---QAEYGFSDEQLHIEEGPADVLIPRTAQKLDAVVTVIGTVARTGLSGA---LIGNTAEVVLDT 266 (290)
T ss_dssp HHHHHHHHHHHHHHH---HHHHTCCTTTEEEEESCHHHHHHHHHHHHTCSEEEEECCSSCCGGGC---CSCHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHH---HHHcCCCcceEEEeccCHHHHHHHHHHhcCCCEEEECCCCCcCCcce---ecchHHHHHHhc
Confidence 333444455555554 34447864444455589999999999999999999999944444332 334467789999
Q ss_pred CCCccEEEEEe
Q 003384 123 APASCHIWFIC 133 (824)
Q Consensus 123 a~~~C~v~~i~ 133 (824)
++ |.|.+|-
T Consensus 267 ~~--~pVLvv~ 275 (290)
T 3mt0_A 267 LE--SDVLVLK 275 (290)
T ss_dssp CS--SEEEEEC
T ss_pred CC--CCEEEEC
Confidence 76 9999983
|
| >1jm7_A BRCA1, breast cancer type 1 susceptibility protein; ring finger, zinc-binding protein, heterodimer, ubiquitin ligase, antitumor; NMR {Homo sapiens} SCOP: g.44.1.1 | Back alignment and structure |
|---|
Probab=96.00 E-value=0.003 Score=56.98 Aligned_cols=66 Identities=15% Similarity=0.336 Sum_probs=59.2
Q ss_pred CCcccchhhhccCCccccCCccchhhhhhhhhcCC--CCCCCCCCCCCCCCCCCchHHHHHHHHHHHH
Q 003384 757 YFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSG--HETSPMTNLPLAHKNLVPNLALRSAIQEWLQ 822 (824)
Q Consensus 757 ~f~cPi~~evm~dPvi~~~g~tye~~~i~~wl~~~--~~t~p~t~~~l~~~~l~pn~~lr~~i~~~~~ 822 (824)
.+.|||+.+.+.+|+++.=|++|=...|..|+... ..+||+.+.++....+.+|..|.+.+..+..
T Consensus 21 ~~~C~IC~~~~~~p~~~~CgH~fC~~Ci~~~~~~~~~~~~CP~Cr~~~~~~~~~~~~~l~~~~~~~~~ 88 (112)
T 1jm7_A 21 ILECPICLELIKEPVSTKCDHIFCKFCMLKLLNQKKGPSQCPLCKNDITKRSLQESTRFSQLVEELLK 88 (112)
T ss_dssp HTSCSSSCCCCSSCCBCTTSCCCCSHHHHHHHHSSSSSCCCTTTSCCCCTTTCBCCCSSSHHHHHHHH
T ss_pred CCCCcccChhhcCeEECCCCCHHHHHHHHHHHHhCCCCCCCcCCCCcCCHhhcCccHHHHHHHHHHHH
Confidence 46899999999999999999999999999999853 3589999999999999999999888888764
|
| >3l11_A E3 ubiquitin-protein ligase RNF168; E3 ligase, ring domain, DNA damage, chromatin regulator, CHR protein, DNA repair, metal-binding, nucleus; 2.12A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.00 E-value=0.0036 Score=56.96 Aligned_cols=67 Identities=16% Similarity=0.246 Sum_probs=61.2
Q ss_pred CCCCcccchhhhccCCccccCCccchhhhhhhhhcCCCCCCCCCCCCCCC-------CCCCchHHHHHHHHHHH
Q 003384 755 PPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAH-------KNLVPNLALRSAIQEWL 821 (824)
Q Consensus 755 P~~f~cPi~~evm~dPvi~~~g~tye~~~i~~wl~~~~~t~p~t~~~l~~-------~~l~pn~~lr~~i~~~~ 821 (824)
.+.+.|||+.+++.+|++..=|++|=...|..|+..+..+||+.+.++.. ..+.+|..|...|+.|+
T Consensus 13 ~~~~~C~iC~~~~~~p~~~~CgH~fC~~Ci~~~~~~~~~~CP~Cr~~~~~~~~~~~~~~~~~n~~l~~~i~~~~ 86 (115)
T 3l11_A 13 LSECQCGICMEILVEPVTLPCNHTLCKPCFQSTVEKASLCCPFCRRRVSSWTRYHTRRNSLVNVELWTIIQKHY 86 (115)
T ss_dssp HHHHBCTTTCSBCSSCEECTTSCEECHHHHCCCCCTTTSBCTTTCCBCHHHHHHHHHTTCCBCHHHHHHHHHHS
T ss_pred CCCCCCccCCcccCceeEcCCCCHHhHHHHHHHHhHCcCCCCCCCcccCccccccccccchhhHHHHHHHHHHC
Confidence 45689999999999999999999999999999999888899999999863 67889999999999986
|
| >2csy_A Zinc finger protein 183-like 1; ring finger protein 161, ring domain, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.71 E-value=0.01 Score=50.20 Aligned_cols=65 Identities=17% Similarity=0.229 Sum_probs=56.7
Q ss_pred CCCCCCcccchhhhccCCccccCCccchhhhhhhhhcCCCCCCCCCCCCCCCCCCCchHHHHHHHHH
Q 003384 753 EPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQE 819 (824)
Q Consensus 753 ~~P~~f~cPi~~evm~dPvi~~~g~tye~~~i~~wl~~~~~t~p~t~~~l~~~~l~pn~~lr~~i~~ 819 (824)
.....+.|||..+.+.+|+++.=|++|=...|..|+.. ..+||+.+.++. ..+.||..|...+..
T Consensus 11 ~~~~~~~C~IC~~~~~~p~~~~CgH~fC~~Ci~~~~~~-~~~CP~Cr~~~~-~~~~~~~~l~~~~~~ 75 (81)
T 2csy_A 11 EEEIPFRCFICRQAFQNPVVTKCRHYFCESCALEHFRA-TPRCYICDQPTG-GIFNPAKELMAKLQK 75 (81)
T ss_dssp CCCCCSBCSSSCSBCCSEEECTTSCEEEHHHHHHHHHH-CSBCSSSCCBCC-SCCEECHHHHHHHSS
T ss_pred cCCCCCCCcCCCchhcCeeEccCCCHhHHHHHHHHHHC-CCcCCCcCcccc-ccCCcHHHHHHHHHh
Confidence 34567899999999999999999999999999999976 679999999997 788899888776654
|
| >3lrq_A E3 ubiquitin-protein ligase TRIM37; structural genomics, PSI-2, protein structure initiative, northeast structural genomics consortium, NESG; HET: MSE; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.65 E-value=0.0042 Score=55.16 Aligned_cols=65 Identities=20% Similarity=0.298 Sum_probs=58.2
Q ss_pred CCCcccchhhhccCCcc-ccCCccchhhhhhhhhcCCCCCCCCCCCCCCCCCCCchHHHHHHHHHH
Q 003384 756 PYFTCPIFQEVMQDPHV-AADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEW 820 (824)
Q Consensus 756 ~~f~cPi~~evm~dPvi-~~~g~tye~~~i~~wl~~~~~t~p~t~~~l~~~~l~pn~~lr~~i~~~ 820 (824)
..+.|||+.+++.+|+. ..=|++|=...|..|+.....+||+.+.++....|++|..|.+.+...
T Consensus 21 ~~~~C~IC~~~~~~p~~~~~CgH~FC~~Ci~~~~~~~~~~CP~Cr~~~~~~~l~~~~~~~~i~~~~ 86 (100)
T 3lrq_A 21 EVFRCFICMEKLRDARLCPHCSKLCCFSCIRRWLTEQRAQCPHCRAPLQLRELVNCRWAEEVTQQL 86 (100)
T ss_dssp HHTBCTTTCSBCSSEEECTTTCCEEEHHHHHHHHHHTCSBCTTTCCBCCGGGCEECTTHHHHHHHH
T ss_pred CCCCCccCCccccCccccCCCCChhhHHHHHHHHHHCcCCCCCCCCcCCHHHhHhhHHHHHHHHHH
Confidence 45789999999999999 888999999999999998667999999999999999999888776543
|
| >3loq_A Universal stress protein; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: AMP; 2.32A {Archaeoglobus fulgidus} | Back alignment and structure |
|---|
Probab=95.63 E-value=0.021 Score=60.17 Aligned_cols=78 Identities=13% Similarity=0.149 Sum_probs=61.3
Q ss_pred HHHHHHHHHHHhhcCeeeEEEEeecCchHHHHHHHHHHcCCCEEEeccCcCccchhhhcccchhhHHhhhccCCCccEEE
Q 003384 51 HNHLDMCLLICRQMGVRAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAPASCHIW 130 (824)
Q Consensus 51 ~~~l~~~~~~C~~~~V~~~~~~ie~~dv~~~i~e~i~~~~i~~LV~Ga~~~~~~~~~~~~~~s~~a~~v~~~a~~~C~v~ 130 (824)
.+.++.+...+.+.+++++..+.+ ++++++|++++..++++.||||+...+...+.. -...+..|+..++ |.|.
T Consensus 213 ~~~l~~~~~~l~~~~~~~~~~~~~-g~~~~~I~~~a~~~~~dLlV~G~~~~~~~~~~~---~Gs~~~~vl~~~~--~pvL 286 (294)
T 3loq_A 213 TADLRVMEEVIGAEGIEVHVHIES-GTPHKAILAKREEINATTIFMGSRGAGSVMTMI---LGSTSESVIRRSP--VPVF 286 (294)
T ss_dssp HHHHHHHHHHHHHTTCCEEEEEEC-SCHHHHHHHHHHHTTCSEEEEECCCCSCHHHHH---HHCHHHHHHHHCS--SCEE
T ss_pred HHHHHHHHHHHHHcCCcEEEEEec-CCHHHHHHHHHHhcCcCEEEEeCCCCCCcccee---eCcHHHHHHhcCC--CCEE
Confidence 456778888888899998877665 799999999999999999999999544444332 2335668888876 9999
Q ss_pred EEec
Q 003384 131 FICN 134 (824)
Q Consensus 131 ~i~~ 134 (824)
++..
T Consensus 287 vv~~ 290 (294)
T 3loq_A 287 VCKR 290 (294)
T ss_dssp EECS
T ss_pred EECC
Confidence 9853
|
| >2ecy_A TNF receptor-associated factor 3; metal binding protein, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.63 E-value=0.014 Score=47.32 Aligned_cols=55 Identities=11% Similarity=0.224 Sum_probs=49.2
Q ss_pred CCCCCCcccchhhhccCCccccCCccchhhhhhhhhcCCCCCCCCCCCCCCCCCC
Q 003384 753 EPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNL 807 (824)
Q Consensus 753 ~~P~~f~cPi~~evm~dPvi~~~g~tye~~~i~~wl~~~~~t~p~t~~~l~~~~l 807 (824)
..++.+.|||..+.+.+|+++.=|++|=...|..|+..+..+||+.+.++...++
T Consensus 11 ~~~~~~~C~IC~~~~~~p~~~~CgH~fC~~Ci~~~~~~~~~~CP~Cr~~~~~~~i 65 (66)
T 2ecy_A 11 TVEDKYKCEKCHLVLCSPKQTECGHRFCESCMAALLSSSSPKCTACQESIVKDKV 65 (66)
T ss_dssp SCCCCEECTTTCCEESSCCCCSSSCCCCHHHHHHHHTTSSCCCTTTCCCCCTTTC
T ss_pred cCCcCCCCCCCChHhcCeeECCCCCHHHHHHHHHHHHhCcCCCCCCCcCCChhhc
Confidence 4567899999999999999999999999999999998777899999999886655
|
| >3olq_A Universal stress protein E; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: UNL; 1.82A {Proteus mirabilis} | Back alignment and structure |
|---|
Probab=95.56 E-value=0.024 Score=60.30 Aligned_cols=85 Identities=13% Similarity=0.168 Sum_probs=60.6
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHhhcCeeeEEEEeecCchHHHHHHHHHHcCCCEEEeccCcCccchhhhcccchhhHHhh
Q 003384 40 QAYREIERQDMHNHLDMCLLICRQMGVRAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISV 119 (824)
Q Consensus 40 ~~~~~~e~~~~~~~l~~~~~~C~~~~V~~~~~~ie~~dv~~~i~e~i~~~~i~~LV~Ga~~~~~~~~~~~~~~s~~a~~v 119 (824)
..+.++.++...+.|..|+ .+.++......+..++++++|++++..++++.||||++..+.+.+.. -...+..|
T Consensus 219 ~~~~~~~~~~~~~~l~~~~---~~~~~~~~~~~v~~g~~~~~I~~~a~~~~~dLiV~G~~g~~~~~~~~---~Gsv~~~v 292 (319)
T 3olq_A 219 NLYNNALRGQHLIAMKELR---QKFSIPEEKTHVKEGLPEQVIPQVCEELNAGIVVLGILGRTGLSAAF---LGNTAEQL 292 (319)
T ss_dssp HHHHHHHHHHHHHHHHHHH---HHTTCCGGGEEEEESCHHHHHHHHHHHTTEEEEEEECCSCCSTHHHH---HHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHH---HHhCCCcccEEEecCCcHHHHHHHHHHhCCCEEEEeccCccCCcccc---ccHHHHHH
Confidence 3455555666666666654 45566433344556899999999999999999999999555544332 23457789
Q ss_pred hccCCCccEEEEE
Q 003384 120 RQQAPASCHIWFI 132 (824)
Q Consensus 120 ~~~a~~~C~v~~i 132 (824)
+.+++ |.|.+|
T Consensus 293 l~~~~--~pVLvv 303 (319)
T 3olq_A 293 IDHIK--CDLLAI 303 (319)
T ss_dssp HTTCC--SEEEEE
T ss_pred HhhCC--CCEEEE
Confidence 99876 999998
|
| >3mt0_A Uncharacterized protein PA1789; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: MSE; 1.58A {Pseudomonas aeruginosa} | Back alignment and structure |
|---|
Probab=95.46 E-value=0.033 Score=58.54 Aligned_cols=79 Identities=14% Similarity=0.122 Sum_probs=62.4
Q ss_pred HHHHHHHHHHHHhhcCeeeEEEEeecCchHHHHHHHHHHcCCCEEEeccCcCccchhhhcccchhhHHhhhccCCCccEE
Q 003384 50 MHNHLDMCLLICRQMGVRAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAPASCHI 129 (824)
Q Consensus 50 ~~~~l~~~~~~C~~~~V~~~~~~ie~~dv~~~i~e~i~~~~i~~LV~Ga~~~~~~~~~~~~~~s~~a~~v~~~a~~~C~v 129 (824)
.++.|+.+...+...+|+++..+.+.++++.+|++++...+++.+|||++...... +.+-+..+..|+..++ |-|
T Consensus 49 ~~~~l~~~~~~~~~~~~~~~~~~~~~g~~~~~i~~~a~~~~~dliV~G~~~~~~~~---~~~~gs~~~~vl~~~~--~PV 123 (290)
T 3mt0_A 49 HSAALNDLAQELREEGYSVSTNQAWKDSLHQTIIAEQQAEGCGLIIKQHFPDNPLK---KAILTPDDWKLLRFAP--CPV 123 (290)
T ss_dssp CHHHHHHHHHHHHHTTCCEEEEEECSSSHHHHHHHHHHHHTCSEEEEECCCSCTTS---TTSCCHHHHHHHHHCS--SCE
T ss_pred HHHHHHHHHHHHhhCCCeEEEEEEeCCCHHHHHHHHHHhcCCCEEEEecccCCchh---hcccCHHHHHHHhcCC--CCE
Confidence 34566777777788999999999888999999999999999999999999433332 2233446778888876 999
Q ss_pred EEEe
Q 003384 130 WFIC 133 (824)
Q Consensus 130 ~~i~ 133 (824)
+++-
T Consensus 124 lvv~ 127 (290)
T 3mt0_A 124 LMTK 127 (290)
T ss_dssp EEEC
T ss_pred EEec
Confidence 9983
|
| >2yur_A Retinoblastoma-binding protein 6; P53-associated cellular protein of testis, proliferation potential-related protein, protein P2P-R; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.45 E-value=0.011 Score=49.18 Aligned_cols=60 Identities=22% Similarity=0.238 Sum_probs=50.3
Q ss_pred CCCCCCCcccchhhhccCCcccc-CCccchhhhhhhhhcCC-CCCCCCCCCCCC-CCCCCchH
Q 003384 752 CEPPPYFTCPIFQEVMQDPHVAA-DGFTYEAEALKGWLDSG-HETSPMTNLPLA-HKNLVPNL 811 (824)
Q Consensus 752 ~~~P~~f~cPi~~evm~dPvi~~-~g~tye~~~i~~wl~~~-~~t~p~t~~~l~-~~~l~pn~ 811 (824)
...+..+.|||..+++.+|+++. =|++|=...|..|+... ..+||+.+.+.. ...+++|.
T Consensus 10 ~~~~~~~~C~IC~~~~~~p~~~~~CgH~fC~~Ci~~~~~~~~~~~CP~Cr~~~~~~~~~~~n~ 72 (74)
T 2yur_A 10 DPIPDELLCLICKDIMTDAVVIPCCGNSYCDECIRTALLESDEHTCPTCHQNDVSPDALSGPS 72 (74)
T ss_dssp CCSCGGGSCSSSCCCCTTCEECSSSCCEECTTHHHHHHHHSSSSCCSSSCCSSCCTTTTTCTT
T ss_pred ccCCCCCCCcCCChHHhCCeEcCCCCCHHHHHHHHHHHHhcCCCcCCCCCCcCCCccccccCC
Confidence 35678899999999999999998 69999999999999853 368999999844 56777773
|
| >1rmd_A RAG1; V(D)J recombination, antibody, MAD, ring finger, zinc binuclear cluster, zinc finger, DNA-binding protein; 2.10A {Mus musculus} SCOP: g.37.1.1 g.44.1.1 | Back alignment and structure |
|---|
Probab=95.38 E-value=0.0092 Score=54.28 Aligned_cols=65 Identities=14% Similarity=0.212 Sum_probs=56.4
Q ss_pred CCCCcccchhhhccCCccccCCccchhhhhhhhhcCCCCCCCCCCCCCCCCCCC-chHHHHHHHHH
Q 003384 755 PPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLV-PNLALRSAIQE 819 (824)
Q Consensus 755 P~~f~cPi~~evm~dPvi~~~g~tye~~~i~~wl~~~~~t~p~t~~~l~~~~l~-pn~~lr~~i~~ 819 (824)
++.+.|||..+++.+|+++.=|++|=...|..|+..++.+||+.+.++...++. |+..|.++|.+
T Consensus 21 ~~~~~C~IC~~~~~~p~~~~CgH~fC~~Ci~~~~~~~~~~CP~Cr~~~~~~~~~~~~~~l~~~i~~ 86 (116)
T 1rmd_A 21 VKSISCQICEHILADPVETSCKHLFCRICILRCLKVMGSYCPSCRYPCFPTDLESPVKSFLNILNS 86 (116)
T ss_dssp HHHTBCTTTCSBCSSEEECTTSCEEEHHHHHHHHHHTCSBCTTTCCBCCGGGCBCCCHHHHHHHHH
T ss_pred cCCCCCCCCCcHhcCcEEcCCCCcccHHHHHHHHhHCcCcCCCCCCCCCHhhccccHHHHHHHHHH
Confidence 456889999999999999999999999999999998778999999999877765 56777777764
|
| >3knv_A TNF receptor-associated factor 2; cross-brace, alternative splicing, apoptosis, cytoplasm, metal-binding, UBL conjugation, zinc, zinc-finger; 1.90A {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.22 E-value=0.003 Score=59.97 Aligned_cols=67 Identities=19% Similarity=0.288 Sum_probs=57.8
Q ss_pred CCCCCCcccchhhhccCCccccCCccchhhhhhhhhcCCCCCCCCCCCCCC---------CCCCCchHHHHHHHHH
Q 003384 753 EPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLA---------HKNLVPNLALRSAIQE 819 (824)
Q Consensus 753 ~~P~~f~cPi~~evm~dPvi~~~g~tye~~~i~~wl~~~~~t~p~t~~~l~---------~~~l~pn~~lr~~i~~ 819 (824)
..++.|.|||+.+++.+|+.+.=|++|=+..|..|+..+..+||+.+.++. ...++||.+++..|.+
T Consensus 27 ~l~~~~~C~IC~~~~~~pv~~~CgH~FC~~Ci~~~~~~~~~~CP~Cr~~~~~~~~~~~l~~~~~~~d~~~~~~i~~ 102 (141)
T 3knv_A 27 KLEAKYLCSACRNVLRRPFQAQCGHRYCSFCLASILSSGPQNCAACVHEGIYEEGISILESSSAFPDNAARREVES 102 (141)
T ss_dssp GCCGGGBCTTTCSBCSSEEECTTSCEEEHHHHHHHGGGSCEECHHHHHTTCCCTTTTEECGGGCEECHHHHHHHHT
T ss_pred cCCcCcCCCCCChhhcCcEECCCCCccCHHHHHHHHhcCCCCCCCCCCcccccccccccchhhhcccHHHHHHHcc
Confidence 456789999999999999999999999999999999987779999987642 3467899999998864
|
| >3cis_A Uncharacterized protein; alpha/beta hydrolase, ATP, universal stress protein, unknown function; HET: ATP; 2.90A {Mycobacterium tuberculosis} PDB: 2jax_A* | Back alignment and structure |
|---|
Probab=94.79 E-value=0.062 Score=56.98 Aligned_cols=76 Identities=13% Similarity=0.109 Sum_probs=54.8
Q ss_pred HHHHHHHHHHHHhh--cCeeeEEEEeecCchHHHHHHHHHHcCCCEEEeccCcCccchhhhcccchhhHHhhhccCCCcc
Q 003384 50 MHNHLDMCLLICRQ--MGVRAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAPASC 127 (824)
Q Consensus 50 ~~~~l~~~~~~C~~--~~V~~~~~~ie~~dv~~~i~e~i~~~~i~~LV~Ga~~~~~~~~~~~~~~s~~a~~v~~~a~~~C 127 (824)
.++.|..++..+.. .+|+++..+.+ ++++++|++++. +++.||||+.....+.+. +-...+..|+..++ |
T Consensus 228 ~~~~l~~~~~~~~~~~~~~~~~~~~~~-g~~~~~I~~~a~--~adliV~G~~~~~~~~~~---l~Gsv~~~vl~~~~--~ 299 (309)
T 3cis_A 228 AEQVLAERLAGWQERYPNVAITRVVVR-DQPARQLVQRSE--EAQLVVVGSRGRGGYAGM---LVGSVGETVAQLAR--T 299 (309)
T ss_dssp HHHHHHHHHTTHHHHCTTSCEEEEEES-SCHHHHHHHHHT--TCSEEEEESSCSSCCTTC---SSCHHHHHHHHHCS--S
T ss_pred HHHHHHHHHHHHHhhCCCCcEEEEEEc-CCHHHHHHHhhC--CCCEEEECCCCCCCcccc---ccCcHHHHHHhcCC--C
Confidence 34455555554433 58888877655 899999999997 999999999954444333 23446778999976 9
Q ss_pred EEEEEe
Q 003384 128 HIWFIC 133 (824)
Q Consensus 128 ~v~~i~ 133 (824)
-|.++-
T Consensus 300 pVlvv~ 305 (309)
T 3cis_A 300 PVIVAR 305 (309)
T ss_dssp CEEEEC
T ss_pred CEEEeC
Confidence 999983
|
| >4ayc_A E3 ubiquitin-protein ligase RNF8; DNA damage, K63 chains; HET: CPQ; 1.90A {Homo sapiens} PDB: 4epo_C | Back alignment and structure |
|---|
Probab=94.69 E-value=0.02 Score=53.82 Aligned_cols=62 Identities=15% Similarity=0.309 Sum_probs=49.7
Q ss_pred CCcccchhhhccCCccccCCccchhhhhhhhhcCCCCCCCCCCCCCCCCCCCchHHHHHHHHHHH
Q 003384 757 YFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWL 821 (824)
Q Consensus 757 ~f~cPi~~evm~dPvi~~~g~tye~~~i~~wl~~~~~t~p~t~~~l~~~~l~pn~~lr~~i~~~~ 821 (824)
.+.|||+.+.+.+|++..=|++|=...|..|+.. +.+||+.+.++... .+|..+...|..++
T Consensus 53 ~~~C~iC~~~~~~~~~~~CgH~fc~~Ci~~~~~~-~~~CP~Cr~~~~~~--~~~~~~~~~i~~~~ 114 (138)
T 4ayc_A 53 ELQCIICSEYFIEAVTLNCAHSFCSYCINEWMKR-KIECPICRKDIKSK--TYSLVLDNCINKMV 114 (138)
T ss_dssp HSBCTTTCSBCSSEEEETTSCEEEHHHHHHHTTT-CSBCTTTCCBCCCE--EECHHHHHHHHHHH
T ss_pred cCCCcccCcccCCceECCCCCCccHHHHHHHHHc-CCcCCCCCCcCCCC--CCccchhHHHHHHH
Confidence 4689999999999999999999999999999987 67999999998643 23444444554443
|
| >2djb_A Polycomb group ring finger protein 6; PCGF6, ring domain, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.55 E-value=0.031 Score=46.11 Aligned_cols=58 Identities=16% Similarity=0.242 Sum_probs=51.4
Q ss_pred CCCCCCcccchhhhccCCccc-cCCccchhhhhhhhhcCCCCCCCCCCCCCCCCCCCchH
Q 003384 753 EPPPYFTCPIFQEVMQDPHVA-ADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNL 811 (824)
Q Consensus 753 ~~P~~f~cPi~~evm~dPvi~-~~g~tye~~~i~~wl~~~~~t~p~t~~~l~~~~l~pn~ 811 (824)
...+.+.|||..+.+.+|++. .=|++|=...|..|+.. ..+||+.+.++...++++|.
T Consensus 11 ~~~~~~~C~IC~~~~~~p~~~~~CgH~fC~~Ci~~~~~~-~~~CP~Cr~~~~~~~~~~~~ 69 (72)
T 2djb_A 11 ELTPYILCSICKGYLIDATTITECLHTFCKSCIVRHFYY-SNRCPKCNIVVHQTQPLSGP 69 (72)
T ss_dssp CCCGGGSCTTTSSCCSSCEECSSSCCEECHHHHHHHHHH-CSSCTTTCCCCCSSCSCCCC
T ss_pred hcCCCCCCCCCChHHHCcCEECCCCCHHHHHHHHHHHHc-CCcCCCcCcccCcccccccC
Confidence 456788999999999999986 89999999999999976 67999999999988888763
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=94.40 E-value=0.15 Score=51.60 Aligned_cols=122 Identities=16% Similarity=0.136 Sum_probs=75.3
Q ss_pred ChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCCC
Q 003384 543 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 622 (824)
Q Consensus 543 sL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~ 622 (824)
||.++|... ..|+++.+++.++.|.+.+|.-+-... .+ ..+=+.|..|+|..+|.|-+.+ +.+.
T Consensus 34 SL~eIL~~~--~~PlsEEqaWALc~Qc~~~L~~~~~~~-~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 34 SLEEILRLY--NQPINEEQAWAVCYQCCGSLRAAARRR-QP-RHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT-CC-CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred cHHHHHHHc--CCCcCHHHHHHHHHHHHHHHHhhhhcc-cC-CceecCCcceEEecCCceeccc-cccc-----------
Confidence 688888644 468999999999999999887662100 01 1223356899999999877653 2110
Q ss_pred ccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHHHHhhhccccccCCCCCCCChhh
Q 003384 623 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQ 701 (824)
Q Consensus 623 ~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~ 701 (824)
.....+.+||.+. ...+.+.=|||||+++|.-+- |-++ +-+...
T Consensus 98 ---------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e-------------------------~eE~eL 142 (229)
T 2yle_A 98 ---------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKE-------------------------NEEREL 142 (229)
T ss_dssp ------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCT-------------------------TEEECC
T ss_pred ---------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCc-------------------------ccchhh
Confidence 0123456888753 344567889999999999886 3221 113344
Q ss_pred HHHHHHHHHHHhhh
Q 003384 702 AEQLANLAMRCCEM 715 (824)
Q Consensus 702 ~~~l~~Li~~Cl~~ 715 (824)
++.|-.|+..|++.
T Consensus 143 S~~LE~LL~~Mt~~ 156 (229)
T 2yle_A 143 SPPLEQLIDHMANT 156 (229)
T ss_dssp CHHHHHHHHHHTTC
T ss_pred CHHHHHHHHHHHhc
Confidence 56777888887755
|
| >2ysl_A Tripartite motif-containing protein 31; ring-type zinc finger domain, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.06 E-value=0.09 Score=43.12 Aligned_cols=55 Identities=15% Similarity=0.332 Sum_probs=47.9
Q ss_pred CCCCCCcccchhhhccCCccccCCccchhhhhhhhhc--CCCCCCCCCCCCCCCCCC
Q 003384 753 EPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLD--SGHETSPMTNLPLAHKNL 807 (824)
Q Consensus 753 ~~P~~f~cPi~~evm~dPvi~~~g~tye~~~i~~wl~--~~~~t~p~t~~~l~~~~l 807 (824)
...+.+.|||..+.+.+|++..=|++|=...|..|+. .+..+||+.+.++...++
T Consensus 16 ~~~~~~~C~IC~~~~~~~~~~~CgH~fC~~Ci~~~~~~~~~~~~CP~Cr~~~~~~~~ 72 (73)
T 2ysl_A 16 KLQEEVICPICLDILQKPVTIDCGHNFCLKCITQIGETSCGFFKCPLCKTSVRKNAI 72 (73)
T ss_dssp CCCCCCBCTTTCSBCSSEEECTTCCEEEHHHHHHHCSSSCSCCCCSSSCCCCCCCCC
T ss_pred hCccCCEeccCCcccCCeEEcCCCChhhHHHHHHHHHcCCCCCCCCCCCCcCCcccC
Confidence 4577899999999999999999999999999999997 356789999999875543
|
| >1g25_A CDK-activating kinase assembly factor MAT1; ring finger (C3HC4), metal binding protein; NMR {Homo sapiens} SCOP: g.44.1.1 | Back alignment and structure |
|---|
Probab=92.33 E-value=0.1 Score=41.94 Aligned_cols=55 Identities=20% Similarity=0.282 Sum_probs=48.5
Q ss_pred CCCcccchhh-hccCCc----cccCCccchhhhhhhhhcCCCCCCCCCCCCCCCCCCCch
Q 003384 756 PYFTCPIFQE-VMQDPH----VAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPN 810 (824)
Q Consensus 756 ~~f~cPi~~e-vm~dPv----i~~~g~tye~~~i~~wl~~~~~t~p~t~~~l~~~~l~pn 810 (824)
+.+.|||..+ .+.+|. ++.=|++|=...|.+|+..+..+||+.+.++...++.||
T Consensus 2 ~~~~C~IC~~~~~~~~~~~~~~~~CgH~fC~~Ci~~~~~~~~~~CP~Cr~~~~~~~~~~~ 61 (65)
T 1g25_A 2 DDQGCPRCKTTKYRNPSLKLMVNVCGHTLCESCVDLLFVRGAGNCPECGTPLRKSNFRVQ 61 (65)
T ss_dssp CTTCCSTTTTHHHHCSSCCEEECTTCCCEEHHHHHHHHHTTSSSCTTTCCCCSSCCCEEE
T ss_pred CCCcCCcCCCCccCCCccCeecCCCCCHhHHHHHHHHHHcCCCcCCCCCCccccccceee
Confidence 4578999999 999994 678899999999999988777899999999998888876
|
| >3ng2_A RNF4, snurf, ring finger protein 4; ring domain, E3 ligase, ubiquitylation, sumoylation, zinc-FI metal binding protein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=92.03 E-value=0.051 Score=44.34 Aligned_cols=57 Identities=21% Similarity=0.374 Sum_probs=50.0
Q ss_pred CCCCCcccchhhhccCC-------ccccCCccchhhhhhhhhcCCCCCCCCCCCCCCCCCCCchH
Q 003384 754 PPPYFTCPIFQEVMQDP-------HVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNL 811 (824)
Q Consensus 754 ~P~~f~cPi~~evm~dP-------vi~~~g~tye~~~i~~wl~~~~~t~p~t~~~l~~~~l~pn~ 811 (824)
..+.+.|||..+.+.+| ++..=|++|=...|..|+.. +.+||+.+.++...++.|++
T Consensus 7 ~~~~~~C~IC~~~~~~~~~~~~~~~~~~CgH~fc~~Ci~~~~~~-~~~CP~Cr~~~~~~~~~~~~ 70 (71)
T 3ng2_A 7 PSGTVSCPICMDGYSEIVQNGRLIVSTECGHVFCSQCLRDSLKN-ANTCPTCRKKINHKRYHPIY 70 (71)
T ss_dssp CTTCCBCTTTCCBHHHHHTTTCCEEECTTSCEEEHHHHHHHHHH-CSBCTTTCCBCCCCSCCCCC
T ss_pred CCCCCCCcccChhhhccccccCCeEeCCCCChHhHHHHHHHHHc-CCCCCCCCCccChhheeecc
Confidence 34678899999999998 77888999999999999987 46999999999998888874
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.76 E-value=0.44 Score=52.70 Aligned_cols=30 Identities=33% Similarity=0.444 Sum_probs=25.1
Q ss_pred ceEeccccCCcEEe------cCCCcceeeccccccc
Q 003384 583 SIVHGDLKPANILL------DANFVSKLSDFGISRF 612 (824)
Q Consensus 583 giiHrDLKp~NILl------d~~~~vKL~DFGla~~ 612 (824)
.++|+|+.+.|||+ +.+..++++||.+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 46799999999999 4466799999998764
|
| >3ab8_A Putative uncharacterized protein TTHA0350; tandem-type universal stress protein, unknown function; HET: ATP; 1.70A {Thermus thermophilus} PDB: 3ab7_A* | Back alignment and structure |
|---|
Probab=90.26 E-value=0.42 Score=49.11 Aligned_cols=71 Identities=18% Similarity=0.098 Sum_probs=53.2
Q ss_pred HHHHHHHHHHHHhhcCeeeEEEEeecCchHHHHHHHHHHcCCCEEEeccCcCccchhhhcccchhhHHhhhccCCCccEE
Q 003384 50 MHNHLDMCLLICRQMGVRAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAPASCHI 129 (824)
Q Consensus 50 ~~~~l~~~~~~C~~~~V~~~~~~ie~~dv~~~i~e~i~~~~i~~LV~Ga~~~~~~~~~~~~~~s~~a~~v~~~a~~~C~v 129 (824)
..+.|+.+...+.+.||+++..+.. ++++++|++++..+ +.||||+ .+.+. +-...+..|+..++ |-|
T Consensus 197 ~~~~l~~~~~~l~~~~~~~~~~~~~-g~~~~~i~~~a~~~--dliV~G~----~~~~~---~~Gs~~~~vl~~~~--~pv 264 (268)
T 3ab8_A 197 AEAWALEAEAYLRDHGVEASALVLG-GDAADHLLRLQGPG--DLLALGA----PVRRL---VFGSTAERVIRNAQ--GPV 264 (268)
T ss_dssp HHHHHHHHHHHHHHTTCCEEEEEEC-SCHHHHHHHHCCTT--EEEEEEC----CCSCC---SSCCHHHHHHHHCS--SCE
T ss_pred HHHHHHHHHHHHHHcCCceEEEEeC-CChHHHHHHHHHhC--CEEEECC----ccccc---EeccHHHHHHhcCC--CCE
Confidence 3556777788888889999877665 89999999999998 9999999 22222 11224558888865 888
Q ss_pred EEE
Q 003384 130 WFI 132 (824)
Q Consensus 130 ~~i 132 (824)
.++
T Consensus 265 lvv 267 (268)
T 3ab8_A 265 LTA 267 (268)
T ss_dssp EEE
T ss_pred EEe
Confidence 876
|
| >2ysj_A Tripartite motif-containing protein 31; ring-type zinc finger domain, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=90.07 E-value=0.33 Score=38.49 Aligned_cols=45 Identities=18% Similarity=0.383 Sum_probs=39.3
Q ss_pred CCCCCCcccchhhhccCCccccCCccchhhhhhhhhcC--CCCCCCC
Q 003384 753 EPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDS--GHETSPM 797 (824)
Q Consensus 753 ~~P~~f~cPi~~evm~dPvi~~~g~tye~~~i~~wl~~--~~~t~p~ 797 (824)
...+.+.|||..+.+.+|+++.=|++|=...|.+|+.. +..+||+
T Consensus 16 ~~~~~~~C~IC~~~~~~p~~~~CgH~fC~~Ci~~~~~~~~~~~~CP~ 62 (63)
T 2ysj_A 16 KLQEEVICPICLDILQKPVTIDCGHNFCLKCITQIGETSCGFFKCPL 62 (63)
T ss_dssp CCCCCCBCTTTCSBCSSCEECTTSSEECHHHHHHHHHHCSSCCCCSC
T ss_pred hCccCCCCCcCCchhCCeEEeCCCCcchHHHHHHHHHcCCCCCcCcC
Confidence 45678999999999999999999999999999999974 4557875
|
| >2xeu_A Ring finger protein 4; transcription, zinc-finger, metal-binding; HET: SUC; 1.50A {Homo sapiens} | Back alignment and structure |
|---|
Probab=90.02 E-value=0.066 Score=42.55 Aligned_cols=54 Identities=20% Similarity=0.365 Sum_probs=47.4
Q ss_pred CCcccchhhhccCC-------ccccCCccchhhhhhhhhcCCCCCCCCCCCCCCCCCCCchH
Q 003384 757 YFTCPIFQEVMQDP-------HVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNL 811 (824)
Q Consensus 757 ~f~cPi~~evm~dP-------vi~~~g~tye~~~i~~wl~~~~~t~p~t~~~l~~~~l~pn~ 811 (824)
.+.|||..+.+.+| ++..=|++|=...|.+|+.. +.+||+.+.++...++.|++
T Consensus 3 ~~~C~IC~~~~~~~~~~~~~~~~~~CgH~fc~~Ci~~~~~~-~~~CP~Cr~~~~~~~~~~~~ 63 (64)
T 2xeu_A 3 MVSCPICMDGYSEIVQNGRLIVSTECGHVFCSQCLRDSLKN-ANTCPTCRKKINHKRYHPIY 63 (64)
T ss_dssp CCBCTTTCCBHHHHHHTTCCEEEETTSCEEEHHHHHHHHHH-CSBCTTTCCBCTTTCEEECC
T ss_pred CCCCCccChhhhCccccCCCEEeCCCCCchhHHHHHHHHHc-CCCCCCCCccCCccceeeee
Confidence 46899999999887 77888999999999999987 67999999999988887763
|
| >3vkg_A Dynein heavy chain, cytoplasmic; AAA+ protein, molecular motor, microtubles, motor protein; HET: ADP SPM; 2.81A {Dictyostelium discoideum} PDB: 3vkh_A* | Back alignment and structure |
|---|
Probab=89.74 E-value=18 Score=49.98 Aligned_cols=29 Identities=17% Similarity=0.178 Sum_probs=16.0
Q ss_pred CchHHHHHHHHHHc---CCCEEEeccCcCccchhh
Q 003384 76 ESTEKGILELISHY---GIRKLVMGAAADKHYKKK 107 (824)
Q Consensus 76 ~dv~~~i~e~i~~~---~i~~LV~Ga~~~~~~~~~ 107 (824)
+|+-+-|+-....+ +=..|.+|.. +.||.
T Consensus 1629 ~daleHv~RI~RIL~qp~GhaLLVGvg---GSGkq 1660 (3245)
T 3vkg_A 1629 NEVLDHILRIDRVFRQPQGHALLIGVS---GGGKS 1660 (3245)
T ss_dssp HHHHHHHHHHHHHHTSTTCCEEEEEST---TSSHH
T ss_pred HHHHHHHHHHHHHHccCCCCeEEecCC---CCcHH
Confidence 44544444444333 3467888887 55444
|
| >2fxo_A Myosin heavy chain, cardiac muscle beta isoform; coiled coil (dimeric, parallel), familial hypertrophic cardiomyopathy, FHC-associated mutant E924K; 2.50A {Homo sapiens} SCOP: h.1.26.1 PDB: 2fxm_A | Back alignment and structure |
|---|
Probab=89.44 E-value=13 Score=34.18 Aligned_cols=94 Identities=17% Similarity=0.172 Sum_probs=48.4
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHhhchHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHHHH
Q 003384 332 RAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQ 411 (824)
Q Consensus 332 ~~~~~e~~~~~e~~~rke~ee~la~~k~ele~l~~~~~e~~eel~~~~~~~~~l~~~~~e~~~~~~e~e~~~~~~~~~l~ 411 (824)
+.+.....+..+-..|++++.....-..+...+..+++.-...+..+.+....+..+-.+......+++.++...-+...
T Consensus 21 el~~lke~l~k~e~~r~ele~~~~~l~~Ek~~L~~qL~~E~~~l~e~EE~~~~L~~~k~eLe~~l~el~~rleeeee~~~ 100 (129)
T 2fxo_A 21 EFTRLKEALEKSEARRKELEEKMVSLLQEKNDLQLQVQAEQDNLADAEERCDQLIKNKIQLEAKVKEMNKRLEDEEEMNA 100 (129)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 55666677777777888888777766666666665554433333333444444434433433444444444443333333
Q ss_pred HHHHHHHHHHHHHH
Q 003384 412 NYKKEQDELQMERD 425 (824)
Q Consensus 412 ~~k~e~~~~~~~~~ 425 (824)
.+......++.+..
T Consensus 101 ~L~~~kkkle~e~~ 114 (129)
T 2fxo_A 101 ELTAKKRKLEDECS 114 (129)
T ss_dssp HHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHH
Confidence 33333333333333
|
| >2ct2_A Tripartite motif protein 32; zinc-finger protein HT2A, TAT- interacting protein, ring domain, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.99 E-value=0.21 Score=42.41 Aligned_cols=62 Identities=23% Similarity=0.304 Sum_probs=51.4
Q ss_pred CCCCCCcccchhhhccC----CccccCCccchhhhhhhhhcCC--CCCCCCCCCCCCC---CCCCchHHHH
Q 003384 753 EPPPYFTCPIFQEVMQD----PHVAADGFTYEAEALKGWLDSG--HETSPMTNLPLAH---KNLVPNLALR 814 (824)
Q Consensus 753 ~~P~~f~cPi~~evm~d----Pvi~~~g~tye~~~i~~wl~~~--~~t~p~t~~~l~~---~~l~pn~~lr 814 (824)
...+.+.|||..+.+.+ |++..=|++|=...|..|+... ..+||+.+.++.. ..|.+|+.+.
T Consensus 11 ~~~~~~~C~IC~~~~~~~~~~~~~~~CgH~fC~~Ci~~~~~~~~~~~~CP~Cr~~~~~~~i~~l~~n~~~~ 81 (88)
T 2ct2_A 11 ALREVLECPICMESFTEEQLRPKLLHCGHTICRQCLEKLLASSINGVRCPFCSKITRITSLTQLTDNLTVL 81 (88)
T ss_dssp CCCSCCBCTTTCCBCCTTSSCEEECSSSCEEEHHHHHHHHHHCSSCBCCTTTCCCBCCSSTTTSEECTTTT
T ss_pred hccCCCCCccCCccccccCCCeEECCCCChhhHHHHHHHHHcCCCCcCCCCCCCcccchhHHHHHHHHHHH
Confidence 45677899999999999 9999999999999999999864 5799999988764 4667776553
|
| >2ect_A Ring finger protein 126; metal binding protein, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=88.64 E-value=0.47 Score=39.31 Aligned_cols=56 Identities=18% Similarity=0.371 Sum_probs=46.7
Q ss_pred CCCCCcccchhhhccCCcc---ccCCccchhhhhhhhhcCCCCCCCCCCCCCCCCCCCch
Q 003384 754 PPPYFTCPIFQEVMQDPHV---AADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPN 810 (824)
Q Consensus 754 ~P~~f~cPi~~evm~dPvi---~~~g~tye~~~i~~wl~~~~~t~p~t~~~l~~~~l~pn 810 (824)
....+.|||..+.+.++.. ..=|+.|=...|..|+.. +.+||+.+.++....+.||
T Consensus 12 ~~~~~~C~IC~~~~~~~~~~~~~~C~H~fc~~Ci~~~~~~-~~~CP~Cr~~~~~~~~~~~ 70 (78)
T 2ect_A 12 VGSGLECPVCKEDYALGESVRQLPCNHLFHDSCIVPWLEQ-HDSCPVCRKSLTGQNTATN 70 (78)
T ss_dssp SSSSCCCTTTTSCCCTTSCEEECTTSCEEETTTTHHHHTT-TCSCTTTCCCCCCSCSCCC
T ss_pred CCCCCCCeeCCccccCCCCEEEeCCCCeecHHHHHHHHHc-CCcCcCcCCccCCcccCCC
Confidence 3456889999999987743 477899999999999986 5799999999998888776
|
| >2ecj_A Tripartite motif-containing protein 39; TRIM39, ring domain, zinc-binding domain, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=87.40 E-value=0.66 Score=35.82 Aligned_cols=45 Identities=13% Similarity=0.391 Sum_probs=38.8
Q ss_pred CCCCCCcccchhhhccCCccccCCccchhhhhhhhhcC--CCCCCCC
Q 003384 753 EPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDS--GHETSPM 797 (824)
Q Consensus 753 ~~P~~f~cPi~~evm~dPvi~~~g~tye~~~i~~wl~~--~~~t~p~ 797 (824)
...+.+.|||..+.+.+|++..=|++|=...|..|+.. ...+||+
T Consensus 11 ~~~~~~~C~IC~~~~~~p~~~~CgH~fC~~Ci~~~~~~~~~~~~CP~ 57 (58)
T 2ecj_A 11 NLQVEASCSVCLEYLKEPVIIECGHNFCKACITRWWEDLERDFPCPV 57 (58)
T ss_dssp CSCCCCBCSSSCCBCSSCCCCSSCCCCCHHHHHHHTTSSCCSCCCSC
T ss_pred ccccCCCCccCCcccCccEeCCCCCccCHHHHHHHHHhcCCCCCCCC
Confidence 45677899999999999999999999999999999765 5567775
|
| >3vkg_A Dynein heavy chain, cytoplasmic; AAA+ protein, molecular motor, microtubles, motor protein; HET: ADP SPM; 2.81A {Dictyostelium discoideum} PDB: 3vkh_A* | Back alignment and structure |
|---|
Probab=87.17 E-value=19 Score=49.68 Aligned_cols=17 Identities=12% Similarity=0.122 Sum_probs=11.5
Q ss_pred HHHHHHHHHHHHHHHHH
Q 003384 297 QLAQAMAEAENSRREAF 313 (824)
Q Consensus 297 ~l~~a~~eae~~~~ea~ 313 (824)
.|.+|..+++..+.++-
T Consensus 1928 KL~et~~~V~~l~~~L~ 1944 (3245)
T 3vkg_A 1928 KLRDTEAQVKDLQVSLA 1944 (3245)
T ss_dssp HHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHH
Confidence 57777777777766663
|
| >2d8t_A Dactylidin, ring finger protein 146; RNF146, ring domain, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=86.53 E-value=0.26 Score=40.30 Aligned_cols=50 Identities=10% Similarity=0.041 Sum_probs=44.2
Q ss_pred CCCCCcccchhhhccCCccccCCccchhhhhhhhhcCCCCCCCCCCCCCCC
Q 003384 754 PPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAH 804 (824)
Q Consensus 754 ~P~~f~cPi~~evm~dPvi~~~g~tye~~~i~~wl~~~~~t~p~t~~~l~~ 804 (824)
..+.+.|||..+.+.+|++..=|++|=...|..|+.. +.+||+.+.++..
T Consensus 12 ~~~~~~C~IC~~~~~~~~~~~CgH~fC~~Ci~~~~~~-~~~CP~Cr~~~~~ 61 (71)
T 2d8t_A 12 SLTVPECAICLQTCVHPVSLPCKHVFCYLCVKGASWL-GKRCALCRQEIPE 61 (71)
T ss_dssp SSSCCBCSSSSSBCSSEEEETTTEEEEHHHHHHCTTC-SSBCSSSCCBCCH
T ss_pred CCCCCCCccCCcccCCCEEccCCCHHHHHHHHHHHHC-CCcCcCcCchhCH
Confidence 3456889999999999999999999999999999987 4799999998863
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=86.31 E-value=16 Score=42.10 Aligned_cols=20 Identities=25% Similarity=0.313 Sum_probs=7.6
Q ss_pred HHHHHHHHHHHHHHHHHHHH
Q 003384 411 QNYKKEQDELQMERDKAVKE 430 (824)
Q Consensus 411 ~~~k~e~~~~~~~~~~~~~e 430 (824)
+..++...+++.+......+
T Consensus 554 ~~~~~~~~~l~~e~~~~~~~ 573 (597)
T 3oja_B 554 DNKRAKQAELRQETSLKRQK 573 (597)
T ss_dssp HHHHHHHHHHHHHHHHHHHH
T ss_pred hhhhhHHHHHHHHHHHHHHH
Confidence 33333334444343333333
|
| >3qwe_A GMIP, GEM-interacting protein; structural genomics consortium, SGC, protein binding; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=84.78 E-value=21 Score=37.17 Aligned_cols=57 Identities=28% Similarity=0.420 Sum_probs=49.6
Q ss_pred chHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 003384 293 NLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKE 349 (824)
Q Consensus 293 ~~~~~l~~a~~eae~~~~ea~~e~~r~~k~e~~~~~~~~~~~~~e~~~~~e~~~rke 349 (824)
.+|+.|..-..++|..|++..++..|-+|.=.++..+++||+.-=....+|..+-+.
T Consensus 98 ~~~~~L~~~~~e~ek~RK~~Ke~w~r~eKk~~dae~~l~KAK~~Y~~r~ee~ekak~ 154 (279)
T 3qwe_A 98 DYYQPLAAKRTEIEKWRKEFKEQWMKEQKRMNEAVQALRRAQLQYVQRSEDLRARSQ 154 (279)
T ss_dssp HTHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTCC
T ss_pred hhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhc
Confidence 467888889999999999999999999999999999999999988888888775554
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=84.03 E-value=13 Score=42.89 Aligned_cols=28 Identities=14% Similarity=0.124 Sum_probs=11.5
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 003384 394 QTAKELEQKIISAVELLQNYKKEQDELQ 421 (824)
Q Consensus 394 ~~~~e~e~~~~~~~~~l~~~k~e~~~~~ 421 (824)
+...+++.+++...+.++.++++...+.
T Consensus 544 ~~~~~le~~~~~~~~~~~~l~~e~~~~~ 571 (597)
T 3oja_B 544 QENIALEKQLDNKRAKQAELRQETSLKR 571 (597)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhHHHHHHHhhhhhHHHHHHHHHHHHH
Confidence 3333444444444444444444444333
|
| >2ea6_A Ring finger protein 4; RNF4, RES4-26, ring domain, zinc- binding domain, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=83.80 E-value=0.62 Score=37.31 Aligned_cols=51 Identities=20% Similarity=0.379 Sum_probs=44.1
Q ss_pred CCCCCCcccchhhhccCC-------ccccCCccchhhhhhhhhcCCCCCCCCCCCCCCC
Q 003384 753 EPPPYFTCPIFQEVMQDP-------HVAADGFTYEAEALKGWLDSGHETSPMTNLPLAH 804 (824)
Q Consensus 753 ~~P~~f~cPi~~evm~dP-------vi~~~g~tye~~~i~~wl~~~~~t~p~t~~~l~~ 804 (824)
..+..+.|||..+.+.+| ++..=|++|=...|..|+.. +.+||+.+.++..
T Consensus 11 ~~~~~~~C~IC~~~~~~~~~~~~~~~~~~CgH~fc~~Ci~~~~~~-~~~CP~Cr~~~~~ 68 (69)
T 2ea6_A 11 RPSGTVSCPICMDGYSEIVQNGRLIVSTECGHVFCSQCLRDSLKN-ANTCPTCRKKINH 68 (69)
T ss_dssp CTTCCCCCTTTCCCHHHHTTTTCCEEECSSSCEEEHHHHHHHHHH-CSSCTTTCCCCCC
T ss_pred CCCCCCCCcccCccccccccccCCeEeCCCCChhcHHHHHHHHHc-CCCCCCCCCccCc
Confidence 456778999999999988 77888999999999999987 6799999988753
|
| >1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A | Back alignment and structure |
|---|
Probab=83.61 E-value=3.3 Score=52.30 Aligned_cols=45 Identities=11% Similarity=0.178 Sum_probs=26.4
Q ss_pred HHHHHHHHHHHHHHHHH-----HHHhhcCeeeEEEEeecCchHHHHHHHHHH
Q 003384 42 YREIERQDMHNHLDMCL-----LICRQMGVRAEKLDTESESTEKGILELISH 88 (824)
Q Consensus 42 ~~~~e~~~~~~~l~~~~-----~~C~~~~V~~~~~~ie~~dv~~~i~e~i~~ 88 (824)
+.+.=.++.+++|..+. .-+.+-||....|-...|+ ..+||||..
T Consensus 480 ciNy~nEkLq~~f~~~~f~~eq~ey~~Egi~~~~i~~~~dn--~~~~~lie~ 529 (1184)
T 1i84_S 480 CINYTNEKLQQLFNHTMFILEQEEYQREGIEWNFIDFGLDL--QPCIELIER 529 (1184)
T ss_dssp HHHHHHHHHHHHHHHHHTHHHHHHHHHHTCSCCCCCCCCCC--HHHHHTTSC
T ss_pred HHHHHHHHHHHHHHHhhhHHHHHHHHhcCCCccccccCCCc--HHHHHHHhC
Confidence 55555566666665544 5677888888766553232 245566553
|
| >2dfs_A Myosin-5A; myosin-V, inhibited state, cryoelectron tomograp contractIle protein-transport protein complex; 24.00A {Gallus gallus} | Back alignment and structure |
|---|
Probab=83.52 E-value=26 Score=43.70 Aligned_cols=44 Identities=9% Similarity=0.122 Sum_probs=24.4
Q ss_pred HHHHHHHHHHHHHHHHH-----HHHhhcCeeeEEEEeecCchHHHHHHHHHH
Q 003384 42 YREIERQDMHNHLDMCL-----LICRQMGVRAEKLDTESESTEKGILELISH 88 (824)
Q Consensus 42 ~~~~e~~~~~~~l~~~~-----~~C~~~~V~~~~~~ie~~dv~~~i~e~i~~ 88 (824)
+.+.-.++.+++|.... .-+.+-||....+-..+. ..+||||..
T Consensus 453 cINy~NEkLQq~F~~~~f~~EqeeY~~EgI~w~~i~f~dn---~~~idlie~ 501 (1080)
T 2dfs_A 453 CINYANEKLQQQFNMHVFKLEQEEYMKEQIPWTLIDFYDN---QPCINLIEA 501 (1080)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHHTCCTTCCCCCCC---HHHHHHHHS
T ss_pred HHHhhhHHHHHHHHHHhhHHHHHHHhhcCCcccccccccc---HHHHHHHhc
Confidence 44544555555554443 456777887776655432 235666654
|
| >4ap4_A E3 ubiquitin ligase RNF4; ligase-signalling protein complex, chimera; 2.21A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=82.34 E-value=0.48 Score=43.28 Aligned_cols=55 Identities=20% Similarity=0.341 Sum_probs=48.1
Q ss_pred CCCCcccchhhhccCC-------ccccCCccchhhhhhhhhcCCCCCCCCCCCCCCCCCCCch
Q 003384 755 PPYFTCPIFQEVMQDP-------HVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPN 810 (824)
Q Consensus 755 P~~f~cPi~~evm~dP-------vi~~~g~tye~~~i~~wl~~~~~t~p~t~~~l~~~~l~pn 810 (824)
++.+.|||..+.+.+| ++..=|++|=...|.+|+.. ..+||+.+.++....+.|+
T Consensus 5 ~~~~~C~IC~~~~~~~~~~~~~~~~~~CgH~fc~~Ci~~~~~~-~~~CP~Cr~~~~~~~l~~l 66 (133)
T 4ap4_A 5 SGTVSCPICMDGYSEIVQNGRLIVSTECGHVFCSQCLRDSLKN-ANTCPTCRKKINHKRYHPI 66 (133)
T ss_dssp CCSCBCTTTCCBHHHHHHTTCCEEEETTCCEEEHHHHHHHHTT-CSBCTTTCCBCTTTCEEEC
T ss_pred CCCCCCcccChhhhCccccccCeEecCCCChhhHHHHHHHHHh-CCCCCCCCCcCcccccccc
Confidence 4678999999999999 88899999999999999987 4599999999987776654
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=82.30 E-value=2.6 Score=42.45 Aligned_cols=113 Identities=6% Similarity=0.173 Sum_probs=74.2
Q ss_pred CCCceeeE-ecccCCceEEEEEecCCC-ChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcE
Q 003384 517 RHPNLVTL-VGACPEVWTLVYEYLPNG-SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANI 594 (824)
Q Consensus 517 ~HpnIv~L-~g~~~~~~~LV~Ey~~gg-sL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NI 594 (824)
.||+++.. +..-.+.+.+.|+.-+++ ++.. + ..++...+++++..|+....+++. -+|--|.|+||
T Consensus 43 ~~~~Fl~~~I~e~eD~v~~~y~~~~~~~~f~~-i------k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL 110 (215)
T 4ann_A 43 HSPYFIDAELTELRDSFQIHYDINDNHTPFDN-I------KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDEL 110 (215)
T ss_dssp CCTTBCCEEEEECSSEEEEEECCCTTSEEGGG-G------GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGE
T ss_pred cCCcccceEEEEcccEEEEEEEcCcccCCHHH-H------HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceE
Confidence 57888754 222244444444443322 3332 2 246778999999999988766654 57888999999
Q ss_pred EecCCCcceeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCC
Q 003384 595 LLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPAL 671 (824)
Q Consensus 595 Lld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf 671 (824)
+++.++.++|.-.|+-..+.+. .++...=+-.+=|++..+++|+..|
T Consensus 111 ~f~~~~~p~i~~RGik~~l~P~------------------------------~~~ee~fL~qyKAliiall~~K~~F 157 (215)
T 4ann_A 111 FFTRDGLPIAKTRGLQNVVDPL------------------------------PVSEAEFLTRYKALVICAFNEKQSF 157 (215)
T ss_dssp EECTTSCEEESCCEETTTBSCC------------------------------CCCHHHHHHHHHHHHHHHHCTTCCH
T ss_pred EEcCCCCEEEEEccCccCCCCC------------------------------CCCHHHHHHHHHHHHHHHHcCCCCH
Confidence 9999999999988864322111 1122222345778899999998887
|
| >2i1j_A Moesin; FERM, coiled-coil, C-ermad, ERM, radixin, ezrin, MER actin binding, masking, regulation, SELF-inhibition, cell A membrane protein; 2.10A {Spodoptera frugiperda} PDB: 2i1k_A 1e5w_A | Back alignment and structure |
|---|
Probab=82.20 E-value=1.7 Score=50.36 Aligned_cols=15 Identities=13% Similarity=0.053 Sum_probs=7.9
Q ss_pred hhccCCCccEEEEEe
Q 003384 119 VRQQAPASCHIWFIC 133 (824)
Q Consensus 119 v~~~a~~~C~v~~i~ 133 (824)
+.+.-|.|-.-+|-+
T Consensus 194 ~a~~lp~YG~~~F~v 208 (575)
T 2i1j_A 194 IAQDLEMYGVNYFEI 208 (575)
T ss_dssp HHTTSTTTTCEEEEE
T ss_pred HHHhccccCCEEEEE
Confidence 445556665555544
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 824 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-64 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-56 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-54 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-54 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-54 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-54 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-54 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-53 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-53 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 6e-53 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-52 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-52 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-52 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-52 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-51 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-51 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-50 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-50 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-50 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 8e-50 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 9e-50 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-49 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-48 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-48 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-47 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-46 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-46 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-46 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 7e-46 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-45 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 7e-45 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-44 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-44 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-44 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-43 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-43 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-41 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-40 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-40 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 8e-40 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 9e-40 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-39 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-39 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-38 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 6e-38 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-37 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-37 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-36 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-36 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-35 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-35 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-34 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-33 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-33 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 9e-33 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-31 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-31 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-30 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 9e-29 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 7e-28 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-26 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-25 | |
| d1t1ha_ | 78 | g.44.1.2 (A:) E3 ubiquitin ligase PUB14 {Thale-cre | 2e-20 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-18 | |
| d2c2la2 | 80 | g.44.1.2 (A:225-304) STIP1 homology and U box-cont | 3e-14 | |
| d1wgma_ | 98 | g.44.1.2 (A:) Ubiquitin conjugation factor E4A {Hu | 2e-11 | |
| d1jm7a_ | 103 | g.44.1.1 (A:) brca1 RING domain {Human (Homo sapie | 3e-07 | |
| d1f5na1 | 300 | a.114.1.1 (A:284-583) Interferon-induced guanylate | 2e-05 | |
| d1eq1a_ | 166 | a.63.1.1 (A:) Apolipophorin-III {Manduca sexta [Ta | 2e-04 | |
| d2baya1 | 56 | g.44.1.2 (A:1-56) Pre-mRNA splicing factor Prp19 { | 6e-04 | |
| d2es4d1 | 280 | a.137.15.1 (D:53-332) Lipase chaperone LifO (LipB) | 0.001 | |
| d2es4d1 | 280 | a.137.15.1 (D:53-332) Lipase chaperone LifO (LipB) | 0.003 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (548), Expect = 1e-64
Identities = 72/276 (26%), Positives = 119/276 (43%), Gaps = 26/276 (9%)
Query: 471 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGAC 528
+IG G +G++YKG VA+KML+ + Q F+ E+ +L K RH N++ +G
Sbjct: 15 RIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 529 PEVWT-LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 587
+V ++ SL L I IA + + +LH SI+H
Sbjct: 74 TAPQLAIVTQWCEGSSLYHHL--HIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHR 128
Query: 588 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL---A 644
DLK NI L + K+ DFG++ S+ S L G+ +M PE +
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS------GSILWMAPEVIRMQD 182
Query: 645 SGELTPKSDVYSFGIILLRLLTGRP---ALGITKEVQYALDTGKLKNLLDPLAGDWPFVQ 701
+ +SDVY+FGI+L L+TG+ + ++ + + G L L + + P
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP--- 239
Query: 702 AEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 737
+ + L C + R RP + +E + S
Sbjct: 240 -KAMKRLMAECLKKKRDERPLF-PQILASIELLARS 273
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 1e-56
Identities = 73/270 (27%), Positives = 120/270 (44%), Gaps = 22/270 (8%)
Query: 471 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC- 528
++G G +G ++ G H +VA+K L S P F E +++ +++H LV L
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 529 PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGD 588
E ++ EY+ NGSL D L + L+ + +A ++ + F+ + +H D
Sbjct: 79 QEPIYIITEYMENGSLVDFLK-TPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRD 134
Query: 589 LKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL 648
L+ ANIL+ K++DFG++R + NE R K + PE + G
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDNE-------YTAREGAKFPIKWTAPEAINYGTF 187
Query: 649 TPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLAN 707
T KSDV+SFGI+L ++T GR + ++NL P E+L
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV------IQNLERGYRMVRPDNCPEELYQ 241
Query: 708 LAMRCCEMSRKSRPELGKDVWRVLEPMRAS 737
L C + + RP + VLE +
Sbjct: 242 LMRLCWKERPEDRPTF-DYLRSVLEDFFTA 270
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 2e-54
Identities = 65/269 (24%), Positives = 114/269 (42%), Gaps = 28/269 (10%)
Query: 471 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC-- 528
IG+G +G + G R +VA+K + + F E +++++RH NLV L+G
Sbjct: 14 TIGKGEFGDVMLGDYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 71
Query: 529 -PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 587
+V EY+ GSL D L + S L ++ + ++C + +L ++ VH
Sbjct: 72 EKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEG---NNFVHR 127
Query: 588 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 647
DL N+L+ + V+K+SDFG+++ S + K + PE L +
Sbjct: 128 DLAARNVLVSEDNVAKVSDFGLTKEASST-----------QDTGKLPVKWTAPEALREKK 176
Query: 648 LTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLA 706
+ KSDV+SFGI+L + + GR + + D P +
Sbjct: 177 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV------VPRVEKGYKMDAPDGCPPAVY 230
Query: 707 NLAMRCCEMSRKSRPELGKDVWRVLEPMR 735
+ C + RP + LE ++
Sbjct: 231 EVMKNCWHLDAAMRPSF-LQLREQLEHIK 258
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 2e-54
Identities = 53/216 (24%), Positives = 100/216 (46%), Gaps = 20/216 (9%)
Query: 459 IEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQG-PSEFQQEIDILSK 515
+E +F+ ++G G G ++K + + +A K++H ++ +E+ +L +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 516 IRHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVL 573
P +V GA ++ E++ GSL+ L + + Q +++ + L
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGL 117
Query: 574 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 633
+L H I+H D+KP+NIL+++ KL DFG+S L + G
Sbjct: 118 TYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----------ANSFVG 165
Query: 634 TFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 669
T +YM PE L + +SD++S G+ L+ + GR
Sbjct: 166 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRY 201
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 187 bits (476), Expect = 3e-54
Identities = 72/304 (23%), Positives = 129/304 (42%), Gaps = 35/304 (11%)
Query: 450 FFSDFSFSEIEGATHNFDPSL---------KIGEGGYGSIYKGLLR-----HMQVAIKML 495
F F+F + A F + IG G +G + G L+ + VAIK L
Sbjct: 3 FIDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTL 62
Query: 496 HP-HSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKD 552
++ + +F E I+ + HPN++ L G ++ E++ NGSL+ +
Sbjct: 63 KSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSF--LRQ 120
Query: 553 NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 612
N + + + + + + +L + VH DL NIL+++N V K+SDFG+SRF
Sbjct: 121 NDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRF 177
Query: 613 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG--RPA 670
L + +++ T K + PE + + T SDV+S+GI++ +++ RP
Sbjct: 178 LEDD---TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPY 234
Query: 671 LGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRV 730
+T + + + P L L + C + R RP+ +
Sbjct: 235 WDMTNQDV-------INAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKF-GQIVNT 286
Query: 731 LEPM 734
L+ M
Sbjct: 287 LDKM 290
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 5e-54
Identities = 60/270 (22%), Positives = 119/270 (44%), Gaps = 22/270 (8%)
Query: 471 KIGEGGYGSIYKGLLRHMQ-VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC- 528
+IG G +G ++ G + VAIK + + +F +E +++ K+ HP LV L G C
Sbjct: 12 EIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCL 70
Query: 529 -PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 587
LV+E++ +G L D + + +T + + ++C + + ++H
Sbjct: 71 EQAPICLVFEFMEHGCLSDY--LRTQRGLFAAETLLGMCLDVCEGM---AYLEEACVIHR 125
Query: 588 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 647
DL N L+ N V K+SDFG++RF+ ++ +S+ T K + PE +
Sbjct: 126 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT-------KFPVKWASPEVFSFSR 178
Query: 648 LTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLAN 707
+ KSDV+SFG+++ + + + ++++ P + + +
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV-----VEDISTGFRLYKPRLASTHVYQ 233
Query: 708 LAMRCCEMSRKSRPELGKDVWRVLEPMRAS 737
+ C + + RP + R L + S
Sbjct: 234 IMNHCWKERPEDRPAF-SRLLRQLAEIAES 262
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 6e-54
Identities = 78/269 (28%), Positives = 119/269 (44%), Gaps = 20/269 (7%)
Query: 471 KIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC- 528
K+G+G +G ++ G +VAIK L P + P F QE ++ K+RH LV L
Sbjct: 24 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 82
Query: 529 PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGD 588
E +V EY+ GSL + L + +A ++ S + ++ + VH D
Sbjct: 83 EEPIYIVTEYMSKGSL-LDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 138
Query: 589 LKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL 648
L+ ANIL+ N V K++DFG++R + NE ++ R K + PE G
Sbjct: 139 LRAANILVGENLVCKVADFGLARLIEDNEYTA-------RQGAKFPIKWTAPEAALYGRF 191
Query: 649 TPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANL 708
T KSDV+SFGI+L L T + LD + P + P E L +L
Sbjct: 192 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ-VERGYRMPCPPECP----ESLHDL 246
Query: 709 AMRCCEMSRKSRPELGKDVWRVLEPMRAS 737
+C + RP + + LE S
Sbjct: 247 MCQCWRKEPEERPTF-EYLQAFLEDYFTS 274
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 2e-53
Identities = 65/297 (21%), Positives = 114/297 (38%), Gaps = 42/297 (14%)
Query: 471 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC-- 528
IG+G +G +++G R +VA+K+ + + EI +RH N++ + A
Sbjct: 10 SIGKGRFGEVWRGKWRGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADNK 68
Query: 529 ----PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS-----C 579
LV +Y +GSL D L N ++ + I++A S L LH
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 580 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 639
+I H DLK NIL+ N ++D G++ S+ +T GT YM
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD----SATDTIDIAPNHRVGTKRYMA 180
Query: 640 PEFLAS------GELTPKSDVYSFGIILLRLLTGRPALGITKEVQY-------------A 680
PE L E ++D+Y+ G++ + GI ++ Q
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240
Query: 681 LDTGKLKNLLDP-LAGDWPFVQA-EQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 735
+ + L P + W +A +A + C + +R + + L +
Sbjct: 241 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA-LRIKKTLSQLS 296
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 4e-53
Identities = 56/262 (21%), Positives = 105/262 (40%), Gaps = 30/262 (11%)
Query: 471 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVG 526
+IG G + ++YKGL ++VA L L F++E ++L ++HPN+V
Sbjct: 16 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 75
Query: 527 AC------PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 580
+ + LV E + +G+L+ L + + ++ L FLH+
Sbjct: 76 SWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHTRT 132
Query: 581 PHSIVHGDLKPANILLDA-NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 639
P I+H DLK NI + K+ D G++ +S + GT +M
Sbjct: 133 PP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKR----ASFAKAVI------GTPEFMA 181
Query: 640 PEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPF 699
PE + + DVY+FG+ +L + T + ++ + + P +
Sbjct: 182 PE-MYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR--RVTSGVKPA--SFDK 236
Query: 700 VQAEQLANLAMRCCEMSRKSRP 721
V ++ + C ++ R
Sbjct: 237 VAIPEVKEIIEGCIRQNKDERY 258
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 183 bits (466), Expect = 6e-53
Identities = 72/288 (25%), Positives = 140/288 (48%), Gaps = 24/288 (8%)
Query: 452 SDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQE 509
S ++ + E + K+G G YG +Y+G+ + + VA+K L +++ EF +E
Sbjct: 5 SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKE 63
Query: 510 IDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIAT 567
++ +I+HPNLV L+G C + ++ E++ G+L D L + N +S + +AT
Sbjct: 64 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMAT 122
Query: 568 ELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCC 627
++ S + +L + +H DL N L+ N + K++DFG+SR ++ + +++
Sbjct: 123 QISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA--- 176
Query: 628 RTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLK 687
K + PE LA + + KSDV++FG++L + T + +D ++
Sbjct: 177 ----KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP------YPGIDLSQVY 226
Query: 688 NLLDP-LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 734
LL+ + P E++ L C + + RP ++ + E M
Sbjct: 227 ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSF-AEIHQAFETM 273
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 1e-52
Identities = 61/272 (22%), Positives = 115/272 (42%), Gaps = 23/272 (8%)
Query: 465 NFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVT 523
+ ++G G +G + G R VAIKM+ S EF +E ++ + H LV
Sbjct: 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQ 63
Query: 524 LVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 581
L G C ++ EY+ NG L + L + Q + + ++C + +L
Sbjct: 64 LYGVCTKQRPIFIITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLE---S 118
Query: 582 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 641
+H DL N L++ V K+SDFG+SR++ +E +S K + PE
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS-------SVGSKFPVRWSPPE 171
Query: 642 FLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV 700
L + + KSD+++FG+++ + + G+ + +++ L P +
Sbjct: 172 VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET------AEHIAQGLRLYRPHL 225
Query: 701 QAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 732
+E++ + C RP + +L+
Sbjct: 226 ASEKVYTIMYSCWHEKADERPTFKILLSNILD 257
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 2e-52
Identities = 57/270 (21%), Positives = 110/270 (40%), Gaps = 24/270 (8%)
Query: 470 LKIGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTL 524
+++G G +GS+ +G+ R + VAIK+L + + E +E I+ ++ +P +V L
Sbjct: 15 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 74
Query: 525 VGACPEV-WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 583
+G C LV E G L L + + ++ + +L +
Sbjct: 75 IGVCQAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLE---EKN 129
Query: 584 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 643
VH DL N+LL +K+SDFG+S+ L ++ + + PE +
Sbjct: 130 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK-----WPLKWYAPECI 184
Query: 644 ASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQA 702
+ + +SDV+S+G+ + L+ G+ K + + + + P
Sbjct: 185 NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV------MAFIEQGKRMECPPECP 238
Query: 703 EQLANLAMRCCEMSRKSRPELGKDVWRVLE 732
+L L C + RP+ V + +
Sbjct: 239 PELYALMSDCWIYKWEDRPDF-LTVEQRMR 267
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 4e-52
Identities = 63/274 (22%), Positives = 116/274 (42%), Gaps = 30/274 (10%)
Query: 471 KIGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTL 524
++G G +G++ KG + VA+K+L + E E +++ ++ +P +V +
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 525 VGAC-PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 583
+G C E W LV E G L L + + + I + ++ + +L +
Sbjct: 74 IGICEAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLE---ESN 127
Query: 584 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 643
VH DL N+LL +K+SDFG+S+ L ++ +T K + PE +
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALR-----ADENYYKAQTHGKWPVKWYAPECI 182
Query: 644 ASGELTPKSDVYSFGIILLRLLTG--RPALGIT-KEVQYALDTGKLKNLLDPLAGDWPFV 700
+ + KSDV+SFG+++ + +P G+ EV L+ G+ P
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE----RMGCPAGCP-- 236
Query: 701 QAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 734
++ +L C ++RP V L
Sbjct: 237 --REMYDLMNLCWTYDVENRPGF-AAVELRLRNY 267
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 6e-52
Identities = 63/268 (23%), Positives = 106/268 (39%), Gaps = 25/268 (9%)
Query: 465 NFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPN 520
+++ IG G YG K + + K L S+ E+++L +++HPN
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 521 LVTLVGAC----PEVWTLVYEYLPNGSLEDRLS-CKDNSPPLSWQTRIRIATELCSVLIF 575
+V +V EY G L ++ L + +R+ T+L L
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 576 LH--SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 633
H S H+++H DLKPAN+ LD KL DFG++R L+ + +S
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD--TSFAKAFVG------ 176
Query: 634 TFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPL 693
T YM PE + KSD++S G +L L P + + + +
Sbjct: 177 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL------AGKIREGK 230
Query: 694 AGDWPFVQAEQLANLAMRCCEMSRKSRP 721
P+ +++L + R + RP
Sbjct: 231 FRRIPYRYSDELNEIITRMLNLKDYHRP 258
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 3e-51
Identities = 71/274 (25%), Positives = 113/274 (41%), Gaps = 27/274 (9%)
Query: 465 NFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNL 521
++D +GEG YG + + R VA+K++ ++ P ++EI I + H N+
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65
Query: 522 VTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 579
V G + L EY G L DR+ + R +L + +++LH
Sbjct: 66 VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHG- 121
Query: 580 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 639
I H D+KP N+LLD K+SDFG++ N +C GT Y+
Sbjct: 122 --IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC------GTLPYVA 173
Query: 640 PEFLASGEL-TPKSDVYSFGIILLRLLTGRPAL-GITKEVQYALDTGKLKNLLDPLAGDW 697
PE L E DV+S GI+L +L G + Q D + K L+P W
Sbjct: 174 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP----W 229
Query: 698 PFVQAEQLANLAMRCCEMSRKSRP---ELGKDVW 728
+ + L + + +R ++ KD W
Sbjct: 230 KKIDSA-PLALLHKILVENPSARITIPDIKKDRW 262
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 3e-51
Identities = 61/260 (23%), Positives = 108/260 (41%), Gaps = 26/260 (10%)
Query: 471 KIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 528
++G+G +G +YK + A K++ S + ++ EIDIL+ HPN+V L+ A
Sbjct: 19 ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 78
Query: 529 --PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 586
++ E+ G+++ + + PL+ + + L +LH + I+H
Sbjct: 79 YYENNLWILIEFCAGGAVDAVM--LELERPLTESQIQVVCKQTLDALNYLHD---NKIIH 133
Query: 587 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS- 645
DLK NIL + KL+DFG+S ++ T+ R GT +M PE +
Sbjct: 134 RDLKAGNILFTLDGDIKLADFGVSAKNTR--------TIQRRDSFIGTPYWMAPEVVMCE 185
Query: 646 ----GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQ 701
K+DV+S GI L+ + P ++ L K + W
Sbjct: 186 TSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWS--- 242
Query: 702 AEQLANLAMRCCEMSRKSRP 721
+ +C E + +R
Sbjct: 243 -SNFKDFLKKCLEKNVDARW 261
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (451), Expect = 1e-50
Identities = 66/277 (23%), Positives = 120/277 (43%), Gaps = 26/277 (9%)
Query: 471 KIGEGGYGSIYKGLLRH-----MQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTL 524
IG G +G +Y G L + A+K L+ + G S+F E I+ HPN+++L
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 525 VGACPE---VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 581
+G C +V Y+ +G L + ++ + + + I ++ +
Sbjct: 94 LGICLRSEGSPLVVLPYMKHGDLRNF--IRNETHNPTVKDLIGFGLQVAKGM---KFLAS 148
Query: 582 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 641
VH DL N +LD F K++DFG++R + E ++ +T K +M E
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF----DSVHNKTGAKLPVKWMALE 204
Query: 642 FLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV 700
L + + T KSDV+SFG++L L+T G P + + + LL P P
Sbjct: 205 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP--EYCP-- 260
Query: 701 QAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 737
+ L + ++C + RP ++ + + ++
Sbjct: 261 --DPLYEVMLKCWHPKAEMRPSF-SELVSRISAIFST 294
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 2e-50
Identities = 65/260 (25%), Positives = 107/260 (41%), Gaps = 23/260 (8%)
Query: 471 KIGEGGYGSIYKGLL-----RHMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLV 522
K+G+G +G + +G + + VA+K L P L + +F +E++ + + H NL+
Sbjct: 15 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 523 TLVGACPEVWT-LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 581
L G +V E P GSL DR + + T R A ++ + +L S
Sbjct: 75 RLYGVVLTPPMKMVTELAPLGSLLDR--LRKHQGHFLLGTLSRYAVQVAEGMGYLES--- 129
Query: 582 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 641
+H DL N+LL + K+ DFG+ R L QN+ FA+ PE
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK-----VPFAWCAPE 184
Query: 642 FLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQ 701
L + + SD + FG+ L + T I L + P D P
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP--- 241
Query: 702 AEQLANLAMRCCEMSRKSRP 721
+ + N+ ++C + RP
Sbjct: 242 -QDIYNVMVQCWAHKPEDRP 260
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 3e-50
Identities = 69/290 (23%), Positives = 125/290 (43%), Gaps = 27/290 (9%)
Query: 457 SEIEGATHNFDPSLKIGEGGYGSIYKGLLR------HMQVAIKMLHPHSLQG-PSEFQQE 509
+EI IG G +G +YKG+L+ + VAIK L + +F E
Sbjct: 2 TEIH--PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGE 59
Query: 510 IDILSKIRHPNLVTLVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIAT 567
I+ + H N++ L G + ++ EY+ NG+L+ ++ S + +
Sbjct: 60 AGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKF--LREKDGEFSVLQLVGMLR 117
Query: 568 ELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCC 627
+ + + +L + VH DL NIL+++N V K+SDFG+SR L + ++ T+
Sbjct: 118 GIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGK 174
Query: 628 RTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLK 687
+ PE ++ + T SDV+SFGI++ ++T +K
Sbjct: 175 -----IPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV-----MK 224
Query: 688 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 737
+ D P + L M+C + R RP+ D+ +L+ + +
Sbjct: 225 AINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKF-ADIVSILDKLIRA 273
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 8e-50
Identities = 68/264 (25%), Positives = 114/264 (43%), Gaps = 30/264 (11%)
Query: 465 NFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPS---EFQQEIDILSKIRHP 519
+F+ +G+G +G++Y + +A+K+L L+ + ++E++I S +RHP
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66
Query: 520 NLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 577
N++ L G L+ EY P G++ L Q TEL + L + H
Sbjct: 67 NILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCH 123
Query: 578 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 637
S ++H D+KP N+LL + K++DFG S SS TTLC GT Y
Sbjct: 124 S---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLC------GTLDY 170
Query: 638 MDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 697
+ PE + K D++S G++ L G+P A + + + +
Sbjct: 171 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-------EANTYQETYKRISRVEFTF 223
Query: 698 PFVQAEQLANLAMRCCEMSRKSRP 721
P E +L R + + RP
Sbjct: 224 PDFVTEGARDLISRLLKHNPSQRP 247
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 175 bits (445), Expect = 9e-50
Identities = 65/261 (24%), Positives = 100/261 (38%), Gaps = 33/261 (12%)
Query: 471 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPS---EFQQEIDILSKIRHPNLVTLV 525
+IG G +G++Y VAIK + Q + +E+ L K+RHPN +
Sbjct: 22 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 526 GAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 583
G LV EY + + + + PL + L +LHS H+
Sbjct: 82 GCYLREHTAWLVMEYCLGSASDL---LEVHKKPLQEVEIAAVTHGALQGLAYLHS---HN 135
Query: 584 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 643
++H D+K NILL + KL DFG + ++ GT +M PE +
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------------NSFVGTPYWMAPEVI 183
Query: 644 AS---GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV 700
+ G+ K DV+S GI + L +P L + AL +G W
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNESPALQSGHWS-- 240
Query: 701 QAEQLANLAMRCCEMSRKSRP 721
E N C + + RP
Sbjct: 241 --EYFRNFVDSCLQKIPQDRP 259
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 174 bits (441), Expect = 2e-49
Identities = 72/315 (22%), Positives = 129/315 (40%), Gaps = 50/315 (15%)
Query: 453 DFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHM-------QVAIKMLHPHSLQG-PS 504
+ +E +N + IGEG +G +++ + VA+KML + +
Sbjct: 2 NPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA 61
Query: 505 EFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRL-------------- 548
+FQ+E ++++ +PN+V L+G C + L++EY+ G L + L
Sbjct: 62 DFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHS 121
Query: 549 -------SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV 601
PPLS ++ IA ++ + + +L K VH DL N L+ N V
Sbjct: 122 DLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMV 178
Query: 602 SKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIIL 661
K++DFG+SR + + + +M PE + T +SDV+++G++L
Sbjct: 179 VKIADFGLSRNIYSADYYKADGNDA------IPIRWMPPESIFYNRYTTESDVWAYGVVL 232
Query: 662 LRLLTGR--PALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKS 719
+ + P G+ E + + D P +L NL C
Sbjct: 233 WEIFSYGLQPYYGMAHEEV-------IYYVRDGNILACPENCPLELYNLMRLCWSKLPAD 285
Query: 720 RPELGKDVWRVLEPM 734
RP + R+L+ M
Sbjct: 286 RPSF-CSIHRILQRM 299
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 6e-48
Identities = 66/284 (23%), Positives = 113/284 (39%), Gaps = 48/284 (16%)
Query: 471 KIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQG-PSEFQQEIDILSKI-RHPNL 521
+G G +G + +QVA+KML + E+ +++++ H N+
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 522 VTLVGAC--PEVWTLVYEYLPNGSLEDRLSCK--------------------DNSPPLSW 559
V L+GAC L++EY G L + L K ++ L++
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163
Query: 560 QTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 619
+ + A ++ + FL S VH DL N+L+ V K+ DFG++R + +
Sbjct: 164 EDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220
Query: 620 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG--RPALGITKEV 677
+M PE L G T KSDV+S+GI+L + + P GI +
Sbjct: 221 VVRGNAR------LPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274
Query: 678 QYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 721
+ K + + D PF E++ + C + RP
Sbjct: 275 NF------YKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRP 312
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 7e-48
Identities = 60/255 (23%), Positives = 108/255 (42%), Gaps = 23/255 (9%)
Query: 471 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 528
KIG+G G++Y + +VAI+ ++ EI ++ + ++PN+V + +
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 529 --PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 586
+ +V EYL GSL D ++ + + E L FLHS + ++H
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHS---NQVIH 139
Query: 587 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG 646
D+K NILL + KL+DFG ++ + R+ GT +M PE +
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--------SKRSTMVGTPYWMAPEVVTRK 191
Query: 647 ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLA 706
PK D++S GI+ + ++ G P ++ + P + + A
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY---LIATNGTPELQNPEKLSAI-FR 247
Query: 707 NLAMRCCEMSRKSRP 721
+ RC +M + R
Sbjct: 248 DFLNRCLDMDVEKRG 262
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 4e-47
Identities = 68/278 (24%), Positives = 112/278 (40%), Gaps = 31/278 (11%)
Query: 471 KIGEGGYGSIYKGLLRH-----MQVAIKMLHPHSLQGPSE-FQQEIDILSKIRHPNLVTL 524
IGEG +G +++G+ + VAIK + E F QE + + HP++V L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 525 VGACPEVWT-LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 583
+G E ++ E G L + L + I A +L + L +L S +
Sbjct: 74 IGVITENPVWIIMELCTLGELRSF--LQVRKYSLDLASLILYAYQLSTALAYLESKR--- 128
Query: 584 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 643
VH D+ N+L+ +N KL DFG+SR++ + + K +M PE +
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA-------SKGKLPIKWMAPESI 181
Query: 644 ASGELTPKSDVYSFGIILLRLLTG--RPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQ 701
T SDV+ FG+ + +L +P G+ P+ + P
Sbjct: 182 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR---IENGERLPMPPNCP--- 235
Query: 702 AEQLANLAMRCCEMSRKSRP---ELGKDVWRVLEPMRA 736
L +L +C RP EL + +LE +A
Sbjct: 236 -PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKA 272
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 3e-46
Identities = 74/308 (24%), Positives = 125/308 (40%), Gaps = 55/308 (17%)
Query: 451 FSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLR----HMQVAIKMLHPH-SLQGPSE 505
++D F + IGEG +G + K ++ M AIK + + S +
Sbjct: 9 WNDIKFQD------------VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD 56
Query: 506 FQQEIDILSKI-RHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRL-------------S 549
F E+++L K+ HPN++ L+GAC L EY P+G+L D L
Sbjct: 57 FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAI 116
Query: 550 CKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI 609
+ LS Q + A ++ + +L +H DL NIL+ N+V+K++DFG+
Sbjct: 117 ANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGL 173
Query: 610 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR- 668
SR +T + +M E L T SDV+S+G++L +++
Sbjct: 174 SRGQEVYV---------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 224
Query: 669 -PALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 727
P G+T Y + L + P +++ +L +C RP +
Sbjct: 225 TPYCGMTCAELY-------EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSF-AQI 276
Query: 728 WRVLEPMR 735
L M
Sbjct: 277 LVSLNRML 284
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 164 bits (415), Expect = 4e-46
Identities = 65/276 (23%), Positives = 118/276 (42%), Gaps = 25/276 (9%)
Query: 471 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPS---EFQQEIDILSKIRHPNLVTLV 525
+G GG ++ H VA+K+L + PS F++E + + HP +V +
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 526 GAC------PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 579
+ +V EY+ +L D + + P++ + I + + C L F H
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQ- 129
Query: 580 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 639
+ I+H D+KPANI++ A K+ DFGI+R ++ + S T GT Y+
Sbjct: 130 --NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI-----GTAQYLS 182
Query: 640 PEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPF 699
PE + +SDVYS G +L +LTG P V A ++ P +
Sbjct: 183 PEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQ--HVREDPIPPSARHEG 240
Query: 700 VQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 735
+ + L + ++ + ++R + ++ L +
Sbjct: 241 L-SADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 6e-46
Identities = 64/290 (22%), Positives = 117/290 (40%), Gaps = 40/290 (13%)
Query: 471 KIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQG-PSEFQQEIDILSKI-RHPNL 521
+G G +G + + M VA+KML P + E+ +LS + H N+
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 522 VTLVGAC--PEVWTLVYEYLPNGSLEDRLSCK---------------DNSPPLSWQTRIR 564
V L+GAC ++ EY G L + L K D+ L + +
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 565 IATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 624
+ ++ + FL S + +H DL NILL ++K+ DFG++R + N++
Sbjct: 150 FSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDI------KNDSN 200
Query: 625 LCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG 684
+ + + +M PE + + T +SDV+S+GI L L + + V
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF--- 257
Query: 685 KLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 734
K + + P ++ ++ C + RP K + +++E
Sbjct: 258 -YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTF-KQIVQLIEKQ 305
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 166 bits (420), Expect = 7e-46
Identities = 54/258 (20%), Positives = 98/258 (37%), Gaps = 25/258 (9%)
Query: 471 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 528
++G G +G +++ R A K + ++EI +S +RHP LV L A
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 529 --PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 586
++YE++ G L ++++ + N +S + ++C L +H ++ VH
Sbjct: 93 EDDNEMVMIYEFMSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHE---NNYVH 147
Query: 587 GDLKPANILL--DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 644
DLKP NI+ + KL DFG++ L GT + PE
Sbjct: 148 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPK---------QSVKVTTGTAEFAAPEVAE 198
Query: 645 SGELTPKSDVYSFGIILLRLLTGRPAL-GITKEVQYALDTGKLKNLLDPLAGDWPFVQAE 703
+ +D++S G++ LL+G G + N+ D E
Sbjct: 199 GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGIS----E 254
Query: 704 QLANLAMRCCEMSRKSRP 721
+ + +R
Sbjct: 255 DGKDFIRKLLLADPNTRM 272
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 2e-45
Identities = 62/313 (19%), Positives = 121/313 (38%), Gaps = 29/313 (9%)
Query: 466 FDPSLKIGEGGYGSIYKGLLRH------MQVAIKMLHP-HSLQGPSEFQQEIDILSKIRH 518
F +G G +G++YKGL + VAIK L S + E E +++ + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 519 PNLVTLVGACPE-VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 577
P++ L+G C L+ + +P G L D +++ + Q + ++ + +L
Sbjct: 71 PHVCRLLGICLTSTVQLITQLMPFGCLLDY--VREHKDNIGSQYLLNWCVQIAKGMNYLE 128
Query: 578 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 637
+VH DL N+L+ K++DFG+++ L E K +
Sbjct: 129 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE------KEYHAEGGKVPIKW 179
Query: 638 MDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGD 696
M E + T +SDV+S+G+ + L+T G + L
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI------SSILEKGERLP 233
Query: 697 WPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGSEERCEPPP 756
P + + + ++C + SRP+ +++ M + +ER P
Sbjct: 234 QPPICTIDVYMIMVKCWMIDADSRPKF-RELIIEFSKMARDP--QRYLVIQGDERMHLPS 290
Query: 757 YFTCPIFQEVMQD 769
++ +M +
Sbjct: 291 PTDSNFYRALMDE 303
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 162 bits (412), Expect = 7e-45
Identities = 54/257 (21%), Positives = 104/257 (40%), Gaps = 23/257 (8%)
Query: 471 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 528
++G G +G +++ + + K ++ + EI I++++ HP L+ L A
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 529 --PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 586
L+ E+L G L DR+ +S I + C L +H HSIVH
Sbjct: 96 EDKYEMVLILEFLSGGELFDRI--AAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVH 150
Query: 587 GDLKPANILLDANFVS--KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 644
D+KP NI+ + S K+ DFG++ L+ +EI T T + PE +
Sbjct: 151 LDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---------ATAEFAAPEIVD 201
Query: 645 SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQ 704
+ +D+++ G++ LL+G +++ + + + + V E
Sbjct: 202 REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV--KRCDWEFDEDAFSSVSPE- 258
Query: 705 LANLAMRCCEMSRKSRP 721
+ + + R
Sbjct: 259 AKDFIKNLLQKEPRKRL 275
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 2e-44
Identities = 67/305 (21%), Positives = 129/305 (42%), Gaps = 35/305 (11%)
Query: 448 PQFFSDFSF---SEIEGATHNFDPSLKIGEGGYGSIYKGLLRHM-------QVAIKMLHP 497
P++FS E E A S ++G+G +G +Y+G+ + + +VAIK ++
Sbjct: 1 PEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE 60
Query: 498 -HSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNS 554
S++ EF E ++ + ++V L+G + ++ E + G L+ L +
Sbjct: 61 AASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPA 120
Query: 555 -------PPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDF 607
P S I++A E+ + +L++ + VH DL N ++ +F K+ DF
Sbjct: 121 MANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDF 177
Query: 608 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG 667
G++R + + + +M PE L G T SDV+SFG++L + T
Sbjct: 178 GMTRDIYETDYYRKGGKGL------LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATL 231
Query: 668 RPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 727
+ L+ +++ D P + L L C + + K RP ++
Sbjct: 232 AEQPYQGLSNEQV-----LRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSF-LEI 285
Query: 728 WRVLE 732
++
Sbjct: 286 ISSIK 290
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 3e-44
Identities = 51/258 (19%), Positives = 101/258 (39%), Gaps = 26/258 (10%)
Query: 471 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 528
+G G +G +++ + K + ++EI IL+ RH N++ L +
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF 70
Query: 529 --PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 586
E +++E++ + +R+ ++ L+ + + ++C L FLHS H+I H
Sbjct: 71 ESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLHS---HNIGH 125
Query: 587 GDLKPANILLDA--NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 644
D++P NI+ + K+ +FG +R L + Y PE
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---------NFRLLFTAPEYYAPEVHQ 176
Query: 645 SGELTPKSDVYSFGIILLRLLTGR-PALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAE 703
++ +D++S G ++ LL+G P L T + + +
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEIS----I 232
Query: 704 QLANLAMRCCEMSRKSRP 721
+ + R RKSR
Sbjct: 233 EAMDFVDRLLVKERKSRM 250
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 5e-44
Identities = 60/264 (22%), Positives = 100/264 (37%), Gaps = 26/264 (9%)
Query: 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPS---EFQQEIDILSKIRHP 519
+F +GEG + ++ + AIK+L + + +E D++S++ HP
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 520 NLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 577
V L E Y NG L + E+ S L +LH
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLH 125
Query: 578 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 637
I+H DLKP NILL+ + +++DFG ++ LS + + GT Y
Sbjct: 126 G---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV------GTAQY 176
Query: 638 MDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 697
+ PE L SD+++ G I+ +L+ G P E KL+ D+
Sbjct: 177 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-------YDF 229
Query: 698 PFVQAEQLANLAMRCCEMSRKSRP 721
P + +L + + R
Sbjct: 230 PEKFFPKARDLVEKLLVLDATKRL 253
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 156 bits (395), Expect = 5e-43
Identities = 63/260 (24%), Positives = 100/260 (38%), Gaps = 28/260 (10%)
Query: 471 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLVGA 527
+G G + + + VAIK + +L+G + EI +L KI+HPN+V L
Sbjct: 16 VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI 75
Query: 528 C--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 585
L+ + + G L DR+ K + + R+ ++ + +LH IV
Sbjct: 76 YESGGHLYLIMQLVSGGELFDRIVEK---GFYTERDASRLIFQVLDAVKYLHDLG---IV 129
Query: 586 HGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 642
H DLKP N+L D + +SDFG+S+ + +T C GT Y+ PE
Sbjct: 130 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL---STAC------GTPGYVAPEV 180
Query: 643 LASGELTPKSDVYSFGIILLRLLTGRPAL-GITKEVQYALDTGKLKNLLDPLAGDWPFVQ 701
LA + D +S G+I LL G P + P D
Sbjct: 181 LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDIS--- 237
Query: 702 AEQLANLAMRCCEMSRKSRP 721
+ + E + R
Sbjct: 238 -DSAKDFIRHLMEKDPEKRF 256
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 155 bits (392), Expect = 7e-43
Identities = 67/278 (24%), Positives = 111/278 (39%), Gaps = 40/278 (14%)
Query: 465 NFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSE---------FQQEIDIL 513
N++P +G G + + + + + A+K++ S +E+DIL
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 514 SKIR-HPNLVTLVGACPEVWT--LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELC 570
K+ HPN++ L LV++ + G L D L+ LS + +I L
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRALL 120
Query: 571 SVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTD 630
V+ LH +IVH DLKP NILLD + KL+DFG S L E +
Sbjct: 121 EVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---------KLRE 168
Query: 631 PKGTFAYMDPEFLASGEL------TPKSDVYSFGIILLRLLTGRPAL-GITKEVQYALDT 683
GT +Y+ PE + + D++S G+I+ LL G P + + +
Sbjct: 169 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM 228
Query: 684 GKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 721
P D+ + + +L R + + R
Sbjct: 229 SGNYQFGSPEWDDYS----DTVKDLVSRFLVVQPQKRY 262
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 151 bits (382), Expect = 2e-41
Identities = 49/261 (18%), Positives = 92/261 (35%), Gaps = 20/261 (7%)
Query: 471 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 528
KIG G +G IY G +VAIK+ + + E I ++ + + C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 529 ---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 585
+ +V E L + S S +T + +A ++ S + ++HS + +
Sbjct: 72 GAEGDYNVMVMELLGPSLEDL---FNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFI 125
Query: 586 HGDLKPANIL---LDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 642
H D+KP N L + + DFG+++ + + + GT Y
Sbjct: 126 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR-THQHIPYRENKNLTGTARYASINT 184
Query: 643 LASGELTPKSDVYSFGIILLRLLTGRPAL--GITKEVQYALDTGKLKNLLDPLAGDWPFV 700
E + + D+ S G +L+ G + + K + P+
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGY 244
Query: 701 QAEQLANLAMRCCEMSRKSRP 721
+E A C + +P
Sbjct: 245 PSE-FATYLNFCRSLRFDDKP 264
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 147 bits (372), Expect = 5e-40
Identities = 49/266 (18%), Positives = 92/266 (34%), Gaps = 28/266 (10%)
Query: 471 KIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 528
+IGEG +G I++G LL + QVAIK S + + E + + V
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 529 ---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 585
LV + L + S +T A ++ + + +H S+V
Sbjct: 70 GQEGLHNVLVIDLLGPSLEDL---LDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLV 123
Query: 586 HGDLKPANILLDANFVS-----KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 640
+ D+KP N L+ + DFG+ +F + ++ + + + GT YM
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR-DPVTKQHIPYREKKNLSGTARYMSI 182
Query: 641 EFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDP-----LAG 695
E + + D+ + G + + L G K ++ L
Sbjct: 183 NTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCA 242
Query: 696 DWPFVQAEQLANLAMRCCEMSRKSRP 721
+P E+ ++ + P
Sbjct: 243 GFP----EEFYKYMHYARNLAFDATP 264
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 6e-40
Identities = 67/294 (22%), Positives = 120/294 (40%), Gaps = 45/294 (15%)
Query: 471 KIGEGGYGSIYKGLLRH---------MQVAIKMLHPHSLQ-GPSEFQQEIDILSKI-RHP 519
+GEG +G + +VA+KML + + S+ E++++ I +H
Sbjct: 20 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79
Query: 520 NLVTLVGACPEVWT--LVYEYLPNGSLEDRLSCK-------------DNSPPLSWQTRIR 564
N++ L+GAC + ++ EY G+L + L + + LS + +
Sbjct: 80 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 139
Query: 565 IATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 624
A ++ + +L S +H DL N+L+ + V K++DFG++R + + T
Sbjct: 140 CAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196
Query: 625 LCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG--RPALGITKEVQYALD 682
+M PE L T +SDV+SFG++L + T P G+ E +
Sbjct: 197 GR------LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF--- 247
Query: 683 TGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 736
K L + D P +L + C RP K + L+ + A
Sbjct: 248 ----KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTF-KQLVEDLDRIVA 296
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 8e-40
Identities = 62/265 (23%), Positives = 102/265 (38%), Gaps = 29/265 (10%)
Query: 465 NFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSE---FQQEIDILSK-IRH 518
+F +G+G +G ++ + AIK L + + E +LS H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 519 PNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFL 576
P L + E V EYL G L + + A E+ L FL
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFL 119
Query: 577 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 636
HS IV+ DLK NILLD + K++DFG+ + + + T C GT
Sbjct: 120 HS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD--AKTNTFC------GTPD 168
Query: 637 YMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 696
Y+ PE L + D +SFG++L +L G+ + D +L + +
Sbjct: 169 YIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF-------HGQDEEELFHSIRMDNPF 221
Query: 697 WPFVQAEQLANLAMRCCEMSRKSRP 721
+P ++ +L ++ + R
Sbjct: 222 YPRWLEKEAKDLLVKLFVREPEKRL 246
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 147 bits (372), Expect = 9e-40
Identities = 62/264 (23%), Positives = 104/264 (39%), Gaps = 31/264 (11%)
Query: 465 NFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSE---FQQEIDILSKIRHP 519
+F +G G +G ++ RH A+K+L + + E +LS + HP
Sbjct: 5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 64
Query: 520 NLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 577
++ + G + ++ +Y+ G L L P A E+C L +LH
Sbjct: 65 FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFP---NPVAKFYAAEVCLALEYLH 121
Query: 578 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 637
S I++ DLKP NILLD N K++DFG ++++ GT Y
Sbjct: 122 S---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----------TYTLCGTPDY 167
Query: 638 MDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 697
+ PE +++ D +SFGI++ +L G Y +T K + +
Sbjct: 168 IAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF-------YDSNTMKTYEKILNAELRF 220
Query: 698 PFVQAEQLANLAMRCCEMSRKSRP 721
P E + +L R R
Sbjct: 221 PPFFNEDVKDLLSRLITRDLSQRL 244
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 3e-39
Identities = 60/289 (20%), Positives = 107/289 (37%), Gaps = 39/289 (13%)
Query: 471 KIGEGGYGSIYKGLLRHM-------QVAIKMLHPHSLQGP-SEFQQEIDILSKIRH-PNL 521
+G G +G + + + VA+KML + E+ IL I H N+
Sbjct: 20 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79
Query: 522 VTLVGACPE---VWTLVYEYLPNGSLEDRLSCKDNSP-------------PLSWQTRIRI 565
V L+GAC + ++ E+ G+L L K N L+ + I
Sbjct: 80 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139
Query: 566 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 625
+ ++ + FL S +H DL NILL V K+ DFG++R + ++
Sbjct: 140 SFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 196
Query: 626 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK 685
+M PE + T +SDV+SFG++L + + + ++
Sbjct: 197 R------LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF---- 246
Query: 686 LKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 734
+ L + P ++ + C RP ++ L +
Sbjct: 247 CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTF-SELVEHLGNL 294
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 3e-39
Identities = 61/263 (23%), Positives = 104/263 (39%), Gaps = 16/263 (6%)
Query: 471 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLVGA 527
IGEG YG + ++VAIK + P Q +EI IL + RH N++ +
Sbjct: 15 YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 74
Query: 528 C--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 585
P + + YL + L + LS ++ L ++HS +++
Sbjct: 75 IRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVL 131
Query: 586 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS 645
H DLKP+N+LL+ K+ DFG++R ++ T+ T Y PE + +
Sbjct: 132 HRDLKPSNLLLNTTCDLKICDFGLARV-----ADPDHDHTGFLTEYVATRWYRAPEIMLN 186
Query: 646 GEL-TPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQ 704
+ T D++S G IL +L+ RP + L L P D + +
Sbjct: 187 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD--QLNHILGILGSPSQEDLNCIINLK 244
Query: 705 LANLAMRCCEMSRKSRPELGKDV 727
N + ++ L +
Sbjct: 245 ARNYLLSLPHKNKVPWNRLFPNA 267
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 4e-38
Identities = 55/264 (20%), Positives = 105/264 (39%), Gaps = 33/264 (12%)
Query: 472 IGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGAC 528
+G G G + + + + A+KML + ++E+++ + + P++V +V
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKMLQDCP-----KARREVELHWRASQCPHIVRIVDVY 74
Query: 529 PEVWT------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 582
++ +V E L G L R+ + + I + + +LHS
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQ-DRGDQAFTEREASEIMKSIGEAIQYLHS---I 130
Query: 583 SIVHGDLKPANILLDA---NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 639
+I H D+KP N+L + N + KL+DFG ++ + + T P T Y+
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---------SLTTPCYTPYYVA 181
Query: 640 PEFLASGELTPKSDVYSFGIILLRLLTGRPAL--GITKEVQYALDTGKLKNLLDPLAGDW 697
PE L + D++S G+I+ LL G P + + T + +W
Sbjct: 182 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 241
Query: 698 PFVQAEQLANLAMRCCEMSRKSRP 721
V +E++ L + R
Sbjct: 242 SEV-SEEVKMLIRNLLKTEPTQRM 264
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 6e-38
Identities = 60/266 (22%), Positives = 104/266 (39%), Gaps = 34/266 (12%)
Query: 471 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGP------SEFQQEIDILSKIRHPNLV 522
++G G + + K + +Q A K + + + ++E+ IL +I+HPN++
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 523 TLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 580
TL L+ E + G L D L+ + ++ + + +LHS
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFD---FLAEKESLTEEEATEFLKQILNGVYYLHS-- 131
Query: 581 PHSIVHGDLKPANILLDANFVS----KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 636
I H DLKP NI+L V K+ DFG++ + + GT
Sbjct: 132 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---------EFKNIFGTPE 181
Query: 637 YMDPEFLASGELTPKSDVYSFGIILLRLLTGR-PALGITKEVQYALDTGKLKNLLDPLAG 695
++ PE + L ++D++S G+I LL+G P LG TK+ A + D
Sbjct: 182 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 241
Query: 696 DWPFVQAEQLANLAMRCCEMSRKSRP 721
+ + R K R
Sbjct: 242 NTS----ALAKDFIRRLLVKDPKKRM 263
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 142 bits (359), Expect = 1e-37
Identities = 64/269 (23%), Positives = 106/269 (39%), Gaps = 33/269 (12%)
Query: 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQE---IDILSKI 516
+F IG GG+G +Y A+K L + QG + E + ++S
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 517 RHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLI 574
P +V + A P+ + + + + G L LS S A E+ L
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLE 121
Query: 575 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 634
+H+ +V+ DLKPANILLD + ++SD G++ S+ + GT
Sbjct: 122 HMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----------PHASVGT 168
Query: 635 FAYMDPEFLASGE-LTPKSDVYSFGIILLRLLTGR-PALGITKEVQYALDTGKLKNLLDP 692
YM PE L G +D +S G +L +LL G P + ++ +D L +
Sbjct: 169 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV-- 226
Query: 693 LAGDWPFVQAEQLANLAMRCCEMSRKSRP 721
+ P + +L +L + R
Sbjct: 227 ---ELPDSFSPELRSLLEGLLQRDVNRRL 252
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 6e-37
Identities = 57/239 (23%), Positives = 91/239 (38%), Gaps = 36/239 (15%)
Query: 442 SSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHS 499
++ P + S+++ + IG G +G +Y+ L VAIK +
Sbjct: 8 ATPGQGPDRPQEVSYTDTK----------VIGNGSFGVVYQAKLCDSGELVAIKKV---- 53
Query: 500 LQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWT--------LVYEYLPNGSLEDRLSCK 551
LQ +E+ I+ K+ H N+V L LV +Y+P
Sbjct: 54 LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS 113
Query: 552 DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN-FVSKLSDFGIS 610
L +L L ++HS I H D+KP N+LLD + V KL DFG +
Sbjct: 114 RAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSA 170
Query: 611 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 669
+ L + E + + + + T DV+S G +L LL G+P
Sbjct: 171 KQLVRGE--------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 221
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 1e-36
Identities = 68/274 (24%), Positives = 115/274 (41%), Gaps = 29/274 (10%)
Query: 471 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVG 526
KIG+G +G ++K R +VA+K + + + P +EI IL ++H N+V L+
Sbjct: 17 KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 76
Query: 527 ACPEVWT----------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFL 576
C + LV+++ + + + R+ L + L ++
Sbjct: 77 ICRTKASPYNRCKGSIYLVFDFCEHDLAGL---LSNVLVKFTLSEIKRVMQMLLNGLYYI 133
Query: 577 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 636
H K I+H D+K AN+L+ + V KL+DFG++R S + N+ T+ T
Sbjct: 134 HRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAK----NSQPNRYTNRVVTLW 186
Query: 637 YMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPAL-GITKEVQYALDTGKLKNLLDPLA 694
Y PE L + P D++ G I+ + T P + G T++ Q AL +
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI---SQLCGSITP 243
Query: 695 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVW 728
WP V +L RK + L V
Sbjct: 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVR 277
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 4e-36
Identities = 71/289 (24%), Positives = 111/289 (38%), Gaps = 33/289 (11%)
Query: 462 ATHNFDPSLKIGEGGYGSIYKGLLR---HMQVAIKMLHPHSLQG--PSEFQQEIDILSKI 516
A ++ +IGEG YG ++K VA+K + + + P +E+ +L +
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 517 ---RHPNLVTLVGACPEVWT-------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIA 566
HPN+V L C T LV+E++ K P + +T +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT--YLDKVPEPGVPTETIKDMM 122
Query: 567 TELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLC 626
+L L FLHS H +VH DLKP NIL+ ++ KL+DFG++R S
Sbjct: 123 FQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---------M 170
Query: 627 CRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPAL-GITKEVQYALDTGK 685
T T Y PE L D++S G I + +P G + Q
Sbjct: 171 ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGK---I 227
Query: 686 LKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 734
L + P DWP A + + K ++ + +L
Sbjct: 228 LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKC 276
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 4e-35
Identities = 54/265 (20%), Positives = 97/265 (36%), Gaps = 42/265 (15%)
Query: 471 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSE------FQQEIDILSKIR--HPN 520
+G GG+GS+Y G+ ++ VAIK + + E E+ +L K+
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 521 LVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 578
++ L+ P+ + L+ E + L + ++ + H+
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHN 128
Query: 579 CKPHSIVHGDLKPANILLDAN-FVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 637
++H D+K NIL+D N KL DFG L TD GT Y
Sbjct: 129 ---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----------VYTDFDGTRVY 175
Query: 638 MDPEFLASGEL-TPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 696
PE++ + V+S GI+L ++ G +E+ G++
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII----RGQV---------F 222
Query: 697 WPFVQAEQLANLAMRCCEMSRKSRP 721
+ + + +L C + RP
Sbjct: 223 FRQRVSSECQHLIRWCLALRPSDRP 247
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 4e-35
Identities = 58/209 (27%), Positives = 90/209 (43%), Gaps = 24/209 (11%)
Query: 471 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSE-----FQQEIDILSKIRHPNLVT 523
+GEG + ++YK ++ VAIK + + +EI +L ++ HPN++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 524 LVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 581
L+ A +LV++++ KDNS L+ L +LH
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLEVI---IKDNSLVLTPSHIKAYMLMTLQGLEYLHQ--- 118
Query: 582 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 641
H I+H DLKP N+LLD N V KL+DFG+++ T T Y PE
Sbjct: 119 HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN--------RAYTHQVVTRWYRAPE 170
Query: 642 FLASGEL-TPKSDVYSFGIILLRLLTGRP 669
L + D+++ G IL LL P
Sbjct: 171 LLFGARMYGVGVDMWAVGCILAELLLRVP 199
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 2e-34
Identities = 62/269 (23%), Positives = 104/269 (38%), Gaps = 28/269 (10%)
Query: 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSE---FQQEIDILSKIRHP 519
+FD +G+G +G + + A+K+L + E E +L RHP
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 520 NLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 577
L L A + V EY G L LS + + E+ S L +LH
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLH 122
Query: 578 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 637
S +V+ D+K N++LD + K++DFG+ + E S+ T+ GT Y
Sbjct: 123 S---RDVVYRDIKLENLMLDKDGHIKITDFGLCK-----EGISDGATMKTFC---GTPEY 171
Query: 638 MDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 697
+ PE L + D + G+++ ++ GR Y D +L L+ +
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-------YNQDHERLFELILMEEIRF 224
Query: 698 PFVQAEQLANLAMRCCEMSRKSRPELGKD 726
P + + +L + K R G
Sbjct: 225 PRTLSPEAKSLLAGLLKKDPKQRLGGGPS 253
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 128 bits (323), Expect = 1e-33
Identities = 59/238 (24%), Positives = 101/238 (42%), Gaps = 24/238 (10%)
Query: 471 KIGEGGYGSIYKGLLRHMQ-VAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGA 527
KIGEG YG +YK + + A+K + PS +EI IL +++H N+V L
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 528 CPEVWT--LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 585
LV+E+L + C+ L T +L + + + H ++
Sbjct: 69 IHTKKRLVLVFEHLDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHD---RRVL 122
Query: 586 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA- 644
H DLKP N+L++ K++DFG++R + + Y P+ L
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVT--------LWYRAPDVLMG 174
Query: 645 SGELTPKSDVYSFGIILLRLLTGRPAL-GITKEVQYALDTGKLKNLLDPLAGDWPFVQ 701
S + + D++S G I ++ G P G+++ Q + L P + +WP V
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMR---IFRILGTPNSKNWPNVT 229
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 1e-33
Identities = 58/212 (27%), Positives = 87/212 (41%), Gaps = 20/212 (9%)
Query: 465 NFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPN 520
NF KIGEG YG +YK + VA+K + + PS +EI +L ++ HPN
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 521 LVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 578
+V L+ LV+E+L + + +L L F HS
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLK--KFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 579 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 638
H ++H DLKP N+L++ KL+DFG++R T Y
Sbjct: 121 ---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRTYTHEVVTL------WYR 169
Query: 639 DPEFLA-SGELTPKSDVYSFGIILLRLLTGRP 669
PE L + D++S G I ++T R
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRA 201
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 127 bits (321), Expect = 9e-33
Identities = 55/315 (17%), Positives = 111/315 (35%), Gaps = 47/315 (14%)
Query: 414 KKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIG 473
KK ++ ++ A + + L+K + +++ + QF + +G
Sbjct: 7 KKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQF-------DRIK---------TLG 50
Query: 474 EGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSE---FQQEIDILSKIRHPNLVTLVGAC 528
G +G + + A+K+L + + E IL + P LV L +
Sbjct: 51 TGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF 110
Query: 529 PEVWTL--VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 586
+ L V EY+ G + L S A ++ +LHS +++
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIY 164
Query: 587 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG 646
DLKP N+L+D +++DFG ++ GT + PE + S
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAKR-----------VKGRTWTLCGTPEALAPEIILSK 213
Query: 647 ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLA 706
D ++ G+++ + G P +A ++ + +P + L
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF-------FADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 707 NLAMRCCEMSRKSRP 721
+L ++ R
Sbjct: 267 DLLRNLLQVDLTKRF 281
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 3e-31
Identities = 53/270 (19%), Positives = 102/270 (37%), Gaps = 34/270 (12%)
Query: 471 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVG 526
+G G YG++ + +VAIK L+ +E+ +L +RH N++ L+
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 527 ACPEVWT--------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 578
T LV ++ G+ +L L + ++ L ++H+
Sbjct: 85 VFTPDETLDDFTDFYLVMPFM--GTDLGKLM---KHEKLGEDRIQFLVYQMLKGLRYIHA 139
Query: 579 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 638
H DLKP N+ ++ + K+ DFG++R T T Y
Sbjct: 140 AGII---HRDLKPGNLAVNEDCELKILDFGLARQADSE-----------MTGYVVTRWYR 185
Query: 639 DPEFLASGE-LTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 697
PE + + T D++S G I+ ++TG+ + + +K P A
Sbjct: 186 APEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD--QLKEIMKVTGTPPAEFV 243
Query: 698 PFVQAEQLANLAMRCCEMSRKSRPELGKDV 727
+Q+++ N E+ +K + +
Sbjct: 244 QRLQSDEAKNYMKGLPELEKKDFASILTNA 273
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 121 bits (305), Expect = 7e-31
Identities = 50/246 (20%), Positives = 105/246 (42%), Gaps = 31/246 (12%)
Query: 436 KSRKEASSSSHMPQFFSDFSFSEIE-GATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAI 492
++R ++H P+ + D+ +E G ++ K+G G Y +++ + + +V +
Sbjct: 6 RARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVV 65
Query: 493 KMLHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVGACPE----VWTLVYEYLPNGSLEDR 547
K+L P + + ++EI IL +R PN++TL + LV+E++ N +
Sbjct: 66 KILKPVKKK---KIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL 122
Query: 548 LSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA-NFVSKLSD 606
L+ E+ L + HS I+H D+KP N+++D + +L D
Sbjct: 123 YQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLID 173
Query: 607 FGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL-TPKSDVYSFGIILLRLL 665
+G++ F + + + PE L ++ D++S G +L ++
Sbjct: 174 WGLAEFYHPGQE---------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 224
Query: 666 TGRPAL 671
+
Sbjct: 225 FRKEPF 230
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 2e-30
Identities = 58/236 (24%), Positives = 94/236 (39%), Gaps = 20/236 (8%)
Query: 471 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVG 526
KIGEG YG+++K R H VA+K + PS +EI +L +++H N+V L
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 527 ACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 584
TLV+E+ + SC + + +L L F H ++
Sbjct: 69 VLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD---PEIVKSFLFQLLKGLGFCH---SRNV 122
Query: 585 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 644
+H DLKP N+L++ N KL++FG++R + T +
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGI---PVRCYSAEVVT----LWYRPPDVLFG 175
Query: 645 SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV 700
+ + D++S G I L L +V L + L P WP +
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKR-IFRLLGTPTEEQWPSM 230
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 9e-29
Identities = 64/276 (23%), Positives = 106/276 (38%), Gaps = 30/276 (10%)
Query: 465 NFDPSLKIGEGGYGSIYKGLLRHMQ-----VAIKMLHPHSL----QGPSEFQQEIDILSK 515
NF+ +G G YG ++ A+K+L ++ + + E +L
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 516 IRH-PNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV 572
IR P LVTL A L+ +Y+ G L LS ++ Q + +
Sbjct: 85 IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVG------EI 138
Query: 573 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 632
++ L I++ D+K NILLD+N L+DFG+S+ +E D
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-------RAYDFC 191
Query: 633 GTFAYMDPEFLASGE--LTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLL 690
GT YM P+ + G+ D +S G+++ LLTG + E + +
Sbjct: 192 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS 251
Query: 691 DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD 726
+P +P + +L R K R G
Sbjct: 252 EP---PYPQEMSALAKDLIQRLLMKDPKKRLGCGPR 284
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 7e-28
Identities = 54/269 (20%), Positives = 101/269 (37%), Gaps = 32/269 (11%)
Query: 471 KIGEGGYGSIYKGLLRH--MQVAIKMLHPH--SLQGPSEFQQEIDILSKIRHPNLVTLVG 526
+G G YGS+ ++VA+K L S+ +E+ +L ++H N++ L+
Sbjct: 25 PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84
Query: 527 ACPEVWTL-------VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 579
+L + +L L + + C+ L+ + ++ L ++HS
Sbjct: 85 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHS- 139
Query: 580 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 639
I+H DLKP+N+ ++ + K+ DFG++R +
Sbjct: 140 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----------EMTGYVATRWYRAP 187
Query: 640 PEFLASGELTPKSDVYSFGIILLRLLTGRPAL-GITKEVQYALDTGKLKNLLDPLAGDWP 698
L D++S G I+ LLTGR G Q L L+ + P A
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL---ILRLVGTPGAELLK 244
Query: 699 FVQAEQLANLAMRCCEMSRKSRPELGKDV 727
+ +E N +M + + +
Sbjct: 245 KISSESARNYIQSLTQMPKMNFANVFIGA 273
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 2e-26
Identities = 42/211 (19%), Positives = 76/211 (36%), Gaps = 30/211 (14%)
Query: 471 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVG 526
IG G G + VAIK L +E+ ++ + H N+++L+
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 527 ACPEVWT--------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 578
T LV E + + D + + ++ + LHS
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD------HERMSYLLYQMLCGIKHLHS 137
Query: 579 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 638
+H DLKP+NI++ ++ K+ DFG++R + T T Y
Sbjct: 138 AGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---------MMTPYVVTRYYR 185
Query: 639 DPEFLASGELTPKSDVYSFGIILLRLLTGRP 669
PE + D++S G I+ ++ +
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKI 216
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 105 bits (262), Expect = 5e-25
Identities = 37/217 (17%), Positives = 77/217 (35%), Gaps = 27/217 (12%)
Query: 471 KIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 528
K+G G + +++ ++ + VA+K++ + + EI +L ++ +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 529 ---------------PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVL 573
P +V + G L K + +I+ +L L
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 574 IFLHSCKPHSIVHGDLKPANILLDAN-FVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 632
++ + I+H D+KP N+L++ L I+ + + T
Sbjct: 139 DYM--HRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI------ 190
Query: 633 GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 669
T Y PE L +D++S ++ L+TG
Sbjct: 191 QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDF 227
|
| >d1t1ha_ g.44.1.2 (A:) E3 ubiquitin ligase PUB14 {Thale-cress (Arabidopsis thaliana) [TaxId: 3702]} Length = 78 | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: E3 ubiquitin ligase PUB14 species: Thale-cress (Arabidopsis thaliana) [TaxId: 3702]
Score = 84.0 bits (207), Expect = 2e-20
Identities = 31/72 (43%), Positives = 44/72 (61%)
Query: 753 EPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLA 812
E P YF CPI E+M+DP + + G TYE +++ WLD+GH+T P + L H L PN
Sbjct: 4 EFPEYFRCPISLELMKDPVIVSTGQTYERSSIQKWLDAGHKTCPKSQETLLHAGLTPNYV 63
Query: 813 LRSAIQEWLQQH 824
L+S I W + +
Sbjct: 64 LKSLIALWCESN 75
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 80.6 bits (198), Expect = 5e-18
Identities = 24/158 (15%), Positives = 46/158 (29%), Gaps = 19/158 (12%)
Query: 471 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSL----------QGPSEFQQEIDILSKIRHP 519
+GEG +++ + +K G F ++
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 520 NLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 579
L L G Y + N L + L + + + + + +
Sbjct: 67 ALQKLQGLAVPKV---YAWEGNAVLME-LIDAKELYRVRVENPDEVLDMILEEVAKFYH- 121
Query: 580 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 617
IVHGDL N+L+ + + DF S + +
Sbjct: 122 --RGIVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGEEG 156
|
| >d2c2la2 g.44.1.2 (A:225-304) STIP1 homology and U box-containing protein 1, STUB1 {Mouse (Mus musculus) [TaxId: 10090]} Length = 80 | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: STIP1 homology and U box-containing protein 1, STUB1 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 66.4 bits (161), Expect = 3e-14
Identities = 20/72 (27%), Positives = 39/72 (54%)
Query: 753 EPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLA 812
+ P Y I E+M++P + G TY+ + ++ L +P+T PL + L+PNLA
Sbjct: 3 DIPDYLCGKISFELMREPCITPSGITYDRKDIEEHLQRVGHFNPVTRSPLTQEQLIPNLA 62
Query: 813 LRSAIQEWLQQH 824
++ I ++ ++
Sbjct: 63 MKEVIDAFISEN 74
|
| >d1wgma_ g.44.1.2 (A:) Ubiquitin conjugation factor E4A {Human (Homo sapiens) [TaxId: 9606]} Length = 98 | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: Ubiquitin conjugation factor E4A species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.1 bits (142), Expect = 2e-11
Identities = 25/90 (27%), Positives = 34/90 (37%), Gaps = 2/90 (2%)
Query: 736 ASCGGSTSYRLGSEERCEPPPYFTCPIFQEVMQDPHVAADGF-TYEAEALKGWLDSGHET 794
S G S + E + F PI +M DP V T + + L S +T
Sbjct: 1 GSSGSSGLQQQEEETYADACDEFLDPIMSTLMCDPVVLPSSRVTVDRSTIARHLLS-DQT 59
Query: 795 SPMTNLPLAHKNLVPNLALRSAIQEWLQQH 824
P PL + PN L+ IQ WL +
Sbjct: 60 DPFNRSPLTMDQIRPNTELKEKIQRWLAER 89
|
| >d1jm7a_ g.44.1.1 (A:) brca1 RING domain {Human (Homo sapiens) [TaxId: 9606]} Length = 103 | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: brca1 RING domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.4 bits (112), Expect = 3e-07
Identities = 11/67 (16%), Positives = 26/67 (38%), Gaps = 2/67 (2%)
Query: 758 FTCPIFQEVMQDPHVAADGFTYEAEALKGWLDS--GHETSPMTNLPLAHKNLVPNLALRS 815
CPI E++++P + + L+ G P+ + ++L +
Sbjct: 22 LECPICLELIKEPVSTKCDHIFCKFCMLKLLNQKKGPSQCPLCKNDITKRSLQESTRFSQ 81
Query: 816 AIQEWLQ 822
++E L+
Sbjct: 82 LVEELLK 88
|
| >d1f5na1 a.114.1.1 (A:284-583) Interferon-induced guanylate-binding protein 1 (GBP1), C-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 300 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: Interferon-induced guanylate-binding protein 1 (GBP1), C-terminal domain superfamily: Interferon-induced guanylate-binding protein 1 (GBP1), C-terminal domain family: Interferon-induced guanylate-binding protein 1 (GBP1), C-terminal domain domain: Interferon-induced guanylate-binding protein 1 (GBP1), C-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.7 bits (105), Expect = 2e-05
Identities = 22/141 (15%), Positives = 62/141 (43%)
Query: 296 DQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALA 355
L + E +A E K+++ ++I + + + +E++ + E+
Sbjct: 158 QDLKKKYYEEPRKGIQAEEILQTYLKSKESMTDAILQTDQTLTEKEKEIEVERVKAESAQ 217
Query: 356 NGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKK 415
L M+++++++ME+ + + + ++ E+D+ EQ+ A++L + +
Sbjct: 218 ASAKMLHEMQRKNEQMMEQKERSYQEHLKQLTEKMENDRVQLLKEQERTLALKLQEQEQL 277
Query: 416 EQDELQMERDKAVKEAEELRK 436
++ Q E E ++L+
Sbjct: 278 LKEGFQKESRIMKNEIQDLQT 298
|
| >d1eq1a_ a.63.1.1 (A:) Apolipophorin-III {Manduca sexta [TaxId: 7130]} Length = 166 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: Apolipophorin-III superfamily: Apolipophorin-III family: Apolipophorin-III domain: Apolipophorin-III species: Manduca sexta [TaxId: 7130]
Score = 40.7 bits (95), Expect = 2e-04
Identities = 32/173 (18%), Positives = 63/173 (36%), Gaps = 31/173 (17%)
Query: 288 GSVDDNLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRR 347
G+ + + + F E K+ + + K ++L
Sbjct: 6 GNAFEEMEKHAKEFQKT--------FSEQFNSLVNSKNTQDFNKALKDGSDSVLQQLSAF 57
Query: 348 ------------KEFEEAL--ANGKLEL--ERMKKQHDEVMEEL-QIALDQKSLLESQIA 390
+ +EAL A +E E ++K H +V +E ++ +++ +
Sbjct: 58 SSSLQGAISDANGKAKEALEQARQNVEKTAEELRKAHPDVEKEANAFKDKLQAAVQTTVQ 117
Query: 391 ESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASS 443
ES + AKE+ + + L K+ D VK AEE++K EA++
Sbjct: 118 ESQKLAKEVASNMEETNKKLAPKIKQA------YDDFVKHAEEVQKKLHEAAT 164
|
| >d2baya1 g.44.1.2 (A:1-56) Pre-mRNA splicing factor Prp19 {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 56 | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: Pre-mRNA splicing factor Prp19 species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 36.7 bits (84), Expect = 6e-04
Identities = 12/52 (23%), Positives = 24/52 (46%), Gaps = 2/52 (3%)
Query: 759 TCPIFQEVMQDPHVAA-DGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVP 809
C I +V + P ++ +E L+ ++ P+TN PL+ + +V
Sbjct: 2 LCAISGKVPRRPVLSPKSRTIFEKSLLEQYVKD-TGNDPITNEPLSIEEIVE 52
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 824 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.86 | |
| d1wgma_ | 98 | Ubiquitin conjugation factor E4A {Human (Homo sapi | 99.55 | |
| d1t1ha_ | 78 | E3 ubiquitin ligase PUB14 {Thale-cress (Arabidopsi | 99.5 | |
| d2c2la2 | 80 | STIP1 homology and U box-containing protein 1, STU | 99.49 | |
| d2gm3a1 | 171 | Putative ethylene-responsive protein AT3g01520/F4P | 99.03 | |
| d1mjha_ | 160 | "Hypothetical" protein MJ0577 {Archaeon Methanococ | 98.43 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.4 | |
| d2baya1 | 56 | Pre-mRNA splicing factor Prp19 {Baker's yeast (Sac | 98.32 | |
| d1tq8a_ | 147 | Hypothetical protein Rv1636 {Mycobacterium tubercu | 98.06 | |
| d2z3va1 | 135 | Hypothetical protein TTHA0895 {Thermus thermophilu | 97.99 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.68 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.55 | |
| d1jmva_ | 140 | Universal stress protein A, UspA {Haemophilus infl | 97.5 | |
| d1jm7b_ | 97 | bard1 RING domain {Human (Homo sapiens) [TaxId: 96 | 97.34 | |
| d1q77a_ | 138 | Hypothetical protein Aq_178 {Aquifex aeolicus [Tax | 97.05 | |
| d1jm7a_ | 103 | brca1 RING domain {Human (Homo sapiens) [TaxId: 96 | 97.04 | |
| d1rmda2 | 86 | V(D)J recombination activating protein 1 (RAG1), d | 96.98 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.96 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.4 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 95.98 | |
| d1fbva4 | 79 | CBL {Human (Homo sapiens) [TaxId: 9606]} | 95.5 | |
| d1bora_ | 56 | Acute promyelocytic leukaemia proto-oncoprotein PM | 81.21 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-50 Score=426.67 Aligned_cols=258 Identities=27% Similarity=0.450 Sum_probs=206.2
Q ss_pred cCCCCccceeeecCceEEEEEEECCeEEEEEEecCCCC--CCchhHHHHHHHHHhcCCCceeeEecccC-CceEEEEEec
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVYEYL 539 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~~~~VAvK~l~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~-~~~~LV~Ey~ 539 (824)
.++|...+.||+|+||+||+|.+++ .||||+++.... ...+.|.+|+.+|++++|||||+++|++. +..++|||||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~lv~Ey~ 85 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQWC 85 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEECC
T ss_pred cccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEeccEEEEEEecC
Confidence 4578999999999999999998765 599999975432 23467999999999999999999999984 4689999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccccc
Q 003384 540 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 619 (824)
Q Consensus 540 ~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 619 (824)
+||+|.++|... ..++++..++.|+.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+........
T Consensus 86 ~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 86 EGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp CEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred CCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence 999999999533 3569999999999999999999999 89999999999999999999999999999876543221
Q ss_pred CCCccccccCCCCCCcccCChhhhcc---CCCCcchhHHhHHHHHHHHHhCCCCCCCchHHH---HHHhhhccccccCCC
Q 003384 620 SNNTTLCCRTDPKGTFAYMDPEFLAS---GELTPKSDVYSFGIILLRLLTGRPALGITKEVQ---YALDTGKLKNLLDPL 693 (824)
Q Consensus 620 ~~~~~~~~~~~~~GT~~Y~APE~l~~---~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~---~~~~~~~~~~~ld~~ 693 (824)
.. .....||+.|||||++.+ +.|+.++|||||||+||||+||+.||....... ..+..+. ..+.
T Consensus 161 ~~------~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~----~~p~ 230 (276)
T d1uwha_ 161 HQ------FEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGY----LSPD 230 (276)
T ss_dssp -----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTS----CCCC
T ss_pred cc------ccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCC----CCCc
Confidence 11 134579999999999964 358999999999999999999999997543322 2222221 1222
Q ss_pred CCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhh
Q 003384 694 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 737 (824)
Q Consensus 694 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~~ 737 (824)
....+...+..+.+|+.+||+.+|.+|||+ +++++.|+.+..+
T Consensus 231 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~-~~il~~Le~l~~~ 273 (276)
T d1uwha_ 231 LSKVRSNCPKAMKRLMAECLKKKRDERPLF-PQILASIELLARS 273 (276)
T ss_dssp GGGSCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHT
T ss_pred chhccccchHHHHHHHHHHcCCCHhHCcCH-HHHHHHHHHHHHc
Confidence 223344556789999999999999999999 7788899988763
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=414.03 Aligned_cols=252 Identities=26% Similarity=0.487 Sum_probs=200.4
Q ss_pred CCCCccceeeecCceEEEEEEEC-CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--CCceEEEEEecC
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLP 540 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~-~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~Ey~~ 540 (824)
++|...+.||+|+||+||+|.+. +..||||++.... ...+.|.+|+.++++++|||||+++|+| .+..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 46888899999999999999986 4779999997543 3457899999999999999999999998 457899999999
Q ss_pred CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccC
Q 003384 541 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 620 (824)
Q Consensus 541 ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 620 (824)
+|+|.+++.. ....+++..++.|+.|++.||.|||+ ++|+||||||+||||+.++.+||+|||+++.........
T Consensus 84 ~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 84 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence 9999999853 34568999999999999999999999 899999999999999999999999999998765433211
Q ss_pred CCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHH--HHhhhccccccCCCCCCC
Q 003384 621 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQY--ALDTGKLKNLLDPLAGDW 697 (824)
Q Consensus 621 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~--~~~~~~~~~~ld~~~~~~ 697 (824)
.....||+.|+|||++.+..|+.++|||||||+||||+| |++||........ .+..+ .....
T Consensus 159 -------~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~--------~~~~~ 223 (263)
T d1sm2a_ 159 -------STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG--------FRLYK 223 (263)
T ss_dssp -------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHT--------CCCCC
T ss_pred -------ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhc--------CCCCC
Confidence 123468999999999999999999999999999999999 5777765443222 12221 11223
Q ss_pred ChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhh
Q 003384 698 PFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 737 (824)
Q Consensus 698 p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~~ 737 (824)
|...+..+.+|+.+||+.+|.+||++ +++++.|+.+..+
T Consensus 224 p~~~~~~l~~li~~cl~~~p~~Rps~-~~il~~L~~i~es 262 (263)
T d1sm2a_ 224 PRLASTHVYQIMNHCWKERPEDRPAF-SRLLRQLAEIAES 262 (263)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHH
T ss_pred ccccCHHHHHHHHHHccCCHhHCcCH-HHHHHHHHHHHhC
Confidence 45567789999999999999999999 7788889887653
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=416.02 Aligned_cols=255 Identities=27% Similarity=0.443 Sum_probs=208.3
Q ss_pred cCCCCccceeeecCceEEEEEEECC-eEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC-CceEEEEEecC
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVYEYLP 540 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~~-~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~-~~~~LV~Ey~~ 540 (824)
.++|...+.||+|+||+||+|.+++ ..||||+++... ...+.|.+|+.+|++++|||||+++|+|. +..++||||++
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~iv~Ey~~ 90 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYME 90 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECCT
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeeccCCeEEEEEeCC
Confidence 3578889999999999999999975 789999997543 44678999999999999999999999884 46789999999
Q ss_pred CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccC
Q 003384 541 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 620 (824)
Q Consensus 541 ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 620 (824)
+|+|.+++... ...++++..++.|+.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+|+.+.......
T Consensus 91 ~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~ 166 (272)
T d1qpca_ 91 NGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (272)
T ss_dssp TCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred CCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccCCcccc
Confidence 99999987433 22359999999999999999999999 899999999999999999999999999999775433211
Q ss_pred CCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhC-CCCCCCchHHHHHHhhhccccccCCCCCCCCh
Q 003384 621 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG-RPALGITKEVQYALDTGKLKNLLDPLAGDWPF 699 (824)
Q Consensus 621 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG-~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~ 699 (824)
.....||+.|+|||++.++.++.++|||||||+||||+|| ++||............ ........|.
T Consensus 167 -------~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i------~~~~~~~~p~ 233 (272)
T d1qpca_ 167 -------REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL------ERGYRMVRPD 233 (272)
T ss_dssp -------CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH------HTTCCCCCCT
T ss_pred -------ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHH------HhcCCCCCcc
Confidence 2345699999999999999999999999999999999995 5666544332211111 1111222345
Q ss_pred hhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHh
Q 003384 700 VQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 736 (824)
Q Consensus 700 ~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~ 736 (824)
..+..+.+|+.+||+.+|.+|||+ ++|++.|+++-.
T Consensus 234 ~~~~~l~~li~~cl~~~P~~Rpt~-~ei~~~L~~~ft 269 (272)
T d1qpca_ 234 NCPEELYQLMRLCWKERPEDRPTF-DYLRSVLEDFFT 269 (272)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHH
T ss_pred cChHHHHHHHHHHcCCCHhHCcCH-HHHHHHhhhhhh
Confidence 566789999999999999999999 778888887643
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-48 Score=421.64 Aligned_cols=255 Identities=26% Similarity=0.436 Sum_probs=196.1
Q ss_pred CCCccceeeecCceEEEEEEECC-----eEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccC--CceEEEE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLRH-----MQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 536 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~~-----~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~ 536 (824)
+|...++||+|+||+||+|.+.. ..||||.+...... ..+.|.+|+.+|++++|||||+++|+|. +..++||
T Consensus 27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~ 106 (299)
T d1jpaa_ 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIIT 106 (299)
T ss_dssp GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence 46667899999999999998852 35899988654322 2356999999999999999999999984 5789999
Q ss_pred EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccc
Q 003384 537 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 616 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 616 (824)
|||++|+|.+++.. ....+++..++.|+.||+.||.|||+ ++||||||||+||||+.++++||+|||+|+.+...
T Consensus 107 Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 107 EFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp ECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEECCCCcEEECCcccceEccCC
Confidence 99999999998853 34569999999999999999999999 89999999999999999999999999999977644
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHH--HHhhhccccccCCC
Q 003384 617 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQY--ALDTGKLKNLLDPL 693 (824)
Q Consensus 617 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~--~~~~~~~~~~ld~~ 693 (824)
...... .......||+.|+|||++.++.|+.++|||||||+||||+| |++||........ .+..+ .
T Consensus 182 ~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~--------~ 250 (299)
T d1jpaa_ 182 TSDPTY---TSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQD--------Y 250 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT--------C
T ss_pred CCccee---eecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--------C
Confidence 322111 11133468999999999999999999999999999999998 8999976543321 11111 1
Q ss_pred CCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHh
Q 003384 694 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 736 (824)
Q Consensus 694 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~ 736 (824)
..+.|...+..+.+|+.+||+.+|.+||++ .+|++.|+.+..
T Consensus 251 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~-~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 251 RLPPPMDCPSALHQLMLDCWQKDRNHRPKF-GQIVNTLDKMIR 292 (299)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSTTTSCCH-HHHHHHHHHHHH
T ss_pred CCCCCccchHHHHHHHHHHcCCCHhHCcCH-HHHHHHHHHHhc
Confidence 223345567889999999999999999999 678888887654
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-48 Score=413.75 Aligned_cols=242 Identities=24% Similarity=0.381 Sum_probs=202.9
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--CCceEEEEEec
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 539 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~Ey~ 539 (824)
.+|...+.||+|+||+||+|.+. +..||||++........+.+.+|+.+|++++|||||+++++| .+..|+|||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 36899999999999999999876 689999999876555667899999999999999999999988 45789999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccccc
Q 003384 540 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 619 (824)
Q Consensus 540 ~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 619 (824)
+||+|.+++.. ..+++..+..|+.||+.||.|||+ +|||||||||+||||+.+|.+||+|||+|+.+......
T Consensus 100 ~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 172 (293)
T d1yhwa1 100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (293)
T ss_dssp TTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred CCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeecccccc
Confidence 99999998743 358999999999999999999999 89999999999999999999999999999876543211
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCCCh
Q 003384 620 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPF 699 (824)
Q Consensus 620 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~ 699 (824)
.....||+.|+|||++.+..|+.++|||||||+||+|+||++||............... . ......+.
T Consensus 173 --------~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~-~---~~~~~~~~ 240 (293)
T d1yhwa1 173 --------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-G---TPELQNPE 240 (293)
T ss_dssp --------BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHH-C---SCCCSSGG
T ss_pred --------ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhC-C---CCCCCCcc
Confidence 13456999999999999999999999999999999999999999766543322211100 0 01112344
Q ss_pred hhHHHHHHHHHHHhhhccCCCCChH
Q 003384 700 VQAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 700 ~~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
..+..+.+|+.+||+.+|.+||++.
T Consensus 241 ~~s~~~~~li~~~L~~dP~~R~s~~ 265 (293)
T d1yhwa1 241 KLSAIFRDFLNRCLDMDVEKRGSAK 265 (293)
T ss_dssp GSCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred cCCHHHHHHHHHHccCChhHCcCHH
Confidence 5678899999999999999999984
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-48 Score=413.70 Aligned_cols=252 Identities=25% Similarity=0.431 Sum_probs=205.2
Q ss_pred CCCccc-eeeecCceEEEEEEEC----CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccC-CceEEEEE
Q 003384 465 NFDPSL-KIGEGGYGSIYKGLLR----HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVYE 537 (824)
Q Consensus 465 ~f~~~~-~LG~G~fG~Vykg~~~----~~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~L~g~~~-~~~~LV~E 537 (824)
+|.... +||+|+||+||+|.++ +..||||+++..... ..+.|.+|+++|++++|||||+++|+|. +..+||||
T Consensus 9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~lvmE 88 (285)
T d1u59a_ 9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVME 88 (285)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEE
T ss_pred CeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccCeEEEEEE
Confidence 455555 4999999999999875 246999999764322 2457999999999999999999999984 57899999
Q ss_pred ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccc
Q 003384 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 617 (824)
Q Consensus 538 y~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 617 (824)
||+||+|.+++. .....+++..+..|+.|++.||.|||+ ++||||||||+||||+.++.+||+|||+|+.+....
T Consensus 89 ~~~~g~L~~~l~--~~~~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 163 (285)
T d1u59a_ 89 MAGGGPLHKFLV--GKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 163 (285)
T ss_dssp CCTTEEHHHHHT--TCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred eCCCCcHHHHhh--ccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence 999999999874 234579999999999999999999999 899999999999999999999999999999775433
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHH--HHHhhhccccccCCCC
Q 003384 618 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--YALDTGKLKNLLDPLA 694 (824)
Q Consensus 618 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~--~~~~~~~~~~~ld~~~ 694 (824)
.... ......||+.|+|||++.++.++.++|||||||+||||+| |++||....... ..+..+. .
T Consensus 164 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~--------~ 230 (285)
T d1u59a_ 164 SYYT-----ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK--------R 230 (285)
T ss_dssp CEEC-----CCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC--------C
T ss_pred cccc-----cccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--------C
Confidence 2111 1234568999999999999999999999999999999998 999997554322 2222221 2
Q ss_pred CCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHH
Q 003384 695 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 735 (824)
Q Consensus 695 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~ 735 (824)
...|...+..+.+|+.+||+.+|.+||++ ..|.+.|+.+-
T Consensus 231 ~~~p~~~~~~l~~li~~cl~~~p~~RPs~-~~i~~~L~~~~ 270 (285)
T d1u59a_ 231 MECPPECPPELYALMSDCWIYKWEDRPDF-LTVEQRMRACY 270 (285)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSGGGSCCH-HHHHHHHHHHH
T ss_pred CCCCCcCCHHHHHHHHHHcCCCHhHCcCH-HHHHHHHHHHH
Confidence 23455667899999999999999999999 66777776543
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-48 Score=410.13 Aligned_cols=245 Identities=26% Similarity=0.349 Sum_probs=195.4
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC-CCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEe
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY 538 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey 538 (824)
++|+..+.||+|+||+||+|.+. +..||||++..... ...+.+.+|+.+|++++|||||++++++. +..+|||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 36888999999999999999986 67899999976432 23457999999999999999999999984 468899999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccc
Q 003384 539 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 618 (824)
Q Consensus 539 ~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 618 (824)
|+||+|.++|. ....+++..+..|+.||+.||.|||+ +|||||||||+||||+.++.+||+|||+|+.+.....
T Consensus 85 ~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 85 CSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp CTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 99999999994 34579999999999999999999999 8999999999999999999999999999997654322
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCCC-CcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCC
Q 003384 619 SSNNTTLCCRTDPKGTFAYMDPEFLASGEL-TPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 697 (824)
Q Consensus 619 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~ 697 (824)
... ....+||+.|+|||++.+..+ +.++|||||||+||||+||++||................ ......
T Consensus 159 ~~~------~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~----~~~~~~ 228 (271)
T d1nvra_ 159 ERL------LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK----KTYLNP 228 (271)
T ss_dssp ECC------BCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTT----CTTSTT
T ss_pred ccc------ccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcC----CCCCCc
Confidence 111 144679999999999988876 578999999999999999999996543221111110000 001111
Q ss_pred ChhhHHHHHHHHHHHhhhccCCCCChH
Q 003384 698 PFVQAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 698 p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
....+..+.+|+.+||+.+|.+|||+.
T Consensus 229 ~~~~s~~~~~li~~~L~~dP~~R~t~~ 255 (271)
T d1nvra_ 229 WKKIDSAPLALLHKILVENPSARITIP 255 (271)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHH
Confidence 233467889999999999999999984
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-48 Score=410.94 Aligned_cols=244 Identities=25% Similarity=0.430 Sum_probs=197.0
Q ss_pred ceeeecCceEEEEEEECC----eEEEEEEecCCCCCC--chhHHHHHHHHHhcCCCceeeEecccC-CceEEEEEecCCC
Q 003384 470 LKIGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVYEYLPNG 542 (824)
Q Consensus 470 ~~LG~G~fG~Vykg~~~~----~~VAvK~l~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~L~g~~~-~~~~LV~Ey~~gg 542 (824)
++||+|+||+||+|.+++ ..||||+++...... .+.|.+|+.+|++++|||||+++|+|. +..+|||||+++|
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~~~lvmE~~~~g 92 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG 92 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccCCEEEEEEcCCCC
Confidence 469999999999998752 579999997543322 356999999999999999999999994 4688999999999
Q ss_pred ChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCCC
Q 003384 543 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 622 (824)
Q Consensus 543 sL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~ 622 (824)
+|.+++.. ..++++..++.|+.||+.||.|||+ ++||||||||+||||+.++.+||+|||+++.+.......
T Consensus 93 ~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~-- 164 (277)
T d1xbba_ 93 PLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY-- 164 (277)
T ss_dssp EHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE--
T ss_pred cHHHHHhh---ccCCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhcccccccc--
Confidence 99999853 3569999999999999999999999 899999999999999999999999999998765432211
Q ss_pred ccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHH--HHHhhhccccccCCCCCCCCh
Q 003384 623 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--YALDTGKLKNLLDPLAGDWPF 699 (824)
Q Consensus 623 ~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~~p~ 699 (824)
.......||+.|+|||++.+..++.++|||||||++|||+| |++||....... ..+..+ .....|.
T Consensus 165 ---~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~--------~~~~~p~ 233 (277)
T d1xbba_ 165 ---KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG--------ERMGCPA 233 (277)
T ss_dssp ---EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT--------CCCCCCT
T ss_pred ---ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcC--------CCCCCCc
Confidence 11234569999999999999999999999999999999998 899997654332 222222 1223455
Q ss_pred hhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHH
Q 003384 700 VQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP 733 (824)
Q Consensus 700 ~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~ 733 (824)
..+..+.+|+.+||+.+|.+||++ ++|.+.|+.
T Consensus 234 ~~~~~~~~li~~cl~~dp~~RPs~-~~i~~~L~~ 266 (277)
T d1xbba_ 234 GCPREMYDLMNLCWTYDVENRPGF-AAVELRLRN 266 (277)
T ss_dssp TCCHHHHHHHHHHTCSSTTTSCCH-HHHHHHHHH
T ss_pred ccCHHHHHHHHHHcCCCHhHCcCH-HHHHHHhhC
Confidence 567899999999999999999999 666666654
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.1e-48 Score=414.20 Aligned_cols=252 Identities=27% Similarity=0.486 Sum_probs=206.8
Q ss_pred hcCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEE
Q 003384 462 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE 537 (824)
Q Consensus 462 ~~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~E 537 (824)
..++|...+.||+|+||+||+|.+. +..||||+++... ...+.|.+|+.+|++++|||||+++|+|. +..++|||
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E 93 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 93 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence 3457888999999999999999986 5789999987543 34678999999999999999999999984 46899999
Q ss_pred ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccc
Q 003384 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 617 (824)
Q Consensus 538 y~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 617 (824)
||++|+|.++|... ....+++..++.|+.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+......
T Consensus 94 ~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 94 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp CCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred cccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence 99999999998643 34579999999999999999999999 899999999999999999999999999998765432
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCC-CCCchHHH--HHHhhhccccccCCCC
Q 003384 618 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPA-LGITKEVQ--YALDTGKLKNLLDPLA 694 (824)
Q Consensus 618 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~P-f~~~~~~~--~~~~~~~~~~~ld~~~ 694 (824)
... .....||+.|+|||++.+..|+.++|||||||++|||+||..| |....... ..+..+ ..
T Consensus 170 ~~~-------~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~--------~~ 234 (287)
T d1opja_ 170 YTA-------HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD--------YR 234 (287)
T ss_dssp SEE-------ETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT--------CC
T ss_pred cee-------eccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcC--------CC
Confidence 111 1234589999999999999999999999999999999996555 44433221 111111 12
Q ss_pred CCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHH
Q 003384 695 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 734 (824)
Q Consensus 695 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l 734 (824)
...|...+..+.+|+.+||+.+|.+|||+ +++.+.|+.+
T Consensus 235 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~-~ei~~~L~~~ 273 (287)
T d1opja_ 235 MERPEGCPEKVYELMRACWQWNPSDRPSF-AEIHQAFETM 273 (287)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHT
T ss_pred CCCCccchHHHHHHHHHHcCCCHhHCcCH-HHHHHHHHHH
Confidence 23455567899999999999999999999 6677777765
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-48 Score=407.03 Aligned_cols=238 Identities=26% Similarity=0.434 Sum_probs=199.4
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCC---CCCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH---SLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE 537 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~---~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~E 537 (824)
+|.+.+.||+|+||+||+|.+. +..||||++... .......+.+|+.+|+.++|||||++++++. +..++|||
T Consensus 7 dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmE 86 (263)
T d2j4za1 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE 86 (263)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEe
Confidence 5888999999999999999986 578999998642 2233567899999999999999999999984 46889999
Q ss_pred ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccc
Q 003384 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 617 (824)
Q Consensus 538 y~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 617 (824)
||+||+|.+++.. ..++++..+..|+.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+......
T Consensus 87 y~~~g~L~~~l~~---~~~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~ 160 (263)
T d2j4za1 87 YAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 160 (263)
T ss_dssp CCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC
T ss_pred ecCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecCCCc
Confidence 9999999999953 3469999999999999999999999 899999999999999999999999999998654321
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCC
Q 003384 618 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 697 (824)
Q Consensus 618 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~ 697 (824)
. ....||+.|+|||++.+..|+.++|||||||+||||+||++||.............. ....+
T Consensus 161 ~----------~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~-------~~~~~ 223 (263)
T d2j4za1 161 R----------TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR-------VEFTF 223 (263)
T ss_dssp C----------EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT-------TCCCC
T ss_pred c----------cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHc-------CCCCC
Confidence 1 234699999999999999999999999999999999999999986654332211111 11224
Q ss_pred ChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 698 PFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 698 p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
|...+..+.+|+.+||+.+|.+|||+.+
T Consensus 224 p~~~s~~~~~li~~~L~~dp~~R~t~~e 251 (263)
T d2j4za1 224 PDFVTEGARDLISRLLKHNPSQRPMLRE 251 (263)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CccCCHHHHHHHHHHccCCHhHCcCHHH
Confidence 4556789999999999999999999843
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-48 Score=409.83 Aligned_cols=245 Identities=26% Similarity=0.410 Sum_probs=191.3
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCC--chhHHHHHHHHHhcCCCceeeEecccC----CceEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACP----EVWTLV 535 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~L~g~~~----~~~~LV 535 (824)
.+|+..+.||+|+||+||+|... +..||||++....... ...+.+|+.+|++++|||||++++++. ..+|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 36889999999999999999886 5789999997654322 345889999999999999999999873 347899
Q ss_pred EEecCCCChhhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CCceEeccccCCcEEecCCCcceeeccccccc
Q 003384 536 YEYLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCK--PHSIVHGDLKPANILLDANFVSKLSDFGISRF 612 (824)
Q Consensus 536 ~Ey~~ggsL~~~L~~~-~~~~~l~~~~~~~ia~qia~aL~~LH~~~--~~giiHrDLKp~NILld~~~~vKL~DFGla~~ 612 (824)
||||+||+|.+++... .....+++..++.|+.|++.||.|||+.. ..+||||||||+||||+.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998543 23457999999999999999999999843 13599999999999999999999999999997
Q ss_pred cccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHH--HHhhhcccccc
Q 003384 613 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQY--ALDTGKLKNLL 690 (824)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~--~~~~~~~~~~l 690 (824)
+...... .....||+.|+|||++.+..|+.++|||||||+||||+||++||........ .+..+..
T Consensus 164 ~~~~~~~--------~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~---- 231 (269)
T d2java1 164 LNHDTSF--------AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF---- 231 (269)
T ss_dssp C-------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC----
T ss_pred cccCCCc--------cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC----
Confidence 6543211 1345699999999999999999999999999999999999999986554332 1222211
Q ss_pred CCCCCCCChhhHHHHHHHHHHHhhhccCCCCChH
Q 003384 691 DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 691 d~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
...|...+.++.+|+.+||+.+|.+||++.
T Consensus 232 ----~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ 261 (269)
T d2java1 232 ----RRIPYRYSDELNEIITRMLNLKDYHRPSVE 261 (269)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred ----CCCCcccCHHHHHHHHHHcCCChhHCcCHH
Confidence 123445667899999999999999999984
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-47 Score=400.54 Aligned_cols=249 Identities=25% Similarity=0.452 Sum_probs=207.1
Q ss_pred CCCCccceeeecCceEEEEEEECC-eEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEecC
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLP 540 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~~-~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey~~ 540 (824)
++|...++||+|+||+||+|.+++ ..||||+++.... ..+.|.+|+.++++++|||||+++|+|. ...++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 578899999999999999999974 6899999986543 4578999999999999999999999984 46899999999
Q ss_pred CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccC
Q 003384 541 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 620 (824)
Q Consensus 541 ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 620 (824)
+|+|.+++... ...+++..+++|+.|++.||.|||+ +||+||||||+|||++.++.+||+|||+++.+.......
T Consensus 83 ~g~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 157 (258)
T d1k2pa_ 83 NGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 157 (258)
T ss_dssp TEEHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred CCcHHHhhhcc--ccCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence 99999987533 3568899999999999999999999 899999999999999999999999999998765433211
Q ss_pred CCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHHHHhhhccccccCCCCCCCCh
Q 003384 621 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPF 699 (824)
Q Consensus 621 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~ 699 (824)
.....||+.|+|||++.+..++.++|||||||++|||+| |+.||............ ........|.
T Consensus 158 -------~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i------~~~~~~~~p~ 224 (258)
T d1k2pa_ 158 -------SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI------AQGLRLYRPH 224 (258)
T ss_dssp -------CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH------HTTCCCCCCT
T ss_pred -------ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHH------HhCCCCCCcc
Confidence 134569999999999999999999999999999999998 89999866543322111 1112223455
Q ss_pred hhHHHHHHHHHHHhhhccCCCCChHHHHHHHHH
Q 003384 700 VQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 732 (824)
Q Consensus 700 ~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le 732 (824)
..+..+.+|+.+||+.+|.+|||+ ++++..|.
T Consensus 225 ~~~~~l~~li~~cl~~dP~~RPt~-~eil~~L~ 256 (258)
T d1k2pa_ 225 LASEKVYTIMYSCWHEKADERPTF-KILLSNIL 256 (258)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCH-HHHHHHHH
T ss_pred cccHHHHHHHHHHccCCHhHCcCH-HHHHHHhh
Confidence 667899999999999999999999 66666554
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=410.66 Aligned_cols=241 Identities=24% Similarity=0.375 Sum_probs=200.2
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--CCceEEEEEecC
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLP 540 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~Ey~~ 540 (824)
.|++.+.||+|+||+||+|.+. +..||||++........+.|.+|+++|++++|||||+++++| .+..++|||||+
T Consensus 13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~ 92 (288)
T d2jfla1 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 92 (288)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCC
Confidence 5888999999999999999986 578999999876656667899999999999999999999998 456899999999
Q ss_pred CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccC
Q 003384 541 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 620 (824)
Q Consensus 541 ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 620 (824)
||+|.+++... ..++++..+..|+.||+.||.|||+ ++||||||||+||||+.+|.+||+|||+|+........
T Consensus 93 ~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~- 166 (288)
T d2jfla1 93 GGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR- 166 (288)
T ss_dssp TEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHH-
T ss_pred CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCCCccc-
Confidence 99999987533 3469999999999999999999999 89999999999999999999999999999865433211
Q ss_pred CCccccccCCCCCCcccCChhhhc-----cCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHH--HhhhccccccCCC
Q 003384 621 NNTTLCCRTDPKGTFAYMDPEFLA-----SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA--LDTGKLKNLLDPL 693 (824)
Q Consensus 621 ~~~~~~~~~~~~GT~~Y~APE~l~-----~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~--~~~~~~~~~ld~~ 693 (824)
.....||+.|+|||++. +..|+.++|||||||+||||+||++||......... +..+. +.
T Consensus 167 -------~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~------~~ 233 (288)
T d2jfla1 167 -------RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSE------PP 233 (288)
T ss_dssp -------HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSC------CC
T ss_pred -------ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC------CC
Confidence 13456999999999984 456899999999999999999999999765432221 11111 11
Q ss_pred CCCCChhhHHHHHHHHHHHhhhccCCCCChH
Q 003384 694 AGDWPFVQAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 694 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
....+...+..+.+|+.+||+.+|.+|||+.
T Consensus 234 ~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ 264 (288)
T d2jfla1 234 TLAQPSRWSSNFKDFLKKCLEKNVDARWTTS 264 (288)
T ss_dssp CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred CCCccccCCHHHHHHHHHHccCChhHCcCHH
Confidence 1223445678999999999999999999983
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-47 Score=406.90 Aligned_cols=254 Identities=26% Similarity=0.443 Sum_probs=198.8
Q ss_pred CCCCccceeeecCceEEEEEEECC------eEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccC--CceEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLRH------MQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTL 534 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~~------~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~L 534 (824)
..|+..++||+|+||+||+|.+++ ..||||++...... ....|.+|+.+|++++|||||+++|+|. +..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 468888999999999999998763 36999999754322 2346899999999999999999999984 46899
Q ss_pred EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccc
Q 003384 535 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 614 (824)
Q Consensus 535 V~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~ 614 (824)
||||+.+|+|.+++.. ....+++..++.|+.|++.||.|||+ ++||||||||+||||+.++.+||+|||+|+.+.
T Consensus 87 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 87 ITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEecccCcchhhhhc--ccccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhccc
Confidence 9999999999988753 34569999999999999999999999 899999999999999999999999999998765
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhC-CCCCCCchHH--HHHHhhhccccccC
Q 003384 615 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG-RPALGITKEV--QYALDTGKLKNLLD 691 (824)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG-~~Pf~~~~~~--~~~~~~~~~~~~ld 691 (824)
....... ......||+.|+|||++.++.++.++|||||||+||||+|| .+|+...... ...+..
T Consensus 162 ~~~~~~~-----~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~-------- 228 (283)
T d1mqba_ 162 DDPEATY-----TTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND-------- 228 (283)
T ss_dssp -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT--------
T ss_pred CCCccce-----EeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhc--------
Confidence 4332111 11344689999999999999999999999999999999995 4555433322 122222
Q ss_pred CCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHh
Q 003384 692 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 736 (824)
Q Consensus 692 ~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~ 736 (824)
......|...+..+.+|+.+||+.+|.+||++ .+|++.|+.+..
T Consensus 229 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~-~eil~~L~~l~~ 272 (283)
T d1mqba_ 229 GFRLPTPMDCPSAIYQLMMQCWQQERARRPKF-ADIVSILDKLIR 272 (283)
T ss_dssp TCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCH-HHHHHHHHHHHH
T ss_pred cCCCCCchhhHHHHHHHHHHHCcCCHhHCcCH-HHHHHHHHHHhh
Confidence 22233455667889999999999999999999 678888888765
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-47 Score=414.15 Aligned_cols=252 Identities=27% Similarity=0.450 Sum_probs=202.5
Q ss_pred cCCCCccceeeecCceEEEEEEECC-------eEEEEEEecCCC-CCCchhHHHHHHHHHhc-CCCceeeEecccC--Cc
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHS-LQGPSEFQQEIDILSKI-RHPNLVTLVGACP--EV 531 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~~-------~~VAvK~l~~~~-~~~~~~f~~Ei~iL~~l-~HpnIv~L~g~~~--~~ 531 (824)
.++|.+.++||+|+||+||+|.+.+ ..||||++.... ......|.+|+.+|.++ +|||||+++|+|. +.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 3578889999999999999998753 369999986543 23356799999999998 8999999999984 46
Q ss_pred eEEEEEecCCCChhhhhhccCC--------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccC
Q 003384 532 WTLVYEYLPNGSLEDRLSCKDN--------------------SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKP 591 (824)
Q Consensus 532 ~~LV~Ey~~ggsL~~~L~~~~~--------------------~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp 591 (824)
.++|||||+||+|.++|..... ...+++..++.|+.||+.||.|||+ ++||||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCch
Confidence 8999999999999999964421 2458999999999999999999999 8999999999
Q ss_pred CcEEecCCCcceeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCC
Q 003384 592 ANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPA 670 (824)
Q Consensus 592 ~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~P 670 (824)
+|||++.++.+||+|||+|+......... ......||+.|||||++.++.|+.++|||||||+||||+| |++|
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~------~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~P 266 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYV------VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 266 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSE------EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred hccccccCCeEEEeeccccccccCCCcee------eeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCC
Confidence 99999999999999999998765433211 1133458999999999999999999999999999999998 8999
Q ss_pred CCCchH---HHHHHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHH
Q 003384 671 LGITKE---VQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 732 (824)
Q Consensus 671 f~~~~~---~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le 732 (824)
|..... +...+..+ ...+.|...+..+.+|+.+||+.+|.+|||+ ++|++.|.
T Consensus 267 f~~~~~~~~~~~~~~~~--------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~-~ei~~~L~ 322 (325)
T d1rjba_ 267 YPGIPVDANFYKLIQNG--------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSF-PNLTSFLG 322 (325)
T ss_dssp STTCCCSHHHHHHHHTT--------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHH
T ss_pred CCCCCHHHHHHHHHhcC--------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCH-HHHHHHHh
Confidence 975432 11222221 1223455667899999999999999999999 67777764
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-46 Score=406.43 Aligned_cols=261 Identities=26% Similarity=0.447 Sum_probs=210.4
Q ss_pred hHhhhcCCCCccceeeecCceEEEEEEECC-------eEEEEEEecCCCCCC-chhHHHHHHHHHhcCCCceeeEecccC
Q 003384 458 EIEGATHNFDPSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLVGACP 529 (824)
Q Consensus 458 ei~~~~~~f~~~~~LG~G~fG~Vykg~~~~-------~~VAvK~l~~~~~~~-~~~f~~Ei~iL~~l~HpnIv~L~g~~~ 529 (824)
+++...++|++.+.||+|+||+||+|.+.+ ..||||+++...... ...|.+|+.+|++++||||++++++|.
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 344456689999999999999999998753 679999987643322 356999999999999999999999984
Q ss_pred --CceEEEEEecCCCChhhhhhccC---------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEe
Q 003384 530 --EVWTLVYEYLPNGSLEDRLSCKD---------------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 586 (824)
Q Consensus 530 --~~~~LV~Ey~~ggsL~~~L~~~~---------------------~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiH 586 (824)
+..++||||+++|+|.++|.... ....+++..++.|+.|++.||+|||+ ++|||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ivH 163 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVH 163 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeEe
Confidence 46899999999999999985432 13358999999999999999999999 89999
Q ss_pred ccccCCcEEecCCCcceeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh
Q 003384 587 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 666 (824)
Q Consensus 587 rDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt 666 (824)
|||||+|||||.++.+||+|||+|+.+........ .+...||+.|+|||++.+..|+.++|||||||+||||++
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~ 237 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA------DGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 237 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----------CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCccccc------cCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHc
Confidence 99999999999999999999999986654332111 134568999999999999999999999999999999999
Q ss_pred CC-CCCCCchHHHHHHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHH
Q 003384 667 GR-PALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 734 (824)
Q Consensus 667 G~-~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l 734 (824)
|. +||........... +.+......|...+.++.+|+.+||+.+|.+|||+ .+|.+.|+.+
T Consensus 238 ~~~~p~~~~~~~e~~~~------v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~-~ev~~~L~~i 299 (301)
T d1lufa_ 238 YGLQPYYGMAHEEVIYY------VRDGNILACPENCPLELYNLMRLCWSKLPADRPSF-CSIHRILQRM 299 (301)
T ss_dssp TTCCTTTTSCHHHHHHH------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHT
T ss_pred cCCCCCCCCCHHHHHHH------HHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCH-HHHHHHHHHh
Confidence 85 78876554332111 11112223455667789999999999999999999 7788888875
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-47 Score=412.90 Aligned_cols=248 Identities=24% Similarity=0.377 Sum_probs=195.5
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCC-chhHHHHHHHHHhcCCCceeeEecccC--CceEEEEE
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE 537 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~-~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~E 537 (824)
.++|+..++||+|+||+||+|.+. +..||||+++...... ...+.+|+.+|+.++|||||+++++|. +..++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 457999999999999999999986 6889999997653322 457899999999999999999999984 46899999
Q ss_pred ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccc
Q 003384 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 617 (824)
Q Consensus 538 y~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 617 (824)
|++||+|.+++... ..+++..+..++.|++.||.|||+. +|||||||||+||||+.+|.+||+|||+|+.+....
T Consensus 85 y~~gg~L~~~l~~~---~~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 159 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 159 (322)
T ss_dssp CCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT
T ss_pred cCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc
Confidence 99999999999643 4589999999999999999999972 379999999999999999999999999998664321
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHh-----hhccc-----
Q 003384 618 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALD-----TGKLK----- 687 (824)
Q Consensus 618 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~-----~~~~~----- 687 (824)
....+||+.|+|||++.+..|+.++|||||||+||||+||+.||...+....... .+...
T Consensus 160 ----------~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (322)
T d1s9ja_ 160 ----------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 229 (322)
T ss_dssp ----------C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------
T ss_pred ----------cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcc
Confidence 1335799999999999999999999999999999999999999965322110000 00000
Q ss_pred --------------------------cccCCCCCCCC-hhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 688 --------------------------NLLDPLAGDWP-FVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 688 --------------------------~~ld~~~~~~p-~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
..........+ ...+.++.+|+.+||+.||.+|||+.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e 294 (322)
T d1s9ja_ 230 PRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 294 (322)
T ss_dssp ----------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred cccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 00000000011 123568999999999999999999943
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=398.61 Aligned_cols=247 Identities=27% Similarity=0.457 Sum_probs=200.7
Q ss_pred CCCCccceeeecCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC---CceEEEEEecC
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP---EVWTLVYEYLP 540 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~---~~~~LV~Ey~~ 540 (824)
++|.+.+.||+|+||.||+|.+++..||||+++.. ...+.|.+|+.+|++++|||||+++|+|. +.+++||||++
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~ 84 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 84 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred HHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccC
Confidence 35778889999999999999999999999999654 34567999999999999999999999883 34799999999
Q ss_pred CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccC
Q 003384 541 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 620 (824)
Q Consensus 541 ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 620 (824)
+|+|.++|... ....+++..+++|+.||+.||.|||+ ++||||||||+|||++.+|.+||+|||+++......
T Consensus 85 ~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~--- 157 (262)
T d1byga_ 85 KGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 157 (262)
T ss_dssp TEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCCCC---
Confidence 99999999543 22358999999999999999999999 899999999999999999999999999998654321
Q ss_pred CCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchH--HHHHHhhhccccccCCCCCCC
Q 003384 621 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKE--VQYALDTGKLKNLLDPLAGDW 697 (824)
Q Consensus 621 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~--~~~~~~~~~~~~~ld~~~~~~ 697 (824)
....+|+.|+|||++.++.+++++|||||||++|||+| |++||..... +...+..+ ...+.
T Consensus 158 --------~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~--------~~~~~ 221 (262)
T d1byga_ 158 --------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG--------YKMDA 221 (262)
T ss_dssp ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT--------CCCCC
T ss_pred --------ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC--------CCCCC
Confidence 22357999999999999999999999999999999998 7888875432 22222221 22334
Q ss_pred ChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHh
Q 003384 698 PFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 736 (824)
Q Consensus 698 p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~ 736 (824)
|...+..+.+|+.+||+.+|.+||++ .++++.|+.++.
T Consensus 222 ~~~~~~~~~~li~~cl~~dP~~Rps~-~~l~~~L~~i~~ 259 (262)
T d1byga_ 222 PDGCPPAVYEVMKNCWHLDAAMRPSF-LQLREQLEHIKT 259 (262)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHH
T ss_pred CccCCHHHHHHHHHHcccCHhHCcCH-HHHHHHHHHHHh
Confidence 55566789999999999999999999 688899988764
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-46 Score=406.91 Aligned_cols=244 Identities=24% Similarity=0.331 Sum_probs=184.8
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEE
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE 537 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~E 537 (824)
.+.|.+.+.||+|+||+||+|.+. +..||||++...... ....+.+|+.+|+.++|||||++++++. +..|||||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 346899999999999999999986 578999999765332 2346889999999999999999999984 46899999
Q ss_pred ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEec---CCCcceeeccccccccc
Q 003384 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD---ANFVSKLSDFGISRFLS 614 (824)
Q Consensus 538 y~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld---~~~~vKL~DFGla~~~~ 614 (824)
||+||+|.++|.. ...+++..+..|+.||+.||.|||+ ++||||||||+|||+. .++.+||+|||+|+...
T Consensus 88 ~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 88 LVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred ccCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 9999999999953 4569999999999999999999999 8999999999999994 57899999999998654
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCC
Q 003384 615 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 694 (824)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~ 694 (824)
.... .....||+.|+|||++.+..|+.++|||||||+||||+||++||.............. ... ...
T Consensus 162 ~~~~---------~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~--~~~-~~~ 229 (307)
T d1a06a_ 162 PGSV---------LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILK--AEY-EFD 229 (307)
T ss_dssp --------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHT--TCC-CCC
T ss_pred CCCe---------eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhc--cCC-CCC
Confidence 3321 1234699999999999999999999999999999999999999976654332211111 111 111
Q ss_pred CCCChhhHHHHHHHHHHHhhhccCCCCChH
Q 003384 695 GDWPFVQAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 695 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
...+...+..+.+|+.+||+.+|.+|||+.
T Consensus 230 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ 259 (307)
T d1a06a_ 230 SPYWDDISDSAKDFIRHLMEKDPEKRFTCE 259 (307)
T ss_dssp TTTTTTSCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred CccccCCCHHHHHHHHHHccCCHhHCcCHH
Confidence 122334567899999999999999999984
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-47 Score=405.34 Aligned_cols=242 Identities=25% Similarity=0.355 Sum_probs=198.7
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCC---CCCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH---SLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 536 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~---~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~ 536 (824)
.+|++.+.||+|+||+||+|.+. +..||||++... .......+.+|+++|++++|||||+++++|. +..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 36899999999999999999986 578999998643 2233467999999999999999999999984 4689999
Q ss_pred EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccc
Q 003384 537 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 616 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 616 (824)
|||+||+|.+++... ..+++..+..++.|++.||.|||+ ++||||||||+||||+.+|.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~~~---~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhcc---CCCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceecccC
Confidence 999999999988533 469999999999999999999999 89999999999999999999999999999876543
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCC
Q 003384 617 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 696 (824)
Q Consensus 617 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~ 696 (824)
..... .....||+.|+|||++.+..|+.++|||||||+||||+||++||...+.......... ....
T Consensus 162 ~~~~~------~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~-------~~~~ 228 (288)
T d1uu3a_ 162 SKQAR------ANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK-------LEYD 228 (288)
T ss_dssp --------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHT-------TCCC
T ss_pred Ccccc------cccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHc-------CCCC
Confidence 22111 1345699999999999999999999999999999999999999986654332211110 1123
Q ss_pred CChhhHHHHHHHHHHHhhhccCCCCChH
Q 003384 697 WPFVQAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 697 ~p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
+|...+..+.+|+.+||+.+|.+|||+.
T Consensus 229 ~p~~~s~~~~~li~~~L~~dP~~R~t~~ 256 (288)
T d1uu3a_ 229 FPEKFFPKARDLVEKLLVLDATKRLGCE 256 (288)
T ss_dssp CCTTCCHHHHHHHHTTSCSSGGGSTTSG
T ss_pred CCccCCHHHHHHHHHHccCCHhHCcCHH
Confidence 4455677899999999999999999983
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-46 Score=399.49 Aligned_cols=250 Identities=31% Similarity=0.497 Sum_probs=199.7
Q ss_pred CCCCccceeeecCceEEEEEEECC-eEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC-CceEEEEEecCC
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVYEYLPN 541 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~~-~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~-~~~~LV~Ey~~g 541 (824)
.+|.+.+.||+|+||.||+|.+++ ..||||+++... ...+.|.+|+.+|++++|||||+++|+|. +..++||||+++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~lv~Ey~~~ 95 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSK 95 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCTT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEecCCeEEEEEecCC
Confidence 468899999999999999999975 679999997543 45678999999999999999999999984 458899999999
Q ss_pred CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccccCC
Q 003384 542 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 621 (824)
Q Consensus 542 gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 621 (824)
|+|..++... ....+++..++.|+.+|+.||+|||+ ++|+||||||+||||+.++++||+|||+|+.+.......
T Consensus 96 g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~- 170 (285)
T d1fmka3 96 GSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA- 170 (285)
T ss_dssp CBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred Cchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCCCcee-
Confidence 9999888543 23459999999999999999999999 899999999999999999999999999998765433211
Q ss_pred CccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhC-CCCCCCchHHH--HHHhhhccccccCCCCCCCC
Q 003384 622 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG-RPALGITKEVQ--YALDTGKLKNLLDPLAGDWP 698 (824)
Q Consensus 622 ~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG-~~Pf~~~~~~~--~~~~~~~~~~~ld~~~~~~p 698 (824)
.....||+.|+|||++.++.++.++|||||||+||||+|| ++|+....... ..+..+ ...+.+
T Consensus 171 ------~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~--------~~~~~~ 236 (285)
T d1fmka3 171 ------RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG--------YRMPCP 236 (285)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT--------CCCCCC
T ss_pred ------eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhc--------CCCCCC
Confidence 1335689999999999999999999999999999999995 45555443221 111111 112234
Q ss_pred hhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHH
Q 003384 699 FVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 734 (824)
Q Consensus 699 ~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l 734 (824)
...+..+.+|+.+||+.+|.+||++ ++|...|+..
T Consensus 237 ~~~~~~l~~li~~cl~~dP~~Rps~-~~i~~~L~~~ 271 (285)
T d1fmka3 237 PECPESLHDLMCQCWRKEPEERPTF-EYLQAFLEDY 271 (285)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHTT
T ss_pred cccCHHHHHHHHHHcccCHhHCcCH-HHHHHHHhhh
Confidence 5567789999999999999999999 6777777764
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-46 Score=404.65 Aligned_cols=252 Identities=23% Similarity=0.410 Sum_probs=204.1
Q ss_pred CCCccceeeecCceEEEEEEECC------eEEEEEEecCC-CCCCchhHHHHHHHHHhcCCCceeeEecccC-CceEEEE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLRH------MQVAIKMLHPH-SLQGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVY 536 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~~------~~VAvK~l~~~-~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~-~~~~LV~ 536 (824)
+|+..++||+|+||+||+|.+.. ..||+|.++.. .....+.|.+|+.+|++++|||||+++|+|. +..++||
T Consensus 10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~v~ 89 (317)
T d1xkka_ 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT 89 (317)
T ss_dssp TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEE
T ss_pred HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeeEEE
Confidence 58999999999999999998753 25999998754 3334567999999999999999999999984 4678999
Q ss_pred EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccc
Q 003384 537 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 616 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 616 (824)
||+.+|+|.+.+.. ....+++..++.|+.||+.||.|||+ ++||||||||+||||+.++++||+|||+|+.+...
T Consensus 90 e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 90 QLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp ECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred EeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 99999999998854 34579999999999999999999999 89999999999999999999999999999976543
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchH--HHHHHhhhccccccCCC
Q 003384 617 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKE--VQYALDTGKLKNLLDPL 693 (824)
Q Consensus 617 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~--~~~~~~~~~~~~~ld~~ 693 (824)
..... .....||+.|+|||++.++.|+.++|||||||+||||+| |.+||..... +...+..+ .
T Consensus 165 ~~~~~------~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~--------~ 230 (317)
T d1xkka_ 165 EKEYH------AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG--------E 230 (317)
T ss_dssp CC--------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHT--------C
T ss_pred ccccc------ccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC--------C
Confidence 32111 133468999999999999999999999999999999998 8999976432 22222222 1
Q ss_pred CCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHh
Q 003384 694 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 736 (824)
Q Consensus 694 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~ 736 (824)
....|...+..+.+|+.+||+.+|.+||++ .+++..|..+..
T Consensus 231 ~~~~p~~~~~~~~~li~~cl~~dP~~RPs~-~eil~~l~~~~~ 272 (317)
T d1xkka_ 231 RLPQPPICTIDVYMIMVKCWMIDADSRPKF-RELIIEFSKMAR 272 (317)
T ss_dssp CCCCCTTBCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHH
T ss_pred CCCCCcccCHHHHHHHHHhCCCChhhCcCH-HHHHHHHHHHHh
Confidence 223455667899999999999999999999 567777776643
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-46 Score=397.51 Aligned_cols=237 Identities=22% Similarity=0.389 Sum_probs=188.8
Q ss_pred CccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHHhcCCCceeeEecccC------CceEEEE
Q 003384 467 DPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP------EVWTLVY 536 (824)
Q Consensus 467 ~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~L~g~~~------~~~~LV~ 536 (824)
....+||+|+||+||+|.+. +..||+|++...... ..+.|.+|+++|++++|||||+++++|. ..+++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 55668999999999999986 468999998754322 2346899999999999999999999873 2478999
Q ss_pred EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCc--eEeccccCCcEEec-CCCcceeecccccccc
Q 003384 537 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS--IVHGDLKPANILLD-ANFVSKLSDFGISRFL 613 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~g--iiHrDLKp~NILld-~~~~vKL~DFGla~~~ 613 (824)
||+++|+|.+++.. ...+++..+..|+.||+.||.|||+ ++ ||||||||+||||+ .++.+||+|||+|+..
T Consensus 92 E~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred eCCCCCcHHHHHhc---cccccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 99999999999953 3468999999999999999999999 55 99999999999996 5899999999999864
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCC
Q 003384 614 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPL 693 (824)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~ 693 (824)
.... .....||+.|+|||++.+ .|+.++|||||||+||||+||++||............ +.....
T Consensus 166 ~~~~----------~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~--i~~~~~-- 230 (270)
T d1t4ha_ 166 RASF----------AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR--VTSGVK-- 230 (270)
T ss_dssp CTTS----------BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHH--HTTTCC--
T ss_pred cCCc----------cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHH--HHcCCC--
Confidence 3221 123469999999999865 6999999999999999999999999754332221111 011011
Q ss_pred CCCCChhhHHHHHHHHHHHhhhccCCCCChH
Q 003384 694 AGDWPFVQAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 694 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
...++...++++.+|+.+||+.+|.+|||+.
T Consensus 231 ~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ 261 (270)
T d1t4ha_ 231 PASFDKVAIPEVKEIIEGCIRQNKDERYSIK 261 (270)
T ss_dssp CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred CcccCccCCHHHHHHHHHHccCCHhHCcCHH
Confidence 1112333456899999999999999999984
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.1e-46 Score=404.42 Aligned_cols=237 Identities=27% Similarity=0.358 Sum_probs=194.2
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCC---chhHHHHHHHHHhcCCCceeeEeccc--CCceEEEEE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYE 537 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~---~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~E 537 (824)
.|+..+.||+|+||+||+|.+. +..||||++....... .+.+.+|+.+|++++|||||+++|+| .+..++|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 4888999999999999999875 5789999997654433 24588999999999999999999998 457899999
Q ss_pred ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccc
Q 003384 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 617 (824)
Q Consensus 538 y~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 617 (824)
||++|+|..++.. ..++++..+..|+.||+.||.|||+ +|||||||||+||||+.++.+||+|||+|+.....
T Consensus 96 ~~~~g~l~~~~~~---~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~- 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (309)
T ss_dssp CCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred ecCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccCCC-
Confidence 9999999776632 3569999999999999999999999 89999999999999999999999999999865322
Q ss_pred ccCCCccccccCCCCCCcccCChhhhcc---CCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCC
Q 003384 618 ISSNNTTLCCRTDPKGTFAYMDPEFLAS---GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 694 (824)
Q Consensus 618 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~---~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~ 694 (824)
....||+.|+|||++.+ +.|+.++|||||||+||||++|++||.............. ... +
T Consensus 169 -----------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~--~~~-~-- 232 (309)
T d1u5ra_ 169 -----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--NES-P-- 232 (309)
T ss_dssp -----------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH--SCC-C--
T ss_pred -----------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh--CCC-C--
Confidence 23469999999999864 4689999999999999999999999976554332211110 000 1
Q ss_pred CCCChhhHHHHHHHHHHHhhhccCCCCChH
Q 003384 695 GDWPFVQAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 695 ~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
...+...+..+.+|+.+||+.+|.+|||+.
T Consensus 233 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ 262 (309)
T d1u5ra_ 233 ALQSGHWSEYFRNFVDSCLQKIPQDRPTSE 262 (309)
T ss_dssp CCSCTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCCCCCCHHHHHHHHHHCcCChhHCcCHH
Confidence 111233467899999999999999999994
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-46 Score=398.25 Aligned_cols=251 Identities=25% Similarity=0.399 Sum_probs=195.7
Q ss_pred CCCCccceeeecCceEEEEEEECC-----eEEEEEEecCCCCCC-chhHHHHHHHHHhcCCCceeeEecccC-CceEEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLRH-----MQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVY 536 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~~-----~~VAvK~l~~~~~~~-~~~f~~Ei~iL~~l~HpnIv~L~g~~~-~~~~LV~ 536 (824)
.+|.+.+.||+|+||.||+|.+.. ..||||.+....... ...|.+|+.+|++++|||||+++|+|. +..++||
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~iv~ 86 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIM 86 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCeEEEEE
Confidence 468889999999999999998753 458999886543222 356899999999999999999999985 4689999
Q ss_pred EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccc
Q 003384 537 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 616 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 616 (824)
||+++|+|.+++.. ...++++..++.++.||+.||.|||+ ++||||||||+|||++.++.+||+|||+|+.+...
T Consensus 87 E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~ 161 (273)
T d1mp8a_ 87 ELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161 (273)
T ss_dssp ECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhheeccCC
Confidence 99999999998753 34568999999999999999999999 89999999999999999999999999999876543
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHH--HHHHhhhccccccCCC
Q 003384 617 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEV--QYALDTGKLKNLLDPL 693 (824)
Q Consensus 617 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~--~~~~~~~~~~~~ld~~ 693 (824)
.... .....||+.|+|||++.+..|+.++|||||||+||||+| |.+||...... ...+..+.
T Consensus 162 ~~~~-------~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~-------- 226 (273)
T d1mp8a_ 162 TYYK-------ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-------- 226 (273)
T ss_dssp ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC--------
T ss_pred ccee-------ccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--------
Confidence 2211 133468999999999999999999999999999999998 89999755432 22222221
Q ss_pred CCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHH
Q 003384 694 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 735 (824)
Q Consensus 694 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~ 735 (824)
....|...+..+.+|+.+||+.+|.+|||+ ++|++.|+.+.
T Consensus 227 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~-~ei~~~L~~i~ 267 (273)
T d1mp8a_ 227 RLPMPPNCPPTLYSLMTKCWAYDPSRRPRF-TELKAQLSTIL 267 (273)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCHhHCcCH-HHHHHHHHHHH
Confidence 123345567889999999999999999999 67777777654
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5.6e-46 Score=409.13 Aligned_cols=245 Identities=21% Similarity=0.333 Sum_probs=200.4
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--CCceEEEEEec
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 539 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~Ey~ 539 (824)
++|++.+.||+|+||.||+|.+. +..||||++........+.+.+|+.+|++++|||||+++++| .+..+||||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 37999999999999999999986 689999999765544456789999999999999999999998 45789999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEec--CCCcceeecccccccccccc
Q 003384 540 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD--ANFVSKLSDFGISRFLSQNE 617 (824)
Q Consensus 540 ~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld--~~~~vKL~DFGla~~~~~~~ 617 (824)
+||+|.+++.. ...++++..+..|+.||+.||.|||+ +|||||||||+||||+ .++.+||+|||+|+.+....
T Consensus 106 ~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 106 SGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred CCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 99999999843 33569999999999999999999999 8999999999999995 46899999999998765432
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCC
Q 003384 618 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 697 (824)
Q Consensus 618 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~ 697 (824)
.. ....||+.|+|||++.+..|+.++|||||||++|+|+||++||...+.............. .....
T Consensus 181 ~~---------~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~---~~~~~ 248 (350)
T d1koaa2 181 SV---------KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWN---MDDSA 248 (350)
T ss_dssp CE---------EEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC---SCCGG
T ss_pred cc---------ceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---CCccc
Confidence 11 2346899999999999999999999999999999999999999866543322111111100 01111
Q ss_pred ChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 698 PFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 698 p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
....+..+.+|+.+||+.||.+|||+.+
T Consensus 249 ~~~~s~~~~~li~~~L~~dP~~R~t~~e 276 (350)
T d1koaa2 249 FSGISEDGKDFIRKLLLADPNTRMTIHQ 276 (350)
T ss_dssp GGGCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHH
Confidence 2345678999999999999999999843
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1e-45 Score=407.25 Aligned_cols=245 Identities=21% Similarity=0.344 Sum_probs=201.1
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEec
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL 539 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey~ 539 (824)
+.|++.+.||+|+||+||+|... +..||||++..........+.+|+.+|++|+|||||+++++|. +..|||||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 36999999999999999999985 6889999997654444557889999999999999999999984 4689999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEec--CCCcceeecccccccccccc
Q 003384 540 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD--ANFVSKLSDFGISRFLSQNE 617 (824)
Q Consensus 540 ~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld--~~~~vKL~DFGla~~~~~~~ 617 (824)
+||+|.+++.. ...++++..+..|+.||+.||.|||+ +|||||||||+||||+ .++.+||+|||+|+.+....
T Consensus 109 ~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 109 SGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp CCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 99999988742 34569999999999999999999999 8999999999999998 67899999999998765432
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCC
Q 003384 618 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 697 (824)
Q Consensus 618 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~ 697 (824)
.. ....||+.|+|||++.+..|+.++|||||||+||+|+||++||................ . ......
T Consensus 184 ~~---------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~--~-~~~~~~ 251 (352)
T d1koba_ 184 IV---------KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCD--W-EFDEDA 251 (352)
T ss_dssp CE---------EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCC--C-CCCSST
T ss_pred ce---------eeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--C-CCCccc
Confidence 11 22358999999999999999999999999999999999999998765443222111111 1 111122
Q ss_pred ChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 698 PFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 698 p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
+...+..+.+|+.+||+.+|.+|||+.+
T Consensus 252 ~~~~s~~~~~li~~~L~~dp~~R~s~~e 279 (352)
T d1koba_ 252 FSSVSPEAKDFIKNLLQKEPRKRLTVHD 279 (352)
T ss_dssp TTTSCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHH
Confidence 3345678999999999999999999843
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2e-45 Score=391.51 Aligned_cols=259 Identities=24% Similarity=0.389 Sum_probs=200.7
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCc---hhHHHHHHHHHhcCCCceeeEecccCC------c
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGP---SEFQQEIDILSKIRHPNLVTLVGACPE------V 531 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~---~~f~~Ei~iL~~l~HpnIv~L~g~~~~------~ 531 (824)
.++|.+.+.||+|+||+||+|.+. ++.||||++......+. ..|.+|+.+|+.++|||||++++++.. .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 356999999999999999999975 68999999987654443 358899999999999999999998732 3
Q ss_pred eEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccc
Q 003384 532 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR 611 (824)
Q Consensus 532 ~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~ 611 (824)
.||||||++||+|.+++... .++++..+..|+.||+.||.|||+ +|||||||||+||||+.++.++|+|||++.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~---~~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhccc---CCCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhhh
Confidence 78999999999999988533 469999999999999999999999 899999999999999999999999999987
Q ss_pred ccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccC
Q 003384 612 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD 691 (824)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld 691 (824)
.......... ......||+.|+|||++.+..|+.++|||||||+||||+||++||............-. ....
T Consensus 160 ~~~~~~~~~~-----~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~--~~~~ 232 (277)
T d1o6ya_ 160 AIADSGNSVT-----QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR--EDPI 232 (277)
T ss_dssp ECC---------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH--CCCC
T ss_pred hhcccccccc-----ccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHh--cCCC
Confidence 6544322111 12345799999999999999999999999999999999999999987655433222111 1000
Q ss_pred CCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHH
Q 003384 692 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 735 (824)
Q Consensus 692 ~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~ 735 (824)
+ ....+...+..+.+|+.+||+.+|.+||+..+++.+.|..+.
T Consensus 233 ~-~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 233 P-PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp C-GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred C-CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 0 011123346789999999999999999954477777776654
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=395.46 Aligned_cols=244 Identities=23% Similarity=0.331 Sum_probs=198.3
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC------CchhHHHHHHHHHhcCCCceeeEecccC--CceE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ------GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWT 533 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~------~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~ 533 (824)
+.|+..+.||+|+||+||+|.++ +..||||++...... ..+.|.+|+.+|++++|||||+++++|. +..+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 46999999999999999999986 678999998754322 2356899999999999999999999984 4688
Q ss_pred EEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCC----cceeecccc
Q 003384 534 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF----VSKLSDFGI 609 (824)
Q Consensus 534 LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~----~vKL~DFGl 609 (824)
||||||+||+|.+++... ..+++..+..++.|++.||.|||+ ++||||||||+|||++.++ .+||+|||+
T Consensus 90 iv~E~~~gg~L~~~i~~~---~~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEcCCCccccchhccc---cccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecchhh
Confidence 999999999999999543 469999999999999999999999 8999999999999998776 599999999
Q ss_pred ccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccc
Q 003384 610 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNL 689 (824)
Q Consensus 610 a~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ 689 (824)
|+....... .....||+.|+|||++.+..++.++|||||||+||||+||++||.................
T Consensus 164 a~~~~~~~~---------~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~- 233 (293)
T d1jksa_ 164 AHKIDFGNE---------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY- 233 (293)
T ss_dssp CEECTTSCB---------CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC-
T ss_pred hhhcCCCcc---------ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC-
Confidence 987654321 1345689999999999999999999999999999999999999986654332211111100
Q ss_pred cCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 690 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 690 ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
......+...+..+.+|+.+||+.+|.+||++.+
T Consensus 234 --~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e 267 (293)
T d1jksa_ 234 --EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQD 267 (293)
T ss_dssp --CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred --CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHH
Confidence 0000111234568999999999999999999943
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=397.50 Aligned_cols=263 Identities=25% Similarity=0.351 Sum_probs=199.6
Q ss_pred hhhHhhhcCCCCccceeeecCceEEEEEEECC-------eEEEEEEecCCCCC-CchhHHHHHHHHHhc-CCCceeeEec
Q 003384 456 FSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQ-GPSEFQQEIDILSKI-RHPNLVTLVG 526 (824)
Q Consensus 456 ~~ei~~~~~~f~~~~~LG~G~fG~Vykg~~~~-------~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l-~HpnIv~L~g 526 (824)
.++++...++|...++||+|+||.||+|.+.+ +.||||+++..... ....+.+|..++.++ +||||+.+++
T Consensus 5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~ 84 (299)
T d1ywna1 5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 84 (299)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeee
Confidence 33443344579999999999999999998642 57999998754322 234577888888877 6899999999
Q ss_pred ccC---CceEEEEEecCCCChhhhhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecccc
Q 003384 527 ACP---EVWTLVYEYLPNGSLEDRLSCKD-------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLK 590 (824)
Q Consensus 527 ~~~---~~~~LV~Ey~~ggsL~~~L~~~~-------------~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLK 590 (824)
++. ...++|||||++|+|.++|.... ....+++..+..|+.||+.||.|||+ ++|||||||
T Consensus 85 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlK 161 (299)
T d1ywna1 85 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLA 161 (299)
T ss_dssp EECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCC
T ss_pred eeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCC
Confidence 873 35799999999999999996432 13458999999999999999999999 899999999
Q ss_pred CCcEEecCCCcceeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhC-CC
Q 003384 591 PANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG-RP 669 (824)
Q Consensus 591 p~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG-~~ 669 (824)
|+||||+.++.+||+|||+|+......... ......||+.|+|||++.++.++.++|||||||++|||+|| .+
T Consensus 162 p~NILl~~~~~~Kl~DFGla~~~~~~~~~~------~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~ 235 (299)
T d1ywna1 162 ARNILLSEKNVVKICDFGLARDIYKDPDYV------RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 235 (299)
T ss_dssp GGGEEECGGGCEEECC------CCSCTTSC------CTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred ccceeECCCCcEEEccCcchhhcccccccc------ccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCC
Confidence 999999999999999999998765433211 12345799999999999999999999999999999999986 56
Q ss_pred CCCCch---HHHHHHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHh
Q 003384 670 ALGITK---EVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 736 (824)
Q Consensus 670 Pf~~~~---~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~ 736 (824)
||.... .+...+..+. ....|...+..+.+|+.+||+.+|.+|||+ +++++.|+.+..
T Consensus 236 p~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~-~eil~~L~~ilq 296 (299)
T d1ywna1 236 PYPGVKIDEEFCRRLKEGT--------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTF-SELVEHLGNLLQ 296 (299)
T ss_dssp SSTTCCCSHHHHHHHHHTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHhcCC--------CCCCCccCCHHHHHHHHHHcCCChhHCcCH-HHHHHHHHHHHh
Confidence 786432 2222223321 122344566789999999999999999999 778888887654
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-46 Score=395.46 Aligned_cols=255 Identities=26% Similarity=0.382 Sum_probs=196.2
Q ss_pred CCCCccceeeecCceEEEEEEECC-----eEEEEEEecCCCCCC---chhHHHHHHHHHhcCCCceeeEecccCC-ceEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLRH-----MQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGACPE-VWTL 534 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~~-----~~VAvK~l~~~~~~~---~~~f~~Ei~iL~~l~HpnIv~L~g~~~~-~~~L 534 (824)
++|+..+.||+|+||.||+|.+.+ ..||||++....... .+.|.+|+.+|++++|||||+++|+|.+ ..++
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~~~~l 87 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM 87 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeecchhe
Confidence 468889999999999999998742 369999987653322 3568999999999999999999999954 5789
Q ss_pred EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccc
Q 003384 535 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 614 (824)
Q Consensus 535 V~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~ 614 (824)
||||+++|+|.+++... ..++++..++.++.|++.||.|||+ ++|+||||||+||||+.++.+||+|||+++.+.
T Consensus 88 v~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 88 VTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeeecCcchhhhhhcc--cCCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 99999999999988543 3469999999999999999999999 899999999999999999999999999999765
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchHHHHHHhhhccccccCCC
Q 003384 615 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPL 693 (824)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~~~~~~~~~ld~~ 693 (824)
....... ......||+.|+|||++.+..++.++|||||||++|||+| |++||...+........... ..
T Consensus 163 ~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~-----~~ 232 (273)
T d1u46a_ 163 QNDDHYV-----MQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE-----GE 232 (273)
T ss_dssp C-CCEEE-----C-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTS-----CC
T ss_pred cCCCcce-----ecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhC-----CC
Confidence 4432211 1133458899999999999999999999999999999998 89999766544322211111 11
Q ss_pred CCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHH
Q 003384 694 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 734 (824)
Q Consensus 694 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l 734 (824)
..+.+...+..+.+|+.+||+.+|++|||+ .+|.+.|.+.
T Consensus 233 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~-~ei~~~L~~~ 272 (273)
T d1u46a_ 233 RLPRPEDCPQDIYNVMVQCWAHKPEDRPTF-VALRDFLLEA 272 (273)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHH
T ss_pred CCCCcccccHHHHHHHHHHcCCChhHCcCH-HHHHHHHHhc
Confidence 122344556789999999999999999999 6677877653
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-45 Score=394.71 Aligned_cols=251 Identities=26% Similarity=0.421 Sum_probs=201.4
Q ss_pred cceeeecCceEEEEEEECC-----eEEEEEEecCCC-CCCchhHHHHHHHHHhcCCCceeeEecccC---CceEEEEEec
Q 003384 469 SLKIGEGGYGSIYKGLLRH-----MQVAIKMLHPHS-LQGPSEFQQEIDILSKIRHPNLVTLVGACP---EVWTLVYEYL 539 (824)
Q Consensus 469 ~~~LG~G~fG~Vykg~~~~-----~~VAvK~l~~~~-~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~---~~~~LV~Ey~ 539 (824)
.++||+|+||+||+|.+.. ..||||+++... ....+.|.+|+++|++++|||||+++|+|. ...++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 4679999999999998753 359999997532 222457999999999999999999999873 3578999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccccc
Q 003384 540 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 619 (824)
Q Consensus 540 ~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 619 (824)
++|+|.+++.. ....+++..++.++.|++.||.|||+ ++|+||||||+||||+.++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 99999998863 34567888999999999999999999 89999999999999999999999999999977654332
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHH---HHHhhhccccccCCCCCC
Q 003384 620 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ---YALDTGKLKNLLDPLAGD 696 (824)
Q Consensus 620 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~---~~~~~~~~~~~ld~~~~~ 696 (824)
.... .....||+.|+|||.+.++.++.++|||||||+||||+||..||....... ..+..+. ...
T Consensus 187 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~--------~~~ 254 (311)
T d1r0pa_ 187 SVHN----KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--------RLL 254 (311)
T ss_dssp CTTC----TTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTC--------CCC
T ss_pred ccee----cccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC--------CCC
Confidence 2111 234579999999999999999999999999999999999777765332111 1112221 122
Q ss_pred CChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhh
Q 003384 697 WPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 737 (824)
Q Consensus 697 ~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~~ 737 (824)
.|...+..+.+|+.+||+.+|++||++ .+|++.|+.+...
T Consensus 255 ~p~~~~~~l~~li~~cl~~dP~~RPs~-~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 255 QPEYCPDPLYEVMLKCWHPKAEMRPSF-SELVSRISAIFST 294 (311)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHT
T ss_pred CcccCcHHHHHHHHHHcCCCHhHCcCH-HHHHHHHHHHHHh
Confidence 344556789999999999999999999 7788889988764
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.5e-45 Score=396.45 Aligned_cols=234 Identities=25% Similarity=0.368 Sum_probs=196.6
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCC---CCCCchhHHHHHHHHHhcCCCceeeEeccc--CCceEEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH---SLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVY 536 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~---~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~ 536 (824)
++|++.+.||+|+||+||+|... +..||||+++.. .....+.+.+|+.+|+.++|||||++++++ .+..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 35889999999999999999976 688999998643 223456799999999999999999999998 45689999
Q ss_pred EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccc
Q 003384 537 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 616 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 616 (824)
|||+||+|..++.. ...++......++.||+.||.|||+ +|||||||||+||||+.+|.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCccccccccc---cccccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 99999999998853 3457888999999999999999999 89999999999999999999999999999876432
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCC
Q 003384 617 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 696 (824)
Q Consensus 617 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~ 696 (824)
. ....||+.|+|||++.+..|+.++|||||||+||+|+||++||...+.......... ....
T Consensus 158 ~-----------~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~-------~~~~ 219 (316)
T d1fota_ 158 T-----------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN-------AELR 219 (316)
T ss_dssp B-----------CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH-------CCCC
T ss_pred c-----------ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHc-------CCCC
Confidence 1 345699999999999999999999999999999999999999987654332211110 0112
Q ss_pred CChhhHHHHHHHHHHHhhhccCCCC
Q 003384 697 WPFVQAEQLANLAMRCCEMSRKSRP 721 (824)
Q Consensus 697 ~p~~~~~~l~~Li~~Cl~~~P~~RP 721 (824)
+|...+..+.+++.+||..+|.+||
T Consensus 220 ~p~~~s~~~~~li~~~L~~dp~~R~ 244 (316)
T d1fota_ 220 FPPFFNEDVKDLLSRLITRDLSQRL 244 (316)
T ss_dssp CCTTSCHHHHHHHHHHTCSCTTTCT
T ss_pred CCCCCCHHHHHHHHHHhhhCHHhcc
Confidence 3455667899999999999999997
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-45 Score=400.10 Aligned_cols=238 Identities=23% Similarity=0.292 Sum_probs=199.3
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCC---CCCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH---SLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 536 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~---~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~ 536 (824)
++|.+.+.||+|+||.||+|... +..||||++... .......+.+|+.+|+.++|||||++++++. +.+|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 46899999999999999999975 689999998743 2234567899999999999999999999984 4689999
Q ss_pred EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccc
Q 003384 537 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 616 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~ 616 (824)
|||+||+|.+++... ..+++..+..++.||+.||.|||+ +|||||||||+||||+.+|.+||+|||+|+.....
T Consensus 85 ey~~gg~L~~~~~~~---~~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 85 EYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eccCCCchhhhhhcc---cCCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 999999999998543 468899999999999999999999 89999999999999999999999999999865433
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCC
Q 003384 617 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 696 (824)
Q Consensus 617 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~ 696 (824)
... .....||+.|+|||++.+..|+.++|||||||+||||+||++||...+........ ... ...
T Consensus 159 ~~~--------~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i--~~~-----~~~ 223 (337)
T d1o6la_ 159 GAT--------MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI--LME-----EIR 223 (337)
T ss_dssp TCC--------BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--HHC-----CCC
T ss_pred Ccc--------cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHH--hcC-----CCC
Confidence 211 13456999999999999999999999999999999999999999876543321111 111 123
Q ss_pred CChhhHHHHHHHHHHHhhhccCCCCC
Q 003384 697 WPFVQAEQLANLAMRCCEMSRKSRPE 722 (824)
Q Consensus 697 ~p~~~~~~l~~Li~~Cl~~~P~~RPt 722 (824)
+|...+..+.+|+.+||+.+|.+||+
T Consensus 224 ~p~~~s~~~~dli~~~L~~dP~~R~~ 249 (337)
T d1o6la_ 224 FPRTLSPEAKSLLAGLLKKDPKQRLG 249 (337)
T ss_dssp CCTTSCHHHHHHHHHHTCSSTTTSTT
T ss_pred CCccCCHHHHHHHHhhccCCchhhcc
Confidence 45566788999999999999999996
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-45 Score=393.98 Aligned_cols=254 Identities=26% Similarity=0.415 Sum_probs=203.1
Q ss_pred CCCCccceeeecCceEEEEEEECC----eEEEEEEecCC-CCCCchhHHHHHHHHHhc-CCCceeeEecccC--CceEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLRH----MQVAIKMLHPH-SLQGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTLV 535 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~~----~~VAvK~l~~~-~~~~~~~f~~Ei~iL~~l-~HpnIv~L~g~~~--~~~~LV 535 (824)
++|++.++||+|+||+||+|.+++ ..||||.+... .....+.|.+|+.+|+++ +|||||+++|+|. +..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 357778899999999999998853 25888987643 333456799999999999 7999999999984 468999
Q ss_pred EEecCCCChhhhhhcc-------------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcc
Q 003384 536 YEYLPNGSLEDRLSCK-------------DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS 602 (824)
Q Consensus 536 ~Ey~~ggsL~~~L~~~-------------~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~v 602 (824)
|||++||+|.++|... .....+++..+..++.||+.||.|||+ ++||||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCce
Confidence 9999999999999643 234679999999999999999999999 899999999999999999999
Q ss_pred eeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCC-CCCCCchHHHHHH
Q 003384 603 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR-PALGITKEVQYAL 681 (824)
Q Consensus 603 KL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~-~Pf~~~~~~~~~~ 681 (824)
||+|||+|+........ ....||..|+|||.+.++.|+.++|||||||++|||++|. +||...+......
T Consensus 167 kl~DfG~a~~~~~~~~~---------~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~ 237 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVKK---------TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 237 (309)
T ss_dssp EECCTTCEESSCEECCC-------------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred EEccccccccccccccc---------cceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 99999999865433211 2345899999999999999999999999999999999965 6786554333211
Q ss_pred hhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHh
Q 003384 682 DTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 736 (824)
Q Consensus 682 ~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~ 736 (824)
.. ........|...+..+.+|+.+||+.+|++||++ ++|++.|+.+..
T Consensus 238 ~i------~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~-~eil~~L~~i~~ 285 (309)
T d1fvra_ 238 KL------PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSF-AQILVSLNRMLE 285 (309)
T ss_dssp HG------GGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHH
T ss_pred HH------HhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCH-HHHHHHHHHHHh
Confidence 11 1111233455667899999999999999999999 778888888754
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-45 Score=391.13 Aligned_cols=258 Identities=25% Similarity=0.400 Sum_probs=205.3
Q ss_pred CCCCccceeeecCceEEEEEEECC---------eEEEEEEecCCCCC-CchhHHHHHHHHHhc-CCCceeeEecccC--C
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLRH---------MQVAIKMLHPHSLQ-GPSEFQQEIDILSKI-RHPNLVTLVGACP--E 530 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~~---------~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l-~HpnIv~L~g~~~--~ 530 (824)
++|.+.+.||+|+||.||+|...+ ..||||+++..... ....+.+|...+.++ +|||||+++|+|. .
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 468888999999999999998642 46999999764432 235688899999888 7999999999984 4
Q ss_pred ceEEEEEecCCCChhhhhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEec
Q 003384 531 VWTLVYEYLPNGSLEDRLSCKD-------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD 597 (824)
Q Consensus 531 ~~~LV~Ey~~ggsL~~~L~~~~-------------~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld 597 (824)
..++||||+++|+|.++|.... ....+++..++.++.||+.||.|||+ ++||||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccceeec
Confidence 6899999999999999996442 13468999999999999999999999 8999999999999999
Q ss_pred CCCcceeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCchH
Q 003384 598 ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKE 676 (824)
Q Consensus 598 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~~ 676 (824)
.++.+||+|||+++.......... .....||+.|+|||++.++.|+.++|||||||+||||+| |++||.....
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~------~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~ 243 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKK------TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCC------CTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred CCCCeEeccchhhccccccccccc------cccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence 999999999999997765432221 134568999999999999999999999999999999998 7999975543
Q ss_pred HHHHHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhh
Q 003384 677 VQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 737 (824)
Q Consensus 677 ~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~~ 737 (824)
... .. .+........|...+..+.+|+.+||+.+|.+|||+ .+|++.|+.+.+.
T Consensus 244 ~~~-~~-----~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~-~eil~~L~~i~a~ 297 (299)
T d1fgka_ 244 EEL-FK-----LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTF-KQLVEDLDRIVAL 297 (299)
T ss_dssp HHH-HH-----HHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHHH
T ss_pred HHH-HH-----HHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCH-HHHHHHHHHHhhc
Confidence 221 11 111122233455667789999999999999999999 7888999988764
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=391.20 Aligned_cols=256 Identities=23% Similarity=0.372 Sum_probs=206.1
Q ss_pred cCCCCccceeeecCceEEEEEEEC-------CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccC--Cce
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVW 532 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~-------~~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~ 532 (824)
.++|...+.||+|+||+||+|.+. +..||||+++..... ....|.+|+.++++++|||||+++|+|. +..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 457888999999999999999875 357999999754321 2245899999999999999999999984 578
Q ss_pred EEEEEecCCCChhhhhhcc-------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceee
Q 003384 533 TLVYEYLPNGSLEDRLSCK-------DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLS 605 (824)
Q Consensus 533 ~LV~Ey~~ggsL~~~L~~~-------~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~ 605 (824)
++||||+++|+|.+++... .....+++..+..|+.+++.||.|||+ ++|+||||||+||||+.++++||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEEEe
Confidence 9999999999999988532 233468999999999999999999999 889999999999999999999999
Q ss_pred ccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhC-CCCCCCchHHHHHHhhh
Q 003384 606 DFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG-RPALGITKEVQYALDTG 684 (824)
Q Consensus 606 DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG-~~Pf~~~~~~~~~~~~~ 684 (824)
|||+|+.+....... ......||+.|+|||.+.+..++.++|||||||+||||+|| ++||...........
T Consensus 176 DFGla~~~~~~~~~~------~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~-- 247 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYR------KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF-- 247 (308)
T ss_dssp CTTCCCGGGGGGCEE------GGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH--
T ss_pred ecccceeccCCccee------eccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHH--
Confidence 999998765443211 12334689999999999999999999999999999999998 578865543321111
Q ss_pred ccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHH
Q 003384 685 KLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 734 (824)
Q Consensus 685 ~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l 734 (824)
+.+....+.|...+..+.+|+.+||+.+|.+||++ ++|++.|+..
T Consensus 248 ----i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~-~~il~~L~~~ 292 (308)
T d1p4oa_ 248 ----VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSF-LEIISSIKEE 292 (308)
T ss_dssp ----HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHGGG
T ss_pred ----HHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCH-HHHHHHHHHh
Confidence 11112223345566789999999999999999999 6677777654
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.8e-44 Score=397.15 Aligned_cols=233 Identities=21% Similarity=0.298 Sum_probs=196.1
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCC---CCCCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH---SLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE 537 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~---~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~E 537 (824)
+|+..+.||+|+||.||+|.++ +..||||++... .......+.+|+.+|+.++|||||++++++. ...++|||
T Consensus 42 ~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e 121 (350)
T d1rdqe_ 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccc
Confidence 6899999999999999999986 689999998642 2233457899999999999999999999884 46789999
Q ss_pred ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccc
Q 003384 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 617 (824)
Q Consensus 538 y~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 617 (824)
|+.||+|.+++... ..+++..+..|+.||+.||.|||+ ++||||||||+||||+.+|.+||+|||+|+.+....
T Consensus 122 ~~~~g~l~~~l~~~---~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~ 195 (350)
T d1rdqe_ 122 YVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195 (350)
T ss_dssp CCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB
T ss_pred cccccchhhhHhhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeeccccc
Confidence 99999999998543 468999999999999999999999 899999999999999999999999999998764321
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCC
Q 003384 618 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 697 (824)
Q Consensus 618 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~ 697 (824)
....||+.|||||++.+..|+.++|||||||+||||+||++||.............. . ....
T Consensus 196 -----------~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~--~-----~~~~ 257 (350)
T d1rdqe_ 196 -----------WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS--G-----KVRF 257 (350)
T ss_dssp -----------CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--C-----CCCC
T ss_pred -----------ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhc--C-----CCCC
Confidence 234599999999999999999999999999999999999999987654332211111 1 1123
Q ss_pred ChhhHHHHHHHHHHHhhhccCCCC
Q 003384 698 PFVQAEQLANLAMRCCEMSRKSRP 721 (824)
Q Consensus 698 p~~~~~~l~~Li~~Cl~~~P~~RP 721 (824)
|...+..+.+|+.+||+.||.+|+
T Consensus 258 p~~~s~~~~~li~~~L~~dP~kR~ 281 (350)
T d1rdqe_ 258 PSHFSSDLKDLLRNLLQVDLTKRF 281 (350)
T ss_dssp CTTCCHHHHHHHHHHSCSCTTTCT
T ss_pred CccCCHHHHHHHHHHhhhCHHhcc
Confidence 445667899999999999999995
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-45 Score=392.78 Aligned_cols=261 Identities=22% Similarity=0.333 Sum_probs=196.4
Q ss_pred CCCccceeeecCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHH--HHHhcCCCceeeEecccCC------ceEEEE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEID--ILSKIRHPNLVTLVGACPE------VWTLVY 536 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~~~~VAvK~l~~~~~~~~~~f~~Ei~--iL~~l~HpnIv~L~g~~~~------~~~LV~ 536 (824)
.|...+.||+|+||.||+|++++..||||++.... ...+.+|.+ .+..++|||||+++|+|.+ ..++||
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 46667889999999999999999999999986432 334445554 4567899999999999832 468999
Q ss_pred EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhc-----CCCceEeccccCCcEEecCCCcceeecccccc
Q 003384 537 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC-----KPHSIVHGDLKPANILLDANFVSKLSDFGISR 611 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~-----~~~giiHrDLKp~NILld~~~~vKL~DFGla~ 611 (824)
||+++|+|.++|.. ..++|..++.++.+++.||.|||+. +.+|||||||||+||||+.+|.+||+|||+++
T Consensus 81 Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 99999999999953 3589999999999999999999973 34699999999999999999999999999998
Q ss_pred ccccccccCCCccccccCCCCCCcccCChhhhccCC------CCcchhHHhHHHHHHHHHhCCCCCCCchH---------
Q 003384 612 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE------LTPKSDVYSFGIILLRLLTGRPALGITKE--------- 676 (824)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~------~t~ksDVwSlGvvL~ELltG~~Pf~~~~~--------- 676 (824)
.......... .......||+.|+|||++.+.. ++.++|||||||+||||+||.+||.....
T Consensus 157 ~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~ 232 (303)
T d1vjya_ 157 RHDSATDTID----IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232 (303)
T ss_dssp EEETTTTEEC----C----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred cccCCCccee----ccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcc
Confidence 7654332111 1123467999999999987642 57789999999999999999988742110
Q ss_pred ----HHHHHhhhccccccCCCC-CCC-ChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhh
Q 003384 677 ----VQYALDTGKLKNLLDPLA-GDW-PFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 737 (824)
Q Consensus 677 ----~~~~~~~~~~~~~ld~~~-~~~-p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~~ 737 (824)
.............+.|.. ..+ +......+.+|+.+||+.+|.+||++ .+|.+.|+.+...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~-~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 233 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA-LRIKKTLSQLSQQ 298 (303)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCH-HHHHHHHHHHHHH
T ss_pred cccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCH-HHHHHHHHHHHHh
Confidence 000001111111111211 111 12344579999999999999999999 7788889887653
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=7.6e-44 Score=379.68 Aligned_cols=241 Identities=27% Similarity=0.409 Sum_probs=197.7
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCc---------hhHHHHHHHHHhcC-CCceeeEecccC--
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGP---------SEFQQEIDILSKIR-HPNLVTLVGACP-- 529 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~---------~~f~~Ei~iL~~l~-HpnIv~L~g~~~-- 529 (824)
.+|++.+.||+|+||+||+|+.. ++.||||++........ +.+.+|+.+|++++ |||||++++++.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 47889999999999999999984 58999999976543321 24789999999997 999999999984
Q ss_pred CceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccc
Q 003384 530 EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI 609 (824)
Q Consensus 530 ~~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGl 609 (824)
+.+|||||||+||+|.++|.. ..++++..+..++.||+.||.|||+ +|||||||||+||||+.++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEccchh
Confidence 468999999999999999953 3469999999999999999999999 8999999999999999999999999999
Q ss_pred ccccccccccCCCccccccCCCCCCcccCChhhhcc------CCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHH--H
Q 003384 610 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS------GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA--L 681 (824)
Q Consensus 610 a~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~------~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~--~ 681 (824)
++.+..... .....||+.|+|||++.+ ..++.++||||+||+||+|+||++||......... +
T Consensus 157 a~~~~~~~~---------~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i 227 (277)
T d1phka_ 157 SCQLDPGEK---------LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI 227 (277)
T ss_dssp CEECCTTCC---------BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred eeEccCCCc---------eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHH
Confidence 987654321 133569999999999864 35788999999999999999999999876543321 1
Q ss_pred hhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChH
Q 003384 682 DTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 682 ~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
..+... .........+.++.+|+.+||+.+|.+||++.
T Consensus 228 ~~~~~~-----~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~ 265 (277)
T d1phka_ 228 MSGNYQ-----FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAE 265 (277)
T ss_dssp HHTCCC-----CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred HhCCCC-----CCCcccccCCHHHHHHHHHHccCChhHCcCHH
Confidence 222111 11112235667899999999999999999984
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.1e-44 Score=398.55 Aligned_cols=239 Identities=26% Similarity=0.332 Sum_probs=191.8
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCC---CCCchhHHHH---HHHHHhcCCCceeeEecccC--CceE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQE---IDILSKIRHPNLVTLVGACP--EVWT 533 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~---~~~~~~f~~E---i~iL~~l~HpnIv~L~g~~~--~~~~ 533 (824)
++|.+.+.||+|+||.||+|.+. +..||||++.... ......+.+| +.+++.++|||||+++++|. +..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 47899999999999999999986 6889999986421 1222334444 66677778999999999984 4689
Q ss_pred EEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccc
Q 003384 534 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 613 (824)
Q Consensus 534 LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~ 613 (824)
+|||||+||+|.++|... ..+++..+..|+.||+.||.|||+ +|||||||||+||||+.+|.+||+|||+|+.+
T Consensus 84 ivmE~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHhc---ccccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 999999999999999543 468899999999999999999999 89999999999999999999999999999876
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhcc-CCCCcchhHHhHHHHHHHHHhCCCCCCCchHH-HHHHhhhccccccC
Q 003384 614 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEV-QYALDTGKLKNLLD 691 (824)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~-~~~~~~~~~~~~ld 691 (824)
..... ....||+.|+|||++.. ..|+.++|||||||+||||+||++||...... ...+... ..
T Consensus 158 ~~~~~----------~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~-----~~ 222 (364)
T d1omwa3 158 SKKKP----------HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM-----TL 222 (364)
T ss_dssp SSSCC----------CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHH-----SS
T ss_pred CCCcc----------cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-----cc
Confidence 54321 23469999999999975 56899999999999999999999999754321 1111111 11
Q ss_pred CCCCCCChhhHHHHHHHHHHHhhhccCCCCCh
Q 003384 692 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 723 (824)
Q Consensus 692 ~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 723 (824)
......|...+..+.+|+.+||+.+|.+||+.
T Consensus 223 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~ 254 (364)
T d1omwa3 223 TMAVELPDSFSPELRSLLEGLLQRDVNRRLGC 254 (364)
T ss_dssp SCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTT
T ss_pred cCCCCCCCCCCHHHHHHHHHHcccCHHHhCCC
Confidence 12223445567889999999999999999995
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-44 Score=387.05 Aligned_cols=256 Identities=24% Similarity=0.393 Sum_probs=206.7
Q ss_pred cCCCCccceeeecCceEEEEEEEC-------CeEEEEEEecCCCCC-CchhHHHHHHHHHhc-CCCceeeEecccC--Cc
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKI-RHPNLVTLVGACP--EV 531 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~-------~~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l-~HpnIv~L~g~~~--~~ 531 (824)
.++|.+.++||+|+||.||+|.+. ++.||||+++..... ....|.+|+.+++++ +|||||+++|+|. +.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 357888999999999999999863 257999999765432 234688999999999 6999999999995 46
Q ss_pred eEEEEEecCCCChhhhhhccC---------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEe
Q 003384 532 WTLVYEYLPNGSLEDRLSCKD---------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL 596 (824)
Q Consensus 532 ~~LV~Ey~~ggsL~~~L~~~~---------------~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILl 596 (824)
.++|||||++|+|.++|.... ....+++..+..|+.||+.||.|||+ ++||||||||+|||+
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccccccccc
Confidence 899999999999999986532 23469999999999999999999999 899999999999999
Q ss_pred cCCCcceeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHh-CCCCCCCch
Q 003384 597 DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITK 675 (824)
Q Consensus 597 d~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELlt-G~~Pf~~~~ 675 (824)
+.++.+||+|||+++......... ......||+.|+|||++.++.++.++|||||||++|||+| |.+||....
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~ 252 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYV------VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSE------ECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cccCcccccccchheeccCCCcce------EeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCC
Confidence 999999999999998765433211 1234568999999999999999999999999999999998 677775432
Q ss_pred H---HHHHHhhhccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHh
Q 003384 676 E---VQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 736 (824)
Q Consensus 676 ~---~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~ 736 (824)
. +...+..+. ....|...+..+.+|+.+||+.+|.+||++ .+++++|+.+..
T Consensus 253 ~~~~~~~~i~~~~--------~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~-~~il~~L~~~i~ 307 (311)
T d1t46a_ 253 VDSKFYKMIKEGF--------RMLSPEHAPAEMYDIMKTCWDADPLKRPTF-KQIVQLIEKQIS 307 (311)
T ss_dssp SSHHHHHHHHHTC--------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHHHHHH
T ss_pred HHHHHHHHHhcCC--------CCCCcccccHHHHHHHHHHcCCChhHCcCH-HHHHHHHHHhhc
Confidence 2 222222221 112334456789999999999999999999 778888887544
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-44 Score=389.16 Aligned_cols=240 Identities=25% Similarity=0.319 Sum_probs=197.8
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCC---CCCCchhHHHHHHHHH-hcCCCceeeEecccC--CceEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH---SLQGPSEFQQEIDILS-KIRHPNLVTLVGACP--EVWTLV 535 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~---~~~~~~~f~~Ei~iL~-~l~HpnIv~L~g~~~--~~~~LV 535 (824)
.+|.+.+.||+|+||+||+|.+. ++.||||++... .......+..|..++. .++|||||++++++. +..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 46889999999999999999985 688999999643 2233456777887765 689999999999984 468999
Q ss_pred EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccc
Q 003384 536 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 615 (824)
Q Consensus 536 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~ 615 (824)
|||++||+|.+++.. ...+++..+..++.||+.||.|||+ ++||||||||+|||++.++.+||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~---~~~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhccc
Confidence 999999999999953 3458899999999999999999999 8999999999999999999999999999986543
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCC
Q 003384 616 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG 695 (824)
Q Consensus 616 ~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~ 695 (824)
.... .....||+.|+|||++.+..|+.++|||||||++|+|+||++||.+........... .. ..
T Consensus 156 ~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~--~~-----~~ 220 (320)
T d1xjda_ 156 GDAK--------TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR--MD-----NP 220 (320)
T ss_dssp TTCC--------BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HC-----CC
T ss_pred cccc--------ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH--cC-----CC
Confidence 3211 134569999999999999999999999999999999999999998665433211110 00 12
Q ss_pred CCChhhHHHHHHHHHHHhhhccCCCCChH
Q 003384 696 DWPFVQAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 696 ~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
.+|...+..+.+|+.+||+.+|.+||++.
T Consensus 221 ~~p~~~s~~~~dli~~~L~~dP~~R~s~~ 249 (320)
T d1xjda_ 221 FYPRWLEKEAKDLLVKLFVREPEKRLGVR 249 (320)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSBTTB
T ss_pred CCCccCCHHHHHHHHHhcccCCCCCcCHH
Confidence 34455678899999999999999999983
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-43 Score=381.07 Aligned_cols=243 Identities=26% Similarity=0.287 Sum_probs=187.8
Q ss_pred cceeeecCceEEEEEEEC--CeEEEEEEecCCCCCC-----chhHHHHHHHHHhcCCCceeeEecccC--CceEEEEEec
Q 003384 469 SLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG-----PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL 539 (824)
Q Consensus 469 ~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~-----~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~Ey~ 539 (824)
+++||+|+||+||+|.+. ++.||||+++...... ...+.+|+.+|++++|||||++++++. +..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 468999999999999875 5789999987543221 346889999999999999999999984 4689999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccccc
Q 003384 540 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 619 (824)
Q Consensus 540 ~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~~ 619 (824)
.++++..++ .....+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+|+........
T Consensus 83 ~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~ 156 (299)
T d1ua2a_ 83 ETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 156 (299)
T ss_dssp SEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred cchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCccc
Confidence 988777666 344568888999999999999999999 89999999999999999999999999999866543211
Q ss_pred CCCccccccCCCCCCcccCChhhhccC-CCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccc------cccCC
Q 003384 620 SNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLK------NLLDP 692 (824)
Q Consensus 620 ~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~------~~ld~ 692 (824)
.....||+.|+|||++... .|+.++|||||||++|||+||++||................ ...+.
T Consensus 157 --------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~ 228 (299)
T d1ua2a_ 157 --------YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 228 (299)
T ss_dssp --------CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSST
T ss_pred --------ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccch
Confidence 1234699999999998755 68999999999999999999999998765544322111000 00000
Q ss_pred ----------CCCCCC-----hhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 693 ----------LAGDWP-----FVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 693 ----------~~~~~p-----~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
.....+ ...+..+.+|+.+||+.||.+|||+.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e 276 (299)
T d1ua2a_ 229 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQ 276 (299)
T ss_dssp TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHH
T ss_pred hccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 000011 123568999999999999999999843
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-44 Score=390.17 Aligned_cols=241 Identities=22% Similarity=0.367 Sum_probs=190.7
Q ss_pred CCCCccc-eeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhc-CCCceeeEecccC------CceE
Q 003384 464 HNFDPSL-KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGACP------EVWT 533 (824)
Q Consensus 464 ~~f~~~~-~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l-~HpnIv~L~g~~~------~~~~ 533 (824)
++|.+.. .||+|+||+||+|.+. +..||||++.. ...+.+|+.++.++ +|||||+++++|. ...|
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 4687764 5999999999999975 57899999863 35788999997655 8999999999873 3479
Q ss_pred EEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecC---CCcceeeccccc
Q 003384 534 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA---NFVSKLSDFGIS 610 (824)
Q Consensus 534 LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~---~~~vKL~DFGla 610 (824)
+|||||+||+|.++|... ....|++..+..|+.||+.||.|||+ +||+||||||+|||++. ++.+||+|||+|
T Consensus 86 ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHH---cCCcccccccccccccccccccccccccccee
Confidence 999999999999999643 23469999999999999999999999 89999999999999985 567999999999
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhcccccc
Q 003384 611 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLL 690 (824)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~l 690 (824)
+....... .....||+.|+|||++.+..|+.++|||||||+||+|+||++||........... +...+
T Consensus 162 ~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~---~~~~i 229 (335)
T d2ozaa1 162 KETTSHNS---------LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG---MKTRI 229 (335)
T ss_dssp EECCCCCC---------CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CC
T ss_pred eeccCCCc---------cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHH---HHHHH
Confidence 87654321 1345699999999999999999999999999999999999999964432111000 00001
Q ss_pred CCCCCCCC----hhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 691 DPLAGDWP----FVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 691 d~~~~~~p----~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
......+| ...+..+.+|+.+||+.+|.+||++.+
T Consensus 230 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e 268 (335)
T d2ozaa1 230 RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITE 268 (335)
T ss_dssp CSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred hcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHH
Confidence 00111112 234678999999999999999999943
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-43 Score=386.06 Aligned_cols=245 Identities=20% Similarity=0.301 Sum_probs=196.6
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc--CCceEEEEEec
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 539 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~Ey~ 539 (824)
++|.+.+.||+|+||+||+|.+. +..||||+++... .+...+.+|+.+|+.++|||||++++++ .+.+|||||||
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 46889999999999999999986 5789999997643 2234688999999999999999999988 45789999999
Q ss_pred CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCC--Ccceeecccccccccccc
Q 003384 540 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN--FVSKLSDFGISRFLSQNE 617 (824)
Q Consensus 540 ~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~--~~vKL~DFGla~~~~~~~ 617 (824)
+||+|.+++.. ...++++..+..|+.||+.||.|||+ +||+||||||+|||++.+ +.+||+|||+++......
T Consensus 84 ~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~ 158 (321)
T d1tkia_ 84 SGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred CCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence 99999999943 23469999999999999999999999 899999999999999854 589999999998654332
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccccCCCCCCC
Q 003384 618 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 697 (824)
Q Consensus 618 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~ 697 (824)
.. ....||+.|+|||.+.+..|+.++|||||||+||+|+||++||..................++ ...
T Consensus 159 ~~---------~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~---~~~ 226 (321)
T d1tkia_ 159 NF---------RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD---EEA 226 (321)
T ss_dssp EE---------EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC---HHH
T ss_pred cc---------cccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---hhh
Confidence 11 223489999999999999999999999999999999999999987654332211111000000 000
Q ss_pred ChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 003384 698 PFVQAEQLANLAMRCCEMSRKSRPELGKDV 727 (824)
Q Consensus 698 p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v 727 (824)
+...+..+.+|+.+||..||.+||++ +++
T Consensus 227 ~~~~s~~~~~li~~~L~~dp~~R~s~-~ei 255 (321)
T d1tkia_ 227 FKEISIEAMDFVDRLLVKERKSRMTA-SEA 255 (321)
T ss_dssp HTTSCHHHHHHHHTTSCSSGGGSCCH-HHH
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCH-HHH
Confidence 11245679999999999999999998 444
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-44 Score=377.91 Aligned_cols=232 Identities=23% Similarity=0.370 Sum_probs=190.9
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC------CchhHHHHHHHHHhcC--CCceeeEecccC--Cc
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ------GPSEFQQEIDILSKIR--HPNLVTLVGACP--EV 531 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~------~~~~f~~Ei~iL~~l~--HpnIv~L~g~~~--~~ 531 (824)
++|.+.+.||+|+||+||+|.+. +..||||++...... ....+.+|+.+|++++ |||||++++++. +.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 47999999999999999999986 688999998754322 2234779999999997 899999999984 46
Q ss_pred eEEEEEecCC-CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecC-CCcceeecccc
Q 003384 532 WTLVYEYLPN-GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA-NFVSKLSDFGI 609 (824)
Q Consensus 532 ~~LV~Ey~~g-gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~-~~~vKL~DFGl 609 (824)
.++||||+.+ +++.+++.. ...+++..+..++.||+.||.|||+ ++||||||||+|||++. ++.+||+|||+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~---~~~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEeccCcchHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECcccc
Confidence 8999999976 577777743 3468999999999999999999999 89999999999999985 47999999999
Q ss_pred ccccccccccCCCccccccCCCCCCcccCChhhhccCCC-CcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhcccc
Q 003384 610 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL-TPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKN 688 (824)
Q Consensus 610 a~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~ 688 (824)
|+...... .+...||+.|+|||++.+..+ +.++|||||||+||||+||++||.....+. .+.
T Consensus 158 a~~~~~~~----------~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i~----~~~--- 220 (273)
T d1xwsa_ 158 GALLKDTV----------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII----RGQ--- 220 (273)
T ss_dssp CEECCSSC----------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH----HCC---
T ss_pred ceeccccc----------ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHHh----hcc---
Confidence 98654321 134569999999999988765 567899999999999999999997654322 111
Q ss_pred ccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChH
Q 003384 689 LLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 689 ~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
..++...+.++.+|+.+||+.+|.+|||+.
T Consensus 221 ------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ 250 (273)
T d1xwsa_ 221 ------VFFRQRVSSECQHLIRWCLALRPSDRPTFE 250 (273)
T ss_dssp ------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred ------cCCCCCCCHHHHHHHHHHccCCHhHCcCHH
Confidence 123344567899999999999999999984
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-42 Score=374.06 Aligned_cols=248 Identities=26% Similarity=0.342 Sum_probs=193.9
Q ss_pred cCCCCccceeeecCceEEEEEEEC---CeEEEEEEecCCCC--CCchhHHHHHHHHHhc---CCCceeeEecccC-----
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR---HMQVAIKMLHPHSL--QGPSEFQQEIDILSKI---RHPNLVTLVGACP----- 529 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~---~~~VAvK~l~~~~~--~~~~~f~~Ei~iL~~l---~HpnIv~L~g~~~----- 529 (824)
.++|+..++||+|+||+||+|.+. +..||||++..... .....+.+|+.+|+.| +||||++++++|.
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 357999999999999999999974 35799999865322 2344678899888776 7999999999872
Q ss_pred --CceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecc
Q 003384 530 --EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDF 607 (824)
Q Consensus 530 --~~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DF 607 (824)
...+++|||+.+|++..... .....+++..+..++.|++.||.|||+ ++||||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecch
Confidence 24789999999887754443 344568999999999999999999999 89999999999999999999999999
Q ss_pred ccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhcc-
Q 003384 608 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL- 686 (824)
Q Consensus 608 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~- 686 (824)
|+++....... .....||+.|+|||++.+..|+.++|||||||+||||+||++||............-..
T Consensus 161 g~~~~~~~~~~---------~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 231 (305)
T d1blxa_ 161 GLARIYSFQMA---------LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 231 (305)
T ss_dssp CSCCCCCGGGG---------GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred hhhhhhccccc---------CCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhh
Confidence 99886543321 14457999999999999999999999999999999999999999876543321111000
Q ss_pred -------------------ccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChH
Q 003384 687 -------------------KNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 687 -------------------~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
..........++...+..+.+|+.+||+.||.+|||+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~ 288 (305)
T d1blxa_ 232 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAY 288 (305)
T ss_dssp CCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred CCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHH
Confidence 00000001112334467889999999999999999984
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-42 Score=373.42 Aligned_cols=248 Identities=26% Similarity=0.378 Sum_probs=190.7
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHHhcCCCceeeEecccC--CceEEEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE 537 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~--~~~~LV~E 537 (824)
.+|...+.||+|+||+||+|.+. ++.||||+++.... .....+.+|+++|++++|||||++++++. ...|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 47889999999999999999986 68899999975432 23567999999999999999999999984 46899999
Q ss_pred ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccc
Q 003384 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 617 (824)
Q Consensus 538 y~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 617 (824)
|+.++ +.+++.. .....+++..+..++.|++.||.|||+ +|||||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~~~-~~~~~~~-~~~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQD-LKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEE-HHHHHHH-TTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCCc-hhhhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccCCc
Confidence 99765 4444422 234569999999999999999999999 899999999999999999999999999998664332
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCC-CCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhh----hccccc---
Q 003384 618 ISSNNTTLCCRTDPKGTFAYMDPEFLASGE-LTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT----GKLKNL--- 689 (824)
Q Consensus 618 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~----~~~~~~--- 689 (824)
.. .....||+.|+|||.+.... ++.++|||||||++|+|++|++||...+........ +.....
T Consensus 157 ~~--------~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 228 (298)
T d1gz8a_ 157 RT--------YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 228 (298)
T ss_dssp BC--------TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred cc--------ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcc
Confidence 11 13346999999999987765 578999999999999999999999766543322111 000000
Q ss_pred ----cCCCCCCC-----------ChhhHHHHHHHHHHHhhhccCCCCChH
Q 003384 690 ----LDPLAGDW-----------PFVQAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 690 ----ld~~~~~~-----------p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
.......+ ....+..+.+|+.+||..+|.+|||+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ 278 (298)
T d1gz8a_ 229 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAK 278 (298)
T ss_dssp TGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred ccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHH
Confidence 00000000 012346789999999999999999994
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.6e-42 Score=368.73 Aligned_cols=247 Identities=23% Similarity=0.287 Sum_probs=192.6
Q ss_pred CCCCccceeeecCceEEEEEEEC-CeEEEEEEecCCCC--CCchhHHHHHHHHHhcCCCceeeEeccc--CCceEEEEEe
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 538 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~-~~~VAvK~l~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~Ey 538 (824)
++|...++||+|+||+||+|.++ +..||||++..... .....+.+|+.+|++++|||||+++++| .+..++||||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 47889999999999999999987 58899999976432 2346799999999999999999999988 4578999999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccccccccccc
Q 003384 539 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 618 (824)
Q Consensus 539 ~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~~ 618 (824)
+.++.+..+. .....++...+..|+.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|........
T Consensus 82 ~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp CSEEHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHH---hhcCCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 9887776665 334679999999999999999999999 8999999999999999999999999999987654321
Q ss_pred cCCCccccccCCCCCCcccCChhhhccC-CCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhc------------
Q 003384 619 SSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK------------ 685 (824)
Q Consensus 619 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~------------ 685 (824)
. .....||+.|+|||.+.+. .++.++|||||||++|||++|++||...+..........
T Consensus 156 ~--------~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 227 (286)
T d1ob3a_ 156 K--------YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN 227 (286)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred c--------cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccc
Confidence 1 1234589999999998764 578999999999999999999999976544332111100
Q ss_pred ---cccccCC-------CCCCCChhhHHHHHHHHHHHhhhccCCCCChH
Q 003384 686 ---LKNLLDP-------LAGDWPFVQAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 686 ---~~~~ld~-------~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
....... .....+...+..+.+|+.+||+.||++|||+.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ 276 (286)
T d1ob3a_ 228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAK 276 (286)
T ss_dssp GGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred hhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHH
Confidence 0000000 00111223456899999999999999999984
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-41 Score=367.85 Aligned_cols=252 Identities=25% Similarity=0.364 Sum_probs=190.8
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHHhcCCCceeeEecccC----------
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP---------- 529 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~---------- 529 (824)
++|...++||+|+||+||+|.+. ++.||||++..... .....+.+|+.+|++++||||+++++++.
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 57999999999999999999986 68899999865432 23457899999999999999999999872
Q ss_pred CceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccc
Q 003384 530 EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI 609 (824)
Q Consensus 530 ~~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGl 609 (824)
...++||||+.++.+.... .....++...+..|+.|++.||.|||+ +|||||||||+||||+.++.+||+|||+
T Consensus 90 ~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp -CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeecce
Confidence 2478999999887766554 344568899999999999999999999 8999999999999999999999999999
Q ss_pred ccccccccccCCCccccccCCCCCCcccCChhhhccC-CCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhcccc
Q 003384 610 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKN 688 (824)
Q Consensus 610 a~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~ 688 (824)
++.+.......... .....||+.|+|||++.+. .|+.++|||||||++|||+||++||.................
T Consensus 164 ~~~~~~~~~~~~~~----~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~ 239 (318)
T d3blha1 164 ARAFSLAKNSQPNR----YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG 239 (318)
T ss_dssp CEECCC-----CCC----CCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred eeeccccccccccc----ccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcC
Confidence 98765443222111 1345799999999998765 689999999999999999999999976554332221111110
Q ss_pred ccCC-----------------CCC-CCC-------hhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 689 LLDP-----------------LAG-DWP-------FVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 689 ~ld~-----------------~~~-~~p-------~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
...+ ... ..+ ......+.+|+.+||+.||++|||+.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~e 301 (318)
T d3blha1 240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDD 301 (318)
T ss_dssp CCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred CCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHH
Confidence 0000 000 000 011346788999999999999999943
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-41 Score=365.59 Aligned_cols=261 Identities=20% Similarity=0.268 Sum_probs=196.8
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEeccc---CCceEEEEEe
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC---PEVWTLVYEY 538 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~---~~~~~LV~Ey 538 (824)
++|.+.+.||+|+||+||+|.+. +..||||++..... ...+..|+++++.++|+|++.+++.| .+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 46999999999999999999986 68999999876432 34689999999999988777666554 4567899999
Q ss_pred cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEec---CCCcceeecccccccccc
Q 003384 539 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD---ANFVSKLSDFGISRFLSQ 615 (824)
Q Consensus 539 ~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld---~~~~vKL~DFGla~~~~~ 615 (824)
+ +|+|.+.+.. ....+++..+..++.|++.||.|||+ ++||||||||+|||++ .++.+||+|||+|+.+..
T Consensus 85 ~-~~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 L-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp C-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred c-CCchhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 9 5566666543 33569999999999999999999999 8999999999999985 456799999999998765
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHh--hhccccccCCC
Q 003384 616 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALD--TGKLKNLLDPL 693 (824)
Q Consensus 616 ~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~--~~~~~~~ld~~ 693 (824)
........ ........||+.|+|||++.+..++.++|||||||++|||+||++||........... .........+
T Consensus 159 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~- 236 (299)
T d1ckia_ 159 ARTHQHIP-YRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP- 236 (299)
T ss_dssp TTTCCBCC-CCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC-
T ss_pred ccccccee-ccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC-
Confidence 43222111 1112456799999999999999999999999999999999999999965432211110 0000000001
Q ss_pred CCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHH
Q 003384 694 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 735 (824)
Q Consensus 694 ~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~ 735 (824)
....+...+..+.+|+.+||+.+|.+||++ +.+.+.|+.+.
T Consensus 237 ~~~~~~~~p~~~~~li~~cl~~~p~~RP~~-~~i~~~l~~~~ 277 (299)
T d1ckia_ 237 IEVLCKGYPSEFATYLNFCRSLRFDDKPDY-SYLRQLFRNLF 277 (299)
T ss_dssp HHHHTTTSCHHHHHHHHHHHHSCTTCCCCH-HHHHHHHHHHH
T ss_pred hhHhccCCCHHHHHHHHHHccCChhHCcCH-HHHHHHHHHHH
Confidence 001112345689999999999999999999 66777777654
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-41 Score=370.65 Aligned_cols=245 Identities=26% Similarity=0.329 Sum_probs=189.3
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCceeeEecccC------C--ceEE
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP------E--VWTL 534 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnIv~L~g~~~------~--~~~L 534 (824)
.|...++||+|+||+||+|++. ++.||||++..... .+.+|+.+|++++||||++++++|. + ..+|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5888889999999999999986 68899999975432 3458999999999999999999872 1 3689
Q ss_pred EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCC-cceeecccccccc
Q 003384 535 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF-VSKLSDFGISRFL 613 (824)
Q Consensus 535 V~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~-~vKL~DFGla~~~ 613 (824)
|||||++|.+..+.........+++..+..|+.||+.||.|||+ +|||||||||+||||+.++ .+||+|||+++.+
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 99999876555544333455679999999999999999999999 8999999999999999765 8999999999876
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhcc-CCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhc-------
Q 003384 614 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK------- 685 (824)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~------- 685 (824)
...... ....||+.|+|||.+.+ ..|+.++|||||||++|||++|++||............-.
T Consensus 174 ~~~~~~---------~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~ 244 (350)
T d1q5ka_ 174 VRGEPN---------VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 244 (350)
T ss_dssp CTTSCC---------CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred cCCccc---------ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChH
Confidence 543211 33469999999998875 4789999999999999999999999976544322111100
Q ss_pred ---------cccccCC------CCCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 686 ---------LKNLLDP------LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 686 ---------~~~~ld~------~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
.....-+ .........+.++.+|+.+||..||.+|||+.+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e 299 (350)
T d1q5ka_ 245 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLE 299 (350)
T ss_dssp HHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHH
Confidence 0000000 000112234678999999999999999999943
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.9e-41 Score=361.40 Aligned_cols=261 Identities=20% Similarity=0.240 Sum_probs=202.6
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcCC-CceeeEeccc--CCceEEEEE
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRH-PNLVTLVGAC--PEVWTLVYE 537 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~H-pnIv~L~g~~--~~~~~LV~E 537 (824)
.++|.+.++||+|+||+||+|++. ++.||||++.... ....+.+|+++++.|.| +|++.+++++ ....++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 457999999999999999999976 6889999986543 34568899999999975 8999998877 456889999
Q ss_pred ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecC-----CCcceeeccccccc
Q 003384 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA-----NFVSKLSDFGISRF 612 (824)
Q Consensus 538 y~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~-----~~~vKL~DFGla~~ 612 (824)
|+ +|+|.+++... ...++..++..++.|++.||.|||+ +|||||||||+||||+. ++.+||+|||+|+.
T Consensus 82 ~~-~~~l~~~~~~~--~~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHhh--ccchhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 99 78999988533 3468999999999999999999999 89999999999999974 57899999999998
Q ss_pred cccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchH---HH--HHHhhhccc
Q 003384 613 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE---VQ--YALDTGKLK 687 (824)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~---~~--~~~~~~~~~ 687 (824)
+.......... ........||+.|||||++.+..++.++|||||||++|||+||+.||..... .. ..+......
T Consensus 156 ~~~~~~~~~~~-~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (293)
T d1csna_ 156 YRDPVTKQHIP-YREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234 (293)
T ss_dssp SBCTTTCCBCC-CCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred cccCcccccee-ecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence 76443221111 1122456799999999999999999999999999999999999999964321 11 111111111
Q ss_pred cccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhh
Q 003384 688 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 737 (824)
Q Consensus 688 ~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~~v~~~Le~l~~~ 737 (824)
.... ..+...+.++.+++..|+..+|.+||++ +.+.+.|+.+...
T Consensus 235 ~~~~----~l~~~~p~~l~~ii~~~~~~~~~~rP~y-~~l~~~l~~~~~~ 279 (293)
T d1csna_ 235 TPLR----ELCAGFPEEFYKYMHYARNLAFDATPDY-DYLQGLFSKVLER 279 (293)
T ss_dssp SCHH----HHTTTSCHHHHHHHHHHHHCCTTCCCCH-HHHHHHHHHHHHH
T ss_pred CChH----HhcCCCCHHHHHHHHHHhcCCcccCcCH-HHHHHHHHHHHHH
Confidence 0000 0112234689999999999999999998 6777888776543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-41 Score=371.05 Aligned_cols=251 Identities=24% Similarity=0.300 Sum_probs=190.7
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCC-CchhHHHHHHHHHhcCCCceeeEecccCC------ceE
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACPE------VWT 533 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~L~g~~~~------~~~ 533 (824)
+.+|...++||+|+||+||+|... +..||||++...... ..+.+.+|+.+|+.++||||+++++++.. ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 457999999999999999999876 688999999754321 23468899999999999999999998832 235
Q ss_pred EEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccc
Q 003384 534 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 613 (824)
Q Consensus 534 LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~ 613 (824)
++++|+.+|+|.+++.. ..+++..+..++.|++.||.|||+ +|||||||||+||||+.++.+||+|||+|+..
T Consensus 87 ~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 66677889999999953 358999999999999999999999 89999999999999999999999999999876
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhcc-CCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhcccc----
Q 003384 614 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKN---- 688 (824)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~---- 688 (824)
......... .....||+.|+|||++.. ..++.++||||+||++|+|+||++||.................
T Consensus 160 ~~~~~~~~~-----~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~ 234 (345)
T d1pmea_ 160 DPDHDHTGF-----LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 234 (345)
T ss_dssp CGGGCBCCT-----TCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH
T ss_pred cCCCcccee-----eccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCCh
Confidence 554322211 244679999999999854 5678999999999999999999999976543221111100000
Q ss_pred ---------------ccCCCCCCCC-----hhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 689 ---------------LLDPLAGDWP-----FVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 689 ---------------~ld~~~~~~p-----~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
...+.....+ ...+..+.+|+.+||+.||.+||++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e 291 (345)
T d1pmea_ 235 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQ 291 (345)
T ss_dssp HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred hhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHH
Confidence 0000001111 123457899999999999999999843
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-41 Score=368.69 Aligned_cols=244 Identities=21% Similarity=0.291 Sum_probs=186.7
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCC--chhHHHHHHHHHhcCCCceeeEecccCC--------
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACPE-------- 530 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~L~g~~~~-------- 530 (824)
..+|...++||+|+||+||+|.+. ++.||||++....... .+.+.+|+.+|+.++|||||+++++|..
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 468999999999999999999986 6889999997543221 3468899999999999999999998832
Q ss_pred ceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeeccccc
Q 003384 531 VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS 610 (824)
Q Consensus 531 ~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla 610 (824)
.+++||||+ +++|..++. ...+++..+..++.||+.||.|||+ +|||||||||+|||++.++.+||+|||+|
T Consensus 97 ~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhcccccccccccccce
Confidence 368999999 667777663 2469999999999999999999999 89999999999999999999999999999
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccC-CCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhcc---
Q 003384 611 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL--- 686 (824)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~--- 686 (824)
+...... +...||+.|+|||++.+. .++.++|||||||++|+|++|++||...+...........
T Consensus 169 ~~~~~~~-----------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~ 237 (346)
T d1cm8a_ 169 RQADSEM-----------TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 237 (346)
T ss_dssp EECCSSC-----------CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred eccCCcc-----------ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCC
Confidence 8654321 345699999999998764 5789999999999999999999999765443221111000
Q ss_pred -----------------ccccCC----CCCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 003384 687 -----------------KNLLDP----LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 725 (824)
Q Consensus 687 -----------------~~~ld~----~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~~ 725 (824)
...+.. .........+..+.+|+.+||..+|.+|||+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e 297 (346)
T d1cm8a_ 238 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGE 297 (346)
T ss_dssp CCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred CcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHH
Confidence 000000 001112234568899999999999999999943
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.2e-39 Score=354.92 Aligned_cols=240 Identities=20% Similarity=0.330 Sum_probs=189.1
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcC-CCceeeEecccC----CceEEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVGACP----EVWTLVY 536 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~-HpnIv~L~g~~~----~~~~LV~ 536 (824)
++|.+.++||+|+||+||+|++. ++.||||+++.. ..+.+.+|+.+|+.+. ||||++++++|. ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 47999999999999999999986 688999998753 3467899999999995 999999999873 3588999
Q ss_pred EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCC-Ccceeecccccccccc
Q 003384 537 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN-FVSKLSDFGISRFLSQ 615 (824)
Q Consensus 537 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~-~~vKL~DFGla~~~~~ 615 (824)
|||.+|+|..+. ..++...+..++.||+.||.|||+ +|||||||||+||||+.+ +.+||+|||+|+....
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999998765 358999999999999999999999 899999999999999865 4699999999987654
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccC-CCCcchhHHhHHHHHHHHHhCCCCCCCchH-HHHHHhh----------
Q 003384 616 NEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKE-VQYALDT---------- 683 (824)
Q Consensus 616 ~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~-~~~~~~~---------- 683 (824)
... .....||+.|+|||.+.+. .++.++|||||||++|+|++|+.||..... .......
T Consensus 183 ~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~ 253 (328)
T d3bqca1 183 GQE---------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLY 253 (328)
T ss_dssp TCC---------CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHH
T ss_pred CCc---------ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhh
Confidence 321 1345689999999998775 579999999999999999999999964321 1100000
Q ss_pred -----h------ccccccCC---------CCCCCChhhHHHHHHHHHHHhhhccCCCCChH
Q 003384 684 -----G------KLKNLLDP---------LAGDWPFVQAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 684 -----~------~~~~~ld~---------~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
. ........ .........+.++.+|+.+||..+|.+|||+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~ 314 (328)
T d3bqca1 254 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAR 314 (328)
T ss_dssp HHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred hhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHH
Confidence 0 00000000 01111223456899999999999999999994
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-40 Score=349.11 Aligned_cols=247 Identities=25% Similarity=0.271 Sum_probs=193.4
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCC--chhHHHHHHHHHhcCCCceeeEeccc--CCceEEEEE
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYE 537 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~L~g~~--~~~~~LV~E 537 (824)
++|+..++||+|+||+||+|.+. +..||||+++...... ...+.+|+.+|+.++||||++++++| .+..++||+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 36889999999999999999985 5789999997654322 45789999999999999999999998 446789999
Q ss_pred ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccccccccc
Q 003384 538 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 617 (824)
Q Consensus 538 y~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~~~~~~~ 617 (824)
|+.+++|..++. ....+++..+..++.|++.||.|||. ++||||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred eccccccccccc---cccccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 999999988774 34568899999999999999999999 899999999999999999999999999998765433
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCC-CCcchhHHhHHHHHHHHHhCCCCCC-CchHHHHHHhh----hcc-----
Q 003384 618 ISSNNTTLCCRTDPKGTFAYMDPEFLASGE-LTPKSDVYSFGIILLRLLTGRPALG-ITKEVQYALDT----GKL----- 686 (824)
Q Consensus 618 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~t~ksDVwSlGvvL~ELltG~~Pf~-~~~~~~~~~~~----~~~----- 686 (824)
... ....+++.|+|||++.+.. ++.++|||||||++|||++|+.||. ..+........ +..
T Consensus 156 ~~~--------~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (292)
T d1unla_ 156 RCY--------SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQW 227 (292)
T ss_dssp SCC--------CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTC
T ss_pred ccc--------eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhh
Confidence 211 2345789999999987765 6899999999999999999998863 33222211110 000
Q ss_pred ---ccccC----------CCCCCCChhhHHHHHHHHHHHhhhccCCCCChH
Q 003384 687 ---KNLLD----------PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 687 ---~~~ld----------~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
....+ ......+...+..+.+|+.+||+.||.+|||+.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~ 278 (292)
T d1unla_ 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAE 278 (292)
T ss_dssp TTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred hhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHH
Confidence 00000 011122234456889999999999999999984
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-41 Score=365.05 Aligned_cols=242 Identities=28% Similarity=0.374 Sum_probs=192.5
Q ss_pred CCCCccceeeecCceEEEEEEE-----CCeEEEEEEecCCC----CCCchhHHHHHHHHHhcCC-CceeeEeccc--CCc
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLL-----RHMQVAIKMLHPHS----LQGPSEFQQEIDILSKIRH-PNLVTLVGAC--PEV 531 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~-----~~~~VAvK~l~~~~----~~~~~~f~~Ei~iL~~l~H-pnIv~L~g~~--~~~ 531 (824)
++|++.+.||+|+||+||+|.. ++..||||+++... ....+.+.+|+.+|++++| |||+++++++ ...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 4599999999999999999986 25789999986532 2234578899999999976 8999999988 456
Q ss_pred eEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccc
Q 003384 532 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR 611 (824)
Q Consensus 532 ~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~ 611 (824)
.++||||+.+|+|.+++... ..++......++.||+.||.|||+ ++||||||||+||||+.+|.+||+|||+|+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~---~~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHhc---ccccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccchh
Confidence 88999999999999998543 356788899999999999999999 899999999999999999999999999998
Q ss_pred ccccccccCCCccccccCCCCCCcccCChhhhccC--CCCcchhHHhHHHHHHHHHhCCCCCCCchHH--HHHHhhhccc
Q 003384 612 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG--ELTPKSDVYSFGIILLRLLTGRPALGITKEV--QYALDTGKLK 687 (824)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~--~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~--~~~~~~~~~~ 687 (824)
.+........ ....||+.|+|||.+.+. .++.++|||||||+||+|+||++||...... ...+..+...
T Consensus 178 ~~~~~~~~~~-------~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~ 250 (322)
T d1vzoa_ 178 EFVADETERA-------YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK 250 (322)
T ss_dssp ECCGGGGGGG-------CGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH
T ss_pred hhcccccccc-------cccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhccc
Confidence 7654432211 234589999999999764 4788999999999999999999999654321 1111111111
Q ss_pred cccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCCh
Q 003384 688 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 723 (824)
Q Consensus 688 ~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~ 723 (824)
. ....|...+..+.+|+.+||+.+|.+||++
T Consensus 251 ~-----~~~~~~~~s~~~~~li~~~l~~dP~~R~s~ 281 (322)
T d1vzoa_ 251 S-----EPPYPQEMSALAKDLIQRLLMKDPKKRLGC 281 (322)
T ss_dssp C-----CCCCCTTSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred C-----CCCCcccCCHHHHHHHHHHcccCHHHcCCC
Confidence 1 122345667899999999999999999974
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-40 Score=360.17 Aligned_cols=243 Identities=20% Similarity=0.252 Sum_probs=182.3
Q ss_pred CCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCC--chhHHHHHHHHHhcCCCceeeEecccC--------Cc
Q 003384 464 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACP--------EV 531 (824)
Q Consensus 464 ~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~L~g~~~--------~~ 531 (824)
++|...++||+|+||+||+|.+. +..||||++....... ...+.+|+.+|++++|||||+++++|. ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57999999999999999999986 6899999997653321 245889999999999999999999883 35
Q ss_pred eEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccc
Q 003384 532 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR 611 (824)
Q Consensus 532 ~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~ 611 (824)
.|+|||||.++.+. .+. ..+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~iv~Ey~~~~l~~-~~~-----~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLCQ-VIQ-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHHH-HHT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchHHHH-hhh-----cCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhhhh
Confidence 78999999766554 442 358899999999999999999999 899999999999999999999999999988
Q ss_pred ccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhh--------
Q 003384 612 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT-------- 683 (824)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~-------- 683 (824)
....... .....||+.|+|||++.+..+++++||||+||++|+|++|++||...+........
T Consensus 168 ~~~~~~~---------~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~ 238 (355)
T d2b1pa1 168 TAGTSFM---------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 238 (355)
T ss_dssp ----------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred ccccccc---------cccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCC
Confidence 6544321 13446899999999999999999999999999999999999999755432211100
Q ss_pred ----------------hcc-------c----cccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChH
Q 003384 684 ----------------GKL-------K----NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 684 ----------------~~~-------~----~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
+.. . ....+.....+...+..+.+|+.+||..+|.+|||+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~ 306 (355)
T d2b1pa1 239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 306 (355)
T ss_dssp HHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHH
T ss_pred HHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHH
Confidence 000 0 0000001111223467889999999999999999994
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-39 Score=357.82 Aligned_cols=244 Identities=20% Similarity=0.275 Sum_probs=188.3
Q ss_pred cCCCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCC--chhHHHHHHHHHhcCCCceeeEecccC-------Cc
Q 003384 463 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACP-------EV 531 (824)
Q Consensus 463 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~L~g~~~-------~~ 531 (824)
..+|...++||+|+||+||+|.+. +..||||++....... .+.+.+|+++|+.++|||||++++++. ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 457999999999999999999875 6899999997643322 346889999999999999999999873 13
Q ss_pred eEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecccccc
Q 003384 532 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR 611 (824)
Q Consensus 532 ~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DFGla~ 611 (824)
.++||+|+.||+|.+++. ...+++..+..++.||+.||.|||+ +|||||||||+|||++.+|.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~----~~~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhcc----cccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchhc
Confidence 467788888999999984 2469999999999999999999999 899999999999999999999999999987
Q ss_pred ccccccccCCCccccccCCCCCCcccCChhhhccC-CCCcchhHHhHHHHHHHHHhCCCCCCCchHHHHHHhhhccccc-
Q 003384 612 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNL- 689 (824)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~~~~~~~~~- 689 (824)
...... ....||+.|+|||.+.+. .++.++|||||||++|+|++|++||...+..............
T Consensus 170 ~~~~~~-----------~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~ 238 (348)
T d2gfsa1 170 HTDDEM-----------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 238 (348)
T ss_dssp CCTGGG-----------SSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ccCccc-----------ccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 554321 345689999999987765 4688999999999999999999999765443221111000000
Q ss_pred ----------------cC--CCCCCC-----ChhhHHHHHHHHHHHhhhccCCCCChH
Q 003384 690 ----------------LD--PLAGDW-----PFVQAEQLANLAMRCCEMSRKSRPELG 724 (824)
Q Consensus 690 ----------------ld--~~~~~~-----p~~~~~~l~~Li~~Cl~~~P~~RPt~~ 724 (824)
.. +..... ....+..+.+|+.+||..||.+|||+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~ 296 (348)
T d2gfsa1 239 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 296 (348)
T ss_dssp CHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred ChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHH
Confidence 00 000000 112356789999999999999999984
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6e-36 Score=328.96 Aligned_cols=247 Identities=17% Similarity=0.260 Sum_probs=184.8
Q ss_pred CCCccceeeecCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHHhcC-----------CCceeeEecccC--
Q 003384 465 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-----------HPNLVTLVGACP-- 529 (824)
Q Consensus 465 ~f~~~~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~-----------HpnIv~L~g~~~-- 529 (824)
+|.+.++||+|+||+||+|+.. +..||||+++.... ..+.+.+|+.+++.++ ||||+++++++.
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 5999999999999999999875 68999999975421 2356788999998885 578999988773
Q ss_pred --CceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCC------c
Q 003384 530 --EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF------V 601 (824)
Q Consensus 530 --~~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~------~ 601 (824)
...+++|+++..+..............+++..+..++.||+.||.|||+. .||+||||||+||||+.++ .
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHeeeeccCcccccce
Confidence 34567788776665544444445567789999999999999999999973 5799999999999998655 3
Q ss_pred ceeeccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCcchhHHhHHHHHHHHHhCCCCCCCchHHH---
Q 003384 602 SKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ--- 678 (824)
Q Consensus 602 vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvvL~ELltG~~Pf~~~~~~~--- 678 (824)
+||+|||.+....... ....||+.|+|||++.+..|+.++||||+||++++|++|++||.......
T Consensus 171 ~kl~dfg~s~~~~~~~-----------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~ 239 (362)
T d1q8ya_ 171 IKIADLGNACWYDEHY-----------TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 239 (362)
T ss_dssp EEECCCTTCEETTBCC-----------CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred eeEeeccccccccccc-----------ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccc
Confidence 8999999987554321 23469999999999999999999999999999999999999996432110
Q ss_pred ------HHH-hhhc----------c-ccccC---------C-----------CCCCCChhhHHHHHHHHHHHhhhccCCC
Q 003384 679 ------YAL-DTGK----------L-KNLLD---------P-----------LAGDWPFVQAEQLANLAMRCCEMSRKSR 720 (824)
Q Consensus 679 ------~~~-~~~~----------~-~~~ld---------~-----------~~~~~p~~~~~~l~~Li~~Cl~~~P~~R 720 (824)
..+ .-|. . ....+ . .....+...+..+.+|+.+||..||.+|
T Consensus 240 ~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R 319 (362)
T d1q8ya_ 240 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR 319 (362)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred hhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHC
Confidence 000 0000 0 00000 0 0112334567789999999999999999
Q ss_pred CChHH
Q 003384 721 PELGK 725 (824)
Q Consensus 721 Pt~~~ 725 (824)
||+.+
T Consensus 320 pta~e 324 (362)
T d1q8ya_ 320 ADAGG 324 (362)
T ss_dssp BCHHH
T ss_pred cCHHH
Confidence 99943
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.86 E-value=2.9e-22 Score=199.86 Aligned_cols=162 Identities=14% Similarity=0.121 Sum_probs=118.1
Q ss_pred CccceeeecCceEEEEEEEC-CeEEEEEEecCCCCC-----C-------------chhHHHHHHHHHhcCCCceeeEecc
Q 003384 467 DPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQ-----G-------------PSEFQQEIDILSKIRHPNLVTLVGA 527 (824)
Q Consensus 467 ~~~~~LG~G~fG~Vykg~~~-~~~VAvK~l~~~~~~-----~-------------~~~f~~Ei~iL~~l~HpnIv~L~g~ 527 (824)
.+.++||+|+||+||+|.+. +..||||+++..... . ...+..|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 45678999999999999875 689999997643110 0 0124568889999999999988876
Q ss_pred cCCceEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEeccccCCcEEecCCCcceeecc
Q 003384 528 CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDF 607 (824)
Q Consensus 528 ~~~~~~LV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~~~giiHrDLKp~NILld~~~~vKL~DF 607 (824)
.. .++||||++++.+.++ +......++.+++.+|.|||. +||+||||||+|||+++++ ++|+||
T Consensus 83 ~~--~~lvme~~~~~~~~~l----------~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~~-~~liDF 146 (191)
T d1zara2 83 EG--NAVLMELIDAKELYRV----------RVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEEG-IWIIDF 146 (191)
T ss_dssp ET--TEEEEECCCCEEGGGC----------CCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETTE-EEECCC
T ss_pred cC--CEEEEEeeccccccch----------hhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCCC-EEEEEC
Confidence 43 4799999988765442 223456789999999999999 8999999999999999765 889999
Q ss_pred ccccccccccccCCCccccccCCCCCCcccCC------hhhhccCCCCcchhHHhHHHHH
Q 003384 608 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMD------PEFLASGELTPKSDVYSFGIIL 661 (824)
Q Consensus 608 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~Y~A------PE~l~~~~~t~ksDVwSlGvvL 661 (824)
|+|........ ..|.. .+++ ...|+.++|+||..--+
T Consensus 147 G~a~~~~~~~~----------------~~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 147 PQSVEVGEEGW----------------REILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TTCEETTSTTH----------------HHHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred CCcccCCCCCc----------------HHHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 99875432210 11111 1122 35678889999976443
|
| >d1wgma_ g.44.1.2 (A:) Ubiquitin conjugation factor E4A {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: Ubiquitin conjugation factor E4A species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.55 E-value=2.5e-15 Score=132.70 Aligned_cols=75 Identities=29% Similarity=0.485 Sum_probs=68.6
Q ss_pred CCCCCCCCCCcccchhhhccCCccccCC-ccchhhhhhhhhcCCCCCCCCCCCCCCCCCCCchHHHHHHHHHHHHhC
Q 003384 749 EERCEPPPYFTCPIFQEVMQDPHVAADG-FTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWLQQH 824 (824)
Q Consensus 749 e~~~~~P~~f~cPi~~evm~dPvi~~~g-~tye~~~i~~wl~~~~~t~p~t~~~l~~~~l~pn~~lr~~i~~~~~~~ 824 (824)
....++|++|.|||+.++|.|||++..| +||++++|..||.. +.+||+|+.+|...+|+||.+||++|++|+.++
T Consensus 14 ~~~~~~P~~f~CPI~~~lm~dPV~~~~~~~ty~r~~I~~~l~~-~~~~P~~~~~l~~~~L~pN~~Lr~~I~~~~~~~ 89 (98)
T d1wgma_ 14 ETYADACDEFLDPIMSTLMCDPVVLPSSRVTVDRSTIARHLLS-DQTDPFNRSPLTMDQIRPNTELKEKIQRWLAER 89 (98)
T ss_dssp CCCCSCCTTTBCTTTCSBCSSEEECTTTCCEEEHHHHHHHTTT-SCBCTTTCSBCCTTTSEECHHHHHHHHHHHHHS
T ss_pred hhhcCCcHHhCCcCchhHHHHHHhcccccchhhHHHHHHHHHh-cCCcccccccccchhhcchHHHHHHHHHHHHHH
Confidence 3445789999999999999999999887 58999999999987 559999999999999999999999999999864
|
| >d1t1ha_ g.44.1.2 (A:) E3 ubiquitin ligase PUB14 {Thale-cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: E3 ubiquitin ligase PUB14 species: Thale-cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=99.50 E-value=4.3e-15 Score=125.71 Aligned_cols=72 Identities=43% Similarity=0.845 Sum_probs=69.7
Q ss_pred CCCCCCcccchhhhccCCccccCCccchhhhhhhhhcCCCCCCCCCCCCCCCCCCCchHHHHHHHHHHHHhC
Q 003384 753 EPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWLQQH 824 (824)
Q Consensus 753 ~~P~~f~cPi~~evm~dPvi~~~g~tye~~~i~~wl~~~~~t~p~t~~~l~~~~l~pn~~lr~~i~~~~~~~ 824 (824)
++|++|.|||+.++|.|||++..|++|.++.|.+|+..++.+||.++.++...+|+||++||++|++|+.+|
T Consensus 4 eiP~~l~CpIc~~~m~dPV~~~cgh~fc~~ci~~~~~~~~~~cP~~~~~l~~~~l~pN~~L~~~I~~~~~~~ 75 (78)
T d1t1ha_ 4 EFPEYFRCPISLELMKDPVIVSTGQTYERSSIQKWLDAGHKTCPKSQETLLHAGLTPNYVLKSLIALWCESN 75 (78)
T ss_dssp CCSSSSSCTTTSCCCSSEEEETTTEEEEHHHHHHHHTTTCCBCTTTCCBCSSCCCEECTTTHHHHHHHHHHS
T ss_pred CCCccCCCcCcCchhhCceEccCCCcchHHHHHHHHHHCCCCCCcccccCCcccccchHHHHHHHHHHHHHh
Confidence 689999999999999999999999999999999999998889999999999999999999999999999886
|
| >d2c2la2 g.44.1.2 (A:225-304) STIP1 homology and U box-containing protein 1, STUB1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: STIP1 homology and U box-containing protein 1, STUB1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.49 E-value=5.3e-15 Score=125.76 Aligned_cols=72 Identities=28% Similarity=0.601 Sum_probs=69.4
Q ss_pred CCCCCCcccchhhhccCCccccCCccchhhhhhhhhcCCCCCCCCCCCCCCCCCCCchHHHHHHHHHHHHhC
Q 003384 753 EPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWLQQH 824 (824)
Q Consensus 753 ~~P~~f~cPi~~evm~dPvi~~~g~tye~~~i~~wl~~~~~t~p~t~~~l~~~~l~pn~~lr~~i~~~~~~~ 824 (824)
++|++|.|||+.++|.|||++..|+||++..|.+|+..++.+||.++.++...+|+||.+||++|++|+.+|
T Consensus 3 eiP~~l~CpIc~~l~~dPv~~~cGhtfc~~ci~~~l~~~~~~cP~c~~~l~~~~l~pN~~L~~~I~~~l~~~ 74 (80)
T d2c2la2 3 DIPDYLCGKISFELMREPCITPSGITYDRKDIEEHLQRVGHFNPVTRSPLTQEQLIPNLAMKEVIDAFISEN 74 (80)
T ss_dssp CCCSTTBCTTTCSBCSSEEECSSCCEEETTHHHHHHHHTCSSCTTTCCCCCGGGCEECHHHHHHHHHHHTTC
T ss_pred CCCccccCcCcCchhhhhcccCCcCeecHHHHHHHHhcCCccCCCccccccccccccHHHHHHHHHHHHHHC
Confidence 689999999999999999999999999999999999988889999999999999999999999999999876
|
| >d2gm3a1 c.26.2.4 (A:5-175) Putative ethylene-responsive protein AT3g01520/F4P13_7 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Putative ethylene-responsive protein AT3g01520/F4P13 7 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=99.03 E-value=4.2e-10 Score=108.51 Aligned_cols=125 Identities=16% Similarity=0.181 Sum_probs=90.7
Q ss_pred chhhHhhhhccccCCC--------CcccC-CCCCccCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHhhcCeeeEEEEe
Q 003384 3 TAEFWREENLHHSCSH--------ARTND-SMGTKFPASSLEEEKVQAYREIERQDMHNHLDMCLLICRQMGVRAEKLDT 73 (824)
Q Consensus 3 ~Al~Wal~n~~~~~~~--------~~~~~-~~~~~~~~~~~~~e~v~~~~~~e~~~~~~~l~~~~~~C~~~~V~~~~~~i 73 (824)
.||.||++|+...... ....+ ......+....+++....++++.++..+++|++|...|...+++++..+.
T Consensus 25 ~Al~wal~~~~~~~~~~~~L~~vhv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~v~ 104 (171)
T d2gm3a1 25 RAFEWTLEKIVRSNTSDFKILLLHVQVVDEDGFDDVDSIYASPEDFRDMRQSNKAKGLHLLEFFVNKCHEIGVGCEAWIK 104 (171)
T ss_dssp HHHHHHHHHTTTTCTTSEEEEEEEEEC----------CCCCSHHHHHHHTTSHHHHHHHHHHHHHHHHHHHTCEEEEEEE
T ss_pred HHHHHHHHHHHHCCCCCcEEEEEEeccccccccccccccccCHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCceEEEEE
Confidence 4999999998632111 00001 11233444567888888999999999999999999999999999998776
Q ss_pred ecCchHHHHHHHHHHcCCCEEEeccCcCccchhhhcccchhhHHhhhccCCCccEEEEEe
Q 003384 74 ESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAPASCHIWFIC 133 (824)
Q Consensus 74 e~~dv~~~i~e~i~~~~i~~LV~Ga~~~~~~~~~~~~~~s~~a~~v~~~a~~~C~v~~i~ 133 (824)
+ ++++++|++++.+++++.||||++..+...+. +-+..+.+|+++++ |.|.+|-
T Consensus 105 ~-G~~~~~I~~~a~~~~~dlIV~G~~g~~~~~~~---~lGSv~~~vi~~~~--cpVlvV~ 158 (171)
T d2gm3a1 105 T-GDPKDVICQEVKRVRPDFLVVGSRGLGRFQKV---FVGTVSAFCVKHAE--CPVMTIK 158 (171)
T ss_dssp E-SCHHHHHHHHHHHHCCSEEEEEECCCC-----------CHHHHHHHHCS--SCEEEEE
T ss_pred e-CChHHHHHHHHhhcCCcEEEeccCCccccccC---ccCcHHHHHHhCCC--CCEEEEe
Confidence 6 89999999999999999999999944333332 22346889999987 9999984
|
| >d1mjha_ c.26.2.4 (A:) "Hypothetical" protein MJ0577 {Archaeon Methanococcus jannaschii [TaxId: 2190]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: "Hypothetical" protein MJ0577 species: Archaeon Methanococcus jannaschii [TaxId: 2190]
Probab=98.43 E-value=8.3e-07 Score=83.43 Aligned_cols=95 Identities=12% Similarity=0.170 Sum_probs=77.7
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHHHHHHHhhcCeeeEEEEeecCchHHHHHHHHHHcCCCEEEeccCcCccchhhhcccc
Q 003384 33 SLEEEKVQAYREIERQDMHNHLDMCLLICRQMGVRAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLK 112 (824)
Q Consensus 33 ~~~~e~v~~~~~~e~~~~~~~l~~~~~~C~~~~V~~~~~~ie~~dv~~~i~e~i~~~~i~~LV~Ga~~~~~~~~~~~~~~ 112 (824)
...++....++++-.+.+++.|+.+...|...+|+++..+.+ ++++++|++++..++++.+|||++..+...+. .-
T Consensus 62 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~gv~~~~~~~~-G~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~---~~ 137 (160)
T d1mjha_ 62 KSVEEFENELKNKLTEEAKNKMENIKKELEDVGFKVKDIIVV-GIPHEEIVKIAEDEGVDIIIMGSHGKTNLKEI---LL 137 (160)
T ss_dssp --CHHHHHHHHHHHHHHHHHHHHHHHHHHHHTTCEEEEEEEE-ECHHHHHHHHHHHTTCSEEEEESCCSSCCTTC---SS
T ss_pred hhHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCeEEEEEEe-ccHHHHHhhhhhccccceEEeccCCCCccccc---cc
Confidence 344555666888888899999999999999999999998887 79999999999999999999999943333332 33
Q ss_pred hhhHHhhhccCCCccEEEEEe
Q 003384 113 SKKAISVRQQAPASCHIWFIC 133 (824)
Q Consensus 113 s~~a~~v~~~a~~~C~v~~i~ 133 (824)
...|..|+.+++ |.|++|-
T Consensus 138 GS~a~~vl~~s~--~pVlvV~ 156 (160)
T d1mjha_ 138 GSVTENVIKKSN--KPVLVVK 156 (160)
T ss_dssp CHHHHHHHHHCC--SCEEEEC
T ss_pred CcHHHHHHhcCC--CCEEEEc
Confidence 447889999986 9999984
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.40 E-value=3.2e-07 Score=93.23 Aligned_cols=146 Identities=16% Similarity=0.150 Sum_probs=98.3
Q ss_pred hHhhhcCCCCccceeeecCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhcC-CCceeeEeccc--CCceEE
Q 003384 458 EIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVGAC--PEVWTL 534 (824)
Q Consensus 458 ei~~~~~~f~~~~~LG~G~fG~Vykg~~~~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~-HpnIv~L~g~~--~~~~~L 534 (824)
+++..-..|...+..+.|+.+.||+....+..+.||+...........+.+|..++..+. +--+.+++.++ .+..++
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~l 87 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEE
Confidence 344444556655544445557899988778889999887655445557889999988774 32245555554 445789
Q ss_pred EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC----------------------------------
Q 003384 535 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK---------------------------------- 580 (824)
Q Consensus 535 V~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~~---------------------------------- 580 (824)
||++++|.++.+..... .....++.+++..|..||+..
T Consensus 88 v~~~l~G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T d1j7la_ 88 LMSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEECCSSEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred EEEeccccccccccccc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence 99999998886654211 112334555556666666421
Q ss_pred ----------------------CCceEeccccCCcEEecCCCcceeecccccc
Q 003384 581 ----------------------PHSIVHGDLKPANILLDANFVSKLSDFGISR 611 (824)
Q Consensus 581 ----------------------~~giiHrDLKp~NILld~~~~vKL~DFGla~ 611 (824)
+..++|+|+.|.|||+++++.+-|+||+.+.
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1237999999999999987777799999765
|
| >d2baya1 g.44.1.2 (A:1-56) Pre-mRNA splicing factor Prp19 {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: Pre-mRNA splicing factor Prp19 species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=98.32 E-value=4.4e-08 Score=76.29 Aligned_cols=52 Identities=23% Similarity=0.436 Sum_probs=47.8
Q ss_pred CcccchhhhccCCccc-cCCccchhhhhhhhhcCCCCCCCCCCCCCCCCCCCch
Q 003384 758 FTCPIFQEVMQDPHVA-ADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPN 810 (824)
Q Consensus 758 f~cPi~~evm~dPvi~-~~g~tye~~~i~~wl~~~~~t~p~t~~~l~~~~l~pn 810 (824)
..|||+.++|.|||++ ..|++|+++.|.+|+.. +.+||+++++|...+|+|.
T Consensus 1 l~C~Ic~~~~~~Pv~~~~cGh~fc~~cI~~~l~~-~~~CP~c~~~l~~~dLipi 53 (56)
T d2baya1 1 MLCAISGKVPRRPVLSPKSRTIFEKSLLEQYVKD-TGNDPITNEPLSIEEIVEI 53 (56)
T ss_dssp CCCTTTCSCCSSEEEETTTTEEEEHHHHHHHHHH-HSBCTTTCCBCCGGGCEEC
T ss_pred CCCccCCchHHhcCccCCCCCcccHHHHHHHHhh-ccCCCccCCcCCHHhceeC
Confidence 3699999999999988 58999999999999998 6699999999999999985
|
| >d1tq8a_ c.26.2.4 (A:) Hypothetical protein Rv1636 {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein Rv1636 species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=98.06 E-value=2.9e-06 Score=78.17 Aligned_cols=89 Identities=11% Similarity=0.131 Sum_probs=67.7
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHhhcCeeeEEEEeecCchHHHHHHHHHHcCCCEEEeccCcCccchhhhcccchhhHHhh
Q 003384 40 QAYREIERQDMHNHLDMCLLICRQMGVRAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISV 119 (824)
Q Consensus 40 ~~~~~~e~~~~~~~l~~~~~~C~~~~V~~~~~~ie~~dv~~~i~e~i~~~~i~~LV~Ga~~~~~~~~~~~~~~s~~a~~v 119 (824)
+.+...+++...+.++.+...|.+.++......+..+++.+.|++++..++++.||||++..+...+. +-+..+..|
T Consensus 57 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~G~~~~~i~~~a~~~~~dlIv~g~~~~~~~~~~---l~Gs~~~~l 133 (147)
T d1tq8a_ 57 ESYKVTGTAPIYEILHDAKERAHNAGAKNVEERPIVGAPVDALVNLADEEKADLLVVGNVGLSTIAGR---LLGSVPANV 133 (147)
T ss_dssp -------CCTHHHHHHHHHHHHHTTTCCEEEEEEECSSHHHHHHHHHHHTTCSEEEEECCCCCSHHHH---HTBBHHHHH
T ss_pred hhHHHHHHHHHHHHHHHHHHHHHHcCCCcEEEEEEecChHHHHHHhhhccceeEEEecCCCCCccccc---ccccHHHHH
Confidence 34566677778999999999999999987677777799999999999999999999999944333332 334456789
Q ss_pred hccCCCccEEEEEe
Q 003384 120 RQQAPASCHIWFIC 133 (824)
Q Consensus 120 ~~~a~~~C~v~~i~ 133 (824)
+++++ |.|++|.
T Consensus 134 l~~~~--~pVlvV~ 145 (147)
T d1tq8a_ 134 SRRAK--VDVLIVH 145 (147)
T ss_dssp HHHTT--CEEEEEC
T ss_pred HHhCC--CCEEEEe
Confidence 99986 9999983
|
| >d2z3va1 c.26.2.4 (A:2-136) Hypothetical protein TTHA0895 {Thermus thermophilus [TaxId: 274]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein TTHA0895 species: Thermus thermophilus [TaxId: 274]
Probab=97.99 E-value=4.7e-06 Score=75.72 Aligned_cols=85 Identities=15% Similarity=0.144 Sum_probs=63.4
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHhhcCeeeEEEEeecCchHHHHHHHHHHcCCCEEEeccCcCccchhhhcccchhhHHhh
Q 003384 40 QAYREIERQDMHNHLDMCLLICRQMGVRAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISV 119 (824)
Q Consensus 40 ~~~~~~e~~~~~~~l~~~~~~C~~~~V~~~~~~ie~~dv~~~i~e~i~~~~i~~LV~Ga~~~~~~~~~~~~~~s~~a~~v 119 (824)
....+...++.++.|+.+.. ..++...+.++..+++.++|++++.+++++.||||++..+...+. +-+..|..|
T Consensus 51 ~~~~~~~~~~~~~~l~~~~~---~~~~~~~~~~~~~g~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~---~~Gs~~~~l 124 (135)
T d2z3va1 51 EEALRRRLERAEGVLEEARA---LTGVPKEDALLLEGVPAEAILQAARAEKADLIVMGTRGLGALGSL---FLGSQSQRV 124 (135)
T ss_dssp HHHHHHHHHHHHHHHHHHHH---HHCCCGGGEEEEESCHHHHHHHHHHHTTCSEEEEESSCSSSCBCS---SCBHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHH---hcCCCeEEEEEEcCChHHHHHHHhhhhheeeEEeccCCCCccccc---ccCcHHHHH
Confidence 34444555666677766654 556777777778899999999999999999999999944443333 334467899
Q ss_pred hccCCCccEEEEE
Q 003384 120 RQQAPASCHIWFI 132 (824)
Q Consensus 120 ~~~a~~~C~v~~i 132 (824)
+.+++ |.|.+|
T Consensus 125 l~~~~--~pVlvV 135 (135)
T d2z3va1 125 VAEAP--CPVLLV 135 (135)
T ss_dssp HHHCS--SCEEEE
T ss_pred HHhCC--CCEEeC
Confidence 99987 999886
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.68 E-value=5e-05 Score=76.00 Aligned_cols=127 Identities=17% Similarity=0.148 Sum_probs=80.7
Q ss_pred eeeecCc-eEEEEEEECC-eEEEEEEecCCCCCCchhHHHHHHHHHhcCCC--ceeeEeccc--CCceEEEEEecCCCCh
Q 003384 471 KIGEGGY-GSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHP--NLVTLVGAC--PEVWTLVYEYLPNGSL 544 (824)
Q Consensus 471 ~LG~G~f-G~Vykg~~~~-~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~Hp--nIv~L~g~~--~~~~~LV~Ey~~ggsL 544 (824)
.+..|.. +.||+....+ ..+.+|...... ...+..|...|+.+... .+.++++++ ....++||+|++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3455553 6789887765 457888765443 33678899998887432 245566554 4467899999998766
Q ss_pred hhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhc---------------------------------------------
Q 003384 545 EDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC--------------------------------------------- 579 (824)
Q Consensus 545 ~~~L~~~~~~~~l~~~~~~~ia~qia~aL~~LH~~--------------------------------------------- 579 (824)
.+.. +. ...++.+++..|..||..
T Consensus 94 ~~~~--------~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 94 LSSH--------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTSC--------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred cccc--------cc---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 4321 11 011222333333333321
Q ss_pred ----------CCCceEeccccCCcEEecCCCcceeecccccc
Q 003384 580 ----------KPHSIVHGDLKPANILLDANFVSKLSDFGISR 611 (824)
Q Consensus 580 ----------~~~giiHrDLKp~NILld~~~~vKL~DFGla~ 611 (824)
.+..+||+|+.|.|||++.+..+-|+||+.+.
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 11247999999999999988777899999654
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.55 E-value=7.5e-05 Score=80.56 Aligned_cols=74 Identities=18% Similarity=0.102 Sum_probs=52.4
Q ss_pred ceeeecCceEEEEEEEC--CeEEEEEEecCC-------CCCCchhHHHHHHHHHhcC-C--CceeeEecccCCceEEEEE
Q 003384 470 LKIGEGGYGSIYKGLLR--HMQVAIKMLHPH-------SLQGPSEFQQEIDILSKIR-H--PNLVTLVGACPEVWTLVYE 537 (824)
Q Consensus 470 ~~LG~G~fG~Vykg~~~--~~~VAvK~l~~~-------~~~~~~~f~~Ei~iL~~l~-H--pnIv~L~g~~~~~~~LV~E 537 (824)
+.||.|....||+.... +..|+||.-.+. ......+...|...|..+. + ..+.+++++..+..++|||
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~~~~~lvmE 111 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTEMAVTVME 111 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETTTTEEEEC
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcCCCCEEEEe
Confidence 46899999999998754 467899965431 1123455677998888763 2 4567788888888899999
Q ss_pred ecCCCC
Q 003384 538 YLPNGS 543 (824)
Q Consensus 538 y~~ggs 543 (824)
|+.+..
T Consensus 112 ~L~~~~ 117 (392)
T d2pula1 112 DLSHLK 117 (392)
T ss_dssp CCTTSE
T ss_pred ccCCcc
Confidence 997754
|
| >d1jmva_ c.26.2.4 (A:) Universal stress protein A, UspA {Haemophilus influenzae [TaxId: 727]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Universal stress protein A, UspA species: Haemophilus influenzae [TaxId: 727]
Probab=97.50 E-value=2.8e-05 Score=70.60 Aligned_cols=73 Identities=14% Similarity=0.128 Sum_probs=57.1
Q ss_pred HHHHHHHHHHhhcCeeeEEEEeecCchHHHHHHHHHHcCCCEEEeccCcCccchhhhcccchhhHHhhhccCCCccEEEE
Q 003384 52 NHLDMCLLICRQMGVRAEKLDTESESTEKGILELISHYGIRKLVMGAAADKHYKKKMMDLKSKKAISVRQQAPASCHIWF 131 (824)
Q Consensus 52 ~~l~~~~~~C~~~~V~~~~~~ie~~dv~~~i~e~i~~~~i~~LV~Ga~~~~~~~~~~~~~~s~~a~~v~~~a~~~C~v~~ 131 (824)
+....+...+.+.+....+.+++.++++++|++++..++++.||||++.+... .+. ..|..++.+++ |.|++
T Consensus 64 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~I~~~a~~~~~dliV~G~~~~~~~-----~lg-s~~~~li~~~~--~pVli 135 (140)
T d1jmva_ 64 ETQKALLDLAESVDYPISEKLSGSGDLGQVLSDAIEQYDVDLLVTGHHQDFWS-----KLM-SSTRQVMNTIK--IDMLV 135 (140)
T ss_dssp HHHHHHHHHHHHSSSCCCCEEEEEECHHHHHHHHHHHTTCCEEEEEECCCCHH-----HHH-HHHHHHHTTCC--SEEEE
T ss_pred HHHHHHHHHHHhcCCceEEEEEEecCHHHHHHHhhhhchhhEEEeccCCCCCC-----Ccc-cHHHHHHhccC--CCEEE
Confidence 44445555677778888888898999999999999999999999998733222 122 35779999987 99999
Q ss_pred E
Q 003384 132 I 132 (824)
Q Consensus 132 i 132 (824)
|
T Consensus 136 V 136 (140)
T d1jmva_ 136 V 136 (140)
T ss_dssp E
T ss_pred E
Confidence 8
|
| >d1jm7b_ g.44.1.1 (B:) bard1 RING domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: bard1 RING domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.34 E-value=0.00011 Score=63.21 Aligned_cols=62 Identities=16% Similarity=0.260 Sum_probs=55.8
Q ss_pred CCcccchhhhccCCccc-cCCccchhhhhhhhhcCCCCCCCCCCCCCCCCCCCchHHHHHHHHHHH
Q 003384 757 YFTCPIFQEVMQDPHVA-ADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWL 821 (824)
Q Consensus 757 ~f~cPi~~evm~dPvi~-~~g~tye~~~i~~wl~~~~~t~p~t~~~l~~~~l~pn~~lr~~i~~~~ 821 (824)
.+.|||+.++|.+|+.. .=|++|-...|.+|+.. +||+.+.++...+|.||.+|+.+|+.+.
T Consensus 22 ~l~C~IC~~~~~~pv~~~~CgH~fC~~Ci~~~~~~---~CP~Cr~~~~~~~l~~n~~l~~lv~~~~ 84 (97)
T d1jm7b_ 22 LLRCSRCTNILREPVCLGGCEHIFCSNCVSDCIGT---GCPVCYTPAWIQDLKINRQLDSMIQLCS 84 (97)
T ss_dssp TTSCSSSCSCCSSCBCCCSSSCCBCTTTGGGGTTT---BCSSSCCBCSCSSCCCCHHHHHHHHHHH
T ss_pred cCCCccCCchhhcCceeCCCCCchhHHHHHHHHhc---cccccCCcCchhhCcccHHHHHHHHHHH
Confidence 47899999999999975 67999999999999854 6999999999999999999999998764
|
| >d1q77a_ c.26.2.4 (A:) Hypothetical protein Aq_178 {Aquifex aeolicus [TaxId: 63363]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein Aq 178 species: Aquifex aeolicus [TaxId: 63363]
Probab=97.05 E-value=0.00017 Score=64.92 Aligned_cols=58 Identities=7% Similarity=-0.014 Sum_probs=49.7
Q ss_pred HHHHHHHHHHHHHHHHHHHHhhcCeeeEEEEeecCchHHHHHHHHHHcCCCEEEeccCc
Q 003384 42 YREIERQDMHNHLDMCLLICRQMGVRAEKLDTESESTEKGILELISHYGIRKLVMGAAA 100 (824)
Q Consensus 42 ~~~~e~~~~~~~l~~~~~~C~~~~V~~~~~~ie~~dv~~~i~e~i~~~~i~~LV~Ga~~ 100 (824)
+++..++++++.|+.+..-+...++.++..+.+ +++++.|++++.+++++.+|||++.
T Consensus 62 ~~e~~~~~~~~~l~~~~~~~~~~~~~~~~~v~~-G~~~~~I~~~a~~~~~DLIV~Gs~g 119 (138)
T d1q77a_ 62 IKEESKKRIERRLREVWEKLTGSTEIPGVEYRI-GPLSEEVKKFVEGKGYELVVWACYP 119 (138)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHSCCCCCCEEEEC-SCHHHHHHHHHTTSCCSEEEECSCC
T ss_pred hhhhhhhhccccchhhcccccccceeEEEeeec-chhHHHHHHhhhhccCCEEEEecCC
Confidence 444556677888888888888899999888776 8999999999999999999999993
|
| >d1jm7a_ g.44.1.1 (A:) brca1 RING domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: brca1 RING domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.04 E-value=0.00012 Score=63.58 Aligned_cols=66 Identities=15% Similarity=0.336 Sum_probs=58.8
Q ss_pred CCcccchhhhccCCccccCCccchhhhhhhhhcCC--CCCCCCCCCCCCCCCCCchHHHHHHHHHHHH
Q 003384 757 YFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSG--HETSPMTNLPLAHKNLVPNLALRSAIQEWLQ 822 (824)
Q Consensus 757 ~f~cPi~~evm~dPvi~~~g~tye~~~i~~wl~~~--~~t~p~t~~~l~~~~l~pn~~lr~~i~~~~~ 822 (824)
.+.|||+.+++.+|+++.=|++|-+..|.+|+... ..+||+.+.++....|.||..|++.|+.+..
T Consensus 21 ~l~CpIC~~~~~~pv~~~CgH~fC~~Ci~~~~~~~~~~~~CP~Cr~~~~~~~l~~n~~l~~~ve~l~~ 88 (103)
T d1jm7a_ 21 ILECPICLELIKEPVSTKCDHIFCKFCMLKLLNQKKGPSQCPLCKNDITKRSLQESTRFSQLVEELLK 88 (103)
T ss_dssp HTSCSSSCCCCSSCCBCTTSCCCCSHHHHHHHHSSSSSCCCTTTSCCCCTTTCBCCCSSSHHHHHHHH
T ss_pred CcCCCccCchhCCeEEcCCCCchhhHHHHHHHHHCCCCCcCcCCCCcCChhhCCcCHHHHHHHHHHHH
Confidence 36799999999999999999999999999999653 3579999999999999999999998888753
|
| >d1rmda2 g.44.1.1 (A:1-86) V(D)J recombination activating protein 1 (RAG1), dimerization domain {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: V(D)J recombination activating protein 1 (RAG1), dimerization domain species: Mouse (Mus musculus) [TaxId: 10090]
Probab=96.98 E-value=0.0002 Score=59.95 Aligned_cols=62 Identities=15% Similarity=0.234 Sum_probs=55.1
Q ss_pred CCcccchhhhccCCccccCCccchhhhhhhhhcCCCCCCCCCCCCCCCCCCC-chHHHHHHHH
Q 003384 757 YFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLV-PNLALRSAIQ 818 (824)
Q Consensus 757 ~f~cPi~~evm~dPvi~~~g~tye~~~i~~wl~~~~~t~p~t~~~l~~~~l~-pn~~lr~~i~ 818 (824)
.+.|||..+++.||+++.=|++|=+..|.+|++.++.+||+.+.++...+|. |..++.+.+.
T Consensus 23 ~l~C~IC~~~~~~pv~~~CgH~FC~~Ci~~~~~~~~~~CP~Cr~p~~~~~l~~P~~~~l~~l~ 85 (86)
T d1rmda2 23 SISCQICEHILADPVETSCKHLFCRICILRCLKVMGSYCPSCRYPCFPTDLESPVKSFLNILN 85 (86)
T ss_dssp HTBCTTTCSBCSSEEECTTSCEEEHHHHHHHHHHTCSBCTTTCCBCCGGGCBCCCHHHHHHHH
T ss_pred CcCCccCCcchhcceecCCCChhhHHHHHHHHhhCCCcCcccCCCCChhhccCHHHHHHHHhc
Confidence 3689999999999999999999999999999988788999999999877766 7888887653
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.96 E-value=0.0025 Score=65.53 Aligned_cols=155 Identities=14% Similarity=0.108 Sum_probs=83.1
Q ss_pred ChhhHhhhcCCCCccce-----eeecCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCce--eeEecc
Q 003384 455 SFSEIEGATHNFDPSLK-----IGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNL--VTLVGA 527 (824)
Q Consensus 455 ~~~ei~~~~~~f~~~~~-----LG~G~fG~Vykg~~~~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnI--v~L~g~ 527 (824)
+.+++.....+|.++.. |..|---+.|+....+..+++|++... .+...+..|+.++..|...++ ...+-.
T Consensus 4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~~~--~~~~~l~~~~~~l~~L~~~g~pvp~pi~~ 81 (316)
T d2ppqa1 4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPR 81 (316)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCB
T ss_pred CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCcEEEEEcCCC--CCHHHHHHHHHHHHhhhhcccccccccee
Confidence 34555555566765443 334555778998888788999998653 234567788888888743222 111111
Q ss_pred --------cCCceEEEEEecCCCChhhh--------------hhc--c--C--CCCCCCHH------------------H
Q 003384 528 --------CPEVWTLVYEYLPNGSLEDR--------------LSC--K--D--NSPPLSWQ------------------T 561 (824)
Q Consensus 528 --------~~~~~~LV~Ey~~ggsL~~~--------------L~~--~--~--~~~~l~~~------------------~ 561 (824)
.......++.++.|...... ++. . . ........ .
T Consensus 82 ~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (316)
T d2ppqa1 82 KDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKG 161 (316)
T ss_dssp TTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTT
T ss_pred cCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchh
Confidence 13345667777766433210 000 0 0 00000000 0
Q ss_pred HHHHHHHHHHHHHHHhh-cCCCceEeccccCCcEEecCCCcceeecccccc
Q 003384 562 RIRIATELCSVLIFLHS-CKPHSIVHGDLKPANILLDANFVSKLSDFGISR 611 (824)
Q Consensus 562 ~~~ia~qia~aL~~LH~-~~~~giiHrDLKp~NILld~~~~vKL~DFGla~ 611 (824)
....+..+...+.-.+. .-+.|+||+|+.++|||++.+...-|.||+.|.
T Consensus 162 ~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 162 LREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 11111112222222221 235789999999999999988877899999765
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.40 E-value=0.0043 Score=66.15 Aligned_cols=71 Identities=20% Similarity=0.266 Sum_probs=48.4
Q ss_pred ceeeecCceEEEEEEECC---------eEEEEEEecCCCCCCchhHHHHHHHHHhcCCCce-eeEecccCCceEEEEEec
Q 003384 470 LKIGEGGYGSIYKGLLRH---------MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNL-VTLVGACPEVWTLVYEYL 539 (824)
Q Consensus 470 ~~LG~G~fG~Vykg~~~~---------~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnI-v~L~g~~~~~~~LV~Ey~ 539 (824)
..|+.|---.+|+..... ..|.+++... ....-...+|..+++.+.-.++ .+++++|.+ .+||||+
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~--g~I~efi 123 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFSG--GRLEEYI 123 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT--EEEECCC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC--ceEEEEe
Confidence 457778888999987542 4577777642 2223346689999998853343 477888765 5799999
Q ss_pred CCCCh
Q 003384 540 PNGSL 544 (824)
Q Consensus 540 ~ggsL 544 (824)
+|.+|
T Consensus 124 ~g~~l 128 (395)
T d1nw1a_ 124 PSRPL 128 (395)
T ss_dssp CEEEC
T ss_pred ccccC
Confidence 87554
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=95.98 E-value=0.011 Score=61.07 Aligned_cols=131 Identities=12% Similarity=0.177 Sum_probs=75.1
Q ss_pred eEEEEEEEC-CeEEEEEEecCCCCCCchhHHHHHHHHHhcCCCce--eeEecc-------cCCceEEEEEecCCCChhh-
Q 003384 478 GSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNL--VTLVGA-------CPEVWTLVYEYLPNGSLED- 546 (824)
Q Consensus 478 G~Vykg~~~-~~~VAvK~l~~~~~~~~~~f~~Ei~iL~~l~HpnI--v~L~g~-------~~~~~~LV~Ey~~ggsL~~- 546 (824)
-.||+.... |..|++|+.++.. .+.+++..|...+..|...+| +..+.. .....+.+++|++|..+..
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 479998775 6789999987643 345678899999988742222 111111 1345678999998744321
Q ss_pred ----------h---hhc----c--CCCCCCCHHH-------------------HHHHHHHHHHHHHHHhh----cCCCce
Q 003384 547 ----------R---LSC----K--DNSPPLSWQT-------------------RIRIATELCSVLIFLHS----CKPHSI 584 (824)
Q Consensus 547 ----------~---L~~----~--~~~~~l~~~~-------------------~~~ia~qia~aL~~LH~----~~~~gi 584 (824)
. ++. . .....+++.. +..+...+...+..+.. ..+.++
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 0 000 0 0111222211 11112222233333322 235689
Q ss_pred EeccccCCcEEecCCCcceeecccccc
Q 003384 585 VHGDLKPANILLDANFVSKLSDFGISR 611 (824)
Q Consensus 585 iHrDLKp~NILld~~~~vKL~DFGla~ 611 (824)
||+|+.|.|||++.+ ..++||+-|.
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred ecCCCCcccEEEeCC--ceEEechhcc
Confidence 999999999999754 3589999765
|
| >d1fbva4 g.44.1.1 (A:356-434) CBL {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: CBL species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.50 E-value=0.005 Score=50.29 Aligned_cols=50 Identities=18% Similarity=0.345 Sum_probs=45.6
Q ss_pred CCcccchhhhccCCccccCCccchhhhhhhhhcCCCCCCCCCCCCCCCCC
Q 003384 757 YFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKN 806 (824)
Q Consensus 757 ~f~cPi~~evm~dPvi~~~g~tye~~~i~~wl~~~~~t~p~t~~~l~~~~ 806 (824)
...|||..+.+.+|+++.=|++|-+..|..||..++.+||+.+..+...+
T Consensus 23 ~~~C~IC~~~~~~~~~~~CgH~fC~~Ci~~wl~~~~~~CP~Cr~~i~~~~ 72 (79)
T d1fbva4 23 FQLCKICAENDKDVKIEPCGHLMCTSCLTSWQESEGQGCPFCRCEIKGTE 72 (79)
T ss_dssp TTBCTTTSSSBCCEECSSSCCEECHHHHHHHHHTTCCSCTTTCCCCCCCC
T ss_pred CCCCccCCCcCCCeEEeCCCCeeeHHHHHHHHHHCcCcCCCCCcCccCCc
Confidence 34699999999999999999999999999999988889999999998654
|
| >d1bora_ g.44.1.1 (A:) Acute promyelocytic leukaemia proto-oncoprotein PML {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: Acute promyelocytic leukaemia proto-oncoprotein PML species: Human (Homo sapiens) [TaxId: 9606]
Probab=81.21 E-value=0.53 Score=35.03 Aligned_cols=50 Identities=16% Similarity=0.208 Sum_probs=42.6
Q ss_pred CCcccchhhhccCCccccCCccchhhhhhhhhcCCCCCCCCCCCCCCCCCCCch
Q 003384 757 YFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPN 810 (824)
Q Consensus 757 ~f~cPi~~evm~dPvi~~~g~tye~~~i~~wl~~~~~t~p~t~~~l~~~~l~pn 810 (824)
.+.|||..+.+.||++.+=|++|=..-|..| ..+||+.+.+++....+|.
T Consensus 6 ~l~C~IC~~~~~~p~~lpCgH~fC~~Ci~~~----~~~CP~Cr~~~~~~~~~~a 55 (56)
T d1bora_ 6 FLRCQQCQAEAKCPKLLPCLHTLCSGCLEAS----GMQCPICQAPWPLGADTPA 55 (56)
T ss_dssp CSSCSSSCSSCBCCSCSTTSCCSBTTTCSSS----SSSCSSCCSSSSCCSSCCC
T ss_pred CCCCcccCcccCCCEEecCCCHHhHHHHHcC----CCcCcCCCCcccCCCCCCC
Confidence 4689999999999999999999998888766 5689999999987666553
|